data_2mii_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mii _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.713 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.7 m-30 . . . . . 0 N--CA 1.426 -1.672 0 CA-C-O 120.455 0.169 . . . . 0.76000000000000001 111.182 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 7.6 t70 -84.55 67.82 10.09 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 123.363 1.554 . . . . 0.34999999999999998 108.487 172.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.738 ' CZ3' HG13 ' A' ' 194' ' ' VAL . 93.8 m95 -57.96 -42.5 85.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 112.219 -2.264 . . . . 0.10000000000000001 112.455 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.584 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 9.5 t-20 -53.22 -26.14 16.61 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.13 -1.395 . . . . 1.1100000000000001 111.52 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.29 -15.61 79.81 Favored Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.279 -0.873 . . . . 0.23000000000000001 111.267 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.62 -53.19 3.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.104 -1.048 . . . . 1.01 110.991 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.751 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.2 mtt -65.43 -59.38 4.07 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 114.08 -1.418 . . . . 0.089999999999999997 112.035 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.584 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.9 mm-40 -39.28 -54.98 3.34 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 114.679 1.362 . . . . 0.63 114.679 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.749 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.8 Cg_endo -63.61 -28.47 69.63 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.988 1.792 . . . . 0.17000000000000001 110.768 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.62 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 8.2 mtm -83.17 -44.47 15.02 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.088 -0.96 . . . . 0.69999999999999996 112.09 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 68' ' ' MET . 58.6 t -56.86 -39.14 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-N 114.312 -1.313 . . . . 1.04 108.715 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -60.13 -32.96 71.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.966 -1.924 . . . . 1.1200000000000001 110.974 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.749 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 5.0 mtpm? -83.79 -35.76 24.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.843 0.457 . . . . 1.8799999999999999 111.159 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.87 ' O ' HG13 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.85 -26.54 68.66 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.461 -0.791 . . . . 0.5 111.295 -172.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' N ' ' HG2' ' A' ' 75' ' ' MET . 5.5 mt -93.46 -3.48 52.96 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.071 0.938 . . . . 1.29 110.841 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.27 15.41 42.99 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 109.147 -1.581 . . . . 0.17999999999999999 109.147 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.619 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.89 160.95 19.28 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.526 -0.837 . . . . 1.0 110.282 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.21 104.97 16.26 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.288 -0.869 . . . . 1.72 110.093 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.612 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.03 -23.83 3.16 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.842 -0.903 . . . . 0.13 110.842 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 75' ' ' MET . 11.9 p -103.07 150.67 6.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.635 0.731 . . . . 1.01 111.75 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.7 m -136.57 141.31 43.33 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.919 -1.037 . . . . 1.1000000000000001 111.102 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB1' ' HE3' ' A' ' 118' ' ' LYS . . . -55.12 132.95 48.57 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.779 -1.1 . . . . 1.1200000000000001 110.741 167.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.47 9.55 50.16 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 121.174 -0.536 . . . . 0.28000000000000003 112.8 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.66 149.64 21.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.327 -0.549 . . . . 1.55 110.647 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.659 HG12 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -80.84 116.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.168 0.985 . . . . 1.03 108.925 166.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.722 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -105.16 109.51 21.53 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.044 -0.98 . . . . 1.03 108.903 -172.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.675 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.78 94.42 1.39 Allowed 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 114.428 -1.26 . . . . 1.01 108.32 177.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.7 m -72.58 119.18 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 106.978 -1.49 . . . . 1.6200000000000001 106.978 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.839 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 12.3 t0 -77.33 162.35 27.35 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.703 -1.221 . . . . 0.64000000000000001 107.703 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.547 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.1 m -62.17 143.21 57.06 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.59 -1.633 . . . . 1.05 106.59 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.589 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 27.3 t -71.73 139.76 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.118 0 N-CA-C 107.534 -1.284 . . . . 1.02 107.534 168.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.64 ' H ' ' HA ' ' A' ' 164' ' ' SER . 8.0 t-20 -84.9 163.28 19.09 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.497 -0.774 . . . . 0.20000000000000001 110.07 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.768 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.14 85.22 2.38 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.96 -1.126 . . . . 0.12 107.96 175.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.509 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.9 mtp180 -107.02 -4.17 19.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.037 -1.438 . . . . 0.84999999999999998 108.764 -171.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 19.1 p -51.05 -170.94 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.83 -1.986 . . . . 0.91000000000000003 115.499 -175.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.472 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 38.3 t30 -70.96 -6.35 38.05 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.718 -2.037 . . . . 0.62 110.53 173.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.534 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -157.48 -144.05 3.83 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.396 -0.907 . . . . 0.14000000000000001 113.297 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.627 ' N ' HG22 ' A' ' 169' ' ' VAL . 94.8 p -121.42 130.31 53.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.612 0.597 . . . . 1.76 112.612 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.768 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.2 pp -136.48 159.49 41.64 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-O 121.855 0.836 . . . . 1.01 110.579 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.678 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -80.74 82.17 6.81 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 113.856 -1.52 . . . . 0.20999999999999999 107.975 175.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -70.84 -15.64 62.66 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.355 -1.293 . . . . 1.0 109.81 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.501 ' HB3' ' CG ' ' A' ' 139' ' ' GLN . . . -78.66 -31.53 46.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.793 0.806 . . . . 1.02 108.849 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.678 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 21.5 tt0 -62.83 -38.61 91.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 114.053 -1.43 . . . . 1.73 109.109 169.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.564 ' O ' ' HE2' ' A' ' 68' ' ' MET . . . -69.54 -44.62 70.57 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 112.867 -1.97 . . . . 1.04 109.005 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.594 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 60.6 m -64.89 -31.82 73.23 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.126 -1.397 . . . . 1.04 110.533 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.15 -51.24 59.74 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.972 -1.121 . . . . 1.47 107.972 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.583 HG22 ' HB2' ' A' ' 64' ' ' TRP . 31.7 m -56.69 -33.15 66.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.532 -0.758 . . . . 1.03 111.436 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.751 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.3 mt -50.55 -68.69 0.15 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 109.61 -0.515 . . . . 1.3 109.61 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.545 ' O ' HD13 ' A' ' 121' ' ' LEU . 19.0 mtp180 -42.81 -36.92 1.63 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.883 -1.053 . . . . 1.8 110.973 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -71.9 -47.47 52.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.245 -1.343 . . . . 0.41999999999999998 111.854 -175.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 69' ' ' GLN . . . -72.21 -33.31 67.51 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.328 1.061 . . . . 1.01 108.403 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.668 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.86 -32.9 74.58 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.514 -1.676 . . . . 1.01 109.918 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.499 ' CB ' HD12 ' A' ' 121' ' ' LEU . . . -76.28 -40.82 50.72 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.812 -1.086 . . . . 1.03 111.364 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.05 -26.87 66.96 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.99 -1.005 . . . . 1.55 110.682 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -88.08 -17.94 29.98 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.147 -0.621 . . . . 2.0499999999999998 110.429 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.21 -12.83 2.99 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 116.048 1.179 . . . . 0.54000000000000004 116.048 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.472 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 57.8 mtpt -77.39 -14.3 59.74 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 117.802 0.801 . . . . 1.6000000000000001 111.463 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.722 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 23.2 m-85 -109.29 172.76 6.66 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 122.648 1.213 . . . . 0.27000000000000002 113.669 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.546 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 14.7 m -117.27 117.42 29.5 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 112.305 -2.225 . . . . 1.0800000000000001 108.031 169.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.597 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -88.52 139.02 30.9 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.437 -0.801 . . . . 1.1499999999999999 110.517 -171.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.498 HG11 HD22 ' A' ' 88' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.301 -1.52 0 N-CA-C 108.871 -0.788 . . . . 1.0900000000000001 108.871 172.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.484 HD12 HD21 ' A' ' 88' ' ' LEU . 26.5 tp . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 112.8 0.667 . . . . 2.04 112.8 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.682 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 2.6 t -49.39 -44.56 45.19 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 123.308 1.528 . . . . 1.1499999999999999 109.408 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.706 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 19.0 mmt -58.44 -61.61 2.46 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 111.064 -2.789 . . . . 2.27 110.694 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.701 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -42.81 -46.15 5.13 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 124.484 1.115 . . . . 1.0700000000000001 112.197 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.511 ' NZ ' ' H ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -54.95 -51.36 66.39 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 108.624 -0.88 . . . . 2.1000000000000001 108.624 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 128' ' ' SER . 40.9 mt-30 -65.68 -40.78 92.72 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.23 -0.895 . . . . 0.42999999999999999 111.162 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.706 ' HG3' ' O ' ' A' ' 129' ' ' MET . 54.5 mt-30 -57.81 -34.73 69.96 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 114.354 -1.294 . . . . 0.38 109.525 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.501 HD21 ' N ' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.08 -28.93 17.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 113.754 -1.567 . . . . 1.05 109.284 -176.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.62 -49.79 0.52 Allowed Glycine 0 CA--C 1.496 -1.137 0 CA-C-O 122.667 1.148 . . . . 0.33000000000000002 113.323 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 141' ' ' SER . 87.9 mt -64.92 -169.73 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 112.332 -1.934 . . . . 1.0700000000000001 115.669 -171.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.0 m -116.3 155.05 48.82 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 110.858 -2.883 . . . . 1.24 107.517 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.682 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 46.1 Cg_endo -67.26 1.35 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.661 2.241 . . . . 0.39000000000000001 110.866 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.547 ' H ' ' C ' ' A' ' 137' ' ' SER . 31.4 mt-30 -118.27 -24.31 6.97 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.946 -1.479 . . . . 1.79 111.525 -173.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.675 ' O ' ' HB2' ' A' ' 141' ' ' SER . 7.1 t70 -72.92 -23.61 60.72 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 114.838 -1.073 . . . . 0.65000000000000002 108.793 -168.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.675 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 31.5 m 75.78 166.33 0.27 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.532 -2.122 . . . . 0.73999999999999999 110.56 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.839 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 4.2 mt -64.99 -40.4 94.91 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.581 1.182 . . . . 1.48 108.777 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.71 -12.16 0.16 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 112.607 -2.088 . . . . 0.34999999999999998 114.612 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.438 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -151.79 125.45 8.97 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 118.832 -0.604 . . . . 1.02 109.57 -173.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.609 ' O ' ' HB1' ' A' ' 148' ' ' ALA . 16.8 mmt85 -42.27 -48.13 4.9 Favored 'General case' 0 C--O 1.211 -0.944 0 O-C-N 123.413 0.446 . . . . 2.21 111.915 -176.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 41.9 t -72.23 -26.33 61.98 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.595 0.712 . . . . 0.93000000000000005 111.236 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -74.37 -28.97 61.36 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.6 1.19 . . . . 1.8899999999999999 108.505 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.695 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -76.47 -47.92 21.32 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-N 112.471 -2.149 . . . . 0.98999999999999999 110.427 177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.528 HG13 ' HE2' ' A' ' 179' ' ' MET . 43.2 mt -66.51 -40.17 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 CA-C-N 112.856 -1.975 . . . . 1.03 110.073 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.46 -55.26 25.69 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 114.652 -1.158 . . . . 0.14999999999999999 110.965 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.717 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 92.1 mt -66.42 -48.55 80.4 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.07 0 N-CA-C 112.683 0.623 . . . . 1.05 112.683 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.648 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.36 -41.2 72.22 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 123.227 0.329 . . . . 1.03 111.079 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.418 ' HD2' HG21 ' A' ' 149' ' ' ILE . 24.8 mtp180 -81.22 -23.02 38.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.597 0.713 . . . . 1.29 110.459 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.448 HD21 ' CB ' ' A' ' 130' ' ' ALA . 21.4 t30 -82.84 -10.26 58.93 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.438 -1.319 . . . . 0.5 107.438 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.717 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.1 t -108.51 -29.47 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 113.18 -1.827 . . . . 1.05 111.0 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.83 35.86 4.16 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.077 -1.058 . . . . 0.17000000000000001 112.486 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.675 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.15 159.65 17.65 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.866 0.691 . . . . 1.02 112.866 -171.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.659 ' N ' HG12 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -99.85 -28.17 13.25 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 123.414 0.686 . . . . 0.39000000000000001 109.681 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.571 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.3 m-85 -135.44 -173.17 3.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.161 -0.927 . . . . 0.81000000000000005 110.945 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.711 ' O ' HD21 ' A' ' 178' ' ' LEU . 1.2 t -137.18 140.35 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.004 -0.998 . . . . 1.03 108.786 166.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.606 HD22 ' SD ' ' A' ' 176' ' ' MET . 37.0 tp -109.31 100.95 10.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 119.417 -0.913 . . . . 1.02 109.3 165.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.505 ' HH ' ' HB2' ' A' ' 142' ' ' LEU . 2.4 m-85 -79.83 113.59 18.1 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 114.434 -1.257 . . . . 0.87 109.027 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.864 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 6.4 t -126.64 161.25 28.51 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 122.143 0.973 . . . . 1.45 110.881 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.791 ' O ' HD11 ' A' ' 174' ' ' LEU . 2.2 p -164.51 174.55 10.79 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.949 -1.478 . . . . 0.12 110.859 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.29 134.67 38.23 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 114.2 -1.363 . . . . 0.94999999999999996 108.632 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.7 m -144.73 -175.96 4.87 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.185 -0.672 . . . . 1.1499999999999999 109.185 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.82 -84.53 0.8 Allowed Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 119.536 -1.316 . . . . 0.14999999999999999 111.325 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.7 t30 -144.23 127.22 16.45 Favored 'General case' 0 C--O 1.197 -1.676 0 N-CA-C 107.596 -1.261 . . . . 0.58999999999999997 107.596 175.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.627 HG22 ' N ' ' A' ' 99' ' ' SER . 3.5 p -63.34 -39.53 85.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.364 -171.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.461 ' N ' HG13 ' A' ' 169' ' ' VAL . 4.4 m120 -60.72 -31.47 70.77 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 122.086 0.946 . . . . 1.9199999999999999 109.753 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.55 88.89 3.29 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 113.169 -1.832 . . . . 1.0600000000000001 108.307 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.653 ' HD2' HG22 ' A' ' 194' ' ' VAL . 52.4 Cg_endo -89.99 163.73 4.88 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 124.335 3.357 . . . . 0.089999999999999997 114.883 -169.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.55 HG21 ' HB3' ' A' ' 191' ' ' LYS . 63.8 m -82.93 117.97 23.14 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 106.965 -1.494 . . . . 1.0600000000000001 106.965 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.834 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 38.5 tp -83.9 97.49 9.26 Favored 'General case' 0 N--CA 1.413 -2.325 0 C-N-CA 119.294 -0.963 . . . . 1.02 108.402 177.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.556 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 6.3 mt-30 -87.87 109.47 19.8 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.098 -0.955 . . . . 0.34000000000000002 109.153 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.864 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -112.85 164.75 13.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.684 -1.144 . . . . 1.0900000000000001 111.481 -173.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 56.7 tt0 -170.57 118.16 0.52 Allowed 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 116.077 -0.51 . . . . 0.68000000000000005 110.076 -166.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER -100.37 100.56 11.36 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.741 -0.837 . . . . 1.03 108.741 -172.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.598 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 18.2 ttp -90.52 121.93 32.9 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.445 -0.798 . . . . 0.89000000000000001 109.614 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.82 127.09 30.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.122 -1.436 . . . . 1.04 107.122 166.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.525 HG21 ' HB1' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.52 -34.4 13.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 119.33 0.968 . . . . 1.02 110.758 178.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -63.08 -14.69 51.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.265 -0.88 . . . . 0.40000000000000002 111.577 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.1 p -130.58 -36.97 1.4 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.677 0.751 . . . . 1.03 110.277 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.403 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.17 19.0 44.02 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.556 -1.202 . . . . 0.17999999999999999 112.25 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.7 156.79 16.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.529 -0.336 . . . . 0.72999999999999998 110.494 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.474 HD11 ' HG2' ' A' ' 177' ' ' GLN . 33.7 mm -91.58 115.85 31.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.637 0.732 . . . . 1.03 109.52 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.687 ' CD1' HD13 ' A' ' 178' ' ' LEU . 1.5 pp -103.28 -29.61 2.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.019 -0.991 . . . . 1.01 110.681 -173.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.639 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.0 t90 -137.2 153.26 50.45 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.371 -0.831 . . . . 0.070000000000000007 109.508 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 79.9 p -153.47 165.47 35.75 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.822 0.675 . . . . 0.64000000000000001 112.822 163.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -161.79 -175.91 33.32 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-O 121.718 0.621 . . . . 0.12 111.762 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.834 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 1.5 mttp -154.74 152.02 29.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.095 -1.817 . . . . 1.76 106.095 164.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.526 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -157.33 127.31 1.9 Allowed Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 119.612 -1.28 . . . . 0.13 111.833 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.42 115.2 10.32 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.391 0.615 . . . . 1.01 110.487 -175.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.738 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -90.98 158.68 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-O 122.47 1.128 . . . . 1.01 109.647 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.684 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.23 171.58 7.52 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 112.848 -1.978 . . . . 0.92000000000000004 109.256 -172.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 6.8 tt0 -101.64 128.96 47.7 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.074 -0.713 . . . . 0.91000000000000003 109.074 168.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.492 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 19.3 mm-40 . . . . . 0 C--N 1.309 -1.177 0 CA-C-N 115.505 -0.771 . . . . 1.24 110.732 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.723 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.1 m-30 . . . . . 0 N--CA 1.426 -1.656 0 CA-C-O 120.252 0.072 . . . . 0.76000000000000001 110.973 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.521 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 15.8 t70 -85.05 67.75 10.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 123.538 1.637 . . . . 0.34999999999999998 108.444 173.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.745 ' CZ3' HG13 ' A' ' 194' ' ' VAL . 93.1 m95 -55.64 -43.33 76.12 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 112.006 -2.361 . . . . 0.10000000000000001 112.752 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.498 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 11.1 t-20 -50.8 -30.87 15.33 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.762 -1.563 . . . . 1.1100000000000001 111.643 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.28 -17.15 79.62 Favored Glycine 0 CA--C 1.503 -0.693 0 CA-C-N 115.506 -0.77 . . . . 0.23000000000000001 111.423 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.96 -51.51 3.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.114 -1.043 . . . . 1.01 110.806 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.776 ' SD ' HD23 ' A' ' 109' ' ' LEU . 37.6 mtt -65.69 -56.29 12.9 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 114.182 -1.372 . . . . 0.089999999999999997 112.473 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.498 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 7.0 mm-40 -39.74 -54.29 4.15 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 114.804 1.409 . . . . 0.63 114.804 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.817 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 29.6 Cg_endo -63.55 -32.0 70.39 Favored 'Trans proline' 0 CA--C 1.508 -0.804 0 C-N-CA 121.919 1.746 . . . . 0.17000000000000001 110.799 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.65 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 7.7 mtm -79.64 -47.59 15.16 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 114.979 -1.01 . . . . 0.69999999999999996 111.515 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 68' ' ' MET . 53.3 t -54.52 -41.19 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 CA-C-N 114.089 -1.414 . . . . 1.04 108.955 176.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.9 t -60.0 -36.68 77.72 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.256 -1.793 . . . . 1.1200000000000001 110.791 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.817 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 20.0 mtpp -77.6 -35.36 52.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.303 0.573 . . . . 1.8799999999999999 110.498 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.862 ' O ' HG13 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.14 -29.81 71.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.765 -1.107 . . . . 0.5 111.44 -173.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -83.68 -6.82 59.54 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.193 0.52 . . . . 1.29 111.235 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -108.76 13.97 34.98 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.614 -1.395 . . . . 0.17999999999999999 109.614 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -81.58 161.36 23.56 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.663 -0.768 . . . . 1.0 110.285 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.99 106.26 17.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.345 -0.843 . . . . 1.72 109.579 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.632 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.76 -24.68 3.46 Favored Glycine 0 N--CA 1.418 -2.542 0 C-N-CA 119.797 -1.192 . . . . 0.13 110.666 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.862 HG13 ' O ' ' A' ' 75' ' ' MET . 10.9 p -97.47 155.9 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.702 0.763 . . . . 1.01 111.541 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.754 ' HG1' ' HH ' ' A' ' 159' ' ' TYR . 6.5 m -132.85 136.62 46.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 114.51 -1.223 . . . . 1.1000000000000001 110.901 -176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.428 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.6 130.21 45.74 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.864 -1.062 . . . . 1.1200000000000001 110.332 167.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.86 12.15 60.86 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.719 -0.753 . . . . 0.28000000000000003 113.233 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.462 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 61.9 m -97.56 147.73 23.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.124 0.462 . . . . 1.55 110.156 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.661 HG12 ' N ' ' A' ' 158' ' ' HIS . 2.2 p -77.0 124.8 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 122.09 0.948 . . . . 1.03 109.194 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.661 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.7 tm? -110.84 110.17 20.66 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.984 -1.007 . . . . 1.03 108.58 -172.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.646 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -71.34 92.85 1.08 Allowed 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.334 -1.358 . . . . 1.01 107.334 176.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -73.68 113.41 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.416 -1.327 . . . . 1.6200000000000001 107.416 177.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.811 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 23.1 t0 -77.28 172.04 13.9 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 114.778 -1.101 . . . . 0.64000000000000001 108.815 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.547 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.7 OUTLIER -61.8 157.78 17.31 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 122.767 1.27 . . . . 1.05 108.371 168.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 39.3 t -86.87 139.63 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.202 0 CA-C-N 113.692 -1.595 . . . . 1.02 107.047 165.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.657 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.6 t-20 -83.8 163.35 20.2 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.854 0.835 . . . . 0.20000000000000001 110.555 173.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.763 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.74 84.86 2.32 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.348 -1.296 . . . . 0.12 107.977 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -108.48 -2.6 18.85 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.847 -1.524 . . . . 0.84999999999999998 108.727 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 22.6 p -51.4 -170.13 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 112.678 -2.055 . . . . 0.91000000000000003 115.156 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 29.8 t30 -70.49 -10.66 59.77 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.083 -1.871 . . . . 0.62 110.531 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.509 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.37 -144.74 3.98 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.176 -1.011 . . . . 0.14000000000000001 113.573 -176.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.631 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 16.5 m -121.27 130.75 53.83 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.8 0.44 . . . . 1.76 110.935 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.763 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -136.8 157.48 46.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.962 0.887 . . . . 1.01 110.735 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.709 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -77.17 80.74 3.68 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.628 -1.623 . . . . 0.20999999999999999 107.56 175.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 92' ' ' VAL . . . -70.17 -14.71 62.76 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.863 -1.062 . . . . 1.0 109.767 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.86 -29.6 35.74 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.413 -0.958 . . . . 1.02 108.413 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.709 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 29.3 tt0 -61.62 -40.64 95.56 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.207 -1.36 . . . . 1.73 109.125 168.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 102' ' ' ALA . . . -68.15 -45.29 73.94 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 112.826 -1.988 . . . . 1.04 108.845 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 47.2 m -63.78 -33.28 75.32 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 113.821 -1.536 . . . . 1.04 110.618 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -44.83 84.89 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.637 -1.245 . . . . 1.47 107.637 172.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.59 HG23 ' HB2' ' A' ' 64' ' ' TRP . 34.6 m -63.24 -30.11 71.32 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.234 -0.894 . . . . 1.03 110.867 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.776 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.57 -68.34 0.18 Allowed 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.589 -0.732 . . . . 1.3 109.658 171.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.561 HH21 ' HB3' ' A' ' 127' ' ' LEU . 5.8 mpt_? -40.31 -36.63 0.56 Allowed 'General case' 0 C--O 1.213 -0.865 0 O-C-N 124.226 0.954 . . . . 1.8 110.888 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.555 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -74.6 -46.35 39.12 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.665 -1.152 . . . . 0.41999999999999998 112.0 -174.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.55 63.36 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.471 -0.937 . . . . 1.01 108.471 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.666 ' HB3' ' CD2' ' A' ' 121' ' ' LEU . 4.5 mm? -61.64 -35.21 77.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.649 -1.614 . . . . 1.01 109.442 172.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 110' ' ' ARG . . . -73.46 -41.69 62.86 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 114.574 -1.194 . . . . 1.03 110.937 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.85 -8.5 54.7 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.15 -0.932 . . . . 1.55 110.281 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -77.81 -49.08 15.02 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.523 -0.917 . . . . 2.0499999999999998 108.523 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.87 -7.15 82.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.416 -0.811 . . . . 0.54000000000000004 113.735 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.453 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 58.7 mtpt -86.64 -33.13 20.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.289 0.545 . . . . 1.6000000000000001 111.322 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.717 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 6.5 m-85 -88.81 171.47 9.91 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.303 1.049 . . . . 0.27000000000000002 112.988 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 7.9 m -116.46 119.32 35.24 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.144 -1.844 . . . . 1.0800000000000001 108.222 168.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.666 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -89.01 140.82 29.05 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 119.466 -0.893 . . . . 1.1499999999999999 111.368 -171.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.523 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.299 -1.596 0 N-CA-C 108.42 -0.956 . . . . 1.0900000000000001 108.42 170.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.611 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 1.3 tm? . . . . . 0 C--O 1.222 -0.356 0 N-CA-C 112.998 0.74 . . . . 2.04 112.998 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.659 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -48.75 -37.83 20.0 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 123.649 1.69 . . . . 1.1499999999999999 108.946 -179.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.643 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 6.6 mmt -65.78 -61.52 2.02 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 110.731 -2.94 . . . . 2.27 110.987 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.685 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.65 -43.61 3.92 Favored 'General case' 0 CA--C 1.503 -0.829 0 O-C-N 124.181 0.925 . . . . 1.0700000000000001 112.384 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -55.24 -52.69 62.58 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 107.806 -1.183 . . . . 2.1000000000000001 107.806 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.9 mt-30 -65.89 -41.05 92.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.064 -0.971 . . . . 0.42999999999999999 111.194 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 129' ' ' MET . 54.2 mt-30 -56.46 -34.72 67.14 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-N 114.365 -1.289 . . . . 0.38 109.617 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -92.57 -31.33 15.23 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.002 -1.454 . . . . 1.05 109.45 -176.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.79 -51.95 0.39 Allowed Glycine 0 CA--C 1.499 -0.917 0 C-N-CA 120.149 -1.024 . . . . 0.33000000000000002 113.759 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 141' ' ' SER . 39.1 mt -67.25 -167.0 0.05 Allowed 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.499 -1.851 . . . . 1.0700000000000001 115.778 -170.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -116.95 154.57 49.68 Favored Pre-proline 0 N--CA 1.421 -1.909 0 CA-C-N 110.994 -2.821 . . . . 1.24 108.002 176.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.659 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 21.9 Cg_endo -62.56 -0.11 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.397 2.731 . . . . 0.39000000000000001 112.207 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.2 tt0 -119.51 -28.73 5.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.172 -0.922 . . . . 1.79 111.096 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.704 ' O ' ' HB2' ' A' ' 141' ' ' SER . 11.7 t70 -66.1 -25.4 66.99 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 113.779 -1.555 . . . . 0.65000000000000002 109.407 -172.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.704 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 5.7 m 75.66 171.75 0.26 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.146 -1.843 . . . . 0.73999999999999999 109.697 -173.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.811 ' HG ' ' CG ' ' A' ' 90' ' ' ASP . 4.0 mt -65.6 -39.24 91.35 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.398 1.094 . . . . 1.48 108.36 -176.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.55 -12.4 0.33 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 112.871 -1.968 . . . . 0.34999999999999998 114.646 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -153.13 124.88 7.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 118.719 -0.658 . . . . 1.02 109.638 -174.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.663 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -40.89 -48.5 3.13 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 112.177 0.436 . . . . 2.21 112.177 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.3 t -72.47 -26.16 61.7 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.443 0.64 . . . . 0.93000000000000005 111.186 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -73.97 -28.42 61.47 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.712 1.244 . . . . 1.8899999999999999 108.528 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.639 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -76.61 -47.25 22.93 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 112.27 -2.241 . . . . 0.98999999999999999 110.253 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.556 HG13 ' HE2' ' A' ' 179' ' ' MET . 36.5 mt -66.75 -41.12 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 112.816 -1.993 . . . . 1.03 110.188 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.98 -54.94 26.3 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 114.613 -1.176 . . . . 0.14999999999999999 111.054 171.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.71 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 75.2 mt -65.63 -47.89 84.57 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 N-CA-C 112.748 0.647 . . . . 1.05 112.748 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.646 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.27 -40.45 74.23 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.939 0.4 . . . . 1.03 110.939 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 30.9 mtp180 -82.13 -20.85 37.16 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.677 0.751 . . . . 1.29 110.451 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -83.28 -10.77 58.33 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.238 -1.393 . . . . 0.5 107.238 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.71 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.0 OUTLIER -109.59 -29.02 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 113.444 -1.707 . . . . 1.05 111.42 -173.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.26 35.92 4.3 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.213 -0.994 . . . . 0.17000000000000001 112.489 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.644 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.45 160.56 17.0 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.294 0.85 . . . . 1.02 113.294 -170.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.661 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.4 m80 -100.86 -26.21 13.84 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.121 -0.945 . . . . 0.39000000000000001 109.613 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.754 ' HH ' ' HG1' ' A' ' 82' ' ' THR . 12.7 m-85 -135.49 -174.29 3.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.19 -0.914 . . . . 0.81000000000000005 111.583 -174.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.657 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -136.57 140.02 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.094 -0.957 . . . . 1.03 109.465 166.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.612 HD22 ' SD ' ' A' ' 176' ' ' MET . 42.9 tp -109.61 100.73 9.73 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 119.61 -0.836 . . . . 1.02 109.144 165.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 142' ' ' LEU . 2.3 m-85 -80.53 112.48 17.92 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 114.464 -1.244 . . . . 0.87 109.31 177.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.841 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.5 t -124.08 163.02 22.31 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 122.144 0.973 . . . . 1.45 111.335 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.805 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.1 p -164.65 173.71 11.62 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 114.037 -1.438 . . . . 0.12 111.007 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -137.35 134.34 35.89 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 114.304 -1.316 . . . . 0.94999999999999996 108.429 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -144.11 -176.19 4.91 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.305 -0.628 . . . . 1.1499999999999999 109.305 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.14 -83.91 0.92 Allowed Glycine 0 CA--C 1.491 -1.414 0 C-N-CA 119.567 -1.302 . . . . 0.14999999999999999 111.213 173.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.467 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.1 t30 -144.59 129.3 18.21 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-N 113.985 -1.108 . . . . 0.58999999999999997 108.149 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.509 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.6 p -63.65 -40.21 88.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.343 -0.844 . . . . 1.0 112.168 -172.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.428 ' N ' HG12 ' A' ' 169' ' ' VAL . 5.5 m120 -60.31 -32.1 70.9 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.982 0.896 . . . . 1.9199999999999999 109.993 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.78 88.75 3.24 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 113.442 -1.708 . . . . 1.0600000000000001 108.363 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.654 ' HD2' HG21 ' A' ' 194' ' ' VAL . 45.9 Cg_endo -90.03 164.51 4.82 Favored 'Trans proline' 0 CA--C 1.49 -1.681 0 C-N-CA 124.028 3.152 . . . . 0.089999999999999997 114.626 -169.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 25.0 m -85.37 118.1 24.7 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 113.877 -1.51 . . . . 1.0600000000000001 107.586 167.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.838 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 42.7 tp -83.89 98.35 9.72 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 108.551 -0.907 . . . . 1.02 108.551 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.585 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 35.7 mt-30 -89.39 109.66 20.55 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-O 122.13 0.967 . . . . 0.34000000000000002 109.259 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.841 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.7 OUTLIER -113.37 163.66 14.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.736 -1.12 . . . . 1.0900000000000001 111.271 -173.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 37.6 tt0 -170.78 119.26 0.52 Allowed 'General case' 0 C--O 1.203 -1.349 0 CA-C-N 115.873 -0.603 . . . . 0.68000000000000005 110.131 -166.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -100.94 102.01 12.94 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.716 -0.846 . . . . 1.03 108.716 -172.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.663 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.9 ttp -91.71 122.95 34.73 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.656 -0.702 . . . . 0.89000000000000001 109.368 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.4 127.2 30.94 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.358 -1.349 . . . . 1.04 107.358 167.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.73 -34.22 11.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 119.151 -1.019 . . . . 1.02 110.758 178.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -62.94 -14.89 52.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.432 -0.804 . . . . 0.40000000000000002 111.379 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.2 p -130.64 -36.57 1.41 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.727 0.775 . . . . 1.03 110.365 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.05 32.51 17.28 Favored Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 114.319 -1.309 . . . . 0.17999999999999999 112.213 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.2 155.21 22.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.59 -0.305 . . . . 0.72999999999999998 110.4 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.437 HD13 ' HG2' ' A' ' 177' ' ' GLN . 29.3 mm -88.23 119.13 35.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.967 -0.753 . . . . 1.03 108.967 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.632 ' HB ' ' HA3' ' A' ' 80' ' ' GLY . 1.3 pp -107.12 -33.04 2.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.277 -0.874 . . . . 1.01 110.514 -174.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.649 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.8 t90 -133.53 151.52 51.75 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.438 -0.801 . . . . 0.070000000000000007 109.24 172.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 22.1 p -153.99 160.84 42.22 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.664 0.616 . . . . 0.64000000000000001 112.664 165.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -157.81 -177.06 30.55 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.536 -1.025 . . . . 0.12 110.536 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.838 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 12.9 mtmt -157.43 150.37 23.36 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 105.508 -2.034 . . . . 1.76 105.508 167.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.493 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -157.96 126.9 1.79 Allowed Glycine 0 C--N 1.279 -2.598 0 C-N-CA 119.51 -1.329 . . . . 0.13 112.243 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.28 114.07 10.0 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.337 0.589 . . . . 1.01 110.946 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.745 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -91.12 158.49 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 122.583 1.182 . . . . 1.01 110.125 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.685 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -98.8 172.16 7.63 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 112.69 -2.05 . . . . 0.92000000000000004 109.727 -173.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.9 tt0 -103.36 127.71 50.64 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.127 -0.694 . . . . 0.91000000000000003 109.127 167.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.531 ' HG2' ' C ' ' A' ' 62' ' ' TYR . 19.8 mm-40 . . . . . 0 C--N 1.306 -1.304 0 CA-C-N 115.513 -0.767 . . . . 1.24 110.585 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.769 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.7 m-30 . . . . . 0 N--CA 1.416 -2.128 0 N-CA-C 109.627 -0.509 . . . . 0.76000000000000001 109.627 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.513 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 2.1 t70 -79.66 68.02 5.59 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 123.785 1.755 . . . . 0.34999999999999998 108.167 170.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.715 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.9 m95 -60.08 -44.53 94.71 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 111.594 -2.548 . . . . 0.10000000000000001 112.199 174.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.55 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 7.1 t-20 -50.03 -30.48 10.83 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.844 -1.525 . . . . 1.1100000000000001 111.607 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.65 -18.3 80.01 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-N 115.503 -0.772 . . . . 0.23000000000000001 111.266 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.58 -52.22 3.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.965 -1.118 . . . . 1.01 110.895 -175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.759 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.1 mtt -64.32 -58.49 6.36 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 114.136 -1.393 . . . . 0.089999999999999997 112.198 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.55 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 6.0 mm-40 -40.11 -53.59 4.97 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 114.912 1.449 . . . . 0.63 114.912 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.795 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.1 Cg_endo -64.19 -30.79 64.75 Favored 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 122.164 1.91 . . . . 0.17000000000000001 110.654 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.647 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 9.3 mtm -80.97 -46.87 14.45 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 115.006 -0.997 . . . . 0.69999999999999996 111.7 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 68' ' ' MET . 57.5 t -54.6 -40.73 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 CA-C-N 114.091 -1.413 . . . . 1.04 108.841 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 t -58.97 -36.81 75.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.028 -1.896 . . . . 1.1200000000000001 110.909 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.795 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.9 mtpt -80.39 -34.1 36.6 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.091 0.472 . . . . 1.8799999999999999 110.775 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.847 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.09 -29.56 70.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.305 -0.862 . . . . 0.5 111.685 -171.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.566 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.3 mt -91.79 -6.18 52.21 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.939 0.876 . . . . 1.29 111.23 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.55 15.35 49.64 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 109.156 -1.578 . . . . 0.17999999999999999 109.156 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.608 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.48 165.48 18.06 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.42 -0.89 . . . . 1.0 110.316 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -88.32 107.6 18.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.066 -0.97 . . . . 1.72 109.787 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.618 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 130.98 -22.88 4.46 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.991 -0.843 . . . . 0.13 110.991 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.847 HG11 ' O ' ' A' ' 75' ' ' MET . 10.1 p -99.27 152.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.861 0.838 . . . . 1.01 111.496 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -134.33 138.73 45.15 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.159 -1.382 . . . . 1.1000000000000001 109.835 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB3' ' HD2' ' A' ' 118' ' ' LYS . . . -65.3 137.82 57.8 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.871 -0.604 . . . . 1.1200000000000001 110.239 169.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.2 -1.41 54.39 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.799 -0.715 . . . . 0.28000000000000003 112.69 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.14 153.07 22.91 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.993 0.425 . . . . 1.55 110.972 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.626 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.0 p -81.86 116.43 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.122 0.963 . . . . 1.03 109.221 166.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.701 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -103.93 109.67 21.52 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.964 -1.017 . . . . 1.03 108.971 -173.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.65 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.76 94.29 1.37 Allowed 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 114.545 -1.207 . . . . 1.01 107.932 176.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.426 HG13 ' HG3' ' A' ' 110' ' ' ARG . 1.7 m -73.12 117.71 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 N-CA-C 107.476 -1.305 . . . . 1.6200000000000001 107.476 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.824 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 8.7 t0 -77.52 156.41 31.0 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.659 -1.155 . . . . 0.64000000000000001 108.134 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.574 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.54 135.89 57.81 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.473 -1.306 . . . . 1.05 107.473 171.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.555 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 23.2 t -63.4 140.08 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.836 0 CA-C-N 114.783 -1.099 . . . . 1.02 108.065 169.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.643 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.6 t-20 -85.56 163.22 18.5 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.248 -0.887 . . . . 0.20000000000000001 109.913 174.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.766 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.98 85.34 2.4 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.604 -1.18 . . . . 0.12 108.487 175.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -108.14 -1.98 19.86 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.969 -1.469 . . . . 0.84999999999999998 108.995 -172.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 24.5 p -52.0 -170.96 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 112.715 -2.039 . . . . 0.91000000000000003 114.975 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.495 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 32.7 t30 -72.48 -4.05 28.05 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 112.992 -1.913 . . . . 0.62 110.558 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.527 ' HA3' HG13 ' A' ' 169' ' ' VAL . . . -157.42 -144.46 3.94 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.052 -1.071 . . . . 0.14000000000000001 113.368 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.631 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 53.8 p -122.09 129.46 52.4 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 112.278 0.473 . . . . 1.76 112.278 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.766 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.12 157.37 47.1 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 121.97 0.89 . . . . 1.01 110.678 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.634 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.6 t-20 -80.48 79.99 7.0 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.053 -1.43 . . . . 0.20999999999999999 107.846 175.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.586 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -67.0 -14.2 62.66 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.479 -1.237 . . . . 1.0 109.988 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.17 44.04 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.721 -0.844 . . . . 1.02 108.721 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.634 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.4 tp10 -66.63 -31.96 72.97 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 122.951 1.358 . . . . 1.73 109.064 172.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 102' ' ' ALA . . . -73.75 -44.18 56.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.036 -1.893 . . . . 1.04 109.657 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.616 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 60.0 m -63.98 -31.6 72.84 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.986 -1.461 . . . . 1.04 110.626 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 1.5 pt-20 -66.97 -43.34 83.32 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.701 -1.222 . . . . 1.47 107.701 172.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 64' ' ' TRP . 56.8 m -63.06 -30.46 71.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.234 -0.894 . . . . 1.03 110.672 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.759 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.74 -69.56 0.11 Allowed 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.205 -0.665 . . . . 1.3 109.205 171.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 10.1 mtp180 -40.22 -38.22 0.74 Allowed 'General case' 0 C--N 1.313 -0.982 0 O-C-N 124.405 1.065 . . . . 1.8 111.29 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.52 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.71 -47.51 59.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.517 -1.22 . . . . 0.41999999999999998 111.897 -176.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.15 -33.72 65.64 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.223 1.011 . . . . 1.01 108.647 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -62.92 -34.65 77.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.416 -1.72 . . . . 1.01 109.976 172.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 110' ' ' ARG . . . -74.78 -42.58 57.88 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 114.752 -1.113 . . . . 1.03 111.097 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -63.2 -29.26 70.64 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.769 -1.105 . . . . 1.55 110.43 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -82.26 -23.89 35.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.535 -0.757 . . . . 2.0499999999999998 110.159 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.71 4.28 57.51 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.975 -1.011 . . . . 0.54000000000000004 114.927 159.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.496 ' CE ' ' HB3' ' A' ' 76' ' ' LEU . 13.5 mtmm -91.18 -34.27 15.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.279 0.539 . . . . 1.6000000000000001 111.156 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.701 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 14.6 m-85 -89.44 175.56 7.26 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 122.355 1.074 . . . . 0.27000000000000002 112.458 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.536 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.5 m -118.92 121.13 39.25 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 113.012 -1.904 . . . . 1.0800000000000001 108.289 169.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.661 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -91.72 141.76 28.34 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 119.389 -0.924 . . . . 1.1499999999999999 111.159 -170.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.486 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.3 m . . . . . 0 C--N 1.299 -1.592 0 N-CA-C 107.892 -1.151 . . . . 1.0900000000000001 107.892 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 31.2 tp . . . . . 0 C--O 1.219 -0.524 0 N-CA-C 113.271 0.841 . . . . 2.04 113.271 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.623 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 3.0 t -50.31 -46.26 55.33 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 123.365 1.555 . . . . 1.1499999999999999 109.105 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.716 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 17.2 mmt -54.31 -63.36 1.17 Allowed 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 110.745 -2.934 . . . . 2.27 110.706 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.71 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -42.91 -46.47 5.37 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.346 1.029 . . . . 1.0700000000000001 112.15 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 137' ' ' SER . 0.8 OUTLIER -54.45 -52.35 62.1 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 108.744 -0.836 . . . . 2.1000000000000001 108.744 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.7 mt-30 -65.18 -39.88 93.49 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.402 -0.817 . . . . 0.42999999999999999 111.034 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.716 ' HG3' ' O ' ' A' ' 129' ' ' MET . 52.1 mt-30 -58.72 -34.74 71.69 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.516 -1.22 . . . . 0.38 109.568 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -90.21 -28.94 18.53 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 113.942 -1.481 . . . . 1.05 109.733 -176.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.96 -45.06 0.69 Allowed Glycine 0 CA--C 1.494 -1.263 0 CA-C-O 122.534 1.075 . . . . 0.33000000000000002 113.094 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.58 HD11 ' O ' ' A' ' 141' ' ' SER . 91.3 mt -66.93 -171.44 0.14 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 112.416 -1.892 . . . . 1.0700000000000001 115.43 -170.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 63.1 m -115.55 152.9 47.64 Favored Pre-proline 0 N--CA 1.425 -1.684 0 CA-C-N 110.641 -2.982 . . . . 1.24 107.661 175.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.623 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 36.9 Cg_endo -66.26 0.44 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.49 2.127 . . . . 0.39000000000000001 112.138 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.443 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.6 tt0 -118.65 -27.06 5.97 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.997 0.903 . . . . 1.79 110.418 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.66 ' O ' ' HB2' ' A' ' 141' ' ' SER . 15.0 t70 -57.87 -25.89 61.36 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-N 113.207 -1.815 . . . . 0.65000000000000002 109.35 -173.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.66 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 21.3 m 73.52 168.95 0.31 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 112.668 -2.06 . . . . 0.73999999999999999 109.186 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.824 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 4.5 mt -66.03 -40.12 90.75 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.24 1.019 . . . . 1.48 108.386 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 64.81 -9.18 0.45 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 112.95 -1.932 . . . . 0.34999999999999998 114.332 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.427 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.7 OUTLIER -155.56 124.64 6.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.065 -0.717 . . . . 1.02 109.065 -175.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.679 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.4 mmt180 -42.27 -45.31 4.14 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 118.072 0.396 . . . . 2.21 112.001 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.8 t -74.13 -25.77 59.95 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.601 0.715 . . . . 0.93000000000000005 111.255 -174.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -73.64 -29.6 62.44 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.625 1.203 . . . . 1.8899999999999999 108.421 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.635 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -76.27 -47.79 22.54 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 112.403 -2.18 . . . . 0.98999999999999999 110.223 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.534 HG13 ' HE2' ' A' ' 179' ' ' MET . 42.1 mt -65.39 -41.52 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 112.794 -2.003 . . . . 1.03 109.865 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.59 -54.56 27.03 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 114.864 -1.062 . . . . 0.14999999999999999 111.082 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.723 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 89.9 mt -66.85 -48.14 80.65 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 N-CA-C 112.5 0.556 . . . . 1.05 112.5 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.636 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.22 -41.01 71.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.939 0.399 . . . . 1.03 111.099 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.462 ' HD2' HG22 ' A' ' 149' ' ' ILE . 58.3 mtp180 -81.84 -21.51 37.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.614 0.721 . . . . 1.29 110.618 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.444 HD21 ' CB ' ' A' ' 130' ' ' ALA . 22.8 t30 -84.76 -11.44 55.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.314 -1.365 . . . . 0.5 107.314 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.723 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.07 -29.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-N 113.184 -1.826 . . . . 1.05 110.932 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.7 34.17 5.05 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.267 -0.968 . . . . 0.17000000000000001 112.424 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.65 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.6 161.45 14.85 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.873 0.694 . . . . 1.02 112.873 -170.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.626 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.0 m80 -100.87 -27.72 13.17 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.24 -0.891 . . . . 0.39000000000000001 109.796 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.613 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 7.5 m-85 -136.15 -174.26 3.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.187 -0.915 . . . . 0.81000000000000005 111.318 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.707 ' O ' HD21 ' A' ' 178' ' ' LEU . 1.1 t -137.06 139.2 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.939 -1.028 . . . . 1.03 108.883 166.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.574 HD23 ' SD ' ' A' ' 176' ' ' MET . 33.9 tp -107.98 100.57 9.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.318 -0.953 . . . . 1.02 109.351 165.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.2 m-85 -79.8 112.94 17.56 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 114.606 -1.179 . . . . 0.87 108.897 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.851 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 10.2 t -124.45 160.58 27.9 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 121.922 0.867 . . . . 1.45 110.564 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.781 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.4 p -162.73 172.96 14.47 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 114.334 -1.303 . . . . 0.12 111.076 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.32 135.33 40.7 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 114.005 -1.452 . . . . 0.94999999999999996 108.633 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.8 m -144.09 -176.12 4.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.254 -0.647 . . . . 1.1499999999999999 109.254 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.11 -84.08 0.92 Allowed Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 119.768 -1.206 . . . . 0.14999999999999999 111.416 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.4 t30 -143.74 131.47 21.35 Favored 'General case' 0 C--O 1.196 -1.762 0 N-CA-C 107.821 -1.178 . . . . 0.58999999999999997 107.821 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 99' ' ' SER . 2.6 p -65.57 -41.34 90.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.14 -0.936 . . . . 1.0 112.426 -171.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.457 ' N ' HG11 ' A' ' 169' ' ' VAL . 11.3 m-20 -60.99 -31.15 70.77 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.732 0.777 . . . . 1.9199999999999999 109.478 -177.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.23 89.07 3.37 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 113.874 -1.512 . . . . 1.0600000000000001 108.16 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.64 ' HD2' HG22 ' A' ' 194' ' ' VAL . 42.6 Cg_endo -91.36 166.61 3.53 Favored 'Trans proline' 0 CA--C 1.494 -1.48 0 C-N-CA 124.551 3.501 . . . . 0.089999999999999997 114.846 -170.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 25.3 m -85.76 119.6 26.26 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 113.745 -1.57 . . . . 1.0600000000000001 107.551 166.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.849 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 50.4 tp -84.56 97.74 9.75 Favored 'General case' 0 N--CA 1.412 -2.326 0 C-N-CA 119.492 -0.883 . . . . 1.02 108.709 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.564 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 34.1 mt-30 -89.26 109.33 20.23 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 122.052 0.929 . . . . 0.34000000000000002 109.053 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.851 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.7 OUTLIER -112.87 164.17 13.74 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.004 -0.998 . . . . 1.0900000000000001 111.638 -173.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 57.0 tt0 -170.78 118.22 0.5 Allowed 'General case' 0 C--O 1.201 -1.476 0 CA-C-N 115.972 -0.558 . . . . 0.68000000000000005 110.236 -166.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.707 HD21 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -100.19 101.99 13.16 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.609 -0.885 . . . . 1.03 108.609 -172.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.679 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.5 ttp -90.43 121.62 32.57 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.462 -0.79 . . . . 0.89000000000000001 109.504 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.91 127.97 34.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.149 -1.426 . . . . 1.04 107.149 166.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -83.69 -34.18 10.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 118.912 -1.115 . . . . 1.02 110.965 178.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -61.6 -15.57 40.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.372 -0.831 . . . . 0.40000000000000002 111.424 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.8 p -130.2 -36.61 1.5 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.745 0.783 . . . . 1.03 110.294 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.59 27.91 25.79 Favored Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 114.316 -1.311 . . . . 0.17999999999999999 112.003 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.81 155.91 19.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.648 0.261 . . . . 0.72999999999999998 110.52 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.468 HD13 ' HG2' ' A' ' 177' ' ' GLN . 30.3 mm -89.85 115.64 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.502 0.668 . . . . 1.03 109.494 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.68 ' CD1' HD12 ' A' ' 178' ' ' LEU . 1.6 pp -103.1 -32.3 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.903 -1.044 . . . . 1.01 110.54 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.681 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.8 t90 -134.81 152.02 51.41 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.245 -0.889 . . . . 0.070000000000000007 109.403 173.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 30.0 p -153.57 162.78 40.94 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.881 0.697 . . . . 0.64000000000000001 112.881 164.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.51 -173.64 27.18 Favored Glycine 0 N--CA 1.427 -1.94 0 N-CA-C 110.721 -0.951 . . . . 0.12 110.721 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.849 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 15.1 mtmm -158.93 154.08 25.33 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.273 -2.121 . . . . 1.76 105.273 166.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.461 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -161.22 127.79 1.81 Allowed Glycine 0 C--N 1.281 -2.484 0 C-N-CA 119.245 -1.455 . . . . 0.13 112.568 175.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 173' ' ' THR . . . -72.55 112.6 8.75 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.72 0.771 . . . . 1.01 111.329 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.664 HG11 ' CZ3' ' A' ' 64' ' ' TRP . 1.9 m -91.77 158.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-O 122.758 1.266 . . . . 1.01 110.816 -176.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.769 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.2 173.43 6.46 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 112.352 -2.203 . . . . 0.92000000000000004 108.652 -173.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.1 tt0 -102.34 133.78 46.71 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.14 -0.624 . . . . 0.91000000000000003 109.758 171.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.506 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 12.3 mm-40 . . . . . 0 C--N 1.315 -0.933 0 CA-C-O 118.804 -0.617 . . . . 1.24 110.906 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.714 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 3.5 m-30 . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 110.633 -0.136 . . . . 0.76000000000000001 110.633 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.548 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 4.4 t0 -82.74 68.15 9.1 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 123.756 1.741 . . . . 0.34999999999999998 108.404 171.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.739 ' CZ3' HG13 ' A' ' 194' ' ' VAL . 93.4 m95 -59.75 -42.94 94.35 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 111.511 -2.586 . . . . 0.10000000000000001 112.288 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.481 ' N ' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -52.77 -31.79 40.21 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.609 -1.632 . . . . 1.1100000000000001 111.077 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.64 -15.88 78.69 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 121.781 0.656 . . . . 0.23000000000000001 111.67 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -94.5 -48.55 6.06 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.18 -1.01 . . . . 1.01 110.15 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.765 ' SD ' HD21 ' A' ' 109' ' ' LEU . 39.4 mtt -66.43 -55.64 14.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.134 -1.394 . . . . 0.089999999999999997 111.715 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.412 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 6.1 mm-40 -38.81 -56.01 2.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 115.233 1.568 . . . . 0.63 115.233 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.802 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 40.3 Cg_endo -65.37 -29.37 54.17 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 121.728 1.619 . . . . 0.17000000000000001 110.418 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.915 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 9.6 mtm -83.65 -40.23 19.23 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.312 -0.858 . . . . 0.69999999999999996 111.446 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 68' ' ' MET . 52.4 t -57.46 -39.91 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-N 114.85 -1.068 . . . . 1.04 108.339 171.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -61.17 -32.76 72.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.238 -1.801 . . . . 1.1200000000000001 111.19 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 34.2 mtpt -84.66 -32.2 23.76 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.086 0.47 . . . . 1.8799999999999999 110.891 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.882 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.23 -29.77 69.51 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.332 -0.849 . . . . 0.5 111.413 -172.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.573 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.3 mt -92.07 -4.14 54.81 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 122.26 1.028 . . . . 1.29 110.644 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.23 17.64 40.38 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 108.984 -1.646 . . . . 0.17999999999999999 108.984 170.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.617 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -88.04 161.8 17.16 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.693 -0.754 . . . . 1.0 110.282 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.94 107.92 18.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.384 -0.825 . . . . 1.72 109.432 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.648 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.58 -24.66 3.33 Favored Glycine 0 N--CA 1.415 -2.716 0 C-N-CA 119.739 -1.219 . . . . 0.13 110.466 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.882 HG11 ' O ' ' A' ' 75' ' ' MET . 11.1 p -102.66 152.32 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.675 -0.762 . . . . 1.01 111.068 -175.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.3 m -135.82 139.64 43.62 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.922 -1.036 . . . . 1.1000000000000001 110.697 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.468 ' HB3' ' HE3' ' A' ' 118' ' ' LYS . . . -55.08 136.01 48.52 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.033 -0.985 . . . . 1.1200000000000001 110.414 167.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.04 3.95 55.6 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.903 -0.665 . . . . 0.28000000000000003 112.936 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.94 149.24 22.68 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.168 -0.613 . . . . 1.55 111.002 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.615 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -80.41 120.58 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 CA-C-O 121.933 0.873 . . . . 1.03 108.802 165.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.851 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.7 tm? -108.77 111.58 23.41 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.416 -0.811 . . . . 1.03 109.047 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.643 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -72.19 93.72 1.48 Allowed 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.833 -1.076 . . . . 1.01 108.158 177.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.448 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.2 m -73.5 115.79 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 107.061 -1.459 . . . . 1.6200000000000001 107.061 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.768 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 16.7 t0 -77.57 170.62 16.25 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-N 115.063 -0.971 . . . . 0.64000000000000001 108.905 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.562 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.8 OUTLIER -61.77 152.59 30.92 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.93 -1.137 . . . . 1.05 107.93 168.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 38.6 t -81.95 140.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.151 0 N-CA-C 107.024 -1.473 . . . . 1.02 107.024 167.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.653 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.7 t-20 -84.01 162.5 20.37 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.967 0.889 . . . . 0.20000000000000001 110.307 174.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.755 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -124.81 85.9 2.48 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.229 -1.35 . . . . 0.12 108.087 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.448 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 14.1 mtp180 -108.74 -0.95 19.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.077 -1.42 . . . . 0.84999999999999998 108.758 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 30.2 p -53.21 -172.62 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.026 -1.897 . . . . 0.91000000000000003 115.348 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 34.2 t30 -68.37 -13.54 62.35 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 112.637 -2.074 . . . . 0.62 110.522 173.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.52 ' HA3' HG13 ' A' ' 169' ' ' VAL . . . -148.16 -145.93 4.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.387 -0.911 . . . . 0.14000000000000001 113.004 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.591 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 19.2 m -121.27 129.6 53.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.959 0.409 . . . . 1.76 110.825 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.755 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.6 pp -135.18 157.63 46.43 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.921 0.867 . . . . 1.01 110.627 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.612 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.57 81.46 7.64 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.954 -1.476 . . . . 0.20999999999999999 107.713 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -69.72 -14.77 62.96 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 114.278 -1.328 . . . . 1.0 109.912 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.59 -29.8 46.32 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.734 -0.839 . . . . 1.02 108.734 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.612 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 15.6 tp10 -67.91 -32.39 72.82 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 123.123 1.44 . . . . 1.73 109.15 170.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.5 -44.75 61.82 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.999 -1.91 . . . . 1.04 109.233 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.9 m -63.92 -34.3 77.65 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.936 -1.484 . . . . 1.04 111.104 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 13.1 pt-20 -68.0 -42.83 80.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 118.368 -1.333 . . . . 1.47 107.651 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 64' ' ' TRP . 58.7 m -61.5 -29.09 69.76 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.226 -0.897 . . . . 1.03 111.176 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.765 HD21 ' SD ' ' A' ' 68' ' ' MET . 9.3 mt -53.69 -68.12 0.2 Allowed 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 115.794 -0.639 . . . . 1.3 109.471 170.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.541 ' O ' HD13 ' A' ' 121' ' ' LEU . 14.2 mtp180 -40.26 -38.08 0.73 Allowed 'General case' 0 C--N 1.31 -1.116 0 O-C-N 124.413 1.071 . . . . 1.8 111.395 174.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 108' ' ' THR . 16.1 m-80 -68.36 -47.41 67.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.675 -1.148 . . . . 0.41999999999999998 112.4 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.93 -35.79 59.62 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.364 -0.976 . . . . 1.01 108.364 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -58.96 -35.67 73.55 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.61 -1.632 . . . . 1.01 109.784 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 110' ' ' ARG . . . -69.46 -41.96 75.51 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.297 -1.32 . . . . 1.03 111.294 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -65.21 -27.21 68.52 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.99 -1.005 . . . . 1.55 111.224 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.86 -16.73 35.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.967 -0.56 . . . . 2.0499999999999998 111.237 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.91 -12.32 0.83 Allowed Glycine 0 C--N 1.334 0.427 0 N-CA-C 115.896 1.118 . . . . 0.54000000000000004 115.896 162.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.468 ' HE3' ' HB3' ' A' ' 83' ' ' ALA . 54.4 mtpt -73.28 -33.47 65.25 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 117.579 0.689 . . . . 1.6000000000000001 110.783 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.851 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 23.4 m-85 -90.4 177.43 6.39 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.54 1.162 . . . . 0.27000000000000002 112.677 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 5.4 m -121.92 119.96 33.06 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 112.651 -2.068 . . . . 1.0800000000000001 108.069 168.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.599 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -89.4 140.74 29.21 Favored 'General case' 0 N--CA 1.414 -2.235 0 C-N-CA 119.337 -0.945 . . . . 1.1499999999999999 111.774 -169.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.473 ' CG1' ' HA ' ' A' ' 88' ' ' LEU . 1.5 m . . . . . 0 C--N 1.298 -1.659 0 N-CA-C 107.605 -1.258 . . . . 1.0900000000000001 107.605 167.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.577 HD11 ' N ' ' A' ' 128' ' ' SER . 1.4 tm? . . . . . 0 C--O 1.223 -0.335 0 N-CA-C 112.572 0.582 . . . . 2.04 112.572 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.668 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.2 t -49.31 -39.05 29.79 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 123.573 1.654 . . . . 1.1499999999999999 109.047 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.633 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 24.2 mmm -64.46 -62.07 1.82 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 110.72 -2.945 . . . . 2.27 110.656 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.672 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -44.28 -43.48 7.4 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 124.106 0.878 . . . . 1.0700000000000001 112.326 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.515 ' HE2' ' CD2' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -51.28 -55.5 17.92 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.293 -1.003 . . . . 2.1000000000000001 108.293 176.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.3 mt-30 -65.33 -41.28 94.11 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 123.951 0.782 . . . . 0.42999999999999999 111.42 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.3 mt-30 -56.26 -34.25 66.23 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.391 -1.277 . . . . 0.38 109.616 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -92.87 -31.19 15.06 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.905 -1.498 . . . . 1.05 109.561 -177.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.06 -52.13 0.4 Allowed Glycine 0 CA--C 1.497 -1.091 0 CA-C-O 122.594 1.108 . . . . 0.33000000000000002 113.45 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 141' ' ' SER . 70.7 mt -63.51 -171.75 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 112.352 -1.924 . . . . 1.0700000000000001 115.717 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.565 ' C ' ' H ' ' A' ' 139' ' ' GLN . 6.3 m -116.14 152.29 47.62 Favored Pre-proline 0 N--CA 1.427 -1.621 0 CA-C-N 110.765 -2.925 . . . . 1.24 107.931 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.668 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 30.3 Cg_endo -65.44 2.67 1.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.751 2.301 . . . . 0.39000000000000001 111.146 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.565 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.7 mm100 -115.17 -19.91 10.63 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 114.098 -1.41 . . . . 1.79 110.091 -174.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.721 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.7 t70 -80.63 -27.72 37.17 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 114.336 -1.302 . . . . 0.65000000000000002 109.839 -169.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.721 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 4.0 m 76.02 175.23 0.22 Allowed 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 125.33 1.644 . . . . 0.73999999999999999 109.053 -168.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.768 ' HG ' ' CG ' ' A' ' 90' ' ' ASP . 3.5 mt -69.41 -39.13 78.11 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.368 1.08 . . . . 1.48 108.701 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.18 -12.03 0.29 Allowed Glycine 0 C--N 1.317 -0.488 0 CA-C-N 112.96 -1.927 . . . . 0.34999999999999998 114.809 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -152.54 125.78 8.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 117.548 0.674 . . . . 1.02 109.324 -175.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.701 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.4 mmt180 -41.45 -48.11 3.77 Favored 'General case' 0 C--O 1.213 -0.842 0 O-C-N 123.378 0.424 . . . . 2.21 111.868 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.5 t -72.05 -27.5 62.73 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.58 0.705 . . . . 0.93000000000000005 111.296 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -73.06 -28.25 62.21 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.632 1.206 . . . . 1.8899999999999999 108.587 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.705 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -77.49 -46.0 23.85 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 112.293 -2.23 . . . . 0.98999999999999999 110.304 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.561 HG13 ' HE3' ' A' ' 179' ' ' MET . 35.4 mt -67.33 -42.43 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-N 113.069 -1.878 . . . . 1.03 110.237 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.47 -53.59 31.27 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.955 -1.021 . . . . 0.14999999999999999 111.072 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.72 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 70.2 mt -66.32 -47.53 83.93 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 112.747 0.647 . . . . 1.05 112.747 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.643 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.01 -39.98 72.7 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.017 0.437 . . . . 1.03 110.767 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 149' ' ' ILE . 27.7 mtp-105 -81.56 -23.01 37.45 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.676 0.751 . . . . 1.29 110.635 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.423 HD22 ' CD ' ' A' ' 133' ' ' GLN . 19.1 t30 -82.18 -12.72 57.97 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.332 -1.358 . . . . 0.5 107.332 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.73 -28.53 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 113.245 -1.798 . . . . 1.05 110.838 -174.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.67 35.45 4.89 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.35 -0.929 . . . . 0.17000000000000001 112.282 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.633 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.76 156.38 21.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 113.27 0.841 . . . . 1.02 113.27 -170.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.615 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.9 m80 -95.3 -27.87 15.26 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.194 -0.912 . . . . 0.39000000000000001 109.807 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.564 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 9.2 m-85 -136.38 -179.1 5.47 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.476 -0.784 . . . . 0.81000000000000005 111.049 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.639 ' O ' HD21 ' A' ' 178' ' ' LEU . 1.2 t -131.97 140.75 47.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.438 -0.801 . . . . 1.03 109.232 167.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.535 HD23 ' HE1' ' A' ' 176' ' ' MET . 38.2 tp -110.4 101.06 9.81 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.708 -0.797 . . . . 1.02 108.946 164.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.705 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.23 116.72 19.67 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.21 -1.359 . . . . 0.87 108.269 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.801 ' OG ' HD12 ' A' ' 174' ' ' LEU . 27.6 t -126.68 163.44 23.49 Favored 'General case' 0 C--N 1.279 -2.493 0 C-N-CA 119.495 -0.882 . . . . 1.45 111.015 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.803 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.9 p -164.23 178.27 7.7 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 114.264 -1.334 . . . . 0.12 111.065 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -141.91 141.34 32.99 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 114.155 -1.384 . . . . 0.94999999999999996 108.673 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 t -149.44 -171.35 3.87 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.208 -0.597 . . . . 1.1499999999999999 110.115 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.66 -80.69 1.25 Allowed Glycine 0 C--N 1.288 -2.138 0 CA-C-N 115.179 -0.919 . . . . 0.14999999999999999 111.567 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 59.1 t30 -145.58 127.5 15.46 Favored 'General case' 0 C--O 1.195 -1.767 0 N-CA-C 108.108 -1.071 . . . . 0.58999999999999997 108.108 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.52 HG13 ' HA3' ' A' ' 98' ' ' GLY . 2.4 p -61.76 -43.9 97.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.14 -0.936 . . . . 1.0 113.008 -172.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.416 ' N ' HG11 ' A' ' 169' ' ' VAL . 10.6 m120 -61.48 -29.71 70.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.49 0.662 . . . . 1.9199999999999999 109.635 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.44 88.16 3.73 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 114.588 -1.187 . . . . 1.0600000000000001 108.021 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.658 ' HD2' HG22 ' A' ' 194' ' ' VAL . 51.3 Cg_endo -91.29 163.56 3.69 Favored 'Trans proline' 0 CA--C 1.49 -1.697 0 C-N-CA 124.596 3.531 . . . . 0.089999999999999997 114.731 -170.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 18.8 m -81.77 117.17 21.86 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 113.854 -1.521 . . . . 1.0600000000000001 107.693 166.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.836 ' O ' ' HE3' ' A' ' 71' ' ' MET . 38.8 tp -83.73 98.94 9.95 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-O 121.885 0.85 . . . . 1.02 109.126 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.59 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.0 mt-30 -89.09 107.81 19.25 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.909 -1.041 . . . . 0.34000000000000002 109.048 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.915 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 34.7 mtp -108.25 162.84 13.71 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.848 -1.069 . . . . 1.0900000000000001 110.203 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 36.8 tt0 -169.49 119.99 0.68 Allowed 'General case' 0 C--O 1.204 -1.315 0 CA-C-O 121.377 0.608 . . . . 0.68000000000000005 109.908 -167.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.639 HD21 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -101.44 102.38 13.17 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.934 -0.765 . . . . 1.03 108.934 -172.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.701 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.1 ttp -92.48 122.91 35.38 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.533 -0.758 . . . . 0.89000000000000001 109.402 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.42 HD21 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -58.83 127.46 32.29 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.161 -1.422 . . . . 1.04 107.161 166.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -82.2 -33.63 11.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 119.35 0.977 . . . . 1.02 110.718 178.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.429 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.9 mt-30 -64.25 -14.77 57.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.291 -0.868 . . . . 0.40000000000000002 111.498 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 76.9 p -130.52 -36.96 1.41 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.766 0.794 . . . . 1.03 110.251 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.419 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.36 24.09 29.82 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.481 -1.236 . . . . 0.17999999999999999 112.496 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.92 155.61 18.5 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.684 0.278 . . . . 0.72999999999999998 110.682 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.459 HD13 ' HG2' ' A' ' 177' ' ' GLN . 34.2 mm -87.95 119.25 35.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.433 0.635 . . . . 1.03 109.507 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.648 ' HB ' ' HA3' ' A' ' 80' ' ' GLY . 1.4 pp -108.28 -30.56 2.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.966 -1.016 . . . . 1.01 110.536 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.617 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.1 t90 -135.38 151.83 50.84 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 115.206 -0.906 . . . . 0.070000000000000007 109.351 171.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 57.0 p -154.06 161.85 41.62 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.768 0.655 . . . . 0.64000000000000001 112.768 163.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -156.68 -178.91 31.25 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 110.68 -0.968 . . . . 0.12 110.68 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.7 mtmt -156.75 148.38 22.56 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.326 -1.731 . . . . 1.76 106.326 167.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -159.33 127.29 1.8 Allowed Glycine 0 C--N 1.282 -2.42 0 C-N-CA 119.907 -1.14 . . . . 0.13 112.542 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.83 113.05 9.43 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.543 0.687 . . . . 1.01 111.455 -173.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.739 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -88.38 159.18 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.518 1.151 . . . . 1.01 110.298 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.706 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -98.86 172.84 7.18 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 112.781 -2.009 . . . . 0.92000000000000004 109.132 -172.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -102.85 127.65 49.95 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.873 -0.417 . . . . 0.91000000000000003 109.873 169.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.532 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 17.9 mm-40 . . . . . 0 C--N 1.313 -1.017 0 CA-C-O 118.524 -0.75 . . . . 1.24 110.838 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.775 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.2 m-30 . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 109.565 -0.532 . . . . 0.76000000000000001 109.565 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 5.0 t70 -80.91 67.0 6.65 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 123.707 1.718 . . . . 0.34999999999999998 108.065 172.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.696 ' CZ3' HG12 ' A' ' 194' ' ' VAL . 90.0 m95 -56.94 -44.45 82.53 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 111.591 -2.55 . . . . 0.10000000000000001 112.389 175.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.448 ' N ' HG22 ' A' ' 108' ' ' THR . 10.2 t-20 -51.05 -30.72 16.46 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.832 -1.531 . . . . 1.1100000000000001 111.687 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.81 -15.38 81.36 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-O 121.868 0.704 . . . . 0.23000000000000001 111.469 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.86 -52.06 3.4 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.076 -1.062 . . . . 1.01 110.782 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.775 ' SD ' HD21 ' A' ' 109' ' ' LEU . 39.7 mtt -64.13 -58.06 7.73 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 114.127 -1.397 . . . . 0.089999999999999997 111.952 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.455 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.8 mm-40 -39.52 -54.66 3.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 114.856 1.428 . . . . 0.63 114.856 -176.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.6 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.1 Cg_endo -64.45 -28.78 62.35 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.004 1.802 . . . . 0.17000000000000001 110.667 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.641 ' HE3' ' N ' ' A' ' 192' ' ' GLY . 6.4 mtm -82.4 -46.26 13.77 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 114.874 -1.057 . . . . 0.69999999999999996 111.902 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.679 HG21 ' O ' ' A' ' 68' ' ' MET . 57.7 t -54.34 -40.29 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-N 114.031 -1.44 . . . . 1.04 108.633 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -59.28 -37.72 78.35 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.167 -1.833 . . . . 1.1200000000000001 110.798 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 25.1 mtmt -77.08 -36.06 56.08 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 120.821 0.343 . . . . 1.8799999999999999 111.649 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.804 ' O ' HG13 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.0 -29.33 70.49 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.715 -0.675 . . . . 0.5 111.557 -170.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.604 HD11 ' CG ' ' A' ' 118' ' ' LYS . 5.2 mt -93.14 -6.78 47.14 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.102 0.953 . . . . 1.29 111.012 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.49 17.79 46.02 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.02 -1.632 . . . . 0.17999999999999999 109.02 171.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.581 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -87.02 162.08 17.82 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.626 -0.787 . . . . 1.0 110.355 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.54 108.04 17.76 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.057 -0.974 . . . . 1.72 109.235 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.62 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 131.04 -21.2 4.67 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.699 -1.239 . . . . 0.13 110.955 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 75' ' ' MET . 14.8 p -101.75 152.78 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.77 -0.715 . . . . 1.01 110.887 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 83' ' ' ALA . 26.5 m -135.75 140.28 44.22 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.011 -0.995 . . . . 1.1000000000000001 110.625 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.421 ' O ' HG23 ' A' ' 82' ' ' THR . . . -58.59 140.13 54.82 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.123 -0.944 . . . . 1.1200000000000001 110.484 167.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.3 10.08 54.61 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.88 -0.676 . . . . 0.28000000000000003 112.753 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.9 149.65 21.31 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 120.569 -0.452 . . . . 1.55 110.689 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.648 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.6 p -79.09 114.75 20.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-O 122.218 1.008 . . . . 1.03 109.304 164.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.65 ' HG ' ' CE2' ' A' ' 119' ' ' PHE . 2.6 tm? -102.9 106.99 17.66 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.965 -1.016 . . . . 1.03 109.065 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.649 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.7 OUTLIER -71.88 96.76 1.72 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 114.226 -1.352 . . . . 1.01 108.039 176.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.914 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.1 m -71.66 118.06 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.158 -1.423 . . . . 1.6200000000000001 107.158 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.778 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 1.1 t70 -76.65 146.1 38.37 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.656 -1.239 . . . . 0.64000000000000001 107.656 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.583 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.1 m -50.97 132.38 27.2 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.582 -1.266 . . . . 1.05 107.582 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 22.7 t -60.66 138.35 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.959 0 N-CA-C 107.79 -1.189 . . . . 1.02 107.79 171.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.614 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.6 t-20 -83.51 162.03 21.04 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.202 -0.908 . . . . 0.20000000000000001 109.589 174.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.746 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.99 86.01 2.49 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.54 -1.209 . . . . 0.12 107.861 175.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.45 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 9.7 mtp180 -108.61 -3.71 17.74 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.847 -1.524 . . . . 0.84999999999999998 108.893 -172.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 20.6 p -49.99 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.067 -1.878 . . . . 0.91000000000000003 114.36 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.5 OUTLIER -76.53 -3.8 39.37 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.309 -1.769 . . . . 0.62 110.36 174.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.498 ' HA3' HG13 ' A' ' 169' ' ' VAL . . . -146.54 -153.07 5.79 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.692 -0.685 . . . . 0.14000000000000001 112.634 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.541 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 50.7 m -121.31 130.32 53.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 1.76 111.457 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.746 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.9 pp -134.01 157.44 46.08 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.824 0.821 . . . . 1.01 110.746 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.623 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -80.75 80.06 7.29 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.162 -1.381 . . . . 0.20999999999999999 107.803 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.576 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -67.14 -15.0 63.44 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.481 -1.236 . . . . 1.0 110.167 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.64 -29.65 41.06 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.576 -0.898 . . . . 1.02 108.576 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.623 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 16.1 tp10 -67.67 -33.38 74.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.283 -1.326 . . . . 1.73 109.143 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 102' ' ' ALA . . . -72.74 -43.5 62.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.24 -1.8 . . . . 1.04 109.505 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.639 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.3 m -63.41 -30.52 71.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.838 -1.528 . . . . 1.04 110.564 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 2.0 pt-20 -69.43 -42.97 74.3 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.849 -1.167 . . . . 1.47 107.849 173.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.637 HG22 ' HB2' ' A' ' 64' ' ' TRP . 85.2 m -62.58 -29.96 70.97 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.241 -0.891 . . . . 1.03 110.465 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.775 HD21 ' SD ' ' A' ' 68' ' ' MET . 9.5 mt -51.98 -70.27 0.09 Allowed 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 109.13 -0.693 . . . . 1.3 109.13 170.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.59 ' O ' HD12 ' A' ' 121' ' ' LEU . 19.0 mtp180 -40.21 -38.66 0.8 Allowed 'General case' 0 C--N 1.312 -1.032 0 O-C-N 124.465 1.103 . . . . 1.8 111.413 175.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.507 HD21 ' N ' ' A' ' 111' ' ' ASN . 1.0 OUTLIER -70.27 -46.07 65.09 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.754 -1.112 . . . . 0.41999999999999998 112.244 -176.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.05 -33.06 65.46 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.2 1.0 . . . . 1.01 108.437 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.726 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -64.5 -33.88 76.92 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 113.413 -1.721 . . . . 1.01 110.194 173.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.402 ' CB ' HD11 ' A' ' 121' ' ' LEU . . . -70.49 -37.16 74.18 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.789 -1.096 . . . . 1.03 111.164 -175.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -57.48 -31.87 66.42 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.629 -1.169 . . . . 1.55 110.997 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.443 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -77.03 -36.12 56.39 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.681 -1.145 . . . . 2.0499999999999998 110.211 -177.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.53 -4.56 8.92 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.313 -0.47 . . . . 0.54000000000000004 113.93 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.604 ' CG ' HD11 ' A' ' 76' ' ' LEU . 11.7 ptmt -83.93 -30.27 26.44 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 122.328 -0.513 . . . . 1.6000000000000001 111.462 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.666 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 4.1 m-85 -89.39 168.74 11.98 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.708 0.766 . . . . 0.27000000000000002 111.285 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.565 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.1 m -116.5 121.18 41.06 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 114.063 -1.426 . . . . 1.0800000000000001 108.154 171.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.597 HD21 ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -91.01 139.47 30.74 Favored 'General case' 0 N--CA 1.416 -2.151 0 C-N-CA 119.307 -0.957 . . . . 1.1499999999999999 110.647 -171.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.9 m . . . . . 0 C--N 1.3 -1.576 0 N-CA-C 107.919 -1.141 . . . . 1.0900000000000001 107.919 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 89' ' ' VAL . 6.2 tt . . . . . 0 CA--C 1.516 -0.353 0 N-CA-C 113.349 0.87 . . . . 2.04 113.349 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 15.4 m -57.16 -35.75 69.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 123.245 1.498 . . . . 1.1499999999999999 108.786 -175.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.595 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -59.47 -60.34 4.01 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 111.811 -2.449 . . . . 2.27 112.205 173.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.671 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.95 -44.02 4.42 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 124.308 1.043 . . . . 1.0700000000000001 112.23 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.51 ' HZ2' ' C ' ' A' ' 141' ' ' SER . 3.4 mttt -52.59 -54.7 29.4 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.172 -0.677 . . . . 2.1000000000000001 109.172 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -62.81 -41.75 99.43 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.398 -0.819 . . . . 0.42999999999999999 111.0 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 129' ' ' MET . 47.6 mt-30 -57.06 -35.02 68.86 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 114.215 -1.357 . . . . 0.38 109.668 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.46 -30.39 16.49 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.95 -1.477 . . . . 1.05 109.738 -176.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.42 -46.57 0.56 Allowed Glycine 0 CA--C 1.494 -1.224 0 C-N-CA 119.845 -1.169 . . . . 0.33000000000000002 113.569 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 141' ' ' SER . 98.3 mt -65.92 -169.64 0.07 Allowed 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 112.437 -1.882 . . . . 1.0700000000000001 115.395 -170.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.515 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 6.7 m -114.76 149.32 42.17 Favored Pre-proline 0 N--CA 1.416 -2.153 0 CA-C-N 110.49 -3.05 . . . . 1.24 107.676 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.559 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 59.0 Cg_endo -66.28 0.57 3.21 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 122.774 2.316 . . . . 0.39000000000000001 112.285 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 137' ' ' SER . 2.3 tt0 -118.23 -26.52 6.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.825 0.821 . . . . 1.79 110.286 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.72 ' O ' ' HB2' ' A' ' 141' ' ' SER . 15.2 t70 -58.26 -23.45 56.16 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-N 113.346 -1.752 . . . . 0.65000000000000002 109.168 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.72 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 20.8 m 76.05 171.23 0.25 Allowed 'General case' 0 N--CA 1.42 -1.933 0 O-C-N 125.817 1.948 . . . . 0.73999999999999999 108.385 -173.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.778 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 6.9 mt -63.95 -39.06 93.29 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.724 -1.213 . . . . 1.48 107.724 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.25 -11.85 1.39 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 113.059 -1.882 . . . . 0.34999999999999998 114.334 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 1.2 m -155.42 128.06 7.94 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.076 -0.713 . . . . 1.02 109.076 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.661 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.0 mmt180 -42.92 -46.87 5.54 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 117.995 0.361 . . . . 2.21 111.556 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.1 t -72.3 -26.21 61.87 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.511 0.672 . . . . 0.93000000000000005 111.431 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 31.4 mttm -74.38 -32.17 62.63 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.661 1.219 . . . . 1.8899999999999999 108.797 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.798 ' HB3' ' OH ' ' A' ' 162' ' ' TYR . . . -71.11 -46.43 61.7 Favored 'General case' 0 CA--C 1.483 -1.627 0 CA-C-N 112.299 -2.228 . . . . 0.98999999999999999 109.976 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.548 HG13 ' HE3' ' A' ' 179' ' ' MET . 36.6 mt -67.22 -41.79 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-N 112.764 -2.016 . . . . 1.03 109.974 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.53 -54.39 30.43 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 114.769 -1.105 . . . . 0.14999999999999999 111.297 171.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.686 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 79.1 mt -66.61 -47.77 82.38 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.029 0 N-CA-C 112.729 0.64 . . . . 1.05 112.729 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.606 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.76 -41.66 74.31 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.809 0.338 . . . . 1.03 110.9 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 149' ' ' ILE . 26.8 mtp180 -79.97 -23.98 41.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.48 0.657 . . . . 1.29 110.53 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.438 HD22 ' CD ' ' A' ' 133' ' ' GLN . 17.6 t30 -80.0 -12.83 59.68 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.337 -1.357 . . . . 0.5 107.337 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.686 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.39 -29.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 113.018 -1.901 . . . . 1.05 110.79 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.82 34.21 5.28 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.586 -0.816 . . . . 0.17000000000000001 112.632 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.06 161.24 14.92 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.031 0.752 . . . . 1.02 113.031 -169.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.648 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.6 m80 -100.31 -28.69 12.84 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.065 -0.97 . . . . 0.39000000000000001 109.348 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.59 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.3 m-85 -136.89 -177.96 4.98 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.935 -1.03 . . . . 0.81000000000000005 110.936 -175.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.713 ' O ' HD22 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -133.65 140.24 47.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.077 -0.965 . . . . 1.03 108.823 167.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.607 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 24.9 tp -110.46 99.05 8.12 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.333 -0.947 . . . . 1.02 109.725 166.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.798 ' OH ' ' HB3' ' A' ' 148' ' ' ALA . 2.1 m-85 -78.75 112.59 16.03 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.893 -1.049 . . . . 0.87 109.143 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.872 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.3 t -123.69 163.24 21.49 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 121.875 0.845 . . . . 1.45 110.275 -177.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.798 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.6 p -163.87 176.28 9.62 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 114.397 -1.274 . . . . 0.12 111.33 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.57 132.52 29.39 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 113.844 -1.526 . . . . 0.94999999999999996 108.531 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -142.34 -176.94 5.03 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.21 -0.596 . . . . 1.1499999999999999 109.492 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.09 -81.82 0.88 Allowed Glycine 0 C--N 1.303 -1.258 0 C-N-CA 119.649 -1.262 . . . . 0.14999999999999999 111.615 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.2 t30 -146.78 126.6 13.5 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 107.705 -1.221 . . . . 0.58999999999999997 107.705 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.498 HG13 ' HA3' ' A' ' 98' ' ' GLY . 2.2 p -58.75 -44.09 89.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 114.502 -1.226 . . . . 1.0 112.723 -173.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.44 ' N ' HG11 ' A' ' 169' ' ' VAL . 7.9 m-20 -61.99 -29.91 70.58 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.776 0.798 . . . . 1.9199999999999999 109.788 -175.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.99 88.11 3.56 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 114.387 -1.279 . . . . 1.0600000000000001 108.224 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.651 ' HD2' HG22 ' A' ' 194' ' ' VAL . 45.9 Cg_endo -90.06 165.54 4.74 Favored 'Trans proline' 0 CA--C 1.491 -1.631 0 C-N-CA 124.644 3.562 . . . . 0.089999999999999997 114.412 -170.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 25.6 m -83.3 118.27 23.55 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.942 -1.481 . . . . 1.0600000000000001 107.513 166.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.836 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 45.3 tp -83.76 99.51 10.32 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.367 -0.975 . . . . 1.02 108.367 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.571 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -91.34 109.02 20.29 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-O 122.09 0.948 . . . . 0.34000000000000002 109.196 -176.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.872 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.1 mmm -111.87 163.54 14.09 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.983 -1.008 . . . . 1.0900000000000001 111.487 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 58.6 tt0 -171.15 116.91 0.44 Allowed 'General case' 0 C--O 1.203 -1.366 0 CA-C-N 116.019 -0.537 . . . . 0.68000000000000005 110.404 -165.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.713 HD22 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -99.39 102.27 13.8 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.743 -0.836 . . . . 1.03 108.743 -172.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.661 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 17.2 ttp -91.62 121.88 33.68 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.89000000000000001 109.534 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.425 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.6 128.04 35.04 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.159 -1.423 . . . . 1.04 107.159 166.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -83.09 -35.04 11.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 119.303 0.956 . . . . 1.02 110.747 178.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.435 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.4 mt-30 -61.45 -16.55 48.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.335 -0.848 . . . . 0.40000000000000002 111.358 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.7 p -130.08 -37.34 1.48 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.794 0.807 . . . . 1.03 110.224 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.441 ' CA ' HD13 ' A' ' 149' ' ' ILE . . . 90.48 25.29 26.2 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 114.449 -1.25 . . . . 0.17999999999999999 112.528 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.43 156.81 17.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.679 0.276 . . . . 0.72999999999999998 110.672 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.471 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.3 mm -91.46 112.8 25.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.454 0.645 . . . . 1.03 109.679 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.67 ' CD1' HD12 ' A' ' 178' ' ' LEU . 1.6 pp -101.11 -31.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.018 -0.992 . . . . 1.01 110.597 -173.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.639 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.6 t90 -134.06 152.62 51.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.359 -0.837 . . . . 0.070000000000000007 109.752 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 51.8 p -153.8 164.17 38.79 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.399 0.888 . . . . 0.64000000000000001 113.399 164.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.47 -177.06 33.23 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 110.876 -0.889 . . . . 0.12 110.876 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.836 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.1 mtmt -157.46 152.8 26.16 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.645 -1.983 . . . . 1.76 105.645 166.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.641 ' N ' ' HE3' ' A' ' 71' ' ' MET . . . -163.76 128.18 1.79 Allowed Glycine 0 C--N 1.281 -2.498 0 C-N-CA 119.749 -1.215 . . . . 0.13 112.477 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.64 118.76 14.87 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.298 0.571 . . . . 1.01 110.854 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.696 HG12 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -94.62 158.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.569 1.176 . . . . 1.01 110.621 -177.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.775 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -98.02 172.98 7.28 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 112.667 -2.061 . . . . 0.92000000000000004 108.861 -173.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -102.45 130.97 49.4 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.501 -0.48 . . . . 0.91000000000000003 109.962 170.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.506 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 15.4 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.844 -0.598 . . . . 1.24 110.744 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.759 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.9 m-30 . . . . . 0 N--CA 1.421 -1.899 0 N-CA-C 109.911 -0.403 . . . . 0.76000000000000001 109.911 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 4.3 t70 -81.73 67.91 7.89 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 123.595 1.664 . . . . 0.34999999999999998 108.292 171.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.701 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 92.0 m95 -58.29 -43.1 87.87 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 111.682 -2.508 . . . . 0.10000000000000001 112.547 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.502 ' N ' HG21 ' A' ' 108' ' ' THR . 8.6 t-20 -51.82 -28.86 17.04 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.962 -1.472 . . . . 1.1100000000000001 111.598 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.44 -17.6 80.12 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.137 -0.938 . . . . 0.23000000000000001 111.104 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.1 -53.18 3.09 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.036 -1.082 . . . . 1.01 110.949 -176.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.746 ' SD ' HD22 ' A' ' 109' ' ' LEU . 42.2 mtt -64.24 -59.57 4.25 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.241 -1.345 . . . . 0.089999999999999997 112.593 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -39.34 -54.66 3.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 114.624 1.342 . . . . 0.63 114.624 -175.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.782 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.0 Cg_endo -64.21 -28.84 64.49 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 121.788 1.658 . . . . 0.17000000000000001 110.614 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.899 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 11.8 mtm -84.99 -41.25 16.01 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.16 -0.927 . . . . 0.69999999999999996 111.476 -177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.663 HG21 ' O ' ' A' ' 68' ' ' MET . 61.2 t -55.91 -39.96 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 CA-C-N 114.629 -1.169 . . . . 1.04 108.697 172.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.7 t -60.93 -32.27 71.78 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.32 -1.764 . . . . 1.1200000000000001 111.085 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.782 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 16.6 mtpp -84.71 -33.48 23.13 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.147 0.498 . . . . 1.8799999999999999 110.736 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.872 ' O ' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -65.36 -27.91 68.91 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.169 -0.923 . . . . 0.5 111.334 -172.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.552 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.2 mt -92.92 -2.93 55.38 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.97 0.89 . . . . 1.29 110.917 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.79 15.36 37.61 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.236 -1.546 . . . . 0.17999999999999999 109.236 170.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.626 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.27 165.0 17.69 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.679 -0.761 . . . . 1.0 110.276 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -91.08 104.49 17.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.22 -0.9 . . . . 1.72 110.046 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.77 -21.78 3.72 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.097 -0.956 . . . . 0.13 110.735 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.872 HG12 ' O ' ' A' ' 75' ' ' MET . 12.4 p -100.0 153.62 4.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.605 0.716 . . . . 1.01 111.002 -177.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -135.15 136.39 41.84 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 114.838 -1.074 . . . . 1.1000000000000001 110.592 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.468 ' HB1' ' HE3' ' A' ' 118' ' ' LYS . . . -55.47 131.06 45.08 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.467 -0.788 . . . . 1.1200000000000001 110.179 166.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.96 9.91 44.25 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.79 -0.719 . . . . 0.28000000000000003 113.113 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.92 153.08 18.99 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 120.6 -0.44 . . . . 1.55 110.956 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.647 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -81.87 114.91 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 122.116 0.96 . . . . 1.03 109.128 166.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.736 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -102.1 108.97 20.55 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.024 -0.989 . . . . 1.03 109.264 -172.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.701 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -72.25 95.05 1.64 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 114.471 -1.24 . . . . 1.01 108.272 175.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.435 HG12 ' HG3' ' A' ' 110' ' ' ARG . 1.6 m -73.01 118.21 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 107.83 -1.174 . . . . 1.6200000000000001 107.83 176.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.772 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 7.9 t0 -77.47 156.95 30.72 Favored 'General case' 0 CA--C 1.489 -1.397 0 CA-C-N 114.385 -1.28 . . . . 0.64000000000000001 107.856 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.564 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -58.38 136.98 57.55 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 108.075 -1.083 . . . . 1.05 108.075 171.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.559 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.2 t -64.0 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.982 0 N-CA-C 107.778 -1.193 . . . . 1.02 107.778 167.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.645 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.8 t-20 -86.2 163.26 17.9 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.006 -0.997 . . . . 0.20000000000000001 110.069 174.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.75 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.57 84.65 2.3 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.303 -1.317 . . . . 0.12 108.134 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.499 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 7.2 mtp180 -109.09 -1.04 19.12 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 113.783 -1.553 . . . . 0.84999999999999998 108.627 -172.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 18.5 p -52.83 -171.97 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 112.73 -2.032 . . . . 0.91000000000000003 115.034 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.497 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.1 t30 -71.3 -9.39 58.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.759 -2.019 . . . . 0.62 110.476 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.532 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -151.94 -146.33 4.32 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.472 -0.871 . . . . 0.14000000000000001 112.903 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.577 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 54.8 p -121.87 131.02 53.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.245 0.461 . . . . 1.76 112.245 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.75 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.91 156.72 48.34 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.802 0.81 . . . . 1.01 110.629 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.639 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -79.79 79.6 6.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.978 -1.465 . . . . 0.20999999999999999 107.742 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -68.35 -14.44 62.99 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.307 -1.315 . . . . 1.0 109.749 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.45 -31.38 37.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.747 -0.834 . . . . 1.02 108.747 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.639 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 4.8 tp10 -66.32 -34.37 77.83 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.392 -1.277 . . . . 1.73 108.933 171.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -71.56 -43.57 66.09 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.236 -1.802 . . . . 1.04 109.551 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 81.0 m -62.92 -30.61 71.68 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 113.776 -1.556 . . . . 1.04 110.162 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.6 -49.68 70.14 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.722 -0.844 . . . . 1.47 108.722 169.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.603 HG21 ' HB2' ' A' ' 64' ' ' TRP . 53.1 m -59.38 -31.08 68.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.43 -0.804 . . . . 1.03 110.789 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.746 HD22 ' SD ' ' A' ' 68' ' ' MET . 8.6 mt -51.2 -69.22 0.12 Allowed 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 115.902 -0.59 . . . . 1.3 109.874 172.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.718 ' O ' HD11 ' A' ' 121' ' ' LEU . 4.9 mtp180 -41.85 -38.8 1.61 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.615 1.198 . . . . 1.8 110.886 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -68.56 -49.04 62.53 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.32 -1.763 . . . . 0.41999999999999998 112.107 -176.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.93 -32.89 69.94 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.357 1.075 . . . . 1.01 108.446 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.683 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -64.14 -32.53 74.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.091 -1.868 . . . . 1.01 109.969 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.88 -38.53 61.88 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 114.749 -1.114 . . . . 1.03 111.802 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -67.31 -23.29 65.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.518 -0.764 . . . . 1.55 111.449 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -89.27 -13.22 38.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 2.0499999999999998 111.877 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.95 -12.05 0.59 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 115.936 1.135 . . . . 0.54000000000000004 115.936 163.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.468 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 58.7 mtpt -75.81 -34.33 60.15 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 117.529 0.665 . . . . 1.6000000000000001 111.116 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.736 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 13.9 m-85 -91.42 177.67 6.17 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.889 1.328 . . . . 0.27000000000000002 113.823 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 12.7 m -125.02 114.17 18.75 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 112.244 -2.253 . . . . 1.0800000000000001 107.818 167.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -99.13 128.02 45.18 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.712 -0.795 . . . . 1.1499999999999999 112.216 -168.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.456 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.306 -1.32 0 N-CA-C 108.068 -1.086 . . . . 1.0900000000000001 108.068 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.495 HD11 ' N ' ' A' ' 128' ' ' SER . 2.0 tm? . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 113.331 0.863 . . . . 2.04 113.331 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.672 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.1 t -50.49 -39.4 48.29 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 123.648 1.689 . . . . 1.1499999999999999 109.028 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.675 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -63.59 -63.18 1.25 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 110.644 -2.98 . . . . 2.27 110.688 178.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.698 ' CB ' HG22 ' A' ' 151' ' ' ILE . . . -42.31 -44.54 3.91 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 124.363 1.04 . . . . 1.0700000000000001 111.646 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -49.47 -60.81 2.52 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 123.435 0.46 . . . . 2.1000000000000001 110.044 176.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.9 mt-30 -58.79 -43.96 90.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.665 -1.152 . . . . 0.42999999999999999 111.46 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.675 ' HG3' ' O ' ' A' ' 129' ' ' MET . 49.4 mt-30 -56.14 -34.83 66.49 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.779 -1.1 . . . . 0.38 109.895 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.481 HD22 ' HB2' ' A' ' 133' ' ' GLN . 0.4 OUTLIER -90.67 -30.98 16.8 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 113.89 -1.504 . . . . 1.05 109.487 -177.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.6 -50.69 0.44 Allowed Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 120.095 -1.05 . . . . 0.33000000000000002 113.64 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 141' ' ' SER . 86.1 mt -64.13 -173.02 0.08 Allowed 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 115.841 1.793 . . . . 1.0700000000000001 115.841 -169.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.8 m -110.5 150.29 41.45 Favored Pre-proline 0 N--CA 1.421 -1.907 0 CA-C-N 111.005 -2.816 . . . . 1.24 108.9 169.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.672 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 28.6 Cg_endo -64.13 1.12 1.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.003 2.469 . . . . 0.39000000000000001 112.831 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.432 ' H ' ' C ' ' A' ' 137' ' ' SER . 0.9 OUTLIER -118.33 -22.96 7.43 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.123 0.963 . . . . 1.79 110.487 -178.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.643 ' O ' ' HB2' ' A' ' 141' ' ' SER . 10.6 t70 -63.61 -21.94 66.63 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 113.062 -1.881 . . . . 0.65000000000000002 109.375 -174.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.643 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 17.6 m 72.86 169.97 0.31 Allowed 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.42 -1.718 . . . . 0.73999999999999999 109.517 -173.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.772 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 4.7 mt -64.44 -39.58 94.11 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 122.349 1.071 . . . . 1.48 108.268 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.97 -5.98 2.3 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 113.025 -1.898 . . . . 0.34999999999999998 114.421 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 m -159.78 127.8 4.83 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.913 -0.773 . . . . 1.02 108.913 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.721 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.5 mmt180 -42.42 -47.94 5.08 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 118.182 0.446 . . . . 2.21 111.256 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.7 t -70.92 -25.79 62.92 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.503 0.668 . . . . 0.93000000000000005 111.591 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 26.8 mttm -75.21 -30.36 60.58 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 122.626 1.203 . . . . 1.8899999999999999 108.675 176.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.721 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -75.46 -46.57 31.73 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 112.472 -2.149 . . . . 0.98999999999999999 110.288 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.546 ' HA ' HG23 ' A' ' 181' ' ' VAL . 43.5 mt -66.78 -41.71 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-N 112.811 -1.995 . . . . 1.03 110.004 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.11 -54.5 28.82 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.747 -1.115 . . . . 0.14999999999999999 111.134 171.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.698 HG22 ' CB ' ' A' ' 130' ' ' ALA . 72.2 mt -66.2 -47.86 83.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 N-CA-C 112.831 0.678 . . . . 1.05 112.831 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.641 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.88 -40.36 72.85 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.926 0.393 . . . . 1.03 110.975 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.4 ' HD2' HG21 ' A' ' 149' ' ' ILE . 39.7 mtp180 -81.44 -22.67 38.01 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.745 0.783 . . . . 1.29 110.48 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -81.74 -12.04 58.76 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.199 -1.408 . . . . 0.5 107.199 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.69 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -107.4 -29.14 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 113.247 -1.797 . . . . 1.05 110.918 -174.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.44 35.84 4.81 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.313 -0.946 . . . . 0.17000000000000001 112.483 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.701 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.59 159.16 17.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.131 0.789 . . . . 1.02 113.131 -169.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.647 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -98.0 -27.06 14.41 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.18 -0.918 . . . . 0.39000000000000001 109.569 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 9.5 m-85 -136.65 -173.42 3.42 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.354 -0.839 . . . . 0.81000000000000005 111.586 -174.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.691 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -137.76 138.43 44.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.803 -1.089 . . . . 1.03 109.145 166.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.557 HD21 ' HE1' ' A' ' 176' ' ' MET . 34.7 tp -107.82 99.43 8.9 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.379 -0.928 . . . . 1.02 109.281 165.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.721 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.0 m-85 -78.78 111.99 15.47 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.56 -1.2 . . . . 0.87 108.743 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.819 ' OG ' HD11 ' A' ' 174' ' ' LEU . 26.8 t -123.6 159.22 29.72 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 121.776 0.798 . . . . 1.45 110.123 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.783 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.4 p -163.38 170.06 18.07 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-N 114.497 -1.229 . . . . 0.12 111.18 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -133.86 135.93 44.05 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.143 -1.39 . . . . 0.94999999999999996 108.636 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.643 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -144.23 -176.96 5.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.192 -0.67 . . . . 1.1499999999999999 109.192 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.08 -86.18 0.92 Allowed Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 119.628 -1.272 . . . . 0.14999999999999999 111.006 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.9 t30 -143.75 127.76 17.47 Favored 'General case' 0 C--O 1.191 -1.982 0 N-CA-C 107.375 -1.343 . . . . 0.58999999999999997 107.375 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 99' ' ' SER . 2.9 p -61.36 -49.71 83.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 114.061 -1.427 . . . . 1.0 112.916 -170.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.483 ' N ' HG13 ' A' ' 169' ' ' VAL . 89.8 m-20 -58.83 -26.83 64.52 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.222 0.534 . . . . 1.9199999999999999 110.904 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.13 88.18 3.51 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 114.903 -1.044 . . . . 1.0600000000000001 108.394 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.651 ' HD2' HG23 ' A' ' 194' ' ' VAL . 43.3 Cg_endo -91.44 167.26 3.44 Favored 'Trans proline' 0 CA--C 1.493 -1.55 0 C-N-CA 124.947 3.765 . . . . 0.089999999999999997 114.854 -170.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 16.9 m -86.13 118.13 25.39 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 113.755 -1.566 . . . . 1.0600000000000001 107.694 166.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.819 HD11 ' OG ' ' A' ' 163' ' ' SER . 54.1 tp -84.46 97.89 9.78 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-O 121.988 0.899 . . . . 1.02 109.337 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.58 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 34.9 mt-30 -87.64 107.66 18.72 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 114.567 -1.197 . . . . 0.34000000000000002 108.685 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.899 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 35.1 mtp -108.26 163.0 13.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.235 -0.893 . . . . 1.0900000000000001 110.063 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.517 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 36.5 tt0 -169.91 117.85 0.58 Allowed 'General case' 0 C--O 1.202 -1.438 0 CA-C-O 121.256 0.551 . . . . 0.68000000000000005 110.136 -167.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -100.34 101.76 12.83 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.818 -0.808 . . . . 1.03 108.818 -172.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.721 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.2 ttp -91.3 123.13 34.5 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.479 -0.782 . . . . 0.89000000000000001 109.533 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.77 127.37 31.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.075 -1.454 . . . . 1.04 107.075 166.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.546 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -82.05 -35.8 13.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.192 -1.003 . . . . 1.02 110.645 178.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.439 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.5 mt-30 -61.72 -15.5 41.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.259 -0.882 . . . . 0.40000000000000002 111.37 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p -130.08 -37.54 1.47 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.514 0.674 . . . . 1.03 110.127 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.411 ' CA ' HD13 ' A' ' 149' ' ' ILE . . . 90.15 26.13 24.66 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 114.631 -1.168 . . . . 0.17999999999999999 112.429 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 179' ' ' MET . 9.8 pt-20 -105.23 156.76 17.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.605 0.24 . . . . 0.72999999999999998 110.946 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.474 HD11 ' HG2' ' A' ' 177' ' ' GLN . 36.8 mm -91.25 110.59 22.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.792 0.806 . . . . 1.03 109.706 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.665 ' CD1' HD12 ' A' ' 178' ' ' LEU . 1.5 pp -98.11 -32.39 3.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.695 -1.139 . . . . 1.01 110.514 -173.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.626 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.6 t90 -135.49 151.78 50.7 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.383 -0.826 . . . . 0.070000000000000007 109.541 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 33.0 p -153.84 163.17 40.48 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.742 0.645 . . . . 0.64000000000000001 112.742 164.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.29 -178.41 32.29 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 110.841 -0.903 . . . . 0.12 110.841 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 16.3 mtmm -156.91 148.19 22.13 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.433 -1.692 . . . . 1.76 106.433 167.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -157.59 127.06 1.84 Allowed Glycine 0 C--N 1.283 -2.38 0 C-N-CA 119.682 -1.247 . . . . 0.13 112.293 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.94 116.05 12.98 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.413 0.625 . . . . 1.01 111.069 -174.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.67 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -93.39 159.46 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 122.604 1.192 . . . . 1.01 110.716 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -100.82 172.55 6.99 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.485 -2.143 . . . . 0.92000000000000004 108.682 -174.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.1 tt0 -101.25 133.24 46.13 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 120.103 -0.639 . . . . 0.91000000000000003 109.601 171.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.524 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 36.7 mm-40 . . . . . 0 C--N 1.313 -1.02 0 CA-C-O 118.467 -0.778 . . . . 1.24 110.257 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.745 ' OH ' ' HB3' ' A' ' 100' ' ' LEU . 1.2 m-30 . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 110.032 -0.358 . . . . 0.76000000000000001 110.032 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 0.9 OUTLIER -81.73 67.46 7.71 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 123.578 1.656 . . . . 0.34999999999999998 107.949 170.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.707 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.8 m95 -60.03 -44.11 94.86 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 111.994 -2.366 . . . . 0.10000000000000001 112.256 174.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.538 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 12.0 t-20 -51.65 -27.12 10.52 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.163 -1.38 . . . . 1.1100000000000001 111.269 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.15 -18.21 76.9 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.033 -0.985 . . . . 0.23000000000000001 111.292 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.22 -53.9 2.91 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.026 -1.087 . . . . 1.01 111.157 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.748 ' SD ' HD22 ' A' ' 109' ' ' LEU . 41.5 mtt -63.06 -60.49 3.37 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 114.052 -1.431 . . . . 0.089999999999999997 111.967 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.538 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.6 mm-40 -38.36 -54.09 2.87 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 114.984 1.476 . . . . 0.63 114.984 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.784 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 39.2 Cg_endo -66.16 -29.14 47.85 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.702 1.601 . . . . 0.17000000000000001 110.57 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.817 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 15.6 mtm -84.48 -41.86 16.14 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.428 -0.806 . . . . 0.69999999999999996 111.818 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 68' ' ' MET . 60.7 t -57.0 -37.45 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 114.578 -1.192 . . . . 1.04 108.471 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -63.16 -33.12 74.79 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.961 -1.927 . . . . 1.1200000000000001 111.096 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.784 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.4 mtpt -83.42 -32.47 26.1 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.028 0.442 . . . . 1.8799999999999999 110.632 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.853 ' O ' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -66.03 -27.0 67.78 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.225 -0.898 . . . . 0.5 111.202 -173.05 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.531 ' N ' ' HG2' ' A' ' 75' ' ' MET . 5.9 mt -93.45 -7.29 44.9 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.951 0.882 . . . . 1.29 110.669 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.0 16.97 53.69 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 108.885 -1.686 . . . . 0.17999999999999999 108.885 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.646 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -88.07 164.57 15.67 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.523 -0.838 . . . . 1.0 110.307 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -89.2 106.66 18.59 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.978 -1.01 . . . . 1.72 109.407 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.631 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.19 -23.7 3.65 Favored Glycine 0 N--CA 1.417 -2.626 0 C-N-CA 119.69 -1.243 . . . . 0.13 110.791 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.853 HG12 ' O ' ' A' ' 75' ' ' MET . 11.4 p -100.06 153.75 4.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.787 0.803 . . . . 1.01 111.875 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -135.14 137.91 43.23 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.48 -1.236 . . . . 1.1000000000000001 110.639 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HB3' ' HE3' ' A' ' 118' ' ' LYS . . . -59.35 130.78 48.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.462 -0.79 . . . . 1.1200000000000001 110.335 167.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.91 -3.92 33.94 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.966 -0.635 . . . . 0.28000000000000003 112.77 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.98 152.03 25.62 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 120.91 0.386 . . . . 1.55 111.122 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.63 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.7 p -80.67 117.84 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-O 121.978 0.894 . . . . 1.03 109.05 165.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.75 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.3 tm? -106.16 109.57 21.55 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.166 -0.925 . . . . 1.03 108.91 -172.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.667 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.92 96.12 1.65 Allowed 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.124 -1.398 . . . . 1.01 108.163 177.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.527 HG11 ' CD1' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -71.88 120.04 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 N-CA-C 106.878 -1.527 . . . . 1.6200000000000001 106.878 177.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.751 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 10.5 t0 -77.71 155.58 31.19 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.08 -1.452 . . . . 0.64000000000000001 107.08 177.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.539 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.0 OUTLIER -59.2 136.95 58.12 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.584 -1.265 . . . . 1.05 107.584 171.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.571 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.7 t -63.15 139.04 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.831 0 N-CA-C 107.78 -1.193 . . . . 1.02 107.78 168.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.643 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -86.03 163.52 17.89 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.239 -0.891 . . . . 0.20000000000000001 110.083 174.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.06 85.5 2.42 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.55 -1.204 . . . . 0.12 108.22 175.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.436 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.1 mtp180 -108.92 -0.24 19.79 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.027 -1.442 . . . . 0.84999999999999998 108.746 -172.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 21.7 p -52.18 -177.01 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.21 -1.814 . . . . 0.91000000000000003 113.681 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.453 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.3 OUTLIER -73.92 -9.36 58.56 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.375 -1.738 . . . . 0.62 110.133 173.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.502 ' HA3' ' CG1' ' A' ' 169' ' ' VAL . . . -139.9 -151.63 5.69 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.852 -0.69 . . . . 0.14000000000000001 112.846 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.557 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 65.7 p -122.03 130.62 53.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.512 0.56 . . . . 1.76 112.512 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.758 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.8 pp -136.2 156.9 48.01 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.009 0.909 . . . . 1.01 111.604 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.6 t-20 -80.9 79.77 7.5 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.817 -1.538 . . . . 0.20999999999999999 107.867 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -67.52 -13.08 61.74 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.469 -1.242 . . . . 1.0 110.038 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.41 -32.72 37.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.643 -0.873 . . . . 1.02 108.643 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.609 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 6.1 tp10 -65.45 -33.81 76.82 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 122.804 1.288 . . . . 1.73 109.076 171.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -72.02 -44.08 63.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.928 -1.942 . . . . 1.04 109.51 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 61.4 m -63.65 -29.07 70.36 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.124 -1.398 . . . . 1.04 110.292 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.64 -52.37 52.39 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.185 -1.043 . . . . 1.47 108.185 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.605 HG22 ' HB2' ' A' ' 64' ' ' TRP . 39.3 m -55.44 -33.93 64.03 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.671 -0.695 . . . . 1.03 111.144 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.748 HD22 ' SD ' ' A' ' 68' ' ' MET . 8.0 mt -49.45 -69.22 0.12 Allowed 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 116.2 -0.455 . . . . 1.3 109.862 172.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 13.9 mtp180 -43.31 -36.95 2.03 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.442 1.089 . . . . 1.8 110.82 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.599 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -70.83 -47.61 58.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.009 -1.451 . . . . 0.41999999999999998 111.561 -175.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . . . -72.36 -34.72 68.19 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 122.168 0.985 . . . . 1.01 108.631 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.65 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -62.34 -33.94 75.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.56 -1.655 . . . . 1.01 109.954 173.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 110' ' ' ARG . . . -75.15 -42.33 56.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 114.717 -1.129 . . . . 1.03 111.053 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -63.63 -19.28 64.74 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.825 -1.08 . . . . 1.55 110.667 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.42 -19.43 18.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.567 -0.742 . . . . 2.0499999999999998 111.565 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.04 14.19 10.26 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 115.357 0.903 . . . . 0.54000000000000004 115.357 164.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 83' ' ' ALA . 56.8 mtpt -98.42 -2.35 39.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.268 0.534 . . . . 1.6000000000000001 109.913 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.75 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 34.8 m-85 -122.2 174.98 6.63 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.144 0.973 . . . . 0.27000000000000002 112.674 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 5.4 m -118.08 121.14 39.82 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 112.935 -1.939 . . . . 1.0800000000000001 107.742 170.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.649 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -92.31 139.47 30.58 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 119.164 -1.014 . . . . 1.1499999999999999 111.837 -169.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.46 HG11 HD22 ' A' ' 88' ' ' LEU . 1.8 m . . . . . 0 C--N 1.3 -1.567 0 N-CA-C 108.047 -1.094 . . . . 1.0900000000000001 108.047 170.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.458 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 31.7 tp . . . . . 0 C--O 1.218 -0.563 0 N-CA-C 113.253 0.834 . . . . 2.04 113.253 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.637 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 5.6 t -50.39 -46.56 56.18 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 123.275 1.512 . . . . 1.1499999999999999 109.203 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.72 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -52.84 -63.75 1.04 Allowed 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 111.053 -2.794 . . . . 2.27 110.374 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.713 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -44.77 -46.15 10.38 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 124.574 1.171 . . . . 1.0700000000000001 112.195 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 137' ' ' SER . 0.8 OUTLIER -54.39 -51.83 63.61 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 108.835 -0.802 . . . . 2.1000000000000001 108.835 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.3 mt-30 -65.75 -38.86 90.25 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.313 -0.858 . . . . 0.42999999999999999 111.136 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.72 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.3 mt-30 -59.46 -33.84 71.8 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-N 114.486 -1.234 . . . . 0.38 109.678 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.572 HD21 ' N ' ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.43 -27.31 18.38 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.079 -1.418 . . . . 1.05 109.552 -177.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.78 -48.79 0.58 Allowed Glycine 0 CA--C 1.495 -1.16 0 CA-C-O 122.598 1.11 . . . . 0.33000000000000002 113.259 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.579 HD11 ' O ' ' A' ' 141' ' ' SER . 96.6 mt -64.89 -171.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.102 -2.049 . . . . 1.0700000000000001 115.716 -170.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.3 m -116.17 153.34 48.51 Favored Pre-proline 0 N--CA 1.428 -1.557 0 CA-C-N 110.705 -2.952 . . . . 1.24 107.932 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.637 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 37.1 Cg_endo -65.81 -0.37 3.81 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.611 2.207 . . . . 0.39000000000000001 112.561 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -118.41 -26.61 6.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.864 0.84 . . . . 1.79 110.704 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.633 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.1 t70 -56.86 -24.45 51.64 Favored 'General case' 0 CA--C 1.489 -1.366 0 CA-C-N 113.217 -1.81 . . . . 0.65000000000000002 109.677 -173.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 13.0 m 73.47 170.26 0.31 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 112.964 -1.926 . . . . 0.73999999999999999 109.434 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.751 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 3.1 mt -69.19 -39.97 78.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.369 1.08 . . . . 1.48 108.609 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.56 -12.11 0.52 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 112.94 -1.936 . . . . 0.34999999999999998 114.099 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -152.77 128.65 10.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.775 -0.631 . . . . 1.02 109.482 -175.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.68 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 22.5 mmt-85 -42.82 -50.1 5.7 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 118.043 0.383 . . . . 2.21 111.36 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.5 t -69.32 -27.28 65.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.456 0.646 . . . . 0.93000000000000005 111.365 -175.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 24.1 mttm -73.92 -27.63 61.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.666 1.222 . . . . 1.8899999999999999 108.663 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.614 ' CB ' HD11 ' A' ' 142' ' ' LEU . . . -79.61 -46.75 16.66 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 112.351 -2.204 . . . . 0.98999999999999999 110.586 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.542 HG13 ' HE2' ' A' ' 179' ' ' MET . 44.4 mt -65.78 -41.66 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 112.946 -1.934 . . . . 1.03 110.099 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.25 -52.37 40.94 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.743 -1.117 . . . . 0.14999999999999999 111.243 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.713 HG21 ' CB ' ' A' ' 130' ' ' ALA . 89.1 mt -68.24 -48.43 73.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 N-CA-C 112.358 0.503 . . . . 1.05 112.358 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.644 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.0 -41.31 71.12 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.948 0.404 . . . . 1.03 111.218 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.442 ' HD2' HG21 ' A' ' 149' ' ' ILE . 45.8 mtp180 -80.4 -24.26 39.82 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.597 0.713 . . . . 1.29 110.506 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.434 HD22 ' CD ' ' A' ' 133' ' ' GLN . 39.2 t30 -80.89 -14.35 58.09 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 107.641 -1.244 . . . . 0.5 107.641 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.694 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -103.2 -28.64 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.188 -1.824 . . . . 1.05 110.629 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.5 35.03 5.08 Favored Glycine 0 CA--C 1.5 -0.886 0 C-N-CA 120.153 -1.023 . . . . 0.17000000000000001 112.16 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.667 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.39 158.58 17.38 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.756 0.65 . . . . 1.02 112.756 -170.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.63 ' N ' HG12 ' A' ' 86' ' ' VAL . 2.1 m80 -98.2 -28.52 13.67 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.144 -0.934 . . . . 0.39000000000000001 109.392 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 6.2 m-85 -136.12 -174.89 3.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.089 -0.959 . . . . 0.81000000000000005 111.235 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.717 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -135.67 140.23 44.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.091 -0.959 . . . . 1.03 108.71 166.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.512 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 37.6 tp -109.31 101.75 10.72 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.292 -0.963 . . . . 1.02 109.45 165.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.578 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.11 113.87 17.6 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.405 -1.27 . . . . 0.87 108.673 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.702 ' OG ' HD13 ' A' ' 109' ' ' LEU . 4.2 p -121.33 157.73 29.77 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.444 -0.798 . . . . 1.45 109.791 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.8 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.7 p -164.62 173.24 12.17 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.985 -1.007 . . . . 0.12 111.202 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.49 136.82 41.56 Favored 'General case' 0 N--CA 1.412 -2.334 0 CA-C-N 114.156 -1.384 . . . . 0.94999999999999996 108.795 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.7 t -146.06 -171.29 3.68 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.882 -0.727 . . . . 1.1499999999999999 110.345 176.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.41 -78.0 1.51 Allowed Glycine 0 C--N 1.288 -2.099 0 CA-C-N 115.283 -0.871 . . . . 0.14999999999999999 111.713 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.2 t30 -148.85 131.56 15.97 Favored 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 107.62 -1.252 . . . . 0.58999999999999997 107.62 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.542 HG21 ' N ' ' A' ' 99' ' ' SER . 3.7 p -64.38 -41.8 93.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.102 -0.953 . . . . 1.0 112.863 -172.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.47 ' N ' HG13 ' A' ' 169' ' ' VAL . 5.2 m-20 -63.91 -28.85 70.11 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.293 1.045 . . . . 1.9199999999999999 109.338 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.5 88.41 3.68 Favored Pre-proline 0 C--N 1.304 -1.374 0 CA-C-N 114.279 -1.328 . . . . 1.0600000000000001 108.456 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.648 ' HD2' HG22 ' A' ' 194' ' ' VAL . 41.3 Cg_endo -92.0 166.25 3.15 Favored 'Trans proline' 0 CA--C 1.495 -1.447 0 C-N-CA 124.341 3.361 . . . . 0.089999999999999997 114.612 -171.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 49.2 m -85.02 118.8 24.81 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 113.793 -1.549 . . . . 1.0600000000000001 107.888 166.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.817 ' O ' ' HE3' ' A' ' 71' ' ' MET . 43.9 tp -84.11 96.72 9.01 Favored 'General case' 0 N--CA 1.414 -2.239 0 C-N-CA 119.26 -0.976 . . . . 1.02 108.66 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.608 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 31.9 mt-30 -85.83 108.94 18.35 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 114.638 -1.165 . . . . 0.34000000000000002 108.558 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.583 ' SD ' ' HB3' ' A' ' 163' ' ' SER . 2.9 mmm -112.06 163.52 14.19 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.655 -1.157 . . . . 1.0900000000000001 111.047 -174.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.519 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 36.4 tt0 -171.48 118.75 0.45 Allowed 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 115.917 -0.583 . . . . 0.68000000000000005 109.949 -167.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.717 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -100.74 99.35 9.87 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.524 -0.917 . . . . 1.03 108.524 -173.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.68 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.9 ttp -88.35 118.47 28.0 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.462 -0.79 . . . . 0.89000000000000001 109.22 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.471 ' HB2' HG23 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.17 115.65 4.31 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.067 -1.457 . . . . 1.04 107.067 169.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.542 HG23 ' HB1' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -71.28 -36.21 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.063 0.847 . . . . 1.02 111.348 -176.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.448 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 32.2 mt-30 -58.78 -15.53 12.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.525 -0.761 . . . . 0.40000000000000002 111.897 -177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.461 ' HG1' ' HG2' ' A' ' 185' ' ' GLU . 39.8 p -128.97 -37.28 1.72 Allowed 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.076 0.941 . . . . 1.03 110.02 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' LEU . . . 88.28 23.79 36.28 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 113.663 -1.608 . . . . 0.17999999999999999 111.793 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.461 ' HG2' ' HG1' ' A' ' 183' ' ' THR . 8.4 pt-20 -104.4 154.29 20.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.893 0.377 . . . . 0.72999999999999998 110.423 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.475 HD13 ' HG2' ' A' ' 177' ' ' GLN . 32.1 mm -87.6 116.19 29.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.53 0.681 . . . . 1.03 109.358 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.662 ' CD1' HD12 ' A' ' 178' ' ' LEU . 1.7 pp -103.49 -31.34 2.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.93 -1.032 . . . . 1.01 110.476 -173.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.646 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 79.0 t90 -135.16 153.41 51.99 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.325 -0.852 . . . . 0.070000000000000007 109.314 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 77.8 p -153.73 164.0 39.05 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.085 -0.646 . . . . 0.64000000000000001 112.697 163.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.61 -177.53 32.78 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.573 -1.011 . . . . 0.12 110.573 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.813 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 18.7 mtmm -157.98 148.2 20.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.488 -2.042 . . . . 1.76 105.488 166.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -155.65 126.89 1.92 Allowed Glycine 0 C--N 1.282 -2.445 0 C-N-CA 119.405 -1.379 . . . . 0.13 112.306 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.14 110.88 8.79 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.579 0.704 . . . . 1.01 111.094 -173.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.648 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -89.91 157.73 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.583 -1.189 . . . . 1.01 110.581 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.73 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -97.83 172.77 7.45 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 112.612 -2.085 . . . . 0.92000000000000004 108.982 -175.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.615 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 1.9 tt0 -107.48 132.38 53.28 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.933 -1.107 . . . . 0.91000000000000003 110.79 171.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.546 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 35.9 mm-40 . . . . . 0 C--O 1.247 0.957 0 CA-C-N 114.811 -1.086 . . . . 1.24 110.948 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.742 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 . . . . . 0 N--CA 1.42 -1.944 0 N-CA-C 109.914 -0.402 . . . . 0.76000000000000001 109.914 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 10.9 t70 -84.05 67.35 9.64 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 123.492 1.615 . . . . 0.34999999999999998 108.125 170.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.731 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 91.1 m95 -58.96 -43.91 91.38 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 111.678 -2.51 . . . . 0.10000000000000001 112.437 175.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.501 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 11.8 t-20 -50.56 -28.59 8.93 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.879 -1.51 . . . . 1.1100000000000001 111.415 174.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.08 -17.78 79.81 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.341 -0.845 . . . . 0.23000000000000001 111.215 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.62 -54.31 2.78 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.863 -1.168 . . . . 1.01 111.125 -175.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.757 ' SD ' HD23 ' A' ' 109' ' ' LEU . 40.1 mtt -62.59 -59.5 4.85 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 114.177 -1.374 . . . . 0.089999999999999997 112.105 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.501 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 6.2 mm-40 -37.33 -55.31 1.86 Allowed Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 115.276 1.584 . . . . 0.63 115.276 -177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.777 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.3 Cg_endo -65.73 -29.74 50.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.648 1.565 . . . . 0.17000000000000001 110.458 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.936 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 13.0 mtm -83.91 -41.43 17.4 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 115.447 -0.797 . . . . 0.69999999999999996 111.541 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.666 HG21 ' O ' ' A' ' 68' ' ' MET . 58.8 t -55.97 -39.1 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 CA-C-N 114.718 -1.128 . . . . 1.04 108.812 171.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.2 t -61.74 -34.35 75.68 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.393 -1.73 . . . . 1.1200000000000001 110.813 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.777 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.2 mtpt -81.67 -33.93 31.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.073 -0.512 . . . . 1.8799999999999999 110.464 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.872 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.72 -28.67 69.74 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.406 -0.815 . . . . 0.5 111.637 -171.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.554 ' N ' ' HG2' ' A' ' 75' ' ' MET . 5.5 mt -92.81 -4.84 52.31 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.081 0.943 . . . . 1.29 111.133 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.68 15.9 44.65 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 108.914 -1.674 . . . . 0.17999999999999999 108.914 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.639 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.47 165.62 17.0 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.386 -0.907 . . . . 1.0 109.869 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -92.97 104.91 17.09 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.277 -0.874 . . . . 1.72 110.303 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.643 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.82 -23.72 3.36 Favored Glycine 0 N--CA 1.428 -1.886 0 CA-C-N 115.018 -0.992 . . . . 0.13 110.69 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 75' ' ' MET . 9.9 p -98.76 155.46 3.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.748 0.785 . . . . 1.01 111.444 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.8 m -134.54 135.75 42.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.604 -1.18 . . . . 1.1000000000000001 111.034 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.442 ' HB1' ' HE3' ' A' ' 118' ' ' LYS . . . -60.23 129.31 41.07 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.222 -0.899 . . . . 1.1200000000000001 109.728 165.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.32 6.0 53.8 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.78 -0.724 . . . . 0.28000000000000003 112.938 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.493 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 65.7 m -98.12 146.93 25.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 120.719 -0.392 . . . . 1.55 110.51 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.652 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -76.8 132.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.029 -0.73 . . . . 1.03 109.029 172.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.791 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.6 tm? -119.12 110.01 16.56 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.603 -0.726 . . . . 1.03 109.084 -170.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.645 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -71.77 93.99 1.34 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.815 -1.18 . . . . 1.01 107.815 175.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.463 HG23 ' CD1' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -73.23 115.29 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.435 -1.32 . . . . 1.6200000000000001 107.435 176.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.809 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 12.3 t0 -77.74 170.92 15.76 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 114.997 -1.001 . . . . 0.64000000000000001 109.009 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.561 ' OG ' ' HE3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -62.48 152.92 33.16 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 122.42 1.105 . . . . 1.05 108.668 168.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 33.9 t -81.64 139.31 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.067 0 N-CA-C 106.985 -1.487 . . . . 1.02 106.985 166.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.66 ' H ' ' HA ' ' A' ' 164' ' ' SER . 8.0 t-20 -83.65 163.35 20.37 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.922 0.867 . . . . 0.20000000000000001 110.498 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.765 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.2 t-20 -125.71 86.27 2.51 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.208 -1.36 . . . . 0.12 108.124 175.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -108.72 -2.03 18.94 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.124 -1.398 . . . . 0.84999999999999998 108.724 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 27.5 p -52.18 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 112.998 -1.91 . . . . 0.91000000000000003 115.39 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 35.4 t30 -69.9 -9.71 55.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 112.762 -2.017 . . . . 0.62 110.492 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.533 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -153.27 -144.77 3.99 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.519 -0.848 . . . . 0.14000000000000001 113.123 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.595 ' N ' HG23 ' A' ' 169' ' ' VAL . 86.7 p -121.81 129.89 52.98 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.444 0.64 . . . . 1.76 112.725 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.4 pp -135.52 156.51 48.78 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.923 0.868 . . . . 1.01 110.852 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.622 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -80.95 79.44 7.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.961 -1.472 . . . . 0.20999999999999999 107.889 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -67.73 -14.28 62.81 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.433 -1.258 . . . . 1.0 109.96 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.73 -30.48 36.25 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.555 -0.906 . . . . 1.02 108.555 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.622 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.4 tp10 -66.21 -35.11 79.59 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.378 -1.283 . . . . 1.73 109.153 170.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -70.82 -43.86 67.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.107 -1.861 . . . . 1.04 109.369 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.659 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 63.0 m -61.77 -31.84 72.07 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 113.532 -1.667 . . . . 1.04 110.135 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.73 -46.77 77.64 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.843 -0.799 . . . . 1.47 108.843 171.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.617 HG23 ' HB2' ' A' ' 64' ' ' TRP . 50.9 m -60.19 -31.04 69.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.345 -0.843 . . . . 1.03 110.91 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.757 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -51.96 -68.15 0.19 Allowed 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.749 -0.66 . . . . 1.3 110.361 172.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.455 ' O ' HD12 ' A' ' 121' ' ' LEU . 6.1 mpt_? -40.55 -37.36 0.7 Allowed 'General case' 0 C--O 1.213 -0.844 0 O-C-N 124.387 1.054 . . . . 1.8 110.456 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -72.49 -46.8 53.07 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.304 -1.316 . . . . 0.41999999999999998 111.79 -174.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.413 ' HB2' ' HG2' ' A' ' 69' ' ' GLN . . . -73.21 -33.51 65.41 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.069 0.938 . . . . 1.01 108.718 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.679 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.69 -34.62 78.27 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.746 -1.57 . . . . 1.01 109.886 172.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 110' ' ' ARG . . . -72.99 -40.51 65.17 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.696 -1.138 . . . . 1.03 111.096 -176.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -61.89 -25.53 67.62 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.854 -1.067 . . . . 1.55 110.69 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -92.52 -20.24 21.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.003 -0.544 . . . . 2.0499999999999998 111.467 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.9 0.78 4.38 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 115.693 1.037 . . . . 0.54000000000000004 115.693 162.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HD3' HD11 ' A' ' 76' ' ' LEU . 53.0 mtpt -78.84 -33.99 45.52 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 117.395 0.598 . . . . 1.6000000000000001 109.812 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.791 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 19.0 m-85 -89.44 177.81 6.48 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-O 122.23 1.014 . . . . 0.27000000000000002 112.298 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.47 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.4 m -122.41 119.28 30.56 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 113.103 -1.862 . . . . 1.0800000000000001 108.31 167.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.662 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -86.92 145.43 26.55 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.448 -0.796 . . . . 1.1499999999999999 111.317 -170.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.537 ' CG1' ' HA ' ' A' ' 88' ' ' LEU . 1.9 m . . . . . 0 C--N 1.298 -1.633 0 CA-C-N 115.364 -0.835 . . . . 1.0900000000000001 109.175 169.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.547 ' CD2' ' HE2' ' A' ' 131' ' ' LYS . 1.5 tm? . . . . . 0 C--O 1.225 -0.234 0 N-CA-C 113.205 0.817 . . . . 2.04 113.205 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.648 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.3 t -49.54 -38.39 30.68 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 123.645 1.688 . . . . 1.1499999999999999 109.189 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.644 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 33.7 mmm -64.02 -63.08 1.25 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 110.705 -2.952 . . . . 2.27 111.191 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.672 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.26 -43.49 3.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 124.31 1.006 . . . . 1.0700000000000001 111.442 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.561 ' HE3' ' OG ' ' A' ' 91' ' ' SER . 3.7 mptp? -48.38 -65.57 0.54 Allowed 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.541 -0.541 . . . . 2.1000000000000001 109.541 174.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.1 mt-30 -55.2 -44.61 75.52 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.828 -1.078 . . . . 0.42999999999999999 111.71 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.0 mt-30 -55.67 -36.0 66.62 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 114.745 -1.116 . . . . 0.38 110.022 -177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.18 -31.34 16.23 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.118 -1.401 . . . . 1.05 109.285 -176.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.33 -48.32 0.43 Allowed Glycine 0 CA--C 1.496 -1.136 0 C-N-CA 119.801 -1.19 . . . . 0.33000000000000002 113.632 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 141' ' ' SER . 35.4 mt -66.24 -174.2 0.25 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 123.923 1.82 . . . . 1.0700000000000001 115.781 -168.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.6 m -110.03 148.64 38.7 Favored Pre-proline 0 N--CA 1.421 -1.924 0 CA-C-N 110.791 -2.913 . . . . 1.24 108.33 169.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.648 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 17.9 Cg_endo -61.38 0.4 1.03 Allowed 'Trans proline' 0 C--N 1.333 -0.255 0 C-N-CA 123.163 2.575 . . . . 0.39000000000000001 112.801 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.7 tt0 -117.9 -24.11 7.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.185 0.993 . . . . 1.79 110.424 -177.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.642 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.8 t70 -64.61 -22.56 67.0 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 113.213 -1.812 . . . . 0.65000000000000002 109.719 -174.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.642 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 2.0 m 74.83 173.24 0.27 Allowed 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 125.322 1.639 . . . . 0.73999999999999999 109.652 -173.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.809 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 4.3 mt -64.72 -38.85 92.38 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.281 -1.007 . . . . 1.48 108.281 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.462 ' C ' ' HG1' ' A' ' 144' ' ' THR . . . 69.38 -11.82 1.48 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 113.327 -1.76 . . . . 0.34999999999999998 114.417 176.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.462 ' HG1' ' C ' ' A' ' 143' ' ' GLY . 0.8 OUTLIER -157.19 130.22 7.73 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 118.672 -0.68 . . . . 1.02 109.276 -178.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.624 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.1 mmt85 -43.29 -48.68 6.8 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 118.008 0.367 . . . . 2.21 111.554 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 16.6 t -72.13 -24.93 61.54 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.531 0.681 . . . . 0.93000000000000005 111.202 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.412 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 25.3 mttm -74.6 -30.68 61.76 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.66 1.219 . . . . 1.8899999999999999 108.773 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.681 ' HB3' ' OH ' ' A' ' 162' ' ' TYR . . . -74.82 -46.2 38.2 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-N 112.411 -2.177 . . . . 0.98999999999999999 110.236 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.555 HG13 ' HE3' ' A' ' 179' ' ' MET . 38.8 mt -67.53 -41.96 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 112.633 -2.076 . . . . 1.03 109.821 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.48 -53.85 30.06 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.71 -1.132 . . . . 0.14999999999999999 111.012 171.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.725 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 76.2 mt -66.96 -47.85 81.18 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 N-CA-C 112.641 0.608 . . . . 1.05 112.641 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.645 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.29 -39.95 73.53 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.984 0.421 . . . . 1.03 111.02 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.452 ' HD2' HG21 ' A' ' 149' ' ' ILE . 45.5 mtp180 -82.59 -21.8 35.05 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.827 0.822 . . . . 1.29 110.343 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -82.82 -11.27 58.38 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.267 -1.382 . . . . 0.5 107.267 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.725 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.15 -29.66 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-N 113.143 -1.844 . . . . 1.05 111.111 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.23 35.88 4.32 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.414 -0.898 . . . . 0.17000000000000001 112.767 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.625 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.19 157.98 19.45 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.192 0.812 . . . . 1.02 113.192 -170.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.652 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.9 m80 -97.32 -25.97 15.06 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.27 -0.877 . . . . 0.39000000000000001 109.861 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 15.4 m-85 -136.12 -178.32 5.1 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.312 -0.858 . . . . 0.81000000000000005 111.584 -174.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.598 ' O ' HD21 ' A' ' 178' ' ' LEU . 1.2 t -133.37 141.53 44.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.1 -0.955 . . . . 1.03 109.202 167.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.561 HD23 ' HE1' ' A' ' 176' ' ' MET . 46.7 tp -111.43 102.26 10.64 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.628 -0.829 . . . . 1.02 109.255 164.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.681 ' OH ' ' HB3' ' A' ' 148' ' ' ALA . 1.8 m-85 -80.21 112.64 17.72 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.241 -1.345 . . . . 0.87 109.198 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.691 ' OG ' HD12 ' A' ' 109' ' ' LEU . 3.8 p -119.15 158.12 26.57 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.959 0.885 . . . . 1.45 111.489 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.798 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.4 p -164.22 171.64 14.69 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-N 114.251 -1.341 . . . . 0.12 111.255 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.14 134.91 33.49 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 114.118 -1.401 . . . . 0.94999999999999996 108.658 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.9 m -144.74 -173.79 4.16 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.295 -0.631 . . . . 1.1499999999999999 109.295 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.54 -82.43 0.94 Allowed Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.616 -1.278 . . . . 0.14999999999999999 111.279 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.482 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 59.8 t30 -145.78 129.16 16.86 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 107.653 -1.24 . . . . 0.58999999999999997 107.653 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.595 HG23 ' N ' ' A' ' 99' ' ' SER . 3.3 p -65.03 -42.51 94.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.447 -0.797 . . . . 1.0 112.552 -171.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.471 ' N ' HG12 ' A' ' 169' ' ' VAL . 7.4 m120 -60.66 -30.28 69.8 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.784 0.802 . . . . 1.9199999999999999 110.087 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.01 89.26 3.41 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 113.645 -1.616 . . . . 1.0600000000000001 108.557 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.659 ' HD2' HG22 ' A' ' 194' ' ' VAL . 43.1 Cg_endo -91.85 165.53 3.27 Favored 'Trans proline' 0 CA--C 1.496 -1.402 0 C-N-CA 124.678 3.586 . . . . 0.089999999999999997 115.301 -170.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.5 m -84.11 116.96 23.15 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 113.88 -1.509 . . . . 1.0600000000000001 107.83 166.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.825 ' O ' ' HE3' ' A' ' 71' ' ' MET . 43.9 tp -84.22 98.12 9.78 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.988 0.899 . . . . 1.02 109.25 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.581 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 35.4 mt-30 -87.11 108.32 18.84 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 114.586 -1.188 . . . . 0.34000000000000002 108.925 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.936 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 76.6 mtp -107.29 162.63 13.72 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.827 -1.079 . . . . 1.0900000000000001 110.357 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 57.4 tt0 -169.71 119.54 0.65 Allowed 'General case' 0 C--O 1.202 -1.411 0 CA-C-O 121.309 0.576 . . . . 0.68000000000000005 109.904 -169.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.598 HD21 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -101.11 101.98 12.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.001 -0.74 . . . . 1.03 109.001 -172.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.624 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.7 ttp -92.47 121.98 34.46 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.557 -0.747 . . . . 0.89000000000000001 109.407 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.3 128.44 37.0 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.285 -1.376 . . . . 1.04 107.285 166.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -84.66 -34.09 9.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 119.096 -1.042 . . . . 1.02 110.738 178.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.439 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 27.3 mt-30 -61.2 -16.31 43.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.371 -0.832 . . . . 0.40000000000000002 111.388 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.7 p -130.53 -37.49 1.38 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.505 0.669 . . . . 1.03 110.247 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.403 ' CA ' HD12 ' A' ' 149' ' ' ILE . . . 90.95 24.59 27.0 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.641 -1.163 . . . . 0.17999999999999999 112.479 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 179' ' ' MET . 10.4 pt-20 -103.81 157.78 16.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.654 -0.273 . . . . 0.72999999999999998 110.863 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.462 HD11 ' HG2' ' A' ' 177' ' ' GLN . 36.3 mm -93.04 114.19 29.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.574 0.702 . . . . 1.03 109.375 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.643 ' HB ' ' HA3' ' A' ' 80' ' ' GLY . 1.3 pp -102.38 -30.75 2.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.996 -1.002 . . . . 1.01 110.816 -174.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.639 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.3 t90 -135.43 152.11 51.07 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.274 -0.876 . . . . 0.070000000000000007 109.547 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 61.9 p -153.71 164.21 38.7 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.915 0.709 . . . . 0.64000000000000001 112.915 163.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.18 -178.69 32.44 Favored Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 110.927 -0.869 . . . . 0.12 110.927 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.794 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 12.0 mtmt -157.05 148.02 21.76 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.207 -1.775 . . . . 1.76 106.207 166.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -159.29 127.51 1.85 Allowed Glycine 0 C--N 1.28 -2.529 0 C-N-CA 119.769 -1.205 . . . . 0.13 112.343 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.82 114.79 11.35 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.659 0.742 . . . . 1.01 111.108 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.721 HG11 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -90.6 158.96 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 122.718 1.247 . . . . 1.01 110.476 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.742 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -101.43 172.08 7.19 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.399 -2.182 . . . . 0.92000000000000004 108.445 -175.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.3 tt0 -101.26 135.79 42.15 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.201 -0.6 . . . . 0.91000000000000003 109.633 172.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.549 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 23.0 mt-30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.424 -0.798 . . . . 1.24 110.927 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.772 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.4 m-30 . . . . . 0 N--CA 1.42 -1.931 0 N-CA-C 109.73 -0.47 . . . . 0.76000000000000001 109.73 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 1.7 t70 -80.68 67.92 6.72 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 123.593 1.663 . . . . 0.34999999999999998 107.95 171.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.693 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.9 m95 -59.51 -44.5 93.12 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 111.643 -2.526 . . . . 0.10000000000000001 112.497 175.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.513 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 10.3 t-20 -51.92 -28.99 18.24 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.055 -1.43 . . . . 1.1100000000000001 111.281 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.19 -16.91 80.35 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.326 -0.852 . . . . 0.23000000000000001 111.144 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.31 -52.78 3.17 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.109 -1.046 . . . . 1.01 111.008 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.72 ' SD ' HD23 ' A' ' 109' ' ' LEU . 43.3 mtt -62.36 -60.32 3.73 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 114.213 -1.358 . . . . 0.089999999999999997 112.179 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.513 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 6.2 mm-40 -38.76 -53.19 3.47 Favored Pre-proline 0 C--O 1.225 -0.211 0 N-CA-C 115.554 1.687 . . . . 0.63 115.554 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 49.8 Cg_endo -66.98 -25.91 44.14 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.784 1.656 . . . . 0.17000000000000001 110.746 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.901 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 12.4 mtm -88.05 -43.26 11.84 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.956 -1.02 . . . . 0.69999999999999996 111.978 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 68' ' ' MET . 65.6 t -53.63 -40.43 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 CA-C-N 114.439 -1.255 . . . . 1.04 108.71 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.4 t -57.29 -39.6 76.05 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.005 -1.907 . . . . 1.1200000000000001 110.954 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 25.4 mtmt -77.49 -31.79 53.86 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.024 0.379 . . . . 1.8799999999999999 112.024 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.875 ' O ' HG13 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -65.26 -26.68 68.2 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.545 -0.752 . . . . 0.5 111.559 -169.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.516 ' N ' ' HG2' ' A' ' 75' ' ' MET . 4.6 mt -94.48 -5.52 45.96 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 122.052 0.93 . . . . 1.29 111.157 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.43 15.18 50.33 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 109.004 -1.638 . . . . 0.17999999999999999 109.004 170.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.632 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.74 165.54 17.74 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.426 -0.887 . . . . 1.0 110.235 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -91.4 103.33 15.97 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.06 -0.973 . . . . 1.72 110.601 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.622 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.96 -21.97 3.48 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.56 -1.016 . . . . 0.13 110.56 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 75' ' ' MET . 11.9 p -101.36 152.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.746 0.784 . . . . 1.01 110.993 -176.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.3 m -135.93 141.0 44.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.724 -1.125 . . . . 1.1000000000000001 110.653 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -57.2 129.46 41.87 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.122 -0.944 . . . . 1.1200000000000001 110.838 168.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.52 14.16 24.41 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.101 -0.571 . . . . 0.28000000000000003 112.943 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.21 152.42 18.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.515 -0.474 . . . . 1.55 110.941 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.64 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.7 p -81.32 115.2 23.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.981 0.896 . . . . 1.03 109.081 166.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.686 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -102.77 109.11 20.58 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.236 -0.893 . . . . 1.03 109.099 -172.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.672 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.61 96.38 1.55 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.21 -1.359 . . . . 1.01 108.318 176.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.505 HG11 ' CD1' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -71.8 121.16 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 106.852 -1.536 . . . . 1.6200000000000001 106.852 177.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.812 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 9.5 t0 -77.54 156.5 30.91 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.268 -1.382 . . . . 0.64000000000000001 107.268 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.549 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.57 138.04 57.83 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.061 -1.459 . . . . 1.05 107.061 171.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 21.8 t -64.49 137.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.073 0 N-CA-C 107.658 -1.238 . . . . 1.02 107.658 168.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.633 ' H ' ' HA ' ' A' ' 164' ' ' SER . 5.1 t-20 -83.97 161.33 20.81 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.234 -0.894 . . . . 0.20000000000000001 109.614 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.766 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 1.9 t-20 -124.52 85.13 2.37 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.675 -1.148 . . . . 0.12 108.083 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.521 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.8 mtp180 -108.6 -1.96 19.17 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 113.756 -1.565 . . . . 0.84999999999999998 108.502 -172.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 18.1 p -52.94 -172.77 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.044 -1.889 . . . . 0.91000000000000003 115.074 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 167' ' ' GLY . 58.8 t30 -71.59 -5.19 31.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.643 -2.072 . . . . 0.62 110.828 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.542 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -156.38 -143.95 3.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.671 -0.776 . . . . 0.14000000000000001 112.807 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.597 ' N ' HG23 ' A' ' 169' ' ' VAL . 55.6 p -122.19 130.56 53.32 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.178 0.436 . . . . 1.76 112.178 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.766 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.2 pp -136.22 157.37 46.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.858 0.837 . . . . 1.01 110.863 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.616 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.15 79.44 7.81 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.85 -1.523 . . . . 0.20999999999999999 107.631 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 92' ' ' VAL . . . -68.33 -14.07 62.73 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.511 -1.222 . . . . 1.0 109.915 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.66 -32.74 41.6 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.672 -0.862 . . . . 1.02 108.672 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.616 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.9 tp10 -65.94 -33.27 75.45 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 122.767 1.27 . . . . 1.73 108.943 171.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.46 -43.92 63.06 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 113.078 -1.874 . . . . 1.04 109.5 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.63 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 67.1 m -64.01 -31.43 72.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.115 -1.402 . . . . 1.04 110.476 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -42.69 81.2 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.895 -1.15 . . . . 1.47 107.895 172.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.628 HG22 ' HB2' ' A' ' 64' ' ' TRP . 30.1 m -63.34 -31.36 72.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.994 -1.003 . . . . 1.03 110.816 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.72 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -50.88 -69.83 0.1 Allowed 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 115.691 -0.686 . . . . 1.3 109.518 171.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.542 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.2 mtp180 -40.71 -39.4 1.08 Allowed 'General case' 0 C--N 1.314 -0.942 0 O-C-N 124.539 1.15 . . . . 1.8 111.122 175.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.54 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -69.7 -45.43 68.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.604 -1.18 . . . . 0.41999999999999998 111.948 -176.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . . . -73.95 -32.91 63.69 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.289 1.043 . . . . 1.01 108.605 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.693 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -65.71 -32.1 73.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.608 -1.633 . . . . 1.01 110.26 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.435 ' CB ' HD12 ' A' ' 121' ' ' LEU . . . -73.58 -40.68 63.7 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 114.671 -1.149 . . . . 1.03 111.489 -174.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -59.92 -27.96 67.2 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.562 -1.199 . . . . 1.55 110.755 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.435 ' OD1' HD11 ' A' ' 76' ' ' LEU . 8.0 t-20 -82.16 -35.51 28.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.54 -1.209 . . . . 2.0499999999999998 110.554 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.28 0.64 30.6 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 114.626 0.61 . . . . 0.54000000000000004 114.626 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 58.5 mtpt -86.92 -8.12 57.55 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.935 -0.744 . . . . 1.6000000000000001 110.814 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.725 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 29.5 m-85 -119.09 175.37 5.81 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 122.159 0.98 . . . . 0.27000000000000002 112.497 171.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.5 m -119.7 123.73 44.52 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 112.987 -1.915 . . . . 1.0800000000000001 107.862 169.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.592 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -93.02 138.47 31.46 Favored 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 119.43 -0.908 . . . . 1.1499999999999999 111.651 -170.158 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 88' ' ' LEU . 1.7 m . . . . . 0 C--N 1.299 -1.629 0 N-CA-C 107.333 -1.358 . . . . 1.0900000000000001 107.333 169.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 30.8 tp . . . . . 0 C--O 1.221 -0.439 0 N-CA-C 113.34 0.867 . . . . 2.04 113.34 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.644 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 4.3 t -49.97 -46.1 52.16 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 123.336 1.541 . . . . 1.1499999999999999 109.289 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.683 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 52.0 mmm -55.4 -61.66 2.19 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 111.125 -2.761 . . . . 2.27 110.64 175.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.684 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.79 -45.57 10.12 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 124.382 1.051 . . . . 1.0700000000000001 112.472 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.502 ' HG3' ' HA ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -55.14 -51.36 66.71 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 107.963 -1.125 . . . . 2.1000000000000001 107.963 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 128' ' ' SER . 40.2 mt-30 -64.56 -40.87 96.36 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.047 -0.979 . . . . 0.42999999999999999 111.325 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.683 ' HG3' ' O ' ' A' ' 129' ' ' MET . 49.5 mt-30 -58.3 -34.21 70.3 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 114.429 -1.26 . . . . 0.38 109.383 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.527 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.14 -26.92 18.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.764 -1.562 . . . . 1.05 109.381 -177.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.44 -52.05 0.52 Allowed Glycine 0 CA--C 1.497 -1.041 0 CA-C-O 122.677 1.154 . . . . 0.33000000000000002 113.039 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 141' ' ' SER . 77.7 mt -62.65 -171.15 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 111.761 -2.22 . . . . 1.0700000000000001 116.046 -171.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.5 m -117.21 153.21 49.8 Favored Pre-proline 0 N--CA 1.428 -1.551 0 CA-C-N 110.929 -2.851 . . . . 1.24 108.307 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.644 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 24.5 Cg_endo -63.14 -2.07 3.48 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.026 2.484 . . . . 0.39000000000000001 112.676 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.6 tt0 -118.15 -27.67 6.02 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.781 0.8 . . . . 1.79 110.463 -177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.2 t70 -60.54 -23.83 64.89 Favored 'General case' 0 CA--C 1.487 -1.442 0 CA-C-N 113.604 -1.635 . . . . 0.65000000000000002 109.483 -174.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 17.8 m 74.8 169.49 0.29 Allowed 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 112.785 -2.007 . . . . 0.73999999999999999 110.455 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.812 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 6.7 mt -64.4 -40.25 95.42 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.336 1.065 . . . . 1.48 108.477 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.436 ' C ' ' HG1' ' A' ' 144' ' ' THR . . . 64.49 -11.13 0.25 Allowed Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 112.978 -1.919 . . . . 0.34999999999999998 114.666 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 142' ' ' LEU . 1.5 m -152.86 125.53 8.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.081 -0.711 . . . . 1.02 109.081 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.727 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 12.3 mmt180 -41.66 -45.95 3.57 Favored 'General case' 0 C--O 1.213 -0.84 0 O-C-N 123.279 0.362 . . . . 2.21 111.792 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.9 t -73.43 -25.59 60.58 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.628 0.728 . . . . 0.93000000000000005 111.505 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 29.7 mttm -75.0 -32.05 61.55 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.744 1.259 . . . . 1.8899999999999999 108.684 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.736 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -71.32 -46.99 59.33 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-N 112.217 -2.265 . . . . 0.98999999999999999 110.044 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.529 ' HA ' HG22 ' A' ' 181' ' ' VAL . 38.2 mt -67.07 -40.86 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 CA-C-N 112.678 -2.056 . . . . 1.03 109.839 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.08 -56.3 19.68 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 114.737 -1.119 . . . . 0.14999999999999999 111.129 171.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.72 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 85.3 mt -65.43 -47.98 84.78 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 N-CA-C 112.733 0.642 . . . . 1.05 112.733 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.646 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.23 -40.49 74.19 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.845 0.355 . . . . 1.03 111.14 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.438 ' HD2' HG23 ' A' ' 149' ' ' ILE . 61.6 mtp180 -81.92 -21.75 37.16 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.695 0.759 . . . . 1.29 110.533 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.444 HD22 ' CD ' ' A' ' 133' ' ' GLN . 17.8 t30 -84.06 -11.12 57.22 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.323 -1.362 . . . . 0.5 107.323 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -107.08 -29.11 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 113.143 -1.844 . . . . 1.05 110.917 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.59 34.2 5.34 Favored Glycine 0 CA--C 1.504 -0.602 0 C-N-CA 120.403 -0.904 . . . . 0.17000000000000001 112.553 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.672 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.34 161.83 14.45 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.637 0.606 . . . . 1.02 112.637 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.64 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.2 m80 -99.82 -28.16 13.27 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.561 -0.745 . . . . 0.39000000000000001 109.586 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.573 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.7 m-85 -136.67 -172.9 3.28 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.223 -0.899 . . . . 0.81000000000000005 111.141 -174.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.688 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -137.44 139.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.835 -1.075 . . . . 1.03 108.645 166.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.545 HD23 ' HE1' ' A' ' 176' ' ' MET . 29.4 tp -108.35 100.56 9.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.584 -0.846 . . . . 1.02 109.329 165.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.672 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -79.25 112.56 16.59 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.831 -1.077 . . . . 0.87 108.723 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.825 ' OG ' HD13 ' A' ' 174' ' ' LEU . 23.3 t -124.86 159.75 30.37 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-O 121.828 0.823 . . . . 1.45 110.052 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.801 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.5 p -163.75 173.03 13.34 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 114.505 -1.225 . . . . 0.12 111.154 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.73 134.33 37.03 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 114.071 -1.422 . . . . 0.94999999999999996 108.477 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.645 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -143.9 -176.72 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.373 -0.602 . . . . 1.1499999999999999 109.373 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 95.16 -82.68 0.88 Allowed Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 119.389 -1.386 . . . . 0.14999999999999999 111.856 172.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.4 t30 -143.07 123.82 14.18 Favored 'General case' 0 C--O 1.195 -1.782 0 N-CA-C 107.125 -1.435 . . . . 0.58999999999999997 107.125 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.597 HG23 ' N ' ' A' ' 99' ' ' SER . 3.1 p -63.04 -44.59 99.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 112.944 0.72 . . . . 1.0 112.944 -172.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.476 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.1 m120 -61.28 -27.93 68.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 118.59 0.632 . . . . 1.9199999999999999 109.891 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.4 88.74 3.35 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 114.855 -1.066 . . . . 1.0600000000000001 108.436 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.651 ' HD2' HG21 ' A' ' 194' ' ' VAL . 44.8 Cg_endo -91.48 166.37 3.47 Favored 'Trans proline' 0 CA--C 1.492 -1.585 0 C-N-CA 124.996 3.797 . . . . 0.089999999999999997 115.183 -169.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 12.7 m -84.58 117.35 23.67 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.689 -1.596 . . . . 1.0600000000000001 107.672 167.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.825 HD13 ' OG ' ' A' ' 163' ' ' SER . 48.2 tp -84.39 98.19 9.9 Favored 'General case' 0 N--CA 1.412 -2.326 0 C-N-CA 119.589 -0.844 . . . . 1.02 109.183 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.605 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.8 mt-30 -88.06 107.87 18.96 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 114.665 -1.152 . . . . 0.34000000000000002 109.092 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.901 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 36.0 mtp -108.15 162.06 14.41 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.012 -0.995 . . . . 1.0900000000000001 110.266 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 55.5 tt0 -169.72 117.59 0.6 Allowed 'General case' 0 C--O 1.205 -1.275 0 CA-C-O 121.308 0.575 . . . . 0.68000000000000005 109.927 -168.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.691 HD12 ' CD1' ' A' ' 187' ' ' ILE . 0.6 OUTLIER -99.84 101.41 12.53 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.695 -0.854 . . . . 1.03 108.695 -170.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.727 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 16.9 ttp -91.39 122.63 34.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.373 -0.83 . . . . 0.89000000000000001 109.625 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.406 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -59.14 127.57 32.83 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.201 -1.407 . . . . 1.04 107.201 166.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.535 HG11 ' CA ' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -82.18 -34.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 119.065 -1.054 . . . . 1.02 110.865 178.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -62.54 -14.43 42.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.446 -0.797 . . . . 0.40000000000000002 111.592 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 79.3 p -130.65 -36.41 1.41 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.862 0.839 . . . . 1.03 110.416 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.419 ' CA ' HD12 ' A' ' 149' ' ' ILE . . . 87.9 27.6 25.92 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.397 -1.274 . . . . 0.17999999999999999 112.313 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -106.77 155.93 19.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.624 -0.288 . . . . 0.72999999999999998 110.624 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.465 HD11 ' HG2' ' A' ' 177' ' ' GLN . 33.1 mm -89.01 120.09 37.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.665 0.745 . . . . 1.03 109.375 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.691 ' CD1' HD12 ' A' ' 178' ' ' LEU . 1.3 pp -108.18 -30.33 2.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.904 -1.043 . . . . 1.01 110.422 -173.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.632 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.2 t90 -136.96 152.89 50.69 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.177 -0.92 . . . . 0.070000000000000007 109.385 172.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 62.1 p -153.53 164.49 38.14 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.938 0.718 . . . . 0.64000000000000001 112.938 164.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.71 179.84 35.01 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.671 -0.971 . . . . 0.12 110.671 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.817 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.6 mtmt -156.91 147.45 21.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.181 -1.785 . . . . 1.76 106.181 168.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -157.64 127.38 1.9 Allowed Glycine 0 C--N 1.283 -2.399 0 C-N-CA 119.674 -1.25 . . . . 0.13 112.43 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.65 110.96 9.37 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.787 0.803 . . . . 1.01 111.503 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.672 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -88.53 159.5 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 122.797 1.284 . . . . 1.01 110.9 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.772 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -99.73 173.03 6.9 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 112.254 -2.248 . . . . 0.92000000000000004 108.895 -174.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.3 tt0 -104.34 133.52 49.1 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.936 -0.705 . . . . 0.91000000000000003 110.107 173.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.542 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 14.4 mm-40 . . . . . 0 C--N 1.313 -1.004 0 CA-C-O 118.551 -0.737 . . . . 1.24 110.617 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.712 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.2 m-30 . . . . . 0 N--CA 1.428 -1.571 0 CA-C-O 120.308 0.099 . . . . 0.76000000000000001 110.878 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.484 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 23.4 t70 -87.11 67.02 9.58 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 123.401 1.572 . . . . 0.34999999999999998 108.399 172.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.754 ' CZ3' HG12 ' A' ' 194' ' ' VAL . 92.9 m95 -54.25 -43.58 71.05 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.089 -2.323 . . . . 0.10000000000000001 112.997 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.486 ' N ' HG21 ' A' ' 108' ' ' THR . 8.6 t-20 -50.15 -30.56 11.51 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.806 -1.543 . . . . 1.1100000000000001 111.743 177.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.48 -16.41 80.64 Favored Glycine 0 CA--C 1.501 -0.801 0 N-CA-C 111.358 -0.697 . . . . 0.23000000000000001 111.358 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.73 -49.77 4.26 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.118 -1.041 . . . . 1.01 110.736 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.749 ' SD ' HD21 ' A' ' 109' ' ' LEU . 39.0 mtt -66.56 -57.65 6.83 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.089 -1.414 . . . . 0.089999999999999997 111.94 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.464 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 7.0 mm-40 -38.75 -54.96 2.88 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 114.958 1.466 . . . . 0.63 114.958 -177.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.8 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 31.9 Cg_endo -63.46 -30.77 72.09 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 121.908 1.739 . . . . 0.17000000000000001 110.45 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.676 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 7.6 mtm -81.59 -45.63 15.57 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 115.123 -0.944 . . . . 0.69999999999999996 111.851 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 68' ' ' MET . 46.8 t -56.54 -39.86 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-N 114.217 -1.356 . . . . 1.04 108.751 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -59.39 -34.39 72.37 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.064 -1.88 . . . . 1.1200000000000001 111.052 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 17.2 mtpp -83.41 -33.86 25.64 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.069 0.461 . . . . 1.8799999999999999 110.912 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.834 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.81 -26.35 68.31 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.291 -0.868 . . . . 0.5 111.295 -173.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.516 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.4 mt -94.11 -6.35 45.19 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.205 1.002 . . . . 1.29 110.788 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.64 16.05 52.19 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 108.934 -1.666 . . . . 0.17999999999999999 108.934 170.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.643 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -86.36 165.7 16.18 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.598 -0.801 . . . . 1.0 109.925 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -92.87 105.52 17.63 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.255 -0.884 . . . . 1.72 110.195 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.629 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.05 -22.48 3.59 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 115.138 -0.937 . . . . 0.13 111.051 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.834 HG11 ' O ' ' A' ' 75' ' ' MET . 9.9 p -99.53 154.77 4.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.519 0.676 . . . . 1.01 111.617 -174.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.441 ' HG1' ' HH ' ' A' ' 159' ' ' TYR . 3.6 m -135.0 135.01 41.05 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.692 -1.14 . . . . 1.1000000000000001 110.897 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.442 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -60.59 121.41 12.12 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.394 -0.821 . . . . 1.1200000000000001 110.66 168.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.1 4.6 23.96 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.979 -0.629 . . . . 0.28000000000000003 112.55 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.3 152.46 21.93 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.804 -0.359 . . . . 1.55 110.526 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.669 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.5 p -80.02 120.71 31.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.819 0.819 . . . . 1.03 108.906 165.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.752 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -109.36 107.7 17.98 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.821 0.82 . . . . 1.03 109.154 -172.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.65 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -72.11 97.35 1.91 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.228 -1.351 . . . . 1.01 107.679 174.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.834 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.2 m -70.88 125.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 105.82 -1.919 . . . . 1.6200000000000001 105.82 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.873 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 10.0 t0 -78.26 157.7 29.16 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.401 -1.333 . . . . 0.64000000000000001 107.401 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.621 ' OG ' ' HE3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -57.7 135.39 56.75 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 106.842 -1.54 . . . . 1.05 106.842 170.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.593 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 28.3 t -64.9 139.68 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.951 0 N-CA-C 107.777 -1.194 . . . . 1.02 107.777 169.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.642 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.5 t-20 -84.11 162.45 20.28 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.016 -0.993 . . . . 0.20000000000000001 109.778 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.757 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.36 85.02 2.35 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.683 -1.144 . . . . 0.12 108.004 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.45 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.2 mtp180 -107.09 -3.16 20.25 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 113.9 -1.5 . . . . 0.84999999999999998 108.653 -172.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 28.6 p -50.57 -175.36 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.24 -1.8 . . . . 0.91000000000000003 114.271 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.4 OUTLIER -72.3 -8.56 55.54 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.206 -1.816 . . . . 0.62 110.599 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.513 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -146.47 -148.91 4.87 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.751 -0.738 . . . . 0.14000000000000001 112.843 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.619 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.3 p -121.45 130.3 53.49 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.329 0.492 . . . . 1.76 112.329 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.757 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -135.16 157.81 45.97 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.954 0.883 . . . . 1.01 111.028 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.699 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -77.74 80.4 4.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.579 -1.646 . . . . 0.20999999999999999 107.86 175.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -69.41 -15.43 63.29 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.873 -1.058 . . . . 1.0 109.77 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.84 -29.19 40.07 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.609 -0.886 . . . . 1.02 108.609 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.699 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 20.9 tt0 -63.61 -39.71 95.07 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.054 -1.43 . . . . 1.73 109.32 168.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.546 ' O ' ' HE2' ' A' ' 68' ' ' MET . . . -68.48 -44.64 74.33 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.005 -1.907 . . . . 1.04 108.928 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 51.1 m -64.88 -31.44 72.68 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 113.946 -1.479 . . . . 1.04 110.61 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -44.79 78.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.695 -1.224 . . . . 1.47 107.695 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.599 HG21 ' HB2' ' A' ' 64' ' ' TRP . 40.1 m -64.01 -31.7 72.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.173 -0.921 . . . . 1.03 110.945 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.749 HD21 ' SD ' ' A' ' 68' ' ' MET . 8.7 mt -49.86 -69.7 0.11 Allowed 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.277 -0.638 . . . . 1.3 109.277 171.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.445 ' O ' HD11 ' A' ' 121' ' ' LEU . 16.4 mtp180 -41.05 -39.75 1.29 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.508 1.13 . . . . 1.8 111.394 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.532 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -68.89 -45.97 69.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.65 -1.159 . . . . 0.41999999999999998 112.012 -176.053 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.99 66.94 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.467 -0.938 . . . . 1.01 108.467 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.679 HD21 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -59.58 -34.4 72.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.715 -1.584 . . . . 1.01 110.131 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.452 ' CB ' HD13 ' A' ' 121' ' ' LEU . . . -72.53 -39.11 67.8 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 114.662 -1.154 . . . . 1.03 110.717 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -24.58 67.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.709 -1.132 . . . . 1.55 110.832 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -89.55 -25.18 21.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.648 -0.705 . . . . 2.0499999999999998 110.576 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 58.29 27.98 61.14 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.743 -0.662 . . . . 0.54000000000000004 114.147 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.482 ' HB2' ' CD1' ' A' ' 76' ' ' LEU . 58.2 mtpt -110.87 -1.35 16.53 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.61 -0.515 . . . . 1.6000000000000001 109.61 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 40.1 m-85 -124.44 173.6 8.33 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.085 0.945 . . . . 0.27000000000000002 112.571 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.2 m -116.62 120.78 39.75 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 113.206 -1.815 . . . . 1.0800000000000001 107.532 169.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.632 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -89.85 146.23 24.58 Favored 'General case' 0 N--CA 1.415 -2.203 0 C-N-CA 119.344 -0.943 . . . . 1.1499999999999999 111.223 -170.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.535 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.6 m . . . . . 0 C--N 1.303 -1.455 0 N-CA-C 107.765 -1.198 . . . . 1.0900000000000001 107.765 170.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 89' ' ' VAL . 5.8 tt . . . . . 0 CA--C 1.519 -0.223 0 N-CA-C 113.284 0.846 . . . . 2.04 113.284 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.612 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.0 OUTLIER -53.17 -42.9 66.64 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 123.618 1.675 . . . . 1.1499999999999999 109.208 -178.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.686 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 6.3 mmt -55.29 -62.85 1.4 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 110.942 -2.845 . . . . 2.27 111.13 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.699 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.27 -44.4 5.37 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.106 0.879 . . . . 1.0700000000000001 111.833 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.621 ' HE3' ' OG ' ' A' ' 91' ' ' SER . 4.0 mptp? -49.28 -65.02 0.64 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.287 -0.634 . . . . 2.1000000000000001 109.287 175.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.415 ' H ' ' HG3' ' A' ' 132' ' ' GLN . 39.1 mt-30 -54.06 -45.49 71.71 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.895 -1.048 . . . . 0.42999999999999999 112.001 177.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.686 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.4 mt-30 -55.65 -36.37 66.97 Favored 'General case' 0 CA--C 1.488 -1.424 0 CA-C-N 114.843 -1.071 . . . . 0.38 109.916 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.523 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -90.47 -29.39 17.96 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.172 -1.376 . . . . 1.05 109.57 -176.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.07 -38.68 0.73 Allowed Glycine 0 CA--C 1.497 -1.069 0 C-N-CA 119.558 -1.306 . . . . 0.33000000000000002 113.933 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 141' ' ' SER . 92.1 mt -73.12 -173.49 1.3 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 123.94 1.829 . . . . 1.0700000000000001 115.275 -167.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 139' ' ' GLN . 15.3 m -109.4 147.85 36.86 Favored Pre-proline 0 N--CA 1.42 -1.944 0 CA-C-N 110.72 -2.945 . . . . 1.24 107.984 168.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.612 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 34.3 Cg_endo -63.78 1.2 1.54 Allowed 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 123.058 2.505 . . . . 0.39000000000000001 112.176 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 137' ' ' SER . 0.1 OUTLIER -117.1 -22.25 8.47 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.136 0.969 . . . . 1.79 110.251 -178.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.717 ' O ' ' HB2' ' A' ' 141' ' ' SER . 17.2 t70 -61.0 -24.29 66.04 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 112.963 -1.926 . . . . 0.65000000000000002 109.211 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.717 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 14.0 m 74.42 174.83 0.26 Allowed 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 125.942 2.026 . . . . 0.73999999999999999 108.468 -170.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.873 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 3.4 mt -69.76 -39.72 76.52 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.21 -1.033 . . . . 1.48 108.21 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.41 -12.0 0.73 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 113.276 -1.783 . . . . 0.34999999999999998 114.41 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -153.96 125.11 7.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.605 -0.712 . . . . 1.02 109.118 -175.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.707 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -40.86 -47.95 3.01 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 118.075 0.398 . . . . 2.21 111.81 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.3 t -71.25 -29.22 64.83 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.391 0.615 . . . . 0.93000000000000005 111.592 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -71.15 -27.57 63.64 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.681 1.229 . . . . 1.8899999999999999 108.374 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.636 ' CB ' HD12 ' A' ' 142' ' ' LEU . . . -78.6 -47.88 16.26 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 112.287 -2.233 . . . . 0.98999999999999999 110.395 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.552 HG13 ' HE3' ' A' ' 179' ' ' MET . 36.7 mt -65.28 -42.12 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 112.837 -1.983 . . . . 1.03 110.252 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.3 -56.76 15.69 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.778 -1.101 . . . . 0.14999999999999999 110.964 171.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.705 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 70.8 mt -63.99 -47.73 89.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 N-CA-C 112.458 0.54 . . . . 1.05 112.458 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.613 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.13 -42.01 76.24 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 123.241 0.338 . . . . 1.03 110.682 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 149' ' ' ILE . 29.5 mtp180 -80.5 -23.05 40.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.643 0.735 . . . . 1.29 110.795 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -80.9 -12.99 59.31 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.424 -1.324 . . . . 0.5 107.424 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.705 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.49 -29.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 112.987 -1.915 . . . . 1.05 110.741 -175.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.441 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.46 34.19 5.11 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.59 -0.814 . . . . 0.17000000000000001 112.612 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.65 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.66 159.81 16.44 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.912 0.708 . . . . 1.02 112.912 -169.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.669 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.5 m80 -99.29 -28.21 13.42 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.212 -0.904 . . . . 0.39000000000000001 109.323 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.582 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.6 m-85 -136.26 -176.91 4.48 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.963 -1.017 . . . . 0.81000000000000005 111.008 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.699 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -134.06 141.34 44.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.665 -1.152 . . . . 1.03 108.609 167.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.64 HD21 ' SD ' ' A' ' 176' ' ' MET . 29.9 tp -110.21 100.39 9.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.666 -0.814 . . . . 1.02 109.441 165.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.528 ' HH ' ' HB2' ' A' ' 142' ' ' LEU . 2.0 m-85 -79.06 112.45 16.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.579 -1.192 . . . . 0.87 108.899 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.864 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 5.5 t -126.09 161.91 26.54 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-O 121.956 0.884 . . . . 1.45 110.691 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.82 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.7 p -162.83 177.59 9.16 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.23 -1.35 . . . . 0.12 111.141 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -140.85 133.77 29.13 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.175 -1.375 . . . . 0.94999999999999996 108.551 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -143.36 -176.61 5.01 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.307 -0.557 . . . . 1.1499999999999999 109.592 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.39 -81.37 0.94 Allowed Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.669 -1.253 . . . . 0.14999999999999999 111.873 172.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 53.1 t-20 -142.2 127.37 18.58 Favored 'General case' 0 C--O 1.197 -1.681 0 N-CA-C 106.747 -1.575 . . . . 0.58999999999999997 106.747 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.596 HG23 ' N ' ' A' ' 99' ' ' SER . 2.9 p -63.25 -41.13 91.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-N 115.438 -0.801 . . . . 1.0 112.125 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.48 ' N ' HG13 ' A' ' 169' ' ' VAL . 91.9 m-20 -65.14 -28.45 69.43 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.317 0.579 . . . . 1.9199999999999999 110.496 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.51 88.47 3.35 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 114.571 -1.195 . . . . 1.0600000000000001 108.138 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.652 ' HD2' HG21 ' A' ' 194' ' ' VAL . 50.9 Cg_endo -90.09 164.96 4.75 Favored 'Trans proline' 0 CA--C 1.491 -1.658 0 C-N-CA 124.56 3.507 . . . . 0.089999999999999997 114.998 -170.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 20.6 m -84.4 117.83 23.87 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.898 -1.501 . . . . 1.0600000000000001 107.628 166.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.831 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 40.4 tp -84.23 99.47 10.58 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.58 -0.896 . . . . 1.02 108.58 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.579 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.3 mt-30 -90.69 109.41 20.59 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-O 122.063 0.935 . . . . 0.34000000000000002 109.634 -175.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.864 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -112.84 164.36 13.5 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.958 -1.019 . . . . 1.0900000000000001 111.789 -172.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 55.9 tt0 -171.56 116.84 0.41 Allowed 'General case' 0 C--O 1.202 -1.395 0 CA-C-N 115.98 -0.555 . . . . 0.68000000000000005 109.967 -166.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -99.23 101.53 12.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.554 -0.906 . . . . 1.03 108.554 -171.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.707 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 18.4 ttp -91.18 122.69 34.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.404 -0.816 . . . . 0.89000000000000001 109.87 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.81 126.35 27.29 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.234 -1.395 . . . . 1.04 107.234 165.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -80.91 -35.68 14.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 119.303 -0.959 . . . . 1.02 110.72 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.454 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.8 mt-30 -60.57 -16.99 43.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.328 -0.851 . . . . 0.40000000000000002 111.603 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.8 p -129.33 -37.37 1.64 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.969 0.89 . . . . 1.03 110.155 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.436 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.5 23.67 28.15 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 114.402 -1.272 . . . . 0.17999999999999999 112.293 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 179' ' ' MET . 9.7 pt-20 -100.81 156.88 17.11 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.607 0.241 . . . . 0.72999999999999998 110.672 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.473 HD12 ' HG2' ' A' ' 177' ' ' GLN . 37.9 mm -92.87 114.94 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.543 0.687 . . . . 1.03 109.597 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.687 ' CD1' HD13 ' A' ' 178' ' ' LEU . 1.4 pp -102.22 -31.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.878 -1.055 . . . . 1.01 110.603 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.643 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.9 t90 -135.59 153.33 51.71 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.487 -0.779 . . . . 0.070000000000000007 109.87 173.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 28.0 p -153.61 163.4 40.05 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.157 0.799 . . . . 0.64000000000000001 113.157 164.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.38 -175.47 31.41 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 110.839 -0.904 . . . . 0.12 110.839 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.831 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.4 mtmt -158.25 151.14 22.59 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.421 -2.066 . . . . 1.76 105.421 166.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.487 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -160.88 127.75 1.81 Allowed Glycine 0 C--N 1.281 -2.515 0 C-N-CA 119.879 -1.153 . . . . 0.13 112.195 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.39 118.16 14.93 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.444 0.64 . . . . 1.01 111.199 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.754 HG12 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -93.34 158.5 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-O 122.42 1.105 . . . . 1.01 109.868 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.697 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -97.98 171.46 8.26 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 112.879 -1.964 . . . . 0.92000000000000004 109.581 -173.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 7.4 tt0 -103.09 127.48 50.35 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.984 -0.747 . . . . 0.91000000000000003 108.984 166.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.484 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 14.2 mm-40 . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 118.724 -0.655 . . . . 1.24 110.817 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.763 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 1.8 m-30 . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 120.388 0.137 . . . . 0.76000000000000001 110.919 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 11.5 t70 -82.66 67.98 8.94 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 123.481 1.61 . . . . 0.34999999999999998 108.627 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.763 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 93.3 m95 -60.51 -43.75 96.73 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 112.14 -2.3 . . . . 0.10000000000000001 112.312 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.466 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 12.1 t-20 -52.3 -29.0 21.23 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.064 -1.425 . . . . 1.1100000000000001 111.211 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.37 -16.48 80.69 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 115.35 -0.841 . . . . 0.23000000000000001 111.295 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.97 -51.64 3.49 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.183 -1.009 . . . . 1.01 110.959 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.758 ' SD ' HD21 ' A' ' 109' ' ' LEU . 38.5 mtt -65.61 -56.63 11.21 Favored 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 114.086 -1.415 . . . . 0.089999999999999997 112.517 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.466 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.6 mm-40 -40.21 -54.57 4.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 114.732 1.382 . . . . 0.63 114.732 -176.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.779 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.2 Cg_endo -64.27 -30.09 63.95 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 121.916 1.744 . . . . 0.17000000000000001 110.664 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.644 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 7.7 mtm -81.62 -44.59 17.0 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 115.165 -0.925 . . . . 0.69999999999999996 111.826 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 68' ' ' MET . 49.0 t -56.74 -39.54 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-N 114.279 -1.328 . . . . 1.04 108.443 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.6 t -59.67 -32.62 70.64 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.049 -1.887 . . . . 1.1200000000000001 111.177 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.779 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.2 mtpt -85.98 -33.29 21.14 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.929 0.395 . . . . 1.8799999999999999 111.046 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.852 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.65 -27.64 69.07 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.484 -0.78 . . . . 0.5 111.786 -171.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.548 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.0 mt -93.05 -5.68 49.94 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.94 0.876 . . . . 1.29 111.257 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.14 15.29 47.56 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.201 -1.559 . . . . 0.17999999999999999 109.201 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.633 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -83.47 165.99 18.69 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.409 -0.895 . . . . 1.0 111.148 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.52 105.68 14.65 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.876 -1.056 . . . . 1.72 110.382 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.591 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 129.25 -21.12 5.22 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.151 -1.023 . . . . 0.13 111.175 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.852 HG11 ' O ' ' A' ' 75' ' ' MET . 11.2 p -100.81 149.42 6.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.896 0.855 . . . . 1.01 110.837 -176.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.3 m -136.19 142.27 44.1 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.197 -1.365 . . . . 1.1000000000000001 109.701 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 118' ' ' LYS . . . -62.37 136.21 57.81 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.54 -0.755 . . . . 1.1200000000000001 110.754 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.08 9.54 39.14 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.957 -0.64 . . . . 0.28000000000000003 112.777 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.37 152.03 18.75 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.742 -0.383 . . . . 1.55 110.711 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.643 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -80.95 120.12 31.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 122.015 0.912 . . . . 1.03 109.103 165.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.646 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -107.45 110.57 22.55 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.137 -0.938 . . . . 1.03 108.799 -172.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.655 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -70.67 99.39 1.67 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 114.786 -1.097 . . . . 1.01 108.419 179.484 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.407 HG13 ' HG3' ' A' ' 110' ' ' ARG . 85.3 t -72.82 108.93 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 114.324 -1.307 . . . . 1.6200000000000001 108.416 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.802 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 6.8 t0 -77.79 154.56 31.8 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.982 -1.118 . . . . 0.64000000000000001 107.982 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.539 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.37 138.14 57.75 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.588 -1.264 . . . . 1.05 107.588 171.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.545 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 26.3 t -66.5 141.08 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.633 0 N-CA-C 107.904 -1.147 . . . . 1.02 107.904 168.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.64 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.8 t-20 -86.2 163.08 18.0 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.459 -0.792 . . . . 0.20000000000000001 109.917 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.757 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 1.8 t-20 -126.01 84.84 2.32 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.669 -1.15 . . . . 0.12 108.29 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.423 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 13.7 mtp180 -108.97 -2.1 18.51 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.076 -1.42 . . . . 0.84999999999999998 108.705 -171.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 17.6 p -50.7 -172.07 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 112.608 -2.087 . . . . 0.91000000000000003 115.483 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.461 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.0 t30 -67.71 -13.1 61.81 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.028 -1.896 . . . . 0.62 110.558 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.518 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -148.86 -146.26 4.29 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.592 -0.813 . . . . 0.14000000000000001 112.884 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.608 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 49.2 m -122.15 129.0 51.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.943 0.402 . . . . 1.76 111.134 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.757 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -132.12 159.29 39.34 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.525 0.678 . . . . 1.01 110.054 -177.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.613 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.37 82.25 7.26 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.317 -1.311 . . . . 0.20999999999999999 108.229 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -69.25 -15.13 63.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.205 -1.361 . . . . 1.0 109.907 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.28 -30.33 48.42 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.999 -0.741 . . . . 1.02 108.999 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.613 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 14.2 tp10 -65.64 -35.2 80.12 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.784 1.278 . . . . 1.73 108.936 170.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.9 -45.9 63.48 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 112.832 -1.985 . . . . 1.04 109.366 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.603 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 55.9 m -63.87 -34.13 77.26 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.064 -1.426 . . . . 1.04 110.527 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -42.03 85.39 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.884 -1.154 . . . . 1.47 107.884 173.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 64' ' ' TRP . 60.0 m -65.45 -30.99 71.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.252 -0.885 . . . . 1.03 110.984 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.758 HD21 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.21 -69.54 0.11 Allowed 'General case' 0 CA--C 1.492 -1.265 0 CA-C-N 115.781 -0.645 . . . . 1.3 109.282 172.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.583 ' O ' HD11 ' A' ' 121' ' ' LEU . 60.1 mtp180 -40.64 -37.61 0.76 Allowed 'General case' 0 C--N 1.311 -1.073 0 O-C-N 124.3 1.0 . . . . 1.8 111.499 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -70.79 -46.24 63.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.716 -1.129 . . . . 0.41999999999999998 112.067 -177.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.52 64.89 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.156 0.979 . . . . 1.01 108.532 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.673 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -63.58 -33.95 76.74 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.454 -1.703 . . . . 1.01 109.918 172.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 110' ' ' ARG . . . -76.09 -43.51 43.11 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.763 -1.108 . . . . 1.03 111.226 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.28 -38.49 65.94 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.562 -1.199 . . . . 1.55 110.414 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.545 ' OD1' ' HG3' ' A' ' 118' ' ' LYS . 12.2 t-20 -69.11 -47.59 64.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 113.382 -1.736 . . . . 2.0499999999999998 109.398 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.53 -8.39 68.81 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 116.033 -0.531 . . . . 0.54000000000000004 113.762 171.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.545 ' HG3' ' OD1' ' A' ' 116' ' ' ASN . 15.6 mtmm -72.67 -33.93 66.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.096 -0.642 . . . . 1.6000000000000001 111.154 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.699 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 15.1 m-85 -90.92 176.91 6.44 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 122.328 1.061 . . . . 0.27000000000000002 112.526 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.8 m -120.8 117.61 27.86 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 112.85 -1.977 . . . . 1.0800000000000001 108.151 168.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -88.63 132.85 34.38 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 115.362 -0.836 . . . . 1.1499999999999999 110.367 -171.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 88' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.301 -1.517 0 N-CA-C 109.057 -0.72 . . . . 1.0900000000000001 109.057 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.49 HD13 HD23 ' A' ' 88' ' ' LEU . 17.7 tp . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 113.603 0.964 . . . . 2.04 113.603 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.597 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 56.8 m -52.09 -40.58 61.46 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 123.37 1.557 . . . . 1.1499999999999999 109.116 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.675 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 13.6 mmt -57.26 -62.63 1.63 Allowed 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 111.177 -2.738 . . . . 2.27 111.002 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.695 ' CB ' HG22 ' A' ' 151' ' ' ILE . . . -42.22 -45.43 4.12 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 124.38 1.05 . . . . 1.0700000000000001 111.875 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.464 ' NZ ' ' HA ' ' A' ' 141' ' ' SER . 1.0 OUTLIER -53.55 -53.6 49.26 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 108.954 -0.758 . . . . 2.1000000000000001 108.954 178.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.0 mt-30 -64.23 -39.77 94.67 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.466 -0.788 . . . . 0.42999999999999999 111.128 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.675 ' HG3' ' O ' ' A' ' 129' ' ' MET . 53.0 mt-30 -59.0 -34.66 72.11 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 114.354 -1.294 . . . . 0.38 109.83 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.581 HD23 ' N ' ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.7 -28.79 17.21 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 114.243 -1.344 . . . . 1.05 109.644 -176.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.58 -42.92 0.7 Allowed Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 119.894 -1.146 . . . . 0.33000000000000002 113.426 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.542 HD11 ' O ' ' A' ' 141' ' ' SER . 94.0 mt -69.9 -171.46 0.42 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 124.102 1.906 . . . . 1.0700000000000001 115.472 -169.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 32.1 m -114.89 153.93 46.99 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 110.353 -3.112 . . . . 1.24 107.194 174.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.597 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 64.6 Cg_endo -68.91 1.22 4.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.416 2.077 . . . . 0.39000000000000001 110.91 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 137' ' ' SER . 20.8 mt-30 -117.56 -23.35 7.72 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.132 -1.395 . . . . 1.79 111.031 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.627 ' O ' ' HB2' ' A' ' 141' ' ' SER . 14.3 t70 -69.05 -22.14 64.05 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 114.515 -1.22 . . . . 0.65000000000000002 108.879 -169.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.627 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 32.3 m 71.76 166.94 0.3 Allowed 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 112.485 -2.143 . . . . 0.73999999999999999 109.578 -170.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.802 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 3.6 mt -65.48 -40.15 92.78 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 122.191 0.996 . . . . 1.48 108.317 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.14 -12.18 0.27 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 113.047 -1.888 . . . . 0.34999999999999998 114.476 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -152.25 123.3 7.57 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.023 -0.732 . . . . 1.02 109.023 -173.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.657 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -42.43 -45.56 4.43 Favored 'General case' 0 C--O 1.213 -0.843 0 O-C-N 123.394 0.434 . . . . 2.21 111.73 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -73.93 -25.49 60.01 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.676 0.751 . . . . 0.93000000000000005 111.407 -174.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -73.55 -30.47 63.07 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.634 1.207 . . . . 1.8899999999999999 108.331 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.642 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -75.41 -47.72 26.09 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 112.577 -2.102 . . . . 0.98999999999999999 110.36 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.553 ' HA ' HG21 ' A' ' 181' ' ' VAL . 43.6 mt -65.49 -41.46 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-N 112.88 -1.964 . . . . 1.03 110.44 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.12 -53.53 36.8 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.67 -1.15 . . . . 0.14999999999999999 111.25 171.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.706 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 83.9 mt -66.67 -48.3 80.58 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 N-CA-C 112.172 0.434 . . . . 1.05 112.172 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.655 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -54.43 -44.46 72.46 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 123.603 0.565 . . . . 1.03 111.248 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.447 ' NE ' HG21 ' A' ' 149' ' ' ILE . 49.7 mtt180 -78.76 -23.14 45.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.295 0.569 . . . . 1.29 110.882 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.467 HD22 ' CD ' ' A' ' 133' ' ' GLN . 35.0 t30 -81.6 -13.66 57.72 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.641 -1.244 . . . . 0.5 107.641 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.706 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.01 -28.91 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 113.313 -1.767 . . . . 1.05 111.041 -173.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.88 34.85 4.76 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.261 -0.971 . . . . 0.17000000000000001 112.365 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.608 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.91 157.34 19.34 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.886 0.698 . . . . 1.02 112.886 -170.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.643 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.8 m80 -98.92 -28.63 13.35 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.137 -0.938 . . . . 0.39000000000000001 109.425 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.567 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.1 m-85 -135.13 -173.97 3.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.063 -0.971 . . . . 0.81000000000000005 110.856 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.704 ' O ' HD21 ' A' ' 178' ' ' LEU . 1.2 t -136.97 139.97 43.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.13 -0.941 . . . . 1.03 108.93 166.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.6 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 40.1 tp -107.8 100.12 9.52 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.237 -0.985 . . . . 1.02 109.318 165.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.547 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.7 m-85 -80.39 116.65 20.57 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.226 -1.352 . . . . 0.87 108.577 176.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.871 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 4.7 t -129.01 162.55 27.36 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.948 0.88 . . . . 1.45 110.607 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.79 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.4 p -162.4 176.24 10.7 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.4 -1.273 . . . . 0.12 110.971 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -137.91 134.76 35.38 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.086 -1.416 . . . . 0.94999999999999996 108.513 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.4 m -144.19 -176.0 4.84 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.278 -0.638 . . . . 1.1499999999999999 109.278 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -84.21 0.92 Allowed Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.824 -1.179 . . . . 0.14999999999999999 111.407 173.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.3 t30 -144.49 128.19 17.2 Favored 'General case' 0 C--O 1.197 -1.665 0 N-CA-C 107.921 -1.141 . . . . 0.58999999999999997 107.921 176.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.518 HG12 ' HA3' ' A' ' 98' ' ' GLY . 2.7 p -63.22 -41.77 94.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.136 -0.938 . . . . 1.0 112.334 -172.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.454 ' N ' HG13 ' A' ' 169' ' ' VAL . 8.7 m120 -59.17 -31.67 69.2 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.49 0.662 . . . . 1.9199999999999999 109.552 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.05 89.2 3.11 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 114.329 -1.305 . . . . 1.0600000000000001 108.351 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.648 ' HD2' HG23 ' A' ' 194' ' ' VAL . 44.5 Cg_endo -90.49 166.98 4.23 Favored 'Trans proline' 0 CA--C 1.494 -1.492 0 C-N-CA 124.481 3.454 . . . . 0.089999999999999997 114.815 -169.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 25.3 m -85.75 120.19 26.91 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 113.904 -1.498 . . . . 1.0600000000000001 107.369 165.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.83 HD12 ' OG ' ' A' ' 163' ' ' SER . 44.4 tp -84.68 98.66 10.34 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 108.714 -0.847 . . . . 1.02 108.714 176.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.532 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -89.93 109.39 20.41 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 122.097 0.951 . . . . 0.34000000000000002 109.265 -176.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.871 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.9 OUTLIER -112.48 163.83 14.0 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.76 -1.109 . . . . 1.0900000000000001 111.538 -173.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.547 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 56.5 tt0 -170.67 119.02 0.53 Allowed 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.89 -0.596 . . . . 0.68000000000000005 109.98 -166.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.704 HD21 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -101.25 100.15 10.64 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.671 -0.863 . . . . 1.03 108.671 -173.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.657 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.8 ttp -89.42 123.06 33.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.433 -0.803 . . . . 0.89000000000000001 109.548 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.2 OUTLIER -59.63 127.36 31.64 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.892 -1.522 . . . . 1.04 106.892 166.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -81.93 -35.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 O-C-N 121.131 -0.981 . . . . 1.02 110.904 179.214 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -61.68 -16.2 46.79 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 0.40000000000000002 111.087 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 73.9 p -129.66 -37.05 1.59 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.752 0.786 . . . . 1.03 110.199 178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.432 ' CA ' HD12 ' A' ' 149' ' ' ILE . . . 90.82 24.88 26.51 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 114.701 -1.136 . . . . 0.17999999999999999 112.387 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -103.85 156.4 17.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.679 0.276 . . . . 0.72999999999999998 110.481 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.469 HD11 ' HG2' ' A' ' 177' ' ' GLN . 32.1 mm -89.22 117.0 31.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.552 0.692 . . . . 1.03 109.335 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.704 ' CD1' HD13 ' A' ' 178' ' ' LEU . 1.4 pp -104.99 -30.54 2.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.098 -0.955 . . . . 1.01 110.341 -174.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.646 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.0 t90 -136.42 152.22 50.36 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.397 -0.819 . . . . 0.070000000000000007 109.417 172.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 77.2 p -153.59 163.32 40.18 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.891 -0.724 . . . . 0.64000000000000001 112.926 163.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.44 -174.93 28.78 Favored Glycine 0 N--CA 1.425 -2.047 0 N-CA-C 110.885 -0.886 . . . . 0.12 110.885 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.83 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.8 mtmt -158.96 151.28 21.4 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.383 -2.08 . . . . 1.76 105.383 165.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.446 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -159.43 127.24 1.79 Allowed Glycine 0 C--N 1.278 -2.676 0 C-N-CA 119.623 -1.275 . . . . 0.13 112.108 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 173' ' ' THR . . . -72.17 115.08 10.98 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.404 0.621 . . . . 1.01 111.065 -174.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.71 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -91.87 158.45 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-O 122.59 1.186 . . . . 1.01 110.181 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.676 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.85 172.26 7.04 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 112.564 -2.107 . . . . 0.92000000000000004 109.166 -174.265 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.9 tt0 -100.42 130.65 46.53 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.261 -0.644 . . . . 0.91000000000000003 109.261 169.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.466 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 26.7 mm-40 . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 115.883 -0.599 . . . . 1.24 110.138 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.753 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.6 m-30 . . . . . 0 N--CA 1.417 -2.079 0 N-CA-C 109.662 -0.496 . . . . 0.76000000000000001 109.662 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 15.7 t70 -80.15 67.06 5.85 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 123.289 1.519 . . . . 0.34999999999999998 108.257 172.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.714 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.6 m95 -59.01 -44.17 91.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 111.77 -2.468 . . . . 0.10000000000000001 112.109 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.451 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 13.3 t-20 -51.51 -29.33 16.29 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.04 -1.436 . . . . 1.1100000000000001 111.37 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.5 -16.49 80.69 Favored Glycine 0 C--N 1.314 -0.683 0 CA-C-N 115.385 -0.825 . . . . 0.23000000000000001 111.254 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.73 -53.16 3.03 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.062 -1.069 . . . . 1.01 111.091 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.734 ' SD ' HD21 ' A' ' 109' ' ' LEU . 41.8 mtt -63.56 -57.94 8.55 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 114.229 -1.35 . . . . 0.089999999999999997 112.139 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.451 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.9 mm-40 -38.61 -55.31 2.67 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 115.172 1.545 . . . . 0.63 115.172 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.73 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.6 Cg_endo -65.04 -28.85 57.22 Favored 'Trans proline' 0 CA--C 1.51 -0.716 0 C-N-CA 121.673 1.582 . . . . 0.17000000000000001 110.649 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.889 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 11.3 mtm -84.47 -40.73 17.35 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.198 -0.91 . . . . 0.69999999999999996 111.452 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 68' ' ' MET . 60.4 t -57.73 -38.32 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 CA-C-O 122.353 1.073 . . . . 1.04 108.506 172.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 t -60.52 -35.41 75.9 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.014 -1.903 . . . . 1.1200000000000001 111.11 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.73 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 27.6 mtpt -81.37 -38.82 26.01 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.577 -0.527 . . . . 1.8799999999999999 109.577 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.826 ' SD ' ' HE2' ' A' ' 119' ' ' PHE . 1.2 ttm -47.19 -54.6 10.29 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 123.901 0.751 . . . . 0.5 110.355 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.636 ' N ' ' HG2' ' A' ' 75' ' ' MET . 4.7 mt -80.03 7.62 8.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.525 -1.216 . . . . 1.29 112.285 -169.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.96 17.33 8.68 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 113.941 -1.481 . . . . 0.17999999999999999 109.88 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.586 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -81.83 165.15 21.11 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.404 0.621 . . . . 1.0 110.252 176.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -87.06 107.6 18.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.281 -0.872 . . . . 1.72 109.797 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.643 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 133.96 -24.89 3.58 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 110.763 -0.935 . . . . 0.13 110.763 -178.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 75' ' ' MET . 10.8 p -102.92 151.08 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.777 0.799 . . . . 1.01 111.164 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.5 m -135.91 142.73 44.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.43 -1.259 . . . . 1.1000000000000001 110.211 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.477 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -56.14 142.84 35.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.585 -0.734 . . . . 1.1200000000000001 110.469 166.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.32 11.33 58.55 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.778 -0.725 . . . . 0.28000000000000003 113.17 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.55 153.14 18.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.148 0.474 . . . . 1.55 110.552 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -82.28 120.47 33.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 108.772 -0.825 . . . . 1.03 108.772 166.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.622 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -108.45 109.78 21.14 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.542 -0.754 . . . . 1.03 109.308 -171.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.715 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -73.13 94.5 1.94 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.504 -1.225 . . . . 1.01 108.945 177.378 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 2.0 m -73.04 115.93 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 106.902 -1.518 . . . . 1.6200000000000001 106.902 174.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.86 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 13.3 t0 -79.97 170.4 16.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.331 -0.989 . . . . 0.64000000000000001 108.331 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.522 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.5 OUTLIER -55.5 148.72 14.94 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-O 122.774 1.273 . . . . 1.05 109.375 170.278 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.555 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 34.6 t -77.62 140.5 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.172 0 N-CA-C 106.81 -1.552 . . . . 1.02 106.81 165.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.642 ' H ' ' HA ' ' A' ' 164' ' ' SER . 5.5 t-20 -85.55 160.91 19.54 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 122.031 0.919 . . . . 0.20000000000000001 110.344 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.748 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -124.27 84.63 2.3 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 113.939 -1.482 . . . . 0.12 107.575 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 13.2 mtp180 -107.18 -2.07 21.24 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 113.66 -1.609 . . . . 0.84999999999999998 108.411 -172.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 22.3 p -50.96 -177.73 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.36 -1.745 . . . . 0.91000000000000003 113.799 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 1.5 t30 -73.49 -7.62 52.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.065 -1.88 . . . . 0.62 110.263 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.529 ' HA3' HG13 ' A' ' 169' ' ' VAL . . . -142.37 -151.43 5.51 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.944 -0.645 . . . . 0.14000000000000001 112.869 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.585 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 51.8 m -121.92 130.58 53.45 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.955 0.407 . . . . 1.76 111.728 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.748 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.0 pp -134.84 158.19 44.85 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.876 0.846 . . . . 1.01 110.795 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.601 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -80.64 79.69 7.23 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.019 -1.446 . . . . 0.20999999999999999 108.08 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.592 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -67.57 -15.77 63.83 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.376 -1.284 . . . . 1.0 109.846 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.55 -31.56 42.02 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.888 -0.782 . . . . 1.02 108.888 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.601 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.6 tp10 -66.04 -33.98 77.03 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.697 1.237 . . . . 1.73 108.876 171.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -72.29 -43.42 64.25 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 113.118 -1.855 . . . . 1.04 109.656 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 63.7 m -63.91 -32.2 73.65 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.107 -1.406 . . . . 1.04 110.537 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -40.99 80.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.997 -1.112 . . . . 1.47 107.997 173.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.643 HG23 ' HB2' ' A' ' 64' ' ' TRP . 54.7 m -64.5 -31.06 72.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.21 -0.904 . . . . 1.03 110.693 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.734 HD21 ' SD ' ' A' ' 68' ' ' MET . 8.4 mt -51.74 -70.05 0.1 Allowed 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.296 -0.631 . . . . 1.3 109.296 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.672 ' O ' HD12 ' A' ' 121' ' ' LEU . 21.2 mtp180 -39.72 -38.46 0.64 Allowed 'General case' 0 C--N 1.315 -0.933 0 O-C-N 124.436 1.085 . . . . 1.8 111.331 174.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.524 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.86 -46.89 61.87 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.578 -1.192 . . . . 0.41999999999999998 112.313 -177.253 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 69' ' ' GLN . . . -72.57 -31.0 64.89 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.227 1.013 . . . . 1.01 108.471 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.725 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -66.15 -32.55 74.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.511 -1.677 . . . . 1.01 109.906 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.405 ' CB ' HD11 ' A' ' 121' ' ' LEU . . . -72.31 -39.39 68.27 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.48 -1.236 . . . . 1.03 111.565 -175.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -66.97 -21.69 65.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.061 -0.972 . . . . 1.55 111.265 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.69 -14.41 28.08 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.053 -0.521 . . . . 2.0499999999999998 111.753 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.24 -11.89 0.69 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 116.164 1.226 . . . . 0.54000000000000004 116.164 163.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 51.7 mtpt -74.51 -33.03 62.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.819 0.81 . . . . 1.6000000000000001 111.139 -177.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.826 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 20.8 m-85 -93.6 178.2 5.77 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 122.391 1.091 . . . . 0.27000000000000002 112.678 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 6.2 m -121.25 116.95 25.83 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 112.901 -1.954 . . . . 1.0800000000000001 107.822 168.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -87.54 135.49 33.33 Favored 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 119.477 -0.889 . . . . 1.1499999999999999 110.751 -171.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.507 HG12 HD21 ' A' ' 88' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.296 -1.759 0 N-CA-C 108.923 -0.769 . . . . 1.0900000000000001 108.923 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.655 HD23 ' NZ ' ' A' ' 131' ' ' LYS . 1.9 tm? . . . . . 0 C--O 1.236 0.354 0 N-CA-C 113.218 0.822 . . . . 2.04 113.218 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.624 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.5 OUTLIER -52.34 -39.89 61.26 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 123.712 1.72 . . . . 1.1499999999999999 108.753 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.603 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -62.9 -59.85 4.28 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 110.694 -2.957 . . . . 2.27 110.783 179.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.68 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.86 -40.01 5.85 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 124.098 0.874 . . . . 1.0700000000000001 112.006 175.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.74 ' NZ ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -51.52 -60.46 3.12 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.825 -0.75 . . . . 2.1000000000000001 109.215 175.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 40.3 mt-30 -58.74 -44.66 90.58 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.379 -1.282 . . . . 0.42999999999999999 111.7 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 129' ' ' MET . 43.5 mt-30 -55.33 -34.2 64.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.986 -1.006 . . . . 0.38 110.151 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -93.59 -30.56 14.91 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.991 -1.459 . . . . 1.05 109.364 -178.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 161.43 -54.9 0.32 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.929 -1.129 . . . . 0.33000000000000002 114.086 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.506 ' CD1' ' HA ' ' A' ' 142' ' ' LEU . 43.8 mt -64.05 -172.36 0.06 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 116.385 1.994 . . . . 1.0700000000000001 116.385 -168.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.5 m -111.16 150.7 42.37 Favored Pre-proline 0 N--CA 1.428 -1.54 0 CA-C-N 110.954 -2.839 . . . . 1.24 108.777 170.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.624 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 15.1 Cg_endo -60.08 -2.49 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 123.357 2.705 . . . . 0.39000000000000001 113.107 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 101' ' ' ASN . 0.8 OUTLIER -117.44 -26.41 6.68 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.911 0.862 . . . . 1.79 110.647 -177.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 141' ' ' SER . 4.6 t70 -64.8 -24.56 67.59 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 113.696 -1.593 . . . . 0.65000000000000002 109.359 -171.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.54 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 22.6 m 66.33 161.56 0.15 Allowed 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 112.689 -2.05 . . . . 0.73999999999999999 109.995 -175.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.86 ' HG ' ' CG ' ' A' ' 90' ' ' ASP . 9.2 mt -73.19 -35.63 66.4 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.148 -1.842 . . . . 1.48 109.204 -169.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.36 2.98 0.31 Allowed Glycine 0 C--N 1.318 -0.464 0 CA-C-N 113.164 -1.835 . . . . 0.34999999999999998 114.949 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 118.14 5.27 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 109.07 -0.715 . . . . 1.02 109.07 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.685 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 13.0 mmt180 -40.23 -47.87 2.5 Favored 'General case' 0 C--O 1.214 -0.783 0 O-C-N 123.696 0.623 . . . . 2.21 111.448 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -69.77 -28.24 65.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.477 0.656 . . . . 0.93000000000000005 111.461 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.536 ' O ' HD11 ' A' ' 151' ' ' ILE . 21.2 mttm -72.82 -31.32 64.72 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.38 1.086 . . . . 1.8899999999999999 108.276 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.687 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -77.75 -38.94 45.86 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 113.15 -1.841 . . . . 0.98999999999999999 110.798 178.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.527 HG13 ' HE2' ' A' ' 179' ' ' MET . 33.0 mt -69.78 -43.17 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 CA-C-N 113.821 -1.536 . . . . 1.03 109.978 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.73 -53.57 35.43 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.177 -0.919 . . . . 0.14999999999999999 110.979 171.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.732 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 7.6 mt -67.14 -44.92 87.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.028 0 N-CA-C 113.069 0.766 . . . . 1.05 113.069 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.631 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.65 -37.9 76.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 118.447 0.567 . . . . 1.03 110.513 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -83.18 -21.7 33.44 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.799 0.809 . . . . 1.29 110.407 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 13.8 t30 -82.58 -10.32 59.02 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.187 -1.412 . . . . 0.5 107.187 175.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.732 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -109.79 -29.24 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 113.294 -1.775 . . . . 1.05 111.107 -174.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.76 35.38 4.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.563 -0.827 . . . . 0.17000000000000001 112.642 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.715 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -112.09 159.28 18.66 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.416 0.895 . . . . 1.02 113.416 -169.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.651 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.1 m80 -100.32 -25.99 14.05 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.486 -0.779 . . . . 0.39000000000000001 110.068 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.571 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.5 m-85 -135.57 -172.62 3.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.234 -0.894 . . . . 0.81000000000000005 110.959 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.687 ' O ' HD21 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -138.81 136.72 43.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.013 -0.994 . . . . 1.03 108.964 167.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.525 HD22 ' HE1' ' A' ' 176' ' ' MET . 48.6 tp -106.96 99.44 9.01 Favored 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 119.637 -0.825 . . . . 1.02 108.995 165.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.687 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -81.54 111.97 18.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.103 -1.408 . . . . 0.87 109.448 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.842 ' OG ' HD11 ' A' ' 174' ' ' LEU . 31.4 t -121.31 166.33 14.2 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 121.699 0.761 . . . . 1.45 110.753 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.814 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.5 p -164.87 176.34 8.79 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-N 114.625 -1.17 . . . . 0.12 111.351 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -142.64 135.36 28.03 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.294 -1.321 . . . . 0.94999999999999996 108.499 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.643 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 3.1 m -144.42 -175.79 4.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.516 -0.55 . . . . 1.1499999999999999 109.516 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.6 -80.12 0.82 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 119.463 -1.351 . . . . 0.14999999999999999 112.025 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.5 t30 -148.92 123.2 9.58 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 106.917 -1.512 . . . . 0.58999999999999997 106.917 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.529 HG13 ' HA3' ' A' ' 98' ' ' GLY . 2.3 p -59.49 -45.65 93.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.121 -0.945 . . . . 1.0 113.287 -172.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.443 ' N ' HG11 ' A' ' 169' ' ' VAL . 8.9 m120 -60.02 -29.57 68.59 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.452 0.644 . . . . 1.9199999999999999 109.703 -176.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.91 88.03 3.6 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.441 -1.254 . . . . 1.0600000000000001 108.512 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.65 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.6 Cg_endo -91.22 166.47 3.63 Favored 'Trans proline' 0 CA--C 1.496 -1.407 0 C-N-CA 124.835 3.69 . . . . 0.089999999999999997 114.98 -170.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.2 m -83.19 117.95 23.27 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.856 -1.52 . . . . 1.0600000000000001 107.638 166.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.842 HD11 ' OG ' ' A' ' 163' ' ' SER . 46.4 tp -84.46 99.25 10.57 Favored 'General case' 0 N--CA 1.412 -2.325 0 C-N-CA 119.747 -0.781 . . . . 1.02 109.289 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.615 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.2 mt-30 -89.51 107.36 19.03 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 114.966 -1.015 . . . . 0.34000000000000002 109.291 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.889 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 37.5 mtp -106.52 161.83 14.26 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.212 -0.904 . . . . 1.0900000000000001 110.382 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.489 ' HG2' HD12 ' A' ' 186' ' ' ILE . 53.2 tt0 -167.47 119.03 0.88 Allowed 'General case' 0 C--O 1.207 -1.183 0 CA-C-O 121.165 0.507 . . . . 0.68000000000000005 110.025 -168.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.687 HD21 ' O ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER -101.01 101.34 12.1 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.826 -0.805 . . . . 1.03 108.826 -172.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.685 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.0 ttp -91.14 118.95 30.86 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.603 -0.726 . . . . 0.89000000000000001 109.318 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -61.85 118.49 7.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.273 -1.38 . . . . 1.04 107.273 169.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.518 HG22 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -73.2 -32.88 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 119.516 1.053 . . . . 1.02 111.408 -176.393 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.436 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.1 mt-30 -64.1 -12.84 43.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.40000000000000002 111.538 -177.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 33.1 p -130.12 -37.56 1.46 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.079 0.943 . . . . 1.03 109.892 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.466 ' CA ' HD13 ' A' ' 149' ' ' ILE . . . 88.82 19.47 51.25 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 113.756 -1.565 . . . . 0.17999999999999999 112.08 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.66 156.56 17.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.055 0.455 . . . . 0.72999999999999998 110.677 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.489 HD12 ' HG2' ' A' ' 177' ' ' GLN . 37.9 mm -88.4 117.48 32.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.679 0.752 . . . . 1.03 109.424 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.657 ' CD1' HD12 ' A' ' 178' ' ' LEU . 1.8 pp -104.79 -30.1 2.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.527 -1.215 . . . . 1.01 110.353 -172.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.586 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.3 t90 -137.43 152.33 49.48 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.191 -0.913 . . . . 0.070000000000000007 109.338 172.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 61.2 p -153.58 165.52 35.65 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.865 0.691 . . . . 0.64000000000000001 112.865 164.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.16 -179.43 33.99 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.892 -0.883 . . . . 0.12 110.892 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.817 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.8 mtmt -156.78 147.08 21.26 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.33 -1.73 . . . . 1.76 106.33 167.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -158.04 127.45 1.9 Allowed Glycine 0 C--N 1.283 -2.387 0 C-N-CA 119.94 -1.124 . . . . 0.13 112.266 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.72 117.02 13.9 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.425 0.631 . . . . 1.01 111.003 -174.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.674 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -93.99 159.25 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 122.589 1.185 . . . . 1.01 110.736 -177.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.753 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -101.8 172.08 7.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 112.501 -2.136 . . . . 0.92000000000000004 108.861 -174.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 8.3 tt0 -100.77 133.2 45.59 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.075 -0.65 . . . . 0.91000000000000003 109.411 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.504 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 35.1 mm-40 . . . . . 0 C--N 1.316 -0.89 0 CA-C-O 118.656 -0.688 . . . . 1.24 110.518 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.761 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.9 m-30 . . . . . 0 N--CA 1.434 -1.243 0 CA-C-O 120.207 0.051 . . . . 0.76000000000000001 110.878 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.528 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 10.6 t0 -85.16 67.64 10.25 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 123.395 1.569 . . . . 0.34999999999999998 108.473 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.761 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 94.9 m95 -57.44 -41.9 81.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.008 -2.36 . . . . 0.10000000000000001 112.769 175.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.484 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 14.7 t-20 -51.95 -25.43 8.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.197 -1.365 . . . . 1.1100000000000001 111.696 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.69 -16.58 78.97 Favored Glycine 0 C--N 1.312 -0.763 0 CA-C-N 115.147 -0.933 . . . . 0.23000000000000001 111.278 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.41 -52.84 3.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.118 -1.041 . . . . 1.01 111.199 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.758 ' SD ' HD22 ' A' ' 109' ' ' LEU . 41.4 mtt -64.59 -58.67 5.7 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 114.122 -1.399 . . . . 0.089999999999999997 112.507 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.515 HE21 ' HA ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -39.42 -54.78 3.56 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 114.794 1.405 . . . . 0.63 114.794 -176.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.785 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 37.4 Cg_endo -64.64 -28.97 60.64 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.532 1.488 . . . . 0.17000000000000001 110.16 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.828 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 10.9 mtm -83.09 -42.04 17.88 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.358 -0.837 . . . . 0.69999999999999996 112.108 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 68' ' ' MET . 58.2 t -57.01 -40.13 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 CA-C-N 114.26 -1.336 . . . . 1.04 108.802 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.68 -36.09 73.64 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.152 -1.84 . . . . 1.1200000000000001 111.054 173.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.785 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.1 mtpt -82.08 -32.91 30.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.011 -0.541 . . . . 1.8799999999999999 111.207 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.851 ' O ' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.82 -26.16 68.22 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.39 -0.823 . . . . 0.5 111.677 -172.19 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.47 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.9 mt -94.21 -8.02 40.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.124 0.964 . . . . 1.29 110.997 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.82 14.67 60.17 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.664 -1.774 . . . . 0.17999999999999999 108.664 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.661 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -86.46 165.72 16.08 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.159 -1.02 . . . . 1.0 109.818 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -94.46 105.38 17.35 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.252 -0.886 . . . . 1.72 109.914 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.635 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 136.23 -23.4 3.32 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.722 -0.951 . . . . 0.13 110.722 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.851 HG12 ' O ' ' A' ' 75' ' ' MET . 10.7 p -101.21 153.76 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.431 0.634 . . . . 1.01 111.197 -175.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.8 m -135.35 141.84 45.64 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.923 -1.035 . . . . 1.1000000000000001 110.441 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.474 ' HB3' ' HE3' ' A' ' 118' ' ' LYS . . . -59.38 130.25 45.98 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.346 -0.843 . . . . 1.1200000000000001 110.272 168.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.17 3.23 38.77 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.006 -0.616 . . . . 0.28000000000000003 112.876 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.0 151.89 22.87 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 120.488 -0.485 . . . . 1.55 110.97 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.646 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -80.73 119.14 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 121.988 0.899 . . . . 1.03 109.031 165.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.742 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -108.38 107.56 18.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.28 -0.873 . . . . 1.03 109.108 -171.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.676 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -71.43 97.9 1.71 Allowed 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.141 -1.39 . . . . 1.01 107.847 175.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.882 ' O ' HD13 ' A' ' 127' ' ' LEU . 2.5 m -71.08 121.91 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 106.608 -1.627 . . . . 1.6200000000000001 106.608 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.791 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 5.0 t0 -76.86 151.04 36.0 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.17 -1.419 . . . . 0.64000000000000001 107.17 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.571 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.1 m -57.53 132.78 54.21 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 106.947 -1.501 . . . . 1.05 106.947 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.586 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 23.1 t -60.55 138.31 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.988 0 N-CA-C 107.88 -1.155 . . . . 1.02 107.88 170.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.641 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -84.19 162.95 20.03 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.337 -0.847 . . . . 0.20000000000000001 109.704 174.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.781 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.1 85.19 2.37 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.748 -1.114 . . . . 0.12 108.114 175.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.46 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.3 mtp180 -108.18 -4.09 17.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.852 -1.522 . . . . 0.84999999999999998 108.77 -171.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 21.4 p -50.59 -171.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.854 -1.975 . . . . 0.91000000000000003 115.547 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 33.3 t30 -68.89 -10.66 58.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.883 -1.962 . . . . 0.62 110.739 173.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.528 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -152.48 -143.93 3.8 Favored Glycine 0 C--O 1.236 0.244 0 C-N-CA 120.258 -0.972 . . . . 0.14000000000000001 113.153 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.591 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 51.5 p -122.36 131.61 53.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.148 0.499 . . . . 1.76 111.949 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.781 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.4 pp -137.43 156.43 48.19 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.846 0.831 . . . . 1.01 110.633 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -79.87 81.09 6.19 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.787 -1.551 . . . . 0.20999999999999999 107.852 176.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 92' ' ' VAL . . . -68.93 -14.72 63.21 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.193 -1.367 . . . . 1.0 109.929 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.74 -30.23 40.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.685 -0.857 . . . . 1.02 108.685 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.617 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 28.2 tp10 -66.0 -34.57 78.4 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.78 1.276 . . . . 1.73 109.068 170.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -71.03 -45.22 64.3 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.049 -1.887 . . . . 1.04 109.227 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 49.1 m -64.8 -30.58 71.59 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.029 -1.441 . . . . 1.04 110.5 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -67.2 -44.04 80.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.749 -1.204 . . . . 1.47 107.749 171.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.626 HG23 ' HB2' ' A' ' 64' ' ' TRP . 37.7 m -63.24 -31.46 72.61 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.237 -0.892 . . . . 1.03 110.783 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.758 HD22 ' SD ' ' A' ' 68' ' ' MET . 9.3 mt -50.16 -70.47 0.09 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.05 -0.722 . . . . 1.3 109.05 170.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' ' 121' ' ' LEU . 10.9 mtp180 -40.08 -40.32 1.05 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.487 1.117 . . . . 1.8 111.358 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.521 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -67.26 -48.18 68.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.556 -1.202 . . . . 0.41999999999999998 112.137 -177.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.2 -34.97 68.8 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.315 1.055 . . . . 1.01 108.524 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -63.91 -32.33 73.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.158 -1.837 . . . . 1.01 110.064 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 110' ' ' ARG . . . -76.01 -47.5 24.62 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 114.523 -1.217 . . . . 1.03 111.302 -174.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -55.99 -33.13 64.56 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.336 -1.302 . . . . 1.55 110.11 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -70.17 -43.77 70.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.244 -1.798 . . . . 2.0499999999999998 110.784 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.12 -3.39 66.04 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 114.749 0.659 . . . . 0.54000000000000004 114.749 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 83' ' ' ALA . 58.7 mtpt -87.36 -8.2 56.89 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.066 0.933 . . . . 1.6000000000000001 111.192 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.742 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 27.0 m-85 -118.12 174.42 6.22 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 122.421 1.105 . . . . 0.27000000000000002 113.303 173.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.543 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.0 m -118.47 123.88 46.25 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 112.672 -2.058 . . . . 1.0800000000000001 108.021 170.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.661 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -95.66 141.33 29.27 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 119.291 -0.964 . . . . 1.1499999999999999 111.519 -169.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.541 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.2 m . . . . . 0 C--N 1.306 -1.314 0 N-CA-C 107.802 -1.184 . . . . 1.0900000000000001 107.802 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.882 HD13 ' O ' ' A' ' 89' ' ' VAL . 6.3 tt . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 113.268 0.84 . . . . 2.04 113.268 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.677 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -53.92 -43.72 70.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 123.389 1.566 . . . . 1.1499999999999999 109.116 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.669 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -55.59 -60.85 2.85 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 111.226 -2.715 . . . . 2.27 111.3 175.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.7 ' CB ' HG22 ' A' ' 151' ' ' ILE . . . -43.49 -46.22 6.77 Favored 'General case' 0 CA--C 1.497 -1.083 0 O-C-N 124.493 1.121 . . . . 1.0700000000000001 111.807 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.505 ' HZ3' ' C ' ' A' ' 141' ' ' SER . 5.8 mttt -53.32 -52.13 60.15 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.39 -0.596 . . . . 2.1000000000000001 109.39 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.1 mt-30 -66.9 -38.63 86.6 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.542 -0.754 . . . . 0.42999999999999999 110.878 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.669 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.2 mt-30 -59.04 -32.3 69.63 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 114.551 -1.204 . . . . 0.38 109.845 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.531 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.7 OUTLIER -94.3 -30.49 14.51 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.123 -1.399 . . . . 1.05 109.929 -177.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.06 -50.72 0.46 Allowed Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 120.012 -1.089 . . . . 0.33000000000000002 113.664 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 141' ' ' SER . 92.9 mt -65.36 -171.03 0.07 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 112.496 -1.852 . . . . 1.0700000000000001 115.954 -171.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.1 m -115.72 151.67 46.5 Favored Pre-proline 0 N--CA 1.424 -1.736 0 CA-C-N 110.65 -2.977 . . . . 1.24 107.985 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.677 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 36.2 Cg_endo -65.4 0.07 3.13 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.871 2.381 . . . . 0.39000000000000001 112.651 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.1 tt0 -118.74 -25.33 6.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.869 0.843 . . . . 1.79 110.519 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 141' ' ' SER . 9.1 t70 -60.98 -23.09 65.09 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.364 -1.744 . . . . 0.65000000000000002 109.079 -173.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 32.6 m 73.91 167.37 0.3 Allowed 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 112.848 -1.978 . . . . 0.73999999999999999 109.393 -174.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.791 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 3.3 mt -64.46 -39.49 93.92 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-O 122.439 1.114 . . . . 1.48 108.421 -175.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.37 -7.29 1.39 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 113.062 -1.881 . . . . 0.34999999999999998 114.163 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.49 126.35 6.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.995 -0.743 . . . . 1.02 108.995 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.67 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.2 mmt180 -41.83 -49.19 4.44 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 118.039 0.381 . . . . 2.21 110.995 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.6 t -69.34 -28.16 65.98 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.368 0.604 . . . . 0.93000000000000005 111.658 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 24.3 mttm -73.78 -29.95 62.49 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.618 1.199 . . . . 1.8899999999999999 108.668 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.631 ' CB ' HD11 ' A' ' 142' ' ' LEU . . . -75.25 -46.27 34.84 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-N 112.358 -2.201 . . . . 0.98999999999999999 110.358 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.524 HG13 ' HE3' ' A' ' 179' ' ' MET . 43.7 mt -65.97 -42.22 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 112.71 -2.041 . . . . 1.03 110.046 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.0 -52.63 41.99 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.849 -1.069 . . . . 0.14999999999999999 111.433 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.7 HG22 ' CB ' ' A' ' 130' ' ' ALA . 16.7 mt -68.34 -46.95 79.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 N-CA-C 112.346 0.498 . . . . 1.05 112.346 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.612 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.71 -39.7 74.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.954 0.407 . . . . 1.03 110.693 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.426 ' HD2' HG23 ' A' ' 149' ' ' ILE . 34.5 mtp180 -81.41 -23.13 37.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.52 0.676 . . . . 1.29 110.894 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.442 HD22 ' CD ' ' A' ' 133' ' ' GLN . 34.9 t30 -81.09 -13.18 58.98 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.627 -1.249 . . . . 0.5 107.627 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.685 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.92 -29.11 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 113.196 -1.82 . . . . 1.05 110.772 -174.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.59 34.6 5.21 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 120.198 -1.001 . . . . 0.17000000000000001 112.408 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.676 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.92 157.27 18.79 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 112.693 0.627 . . . . 1.02 112.693 -170.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.646 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.7 m80 -96.74 -27.16 14.88 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.362 -0.835 . . . . 0.39000000000000001 109.445 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.586 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.1 m-85 -137.29 -174.53 3.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.061 -0.972 . . . . 0.81000000000000005 111.325 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.69 ' O ' HD22 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -136.48 140.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.583 -1.19 . . . . 1.03 108.553 166.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.601 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 26.2 tp -110.02 99.89 8.92 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.466 -0.893 . . . . 1.02 109.704 166.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.515 ' HH ' ' HB2' ' A' ' 142' ' ' LEU . 2.3 m-85 -77.92 112.03 14.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.914 -1.039 . . . . 0.87 108.785 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.683 ' OG ' HD12 ' A' ' 109' ' ' LEU . 4.0 p -120.06 158.93 25.81 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 115.093 -0.958 . . . . 1.45 109.56 -175.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.77 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.2 p -163.75 172.56 13.99 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 115.154 -0.93 . . . . 0.12 110.875 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.67 131.81 36.18 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 113.956 -1.475 . . . . 0.94999999999999996 108.536 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -142.5 -176.39 4.83 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.158 -0.682 . . . . 1.1499999999999999 109.158 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -86.05 0.98 Allowed Glycine 0 CA--C 1.49 -1.492 0 C-N-CA 119.55 -1.309 . . . . 0.14999999999999999 111.101 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.3 t30 -141.59 129.06 21.31 Favored 'General case' 0 C--O 1.198 -1.629 0 CA-C-N 113.867 -1.167 . . . . 0.58999999999999997 107.963 175.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 99' ' ' SER . 3.7 p -64.7 -39.39 85.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.226 -0.897 . . . . 1.0 111.991 -172.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.473 ' N ' HG13 ' A' ' 169' ' ' VAL . 14.4 m-20 -61.3 -31.15 70.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.696 0.76 . . . . 1.9199999999999999 109.411 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.99 88.79 3.17 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 113.916 -1.493 . . . . 1.0600000000000001 107.962 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.657 ' HD2' HG22 ' A' ' 194' ' ' VAL . 51.3 Cg_endo -90.21 165.32 4.61 Favored 'Trans proline' 0 CA--C 1.491 -1.645 0 C-N-CA 124.315 3.343 . . . . 0.089999999999999997 114.837 -169.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 23.8 m -85.39 117.84 24.55 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 113.715 -1.584 . . . . 1.0600000000000001 107.769 167.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.828 ' O ' ' HE3' ' A' ' 71' ' ' MET . 38.6 tp -84.31 97.77 9.63 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 119.485 -0.886 . . . . 1.02 108.88 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.595 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -87.48 109.0 19.29 Favored 'General case' 0 C--N 1.277 -2.587 0 CA-C-N 114.64 -1.163 . . . . 0.34000000000000002 109.053 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.575 ' SD ' ' HB3' ' A' ' 163' ' ' SER . 2.6 mmm -111.03 163.57 13.71 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.51 -1.223 . . . . 1.0900000000000001 111.464 -173.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.517 ' HA ' ' HA ' ' A' ' 189' ' ' SER . 36.4 tt0 -172.08 117.59 0.38 Allowed 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 115.978 -0.556 . . . . 0.68000000000000005 110.114 -166.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER -100.05 101.54 12.64 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.53 -0.915 . . . . 1.03 108.53 -172.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.67 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 17.0 ttp -90.66 122.86 33.8 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.468 -0.787 . . . . 0.89000000000000001 109.639 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -59.19 127.19 30.91 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.268 -1.382 . . . . 1.04 107.268 166.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.16 -34.4 12.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.172 -1.011 . . . . 1.02 110.701 178.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -61.88 -15.95 46.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.333 -0.848 . . . . 0.40000000000000002 111.604 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.7 p -130.38 -36.74 1.45 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.826 0.822 . . . . 1.03 110.202 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.422 ' CA ' HD13 ' A' ' 149' ' ' ILE . . . 90.89 23.84 29.18 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 114.528 -1.214 . . . . 0.17999999999999999 112.272 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -103.63 156.72 17.57 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.656 0.265 . . . . 0.72999999999999998 110.653 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.466 HD12 ' HG2' ' A' ' 177' ' ' GLN . 35.0 mm -90.07 120.02 38.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.616 0.722 . . . . 1.03 109.379 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.684 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.4 pp -108.62 -30.19 2.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.942 -1.026 . . . . 1.01 110.495 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.661 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 80.9 t90 -136.36 152.85 51.09 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 115.108 -0.951 . . . . 0.070000000000000007 109.501 172.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 35.6 p -153.32 163.19 40.35 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 113.253 0.834 . . . . 0.64000000000000001 113.253 164.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.42 -175.55 29.47 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 110.967 -0.853 . . . . 0.12 110.967 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.811 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.4 mtmt -159.51 149.74 18.98 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 105.704 -1.961 . . . . 1.76 105.704 165.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -161.13 128.02 1.85 Allowed Glycine 0 C--N 1.28 -2.542 0 C-N-CA 119.601 -1.285 . . . . 0.13 112.142 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.3 120.2 17.57 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.58 0.705 . . . . 1.01 111.116 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.748 HG11 ' CE3' ' A' ' 64' ' ' TRP . 2.0 m -94.96 158.91 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-N 114.65 -1.159 . . . . 1.01 109.753 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.699 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -100.35 171.34 7.83 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 112.981 -1.918 . . . . 0.92000000000000004 109.292 -174.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 7.6 tt0 -101.5 130.35 47.74 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.253 -0.647 . . . . 0.91000000000000003 109.253 169.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.528 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 19.5 mm-40 . . . . . 0 C--N 1.31 -1.146 0 CA-C-O 118.431 -0.795 . . . . 1.24 110.383 176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.749 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.0 m-30 . . . . . 0 N--CA 1.415 -2.219 0 N-CA-C 109.41 -0.589 . . . . 0.76000000000000001 109.41 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 6.1 t70 -81.49 67.51 7.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.499 1.619 . . . . 0.34999999999999998 107.931 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.727 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 93.3 m95 -59.64 -42.34 92.55 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 111.933 -2.394 . . . . 0.10000000000000001 111.911 174.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.517 ' N ' HG23 ' A' ' 108' ' ' THR . 8.9 t-20 -52.53 -24.88 8.94 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.062 -1.426 . . . . 1.1100000000000001 111.452 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.49 -16.73 77.34 Favored Glycine 0 C--N 1.312 -0.773 0 CA-C-N 115.129 -0.941 . . . . 0.23000000000000001 111.175 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.16 -55.11 2.55 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.897 -1.152 . . . . 1.01 111.41 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.76 ' SD ' HD22 ' A' ' 109' ' ' LEU . 40.9 mtt -64.05 -57.21 10.34 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.117 -1.401 . . . . 0.089999999999999997 112.893 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.577 HE22 ' ND2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -38.85 -54.93 2.96 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 114.53 1.307 . . . . 0.63 114.53 -176.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.781 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.7 Cg_endo -64.71 -31.64 58.39 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 121.949 1.766 . . . . 0.17000000000000001 110.956 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.718 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 10.2 mtm -79.58 -44.04 21.81 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.433 -0.803 . . . . 0.69999999999999996 111.54 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 68' ' ' MET . 40.5 t -57.17 -39.09 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 114.366 -1.288 . . . . 1.04 108.509 175.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.7 t -59.19 -36.44 75.35 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.153 -1.839 . . . . 1.1200000000000001 110.811 174.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.781 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 32.8 mtpt -81.55 -34.13 31.3 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.168 0.508 . . . . 1.8799999999999999 110.823 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.851 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.54 -29.07 70.38 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.235 -0.893 . . . . 0.5 111.563 -171.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.54 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.0 mt -90.77 -8.07 50.7 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.922 0.867 . . . . 1.29 111.118 -177.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.38 13.09 58.49 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 109.182 -1.567 . . . . 0.17999999999999999 109.182 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.639 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -83.54 160.25 21.5 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.441 -0.879 . . . . 1.0 110.245 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.47 106.29 16.71 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.062 -0.972 . . . . 1.72 110.115 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.52 -22.8 3.67 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 110.766 -0.933 . . . . 0.13 110.766 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.851 HG11 ' O ' ' A' ' 75' ' ' MET . 11.3 p -102.95 150.0 6.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.639 0.733 . . . . 1.01 111.514 -176.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.0 m -137.61 141.33 41.26 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.695 -1.139 . . . . 1.1000000000000001 111.135 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.508 ' HB3' ' HE3' ' A' ' 118' ' ' LYS . . . -55.97 132.36 49.69 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.745 -1.116 . . . . 1.1200000000000001 111.285 169.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.57 2.27 37.52 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.859 -0.686 . . . . 0.28000000000000003 112.709 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.26 149.91 22.86 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 120.233 -0.587 . . . . 1.55 110.923 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.648 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -79.48 117.55 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 122.196 0.998 . . . . 1.03 108.871 164.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.763 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -104.92 109.75 21.85 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.521 -0.918 . . . . 1.03 108.521 -172.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.671 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.27 94.06 1.16 Allowed 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.788 -1.19 . . . . 1.01 107.788 176.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.437 HG12 ' HG3' ' A' ' 110' ' ' ARG . 1.1 m -72.87 116.14 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 107.124 -1.436 . . . . 1.6200000000000001 107.124 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.841 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 8.3 t0 -76.98 154.77 33.2 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.723 -1.214 . . . . 0.64000000000000001 107.723 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.558 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.0 OUTLIER -58.05 136.38 57.15 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 107.527 -1.286 . . . . 1.05 107.527 171.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.562 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.8 t -64.0 139.0 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 107.835 -1.172 . . . . 1.02 107.835 168.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.656 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.6 t-20 -85.61 163.24 18.45 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.128 -0.942 . . . . 0.20000000000000001 110.063 174.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.749 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.31 85.25 2.38 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.407 -1.27 . . . . 0.12 108.187 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.454 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 9.7 mtp180 -108.88 -1.12 19.37 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.056 -1.429 . . . . 0.84999999999999998 108.644 -172.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 20.6 p -53.36 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.991 -1.913 . . . . 0.91000000000000003 115.106 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 22.4 t30 -67.45 -13.31 61.92 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.712 -2.04 . . . . 0.62 110.479 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.519 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -149.71 -145.02 4.05 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.259 -0.972 . . . . 0.14000000000000001 113.109 -176.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.6 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.4 p -121.89 132.65 54.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.18 0.514 . . . . 1.76 111.747 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.749 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.0 pp -137.75 157.01 47.36 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.827 0.822 . . . . 1.01 110.641 -178.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.608 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -80.57 79.43 7.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 113.959 -1.473 . . . . 0.20999999999999999 107.647 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.563 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -68.16 -14.26 62.85 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.545 -1.207 . . . . 1.0 109.836 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.415 ' HB1' ' HG3' ' A' ' 139' ' ' GLN . . . -80.17 -30.01 38.78 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.632 -0.877 . . . . 1.02 108.632 -178.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.608 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.1 tp10 -67.93 -34.01 75.78 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.304 -1.317 . . . . 1.73 109.104 171.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 102' ' ' ALA . . . -71.44 -43.69 66.23 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 113.213 -1.812 . . . . 1.04 109.613 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.558 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 63.5 m -63.56 -28.13 69.73 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.73 -1.577 . . . . 1.04 110.159 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 104' ' ' GLU . 3.7 tp10 -66.04 -52.06 52.5 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.16 -1.052 . . . . 1.47 108.16 169.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 32.2 m -56.36 -33.93 66.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.669 -0.696 . . . . 1.03 111.319 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.76 HD22 ' SD ' ' A' ' 68' ' ' MET . 8.7 mt -50.46 -68.02 0.21 Allowed 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 116.12 -0.491 . . . . 1.3 109.799 172.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.504 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.7 mtp180 -43.04 -35.47 1.28 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.129 0.966 . . . . 1.8 111.194 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.61 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -72.56 -45.62 58.36 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.49 -1.232 . . . . 0.41999999999999998 112.101 -175.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.56 -33.59 60.66 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.309 -0.997 . . . . 1.01 108.309 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.689 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -62.99 -34.45 77.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 113.651 -1.613 . . . . 1.01 110.064 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 110' ' ' ARG . . . -69.84 -38.28 76.45 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.521 -1.218 . . . . 1.03 111.208 -175.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . 0.577 ' ND2' HE22 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -60.97 -29.21 69.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.736 -1.12 . . . . 1.55 111.179 -175.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -81.31 -30.25 33.98 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.746 -0.661 . . . . 2.0499999999999998 111.141 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.28 3.82 10.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.049 -0.596 . . . . 0.54000000000000004 113.228 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' A' ' 83' ' ' ALA . 54.2 mtpt -88.28 -6.31 57.84 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.963 0.411 . . . . 1.6000000000000001 110.092 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.763 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 27.8 m-85 -122.49 175.32 6.52 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 122.491 1.139 . . . . 0.27000000000000002 113.099 172.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 7.1 m -121.11 119.26 31.9 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 112.621 -2.081 . . . . 1.0800000000000001 107.947 168.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -89.6 139.44 30.55 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.345 -0.942 . . . . 1.1499999999999999 111.319 -170.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.461 HG13 HD22 ' A' ' 88' ' ' LEU . 1.6 m . . . . . 0 C--N 1.3 -1.568 0 N-CA-C 108.222 -1.029 . . . . 1.0900000000000001 108.222 170.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.439 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 26.1 tp . . . . . 0 CA--C 1.514 -0.429 0 N-CA-C 113.104 0.779 . . . . 2.04 113.104 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.637 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.8 t -50.47 -43.73 55.49 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 123.365 1.555 . . . . 1.1499999999999999 109.117 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.706 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -57.69 -61.42 2.52 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 111.145 -2.752 . . . . 2.27 110.521 177.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.691 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.76 -45.79 7.35 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 124.564 1.165 . . . . 1.0700000000000001 112.169 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.501 ' NZ ' ' HA ' ' A' ' 141' ' ' SER . 0.4 OUTLIER -54.44 -53.23 56.96 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 108.701 -0.851 . . . . 2.1000000000000001 108.701 179.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 128' ' ' SER . 40.2 mt-30 -63.83 -39.89 95.29 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.563 -0.744 . . . . 0.42999999999999999 111.287 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.706 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.9 mt-30 -58.89 -35.07 72.42 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 114.471 -1.24 . . . . 0.38 109.548 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 134' ' ' LEU . 0.5 OUTLIER -90.06 -30.67 17.57 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 113.798 -1.546 . . . . 1.05 109.502 -176.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.27 -45.89 0.6 Allowed Glycine 0 CA--C 1.495 -1.162 0 CA-C-O 122.422 1.012 . . . . 0.33000000000000002 113.376 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 141' ' ' SER . 92.3 mt -66.38 -171.09 0.11 Allowed 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.362 -1.919 . . . . 1.0700000000000001 115.613 -170.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.536 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.1 m -115.78 151.45 46.33 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 110.716 -2.947 . . . . 1.24 107.924 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.637 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 34.0 Cg_endo -64.81 0.2 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.526 2.151 . . . . 0.39000000000000001 112.638 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 137' ' ' SER . 0.7 OUTLIER -119.13 -23.9 6.66 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.871 0.843 . . . . 1.79 110.811 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' SER . 14.4 t70 -61.4 -21.5 64.15 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.471 -1.695 . . . . 0.65000000000000002 109.359 -173.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 26.3 m 70.56 167.84 0.3 Allowed 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 112.641 -2.072 . . . . 0.73999999999999999 110.12 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.841 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 5.4 mt -64.97 -40.29 94.77 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.257 -1.016 . . . . 1.48 108.257 -177.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 62.39 -10.16 0.12 Allowed Glycine 0 C--N 1.32 -0.357 0 CA-C-N 113.098 -1.864 . . . . 0.34999999999999998 114.586 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.7 OUTLIER -153.8 124.51 7.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.026 -0.731 . . . . 1.02 109.026 -175.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.683 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.3 mmt180 -41.28 -45.69 3.02 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 112.101 0.408 . . . . 2.21 112.101 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 31.3 t -75.04 -25.58 58.81 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.791 0.805 . . . . 0.93000000000000005 111.247 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.53 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 48.2 mttt -72.77 -29.28 63.18 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.755 1.264 . . . . 1.8899999999999999 108.156 175.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.676 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -77.57 -49.02 15.52 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 112.31 -2.223 . . . . 0.98999999999999999 110.273 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.541 ' HA ' HG21 ' A' ' 181' ' ' VAL . 38.3 mt -65.26 -41.19 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-N 113.016 -1.902 . . . . 1.03 110.151 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.84 -55.0 25.61 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.745 -1.116 . . . . 0.14999999999999999 111.09 171.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.725 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 87.6 mt -66.78 -47.34 83.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 N-CA-C 112.637 0.606 . . . . 1.05 112.637 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.654 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.0 -41.14 74.4 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.046 0.45 . . . . 1.03 111.133 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.446 ' HD2' HG23 ' A' ' 149' ' ' ILE . 54.3 mtp180 -81.01 -23.15 38.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.852 0.835 . . . . 1.29 110.242 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.424 HD22 ' CD ' ' A' ' 133' ' ' GLN . 12.7 t30 -82.73 -10.7 58.78 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.323 -1.362 . . . . 0.5 107.323 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.725 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.14 -28.8 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 113.148 -1.842 . . . . 1.05 110.965 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.74 35.26 4.66 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.443 -0.884 . . . . 0.17000000000000001 112.6 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.671 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.4 159.5 16.96 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.02 0.748 . . . . 1.02 113.02 -169.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.648 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -98.64 -29.11 13.23 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.211 -0.904 . . . . 0.39000000000000001 109.434 178.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.576 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.4 m-85 -135.51 -173.17 3.27 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.055 -0.975 . . . . 0.81000000000000005 111.037 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.701 ' O ' HD22 ' A' ' 178' ' ' LEU . 1.1 t -136.74 138.54 46.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.645 -1.161 . . . . 1.03 108.921 166.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.565 HD21 ' SD ' ' A' ' 176' ' ' MET . 35.1 tp -107.85 100.96 10.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.435 -0.906 . . . . 1.02 109.137 165.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.607 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.4 m-85 -78.5 119.04 21.24 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.401 -1.272 . . . . 0.87 108.131 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.87 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 13.3 t -130.69 158.76 39.19 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 122.12 0.962 . . . . 1.45 110.413 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.656 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.5 p -162.03 170.67 18.86 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.038 -1.437 . . . . 0.12 110.718 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -132.27 135.73 46.46 Favored 'General case' 0 N--CA 1.406 -2.666 0 CA-C-N 114.044 -1.434 . . . . 0.94999999999999996 108.766 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.7 t -144.52 -170.69 3.44 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.608 -0.837 . . . . 1.1499999999999999 110.376 176.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 89.84 -83.23 1.38 Allowed Glycine 0 C--N 1.289 -2.065 0 CA-C-N 114.906 -1.043 . . . . 0.14999999999999999 111.062 175.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 57.7 t30 -141.67 129.37 21.6 Favored 'General case' 0 C--O 1.199 -1.602 0 CA-C-N 113.872 -1.164 . . . . 0.58999999999999997 108.205 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 99' ' ' SER . 4.2 p -65.28 -41.88 92.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 115.378 -0.828 . . . . 1.0 112.63 -171.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 169' ' ' VAL . 9.7 m120 -61.56 -29.44 70.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.378 0.608 . . . . 1.9199999999999999 109.462 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.35 88.93 3.35 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 114.592 -1.185 . . . . 1.0600000000000001 108.9 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.663 ' HD2' HG23 ' A' ' 194' ' ' VAL . 40.7 Cg_endo -92.24 163.88 3.08 Favored 'Trans proline' 0 CA--C 1.501 -1.147 0 C-N-CA 124.858 3.705 . . . . 0.089999999999999997 115.458 -170.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.575 HG23 ' HB3' ' A' ' 191' ' ' LYS . 14.3 m -82.73 120.54 25.72 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.837 -1.529 . . . . 1.0600000000000001 107.563 168.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.957 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 22.1 tp -82.78 95.16 7.8 Favored 'General case' 0 CA--C 1.476 -1.901 0 C-N-CA 119.434 -0.906 . . . . 1.02 109.11 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.496 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 35.8 mt-30 -86.18 107.74 18.02 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-O 122.044 0.926 . . . . 0.34000000000000002 108.61 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.87 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.0 OUTLIER -111.85 163.18 14.48 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.893 -1.048 . . . . 1.0900000000000001 111.245 -174.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.607 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 55.4 tt0 -170.48 117.81 0.53 Allowed 'General case' 0 C--O 1.204 -1.332 0 CA-C-N 115.87 -0.604 . . . . 0.68000000000000005 110.327 -167.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -100.1 100.51 11.38 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.414 -0.958 . . . . 1.03 108.414 -173.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.683 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.6 ttp -90.61 123.39 34.2 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.492 -0.776 . . . . 0.89000000000000001 109.608 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.96 126.65 28.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.096 -1.446 . . . . 1.04 107.096 166.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -81.6 -35.06 13.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 119.103 -1.039 . . . . 1.02 110.81 179.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.442 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.9 mt-30 -62.81 -15.06 52.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.377 -0.828 . . . . 0.40000000000000002 111.58 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.1 p -130.05 -34.89 1.64 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.724 0.773 . . . . 1.03 110.276 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 84.6 29.83 28.65 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.462 -1.244 . . . . 0.17999999999999999 112.12 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 179' ' ' MET . 9.8 pt-20 -105.3 158.19 16.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.42 -0.39 . . . . 0.72999999999999998 110.447 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.471 HD13 ' HG2' ' A' ' 177' ' ' GLN . 32.0 mm -93.58 112.07 25.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.623 0.725 . . . . 1.03 109.659 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.682 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.2 pp -99.48 -30.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.067 -0.969 . . . . 1.01 110.853 -173.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.639 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.0 t90 -136.76 152.82 50.76 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.403 -0.817 . . . . 0.070000000000000007 109.743 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 35.9 p -153.99 163.9 39.31 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.107 0.78 . . . . 0.64000000000000001 113.107 165.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.01 -173.65 27.69 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 111.125 -0.79 . . . . 0.12 111.125 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.957 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.5 mttt -158.8 148.96 19.54 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.409 -1.7 . . . . 1.76 106.409 165.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 174' ' ' LEU . . . -154.13 125.38 1.72 Allowed Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 118.574 -1.774 . . . . 0.13 113.905 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.75 107.93 5.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.648 0.737 . . . . 1.01 110.862 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.688 HG12 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -88.57 158.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-N 114.224 -1.353 . . . . 1.01 110.586 -175.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.749 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -100.47 171.99 7.4 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 112.573 -2.103 . . . . 0.92000000000000004 108.751 -175.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 8.8 tt0 -101.82 132.86 47.35 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.086 -0.646 . . . . 0.91000000000000003 109.621 172.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.532 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 36.0 mm-40 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.496 -0.764 . . . . 1.24 110.672 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.756 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 . . . . . 0 N--CA 1.418 -2.046 0 N-CA-C 109.499 -0.556 . . . . 0.76000000000000001 109.499 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.504 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 5.1 t70 -82.49 67.47 8.54 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 123.618 1.675 . . . . 0.34999999999999998 108.144 171.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.729 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 91.9 m95 -57.58 -42.98 84.19 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 111.678 -2.51 . . . . 0.10000000000000001 112.026 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.477 ' N ' HG23 ' A' ' 108' ' ' THR . 13.4 t-20 -51.21 -28.3 11.08 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.914 -1.494 . . . . 1.1100000000000001 111.331 174.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 -18.56 79.06 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.096 -0.956 . . . . 0.23000000000000001 111.258 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.84 -54.35 2.84 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.868 -1.166 . . . . 1.01 110.879 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.752 ' SD ' HD21 ' A' ' 109' ' ' LEU . 40.8 mtt -60.2 -62.54 1.79 Allowed 'General case' 0 C--O 1.21 -0.998 0 CA-C-N 113.878 -1.51 . . . . 0.089999999999999997 111.61 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.47 HE21 ' HA ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -37.22 -54.89 1.87 Allowed Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 114.593 1.331 . . . . 0.63 114.593 -172.259 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.726 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 34.4 Cg_endo -64.14 -31.56 64.54 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.355 2.036 . . . . 0.17000000000000001 111.001 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.655 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 8.1 mtm -78.24 -43.96 26.86 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 114.988 -1.005 . . . . 0.69999999999999996 111.271 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.654 HG21 ' O ' ' A' ' 68' ' ' MET . 42.4 t -58.57 -38.94 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-N 114.284 -1.326 . . . . 1.04 108.716 176.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.2 t -58.71 -37.25 75.72 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.956 -1.929 . . . . 1.1200000000000001 111.026 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.726 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 4.8 mtpm? -78.57 -41.92 30.63 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.627 -0.509 . . . . 1.8799999999999999 109.627 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.835 ' SD ' ' HE2' ' A' ' 119' ' ' PHE . 1.0 OUTLIER -45.88 -53.53 9.64 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.724 0.809 . . . . 0.5 110.099 -175.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.642 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.9 mt -80.29 7.41 9.58 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.288 -1.324 . . . . 1.29 112.249 -170.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.55 15.62 9.82 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.075 -1.421 . . . . 0.17999999999999999 109.805 170.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.594 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -80.54 165.25 22.29 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.235 0.54 . . . . 1.0 110.423 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -87.8 105.81 17.65 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 115.597 -0.729 . . . . 1.72 109.124 175.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.648 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.29 -25.37 3.02 Favored Glycine 0 N--CA 1.415 -2.731 0 C-N-CA 119.623 -1.275 . . . . 0.13 110.437 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.758 HG11 ' O ' ' A' ' 75' ' ' MET . 12.8 p -103.21 149.35 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.86 0.838 . . . . 1.01 111.365 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.1 m -135.52 140.33 44.66 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.692 -1.14 . . . . 1.1000000000000001 110.744 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.441 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -54.77 131.49 43.95 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.07 -0.968 . . . . 1.1200000000000001 110.698 168.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.04 0.2 38.62 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.951 -0.642 . . . . 0.28000000000000003 113.271 176.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.87 151.22 23.52 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 120.537 -0.465 . . . . 1.55 111.081 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.658 HG11 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -81.16 120.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-O 121.865 0.84 . . . . 1.03 109.074 165.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.703 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -108.42 111.02 22.7 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.412 -0.813 . . . . 1.03 109.061 -171.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.664 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -72.31 101.09 2.78 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 114.849 -1.069 . . . . 1.01 109.329 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.468 HG23 ' HG3' ' A' ' 110' ' ' ARG . 53.1 t -74.34 106.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 114.495 -1.229 . . . . 1.6200000000000001 109.511 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.923 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 2.3 t70 -78.29 158.39 28.89 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.592 -1.186 . . . . 0.64000000000000001 108.344 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.649 ' HG ' ' HA ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -62.32 135.28 57.39 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 115.378 -0.828 . . . . 1.05 109.325 175.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 33.4 t -62.28 138.49 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 106.983 -1.488 . . . . 1.02 106.983 167.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.669 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.0 t-20 -85.01 161.49 19.73 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.836 0.827 . . . . 0.20000000000000001 110.114 174.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.762 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.95 84.94 2.34 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.368 -1.287 . . . . 0.12 108.261 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -108.51 -2.75 18.68 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 113.912 -1.495 . . . . 0.84999999999999998 108.572 -172.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 20.5 p -51.1 -170.94 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.683 -2.053 . . . . 0.91000000000000003 115.107 -176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 36.5 t30 -70.43 -10.45 59.14 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.134 -1.848 . . . . 0.62 110.567 173.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.523 ' HA3' HG13 ' A' ' 169' ' ' VAL . . . -152.22 -144.45 3.92 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.414 -0.898 . . . . 0.14000000000000001 113.128 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.593 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 54.6 p -122.14 131.73 54.11 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.165 0.432 . . . . 1.76 112.165 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.762 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.8 pp -136.84 156.76 48.06 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.772 0.796 . . . . 1.01 110.947 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.579 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -79.81 81.18 6.11 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.814 -1.539 . . . . 0.20999999999999999 107.961 175.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 92' ' ' VAL . . . -67.97 -15.1 63.45 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.933 -1.485 . . . . 1.0 110.112 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.461 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.92 -32.79 40.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.73 -0.841 . . . . 1.02 108.73 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.579 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 12.8 tp10 -65.22 -34.48 78.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.432 -1.258 . . . . 1.73 108.929 171.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.06 -43.41 64.95 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 113.243 -1.798 . . . . 1.04 109.367 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.637 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 76.5 m -64.73 -28.8 69.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.062 -1.426 . . . . 1.04 110.405 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -43.53 67.31 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.05 -1.093 . . . . 1.47 108.05 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 64' ' ' TRP . 75.9 m -61.96 -31.6 71.96 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.327 -0.852 . . . . 1.03 110.613 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.752 HD21 ' SD ' ' A' ' 68' ' ' MET . 9.0 mt -51.43 -69.48 0.11 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 109.209 -0.663 . . . . 1.3 109.209 171.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.76 ' O ' HD12 ' A' ' 121' ' ' LEU . 8.9 mtp180 -40.09 -38.86 0.79 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.424 1.078 . . . . 1.8 111.182 175.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.528 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.88 -47.33 59.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.473 -1.24 . . . . 0.41999999999999998 112.159 -176.073 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.8 -33.08 68.25 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.107 0.956 . . . . 1.01 108.424 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.71 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.1 mm? -61.99 -32.98 73.5 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.437 -1.71 . . . . 1.01 109.894 173.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.43 -41.5 60.74 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.484 -1.234 . . . . 1.03 111.604 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -64.93 -25.64 67.97 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.4 -0.818 . . . . 1.55 111.199 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 10.7 m120 -84.15 -16.53 43.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.529 -0.76 . . . . 2.0499999999999998 110.844 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.6 17.2 19.17 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 115.432 0.933 . . . . 0.54000000000000004 115.432 164.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 53.3 mtpt -98.16 -34.4 10.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.541 0.67 . . . . 1.6000000000000001 109.997 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.835 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 13.7 m-85 -89.32 177.85 6.49 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 122.728 1.251 . . . . 0.27000000000000002 113.095 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.507 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 21.2 m -123.67 111.07 15.75 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 112.299 -2.228 . . . . 1.0800000000000001 107.84 168.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.76 HD12 ' O ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -89.37 123.66 33.74 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.719 -1.128 . . . . 1.1499999999999999 110.734 -170.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.484 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.3 -1.579 0 CA-C-N 115.354 -0.839 . . . . 1.0900000000000001 109.102 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.703 HD13 ' NZ ' ' A' ' 131' ' ' LYS . 1.1 tm? . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 113.514 0.931 . . . . 2.04 113.514 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.575 ' N ' HD11 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -50.8 -37.97 45.72 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 123.684 1.707 . . . . 1.1499999999999999 108.637 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.674 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 29.2 mmm -62.82 -62.09 1.96 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 110.417 -3.083 . . . . 2.27 111.403 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.725 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -40.99 -45.12 2.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 124.478 1.111 . . . . 1.0700000000000001 111.905 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.703 ' NZ ' HD13 ' A' ' 127' ' ' LEU . 95.3 mttt -52.38 -58.09 7.77 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.847 -0.615 . . . . 2.1000000000000001 109.845 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.597 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 41.7 mt-30 -58.12 -44.72 87.89 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.566 -1.197 . . . . 0.42999999999999999 111.622 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.674 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.5 mt-30 -56.47 -36.37 68.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.627 -1.17 . . . . 0.38 109.871 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -88.49 -29.38 20.18 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.972 -1.467 . . . . 1.05 109.431 -177.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.8 -41.46 0.58 Allowed Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 119.36 -1.4 . . . . 0.33000000000000002 114.328 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 91.2 mt -73.75 -172.89 1.36 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 123.868 1.794 . . . . 1.0700000000000001 115.262 -168.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 52.4 m -111.44 151.4 43.23 Favored Pre-proline 0 N--CA 1.425 -1.675 0 CA-C-N 110.783 -2.917 . . . . 1.24 107.964 169.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.623 ' HA ' ' HD2' ' A' ' 131' ' ' LYS . 14.3 Cg_endo -60.6 -3.27 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.736 2.29 . . . . 0.39000000000000001 112.782 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.504 ' OE1' ' HA ' ' A' ' 101' ' ' ASN . 0.9 OUTLIER -118.6 -20.88 8.18 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 123.132 0.573 . . . . 1.79 109.954 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.6 t70 -60.44 -33.55 72.71 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.699 -1.223 . . . . 0.65000000000000002 107.699 -174.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.649 ' HA ' ' HG ' ' A' ' 91' ' ' SER . 18.4 m 78.92 156.64 0.16 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 110.441 -3.072 . . . . 0.73999999999999999 111.059 -173.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.923 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 7.2 mt -63.82 -39.34 94.0 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.15 -1.426 . . . . 1.48 107.15 -172.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.1 -3.6 0.16 Allowed Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 112.849 -1.978 . . . . 0.34999999999999998 115.166 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 m -149.66 121.67 8.25 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.881 -0.785 . . . . 1.02 108.881 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.584 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.3 mmt180 -41.91 -45.06 3.62 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 123.61 0.569 . . . . 2.21 111.366 -175.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.3 t -73.17 -26.55 61.23 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.541 0.686 . . . . 0.93000000000000005 111.525 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.538 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 49.1 mttt -73.15 -33.04 65.26 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.138 -1.06 . . . . 1.8899999999999999 108.138 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.684 ' HB1' ' OH ' ' A' ' 162' ' ' TYR . . . -74.98 -43.46 53.85 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-N 113.019 -1.901 . . . . 0.98999999999999999 110.465 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.533 HG13 ' HE3' ' A' ' 179' ' ' MET . 43.4 mt -67.1 -42.69 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 113.589 -1.641 . . . . 1.03 110.159 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.31 -52.33 41.4 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.856 -1.065 . . . . 0.14999999999999999 111.287 171.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.725 HG21 ' CB ' ' A' ' 130' ' ' ALA . 71.8 mt -68.5 -47.25 78.14 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 N-CA-C 112.891 0.7 . . . . 1.05 112.891 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.664 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.28 -38.34 71.07 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.001 0.429 . . . . 1.03 111.23 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -84.04 -20.01 33.43 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.666 0.746 . . . . 1.29 110.443 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.425 HD21 ' CB ' ' A' ' 130' ' ' ALA . 16.6 t30 -84.36 -10.38 57.63 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.307 -1.368 . . . . 0.5 107.307 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.694 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -109.69 -29.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 113.262 -1.79 . . . . 1.05 111.094 -173.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.13 34.74 4.73 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.391 -0.909 . . . . 0.17000000000000001 112.833 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.61 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.64 161.29 15.53 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.15 0.796 . . . . 1.02 113.15 -169.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.658 ' N ' HG11 ' A' ' 86' ' ' VAL . 1.6 m80 -101.91 -28.14 12.57 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.375 -0.829 . . . . 0.39000000000000001 109.78 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.561 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.4 m-85 -135.39 -172.57 3.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.261 -0.881 . . . . 0.81000000000000005 110.959 -175.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.71 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -138.85 139.62 40.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.098 -0.955 . . . . 1.03 109.221 167.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.574 HD23 ' SD ' ' A' ' 176' ' ' MET . 43.9 tp -107.62 99.84 9.29 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 119.386 -0.925 . . . . 1.02 109.395 165.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.684 ' OH ' ' HB1' ' A' ' 148' ' ' ALA . 3.0 m-85 -81.69 112.81 19.21 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.234 -1.348 . . . . 0.87 109.556 176.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.866 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 4.9 t -123.08 166.12 15.68 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-O 121.77 0.795 . . . . 1.45 111.033 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.811 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.6 p -162.79 176.18 10.52 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 114.548 -1.205 . . . . 0.12 111.313 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.65 133.4 30.58 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 113.865 -1.516 . . . . 0.94999999999999996 108.279 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.625 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -143.14 -177.17 5.23 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.354 -0.61 . . . . 1.1499999999999999 109.354 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.76 -83.72 0.86 Allowed Glycine 0 CA--C 1.493 -1.336 0 C-N-CA 119.62 -1.276 . . . . 0.14999999999999999 111.355 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.7 t30 -144.17 130.5 19.8 Favored 'General case' 0 C--O 1.199 -1.598 0 N-CA-C 107.972 -1.121 . . . . 0.58999999999999997 107.972 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 99' ' ' SER . 3.2 p -64.48 -41.56 92.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.123 -0.944 . . . . 1.0 112.36 -171.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.469 ' N ' HG11 ' A' ' 169' ' ' VAL . 10.9 m-20 -61.19 -30.76 70.61 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.793 0.806 . . . . 1.9199999999999999 109.509 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.11 88.39 3.49 Favored Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 113.868 -1.514 . . . . 1.0600000000000001 108.376 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.646 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.0 Cg_endo -90.72 167.0 4.01 Favored 'Trans proline' 0 CA--C 1.492 -1.579 0 C-N-CA 124.579 3.52 . . . . 0.089999999999999997 114.72 -170.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 23.7 m -86.39 119.41 26.63 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 113.732 -1.577 . . . . 1.0600000000000001 107.643 166.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.843 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 42.2 tp -84.13 98.67 10.03 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 108.643 -0.873 . . . . 1.02 108.643 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.579 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.0 mt-30 -90.49 109.02 20.17 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 122.089 0.947 . . . . 0.34000000000000002 109.276 -176.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.866 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -111.73 164.54 12.93 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.936 -1.029 . . . . 1.0900000000000001 111.795 -172.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 56.0 tt0 -170.64 119.5 0.54 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 115.813 -0.63 . . . . 0.68000000000000005 110.245 -166.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -101.32 101.84 12.58 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.929 -0.767 . . . . 1.03 108.929 -173.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.584 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.4 ttp -90.88 118.35 30.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.755 -0.657 . . . . 0.89000000000000001 109.675 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.454 ' HB2' HG22 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -61.7 117.89 6.41 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.936 -1.505 . . . . 1.04 106.936 168.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -71.9 -36.35 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.05 0.841 . . . . 1.02 111.485 -176.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -60.85 -15.25 28.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.364 -0.835 . . . . 0.40000000000000002 111.685 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 185' ' ' GLU . 40.5 p -127.91 -37.02 1.95 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.308 1.051 . . . . 1.03 109.896 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.445 ' CA ' HD12 ' A' ' 149' ' ' ILE . . . 86.83 24.32 38.73 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 113.765 -1.561 . . . . 0.17999999999999999 111.733 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.43 ' HG2' ' OG1' ' A' ' 183' ' ' THR . 11.0 pt-20 -105.22 158.03 16.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.882 0.372 . . . . 0.72999999999999998 110.248 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.471 HD13 ' HG2' ' A' ' 177' ' ' GLN . 36.0 mm -91.5 117.14 34.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.498 0.666 . . . . 1.03 109.391 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.658 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.8 pp -105.02 -29.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 114.777 -1.101 . . . . 1.01 110.44 -171.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.594 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.4 t90 -136.95 152.2 49.9 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.145 -0.934 . . . . 0.070000000000000007 109.621 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 53.9 p -153.41 163.46 39.9 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.963 0.727 . . . . 0.64000000000000001 112.963 164.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.69 -173.82 27.6 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 111.214 -0.755 . . . . 0.12 111.214 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.843 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.4 mtmt -158.91 151.44 21.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.668 -1.975 . . . . 1.76 105.668 165.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -161.02 127.74 1.81 Allowed Glycine 0 C--N 1.282 -2.43 0 C-N-CA 119.866 -1.159 . . . . 0.13 112.235 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 173' ' ' THR . . . -72.63 117.85 14.83 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.518 0.675 . . . . 1.01 111.528 -173.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.693 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 1.9 m -95.53 158.16 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-O 122.633 1.206 . . . . 1.01 110.676 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.756 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -99.56 172.2 7.44 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.531 -2.122 . . . . 0.92000000000000004 108.966 -175.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 8.9 tt0 -102.67 134.04 46.69 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.19 -0.604 . . . . 0.91000000000000003 109.877 171.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.525 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 15.2 mm-40 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.477 -0.773 . . . . 1.24 110.524 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.768 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 . . . . . 0 N--CA 1.415 -2.186 0 N-CA-C 109.264 -0.643 . . . . 0.76000000000000001 109.264 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.504 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 2.8 t70 -80.01 68.09 6.02 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 123.692 1.711 . . . . 0.34999999999999998 108.36 171.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.723 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.3 m95 -59.41 -44.53 92.83 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 111.407 -2.633 . . . . 0.10000000000000001 112.312 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' N ' HG22 ' A' ' 108' ' ' THR . 12.8 t-20 -51.36 -30.26 18.18 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.036 -1.438 . . . . 1.1100000000000001 111.524 176.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.79 -16.31 80.74 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 115.601 -0.727 . . . . 0.23000000000000001 111.385 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.96 -51.12 3.62 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 113.95 -1.125 . . . . 1.01 110.908 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.766 ' SD ' HD23 ' A' ' 109' ' ' LEU . 40.7 mtt -65.33 -55.62 17.21 Favored 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 114.094 -1.412 . . . . 0.089999999999999997 112.224 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.481 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.7 mm-40 -41.23 -54.76 5.68 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 114.558 1.318 . . . . 0.63 114.558 -176.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.806 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 23.7 Cg_endo -62.29 -31.61 81.91 Favored 'Trans proline' 0 CA--C 1.506 -0.891 0 C-N-CA 122.159 1.906 . . . . 0.17000000000000001 110.478 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.659 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 6.7 mtm -79.62 -46.5 17.1 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 114.863 -1.062 . . . . 0.69999999999999996 111.587 -176.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.702 HG21 ' O ' ' A' ' 68' ' ' MET . 61.1 t -55.92 -41.13 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 CA-C-N 114.025 -1.443 . . . . 1.04 108.869 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 t -59.43 -35.26 73.68 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.248 -1.796 . . . . 1.1200000000000001 110.952 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.806 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 21.0 mtpp -81.45 -34.67 31.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.926 0.49 . . . . 1.8799999999999999 111.392 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.857 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.68 -27.66 69.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.693 -0.685 . . . . 0.5 111.592 -171.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.52 ' N ' ' HG2' ' A' ' 75' ' ' MET . 5.7 mt -92.92 -6.16 49.2 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.059 0.933 . . . . 1.29 110.817 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.72 18.02 51.41 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 108.726 -1.75 . . . . 0.17999999999999999 108.726 170.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.66 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.17 163.15 15.56 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.318 -0.941 . . . . 1.0 110.279 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.55 106.14 18.26 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.8 -1.091 . . . . 1.72 109.855 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.622 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.27 -23.85 3.62 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.201 -0.999 . . . . 0.13 111.056 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.857 HG11 ' O ' ' A' ' 75' ' ' MET . 10.4 p -100.22 152.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.661 0.743 . . . . 1.01 111.388 -174.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.5 m -135.25 139.45 44.45 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.643 -1.162 . . . . 1.1000000000000001 111.011 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.48 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.07 140.52 37.73 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.624 -1.171 . . . . 1.1200000000000001 111.155 167.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.91 2.95 68.64 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 121.262 -0.494 . . . . 0.28000000000000003 113.007 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.31 148.84 25.43 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 120.053 -0.659 . . . . 1.55 111.06 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.614 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -79.59 116.18 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-O 122.196 0.998 . . . . 1.03 109.517 166.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.886 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -104.69 109.63 21.63 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.118 -0.946 . . . . 1.03 109.427 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.63 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -72.16 99.28 2.3 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.832 -1.531 . . . . 1.01 108.421 177.1 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.745 ' O ' HD21 ' A' ' 127' ' ' LEU . 3.0 m -72.02 117.6 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.699 -1.223 . . . . 1.6200000000000001 107.699 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.732 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -77.65 137.4 38.51 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.846 -1.168 . . . . 0.64000000000000001 107.846 -178.013 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.501 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.2 m -53.51 127.98 27.22 Favored 'General case' 0 CA--C 1.49 -1.356 0 CA-C-O 122.064 0.935 . . . . 1.05 108.579 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.66 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 19.8 t -55.53 134.97 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 107.695 -1.224 . . . . 1.02 107.695 173.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.656 ' H ' ' HA ' ' A' ' 164' ' ' SER . 10.2 t-20 -85.62 163.59 18.23 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 114.842 -1.072 . . . . 0.20000000000000001 109.96 175.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.753 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.11 86.19 2.52 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.383 -1.281 . . . . 0.12 107.894 176.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.402 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 15.1 mtp180 -109.5 -3.51 16.93 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.048 -1.433 . . . . 0.84999999999999998 108.628 -172.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 20.5 p -50.81 -171.47 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.942 -1.935 . . . . 0.91000000000000003 115.491 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 37.5 t30 -71.27 -4.46 25.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.776 -2.011 . . . . 0.62 110.719 173.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.532 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -157.85 -145.99 4.38 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.428 -0.892 . . . . 0.14000000000000001 113.062 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.631 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 59.9 p -121.39 131.97 54.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.347 0.594 . . . . 1.76 112.274 -178.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.753 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -137.21 158.31 44.72 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.015 0.912 . . . . 1.01 110.808 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.596 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -81.4 79.76 7.94 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.821 -1.536 . . . . 0.20999999999999999 108.067 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 92' ' ' VAL . . . -68.98 -14.38 63.0 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.377 -1.283 . . . . 1.0 109.991 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.77 -30.22 36.05 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.726 -0.842 . . . . 1.02 108.726 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.596 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 14.1 tp10 -67.62 -33.84 75.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 114.451 -1.25 . . . . 1.73 108.96 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.45 -44.19 65.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.186 -1.824 . . . . 1.04 109.567 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 77.6 m -64.0 -30.97 72.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.013 -1.448 . . . . 1.04 110.372 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -43.32 76.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.077 -1.083 . . . . 1.47 108.077 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.636 HG22 ' HB2' ' A' ' 64' ' ' TRP . 79.2 m -63.14 -30.6 71.72 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.317 -0.856 . . . . 1.03 110.714 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.766 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.1 mt -51.5 -69.04 0.12 Allowed 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 109.404 -0.591 . . . . 1.3 109.404 172.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.526 ' O ' HD13 ' A' ' 121' ' ' LEU . 18.5 mtp180 -41.06 -39.2 1.17 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.644 -1.162 . . . . 1.8 110.989 175.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.537 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.0 -46.51 64.97 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.476 -1.238 . . . . 0.41999999999999998 112.038 -176.271 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.81 -32.84 65.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 122.149 0.976 . . . . 1.01 108.594 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.682 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -64.17 -34.38 77.95 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.588 -1.642 . . . . 1.01 110.1 174.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.473 ' CB ' HD12 ' A' ' 121' ' ' LEU . . . -70.97 -38.47 72.77 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.83 -1.077 . . . . 1.03 111.45 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.82 -28.66 68.97 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.403 -1.271 . . . . 1.55 111.041 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.42 ' OD1' HD13 ' A' ' 76' ' ' LEU . 9.1 t-20 -83.24 -36.25 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.913 -1.04 . . . . 2.0499999999999998 110.19 -174.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.18 -5.23 35.35 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.62 -0.8 . . . . 0.54000000000000004 114.35 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 53.7 mtpt -81.6 -9.89 59.56 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 117.774 0.787 . . . . 1.6000000000000001 110.787 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.886 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 28.5 m-85 -115.73 176.08 5.24 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.505 1.145 . . . . 0.27000000000000002 113.272 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.9 m -121.83 120.53 34.83 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 112.474 -2.148 . . . . 1.0800000000000001 107.896 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.607 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -88.1 140.01 29.92 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 119.512 -0.875 . . . . 1.1499999999999999 109.929 -171.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.495 HG11 HD21 ' A' ' 88' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.429 -1.477 0 N-CA-C 108.56 -0.904 . . . . 1.0900000000000001 108.56 177.266 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.745 HD21 ' O ' ' A' ' 89' ' ' VAL . 13.6 tp . . . . . 0 C--O 1.236 0.381 0 N-CA-C 114.58 1.326 . . . . 2.04 114.58 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.543 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 66.6 m -56.23 -36.95 69.07 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 123.227 1.489 . . . . 1.1499999999999999 108.456 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.594 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 9.3 mmt -62.98 -58.66 6.55 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 111.614 -2.539 . . . . 2.27 110.997 174.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.651 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -42.63 -41.66 3.16 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 124.224 0.953 . . . . 1.0700000000000001 111.91 176.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.783 ' NZ ' HD21 ' A' ' 142' ' ' LEU . 0.6 OUTLIER -52.46 -57.61 9.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.153 -0.619 . . . . 2.1000000000000001 109.912 175.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 40.2 mt-30 -61.4 -43.0 99.62 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.636 -1.166 . . . . 0.42999999999999999 111.445 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 129' ' ' MET . 47.8 mt-30 -56.29 -35.99 68.13 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 114.434 -1.257 . . . . 0.38 109.683 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -90.34 -29.95 17.75 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.029 -1.442 . . . . 1.05 109.408 -178.052 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.62 -53.62 0.38 Allowed Glycine 0 CA--C 1.498 -0.976 0 C-N-CA 119.657 -1.259 . . . . 0.33000000000000002 114.174 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.754 HD13 ' O ' ' A' ' 141' ' ' SER . 14.9 mt -62.36 -171.07 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 112.254 -1.973 . . . . 1.0700000000000001 116.226 -169.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 27.5 m -109.41 150.89 41.73 Favored Pre-proline 0 N--CA 1.421 -1.893 0 CA-C-N 110.759 -2.928 . . . . 1.24 108.146 171.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.543 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 57.2 Cg_endo -66.06 0.19 3.45 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 122.991 2.461 . . . . 0.39000000000000001 112.139 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.5 tt0 -117.62 -31.01 5.32 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 114.717 -1.129 . . . . 1.79 109.39 -175.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.53 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 25.7 t0 -61.71 -27.01 68.4 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 113.028 -1.896 . . . . 0.65000000000000002 107.889 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.754 ' O ' HD13 ' A' ' 136' ' ' LEU . 0.4 OUTLIER 73.28 -170.29 0.13 Allowed 'General case' 0 CA--C 1.477 -1.854 0 CA-C-N 112.233 -2.258 . . . . 0.73999999999999999 109.933 -177.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.783 HD21 ' NZ ' ' A' ' 131' ' ' LYS . 10.1 mt -65.25 -37.97 88.89 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.148 -1.387 . . . . 1.48 107.707 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.37 -12.04 0.13 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 112.701 -2.045 . . . . 0.34999999999999998 115.186 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -155.34 131.68 10.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 118.708 -0.663 . . . . 1.02 109.226 -175.205 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.71 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 18.6 mmt180 -45.21 -50.07 11.82 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 118.069 0.395 . . . . 2.21 111.446 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.406 ' HA ' HD13 ' A' ' 149' ' ' ILE . 71.1 m -71.13 -28.13 64.07 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.384 0.611 . . . . 0.93000000000000005 111.55 -175.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -72.43 -32.17 66.08 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 122.777 1.275 . . . . 1.8899999999999999 108.803 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.747 ' CB ' HD11 ' A' ' 142' ' ' LEU . . . -68.11 -44.82 75.33 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.218 -2.265 . . . . 0.98999999999999999 109.906 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.526 ' HA ' HG22 ' A' ' 181' ' ' VAL . 37.3 mt -68.72 -43.75 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 CA-C-N 112.958 -1.928 . . . . 1.03 110.411 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.41 -53.22 32.85 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.935 -1.03 . . . . 0.14999999999999999 111.036 172.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.72 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 79.1 mt -66.98 -47.7 81.54 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 112.845 0.683 . . . . 1.05 112.845 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.626 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.37 -39.28 72.66 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.878 0.37 . . . . 1.03 110.506 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 149' ' ' ILE . 21.7 mtp180 -82.74 -21.78 34.6 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.464 0.649 . . . . 1.29 110.664 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 17.0 t30 -82.16 -11.2 58.86 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 107.116 -1.438 . . . . 0.5 107.116 176.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.65 -29.74 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 113.13 -1.85 . . . . 1.05 110.978 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.48 35.75 4.57 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.226 -0.988 . . . . 0.17000000000000001 112.64 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.63 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.54 155.11 22.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.353 0.872 . . . . 1.02 113.353 -170.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.614 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.2 m80 -94.03 -28.93 15.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.784 0.833 . . . . 0.39000000000000001 109.852 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 10.3 m-85 -136.59 -178.16 5.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.342 -0.845 . . . . 0.81000000000000005 111.15 -173.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.674 ' O ' HD22 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -135.31 139.21 47.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.103 -0.953 . . . . 1.03 109.012 166.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.732 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 22.6 tp -109.96 98.92 8.12 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.607 -0.837 . . . . 1.02 109.932 167.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.618 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.0 m-85 -78.42 112.22 15.23 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.252 -0.885 . . . . 0.87 109.367 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.88 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.0 t -124.07 159.62 29.53 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 122.397 1.094 . . . . 1.45 110.323 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.774 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.4 p -164.44 171.97 13.98 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.016 -1.447 . . . . 0.12 111.098 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -133.28 133.96 43.3 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.082 -1.417 . . . . 0.94999999999999996 108.714 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.1 m -143.67 -176.33 4.93 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.025 -0.732 . . . . 1.1499999999999999 109.025 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.93 -83.21 0.91 Allowed Glycine 0 C--N 1.301 -1.387 0 C-N-CA 119.698 -1.239 . . . . 0.14999999999999999 111.454 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.489 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 60.2 t30 -144.7 126.67 15.45 Favored 'General case' 0 C--O 1.196 -1.748 0 N-CA-C 108.066 -1.087 . . . . 0.58999999999999997 108.066 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.598 HG22 ' N ' ' A' ' 99' ' ' SER . 3.0 p -62.43 -44.12 98.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.316 -0.856 . . . . 1.0 113.217 -170.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.47 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.9 m120 -62.1 -28.59 69.73 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.398 0.618 . . . . 1.9199999999999999 109.728 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.86 88.2 3.59 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 114.681 -1.145 . . . . 1.0600000000000001 108.436 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.64 ' HD2' HG22 ' A' ' 194' ' ' VAL . 42.9 Cg_endo -91.69 167.7 3.26 Favored 'Trans proline' 0 CA--C 1.498 -1.321 0 C-N-CA 125.045 3.83 . . . . 0.089999999999999997 115.151 -169.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 191' ' ' LYS . 32.3 m -84.35 118.96 24.55 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 113.796 -1.547 . . . . 1.0600000000000001 107.381 165.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.854 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 48.8 tp -84.43 98.11 9.89 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 108.378 -0.971 . . . . 1.02 108.378 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.543 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 31.4 mt-30 -88.96 109.3 20.13 Favored 'General case' 0 C--N 1.272 -2.761 0 CA-C-O 121.891 0.853 . . . . 0.34000000000000002 109.239 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.88 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.6 OUTLIER -112.34 164.28 13.42 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.109 -0.951 . . . . 1.0900000000000001 111.495 -174.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.618 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 60.1 tt0 -171.71 116.92 0.4 Allowed 'General case' 0 C--O 1.202 -1.446 0 CA-C-N 116.027 -0.533 . . . . 0.68000000000000005 110.588 -166.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.684 HD11 ' CD1' ' A' ' 187' ' ' ILE . 0.8 OUTLIER -98.85 103.23 15.16 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.353 -0.842 . . . . 1.03 108.851 -170.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.656 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 16.3 ttp -92.12 122.29 34.48 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.261 -0.882 . . . . 0.89000000000000001 109.713 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.421 HD21 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -59.45 126.75 28.89 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.215 -1.402 . . . . 1.04 107.215 166.287 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -80.45 -35.56 15.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.433 -0.907 . . . . 1.02 110.682 178.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.43 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.4 mt-30 -64.02 -13.98 50.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.282 -0.872 . . . . 0.40000000000000002 111.527 -178.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.6 p -131.12 -32.62 1.58 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.902 0.858 . . . . 1.03 110.623 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.95 28.03 39.12 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.357 -1.292 . . . . 0.17999999999999999 112.136 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.43 152.38 24.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.64 -0.28 . . . . 0.72999999999999998 110.502 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.451 HD13 ' HG2' ' A' ' 177' ' ' GLN . 30.4 mm -86.48 121.34 37.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.368 0.604 . . . . 1.03 109.464 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.684 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.2 pp -109.28 -29.93 2.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.112 -0.949 . . . . 1.01 110.402 -174.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.66 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 80.6 t90 -136.48 153.43 51.04 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.056 -0.975 . . . . 0.070000000000000007 109.562 173.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 58.1 p -153.36 164.34 38.31 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.235 0.828 . . . . 0.64000000000000001 113.235 164.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.2 -173.78 28.07 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 111.244 -0.742 . . . . 0.12 111.244 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.854 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 18.1 mttt -157.69 153.73 27.15 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.221 -2.14 . . . . 1.76 105.221 165.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.532 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -158.19 126.89 1.78 Allowed Glycine 0 C--N 1.279 -2.585 0 C-N-CA 119.525 -1.321 . . . . 0.13 111.663 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -73.94 111.87 9.52 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.508 0.67 . . . . 1.01 110.774 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.667 HG12 ' CZ3' ' A' ' 64' ' ' TRP . 1.9 m -91.3 158.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 122.693 1.235 . . . . 1.01 111.051 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.768 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -98.67 172.38 7.52 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 112.38 -2.191 . . . . 0.92000000000000004 108.722 -174.548 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.6 tt0 -102.61 133.16 48.06 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.997 -0.681 . . . . 0.91000000000000003 109.505 169.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.515 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 14.8 mm-40 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.795 -0.622 . . . . 1.24 110.602 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.781 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.0 m-30 . . . . . 0 N--CA 1.421 -1.88 0 N-CA-C 109.821 -0.437 . . . . 0.76000000000000001 109.821 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.532 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 4.4 t70 -80.73 67.54 6.65 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 123.761 1.743 . . . . 0.34999999999999998 108.25 171.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.679 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 92.1 m95 -56.23 -42.28 77.05 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 111.361 -2.654 . . . . 0.10000000000000001 112.345 174.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.575 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 9.8 t-20 -49.55 -31.14 9.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.537 -1.665 . . . . 1.1100000000000001 112.183 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.2 -16.58 80.52 Favored Glycine 0 CA--C 1.505 -0.547 0 CA-C-O 122.091 0.828 . . . . 0.23000000000000001 111.193 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -100.89 -54.14 2.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.846 -1.177 . . . . 1.01 110.874 -176.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.71 ' O ' HG21 ' A' ' 72' ' ' VAL . 41.8 mtt -64.33 -59.12 4.75 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 114.256 -1.338 . . . . 0.089999999999999997 112.798 -176.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.575 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -39.47 -55.12 3.47 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 114.548 1.314 . . . . 0.63 114.548 -175.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.798 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 43.1 Cg_endo -66.14 -29.68 47.52 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.708 1.605 . . . . 0.17000000000000001 110.471 -177.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.894 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 11.1 mtm -82.19 -40.46 21.7 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.292 -0.867 . . . . 0.69999999999999996 111.397 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.71 HG21 ' O ' ' A' ' 68' ' ' MET . 47.9 t -57.44 -39.06 66.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 114.608 -1.178 . . . . 1.04 108.382 172.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -62.12 -33.6 74.76 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.204 -1.816 . . . . 1.1200000000000001 110.94 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.798 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 32.9 mtpt -82.4 -31.57 29.55 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.203 0.525 . . . . 1.8799999999999999 110.886 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.859 ' O ' HG13 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.32 -28.52 68.06 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.255 -0.884 . . . . 0.5 111.425 -172.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.632 HD13 ' CG ' ' A' ' 118' ' ' LYS . 5.6 mt -93.53 -4.18 51.5 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.412 1.101 . . . . 1.29 110.588 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.49 17.93 42.31 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 108.837 -1.705 . . . . 0.17999999999999999 108.837 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.606 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.33 163.98 15.1 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.615 -0.792 . . . . 1.0 109.897 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -92.26 106.42 18.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.517 -0.765 . . . . 1.72 109.732 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.619 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.21 -24.69 3.07 Favored Glycine 0 N--CA 1.418 -2.519 0 C-N-CA 119.998 -1.096 . . . . 0.13 110.373 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 75' ' ' MET . 11.4 p -99.59 153.57 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 114.738 -0.731 . . . . 1.01 111.153 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.6 m -134.55 139.27 45.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.795 -1.093 . . . . 1.1000000000000001 110.267 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.429 ' CB ' ' HE3' ' A' ' 118' ' ' LYS . . . -58.89 143.9 46.24 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.432 -0.804 . . . . 1.1200000000000001 110.514 168.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.62 69.64 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.89 -0.672 . . . . 0.28000000000000003 113.141 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.95 153.65 22.03 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 117.078 0.439 . . . . 1.55 110.658 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.668 HG12 ' N ' ' A' ' 158' ' ' HIS . 2.2 p -81.91 116.49 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 122.051 0.929 . . . . 1.03 109.301 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -104.37 110.06 22.16 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.173 -0.922 . . . . 1.03 109.106 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.663 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -71.65 101.09 2.45 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.954 -1.021 . . . . 1.01 108.65 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.644 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 73.0 t -73.66 111.18 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.863 -1.062 . . . . 1.6200000000000001 109.048 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.757 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 6.1 t0 -77.35 152.87 34.25 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 114.735 -1.12 . . . . 0.64000000000000001 108.167 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.561 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.7 OUTLIER -61.39 137.24 58.24 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.718 -1.128 . . . . 1.05 107.999 173.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.59 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 20.6 t -63.58 138.84 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.88 0 N-CA-C 107.903 -1.147 . . . . 1.02 107.903 167.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.638 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -84.21 162.81 20.06 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.123 -0.944 . . . . 0.20000000000000001 110.138 173.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.755 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.22 85.7 2.44 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.37 -1.287 . . . . 0.12 108.241 175.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.442 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.4 mtp180 -108.73 -1.69 19.19 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.029 -1.441 . . . . 0.84999999999999998 108.823 -172.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 24.6 p -52.46 -171.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 112.927 -1.942 . . . . 0.91000000000000003 115.281 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 30.5 t30 -71.24 -9.39 58.03 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.107 -1.861 . . . . 0.62 110.539 173.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.497 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -151.73 -146.34 4.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.358 -0.925 . . . . 0.14000000000000001 112.841 -177.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.601 ' N ' HG23 ' A' ' 169' ' ' VAL . 60.1 p -121.19 129.7 53.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.119 0.485 . . . . 1.76 112.147 -177.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.755 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -134.73 156.76 48.24 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-O 121.876 0.846 . . . . 1.01 110.855 -177.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.608 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -80.44 80.7 6.84 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 113.845 -1.525 . . . . 0.20999999999999999 107.977 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -68.04 -14.71 63.19 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.261 -1.336 . . . . 1.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . 0.471 ' HB1' ' HG3' ' A' ' 139' ' ' GLN . . . -80.33 -32.63 37.86 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.812 -0.81 . . . . 1.02 108.812 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.608 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.0 tp10 -65.5 -32.84 74.66 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.384 -1.28 . . . . 1.73 108.901 172.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -73.58 -45.18 54.84 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 112.96 -1.927 . . . . 1.04 109.683 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.619 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 73.1 m -62.84 -31.49 72.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.155 -1.384 . . . . 1.04 110.228 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -66.85 -44.09 81.91 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.136 -1.061 . . . . 1.47 108.136 172.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.62 HG21 ' HB2' ' A' ' 64' ' ' TRP . 51.7 m -62.79 -31.73 72.77 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.4 -0.818 . . . . 1.03 110.584 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.701 ' O ' HD21 ' A' ' 113' ' ' LEU . 10.3 mt -52.67 -69.66 0.11 Allowed 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.737 -0.665 . . . . 1.3 109.283 171.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.678 ' O ' HD12 ' A' ' 121' ' ' LEU . 9.4 mtp180 -40.05 -36.57 0.5 Allowed 'General case' 0 C--N 1.313 -0.991 0 O-C-N 124.365 1.041 . . . . 1.8 111.606 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.535 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -73.4 -46.98 45.55 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.501 -1.227 . . . . 0.41999999999999998 111.97 -176.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.42 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . . . -72.2 -31.99 66.39 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.261 1.029 . . . . 1.01 108.455 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.701 HD21 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.23 -35.75 81.38 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.213 -1.812 . . . . 1.01 109.579 172.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.61 -39.93 64.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 114.855 -1.066 . . . . 1.03 111.383 -175.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -61.01 -32.03 71.63 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.623 -0.717 . . . . 1.55 110.85 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -76.46 -21.34 56.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.412 -0.813 . . . . 2.0499999999999998 111.076 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 60.91 11.83 26.23 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 115.492 0.957 . . . . 0.54000000000000004 115.492 162.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.632 ' CG ' HD13 ' A' ' 76' ' ' LEU . 8.6 ptmt -108.47 -23.64 11.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.413 0.606 . . . . 1.6000000000000001 111.225 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.646 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 3.2 m-85 -87.87 170.15 11.42 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.924 0.869 . . . . 0.27000000000000002 111.676 172.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.524 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 23.5 m -120.66 105.44 10.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 113.425 -1.716 . . . . 1.0800000000000001 108.064 170.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -98.17 130.67 44.91 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 114.379 -1.282 . . . . 1.1499999999999999 112.249 -168.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.578 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.297 -1.711 0 CA-C-N 113.973 -1.467 . . . . 1.0900000000000001 107.77 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 89' ' ' VAL . 1.8 tm? . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 112.906 0.706 . . . . 2.04 112.906 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.702 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -50.89 -39.15 53.45 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 123.62 1.676 . . . . 1.1499999999999999 109.248 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.683 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -63.87 -61.81 2.04 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 110.904 -2.862 . . . . 2.27 110.837 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.691 ' CB ' HG22 ' A' ' 151' ' ' ILE . . . -42.82 -44.78 4.61 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 124.496 1.122 . . . . 1.0700000000000001 112.134 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.534 ' HZ1' ' N ' ' A' ' 142' ' ' LEU . 13.3 mmtt -49.32 -60.37 2.88 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.471 -0.566 . . . . 2.1000000000000001 109.471 175.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -59.16 -43.11 92.09 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.234 -0.894 . . . . 0.42999999999999999 111.059 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.683 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.1 mt-30 -56.41 -36.3 68.76 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 114.238 -1.346 . . . . 0.38 109.69 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -89.94 -31.36 17.3 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.162 -1.381 . . . . 1.05 109.622 -176.441 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.53 -45.41 0.55 Allowed Glycine 0 CA--C 1.495 -1.207 0 C-N-CA 120.096 -1.05 . . . . 0.33000000000000002 113.278 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.572 HD13 ' O ' ' A' ' 141' ' ' SER . 95.7 mt -67.95 -171.16 0.2 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 112.448 -1.876 . . . . 1.0700000000000001 115.486 -169.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 9.5 m -115.1 149.91 43.38 Favored Pre-proline 0 N--CA 1.422 -1.875 0 CA-C-N 110.7 -2.954 . . . . 1.24 107.765 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.702 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 28.8 Cg_endo -64.5 1.02 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.534 2.156 . . . . 0.39000000000000001 112.034 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.476 ' H ' ' C ' ' A' ' 137' ' ' SER . 0.5 OUTLIER -117.36 -21.62 8.61 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.382 -0.826 . . . . 1.79 110.862 -177.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.606 ' O ' ' HB2' ' A' ' 141' ' ' SER . 16.3 t70 -71.42 -20.32 62.13 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.222 -1.354 . . . . 0.65000000000000002 108.932 -171.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.606 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 26.3 m 72.84 169.05 0.32 Allowed 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 113.005 -1.907 . . . . 0.73999999999999999 109.338 -174.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.757 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 4.9 mt -63.48 -39.12 93.62 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.685 -1.228 . . . . 1.48 107.685 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.43 -11.84 2.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 113.369 -1.741 . . . . 0.34999999999999998 114.402 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.5 m -157.04 128.76 7.09 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.068 -0.716 . . . . 1.02 109.068 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.651 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.3 mmt180 -43.93 -46.46 8.14 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 117.991 0.359 . . . . 2.21 111.385 -178.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.7 t -71.27 -25.81 62.62 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.68 0.753 . . . . 0.93000000000000005 111.459 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 22.8 mttm -75.04 -32.21 61.5 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.588 1.185 . . . . 1.8899999999999999 108.678 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.736 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -72.57 -46.02 56.37 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 112.385 -2.189 . . . . 0.98999999999999999 110.017 177.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.551 HG13 ' HE2' ' A' ' 179' ' ' MET . 41.5 mt -67.14 -42.38 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 112.768 -2.015 . . . . 1.03 109.995 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.92 -52.72 37.48 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 114.74 -1.118 . . . . 0.14999999999999999 111.301 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.694 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 69.5 mt -67.12 -48.44 78.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.072 0 N-CA-C 112.7 0.63 . . . . 1.05 112.7 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.663 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.94 -40.39 73.09 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.826 0.345 . . . . 1.03 111.344 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.436 ' HD2' HG21 ' A' ' 149' ' ' ILE . 43.0 mtp180 -81.64 -22.26 37.71 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.625 0.726 . . . . 1.29 110.321 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -81.83 -12.95 58.27 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 107.16 -1.422 . . . . 0.5 107.16 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.694 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.05 -29.17 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 113.231 -1.804 . . . . 1.05 110.898 -174.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.99 35.63 4.75 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.357 -0.925 . . . . 0.17000000000000001 112.466 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.654 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.68 158.13 19.65 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.275 0.842 . . . . 1.02 113.275 -169.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.668 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.5 m80 -98.66 -27.79 13.83 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.322 -0.854 . . . . 0.39000000000000001 109.757 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 9.3 m-85 -135.58 -173.35 3.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.049 -0.978 . . . . 0.81000000000000005 111.281 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.694 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -138.42 139.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.9 -1.045 . . . . 1.03 109.231 167.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.714 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 40.8 tp -108.5 97.27 6.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.468 -0.893 . . . . 1.02 109.505 165.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.736 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 1.4 m-85 -78.82 112.45 15.99 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.687 -1.142 . . . . 0.87 108.959 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.83 ' OG ' HD11 ' A' ' 174' ' ' LEU . 27.0 t -122.26 163.19 20.08 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 122.002 0.906 . . . . 1.45 110.515 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.782 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.6 p -164.33 173.15 12.59 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 114.37 -1.286 . . . . 0.12 111.049 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.73 139.72 42.09 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 114.14 -1.391 . . . . 0.94999999999999996 108.758 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 t -146.42 -172.54 3.98 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.954 -0.698 . . . . 1.1499999999999999 110.267 176.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 90.3 -84.49 1.34 Allowed Glycine 0 N--CA 1.424 -2.16 0 CA-C-N 114.883 -1.053 . . . . 0.14999999999999999 111.593 174.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 49.2 t-20 -135.29 128.04 31.05 Favored 'General case' 0 C--O 1.196 -1.719 0 N-CA-C 106.925 -1.509 . . . . 0.58999999999999997 106.925 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.601 HG23 ' N ' ' A' ' 99' ' ' SER . 2.9 p -64.03 -41.51 92.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.553 -0.749 . . . . 1.0 112.37 -177.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.454 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.9 m120 -67.56 -26.45 66.31 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.468 0.651 . . . . 1.9199999999999999 109.461 -175.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.52 89.21 3.26 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 114.887 -1.051 . . . . 1.0600000000000001 108.304 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.647 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.6 Cg_endo -90.27 165.0 4.56 Favored 'Trans proline' 0 CA--C 1.488 -1.804 0 C-N-CA 124.519 3.479 . . . . 0.089999999999999997 114.97 -171.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 19.4 m -83.24 117.32 22.87 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.548 -1.66 . . . . 1.0600000000000001 107.602 166.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.83 HD11 ' OG ' ' A' ' 163' ' ' SER . 49.1 tp -84.09 98.53 9.93 Favored 'General case' 0 N--CA 1.411 -2.381 0 C-N-CA 119.641 -0.824 . . . . 1.02 109.055 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.573 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.8 mt-30 -89.13 107.21 18.92 Favored 'General case' 0 C--N 1.273 -2.749 0 CA-C-N 114.811 -1.086 . . . . 0.34000000000000002 108.95 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.894 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 37.0 mtp -107.08 163.73 12.74 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.138 -0.937 . . . . 1.0900000000000001 110.393 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.52 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 57.9 tt0 -170.09 117.41 0.55 Allowed 'General case' 0 C--O 1.202 -1.445 0 CA-C-O 121.179 0.514 . . . . 0.68000000000000005 110.208 -167.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER -100.12 102.06 13.28 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.705 -0.85 . . . . 1.03 108.705 -172.447 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.651 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.8 ttp -91.67 122.57 34.35 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.416 -0.811 . . . . 0.89000000000000001 109.755 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.457 ' HB3' ' OG1' ' A' ' 183' ' ' THR . 0.1 OUTLIER -58.53 126.45 27.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.311 -1.366 . . . . 1.04 107.311 166.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.63 -33.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 O-C-N 120.939 -1.101 . . . . 1.02 110.55 178.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.0 mt-30 -63.85 -13.95 49.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.235 -0.893 . . . . 0.40000000000000002 111.449 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 180' ' ' LEU . 60.3 p -130.62 -36.69 1.41 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.945 0.878 . . . . 1.03 110.26 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.418 ' CA ' HD12 ' A' ' 149' ' ' ILE . . . 87.08 24.35 37.81 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.334 -1.303 . . . . 0.17999999999999999 112.022 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 186' ' ' ILE . 0.2 OUTLIER -104.26 152.37 22.29 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.621 -0.29 . . . . 0.72999999999999998 110.658 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.472 ' N ' ' HG3' ' A' ' 185' ' ' GLU . 33.0 mm -87.85 113.6 25.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.811 0.815 . . . . 1.03 109.532 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.679 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.6 pp -101.8 -29.61 3.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 114.729 -1.123 . . . . 1.01 110.587 -173.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.624 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.4 t90 -136.82 152.47 50.31 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.304 -0.862 . . . . 0.070000000000000007 109.737 172.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 37.3 p -153.78 162.93 40.82 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.003 0.742 . . . . 0.64000000000000001 113.003 164.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -156.53 -178.24 30.46 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 110.985 -0.846 . . . . 0.12 110.985 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.823 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.1 mtmt -157.12 149.39 22.97 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.343 -1.725 . . . . 1.76 106.343 166.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -159.35 127.69 1.88 Allowed Glycine 0 C--N 1.285 -2.258 0 C-N-CA 119.973 -1.108 . . . . 0.13 112.258 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.09 114.45 12.43 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.547 0.689 . . . . 1.01 111.472 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.674 HG11 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -91.73 159.47 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 122.609 1.195 . . . . 1.01 111.065 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.781 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -99.68 173.78 6.54 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.319 -2.218 . . . . 0.92000000000000004 108.974 -173.051 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -102.94 130.3 49.95 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.64 -0.424 . . . . 0.91000000000000003 110.895 171.35 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.532 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 15.3 mm-40 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.609 -0.71 . . . . 1.24 110.722 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.753 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.8 m-30 . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 109.593 -0.521 . . . . 0.76000000000000001 109.593 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 3.0 t70 -79.24 67.39 4.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 123.762 1.744 . . . . 0.34999999999999998 108.291 171.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.753 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 89.3 m95 -59.83 -44.43 94.07 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 111.478 -2.601 . . . . 0.10000000000000001 112.113 174.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.437 ' N ' HG23 ' A' ' 108' ' ' THR . 13.4 t-20 -51.04 -31.44 18.53 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.939 -1.482 . . . . 1.1100000000000001 111.35 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.35 -16.61 79.81 Favored Glycine 0 C--N 1.312 -0.754 0 CA-C-N 115.504 -0.771 . . . . 0.23000000000000001 111.318 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.57 -53.67 2.93 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.996 -1.102 . . . . 1.01 110.817 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.735 ' SD ' HD22 ' A' ' 109' ' ' LEU . 42.4 mtt -62.89 -59.61 4.61 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 114.206 -1.361 . . . . 0.089999999999999997 112.554 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -38.53 -55.23 2.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 114.83 1.419 . . . . 0.63 114.83 -176.226 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.775 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.1 Cg_endo -65.46 -30.13 52.91 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.674 1.583 . . . . 0.17000000000000001 110.588 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.949 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 13.7 mtm -83.35 -39.69 20.39 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 115.413 -0.812 . . . . 0.69999999999999996 111.205 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.678 HG21 ' O ' ' A' ' 68' ' ' MET . 58.9 t -56.82 -39.29 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 114.555 -1.202 . . . . 1.04 108.465 172.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -61.67 -35.33 77.65 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 113.176 -1.829 . . . . 1.1200000000000001 110.9 174.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.775 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.3 mtpt -81.31 -31.55 33.49 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.093 0.473 . . . . 1.8799999999999999 110.618 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.875 ' O ' HG13 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.26 -25.17 65.94 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.355 -0.839 . . . . 0.5 111.119 -173.086 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' HG ' ' HG2' ' A' ' 75' ' ' MET . 6.7 mt -95.2 -5.09 44.69 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.069 0.938 . . . . 1.29 110.762 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.92 17.46 41.7 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 108.888 -1.685 . . . . 0.17999999999999999 108.888 169.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.639 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -87.39 162.08 17.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.576 -0.812 . . . . 1.0 110.036 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -90.4 105.32 17.73 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.253 -0.885 . . . . 1.72 110.273 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.634 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.92 -22.2 3.47 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.978 -1.01 . . . . 0.13 110.807 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 75' ' ' MET . 10.7 p -102.08 153.88 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.678 0.752 . . . . 1.01 111.704 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.6 m -135.14 139.9 45.0 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.726 -1.124 . . . . 1.1000000000000001 110.796 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.496 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.81 126.89 29.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.332 -0.849 . . . . 1.1200000000000001 110.481 166.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.05 8.25 29.83 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.849 -0.691 . . . . 0.28000000000000003 112.56 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.31 153.2 19.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 120.721 -0.392 . . . . 1.55 110.52 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.628 HG12 ' N ' ' A' ' 158' ' ' HIS . 2.0 p -82.1 117.32 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 122.009 0.909 . . . . 1.03 108.956 166.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.643 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -105.42 110.23 22.5 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.301 -0.863 . . . . 1.03 109.267 -171.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.674 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -73.04 94.5 1.9 Allowed 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 114.446 -1.252 . . . . 1.01 109.133 178.044 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.442 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.4 m -73.39 116.78 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 107.542 -1.281 . . . . 1.6200000000000001 107.542 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.812 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 7.0 t0 -79.26 170.81 16.07 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.201 -1.036 . . . . 0.64000000000000001 108.201 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.633 ' HG ' ' HA ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -59.96 149.42 31.95 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 122.773 1.273 . . . . 1.05 108.937 171.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 36.7 t -74.34 138.55 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.476 0 CA-C-N 113.576 -1.647 . . . . 1.02 106.612 163.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.654 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.4 t-20 -84.45 158.97 20.87 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-O 121.888 0.852 . . . . 0.20000000000000001 109.875 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.747 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -122.81 84.8 2.32 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.281 -1.327 . . . . 0.12 107.938 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.428 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 15.0 mtp180 -107.67 -1.83 20.73 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 113.547 -1.66 . . . . 0.84999999999999998 108.574 -172.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 24.1 p -51.82 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.156 -1.838 . . . . 0.91000000000000003 114.216 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.3 OUTLIER -76.06 -2.99 33.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.233 -1.803 . . . . 0.62 110.33 174.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.516 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -149.66 -150.22 5.19 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.922 -0.656 . . . . 0.14000000000000001 112.905 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 169' ' ' VAL . 60.1 p -121.83 130.58 53.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.514 0.561 . . . . 1.76 112.514 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.747 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.6 157.38 47.02 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.855 0.836 . . . . 1.01 111.155 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.59 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -80.14 79.49 6.69 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.002 -1.454 . . . . 0.20999999999999999 107.993 175.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 92' ' ' VAL . . . -67.38 -15.57 63.75 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.285 -1.325 . . . . 1.0 109.997 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.57 -29.97 37.01 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.944 -0.762 . . . . 1.02 108.944 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.59 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.3 tp10 -66.46 -34.64 78.4 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 122.681 1.229 . . . . 1.73 109.131 170.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -71.99 -43.4 65.17 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 113.203 -1.817 . . . . 1.04 109.664 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 55.7 m -63.77 -31.02 72.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.898 -1.501 . . . . 1.04 110.536 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -67.85 -42.45 81.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.609 -1.256 . . . . 1.47 107.609 172.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.646 HG23 ' HB2' ' A' ' 64' ' ' TRP . 57.2 m -63.56 -31.02 72.06 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.171 -0.922 . . . . 1.03 110.672 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.735 HD22 ' SD ' ' A' ' 68' ' ' MET . 8.3 mt -50.9 -70.47 0.08 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 115.776 -0.647 . . . . 1.3 109.278 171.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.427 ' O ' HD13 ' A' ' 121' ' ' LEU . 17.0 mtp180 -41.0 -38.78 1.04 Allowed 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.475 1.109 . . . . 1.8 111.197 176.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -68.37 -46.49 69.93 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.367 -1.288 . . . . 0.41999999999999998 112.358 -177.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.38 -33.4 65.01 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.299 1.047 . . . . 1.01 108.417 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.701 HD21 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -65.2 -31.89 73.28 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.186 -1.824 . . . . 1.01 110.131 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.513 ' CB ' HD12 ' A' ' 121' ' ' LEU . . . -72.85 -44.69 61.07 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 114.335 -1.302 . . . . 1.03 111.713 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -65.72 -28.75 69.28 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.54 -1.209 . . . . 1.55 110.832 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -81.43 -19.78 41.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.3 -0.864 . . . . 2.0499999999999998 111.885 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 59.24 11.05 11.53 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 115.586 0.995 . . . . 0.54000000000000004 115.586 163.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.496 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 56.2 mtpt -96.93 -3.96 40.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.35 0.575 . . . . 1.6000000000000001 109.759 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.643 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 29.0 m-85 -121.22 173.2 7.46 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.481 1.134 . . . . 0.27000000000000002 112.726 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.475 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 16.3 m -117.85 115.82 25.74 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 112.658 -2.065 . . . . 1.0800000000000001 107.776 170.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.582 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -83.07 137.57 34.05 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.152 -0.931 . . . . 1.1499999999999999 110.376 -172.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.295 -1.782 0 N-CA-C 108.074 -1.084 . . . . 1.0900000000000001 108.074 171.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.729 HD13 ' NZ ' ' A' ' 131' ' ' LYS . 1.2 tm? . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 113.574 0.953 . . . . 2.04 113.574 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.575 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -51.94 -37.56 53.22 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.582 1.658 . . . . 1.1499999999999999 108.407 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.628 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.4 OUTLIER -62.89 -60.13 3.89 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 110.714 -2.948 . . . . 2.27 111.292 178.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.688 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -44.15 -43.03 6.77 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 124.304 1.003 . . . . 1.0700000000000001 112.148 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.729 ' NZ ' HD13 ' A' ' 127' ' ' LEU . 22.3 mttt -52.77 -55.52 22.25 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 120.326 -0.549 . . . . 2.1000000000000001 109.691 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 40.8 mt-30 -62.14 -41.74 98.57 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.021 -0.99 . . . . 0.42999999999999999 111.28 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 129' ' ' MET . 53.5 mt-30 -57.06 -36.45 70.56 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.257 -1.338 . . . . 0.38 110.034 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.527 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.06 -31.0 16.44 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.243 -1.344 . . . . 1.05 109.084 -176.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.52 -51.24 0.36 Allowed Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.015 -1.088 . . . . 0.33000000000000002 113.979 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 46.8 mt -67.41 -171.1 0.16 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 116.12 1.896 . . . . 1.0700000000000001 116.12 -169.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.553 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.8 m -115.58 152.55 47.31 Favored Pre-proline 0 N--CA 1.427 -1.62 0 CA-C-N 110.732 -2.94 . . . . 1.24 108.158 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.575 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 11.8 Cg_endo -59.2 -4.9 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.027 2.485 . . . . 0.39000000000000001 113.171 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 137' ' ' SER . 2.2 tt0 -117.49 -30.41 5.53 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.826 0.822 . . . . 1.79 111.104 -176.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.4 t70 -58.28 -25.49 61.87 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.42 -1.718 . . . . 0.65000000000000002 109.065 -174.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.633 ' HA ' ' HG ' ' A' ' 91' ' ' SER . 5.5 m 72.9 161.37 0.24 Allowed 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 111.495 -2.593 . . . . 0.73999999999999999 111.822 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.812 ' HG ' ' CG ' ' A' ' 90' ' ' ASP . 8.5 mt -66.64 -38.76 87.58 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.25 -1.389 . . . . 1.48 107.25 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.34 -4.78 0.32 Allowed Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 112.576 -2.102 . . . . 0.34999999999999998 114.703 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.48 124.35 9.24 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 118.603 -0.713 . . . . 1.02 109.369 -174.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.58 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 16.6 mmt85 -41.66 -51.16 4.11 Favored 'General case' 0 C--O 1.212 -0.92 0 O-C-N 123.563 0.539 . . . . 2.21 111.046 -177.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.9 t -67.81 -29.16 68.27 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.493 0.663 . . . . 0.93000000000000005 111.21 -174.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 20.6 mttm -72.76 -31.17 64.72 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.355 1.074 . . . . 1.8899999999999999 108.519 177.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.672 ' HB3' ' OH ' ' A' ' 162' ' ' TYR . . . -76.97 -41.91 41.12 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 113.049 -1.887 . . . . 0.98999999999999999 110.746 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.529 ' HA ' HG21 ' A' ' 181' ' ' VAL . 43.0 mt -69.12 -42.21 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 113.393 -1.731 . . . . 1.03 110.189 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.66 -48.77 64.13 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.904 -1.044 . . . . 0.14999999999999999 111.27 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.688 HG21 ' CB ' ' A' ' 130' ' ' ALA . 67.2 mt -71.23 -48.08 56.58 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 N-CA-C 112.87 0.693 . . . . 1.05 112.87 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.638 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.57 -39.42 70.63 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.935 0.398 . . . . 1.03 110.633 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.402 ' HD2' ' CG2' ' A' ' 149' ' ' ILE . 28.7 mtp180 -81.01 -24.4 37.96 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.522 0.677 . . . . 1.29 110.672 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.501 HD22 ' CD ' ' A' ' 133' ' ' GLN . 32.3 t30 -79.28 -14.12 59.23 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.508 -1.293 . . . . 0.5 107.508 175.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.69 -29.98 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 113.196 -1.82 . . . . 1.05 110.967 -173.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.05 33.04 5.36 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.681 -0.771 . . . . 0.17000000000000001 112.437 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.674 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -106.89 159.75 16.02 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.92 0.711 . . . . 1.02 112.92 -170.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.628 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.9 m80 -99.65 -27.24 13.77 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.379 -0.828 . . . . 0.39000000000000001 109.686 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.564 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.6 m-85 -135.58 -173.02 3.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.262 -0.881 . . . . 0.81000000000000005 110.941 -175.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.716 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -137.63 138.6 44.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.941 -1.027 . . . . 1.03 108.897 166.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.555 HD21 ' HE1' ' A' ' 176' ' ' MET . 45.5 tp -107.93 101.36 10.63 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 119.715 -0.794 . . . . 1.02 109.038 165.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.672 ' OH ' ' HB3' ' A' ' 148' ' ' ALA . 2.4 m-85 -81.38 113.03 19.19 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.087 -1.415 . . . . 0.87 109.559 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.717 ' OG ' HD13 ' A' ' 109' ' ' LEU . 4.2 p -118.09 159.99 22.3 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.717 0.77 . . . . 1.45 110.749 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.815 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.9 p -163.94 173.6 12.45 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 114.862 -1.063 . . . . 0.12 111.414 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.09 139.01 37.58 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 113.951 -1.477 . . . . 0.94999999999999996 108.464 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.4 t -147.2 -171.47 3.79 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.055 -0.658 . . . . 1.1499999999999999 110.073 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.05 -80.71 1.43 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.128 -1.034 . . . . 0.14999999999999999 111.773 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.441 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.5 t30 -144.52 125.47 14.4 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 107.99 -1.115 . . . . 0.58999999999999997 107.99 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.603 HG23 ' N ' ' A' ' 99' ' ' SER . 3.3 p -63.12 -42.97 98.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.479 -0.782 . . . . 1.0 112.934 -171.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 169' ' ' VAL . 9.7 m120 -61.66 -29.53 70.13 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.391 0.615 . . . . 1.9199999999999999 109.532 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.9 88.52 3.54 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.634 -1.167 . . . . 1.0600000000000001 108.508 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.653 ' HD2' HG21 ' A' ' 194' ' ' VAL . 44.3 Cg_endo -91.55 167.7 3.34 Favored 'Trans proline' 0 CA--C 1.497 -1.374 0 C-N-CA 124.927 3.751 . . . . 0.089999999999999997 115.015 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 14.5 m -85.73 118.0 24.96 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.041 -1.436 . . . . 1.0600000000000001 108.098 166.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.815 HD13 ' O ' ' A' ' 164' ' ' SER . 43.4 tp -84.49 98.66 10.23 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-O 122.057 0.932 . . . . 1.02 109.386 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.614 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.7 mt-30 -87.7 108.08 18.94 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.576 -1.193 . . . . 0.34000000000000002 109.088 -178.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.949 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 80.9 mtp -105.74 162.42 13.55 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.059 -0.973 . . . . 1.0900000000000001 110.483 -176.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.485 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.7 tt0 -169.74 119.38 0.64 Allowed 'General case' 0 C--O 1.203 -1.39 0 CA-C-O 121.324 0.583 . . . . 0.68000000000000005 109.792 -170.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.716 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER -101.2 100.85 11.45 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.542 -0.91 . . . . 1.03 108.542 -172.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.58 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.9 ttp -90.47 120.06 31.26 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.764 -0.653 . . . . 0.89000000000000001 109.448 176.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.489 ' HB2' HG22 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.66 117.77 6.73 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.222 -1.399 . . . . 1.04 107.222 169.315 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.536 HG23 ' HB2' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -71.72 -35.71 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.162 0.892 . . . . 1.02 111.439 -176.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -61.38 -13.62 21.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.411 -0.813 . . . . 0.40000000000000002 111.581 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 34.5 p -130.22 -37.96 1.42 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.176 0.989 . . . . 1.03 110.086 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.445 ' CA ' HD13 ' A' ' 149' ' ' ILE . . . 91.59 16.27 52.79 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 113.801 -1.545 . . . . 0.17999999999999999 112.138 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -98.09 156.34 16.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.94 0.4 . . . . 0.72999999999999998 110.619 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.485 HD12 ' HG2' ' A' ' 177' ' ' GLN . 31.6 mm -88.78 118.74 34.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.572 0.701 . . . . 1.03 109.404 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.664 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.7 pp -106.49 -29.08 2.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.804 -1.089 . . . . 1.01 110.123 -172.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.646 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.3 t90 -137.92 153.37 49.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.547 -0.751 . . . . 0.070000000000000007 110.135 171.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 54.9 p -153.52 164.4 38.29 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 113.379 0.881 . . . . 0.64000000000000001 113.379 164.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.93 -178.49 32.99 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.039 -0.825 . . . . 0.12 111.039 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.798 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.3 mtmt -157.86 146.5 19.22 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.446 -1.687 . . . . 1.76 106.446 166.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.466 ' N ' ' HE3' ' A' ' 71' ' ' MET . . . -157.45 128.02 2.04 Favored Glycine 0 C--N 1.284 -2.357 0 CA-C-N 114.677 -1.147 . . . . 0.13 112.064 -177.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.52 116.05 14.75 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.544 0.687 . . . . 1.01 111.343 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.696 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 1.9 m -94.1 158.82 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 122.618 1.199 . . . . 1.01 110.979 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.745 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -100.89 171.98 7.32 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 112.527 -2.124 . . . . 0.92000000000000004 108.844 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 7.7 tt0 -101.56 131.6 47.65 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.121 -0.632 . . . . 0.91000000000000003 109.376 169.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.519 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 15.2 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.418 -0.801 . . . . 1.24 110.931 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.787 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.5 m-30 . . . . . 0 N--CA 1.418 -2.041 0 N-CA-C 109.936 -0.394 . . . . 0.76000000000000001 109.936 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.502 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 4.0 t70 -80.97 68.28 7.19 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 123.68 1.705 . . . . 0.34999999999999998 108.125 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.701 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.5 m95 -57.85 -41.52 82.53 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.599 -2.546 . . . . 0.10000000000000001 111.94 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.57 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 13.0 t-20 -52.98 -27.71 20.4 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.99 -1.459 . . . . 1.1100000000000001 111.496 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.57 -15.2 81.21 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.412 -0.813 . . . . 0.23000000000000001 111.129 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.96 -53.64 2.9 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.908 -1.146 . . . . 1.01 111.17 -176.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.77 ' SD ' HD23 ' A' ' 109' ' ' LEU . 38.5 mtt -65.27 -57.77 7.62 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.263 -1.335 . . . . 0.089999999999999997 112.132 -177.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.57 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.1 mm-40 -40.25 -55.88 3.8 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 114.348 1.24 . . . . 0.63 114.348 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.749 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.3 Cg_endo -63.88 -27.3 67.11 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.541 1.494 . . . . 0.17000000000000001 110.74 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.791 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 12.7 mtm -85.56 -43.2 13.72 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.562 -0.745 . . . . 0.69999999999999996 112.174 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 68' ' ' MET . 31.5 t -59.0 -37.91 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 CA-C-N 115.011 -0.995 . . . . 1.04 108.826 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -57.11 -36.56 70.78 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.409 -1.723 . . . . 1.1200000000000001 110.396 174.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.749 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.7 mtpt -80.91 -37.3 29.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.087 -0.96 . . . . 1.8799999999999999 110.49 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.868 ' O ' HG11 ' A' ' 81' ' ' VAL . 2.5 ttp -57.65 -31.61 66.46 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.421 -1.263 . . . . 0.5 111.439 -175.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 22.5 mt -88.51 -5.31 58.3 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.917 0.865 . . . . 1.29 111.594 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.96 17.4 35.32 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.286 -1.525 . . . . 0.17999999999999999 109.286 172.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.702 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.03 161.76 16.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.807 -0.696 . . . . 1.0 109.733 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 9.7 p-10 -89.16 107.73 19.21 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.362 1.077 . . . . 1.72 111.443 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.646 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.73 -24.32 3.03 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 114.268 -1.333 . . . . 0.13 110.45 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.868 HG11 ' O ' ' A' ' 75' ' ' MET . 14.9 p -102.83 153.05 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.526 0.679 . . . . 1.01 111.762 -173.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.4 m -134.98 138.82 44.36 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.653 -1.158 . . . . 1.1000000000000001 110.577 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.59 131.26 50.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.757 -0.656 . . . . 1.1200000000000001 110.182 166.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.14 -1.47 31.35 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.026 -0.607 . . . . 0.28000000000000003 112.593 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.89 150.64 23.96 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.264 -0.575 . . . . 1.55 111.016 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.634 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.6 p -80.05 113.81 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-O 122.277 1.037 . . . . 1.03 109.01 164.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -100.88 107.21 18.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.814 -1.085 . . . . 1.03 108.722 -172.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.648 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -70.92 97.88 1.5 Allowed 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 114.169 -1.378 . . . . 1.01 108.019 177.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.457 HG12 ' CD1' ' A' ' 87' ' ' LEU . 2.2 m -71.37 118.27 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.243 0 N-CA-C 106.888 -1.523 . . . . 1.6200000000000001 106.888 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.769 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -77.09 146.32 37.31 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 107.159 -1.422 . . . . 0.64000000000000001 107.159 178.098 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.519 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -55.36 134.43 50.19 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.448 -1.315 . . . . 1.05 107.448 175.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.607 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 22.0 t -61.46 138.4 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.011 0 N-CA-C 107.768 -1.197 . . . . 1.02 107.768 170.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.627 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.4 t-20 -84.95 163.02 19.19 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.156 -0.929 . . . . 0.20000000000000001 109.714 175.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.755 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.88 86.12 2.51 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.524 -1.216 . . . . 0.12 108.185 175.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -106.88 -4.22 19.43 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 113.97 -1.468 . . . . 0.84999999999999998 108.827 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 21.8 p -50.67 -177.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.516 -1.674 . . . . 0.91000000000000003 114.318 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 1.4 t30 -70.13 -10.7 59.62 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.476 -1.693 . . . . 0.62 110.325 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.483 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -140.55 -152.56 5.81 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.668 -0.696 . . . . 0.14000000000000001 112.564 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.597 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 70.7 m -122.44 129.36 51.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.071 0.462 . . . . 1.76 111.129 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.755 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.9 pp -132.5 160.1 37.47 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.786 0.803 . . . . 1.01 110.551 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.598 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -82.94 79.85 9.17 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.902 -1.499 . . . . 0.20999999999999999 107.889 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.607 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -68.28 -14.11 62.75 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.483 -1.235 . . . . 1.0 109.958 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.23 39.34 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.545 -0.909 . . . . 1.02 108.545 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.598 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 42.8 tp10 -66.43 -33.71 76.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 114.325 -1.307 . . . . 1.73 109.05 171.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.54 -43.91 65.55 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.113 -1.858 . . . . 1.04 109.509 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.602 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 62.9 m -63.34 -29.73 70.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.808 -1.542 . . . . 1.04 110.417 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -44.68 76.58 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.119 -1.067 . . . . 1.47 108.119 171.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.605 HG21 ' HB2' ' A' ' 64' ' ' TRP . 73.2 m -62.48 -30.79 71.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.412 -0.813 . . . . 1.03 110.718 178.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.77 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -50.99 -68.98 0.12 Allowed 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 109.326 -0.62 . . . . 1.3 109.326 171.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.449 ' O ' HD11 ' A' ' 121' ' ' LEU . 9.3 mtp180 -40.99 -37.61 0.84 Allowed 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.345 1.028 . . . . 1.8 111.411 175.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.564 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -71.54 -46.12 60.41 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.576 -1.193 . . . . 0.41999999999999998 111.968 -176.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.445 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . . . -73.56 -32.04 63.95 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 122.402 1.096 . . . . 1.01 108.701 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -65.79 -33.67 76.4 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.498 -1.683 . . . . 1.01 109.88 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 110' ' ' ARG . . . -72.93 -41.49 64.45 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 114.636 -1.166 . . . . 1.03 111.06 -176.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -64.21 -27.2 68.9 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.895 -1.048 . . . . 1.55 110.332 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -81.92 -21.76 37.15 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.466 -0.788 . . . . 2.0499999999999998 111.01 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 59.78 15.61 34.98 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 115.588 0.995 . . . . 0.54000000000000004 115.588 163.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.541 ' HE2' ' HB3' ' A' ' 76' ' ' LEU . 19.7 mtmt -101.81 -28.62 12.34 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 117.719 0.76 . . . . 1.6000000000000001 109.969 174.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 26.1 m-85 -92.23 173.81 7.63 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 122.152 0.977 . . . . 0.27000000000000002 112.447 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.577 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.7 m -118.4 123.19 44.63 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 113.31 -1.768 . . . . 1.0800000000000001 107.89 169.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.643 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -94.05 139.55 30.82 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 119.329 -0.949 . . . . 1.1499999999999999 111.865 -170.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.446 HG12 HD23 ' A' ' 88' ' ' LEU . 1.3 m . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 107.786 -1.19 . . . . 1.0900000000000001 107.786 170.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.641 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 35.3 tp . . . . . 0 CA--C 1.518 -0.27 0 N-CA-C 113.456 0.91 . . . . 2.04 113.456 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.631 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 3.5 t -50.67 -47.35 58.82 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 123.396 1.57 . . . . 1.1499999999999999 109.374 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.663 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 16.7 mmt -54.0 -61.82 2.06 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 111.24 -2.709 . . . . 2.27 110.818 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.703 ' CB ' HG22 ' A' ' 151' ' ' ILE . . . -43.83 -44.97 7.16 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 124.124 0.89 . . . . 1.0700000000000001 112.626 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.746 ' NZ ' HD13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -55.94 -51.5 67.44 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 107.343 -1.354 . . . . 2.1000000000000001 107.343 -178.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.3 mt-30 -65.15 -41.03 95.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.672 -1.149 . . . . 0.42999999999999999 111.173 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.663 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.2 mt-30 -57.6 -32.56 67.31 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 114.628 -1.169 . . . . 0.38 109.574 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 134' ' ' LEU . 0.8 OUTLIER -93.96 -27.15 16.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 113.911 -1.495 . . . . 1.05 109.719 -177.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.38 -50.12 0.53 Allowed Glycine 0 CA--C 1.5 -0.904 0 CA-C-O 122.766 1.204 . . . . 0.33000000000000002 113.428 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.603 HD13 ' O ' ' A' ' 141' ' ' SER . 78.4 mt -66.58 -170.95 0.11 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 112.175 -2.012 . . . . 1.0700000000000001 116.025 -170.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.1 m -116.22 152.86 48.37 Favored Pre-proline 0 N--CA 1.431 -1.415 0 CA-C-N 111.129 -2.759 . . . . 1.24 108.56 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.631 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 18.1 Cg_endo -62.34 -2.0 2.86 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.086 2.524 . . . . 0.39000000000000001 112.993 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.424 ' H ' ' C ' ' A' ' 137' ' ' SER . 0.7 OUTLIER -118.74 -26.85 5.99 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.579 0.704 . . . . 1.79 110.746 -177.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.3 t70 -63.04 -21.89 66.47 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 113.895 -1.502 . . . . 0.65000000000000002 109.127 -173.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.603 ' O ' HD13 ' A' ' 136' ' ' LEU . 38.1 m 74.4 168.59 0.3 Allowed 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.666 -2.061 . . . . 0.73999999999999999 110.653 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.769 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 6.4 mt -64.78 -40.53 95.4 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.321 1.058 . . . . 1.48 108.331 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.7 -12.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 112.823 -1.99 . . . . 0.34999999999999998 114.507 177.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -151.32 125.11 9.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.073 -0.714 . . . . 1.02 109.073 -174.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.65 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.3 mmt180 -42.6 -47.33 5.2 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 118.047 0.385 . . . . 2.21 111.936 -176.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.9 t -71.22 -25.85 62.67 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.664 0.745 . . . . 0.93000000000000005 111.35 -175.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -75.84 -30.75 59.06 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 122.766 1.269 . . . . 1.8899999999999999 108.862 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.786 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -72.1 -46.77 55.4 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 112.184 -2.28 . . . . 0.98999999999999999 110.236 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.535 ' HA ' HG22 ' A' ' 181' ' ' VAL . 37.3 mt -68.07 -41.4 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 112.909 -1.95 . . . . 1.03 110.054 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.42 -54.83 27.82 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.51 -1.223 . . . . 0.14999999999999999 111.107 170.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.746 HD13 ' NZ ' ' A' ' 131' ' ' LYS . 12.4 mt -66.27 -46.6 86.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.062 0 N-CA-C 112.693 0.627 . . . . 1.05 112.693 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.636 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -57.73 -40.73 80.27 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 118.013 0.37 . . . . 1.03 111.015 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . 0.41 ' HD2' HG22 ' A' ' 149' ' ' ILE . 28.5 mtp-105 -81.49 -22.34 38.09 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.826 0.822 . . . . 1.29 110.346 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.472 HD22 ' CD ' ' A' ' 133' ' ' GLN . 12.7 t30 -82.01 -11.64 58.73 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 114.274 -1.33 . . . . 0.5 107.449 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.705 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.91 -29.13 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 113.267 -1.788 . . . . 1.05 110.794 -174.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.465 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.37 34.92 4.88 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.387 -0.911 . . . . 0.17000000000000001 112.362 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.648 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.98 160.57 16.31 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 113.138 0.792 . . . . 1.02 113.138 -169.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.634 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -99.78 -28.96 12.89 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.0 -1.0 . . . . 0.39000000000000001 109.744 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.664 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 11.6 m-85 -136.65 -175.43 4.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.96 -1.018 . . . . 0.81000000000000005 110.83 -174.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.667 ' O ' HD22 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -135.64 138.59 47.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.062 -0.972 . . . . 1.03 108.562 166.282 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 33.8 tp -108.26 99.59 8.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.281 -0.968 . . . . 1.02 109.483 166.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.786 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.64 112.54 17.01 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.784 -1.098 . . . . 0.87 109.322 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.887 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 13.0 t -124.37 158.88 31.63 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 122.157 0.979 . . . . 1.45 110.239 -177.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.646 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.8 p -160.75 173.47 15.36 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.166 -1.379 . . . . 0.12 110.564 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.88 132.07 34.02 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-N 114.36 -1.291 . . . . 0.94999999999999996 108.613 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -140.89 -178.01 5.35 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.055 -0.658 . . . . 1.1499999999999999 109.73 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.43 -83.26 0.87 Allowed Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 119.774 -1.203 . . . . 0.14999999999999999 111.847 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 43.5 t-20 -140.08 127.18 20.97 Favored 'General case' 0 C--O 1.195 -1.794 0 N-CA-C 106.294 -1.743 . . . . 0.58999999999999997 106.294 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.483 HG12 ' HA3' ' A' ' 98' ' ' GLY . 2.3 p -60.64 -44.52 97.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 114.861 -1.063 . . . . 1.0 111.65 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.458 ' N ' HG13 ' A' ' 169' ' ' VAL . 43.2 m-80 -66.9 -24.92 66.15 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.338 0.59 . . . . 1.9199999999999999 109.777 -174.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.04 88.28 3.21 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 114.996 -1.002 . . . . 1.0600000000000001 108.474 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.661 ' HD2' HG21 ' A' ' 194' ' ' VAL . 44.1 Cg_endo -91.01 163.7 3.86 Favored 'Trans proline' 0 CA--C 1.492 -1.576 0 C-N-CA 124.652 3.568 . . . . 0.089999999999999997 115.253 -170.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 191' ' ' LYS . 7.7 m -84.83 119.71 25.62 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 113.668 -1.605 . . . . 1.0600000000000001 107.998 170.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.956 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 21.8 tp -82.59 95.83 7.89 Favored 'General case' 0 CA--C 1.472 -2.043 0 C-N-CA 119.655 -0.818 . . . . 1.02 109.474 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.542 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 39.1 mt-30 -87.2 106.76 18.12 Favored 'General case' 0 C--N 1.253 -3.609 0 CA-C-O 122.415 1.102 . . . . 0.34000000000000002 108.663 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.887 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.3 mmm -110.97 162.97 14.3 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.516 -1.22 . . . . 1.0900000000000001 110.944 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 56.4 tt0 -171.41 118.92 0.46 Allowed 'General case' 0 C--O 1.205 -1.288 0 CA-C-O 121.165 0.507 . . . . 0.68000000000000005 110.702 -166.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.679 HD13 ' CD1' ' A' ' 187' ' ' ILE . 0.4 OUTLIER -100.36 100.9 11.76 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.853 -0.795 . . . . 1.03 108.853 -172.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.65 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.2 ttp -91.16 120.95 32.52 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.161 -0.927 . . . . 0.89000000000000001 109.398 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.409 HD22 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -58.49 126.76 28.93 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.066 -1.457 . . . . 1.04 107.066 166.38 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -81.18 -36.2 14.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 119.435 -0.906 . . . . 1.02 110.376 178.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 23.3 mt-30 -61.03 -16.26 41.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.093 -0.958 . . . . 0.40000000000000002 111.529 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 66.9 p -129.04 -37.0 1.73 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.769 0.795 . . . . 1.03 110.077 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.444 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.26 29.37 19.95 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 114.299 -1.319 . . . . 0.17999999999999999 112.205 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.73 154.3 23.1 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.674 0.273 . . . . 0.72999999999999998 110.6 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.474 HD11 ' HG2' ' A' ' 177' ' ' GLN . 29.5 mm -86.53 121.4 37.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.402 0.62 . . . . 1.03 109.365 177.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.679 ' CD1' HD13 ' A' ' 178' ' ' LEU . 1.4 pp -109.76 -33.06 2.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.095 -0.957 . . . . 1.01 110.45 -174.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.702 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 79.8 t90 -132.14 152.19 51.38 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.581 -0.736 . . . . 0.070000000000000007 109.356 172.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 27.0 p -153.79 162.8 40.93 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.265 0.839 . . . . 0.64000000000000001 113.265 164.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -157.69 -175.12 28.26 Favored Glycine 0 N--CA 1.427 -1.932 0 N-CA-C 110.817 -0.913 . . . . 0.12 110.817 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.956 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.2 mtmt -158.98 147.94 18.54 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.386 -1.709 . . . . 1.76 106.386 165.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 174' ' ' LEU . . . -156.05 125.89 1.72 Allowed Glycine 0 C--N 1.289 -2.047 0 C-N-CA 118.638 -1.744 . . . . 0.13 114.021 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.75 112.59 7.98 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.619 0.723 . . . . 1.01 110.979 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.701 HG11 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -90.76 159.28 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 114.545 -1.207 . . . . 1.01 110.269 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.787 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -100.08 174.18 6.29 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 112.801 -2.0 . . . . 0.92000000000000004 108.825 -173.319 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -102.16 131.48 48.64 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.492 -0.483 . . . . 0.91000000000000003 110.532 171.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.509 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 17.4 mm-40 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.514 -0.755 . . . . 1.24 110.264 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.758 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.9 m-30 . . . . . 0 N--CA 1.421 -1.907 0 N-CA-C 109.638 -0.504 . . . . 0.76000000000000001 109.638 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.513 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 7.3 t70 -81.65 67.32 7.57 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 123.795 1.759 . . . . 0.34999999999999998 107.978 171.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . 0.713 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 92.9 m95 -58.17 -42.15 85.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 111.361 -2.654 . . . . 0.10000000000000001 111.847 173.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.562 ' N ' HG22 ' A' ' 108' ' ' THR . 0.2 OUTLIER -56.35 -27.76 56.9 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.138 -1.392 . . . . 1.1100000000000001 110.285 178.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.23 -14.47 76.65 Favored Glycine 0 CA--C 1.498 -1.013 0 N-CA-C 110.816 -0.914 . . . . 0.23000000000000001 110.816 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.451 ' O ' ' HD2' ' A' ' 70' ' ' PRO . . . -97.38 -54.56 3.11 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 113.966 -1.117 . . . . 1.01 110.32 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' MET . . . . . 0.841 ' HA ' ' SD ' ' A' ' 71' ' ' MET . 40.6 mtt -61.87 -49.65 75.39 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 124.545 1.153 . . . . 0.089999999999999997 112.454 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.421 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.7 mm-40 -41.39 -55.33 5.44 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 115.269 1.581 . . . . 0.63 115.269 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.789 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.8 Cg_endo -64.18 -29.22 64.73 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.063 1.842 . . . . 0.17000000000000001 111.353 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' MET . . . . . 0.841 ' SD ' ' HA ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -80.96 -45.15 17.09 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 114.98 -1.009 . . . . 0.69999999999999996 110.122 -178.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 68' ' ' MET . 61.3 t -56.29 -40.78 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 114.246 -1.343 . . . . 1.04 108.729 174.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -57.15 -35.25 69.31 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.075 -1.875 . . . . 1.1200000000000001 111.189 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.789 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 26.8 mtpt -85.96 -33.08 21.22 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.918 0.39 . . . . 1.8799999999999999 110.981 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . 0.823 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.98 -26.98 68.82 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.618 -0.719 . . . . 0.5 111.477 -170.3 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.498 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.3 mt -93.1 -7.17 46.28 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.971 0.891 . . . . 1.29 111.387 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.27 13.84 55.03 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.143 -1.583 . . . . 0.17999999999999999 109.143 172.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.59 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.11 164.33 19.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.428 -0.886 . . . . 1.0 110.348 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -86.39 106.87 17.73 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.324 -0.853 . . . . 1.72 109.844 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.632 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 132.92 -21.47 4.17 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 120.4 -0.905 . . . . 0.13 111.146 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.823 HG11 ' O ' ' A' ' 75' ' ' MET . 12.5 p -103.74 152.56 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.853 0.835 . . . . 1.01 112.243 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.469 HG21 ' O ' ' A' ' 83' ' ' ALA . 25.7 m -136.4 144.43 44.51 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.438 -1.256 . . . . 1.1000000000000001 110.823 175.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB1' ' CE ' ' A' ' 118' ' ' LYS . . . -61.92 142.68 57.27 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.254 -0.884 . . . . 1.1200000000000001 110.05 166.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.78 -0.34 69.94 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.847 -0.692 . . . . 0.28000000000000003 112.568 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' SER . . . . . 0.485 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 63.1 m -94.57 145.83 24.54 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.552 -0.459 . . . . 1.55 109.977 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.645 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -76.44 126.67 37.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.685 0.755 . . . . 1.03 109.882 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.883 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -113.68 108.24 16.85 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.203 -0.908 . . . . 1.03 109.399 -170.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.649 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -73.32 94.51 2.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.39 -1.277 . . . . 1.01 108.868 176.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.446 HG23 HD21 ' A' ' 109' ' ' LEU . 2.0 m -73.12 116.72 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 107.718 -1.215 . . . . 1.6200000000000001 107.718 176.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.74 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 5.5 t0 -79.06 171.25 15.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.517 -0.92 . . . . 0.64000000000000001 108.517 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.652 ' HG ' ' HA ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -59.73 148.38 34.38 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-O 122.544 1.164 . . . . 1.05 108.757 171.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 24.7 t -73.97 138.25 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.498 0 N-CA-C 106.516 -1.661 . . . . 1.02 106.516 162.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.684 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.3 t-20 -85.23 163.73 18.5 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 121.744 0.783 . . . . 0.20000000000000001 110.108 174.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASN . . . . . 0.736 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.3 t-20 -124.82 86.23 2.53 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.633 -1.167 . . . . 0.12 108.384 175.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -107.72 -2.93 19.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.952 -1.476 . . . . 0.84999999999999998 108.731 -173.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 32.7 p -51.85 -172.18 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.232 -1.804 . . . . 0.91000000000000003 115.5 -176.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . 0.486 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.8 t30 -70.77 -8.91 55.81 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 112.537 -2.12 . . . . 0.62 110.562 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.514 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -153.26 -145.41 4.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.518 -0.849 . . . . 0.14000000000000001 113.045 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.61 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 58.1 p -121.43 130.58 53.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.626 0.602 . . . . 1.76 112.626 -176.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.736 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -136.17 153.5 51.24 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.626 0.727 . . . . 1.01 110.667 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.643 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -76.57 80.11 3.24 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.155 -1.384 . . . . 0.20999999999999999 107.771 175.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 92' ' ' VAL . . . -67.52 -15.23 63.55 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.155 -1.384 . . . . 1.0 110.07 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.07 -30.2 34.8 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.72 -0.845 . . . . 1.02 108.72 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.643 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 9.2 tp10 -66.07 -35.67 81.14 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.503 -1.226 . . . . 1.73 108.877 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.577 ' HB1' ' O ' ' A' ' 102' ' ' ALA . . . -70.66 -44.98 65.98 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 113.251 -1.795 . . . . 1.04 109.232 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.606 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 52.1 m -59.75 -32.03 70.2 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.965 -1.471 . . . . 1.04 110.947 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -43.87 71.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.476 -0.935 . . . . 1.47 108.476 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.645 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 56.7 m -62.76 -29.48 70.72 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.328 -0.851 . . . . 1.03 110.54 176.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.693 ' O ' HD21 ' A' ' 113' ' ' LEU . 9.1 tp -56.27 -64.26 0.92 Allowed 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.937 -1.029 . . . . 1.3 109.185 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.726 ' O ' HD13 ' A' ' 121' ' ' LEU . 23.4 mtp180 -43.07 -37.38 1.95 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.172 0.987 . . . . 1.8 111.114 172.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.645 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -69.21 -46.9 66.26 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.25 -1.341 . . . . 0.41999999999999998 112.165 -175.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.19 -33.67 65.53 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.58 -0.896 . . . . 1.01 108.58 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.693 HD21 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -59.21 -38.06 79.0 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.725 -1.579 . . . . 1.01 109.685 170.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.82 -40.68 60.94 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.177 -0.919 . . . . 1.03 110.926 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -56.47 -36.17 68.77 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.633 -1.167 . . . . 1.55 110.393 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -72.07 -47.61 50.28 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 113.636 -1.62 . . . . 2.0499999999999998 109.965 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.95 -11.96 63.28 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 114.947 0.739 . . . . 0.54000000000000004 114.947 172.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.514 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 53.9 mtpt -69.42 -36.68 76.95 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.515 1.157 . . . . 1.6000000000000001 111.081 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.883 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 20.6 m-85 -88.35 177.56 6.81 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 122.625 1.202 . . . . 0.27000000000000002 113.412 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 18.2 m -122.37 106.17 10.83 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 112.616 -2.083 . . . . 1.0800000000000001 108.041 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.726 HD13 ' O ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -94.42 128.6 41.07 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.563 -1.199 . . . . 1.1499999999999999 112.277 -168.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.559 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.301 -1.542 0 CA-C-N 114.218 -1.356 . . . . 1.0900000000000001 108.066 174.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.754 HD12 ' NZ ' ' A' ' 131' ' ' LYS . 1.1 tm? . . . . . 0 C--O 1.233 0.207 0 N-CA-C 113.721 1.008 . . . . 2.04 113.721 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.602 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -53.4 -38.99 63.92 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 123.547 1.642 . . . . 1.1499999999999999 108.437 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.677 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 41.9 mmm -63.37 -60.31 3.54 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 110.923 -2.853 . . . . 2.27 111.18 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.708 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.45 -44.19 5.72 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 124.259 0.974 . . . . 1.0700000000000001 112.166 176.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.754 ' NZ ' HD12 ' A' ' 127' ' ' LEU . 26.3 mttt -52.47 -55.52 21.4 Favored 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 120.065 -0.654 . . . . 2.1000000000000001 109.589 176.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 42.4 mt-30 -61.49 -42.59 99.03 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.894 -1.048 . . . . 0.42999999999999999 111.469 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLN . . . . . 0.677 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.5 mt-30 -57.55 -37.0 72.39 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.334 -1.303 . . . . 0.38 109.703 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.525 HD21 ' N ' ' A' ' 134' ' ' LEU . 0.4 OUTLIER -89.31 -31.36 17.86 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.804 -1.544 . . . . 1.05 109.063 -177.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 131' ' ' LYS . . . 159.64 -56.11 0.34 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-O 122.632 1.129 . . . . 0.33000000000000002 113.921 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 74.3 mt -61.88 -172.62 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 112.372 -1.914 . . . . 1.0700000000000001 116.025 -169.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.7 m -114.32 151.7 45.32 Favored Pre-proline 0 N--CA 1.428 -1.556 0 CA-C-N 110.846 -2.888 . . . . 1.24 108.581 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.602 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 10.2 Cg_endo -57.67 -7.56 3.31 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.177 2.585 . . . . 0.39000000000000001 113.423 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -116.98 -30.53 5.67 Favored 'General case' 0 CA--C 1.499 -1.008 0 O-C-N 123.709 0.63 . . . . 1.79 109.542 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 141' ' ' SER . 8.7 t70 -50.74 -36.11 34.91 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.506 1.146 . . . . 0.65000000000000002 108.778 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.652 ' HA ' ' HG ' ' A' ' 91' ' ' SER . 1.9 m 81.07 159.47 0.15 Allowed 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 110.747 -2.933 . . . . 0.73999999999999999 111.149 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.74 ' HG ' ' CG ' ' A' ' 90' ' ' ASP . 7.6 mt -66.27 -38.05 86.9 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.233 -1.395 . . . . 1.48 107.233 -172.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.17 0.16 0.68 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 112.545 -2.116 . . . . 0.34999999999999998 114.856 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -152.31 120.49 6.28 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.69 -0.855 . . . . 1.02 108.69 -174.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . 0.663 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.0 mmt180 -40.97 -48.08 3.12 Favored 'General case' 0 C--O 1.212 -0.874 0 O-C-N 123.691 0.619 . . . . 2.21 110.906 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 t -69.68 -29.77 67.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.23 0.538 . . . . 0.93000000000000005 111.817 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 23.9 mttm -72.36 -32.48 66.5 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.399 1.095 . . . . 1.8899999999999999 108.611 176.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ALA . . . . . 0.608 ' HA ' HD12 ' A' ' 142' ' ' LEU . . . -74.02 -43.06 59.29 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-N 112.761 -2.018 . . . . 0.98999999999999999 110.15 178.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.534 HG13 ' HE3' ' A' ' 179' ' ' MET . 40.2 mt -67.66 -42.66 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 CA-C-N 113.498 -1.683 . . . . 1.03 110.1 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.42 -51.99 44.08 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 114.955 -1.02 . . . . 0.14999999999999999 111.096 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ILE . . . . . 0.708 HG23 ' CB ' ' A' ' 130' ' ' ALA . 65.7 mt -68.25 -47.22 79.07 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 N-CA-C 113.01 0.744 . . . . 1.05 113.01 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . 0.638 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.24 -39.58 72.78 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.985 0.421 . . . . 1.03 110.816 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 23.6 mtp-105 -82.55 -19.9 37.66 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.526 0.679 . . . . 1.29 110.818 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.423 HD22 ' CD ' ' A' ' 133' ' ' GLN . 17.0 t30 -84.57 -11.22 56.46 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.344 -1.354 . . . . 0.5 107.344 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.703 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.08 -29.02 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 113.137 -1.847 . . . . 1.05 111.052 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.48 35.38 4.7 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.283 -0.96 . . . . 0.17000000000000001 112.485 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.83 156.24 21.42 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.249 0.833 . . . . 1.02 113.249 -169.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' HIS . . . . . 0.645 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.6 m80 -96.53 -26.53 15.23 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.838 -1.074 . . . . 0.39000000000000001 109.751 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' TYR . . . . . 0.599 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 15.6 m-85 -135.99 -179.53 5.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.218 -0.901 . . . . 0.81000000000000005 111.064 -173.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.707 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -133.06 139.79 48.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.61 -0.885 . . . . 1.03 108.61 166.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.496 HD21 ' HE2' ' A' ' 176' ' ' MET . 46.4 tp -110.54 101.33 10.01 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 119.407 -0.917 . . . . 1.02 109.244 165.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . 0.466 ' CD2' HG13 ' A' ' 160' ' ' VAL . 4.5 m-85 -82.05 112.79 19.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.222 -1.354 . . . . 0.87 109.421 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.886 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 10.3 t -122.81 162.19 22.59 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.768 0.794 . . . . 1.45 110.613 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' SER . . . . . 0.775 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -162.85 175.09 11.59 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.522 -1.217 . . . . 0.12 111.101 -177.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.32 136.77 35.19 Favored 'General case' 0 N--CA 1.413 -2.317 0 CA-C-N 114.413 -1.267 . . . . 0.94999999999999996 108.853 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 3.5 m -144.97 -172.97 3.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 109.219 -0.66 . . . . 1.1499999999999999 109.219 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.14 -84.87 1.11 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.606 -1.283 . . . . 0.14999999999999999 110.834 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 66.1 t30 -143.09 122.86 13.39 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.432 -0.884 . . . . 0.58999999999999997 109.923 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 99' ' ' SER . 2.4 p -54.32 -49.73 61.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 112.678 0.622 . . . . 1.0 112.678 -169.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASN . . . . . 0.438 ' N ' HG12 ' A' ' 169' ' ' VAL . 5.5 m-20 -56.83 -31.89 65.21 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.777 0.798 . . . . 1.9199999999999999 110.288 -174.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.49 87.51 4.15 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 114.263 -1.335 . . . . 1.0600000000000001 108.119 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . 0.654 ' HD2' HG23 ' A' ' 194' ' ' VAL . 48.1 Cg_endo -90.64 165.48 4.17 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 124.712 3.608 . . . . 0.089999999999999997 114.999 -170.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 28.7 m -81.31 117.91 22.19 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.745 -1.571 . . . . 1.0600000000000001 107.098 165.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.836 HD13 ' OG ' ' A' ' 163' ' ' SER . 43.1 tp -83.83 100.12 10.76 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.256 -1.016 . . . . 1.02 108.256 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLN . . . . . 0.558 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 35.5 mt-30 -90.05 109.56 20.61 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 121.897 0.856 . . . . 0.34000000000000002 109.152 -177.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' MET . . . . . 0.886 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.0 OUTLIER -111.46 163.84 13.6 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.233 -0.894 . . . . 1.0900000000000001 111.356 -174.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 57.8 tt0 -169.65 118.19 0.62 Allowed 'General case' 0 C--O 1.207 -1.171 0 CA-C-O 121.353 0.597 . . . . 0.68000000000000005 110.12 -165.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -101.16 102.29 13.18 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.038 -0.727 . . . . 1.03 109.038 -173.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.663 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.9 ttp -91.6 117.79 30.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.755 -0.657 . . . . 0.89000000000000001 109.491 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.447 ' HB2' HG22 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.48 113.0 2.7 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.655 -1.239 . . . . 1.04 107.655 170.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.525 HG23 ' HB1' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -67.53 -35.76 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.989 0.813 . . . . 1.02 111.611 -175.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -61.3 -12.52 13.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.726 -0.67 . . . . 0.40000000000000002 111.9 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' THR . . . . . 0.473 ' HG1' ' HG2' ' A' ' 185' ' ' GLU . 43.4 p -130.46 -37.26 1.41 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.211 1.005 . . . . 1.03 110.333 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . 0.437 ' CA ' HD13 ' A' ' 149' ' ' ILE . . . 88.91 21.05 44.14 Favored Glycine 0 N--CA 1.428 -1.88 0 CA-C-N 113.528 -1.669 . . . . 0.17999999999999999 111.596 -176.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.473 ' HG2' ' HG1' ' A' ' 183' ' ' THR . 14.1 pt-20 -99.62 154.31 18.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.906 0.384 . . . . 0.72999999999999998 110.537 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ILE . . . . . 0.435 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.7 mm -88.8 111.81 23.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.034 -0.728 . . . . 1.03 109.034 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.665 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.6 pp -98.49 -31.37 3.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.815 -1.084 . . . . 1.01 110.248 -173.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' TRP . . . . . 0.675 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 82.7 t90 -135.95 152.51 51.05 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.164 -0.925 . . . . 0.070000000000000007 109.914 173.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 64.9 p -154.01 162.71 41.01 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 112.172 0.434 . . . . 0.64000000000000001 112.172 163.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -162.15 -177.98 35.64 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.638 -0.985 . . . . 0.12 110.638 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' LYS . . . . . 0.833 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 13.2 mttt -151.78 153.77 34.94 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.537 -1.653 . . . . 1.76 106.537 166.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -159.82 128.22 1.95 Allowed Glycine 0 C--N 1.286 -2.236 0 CA-C-N 114.888 -1.051 . . . . 0.13 111.942 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -73.2 119.35 17.31 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.699 0.761 . . . . 1.01 111.286 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.708 HG12 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -94.42 159.22 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 CA-C-N 114.682 -1.145 . . . . 1.01 110.708 -176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' SER . . . . . 0.758 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -99.34 172.84 7.08 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.648 -2.069 . . . . 0.92000000000000004 109.001 -174.408 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -102.47 130.93 49.42 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.733 -0.387 . . . . 0.91000000000000003 110.17 171.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.528 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 16.1 mm-40 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.408 -0.806 . . . . 1.24 110.391 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.802 0 N-CA-C 112.269 -0.332 . . . . 88.920000000000002 112.269 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -74.01 105.66 5.35 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.792 -0.24 . . . . 87.459999999999994 110.382 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 62.32 -166.73 0.21 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.66 0.743 . . . . 87.5 111.174 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.3 ttm 68.05 34.2 4.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.038 -1.437 . . . . 85.340000000000003 111.625 167.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -109.73 -50.01 6.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.597 -1.183 . . . . 85.230000000000004 110.212 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.71 56.03 25.23 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.693 -0.765 . . . . 84.849999999999994 111.893 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -67.74 134.03 50.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.549 -0.326 . . . . 85.599999999999994 110.584 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 61.31 76.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.196 0.522 . . . . 85.310000000000002 111.566 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.78 159.3 85.68 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.737 -0.665 . . . . 82.170000000000002 109.863 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HB2' ' H ' ' A' ' 11' ' ' ALA . 35.7 Cg_exo -58.48 -89.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.081 2.521 . . . . 82.069999999999993 112.166 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.47 ' H ' ' HB2' ' A' ' 10' ' ' PRO . . . -179.04 -50.47 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.236 0 C-N-CA 122.748 0.419 . . . . 79.709999999999994 110.23 -175.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.79 143.64 46.42 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.481 1.454 . . . . 79.019999999999996 110.853 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.2 m -61.87 142.2 16.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.89 0.376 . . . . 77.260000000000005 110.871 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -168.26 143.35 3.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.806 -0.634 . . . . 75.739999999999995 110.613 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -75.14 149.44 39.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.352 -0.61 . . . . 74.010000000000005 109.352 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.52 105.38 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.926 -0.579 . . . . 72.569999999999993 110.705 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.448 ' C ' ' H ' ' A' ' 19' ' ' ALA . 26.4 mtpp -80.17 -37.45 1.07 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.933 0.716 . . . . 71.379999999999995 112.933 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.38 42.19 0.45 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.754 1.636 . . . . 70.189999999999998 112.224 172.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -168.96 101.73 0.5 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.501 -0.772 . . . . 67.769999999999996 109.126 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.14 -62.65 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.262 2.641 . . . . 67.180000000000007 112.412 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -137.1 -68.06 0.48 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.605 . . . . 65.200000000000003 111.176 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 41.0 67.59 2.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 O-C-N 123.747 0.654 . . . . 63.460000000000001 111.495 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -62.4 159.32 36.34 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.272 2.648 . . . . 62.479999999999997 112.619 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.64 113.0 6.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.684 -0.689 . . . . 59.869999999999997 110.091 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -66.6 137.92 95.34 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.596 . . . . 58.890000000000001 110.951 -176.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -59.59 130.1 33.93 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.536 2.158 . . . . 57.890000000000001 112.158 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -71.2 -38.81 72.07 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.584 -0.525 . . . . 55.729999999999997 109.584 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -140.54 127.62 12.17 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.753 -0.658 . . . . 54.079999999999998 110.348 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.5 -21.47 25.92 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 121.635 1.557 . . . . 53.299999999999997 112.428 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 m -85.82 124.7 70.54 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-O 121.062 0.458 . . . . 51.130000000000003 111.378 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -90.14 37.21 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.86 2.374 . . . . 49.75 111.236 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 p -83.47 153.58 24.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.489 -0.778 . . . . 47.700000000000003 111.911 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.0 109.57 10.72 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.368 -0.833 . . . . 46.109999999999999 110.25 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.424 ' C ' ' HG ' ' A' ' 35' ' ' SER . 71.2 Cg_exo -55.26 156.32 17.21 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.024 2.483 . . . . 45.890000000000001 112.437 178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.424 ' HG ' ' C ' ' A' ' 34' ' ' PRO . 50.0 m -155.49 122.04 5.28 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.447 -0.797 . . . . 43.0 110.327 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.19 115.55 42.71 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.991 -0.549 . . . . 40.789999999999999 110.401 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -79.24 151.95 23.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.636 2.224 . . . . 40.450000000000003 112.483 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 m -72.31 140.42 48.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.007 -0.542 . . . . 37.729999999999997 110.533 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.0 mt -87.82 117.49 68.55 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.918 -0.583 . . . . 35.990000000000002 110.082 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.91 161.94 14.44 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.792 2.328 . . . . 34.350000000000001 112.304 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -80.79 97.31 7.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.229 0.538 . . . . 31.780000000000001 111.073 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -85.21 131.66 47.7 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.73 -0.668 . . . . 30.390000000000001 109.844 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.69 164.94 31.25 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.41 2.074 . . . . 29.940000000000001 112.422 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.76 173.29 19.99 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.941 -0.647 . . . . 26.75 112.017 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.32 134.52 33.81 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.073 2.515 . . . . 25.879999999999999 112.257 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.0 mt -81.92 -57.28 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.148 -0.478 . . . . 24.16 109.974 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 56.77 81.09 0.14 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.508 -0.769 . . . . 21.829999999999998 111.486 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -77.68 164.85 24.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.905 -0.589 . . . . 20.620000000000001 110.211 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.26 178.44 4.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.716 -0.675 . . . . 16.559999999999999 110.556 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -121.66 69.4 0.92 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.87 -0.15 . . . . 15.050000000000001 111.086 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 66.41 132.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.437 0.46 . . . . 14.66 111.677 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.3 p -67.97 148.92 50.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.511 0.672 . . . . 11.84 111.392 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.65 109.71 18.9 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.138 -0.937 . . . . 8.4399999999999995 109.637 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.39 114.76 2.82 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.743 2.296 . . . . 7.6600000000000001 112.453 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.36 -43.11 61.66 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.445 2.097 . . . . 5.6600000000000001 111.653 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 65.03 110.36 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.283 0 O-C-N 124.036 0.835 . . . . 2.8700000000000001 111.35 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.95 -177.0 1.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.968 2.446 . . . . 1.8300000000000001 112.316 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -120.48 141.5 50.13 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.002 -0.999 . . . . 4.2199999999999998 110.485 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 60' ' ' ARG . 9.0 mt -89.3 174.49 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.268 -0.878 . . . . 1.1299999999999999 111.049 -177.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.576 ' N ' HG22 ' A' ' 59' ' ' ILE . 36.7 mtt85 -61.46 -150.32 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.77 -1.559 . . . . 3.1400000000000001 111.826 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.597 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 23.5 t-160 -159.6 137.01 9.78 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-N 112.899 -1.955 . . . . 2.7400000000000002 106.588 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.713 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.7 m-30 -121.26 156.11 33.2 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.587 -0.733 . . . . 0.76000000000000001 111.182 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 7.6 t70 -84.55 67.82 10.09 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 123.363 1.554 . . . . 0.34999999999999998 108.487 172.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.738 ' CZ3' HG13 ' A' ' 194' ' ' VAL . 93.8 m95 -57.96 -42.5 85.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 112.219 -2.264 . . . . 0.10000000000000001 112.455 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.584 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 9.5 t-20 -53.22 -26.14 16.61 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.13 -1.395 . . . . 1.1100000000000001 111.52 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.29 -15.61 79.81 Favored Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.279 -0.873 . . . . 0.23000000000000001 111.267 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.62 -53.19 3.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.104 -1.048 . . . . 1.01 110.991 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.751 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.2 mtt -65.43 -59.38 4.07 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 114.08 -1.418 . . . . 0.089999999999999997 112.035 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.584 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.9 mm-40 -39.28 -54.98 3.34 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 114.679 1.362 . . . . 0.63 114.679 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.749 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.8 Cg_endo -63.61 -28.47 69.63 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.988 1.792 . . . . 0.17000000000000001 110.768 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.62 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 8.2 mtm -83.17 -44.47 15.02 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.088 -0.96 . . . . 0.69999999999999996 112.09 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 68' ' ' MET . 58.6 t -56.86 -39.14 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-N 114.312 -1.313 . . . . 1.04 108.715 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -60.13 -32.96 71.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.966 -1.924 . . . . 1.1200000000000001 110.974 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.749 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 5.0 mtpm? -83.79 -35.76 24.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.843 0.457 . . . . 1.8799999999999999 111.159 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.87 ' O ' HG13 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.85 -26.54 68.66 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.461 -0.791 . . . . 0.5 111.295 -172.238 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' N ' ' HG2' ' A' ' 75' ' ' MET . 5.5 mt -93.46 -3.48 52.96 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.071 0.938 . . . . 1.29 110.841 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.27 15.41 42.99 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 109.147 -1.581 . . . . 0.17999999999999999 109.147 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.619 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.89 160.95 19.28 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.526 -0.837 . . . . 1.0 110.282 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.21 104.97 16.26 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.288 -0.869 . . . . 1.72 110.093 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.612 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.03 -23.83 3.16 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.842 -0.903 . . . . 0.13 110.842 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 75' ' ' MET . 11.9 p -103.07 150.67 6.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.635 0.731 . . . . 1.01 111.75 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.7 m -136.57 141.31 43.33 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.919 -1.037 . . . . 1.1000000000000001 111.102 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' HB1' ' HE3' ' A' ' 118' ' ' LYS . . . -55.12 132.95 48.57 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.779 -1.1 . . . . 1.1200000000000001 110.741 167.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.47 9.55 50.16 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 121.174 -0.536 . . . . 0.28000000000000003 112.8 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.66 149.64 21.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.327 -0.549 . . . . 1.55 110.647 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.659 HG12 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -80.84 116.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.168 0.985 . . . . 1.03 108.925 166.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.722 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -105.16 109.51 21.53 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.044 -0.98 . . . . 1.03 108.903 -172.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.675 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.78 94.42 1.39 Allowed 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 114.428 -1.26 . . . . 1.01 108.32 177.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.419 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.7 m -72.58 119.18 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 106.978 -1.49 . . . . 1.6200000000000001 106.978 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.839 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 12.3 t0 -77.33 162.35 27.35 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.703 -1.221 . . . . 0.64000000000000001 107.703 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.547 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.1 m -62.17 143.21 57.06 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.59 -1.633 . . . . 1.05 106.59 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.589 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 27.3 t -71.73 139.76 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.118 0 N-CA-C 107.534 -1.284 . . . . 1.02 107.534 168.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.64 ' H ' ' HA ' ' A' ' 164' ' ' SER . 8.0 t-20 -84.9 163.28 19.09 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.497 -0.774 . . . . 0.20000000000000001 110.07 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.768 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.14 85.22 2.38 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.96 -1.126 . . . . 0.12 107.96 175.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.509 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.9 mtp180 -107.02 -4.17 19.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.037 -1.438 . . . . 0.84999999999999998 108.764 -171.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.65 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 19.1 p -51.05 -170.94 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.83 -1.986 . . . . 0.91000000000000003 115.499 -175.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.472 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 38.3 t30 -70.96 -6.35 38.05 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.718 -2.037 . . . . 0.62 110.53 173.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.534 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -157.48 -144.05 3.83 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.396 -0.907 . . . . 0.14000000000000001 113.297 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.627 ' N ' HG22 ' A' ' 169' ' ' VAL . 94.8 p -121.42 130.31 53.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.612 0.597 . . . . 1.76 112.612 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.768 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.2 pp -136.48 159.49 41.64 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-O 121.855 0.836 . . . . 1.01 110.579 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.678 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -80.74 82.17 6.81 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 113.856 -1.52 . . . . 0.20999999999999999 107.975 175.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -70.84 -15.64 62.66 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.355 -1.293 . . . . 1.0 109.81 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.501 ' HB3' ' CG ' ' A' ' 139' ' ' GLN . . . -78.66 -31.53 46.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.793 0.806 . . . . 1.02 108.849 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.678 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 21.5 tt0 -62.83 -38.61 91.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 114.053 -1.43 . . . . 1.73 109.109 169.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.564 ' O ' ' HE2' ' A' ' 68' ' ' MET . . . -69.54 -44.62 70.57 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 112.867 -1.97 . . . . 1.04 109.005 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.594 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 60.6 m -64.89 -31.82 73.23 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.126 -1.397 . . . . 1.04 110.533 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.15 -51.24 59.74 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.972 -1.121 . . . . 1.47 107.972 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.583 HG22 ' HB2' ' A' ' 64' ' ' TRP . 31.7 m -56.69 -33.15 66.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.532 -0.758 . . . . 1.03 111.436 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.751 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.3 mt -50.55 -68.69 0.15 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 109.61 -0.515 . . . . 1.3 109.61 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.545 ' O ' HD13 ' A' ' 121' ' ' LEU . 19.0 mtp180 -42.81 -36.92 1.63 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.883 -1.053 . . . . 1.8 110.973 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.563 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -71.9 -47.47 52.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.245 -1.343 . . . . 0.41999999999999998 111.854 -175.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.426 ' HB2' ' HG2' ' A' ' 69' ' ' GLN . . . -72.21 -33.31 67.51 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.328 1.061 . . . . 1.01 108.403 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.668 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.86 -32.9 74.58 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.514 -1.676 . . . . 1.01 109.918 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.499 ' CB ' HD12 ' A' ' 121' ' ' LEU . . . -76.28 -40.82 50.72 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.812 -1.086 . . . . 1.03 111.364 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.05 -26.87 66.96 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.99 -1.005 . . . . 1.55 110.682 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -88.08 -17.94 29.98 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.147 -0.621 . . . . 2.0499999999999998 110.429 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.21 -12.83 2.99 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 116.048 1.179 . . . . 0.54000000000000004 116.048 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.472 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 57.8 mtpt -77.39 -14.3 59.74 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 117.802 0.801 . . . . 1.6000000000000001 111.463 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.722 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 23.2 m-85 -109.29 172.76 6.66 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 122.648 1.213 . . . . 0.27000000000000002 113.669 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.546 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 14.7 m -117.27 117.42 29.5 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 112.305 -2.225 . . . . 1.0800000000000001 108.031 169.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.597 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -88.52 139.02 30.9 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.437 -0.801 . . . . 1.1499999999999999 110.517 -171.814 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.53 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.7 OUTLIER -84.59 155.03 3.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.871 -0.788 . . . . 1.0900000000000001 108.871 172.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.26 152.57 19.27 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.602 0.715 . . . . 1.8200000000000001 109.427 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.657 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -64.32 -19.43 65.43 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 114.502 -1.227 . . . . 1.1899999999999999 110.121 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.598 ' O ' ' HG3' ' A' ' 129' ' ' MET . 0.4 OUTLIER -57.22 -29.89 64.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.022 -0.99 . . . . 2.04 109.612 172.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.565 ' HB2' HG23 ' A' ' 155' ' ' VAL . 1.7 mt-30 -98.82 -54.66 2.94 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 122.427 1.108 . . . . 0.42999999999999999 110.101 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.504 ' HB3' ' HA ' ' A' ' 124' ' ' ALA . 26.5 tp -60.79 -63.22 1.37 Allowed 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 113.165 -1.834 . . . . 2.04 112.8 -169.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.682 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 2.6 t -49.39 -44.56 45.19 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 123.308 1.528 . . . . 1.1499999999999999 109.408 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.706 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 19.0 mmt -58.44 -61.61 2.46 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 111.064 -2.789 . . . . 2.27 110.694 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.701 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -42.81 -46.15 5.13 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 124.484 1.115 . . . . 1.0700000000000001 112.197 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.511 ' NZ ' ' H ' ' A' ' 91' ' ' SER . 0.0 OUTLIER -54.95 -51.36 66.39 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 108.624 -0.88 . . . . 2.1000000000000001 108.624 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.495 ' HG3' ' O ' ' A' ' 128' ' ' SER . 40.9 mt-30 -65.68 -40.78 92.72 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.23 -0.895 . . . . 0.42999999999999999 111.162 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.706 ' HG3' ' O ' ' A' ' 129' ' ' MET . 54.5 mt-30 -57.81 -34.73 69.96 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 114.354 -1.294 . . . . 0.38 109.525 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.501 HD21 ' N ' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.08 -28.93 17.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 113.754 -1.567 . . . . 1.05 109.284 -176.939 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.62 -49.79 0.52 Allowed Glycine 0 CA--C 1.496 -1.137 0 CA-C-O 122.667 1.148 . . . . 0.33000000000000002 113.323 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.54 HD13 ' O ' ' A' ' 141' ' ' SER . 87.9 mt -64.92 -169.73 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 112.332 -1.934 . . . . 1.0700000000000001 115.669 -171.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.0 m -116.3 155.05 48.82 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 110.858 -2.883 . . . . 1.24 107.517 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.682 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 46.1 Cg_endo -67.26 1.35 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.661 2.241 . . . . 0.39000000000000001 110.866 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.547 ' H ' ' C ' ' A' ' 137' ' ' SER . 31.4 mt-30 -118.27 -24.31 6.97 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.946 -1.479 . . . . 1.79 111.525 -173.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.675 ' O ' ' HB2' ' A' ' 141' ' ' SER . 7.1 t70 -72.92 -23.61 60.72 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 114.838 -1.073 . . . . 0.65000000000000002 108.793 -168.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.675 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 31.5 m 75.78 166.33 0.27 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.532 -2.122 . . . . 0.73999999999999999 110.56 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.839 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 4.2 mt -64.99 -40.4 94.91 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.581 1.182 . . . . 1.48 108.777 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.71 -12.16 0.16 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 112.607 -2.088 . . . . 0.34999999999999998 114.612 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.438 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -151.79 125.45 8.97 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 118.832 -0.604 . . . . 1.02 109.57 -173.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.609 ' O ' ' HB1' ' A' ' 148' ' ' ALA . 16.8 mmt85 -42.27 -48.13 4.9 Favored 'General case' 0 C--O 1.211 -0.944 0 O-C-N 123.413 0.446 . . . . 2.21 111.915 -176.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 41.9 t -72.23 -26.33 61.98 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.595 0.712 . . . . 0.93000000000000005 111.236 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -74.37 -28.97 61.36 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.6 1.19 . . . . 1.8899999999999999 108.505 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.695 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -76.47 -47.92 21.32 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-N 112.471 -2.149 . . . . 0.98999999999999999 110.427 177.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.528 HG13 ' HE2' ' A' ' 179' ' ' MET . 43.2 mt -66.51 -40.17 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 CA-C-N 112.856 -1.975 . . . . 1.03 110.073 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.46 -55.26 25.69 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 114.652 -1.158 . . . . 0.14999999999999999 110.965 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.717 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 92.1 mt -66.42 -48.55 80.4 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.07 0 N-CA-C 112.683 0.623 . . . . 1.05 112.683 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.648 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.36 -41.2 72.22 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 123.227 0.329 . . . . 1.03 111.079 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.418 ' HD2' HG21 ' A' ' 149' ' ' ILE . 24.8 mtp180 -81.22 -23.02 38.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.597 0.713 . . . . 1.29 110.459 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.448 HD21 ' CB ' ' A' ' 130' ' ' ALA . 21.4 t30 -82.84 -10.26 58.93 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.438 -1.319 . . . . 0.5 107.438 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.717 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.1 t -108.51 -29.47 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 113.18 -1.827 . . . . 1.05 111.0 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.83 35.86 4.16 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.077 -1.058 . . . . 0.17000000000000001 112.486 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.675 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.15 159.65 17.65 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.866 0.691 . . . . 1.02 112.866 -171.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.659 ' N ' HG12 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -99.85 -28.17 13.25 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 123.414 0.686 . . . . 0.39000000000000001 109.681 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.571 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.3 m-85 -135.44 -173.17 3.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.161 -0.927 . . . . 0.81000000000000005 110.945 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.711 ' O ' HD21 ' A' ' 178' ' ' LEU . 1.2 t -137.18 140.35 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.004 -0.998 . . . . 1.03 108.786 166.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.606 HD22 ' SD ' ' A' ' 176' ' ' MET . 37.0 tp -109.31 100.95 10.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 119.417 -0.913 . . . . 1.02 109.3 165.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.505 ' HH ' ' HB2' ' A' ' 142' ' ' LEU . 2.4 m-85 -79.83 113.59 18.1 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 114.434 -1.257 . . . . 0.87 109.027 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.864 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 6.4 t -126.64 161.25 28.51 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 122.143 0.973 . . . . 1.45 110.881 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.791 ' O ' HD11 ' A' ' 174' ' ' LEU . 2.2 p -164.51 174.55 10.79 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.949 -1.478 . . . . 0.12 110.859 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.29 134.67 38.23 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 114.2 -1.363 . . . . 0.94999999999999996 108.632 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.65 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.7 m -144.73 -175.96 4.87 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.185 -0.672 . . . . 1.1499999999999999 109.185 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.82 -84.53 0.8 Allowed Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 119.536 -1.316 . . . . 0.14999999999999999 111.325 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.472 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.7 t30 -144.23 127.22 16.45 Favored 'General case' 0 C--O 1.197 -1.676 0 N-CA-C 107.596 -1.261 . . . . 0.58999999999999997 107.596 175.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.627 HG22 ' N ' ' A' ' 99' ' ' SER . 3.5 p -63.34 -39.53 85.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.398 -0.819 . . . . 1.0 112.364 -171.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.461 ' N ' HG13 ' A' ' 169' ' ' VAL . 4.4 m120 -60.72 -31.47 70.77 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 122.086 0.946 . . . . 1.9199999999999999 109.753 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.55 88.89 3.29 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 113.169 -1.832 . . . . 1.0600000000000001 108.307 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.653 ' HD2' HG22 ' A' ' 194' ' ' VAL . 52.4 Cg_endo -89.99 163.73 4.88 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 124.335 3.357 . . . . 0.089999999999999997 114.883 -169.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.55 HG21 ' HB3' ' A' ' 191' ' ' LYS . 63.8 m -82.93 117.97 23.14 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 106.965 -1.494 . . . . 1.0600000000000001 106.965 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.834 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 38.5 tp -83.9 97.49 9.26 Favored 'General case' 0 N--CA 1.413 -2.325 0 C-N-CA 119.294 -0.963 . . . . 1.02 108.402 177.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.556 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 6.3 mt-30 -87.87 109.47 19.8 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.098 -0.955 . . . . 0.34000000000000002 109.153 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.864 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -112.85 164.75 13.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.684 -1.144 . . . . 1.0900000000000001 111.481 -173.787 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 56.7 tt0 -170.57 118.16 0.52 Allowed 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 116.077 -0.51 . . . . 0.68000000000000005 110.076 -166.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER -100.37 100.56 11.36 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.741 -0.837 . . . . 1.03 108.741 -172.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.598 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 18.2 ttp -90.52 121.93 32.9 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.445 -0.798 . . . . 0.89000000000000001 109.614 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.82 127.09 30.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.122 -1.436 . . . . 1.04 107.122 166.284 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.525 HG21 ' HB1' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.52 -34.4 13.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 119.33 0.968 . . . . 1.02 110.758 178.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 30.7 mt-30 -63.08 -14.69 51.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.265 -0.88 . . . . 0.40000000000000002 111.577 -177.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.1 p -130.58 -36.97 1.4 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.677 0.751 . . . . 1.03 110.277 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.403 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.17 19.0 44.02 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.556 -1.202 . . . . 0.17999999999999999 112.25 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.7 156.79 16.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.529 -0.336 . . . . 0.72999999999999998 110.494 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.474 HD11 ' HG2' ' A' ' 177' ' ' GLN . 33.7 mm -91.58 115.85 31.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.637 0.732 . . . . 1.03 109.52 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.687 ' CD1' HD13 ' A' ' 178' ' ' LEU . 1.5 pp -103.28 -29.61 2.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.019 -0.991 . . . . 1.01 110.681 -173.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.639 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.0 t90 -137.2 153.26 50.45 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.371 -0.831 . . . . 0.070000000000000007 109.508 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 79.9 p -153.47 165.47 35.75 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.822 0.675 . . . . 0.64000000000000001 112.822 163.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -161.79 -175.91 33.32 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-O 121.718 0.621 . . . . 0.12 111.762 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.834 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 1.5 mttp -154.74 152.02 29.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.095 -1.817 . . . . 1.76 106.095 164.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.526 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -157.33 127.31 1.9 Allowed Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 119.612 -1.28 . . . . 0.13 111.833 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.42 115.2 10.32 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.391 0.615 . . . . 1.01 110.487 -175.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.738 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -90.98 158.68 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-O 122.47 1.128 . . . . 1.01 109.647 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.684 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.23 171.58 7.52 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 112.848 -1.978 . . . . 0.92000000000000004 109.256 -172.612 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 6.8 tt0 -101.64 128.96 47.7 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.074 -0.713 . . . . 0.91000000000000003 109.074 168.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.492 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 19.3 mm-40 . . . . . 0 C--N 1.309 -1.177 0 CA-C-N 115.505 -0.771 . . . . 1.24 110.732 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.853 0 N-CA-C 111.977 -0.449 . . . . 88.920000000000002 111.977 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -71.37 -41.15 70.07 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 122.323 0.249 . . . . 87.459999999999994 111.281 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 56.27 71.3 0.57 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.815 0.341 . . . . 87.5 110.293 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.8 ttt -129.73 57.59 1.67 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.694 0.759 . . . . 85.340000000000003 109.763 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.69 -15.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.477 -0.783 . . . . 85.230000000000004 111.155 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.55 55.3 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.957 -0.64 . . . . 84.849999999999994 111.846 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -89.21 117.63 28.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.699 0.761 . . . . 85.599999999999994 110.738 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 55.33 66.22 1.28 Allowed 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 113.695 -1.593 . . . . 85.310000000000002 111.945 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 10.0 mm-40 -58.79 128.79 84.63 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-O 120.972 0.415 . . . . 82.170000000000002 111.039 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 22.7 Cg_exo -65.43 -33.28 47.69 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.657 2.238 . . . . 82.069999999999993 111.794 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.95 133.87 10.0 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.648 -0.705 . . . . 79.709999999999994 109.988 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.15 164.91 28.77 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.948 2.432 . . . . 79.019999999999996 112.475 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.0 m -95.84 156.47 3.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.812 -0.631 . . . . 77.260000000000005 111.303 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 59.6 97.51 0.03 OUTLIER 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.91 -1.041 . . . . 75.739999999999995 112.716 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -82.4 89.19 6.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.378 0.609 . . . . 74.010000000000005 109.575 172.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.401 HG22 ' HD3' ' A' ' 18' ' ' PRO . 6.4 p -69.83 107.53 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.286 -0.87 . . . . 72.569999999999993 111.307 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -125.45 84.06 60.61 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.505 -0.771 . . . . 71.379999999999995 109.66 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.401 ' HD3' HG22 ' A' ' 16' ' ' VAL . 98.8 Cg_endo -82.47 166.47 15.8 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.591 2.194 . . . . 70.189999999999998 112.505 -177.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.07 110.64 27.37 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.112 -0.495 . . . . 67.769999999999996 110.337 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.62 62.04 5.44 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.047 2.498 . . . . 67.180000000000007 112.14 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -129.44 174.78 9.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.886 -0.597 . . . . 65.200000000000003 109.685 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.402 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 58.4 tt0 -115.65 121.73 33.9 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.899 -0.408 . . . . 63.460000000000001 109.899 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 52.0 Cg_exo -62.87 173.71 3.59 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.894 2.396 . . . . 62.479999999999997 112.907 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.406 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . 54.14 60.68 3.45 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 112.496 -2.138 . . . . 59.869999999999997 112.542 175.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.56 104.19 2.15 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.711 -1.131 . . . . 58.890000000000001 110.29 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 24' ' ' ALA . 1.1 Cg_endo -82.4 13.57 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.898 2.399 . . . . 57.890000000000001 112.424 -175.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.403 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 6.1 tp60 -139.15 148.97 43.92 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.111 -0.699 . . . . 55.729999999999997 109.111 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -72.05 115.58 39.86 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 110.279 -0.267 . . . . 54.079999999999998 110.279 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.72 -43.01 41.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.684 2.256 . . . . 53.299999999999997 111.316 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.82 106.14 26.13 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.441 -0.8 . . . . 51.130000000000003 110.217 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.66 37.27 0.67 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.799 2.333 . . . . 49.75 112.249 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.39 166.25 15.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.549 0.69 . . . . 47.700000000000003 110.423 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.0 m -110.99 142.05 25.45 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-N 114.864 -1.062 . . . . 46.109999999999999 109.645 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -55.63 154.04 27.11 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.562 2.175 . . . . 45.890000000000001 111.994 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -70.29 129.11 38.44 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.354 -0.839 . . . . 43.0 111.586 -172.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.77 81.63 69.9 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.356 -0.838 . . . . 40.789999999999999 111.01 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.85 -21.98 69.07 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.771 2.314 . . . . 40.450000000000003 111.607 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -172.3 150.7 2.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.213 -0.903 . . . . 37.729999999999997 109.558 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.2 mt -98.56 105.06 27.64 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.888 -0.596 . . . . 35.990000000000002 109.576 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.15 60.16 3.84 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.986 2.457 . . . . 34.350000000000001 112.827 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -132.0 174.97 9.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.088 -0.505 . . . . 31.780000000000001 110.219 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 70.14 129.43 0.03 OUTLIER Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 114.765 -1.107 . . . . 30.390000000000001 111.313 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -62.8 146.46 95.06 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 121.919 1.746 . . . . 29.940000000000001 111.666 176.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.72 -169.97 38.0 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.713 -0.756 . . . . 26.75 112.034 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.12 125.45 10.33 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.675 2.25 . . . . 25.879999999999999 111.599 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.8 mm -67.85 -54.29 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.876 -0.602 . . . . 24.16 110.715 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 50.55 76.96 0.13 Allowed 'General case' 0 C--O 1.235 0.324 0 O-C-N 124.137 0.898 . . . . 21.829999999999998 111.213 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -86.58 174.72 8.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.262 0.554 . . . . 20.620000000000001 110.823 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.63 164.54 22.67 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.361 -0.836 . . . . 16.559999999999999 109.349 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -101.5 17.37 22.94 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.673 0.749 . . . . 15.050000000000001 110.963 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 58.6 -85.7 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.508 -1.678 . . . . 14.66 110.772 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.669 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 41.1 p -88.35 158.48 18.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.388 -0.369 . . . . 11.84 110.237 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.43 95.58 6.18 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.813 -0.631 . . . . 8.4399999999999995 111.877 -174.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.669 ' HD3' ' O ' ' A' ' 52' ' ' THR . 36.0 Cg_endo -96.68 131.22 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.432 2.755 . . . . 7.6600000000000001 112.528 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.65 -34.62 83.81 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.393 2.062 . . . . 5.6600000000000001 111.618 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.12 122.83 7.03 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.501 -0.772 . . . . 2.8700000000000001 109.146 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.4 -177.84 1.94 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 123.198 2.599 . . . . 1.8300000000000001 112.928 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -115.56 141.71 47.69 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 113.798 -1.546 . . . . 4.2199999999999998 109.544 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 60' ' ' ARG . 10.0 mt -84.43 167.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.875 0.845 . . . . 1.1299999999999999 112.162 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.618 HH11 ' HH ' ' A' ' 62' ' ' TYR . 35.8 mtt85 -71.81 -150.28 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.516 -1.675 . . . . 3.1400000000000001 111.435 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.75 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 23.6 t-160 -158.74 136.35 10.21 Favored 'General case' 0 CA--C 1.476 -1.869 0 CA-C-N 112.948 -1.933 . . . . 2.7400000000000002 107.001 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.75 ' HD1' ' C ' ' A' ' 61' ' ' HIS . 2.1 m-30 -122.17 154.19 37.78 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.322 -0.854 . . . . 0.76000000000000001 110.973 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.521 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 15.8 t70 -85.05 67.75 10.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 123.538 1.637 . . . . 0.34999999999999998 108.444 173.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.745 ' CZ3' HG13 ' A' ' 194' ' ' VAL . 93.1 m95 -55.64 -43.33 76.12 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 112.006 -2.361 . . . . 0.10000000000000001 112.752 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.498 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 11.1 t-20 -50.8 -30.87 15.33 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.762 -1.563 . . . . 1.1100000000000001 111.643 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.28 -17.15 79.62 Favored Glycine 0 CA--C 1.503 -0.693 0 CA-C-N 115.506 -0.77 . . . . 0.23000000000000001 111.423 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.96 -51.51 3.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.114 -1.043 . . . . 1.01 110.806 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.776 ' SD ' HD23 ' A' ' 109' ' ' LEU . 37.6 mtt -65.69 -56.29 12.9 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 114.182 -1.372 . . . . 0.089999999999999997 112.473 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.498 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 7.0 mm-40 -39.74 -54.29 4.15 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 114.804 1.409 . . . . 0.63 114.804 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.817 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 29.6 Cg_endo -63.55 -32.0 70.39 Favored 'Trans proline' 0 CA--C 1.508 -0.804 0 C-N-CA 121.919 1.746 . . . . 0.17000000000000001 110.799 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.65 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 7.7 mtm -79.64 -47.59 15.16 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 114.979 -1.01 . . . . 0.69999999999999996 111.515 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.705 HG23 ' O ' ' A' ' 68' ' ' MET . 53.3 t -54.52 -41.19 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 CA-C-N 114.089 -1.414 . . . . 1.04 108.955 176.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.9 t -60.0 -36.68 77.72 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.256 -1.793 . . . . 1.1200000000000001 110.791 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.817 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 20.0 mtpp -77.6 -35.36 52.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.303 0.573 . . . . 1.8799999999999999 110.498 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.862 ' O ' HG13 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.14 -29.81 71.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.765 -1.107 . . . . 0.5 111.44 -173.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -83.68 -6.82 59.54 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.193 0.52 . . . . 1.29 111.235 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -108.76 13.97 34.98 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.614 -1.395 . . . . 0.17999999999999999 109.614 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -81.58 161.36 23.56 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.663 -0.768 . . . . 1.0 110.285 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.99 106.26 17.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.345 -0.843 . . . . 1.72 109.579 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.632 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.76 -24.68 3.46 Favored Glycine 0 N--CA 1.418 -2.542 0 C-N-CA 119.797 -1.192 . . . . 0.13 110.666 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.862 HG13 ' O ' ' A' ' 75' ' ' MET . 10.9 p -97.47 155.9 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.702 0.763 . . . . 1.01 111.541 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.754 ' HG1' ' HH ' ' A' ' 159' ' ' TYR . 6.5 m -132.85 136.62 46.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 114.51 -1.223 . . . . 1.1000000000000001 110.901 -176.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.428 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.6 130.21 45.74 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.864 -1.062 . . . . 1.1200000000000001 110.332 167.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.86 12.15 60.86 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.719 -0.753 . . . . 0.28000000000000003 113.233 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.462 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 61.9 m -97.56 147.73 23.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.124 0.462 . . . . 1.55 110.156 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.661 HG12 ' N ' ' A' ' 158' ' ' HIS . 2.2 p -77.0 124.8 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 122.09 0.948 . . . . 1.03 109.194 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.661 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.7 tm? -110.84 110.17 20.66 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.984 -1.007 . . . . 1.03 108.58 -172.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.646 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -71.34 92.85 1.08 Allowed 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.334 -1.358 . . . . 1.01 107.334 176.336 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' A' ' 110' ' ' ARG . 0.2 OUTLIER -73.68 113.41 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.416 -1.327 . . . . 1.6200000000000001 107.416 177.27 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.811 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 23.1 t0 -77.28 172.04 13.9 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 114.778 -1.101 . . . . 0.64000000000000001 108.815 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.547 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.7 OUTLIER -61.8 157.78 17.31 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 122.767 1.27 . . . . 1.05 108.371 168.234 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 39.3 t -86.87 139.63 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.202 0 CA-C-N 113.692 -1.595 . . . . 1.02 107.047 165.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.657 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.6 t-20 -83.8 163.35 20.2 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.854 0.835 . . . . 0.20000000000000001 110.555 173.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.763 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.74 84.86 2.32 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.348 -1.296 . . . . 0.12 107.977 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -108.48 -2.6 18.85 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.847 -1.524 . . . . 0.84999999999999998 108.727 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.617 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 22.6 p -51.4 -170.13 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 112.678 -2.055 . . . . 0.91000000000000003 115.156 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.467 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 29.8 t30 -70.49 -10.66 59.77 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.083 -1.871 . . . . 0.62 110.531 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.509 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.37 -144.74 3.98 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.176 -1.011 . . . . 0.14000000000000001 113.573 -176.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.631 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 16.5 m -121.27 130.75 53.83 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.8 0.44 . . . . 1.76 110.935 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.763 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -136.8 157.48 46.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.962 0.887 . . . . 1.01 110.735 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.709 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -77.17 80.74 3.68 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.628 -1.623 . . . . 0.20999999999999999 107.56 175.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 92' ' ' VAL . . . -70.17 -14.71 62.76 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.863 -1.062 . . . . 1.0 109.767 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.86 -29.6 35.74 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.413 -0.958 . . . . 1.02 108.413 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.709 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 29.3 tt0 -61.62 -40.64 95.56 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.207 -1.36 . . . . 1.73 109.125 168.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.558 ' HB1' ' O ' ' A' ' 102' ' ' ALA . . . -68.15 -45.29 73.94 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 112.826 -1.988 . . . . 1.04 108.845 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.613 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 47.2 m -63.78 -33.28 75.32 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 113.821 -1.536 . . . . 1.04 110.618 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -44.83 84.89 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.637 -1.245 . . . . 1.47 107.637 172.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.59 HG23 ' HB2' ' A' ' 64' ' ' TRP . 34.6 m -63.24 -30.11 71.32 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.234 -0.894 . . . . 1.03 110.867 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.776 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.57 -68.34 0.18 Allowed 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.589 -0.732 . . . . 1.3 109.658 171.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.561 HH21 ' HB3' ' A' ' 127' ' ' LEU . 5.8 mpt_? -40.31 -36.63 0.56 Allowed 'General case' 0 C--O 1.213 -0.865 0 O-C-N 124.226 0.954 . . . . 1.8 110.888 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.555 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -74.6 -46.35 39.12 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.665 -1.152 . . . . 0.41999999999999998 112.0 -174.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.55 63.36 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.471 -0.937 . . . . 1.01 108.471 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.666 ' HB3' ' CD2' ' A' ' 121' ' ' LEU . 4.5 mm? -61.64 -35.21 77.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.649 -1.614 . . . . 1.01 109.442 172.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 110' ' ' ARG . . . -73.46 -41.69 62.86 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 114.574 -1.194 . . . . 1.03 110.937 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.85 -8.5 54.7 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.15 -0.932 . . . . 1.55 110.281 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -77.81 -49.08 15.02 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.523 -0.917 . . . . 2.0499999999999998 108.523 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.87 -7.15 82.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.416 -0.811 . . . . 0.54000000000000004 113.735 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.453 ' HB2' ' HG ' ' A' ' 76' ' ' LEU . 58.7 mtpt -86.64 -33.13 20.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.289 0.545 . . . . 1.6000000000000001 111.322 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.717 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 6.5 m-85 -88.81 171.47 9.91 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.303 1.049 . . . . 0.27000000000000002 112.988 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.563 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 7.9 m -116.46 119.32 35.24 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.144 -1.844 . . . . 1.0800000000000001 108.222 168.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.666 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -89.01 140.82 29.05 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 119.466 -0.893 . . . . 1.1499999999999999 111.368 -171.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.546 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.9 OUTLIER -89.42 147.81 4.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.42 -0.956 . . . . 1.0900000000000001 108.42 170.055 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.642 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 1.4 m -102.0 164.63 11.61 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.326 1.06 . . . . 1.8200000000000001 110.06 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -64.26 -34.62 78.54 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 112.939 -1.937 . . . . 1.1899999999999999 111.348 -171.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.668 ' O ' ' HG3' ' A' ' 129' ' ' MET . 10.2 pt20 -50.12 -30.13 10.49 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.501 -1.681 . . . . 2.04 110.966 172.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.552 ' HB2' HG22 ' A' ' 155' ' ' VAL . 0.5 OUTLIER -97.24 -55.04 2.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.648 -1.16 . . . . 0.42999999999999999 110.586 171.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.611 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 1.3 tm? -69.62 -64.76 0.82 Allowed 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 114.679 -1.146 . . . . 2.04 112.998 -168.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.659 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -48.75 -37.83 20.0 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 123.649 1.69 . . . . 1.1499999999999999 108.946 -179.288 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.668 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 6.6 mmt -65.78 -61.52 2.02 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 110.731 -2.94 . . . . 2.27 110.987 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.685 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.65 -43.61 3.92 Favored 'General case' 0 CA--C 1.503 -0.829 0 O-C-N 124.181 0.925 . . . . 1.0700000000000001 112.384 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.611 ' HG2' ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -55.24 -52.69 62.58 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 107.806 -1.183 . . . . 2.1000000000000001 107.806 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.9 mt-30 -65.89 -41.05 92.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.064 -0.971 . . . . 0.42999999999999999 111.194 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.643 ' HG3' ' O ' ' A' ' 129' ' ' MET . 54.2 mt-30 -56.46 -34.72 67.14 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-N 114.365 -1.289 . . . . 0.38 109.617 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -92.57 -31.33 15.23 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.002 -1.454 . . . . 1.05 109.45 -176.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.79 -51.95 0.39 Allowed Glycine 0 CA--C 1.499 -0.917 0 C-N-CA 120.149 -1.024 . . . . 0.33000000000000002 113.759 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.633 HD12 ' O ' ' A' ' 141' ' ' SER . 39.1 mt -67.25 -167.0 0.05 Allowed 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.499 -1.851 . . . . 1.0700000000000001 115.778 -170.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -116.95 154.57 49.68 Favored Pre-proline 0 N--CA 1.421 -1.909 0 CA-C-N 110.994 -2.821 . . . . 1.24 108.002 176.58 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.659 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 21.9 Cg_endo -62.56 -0.11 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.397 2.731 . . . . 0.39000000000000001 112.207 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.504 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.2 tt0 -119.51 -28.73 5.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.172 -0.922 . . . . 1.79 111.096 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.704 ' O ' ' HB2' ' A' ' 141' ' ' SER . 11.7 t70 -66.1 -25.4 66.99 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 113.779 -1.555 . . . . 0.65000000000000002 109.407 -172.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.704 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 5.7 m 75.66 171.75 0.26 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.146 -1.843 . . . . 0.73999999999999999 109.697 -173.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.811 ' HG ' ' CG ' ' A' ' 90' ' ' ASP . 4.0 mt -65.6 -39.24 91.35 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.398 1.094 . . . . 1.48 108.36 -176.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.55 -12.4 0.33 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 112.871 -1.968 . . . . 0.34999999999999998 114.646 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -153.13 124.88 7.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 118.719 -0.658 . . . . 1.02 109.638 -174.672 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.663 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -40.89 -48.5 3.13 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 112.177 0.436 . . . . 2.21 112.177 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.3 t -72.47 -26.16 61.7 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.443 0.64 . . . . 0.93000000000000005 111.186 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -73.97 -28.42 61.47 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.712 1.244 . . . . 1.8899999999999999 108.528 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.639 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -76.61 -47.25 22.93 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 112.27 -2.241 . . . . 0.98999999999999999 110.253 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.556 HG13 ' HE2' ' A' ' 179' ' ' MET . 36.5 mt -66.75 -41.12 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 112.816 -1.993 . . . . 1.03 110.188 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.98 -54.94 26.3 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 114.613 -1.176 . . . . 0.14999999999999999 111.054 171.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.71 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 75.2 mt -65.63 -47.89 84.57 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 N-CA-C 112.748 0.647 . . . . 1.05 112.748 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.646 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.27 -40.45 74.23 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.939 0.4 . . . . 1.03 110.939 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 30.9 mtp180 -82.13 -20.85 37.16 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.677 0.751 . . . . 1.29 110.451 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -83.28 -10.77 58.33 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.238 -1.393 . . . . 0.5 107.238 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.71 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.0 OUTLIER -109.59 -29.02 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 113.444 -1.707 . . . . 1.05 111.42 -173.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.26 35.92 4.3 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.213 -0.994 . . . . 0.17000000000000001 112.489 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.644 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.45 160.56 17.0 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.294 0.85 . . . . 1.02 113.294 -170.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.661 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.4 m80 -100.86 -26.21 13.84 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.121 -0.945 . . . . 0.39000000000000001 109.613 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.754 ' HH ' ' HG1' ' A' ' 82' ' ' THR . 12.7 m-85 -135.49 -174.29 3.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.19 -0.914 . . . . 0.81000000000000005 111.583 -174.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.657 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -136.57 140.02 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.094 -0.957 . . . . 1.03 109.465 166.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.612 HD22 ' SD ' ' A' ' 176' ' ' MET . 42.9 tp -109.61 100.73 9.73 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 119.61 -0.836 . . . . 1.02 109.144 165.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 142' ' ' LEU . 2.3 m-85 -80.53 112.48 17.92 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 114.464 -1.244 . . . . 0.87 109.31 177.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.841 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.5 t -124.08 163.02 22.31 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 122.144 0.973 . . . . 1.45 111.335 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.805 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.1 p -164.65 173.71 11.62 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 114.037 -1.438 . . . . 0.12 111.007 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -137.35 134.34 35.89 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 114.304 -1.316 . . . . 0.94999999999999996 108.429 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.617 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -144.11 -176.19 4.91 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.305 -0.628 . . . . 1.1499999999999999 109.305 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.14 -83.91 0.92 Allowed Glycine 0 CA--C 1.491 -1.414 0 C-N-CA 119.567 -1.302 . . . . 0.14999999999999999 111.213 173.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.467 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.1 t30 -144.59 129.3 18.21 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-N 113.985 -1.108 . . . . 0.58999999999999997 108.149 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.509 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.6 p -63.65 -40.21 88.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.343 -0.844 . . . . 1.0 112.168 -172.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.428 ' N ' HG12 ' A' ' 169' ' ' VAL . 5.5 m120 -60.31 -32.1 70.9 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.982 0.896 . . . . 1.9199999999999999 109.993 -177.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.78 88.75 3.24 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 113.442 -1.708 . . . . 1.0600000000000001 108.363 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.654 ' HD2' HG21 ' A' ' 194' ' ' VAL . 45.9 Cg_endo -90.03 164.51 4.82 Favored 'Trans proline' 0 CA--C 1.49 -1.681 0 C-N-CA 124.028 3.152 . . . . 0.089999999999999997 114.626 -169.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 25.0 m -85.37 118.1 24.7 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 113.877 -1.51 . . . . 1.0600000000000001 107.586 167.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.838 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 42.7 tp -83.89 98.35 9.72 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 108.551 -0.907 . . . . 1.02 108.551 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.585 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 35.7 mt-30 -89.39 109.66 20.55 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-O 122.13 0.967 . . . . 0.34000000000000002 109.259 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.841 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.7 OUTLIER -113.37 163.66 14.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.736 -1.12 . . . . 1.0900000000000001 111.271 -173.859 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 37.6 tt0 -170.78 119.26 0.52 Allowed 'General case' 0 C--O 1.203 -1.349 0 CA-C-N 115.873 -0.603 . . . . 0.68000000000000005 110.131 -166.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.657 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -100.94 102.01 12.94 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.716 -0.846 . . . . 1.03 108.716 -172.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.663 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.9 ttp -91.71 122.95 34.73 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.656 -0.702 . . . . 0.89000000000000001 109.368 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.4 127.2 30.94 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.358 -1.349 . . . . 1.04 107.358 167.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.73 -34.22 11.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 119.151 -1.019 . . . . 1.02 110.758 178.415 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -62.94 -14.89 52.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.432 -0.804 . . . . 0.40000000000000002 111.379 -178.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.2 p -130.64 -36.57 1.41 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.727 0.775 . . . . 1.03 110.365 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 86.05 32.51 17.28 Favored Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 114.319 -1.309 . . . . 0.17999999999999999 112.213 -177.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.2 155.21 22.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.59 -0.305 . . . . 0.72999999999999998 110.4 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.437 HD13 ' HG2' ' A' ' 177' ' ' GLN . 29.3 mm -88.23 119.13 35.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.967 -0.753 . . . . 1.03 108.967 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.632 ' HB ' ' HA3' ' A' ' 80' ' ' GLY . 1.3 pp -107.12 -33.04 2.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.277 -0.874 . . . . 1.01 110.514 -174.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.649 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.8 t90 -133.53 151.52 51.75 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.438 -0.801 . . . . 0.070000000000000007 109.24 172.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 22.1 p -153.99 160.84 42.22 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.664 0.616 . . . . 0.64000000000000001 112.664 165.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -157.81 -177.06 30.55 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.536 -1.025 . . . . 0.12 110.536 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.838 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 12.9 mtmt -157.43 150.37 23.36 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 105.508 -2.034 . . . . 1.76 105.508 167.254 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.493 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -157.96 126.9 1.79 Allowed Glycine 0 C--N 1.279 -2.598 0 C-N-CA 119.51 -1.329 . . . . 0.13 112.243 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.28 114.07 10.0 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.337 0.589 . . . . 1.01 110.946 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.745 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -91.12 158.49 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 122.583 1.182 . . . . 1.01 110.125 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.685 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -98.8 172.16 7.63 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 112.69 -2.05 . . . . 0.92000000000000004 109.727 -173.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.551 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.9 tt0 -103.36 127.71 50.64 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.127 -0.694 . . . . 0.91000000000000003 109.127 167.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.531 ' HG2' ' C ' ' A' ' 62' ' ' TYR . 19.8 mm-40 . . . . . 0 C--N 1.306 -1.304 0 CA-C-N 115.513 -0.767 . . . . 1.24 110.585 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.564 -0.614 . . . . 88.920000000000002 111.564 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 t -91.53 -7.28 50.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.107 0.48 . . . . 87.459999999999994 110.596 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 73.06 132.75 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.815 -1.084 . . . . 87.5 111.684 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.1 mtt 46.44 48.36 13.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.705 0.765 . . . . 85.340000000000003 111.504 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.4 p -111.94 -9.11 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.534 -1.212 . . . . 85.230000000000004 108.59 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.87 -68.03 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.725 -1.125 . . . . 84.849999999999994 111.164 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 63.56 109.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.181 0.991 . . . . 85.599999999999994 111.709 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 57.63 56.12 5.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 113.893 -1.503 . . . . 85.310000000000002 110.937 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.597 ' OE1' ' HA ' ' A' ' 12' ' ' PRO . 24.2 tt0 -120.04 116.15 32.83 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 114.863 -1.062 . . . . 82.170000000000002 109.157 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.66 -41.19 79.93 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.279 2.652 . . . . 82.069999999999993 112.658 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.61 93.53 24.32 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.003 -0.544 . . . . 79.709999999999994 109.59 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.597 ' HA ' ' OE1' ' A' ' 9' ' ' GLU . 15.2 Cg_endo -59.06 138.31 84.65 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.46 2.107 . . . . 79.019999999999996 112.014 -177.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -63.08 156.79 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 115.797 -0.638 . . . . 77.260000000000005 111.705 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 67.95 89.91 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.928 -1.033 . . . . 75.739999999999995 110.69 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -70.17 104.49 2.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.705 -0.68 . . . . 74.010000000000005 110.876 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.11 110.86 22.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.212 0.53 . . . . 72.569999999999993 110.987 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -127.55 145.56 55.15 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.922 -0.581 . . . . 71.379999999999995 110.109 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.03 118.52 5.56 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.603 2.202 . . . . 70.189999999999998 112.059 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.97 107.79 51.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.09 -0.505 . . . . 67.769999999999996 110.673 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.35 -73.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.376 2.051 . . . . 67.180000000000007 112.449 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -167.49 63.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.698 0.761 . . . . 65.200000000000003 109.799 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.483 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 24.3 mt-30 -64.0 -48.16 78.61 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.161 -0.927 . . . . 63.460000000000001 112.291 -177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 22' ' ' GLN . 33.8 Cg_exo -65.83 146.78 84.22 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.983 1.788 . . . . 62.479999999999997 112.503 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -146.04 112.31 5.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.234 -0.439 . . . . 59.869999999999997 110.6 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -123.92 97.56 40.91 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.521 -0.309 . . . . 58.890000000000001 110.798 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.17 85.65 1.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.508 2.139 . . . . 57.890000000000001 111.504 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -64.93 142.57 58.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.04 0.448 . . . . 55.729999999999997 110.825 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -146.94 83.59 7.92 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.649 -0.705 . . . . 54.079999999999998 109.718 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.13 131.7 35.75 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.865 2.377 . . . . 53.299999999999997 111.908 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.8 m -122.77 133.76 24.63 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 51.130000000000003 110.876 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.98 148.84 70.98 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.894 2.396 . . . . 49.75 112.228 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -80.2 167.84 19.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.5 0.667 . . . . 47.700000000000003 110.613 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.463 ' H ' HG22 ' A' ' 32' ' ' THR . 11.5 m -118.24 107.76 42.98 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 114.853 -1.067 . . . . 46.109999999999999 111.252 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -55.84 160.2 10.32 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.628 2.886 . . . . 45.890000000000001 112.847 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 p -79.92 141.8 35.73 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.953 -1.021 . . . . 43.0 111.315 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.97 121.71 77.35 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.567 -0.742 . . . . 40.789999999999999 110.795 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.07 159.7 33.31 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.841 2.36 . . . . 40.450000000000003 112.16 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -76.58 120.79 22.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.14 0.495 . . . . 37.729999999999997 111.471 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -82.99 128.58 64.85 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.45 -0.796 . . . . 35.990000000000002 109.69 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.47 ' HG2' ' OE1' ' A' ' 42' ' ' GLN . 36.7 Cg_endo -67.22 -175.91 0.73 Allowed 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.565 2.177 . . . . 34.350000000000001 113.66 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -115.53 94.45 4.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.503 1.144 . . . . 31.780000000000001 111.204 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.47 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 2.2 mp0 -70.77 -39.14 8.5 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 114.039 -1.437 . . . . 30.390000000000001 113.301 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.92 149.84 20.54 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 121.841 1.694 . . . . 29.940000000000001 111.096 171.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.26 171.17 41.88 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.027 -1.082 . . . . 26.75 113.086 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.53 134.55 33.39 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.574 2.85 . . . . 25.879999999999999 111.979 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.2 mt -73.91 -58.81 4.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.243 -0.89 . . . . 24.16 110.04 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 56.53 80.63 0.15 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.005 0.742 . . . . 21.829999999999998 113.005 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -154.85 164.26 39.09 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.99 -0.55 . . . . 20.620000000000001 111.1 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.67 170.91 13.21 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.576 -0.738 . . . . 16.559999999999999 110.179 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.43 73.15 10.57 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.035 -0.728 . . . . 15.050000000000001 109.035 173.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -50.03 -57.75 6.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.155 -0.93 . . . . 14.66 112.342 -172.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 p -119.76 134.27 55.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.469 . . . . 11.84 111.801 -173.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.45 100.91 4.38 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.383 -0.826 . . . . 8.4399999999999995 110.52 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.16 120.61 8.0 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.754 2.303 . . . . 7.6600000000000001 112.032 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -79.35 -93.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.438 2.092 . . . . 5.6600000000000001 113.106 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.32 62.01 12.48 Favored Pre-proline 0 C--O 1.236 0.383 0 C-N-CA 122.729 0.411 . . . . 2.8700000000000001 111.632 -177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.31 -176.43 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.029 2.486 . . . . 1.8300000000000001 112.986 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -127.39 148.72 50.27 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.311 -1.313 . . . . 4.2199999999999998 110.252 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 60' ' ' ARG . 9.6 mt -90.35 168.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.0 0.905 . . . . 1.1299999999999999 112.087 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.605 ' N ' HG22 ' A' ' 59' ' ' ILE . 42.8 mtt180 -71.14 -158.84 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.557 -1.656 . . . . 3.1400000000000001 112.222 178.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.669 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 17.3 t-160 -157.85 150.28 22.49 Favored 'General case' 0 CA--C 1.47 -2.116 0 CA-C-N 111.885 -2.416 . . . . 2.7400000000000002 105.771 176.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.769 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.7 m-30 -125.44 160.05 30.38 Favored 'General case' 0 N--CA 1.416 -2.128 0 O-C-N 123.736 0.648 . . . . 0.76000000000000001 109.627 -176.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.513 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 2.1 t70 -79.66 68.02 5.59 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 123.785 1.755 . . . . 0.34999999999999998 108.167 170.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.715 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.9 m95 -60.08 -44.53 94.71 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 111.594 -2.548 . . . . 0.10000000000000001 112.199 174.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.55 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 7.1 t-20 -50.03 -30.48 10.83 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.844 -1.525 . . . . 1.1100000000000001 111.607 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.65 -18.3 80.01 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-N 115.503 -0.772 . . . . 0.23000000000000001 111.266 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.58 -52.22 3.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.965 -1.118 . . . . 1.01 110.895 -175.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.759 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.1 mtt -64.32 -58.49 6.36 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 114.136 -1.393 . . . . 0.089999999999999997 112.198 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.55 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 6.0 mm-40 -40.11 -53.59 4.97 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 114.912 1.449 . . . . 0.63 114.912 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.795 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.1 Cg_endo -64.19 -30.79 64.75 Favored 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 122.164 1.91 . . . . 0.17000000000000001 110.654 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.647 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 9.3 mtm -80.97 -46.87 14.45 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 115.006 -0.997 . . . . 0.69999999999999996 111.7 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 68' ' ' MET . 57.5 t -54.6 -40.73 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 CA-C-N 114.091 -1.413 . . . . 1.04 108.841 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 t -58.97 -36.81 75.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.028 -1.896 . . . . 1.1200000000000001 110.909 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.795 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.9 mtpt -80.39 -34.1 36.6 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.091 0.472 . . . . 1.8799999999999999 110.775 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.847 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.09 -29.56 70.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.305 -0.862 . . . . 0.5 111.685 -171.667 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.566 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.3 mt -91.79 -6.18 52.21 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.939 0.876 . . . . 1.29 111.23 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.55 15.35 49.64 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 109.156 -1.578 . . . . 0.17999999999999999 109.156 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.608 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.48 165.48 18.06 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.42 -0.89 . . . . 1.0 110.316 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -88.32 107.6 18.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.066 -0.97 . . . . 1.72 109.787 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.618 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 130.98 -22.88 4.46 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.991 -0.843 . . . . 0.13 110.991 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.847 HG11 ' O ' ' A' ' 75' ' ' MET . 10.1 p -99.27 152.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.861 0.838 . . . . 1.01 111.496 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -134.33 138.73 45.15 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.159 -1.382 . . . . 1.1000000000000001 109.835 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' HB3' ' HD2' ' A' ' 118' ' ' LYS . . . -65.3 137.82 57.8 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.871 -0.604 . . . . 1.1200000000000001 110.239 169.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.2 -1.41 54.39 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.799 -0.715 . . . . 0.28000000000000003 112.69 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.14 153.07 22.91 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.993 0.425 . . . . 1.55 110.972 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.626 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.0 p -81.86 116.43 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.122 0.963 . . . . 1.03 109.221 166.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.701 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -103.93 109.67 21.52 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.964 -1.017 . . . . 1.03 108.971 -173.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.65 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.76 94.29 1.37 Allowed 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 114.545 -1.207 . . . . 1.01 107.932 176.804 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.426 HG13 ' HG3' ' A' ' 110' ' ' ARG . 1.7 m -73.12 117.71 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 N-CA-C 107.476 -1.305 . . . . 1.6200000000000001 107.476 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.824 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 8.7 t0 -77.52 156.41 31.0 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.659 -1.155 . . . . 0.64000000000000001 108.134 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.574 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.54 135.89 57.81 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.473 -1.306 . . . . 1.05 107.473 171.075 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.555 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 23.2 t -63.4 140.08 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.836 0 CA-C-N 114.783 -1.099 . . . . 1.02 108.065 169.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.643 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.6 t-20 -85.56 163.22 18.5 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.248 -0.887 . . . . 0.20000000000000001 109.913 174.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.766 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.98 85.34 2.4 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.604 -1.18 . . . . 0.12 108.487 175.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -108.14 -1.98 19.86 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.969 -1.469 . . . . 0.84999999999999998 108.995 -172.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 24.5 p -52.0 -170.96 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 112.715 -2.039 . . . . 0.91000000000000003 114.975 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.495 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 32.7 t30 -72.48 -4.05 28.05 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 112.992 -1.913 . . . . 0.62 110.558 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.527 ' HA3' HG13 ' A' ' 169' ' ' VAL . . . -157.42 -144.46 3.94 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.052 -1.071 . . . . 0.14000000000000001 113.368 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.631 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 53.8 p -122.09 129.46 52.4 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 112.278 0.473 . . . . 1.76 112.278 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.766 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.12 157.37 47.1 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 121.97 0.89 . . . . 1.01 110.678 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.634 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.6 t-20 -80.48 79.99 7.0 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.053 -1.43 . . . . 0.20999999999999999 107.846 175.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.586 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -67.0 -14.2 62.66 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.479 -1.237 . . . . 1.0 109.988 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.19 -32.17 44.04 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.721 -0.844 . . . . 1.02 108.721 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.634 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.4 tp10 -66.63 -31.96 72.97 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 122.951 1.358 . . . . 1.73 109.064 172.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 102' ' ' ALA . . . -73.75 -44.18 56.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.036 -1.893 . . . . 1.04 109.657 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.616 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 60.0 m -63.98 -31.6 72.84 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.986 -1.461 . . . . 1.04 110.626 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 1.5 pt-20 -66.97 -43.34 83.32 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.701 -1.222 . . . . 1.47 107.701 172.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.625 HG21 ' HB2' ' A' ' 64' ' ' TRP . 56.8 m -63.06 -30.46 71.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.234 -0.894 . . . . 1.03 110.672 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.759 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.74 -69.56 0.11 Allowed 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.205 -0.665 . . . . 1.3 109.205 171.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.453 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 10.1 mtp180 -40.22 -38.22 0.74 Allowed 'General case' 0 C--N 1.313 -0.982 0 O-C-N 124.405 1.065 . . . . 1.8 111.29 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.52 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.71 -47.51 59.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.517 -1.22 . . . . 0.41999999999999998 111.897 -176.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.15 -33.72 65.64 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.223 1.011 . . . . 1.01 108.647 -178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -62.92 -34.65 77.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.416 -1.72 . . . . 1.01 109.976 172.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 110' ' ' ARG . . . -74.78 -42.58 57.88 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 114.752 -1.113 . . . . 1.03 111.097 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -63.2 -29.26 70.64 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.769 -1.105 . . . . 1.55 110.43 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -82.26 -23.89 35.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.535 -0.757 . . . . 2.0499999999999998 110.159 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.71 4.28 57.51 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.975 -1.011 . . . . 0.54000000000000004 114.927 159.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.496 ' CE ' ' HB3' ' A' ' 76' ' ' LEU . 13.5 mtmm -91.18 -34.27 15.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.279 0.539 . . . . 1.6000000000000001 111.156 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.701 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 14.6 m-85 -89.44 175.56 7.26 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 122.355 1.074 . . . . 0.27000000000000002 112.458 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.536 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.5 m -118.92 121.13 39.25 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 113.012 -1.904 . . . . 1.0800000000000001 108.289 169.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.661 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -91.72 141.76 28.34 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 119.389 -0.924 . . . . 1.1499999999999999 111.159 -170.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.779 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.3 m -91.74 150.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.892 -1.151 . . . . 1.0900000000000001 107.892 169.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.493 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 1.4 m -101.88 -177.1 3.32 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 119.893 -0.723 . . . . 1.8200000000000001 110.271 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.0 -29.98 70.46 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.34 -0.985 . . . . 1.1899999999999999 108.34 176.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.609 ' O ' ' HG3' ' A' ' 129' ' ' MET . 10.0 mt-30 -44.13 -40.81 5.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.091 -1.868 . . . . 2.04 111.212 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.779 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 6.8 mt-30 -98.05 -53.29 3.42 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 122.105 0.955 . . . . 0.42999999999999999 109.982 173.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.486 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 31.2 tp -62.94 -65.81 0.63 Allowed 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 113.303 -1.772 . . . . 2.04 113.271 -166.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.623 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 3.0 t -50.31 -46.26 55.33 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 123.365 1.555 . . . . 1.1499999999999999 109.105 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.716 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 17.2 mmt -54.31 -63.36 1.17 Allowed 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 110.745 -2.934 . . . . 2.27 110.706 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.71 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -42.91 -46.47 5.37 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.346 1.029 . . . . 1.0700000000000001 112.15 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.485 ' HD3' ' O ' ' A' ' 137' ' ' SER . 0.8 OUTLIER -54.45 -52.35 62.1 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 108.744 -0.836 . . . . 2.1000000000000001 108.744 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.7 mt-30 -65.18 -39.88 93.49 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.402 -0.817 . . . . 0.42999999999999999 111.034 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.716 ' HG3' ' O ' ' A' ' 129' ' ' MET . 52.1 mt-30 -58.72 -34.74 71.69 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.516 -1.22 . . . . 0.38 109.568 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.496 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -90.21 -28.94 18.53 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 113.942 -1.481 . . . . 1.05 109.733 -176.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.96 -45.06 0.69 Allowed Glycine 0 CA--C 1.494 -1.263 0 CA-C-O 122.534 1.075 . . . . 0.33000000000000002 113.094 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.58 HD11 ' O ' ' A' ' 141' ' ' SER . 91.3 mt -66.93 -171.44 0.14 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 112.416 -1.892 . . . . 1.0700000000000001 115.43 -170.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.547 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 63.1 m -115.55 152.9 47.64 Favored Pre-proline 0 N--CA 1.425 -1.684 0 CA-C-N 110.641 -2.982 . . . . 1.24 107.661 175.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.623 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 36.9 Cg_endo -66.26 0.44 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.49 2.127 . . . . 0.39000000000000001 112.138 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.443 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.6 tt0 -118.65 -27.06 5.97 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.997 0.903 . . . . 1.79 110.418 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.66 ' O ' ' HB2' ' A' ' 141' ' ' SER . 15.0 t70 -57.87 -25.89 61.36 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-N 113.207 -1.815 . . . . 0.65000000000000002 109.35 -173.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.66 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 21.3 m 73.52 168.95 0.31 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 112.668 -2.06 . . . . 0.73999999999999999 109.186 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.824 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 4.5 mt -66.03 -40.12 90.75 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.24 1.019 . . . . 1.48 108.386 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 64.81 -9.18 0.45 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 112.95 -1.932 . . . . 0.34999999999999998 114.332 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.427 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.7 OUTLIER -155.56 124.64 6.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.065 -0.717 . . . . 1.02 109.065 -175.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.679 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.4 mmt180 -42.27 -45.31 4.14 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 118.072 0.396 . . . . 2.21 112.001 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.8 t -74.13 -25.77 59.95 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.601 0.715 . . . . 0.93000000000000005 111.255 -174.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -73.64 -29.6 62.44 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.625 1.203 . . . . 1.8899999999999999 108.421 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.635 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -76.27 -47.79 22.54 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 112.403 -2.18 . . . . 0.98999999999999999 110.223 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.534 HG13 ' HE2' ' A' ' 179' ' ' MET . 42.1 mt -65.39 -41.52 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 112.794 -2.003 . . . . 1.03 109.865 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.59 -54.56 27.03 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 114.864 -1.062 . . . . 0.14999999999999999 111.082 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.723 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 89.9 mt -66.85 -48.14 80.65 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 N-CA-C 112.5 0.556 . . . . 1.05 112.5 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.636 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.22 -41.01 71.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.939 0.399 . . . . 1.03 111.099 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.462 ' HD2' HG22 ' A' ' 149' ' ' ILE . 58.3 mtp180 -81.84 -21.51 37.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.614 0.721 . . . . 1.29 110.618 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.444 HD21 ' CB ' ' A' ' 130' ' ' ALA . 22.8 t30 -84.76 -11.44 55.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.314 -1.365 . . . . 0.5 107.314 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.723 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.07 -29.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-N 113.184 -1.826 . . . . 1.05 110.932 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.7 34.17 5.05 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.267 -0.968 . . . . 0.17000000000000001 112.424 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.65 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.6 161.45 14.85 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.873 0.694 . . . . 1.02 112.873 -170.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.626 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.0 m80 -100.87 -27.72 13.17 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.24 -0.891 . . . . 0.39000000000000001 109.796 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.613 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 7.5 m-85 -136.15 -174.26 3.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.187 -0.915 . . . . 0.81000000000000005 111.318 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.707 ' O ' HD21 ' A' ' 178' ' ' LEU . 1.1 t -137.06 139.2 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.939 -1.028 . . . . 1.03 108.883 166.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.574 HD23 ' SD ' ' A' ' 176' ' ' MET . 33.9 tp -107.98 100.57 9.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.318 -0.953 . . . . 1.02 109.351 165.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.562 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.2 m-85 -79.8 112.94 17.56 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 114.606 -1.179 . . . . 0.87 108.897 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.851 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 10.2 t -124.45 160.58 27.9 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 121.922 0.867 . . . . 1.45 110.564 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.781 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.4 p -162.73 172.96 14.47 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 114.334 -1.303 . . . . 0.12 111.076 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.32 135.33 40.7 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 114.005 -1.452 . . . . 0.94999999999999996 108.633 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.627 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.8 m -144.09 -176.12 4.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.254 -0.647 . . . . 1.1499999999999999 109.254 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.11 -84.08 0.92 Allowed Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 119.768 -1.206 . . . . 0.14999999999999999 111.416 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.495 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.4 t30 -143.74 131.47 21.35 Favored 'General case' 0 C--O 1.196 -1.762 0 N-CA-C 107.821 -1.178 . . . . 0.58999999999999997 107.821 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.583 HG22 ' N ' ' A' ' 99' ' ' SER . 2.6 p -65.57 -41.34 90.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.14 -0.936 . . . . 1.0 112.426 -171.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.457 ' N ' HG11 ' A' ' 169' ' ' VAL . 11.3 m-20 -60.99 -31.15 70.77 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.732 0.777 . . . . 1.9199999999999999 109.478 -177.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.23 89.07 3.37 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 113.874 -1.512 . . . . 1.0600000000000001 108.16 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.64 ' HD2' HG22 ' A' ' 194' ' ' VAL . 42.6 Cg_endo -91.36 166.61 3.53 Favored 'Trans proline' 0 CA--C 1.494 -1.48 0 C-N-CA 124.551 3.501 . . . . 0.089999999999999997 114.846 -170.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.512 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 25.3 m -85.76 119.6 26.26 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 113.745 -1.57 . . . . 1.0600000000000001 107.551 166.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.849 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 50.4 tp -84.56 97.74 9.75 Favored 'General case' 0 N--CA 1.412 -2.326 0 C-N-CA 119.492 -0.883 . . . . 1.02 108.709 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.564 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 34.1 mt-30 -89.26 109.33 20.23 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 122.052 0.929 . . . . 0.34000000000000002 109.053 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.851 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.7 OUTLIER -112.87 164.17 13.74 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.004 -0.998 . . . . 1.0900000000000001 111.638 -173.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.562 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 57.0 tt0 -170.78 118.22 0.5 Allowed 'General case' 0 C--O 1.201 -1.476 0 CA-C-N 115.972 -0.558 . . . . 0.68000000000000005 110.236 -166.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.707 HD21 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -100.19 101.99 13.16 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.609 -0.885 . . . . 1.03 108.609 -172.801 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.679 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.5 ttp -90.43 121.62 32.57 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.462 -0.79 . . . . 0.89000000000000001 109.504 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.41 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.91 127.97 34.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.149 -1.426 . . . . 1.04 107.149 166.606 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -83.69 -34.18 10.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 118.912 -1.115 . . . . 1.02 110.965 178.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 28.7 mt-30 -61.6 -15.57 40.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.372 -0.831 . . . . 0.40000000000000002 111.424 -179.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.8 p -130.2 -36.61 1.5 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.745 0.783 . . . . 1.03 110.294 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 87.59 27.91 25.79 Favored Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 114.316 -1.311 . . . . 0.17999999999999999 112.003 -178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.81 155.91 19.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.648 0.261 . . . . 0.72999999999999998 110.52 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.468 HD13 ' HG2' ' A' ' 177' ' ' GLN . 30.3 mm -89.85 115.64 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.502 0.668 . . . . 1.03 109.494 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.68 ' CD1' HD12 ' A' ' 178' ' ' LEU . 1.6 pp -103.1 -32.3 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.903 -1.044 . . . . 1.01 110.54 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.681 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.8 t90 -134.81 152.02 51.41 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.245 -0.889 . . . . 0.070000000000000007 109.403 173.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 30.0 p -153.57 162.78 40.94 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.881 0.697 . . . . 0.64000000000000001 112.881 164.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.51 -173.64 27.18 Favored Glycine 0 N--CA 1.427 -1.94 0 N-CA-C 110.721 -0.951 . . . . 0.12 110.721 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.849 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 15.1 mtmm -158.93 154.08 25.33 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.273 -2.121 . . . . 1.76 105.273 166.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.461 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -161.22 127.79 1.81 Allowed Glycine 0 C--N 1.281 -2.484 0 C-N-CA 119.245 -1.455 . . . . 0.13 112.568 175.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 173' ' ' THR . . . -72.55 112.6 8.75 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.72 0.771 . . . . 1.01 111.329 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.664 HG11 ' CZ3' ' A' ' 64' ' ' TRP . 1.9 m -91.77 158.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-O 122.758 1.266 . . . . 1.01 110.816 -176.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.769 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.2 173.43 6.46 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 112.352 -2.203 . . . . 0.92000000000000004 108.652 -173.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.554 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.1 tt0 -102.34 133.78 46.71 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.14 -0.624 . . . . 0.91000000000000003 109.758 171.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.506 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 12.3 mm-40 . . . . . 0 C--N 1.315 -0.933 0 CA-C-O 118.804 -0.617 . . . . 1.24 110.906 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.943 0 N-CA-C 112.297 -0.321 . . . . 88.920000000000002 112.297 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 p -100.18 177.47 5.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.058 -0.349 . . . . 87.459999999999994 110.058 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -100.36 59.29 0.99 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.532 0.682 . . . . 87.5 110.309 176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.5 ttp -119.56 49.28 1.38 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.042 0.925 . . . . 85.340000000000003 109.438 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.58 -18.66 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.229 -0.896 . . . . 85.230000000000004 110.936 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.0 22.76 4.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.067 -0.587 . . . . 84.849999999999994 111.995 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.476 ' HG3' ' N ' ' A' ' 8' ' ' ARG . 2.8 pt20 -60.49 -42.93 97.33 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.061 -0.569 . . . . 85.599999999999994 111.005 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.476 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 34.6 mmt180 64.31 113.58 0.03 OUTLIER 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.142 0.496 . . . . 85.310000000000002 111.652 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 73.46 119.55 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 114.86 -1.064 . . . . 82.170000000000002 111.668 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.42 -34.67 92.92 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.257 1.971 . . . . 82.069999999999993 110.564 172.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.34 93.15 10.16 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.116 -0.947 . . . . 79.709999999999994 109.369 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.03 133.87 60.52 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.829 2.353 . . . . 79.019999999999996 112.553 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.52 149.58 33.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.732 -0.667 . . . . 77.260000000000005 111.065 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -96.88 50.2 1.1 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.557 -0.747 . . . . 75.739999999999995 110.106 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.86 84.02 7.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.574 . . . . 74.010000000000005 110.374 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.19 133.25 32.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.185 -0.916 . . . . 72.569999999999993 109.852 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -83.76 134.41 44.54 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.311 -0.404 . . . . 71.379999999999995 110.133 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_exo -58.73 128.91 29.86 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.648 2.232 . . . . 70.189999999999998 112.89 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.22 99.94 53.08 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.971 -0.559 . . . . 67.769999999999996 109.859 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.43 62.44 4.41 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.694 2.263 . . . . 67.180000000000007 112.854 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -80.48 -61.4 1.99 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.982 -0.377 . . . . 65.200000000000003 109.982 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 44.91 73.78 0.91 Allowed Pre-proline 0 C--O 1.24 0.579 0 O-C-N 123.786 0.678 . . . . 63.460000000000001 111.76 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -61.12 143.17 98.75 Favored 'Trans proline' 0 CA--C 1.519 -0.229 0 C-N-CA 123.411 2.74 . . . . 62.479999999999997 112.924 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.55 59.86 1.35 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.988 0.899 . . . . 59.869999999999997 109.125 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -115.11 95.35 41.88 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 113.629 -1.623 . . . . 58.890000000000001 110.055 -172.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.68 105.71 1.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.281 1.987 . . . . 57.890000000000001 112.063 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.601 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 90.4 mt-30 -95.65 -5.68 41.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.378 -0.374 . . . . 55.729999999999997 110.913 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -104.09 96.26 9.29 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.371 -0.377 . . . . 54.079999999999998 111.118 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 2.4 Cg_endo -82.01 135.73 8.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.079 2.519 . . . . 53.299999999999997 111.383 175.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -118.76 87.65 33.25 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.907 0.384 . . . . 51.130000000000003 110.83 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -91.34 174.07 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.388 2.725 . . . . 49.75 111.805 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 p -107.05 150.29 26.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.99 0.424 . . . . 47.700000000000003 110.877 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.4 t -98.81 108.37 48.4 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.695 -0.684 . . . . 46.109999999999999 110.462 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.69 156.02 39.7 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.673 2.249 . . . . 45.890000000000001 112.084 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.4 m -160.92 127.23 3.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.532 -0.758 . . . . 43.0 110.407 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -121.73 121.95 28.03 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.722 -0.672 . . . . 40.789999999999999 110.233 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.76 146.85 64.24 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 122.549 2.166 . . . . 40.450000000000003 112.151 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.8 m -141.24 106.38 4.99 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.31 0.576 . . . . 37.729999999999997 110.744 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -96.23 115.32 65.53 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.489 -0.778 . . . . 35.990000000000002 110.311 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.18 122.4 8.69 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.28 1.987 . . . . 34.350000000000001 111.966 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -135.77 -178.37 5.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.041 -0.527 . . . . 31.780000000000001 110.333 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -116.77 87.7 22.68 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.354 -0.61 . . . . 30.390000000000001 109.354 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.65 121.21 9.05 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.346 2.031 . . . . 29.940000000000001 111.433 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.86 161.95 8.91 Favored Glycine 0 N--CA 1.437 -1.233 0 N-CA-C 111.161 -0.776 . . . . 26.75 111.161 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.1 125.81 11.81 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.444 2.096 . . . . 25.879999999999999 112.391 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.07 -55.14 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.147 -0.478 . . . . 24.16 109.725 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 59.4 85.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.234 -0.893 . . . . 21.829999999999998 111.179 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -86.97 157.13 19.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.957 0.408 . . . . 20.620000000000001 110.807 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -175.62 131.31 0.27 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.371 -0.831 . . . . 16.559999999999999 109.444 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -106.03 75.44 1.11 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.286 -0.87 . . . . 15.050000000000001 110.267 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -51.59 132.85 30.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.531 -1.213 . . . . 14.66 110.634 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.4 p -69.58 160.35 31.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.663 0.744 . . . . 11.84 112.084 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.558 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -130.78 84.81 57.44 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 114.748 -1.114 . . . . 8.4399999999999995 110.203 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -85.63 105.61 0.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.745 2.296 . . . . 7.6600000000000001 112.732 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 72.2 Cg_endo -87.91 137.37 3.91 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.286 1.991 . . . . 5.6600000000000001 112.287 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.75 78.61 72.98 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.309 -0.405 . . . . 2.8700000000000001 110.663 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.34 -177.22 3.14 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 123.441 2.76 . . . . 1.8300000000000001 113.028 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -109.64 139.2 44.95 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.522 -1.672 . . . . 4.2199999999999998 109.056 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.598 HG21 ' N ' ' A' ' 60' ' ' ARG . 12.4 mt -76.47 164.99 3.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.106 0.955 . . . . 1.1299999999999999 112.436 -169.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.598 ' N ' HG21 ' A' ' 59' ' ' ILE . 37.4 mtt85 -75.95 -158.57 0.09 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.651 -1.613 . . . . 3.1400000000000001 112.114 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.595 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 41.9 m80 -152.14 141.09 21.13 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 112.211 -2.268 . . . . 2.7400000000000002 107.161 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.714 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 3.5 m-30 -127.02 156.23 41.97 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.59 -0.732 . . . . 0.76000000000000001 110.633 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.548 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 4.4 t0 -82.74 68.15 9.1 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 123.756 1.741 . . . . 0.34999999999999998 108.404 171.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.739 ' CZ3' HG13 ' A' ' 194' ' ' VAL . 93.4 m95 -59.75 -42.94 94.35 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 111.511 -2.586 . . . . 0.10000000000000001 112.288 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.481 ' N ' HG22 ' A' ' 108' ' ' THR . 0.1 OUTLIER -52.77 -31.79 40.21 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.609 -1.632 . . . . 1.1100000000000001 111.077 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.64 -15.88 78.69 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 121.781 0.656 . . . . 0.23000000000000001 111.67 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.444 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -94.5 -48.55 6.06 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.18 -1.01 . . . . 1.01 110.15 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.765 ' SD ' HD21 ' A' ' 109' ' ' LEU . 39.4 mtt -66.43 -55.64 14.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.134 -1.394 . . . . 0.089999999999999997 111.715 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.412 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 6.1 mm-40 -38.81 -56.01 2.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 115.233 1.568 . . . . 0.63 115.233 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.802 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 40.3 Cg_endo -65.37 -29.37 54.17 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 121.728 1.619 . . . . 0.17000000000000001 110.418 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.915 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 9.6 mtm -83.65 -40.23 19.23 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.312 -0.858 . . . . 0.69999999999999996 111.446 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.694 HG23 ' O ' ' A' ' 68' ' ' MET . 52.4 t -57.46 -39.91 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-N 114.85 -1.068 . . . . 1.04 108.339 171.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -61.17 -32.76 72.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.238 -1.801 . . . . 1.1200000000000001 111.19 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 34.2 mtpt -84.66 -32.2 23.76 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.086 0.47 . . . . 1.8799999999999999 110.891 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.882 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.23 -29.77 69.51 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.332 -0.849 . . . . 0.5 111.413 -172.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.573 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.3 mt -92.07 -4.14 54.81 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 122.26 1.028 . . . . 1.29 110.644 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.23 17.64 40.38 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 108.984 -1.646 . . . . 0.17999999999999999 108.984 170.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.617 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -88.04 161.8 17.16 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.693 -0.754 . . . . 1.0 110.282 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.94 107.92 18.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.384 -0.825 . . . . 1.72 109.432 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.648 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.58 -24.66 3.33 Favored Glycine 0 N--CA 1.415 -2.716 0 C-N-CA 119.739 -1.219 . . . . 0.13 110.466 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.882 HG11 ' O ' ' A' ' 75' ' ' MET . 11.1 p -102.66 152.32 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.675 -0.762 . . . . 1.01 111.068 -175.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.3 m -135.82 139.64 43.62 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.922 -1.036 . . . . 1.1000000000000001 110.697 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.468 ' HB3' ' HE3' ' A' ' 118' ' ' LYS . . . -55.08 136.01 48.52 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.033 -0.985 . . . . 1.1200000000000001 110.414 167.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.04 3.95 55.6 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.903 -0.665 . . . . 0.28000000000000003 112.936 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.94 149.24 22.68 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.168 -0.613 . . . . 1.55 111.002 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.615 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -80.41 120.58 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 CA-C-O 121.933 0.873 . . . . 1.03 108.802 165.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.851 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.7 tm? -108.77 111.58 23.41 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.416 -0.811 . . . . 1.03 109.047 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.643 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -72.19 93.72 1.48 Allowed 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.833 -1.076 . . . . 1.01 108.158 177.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.448 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.2 m -73.5 115.79 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 107.061 -1.459 . . . . 1.6200000000000001 107.061 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.768 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 16.7 t0 -77.57 170.62 16.25 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-N 115.063 -0.971 . . . . 0.64000000000000001 108.905 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.562 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.8 OUTLIER -61.77 152.59 30.92 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.93 -1.137 . . . . 1.05 107.93 168.038 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.547 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 38.6 t -81.95 140.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.151 0 N-CA-C 107.024 -1.473 . . . . 1.02 107.024 167.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.653 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.7 t-20 -84.01 162.5 20.37 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.967 0.889 . . . . 0.20000000000000001 110.307 174.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.755 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -124.81 85.9 2.48 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.229 -1.35 . . . . 0.12 108.087 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.448 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 14.1 mtp180 -108.74 -0.95 19.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.077 -1.42 . . . . 0.84999999999999998 108.758 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 30.2 p -53.21 -172.62 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.026 -1.897 . . . . 0.91000000000000003 115.348 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.466 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 34.2 t30 -68.37 -13.54 62.35 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 112.637 -2.074 . . . . 0.62 110.522 173.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.52 ' HA3' HG13 ' A' ' 169' ' ' VAL . . . -148.16 -145.93 4.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.387 -0.911 . . . . 0.14000000000000001 113.004 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.591 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 19.2 m -121.27 129.6 53.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.959 0.409 . . . . 1.76 110.825 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.755 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.6 pp -135.18 157.63 46.43 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.921 0.867 . . . . 1.01 110.627 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.612 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.57 81.46 7.64 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.954 -1.476 . . . . 0.20999999999999999 107.713 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.61 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -69.72 -14.77 62.96 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 114.278 -1.328 . . . . 1.0 109.912 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.59 -29.8 46.32 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.734 -0.839 . . . . 1.02 108.734 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.612 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 15.6 tp10 -67.91 -32.39 72.82 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 123.123 1.44 . . . . 1.73 109.15 170.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.5 -44.75 61.82 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.999 -1.91 . . . . 1.04 109.233 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.9 m -63.92 -34.3 77.65 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.936 -1.484 . . . . 1.04 111.104 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.537 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 13.1 pt-20 -68.0 -42.83 80.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 118.368 -1.333 . . . . 1.47 107.651 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 64' ' ' TRP . 58.7 m -61.5 -29.09 69.76 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.226 -0.897 . . . . 1.03 111.176 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.765 HD21 ' SD ' ' A' ' 68' ' ' MET . 9.3 mt -53.69 -68.12 0.2 Allowed 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 115.794 -0.639 . . . . 1.3 109.471 170.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.541 ' O ' HD13 ' A' ' 121' ' ' LEU . 14.2 mtp180 -40.26 -38.08 0.73 Allowed 'General case' 0 C--N 1.31 -1.116 0 O-C-N 124.413 1.071 . . . . 1.8 111.395 174.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.571 ' HB2' ' O ' ' A' ' 108' ' ' THR . 16.1 m-80 -68.36 -47.41 67.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.675 -1.148 . . . . 0.41999999999999998 112.4 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.93 -35.79 59.62 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.364 -0.976 . . . . 1.01 108.364 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.662 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -58.96 -35.67 73.55 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.61 -1.632 . . . . 1.01 109.784 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.451 ' HB1' ' O ' ' A' ' 110' ' ' ARG . . . -69.46 -41.96 75.51 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.297 -1.32 . . . . 1.03 111.294 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -65.21 -27.21 68.52 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.99 -1.005 . . . . 1.55 111.224 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.86 -16.73 35.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.967 -0.56 . . . . 2.0499999999999998 111.237 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.91 -12.32 0.83 Allowed Glycine 0 C--N 1.334 0.427 0 N-CA-C 115.896 1.118 . . . . 0.54000000000000004 115.896 162.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.468 ' HE3' ' HB3' ' A' ' 83' ' ' ALA . 54.4 mtpt -73.28 -33.47 65.25 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 117.579 0.689 . . . . 1.6000000000000001 110.783 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.851 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 23.4 m-85 -90.4 177.43 6.39 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.54 1.162 . . . . 0.27000000000000002 112.677 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 5.4 m -121.92 119.96 33.06 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 112.651 -2.068 . . . . 1.0800000000000001 108.069 168.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.599 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -89.4 140.74 29.21 Favored 'General case' 0 N--CA 1.414 -2.235 0 C-N-CA 119.337 -0.945 . . . . 1.1499999999999999 111.774 -169.892 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.738 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.5 m -90.32 150.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.605 -1.258 . . . . 1.0900000000000001 107.605 167.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.424 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -102.51 170.45 8.03 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.019 -0.672 . . . . 1.8200000000000001 110.844 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -56.48 -35.02 67.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.27 0.557 . . . . 1.1899999999999999 110.059 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.665 ' O ' ' HG3' ' A' ' 129' ' ' MET . 1.5 pt20 -47.1 -33.1 4.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.49 -1.232 . . . . 2.04 111.04 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.738 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 6.6 mt-30 -98.21 -53.78 3.26 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-O 121.784 0.802 . . . . 0.42999999999999999 110.632 172.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.577 HD11 ' N ' ' A' ' 128' ' ' SER . 1.4 tm? -67.29 -64.07 0.93 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 113.916 -1.493 . . . . 2.04 112.572 -168.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.668 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.2 t -49.31 -39.05 29.79 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 123.573 1.654 . . . . 1.1499999999999999 109.047 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.665 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 24.2 mmm -64.46 -62.07 1.82 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 110.72 -2.945 . . . . 2.27 110.656 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.672 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -44.28 -43.48 7.4 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 124.106 0.878 . . . . 1.0700000000000001 112.326 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.515 ' HE2' ' CD2' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -51.28 -55.5 17.92 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.293 -1.003 . . . . 2.1000000000000001 108.293 176.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.539 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.3 mt-30 -65.33 -41.28 94.11 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 123.951 0.782 . . . . 0.42999999999999999 111.42 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.3 mt-30 -56.26 -34.25 66.23 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.391 -1.277 . . . . 0.38 109.616 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.488 HD22 ' HB2' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -92.87 -31.19 15.06 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.905 -1.498 . . . . 1.05 109.561 -177.678 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.06 -52.13 0.4 Allowed Glycine 0 CA--C 1.497 -1.091 0 CA-C-O 122.594 1.108 . . . . 0.33000000000000002 113.45 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.686 HD13 ' O ' ' A' ' 141' ' ' SER . 70.7 mt -63.51 -171.75 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 112.352 -1.924 . . . . 1.0700000000000001 115.717 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.565 ' C ' ' H ' ' A' ' 139' ' ' GLN . 6.3 m -116.14 152.29 47.62 Favored Pre-proline 0 N--CA 1.427 -1.621 0 CA-C-N 110.765 -2.925 . . . . 1.24 107.931 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.668 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 30.3 Cg_endo -65.44 2.67 1.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.751 2.301 . . . . 0.39000000000000001 111.146 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.565 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.7 mm100 -115.17 -19.91 10.63 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 114.098 -1.41 . . . . 1.79 110.091 -174.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.721 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.7 t70 -80.63 -27.72 37.17 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 114.336 -1.302 . . . . 0.65000000000000002 109.839 -169.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.721 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 4.0 m 76.02 175.23 0.22 Allowed 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 125.33 1.644 . . . . 0.73999999999999999 109.053 -168.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.768 ' HG ' ' CG ' ' A' ' 90' ' ' ASP . 3.5 mt -69.41 -39.13 78.11 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.368 1.08 . . . . 1.48 108.701 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.18 -12.03 0.29 Allowed Glycine 0 C--N 1.317 -0.488 0 CA-C-N 112.96 -1.927 . . . . 0.34999999999999998 114.809 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -152.54 125.78 8.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 117.548 0.674 . . . . 1.02 109.324 -175.58 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.701 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.4 mmt180 -41.45 -48.11 3.77 Favored 'General case' 0 C--O 1.213 -0.842 0 O-C-N 123.378 0.424 . . . . 2.21 111.868 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.5 t -72.05 -27.5 62.73 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.58 0.705 . . . . 0.93000000000000005 111.296 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -73.06 -28.25 62.21 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.632 1.206 . . . . 1.8899999999999999 108.587 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.705 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -77.49 -46.0 23.85 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 112.293 -2.23 . . . . 0.98999999999999999 110.304 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.561 HG13 ' HE3' ' A' ' 179' ' ' MET . 35.4 mt -67.33 -42.43 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-N 113.069 -1.878 . . . . 1.03 110.237 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.47 -53.59 31.27 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.955 -1.021 . . . . 0.14999999999999999 111.072 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.72 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 70.2 mt -66.32 -47.53 83.93 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 112.747 0.647 . . . . 1.05 112.747 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.643 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.01 -39.98 72.7 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.017 0.437 . . . . 1.03 110.767 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' A' ' 149' ' ' ILE . 27.7 mtp-105 -81.56 -23.01 37.45 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.676 0.751 . . . . 1.29 110.635 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.423 HD22 ' CD ' ' A' ' 133' ' ' GLN . 19.1 t30 -82.18 -12.72 57.97 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.332 -1.358 . . . . 0.5 107.332 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.73 -28.53 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 113.245 -1.798 . . . . 1.05 110.838 -174.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.67 35.45 4.89 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.35 -0.929 . . . . 0.17000000000000001 112.282 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.633 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.76 156.38 21.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 113.27 0.841 . . . . 1.02 113.27 -170.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.615 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.9 m80 -95.3 -27.87 15.26 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.194 -0.912 . . . . 0.39000000000000001 109.807 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.564 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 9.2 m-85 -136.38 -179.1 5.47 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.476 -0.784 . . . . 0.81000000000000005 111.049 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.639 ' O ' HD21 ' A' ' 178' ' ' LEU . 1.2 t -131.97 140.75 47.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.438 -0.801 . . . . 1.03 109.232 167.356 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.535 HD23 ' HE1' ' A' ' 176' ' ' MET . 38.2 tp -110.4 101.06 9.81 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.708 -0.797 . . . . 1.02 108.946 164.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.705 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.23 116.72 19.67 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.21 -1.359 . . . . 0.87 108.269 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.801 ' OG ' HD12 ' A' ' 174' ' ' LEU . 27.6 t -126.68 163.44 23.49 Favored 'General case' 0 C--N 1.279 -2.493 0 C-N-CA 119.495 -0.882 . . . . 1.45 111.015 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.803 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.9 p -164.23 178.27 7.7 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 114.264 -1.334 . . . . 0.12 111.065 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -141.91 141.34 32.99 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 114.155 -1.384 . . . . 0.94999999999999996 108.673 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.679 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 t -149.44 -171.35 3.87 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.208 -0.597 . . . . 1.1499999999999999 110.115 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.66 -80.69 1.25 Allowed Glycine 0 C--N 1.288 -2.138 0 CA-C-N 115.179 -0.919 . . . . 0.14999999999999999 111.567 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.466 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 59.1 t30 -145.58 127.5 15.46 Favored 'General case' 0 C--O 1.195 -1.767 0 N-CA-C 108.108 -1.071 . . . . 0.58999999999999997 108.108 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.52 HG13 ' HA3' ' A' ' 98' ' ' GLY . 2.4 p -61.76 -43.9 97.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.14 -0.936 . . . . 1.0 113.008 -172.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.416 ' N ' HG11 ' A' ' 169' ' ' VAL . 10.6 m120 -61.48 -29.71 70.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.49 0.662 . . . . 1.9199999999999999 109.635 -177.152 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.44 88.16 3.73 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 114.588 -1.187 . . . . 1.0600000000000001 108.021 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.658 ' HD2' HG22 ' A' ' 194' ' ' VAL . 51.3 Cg_endo -91.29 163.56 3.69 Favored 'Trans proline' 0 CA--C 1.49 -1.697 0 C-N-CA 124.596 3.531 . . . . 0.089999999999999997 114.731 -170.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.589 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 18.8 m -81.77 117.17 21.86 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 113.854 -1.521 . . . . 1.0600000000000001 107.693 166.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.836 ' O ' ' HE3' ' A' ' 71' ' ' MET . 38.8 tp -83.73 98.94 9.95 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-O 121.885 0.85 . . . . 1.02 109.126 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.59 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.0 mt-30 -89.09 107.81 19.25 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.909 -1.041 . . . . 0.34000000000000002 109.048 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.915 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 34.7 mtp -108.25 162.84 13.71 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.848 -1.069 . . . . 1.0900000000000001 110.203 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 36.8 tt0 -169.49 119.99 0.68 Allowed 'General case' 0 C--O 1.204 -1.315 0 CA-C-O 121.377 0.608 . . . . 0.68000000000000005 109.908 -167.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.639 HD21 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -101.44 102.38 13.17 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.934 -0.765 . . . . 1.03 108.934 -172.202 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.701 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.1 ttp -92.48 122.91 35.38 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.533 -0.758 . . . . 0.89000000000000001 109.402 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.42 HD21 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -58.83 127.46 32.29 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.161 -1.422 . . . . 1.04 107.161 166.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.526 HG21 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -82.2 -33.63 11.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 119.35 0.977 . . . . 1.02 110.718 178.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.429 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.9 mt-30 -64.25 -14.77 57.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.291 -0.868 . . . . 0.40000000000000002 111.498 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 76.9 p -130.52 -36.96 1.41 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.766 0.794 . . . . 1.03 110.251 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.419 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.36 24.09 29.82 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.481 -1.236 . . . . 0.17999999999999999 112.496 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.92 155.61 18.5 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.684 0.278 . . . . 0.72999999999999998 110.682 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.459 HD13 ' HG2' ' A' ' 177' ' ' GLN . 34.2 mm -87.95 119.25 35.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.433 0.635 . . . . 1.03 109.507 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.648 ' HB ' ' HA3' ' A' ' 80' ' ' GLY . 1.4 pp -108.28 -30.56 2.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.966 -1.016 . . . . 1.01 110.536 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.617 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.1 t90 -135.38 151.83 50.84 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 115.206 -0.906 . . . . 0.070000000000000007 109.351 171.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 57.0 p -154.06 161.85 41.62 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.768 0.655 . . . . 0.64000000000000001 112.768 163.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -156.68 -178.91 31.25 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 110.68 -0.968 . . . . 0.12 110.68 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.7 mtmt -156.75 148.38 22.56 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.326 -1.731 . . . . 1.76 106.326 167.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -159.33 127.29 1.8 Allowed Glycine 0 C--N 1.282 -2.42 0 C-N-CA 119.907 -1.14 . . . . 0.13 112.542 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.83 113.05 9.43 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.543 0.687 . . . . 1.01 111.455 -173.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.739 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -88.38 159.18 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.518 1.151 . . . . 1.01 110.298 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.706 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -98.86 172.84 7.18 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 112.781 -2.009 . . . . 0.92000000000000004 109.132 -172.763 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -102.85 127.65 49.95 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.873 -0.417 . . . . 0.91000000000000003 109.873 169.799 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.532 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 17.9 mm-40 . . . . . 0 C--N 1.313 -1.017 0 CA-C-O 118.524 -0.75 . . . . 1.24 110.838 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.995 -0.442 . . . . 88.920000000000002 111.995 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.4 p 40.88 -103.09 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.966 0.906 . . . . 87.459999999999994 112.601 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -148.15 139.05 23.15 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.256 -0.646 . . . . 87.5 109.256 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.476 ' O ' HG11 ' A' ' 5' ' ' VAL . 25.2 ptm -69.41 142.59 53.85 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.442 -0.577 . . . . 85.340000000000003 109.442 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.476 HG11 ' O ' ' A' ' 4' ' ' MET . 3.2 p 50.85 13.79 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.208 1.403 . . . . 85.230000000000004 112.971 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.01 -46.73 5.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.125 -0.559 . . . . 84.849999999999994 112.058 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -76.0 -31.74 59.08 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.765 -0.457 . . . . 85.599999999999994 109.765 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 33.05 69.75 0.12 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.618 1.199 . . . . 85.310000000000002 112.557 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -71.02 158.46 88.12 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 116.05 -0.523 . . . . 82.170000000000002 110.378 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -49.56 -44.5 34.98 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.124 1.882 . . . . 82.069999999999993 111.298 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.57 101.61 20.91 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.486 -0.779 . . . . 79.709999999999994 109.707 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.36 139.9 92.38 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.397 2.064 . . . . 79.019999999999996 112.154 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -64.97 153.97 7.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.511 0.672 . . . . 77.260000000000005 111.911 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -106.45 -136.27 0.35 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.116 -0.947 . . . . 75.739999999999995 109.247 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -78.02 89.81 4.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.162 0.506 . . . . 74.010000000000005 110.191 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.73 127.61 30.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.462 -0.79 . . . . 72.569999999999993 110.334 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.403 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 12.5 mmmm -60.39 133.89 91.06 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.706 -0.679 . . . . 71.379999999999995 111.768 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 17' ' ' LYS . 38.6 Cg_exo -61.44 141.37 91.88 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.614 2.209 . . . . 70.189999999999998 111.424 174.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.5 -39.38 66.77 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 113.831 1.048 . . . . 67.769999999999996 113.831 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.79 49.02 0.87 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.358 2.039 . . . . 67.180000000000007 113.651 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -84.04 90.03 7.37 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.117 -0.697 . . . . 65.200000000000003 109.117 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -154.29 81.65 4.5 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.79 -0.641 . . . . 63.460000000000001 110.501 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.82 132.52 42.94 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 122.865 2.377 . . . . 62.479999999999997 112.489 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.16 75.03 1.33 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.228 -0.896 . . . . 59.869999999999997 110.653 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.576 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 48.4 mt-10 -133.69 -50.56 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.741 -1.118 . . . . 58.890000000000001 111.905 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 25' ' ' GLU . 77.8 Cg_endo -78.93 177.51 8.62 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.136 1.224 . . . . 57.890000000000001 111.883 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.416 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -112.0 143.28 43.26 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.126 -0.694 . . . . 55.729999999999997 109.126 178.978 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -66.45 107.88 1.93 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 54.079999999999998 110.754 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 93.3 Cg_endo -83.34 61.78 7.25 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.491 2.128 . . . . 53.299999999999997 112.294 -176.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 20.1 m -121.19 147.8 47.76 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.911 -0.586 . . . . 51.130000000000003 110.466 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 30' ' ' VAL . 2.9 Cg_exo -75.08 149.98 37.15 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.603 2.202 . . . . 49.75 111.446 176.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p -73.14 145.85 46.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.88 0.371 . . . . 47.700000000000003 110.439 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -92.62 120.43 67.37 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.255 -0.429 . . . . 46.109999999999999 111.551 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.77 157.34 28.54 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.932 2.422 . . . . 45.890000000000001 111.695 173.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.6 m -155.04 120.7 5.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.74 -0.664 . . . . 43.0 110.512 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.5 t -105.13 101.65 31.66 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.636 -0.711 . . . . 40.789999999999999 109.465 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.34 156.44 55.98 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.322 2.015 . . . . 40.450000000000003 112.9 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.1 m -85.74 124.72 32.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.504 0.669 . . . . 37.729999999999997 110.73 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.9 mt -94.49 136.33 23.34 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.362 -0.835 . . . . 35.990000000000002 109.039 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.59 91.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.447 2.098 . . . . 34.350000000000001 111.752 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -96.06 -40.19 9.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.007 -0.542 . . . . 31.780000000000001 110.35 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 58.23 79.66 0.31 Allowed Pre-proline 0 C--O 1.235 0.314 0 O-C-N 123.475 0.484 . . . . 30.390000000000001 110.678 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -53.95 122.79 12.03 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.126 2.551 . . . . 29.940000000000001 111.792 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.59 144.98 0.57 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.922 -0.581 . . . . 26.75 112.154 -172.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.61 128.81 19.78 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 122.914 2.409 . . . . 25.879999999999999 112.268 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.6 mt -68.94 -48.35 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.312 0.577 . . . . 24.16 109.585 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.98 77.74 0.48 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.616 -1.175 . . . . 21.829999999999998 109.039 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.485 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 3.9 t-160 -71.7 176.41 4.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.01 -0.996 . . . . 20.620000000000001 111.99 -175.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.485 ' H ' ' CG ' ' A' ' 48' ' ' HIS . 15.1 pt-20 -59.35 179.53 0.1 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.115 -0.948 . . . . 16.559999999999999 112.729 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -112.67 80.77 1.38 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.685 -0.689 . . . . 15.050000000000001 110.26 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -53.15 -61.91 1.99 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.936 0.147 . . . . 14.66 110.745 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.5 p 60.95 157.87 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.259 1.023 . . . . 11.84 113.188 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.27 93.52 29.56 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.904 -1.044 . . . . 8.4399999999999995 110.76 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.78 141.14 44.33 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.787 2.325 . . . . 7.6600000000000001 112.423 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -85.23 -168.3 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.77 2.313 . . . . 5.6600000000000001 112.881 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 60.6 70.41 0.98 Allowed Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 114.833 -1.076 . . . . 2.8700000000000001 111.6 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.34 -176.7 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.28 2.654 . . . . 1.8300000000000001 112.51 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -117.01 145.22 43.8 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.505 -1.225 . . . . 4.2199999999999998 109.868 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.607 HG23 ' N ' ' A' ' 60' ' ' ARG . 11.4 mt -86.38 168.86 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.716 0.77 . . . . 1.1299999999999999 112.115 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.607 ' N ' HG23 ' A' ' 59' ' ' ILE . 34.6 mtt-85 -69.6 -157.13 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.875 -1.511 . . . . 3.1400000000000001 112.194 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.661 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 17.9 t-160 -158.83 147.99 18.82 Favored 'General case' 0 CA--C 1.473 -1.988 0 CA-C-N 112.245 -2.252 . . . . 2.7400000000000002 107.074 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.775 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.2 m-30 -125.38 158.97 32.98 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.291 -0.868 . . . . 0.76000000000000001 109.565 -176.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 5.0 t70 -80.91 67.0 6.65 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 123.707 1.718 . . . . 0.34999999999999998 108.065 172.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.696 ' CZ3' HG12 ' A' ' 194' ' ' VAL . 90.0 m95 -56.94 -44.45 82.53 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 111.591 -2.55 . . . . 0.10000000000000001 112.389 175.032 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.448 ' N ' HG22 ' A' ' 108' ' ' THR . 10.2 t-20 -51.05 -30.72 16.46 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.832 -1.531 . . . . 1.1100000000000001 111.687 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.81 -15.38 81.36 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-O 121.868 0.704 . . . . 0.23000000000000001 111.469 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.86 -52.06 3.4 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.076 -1.062 . . . . 1.01 110.782 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.775 ' SD ' HD21 ' A' ' 109' ' ' LEU . 39.7 mtt -64.13 -58.06 7.73 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 114.127 -1.397 . . . . 0.089999999999999997 111.952 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.455 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.8 mm-40 -39.52 -54.66 3.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 114.856 1.428 . . . . 0.63 114.856 -176.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.6 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.1 Cg_endo -64.45 -28.78 62.35 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.004 1.802 . . . . 0.17000000000000001 110.667 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.641 ' HE3' ' N ' ' A' ' 192' ' ' GLY . 6.4 mtm -82.4 -46.26 13.77 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 114.874 -1.057 . . . . 0.69999999999999996 111.902 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.679 HG21 ' O ' ' A' ' 68' ' ' MET . 57.7 t -54.34 -40.29 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-N 114.031 -1.44 . . . . 1.04 108.633 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -59.28 -37.72 78.35 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.167 -1.833 . . . . 1.1200000000000001 110.798 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.6 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 25.1 mtmt -77.08 -36.06 56.08 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 120.821 0.343 . . . . 1.8799999999999999 111.649 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.804 ' O ' HG13 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.0 -29.33 70.49 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.715 -0.675 . . . . 0.5 111.557 -170.594 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.604 HD11 ' CG ' ' A' ' 118' ' ' LYS . 5.2 mt -93.14 -6.78 47.14 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.102 0.953 . . . . 1.29 111.012 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.49 17.79 46.02 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.02 -1.632 . . . . 0.17999999999999999 109.02 171.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.581 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -87.02 162.08 17.82 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.626 -0.787 . . . . 1.0 110.355 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.54 108.04 17.76 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.057 -0.974 . . . . 1.72 109.235 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.62 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 131.04 -21.2 4.67 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.699 -1.239 . . . . 0.13 110.955 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.804 HG13 ' O ' ' A' ' 75' ' ' MET . 14.8 p -101.75 152.78 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.77 -0.715 . . . . 1.01 110.887 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.421 HG23 ' O ' ' A' ' 83' ' ' ALA . 26.5 m -135.75 140.28 44.22 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.011 -0.995 . . . . 1.1000000000000001 110.625 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.421 ' O ' HG23 ' A' ' 82' ' ' THR . . . -58.59 140.13 54.82 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.123 -0.944 . . . . 1.1200000000000001 110.484 167.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.3 10.08 54.61 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.88 -0.676 . . . . 0.28000000000000003 112.753 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.9 149.65 21.31 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 120.569 -0.452 . . . . 1.55 110.689 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.648 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.6 p -79.09 114.75 20.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-O 122.218 1.008 . . . . 1.03 109.304 164.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.65 ' HG ' ' CE2' ' A' ' 119' ' ' PHE . 2.6 tm? -102.9 106.99 17.66 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.965 -1.016 . . . . 1.03 109.065 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.649 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.7 OUTLIER -71.88 96.76 1.72 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 114.226 -1.352 . . . . 1.01 108.039 176.537 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.914 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.1 m -71.66 118.06 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.158 -1.423 . . . . 1.6200000000000001 107.158 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.778 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 1.1 t70 -76.65 146.1 38.37 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.656 -1.239 . . . . 0.64000000000000001 107.656 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.583 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.1 m -50.97 132.38 27.2 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.582 -1.266 . . . . 1.05 107.582 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.57 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 22.7 t -60.66 138.35 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.959 0 N-CA-C 107.79 -1.189 . . . . 1.02 107.79 171.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.614 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.6 t-20 -83.51 162.03 21.04 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.202 -0.908 . . . . 0.20000000000000001 109.589 174.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.746 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.99 86.01 2.49 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.54 -1.209 . . . . 0.12 107.861 175.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.45 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 9.7 mtp180 -108.61 -3.71 17.74 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.847 -1.524 . . . . 0.84999999999999998 108.893 -172.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 20.6 p -49.99 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.067 -1.878 . . . . 0.91000000000000003 114.36 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.474 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.5 OUTLIER -76.53 -3.8 39.37 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.309 -1.769 . . . . 0.62 110.36 174.637 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.498 ' HA3' HG13 ' A' ' 169' ' ' VAL . . . -146.54 -153.07 5.79 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.692 -0.685 . . . . 0.14000000000000001 112.634 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.541 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 50.7 m -121.31 130.32 53.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 1.76 111.457 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.746 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.9 pp -134.01 157.44 46.08 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.824 0.821 . . . . 1.01 110.746 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.623 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -80.75 80.06 7.29 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.162 -1.381 . . . . 0.20999999999999999 107.803 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.576 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -67.14 -15.0 63.44 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.481 -1.236 . . . . 1.0 110.167 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.64 -29.65 41.06 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.576 -0.898 . . . . 1.02 108.576 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.623 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 16.1 tp10 -67.67 -33.38 74.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.283 -1.326 . . . . 1.73 109.143 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB1' ' O ' ' A' ' 102' ' ' ALA . . . -72.74 -43.5 62.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.24 -1.8 . . . . 1.04 109.505 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.639 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.3 m -63.41 -30.52 71.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.838 -1.528 . . . . 1.04 110.564 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.58 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 2.0 pt-20 -69.43 -42.97 74.3 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.849 -1.167 . . . . 1.47 107.849 173.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.637 HG22 ' HB2' ' A' ' 64' ' ' TRP . 85.2 m -62.58 -29.96 70.97 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.241 -0.891 . . . . 1.03 110.465 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.775 HD21 ' SD ' ' A' ' 68' ' ' MET . 9.5 mt -51.98 -70.27 0.09 Allowed 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 109.13 -0.693 . . . . 1.3 109.13 170.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.59 ' O ' HD12 ' A' ' 121' ' ' LEU . 19.0 mtp180 -40.21 -38.66 0.8 Allowed 'General case' 0 C--N 1.312 -1.032 0 O-C-N 124.465 1.103 . . . . 1.8 111.413 175.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.507 HD21 ' N ' ' A' ' 111' ' ' ASN . 1.0 OUTLIER -70.27 -46.07 65.09 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.754 -1.112 . . . . 0.41999999999999998 112.244 -176.88 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.05 -33.06 65.46 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.2 1.0 . . . . 1.01 108.437 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.726 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -64.5 -33.88 76.92 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 113.413 -1.721 . . . . 1.01 110.194 173.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.402 ' CB ' HD11 ' A' ' 121' ' ' LEU . . . -70.49 -37.16 74.18 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.789 -1.096 . . . . 1.03 111.164 -175.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -57.48 -31.87 66.42 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.629 -1.169 . . . . 1.55 110.997 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.443 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -77.03 -36.12 56.39 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.681 -1.145 . . . . 2.0499999999999998 110.211 -177.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.53 -4.56 8.92 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.313 -0.47 . . . . 0.54000000000000004 113.93 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.604 ' CG ' HD11 ' A' ' 76' ' ' LEU . 11.7 ptmt -83.93 -30.27 26.44 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 122.328 -0.513 . . . . 1.6000000000000001 111.462 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.666 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 4.1 m-85 -89.39 168.74 11.98 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.708 0.766 . . . . 0.27000000000000002 111.285 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.565 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.1 m -116.5 121.18 41.06 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 114.063 -1.426 . . . . 1.0800000000000001 108.154 171.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.597 HD21 ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -91.01 139.47 30.74 Favored 'General case' 0 N--CA 1.416 -2.151 0 C-N-CA 119.307 -0.957 . . . . 1.1499999999999999 110.647 -171.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.546 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.9 m -92.54 143.01 12.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.919 -1.141 . . . . 1.0900000000000001 107.919 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.45 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 6.3 t -95.23 171.03 8.98 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 123.066 1.413 . . . . 1.8200000000000001 109.608 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.29 -16.75 64.29 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 111.264 -2.698 . . . . 1.1899999999999999 109.09 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.57 ' O ' ' HG3' ' A' ' 129' ' ' MET . 27.1 mt-30 -59.51 -36.76 76.7 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 112.705 -2.043 . . . . 2.04 109.824 175.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.542 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 6.0 mt-30 -99.01 -51.87 3.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.981 0.896 . . . . 0.42999999999999999 110.205 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.914 HD12 ' O ' ' A' ' 89' ' ' VAL . 6.2 tt -64.01 -67.25 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.407 -1.724 . . . . 2.04 113.349 -167.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.559 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 15.4 m -57.16 -35.75 69.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 123.245 1.498 . . . . 1.1499999999999999 108.786 -175.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.595 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -59.47 -60.34 4.01 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 111.811 -2.449 . . . . 2.27 112.205 173.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.671 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.95 -44.02 4.42 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 124.308 1.043 . . . . 1.0700000000000001 112.23 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.51 ' HZ2' ' C ' ' A' ' 141' ' ' SER . 3.4 mttt -52.59 -54.7 29.4 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.172 -0.677 . . . . 2.1000000000000001 109.172 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -62.81 -41.75 99.43 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.398 -0.819 . . . . 0.42999999999999999 111.0 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 129' ' ' MET . 47.6 mt-30 -57.06 -35.02 68.86 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 114.215 -1.357 . . . . 0.38 109.668 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.46 -30.39 16.49 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.95 -1.477 . . . . 1.05 109.738 -176.792 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.42 -46.57 0.56 Allowed Glycine 0 CA--C 1.494 -1.224 0 C-N-CA 119.845 -1.169 . . . . 0.33000000000000002 113.569 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.604 HD12 ' O ' ' A' ' 141' ' ' SER . 98.3 mt -65.92 -169.64 0.07 Allowed 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 112.437 -1.882 . . . . 1.0700000000000001 115.395 -170.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.515 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 6.7 m -114.76 149.32 42.17 Favored Pre-proline 0 N--CA 1.416 -2.153 0 CA-C-N 110.49 -3.05 . . . . 1.24 107.676 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.559 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 59.0 Cg_endo -66.28 0.57 3.21 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 122.774 2.316 . . . . 0.39000000000000001 112.285 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 137' ' ' SER . 2.3 tt0 -118.23 -26.52 6.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.825 0.821 . . . . 1.79 110.286 -177.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.72 ' O ' ' HB2' ' A' ' 141' ' ' SER . 15.2 t70 -58.26 -23.45 56.16 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-N 113.346 -1.752 . . . . 0.65000000000000002 109.168 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.72 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 20.8 m 76.05 171.23 0.25 Allowed 'General case' 0 N--CA 1.42 -1.933 0 O-C-N 125.817 1.948 . . . . 0.73999999999999999 108.385 -173.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.778 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 6.9 mt -63.95 -39.06 93.29 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.724 -1.213 . . . . 1.48 107.724 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.25 -11.85 1.39 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 113.059 -1.882 . . . . 0.34999999999999998 114.334 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.406 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 1.2 m -155.42 128.06 7.94 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.076 -0.713 . . . . 1.02 109.076 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.661 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.0 mmt180 -42.92 -46.87 5.54 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 117.995 0.361 . . . . 2.21 111.556 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.1 t -72.3 -26.21 61.87 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.511 0.672 . . . . 0.93000000000000005 111.431 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.406 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 31.4 mttm -74.38 -32.17 62.63 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.661 1.219 . . . . 1.8899999999999999 108.797 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.798 ' HB3' ' OH ' ' A' ' 162' ' ' TYR . . . -71.11 -46.43 61.7 Favored 'General case' 0 CA--C 1.483 -1.627 0 CA-C-N 112.299 -2.228 . . . . 0.98999999999999999 109.976 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.548 HG13 ' HE3' ' A' ' 179' ' ' MET . 36.6 mt -67.22 -41.79 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-N 112.764 -2.016 . . . . 1.03 109.974 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.53 -54.39 30.43 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 114.769 -1.105 . . . . 0.14999999999999999 111.297 171.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.686 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 79.1 mt -66.61 -47.77 82.38 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.029 0 N-CA-C 112.729 0.64 . . . . 1.05 112.729 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.606 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.76 -41.66 74.31 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.809 0.338 . . . . 1.03 110.9 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.435 ' HG3' ' O ' ' A' ' 149' ' ' ILE . 26.8 mtp180 -79.97 -23.98 41.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.48 0.657 . . . . 1.29 110.53 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.438 HD22 ' CD ' ' A' ' 133' ' ' GLN . 17.6 t30 -80.0 -12.83 59.68 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.337 -1.357 . . . . 0.5 107.337 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.686 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.39 -29.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 113.018 -1.901 . . . . 1.05 110.79 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.82 34.21 5.28 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.586 -0.816 . . . . 0.17000000000000001 112.632 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.06 161.24 14.92 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.031 0.752 . . . . 1.02 113.031 -169.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.648 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.6 m80 -100.31 -28.69 12.84 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.065 -0.97 . . . . 0.39000000000000001 109.348 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.59 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.3 m-85 -136.89 -177.96 4.98 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.935 -1.03 . . . . 0.81000000000000005 110.936 -175.027 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.713 ' O ' HD22 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -133.65 140.24 47.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.077 -0.965 . . . . 1.03 108.823 167.58 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.607 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 24.9 tp -110.46 99.05 8.12 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.333 -0.947 . . . . 1.02 109.725 166.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.798 ' OH ' ' HB3' ' A' ' 148' ' ' ALA . 2.1 m-85 -78.75 112.59 16.03 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.893 -1.049 . . . . 0.87 109.143 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.872 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.3 t -123.69 163.24 21.49 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 121.875 0.845 . . . . 1.45 110.275 -177.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.798 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.6 p -163.87 176.28 9.62 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 114.397 -1.274 . . . . 0.12 111.33 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.57 132.52 29.39 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 113.844 -1.526 . . . . 0.94999999999999996 108.531 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.63 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -142.34 -176.94 5.03 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.21 -0.596 . . . . 1.1499999999999999 109.492 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.09 -81.82 0.88 Allowed Glycine 0 C--N 1.303 -1.258 0 C-N-CA 119.649 -1.262 . . . . 0.14999999999999999 111.615 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.474 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.2 t30 -146.78 126.6 13.5 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 107.705 -1.221 . . . . 0.58999999999999997 107.705 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.498 HG13 ' HA3' ' A' ' 98' ' ' GLY . 2.2 p -58.75 -44.09 89.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 114.502 -1.226 . . . . 1.0 112.723 -173.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.44 ' N ' HG11 ' A' ' 169' ' ' VAL . 7.9 m-20 -61.99 -29.91 70.58 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.776 0.798 . . . . 1.9199999999999999 109.788 -175.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.99 88.11 3.56 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 114.387 -1.279 . . . . 1.0600000000000001 108.224 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.651 ' HD2' HG22 ' A' ' 194' ' ' VAL . 45.9 Cg_endo -90.06 165.54 4.74 Favored 'Trans proline' 0 CA--C 1.491 -1.631 0 C-N-CA 124.644 3.562 . . . . 0.089999999999999997 114.412 -170.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.542 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 25.6 m -83.3 118.27 23.55 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.942 -1.481 . . . . 1.0600000000000001 107.513 166.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.836 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 45.3 tp -83.76 99.51 10.32 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.367 -0.975 . . . . 1.02 108.367 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.571 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -91.34 109.02 20.29 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-O 122.09 0.948 . . . . 0.34000000000000002 109.196 -176.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.872 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.1 mmm -111.87 163.54 14.09 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.983 -1.008 . . . . 1.0900000000000001 111.487 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.511 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 58.6 tt0 -171.15 116.91 0.44 Allowed 'General case' 0 C--O 1.203 -1.366 0 CA-C-N 116.019 -0.537 . . . . 0.68000000000000005 110.404 -165.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.713 HD22 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -99.39 102.27 13.8 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.743 -0.836 . . . . 1.03 108.743 -172.309 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.661 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 17.2 ttp -91.62 121.88 33.68 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.89000000000000001 109.534 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.425 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.6 128.04 35.04 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.159 -1.423 . . . . 1.04 107.159 166.195 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -83.09 -35.04 11.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 119.303 0.956 . . . . 1.02 110.747 178.5 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.435 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.4 mt-30 -61.45 -16.55 48.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.335 -0.848 . . . . 0.40000000000000002 111.358 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.7 p -130.08 -37.34 1.48 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.794 0.807 . . . . 1.03 110.224 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.441 ' CA ' HD13 ' A' ' 149' ' ' ILE . . . 90.48 25.29 26.2 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 114.449 -1.25 . . . . 0.17999999999999999 112.528 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.43 156.81 17.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.679 0.276 . . . . 0.72999999999999998 110.672 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.471 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.3 mm -91.46 112.8 25.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.454 0.645 . . . . 1.03 109.679 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.67 ' CD1' HD12 ' A' ' 178' ' ' LEU . 1.6 pp -101.11 -31.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.018 -0.992 . . . . 1.01 110.597 -173.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.639 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.6 t90 -134.06 152.62 51.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.359 -0.837 . . . . 0.070000000000000007 109.752 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.487 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 51.8 p -153.8 164.17 38.79 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.399 0.888 . . . . 0.64000000000000001 113.399 164.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.47 -177.06 33.23 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 110.876 -0.889 . . . . 0.12 110.876 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.836 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.1 mtmt -157.46 152.8 26.16 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.645 -1.983 . . . . 1.76 105.645 166.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.641 ' N ' ' HE3' ' A' ' 71' ' ' MET . . . -163.76 128.18 1.79 Allowed Glycine 0 C--N 1.281 -2.498 0 C-N-CA 119.749 -1.215 . . . . 0.13 112.477 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.64 118.76 14.87 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.298 0.571 . . . . 1.01 110.854 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.696 HG12 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -94.62 158.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.569 1.176 . . . . 1.01 110.621 -177.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.775 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -98.02 172.98 7.28 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 112.667 -2.061 . . . . 0.92000000000000004 108.861 -173.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -102.45 130.97 49.4 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.501 -0.48 . . . . 0.91000000000000003 109.962 170.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.506 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 15.4 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.844 -0.598 . . . . 1.24 110.744 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.828 -0.509 . . . . 88.920000000000002 111.828 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m 61.65 69.29 0.65 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.292 0.567 . . . . 87.459999999999994 111.253 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -125.96 84.53 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.592 0.71 . . . . 87.5 109.815 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.522 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.4 pmm? -71.89 135.33 46.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.702 -0.681 . . . . 85.340000000000003 110.621 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 4' ' ' MET . 1.4 p 54.7 5.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.329 1.452 . . . . 85.230000000000004 113.724 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.27 -7.65 64.25 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.975 -0.631 . . . . 84.849999999999994 112.596 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.44 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 36.4 tt0 54.1 99.97 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.537 0.735 . . . . 85.599999999999994 111.586 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.44 ' HB2' ' O ' ' A' ' 7' ' ' GLN . 84.8 mtp180 73.56 150.33 0.11 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.726 -1.124 . . . . 85.310000000000002 110.404 -175.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -74.19 137.43 75.46 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.872 -0.603 . . . . 82.170000000000002 109.756 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.4 -2.03 7.54 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.112 1.875 . . . . 82.069999999999993 112.132 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.54 98.07 10.19 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.937 -0.574 . . . . 79.709999999999994 109.996 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.54 133.99 16.43 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.971 1.78 . . . . 79.019999999999996 111.842 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.5 m -148.16 170.43 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.853 -0.612 . . . . 77.260000000000005 110.79 -176.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -63.55 -72.18 0.15 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.701 -0.682 . . . . 75.739999999999995 109.604 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -171.6 103.29 0.19 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.819 -0.628 . . . . 74.010000000000005 110.086 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.2 t -89.57 100.8 11.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.041 0.448 . . . . 72.569999999999993 109.793 177.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.447 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 39.0 mtmm -66.08 -46.98 63.43 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.956 -0.565 . . . . 71.379999999999995 111.851 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 17' ' ' LYS . 17.1 Cg_exo -67.43 160.01 49.77 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.625 1.55 . . . . 70.189999999999998 111.458 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.29 158.28 37.37 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.293 -0.412 . . . . 67.769999999999996 110.238 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.46 142.79 37.52 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.497 2.131 . . . . 67.180000000000007 111.165 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.59 133.97 46.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.703 -0.681 . . . . 65.200000000000003 111.982 -172.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -129.51 78.47 75.55 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.302 -0.863 . . . . 63.460000000000001 110.688 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.95 155.42 55.32 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.248 2.632 . . . . 62.479999999999997 112.489 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.12 85.84 0.55 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.451 0.643 . . . . 59.869999999999997 111.291 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.447 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 5.8 mm-40 -89.99 -44.57 0.41 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.418 -0.81 . . . . 58.890000000000001 112.202 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 23.2 Cg_exo -67.14 -12.0 34.34 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.121 1.881 . . . . 57.890000000000001 111.717 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -73.1 81.56 1.26 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.293 -0.867 . . . . 55.729999999999997 110.105 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -129.71 65.93 76.08 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.685 -0.689 . . . . 54.079999999999998 109.309 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -94.85 38.33 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.742 2.961 . . . . 53.299999999999997 112.584 -170.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.1 t -66.28 127.18 93.12 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.72 -0.673 . . . . 51.130000000000003 109.268 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.44 92.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.928 2.419 . . . . 49.75 112.352 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.9 p -73.98 145.09 44.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.768 -0.651 . . . . 47.700000000000003 110.646 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.12 120.61 81.27 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.75 -0.659 . . . . 46.109999999999999 109.973 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.38 148.26 52.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.183 2.589 . . . . 45.890000000000001 112.001 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -132.48 136.78 46.91 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.057 -0.974 . . . . 43.0 110.559 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.24 121.48 56.36 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.814 -0.63 . . . . 40.789999999999999 111.091 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.75 156.59 47.27 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.939 2.426 . . . . 40.450000000000003 112.116 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.0 t -78.92 144.53 34.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.289 -0.414 . . . . 37.729999999999997 110.03 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.8 mt -89.22 115.07 62.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.844 -0.616 . . . . 35.990000000000002 110.355 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.15 -175.67 2.65 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.7 2.267 . . . . 34.350000000000001 112.33 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -105.95 77.45 1.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.605 0.717 . . . . 31.780000000000001 110.585 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.583 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 7.4 tp-100 -60.9 -39.85 69.15 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 114.606 -1.179 . . . . 30.390000000000001 112.526 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 18.4 Cg_endo -60.26 123.16 12.55 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.493 1.462 . . . . 29.940000000000001 111.43 172.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.96 165.19 19.24 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 116.024 -0.534 . . . . 26.75 111.958 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.79 158.8 40.58 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.789 2.326 . . . . 25.879999999999999 112.47 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.04 -57.64 10.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 120.853 0.359 . . . . 24.16 110.431 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 60.2 82.08 0.16 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.122 -0.945 . . . . 21.829999999999998 111.594 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -170.76 159.09 6.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.397 -0.82 . . . . 20.620000000000001 109.238 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -129.86 -87.71 0.51 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.642 -0.708 . . . . 16.559999999999999 110.716 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.5 t70 45.08 70.01 0.39 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.833 0.825 . . . . 15.050000000000001 111.566 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -75.85 -54.68 6.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.91 -1.041 . . . . 14.66 110.196 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.1 p -131.18 139.47 49.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.206 -0.452 . . . . 11.84 110.416 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.92 78.74 19.37 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.132 -0.486 . . . . 8.4399999999999995 111.345 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -84.39 155.9 12.49 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.215 1.943 . . . . 7.6600000000000001 112.595 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.84 15.87 1.97 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.344 2.029 . . . . 5.6600000000000001 111.961 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 59.44 66.12 2.34 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 115.556 -0.747 . . . . 2.8700000000000001 111.62 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -72.11 -175.96 1.94 Allowed 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 123.173 2.582 . . . . 1.8300000000000001 111.989 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -116.66 142.5 46.81 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.597 -1.183 . . . . 4.2199999999999998 110.688 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.604 HG23 ' N ' ' A' ' 60' ' ' ARG . 8.0 mt -95.11 170.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.992 0.901 . . . . 1.1299999999999999 111.969 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.604 ' N ' HG23 ' A' ' 59' ' ' ILE . 56.7 mtt-85 -76.51 -156.81 0.07 Allowed 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 113.79 -1.55 . . . . 3.1400000000000001 111.727 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.632 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 19.4 t-160 -157.28 147.96 21.33 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 112.404 -2.18 . . . . 2.7400000000000002 106.363 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.759 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.9 m-30 -125.34 160.34 29.57 Favored 'General case' 0 N--CA 1.421 -1.899 0 O-C-N 123.856 0.723 . . . . 0.76000000000000001 109.911 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.508 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 4.3 t70 -81.73 67.91 7.89 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 123.595 1.664 . . . . 0.34999999999999998 108.292 171.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.701 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 92.0 m95 -58.29 -43.1 87.87 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 111.682 -2.508 . . . . 0.10000000000000001 112.547 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.502 ' N ' HG21 ' A' ' 108' ' ' THR . 8.6 t-20 -51.82 -28.86 17.04 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.962 -1.472 . . . . 1.1100000000000001 111.598 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.44 -17.6 80.12 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.137 -0.938 . . . . 0.23000000000000001 111.104 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.484 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.1 -53.18 3.09 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.036 -1.082 . . . . 1.01 110.949 -176.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.746 ' SD ' HD22 ' A' ' 109' ' ' LEU . 42.2 mtt -64.24 -59.57 4.25 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.241 -1.345 . . . . 0.089999999999999997 112.593 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -39.34 -54.66 3.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 114.624 1.342 . . . . 0.63 114.624 -175.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.782 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.0 Cg_endo -64.21 -28.84 64.49 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 121.788 1.658 . . . . 0.17000000000000001 110.614 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.899 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 11.8 mtm -84.99 -41.25 16.01 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.16 -0.927 . . . . 0.69999999999999996 111.476 -177.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.663 HG21 ' O ' ' A' ' 68' ' ' MET . 61.2 t -55.91 -39.96 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 CA-C-N 114.629 -1.169 . . . . 1.04 108.697 172.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.7 t -60.93 -32.27 71.78 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.32 -1.764 . . . . 1.1200000000000001 111.085 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.782 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 16.6 mtpp -84.71 -33.48 23.13 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.147 0.498 . . . . 1.8799999999999999 110.736 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.872 ' O ' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -65.36 -27.91 68.91 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.169 -0.923 . . . . 0.5 111.334 -172.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.552 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.2 mt -92.92 -2.93 55.38 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.97 0.89 . . . . 1.29 110.917 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.79 15.36 37.61 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.236 -1.546 . . . . 0.17999999999999999 109.236 170.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.626 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.27 165.0 17.69 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.679 -0.761 . . . . 1.0 110.276 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -91.08 104.49 17.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.22 -0.9 . . . . 1.72 110.046 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.77 -21.78 3.72 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.097 -0.956 . . . . 0.13 110.735 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.872 HG12 ' O ' ' A' ' 75' ' ' MET . 12.4 p -100.0 153.62 4.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.605 0.716 . . . . 1.01 111.002 -177.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -135.15 136.39 41.84 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 114.838 -1.074 . . . . 1.1000000000000001 110.592 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.468 ' HB1' ' HE3' ' A' ' 118' ' ' LYS . . . -55.47 131.06 45.08 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.467 -0.788 . . . . 1.1200000000000001 110.179 166.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.96 9.91 44.25 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.79 -0.719 . . . . 0.28000000000000003 113.113 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.92 153.08 18.99 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 120.6 -0.44 . . . . 1.55 110.956 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.647 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -81.87 114.91 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 122.116 0.96 . . . . 1.03 109.128 166.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.736 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -102.1 108.97 20.55 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.024 -0.989 . . . . 1.03 109.264 -172.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.701 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -72.25 95.05 1.64 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 114.471 -1.24 . . . . 1.01 108.272 175.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.435 HG12 ' HG3' ' A' ' 110' ' ' ARG . 1.6 m -73.01 118.21 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 107.83 -1.174 . . . . 1.6200000000000001 107.83 176.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.772 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 7.9 t0 -77.47 156.95 30.72 Favored 'General case' 0 CA--C 1.489 -1.397 0 CA-C-N 114.385 -1.28 . . . . 0.64000000000000001 107.856 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.564 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -58.38 136.98 57.55 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 108.075 -1.083 . . . . 1.05 108.075 171.234 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.559 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.2 t -64.0 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.982 0 N-CA-C 107.778 -1.193 . . . . 1.02 107.778 167.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.645 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.8 t-20 -86.2 163.26 17.9 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.006 -0.997 . . . . 0.20000000000000001 110.069 174.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.75 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.57 84.65 2.3 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.303 -1.317 . . . . 0.12 108.134 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.499 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 7.2 mtp180 -109.09 -1.04 19.12 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 113.783 -1.553 . . . . 0.84999999999999998 108.627 -172.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 18.5 p -52.83 -171.97 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 112.73 -2.032 . . . . 0.91000000000000003 115.034 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.497 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.1 t30 -71.3 -9.39 58.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.759 -2.019 . . . . 0.62 110.476 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.532 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -151.94 -146.33 4.32 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.472 -0.871 . . . . 0.14000000000000001 112.903 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.577 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 54.8 p -121.87 131.02 53.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.245 0.461 . . . . 1.76 112.245 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.75 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.91 156.72 48.34 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.802 0.81 . . . . 1.01 110.629 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.639 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -79.79 79.6 6.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.978 -1.465 . . . . 0.20999999999999999 107.742 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.57 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -68.35 -14.44 62.99 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.307 -1.315 . . . . 1.0 109.749 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.45 -31.38 37.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.747 -0.834 . . . . 1.02 108.747 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.639 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 4.8 tp10 -66.32 -34.37 77.83 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.392 -1.277 . . . . 1.73 108.933 171.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.57 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -71.56 -43.57 66.09 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.236 -1.802 . . . . 1.04 109.551 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 81.0 m -62.92 -30.61 71.68 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 113.776 -1.556 . . . . 1.04 110.162 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.6 -49.68 70.14 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.722 -0.844 . . . . 1.47 108.722 169.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.603 HG21 ' HB2' ' A' ' 64' ' ' TRP . 53.1 m -59.38 -31.08 68.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.43 -0.804 . . . . 1.03 110.789 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.746 HD22 ' SD ' ' A' ' 68' ' ' MET . 8.6 mt -51.2 -69.22 0.12 Allowed 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 115.902 -0.59 . . . . 1.3 109.874 172.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.718 ' O ' HD11 ' A' ' 121' ' ' LEU . 4.9 mtp180 -41.85 -38.8 1.61 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.615 1.198 . . . . 1.8 110.886 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -68.56 -49.04 62.53 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.32 -1.763 . . . . 0.41999999999999998 112.107 -176.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.93 -32.89 69.94 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.357 1.075 . . . . 1.01 108.446 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.683 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -64.14 -32.53 74.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.091 -1.868 . . . . 1.01 109.969 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.88 -38.53 61.88 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 114.749 -1.114 . . . . 1.03 111.802 -174.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -67.31 -23.29 65.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.518 -0.764 . . . . 1.55 111.449 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -89.27 -13.22 38.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 2.0499999999999998 111.877 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.95 -12.05 0.59 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 115.936 1.135 . . . . 0.54000000000000004 115.936 163.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.468 ' HE3' ' HB1' ' A' ' 83' ' ' ALA . 58.7 mtpt -75.81 -34.33 60.15 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 117.529 0.665 . . . . 1.6000000000000001 111.116 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.736 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 13.9 m-85 -91.42 177.67 6.17 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.889 1.328 . . . . 0.27000000000000002 113.823 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.535 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 12.7 m -125.02 114.17 18.75 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 112.244 -2.253 . . . . 1.0800000000000001 107.818 167.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.718 HD11 ' O ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -99.13 128.02 45.18 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.712 -0.795 . . . . 1.1499999999999999 112.216 -168.095 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.784 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.8 OUTLIER -75.03 153.17 6.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.068 -1.086 . . . . 1.0900000000000001 108.068 173.943 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.431 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 9.1 t -101.29 -175.32 2.83 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.416 -0.914 . . . . 1.8200000000000001 110.349 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.91 -26.41 67.6 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.703 -1.221 . . . . 1.1899999999999999 107.703 174.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.647 ' O ' ' HG3' ' A' ' 129' ' ' MET . 15.3 mt-30 -48.84 -39.67 26.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 113.182 -1.826 . . . . 2.04 110.715 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.784 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 4.9 mt-30 -98.33 -50.06 4.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.68 0.752 . . . . 0.42999999999999999 110.136 173.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.495 HD11 ' N ' ' A' ' 128' ' ' SER . 2.0 tm? -66.47 -63.07 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.008 -1.451 . . . . 2.04 113.331 -167.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.672 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.1 t -50.49 -39.4 48.29 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 123.648 1.689 . . . . 1.1499999999999999 109.028 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.675 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -63.59 -63.18 1.25 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 110.644 -2.98 . . . . 2.27 110.688 178.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.698 ' CB ' HG22 ' A' ' 151' ' ' ILE . . . -42.31 -44.54 3.91 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 124.363 1.04 . . . . 1.0700000000000001 111.646 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.506 ' HD3' ' HA ' ' A' ' 138' ' ' PRO . 0.0 OUTLIER -49.47 -60.81 2.52 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 123.435 0.46 . . . . 2.1000000000000001 110.044 176.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.425 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.9 mt-30 -58.79 -43.96 90.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.665 -1.152 . . . . 0.42999999999999999 111.46 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.675 ' HG3' ' O ' ' A' ' 129' ' ' MET . 49.4 mt-30 -56.14 -34.83 66.49 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.779 -1.1 . . . . 0.38 109.895 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.481 HD22 ' HB2' ' A' ' 133' ' ' GLN . 0.4 OUTLIER -90.67 -30.98 16.8 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 113.89 -1.504 . . . . 1.05 109.487 -177.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.6 -50.69 0.44 Allowed Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 120.095 -1.05 . . . . 0.33000000000000002 113.64 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.627 HD12 ' O ' ' A' ' 141' ' ' SER . 86.1 mt -64.13 -173.02 0.08 Allowed 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 115.841 1.793 . . . . 1.0700000000000001 115.841 -169.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.473 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.8 m -110.5 150.29 41.45 Favored Pre-proline 0 N--CA 1.421 -1.907 0 CA-C-N 111.005 -2.816 . . . . 1.24 108.9 169.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.672 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 28.6 Cg_endo -64.13 1.12 1.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.003 2.469 . . . . 0.39000000000000001 112.831 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.432 ' H ' ' C ' ' A' ' 137' ' ' SER . 0.9 OUTLIER -118.33 -22.96 7.43 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.123 0.963 . . . . 1.79 110.487 -178.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.643 ' O ' ' HB2' ' A' ' 141' ' ' SER . 10.6 t70 -63.61 -21.94 66.63 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 113.062 -1.881 . . . . 0.65000000000000002 109.375 -174.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.643 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 17.6 m 72.86 169.97 0.31 Allowed 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.42 -1.718 . . . . 0.73999999999999999 109.517 -173.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.772 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 4.7 mt -64.44 -39.58 94.11 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 122.349 1.071 . . . . 1.48 108.268 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.97 -5.98 2.3 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 113.025 -1.898 . . . . 0.34999999999999998 114.421 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 m -159.78 127.8 4.83 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.913 -0.773 . . . . 1.02 108.913 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.721 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.5 mmt180 -42.42 -47.94 5.08 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 118.182 0.446 . . . . 2.21 111.256 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.7 t -70.92 -25.79 62.92 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.503 0.668 . . . . 0.93000000000000005 111.591 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 26.8 mttm -75.21 -30.36 60.58 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 122.626 1.203 . . . . 1.8899999999999999 108.675 176.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.721 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -75.46 -46.57 31.73 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 112.472 -2.149 . . . . 0.98999999999999999 110.288 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.546 ' HA ' HG23 ' A' ' 181' ' ' VAL . 43.5 mt -66.78 -41.71 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-N 112.811 -1.995 . . . . 1.03 110.004 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.11 -54.5 28.82 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.747 -1.115 . . . . 0.14999999999999999 111.134 171.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.698 HG22 ' CB ' ' A' ' 130' ' ' ALA . 72.2 mt -66.2 -47.86 83.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 N-CA-C 112.831 0.678 . . . . 1.05 112.831 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.641 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.88 -40.36 72.85 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.926 0.393 . . . . 1.03 110.975 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.4 ' HD2' HG21 ' A' ' 149' ' ' ILE . 39.7 mtp180 -81.44 -22.67 38.01 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.745 0.783 . . . . 1.29 110.48 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -81.74 -12.04 58.76 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.199 -1.408 . . . . 0.5 107.199 176.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.69 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -107.4 -29.14 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 113.247 -1.797 . . . . 1.05 110.918 -174.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.44 35.84 4.81 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.313 -0.946 . . . . 0.17000000000000001 112.483 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.701 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.59 159.16 17.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.131 0.789 . . . . 1.02 113.131 -169.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.647 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -98.0 -27.06 14.41 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.18 -0.918 . . . . 0.39000000000000001 109.569 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.634 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 9.5 m-85 -136.65 -173.42 3.42 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.354 -0.839 . . . . 0.81000000000000005 111.586 -174.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.691 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -137.76 138.43 44.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.803 -1.089 . . . . 1.03 109.145 166.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.557 HD21 ' HE1' ' A' ' 176' ' ' MET . 34.7 tp -107.82 99.43 8.9 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.379 -0.928 . . . . 1.02 109.281 165.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.721 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.0 m-85 -78.78 111.99 15.47 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.56 -1.2 . . . . 0.87 108.743 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.819 ' OG ' HD11 ' A' ' 174' ' ' LEU . 26.8 t -123.6 159.22 29.72 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 121.776 0.798 . . . . 1.45 110.123 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.783 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.4 p -163.38 170.06 18.07 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-N 114.497 -1.229 . . . . 0.12 111.18 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -133.86 135.93 44.05 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.143 -1.39 . . . . 0.94999999999999996 108.636 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.643 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -144.23 -176.96 5.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.192 -0.67 . . . . 1.1499999999999999 109.192 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.08 -86.18 0.92 Allowed Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 119.628 -1.272 . . . . 0.14999999999999999 111.006 174.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.497 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.9 t30 -143.75 127.76 17.47 Favored 'General case' 0 C--O 1.191 -1.982 0 N-CA-C 107.375 -1.343 . . . . 0.58999999999999997 107.375 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.568 HG23 ' N ' ' A' ' 99' ' ' SER . 2.9 p -61.36 -49.71 83.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 114.061 -1.427 . . . . 1.0 112.916 -170.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.483 ' N ' HG13 ' A' ' 169' ' ' VAL . 89.8 m-20 -58.83 -26.83 64.52 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.222 0.534 . . . . 1.9199999999999999 110.904 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.13 88.18 3.51 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 114.903 -1.044 . . . . 1.0600000000000001 108.394 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.651 ' HD2' HG23 ' A' ' 194' ' ' VAL . 43.3 Cg_endo -91.44 167.26 3.44 Favored 'Trans proline' 0 CA--C 1.493 -1.55 0 C-N-CA 124.947 3.765 . . . . 0.089999999999999997 114.854 -170.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 16.9 m -86.13 118.13 25.39 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 113.755 -1.566 . . . . 1.0600000000000001 107.694 166.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.819 HD11 ' OG ' ' A' ' 163' ' ' SER . 54.1 tp -84.46 97.89 9.78 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-O 121.988 0.899 . . . . 1.02 109.337 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.58 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 34.9 mt-30 -87.64 107.66 18.72 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 114.567 -1.197 . . . . 0.34000000000000002 108.685 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.899 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 35.1 mtp -108.26 163.0 13.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.235 -0.893 . . . . 1.0900000000000001 110.063 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.517 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 36.5 tt0 -169.91 117.85 0.58 Allowed 'General case' 0 C--O 1.202 -1.438 0 CA-C-O 121.256 0.551 . . . . 0.68000000000000005 110.136 -167.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -100.34 101.76 12.83 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.818 -0.808 . . . . 1.03 108.818 -172.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.721 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.2 ttp -91.3 123.13 34.5 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.479 -0.782 . . . . 0.89000000000000001 109.533 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.77 127.37 31.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.075 -1.454 . . . . 1.04 107.075 166.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.546 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -82.05 -35.8 13.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.192 -1.003 . . . . 1.02 110.645 178.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.439 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.5 mt-30 -61.72 -15.5 41.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.259 -0.882 . . . . 0.40000000000000002 111.37 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p -130.08 -37.54 1.47 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.514 0.674 . . . . 1.03 110.127 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.411 ' CA ' HD13 ' A' ' 149' ' ' ILE . . . 90.15 26.13 24.66 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 114.631 -1.168 . . . . 0.17999999999999999 112.429 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 179' ' ' MET . 9.8 pt-20 -105.23 156.76 17.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.605 0.24 . . . . 0.72999999999999998 110.946 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.474 HD11 ' HG2' ' A' ' 177' ' ' GLN . 36.8 mm -91.25 110.59 22.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.792 0.806 . . . . 1.03 109.706 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.665 ' CD1' HD12 ' A' ' 178' ' ' LEU . 1.5 pp -98.11 -32.39 3.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.695 -1.139 . . . . 1.01 110.514 -173.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.626 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.6 t90 -135.49 151.78 50.7 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.383 -0.826 . . . . 0.070000000000000007 109.541 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 33.0 p -153.84 163.17 40.48 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.742 0.645 . . . . 0.64000000000000001 112.742 164.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.29 -178.41 32.29 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 110.841 -0.903 . . . . 0.12 110.841 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.814 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 16.3 mtmm -156.91 148.19 22.13 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.433 -1.692 . . . . 1.76 106.433 167.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -157.59 127.06 1.84 Allowed Glycine 0 C--N 1.283 -2.38 0 C-N-CA 119.682 -1.247 . . . . 0.13 112.293 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.505 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.94 116.05 12.98 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.413 0.625 . . . . 1.01 111.069 -174.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.67 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -93.39 159.46 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 122.604 1.192 . . . . 1.01 110.716 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -100.82 172.55 6.99 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.485 -2.143 . . . . 0.92000000000000004 108.682 -174.175 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.537 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.1 tt0 -101.25 133.24 46.13 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 120.103 -0.639 . . . . 0.91000000000000003 109.601 171.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.524 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 36.7 mm-40 . . . . . 0 C--N 1.313 -1.02 0 CA-C-O 118.467 -0.778 . . . . 1.24 110.257 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.874 -0.49 . . . . 88.920000000000002 111.874 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.5 m -106.02 -79.42 0.56 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.015 -0.365 . . . . 87.459999999999994 110.015 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.0 t60 44.13 74.63 0.12 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.745 0.818 . . . . 87.5 112.306 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.8 ttp -72.93 164.24 26.95 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.622 -0.881 . . . . 85.340000000000003 108.622 172.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 5' ' ' VAL . 14.6 p -77.31 55.89 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.843 1.306 . . . . 85.230000000000004 110.672 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -144.13 72.14 0.36 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 114.584 -1.189 . . . . 84.849999999999994 111.399 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -87.64 -175.61 5.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.592 -0.304 . . . . 85.599999999999994 110.993 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 61.01 62.69 1.38 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.417 0.627 . . . . 85.310000000000002 109.899 -175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.29 101.08 53.12 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.18 -0.918 . . . . 82.170000000000002 110.246 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.0 97.69 0.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.261 1.974 . . . . 82.069999999999993 111.969 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.94 119.4 77.0 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.235 -0.439 . . . . 79.709999999999994 110.311 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.464 ' O ' HG22 ' A' ' 13' ' ' VAL . 22.6 Cg_exo -62.91 127.51 20.63 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.11 1.873 . . . . 79.019999999999996 111.734 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.464 HG22 ' O ' ' A' ' 12' ' ' PRO . 5.9 m 50.47 161.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.313 1.445 . . . . 77.260000000000005 113.646 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -166.27 78.92 0.25 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.803 -1.089 . . . . 75.739999999999995 108.967 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -153.53 146.74 24.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.161 -0.472 . . . . 74.010000000000005 111.251 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.4 p -77.53 138.79 19.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.79 -0.641 . . . . 72.569999999999993 110.369 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -82.97 129.97 59.37 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.104 -0.498 . . . . 71.379999999999995 109.978 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.97 -170.97 0.77 Allowed 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.967 2.445 . . . . 70.189999999999998 112.699 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.88 73.05 0.64 Allowed Pre-proline 0 C--N 1.338 0.07 0 CA-C-N 115.073 -0.967 . . . . 67.769999999999996 110.729 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.73 118.25 5.11 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.764 2.309 . . . . 67.180000000000007 112.007 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -68.1 -55.36 12.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.935 -0.394 . . . . 65.200000000000003 109.935 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 67.9 119.85 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 O-C-N 123.96 0.787 . . . . 63.460000000000001 111.663 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -55.97 162.35 7.25 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 123.097 2.532 . . . . 62.479999999999997 112.528 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.64 86.75 0.48 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.725 -0.671 . . . . 59.869999999999997 110.957 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.465 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 76.9 mm-40 -102.51 -53.15 0.13 Allowed Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.275 -0.875 . . . . 58.890000000000001 111.697 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 91.3 Cg_endo -83.08 -156.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.53 1.486 . . . . 57.890000000000001 112.395 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 65.69 -97.67 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.209 -0.905 . . . . 55.729999999999997 110.609 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 56.26 128.19 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 123.703 0.801 . . . . 54.079999999999998 113.051 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.91 133.73 46.12 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.249 1.966 . . . . 53.299999999999997 112.611 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.56 123.57 21.38 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.136 -0.484 . . . . 51.130000000000003 110.175 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.25 143.37 35.3 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.054 1.836 . . . . 49.75 112.02 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 p -76.76 154.78 33.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.613 0.244 . . . . 47.700000000000003 111.574 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 m 37.99 84.62 0.18 Allowed Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.574 1.15 . . . . 46.109999999999999 113.9 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -54.42 160.24 7.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.444 2.762 . . . . 45.890000000000001 112.516 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -71.26 130.7 42.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.809 -1.087 . . . . 43.0 111.298 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.6 m -61.84 160.45 28.28 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.484 -0.78 . . . . 40.789999999999999 111.024 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -46.9 148.12 4.25 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.825 2.35 . . . . 40.450000000000003 113.269 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 t -68.31 129.51 40.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.525 0.679 . . . . 37.729999999999997 111.567 -175.063 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 mt -107.76 128.13 26.43 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.471 -0.786 . . . . 35.990000000000002 110.124 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.68 -179.52 4.61 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.43 2.087 . . . . 34.350000000000001 112.595 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -117.85 17.48 14.23 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 31.780000000000001 111.644 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -160.34 151.06 15.44 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.79 -0.448 . . . . 30.390000000000001 109.79 177.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -71.47 120.61 7.06 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.223 1.949 . . . . 29.940000000000001 111.26 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.11 -164.49 9.88 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.021 -0.609 . . . . 26.75 112.954 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.71 169.34 10.68 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.252 2.635 . . . . 25.879999999999999 112.669 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 54.8 mt -63.88 -69.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.409 -0.36 . . . . 24.16 110.639 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.75 119.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.758 -1.11 . . . . 21.829999999999998 111.508 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -63.43 168.49 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.409 0.623 . . . . 20.620000000000001 111.054 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -100.67 133.98 44.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.359 -0.837 . . . . 16.559999999999999 109.568 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -109.62 78.66 1.15 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.683 -0.69 . . . . 15.050000000000001 110.203 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -59.92 -26.75 66.18 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 114.806 -1.088 . . . . 14.66 110.737 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.8 p -84.81 140.31 31.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.899 -0.591 . . . . 11.84 110.446 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.36 79.26 70.32 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.251 -0.431 . . . . 8.4399999999999995 111.815 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.68 -39.02 94.27 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.521 2.147 . . . . 7.6600000000000001 113.771 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -59.74 107.98 0.43 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 121.305 1.337 . . . . 5.6600000000000001 111.99 170.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.86 130.76 37.47 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.019 -0.537 . . . . 2.8700000000000001 110.007 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.97 -177.17 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.186 2.591 . . . . 1.8300000000000001 112.965 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -121.19 146.81 46.39 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.591 -1.186 . . . . 4.2199999999999998 111.423 -174.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.598 HG23 ' N ' ' A' ' 60' ' ' ARG . 12.0 mt -85.19 170.88 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.423 -1.262 . . . . 1.1299999999999999 111.402 -177.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.598 ' N ' HG23 ' A' ' 59' ' ' ILE . 29.1 mtt-85 -69.22 -157.94 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 113.954 -1.475 . . . . 3.1400000000000001 111.651 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.786 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 16.2 t-160 -156.46 150.6 25.25 Favored 'General case' 0 CA--C 1.467 -2.229 0 CA-C-N 112.778 -2.01 . . . . 2.7400000000000002 106.891 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.786 ' HD1' ' C ' ' A' ' 61' ' ' HIS . 1.2 m-30 -125.79 161.18 27.94 Favored 'General case' 0 N--CA 1.42 -1.94 0 O-C-N 124.005 0.816 . . . . 0.76000000000000001 110.032 -173.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 0.9 OUTLIER -81.73 67.46 7.71 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 123.578 1.656 . . . . 0.34999999999999998 107.949 170.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.707 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.8 m95 -60.03 -44.11 94.86 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 111.994 -2.366 . . . . 0.10000000000000001 112.256 174.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.538 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 12.0 t-20 -51.65 -27.12 10.52 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.163 -1.38 . . . . 1.1100000000000001 111.269 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.15 -18.21 76.9 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.033 -0.985 . . . . 0.23000000000000001 111.292 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.22 -53.9 2.91 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.026 -1.087 . . . . 1.01 111.157 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.748 ' SD ' HD22 ' A' ' 109' ' ' LEU . 41.5 mtt -63.06 -60.49 3.37 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 114.052 -1.431 . . . . 0.089999999999999997 111.967 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.538 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.6 mm-40 -38.36 -54.09 2.87 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 114.984 1.476 . . . . 0.63 114.984 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.784 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 39.2 Cg_endo -66.16 -29.14 47.85 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.702 1.601 . . . . 0.17000000000000001 110.57 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.817 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 15.6 mtm -84.48 -41.86 16.14 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.428 -0.806 . . . . 0.69999999999999996 111.818 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 68' ' ' MET . 60.7 t -57.0 -37.45 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 114.578 -1.192 . . . . 1.04 108.471 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -63.16 -33.12 74.79 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.961 -1.927 . . . . 1.1200000000000001 111.096 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.784 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.4 mtpt -83.42 -32.47 26.1 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.028 0.442 . . . . 1.8799999999999999 110.632 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.853 ' O ' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -66.03 -27.0 67.78 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.225 -0.898 . . . . 0.5 111.202 -173.05 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.531 ' N ' ' HG2' ' A' ' 75' ' ' MET . 5.9 mt -93.45 -7.29 44.9 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.951 0.882 . . . . 1.29 110.669 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.0 16.97 53.69 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 108.885 -1.686 . . . . 0.17999999999999999 108.885 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.646 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -88.07 164.57 15.67 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.523 -0.838 . . . . 1.0 110.307 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -89.2 106.66 18.59 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.978 -1.01 . . . . 1.72 109.407 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.631 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.19 -23.7 3.65 Favored Glycine 0 N--CA 1.417 -2.626 0 C-N-CA 119.69 -1.243 . . . . 0.13 110.791 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.853 HG12 ' O ' ' A' ' 75' ' ' MET . 11.4 p -100.06 153.75 4.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.787 0.803 . . . . 1.01 111.875 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -135.14 137.91 43.23 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.48 -1.236 . . . . 1.1000000000000001 110.639 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HB3' ' HE3' ' A' ' 118' ' ' LYS . . . -59.35 130.78 48.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.462 -0.79 . . . . 1.1200000000000001 110.335 167.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.91 -3.92 33.94 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.966 -0.635 . . . . 0.28000000000000003 112.77 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.98 152.03 25.62 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 120.91 0.386 . . . . 1.55 111.122 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.63 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.7 p -80.67 117.84 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-O 121.978 0.894 . . . . 1.03 109.05 165.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.75 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.3 tm? -106.16 109.57 21.55 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.166 -0.925 . . . . 1.03 108.91 -172.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.667 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.92 96.12 1.65 Allowed 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.124 -1.398 . . . . 1.01 108.163 177.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.527 HG11 ' CD1' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -71.88 120.04 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 N-CA-C 106.878 -1.527 . . . . 1.6200000000000001 106.878 177.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.751 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 10.5 t0 -77.71 155.58 31.19 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.08 -1.452 . . . . 0.64000000000000001 107.08 177.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.539 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.0 OUTLIER -59.2 136.95 58.12 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.584 -1.265 . . . . 1.05 107.584 171.728 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.571 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.7 t -63.15 139.04 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.831 0 N-CA-C 107.78 -1.193 . . . . 1.02 107.78 168.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.643 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -86.03 163.52 17.89 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.239 -0.891 . . . . 0.20000000000000001 110.083 174.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.06 85.5 2.42 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.55 -1.204 . . . . 0.12 108.22 175.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.436 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.1 mtp180 -108.92 -0.24 19.79 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.027 -1.442 . . . . 0.84999999999999998 108.746 -172.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 21.7 p -52.18 -177.01 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.21 -1.814 . . . . 0.91000000000000003 113.681 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.453 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.3 OUTLIER -73.92 -9.36 58.56 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.375 -1.738 . . . . 0.62 110.133 173.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.502 ' HA3' ' CG1' ' A' ' 169' ' ' VAL . . . -139.9 -151.63 5.69 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.852 -0.69 . . . . 0.14000000000000001 112.846 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.557 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 65.7 p -122.03 130.62 53.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.512 0.56 . . . . 1.76 112.512 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.758 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.8 pp -136.2 156.9 48.01 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.009 0.909 . . . . 1.01 111.604 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.609 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.6 t-20 -80.9 79.77 7.5 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.817 -1.538 . . . . 0.20999999999999999 107.867 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.571 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -67.52 -13.08 61.74 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.469 -1.242 . . . . 1.0 110.038 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.41 -32.72 37.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.643 -0.873 . . . . 1.02 108.643 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.609 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 6.1 tp10 -65.45 -33.81 76.82 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 122.804 1.288 . . . . 1.73 109.076 171.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -72.02 -44.08 63.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.928 -1.942 . . . . 1.04 109.51 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 61.4 m -63.65 -29.07 70.36 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.124 -1.398 . . . . 1.04 110.292 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.64 -52.37 52.39 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.185 -1.043 . . . . 1.47 108.185 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.605 HG22 ' HB2' ' A' ' 64' ' ' TRP . 39.3 m -55.44 -33.93 64.03 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.671 -0.695 . . . . 1.03 111.144 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.748 HD22 ' SD ' ' A' ' 68' ' ' MET . 8.0 mt -49.45 -69.22 0.12 Allowed 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 116.2 -0.455 . . . . 1.3 109.862 172.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.454 ' O ' ' HB3' ' A' ' 114' ' ' ALA . 13.9 mtp180 -43.31 -36.95 2.03 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.442 1.089 . . . . 1.8 110.82 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.599 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -70.83 -47.61 58.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.009 -1.451 . . . . 0.41999999999999998 111.561 -175.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . . . -72.36 -34.72 68.19 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 122.168 0.985 . . . . 1.01 108.631 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.65 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -62.34 -33.94 75.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.56 -1.655 . . . . 1.01 109.954 173.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 110' ' ' ARG . . . -75.15 -42.33 56.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 114.717 -1.129 . . . . 1.03 111.053 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -63.63 -19.28 64.74 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.825 -1.08 . . . . 1.55 110.667 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.42 -19.43 18.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.567 -0.742 . . . . 2.0499999999999998 111.565 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.04 14.19 10.26 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 115.357 0.903 . . . . 0.54000000000000004 115.357 164.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.478 ' HE3' ' HB3' ' A' ' 83' ' ' ALA . 56.8 mtpt -98.42 -2.35 39.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.268 0.534 . . . . 1.6000000000000001 109.913 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.75 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 34.8 m-85 -122.2 174.98 6.63 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.144 0.973 . . . . 0.27000000000000002 112.674 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 5.4 m -118.08 121.14 39.82 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 112.935 -1.939 . . . . 1.0800000000000001 107.742 170.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.649 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -92.31 139.47 30.58 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 119.164 -1.014 . . . . 1.1499999999999999 111.837 -169.408 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.79 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.8 m -92.71 146.97 5.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.047 -1.094 . . . . 1.0900000000000001 108.047 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.414 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 17.8 t -101.31 -173.84 2.46 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.896 -0.722 . . . . 1.8200000000000001 110.234 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -66.02 -25.2 66.96 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.901 -1.148 . . . . 1.1899999999999999 107.901 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.631 ' O ' ' HG3' ' A' ' 129' ' ' MET . 34.3 mt-30 -51.32 -39.67 57.46 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.235 -1.802 . . . . 2.04 110.525 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.79 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 6.6 mt-30 -98.47 -53.63 3.27 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 122.265 1.031 . . . . 0.42999999999999999 109.819 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.458 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 31.7 tp -60.37 -65.0 0.76 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 113.122 -1.854 . . . . 2.04 113.253 -168.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.637 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 5.6 t -50.39 -46.56 56.18 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 123.275 1.512 . . . . 1.1499999999999999 109.203 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.72 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -52.84 -63.75 1.04 Allowed 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 111.053 -2.794 . . . . 2.27 110.374 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.713 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -44.77 -46.15 10.38 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 124.574 1.171 . . . . 1.0700000000000001 112.195 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 137' ' ' SER . 0.8 OUTLIER -54.39 -51.83 63.61 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 108.835 -0.802 . . . . 2.1000000000000001 108.835 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.3 mt-30 -65.75 -38.86 90.25 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.313 -0.858 . . . . 0.42999999999999999 111.136 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.72 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.3 mt-30 -59.46 -33.84 71.8 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-N 114.486 -1.234 . . . . 0.38 109.678 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.572 HD21 ' N ' ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.43 -27.31 18.38 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.079 -1.418 . . . . 1.05 109.552 -177.241 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.78 -48.79 0.58 Allowed Glycine 0 CA--C 1.495 -1.16 0 CA-C-O 122.598 1.11 . . . . 0.33000000000000002 113.259 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.579 HD11 ' O ' ' A' ' 141' ' ' SER . 96.6 mt -64.89 -171.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.102 -2.049 . . . . 1.0700000000000001 115.716 -170.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.3 m -116.17 153.34 48.51 Favored Pre-proline 0 N--CA 1.428 -1.557 0 CA-C-N 110.705 -2.952 . . . . 1.24 107.932 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.637 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 37.1 Cg_endo -65.81 -0.37 3.81 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.611 2.207 . . . . 0.39000000000000001 112.561 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -118.41 -26.61 6.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.864 0.84 . . . . 1.79 110.704 -177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.633 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.1 t70 -56.86 -24.45 51.64 Favored 'General case' 0 CA--C 1.489 -1.366 0 CA-C-N 113.217 -1.81 . . . . 0.65000000000000002 109.677 -173.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.633 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 13.0 m 73.47 170.26 0.31 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 112.964 -1.926 . . . . 0.73999999999999999 109.434 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.751 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 3.1 mt -69.19 -39.97 78.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.369 1.08 . . . . 1.48 108.609 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.56 -12.11 0.52 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 112.94 -1.936 . . . . 0.34999999999999998 114.099 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.42 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -152.77 128.65 10.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.775 -0.631 . . . . 1.02 109.482 -175.035 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.68 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 22.5 mmt-85 -42.82 -50.1 5.7 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 118.043 0.383 . . . . 2.21 111.36 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.5 t -69.32 -27.28 65.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.456 0.646 . . . . 0.93000000000000005 111.365 -175.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.451 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 24.1 mttm -73.92 -27.63 61.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.666 1.222 . . . . 1.8899999999999999 108.663 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.614 ' CB ' HD11 ' A' ' 142' ' ' LEU . . . -79.61 -46.75 16.66 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 112.351 -2.204 . . . . 0.98999999999999999 110.586 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.542 HG13 ' HE2' ' A' ' 179' ' ' MET . 44.4 mt -65.78 -41.66 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 112.946 -1.934 . . . . 1.03 110.099 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.25 -52.37 40.94 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.743 -1.117 . . . . 0.14999999999999999 111.243 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.713 HG21 ' CB ' ' A' ' 130' ' ' ALA . 89.1 mt -68.24 -48.43 73.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 N-CA-C 112.358 0.503 . . . . 1.05 112.358 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.644 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.0 -41.31 71.12 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.948 0.404 . . . . 1.03 111.218 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.442 ' HD2' HG21 ' A' ' 149' ' ' ILE . 45.8 mtp180 -80.4 -24.26 39.82 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.597 0.713 . . . . 1.29 110.506 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.434 HD22 ' CD ' ' A' ' 133' ' ' GLN . 39.2 t30 -80.89 -14.35 58.09 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 107.641 -1.244 . . . . 0.5 107.641 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.694 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -103.2 -28.64 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.188 -1.824 . . . . 1.05 110.629 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.5 35.03 5.08 Favored Glycine 0 CA--C 1.5 -0.886 0 C-N-CA 120.153 -1.023 . . . . 0.17000000000000001 112.16 -179.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.667 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.39 158.58 17.38 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.756 0.65 . . . . 1.02 112.756 -170.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.63 ' N ' HG12 ' A' ' 86' ' ' VAL . 2.1 m80 -98.2 -28.52 13.67 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.144 -0.934 . . . . 0.39000000000000001 109.392 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.584 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 6.2 m-85 -136.12 -174.89 3.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.089 -0.959 . . . . 0.81000000000000005 111.235 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.717 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -135.67 140.23 44.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.091 -0.959 . . . . 1.03 108.71 166.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.512 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 37.6 tp -109.31 101.75 10.72 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.292 -0.963 . . . . 1.02 109.45 165.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.578 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.11 113.87 17.6 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.405 -1.27 . . . . 0.87 108.673 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.702 ' OG ' HD13 ' A' ' 109' ' ' LEU . 4.2 p -121.33 157.73 29.77 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.444 -0.798 . . . . 1.45 109.791 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.8 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.7 p -164.62 173.24 12.17 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.985 -1.007 . . . . 0.12 111.202 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.49 136.82 41.56 Favored 'General case' 0 N--CA 1.412 -2.334 0 CA-C-N 114.156 -1.384 . . . . 0.94999999999999996 108.795 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.7 t -146.06 -171.29 3.68 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.882 -0.727 . . . . 1.1499999999999999 110.345 176.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.41 -78.0 1.51 Allowed Glycine 0 C--N 1.288 -2.099 0 CA-C-N 115.283 -0.871 . . . . 0.14999999999999999 111.713 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.2 t30 -148.85 131.56 15.97 Favored 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 107.62 -1.252 . . . . 0.58999999999999997 107.62 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.542 HG21 ' N ' ' A' ' 99' ' ' SER . 3.7 p -64.38 -41.8 93.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.102 -0.953 . . . . 1.0 112.863 -172.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.47 ' N ' HG13 ' A' ' 169' ' ' VAL . 5.2 m-20 -63.91 -28.85 70.11 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.293 1.045 . . . . 1.9199999999999999 109.338 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.5 88.41 3.68 Favored Pre-proline 0 C--N 1.304 -1.374 0 CA-C-N 114.279 -1.328 . . . . 1.0600000000000001 108.456 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.648 ' HD2' HG22 ' A' ' 194' ' ' VAL . 41.3 Cg_endo -92.0 166.25 3.15 Favored 'Trans proline' 0 CA--C 1.495 -1.447 0 C-N-CA 124.341 3.361 . . . . 0.089999999999999997 114.612 -171.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.568 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 49.2 m -85.02 118.8 24.81 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 113.793 -1.549 . . . . 1.0600000000000001 107.888 166.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.817 ' O ' ' HE3' ' A' ' 71' ' ' MET . 43.9 tp -84.11 96.72 9.01 Favored 'General case' 0 N--CA 1.414 -2.239 0 C-N-CA 119.26 -0.976 . . . . 1.02 108.66 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.608 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 31.9 mt-30 -85.83 108.94 18.35 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 114.638 -1.165 . . . . 0.34000000000000002 108.558 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.583 ' SD ' ' HB3' ' A' ' 163' ' ' SER . 2.9 mmm -112.06 163.52 14.19 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.655 -1.157 . . . . 1.0900000000000001 111.047 -174.103 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.519 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 36.4 tt0 -171.48 118.75 0.45 Allowed 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 115.917 -0.583 . . . . 0.68000000000000005 109.949 -167.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.717 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -100.74 99.35 9.87 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.524 -0.917 . . . . 1.03 108.524 -173.313 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.68 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.9 ttp -88.35 118.47 28.0 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.462 -0.79 . . . . 0.89000000000000001 109.22 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.471 ' HB2' HG23 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.17 115.65 4.31 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.067 -1.457 . . . . 1.04 107.067 169.708 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.542 HG23 ' HB1' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -71.28 -36.21 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.063 0.847 . . . . 1.02 111.348 -176.006 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.448 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 32.2 mt-30 -58.78 -15.53 12.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.525 -0.761 . . . . 0.40000000000000002 111.897 -177.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.461 ' HG1' ' HG2' ' A' ' 185' ' ' GLU . 39.8 p -128.97 -37.28 1.72 Allowed 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.076 0.941 . . . . 1.03 110.02 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 180' ' ' LEU . . . 88.28 23.79 36.28 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 113.663 -1.608 . . . . 0.17999999999999999 111.793 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.461 ' HG2' ' HG1' ' A' ' 183' ' ' THR . 8.4 pt-20 -104.4 154.29 20.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.893 0.377 . . . . 0.72999999999999998 110.423 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.475 HD13 ' HG2' ' A' ' 177' ' ' GLN . 32.1 mm -87.6 116.19 29.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.53 0.681 . . . . 1.03 109.358 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.662 ' CD1' HD12 ' A' ' 178' ' ' LEU . 1.7 pp -103.49 -31.34 2.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.93 -1.032 . . . . 1.01 110.476 -173.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.646 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 79.0 t90 -135.16 153.41 51.99 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.325 -0.852 . . . . 0.070000000000000007 109.314 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.504 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 77.8 p -153.73 164.0 39.05 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.085 -0.646 . . . . 0.64000000000000001 112.697 163.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.61 -177.53 32.78 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.573 -1.011 . . . . 0.12 110.573 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.813 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 18.7 mtmm -157.98 148.2 20.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.488 -2.042 . . . . 1.76 105.488 166.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -155.65 126.89 1.92 Allowed Glycine 0 C--N 1.282 -2.445 0 C-N-CA 119.405 -1.379 . . . . 0.13 112.306 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.14 110.88 8.79 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.579 0.704 . . . . 1.01 111.094 -173.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.648 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -89.91 157.73 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.583 -1.189 . . . . 1.01 110.581 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.73 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -97.83 172.77 7.45 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 112.612 -2.085 . . . . 0.92000000000000004 108.982 -175.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.615 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 1.9 tt0 -107.48 132.38 53.28 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.933 -1.107 . . . . 0.91000000000000003 110.79 171.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.546 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 35.9 mm-40 . . . . . 0 C--O 1.247 0.957 0 CA-C-N 114.811 -1.086 . . . . 1.24 110.948 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 111.803 -0.519 . . . . 88.920000000000002 111.803 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 t 60.19 60.65 2.01 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.589 0.355 . . . . 87.459999999999994 110.733 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.2 t60 73.06 129.5 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.352 0.596 . . . . 87.5 111.962 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.458 ' C ' ' H ' ' A' ' 6' ' ' GLY . 26.6 ptt? -61.03 148.98 38.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.668 -0.696 . . . . 85.340000000000003 110.928 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 4' ' ' MET . 0.4 OUTLIER 64.88 -4.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 123.877 0.871 . . . . 85.230000000000004 112.322 -175.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.458 ' H ' ' C ' ' A' ' 4' ' ' MET . . . 63.96 30.58 78.14 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 116.085 -0.507 . . . . 84.849999999999994 113.661 172.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.547 ' HG2' ' H ' ' A' ' 8' ' ' ARG . 52.5 tt0 69.11 -179.77 0.23 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 110.149 -0.315 . . . . 85.599999999999994 110.149 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.547 ' H ' ' HG2' ' A' ' 7' ' ' GLN . 62.4 mtp85 64.62 56.71 1.17 Allowed 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.939 0.876 . . . . 85.310000000000002 109.106 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.464 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 8.4 pt-20 -116.2 138.08 23.96 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 114.163 -1.381 . . . . 82.170000000000002 110.425 -175.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 3.4 Cg_exo -79.6 172.87 13.76 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.526 2.15 . . . . 82.069999999999993 112.723 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.36 166.64 11.53 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.639 -0.709 . . . . 79.709999999999994 109.351 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.84 141.86 34.65 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.246 1.964 . . . . 79.019999999999996 112.126 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.51 148.54 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.341 0.591 . . . . 77.260000000000005 111.745 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.79 -15.75 16.16 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.326 -0.852 . . . . 75.739999999999995 110.202 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -80.64 94.08 6.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.356 -0.838 . . . . 74.010000000000005 110.85 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -77.62 111.59 14.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.536 -0.756 . . . . 72.569999999999993 109.866 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -76.21 112.32 20.26 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.939 -0.573 . . . . 71.379999999999995 109.474 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.53 33.19 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.064 2.509 . . . . 70.189999999999998 113.102 -172.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.35 85.46 0.19 Allowed Pre-proline 0 C--O 1.233 0.237 0 O-C-N 123.755 0.659 . . . . 67.769999999999996 111.954 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.75 46.95 2.02 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.625 2.217 . . . . 67.180000000000007 111.749 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -96.1 149.79 21.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.771 -0.649 . . . . 65.200000000000003 110.69 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -79.69 134.32 57.68 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.051 -0.522 . . . . 63.460000000000001 110.246 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -56.75 144.19 87.73 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.472 2.781 . . . . 62.479999999999997 113.53 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -145.29 136.47 24.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.663 -0.699 . . . . 59.869999999999997 110.297 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 60.28 89.75 0.1 Allowed Pre-proline 0 N--CA 1.465 0.303 0 O-C-N 123.86 0.725 . . . . 58.890000000000001 111.825 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.23 -9.18 16.47 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.547 2.165 . . . . 57.890000000000001 112.667 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.564 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 15.5 mm100 62.57 46.61 5.43 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.981 -1.009 . . . . 55.729999999999997 112.53 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -97.43 103.89 17.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.013 0.435 . . . . 54.079999999999998 111.228 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.564 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 1.6 Cg_endo -82.36 81.85 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.616 2.211 . . . . 53.299999999999997 111.048 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.53 132.66 85.49 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.912 -0.586 . . . . 51.130000000000003 111.74 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.61 94.89 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.582 2.188 . . . . 49.75 111.86 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 p -87.32 158.05 19.14 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.094 -0.503 . . . . 47.700000000000003 111.847 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p 44.26 92.34 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 124.853 1.261 . . . . 46.109999999999999 113.43 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -57.56 165.02 6.55 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.546 2.831 . . . . 45.890000000000001 113.13 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.2 t -92.16 153.99 18.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.202 -0.908 . . . . 43.0 109.78 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 m -81.67 116.59 64.01 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-N 115.938 -0.573 . . . . 40.789999999999999 111.405 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.17 -27.0 7.08 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.024 2.483 . . . . 40.450000000000003 111.328 174.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 m -67.55 139.48 56.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.113 -0.949 . . . . 37.729999999999997 111.294 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 mt -97.36 107.35 38.18 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.719 -0.673 . . . . 35.990000000000002 110.169 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.78 -71.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.873 2.382 . . . . 34.350000000000001 112.395 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 46.54 75.95 0.11 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.548 0.53 . . . . 31.780000000000001 112.017 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -64.25 141.37 98.12 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.751 -0.659 . . . . 30.390000000000001 111.216 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.68 158.75 39.4 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.416 2.077 . . . . 29.940000000000001 111.481 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.95 172.38 29.53 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.498 -0.858 . . . . 26.75 112.093 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.85 160.39 49.53 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.028 2.486 . . . . 25.879999999999999 112.007 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.4 mm -58.25 -61.15 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.759 0.314 . . . . 24.16 110.85 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 53.18 82.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.959 -1.019 . . . . 21.829999999999998 111.198 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -84.17 174.39 10.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.218 0.532 . . . . 20.620000000000001 110.439 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -121.64 138.82 54.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.559 -0.746 . . . . 16.559999999999999 109.456 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -111.47 70.47 0.71 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.428 0.632 . . . . 15.050000000000001 110.439 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -133.96 76.05 1.63 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.441 -1.254 . . . . 14.66 108.81 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.2 p -62.49 149.96 41.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.686 -0.688 . . . . 11.84 111.515 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.79 110.64 15.9 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.715 -0.675 . . . . 8.4399999999999995 111.728 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.79 141.95 87.0 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.884 2.389 . . . . 7.6600000000000001 110.655 172.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.14 116.74 2.63 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.827 2.352 . . . . 5.6600000000000001 113.297 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.508 ' N ' ' HD2' ' A' ' 57' ' ' PRO . . . -64.62 -50.19 66.31 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.664 -0.244 . . . . 2.8700000000000001 111.157 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.508 ' HD2' ' N ' ' A' ' 56' ' ' ALA . 74.1 Cg_endo -68.26 -177.72 1.51 Allowed 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.366 2.044 . . . . 1.8300000000000001 112.337 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -115.1 142.68 46.32 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.723 -1.126 . . . . 4.2199999999999998 111.082 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.614 HG23 ' N ' ' A' ' 60' ' ' ARG . 10.7 mt -87.01 170.36 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.148 -0.933 . . . . 1.1299999999999999 111.844 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.614 ' N ' HG23 ' A' ' 59' ' ' ILE . 31.2 mtt85 -66.5 -158.22 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.462 -1.699 . . . . 3.1400000000000001 112.218 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.673 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 22.4 t-160 -157.66 148.35 21.05 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 112.43 -2.168 . . . . 2.7400000000000002 106.567 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.742 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 -125.51 162.4 24.99 Favored 'General case' 0 N--CA 1.42 -1.944 0 O-C-N 123.616 0.572 . . . . 0.76000000000000001 109.914 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.484 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 10.9 t70 -84.05 67.35 9.64 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 123.492 1.615 . . . . 0.34999999999999998 108.125 170.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.731 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 91.1 m95 -58.96 -43.91 91.38 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 111.678 -2.51 . . . . 0.10000000000000001 112.437 175.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.501 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 11.8 t-20 -50.56 -28.59 8.93 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.879 -1.51 . . . . 1.1100000000000001 111.415 174.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.08 -17.78 79.81 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.341 -0.845 . . . . 0.23000000000000001 111.215 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.62 -54.31 2.78 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.863 -1.168 . . . . 1.01 111.125 -175.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.757 ' SD ' HD23 ' A' ' 109' ' ' LEU . 40.1 mtt -62.59 -59.5 4.85 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 114.177 -1.374 . . . . 0.089999999999999997 112.105 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.501 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 6.2 mm-40 -37.33 -55.31 1.86 Allowed Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 115.276 1.584 . . . . 0.63 115.276 -177.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.777 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.3 Cg_endo -65.73 -29.74 50.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.648 1.565 . . . . 0.17000000000000001 110.458 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.936 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 13.0 mtm -83.91 -41.43 17.4 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 115.447 -0.797 . . . . 0.69999999999999996 111.541 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.666 HG21 ' O ' ' A' ' 68' ' ' MET . 58.8 t -55.97 -39.1 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 CA-C-N 114.718 -1.128 . . . . 1.04 108.812 171.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.2 t -61.74 -34.35 75.68 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.393 -1.73 . . . . 1.1200000000000001 110.813 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.777 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.2 mtpt -81.67 -33.93 31.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.073 -0.512 . . . . 1.8799999999999999 110.464 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.872 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.72 -28.67 69.74 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.406 -0.815 . . . . 0.5 111.637 -171.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.554 ' N ' ' HG2' ' A' ' 75' ' ' MET . 5.5 mt -92.81 -4.84 52.31 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.081 0.943 . . . . 1.29 111.133 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.68 15.9 44.65 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 108.914 -1.674 . . . . 0.17999999999999999 108.914 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.639 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.47 165.62 17.0 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.386 -0.907 . . . . 1.0 109.869 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -92.97 104.91 17.09 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.277 -0.874 . . . . 1.72 110.303 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.643 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.82 -23.72 3.36 Favored Glycine 0 N--CA 1.428 -1.886 0 CA-C-N 115.018 -0.992 . . . . 0.13 110.69 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 75' ' ' MET . 9.9 p -98.76 155.46 3.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.748 0.785 . . . . 1.01 111.444 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.8 m -134.54 135.75 42.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.604 -1.18 . . . . 1.1000000000000001 111.034 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.442 ' HB1' ' HE3' ' A' ' 118' ' ' LYS . . . -60.23 129.31 41.07 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.222 -0.899 . . . . 1.1200000000000001 109.728 165.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.32 6.0 53.8 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.78 -0.724 . . . . 0.28000000000000003 112.938 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.493 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 65.7 m -98.12 146.93 25.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 120.719 -0.392 . . . . 1.55 110.51 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.652 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -76.8 132.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.029 -0.73 . . . . 1.03 109.029 172.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.791 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.6 tm? -119.12 110.01 16.56 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.603 -0.726 . . . . 1.03 109.084 -170.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.645 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.7 OUTLIER -71.77 93.99 1.34 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.815 -1.18 . . . . 1.01 107.815 175.991 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.463 HG23 ' CD1' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -73.23 115.29 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.435 -1.32 . . . . 1.6200000000000001 107.435 176.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.809 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 12.3 t0 -77.74 170.92 15.76 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 114.997 -1.001 . . . . 0.64000000000000001 109.009 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.561 ' OG ' ' HE3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -62.48 152.92 33.16 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 122.42 1.105 . . . . 1.05 108.668 168.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.579 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 33.9 t -81.64 139.31 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.067 0 N-CA-C 106.985 -1.487 . . . . 1.02 106.985 166.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.66 ' H ' ' HA ' ' A' ' 164' ' ' SER . 8.0 t-20 -83.65 163.35 20.37 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.922 0.867 . . . . 0.20000000000000001 110.498 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.765 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.2 t-20 -125.71 86.27 2.51 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.208 -1.36 . . . . 0.12 108.124 175.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 mtp180 -108.72 -2.03 18.94 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.124 -1.398 . . . . 0.84999999999999998 108.724 -173.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.621 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 27.5 p -52.18 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 112.998 -1.91 . . . . 0.91000000000000003 115.39 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 35.4 t30 -69.9 -9.71 55.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 112.762 -2.017 . . . . 0.62 110.492 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.533 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -153.27 -144.77 3.99 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.519 -0.848 . . . . 0.14000000000000001 113.123 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.595 ' N ' HG23 ' A' ' 169' ' ' VAL . 86.7 p -121.81 129.89 52.98 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.444 0.64 . . . . 1.76 112.725 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.4 pp -135.52 156.51 48.78 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.923 0.868 . . . . 1.01 110.852 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.622 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -80.95 79.44 7.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.961 -1.472 . . . . 0.20999999999999999 107.889 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -67.73 -14.28 62.81 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.433 -1.258 . . . . 1.0 109.96 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.73 -30.48 36.25 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.555 -0.906 . . . . 1.02 108.555 -177.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.622 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.4 tp10 -66.21 -35.11 79.59 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.378 -1.283 . . . . 1.73 109.153 170.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -70.82 -43.86 67.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.107 -1.861 . . . . 1.04 109.369 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.659 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 63.0 m -61.77 -31.84 72.07 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 113.532 -1.667 . . . . 1.04 110.135 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.73 -46.77 77.64 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.843 -0.799 . . . . 1.47 108.843 171.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.617 HG23 ' HB2' ' A' ' 64' ' ' TRP . 50.9 m -60.19 -31.04 69.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.345 -0.843 . . . . 1.03 110.91 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.757 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -51.96 -68.15 0.19 Allowed 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.749 -0.66 . . . . 1.3 110.361 172.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.455 ' O ' HD12 ' A' ' 121' ' ' LEU . 6.1 mpt_? -40.55 -37.36 0.7 Allowed 'General case' 0 C--O 1.213 -0.844 0 O-C-N 124.387 1.054 . . . . 1.8 110.456 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.591 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -72.49 -46.8 53.07 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.304 -1.316 . . . . 0.41999999999999998 111.79 -174.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.413 ' HB2' ' HG2' ' A' ' 69' ' ' GLN . . . -73.21 -33.51 65.41 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.069 0.938 . . . . 1.01 108.718 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.679 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.69 -34.62 78.27 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.746 -1.57 . . . . 1.01 109.886 172.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.424 ' HB2' ' O ' ' A' ' 110' ' ' ARG . . . -72.99 -40.51 65.17 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.696 -1.138 . . . . 1.03 111.096 -176.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -61.89 -25.53 67.62 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.854 -1.067 . . . . 1.55 110.69 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -92.52 -20.24 21.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.003 -0.544 . . . . 2.0499999999999998 111.467 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.9 0.78 4.38 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 115.693 1.037 . . . . 0.54000000000000004 115.693 162.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.452 ' HD3' HD11 ' A' ' 76' ' ' LEU . 53.0 mtpt -78.84 -33.99 45.52 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 117.395 0.598 . . . . 1.6000000000000001 109.812 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.791 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 19.0 m-85 -89.44 177.81 6.48 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-O 122.23 1.014 . . . . 0.27000000000000002 112.298 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.47 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.4 m -122.41 119.28 30.56 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 113.103 -1.862 . . . . 1.0800000000000001 108.31 167.162 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.662 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -86.92 145.43 26.55 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.448 -0.796 . . . . 1.1499999999999999 111.317 -170.928 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.568 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.9 m -92.74 152.42 3.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.364 -0.835 . . . . 1.0900000000000001 109.175 169.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.454 ' CB ' ' HG2' ' A' ' 125' ' ' GLN . 4.8 m -101.2 163.15 12.42 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.32 1.057 . . . . 1.8200000000000001 110.416 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -67.15 -22.92 65.75 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 113.027 -1.897 . . . . 1.1899999999999999 110.545 -176.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 129' ' ' MET . 4.4 pt20 -53.74 -32.06 50.73 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 125.039 1.462 . . . . 2.04 109.668 170.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.568 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 7.7 mt-30 -98.05 -53.79 3.27 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 114.593 -1.185 . . . . 0.42999999999999999 110.976 172.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.547 ' CD2' ' HE2' ' A' ' 131' ' ' LYS . 1.5 tm? -69.49 -64.6 0.85 Allowed 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 114.572 -1.195 . . . . 2.04 113.205 -166.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.648 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.3 t -49.54 -38.39 30.68 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 123.645 1.688 . . . . 1.1499999999999999 109.189 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.644 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 33.7 mmm -64.02 -63.08 1.25 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 110.705 -2.952 . . . . 2.27 111.191 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.672 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.26 -43.49 3.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 124.31 1.006 . . . . 1.0700000000000001 111.442 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.561 ' HE3' ' OG ' ' A' ' 91' ' ' SER . 3.7 mptp? -48.38 -65.57 0.54 Allowed 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.541 -0.541 . . . . 2.1000000000000001 109.541 174.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.444 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.1 mt-30 -55.2 -44.61 75.52 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.828 -1.078 . . . . 0.42999999999999999 111.71 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.644 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.0 mt-30 -55.67 -36.0 66.62 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 114.745 -1.116 . . . . 0.38 110.022 -177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.18 -31.34 16.23 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.118 -1.401 . . . . 1.05 109.285 -176.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.33 -48.32 0.43 Allowed Glycine 0 CA--C 1.496 -1.136 0 C-N-CA 119.801 -1.19 . . . . 0.33000000000000002 113.632 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 141' ' ' SER . 35.4 mt -66.24 -174.2 0.25 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 123.923 1.82 . . . . 1.0700000000000001 115.781 -168.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.502 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.6 m -110.03 148.64 38.7 Favored Pre-proline 0 N--CA 1.421 -1.924 0 CA-C-N 110.791 -2.913 . . . . 1.24 108.33 169.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.648 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 17.9 Cg_endo -61.38 0.4 1.03 Allowed 'Trans proline' 0 C--N 1.333 -0.255 0 C-N-CA 123.163 2.575 . . . . 0.39000000000000001 112.801 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.477 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.7 tt0 -117.9 -24.11 7.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.185 0.993 . . . . 1.79 110.424 -177.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.642 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.8 t70 -64.61 -22.56 67.0 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 113.213 -1.812 . . . . 0.65000000000000002 109.719 -174.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.642 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 2.0 m 74.83 173.24 0.27 Allowed 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 125.322 1.639 . . . . 0.73999999999999999 109.652 -173.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.809 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 4.3 mt -64.72 -38.85 92.38 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.281 -1.007 . . . . 1.48 108.281 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.462 ' C ' ' HG1' ' A' ' 144' ' ' THR . . . 69.38 -11.82 1.48 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 113.327 -1.76 . . . . 0.34999999999999998 114.417 176.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.462 ' HG1' ' C ' ' A' ' 143' ' ' GLY . 0.8 OUTLIER -157.19 130.22 7.73 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 118.672 -0.68 . . . . 1.02 109.276 -178.036 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.624 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.1 mmt85 -43.29 -48.68 6.8 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 118.008 0.367 . . . . 2.21 111.554 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 16.6 t -72.13 -24.93 61.54 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.531 0.681 . . . . 0.93000000000000005 111.202 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.412 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 25.3 mttm -74.6 -30.68 61.76 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.66 1.219 . . . . 1.8899999999999999 108.773 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.681 ' HB3' ' OH ' ' A' ' 162' ' ' TYR . . . -74.82 -46.2 38.2 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-N 112.411 -2.177 . . . . 0.98999999999999999 110.236 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.555 HG13 ' HE3' ' A' ' 179' ' ' MET . 38.8 mt -67.53 -41.96 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 112.633 -2.076 . . . . 1.03 109.821 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.48 -53.85 30.06 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.71 -1.132 . . . . 0.14999999999999999 111.012 171.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.725 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 76.2 mt -66.96 -47.85 81.18 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 N-CA-C 112.641 0.608 . . . . 1.05 112.641 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.645 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.29 -39.95 73.53 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.984 0.421 . . . . 1.03 111.02 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.452 ' HD2' HG21 ' A' ' 149' ' ' ILE . 45.5 mtp180 -82.59 -21.8 35.05 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.827 0.822 . . . . 1.29 110.343 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -82.82 -11.27 58.38 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.267 -1.382 . . . . 0.5 107.267 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.725 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.15 -29.66 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-N 113.143 -1.844 . . . . 1.05 111.111 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.23 35.88 4.32 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.414 -0.898 . . . . 0.17000000000000001 112.767 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.625 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.19 157.98 19.45 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.192 0.812 . . . . 1.02 113.192 -170.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.652 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.9 m80 -97.32 -25.97 15.06 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.27 -0.877 . . . . 0.39000000000000001 109.861 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.643 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 15.4 m-85 -136.12 -178.32 5.1 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.312 -0.858 . . . . 0.81000000000000005 111.584 -174.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.598 ' O ' HD21 ' A' ' 178' ' ' LEU . 1.2 t -133.37 141.53 44.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.1 -0.955 . . . . 1.03 109.202 167.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.561 HD23 ' HE1' ' A' ' 176' ' ' MET . 46.7 tp -111.43 102.26 10.64 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.628 -0.829 . . . . 1.02 109.255 164.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.681 ' OH ' ' HB3' ' A' ' 148' ' ' ALA . 1.8 m-85 -80.21 112.64 17.72 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.241 -1.345 . . . . 0.87 109.198 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.691 ' OG ' HD12 ' A' ' 109' ' ' LEU . 3.8 p -119.15 158.12 26.57 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.959 0.885 . . . . 1.45 111.489 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.798 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.4 p -164.22 171.64 14.69 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-N 114.251 -1.341 . . . . 0.12 111.255 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.14 134.91 33.49 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 114.118 -1.401 . . . . 0.94999999999999996 108.658 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.621 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.9 m -144.74 -173.79 4.16 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.295 -0.631 . . . . 1.1499999999999999 109.295 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.54 -82.43 0.94 Allowed Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.616 -1.278 . . . . 0.14999999999999999 111.279 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.482 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 59.8 t30 -145.78 129.16 16.86 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 107.653 -1.24 . . . . 0.58999999999999997 107.653 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.595 HG23 ' N ' ' A' ' 99' ' ' SER . 3.3 p -65.03 -42.51 94.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.447 -0.797 . . . . 1.0 112.552 -171.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.471 ' N ' HG12 ' A' ' 169' ' ' VAL . 7.4 m120 -60.66 -30.28 69.8 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.784 0.802 . . . . 1.9199999999999999 110.087 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.01 89.26 3.41 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 113.645 -1.616 . . . . 1.0600000000000001 108.557 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.659 ' HD2' HG22 ' A' ' 194' ' ' VAL . 43.1 Cg_endo -91.85 165.53 3.27 Favored 'Trans proline' 0 CA--C 1.496 -1.402 0 C-N-CA 124.678 3.586 . . . . 0.089999999999999997 115.301 -170.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.578 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.5 m -84.11 116.96 23.15 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 113.88 -1.509 . . . . 1.0600000000000001 107.83 166.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.825 ' O ' ' HE3' ' A' ' 71' ' ' MET . 43.9 tp -84.22 98.12 9.78 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.988 0.899 . . . . 1.02 109.25 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.581 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 35.4 mt-30 -87.11 108.32 18.84 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 114.586 -1.188 . . . . 0.34000000000000002 108.925 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.936 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 76.6 mtp -107.29 162.63 13.72 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.827 -1.079 . . . . 1.0900000000000001 110.357 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.514 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 57.4 tt0 -169.71 119.54 0.65 Allowed 'General case' 0 C--O 1.202 -1.411 0 CA-C-O 121.309 0.576 . . . . 0.68000000000000005 109.904 -169.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.598 HD21 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -101.11 101.98 12.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.001 -0.74 . . . . 1.03 109.001 -172.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.624 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.7 ttp -92.47 121.98 34.46 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.557 -0.747 . . . . 0.89000000000000001 109.407 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.3 128.44 37.0 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.285 -1.376 . . . . 1.04 107.285 166.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -84.66 -34.09 9.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 119.096 -1.042 . . . . 1.02 110.738 178.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.439 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 27.3 mt-30 -61.2 -16.31 43.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.371 -0.832 . . . . 0.40000000000000002 111.388 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.7 p -130.53 -37.49 1.38 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.505 0.669 . . . . 1.03 110.247 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.403 ' CA ' HD12 ' A' ' 149' ' ' ILE . . . 90.95 24.59 27.0 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.641 -1.163 . . . . 0.17999999999999999 112.479 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 179' ' ' MET . 10.4 pt-20 -103.81 157.78 16.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.654 -0.273 . . . . 0.72999999999999998 110.863 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.462 HD11 ' HG2' ' A' ' 177' ' ' GLN . 36.3 mm -93.04 114.19 29.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.574 0.702 . . . . 1.03 109.375 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.643 ' HB ' ' HA3' ' A' ' 80' ' ' GLY . 1.3 pp -102.38 -30.75 2.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.996 -1.002 . . . . 1.01 110.816 -174.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.639 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.3 t90 -135.43 152.11 51.07 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.274 -0.876 . . . . 0.070000000000000007 109.547 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 61.9 p -153.71 164.21 38.7 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.915 0.709 . . . . 0.64000000000000001 112.915 163.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.18 -178.69 32.44 Favored Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 110.927 -0.869 . . . . 0.12 110.927 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.794 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 12.0 mtmt -157.05 148.02 21.76 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.207 -1.775 . . . . 1.76 106.207 166.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -159.29 127.51 1.85 Allowed Glycine 0 C--N 1.28 -2.529 0 C-N-CA 119.769 -1.205 . . . . 0.13 112.343 -178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.82 114.79 11.35 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.659 0.742 . . . . 1.01 111.108 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.721 HG11 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -90.6 158.96 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 122.718 1.247 . . . . 1.01 110.476 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.742 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -101.43 172.08 7.19 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.399 -2.182 . . . . 0.92000000000000004 108.445 -175.014 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.577 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.3 tt0 -101.26 135.79 42.15 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.201 -0.6 . . . . 0.91000000000000003 109.633 172.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.549 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 23.0 mt-30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.424 -0.798 . . . . 1.24 110.927 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.933 -0.467 . . . . 88.920000000000002 111.933 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.1 m 57.11 61.8 2.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.475 0.655 . . . . 87.459999999999994 111.258 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.9 m80 56.08 62.71 2.26 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 114.566 -1.197 . . . . 87.5 110.572 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.506 ' O ' HG11 ' A' ' 5' ' ' VAL . 16.9 tpt -58.06 142.42 46.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.564 -0.289 . . . . 85.340000000000003 111.136 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.506 HG11 ' O ' ' A' ' 4' ' ' MET . 0.3 OUTLIER 59.83 0.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.481 1.112 . . . . 85.230000000000004 113.111 179.049 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.07 20.01 51.19 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.851 -0.69 . . . . 84.849999999999994 111.903 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 64.25 -166.6 0.22 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 122.797 0.439 . . . . 85.599999999999994 111.074 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 59.3 66.29 1.05 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.376 0.608 . . . . 85.310000000000002 111.058 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.481 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 18.6 mm-40 -62.66 -42.91 81.85 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.051 -0.977 . . . . 82.170000000000002 111.373 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.481 ' HD2' ' N ' ' A' ' 9' ' ' GLU . 43.7 Cg_endo -71.64 122.01 8.19 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.198 1.265 . . . . 82.069999999999993 110.964 167.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.46 ' HB3' ' HD3' ' A' ' 12' ' ' PRO . . . -153.18 -60.16 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.726 -0.39 . . . . 79.709999999999994 111.927 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 11' ' ' ALA . 73.7 Cg_endo -74.75 150.54 39.6 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.284 1.322 . . . . 79.019999999999996 112.196 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.6 153.82 4.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.862 0.363 . . . . 77.260000000000005 110.227 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -82.83 74.1 9.81 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.155 -0.683 . . . . 75.739999999999995 109.155 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.44 140.83 57.05 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.383 -0.826 . . . . 74.010000000000005 110.978 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.47 149.42 7.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.687 -0.688 . . . . 72.569999999999993 110.61 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -60.95 103.4 0.37 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.675 -0.693 . . . . 71.379999999999995 109.772 174.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -85.87 137.24 5.46 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.702 2.268 . . . . 70.189999999999998 113.605 -169.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.07 127.92 19.33 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.687 -0.688 . . . . 67.769999999999996 109.708 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.38 140.18 39.76 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.262 1.975 . . . . 67.180000000000007 112.166 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -85.05 -164.55 1.01 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.254 -0.43 . . . . 65.200000000000003 110.588 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 49.33 73.23 1.03 Allowed Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 113.029 0.751 . . . . 63.460000000000001 113.029 169.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -66.09 162.87 33.72 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.053 2.502 . . . . 62.479999999999997 111.089 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.475 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . -68.45 85.61 0.28 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.001 0.429 . . . . 59.869999999999997 110.327 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -114.59 88.39 16.03 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.414 -0.812 . . . . 58.890000000000001 110.796 -174.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 24' ' ' ALA . 9.7 Cg_endo -91.13 -172.43 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.849 2.366 . . . . 57.890000000000001 112.497 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -134.09 22.74 3.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.586 0.708 . . . . 55.729999999999997 110.008 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.537 ' HA ' HE21 ' A' ' 28' ' ' GLN . 0.0 OUTLIER -154.97 120.93 2.66 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.411 -0.813 . . . . 54.079999999999998 109.974 -179.204 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.81 -145.9 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.577 2.185 . . . . 53.299999999999997 110.924 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.48 111.46 5.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.743 0.306 . . . . 51.130000000000003 110.352 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.51 72.73 5.9 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.881 2.387 . . . . 49.75 112.38 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 p -133.6 152.38 51.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.05 -0.523 . . . . 47.700000000000003 110.985 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 t -115.06 85.5 12.32 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.878 -0.601 . . . . 46.109999999999999 109.743 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.39 162.14 18.34 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.989 2.459 . . . . 45.890000000000001 113.334 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.8 p -94.57 151.88 18.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.219 -0.901 . . . . 43.0 110.654 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.1 t -76.24 115.71 49.51 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.516 -0.766 . . . . 40.789999999999999 109.909 175.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -73.09 -33.76 7.08 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.338 2.025 . . . . 40.450000000000003 112.695 -178.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -75.42 140.8 43.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.403 0.62 . . . . 37.729999999999997 110.9 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.9 mt -105.94 130.78 22.46 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.532 -0.758 . . . . 35.990000000000002 109.922 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.88 64.96 6.84 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.457 2.105 . . . . 34.350000000000001 111.82 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -67.59 -46.9 71.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.245 -0.434 . . . . 31.780000000000001 110.67 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 61.53 84.91 0.19 Allowed Pre-proline 0 C--O 1.237 0.405 0 CA-C-N 115.987 -0.551 . . . . 30.390000000000001 110.527 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.47 133.38 25.94 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.016 2.477 . . . . 29.940000000000001 111.781 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.56 174.08 23.61 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.939 -0.648 . . . . 26.75 111.931 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.22 136.11 36.43 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.113 2.542 . . . . 25.879999999999999 112.284 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.2 mt -90.04 -70.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.293 -0.412 . . . . 24.16 110.13 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 54.35 86.96 0.05 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.569 -0.741 . . . . 21.829999999999998 112.598 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -94.68 173.27 7.69 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.411 -0.516 . . . . 20.620000000000001 110.172 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -138.97 177.31 7.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.853 -0.612 . . . . 16.559999999999999 110.731 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -123.18 32.49 5.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.806 0.812 . . . . 15.050000000000001 110.96 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 64.55 -171.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.788 -1.551 . . . . 14.66 110.715 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.573 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 27.0 p -136.53 153.01 51.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.172 -0.467 . . . . 11.84 110.025 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -112.32 89.47 12.41 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 8.4399999999999995 111.356 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 52' ' ' THR . 55.3 Cg_endo -103.06 89.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.079 3.186 . . . . 7.6600000000000001 112.373 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 83.9 Cg_endo -85.9 -154.88 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.702 2.268 . . . . 5.6600000000000001 111.198 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.75 112.56 3.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 2.8700000000000001 110.447 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.33 -176.48 2.95 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.209 2.606 . . . . 1.8300000000000001 113.496 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -122.11 146.7 46.96 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.906 -1.497 . . . . 4.2199999999999998 108.668 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.616 HG21 ' N ' ' A' ' 60' ' ' ARG . 11.7 mt -81.0 165.51 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.77 0.795 . . . . 1.1299999999999999 111.673 -174.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.616 ' N ' HG21 ' A' ' 59' ' ' ILE . 50.9 mtt-85 -74.6 -155.95 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.736 -1.575 . . . . 3.1400000000000001 112.187 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.64 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 18.2 t-160 -157.63 147.46 20.33 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-N 111.887 -2.415 . . . . 2.7400000000000002 106.174 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.772 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.4 m-30 -125.46 160.86 28.42 Favored 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 123.812 0.695 . . . . 0.76000000000000001 109.73 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 1.7 t70 -80.68 67.92 6.72 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 123.593 1.663 . . . . 0.34999999999999998 107.95 171.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.693 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.9 m95 -59.51 -44.5 93.12 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 111.643 -2.526 . . . . 0.10000000000000001 112.497 175.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.513 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 10.3 t-20 -51.92 -28.99 18.24 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.055 -1.43 . . . . 1.1100000000000001 111.281 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.19 -16.91 80.35 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.326 -0.852 . . . . 0.23000000000000001 111.144 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.31 -52.78 3.17 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.109 -1.046 . . . . 1.01 111.008 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.72 ' SD ' HD23 ' A' ' 109' ' ' LEU . 43.3 mtt -62.36 -60.32 3.73 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 114.213 -1.358 . . . . 0.089999999999999997 112.179 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.513 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 6.2 mm-40 -38.76 -53.19 3.47 Favored Pre-proline 0 C--O 1.225 -0.211 0 N-CA-C 115.554 1.687 . . . . 0.63 115.554 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.505 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 49.8 Cg_endo -66.98 -25.91 44.14 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.784 1.656 . . . . 0.17000000000000001 110.746 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.901 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 12.4 mtm -88.05 -43.26 11.84 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.956 -1.02 . . . . 0.69999999999999996 111.978 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 68' ' ' MET . 65.6 t -53.63 -40.43 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 CA-C-N 114.439 -1.255 . . . . 1.04 108.71 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.4 t -57.29 -39.6 76.05 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.005 -1.907 . . . . 1.1200000000000001 110.954 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 25.4 mtmt -77.49 -31.79 53.86 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.024 0.379 . . . . 1.8799999999999999 112.024 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.875 ' O ' HG13 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -65.26 -26.68 68.2 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.545 -0.752 . . . . 0.5 111.559 -169.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.516 ' N ' ' HG2' ' A' ' 75' ' ' MET . 4.6 mt -94.48 -5.52 45.96 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 122.052 0.93 . . . . 1.29 111.157 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.43 15.18 50.33 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 109.004 -1.638 . . . . 0.17999999999999999 109.004 170.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.632 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.74 165.54 17.74 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.426 -0.887 . . . . 1.0 110.235 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -91.4 103.33 15.97 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.06 -0.973 . . . . 1.72 110.601 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.622 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.96 -21.97 3.48 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.56 -1.016 . . . . 0.13 110.56 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 75' ' ' MET . 11.9 p -101.36 152.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.746 0.784 . . . . 1.01 110.993 -176.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.3 m -135.93 141.0 44.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.724 -1.125 . . . . 1.1000000000000001 110.653 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.505 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -57.2 129.46 41.87 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.122 -0.944 . . . . 1.1200000000000001 110.838 168.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.52 14.16 24.41 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.101 -0.571 . . . . 0.28000000000000003 112.943 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.21 152.42 18.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.515 -0.474 . . . . 1.55 110.941 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.64 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.7 p -81.32 115.2 23.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.981 0.896 . . . . 1.03 109.081 166.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.686 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -102.77 109.11 20.58 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.236 -0.893 . . . . 1.03 109.099 -172.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.672 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.61 96.38 1.55 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.21 -1.359 . . . . 1.01 108.318 176.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.505 HG11 ' CD1' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -71.8 121.16 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 106.852 -1.536 . . . . 1.6200000000000001 106.852 177.459 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.812 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 9.5 t0 -77.54 156.5 30.91 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.268 -1.382 . . . . 0.64000000000000001 107.268 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.549 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.57 138.04 57.83 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.061 -1.459 . . . . 1.05 107.061 171.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.587 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 21.8 t -64.49 137.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.073 0 N-CA-C 107.658 -1.238 . . . . 1.02 107.658 168.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.633 ' H ' ' HA ' ' A' ' 164' ' ' SER . 5.1 t-20 -83.97 161.33 20.81 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.234 -0.894 . . . . 0.20000000000000001 109.614 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.766 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 1.9 t-20 -124.52 85.13 2.37 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.675 -1.148 . . . . 0.12 108.083 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.521 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.8 mtp180 -108.6 -1.96 19.17 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 113.756 -1.565 . . . . 0.84999999999999998 108.502 -172.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.645 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 18.1 p -52.94 -172.77 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.044 -1.889 . . . . 0.91000000000000003 115.074 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 167' ' ' GLY . 58.8 t30 -71.59 -5.19 31.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.643 -2.072 . . . . 0.62 110.828 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.542 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -156.38 -143.95 3.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.671 -0.776 . . . . 0.14000000000000001 112.807 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.597 ' N ' HG23 ' A' ' 169' ' ' VAL . 55.6 p -122.19 130.56 53.32 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.178 0.436 . . . . 1.76 112.178 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.766 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.2 pp -136.22 157.37 46.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.858 0.837 . . . . 1.01 110.863 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.616 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.15 79.44 7.81 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.85 -1.523 . . . . 0.20999999999999999 107.631 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 92' ' ' VAL . . . -68.33 -14.07 62.73 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.511 -1.222 . . . . 1.0 109.915 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.66 -32.74 41.6 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.672 -0.862 . . . . 1.02 108.672 -178.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.616 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.9 tp10 -65.94 -33.27 75.45 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 122.767 1.27 . . . . 1.73 108.943 171.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.46 -43.92 63.06 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 113.078 -1.874 . . . . 1.04 109.5 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.63 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 67.1 m -64.01 -31.43 72.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.115 -1.402 . . . . 1.04 110.476 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -42.69 81.2 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.895 -1.15 . . . . 1.47 107.895 172.662 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.628 HG22 ' HB2' ' A' ' 64' ' ' TRP . 30.1 m -63.34 -31.36 72.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.994 -1.003 . . . . 1.03 110.816 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.72 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -50.88 -69.83 0.1 Allowed 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 115.691 -0.686 . . . . 1.3 109.518 171.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.542 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.2 mtp180 -40.71 -39.4 1.08 Allowed 'General case' 0 C--N 1.314 -0.942 0 O-C-N 124.539 1.15 . . . . 1.8 111.122 175.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.54 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -69.7 -45.43 68.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.604 -1.18 . . . . 0.41999999999999998 111.948 -176.154 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HB3' ' HG2' ' A' ' 69' ' ' GLN . . . -73.95 -32.91 63.69 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.289 1.043 . . . . 1.01 108.605 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.693 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -65.71 -32.1 73.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.608 -1.633 . . . . 1.01 110.26 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.435 ' CB ' HD12 ' A' ' 121' ' ' LEU . . . -73.58 -40.68 63.7 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 114.671 -1.149 . . . . 1.03 111.489 -174.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -59.92 -27.96 67.2 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.562 -1.199 . . . . 1.55 110.755 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.435 ' OD1' HD11 ' A' ' 76' ' ' LEU . 8.0 t-20 -82.16 -35.51 28.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.54 -1.209 . . . . 2.0499999999999998 110.554 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.28 0.64 30.6 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 114.626 0.61 . . . . 0.54000000000000004 114.626 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.505 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 58.5 mtpt -86.92 -8.12 57.55 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.935 -0.744 . . . . 1.6000000000000001 110.814 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.725 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 29.5 m-85 -119.09 175.37 5.81 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 122.159 0.98 . . . . 0.27000000000000002 112.497 171.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.493 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.5 m -119.7 123.73 44.52 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 112.987 -1.915 . . . . 1.0800000000000001 107.862 169.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.592 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -93.02 138.47 31.46 Favored 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 119.43 -0.908 . . . . 1.1499999999999999 111.651 -170.158 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.784 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.7 m -92.11 146.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.333 -1.358 . . . . 1.0900000000000001 107.333 169.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.445 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 9.5 t -101.31 -174.23 2.55 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 119.712 -0.795 . . . . 1.8200000000000001 110.18 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -66.29 -24.77 66.61 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.909 -1.145 . . . . 1.1899999999999999 107.909 175.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.559 ' O ' ' HG3' ' A' ' 129' ' ' MET . 14.6 mt-30 -51.27 -40.05 58.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.219 -1.81 . . . . 2.04 110.51 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.784 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 6.3 mt-30 -98.14 -52.46 3.68 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 122.066 0.936 . . . . 0.42999999999999999 110.094 173.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.455 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 30.8 tp -61.13 -63.7 1.2 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 113.302 -1.772 . . . . 2.04 113.34 -168.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.644 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 4.3 t -49.97 -46.1 52.16 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 123.336 1.541 . . . . 1.1499999999999999 109.289 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.683 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 52.0 mmm -55.4 -61.66 2.19 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 111.125 -2.761 . . . . 2.27 110.64 175.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.684 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.79 -45.57 10.12 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 124.382 1.051 . . . . 1.0700000000000001 112.472 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.502 ' HG3' ' HA ' ' A' ' 128' ' ' SER . 0.0 OUTLIER -55.14 -51.36 66.71 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 107.963 -1.125 . . . . 2.1000000000000001 107.963 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' A' ' 128' ' ' SER . 40.2 mt-30 -64.56 -40.87 96.36 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.047 -0.979 . . . . 0.42999999999999999 111.325 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.683 ' HG3' ' O ' ' A' ' 129' ' ' MET . 49.5 mt-30 -58.3 -34.21 70.3 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 114.429 -1.26 . . . . 0.38 109.383 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.527 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.14 -26.92 18.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.764 -1.562 . . . . 1.05 109.381 -177.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.44 -52.05 0.52 Allowed Glycine 0 CA--C 1.497 -1.041 0 CA-C-O 122.677 1.154 . . . . 0.33000000000000002 113.039 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.59 HD12 ' O ' ' A' ' 141' ' ' SER . 77.7 mt -62.65 -171.15 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 111.761 -2.22 . . . . 1.0700000000000001 116.046 -171.051 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.56 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.5 m -117.21 153.21 49.8 Favored Pre-proline 0 N--CA 1.428 -1.551 0 CA-C-N 110.929 -2.851 . . . . 1.24 108.307 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.644 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 24.5 Cg_endo -63.14 -2.07 3.48 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.026 2.484 . . . . 0.39000000000000001 112.676 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.6 tt0 -118.15 -27.67 6.02 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.781 0.8 . . . . 1.79 110.463 -177.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.619 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.2 t70 -60.54 -23.83 64.89 Favored 'General case' 0 CA--C 1.487 -1.442 0 CA-C-N 113.604 -1.635 . . . . 0.65000000000000002 109.483 -174.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.619 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 17.8 m 74.8 169.49 0.29 Allowed 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 112.785 -2.007 . . . . 0.73999999999999999 110.455 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.812 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 6.7 mt -64.4 -40.25 95.42 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.336 1.065 . . . . 1.48 108.477 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.436 ' C ' ' HG1' ' A' ' 144' ' ' THR . . . 64.49 -11.13 0.25 Allowed Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 112.978 -1.919 . . . . 0.34999999999999998 114.666 177.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 142' ' ' LEU . 1.5 m -152.86 125.53 8.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.081 -0.711 . . . . 1.02 109.081 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.727 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 12.3 mmt180 -41.66 -45.95 3.57 Favored 'General case' 0 C--O 1.213 -0.84 0 O-C-N 123.279 0.362 . . . . 2.21 111.792 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.9 t -73.43 -25.59 60.58 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.628 0.728 . . . . 0.93000000000000005 111.505 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.408 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 29.7 mttm -75.0 -32.05 61.55 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.744 1.259 . . . . 1.8899999999999999 108.684 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.736 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -71.32 -46.99 59.33 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-N 112.217 -2.265 . . . . 0.98999999999999999 110.044 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.529 ' HA ' HG22 ' A' ' 181' ' ' VAL . 38.2 mt -67.07 -40.86 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 CA-C-N 112.678 -2.056 . . . . 1.03 109.839 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.08 -56.3 19.68 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 114.737 -1.119 . . . . 0.14999999999999999 111.129 171.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.72 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 85.3 mt -65.43 -47.98 84.78 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 N-CA-C 112.733 0.642 . . . . 1.05 112.733 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.646 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.23 -40.49 74.19 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.845 0.355 . . . . 1.03 111.14 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.438 ' HD2' HG23 ' A' ' 149' ' ' ILE . 61.6 mtp180 -81.92 -21.75 37.16 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.695 0.759 . . . . 1.29 110.533 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.444 HD22 ' CD ' ' A' ' 133' ' ' GLN . 17.8 t30 -84.06 -11.12 57.22 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.323 -1.362 . . . . 0.5 107.323 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -107.08 -29.11 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 113.143 -1.844 . . . . 1.05 110.917 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.59 34.2 5.34 Favored Glycine 0 CA--C 1.504 -0.602 0 C-N-CA 120.403 -0.904 . . . . 0.17000000000000001 112.553 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.672 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.34 161.83 14.45 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.637 0.606 . . . . 1.02 112.637 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.64 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.2 m80 -99.82 -28.16 13.27 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.561 -0.745 . . . . 0.39000000000000001 109.586 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.573 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.7 m-85 -136.67 -172.9 3.28 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.223 -0.899 . . . . 0.81000000000000005 111.141 -174.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.688 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -137.44 139.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.835 -1.075 . . . . 1.03 108.645 166.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.545 HD23 ' HE1' ' A' ' 176' ' ' MET . 29.4 tp -108.35 100.56 9.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.584 -0.846 . . . . 1.02 109.329 165.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.672 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -79.25 112.56 16.59 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.831 -1.077 . . . . 0.87 108.723 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.825 ' OG ' HD13 ' A' ' 174' ' ' LEU . 23.3 t -124.86 159.75 30.37 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-O 121.828 0.823 . . . . 1.45 110.052 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.801 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.5 p -163.75 173.03 13.34 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 114.505 -1.225 . . . . 0.12 111.154 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.73 134.33 37.03 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 114.071 -1.422 . . . . 0.94999999999999996 108.477 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.645 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -143.9 -176.72 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.373 -0.602 . . . . 1.1499999999999999 109.373 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 95.16 -82.68 0.88 Allowed Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 119.389 -1.386 . . . . 0.14999999999999999 111.856 172.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.42 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.4 t30 -143.07 123.82 14.18 Favored 'General case' 0 C--O 1.195 -1.782 0 N-CA-C 107.125 -1.435 . . . . 0.58999999999999997 107.125 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.597 HG23 ' N ' ' A' ' 99' ' ' SER . 3.1 p -63.04 -44.59 99.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 112.944 0.72 . . . . 1.0 112.944 -172.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.476 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.1 m120 -61.28 -27.93 68.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 118.59 0.632 . . . . 1.9199999999999999 109.891 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.4 88.74 3.35 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 114.855 -1.066 . . . . 1.0600000000000001 108.436 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.651 ' HD2' HG21 ' A' ' 194' ' ' VAL . 44.8 Cg_endo -91.48 166.37 3.47 Favored 'Trans proline' 0 CA--C 1.492 -1.585 0 C-N-CA 124.996 3.797 . . . . 0.089999999999999997 115.183 -169.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.544 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 12.7 m -84.58 117.35 23.67 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.689 -1.596 . . . . 1.0600000000000001 107.672 167.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.825 HD13 ' OG ' ' A' ' 163' ' ' SER . 48.2 tp -84.39 98.19 9.9 Favored 'General case' 0 N--CA 1.412 -2.326 0 C-N-CA 119.589 -0.844 . . . . 1.02 109.183 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.605 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.8 mt-30 -88.06 107.87 18.96 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 114.665 -1.152 . . . . 0.34000000000000002 109.092 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.901 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 36.0 mtp -108.15 162.06 14.41 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.012 -0.995 . . . . 1.0900000000000001 110.266 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 55.5 tt0 -169.72 117.59 0.6 Allowed 'General case' 0 C--O 1.205 -1.275 0 CA-C-O 121.308 0.575 . . . . 0.68000000000000005 109.927 -168.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.691 HD12 ' CD1' ' A' ' 187' ' ' ILE . 0.6 OUTLIER -99.84 101.41 12.53 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.695 -0.854 . . . . 1.03 108.695 -170.972 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.727 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 16.9 ttp -91.39 122.63 34.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.373 -0.83 . . . . 0.89000000000000001 109.625 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.406 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -59.14 127.57 32.83 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.201 -1.407 . . . . 1.04 107.201 166.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.535 HG11 ' CA ' ' A' ' 159' ' ' TYR . 0.2 OUTLIER -82.18 -34.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 119.065 -1.054 . . . . 1.02 110.865 178.529 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 29.4 mt-30 -62.54 -14.43 42.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.446 -0.797 . . . . 0.40000000000000002 111.592 -178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 79.3 p -130.65 -36.41 1.41 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.862 0.839 . . . . 1.03 110.416 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.419 ' CA ' HD12 ' A' ' 149' ' ' ILE . . . 87.9 27.6 25.92 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.397 -1.274 . . . . 0.17999999999999999 112.313 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -106.77 155.93 19.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.624 -0.288 . . . . 0.72999999999999998 110.624 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.465 HD11 ' HG2' ' A' ' 177' ' ' GLN . 33.1 mm -89.01 120.09 37.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.665 0.745 . . . . 1.03 109.375 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.691 ' CD1' HD12 ' A' ' 178' ' ' LEU . 1.3 pp -108.18 -30.33 2.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.904 -1.043 . . . . 1.01 110.422 -173.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.632 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.2 t90 -136.96 152.89 50.69 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.177 -0.92 . . . . 0.070000000000000007 109.385 172.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 62.1 p -153.53 164.49 38.14 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.938 0.718 . . . . 0.64000000000000001 112.938 164.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.71 179.84 35.01 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.671 -0.971 . . . . 0.12 110.671 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.817 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.6 mtmt -156.91 147.45 21.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.181 -1.785 . . . . 1.76 106.181 168.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -157.64 127.38 1.9 Allowed Glycine 0 C--N 1.283 -2.399 0 C-N-CA 119.674 -1.25 . . . . 0.13 112.43 -178.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.65 110.96 9.37 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.787 0.803 . . . . 1.01 111.503 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.672 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -88.53 159.5 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 122.797 1.284 . . . . 1.01 110.9 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.772 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -99.73 173.03 6.9 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 112.254 -2.248 . . . . 0.92000000000000004 108.895 -174.543 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.3 tt0 -104.34 133.52 49.1 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.936 -0.705 . . . . 0.91000000000000003 110.107 173.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.542 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 14.4 mm-40 . . . . . 0 C--N 1.313 -1.004 0 CA-C-O 118.551 -0.737 . . . . 1.24 110.617 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.851 -0.499 . . . . 88.920000000000002 111.851 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m -140.97 160.58 39.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.575 0.226 . . . . 87.459999999999994 110.804 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -87.79 107.27 18.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.312 -0.625 . . . . 87.5 109.312 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.543 ' O ' HG13 ' A' ' 5' ' ' VAL . 62.2 ttp -97.17 78.43 2.76 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.829 -0.349 . . . . 85.340000000000003 110.228 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.543 HG13 ' O ' ' A' ' 4' ' ' MET . 3.5 p 56.78 -36.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.114 1.766 . . . . 85.230000000000004 114.791 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.429 ' H ' ' C ' ' A' ' 4' ' ' MET . . . 165.69 105.76 0.19 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 111.165 -0.774 . . . . 84.849999999999994 111.165 -176.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -118.72 -84.58 0.65 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 119.465 -0.303 . . . . 85.599999999999994 111.249 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 46.94 68.4 0.63 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.405 0.621 . . . . 85.310000000000002 110.646 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -154.21 170.59 8.21 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.295 -0.866 . . . . 82.170000000000002 109.822 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.07 -42.07 67.87 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.728 1.618 . . . . 82.069999999999993 111.531 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 62.78 92.81 0.06 OUTLIER Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 115.288 -0.869 . . . . 79.709999999999994 111.266 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.44 143.51 99.47 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.846 2.364 . . . . 79.019999999999996 111.832 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.24 156.62 5.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 77.260000000000005 110.82 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.07 88.42 1.42 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.672 -0.694 . . . . 75.739999999999995 110.562 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.438 ' HG2' ' H ' ' A' ' 16' ' ' VAL . 33.9 tt0 -81.59 172.8 13.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.274 -0.876 . . . . 74.010000000000005 109.127 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.438 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 8.8 p -37.45 127.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 O-C-N 123.84 0.712 . . . . 72.569999999999993 111.753 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -93.37 152.63 41.21 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.894 -0.594 . . . . 71.379999999999995 110.588 -178.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.96 80.96 0.27 Allowed 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.062 2.508 . . . . 70.189999999999998 112.7 -178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -132.28 76.97 71.7 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.941 -0.572 . . . . 67.769999999999996 110.441 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.23 121.44 6.86 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.194 1.929 . . . . 67.180000000000007 111.889 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -108.01 116.08 31.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.234 0.54 . . . . 65.200000000000003 110.55 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -115.54 130.95 23.9 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.757 -0.656 . . . . 63.460000000000001 109.913 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.97 141.83 93.82 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.027 2.484 . . . . 62.479999999999997 112.956 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.33 65.33 1.59 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.187 -0.915 . . . . 59.869999999999997 108.918 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -80.06 151.21 72.83 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 114.145 -1.388 . . . . 58.890000000000001 110.312 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.457 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 55.6 Cg_endo -70.31 1.33 4.9 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.909 2.406 . . . . 57.890000000000001 112.949 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 55.68 -166.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.041 0.537 . . . . 55.729999999999997 111.553 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.526 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 2.6 mp0 -94.55 -64.56 0.12 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 118.845 -0.598 . . . . 54.079999999999998 111.196 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.526 ' HD3' ' HB2' ' A' ' 28' ' ' GLN . 23.6 Cg_exo -59.5 -56.37 1.31 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.496 1.464 . . . . 53.299999999999997 113.392 -167.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.23 150.74 70.0 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.702 -0.481 . . . . 51.130000000000003 109.702 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 26' ' ' PRO . 16.2 Cg_exo -67.86 -40.78 8.92 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.253 1.969 . . . . 49.75 112.077 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -144.63 143.38 30.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.655 -0.702 . . . . 47.700000000000003 110.188 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.551 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 26.3 t -102.28 -51.34 0.15 Allowed Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.044 -0.525 . . . . 46.109999999999999 111.447 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.551 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 52.1 Cg_exo -61.19 164.32 14.98 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.399 2.066 . . . . 45.890000000000001 113.372 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 m -89.02 140.55 29.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.983 -1.008 . . . . 43.0 109.926 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.9 m -68.17 146.62 98.14 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.583 . . . . 40.789999999999999 111.224 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -50.88 -55.71 3.79 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.513 2.142 . . . . 40.450000000000003 112.678 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.2 m -113.95 123.69 50.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.179 0.514 . . . . 37.729999999999997 111.246 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.58 107.97 59.55 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.407 -0.815 . . . . 35.990000000000002 109.443 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.66 -49.56 16.37 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.092 2.528 . . . . 34.350000000000001 112.423 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 68.32 123.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.992 0.808 . . . . 31.780000000000001 111.748 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -116.28 88.85 24.34 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 30.390000000000001 110.46 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.14 121.71 6.28 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.683 2.255 . . . . 29.940000000000001 111.644 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.23 -176.94 4.61 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.082 -0.58 . . . . 26.75 113.107 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.01 133.51 27.13 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.74 2.293 . . . . 25.879999999999999 111.821 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.9 mt -76.16 -50.75 21.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.027 -0.533 . . . . 24.16 110.661 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.61 84.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.003 -0.999 . . . . 21.829999999999998 111.051 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.24 177.06 6.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.505 0.669 . . . . 20.620000000000001 111.264 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -141.66 170.83 14.98 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.836 -1.074 . . . . 16.559999999999999 109.848 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -103.23 29.33 5.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.982 0.896 . . . . 15.050000000000001 111.247 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.459 ' HB3' ' HG3' ' A' ' 54' ' ' PRO . 8.4 tp-100 179.7 156.05 0.58 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.78 -1.1 . . . . 14.66 108.065 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.2 p -80.75 119.02 22.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.323 0.583 . . . . 11.84 111.395 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.4 ' N ' ' HD3' ' A' ' 54' ' ' PRO . . . 49.47 60.51 15.34 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.141 -1.391 . . . . 8.4399999999999995 113.24 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.459 ' HG3' ' HB3' ' A' ' 51' ' ' GLN . 24.3 Cg_exo -59.8 -47.49 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.584 2.189 . . . . 7.6600000000000001 114.239 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.94 -16.63 36.86 Favored 'Trans proline' 0 C--N 1.356 0.925 0 CA-C-N 120.92 1.364 . . . . 5.6600000000000001 112.654 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -86.91 111.2 38.68 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.802 0.334 . . . . 2.8700000000000001 111.109 -178.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.62 -176.52 3.32 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.231 2.621 . . . . 1.8300000000000001 112.065 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -112.41 137.25 50.85 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.785 -1.098 . . . . 4.2199999999999998 109.612 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.581 HG23 ' N ' ' A' ' 60' ' ' ARG . 13.6 mt -77.64 171.75 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.964 -1.016 . . . . 1.1299999999999999 111.579 -172.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.581 ' N ' HG23 ' A' ' 59' ' ' ILE . 46.9 mtt85 -60.64 -149.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.956 -1.474 . . . . 3.1400000000000001 112.214 176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.63 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 21.1 t-160 -159.43 137.73 10.51 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-N 112.634 -2.076 . . . . 2.7400000000000002 107.017 177.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.712 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.2 m-30 -122.09 156.4 33.66 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.364 -0.834 . . . . 0.76000000000000001 110.878 -177.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.484 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 23.4 t70 -87.11 67.02 9.58 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 123.401 1.572 . . . . 0.34999999999999998 108.399 172.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.754 ' CZ3' HG12 ' A' ' 194' ' ' VAL . 92.9 m95 -54.25 -43.58 71.05 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.089 -2.323 . . . . 0.10000000000000001 112.997 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.486 ' N ' HG21 ' A' ' 108' ' ' THR . 8.6 t-20 -50.15 -30.56 11.51 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.806 -1.543 . . . . 1.1100000000000001 111.743 177.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.48 -16.41 80.64 Favored Glycine 0 CA--C 1.501 -0.801 0 N-CA-C 111.358 -0.697 . . . . 0.23000000000000001 111.358 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.73 -49.77 4.26 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.118 -1.041 . . . . 1.01 110.736 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.749 ' SD ' HD21 ' A' ' 109' ' ' LEU . 39.0 mtt -66.56 -57.65 6.83 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.089 -1.414 . . . . 0.089999999999999997 111.94 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.464 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 7.0 mm-40 -38.75 -54.96 2.88 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 114.958 1.466 . . . . 0.63 114.958 -177.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.8 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 31.9 Cg_endo -63.46 -30.77 72.09 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 121.908 1.739 . . . . 0.17000000000000001 110.45 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.676 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 7.6 mtm -81.59 -45.63 15.57 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 115.123 -0.944 . . . . 0.69999999999999996 111.851 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 68' ' ' MET . 46.8 t -56.54 -39.86 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-N 114.217 -1.356 . . . . 1.04 108.751 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -59.39 -34.39 72.37 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.064 -1.88 . . . . 1.1200000000000001 111.052 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.8 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 17.2 mtpp -83.41 -33.86 25.64 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.069 0.461 . . . . 1.8799999999999999 110.912 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.834 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.81 -26.35 68.31 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.291 -0.868 . . . . 0.5 111.295 -173.186 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.516 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.4 mt -94.11 -6.35 45.19 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.205 1.002 . . . . 1.29 110.788 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.64 16.05 52.19 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 108.934 -1.666 . . . . 0.17999999999999999 108.934 170.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.643 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -86.36 165.7 16.18 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.598 -0.801 . . . . 1.0 109.925 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -92.87 105.52 17.63 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.255 -0.884 . . . . 1.72 110.195 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.629 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.05 -22.48 3.59 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 115.138 -0.937 . . . . 0.13 111.051 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.834 HG11 ' O ' ' A' ' 75' ' ' MET . 9.9 p -99.53 154.77 4.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.519 0.676 . . . . 1.01 111.617 -174.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.441 ' HG1' ' HH ' ' A' ' 159' ' ' TYR . 3.6 m -135.0 135.01 41.05 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.692 -1.14 . . . . 1.1000000000000001 110.897 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.442 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -60.59 121.41 12.12 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.394 -0.821 . . . . 1.1200000000000001 110.66 168.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.1 4.6 23.96 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.979 -0.629 . . . . 0.28000000000000003 112.55 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.3 152.46 21.93 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.804 -0.359 . . . . 1.55 110.526 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.669 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.5 p -80.02 120.71 31.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.819 0.819 . . . . 1.03 108.906 165.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.752 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -109.36 107.7 17.98 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.821 0.82 . . . . 1.03 109.154 -172.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.65 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -72.11 97.35 1.91 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.228 -1.351 . . . . 1.01 107.679 174.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.834 ' O ' HD12 ' A' ' 127' ' ' LEU . 1.2 m -70.88 125.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 105.82 -1.919 . . . . 1.6200000000000001 105.82 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.873 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 10.0 t0 -78.26 157.7 29.16 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.401 -1.333 . . . . 0.64000000000000001 107.401 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.621 ' OG ' ' HE3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -57.7 135.39 56.75 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 106.842 -1.54 . . . . 1.05 106.842 170.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.593 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 28.3 t -64.9 139.68 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.951 0 N-CA-C 107.777 -1.194 . . . . 1.02 107.777 169.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.642 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.5 t-20 -84.11 162.45 20.28 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.016 -0.993 . . . . 0.20000000000000001 109.778 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.757 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.36 85.02 2.35 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.683 -1.144 . . . . 0.12 108.004 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.45 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.2 mtp180 -107.09 -3.16 20.25 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 113.9 -1.5 . . . . 0.84999999999999998 108.653 -172.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 28.6 p -50.57 -175.36 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.24 -1.8 . . . . 0.91000000000000003 114.271 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.4 OUTLIER -72.3 -8.56 55.54 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.206 -1.816 . . . . 0.62 110.599 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.513 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -146.47 -148.91 4.87 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.751 -0.738 . . . . 0.14000000000000001 112.843 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.619 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.3 p -121.45 130.3 53.49 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.329 0.492 . . . . 1.76 112.329 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.757 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -135.16 157.81 45.97 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.954 0.883 . . . . 1.01 111.028 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.699 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -77.74 80.4 4.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.579 -1.646 . . . . 0.20999999999999999 107.86 175.144 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -69.41 -15.43 63.29 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.873 -1.058 . . . . 1.0 109.77 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.84 -29.19 40.07 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.609 -0.886 . . . . 1.02 108.609 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.699 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 20.9 tt0 -63.61 -39.71 95.07 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.054 -1.43 . . . . 1.73 109.32 168.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.546 ' O ' ' HE2' ' A' ' 68' ' ' MET . . . -68.48 -44.64 74.33 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.005 -1.907 . . . . 1.04 108.928 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.563 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 51.1 m -64.88 -31.44 72.68 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 113.946 -1.479 . . . . 1.04 110.61 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -44.79 78.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.695 -1.224 . . . . 1.47 107.695 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.599 HG21 ' HB2' ' A' ' 64' ' ' TRP . 40.1 m -64.01 -31.7 72.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.173 -0.921 . . . . 1.03 110.945 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.749 HD21 ' SD ' ' A' ' 68' ' ' MET . 8.7 mt -49.86 -69.7 0.11 Allowed 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.277 -0.638 . . . . 1.3 109.277 171.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.445 ' O ' HD11 ' A' ' 121' ' ' LEU . 16.4 mtp180 -41.05 -39.75 1.29 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.508 1.13 . . . . 1.8 111.394 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.532 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -68.89 -45.97 69.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.65 -1.159 . . . . 0.41999999999999998 112.012 -176.053 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.99 66.94 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.467 -0.938 . . . . 1.01 108.467 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.679 HD21 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -59.58 -34.4 72.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.715 -1.584 . . . . 1.01 110.131 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.452 ' CB ' HD13 ' A' ' 121' ' ' LEU . . . -72.53 -39.11 67.8 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 114.662 -1.154 . . . . 1.03 110.717 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -64.69 -24.58 67.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.709 -1.132 . . . . 1.55 110.832 -176.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -89.55 -25.18 21.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.648 -0.705 . . . . 2.0499999999999998 110.576 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 58.29 27.98 61.14 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.743 -0.662 . . . . 0.54000000000000004 114.147 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.482 ' HB2' ' CD1' ' A' ' 76' ' ' LEU . 58.2 mtpt -110.87 -1.35 16.53 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.61 -0.515 . . . . 1.6000000000000001 109.61 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.752 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 40.1 m-85 -124.44 173.6 8.33 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.085 0.945 . . . . 0.27000000000000002 112.571 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.2 m -116.62 120.78 39.75 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 113.206 -1.815 . . . . 1.0800000000000001 107.532 169.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.632 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -89.85 146.23 24.58 Favored 'General case' 0 N--CA 1.415 -2.203 0 C-N-CA 119.344 -0.943 . . . . 1.1499999999999999 111.223 -170.495 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.681 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.6 m -100.62 141.2 17.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.765 -1.198 . . . . 1.0900000000000001 107.765 170.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.4 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 1.4 m -96.04 -179.99 4.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.805 -0.758 . . . . 1.8200000000000001 110.55 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.77 -30.37 69.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.785 0.802 . . . . 1.1899999999999999 109.035 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.616 ' O ' ' HG3' ' A' ' 129' ' ' MET . 31.9 mt-30 -44.48 -41.5 6.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.188 -1.823 . . . . 2.04 111.771 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.681 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 8.3 mt-30 -98.52 -48.02 5.16 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.79 0.805 . . . . 0.42999999999999999 110.283 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.834 HD12 ' O ' ' A' ' 89' ' ' VAL . 5.8 tt -64.97 -66.37 0.55 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.4 -1.727 . . . . 2.04 113.284 -166.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.612 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.0 OUTLIER -53.17 -42.9 66.64 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 123.618 1.675 . . . . 1.1499999999999999 109.208 -178.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.686 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 6.3 mmt -55.29 -62.85 1.4 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 110.942 -2.845 . . . . 2.27 111.13 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.699 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.27 -44.4 5.37 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.106 0.879 . . . . 1.0700000000000001 111.833 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.621 ' HE3' ' OG ' ' A' ' 91' ' ' SER . 4.0 mptp? -49.28 -65.02 0.64 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.287 -0.634 . . . . 2.1000000000000001 109.287 175.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.415 ' H ' ' HG3' ' A' ' 132' ' ' GLN . 39.1 mt-30 -54.06 -45.49 71.71 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.895 -1.048 . . . . 0.42999999999999999 112.001 177.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.686 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.4 mt-30 -55.65 -36.37 66.97 Favored 'General case' 0 CA--C 1.488 -1.424 0 CA-C-N 114.843 -1.071 . . . . 0.38 109.916 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.523 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -90.47 -29.39 17.96 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.172 -1.376 . . . . 1.05 109.57 -176.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.07 -38.68 0.73 Allowed Glycine 0 CA--C 1.497 -1.069 0 C-N-CA 119.558 -1.306 . . . . 0.33000000000000002 113.933 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 141' ' ' SER . 92.1 mt -73.12 -173.49 1.3 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 123.94 1.829 . . . . 1.0700000000000001 115.275 -167.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.469 ' C ' ' H ' ' A' ' 139' ' ' GLN . 15.3 m -109.4 147.85 36.86 Favored Pre-proline 0 N--CA 1.42 -1.944 0 CA-C-N 110.72 -2.945 . . . . 1.24 107.984 168.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.612 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 34.3 Cg_endo -63.78 1.2 1.54 Allowed 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 123.058 2.505 . . . . 0.39000000000000001 112.176 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.469 ' H ' ' C ' ' A' ' 137' ' ' SER . 0.1 OUTLIER -117.1 -22.25 8.47 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.136 0.969 . . . . 1.79 110.251 -178.187 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.717 ' O ' ' HB2' ' A' ' 141' ' ' SER . 17.2 t70 -61.0 -24.29 66.04 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 112.963 -1.926 . . . . 0.65000000000000002 109.211 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.717 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 14.0 m 74.42 174.83 0.26 Allowed 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 125.942 2.026 . . . . 0.73999999999999999 108.468 -170.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.873 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 3.4 mt -69.76 -39.72 76.52 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.21 -1.033 . . . . 1.48 108.21 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.41 -12.0 0.73 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 113.276 -1.783 . . . . 0.34999999999999998 114.41 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.413 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -153.96 125.11 7.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.605 -0.712 . . . . 1.02 109.118 -175.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.707 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -40.86 -47.95 3.01 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 118.075 0.398 . . . . 2.21 111.81 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 32.3 t -71.25 -29.22 64.83 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.391 0.615 . . . . 0.93000000000000005 111.592 -175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -71.15 -27.57 63.64 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.681 1.229 . . . . 1.8899999999999999 108.374 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.636 ' CB ' HD12 ' A' ' 142' ' ' LEU . . . -78.6 -47.88 16.26 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 112.287 -2.233 . . . . 0.98999999999999999 110.395 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.552 HG13 ' HE3' ' A' ' 179' ' ' MET . 36.7 mt -65.28 -42.12 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 112.837 -1.983 . . . . 1.03 110.252 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.3 -56.76 15.69 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.778 -1.101 . . . . 0.14999999999999999 110.964 171.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.705 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 70.8 mt -63.99 -47.73 89.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 N-CA-C 112.458 0.54 . . . . 1.05 112.458 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.613 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.13 -42.01 76.24 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 123.241 0.338 . . . . 1.03 110.682 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' A' ' 149' ' ' ILE . 29.5 mtp180 -80.5 -23.05 40.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.643 0.735 . . . . 1.29 110.795 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -80.9 -12.99 59.31 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.424 -1.324 . . . . 0.5 107.424 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.705 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.49 -29.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 112.987 -1.915 . . . . 1.05 110.741 -175.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.441 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.46 34.19 5.11 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.59 -0.814 . . . . 0.17000000000000001 112.612 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.65 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.66 159.81 16.44 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.912 0.708 . . . . 1.02 112.912 -169.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.669 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.5 m80 -99.29 -28.21 13.42 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.212 -0.904 . . . . 0.39000000000000001 109.323 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.582 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.6 m-85 -136.26 -176.91 4.48 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.963 -1.017 . . . . 0.81000000000000005 111.008 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.699 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -134.06 141.34 44.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.665 -1.152 . . . . 1.03 108.609 167.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.64 HD21 ' SD ' ' A' ' 176' ' ' MET . 29.9 tp -110.21 100.39 9.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.666 -0.814 . . . . 1.02 109.441 165.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.528 ' HH ' ' HB2' ' A' ' 142' ' ' LEU . 2.0 m-85 -79.06 112.45 16.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.579 -1.192 . . . . 0.87 108.899 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.864 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 5.5 t -126.09 161.91 26.54 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-O 121.956 0.884 . . . . 1.45 110.691 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.82 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.7 p -162.83 177.59 9.16 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.23 -1.35 . . . . 0.12 111.141 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.565 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -140.85 133.77 29.13 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.175 -1.375 . . . . 0.94999999999999996 108.551 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -143.36 -176.61 5.01 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.307 -0.557 . . . . 1.1499999999999999 109.592 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.39 -81.37 0.94 Allowed Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.669 -1.253 . . . . 0.14999999999999999 111.873 172.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 53.1 t-20 -142.2 127.37 18.58 Favored 'General case' 0 C--O 1.197 -1.681 0 N-CA-C 106.747 -1.575 . . . . 0.58999999999999997 106.747 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.596 HG23 ' N ' ' A' ' 99' ' ' SER . 2.9 p -63.25 -41.13 91.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-N 115.438 -0.801 . . . . 1.0 112.125 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.48 ' N ' HG13 ' A' ' 169' ' ' VAL . 91.9 m-20 -65.14 -28.45 69.43 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.317 0.579 . . . . 1.9199999999999999 110.496 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.51 88.47 3.35 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 114.571 -1.195 . . . . 1.0600000000000001 108.138 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.652 ' HD2' HG21 ' A' ' 194' ' ' VAL . 50.9 Cg_endo -90.09 164.96 4.75 Favored 'Trans proline' 0 CA--C 1.491 -1.658 0 C-N-CA 124.56 3.507 . . . . 0.089999999999999997 114.998 -170.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 20.6 m -84.4 117.83 23.87 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.898 -1.501 . . . . 1.0600000000000001 107.628 166.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.831 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 40.4 tp -84.23 99.47 10.58 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.58 -0.896 . . . . 1.02 108.58 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.579 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.3 mt-30 -90.69 109.41 20.59 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-O 122.063 0.935 . . . . 0.34000000000000002 109.634 -175.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.864 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -112.84 164.36 13.5 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.958 -1.019 . . . . 1.0900000000000001 111.789 -172.857 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.524 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 55.9 tt0 -171.56 116.84 0.41 Allowed 'General case' 0 C--O 1.202 -1.395 0 CA-C-N 115.98 -0.555 . . . . 0.68000000000000005 109.967 -166.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -99.23 101.53 12.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.554 -0.906 . . . . 1.03 108.554 -171.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.707 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 18.4 ttp -91.18 122.69 34.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.404 -0.816 . . . . 0.89000000000000001 109.87 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.81 126.35 27.29 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.234 -1.395 . . . . 1.04 107.234 165.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.542 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -80.91 -35.68 14.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 119.303 -0.959 . . . . 1.02 110.72 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.454 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.8 mt-30 -60.57 -16.99 43.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.328 -0.851 . . . . 0.40000000000000002 111.603 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.8 p -129.33 -37.37 1.64 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.969 0.89 . . . . 1.03 110.155 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.436 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.5 23.67 28.15 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 114.402 -1.272 . . . . 0.17999999999999999 112.293 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 179' ' ' MET . 9.7 pt-20 -100.81 156.88 17.11 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.607 0.241 . . . . 0.72999999999999998 110.672 -179.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.473 HD12 ' HG2' ' A' ' 177' ' ' GLN . 37.9 mm -92.87 114.94 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.543 0.687 . . . . 1.03 109.597 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.687 ' CD1' HD13 ' A' ' 178' ' ' LEU . 1.4 pp -102.22 -31.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.878 -1.055 . . . . 1.01 110.603 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.643 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.9 t90 -135.59 153.33 51.71 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.487 -0.779 . . . . 0.070000000000000007 109.87 173.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.511 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 28.0 p -153.61 163.4 40.05 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.157 0.799 . . . . 0.64000000000000001 113.157 164.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.38 -175.47 31.41 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 110.839 -0.904 . . . . 0.12 110.839 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.831 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.4 mtmt -158.25 151.14 22.59 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.421 -2.066 . . . . 1.76 105.421 166.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.487 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -160.88 127.75 1.81 Allowed Glycine 0 C--N 1.281 -2.515 0 C-N-CA 119.879 -1.153 . . . . 0.13 112.195 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.39 118.16 14.93 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.444 0.64 . . . . 1.01 111.199 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.754 HG12 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -93.34 158.5 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-O 122.42 1.105 . . . . 1.01 109.868 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.697 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -97.98 171.46 8.26 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 112.879 -1.964 . . . . 0.92000000000000004 109.581 -173.042 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.518 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 7.4 tt0 -103.09 127.48 50.35 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.984 -0.747 . . . . 0.91000000000000003 108.984 166.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.484 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 14.2 mm-40 . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 118.724 -0.655 . . . . 1.24 110.817 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 112.147 -0.381 . . . . 88.920000000000002 112.147 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 t -147.34 149.73 33.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.18 -0.674 . . . . 87.459999999999994 109.18 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -84.19 158.21 21.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.679 0.276 . . . . 87.5 110.686 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.1 ptp 48.29 34.91 4.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.559 1.144 . . . . 85.340000000000003 112.734 176.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -112.3 -30.51 2.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.007 -0.997 . . . . 85.230000000000004 109.286 175.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.68 -98.39 0.35 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.191 -1.163 . . . . 84.849999999999994 110.191 173.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 53.5 mt-30 51.59 98.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.169 0.587 . . . . 85.599999999999994 112.582 175.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' NE ' ' HA ' ' A' ' 8' ' ' ARG . 4.2 mmp_? 70.93 41.32 0.84 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.086 -0.961 . . . . 85.310000000000002 110.7 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 175.36 140.04 0.2 Allowed Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.714 -1.584 . . . . 82.170000000000002 109.341 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.67 122.48 10.6 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.569 2.179 . . . . 82.069999999999993 111.683 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.11 105.83 50.6 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.101 -0.499 . . . . 79.709999999999994 110.159 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -71.74 -178.04 2.86 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.7 2.266 . . . . 79.019999999999996 113.891 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -52.45 162.48 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.912 -1.04 . . . . 77.260000000000005 112.728 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -87.56 51.72 2.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.176 -0.92 . . . . 75.739999999999995 110.622 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -111.25 146.64 36.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 74.010000000000005 110.293 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.77 128.53 23.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.993 -1.003 . . . . 72.569999999999993 110.07 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -71.82 130.99 86.21 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.166 -0.47 . . . . 71.379999999999995 110.92 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.5 142.54 95.38 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.477 2.118 . . . . 70.189999999999998 110.75 171.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.13 86.71 0.14 Allowed Pre-proline 0 C--O 1.234 0.278 0 CA-C-O 121.133 0.492 . . . . 67.769999999999996 110.644 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.401 ' O ' ' HB2' ' A' ' 21' ' ' GLU . 3.0 Cg_exo -76.27 27.79 0.41 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.55 2.833 . . . . 67.180000000000007 112.451 -179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 10.7 mm-40 73.1 -44.78 0.6 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.451 0.7 . . . . 65.200000000000003 110.893 -175.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.423 HE21 ' HB2' ' A' ' 22' ' ' GLN . 0.0 OUTLIER -140.66 128.73 12.56 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.799 -0.445 . . . . 63.460000000000001 109.799 173.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -60.96 148.12 93.59 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.144 2.563 . . . . 62.479999999999997 113.043 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -141.64 79.77 1.69 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.38 0.609 . . . . 59.869999999999997 110.419 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -135.78 136.0 22.74 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.343 -0.844 . . . . 58.890000000000001 110.97 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.2 -61.55 0.59 Allowed 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 122.652 2.234 . . . . 57.890000000000001 112.116 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.435 ' HG2' ' N ' ' A' ' 28' ' ' GLN . 34.7 tt0 69.76 163.02 0.24 Allowed 'General case' 0 CA--C 1.532 0.26 0 O-C-N 124.158 0.911 . . . . 55.729999999999997 110.693 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.435 ' N ' ' HG2' ' A' ' 27' ' ' GLN . 79.3 mt-30 66.88 67.19 0.64 Allowed Pre-proline 0 C--O 1.225 -0.222 0 CA-C-N 114.115 -1.402 . . . . 54.079999999999998 110.914 -176.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.05 131.19 35.68 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 121.887 1.725 . . . . 53.299999999999997 112.296 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t 52.56 70.38 1.9 Allowed Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 113.62 -1.627 . . . . 51.130000000000003 111.209 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.84 -9.75 26.83 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.588 2.192 . . . . 49.75 112.606 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 p -103.38 146.19 28.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 47.700000000000003 110.948 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 p -163.1 95.93 1.09 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 121.367 0.604 . . . . 46.109999999999999 110.703 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' C ' ' HG ' ' A' ' 35' ' ' SER . 70.6 Cg_exo -56.92 155.59 27.27 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.869 2.38 . . . . 45.890000000000001 111.824 176.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.412 ' HG ' ' C ' ' A' ' 34' ' ' PRO . 57.5 m -157.34 132.02 8.64 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.819 -0.628 . . . . 43.0 110.536 -175.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.0 t 61.38 84.4 0.19 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.327 -0.851 . . . . 40.789999999999999 110.727 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.32 -29.28 54.63 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.144 2.563 . . . . 40.450000000000003 112.43 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 12.8 t -78.14 158.65 29.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.038 -0.528 . . . . 37.729999999999997 109.766 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.2 mt -91.99 106.99 19.57 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.895 -0.593 . . . . 35.990000000000002 110.443 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -76.52 -10.04 18.74 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.464 2.11 . . . . 34.350000000000001 111.849 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -85.91 93.92 9.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.744 -0.662 . . . . 31.780000000000001 109.595 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -81.91 135.78 48.2 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.16 -0.473 . . . . 30.390000000000001 110.625 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.64 164.74 34.71 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.376 2.051 . . . . 29.940000000000001 112.235 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.19 179.82 19.58 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.694 -0.765 . . . . 26.75 111.617 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.86 133.26 28.78 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.648 2.232 . . . . 25.879999999999999 111.132 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.5 mt -61.06 -42.49 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.274 -0.875 . . . . 24.16 110.498 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -51.46 104.29 0.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.935 -1.03 . . . . 21.829999999999998 111.26 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -123.54 175.08 7.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.843 -0.617 . . . . 20.620000000000001 110.265 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -126.42 166.49 17.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.987 -0.551 . . . . 16.559999999999999 111.182 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -99.43 74.42 1.91 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 15.050000000000001 110.424 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.1 162.6 19.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.621 -0.718 . . . . 14.66 111.517 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.5 p 66.09 160.43 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.065 1.346 . . . . 11.84 111.925 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.01 87.23 50.99 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 115.171 -0.922 . . . . 8.4399999999999995 110.827 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.407 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 9.2 Cg_exo -71.3 158.01 55.54 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.892 2.395 . . . . 7.6600000000000001 112.03 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.22 -49.4 17.6 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.35 2.033 . . . . 5.6600000000000001 112.891 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -119.49 80.17 22.06 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.223 -0.444 . . . . 2.8700000000000001 110.434 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 98.1 Cg_endo -75.15 -176.3 2.83 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.155 2.57 . . . . 1.8300000000000001 113.134 -176.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -126.98 148.57 50.09 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.418 -1.265 . . . . 4.2199999999999998 109.43 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.613 HG22 ' N ' ' A' ' 60' ' ' ARG . 8.9 mt -88.84 167.91 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.767 0.794 . . . . 1.1299999999999999 111.239 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.613 ' N ' HG22 ' A' ' 59' ' ' ILE . 29.9 mtt-85 -69.79 -159.9 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 113.717 -1.583 . . . . 3.1400000000000001 111.709 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.647 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 38.7 m80 -147.58 141.07 25.4 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 112.535 -2.12 . . . . 2.7400000000000002 107.215 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.763 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 1.8 m-30 -126.36 155.62 41.78 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.76 -0.654 . . . . 0.76000000000000001 110.919 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 11.5 t70 -82.66 67.98 8.94 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 123.481 1.61 . . . . 0.34999999999999998 108.627 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.763 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 93.3 m95 -60.51 -43.75 96.73 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 112.14 -2.3 . . . . 0.10000000000000001 112.312 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.466 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 12.1 t-20 -52.3 -29.0 21.23 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.064 -1.425 . . . . 1.1100000000000001 111.211 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.37 -16.48 80.69 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 115.35 -0.841 . . . . 0.23000000000000001 111.295 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.97 -51.64 3.49 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.183 -1.009 . . . . 1.01 110.959 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.758 ' SD ' HD21 ' A' ' 109' ' ' LEU . 38.5 mtt -65.61 -56.63 11.21 Favored 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 114.086 -1.415 . . . . 0.089999999999999997 112.517 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.466 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.6 mm-40 -40.21 -54.57 4.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 114.732 1.382 . . . . 0.63 114.732 -176.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.779 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.2 Cg_endo -64.27 -30.09 63.95 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 121.916 1.744 . . . . 0.17000000000000001 110.664 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.644 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 7.7 mtm -81.62 -44.59 17.0 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 115.165 -0.925 . . . . 0.69999999999999996 111.826 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.698 HG22 ' O ' ' A' ' 68' ' ' MET . 49.0 t -56.74 -39.54 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-N 114.279 -1.328 . . . . 1.04 108.443 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.6 t -59.67 -32.62 70.64 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.049 -1.887 . . . . 1.1200000000000001 111.177 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.779 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.2 mtpt -85.98 -33.29 21.14 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.929 0.395 . . . . 1.8799999999999999 111.046 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.852 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.65 -27.64 69.07 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.484 -0.78 . . . . 0.5 111.786 -171.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.548 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.0 mt -93.05 -5.68 49.94 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.94 0.876 . . . . 1.29 111.257 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.14 15.29 47.56 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.201 -1.559 . . . . 0.17999999999999999 109.201 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.633 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -83.47 165.99 18.69 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.409 -0.895 . . . . 1.0 111.148 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.52 105.68 14.65 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.876 -1.056 . . . . 1.72 110.382 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.591 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 129.25 -21.12 5.22 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.151 -1.023 . . . . 0.13 111.175 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.852 HG11 ' O ' ' A' ' 75' ' ' MET . 11.2 p -100.81 149.42 6.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.896 0.855 . . . . 1.01 110.837 -176.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.3 m -136.19 142.27 44.1 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.197 -1.365 . . . . 1.1000000000000001 109.701 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 118' ' ' LYS . . . -62.37 136.21 57.81 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.54 -0.755 . . . . 1.1200000000000001 110.754 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.08 9.54 39.14 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.957 -0.64 . . . . 0.28000000000000003 112.777 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.37 152.03 18.75 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.742 -0.383 . . . . 1.55 110.711 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.643 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -80.95 120.12 31.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 122.015 0.912 . . . . 1.03 109.103 165.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.646 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -107.45 110.57 22.55 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.137 -0.938 . . . . 1.03 108.799 -172.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.655 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -70.67 99.39 1.67 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 114.786 -1.097 . . . . 1.01 108.419 179.484 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.407 HG13 ' HG3' ' A' ' 110' ' ' ARG . 85.3 t -72.82 108.93 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 114.324 -1.307 . . . . 1.6200000000000001 108.416 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.802 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 6.8 t0 -77.79 154.56 31.8 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.982 -1.118 . . . . 0.64000000000000001 107.982 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.539 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.37 138.14 57.75 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.588 -1.264 . . . . 1.05 107.588 171.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.545 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 26.3 t -66.5 141.08 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.633 0 N-CA-C 107.904 -1.147 . . . . 1.02 107.904 168.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.64 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.8 t-20 -86.2 163.08 18.0 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.459 -0.792 . . . . 0.20000000000000001 109.917 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.757 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 1.8 t-20 -126.01 84.84 2.32 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.669 -1.15 . . . . 0.12 108.29 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.423 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 13.7 mtp180 -108.97 -2.1 18.51 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.076 -1.42 . . . . 0.84999999999999998 108.705 -171.106 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.642 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 17.6 p -50.7 -172.07 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 112.608 -2.087 . . . . 0.91000000000000003 115.483 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.461 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.0 t30 -67.71 -13.1 61.81 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.028 -1.896 . . . . 0.62 110.558 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.518 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -148.86 -146.26 4.29 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.592 -0.813 . . . . 0.14000000000000001 112.884 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.608 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 49.2 m -122.15 129.0 51.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.943 0.402 . . . . 1.76 111.134 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.757 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -132.12 159.29 39.34 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.525 0.678 . . . . 1.01 110.054 -177.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.613 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.37 82.25 7.26 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.317 -1.311 . . . . 0.20999999999999999 108.229 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -69.25 -15.13 63.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.205 -1.361 . . . . 1.0 109.907 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.28 -30.33 48.42 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.999 -0.741 . . . . 1.02 108.999 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.613 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 14.2 tp10 -65.64 -35.2 80.12 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.784 1.278 . . . . 1.73 108.936 170.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.9 -45.9 63.48 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 112.832 -1.985 . . . . 1.04 109.366 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.603 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 55.9 m -63.87 -34.13 77.26 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.064 -1.426 . . . . 1.04 110.527 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -42.03 85.39 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.884 -1.154 . . . . 1.47 107.884 173.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 64' ' ' TRP . 60.0 m -65.45 -30.99 71.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.252 -0.885 . . . . 1.03 110.984 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.758 HD21 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.21 -69.54 0.11 Allowed 'General case' 0 CA--C 1.492 -1.265 0 CA-C-N 115.781 -0.645 . . . . 1.3 109.282 172.04 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.583 ' O ' HD11 ' A' ' 121' ' ' LEU . 60.1 mtp180 -40.64 -37.61 0.76 Allowed 'General case' 0 C--N 1.311 -1.073 0 O-C-N 124.3 1.0 . . . . 1.8 111.499 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -70.79 -46.24 63.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.716 -1.129 . . . . 0.41999999999999998 112.067 -177.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.47 -33.52 64.89 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.156 0.979 . . . . 1.01 108.532 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.673 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -63.58 -33.95 76.74 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.454 -1.703 . . . . 1.01 109.918 172.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 110' ' ' ARG . . . -76.09 -43.51 43.11 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.763 -1.108 . . . . 1.03 111.226 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.28 -38.49 65.94 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.562 -1.199 . . . . 1.55 110.414 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.545 ' OD1' ' HG3' ' A' ' 118' ' ' LYS . 12.2 t-20 -69.11 -47.59 64.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 113.382 -1.736 . . . . 2.0499999999999998 109.398 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.53 -8.39 68.81 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 116.033 -0.531 . . . . 0.54000000000000004 113.762 171.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.545 ' HG3' ' OD1' ' A' ' 116' ' ' ASN . 15.6 mtmm -72.67 -33.93 66.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.096 -0.642 . . . . 1.6000000000000001 111.154 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.699 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 15.1 m-85 -90.92 176.91 6.44 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 122.328 1.061 . . . . 0.27000000000000002 112.526 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.8 m -120.8 117.61 27.86 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 112.85 -1.977 . . . . 1.0800000000000001 108.151 168.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.601 HD23 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -88.63 132.85 34.38 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 115.362 -0.836 . . . . 1.1499999999999999 110.367 -171.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.532 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.9 OUTLIER -78.33 155.37 5.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 109.057 -0.72 . . . . 1.0900000000000001 109.057 177.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.567 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 57.7 m -100.38 160.85 14.01 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.079 0.942 . . . . 1.8200000000000001 110.55 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.08 -27.99 65.06 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 113.322 -1.763 . . . . 1.1899999999999999 110.453 -173.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.672 ' O ' ' HG3' ' A' ' 129' ' ' MET . 9.4 pt20 -55.22 -27.9 49.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.363 -1.744 . . . . 2.04 110.518 172.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.554 ' HB2' HG23 ' A' ' 155' ' ' VAL . 2.6 mt-30 -97.73 -57.0 2.34 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.206 -1.361 . . . . 0.42999999999999999 110.106 172.236 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.49 HD13 HD23 ' A' ' 88' ' ' LEU . 17.7 tp -65.57 -67.4 0.44 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.063 -1.426 . . . . 2.04 113.603 -168.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.597 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 56.8 m -52.09 -40.58 61.46 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 123.37 1.557 . . . . 1.1499999999999999 109.116 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.675 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 13.6 mmt -57.26 -62.63 1.63 Allowed 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 111.177 -2.738 . . . . 2.27 111.002 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.695 ' CB ' HG22 ' A' ' 151' ' ' ILE . . . -42.22 -45.43 4.12 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 124.38 1.05 . . . . 1.0700000000000001 111.875 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.464 ' HA ' HD12 ' A' ' 151' ' ' ILE . 1.0 OUTLIER -53.55 -53.6 49.26 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 108.954 -0.758 . . . . 2.1000000000000001 108.954 178.658 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.0 mt-30 -64.23 -39.77 94.67 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.466 -0.788 . . . . 0.42999999999999999 111.128 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.675 ' HG3' ' O ' ' A' ' 129' ' ' MET . 53.0 mt-30 -59.0 -34.66 72.11 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 114.354 -1.294 . . . . 0.38 109.83 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.581 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.7 -28.79 17.21 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 114.243 -1.344 . . . . 1.05 109.644 -176.259 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.58 -42.92 0.7 Allowed Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 119.894 -1.146 . . . . 0.33000000000000002 113.426 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.542 HD11 ' O ' ' A' ' 141' ' ' SER . 94.0 mt -69.9 -171.46 0.42 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 124.102 1.906 . . . . 1.0700000000000001 115.472 -169.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 32.1 m -114.89 153.93 46.99 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 110.353 -3.112 . . . . 1.24 107.194 174.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.597 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 64.6 Cg_endo -68.91 1.22 4.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.416 2.077 . . . . 0.39000000000000001 110.91 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.498 ' H ' ' C ' ' A' ' 137' ' ' SER . 20.8 mt-30 -117.56 -23.35 7.72 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.132 -1.395 . . . . 1.79 111.031 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.627 ' O ' ' HB2' ' A' ' 141' ' ' SER . 14.3 t70 -69.05 -22.14 64.05 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 114.515 -1.22 . . . . 0.65000000000000002 108.879 -169.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.627 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 32.3 m 71.76 166.94 0.3 Allowed 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 112.485 -2.143 . . . . 0.73999999999999999 109.578 -170.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.802 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 3.6 mt -65.48 -40.15 92.78 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 122.191 0.996 . . . . 1.48 108.317 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.14 -12.18 0.27 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 113.047 -1.888 . . . . 0.34999999999999998 114.476 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.425 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -152.25 123.3 7.57 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.023 -0.732 . . . . 1.02 109.023 -173.254 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.657 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -42.43 -45.56 4.43 Favored 'General case' 0 C--O 1.213 -0.843 0 O-C-N 123.394 0.434 . . . . 2.21 111.73 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -73.93 -25.49 60.01 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.676 0.751 . . . . 0.93000000000000005 111.407 -174.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -73.55 -30.47 63.07 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.634 1.207 . . . . 1.8899999999999999 108.331 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.642 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -75.41 -47.72 26.09 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 112.577 -2.102 . . . . 0.98999999999999999 110.36 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.553 ' HA ' HG21 ' A' ' 181' ' ' VAL . 43.6 mt -65.49 -41.46 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-N 112.88 -1.964 . . . . 1.03 110.44 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.12 -53.53 36.8 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.67 -1.15 . . . . 0.14999999999999999 111.25 171.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.706 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 83.9 mt -66.67 -48.3 80.58 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 N-CA-C 112.172 0.434 . . . . 1.05 112.172 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.655 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -54.43 -44.46 72.46 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 123.603 0.565 . . . . 1.03 111.248 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.447 ' NE ' HG21 ' A' ' 149' ' ' ILE . 49.7 mtt180 -78.76 -23.14 45.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.295 0.569 . . . . 1.29 110.882 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.467 HD22 ' CD ' ' A' ' 133' ' ' GLN . 35.0 t30 -81.6 -13.66 57.72 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.641 -1.244 . . . . 0.5 107.641 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.706 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.01 -28.91 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 113.313 -1.767 . . . . 1.05 111.041 -173.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.88 34.85 4.76 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.261 -0.971 . . . . 0.17000000000000001 112.365 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.608 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.91 157.34 19.34 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.886 0.698 . . . . 1.02 112.886 -170.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.643 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.8 m80 -98.92 -28.63 13.35 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.137 -0.938 . . . . 0.39000000000000001 109.425 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.567 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.1 m-85 -135.13 -173.97 3.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.063 -0.971 . . . . 0.81000000000000005 110.856 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.704 ' O ' HD21 ' A' ' 178' ' ' LEU . 1.2 t -136.97 139.97 43.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.13 -0.941 . . . . 1.03 108.93 166.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.6 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 40.1 tp -107.8 100.12 9.52 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.237 -0.985 . . . . 1.02 109.318 165.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.547 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.7 m-85 -80.39 116.65 20.57 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.226 -1.352 . . . . 0.87 108.577 176.485 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.871 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 4.7 t -129.01 162.55 27.36 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.948 0.88 . . . . 1.45 110.607 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.79 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.4 p -162.4 176.24 10.7 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.4 -1.273 . . . . 0.12 110.971 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -137.91 134.76 35.38 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.086 -1.416 . . . . 0.94999999999999996 108.513 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.642 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.4 m -144.19 -176.0 4.84 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.278 -0.638 . . . . 1.1499999999999999 109.278 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -84.21 0.92 Allowed Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.824 -1.179 . . . . 0.14999999999999999 111.407 173.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.461 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.3 t30 -144.49 128.19 17.2 Favored 'General case' 0 C--O 1.197 -1.665 0 N-CA-C 107.921 -1.141 . . . . 0.58999999999999997 107.921 176.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.518 HG12 ' HA3' ' A' ' 98' ' ' GLY . 2.7 p -63.22 -41.77 94.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.136 -0.938 . . . . 1.0 112.334 -172.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.454 ' N ' HG13 ' A' ' 169' ' ' VAL . 8.7 m120 -59.17 -31.67 69.2 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.49 0.662 . . . . 1.9199999999999999 109.552 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.05 89.2 3.11 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 114.329 -1.305 . . . . 1.0600000000000001 108.351 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.648 ' HD2' HG23 ' A' ' 194' ' ' VAL . 44.5 Cg_endo -90.49 166.98 4.23 Favored 'Trans proline' 0 CA--C 1.494 -1.492 0 C-N-CA 124.481 3.454 . . . . 0.089999999999999997 114.815 -169.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.554 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 25.3 m -85.75 120.19 26.91 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 113.904 -1.498 . . . . 1.0600000000000001 107.369 165.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.83 HD12 ' OG ' ' A' ' 163' ' ' SER . 44.4 tp -84.68 98.66 10.34 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 108.714 -0.847 . . . . 1.02 108.714 176.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.532 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -89.93 109.39 20.41 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 122.097 0.951 . . . . 0.34000000000000002 109.265 -176.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.871 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.9 OUTLIER -112.48 163.83 14.0 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.76 -1.109 . . . . 1.0900000000000001 111.538 -173.286 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.547 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 56.5 tt0 -170.67 119.02 0.53 Allowed 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.89 -0.596 . . . . 0.68000000000000005 109.98 -166.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.704 HD21 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -101.25 100.15 10.64 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.671 -0.863 . . . . 1.03 108.671 -173.268 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.657 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.8 ttp -89.42 123.06 33.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.433 -0.803 . . . . 0.89000000000000001 109.548 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.2 OUTLIER -59.63 127.36 31.64 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.892 -1.522 . . . . 1.04 106.892 166.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -81.93 -35.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 O-C-N 121.131 -0.981 . . . . 1.02 110.904 179.214 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -61.68 -16.2 46.79 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 0.40000000000000002 111.087 -177.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 73.9 p -129.66 -37.05 1.59 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.752 0.786 . . . . 1.03 110.199 178.075 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.432 ' CA ' HD12 ' A' ' 149' ' ' ILE . . . 90.82 24.88 26.51 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 114.701 -1.136 . . . . 0.17999999999999999 112.387 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -103.85 156.4 17.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.679 0.276 . . . . 0.72999999999999998 110.481 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.469 HD11 ' HG2' ' A' ' 177' ' ' GLN . 32.1 mm -89.22 117.0 31.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.552 0.692 . . . . 1.03 109.335 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.704 ' CD1' HD13 ' A' ' 178' ' ' LEU . 1.4 pp -104.99 -30.54 2.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.098 -0.955 . . . . 1.01 110.341 -174.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.646 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.0 t90 -136.42 152.22 50.36 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.397 -0.819 . . . . 0.070000000000000007 109.417 172.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 77.2 p -153.59 163.32 40.18 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.891 -0.724 . . . . 0.64000000000000001 112.926 163.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.44 -174.93 28.78 Favored Glycine 0 N--CA 1.425 -2.047 0 N-CA-C 110.885 -0.886 . . . . 0.12 110.885 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.83 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.8 mtmt -158.96 151.28 21.4 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.383 -2.08 . . . . 1.76 105.383 165.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.446 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -159.43 127.24 1.79 Allowed Glycine 0 C--N 1.278 -2.676 0 C-N-CA 119.623 -1.275 . . . . 0.13 112.108 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 173' ' ' THR . . . -72.17 115.08 10.98 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.404 0.621 . . . . 1.01 111.065 -174.535 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.71 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -91.87 158.45 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-O 122.59 1.186 . . . . 1.01 110.181 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.676 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.85 172.26 7.04 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 112.564 -2.107 . . . . 0.92000000000000004 109.166 -174.265 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.573 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.9 tt0 -100.42 130.65 46.53 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.261 -0.644 . . . . 0.91000000000000003 109.261 169.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.466 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 26.7 mm-40 . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 115.883 -0.599 . . . . 1.24 110.138 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.674 0 N-CA-C 111.884 -0.486 . . . . 88.920000000000002 111.884 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.468 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 44.9 m -142.43 28.11 1.67 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.61 -0.347 . . . . 87.459999999999994 111.446 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.431 ' O ' HG22 ' A' ' 5' ' ' VAL . 96.6 m-70 -71.34 116.78 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 87.5 110.247 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.2 ttp 51.58 44.02 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.897 0.856 . . . . 85.340000000000003 110.127 -171.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' HB ' ' HA ' ' A' ' 2' ' ' SER . 97.3 t -130.73 -46.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.831 -1.077 . . . . 85.230000000000004 109.897 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.35 -112.47 1.34 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.625 -0.798 . . . . 84.849999999999994 112.151 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -118.27 -168.46 1.53 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 123.013 -0.11 . . . . 85.599999999999994 111.085 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 0.1 OUTLIER 53.29 63.85 2.07 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.773 0.671 . . . . 85.310000000000002 111.663 -176.665 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.529 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 44.0 tt0 175.05 -52.97 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 114.822 -1.081 . . . . 82.170000000000002 110.903 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 9' ' ' GLU . 10.2 Cg_endo -51.76 105.67 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.543 2.162 . . . . 82.069999999999993 112.618 177.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.13 77.07 1.19 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.23 -0.441 . . . . 79.709999999999994 110.087 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.68 140.54 81.4 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.159 1.906 . . . . 79.019999999999996 112.318 -176.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.05 160.26 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.439 0.638 . . . . 77.260000000000005 111.233 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.89 133.34 41.37 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.206 -0.906 . . . . 75.739999999999995 109.774 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -135.63 92.79 2.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.134 0.492 . . . . 74.010000000000005 111.08 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 p -69.12 109.03 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.488 -0.778 . . . . 72.569999999999993 109.994 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -112.16 101.05 51.19 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.847 -0.615 . . . . 71.379999999999995 110.32 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.23 -48.51 17.48 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.076 1.85 . . . . 70.189999999999998 111.899 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.05 65.69 4.63 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-N 114.714 -1.13 . . . . 67.769999999999996 111.709 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.79 155.86 39.43 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.078 1.852 . . . . 67.180000000000007 112.169 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -173.03 137.78 0.73 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.076 -0.511 . . . . 65.200000000000003 110.207 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -138.02 125.64 13.82 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.149 -0.686 . . . . 63.460000000000001 109.149 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -49.81 137.13 35.25 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.95 2.434 . . . . 62.479999999999997 112.826 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -119.5 98.11 5.98 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.223 -0.899 . . . . 59.869999999999997 110.207 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -112.16 139.48 22.51 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.978 -0.555 . . . . 58.890000000000001 110.374 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.17 129.02 20.68 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.958 1.772 . . . . 57.890000000000001 111.834 177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -115.44 68.21 0.71 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.698 0.761 . . . . 55.729999999999997 109.94 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -120.32 84.34 34.67 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.511 -0.768 . . . . 54.079999999999998 110.096 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.48 157.27 28.88 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.285 1.99 . . . . 53.299999999999997 112.161 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.5 p -158.71 76.74 3.33 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 122.089 0.947 . . . . 51.130000000000003 110.365 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -86.78 102.77 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.212 2.608 . . . . 49.75 111.287 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.4 p -85.53 141.48 29.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.177 -0.465 . . . . 47.700000000000003 111.592 -175.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.36 82.31 68.18 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.976 -0.557 . . . . 46.109999999999999 110.185 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -64.13 156.28 60.06 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.175 2.584 . . . . 45.890000000000001 112.749 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.0 m -157.21 120.78 4.15 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.413 -0.812 . . . . 43.0 109.988 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.51 103.9 55.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.101 -0.499 . . . . 40.789999999999999 110.658 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -59.29 150.33 75.18 Favored 'Trans proline' 0 CA--C 1.52 -0.194 0 C-N-CA 122.67 2.246 . . . . 40.450000000000003 111.962 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 93.1 m -145.55 124.39 12.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.238 -0.437 . . . . 37.729999999999997 110.459 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.7 mt -96.26 115.03 65.37 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.767 -0.651 . . . . 35.990000000000002 110.905 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.81 144.54 93.79 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.865 2.377 . . . . 34.350000000000001 111.842 177.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -144.13 141.14 29.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.813 -0.439 . . . . 31.780000000000001 109.813 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.407 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 10.5 pt20 -131.59 88.28 43.51 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.103 0.478 . . . . 30.390000000000001 111.116 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.31 134.99 19.82 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.607 2.205 . . . . 29.940000000000001 111.806 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.18 156.71 26.63 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.624 -0.798 . . . . 26.75 112.124 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.68 129.03 8.97 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.339 2.692 . . . . 25.879999999999999 113.052 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.3 mt -84.64 -70.52 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.613 -0.514 . . . . 24.16 109.613 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 60.56 101.85 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.918 -1.037 . . . . 21.829999999999998 112.989 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -120.06 173.54 7.02 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.157 -0.474 . . . . 20.620000000000001 110.207 169.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.02 -176.16 5.8 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.083 -0.508 . . . . 16.559999999999999 110.021 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.7 87.22 2.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.003 -0.544 . . . . 15.050000000000001 110.419 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -86.48 170.02 12.32 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.999 -0.546 . . . . 14.66 110.92 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.5 p -115.52 133.93 55.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.355 0.597 . . . . 11.84 110.117 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.507 ' HB2' ' HD3' ' A' ' 54' ' ' PRO . . . -85.75 -52.36 0.47 Allowed Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.252 -0.885 . . . . 8.4399999999999995 112.222 -175.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HD3' ' HB2' ' A' ' 53' ' ' ALA . 87.7 Cg_endo -88.54 131.02 2.38 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.347 1.365 . . . . 7.6600000000000001 112.446 176.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -73.21 -172.78 1.09 Allowed 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.186 1.924 . . . . 5.6600000000000001 111.901 175.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 60.91 68.34 1.29 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 114.693 -1.139 . . . . 2.8700000000000001 111.933 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -71.1 -177.13 2.14 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.959 2.439 . . . . 1.8300000000000001 112.177 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -114.79 146.66 40.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.737 -1.12 . . . . 4.2199999999999998 109.979 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.601 HG23 ' N ' ' A' ' 60' ' ' ARG . 10.3 mt -88.75 170.44 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.459 -0.791 . . . . 1.1299999999999999 111.615 -177.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.601 ' N ' HG23 ' A' ' 59' ' ' ILE . 30.4 mtt85 -69.79 -156.67 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.763 -1.562 . . . . 3.1400000000000001 112.575 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.638 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 21.5 t-160 -158.41 145.62 17.82 Favored 'General case' 0 CA--C 1.473 -2.0 0 CA-C-N 111.904 -2.407 . . . . 2.7400000000000002 106.595 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.753 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.6 m-30 -124.27 159.6 29.85 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.459 -0.791 . . . . 0.76000000000000001 109.662 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.525 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 15.7 t70 -80.15 67.06 5.85 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 123.289 1.519 . . . . 0.34999999999999998 108.257 172.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.714 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.6 m95 -59.01 -44.17 91.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 111.77 -2.468 . . . . 0.10000000000000001 112.109 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.451 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 13.3 t-20 -51.51 -29.33 16.29 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.04 -1.436 . . . . 1.1100000000000001 111.37 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.5 -16.49 80.69 Favored Glycine 0 C--N 1.314 -0.683 0 CA-C-N 115.385 -0.825 . . . . 0.23000000000000001 111.254 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.73 -53.16 3.03 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.062 -1.069 . . . . 1.01 111.091 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.734 ' SD ' HD21 ' A' ' 109' ' ' LEU . 41.8 mtt -63.56 -57.94 8.55 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 114.229 -1.35 . . . . 0.089999999999999997 112.139 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.451 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.9 mm-40 -38.61 -55.31 2.67 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 115.172 1.545 . . . . 0.63 115.172 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.73 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.6 Cg_endo -65.04 -28.85 57.22 Favored 'Trans proline' 0 CA--C 1.51 -0.716 0 C-N-CA 121.673 1.582 . . . . 0.17000000000000001 110.649 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.889 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 11.3 mtm -84.47 -40.73 17.35 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.198 -0.91 . . . . 0.69999999999999996 111.452 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 68' ' ' MET . 60.4 t -57.73 -38.32 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 CA-C-O 122.353 1.073 . . . . 1.04 108.506 172.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 t -60.52 -35.41 75.9 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.014 -1.903 . . . . 1.1200000000000001 111.11 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.73 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 27.6 mtpt -81.37 -38.82 26.01 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.577 -0.527 . . . . 1.8799999999999999 109.577 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.826 ' SD ' ' HE2' ' A' ' 119' ' ' PHE . 1.2 ttm -47.19 -54.6 10.29 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 123.901 0.751 . . . . 0.5 110.355 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.636 ' N ' ' HG2' ' A' ' 75' ' ' MET . 4.7 mt -80.03 7.62 8.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.525 -1.216 . . . . 1.29 112.285 -169.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.96 17.33 8.68 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 113.941 -1.481 . . . . 0.17999999999999999 109.88 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.586 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -81.83 165.15 21.11 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.404 0.621 . . . . 1.0 110.252 176.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -87.06 107.6 18.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.281 -0.872 . . . . 1.72 109.797 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.643 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 133.96 -24.89 3.58 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 110.763 -0.935 . . . . 0.13 110.763 -178.104 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 75' ' ' MET . 10.8 p -102.92 151.08 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.777 0.799 . . . . 1.01 111.164 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.5 m -135.91 142.73 44.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.43 -1.259 . . . . 1.1000000000000001 110.211 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.477 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -56.14 142.84 35.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.585 -0.734 . . . . 1.1200000000000001 110.469 166.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.32 11.33 58.55 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.778 -0.725 . . . . 0.28000000000000003 113.17 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.55 153.14 18.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.148 0.474 . . . . 1.55 110.552 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -82.28 120.47 33.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 108.772 -0.825 . . . . 1.03 108.772 166.191 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.622 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -108.45 109.78 21.14 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.542 -0.754 . . . . 1.03 109.308 -171.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.715 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -73.13 94.5 1.94 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.504 -1.225 . . . . 1.01 108.945 177.378 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.474 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 2.0 m -73.04 115.93 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 106.902 -1.518 . . . . 1.6200000000000001 106.902 174.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.86 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 13.3 t0 -79.97 170.4 16.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.331 -0.989 . . . . 0.64000000000000001 108.331 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.522 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.5 OUTLIER -55.5 148.72 14.94 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-O 122.774 1.273 . . . . 1.05 109.375 170.278 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.555 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 34.6 t -77.62 140.5 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.172 0 N-CA-C 106.81 -1.552 . . . . 1.02 106.81 165.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.642 ' H ' ' HA ' ' A' ' 164' ' ' SER . 5.5 t-20 -85.55 160.91 19.54 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 122.031 0.919 . . . . 0.20000000000000001 110.344 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.748 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -124.27 84.63 2.3 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 113.939 -1.482 . . . . 0.12 107.575 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 13.2 mtp180 -107.18 -2.07 21.24 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 113.66 -1.609 . . . . 0.84999999999999998 108.411 -172.785 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.643 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 22.3 p -50.96 -177.73 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.36 -1.745 . . . . 0.91000000000000003 113.799 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.413 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 1.5 t30 -73.49 -7.62 52.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.065 -1.88 . . . . 0.62 110.263 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.529 ' HA3' HG13 ' A' ' 169' ' ' VAL . . . -142.37 -151.43 5.51 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.944 -0.645 . . . . 0.14000000000000001 112.869 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.585 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 51.8 m -121.92 130.58 53.45 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.955 0.407 . . . . 1.76 111.728 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.748 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.0 pp -134.84 158.19 44.85 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.876 0.846 . . . . 1.01 110.795 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.601 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -80.64 79.69 7.23 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.019 -1.446 . . . . 0.20999999999999999 108.08 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.592 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -67.57 -15.77 63.83 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.376 -1.284 . . . . 1.0 109.846 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.55 -31.56 42.02 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.888 -0.782 . . . . 1.02 108.888 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.601 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.6 tp10 -66.04 -33.98 77.03 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.697 1.237 . . . . 1.73 108.876 171.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -72.29 -43.42 64.25 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 113.118 -1.855 . . . . 1.04 109.656 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 63.7 m -63.91 -32.2 73.65 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.107 -1.406 . . . . 1.04 110.537 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -40.99 80.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.997 -1.112 . . . . 1.47 107.997 173.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.643 HG23 ' HB2' ' A' ' 64' ' ' TRP . 54.7 m -64.5 -31.06 72.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.21 -0.904 . . . . 1.03 110.693 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.734 HD21 ' SD ' ' A' ' 68' ' ' MET . 8.4 mt -51.74 -70.05 0.1 Allowed 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.296 -0.631 . . . . 1.3 109.296 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.672 ' O ' HD12 ' A' ' 121' ' ' LEU . 21.2 mtp180 -39.72 -38.46 0.64 Allowed 'General case' 0 C--N 1.315 -0.933 0 O-C-N 124.436 1.085 . . . . 1.8 111.331 174.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.524 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.86 -46.89 61.87 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.578 -1.192 . . . . 0.41999999999999998 112.313 -177.253 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.403 ' HB2' ' HG2' ' A' ' 69' ' ' GLN . . . -72.57 -31.0 64.89 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.227 1.013 . . . . 1.01 108.471 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.725 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -66.15 -32.55 74.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.511 -1.677 . . . . 1.01 109.906 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.405 ' CB ' HD11 ' A' ' 121' ' ' LEU . . . -72.31 -39.39 68.27 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.48 -1.236 . . . . 1.03 111.565 -175.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -66.97 -21.69 65.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.061 -0.972 . . . . 1.55 111.265 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.69 -14.41 28.08 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.053 -0.521 . . . . 2.0499999999999998 111.753 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.24 -11.89 0.69 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 116.164 1.226 . . . . 0.54000000000000004 116.164 163.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.477 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 51.7 mtpt -74.51 -33.03 62.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.819 0.81 . . . . 1.6000000000000001 111.139 -177.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.826 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 20.8 m-85 -93.6 178.2 5.77 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 122.391 1.091 . . . . 0.27000000000000002 112.678 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.468 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 6.2 m -121.25 116.95 25.83 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 112.901 -1.954 . . . . 1.0800000000000001 107.822 168.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -87.54 135.49 33.33 Favored 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 119.477 -0.889 . . . . 1.1499999999999999 110.751 -171.781 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.658 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.7 OUTLIER -79.59 154.88 4.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 108.923 -0.769 . . . . 1.0900000000000001 108.923 173.556 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.533 ' CB ' ' HG2' ' A' ' 125' ' ' GLN . 35.0 m -95.52 160.11 14.67 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.713 0.768 . . . . 1.8200000000000001 109.89 176.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.507 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . . . -73.58 -21.09 60.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.129 -1.396 . . . . 1.1899999999999999 109.907 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.662 ' O ' ' HG3' ' A' ' 129' ' ' MET . 9.5 pt20 -57.13 -26.82 61.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.442 -1.254 . . . . 2.04 109.491 170.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.658 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 2.3 mt-30 -98.41 -52.48 3.63 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 114.292 -1.322 . . . . 0.42999999999999999 110.598 171.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.655 HD23 ' NZ ' ' A' ' 131' ' ' LYS . 1.9 tm? -70.26 -62.85 1.23 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.692 -1.14 . . . . 2.04 113.218 -167.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.624 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.5 OUTLIER -52.34 -39.89 61.26 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 123.712 1.72 . . . . 1.1499999999999999 108.753 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.662 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -62.9 -59.85 4.28 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 110.694 -2.957 . . . . 2.27 110.783 179.167 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.68 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.86 -40.01 5.85 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 124.098 0.874 . . . . 1.0700000000000001 112.006 175.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.74 ' NZ ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -51.52 -60.46 3.12 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.825 -0.75 . . . . 2.1000000000000001 109.215 175.329 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 40.3 mt-30 -58.74 -44.66 90.58 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.379 -1.282 . . . . 0.42999999999999999 111.7 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 129' ' ' MET . 43.5 mt-30 -55.33 -34.2 64.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.986 -1.006 . . . . 0.38 110.151 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 134' ' ' LEU . 0.6 OUTLIER -93.59 -30.56 14.91 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.991 -1.459 . . . . 1.05 109.364 -178.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 161.43 -54.9 0.32 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.929 -1.129 . . . . 0.33000000000000002 114.086 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.506 ' CD1' ' HA ' ' A' ' 142' ' ' LEU . 43.8 mt -64.05 -172.36 0.06 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 116.385 1.994 . . . . 1.0700000000000001 116.385 -168.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.524 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.5 m -111.16 150.7 42.37 Favored Pre-proline 0 N--CA 1.428 -1.54 0 CA-C-N 110.954 -2.839 . . . . 1.24 108.777 170.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.624 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 15.1 Cg_endo -60.08 -2.49 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 123.357 2.705 . . . . 0.39000000000000001 113.107 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.495 ' OE1' ' HA ' ' A' ' 101' ' ' ASN . 0.8 OUTLIER -117.44 -26.41 6.68 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.911 0.862 . . . . 1.79 110.647 -177.022 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 141' ' ' SER . 4.6 t70 -64.8 -24.56 67.59 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 113.696 -1.593 . . . . 0.65000000000000002 109.359 -171.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.54 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 22.6 m 66.33 161.56 0.15 Allowed 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 112.689 -2.05 . . . . 0.73999999999999999 109.995 -175.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.86 ' HG ' ' CG ' ' A' ' 90' ' ' ASP . 9.2 mt -73.19 -35.63 66.4 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.148 -1.842 . . . . 1.48 109.204 -169.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.36 2.98 0.31 Allowed Glycine 0 C--N 1.318 -0.464 0 CA-C-N 113.164 -1.835 . . . . 0.34999999999999998 114.949 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 118.14 5.27 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 109.07 -0.715 . . . . 1.02 109.07 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.685 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 13.0 mmt180 -40.23 -47.87 2.5 Favored 'General case' 0 C--O 1.214 -0.783 0 O-C-N 123.696 0.623 . . . . 2.21 111.448 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -69.77 -28.24 65.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.477 0.656 . . . . 0.93000000000000005 111.461 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.536 ' O ' HD11 ' A' ' 151' ' ' ILE . 21.2 mttm -72.82 -31.32 64.72 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.38 1.086 . . . . 1.8899999999999999 108.276 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.687 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -77.75 -38.94 45.86 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 113.15 -1.841 . . . . 0.98999999999999999 110.798 178.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.527 HG13 ' HE2' ' A' ' 179' ' ' MET . 33.0 mt -69.78 -43.17 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 CA-C-N 113.821 -1.536 . . . . 1.03 109.978 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.73 -53.57 35.43 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.177 -0.919 . . . . 0.14999999999999999 110.979 171.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.732 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 7.6 mt -67.14 -44.92 87.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.028 0 N-CA-C 113.069 0.766 . . . . 1.05 113.069 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.631 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.65 -37.9 76.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 118.447 0.567 . . . . 1.03 110.513 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 46.8 mtp180 -83.18 -21.7 33.44 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.799 0.809 . . . . 1.29 110.407 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 13.8 t30 -82.58 -10.32 59.02 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.187 -1.412 . . . . 0.5 107.187 175.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.732 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -109.79 -29.24 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 113.294 -1.775 . . . . 1.05 111.107 -174.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.76 35.38 4.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.563 -0.827 . . . . 0.17000000000000001 112.642 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.715 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -112.09 159.28 18.66 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.416 0.895 . . . . 1.02 113.416 -169.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.651 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.1 m80 -100.32 -25.99 14.05 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.486 -0.779 . . . . 0.39000000000000001 110.068 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.571 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.5 m-85 -135.57 -172.62 3.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.234 -0.894 . . . . 0.81000000000000005 110.959 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.687 ' O ' HD21 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -138.81 136.72 43.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.013 -0.994 . . . . 1.03 108.964 167.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.525 HD22 ' HE1' ' A' ' 176' ' ' MET . 48.6 tp -106.96 99.44 9.01 Favored 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 119.637 -0.825 . . . . 1.02 108.995 165.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.687 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -81.54 111.97 18.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.103 -1.408 . . . . 0.87 109.448 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.842 ' OG ' HD11 ' A' ' 174' ' ' LEU . 31.4 t -121.31 166.33 14.2 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 121.699 0.761 . . . . 1.45 110.753 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.814 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.5 p -164.87 176.34 8.79 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-N 114.625 -1.17 . . . . 0.12 111.351 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -142.64 135.36 28.03 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.294 -1.321 . . . . 0.94999999999999996 108.499 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.643 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 3.1 m -144.42 -175.79 4.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.516 -0.55 . . . . 1.1499999999999999 109.516 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.6 -80.12 0.82 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 119.463 -1.351 . . . . 0.14999999999999999 112.025 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.413 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.5 t30 -148.92 123.2 9.58 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 106.917 -1.512 . . . . 0.58999999999999997 106.917 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.529 HG13 ' HA3' ' A' ' 98' ' ' GLY . 2.3 p -59.49 -45.65 93.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.121 -0.945 . . . . 1.0 113.287 -172.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.443 ' N ' HG11 ' A' ' 169' ' ' VAL . 8.9 m120 -60.02 -29.57 68.59 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.452 0.644 . . . . 1.9199999999999999 109.703 -176.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.91 88.03 3.6 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.441 -1.254 . . . . 1.0600000000000001 108.512 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.65 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.6 Cg_endo -91.22 166.47 3.63 Favored 'Trans proline' 0 CA--C 1.496 -1.407 0 C-N-CA 124.835 3.69 . . . . 0.089999999999999997 114.98 -170.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.611 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.2 m -83.19 117.95 23.27 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.856 -1.52 . . . . 1.0600000000000001 107.638 166.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.842 HD11 ' OG ' ' A' ' 163' ' ' SER . 46.4 tp -84.46 99.25 10.57 Favored 'General case' 0 N--CA 1.412 -2.325 0 C-N-CA 119.747 -0.781 . . . . 1.02 109.289 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.615 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.2 mt-30 -89.51 107.36 19.03 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 114.966 -1.015 . . . . 0.34000000000000002 109.291 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.889 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 37.5 mtp -106.52 161.83 14.26 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.212 -0.904 . . . . 1.0900000000000001 110.382 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.489 ' HG2' HD12 ' A' ' 186' ' ' ILE . 53.2 tt0 -167.47 119.03 0.88 Allowed 'General case' 0 C--O 1.207 -1.183 0 CA-C-O 121.165 0.507 . . . . 0.68000000000000005 110.025 -168.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.687 HD21 ' O ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER -101.01 101.34 12.1 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.826 -0.805 . . . . 1.03 108.826 -172.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.685 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.0 ttp -91.14 118.95 30.86 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.603 -0.726 . . . . 0.89000000000000001 109.318 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.492 ' HB2' HG22 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -61.85 118.49 7.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.273 -1.38 . . . . 1.04 107.273 169.618 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.518 HG22 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -73.2 -32.88 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 119.516 1.053 . . . . 1.02 111.408 -176.393 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.436 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.1 mt-30 -64.1 -12.84 43.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.40000000000000002 111.538 -177.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 33.1 p -130.12 -37.56 1.46 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.079 0.943 . . . . 1.03 109.892 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.466 ' CA ' HD13 ' A' ' 149' ' ' ILE . . . 88.82 19.47 51.25 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 113.756 -1.565 . . . . 0.17999999999999999 112.08 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.66 156.56 17.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.055 0.455 . . . . 0.72999999999999998 110.677 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.489 HD12 ' HG2' ' A' ' 177' ' ' GLN . 37.9 mm -88.4 117.48 32.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.679 0.752 . . . . 1.03 109.424 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.657 ' CD1' HD12 ' A' ' 178' ' ' LEU . 1.8 pp -104.79 -30.1 2.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.527 -1.215 . . . . 1.01 110.353 -172.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.586 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.3 t90 -137.43 152.33 49.48 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.191 -0.913 . . . . 0.070000000000000007 109.338 172.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 61.2 p -153.58 165.52 35.65 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.865 0.691 . . . . 0.64000000000000001 112.865 164.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.16 -179.43 33.99 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.892 -0.883 . . . . 0.12 110.892 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.817 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.8 mtmt -156.78 147.08 21.26 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.33 -1.73 . . . . 1.76 106.33 167.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -158.04 127.45 1.9 Allowed Glycine 0 C--N 1.283 -2.387 0 C-N-CA 119.94 -1.124 . . . . 0.13 112.266 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.533 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.72 117.02 13.9 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.425 0.631 . . . . 1.01 111.003 -174.376 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.674 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -93.99 159.25 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 122.589 1.185 . . . . 1.01 110.736 -177.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.753 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -101.8 172.08 7.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 112.501 -2.136 . . . . 0.92000000000000004 108.861 -174.695 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 8.3 tt0 -100.77 133.2 45.59 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.075 -0.65 . . . . 0.91000000000000003 109.411 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.504 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 35.1 mm-40 . . . . . 0 C--N 1.316 -0.89 0 CA-C-O 118.656 -0.688 . . . . 1.24 110.518 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 N-CA-C 111.761 -0.535 . . . . 88.920000000000002 111.761 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 t -115.71 124.78 51.71 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.902 -0.407 . . . . 87.459999999999994 109.902 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -113.51 63.19 0.65 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.578 -0.527 . . . . 87.5 109.578 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 ptm -110.76 39.26 2.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.383 0.611 . . . . 85.340000000000003 111.32 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.54 -68.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.267 -0.879 . . . . 85.230000000000004 109.715 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.57 74.65 0.42 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.021 -0.609 . . . . 84.849999999999994 112.342 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.24 139.36 38.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.903 0.382 . . . . 85.599999999999994 110.154 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -143.71 100.17 3.54 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.493 0.663 . . . . 85.310000000000002 110.735 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -94.99 126.84 45.18 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.559 -0.746 . . . . 82.170000000000002 110.563 -178.265 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.74 -176.35 2.77 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.108 1.872 . . . . 82.069999999999993 111.95 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.84 124.97 29.58 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.238 -0.437 . . . . 79.709999999999994 110.074 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -63.27 137.55 61.55 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.467 2.112 . . . . 79.019999999999996 111.955 177.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 26.4 m 51.71 138.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 125.628 1.571 . . . . 77.260000000000005 113.931 -177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -87.07 -33.94 19.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.917 -1.038 . . . . 75.739999999999995 110.714 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 54.17 94.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.944 0.778 . . . . 74.010000000000005 112.319 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.51 116.14 19.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.507 -0.769 . . . . 72.569999999999993 110.334 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.482 ' HB3' ' HZ3' ' A' ' 17' ' ' LYS . 8.5 mtpm? -70.25 138.6 86.93 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.469 . . . . 71.379999999999995 110.401 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.52 121.5 9.97 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.491 2.127 . . . . 70.189999999999998 112.647 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -115.94 135.98 22.84 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.814 -0.63 . . . . 67.769999999999996 109.616 177.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -60.43 114.71 2.24 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.242 1.962 . . . . 67.180000000000007 112.012 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.521 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 10.9 pt-20 -119.41 5.86 11.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.806 0.336 . . . . 65.200000000000003 110.816 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.467 ' HA ' HE21 ' A' ' 22' ' ' GLN . 0.1 OUTLIER -114.59 84.43 9.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.504 -0.316 . . . . 63.460000000000001 110.618 -178.368 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 26.9 Cg_exo -71.4 146.99 51.64 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.374 2.716 . . . . 62.479999999999997 112.306 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.56 80.36 1.9 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.37 0.605 . . . . 59.869999999999997 110.346 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -70.56 134.49 86.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.066 -0.97 . . . . 58.890000000000001 111.138 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.16 158.13 55.65 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.282 1.988 . . . . 57.890000000000001 111.483 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -88.93 152.21 21.86 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.908 -0.317 . . . . 55.729999999999997 110.425 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -89.31 138.55 28.64 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.32 -0.4 . . . . 54.079999999999998 110.152 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.9 136.89 46.94 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.197 1.931 . . . . 53.299999999999997 111.237 175.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.15 96.0 32.43 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-O 121.392 0.615 . . . . 51.130000000000003 110.886 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.53 95.21 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.66 2.24 . . . . 49.75 111.854 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 p -83.08 142.71 31.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.21 -0.45 . . . . 47.700000000000003 110.601 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.5 t 63.32 94.2 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 46.109999999999999 110.621 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -56.98 161.25 10.93 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.494 2.796 . . . . 45.890000000000001 112.985 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.0 m -76.13 132.45 40.03 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.892 -1.049 . . . . 43.0 110.092 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.7 m -58.0 147.76 63.12 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.93 -0.577 . . . . 40.789999999999999 111.041 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -48.42 -47.5 19.97 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.163 2.575 . . . . 40.450000000000003 113.961 -172.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.8 t -54.96 135.24 48.78 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.368 0.604 . . . . 37.729999999999997 110.955 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.9 mt -75.83 128.57 83.19 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.795 -0.639 . . . . 35.990000000000002 110.422 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.16 75.76 0.94 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.055 2.504 . . . . 34.350000000000001 112.011 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -157.74 -44.99 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.614 -0.721 . . . . 31.780000000000001 110.121 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 58.26 81.49 0.25 Allowed Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 115.213 -0.903 . . . . 30.390000000000001 111.492 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.43 123.59 10.7 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.0 1.8 . . . . 29.940000000000001 111.447 175.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.92 -168.7 12.47 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.45 -0.66 . . . . 26.75 111.45 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.02 131.99 19.04 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.531 2.154 . . . . 25.879999999999999 112.01 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.9 mt -79.17 -51.26 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.03 -0.532 . . . . 24.16 110.031 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 67.78 76.26 0.27 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.293 -0.867 . . . . 21.829999999999998 110.668 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.08 146.76 35.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.431 -0.804 . . . . 20.620000000000001 110.202 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -169.35 164.08 10.72 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.193 -0.912 . . . . 16.559999999999999 110.256 -175.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -86.71 77.92 9.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.778 0.799 . . . . 15.050000000000001 110.005 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -60.56 136.94 58.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.381 -0.827 . . . . 14.66 110.118 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.1 p -68.28 145.17 54.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.795 0.807 . . . . 11.84 111.973 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.539 ' HB3' ' HD2' ' A' ' 54' ' ' PRO . . . -100.5 -177.61 0.59 Allowed Pre-proline 0 N--CA 1.436 -1.138 0 CA-C-N 114.545 -1.207 . . . . 8.4399999999999995 108.071 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.539 ' HD2' ' HB3' ' A' ' 53' ' ' ALA . 5.6 Cg_exo -30.65 103.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.34 3.36 . . . . 7.6600000000000001 112.886 170.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.73 -58.16 0.66 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.025 2.483 . . . . 5.6600000000000001 113.633 -171.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -107.78 109.8 62.35 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.058 0.392 . . . . 2.8700000000000001 112.058 -174.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.02 -177.3 3.55 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 123.04 2.493 . . . . 1.8300000000000001 110.61 167.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -104.7 132.51 50.86 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.461 -0.79 . . . . 4.2199999999999998 110.122 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.595 HG21 ' N ' ' A' ' 60' ' ' ARG . 10.4 mt -93.21 172.79 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 122.24 1.019 . . . . 1.1299999999999999 112.842 -172.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.595 ' N ' HG21 ' A' ' 59' ' ' ILE . 25.3 mtt85 -72.3 -158.05 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.399 -1.728 . . . . 3.1400000000000001 111.655 175.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.632 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 41.7 m80 -150.56 142.72 24.11 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.761 -2.018 . . . . 2.7400000000000002 107.128 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.761 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.9 m-30 -126.6 155.53 42.35 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 123.665 0.603 . . . . 0.76000000000000001 110.878 -175.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.528 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 10.6 t0 -85.16 67.64 10.25 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 123.395 1.569 . . . . 0.34999999999999998 108.473 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.761 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 94.9 m95 -57.44 -41.9 81.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.008 -2.36 . . . . 0.10000000000000001 112.769 175.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.484 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 14.7 t-20 -51.95 -25.43 8.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.197 -1.365 . . . . 1.1100000000000001 111.696 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.69 -16.58 78.97 Favored Glycine 0 C--N 1.312 -0.763 0 CA-C-N 115.147 -0.933 . . . . 0.23000000000000001 111.278 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.41 -52.84 3.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.118 -1.041 . . . . 1.01 111.199 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.758 ' SD ' HD22 ' A' ' 109' ' ' LEU . 41.4 mtt -64.59 -58.67 5.7 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 114.122 -1.399 . . . . 0.089999999999999997 112.507 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.515 HE21 ' HA ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -39.42 -54.78 3.56 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 114.794 1.405 . . . . 0.63 114.794 -176.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.785 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 37.4 Cg_endo -64.64 -28.97 60.64 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.532 1.488 . . . . 0.17000000000000001 110.16 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.828 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 10.9 mtm -83.09 -42.04 17.88 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.358 -0.837 . . . . 0.69999999999999996 112.108 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 68' ' ' MET . 58.2 t -57.01 -40.13 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 CA-C-N 114.26 -1.336 . . . . 1.04 108.802 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.68 -36.09 73.64 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.152 -1.84 . . . . 1.1200000000000001 111.054 173.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.785 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.1 mtpt -82.08 -32.91 30.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.011 -0.541 . . . . 1.8799999999999999 111.207 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.851 ' O ' HG12 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.82 -26.16 68.22 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.39 -0.823 . . . . 0.5 111.677 -172.19 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.47 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.9 mt -94.21 -8.02 40.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.124 0.964 . . . . 1.29 110.997 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.82 14.67 60.17 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.664 -1.774 . . . . 0.17999999999999999 108.664 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.661 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -86.46 165.72 16.08 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.159 -1.02 . . . . 1.0 109.818 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -94.46 105.38 17.35 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.252 -0.886 . . . . 1.72 109.914 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.635 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 136.23 -23.4 3.32 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.722 -0.951 . . . . 0.13 110.722 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.851 HG12 ' O ' ' A' ' 75' ' ' MET . 10.7 p -101.21 153.76 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.431 0.634 . . . . 1.01 111.197 -175.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.8 m -135.35 141.84 45.64 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.923 -1.035 . . . . 1.1000000000000001 110.441 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.474 ' HB3' ' HE3' ' A' ' 118' ' ' LYS . . . -59.38 130.25 45.98 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.346 -0.843 . . . . 1.1200000000000001 110.272 168.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.17 3.23 38.77 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.006 -0.616 . . . . 0.28000000000000003 112.876 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.0 151.89 22.87 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 120.488 -0.485 . . . . 1.55 110.97 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.646 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -80.73 119.14 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 121.988 0.899 . . . . 1.03 109.031 165.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.742 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -108.38 107.56 18.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.28 -0.873 . . . . 1.03 109.108 -171.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.676 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -71.43 97.9 1.71 Allowed 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.141 -1.39 . . . . 1.01 107.847 175.575 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.882 ' O ' HD13 ' A' ' 127' ' ' LEU . 2.5 m -71.08 121.91 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 106.608 -1.627 . . . . 1.6200000000000001 106.608 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.791 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 5.0 t0 -76.86 151.04 36.0 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.17 -1.419 . . . . 0.64000000000000001 107.17 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.571 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.1 m -57.53 132.78 54.21 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 106.947 -1.501 . . . . 1.05 106.947 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.586 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 23.1 t -60.55 138.31 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.988 0 N-CA-C 107.88 -1.155 . . . . 1.02 107.88 170.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.641 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -84.19 162.95 20.03 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.337 -0.847 . . . . 0.20000000000000001 109.704 174.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.781 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.1 85.19 2.37 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.748 -1.114 . . . . 0.12 108.114 175.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.46 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.3 mtp180 -108.18 -4.09 17.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.852 -1.522 . . . . 0.84999999999999998 108.77 -171.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 21.4 p -50.59 -171.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.854 -1.975 . . . . 0.91000000000000003 115.547 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 33.3 t30 -68.89 -10.66 58.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.883 -1.962 . . . . 0.62 110.739 173.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.528 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -152.48 -143.93 3.8 Favored Glycine 0 C--O 1.236 0.244 0 C-N-CA 120.258 -0.972 . . . . 0.14000000000000001 113.153 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.591 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 51.5 p -122.36 131.61 53.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.148 0.499 . . . . 1.76 111.949 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.781 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.4 pp -137.43 156.43 48.19 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.846 0.831 . . . . 1.01 110.633 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -79.87 81.09 6.19 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.787 -1.551 . . . . 0.20999999999999999 107.852 176.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 92' ' ' VAL . . . -68.93 -14.72 63.21 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.193 -1.367 . . . . 1.0 109.929 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.74 -30.23 40.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.685 -0.857 . . . . 1.02 108.685 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.617 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 28.2 tp10 -66.0 -34.57 78.4 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.78 1.276 . . . . 1.73 109.068 170.245 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.575 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -71.03 -45.22 64.3 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.049 -1.887 . . . . 1.04 109.227 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.605 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 49.1 m -64.8 -30.58 71.59 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.029 -1.441 . . . . 1.04 110.5 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -67.2 -44.04 80.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.749 -1.204 . . . . 1.47 107.749 171.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.626 HG23 ' HB2' ' A' ' 64' ' ' TRP . 37.7 m -63.24 -31.46 72.61 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.237 -0.892 . . . . 1.03 110.783 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.758 HD22 ' SD ' ' A' ' 68' ' ' MET . 9.3 mt -50.16 -70.47 0.09 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.05 -0.722 . . . . 1.3 109.05 170.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.502 ' O ' HD12 ' A' ' 121' ' ' LEU . 10.9 mtp180 -40.08 -40.32 1.05 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.487 1.117 . . . . 1.8 111.358 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.521 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -67.26 -48.18 68.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.556 -1.202 . . . . 0.41999999999999998 112.137 -177.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.2 -34.97 68.8 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.315 1.055 . . . . 1.01 108.524 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.672 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -63.91 -32.33 73.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.158 -1.837 . . . . 1.01 110.064 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.476 ' HB2' ' O ' ' A' ' 110' ' ' ARG . . . -76.01 -47.5 24.62 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 114.523 -1.217 . . . . 1.03 111.302 -174.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -55.99 -33.13 64.56 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.336 -1.302 . . . . 1.55 110.11 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -70.17 -43.77 70.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.244 -1.798 . . . . 2.0499999999999998 110.784 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.12 -3.39 66.04 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 114.749 0.659 . . . . 0.54000000000000004 114.749 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 83' ' ' ALA . 58.7 mtpt -87.36 -8.2 56.89 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.066 0.933 . . . . 1.6000000000000001 111.192 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.742 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 27.0 m-85 -118.12 174.42 6.22 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 122.421 1.105 . . . . 0.27000000000000002 113.303 173.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.543 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.0 m -118.47 123.88 46.25 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 112.672 -2.058 . . . . 1.0800000000000001 108.021 170.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.661 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -95.66 141.33 29.27 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 119.291 -0.964 . . . . 1.1499999999999999 111.519 -169.645 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.551 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.2 m -97.46 140.55 17.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.802 -1.184 . . . . 1.0900000000000001 107.802 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.429 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 8.7 t -93.93 -177.76 4.44 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 119.274 -0.971 . . . . 1.8200000000000001 111.316 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -63.33 -25.88 68.51 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.295 -1.002 . . . . 1.1899999999999999 108.295 177.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.657 ' O ' ' HG3' ' A' ' 129' ' ' MET . 32.8 mt-30 -51.6 -39.56 58.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.185 -1.825 . . . . 2.04 110.907 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.551 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 8.9 mt-30 -98.62 -50.39 4.28 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.964 0.888 . . . . 0.42999999999999999 110.098 172.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.882 HD13 ' O ' ' A' ' 89' ' ' VAL . 6.3 tt -62.43 -64.98 0.76 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.474 -1.693 . . . . 2.04 113.268 -168.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.677 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -53.92 -43.72 70.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 123.389 1.566 . . . . 1.1499999999999999 109.116 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.669 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -55.59 -60.85 2.85 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 111.226 -2.715 . . . . 2.27 111.3 175.592 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.7 ' CB ' HG22 ' A' ' 151' ' ' ILE . . . -43.49 -46.22 6.77 Favored 'General case' 0 CA--C 1.497 -1.083 0 O-C-N 124.493 1.121 . . . . 1.0700000000000001 111.807 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.505 ' HZ3' ' C ' ' A' ' 141' ' ' SER . 5.8 mttt -53.32 -52.13 60.15 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.39 -0.596 . . . . 2.1000000000000001 109.39 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.408 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.1 mt-30 -66.9 -38.63 86.6 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.542 -0.754 . . . . 0.42999999999999999 110.878 -179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.669 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.2 mt-30 -59.04 -32.3 69.63 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 114.551 -1.204 . . . . 0.38 109.845 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.531 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.7 OUTLIER -94.3 -30.49 14.51 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.123 -1.399 . . . . 1.05 109.929 -177.423 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.06 -50.72 0.46 Allowed Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 120.012 -1.089 . . . . 0.33000000000000002 113.664 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.569 HD12 ' O ' ' A' ' 141' ' ' SER . 92.9 mt -65.36 -171.03 0.07 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 112.496 -1.852 . . . . 1.0700000000000001 115.954 -171.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.548 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.1 m -115.72 151.67 46.5 Favored Pre-proline 0 N--CA 1.424 -1.736 0 CA-C-N 110.65 -2.977 . . . . 1.24 107.985 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.677 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 36.2 Cg_endo -65.4 0.07 3.13 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.871 2.381 . . . . 0.39000000000000001 112.651 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.414 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.1 tt0 -118.74 -25.33 6.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.869 0.843 . . . . 1.79 110.519 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.649 ' O ' ' HB2' ' A' ' 141' ' ' SER . 9.1 t70 -60.98 -23.09 65.09 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.364 -1.744 . . . . 0.65000000000000002 109.079 -173.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 32.6 m 73.91 167.37 0.3 Allowed 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 112.848 -1.978 . . . . 0.73999999999999999 109.393 -174.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.791 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 3.3 mt -64.46 -39.49 93.92 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-O 122.439 1.114 . . . . 1.48 108.421 -175.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.37 -7.29 1.39 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 113.062 -1.881 . . . . 0.34999999999999998 114.163 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.49 126.35 6.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.995 -0.743 . . . . 1.02 108.995 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.67 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.2 mmt180 -41.83 -49.19 4.44 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 118.039 0.381 . . . . 2.21 110.995 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.6 t -69.34 -28.16 65.98 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.368 0.604 . . . . 0.93000000000000005 111.658 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.435 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 24.3 mttm -73.78 -29.95 62.49 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.618 1.199 . . . . 1.8899999999999999 108.668 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.631 ' CB ' HD11 ' A' ' 142' ' ' LEU . . . -75.25 -46.27 34.84 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-N 112.358 -2.201 . . . . 0.98999999999999999 110.358 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.524 HG13 ' HE3' ' A' ' 179' ' ' MET . 43.7 mt -65.97 -42.22 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 112.71 -2.041 . . . . 1.03 110.046 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.0 -52.63 41.99 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.849 -1.069 . . . . 0.14999999999999999 111.433 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.7 HG22 ' CB ' ' A' ' 130' ' ' ALA . 16.7 mt -68.34 -46.95 79.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 N-CA-C 112.346 0.498 . . . . 1.05 112.346 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.612 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.71 -39.7 74.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.954 0.407 . . . . 1.03 110.693 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.426 ' HD2' HG23 ' A' ' 149' ' ' ILE . 34.5 mtp180 -81.41 -23.13 37.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.52 0.676 . . . . 1.29 110.894 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.442 HD22 ' CD ' ' A' ' 133' ' ' GLN . 34.9 t30 -81.09 -13.18 58.98 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.627 -1.249 . . . . 0.5 107.627 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.685 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.92 -29.11 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 113.196 -1.82 . . . . 1.05 110.772 -174.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.59 34.6 5.21 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 120.198 -1.001 . . . . 0.17000000000000001 112.408 -179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.676 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.92 157.27 18.79 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 112.693 0.627 . . . . 1.02 112.693 -170.227 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.646 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.7 m80 -96.74 -27.16 14.88 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.362 -0.835 . . . . 0.39000000000000001 109.445 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.586 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.1 m-85 -137.29 -174.53 3.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.061 -0.972 . . . . 0.81000000000000005 111.325 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.69 ' O ' HD22 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -136.48 140.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.583 -1.19 . . . . 1.03 108.553 166.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.601 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 26.2 tp -110.02 99.89 8.92 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.466 -0.893 . . . . 1.02 109.704 166.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.515 ' HH ' ' HB2' ' A' ' 142' ' ' LEU . 2.3 m-85 -77.92 112.03 14.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.914 -1.039 . . . . 0.87 108.785 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.683 ' OG ' HD12 ' A' ' 109' ' ' LEU . 4.0 p -120.06 158.93 25.81 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 115.093 -0.958 . . . . 1.45 109.56 -175.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.77 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.2 p -163.75 172.56 13.99 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 115.154 -0.93 . . . . 0.12 110.875 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.67 131.81 36.18 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 113.956 -1.475 . . . . 0.94999999999999996 108.536 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -142.5 -176.39 4.83 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.158 -0.682 . . . . 1.1499999999999999 109.158 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -86.05 0.98 Allowed Glycine 0 CA--C 1.49 -1.492 0 C-N-CA 119.55 -1.309 . . . . 0.14999999999999999 111.101 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.454 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.3 t30 -141.59 129.06 21.31 Favored 'General case' 0 C--O 1.198 -1.629 0 CA-C-N 113.867 -1.167 . . . . 0.58999999999999997 107.963 175.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.586 HG22 ' N ' ' A' ' 99' ' ' SER . 3.7 p -64.7 -39.39 85.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.226 -0.897 . . . . 1.0 111.991 -172.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.473 ' N ' HG13 ' A' ' 169' ' ' VAL . 14.4 m-20 -61.3 -31.15 70.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.696 0.76 . . . . 1.9199999999999999 109.411 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.99 88.79 3.17 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 113.916 -1.493 . . . . 1.0600000000000001 107.962 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.657 ' HD2' HG22 ' A' ' 194' ' ' VAL . 51.3 Cg_endo -90.21 165.32 4.61 Favored 'Trans proline' 0 CA--C 1.491 -1.645 0 C-N-CA 124.315 3.343 . . . . 0.089999999999999997 114.837 -169.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 23.8 m -85.39 117.84 24.55 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 113.715 -1.584 . . . . 1.0600000000000001 107.769 167.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.828 ' O ' ' HE3' ' A' ' 71' ' ' MET . 38.6 tp -84.31 97.77 9.63 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 119.485 -0.886 . . . . 1.02 108.88 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.595 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -87.48 109.0 19.29 Favored 'General case' 0 C--N 1.277 -2.587 0 CA-C-N 114.64 -1.163 . . . . 0.34000000000000002 109.053 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.575 ' SD ' ' HB3' ' A' ' 163' ' ' SER . 2.6 mmm -111.03 163.57 13.71 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.51 -1.223 . . . . 1.0900000000000001 111.464 -173.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.517 ' HA ' ' HA ' ' A' ' 189' ' ' SER . 36.4 tt0 -172.08 117.59 0.38 Allowed 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 115.978 -0.556 . . . . 0.68000000000000005 110.114 -166.702 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.69 HD22 ' O ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER -100.05 101.54 12.64 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.53 -0.915 . . . . 1.03 108.53 -172.34 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.67 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 17.0 ttp -90.66 122.86 33.8 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.468 -0.787 . . . . 0.89000000000000001 109.639 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.409 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -59.19 127.19 30.91 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.268 -1.382 . . . . 1.04 107.268 166.466 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.529 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.16 -34.4 12.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.172 -1.011 . . . . 1.02 110.701 178.382 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -61.88 -15.95 46.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.333 -0.848 . . . . 0.40000000000000002 111.604 -178.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.7 p -130.38 -36.74 1.45 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.826 0.822 . . . . 1.03 110.202 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.422 ' CA ' HD13 ' A' ' 149' ' ' ILE . . . 90.89 23.84 29.18 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 114.528 -1.214 . . . . 0.17999999999999999 112.272 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -103.63 156.72 17.57 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.656 0.265 . . . . 0.72999999999999998 110.653 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.466 HD12 ' HG2' ' A' ' 177' ' ' GLN . 35.0 mm -90.07 120.02 38.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.616 0.722 . . . . 1.03 109.379 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.684 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.4 pp -108.62 -30.19 2.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.942 -1.026 . . . . 1.01 110.495 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.661 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 80.9 t90 -136.36 152.85 51.09 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 115.108 -0.951 . . . . 0.070000000000000007 109.501 172.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.517 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 35.6 p -153.32 163.19 40.35 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 113.253 0.834 . . . . 0.64000000000000001 113.253 164.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.42 -175.55 29.47 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 110.967 -0.853 . . . . 0.12 110.967 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.811 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.4 mtmt -159.51 149.74 18.98 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 105.704 -1.961 . . . . 1.76 105.704 165.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.435 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -161.13 128.02 1.85 Allowed Glycine 0 C--N 1.28 -2.542 0 C-N-CA 119.601 -1.285 . . . . 0.13 112.142 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.577 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.3 120.2 17.57 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.58 0.705 . . . . 1.01 111.116 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.748 HG11 ' CE3' ' A' ' 64' ' ' TRP . 2.0 m -94.96 158.91 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-N 114.65 -1.159 . . . . 1.01 109.753 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.699 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -100.35 171.34 7.83 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 112.981 -1.918 . . . . 0.92000000000000004 109.292 -174.161 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 7.6 tt0 -101.5 130.35 47.74 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.253 -0.647 . . . . 0.91000000000000003 109.253 169.323 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.528 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 19.5 mm-40 . . . . . 0 C--N 1.31 -1.146 0 CA-C-O 118.431 -0.795 . . . . 1.24 110.383 176.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.089 -0.404 . . . . 88.920000000000002 112.089 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 p -88.26 -5.89 58.1 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 122.137 0.175 . . . . 87.459999999999994 111.158 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 67.57 172.32 0.27 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.177 0.513 . . . . 87.5 110.692 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.4 ptp 40.88 44.94 2.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.591 -1.186 . . . . 85.340000000000003 111.868 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -128.41 -26.04 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.326 -0.852 . . . . 85.230000000000004 111.098 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.01 84.37 0.44 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.692 -0.766 . . . . 84.849999999999994 112.383 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -146.65 23.02 1.27 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.651 -0.5 . . . . 85.599999999999994 109.651 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 54.07 73.44 0.39 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.879 -0.6 . . . . 85.310000000000002 110.811 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.81 145.43 96.83 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.821 -0.627 . . . . 82.170000000000002 110.407 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.81 129.53 29.43 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.985 2.456 . . . . 82.069999999999993 112.012 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.79 93.56 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.968 0.729 . . . . 79.709999999999994 112.968 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.99 130.44 32.67 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.465 1.444 . . . . 79.019999999999996 112.119 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.18 158.42 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.427 -0.806 . . . . 77.260000000000005 109.968 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -96.38 85.1 3.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.322 0.582 . . . . 75.739999999999995 109.94 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.3 152.77 34.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.561 -0.745 . . . . 74.010000000000005 110.436 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.32 102.46 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.459 -0.791 . . . . 72.569999999999993 110.368 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -87.63 -34.3 0.44 Allowed Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 113.393 0.886 . . . . 71.379999999999995 113.393 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 17' ' ' LYS . 39.4 Cg_endo -65.92 102.03 0.51 Allowed 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 121.424 1.416 . . . . 70.189999999999998 112.259 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.03 150.07 54.5 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.715 -0.675 . . . . 67.769999999999996 110.743 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.39 -57.67 2.15 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.124 2.549 . . . . 67.180000000000007 112.263 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 66.52 161.36 0.15 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.517 0.675 . . . . 65.200000000000003 111.915 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.432 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 16.2 mm100 -97.99 132.39 24.8 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.661 -0.7 . . . . 63.460000000000001 110.945 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 51.5 Cg_exo -62.66 150.89 86.41 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.939 2.426 . . . . 62.479999999999997 112.389 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.95 82.57 1.5 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.722 -0.672 . . . . 59.869999999999997 109.301 174.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 43.1 mt-10 -80.64 140.99 51.58 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.58 -0.736 . . . . 58.890000000000001 111.418 -175.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 25' ' ' GLU . 38.3 Cg_exo -62.53 98.61 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.927 2.418 . . . . 57.890000000000001 111.987 175.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.463 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 20.3 mt-30 -88.88 173.66 8.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.247 -0.433 . . . . 55.729999999999997 110.55 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -112.91 93.92 26.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.938 0.399 . . . . 54.079999999999998 111.12 -178.196 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 4.8 Cg_exo -78.73 137.22 14.11 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.734 2.29 . . . . 53.299999999999997 111.542 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t 64.27 97.31 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.253 0 O-C-N 123.523 0.515 . . . . 51.130000000000003 110.664 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.05 -157.04 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.63 2.22 . . . . 49.75 112.406 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p -62.44 142.42 57.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.224 0.535 . . . . 47.700000000000003 111.602 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.5 t -136.0 106.2 9.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.67 -0.695 . . . . 46.109999999999999 109.58 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -55.36 162.91 5.37 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.27 2.647 . . . . 45.890000000000001 113.46 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 m -86.31 124.57 32.83 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.422 -0.808 . . . . 43.0 110.675 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.6 t -115.14 99.39 52.26 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.081 -0.509 . . . . 40.789999999999999 110.257 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.54 -172.31 1.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.752 2.301 . . . . 40.450000000000003 112.191 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.8 m -132.25 144.8 50.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.893 0.378 . . . . 37.729999999999997 110.795 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -105.2 105.21 51.0 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.087 -0.506 . . . . 35.990000000000002 109.959 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HB2' HE21 ' A' ' 42' ' ' GLN . 8.5 Cg_exo -70.97 102.46 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.493 2.129 . . . . 34.350000000000001 112.243 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -61.85 -51.3 68.75 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.916 -0.314 . . . . 31.780000000000001 110.169 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.415 HE21 ' HB2' ' A' ' 40' ' ' PRO . 76.5 mt-30 61.09 75.33 0.46 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.284 -0.871 . . . . 30.390000000000001 111.071 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.72 141.62 50.27 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.686 2.258 . . . . 29.940000000000001 111.564 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.48 158.35 27.69 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.635 -0.793 . . . . 26.75 111.841 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.34 126.25 9.63 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.848 2.366 . . . . 25.879999999999999 113.02 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.0 mt -74.65 -54.3 14.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.679 -0.489 . . . . 24.16 109.679 175.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 58.69 79.41 0.22 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.83 0.706 . . . . 21.829999999999998 109.734 175.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -133.93 149.33 51.27 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.816 -0.629 . . . . 20.620000000000001 111.862 -173.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -166.18 139.19 4.05 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.617 -1.174 . . . . 16.559999999999999 109.554 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -121.75 45.1 2.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.679 0.752 . . . . 15.050000000000001 109.955 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -87.5 131.34 34.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.955 -1.021 . . . . 14.66 110.19 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.9 p -64.66 148.73 50.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.591 0.71 . . . . 11.84 111.304 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.14 -46.41 0.34 Allowed Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.044 -0.98 . . . . 8.4399999999999995 113.397 -173.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -85.98 111.9 1.17 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.232 1.955 . . . . 7.6600000000000001 112.574 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -85.53 76.71 2.91 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.706 2.271 . . . . 5.6600000000000001 111.751 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 66.23 106.96 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.338 0 O-C-N 123.668 0.605 . . . . 2.8700000000000001 110.683 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.16 -177.18 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.858 2.372 . . . . 1.8300000000000001 113.372 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.4 153.46 50.78 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.623 -1.171 . . . . 4.2199999999999998 110.925 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.601 HG21 ' N ' ' A' ' 60' ' ' ARG . 8.5 mt -90.03 168.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.86 -1.064 . . . . 1.1299999999999999 110.665 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.601 ' N ' HG21 ' A' ' 59' ' ' ILE . 20.6 mtt85 -67.29 -158.92 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.34 1.543 . . . . 3.1400000000000001 111.743 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.715 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 19.2 t-160 -160.09 149.07 17.39 Favored 'General case' 0 CA--C 1.468 -2.191 0 CA-C-N 112.105 -2.316 . . . . 2.7400000000000002 105.911 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.749 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.0 m-30 -125.3 160.94 28.07 Favored 'General case' 0 N--CA 1.415 -2.219 0 O-C-N 123.671 0.607 . . . . 0.76000000000000001 109.41 -175.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 6.1 t70 -81.49 67.51 7.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.499 1.619 . . . . 0.34999999999999998 107.931 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.727 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 93.3 m95 -59.64 -42.34 92.55 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 111.933 -2.394 . . . . 0.10000000000000001 111.911 174.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.517 ' N ' HG23 ' A' ' 108' ' ' THR . 8.9 t-20 -52.53 -24.88 8.94 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.062 -1.426 . . . . 1.1100000000000001 111.452 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.49 -16.73 77.34 Favored Glycine 0 C--N 1.312 -0.773 0 CA-C-N 115.129 -0.941 . . . . 0.23000000000000001 111.175 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.16 -55.11 2.55 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.897 -1.152 . . . . 1.01 111.41 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.76 ' SD ' HD22 ' A' ' 109' ' ' LEU . 40.9 mtt -64.05 -57.21 10.34 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.117 -1.401 . . . . 0.089999999999999997 112.893 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.577 HE22 ' ND2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -38.85 -54.93 2.96 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 114.53 1.307 . . . . 0.63 114.53 -176.456 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.781 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.7 Cg_endo -64.71 -31.64 58.39 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 121.949 1.766 . . . . 0.17000000000000001 110.956 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.718 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 10.2 mtm -79.58 -44.04 21.81 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.433 -0.803 . . . . 0.69999999999999996 111.54 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.725 HG22 ' O ' ' A' ' 68' ' ' MET . 40.5 t -57.17 -39.09 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 114.366 -1.288 . . . . 1.04 108.509 175.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.7 t -59.19 -36.44 75.35 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.153 -1.839 . . . . 1.1200000000000001 110.811 174.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.781 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 32.8 mtpt -81.55 -34.13 31.3 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.168 0.508 . . . . 1.8799999999999999 110.823 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.851 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.54 -29.07 70.38 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.235 -0.893 . . . . 0.5 111.563 -171.785 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.54 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.0 mt -90.77 -8.07 50.7 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.922 0.867 . . . . 1.29 111.118 -177.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.38 13.09 58.49 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 109.182 -1.567 . . . . 0.17999999999999999 109.182 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.639 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -83.54 160.25 21.5 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.441 -0.879 . . . . 1.0 110.245 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.47 106.29 16.71 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.062 -0.972 . . . . 1.72 110.115 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.63 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.52 -22.8 3.67 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 110.766 -0.933 . . . . 0.13 110.766 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.851 HG11 ' O ' ' A' ' 75' ' ' MET . 11.3 p -102.95 150.0 6.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.639 0.733 . . . . 1.01 111.514 -176.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.0 m -137.61 141.33 41.26 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.695 -1.139 . . . . 1.1000000000000001 111.135 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.508 ' HB3' ' HE3' ' A' ' 118' ' ' LYS . . . -55.97 132.36 49.69 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.745 -1.116 . . . . 1.1200000000000001 111.285 169.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.57 2.27 37.52 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.859 -0.686 . . . . 0.28000000000000003 112.709 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.26 149.91 22.86 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 120.233 -0.587 . . . . 1.55 110.923 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.648 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -79.48 117.55 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 122.196 0.998 . . . . 1.03 108.871 164.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.763 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -104.92 109.75 21.85 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.521 -0.918 . . . . 1.03 108.521 -172.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.671 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.27 94.06 1.16 Allowed 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.788 -1.19 . . . . 1.01 107.788 176.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.437 HG12 ' HG3' ' A' ' 110' ' ' ARG . 1.1 m -72.87 116.14 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 107.124 -1.436 . . . . 1.6200000000000001 107.124 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.841 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 8.3 t0 -76.98 154.77 33.2 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.723 -1.214 . . . . 0.64000000000000001 107.723 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.558 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.0 OUTLIER -58.05 136.38 57.15 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 107.527 -1.286 . . . . 1.05 107.527 171.648 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.562 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.8 t -64.0 139.0 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 107.835 -1.172 . . . . 1.02 107.835 168.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.656 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.6 t-20 -85.61 163.24 18.45 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.128 -0.942 . . . . 0.20000000000000001 110.063 174.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.749 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.31 85.25 2.38 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.407 -1.27 . . . . 0.12 108.187 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.454 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 9.7 mtp180 -108.88 -1.12 19.37 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.056 -1.429 . . . . 0.84999999999999998 108.644 -172.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 20.6 p -53.36 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.991 -1.913 . . . . 0.91000000000000003 115.106 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 22.4 t30 -67.45 -13.31 61.92 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.712 -2.04 . . . . 0.62 110.479 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.519 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -149.71 -145.02 4.05 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.259 -0.972 . . . . 0.14000000000000001 113.109 -176.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.6 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.4 p -121.89 132.65 54.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.18 0.514 . . . . 1.76 111.747 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.749 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.0 pp -137.75 157.01 47.36 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.827 0.822 . . . . 1.01 110.641 -178.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.608 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -80.57 79.43 7.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 113.959 -1.473 . . . . 0.20999999999999999 107.647 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.563 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -68.16 -14.26 62.85 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.545 -1.207 . . . . 1.0 109.836 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.415 ' HB1' ' HG3' ' A' ' 139' ' ' GLN . . . -80.17 -30.01 38.78 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.632 -0.877 . . . . 1.02 108.632 -178.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.608 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.1 tp10 -67.93 -34.01 75.78 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.304 -1.317 . . . . 1.73 109.104 171.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.563 ' HB1' ' O ' ' A' ' 102' ' ' ALA . . . -71.44 -43.69 66.23 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 113.213 -1.812 . . . . 1.04 109.613 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.558 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 63.5 m -63.56 -28.13 69.73 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.73 -1.577 . . . . 1.04 110.159 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.413 ' HB3' ' O ' ' A' ' 104' ' ' GLU . 3.7 tp10 -66.04 -52.06 52.5 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.16 -1.052 . . . . 1.47 108.16 169.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.61 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 32.2 m -56.36 -33.93 66.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.669 -0.696 . . . . 1.03 111.319 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.76 HD22 ' SD ' ' A' ' 68' ' ' MET . 8.7 mt -50.46 -68.02 0.21 Allowed 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 116.12 -0.491 . . . . 1.3 109.799 172.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.504 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.7 mtp180 -43.04 -35.47 1.28 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.129 0.966 . . . . 1.8 111.194 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.61 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -72.56 -45.62 58.36 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.49 -1.232 . . . . 0.41999999999999998 112.101 -175.501 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.56 -33.59 60.66 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.309 -0.997 . . . . 1.01 108.309 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.689 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -62.99 -34.45 77.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 113.651 -1.613 . . . . 1.01 110.064 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.442 ' HB1' ' O ' ' A' ' 110' ' ' ARG . . . -69.84 -38.28 76.45 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.521 -1.218 . . . . 1.03 111.208 -175.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . 0.577 ' ND2' HE22 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -60.97 -29.21 69.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.736 -1.12 . . . . 1.55 111.179 -175.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -81.31 -30.25 33.98 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.746 -0.661 . . . . 2.0499999999999998 111.141 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.28 3.82 10.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.049 -0.596 . . . . 0.54000000000000004 113.228 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.508 ' HE3' ' HB3' ' A' ' 83' ' ' ALA . 54.2 mtpt -88.28 -6.31 57.84 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.963 0.411 . . . . 1.6000000000000001 110.092 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.763 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 27.8 m-85 -122.49 175.32 6.52 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 122.491 1.139 . . . . 0.27000000000000002 113.099 172.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.542 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 7.1 m -121.11 119.26 31.9 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 112.621 -2.081 . . . . 1.0800000000000001 107.947 168.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -89.6 139.44 30.55 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.345 -0.942 . . . . 1.1499999999999999 111.319 -170.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.737 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.6 m -91.38 147.09 5.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.222 -1.029 . . . . 1.0900000000000001 108.222 170.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.536 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -103.12 178.22 4.62 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.188 -0.605 . . . . 1.8200000000000001 110.574 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.23 -33.34 72.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.422 0.63 . . . . 1.1899999999999999 110.414 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.67 ' O ' ' HG3' ' A' ' 129' ' ' MET . 9.6 pt20 -47.47 -35.88 9.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.285 -1.325 . . . . 2.04 111.374 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.737 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 4.3 mt-30 -97.93 -54.08 3.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 122.052 0.93 . . . . 0.42999999999999999 110.107 173.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.439 ' HB2' ' CG2' ' A' ' 122' ' ' VAL . 26.1 tp -63.86 -65.23 0.71 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 113.367 -1.742 . . . . 2.04 113.104 -168.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.637 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.8 t -50.47 -43.73 55.49 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 123.365 1.555 . . . . 1.1499999999999999 109.117 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.706 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -57.69 -61.42 2.52 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 111.145 -2.752 . . . . 2.27 110.521 177.361 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.691 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.76 -45.79 7.35 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 124.564 1.165 . . . . 1.0700000000000001 112.169 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.501 ' NZ ' ' HA ' ' A' ' 141' ' ' SER . 0.4 OUTLIER -54.44 -53.23 56.96 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 108.701 -0.851 . . . . 2.1000000000000001 108.701 179.138 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 128' ' ' SER . 40.2 mt-30 -63.83 -39.89 95.29 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.563 -0.744 . . . . 0.42999999999999999 111.287 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.706 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.9 mt-30 -58.89 -35.07 72.42 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 114.471 -1.24 . . . . 0.38 109.548 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.538 HD22 ' N ' ' A' ' 134' ' ' LEU . 0.5 OUTLIER -90.06 -30.67 17.57 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 113.798 -1.546 . . . . 1.05 109.502 -176.726 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.27 -45.89 0.6 Allowed Glycine 0 CA--C 1.495 -1.162 0 CA-C-O 122.422 1.012 . . . . 0.33000000000000002 113.376 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.55 HD13 ' O ' ' A' ' 141' ' ' SER . 92.3 mt -66.38 -171.09 0.11 Allowed 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.362 -1.919 . . . . 1.0700000000000001 115.613 -170.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.536 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.1 m -115.78 151.45 46.33 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 110.716 -2.947 . . . . 1.24 107.924 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.637 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 34.0 Cg_endo -64.81 0.2 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.526 2.151 . . . . 0.39000000000000001 112.638 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.42 ' H ' ' C ' ' A' ' 137' ' ' SER . 0.7 OUTLIER -119.13 -23.9 6.66 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.871 0.843 . . . . 1.79 110.811 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' SER . 14.4 t70 -61.4 -21.5 64.15 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.471 -1.695 . . . . 0.65000000000000002 109.359 -173.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.586 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 26.3 m 70.56 167.84 0.3 Allowed 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 112.641 -2.072 . . . . 0.73999999999999999 110.12 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.841 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 5.4 mt -64.97 -40.29 94.77 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.257 -1.016 . . . . 1.48 108.257 -177.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 62.39 -10.16 0.12 Allowed Glycine 0 C--N 1.32 -0.357 0 CA-C-N 113.098 -1.864 . . . . 0.34999999999999998 114.586 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.465 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.7 OUTLIER -153.8 124.51 7.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.026 -0.731 . . . . 1.02 109.026 -175.358 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.683 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.3 mmt180 -41.28 -45.69 3.02 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 112.101 0.408 . . . . 2.21 112.101 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 31.3 t -75.04 -25.58 58.81 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.791 0.805 . . . . 0.93000000000000005 111.247 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.53 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 48.2 mttt -72.77 -29.28 63.18 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.755 1.264 . . . . 1.8899999999999999 108.156 175.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.676 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -77.57 -49.02 15.52 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 112.31 -2.223 . . . . 0.98999999999999999 110.273 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.541 ' HA ' HG21 ' A' ' 181' ' ' VAL . 38.3 mt -65.26 -41.19 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-N 113.016 -1.902 . . . . 1.03 110.151 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.84 -55.0 25.61 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.745 -1.116 . . . . 0.14999999999999999 111.09 171.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.725 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 87.6 mt -66.78 -47.34 83.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 N-CA-C 112.637 0.606 . . . . 1.05 112.637 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.654 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.0 -41.14 74.4 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.046 0.45 . . . . 1.03 111.133 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.446 ' HD2' HG23 ' A' ' 149' ' ' ILE . 54.3 mtp180 -81.01 -23.15 38.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.852 0.835 . . . . 1.29 110.242 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.424 HD22 ' CD ' ' A' ' 133' ' ' GLN . 12.7 t30 -82.73 -10.7 58.78 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.323 -1.362 . . . . 0.5 107.323 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.725 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.14 -28.8 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 113.148 -1.842 . . . . 1.05 110.965 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.74 35.26 4.66 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.443 -0.884 . . . . 0.17000000000000001 112.6 -179.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.671 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.4 159.5 16.96 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.02 0.748 . . . . 1.02 113.02 -169.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.648 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -98.64 -29.11 13.23 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.211 -0.904 . . . . 0.39000000000000001 109.434 178.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.576 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.4 m-85 -135.51 -173.17 3.27 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.055 -0.975 . . . . 0.81000000000000005 111.037 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.701 ' O ' HD22 ' A' ' 178' ' ' LEU . 1.1 t -136.74 138.54 46.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.645 -1.161 . . . . 1.03 108.921 166.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.565 HD21 ' SD ' ' A' ' 176' ' ' MET . 35.1 tp -107.85 100.96 10.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.435 -0.906 . . . . 1.02 109.137 165.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.607 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.4 m-85 -78.5 119.04 21.24 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.401 -1.272 . . . . 0.87 108.131 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.87 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 13.3 t -130.69 158.76 39.19 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 122.12 0.962 . . . . 1.45 110.413 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.656 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.5 p -162.03 170.67 18.86 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.038 -1.437 . . . . 0.12 110.718 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -132.27 135.73 46.46 Favored 'General case' 0 N--CA 1.406 -2.666 0 CA-C-N 114.044 -1.434 . . . . 0.94999999999999996 108.766 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.632 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.7 t -144.52 -170.69 3.44 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.608 -0.837 . . . . 1.1499999999999999 110.376 176.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 89.84 -83.23 1.38 Allowed Glycine 0 C--N 1.289 -2.065 0 CA-C-N 114.906 -1.043 . . . . 0.14999999999999999 111.062 175.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 57.7 t30 -141.67 129.37 21.6 Favored 'General case' 0 C--O 1.199 -1.602 0 CA-C-N 113.872 -1.164 . . . . 0.58999999999999997 108.205 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.582 HG23 ' N ' ' A' ' 99' ' ' SER . 4.2 p -65.28 -41.88 92.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 115.378 -0.828 . . . . 1.0 112.63 -171.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 169' ' ' VAL . 9.7 m120 -61.56 -29.44 70.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.378 0.608 . . . . 1.9199999999999999 109.462 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.35 88.93 3.35 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 114.592 -1.185 . . . . 1.0600000000000001 108.9 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.663 ' HD2' HG23 ' A' ' 194' ' ' VAL . 40.7 Cg_endo -92.24 163.88 3.08 Favored 'Trans proline' 0 CA--C 1.501 -1.147 0 C-N-CA 124.858 3.705 . . . . 0.089999999999999997 115.458 -170.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.575 HG23 ' HB3' ' A' ' 191' ' ' LYS . 14.3 m -82.73 120.54 25.72 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.837 -1.529 . . . . 1.0600000000000001 107.563 168.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.957 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 22.1 tp -82.78 95.16 7.8 Favored 'General case' 0 CA--C 1.476 -1.901 0 C-N-CA 119.434 -0.906 . . . . 1.02 109.11 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.496 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 35.8 mt-30 -86.18 107.74 18.02 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-O 122.044 0.926 . . . . 0.34000000000000002 108.61 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.87 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.0 OUTLIER -111.85 163.18 14.48 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.893 -1.048 . . . . 1.0900000000000001 111.245 -174.428 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.607 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 55.4 tt0 -170.48 117.81 0.53 Allowed 'General case' 0 C--O 1.204 -1.332 0 CA-C-N 115.87 -0.604 . . . . 0.68000000000000005 110.327 -167.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.701 HD22 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -100.1 100.51 11.38 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.414 -0.958 . . . . 1.03 108.414 -173.315 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.683 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.6 ttp -90.61 123.39 34.2 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.492 -0.776 . . . . 0.89000000000000001 109.608 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.96 126.65 28.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.096 -1.446 . . . . 1.04 107.096 166.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.541 HG21 ' HA ' ' A' ' 149' ' ' ILE . 0.3 OUTLIER -81.6 -35.06 13.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 119.103 -1.039 . . . . 1.02 110.81 179.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.442 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.9 mt-30 -62.81 -15.06 52.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.377 -0.828 . . . . 0.40000000000000002 111.58 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.1 p -130.05 -34.89 1.64 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.724 0.773 . . . . 1.03 110.276 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 84.6 29.83 28.65 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.462 -1.244 . . . . 0.17999999999999999 112.12 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.44 ' O ' ' HA ' ' A' ' 179' ' ' MET . 9.8 pt-20 -105.3 158.19 16.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.42 -0.39 . . . . 0.72999999999999998 110.447 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.471 HD13 ' HG2' ' A' ' 177' ' ' GLN . 32.0 mm -93.58 112.07 25.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.623 0.725 . . . . 1.03 109.659 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.682 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.2 pp -99.48 -30.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.067 -0.969 . . . . 1.01 110.853 -173.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.639 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.0 t90 -136.76 152.82 50.76 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.403 -0.817 . . . . 0.070000000000000007 109.743 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 35.9 p -153.99 163.9 39.31 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.107 0.78 . . . . 0.64000000000000001 113.107 165.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.01 -173.65 27.69 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 111.125 -0.79 . . . . 0.12 111.125 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.957 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.5 mttt -158.8 148.96 19.54 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.409 -1.7 . . . . 1.76 106.409 165.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.441 ' C ' ' H ' ' A' ' 174' ' ' LEU . . . -154.13 125.38 1.72 Allowed Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 118.574 -1.774 . . . . 0.13 113.905 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.589 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.75 107.93 5.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.648 0.737 . . . . 1.01 110.862 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.688 HG12 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -88.57 158.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-N 114.224 -1.353 . . . . 1.01 110.586 -175.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.749 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -100.47 171.99 7.4 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 112.573 -2.103 . . . . 0.92000000000000004 108.751 -175.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.547 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 8.8 tt0 -101.82 132.86 47.35 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.086 -0.646 . . . . 0.91000000000000003 109.621 172.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.532 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 36.0 mm-40 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.496 -0.764 . . . . 1.24 110.672 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.646 -0.582 . . . . 88.920000000000002 111.646 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -121.87 -57.66 1.78 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.639 0.257 . . . . 87.459999999999994 110.545 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.3 m80 67.52 114.02 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.477 -0.783 . . . . 87.5 110.847 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.41 ' O ' HG12 ' A' ' 5' ' ' VAL . 90.8 mtp -120.5 147.73 44.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.128 -0.487 . . . . 85.340000000000003 110.436 -177.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 4' ' ' MET . 3.5 p 48.91 15.75 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.183 1.393 . . . . 85.230000000000004 113.411 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.38 -60.05 0.87 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.652 -0.785 . . . . 84.849999999999994 111.584 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -87.81 43.69 1.13 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.553 1.168 . . . . 85.599999999999994 110.573 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.459 ' C ' ' HD3' ' A' ' 10' ' ' PRO . 97.9 mtt180 59.93 63.59 1.43 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 113.15 -1.841 . . . . 85.310000000000002 111.785 -175.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -125.86 69.2 64.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.166 -0.925 . . . . 82.170000000000002 110.324 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD3' ' C ' ' A' ' 8' ' ' ARG . 3.5 Cg_exo -81.55 -71.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.417 2.745 . . . . 82.069999999999993 111.566 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.35 109.66 0.99 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.082 -0.508 . . . . 79.709999999999994 110.28 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.03 137.7 69.63 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.947 2.432 . . . . 79.019999999999996 112.043 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.7 m -139.67 157.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.835 -0.62 . . . . 77.260000000000005 110.677 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -103.71 139.3 39.15 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.738 -0.838 . . . . 75.739999999999995 108.738 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -58.9 137.74 57.69 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.368 -0.378 . . . . 74.010000000000005 111.59 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.21 118.5 7.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.275 0.56 . . . . 72.569999999999993 109.531 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -76.78 -45.9 3.05 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.631 -0.713 . . . . 71.379999999999995 111.816 -175.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -76.61 177.03 9.34 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.454 1.436 . . . . 70.189999999999998 111.679 171.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . . . -153.24 -61.58 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 119.369 -0.348 . . . . 67.769999999999996 111.858 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.485 ' HD3' ' HB2' ' A' ' 19' ' ' ALA . 94.5 Cg_endo -77.82 -7.6 16.57 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.521 1.481 . . . . 67.180000000000007 112.896 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 64.48 -171.46 0.18 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.78 -0.646 . . . . 65.200000000000003 110.563 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -128.28 75.32 79.1 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.477 -0.564 . . . . 63.460000000000001 109.477 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.61 139.0 83.66 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.971 2.447 . . . . 62.479999999999997 113.058 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.401 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . -126.54 92.44 3.56 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.328 -0.851 . . . . 59.869999999999997 110.0 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.457 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 1.2 tt0 -93.21 110.83 48.81 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 115.627 -0.715 . . . . 58.890000000000001 109.671 -177.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.401 ' HD3' ' O ' ' A' ' 24' ' ' ALA . 70.9 Cg_endo -93.5 102.68 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.057 2.505 . . . . 57.890000000000001 112.31 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -127.98 -62.39 1.06 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.531 0.681 . . . . 55.729999999999997 110.659 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 56.96 71.55 1.12 Allowed Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 114.065 -1.425 . . . . 54.079999999999998 110.974 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.89 -26.91 59.05 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.52 2.147 . . . . 53.299999999999997 112.768 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.02 123.37 89.21 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.853 0.359 . . . . 51.130000000000003 111.115 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.7 152.26 32.87 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.551 2.167 . . . . 49.75 112.588 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.58 170.73 10.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.398 0.618 . . . . 47.700000000000003 110.723 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.55 121.34 9.06 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.177 -0.919 . . . . 46.109999999999999 110.504 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -57.66 159.37 17.19 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.287 2.658 . . . . 45.890000000000001 112.648 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 p -74.05 130.29 39.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.173 -0.922 . . . . 43.0 111.287 -176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.19 130.7 10.91 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.727 -0.67 . . . . 40.789999999999999 110.338 -178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.24 -170.47 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.609 2.206 . . . . 40.450000000000003 111.22 174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.5 t -128.26 140.87 51.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.251 0.548 . . . . 37.729999999999997 110.733 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.9 mt -103.53 127.88 28.62 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.625 -0.716 . . . . 35.990000000000002 110.335 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.1 113.72 2.73 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.183 1.922 . . . . 34.350000000000001 111.759 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.458 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 14.8 mm100 -97.74 59.53 1.48 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.117 0.484 . . . . 31.780000000000001 110.172 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -109.65 92.47 12.24 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.109 -0.496 . . . . 30.390000000000001 110.637 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 41' ' ' GLN . 83.5 Cg_endo -91.86 154.91 3.38 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.899 2.399 . . . . 29.940000000000001 112.118 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.92 162.32 36.11 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.457 -0.878 . . . . 26.75 112.059 177.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -97.17 135.32 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.911 3.074 . . . . 25.879999999999999 112.988 -175.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.2 mm -73.78 -50.03 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 24.16 110.21 172.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 36.16 74.51 0.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.61 1.164 . . . . 21.829999999999998 113.246 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -76.07 164.94 25.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.143 0.497 . . . . 20.620000000000001 110.858 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.36 174.92 6.07 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.542 -0.754 . . . . 16.559999999999999 109.305 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -95.22 88.23 5.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.25 -0.648 . . . . 15.050000000000001 109.25 173.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -64.95 82.14 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.853 0.72 . . . . 14.66 110.462 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.3 p -137.07 127.62 26.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.311 -0.404 . . . . 11.84 111.347 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 106.89 3.79 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 115.183 -0.917 . . . . 8.4399999999999995 110.367 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -68.55 124.49 11.64 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.334 2.023 . . . . 7.6600000000000001 111.957 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.77 -38.84 7.22 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 121.963 1.775 . . . . 5.6600000000000001 111.636 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.05 148.45 32.39 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.814 -0.63 . . . . 2.8700000000000001 110.351 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.78 -177.73 2.02 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 123.389 2.726 . . . . 1.8300000000000001 111.297 174.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -104.72 133.58 49.3 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.727 -1.124 . . . . 4.2199999999999998 111.098 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 101' ' ' ASN . 14.1 mt -79.15 174.38 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.571 -1.195 . . . . 1.1299999999999999 112.213 -171.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.594 ' N ' HG22 ' A' ' 59' ' ' ILE . 45.9 mtt180 -62.76 -158.0 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.12 -1.855 . . . . 3.1400000000000001 112.432 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.683 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 16.8 t-160 -155.56 150.97 27.04 Favored 'General case' 0 CA--C 1.471 -2.08 0 CA-C-N 112.126 -2.306 . . . . 2.7400000000000002 106.114 176.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.756 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 -125.24 160.13 29.97 Favored 'General case' 0 N--CA 1.418 -2.046 0 O-C-N 123.827 0.705 . . . . 0.76000000000000001 109.499 -176.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.504 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 5.1 t70 -82.49 67.47 8.54 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 123.618 1.675 . . . . 0.34999999999999998 108.144 171.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.729 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 91.9 m95 -57.58 -42.98 84.19 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 111.678 -2.51 . . . . 0.10000000000000001 112.026 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.477 ' N ' HG23 ' A' ' 108' ' ' THR . 13.4 t-20 -51.21 -28.3 11.08 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.914 -1.494 . . . . 1.1100000000000001 111.331 174.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 -18.56 79.06 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.096 -0.956 . . . . 0.23000000000000001 111.258 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.84 -54.35 2.84 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.868 -1.166 . . . . 1.01 110.879 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.752 ' SD ' HD21 ' A' ' 109' ' ' LEU . 40.8 mtt -60.2 -62.54 1.79 Allowed 'General case' 0 C--O 1.21 -0.998 0 CA-C-N 113.878 -1.51 . . . . 0.089999999999999997 111.61 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.47 HE21 ' HA ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -37.22 -54.89 1.87 Allowed Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 114.593 1.331 . . . . 0.63 114.593 -172.259 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.726 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 34.4 Cg_endo -64.14 -31.56 64.54 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.355 2.036 . . . . 0.17000000000000001 111.001 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.655 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 8.1 mtm -78.24 -43.96 26.86 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 114.988 -1.005 . . . . 0.69999999999999996 111.271 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.654 HG21 ' O ' ' A' ' 68' ' ' MET . 42.4 t -58.57 -38.94 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-N 114.284 -1.326 . . . . 1.04 108.716 176.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.2 t -58.71 -37.25 75.72 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.956 -1.929 . . . . 1.1200000000000001 111.026 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.726 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 4.8 mtpm? -78.57 -41.92 30.63 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.627 -0.509 . . . . 1.8799999999999999 109.627 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.835 ' SD ' ' HE2' ' A' ' 119' ' ' PHE . 1.0 OUTLIER -45.88 -53.53 9.64 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.724 0.809 . . . . 0.5 110.099 -175.207 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.642 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.9 mt -80.29 7.41 9.58 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.288 -1.324 . . . . 1.29 112.249 -170.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.55 15.62 9.82 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.075 -1.421 . . . . 0.17999999999999999 109.805 170.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.594 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -80.54 165.25 22.29 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.235 0.54 . . . . 1.0 110.423 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -87.8 105.81 17.65 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 115.597 -0.729 . . . . 1.72 109.124 175.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.648 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.29 -25.37 3.02 Favored Glycine 0 N--CA 1.415 -2.731 0 C-N-CA 119.623 -1.275 . . . . 0.13 110.437 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.758 HG11 ' O ' ' A' ' 75' ' ' MET . 12.8 p -103.21 149.35 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.86 0.838 . . . . 1.01 111.365 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.1 m -135.52 140.33 44.66 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.692 -1.14 . . . . 1.1000000000000001 110.744 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.441 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -54.77 131.49 43.95 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.07 -0.968 . . . . 1.1200000000000001 110.698 168.426 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.04 0.2 38.62 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.951 -0.642 . . . . 0.28000000000000003 113.271 176.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.87 151.22 23.52 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 120.537 -0.465 . . . . 1.55 111.081 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.658 HG11 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -81.16 120.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-O 121.865 0.84 . . . . 1.03 109.074 165.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.703 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -108.42 111.02 22.7 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.412 -0.813 . . . . 1.03 109.061 -171.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.664 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -72.31 101.09 2.78 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 114.849 -1.069 . . . . 1.01 109.329 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.468 HG23 ' HG3' ' A' ' 110' ' ' ARG . 53.1 t -74.34 106.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 114.495 -1.229 . . . . 1.6200000000000001 109.511 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.923 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 2.3 t70 -78.29 158.39 28.89 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.592 -1.186 . . . . 0.64000000000000001 108.344 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.649 ' HG ' ' HA ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -62.32 135.28 57.39 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 115.378 -0.828 . . . . 1.05 109.325 175.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.606 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 33.4 t -62.28 138.49 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 106.983 -1.488 . . . . 1.02 106.983 167.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.669 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.0 t-20 -85.01 161.49 19.73 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.836 0.827 . . . . 0.20000000000000001 110.114 174.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.762 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.95 84.94 2.34 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.368 -1.287 . . . . 0.12 108.261 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.1 mtp180 -108.51 -2.75 18.68 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 113.912 -1.495 . . . . 0.84999999999999998 108.572 -172.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.625 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 20.5 p -51.1 -170.94 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.683 -2.053 . . . . 0.91000000000000003 115.107 -176.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.471 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 36.5 t30 -70.43 -10.45 59.14 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.134 -1.848 . . . . 0.62 110.567 173.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.523 ' HA3' HG13 ' A' ' 169' ' ' VAL . . . -152.22 -144.45 3.92 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.414 -0.898 . . . . 0.14000000000000001 113.128 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.593 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 54.6 p -122.14 131.73 54.11 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.165 0.432 . . . . 1.76 112.165 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.762 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.8 pp -136.84 156.76 48.06 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.772 0.796 . . . . 1.01 110.947 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.607 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 1.4 t-20 -79.81 81.18 6.11 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.814 -1.539 . . . . 0.20999999999999999 107.961 175.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.606 ' HB2' ' O ' ' A' ' 92' ' ' VAL . . . -67.97 -15.1 63.45 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.933 -1.485 . . . . 1.0 110.112 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.461 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.92 -32.79 40.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.73 -0.841 . . . . 1.02 108.73 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.579 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 12.8 tp10 -65.22 -34.48 78.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.432 -1.258 . . . . 1.73 108.929 171.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.06 -43.41 64.95 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 113.243 -1.798 . . . . 1.04 109.367 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.637 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 76.5 m -64.73 -28.8 69.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.062 -1.426 . . . . 1.04 110.405 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -43.53 67.31 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.05 -1.093 . . . . 1.47 108.05 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 64' ' ' TRP . 75.9 m -61.96 -31.6 71.96 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.327 -0.852 . . . . 1.03 110.613 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.752 HD21 ' SD ' ' A' ' 68' ' ' MET . 9.0 mt -51.43 -69.48 0.11 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 109.209 -0.663 . . . . 1.3 109.209 171.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.76 ' O ' HD12 ' A' ' 121' ' ' LEU . 8.9 mtp180 -40.09 -38.86 0.79 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.424 1.078 . . . . 1.8 111.182 175.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.528 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.88 -47.33 59.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.473 -1.24 . . . . 0.41999999999999998 112.159 -176.073 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.8 -33.08 68.25 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.107 0.956 . . . . 1.01 108.424 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.71 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.1 mm? -61.99 -32.98 73.5 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.437 -1.71 . . . . 1.01 109.894 173.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.43 -41.5 60.74 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.484 -1.234 . . . . 1.03 111.604 -175.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -64.93 -25.64 67.97 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.4 -0.818 . . . . 1.55 111.199 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.42 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 10.7 m120 -84.15 -16.53 43.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.529 -0.76 . . . . 2.0499999999999998 110.844 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.6 17.2 19.17 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 115.432 0.933 . . . . 0.54000000000000004 115.432 164.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.441 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 53.3 mtpt -98.16 -34.4 10.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.541 0.67 . . . . 1.6000000000000001 109.997 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.835 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 13.7 m-85 -89.32 177.85 6.49 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 122.728 1.251 . . . . 0.27000000000000002 113.095 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.507 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 21.2 m -123.67 111.07 15.75 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 112.299 -2.228 . . . . 1.0800000000000001 107.84 168.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.76 HD12 ' O ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -89.37 123.66 33.74 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.719 -1.128 . . . . 1.1499999999999999 110.734 -170.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.484 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 0.7 OUTLIER -65.8 155.21 7.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.354 -0.839 . . . . 1.0900000000000001 109.102 176.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.456 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 67.3 m -93.7 155.77 17.07 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.737 0.78 . . . . 1.8200000000000001 110.029 175.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.537 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . . . -72.91 -19.75 61.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.218 -1.355 . . . . 1.1899999999999999 109.596 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.709 ' O ' ' HG3' ' A' ' 129' ' ' MET . 1.2 pt20 -57.36 -29.09 63.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.11 -1.405 . . . . 2.04 109.993 172.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.606 ' HB2' HG22 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -99.18 -46.75 5.45 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.154 -0.93 . . . . 0.42999999999999999 110.625 171.792 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.703 HD13 ' NZ ' ' A' ' 131' ' ' LYS . 1.1 tm? -73.47 -62.39 1.5 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.682 -1.144 . . . . 2.04 113.514 -167.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.575 ' N ' HD11 ' A' ' 127' ' ' LEU . 0.4 OUTLIER -50.8 -37.97 45.72 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 123.684 1.707 . . . . 1.1499999999999999 108.637 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.709 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 29.2 mmm -62.82 -62.09 1.96 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 110.417 -3.083 . . . . 2.27 111.403 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.725 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -40.99 -45.12 2.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 124.478 1.111 . . . . 1.0700000000000001 111.905 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.703 ' NZ ' HD13 ' A' ' 127' ' ' LEU . 95.3 mttt -52.38 -58.09 7.77 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.847 -0.615 . . . . 2.1000000000000001 109.845 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.597 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 41.7 mt-30 -58.12 -44.72 87.89 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.566 -1.197 . . . . 0.42999999999999999 111.622 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.674 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.5 mt-30 -56.47 -36.37 68.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.627 -1.17 . . . . 0.38 109.871 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.519 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -88.49 -29.38 20.18 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.972 -1.467 . . . . 1.05 109.431 -177.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.8 -41.46 0.58 Allowed Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 119.36 -1.4 . . . . 0.33000000000000002 114.328 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.597 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 91.2 mt -73.75 -172.89 1.36 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 123.868 1.794 . . . . 1.0700000000000001 115.262 -168.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.476 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 52.4 m -111.44 151.4 43.23 Favored Pre-proline 0 N--CA 1.425 -1.675 0 CA-C-N 110.783 -2.917 . . . . 1.24 107.964 169.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.623 ' HA ' ' HD2' ' A' ' 131' ' ' LYS . 14.3 Cg_endo -60.6 -3.27 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.736 2.29 . . . . 0.39000000000000001 112.782 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.504 ' OE1' ' HA ' ' A' ' 101' ' ' ASN . 0.9 OUTLIER -118.6 -20.88 8.18 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 123.132 0.573 . . . . 1.79 109.954 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.59 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.6 t70 -60.44 -33.55 72.71 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.699 -1.223 . . . . 0.65000000000000002 107.699 -174.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.649 ' HA ' ' HG ' ' A' ' 91' ' ' SER . 18.4 m 78.92 156.64 0.16 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 110.441 -3.072 . . . . 0.73999999999999999 111.059 -173.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.923 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 7.2 mt -63.82 -39.34 94.0 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.15 -1.426 . . . . 1.48 107.15 -172.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.1 -3.6 0.16 Allowed Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 112.849 -1.978 . . . . 0.34999999999999998 115.166 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 m -149.66 121.67 8.25 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.881 -0.785 . . . . 1.02 108.881 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.584 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.3 mmt180 -41.91 -45.06 3.62 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 123.61 0.569 . . . . 2.21 111.366 -175.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.3 t -73.17 -26.55 61.23 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.541 0.686 . . . . 0.93000000000000005 111.525 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.538 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 49.1 mttt -73.15 -33.04 65.26 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.138 -1.06 . . . . 1.8899999999999999 108.138 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.684 ' HB1' ' OH ' ' A' ' 162' ' ' TYR . . . -74.98 -43.46 53.85 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-N 113.019 -1.901 . . . . 0.98999999999999999 110.465 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.533 HG13 ' HE3' ' A' ' 179' ' ' MET . 43.4 mt -67.1 -42.69 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 113.589 -1.641 . . . . 1.03 110.159 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.31 -52.33 41.4 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.856 -1.065 . . . . 0.14999999999999999 111.287 171.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.725 HG21 ' CB ' ' A' ' 130' ' ' ALA . 71.8 mt -68.5 -47.25 78.14 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 N-CA-C 112.891 0.7 . . . . 1.05 112.891 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.664 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.28 -38.34 71.07 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.001 0.429 . . . . 1.03 111.23 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 30.4 mtp180 -84.04 -20.01 33.43 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.666 0.746 . . . . 1.29 110.443 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.425 HD21 ' CB ' ' A' ' 130' ' ' ALA . 16.6 t30 -84.36 -10.38 57.63 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.307 -1.368 . . . . 0.5 107.307 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.694 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -109.69 -29.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 113.262 -1.79 . . . . 1.05 111.094 -173.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.13 34.74 4.73 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.391 -0.909 . . . . 0.17000000000000001 112.833 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.61 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.64 161.29 15.53 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.15 0.796 . . . . 1.02 113.15 -169.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.658 ' N ' HG11 ' A' ' 86' ' ' VAL . 1.6 m80 -101.91 -28.14 12.57 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.375 -0.829 . . . . 0.39000000000000001 109.78 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.561 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.4 m-85 -135.39 -172.57 3.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.261 -0.881 . . . . 0.81000000000000005 110.959 -175.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.71 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -138.85 139.62 40.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.098 -0.955 . . . . 1.03 109.221 167.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.574 HD23 ' SD ' ' A' ' 176' ' ' MET . 43.9 tp -107.62 99.84 9.29 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 119.386 -0.925 . . . . 1.02 109.395 165.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.684 ' OH ' ' HB1' ' A' ' 148' ' ' ALA . 3.0 m-85 -81.69 112.81 19.21 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.234 -1.348 . . . . 0.87 109.556 176.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.866 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 4.9 t -123.08 166.12 15.68 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-O 121.77 0.795 . . . . 1.45 111.033 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.811 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.6 p -162.79 176.18 10.52 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 114.548 -1.205 . . . . 0.12 111.313 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.65 133.4 30.58 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 113.865 -1.516 . . . . 0.94999999999999996 108.279 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.625 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -143.14 -177.17 5.23 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.354 -0.61 . . . . 1.1499999999999999 109.354 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.76 -83.72 0.86 Allowed Glycine 0 CA--C 1.493 -1.336 0 C-N-CA 119.62 -1.276 . . . . 0.14999999999999999 111.355 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.7 t30 -144.17 130.5 19.8 Favored 'General case' 0 C--O 1.199 -1.598 0 N-CA-C 107.972 -1.121 . . . . 0.58999999999999997 107.972 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.58 HG23 ' N ' ' A' ' 99' ' ' SER . 3.2 p -64.48 -41.56 92.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.123 -0.944 . . . . 1.0 112.36 -171.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.469 ' N ' HG11 ' A' ' 169' ' ' VAL . 10.9 m-20 -61.19 -30.76 70.61 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.793 0.806 . . . . 1.9199999999999999 109.509 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.11 88.39 3.49 Favored Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 113.868 -1.514 . . . . 1.0600000000000001 108.376 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.646 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.0 Cg_endo -90.72 167.0 4.01 Favored 'Trans proline' 0 CA--C 1.492 -1.579 0 C-N-CA 124.579 3.52 . . . . 0.089999999999999997 114.72 -170.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.563 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 23.7 m -86.39 119.41 26.63 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 113.732 -1.577 . . . . 1.0600000000000001 107.643 166.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.843 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 42.2 tp -84.13 98.67 10.03 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 108.643 -0.873 . . . . 1.02 108.643 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.579 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.0 mt-30 -90.49 109.02 20.17 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 122.089 0.947 . . . . 0.34000000000000002 109.276 -176.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.866 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -111.73 164.54 12.93 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.936 -1.029 . . . . 1.0900000000000001 111.795 -172.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 56.0 tt0 -170.64 119.5 0.54 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 115.813 -0.63 . . . . 0.68000000000000005 110.245 -166.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -101.32 101.84 12.58 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.929 -0.767 . . . . 1.03 108.929 -173.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.584 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.4 ttp -90.88 118.35 30.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.755 -0.657 . . . . 0.89000000000000001 109.675 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.454 ' HB2' HG22 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -61.7 117.89 6.41 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.936 -1.505 . . . . 1.04 106.936 168.881 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.532 HG23 ' HB2' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -71.9 -36.35 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.05 0.841 . . . . 1.02 111.485 -176.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -60.85 -15.25 28.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.364 -0.835 . . . . 0.40000000000000002 111.685 -176.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 185' ' ' GLU . 40.5 p -127.91 -37.02 1.95 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.308 1.051 . . . . 1.03 109.896 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.445 ' CA ' HD12 ' A' ' 149' ' ' ILE . . . 86.83 24.32 38.73 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 113.765 -1.561 . . . . 0.17999999999999999 111.733 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.43 ' HG2' ' OG1' ' A' ' 183' ' ' THR . 11.0 pt-20 -105.22 158.03 16.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.882 0.372 . . . . 0.72999999999999998 110.248 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.471 HD13 ' HG2' ' A' ' 177' ' ' GLN . 36.0 mm -91.5 117.14 34.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.498 0.666 . . . . 1.03 109.391 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.658 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.8 pp -105.02 -29.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 114.777 -1.101 . . . . 1.01 110.44 -171.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.594 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.4 t90 -136.95 152.2 49.9 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.145 -0.934 . . . . 0.070000000000000007 109.621 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 53.9 p -153.41 163.46 39.9 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.963 0.727 . . . . 0.64000000000000001 112.963 164.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.69 -173.82 27.6 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 111.214 -0.755 . . . . 0.12 111.214 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.843 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.4 mtmt -158.91 151.44 21.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.668 -1.975 . . . . 1.76 105.668 165.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -161.02 127.74 1.81 Allowed Glycine 0 C--N 1.282 -2.43 0 C-N-CA 119.866 -1.159 . . . . 0.13 112.235 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 173' ' ' THR . . . -72.63 117.85 14.83 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.518 0.675 . . . . 1.01 111.528 -173.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.693 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 1.9 m -95.53 158.16 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-O 122.633 1.206 . . . . 1.01 110.676 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.756 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -99.56 172.2 7.44 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.531 -2.122 . . . . 0.92000000000000004 108.966 -175.126 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 8.9 tt0 -102.67 134.04 46.69 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.19 -0.604 . . . . 0.91000000000000003 109.877 171.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.525 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 15.2 mm-40 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.477 -0.773 . . . . 1.24 110.524 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 111.828 -0.509 . . . . 88.920000000000002 111.828 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.9 m -92.12 171.08 9.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.698 0.285 . . . . 87.459999999999994 110.451 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -132.78 -172.61 2.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.632 -0.258 . . . . 87.5 110.416 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.471 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.4 pmm? -56.57 150.33 15.7 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.613 0.571 . . . . 85.340000000000003 110.235 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.471 HG13 ' O ' ' A' ' 4' ' ' MET . 4.3 p 49.75 17.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.864 1.266 . . . . 85.230000000000004 112.667 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.41 -101.15 0.86 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.75 -0.738 . . . . 84.849999999999994 111.473 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -142.53 37.7 1.5 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.755 0.788 . . . . 85.599999999999994 110.274 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 65.7 178.59 0.2 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 114.389 -1.278 . . . . 85.310000000000002 111.402 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 58.34 71.16 1.06 Allowed Pre-proline 0 C--O 1.225 -0.194 0 CA-C-N 113.487 -1.688 . . . . 82.170000000000002 112.004 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -45.97 -72.17 0.05 OUTLIER 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.289 2.659 . . . . 82.069999999999993 112.346 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 13' ' ' VAL . . . -155.44 114.32 2.27 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.218 -0.446 . . . . 79.709999999999994 110.477 -175.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.68 132.34 16.57 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.506 2.804 . . . . 79.019999999999996 112.966 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 11' ' ' ALA . 16.9 m -134.12 172.09 16.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.291 -0.868 . . . . 77.260000000000005 110.982 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 70.8 60.23 0.2 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.727 -1.124 . . . . 75.739999999999995 109.911 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -114.05 107.62 15.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.408 -0.815 . . . . 74.010000000000005 110.671 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.51 135.8 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.197 0.522 . . . . 72.569999999999993 111.445 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -97.5 119.26 63.16 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.037 -0.528 . . . . 71.379999999999995 109.893 174.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.39 -168.55 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.663 1.575 . . . . 70.189999999999998 112.209 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.65 98.82 0.04 OUTLIER Pre-proline 0 C--N 1.339 0.137 0 CA-C-N 114.691 -1.141 . . . . 67.769999999999996 111.771 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.22 161.55 39.85 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.135 1.89 . . . . 67.180000000000007 111.419 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.57 -5.98 30.95 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.382 -0.527 . . . . 65.200000000000003 111.932 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 72.15 124.08 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.242 0 O-C-N 124.051 0.845 . . . . 63.460000000000001 110.28 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -51.6 141.31 43.39 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.907 2.404 . . . . 62.479999999999997 112.567 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.86 111.49 12.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 59.869999999999997 110.446 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -121.4 83.86 40.85 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 58.890000000000001 110.85 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.76 -19.51 41.07 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.113 2.542 . . . . 57.890000000000001 111.519 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 58.7 -105.8 0.27 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.348 -0.842 . . . . 55.729999999999997 110.69 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.444 ' C ' ' H ' ' A' ' 30' ' ' VAL . 19.4 mm-40 -144.56 156.01 56.72 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.895 -0.409 . . . . 54.079999999999998 109.895 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.93 35.88 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.952 2.435 . . . . 53.299999999999997 112.534 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.444 ' H ' ' C ' ' A' ' 28' ' ' GLN . 3.0 p -160.32 96.54 1.49 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.288 0.566 . . . . 51.130000000000003 109.997 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.81 123.18 11.84 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.525 2.15 . . . . 49.75 111.551 177.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.3 p -118.21 141.95 47.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.6 -0.273 . . . . 47.700000000000003 111.046 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.5 t 57.38 93.85 0.05 OUTLIER Pre-proline 0 C--O 1.235 0.325 0 O-C-N 123.72 0.637 . . . . 46.109999999999999 111.222 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.92 159.37 12.07 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.045 2.497 . . . . 45.890000000000001 112.572 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -75.94 120.61 21.52 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.458 -0.792 . . . . 43.0 110.741 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.82 108.15 33.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.966 -0.561 . . . . 40.789999999999999 109.97 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.88 -41.75 59.32 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.041 2.494 . . . . 40.450000000000003 112.239 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.9 m -125.34 97.74 5.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 37.729999999999997 110.281 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.8 mt -67.99 123.59 87.54 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.279 -0.873 . . . . 35.990000000000002 110.789 -176.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.73 97.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.029 2.486 . . . . 34.350000000000001 112.812 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -164.68 118.12 1.31 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.899 -0.591 . . . . 31.780000000000001 109.723 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.591 ' H ' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -150.92 -55.56 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 119.111 -0.471 . . . . 30.390000000000001 111.294 -175.549 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.591 ' HD2' ' H ' ' A' ' 42' ' ' GLN . 5.0 Cg_endo -46.49 123.47 6.87 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.712 2.275 . . . . 29.940000000000001 113.444 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.57 171.98 18.25 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.557 -0.747 . . . . 26.75 111.273 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -61.74 129.86 29.24 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.556 2.17 . . . . 25.879999999999999 112.284 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.5 mt -88.16 -66.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.471 -0.331 . . . . 24.16 110.896 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 61.82 92.32 0.06 Allowed 'General case' 0 C--O 1.233 0.188 0 O-C-N 123.712 0.633 . . . . 21.829999999999998 110.482 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -99.01 161.24 13.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.164 -0.471 . . . . 20.620000000000001 111.234 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -179.01 134.5 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.261 -0.881 . . . . 16.559999999999999 109.658 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.02 64.39 1.22 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.55 -0.75 . . . . 15.050000000000001 109.355 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -118.9 25.64 10.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.781 -1.099 . . . . 14.66 110.244 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.2 p -64.43 133.6 52.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.946 -0.57 . . . . 11.84 111.715 -174.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.66 73.65 40.74 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.32 -0.855 . . . . 8.4399999999999995 111.387 -176.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.38 143.31 24.72 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.364 2.043 . . . . 7.6600000000000001 111.737 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.84 130.27 39.65 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.751 2.3 . . . . 5.6600000000000001 111.399 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.65 95.26 0.05 OUTLIER Pre-proline 0 C--O 1.233 0.231 0 O-C-N 123.995 0.809 . . . . 2.8700000000000001 109.735 -169.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.7 -177.0 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.458 2.772 . . . . 1.8300000000000001 113.439 -172.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -120.64 146.4 46.43 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.45 -1.25 . . . . 4.2199999999999998 110.901 -173.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.598 HG22 ' N ' ' A' ' 60' ' ' ARG . 11.0 mt -84.26 169.51 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.187 -0.915 . . . . 1.1299999999999999 111.355 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.598 ' N ' HG22 ' A' ' 59' ' ' ILE . 29.4 mtt85 -66.2 -157.67 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 123.565 1.65 . . . . 3.1400000000000001 112.301 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.679 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 19.2 t-160 -158.82 147.56 18.54 Favored 'General case' 0 CA--C 1.471 -2.072 0 CA-C-N 111.741 -2.481 . . . . 2.7400000000000002 106.344 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.768 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 -125.03 159.87 30.32 Favored 'General case' 0 N--CA 1.415 -2.186 0 O-C-N 123.934 0.771 . . . . 0.76000000000000001 109.264 -176.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.504 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 2.8 t70 -80.01 68.09 6.02 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 123.692 1.711 . . . . 0.34999999999999998 108.36 171.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.723 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.3 m95 -59.41 -44.53 92.83 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 111.407 -2.633 . . . . 0.10000000000000001 112.312 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' N ' HG22 ' A' ' 108' ' ' THR . 12.8 t-20 -51.36 -30.26 18.18 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.036 -1.438 . . . . 1.1100000000000001 111.524 176.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.79 -16.31 80.74 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 115.601 -0.727 . . . . 0.23000000000000001 111.385 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.96 -51.12 3.62 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 113.95 -1.125 . . . . 1.01 110.908 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.766 ' SD ' HD23 ' A' ' 109' ' ' LEU . 40.7 mtt -65.33 -55.62 17.21 Favored 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 114.094 -1.412 . . . . 0.089999999999999997 112.224 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.481 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.7 mm-40 -41.23 -54.76 5.68 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 114.558 1.318 . . . . 0.63 114.558 -176.229 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.806 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 23.7 Cg_endo -62.29 -31.61 81.91 Favored 'Trans proline' 0 CA--C 1.506 -0.891 0 C-N-CA 122.159 1.906 . . . . 0.17000000000000001 110.478 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.659 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 6.7 mtm -79.62 -46.5 17.1 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 114.863 -1.062 . . . . 0.69999999999999996 111.587 -176.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.702 HG21 ' O ' ' A' ' 68' ' ' MET . 61.1 t -55.92 -41.13 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 CA-C-N 114.025 -1.443 . . . . 1.04 108.869 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 t -59.43 -35.26 73.68 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.248 -1.796 . . . . 1.1200000000000001 110.952 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.806 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 21.0 mtpp -81.45 -34.67 31.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.926 0.49 . . . . 1.8799999999999999 111.392 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.857 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.68 -27.66 69.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.693 -0.685 . . . . 0.5 111.592 -171.159 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.52 ' N ' ' HG2' ' A' ' 75' ' ' MET . 5.7 mt -92.92 -6.16 49.2 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.059 0.933 . . . . 1.29 110.817 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.72 18.02 51.41 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 108.726 -1.75 . . . . 0.17999999999999999 108.726 170.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.66 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.17 163.15 15.56 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.318 -0.941 . . . . 1.0 110.279 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.55 106.14 18.26 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.8 -1.091 . . . . 1.72 109.855 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.622 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.27 -23.85 3.62 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.201 -0.999 . . . . 0.13 111.056 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.857 HG11 ' O ' ' A' ' 75' ' ' MET . 10.4 p -100.22 152.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.661 0.743 . . . . 1.01 111.388 -174.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.5 m -135.25 139.45 44.45 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.643 -1.162 . . . . 1.1000000000000001 111.011 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.48 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.07 140.52 37.73 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.624 -1.171 . . . . 1.1200000000000001 111.155 167.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.91 2.95 68.64 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 121.262 -0.494 . . . . 0.28000000000000003 113.007 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.31 148.84 25.43 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 120.053 -0.659 . . . . 1.55 111.06 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.614 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -79.59 116.18 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-O 122.196 0.998 . . . . 1.03 109.517 166.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.886 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -104.69 109.63 21.63 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.118 -0.946 . . . . 1.03 109.427 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.63 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -72.16 99.28 2.3 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.832 -1.531 . . . . 1.01 108.421 177.1 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.745 ' O ' HD21 ' A' ' 127' ' ' LEU . 3.0 m -72.02 117.6 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.699 -1.223 . . . . 1.6200000000000001 107.699 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.732 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -77.65 137.4 38.51 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.846 -1.168 . . . . 0.64000000000000001 107.846 -178.013 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.501 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.2 m -53.51 127.98 27.22 Favored 'General case' 0 CA--C 1.49 -1.356 0 CA-C-O 122.064 0.935 . . . . 1.05 108.579 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.66 ' O ' ' HB3' ' A' ' 102' ' ' ALA . 19.8 t -55.53 134.97 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 107.695 -1.224 . . . . 1.02 107.695 173.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.656 ' H ' ' HA ' ' A' ' 164' ' ' SER . 10.2 t-20 -85.62 163.59 18.23 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 114.842 -1.072 . . . . 0.20000000000000001 109.96 175.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.753 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.11 86.19 2.52 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.383 -1.281 . . . . 0.12 107.894 176.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.402 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 15.1 mtp180 -109.5 -3.51 16.93 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.048 -1.433 . . . . 0.84999999999999998 108.628 -172.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 20.5 p -50.81 -171.47 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.942 -1.935 . . . . 0.91000000000000003 115.491 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 37.5 t30 -71.27 -4.46 25.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.776 -2.011 . . . . 0.62 110.719 173.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.532 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -157.85 -145.99 4.38 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.428 -0.892 . . . . 0.14000000000000001 113.062 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.631 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 59.9 p -121.39 131.97 54.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.347 0.594 . . . . 1.76 112.274 -178.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.753 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -137.21 158.31 44.72 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.015 0.912 . . . . 1.01 110.808 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.596 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -81.4 79.76 7.94 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.821 -1.536 . . . . 0.20999999999999999 108.067 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.66 ' HB3' ' O ' ' A' ' 92' ' ' VAL . . . -68.98 -14.38 63.0 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.377 -1.283 . . . . 1.0 109.991 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.77 -30.22 36.05 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.726 -0.842 . . . . 1.02 108.726 -178.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.596 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 14.1 tp10 -67.62 -33.84 75.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 114.451 -1.25 . . . . 1.73 108.96 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.57 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.45 -44.19 65.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.186 -1.824 . . . . 1.04 109.567 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 77.6 m -64.0 -30.97 72.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.013 -1.448 . . . . 1.04 110.372 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -43.32 76.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.077 -1.083 . . . . 1.47 108.077 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.636 HG22 ' HB2' ' A' ' 64' ' ' TRP . 79.2 m -63.14 -30.6 71.72 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.317 -0.856 . . . . 1.03 110.714 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.766 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.1 mt -51.5 -69.04 0.12 Allowed 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 109.404 -0.591 . . . . 1.3 109.404 172.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.526 ' O ' HD13 ' A' ' 121' ' ' LEU . 18.5 mtp180 -41.06 -39.2 1.17 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.644 -1.162 . . . . 1.8 110.989 175.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.537 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.0 -46.51 64.97 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.476 -1.238 . . . . 0.41999999999999998 112.038 -176.271 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -72.81 -32.84 65.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 122.149 0.976 . . . . 1.01 108.594 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.682 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -64.17 -34.38 77.95 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.588 -1.642 . . . . 1.01 110.1 174.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.473 ' CB ' HD12 ' A' ' 121' ' ' LEU . . . -70.97 -38.47 72.77 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.83 -1.077 . . . . 1.03 111.45 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.82 -28.66 68.97 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.403 -1.271 . . . . 1.55 111.041 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.42 ' OD1' HD13 ' A' ' 76' ' ' LEU . 9.1 t-20 -83.24 -36.25 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.913 -1.04 . . . . 2.0499999999999998 110.19 -174.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.18 -5.23 35.35 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.62 -0.8 . . . . 0.54000000000000004 114.35 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.48 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 53.7 mtpt -81.6 -9.89 59.56 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 117.774 0.787 . . . . 1.6000000000000001 110.787 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.886 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 28.5 m-85 -115.73 176.08 5.24 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.505 1.145 . . . . 0.27000000000000002 113.272 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.9 m -121.83 120.53 34.83 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 112.474 -2.148 . . . . 1.0800000000000001 107.896 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.607 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -88.1 140.01 29.92 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 119.512 -0.875 . . . . 1.1499999999999999 109.929 -171.912 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.495 HG11 HD21 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -88.07 155.11 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.56 -0.904 . . . . 1.0900000000000001 108.56 177.266 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.474 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 73.3 m -91.29 154.3 19.35 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.136 0.97 . . . . 1.8200000000000001 110.773 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.95 -22.07 61.51 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.539 -1.664 . . . . 1.1899999999999999 109.795 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.616 ' O ' ' HG3' ' A' ' 129' ' ' MET . 6.3 pt20 -54.63 -29.68 52.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.504 -1.225 . . . . 2.04 109.37 171.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.566 ' O ' ' HB2' ' A' ' 129' ' ' MET . 2.7 mt-30 -96.29 -56.49 2.61 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 114.358 -1.292 . . . . 0.42999999999999999 109.585 174.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.745 HD21 ' O ' ' A' ' 89' ' ' VAL . 13.6 tp -72.6 -58.21 3.54 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 113.685 -1.598 . . . . 2.04 114.58 -159.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.543 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 66.6 m -56.23 -36.95 69.07 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 123.227 1.489 . . . . 1.1499999999999999 108.456 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.616 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 9.3 mmt -62.98 -58.66 6.55 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 111.614 -2.539 . . . . 2.27 110.997 174.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.651 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -42.63 -41.66 3.16 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 124.224 0.953 . . . . 1.0700000000000001 111.91 176.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.783 ' NZ ' HD21 ' A' ' 142' ' ' LEU . 0.6 OUTLIER -52.46 -57.61 9.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.153 -0.619 . . . . 2.1000000000000001 109.912 175.846 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.459 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 40.2 mt-30 -61.4 -43.0 99.62 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.636 -1.166 . . . . 0.42999999999999999 111.445 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.594 ' HG3' ' O ' ' A' ' 129' ' ' MET . 47.8 mt-30 -56.29 -35.99 68.13 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 114.434 -1.257 . . . . 0.38 109.683 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -90.34 -29.95 17.75 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.029 -1.442 . . . . 1.05 109.408 -178.052 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.62 -53.62 0.38 Allowed Glycine 0 CA--C 1.498 -0.976 0 C-N-CA 119.657 -1.259 . . . . 0.33000000000000002 114.174 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.754 HD13 ' O ' ' A' ' 141' ' ' SER . 14.9 mt -62.36 -171.07 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 112.254 -1.973 . . . . 1.0700000000000001 116.226 -169.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.53 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 27.5 m -109.41 150.89 41.73 Favored Pre-proline 0 N--CA 1.421 -1.893 0 CA-C-N 110.759 -2.928 . . . . 1.24 108.146 171.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.543 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 57.2 Cg_endo -66.06 0.19 3.45 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 122.991 2.461 . . . . 0.39000000000000001 112.139 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.484 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.5 tt0 -117.62 -31.01 5.32 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 114.717 -1.129 . . . . 1.79 109.39 -175.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.53 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 25.7 t0 -61.71 -27.01 68.4 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 113.028 -1.896 . . . . 0.65000000000000002 107.889 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.754 ' O ' HD13 ' A' ' 136' ' ' LEU . 0.4 OUTLIER 73.28 -170.29 0.13 Allowed 'General case' 0 CA--C 1.477 -1.854 0 CA-C-N 112.233 -2.258 . . . . 0.73999999999999999 109.933 -177.77 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.783 HD21 ' NZ ' ' A' ' 131' ' ' LYS . 10.1 mt -65.25 -37.97 88.89 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.148 -1.387 . . . . 1.48 107.707 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.37 -12.04 0.13 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 112.701 -2.045 . . . . 0.34999999999999998 115.186 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.41 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -155.34 131.68 10.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 118.708 -0.663 . . . . 1.02 109.226 -175.205 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.71 ' O ' ' HB2' ' A' ' 148' ' ' ALA . 18.6 mmt180 -45.21 -50.07 11.82 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 118.069 0.395 . . . . 2.21 111.446 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.406 ' HA ' HD13 ' A' ' 149' ' ' ILE . 71.1 m -71.13 -28.13 64.07 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.384 0.611 . . . . 0.93000000000000005 111.55 -175.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -72.43 -32.17 66.08 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 122.777 1.275 . . . . 1.8899999999999999 108.803 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.747 ' CB ' HD11 ' A' ' 142' ' ' LEU . . . -68.11 -44.82 75.33 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.218 -2.265 . . . . 0.98999999999999999 109.906 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.526 ' HA ' HG22 ' A' ' 181' ' ' VAL . 37.3 mt -68.72 -43.75 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 CA-C-N 112.958 -1.928 . . . . 1.03 110.411 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.41 -53.22 32.85 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.935 -1.03 . . . . 0.14999999999999999 111.036 172.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.72 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 79.1 mt -66.98 -47.7 81.54 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 112.845 0.683 . . . . 1.05 112.845 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.626 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.37 -39.28 72.66 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.878 0.37 . . . . 1.03 110.506 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' A' ' 149' ' ' ILE . 21.7 mtp180 -82.74 -21.78 34.6 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.464 0.649 . . . . 1.29 110.664 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 17.0 t30 -82.16 -11.2 58.86 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 107.116 -1.438 . . . . 0.5 107.116 176.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.72 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.65 -29.74 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 113.13 -1.85 . . . . 1.05 110.978 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.48 35.75 4.57 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.226 -0.988 . . . . 0.17000000000000001 112.64 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.63 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.54 155.11 22.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.353 0.872 . . . . 1.02 113.353 -170.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.614 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.2 m80 -94.03 -28.93 15.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.784 0.833 . . . . 0.39000000000000001 109.852 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.583 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 10.3 m-85 -136.59 -178.16 5.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.342 -0.845 . . . . 0.81000000000000005 111.15 -173.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.674 ' O ' HD22 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -135.31 139.21 47.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.103 -0.953 . . . . 1.03 109.012 166.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.732 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 22.6 tp -109.96 98.92 8.12 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.607 -0.837 . . . . 1.02 109.932 167.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.618 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.0 m-85 -78.42 112.22 15.23 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.252 -0.885 . . . . 0.87 109.367 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.88 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.0 t -124.07 159.62 29.53 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 122.397 1.094 . . . . 1.45 110.323 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.774 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.4 p -164.44 171.97 13.98 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.016 -1.447 . . . . 0.12 111.098 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -133.28 133.96 43.3 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.082 -1.417 . . . . 0.94999999999999996 108.714 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.637 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.1 m -143.67 -176.33 4.93 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.025 -0.732 . . . . 1.1499999999999999 109.025 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.93 -83.21 0.91 Allowed Glycine 0 C--N 1.301 -1.387 0 C-N-CA 119.698 -1.239 . . . . 0.14999999999999999 111.454 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.489 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 60.2 t30 -144.7 126.67 15.45 Favored 'General case' 0 C--O 1.196 -1.748 0 N-CA-C 108.066 -1.087 . . . . 0.58999999999999997 108.066 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.598 HG22 ' N ' ' A' ' 99' ' ' SER . 3.0 p -62.43 -44.12 98.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.316 -0.856 . . . . 1.0 113.217 -170.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.47 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.9 m120 -62.1 -28.59 69.73 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.398 0.618 . . . . 1.9199999999999999 109.728 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.86 88.2 3.59 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 114.681 -1.145 . . . . 1.0600000000000001 108.436 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.64 ' HD2' HG22 ' A' ' 194' ' ' VAL . 42.9 Cg_endo -91.69 167.7 3.26 Favored 'Trans proline' 0 CA--C 1.498 -1.321 0 C-N-CA 125.045 3.83 . . . . 0.089999999999999997 115.151 -169.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.549 HG22 ' HB3' ' A' ' 191' ' ' LYS . 32.3 m -84.35 118.96 24.55 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 113.796 -1.547 . . . . 1.0600000000000001 107.381 165.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.854 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 48.8 tp -84.43 98.11 9.89 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 108.378 -0.971 . . . . 1.02 108.378 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.543 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 31.4 mt-30 -88.96 109.3 20.13 Favored 'General case' 0 C--N 1.272 -2.761 0 CA-C-O 121.891 0.853 . . . . 0.34000000000000002 109.239 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.88 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.6 OUTLIER -112.34 164.28 13.42 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.109 -0.951 . . . . 1.0900000000000001 111.495 -174.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.618 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 60.1 tt0 -171.71 116.92 0.4 Allowed 'General case' 0 C--O 1.202 -1.446 0 CA-C-N 116.027 -0.533 . . . . 0.68000000000000005 110.588 -166.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.684 HD11 ' CD1' ' A' ' 187' ' ' ILE . 0.8 OUTLIER -98.85 103.23 15.16 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.353 -0.842 . . . . 1.03 108.851 -170.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.656 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 16.3 ttp -92.12 122.29 34.48 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.261 -0.882 . . . . 0.89000000000000001 109.713 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.421 HD21 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -59.45 126.75 28.89 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.215 -1.402 . . . . 1.04 107.215 166.287 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.526 HG22 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -80.45 -35.56 15.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.433 -0.907 . . . . 1.02 110.682 178.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.43 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.4 mt-30 -64.02 -13.98 50.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.282 -0.872 . . . . 0.40000000000000002 111.527 -178.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.6 p -131.12 -32.62 1.58 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.902 0.858 . . . . 1.03 110.623 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 82.95 28.03 39.12 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.357 -1.292 . . . . 0.17999999999999999 112.136 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.43 152.38 24.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.64 -0.28 . . . . 0.72999999999999998 110.502 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.451 HD13 ' HG2' ' A' ' 177' ' ' GLN . 30.4 mm -86.48 121.34 37.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.368 0.604 . . . . 1.03 109.464 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.684 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.2 pp -109.28 -29.93 2.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.112 -0.949 . . . . 1.01 110.402 -174.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.66 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 80.6 t90 -136.48 153.43 51.04 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.056 -0.975 . . . . 0.070000000000000007 109.562 173.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 58.1 p -153.36 164.34 38.31 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.235 0.828 . . . . 0.64000000000000001 113.235 164.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.2 -173.78 28.07 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 111.244 -0.742 . . . . 0.12 111.244 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.854 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 18.1 mttt -157.69 153.73 27.15 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.221 -2.14 . . . . 1.76 105.221 165.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.532 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -158.19 126.89 1.78 Allowed Glycine 0 C--N 1.279 -2.585 0 C-N-CA 119.525 -1.321 . . . . 0.13 111.663 174.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -73.94 111.87 9.52 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.508 0.67 . . . . 1.01 110.774 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.667 HG12 ' CZ3' ' A' ' 64' ' ' TRP . 1.9 m -91.3 158.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 122.693 1.235 . . . . 1.01 111.051 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.768 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -98.67 172.38 7.52 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 112.38 -2.191 . . . . 0.92000000000000004 108.722 -174.548 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.553 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.6 tt0 -102.61 133.16 48.06 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.997 -0.681 . . . . 0.91000000000000003 109.505 169.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.515 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 14.8 mm-40 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.795 -0.622 . . . . 1.24 110.602 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.556 -0.218 . . . . 88.920000000000002 112.556 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 33.7 t -160.94 125.11 3.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.76 -0.459 . . . . 87.459999999999994 109.76 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 2' ' ' SER . 53.0 m80 70.26 122.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.662 0.601 . . . . 87.5 111.63 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 ttt 61.3 48.97 5.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.888 0.851 . . . . 85.340000000000003 110.264 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -127.35 -38.14 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.697 -1.138 . . . . 85.230000000000004 110.177 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.99 -25.62 48.36 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.618 -0.801 . . . . 84.849999999999994 112.149 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 10.2 pt20 -87.85 -145.8 0.14 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.652 -0.129 . . . . 85.599999999999994 110.652 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.542 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 67.8 mtm180 71.32 178.2 0.26 Allowed 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.075 0.55 . . . . 85.310000000000002 110.456 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -104.07 90.38 3.01 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.55 -0.75 . . . . 82.170000000000002 109.545 172.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 5.0 Cg_exo -73.83 123.57 8.56 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.707 2.271 . . . . 82.069999999999993 112.412 -177.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.46 99.93 39.32 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.027 -0.533 . . . . 79.709999999999994 109.632 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.75 130.98 27.73 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.012 1.808 . . . . 79.019999999999996 112.201 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 m -138.28 156.55 30.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.465 -0.789 . . . . 77.260000000000005 110.493 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -139.17 -71.05 0.4 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.593 -0.73 . . . . 75.739999999999995 109.646 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -95.21 90.0 5.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.11 0.481 . . . . 74.010000000000005 110.403 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.5 t -78.07 113.99 18.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.72 -0.673 . . . . 72.569999999999993 109.666 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -119.91 136.1 24.7 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.468 -0.333 . . . . 71.379999999999995 110.538 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.88 140.12 65.33 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.913 1.742 . . . . 70.189999999999998 110.613 170.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.26 73.23 81.49 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 121.092 -0.243 . . . . 67.769999999999996 110.954 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.29 -49.47 9.2 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.329 2.019 . . . . 67.180000000000007 111.596 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 66.85 132.03 0.02 OUTLIER 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.785 0.678 . . . . 65.200000000000003 111.358 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -127.9 78.85 74.61 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.008 -0.542 . . . . 63.460000000000001 110.63 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.61 143.65 81.97 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.443 2.762 . . . . 62.479999999999997 112.673 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.86 82.51 2.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.403 0.62 . . . . 59.869999999999997 110.24 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -112.2 87.39 9.02 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 114.954 -1.021 . . . . 58.890000000000001 109.965 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.18 155.03 42.08 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.301 2.001 . . . . 57.890000000000001 112.644 -175.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -90.93 141.36 28.92 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.138 0.494 . . . . 55.729999999999997 110.803 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -143.36 125.09 8.41 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.732 -0.667 . . . . 54.079999999999998 109.609 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.24 -154.79 0.05 OUTLIER 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.532 2.155 . . . . 53.299999999999997 111.872 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.9 m -61.38 127.97 89.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.142 0.496 . . . . 51.130000000000003 111.283 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.94 -10.37 19.7 Favored 'Trans proline' 0 CA--C 1.527 0.143 0 C-N-CA 122.629 2.219 . . . . 49.75 111.85 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 p -94.43 143.04 26.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.947 -0.57 . . . . 47.700000000000003 110.979 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.96 119.2 15.67 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.726 -0.67 . . . . 46.109999999999999 110.068 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.03 152.64 81.68 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.755 2.303 . . . . 45.890000000000001 112.47 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 p 45.16 100.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.845 -1.07 . . . . 43.0 113.072 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.49 ' HB ' ' HD3' ' A' ' 37' ' ' PRO . 88.7 t -127.83 -51.26 0.03 OUTLIER Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 115.346 -0.843 . . . . 40.789999999999999 111.983 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 10.9 Cg_exo -72.7 -159.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.097 1.865 . . . . 40.450000000000003 112.539 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 m -57.63 130.79 47.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.998 0.428 . . . . 37.729999999999997 110.865 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -73.49 112.49 16.26 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.837 -0.62 . . . . 35.990000000000002 110.0 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.08 79.02 3.51 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.541 2.161 . . . . 34.350000000000001 113.354 -173.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -145.21 133.57 21.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 31.780000000000001 109.986 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -134.82 79.92 50.83 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.554 -0.294 . . . . 30.390000000000001 111.017 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.39 147.5 65.42 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.173 1.916 . . . . 29.940000000000001 111.54 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.96 -173.09 43.09 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.915 -0.659 . . . . 26.75 111.609 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.68 132.5 23.58 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.484 2.122 . . . . 25.879999999999999 111.663 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.7 mt -87.44 -62.39 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 116.369 -0.378 . . . . 24.16 110.154 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 53.23 73.2 0.38 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.564 -0.744 . . . . 21.829999999999998 110.883 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -73.28 164.48 26.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.668 -0.696 . . . . 20.620000000000001 110.841 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -111.36 177.08 4.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.408 -0.815 . . . . 16.559999999999999 110.49 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -118.94 45.93 1.98 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.75 0.786 . . . . 15.050000000000001 110.043 178.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -81.35 53.05 1.97 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.495 -0.775 . . . . 14.66 110.418 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.2 p -109.25 144.97 36.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.963 -0.562 . . . . 11.84 111.109 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.32 67.34 46.09 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.52 -0.764 . . . . 8.4399999999999995 110.383 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 22.7 Cg_exo -64.63 130.45 26.46 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.503 2.135 . . . . 7.6600000000000001 111.759 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 54' ' ' PRO . 9.5 Cg_exo -71.7 -149.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.932 2.421 . . . . 5.6600000000000001 110.912 173.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.41 107.61 0.95 Allowed Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 109.942 -0.392 . . . . 2.8700000000000001 109.942 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.38 -176.59 3.01 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.319 2.679 . . . . 1.8300000000000001 113.145 -172.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -118.35 139.56 51.17 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.174 -1.375 . . . . 4.2199999999999998 110.168 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.607 HG21 ' N ' ' A' ' 60' ' ' ARG . 9.7 mt -88.02 171.42 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.968 0.889 . . . . 1.1299999999999999 111.574 -176.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.607 ' N ' HG21 ' A' ' 59' ' ' ILE . 50.1 mtt-85 -72.04 -157.16 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 113.746 -1.57 . . . . 3.1400000000000001 112.232 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.628 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 19.1 t-160 -158.09 146.96 19.22 Favored 'General case' 0 CA--C 1.476 -1.904 0 CA-C-N 112.237 -2.256 . . . . 2.7400000000000002 106.616 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.781 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.0 m-30 -125.62 158.58 34.33 Favored 'General case' 0 N--CA 1.421 -1.88 0 O-C-N 123.967 0.792 . . . . 0.76000000000000001 109.821 -175.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.532 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 4.4 t70 -80.73 67.54 6.65 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 123.761 1.743 . . . . 0.34999999999999998 108.25 171.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.679 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 92.1 m95 -56.23 -42.28 77.05 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 111.361 -2.654 . . . . 0.10000000000000001 112.345 174.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.575 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 9.8 t-20 -49.55 -31.14 9.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.537 -1.665 . . . . 1.1100000000000001 112.183 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.2 -16.58 80.52 Favored Glycine 0 CA--C 1.505 -0.547 0 CA-C-O 122.091 0.828 . . . . 0.23000000000000001 111.193 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.534 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -100.89 -54.14 2.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.846 -1.177 . . . . 1.01 110.874 -176.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.71 ' O ' HG21 ' A' ' 72' ' ' VAL . 41.8 mtt -64.33 -59.12 4.75 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 114.256 -1.338 . . . . 0.089999999999999997 112.798 -176.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.575 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -39.47 -55.12 3.47 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 114.548 1.314 . . . . 0.63 114.548 -175.94 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.798 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 43.1 Cg_endo -66.14 -29.68 47.52 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.708 1.605 . . . . 0.17000000000000001 110.471 -177.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.894 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 11.1 mtm -82.19 -40.46 21.7 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.292 -0.867 . . . . 0.69999999999999996 111.397 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.71 HG21 ' O ' ' A' ' 68' ' ' MET . 47.9 t -57.44 -39.06 66.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 114.608 -1.178 . . . . 1.04 108.382 172.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -62.12 -33.6 74.76 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.204 -1.816 . . . . 1.1200000000000001 110.94 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.798 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 32.9 mtpt -82.4 -31.57 29.55 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.203 0.525 . . . . 1.8799999999999999 110.886 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.859 ' O ' HG13 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.32 -28.52 68.06 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.255 -0.884 . . . . 0.5 111.425 -172.168 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.632 HD13 ' CG ' ' A' ' 118' ' ' LYS . 5.6 mt -93.53 -4.18 51.5 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.412 1.101 . . . . 1.29 110.588 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.49 17.93 42.31 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 108.837 -1.705 . . . . 0.17999999999999999 108.837 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.606 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.33 163.98 15.1 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.615 -0.792 . . . . 1.0 109.897 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -92.26 106.42 18.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.517 -0.765 . . . . 1.72 109.732 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.619 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.21 -24.69 3.07 Favored Glycine 0 N--CA 1.418 -2.519 0 C-N-CA 119.998 -1.096 . . . . 0.13 110.373 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 75' ' ' MET . 11.4 p -99.59 153.57 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 114.738 -0.731 . . . . 1.01 111.153 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.6 m -134.55 139.27 45.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.795 -1.093 . . . . 1.1000000000000001 110.267 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.429 ' CB ' ' HE3' ' A' ' 118' ' ' LYS . . . -58.89 143.9 46.24 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.432 -0.804 . . . . 1.1200000000000001 110.514 168.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.62 69.64 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.89 -0.672 . . . . 0.28000000000000003 113.141 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.95 153.65 22.03 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 117.078 0.439 . . . . 1.55 110.658 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.668 HG12 ' N ' ' A' ' 158' ' ' HIS . 2.2 p -81.91 116.49 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 122.051 0.929 . . . . 1.03 109.301 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.568 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -104.37 110.06 22.16 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.173 -0.922 . . . . 1.03 109.106 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.663 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.6 OUTLIER -71.65 101.09 2.45 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.954 -1.021 . . . . 1.01 108.65 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.644 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 73.0 t -73.66 111.18 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.863 -1.062 . . . . 1.6200000000000001 109.048 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.757 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 6.1 t0 -77.35 152.87 34.25 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 114.735 -1.12 . . . . 0.64000000000000001 108.167 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.561 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.7 OUTLIER -61.39 137.24 58.24 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.718 -1.128 . . . . 1.05 107.999 173.253 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.59 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 20.6 t -63.58 138.84 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.88 0 N-CA-C 107.903 -1.147 . . . . 1.02 107.903 167.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.638 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -84.21 162.81 20.06 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.123 -0.944 . . . . 0.20000000000000001 110.138 173.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.755 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.22 85.7 2.44 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.37 -1.287 . . . . 0.12 108.241 175.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.442 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.4 mtp180 -108.73 -1.69 19.19 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.029 -1.441 . . . . 0.84999999999999998 108.823 -172.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 24.6 p -52.46 -171.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 112.927 -1.942 . . . . 0.91000000000000003 115.281 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 30.5 t30 -71.24 -9.39 58.03 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.107 -1.861 . . . . 0.62 110.539 173.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.497 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -151.73 -146.34 4.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.358 -0.925 . . . . 0.14000000000000001 112.841 -177.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.601 ' N ' HG23 ' A' ' 169' ' ' VAL . 60.1 p -121.19 129.7 53.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.119 0.485 . . . . 1.76 112.147 -177.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.755 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -134.73 156.76 48.24 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-O 121.876 0.846 . . . . 1.01 110.855 -177.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.608 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -80.44 80.7 6.84 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 113.845 -1.525 . . . . 0.20999999999999999 107.977 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.59 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -68.04 -14.71 63.19 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.261 -1.336 . . . . 1.0 110.027 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . 0.471 ' HB1' ' HG3' ' A' ' 139' ' ' GLN . . . -80.33 -32.63 37.86 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.812 -0.81 . . . . 1.02 108.812 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.608 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.0 tp10 -65.5 -32.84 74.66 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.384 -1.28 . . . . 1.73 108.901 172.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.572 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -73.58 -45.18 54.84 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 112.96 -1.927 . . . . 1.04 109.683 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.619 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 73.1 m -62.84 -31.49 72.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.155 -1.384 . . . . 1.04 110.228 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -66.85 -44.09 81.91 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.136 -1.061 . . . . 1.47 108.136 172.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.62 HG21 ' HB2' ' A' ' 64' ' ' TRP . 51.7 m -62.79 -31.73 72.77 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.4 -0.818 . . . . 1.03 110.584 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.701 ' O ' HD21 ' A' ' 113' ' ' LEU . 10.3 mt -52.67 -69.66 0.11 Allowed 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.737 -0.665 . . . . 1.3 109.283 171.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.678 ' O ' HD12 ' A' ' 121' ' ' LEU . 9.4 mtp180 -40.05 -36.57 0.5 Allowed 'General case' 0 C--N 1.313 -0.991 0 O-C-N 124.365 1.041 . . . . 1.8 111.606 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.535 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -73.4 -46.98 45.55 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.501 -1.227 . . . . 0.41999999999999998 111.97 -176.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.42 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . . . -72.2 -31.99 66.39 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.261 1.029 . . . . 1.01 108.455 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.701 HD21 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.23 -35.75 81.38 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.213 -1.812 . . . . 1.01 109.579 172.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -73.61 -39.93 64.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 114.855 -1.066 . . . . 1.03 111.383 -175.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -61.01 -32.03 71.63 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.623 -0.717 . . . . 1.55 110.85 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -76.46 -21.34 56.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.412 -0.813 . . . . 2.0499999999999998 111.076 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 60.91 11.83 26.23 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 115.492 0.957 . . . . 0.54000000000000004 115.492 162.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.632 ' CG ' HD13 ' A' ' 76' ' ' LEU . 8.6 ptmt -108.47 -23.64 11.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.413 0.606 . . . . 1.6000000000000001 111.225 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.646 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 3.2 m-85 -87.87 170.15 11.42 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.924 0.869 . . . . 0.27000000000000002 111.676 172.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.524 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 23.5 m -120.66 105.44 10.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 113.425 -1.716 . . . . 1.0800000000000001 108.064 170.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -98.17 130.67 44.91 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 114.379 -1.282 . . . . 1.1499999999999999 112.249 -168.023 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.765 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.7 OUTLIER -75.48 150.86 6.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 113.973 -1.467 . . . . 1.0900000000000001 107.77 174.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.6 t -101.24 -173.07 2.28 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 119.803 -0.759 . . . . 1.8200000000000001 109.765 176.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.478 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -63.32 -25.28 68.23 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.1 -1.074 . . . . 1.1899999999999999 108.1 174.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.604 ' O ' ' HG3' ' A' ' 129' ' ' MET . 36.2 mt-30 -52.52 -39.09 60.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.392 -1.731 . . . . 2.04 110.79 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.765 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 5.7 mt-30 -99.15 -51.16 3.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.774 0.797 . . . . 0.42999999999999999 110.316 172.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 89' ' ' VAL . 1.8 tm? -64.26 -62.5 1.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.801 -1.545 . . . . 2.04 112.906 -167.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.702 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -50.89 -39.15 53.45 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 123.62 1.676 . . . . 1.1499999999999999 109.248 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.683 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -63.87 -61.81 2.04 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 110.904 -2.862 . . . . 2.27 110.837 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.691 ' CB ' HG22 ' A' ' 151' ' ' ILE . . . -42.82 -44.78 4.61 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 124.496 1.122 . . . . 1.0700000000000001 112.134 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.534 ' HZ1' ' N ' ' A' ' 142' ' ' LEU . 13.3 mmtt -49.32 -60.37 2.88 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.471 -0.566 . . . . 2.1000000000000001 109.471 175.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -59.16 -43.11 92.09 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.234 -0.894 . . . . 0.42999999999999999 111.059 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.683 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.1 mt-30 -56.41 -36.3 68.76 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 114.238 -1.346 . . . . 0.38 109.69 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -89.94 -31.36 17.3 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.162 -1.381 . . . . 1.05 109.622 -176.441 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.53 -45.41 0.55 Allowed Glycine 0 CA--C 1.495 -1.207 0 C-N-CA 120.096 -1.05 . . . . 0.33000000000000002 113.278 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.572 HD13 ' O ' ' A' ' 141' ' ' SER . 95.7 mt -67.95 -171.16 0.2 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 112.448 -1.876 . . . . 1.0700000000000001 115.486 -169.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.572 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 9.5 m -115.1 149.91 43.38 Favored Pre-proline 0 N--CA 1.422 -1.875 0 CA-C-N 110.7 -2.954 . . . . 1.24 107.765 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.702 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 28.8 Cg_endo -64.5 1.02 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.534 2.156 . . . . 0.39000000000000001 112.034 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.476 ' H ' ' C ' ' A' ' 137' ' ' SER . 0.5 OUTLIER -117.36 -21.62 8.61 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.382 -0.826 . . . . 1.79 110.862 -177.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.606 ' O ' ' HB2' ' A' ' 141' ' ' SER . 16.3 t70 -71.42 -20.32 62.13 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.222 -1.354 . . . . 0.65000000000000002 108.932 -171.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.606 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 26.3 m 72.84 169.05 0.32 Allowed 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 113.005 -1.907 . . . . 0.73999999999999999 109.338 -174.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.757 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 4.9 mt -63.48 -39.12 93.62 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.685 -1.228 . . . . 1.48 107.685 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.43 -11.84 2.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 113.369 -1.741 . . . . 0.34999999999999998 114.402 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.5 m -157.04 128.76 7.09 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.068 -0.716 . . . . 1.02 109.068 -177.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.651 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.3 mmt180 -43.93 -46.46 8.14 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 117.991 0.359 . . . . 2.21 111.385 -178.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.7 t -71.27 -25.81 62.62 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.68 0.753 . . . . 0.93000000000000005 111.459 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.411 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 22.8 mttm -75.04 -32.21 61.5 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.588 1.185 . . . . 1.8899999999999999 108.678 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.736 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -72.57 -46.02 56.37 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 112.385 -2.189 . . . . 0.98999999999999999 110.017 177.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.551 HG13 ' HE2' ' A' ' 179' ' ' MET . 41.5 mt -67.14 -42.38 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 112.768 -2.015 . . . . 1.03 109.995 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.92 -52.72 37.48 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 114.74 -1.118 . . . . 0.14999999999999999 111.301 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.694 ' O ' ' HB ' ' A' ' 155' ' ' VAL . 69.5 mt -67.12 -48.44 78.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.072 0 N-CA-C 112.7 0.63 . . . . 1.05 112.7 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.663 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.94 -40.39 73.09 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.826 0.345 . . . . 1.03 111.344 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.436 ' HD2' HG21 ' A' ' 149' ' ' ILE . 43.0 mtp180 -81.64 -22.26 37.71 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.625 0.726 . . . . 1.29 110.321 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 15.4 t30 -81.83 -12.95 58.27 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 107.16 -1.422 . . . . 0.5 107.16 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.694 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.05 -29.17 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 113.231 -1.804 . . . . 1.05 110.898 -174.024 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.99 35.63 4.75 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.357 -0.925 . . . . 0.17000000000000001 112.466 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.654 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.68 158.13 19.65 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.275 0.842 . . . . 1.02 113.275 -169.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.668 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.5 m80 -98.66 -27.79 13.83 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.322 -0.854 . . . . 0.39000000000000001 109.757 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.61 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 9.3 m-85 -135.58 -173.35 3.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.049 -0.978 . . . . 0.81000000000000005 111.281 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.694 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -138.42 139.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.9 -1.045 . . . . 1.03 109.231 167.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.714 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 40.8 tp -108.5 97.27 6.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.468 -0.893 . . . . 1.02 109.505 165.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.736 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 1.4 m-85 -78.82 112.45 15.99 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.687 -1.142 . . . . 0.87 108.959 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.83 ' OG ' HD11 ' A' ' 174' ' ' LEU . 27.0 t -122.26 163.19 20.08 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 122.002 0.906 . . . . 1.45 110.515 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.782 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.6 p -164.33 173.15 12.59 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 114.37 -1.286 . . . . 0.12 111.049 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.539 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.73 139.72 42.09 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 114.14 -1.391 . . . . 0.94999999999999996 108.758 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.662 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 t -146.42 -172.54 3.98 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.954 -0.698 . . . . 1.1499999999999999 110.267 176.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 90.3 -84.49 1.34 Allowed Glycine 0 N--CA 1.424 -2.16 0 CA-C-N 114.883 -1.053 . . . . 0.14999999999999999 111.593 174.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 49.2 t-20 -135.29 128.04 31.05 Favored 'General case' 0 C--O 1.196 -1.719 0 N-CA-C 106.925 -1.509 . . . . 0.58999999999999997 106.925 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.601 HG23 ' N ' ' A' ' 99' ' ' SER . 2.9 p -64.03 -41.51 92.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.553 -0.749 . . . . 1.0 112.37 -177.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.454 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.9 m120 -67.56 -26.45 66.31 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.468 0.651 . . . . 1.9199999999999999 109.461 -175.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.52 89.21 3.26 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 114.887 -1.051 . . . . 1.0600000000000001 108.304 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.647 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.6 Cg_endo -90.27 165.0 4.56 Favored 'Trans proline' 0 CA--C 1.488 -1.804 0 C-N-CA 124.519 3.479 . . . . 0.089999999999999997 114.97 -171.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.539 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 19.4 m -83.24 117.32 22.87 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.548 -1.66 . . . . 1.0600000000000001 107.602 166.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.83 HD11 ' OG ' ' A' ' 163' ' ' SER . 49.1 tp -84.09 98.53 9.93 Favored 'General case' 0 N--CA 1.411 -2.381 0 C-N-CA 119.641 -0.824 . . . . 1.02 109.055 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.573 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.8 mt-30 -89.13 107.21 18.92 Favored 'General case' 0 C--N 1.273 -2.749 0 CA-C-N 114.811 -1.086 . . . . 0.34000000000000002 108.95 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.894 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 37.0 mtp -107.08 163.73 12.74 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.138 -0.937 . . . . 1.0900000000000001 110.393 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.52 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 57.9 tt0 -170.09 117.41 0.55 Allowed 'General case' 0 C--O 1.202 -1.445 0 CA-C-O 121.179 0.514 . . . . 0.68000000000000005 110.208 -167.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER -100.12 102.06 13.28 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.705 -0.85 . . . . 1.03 108.705 -172.447 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.651 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.8 ttp -91.67 122.57 34.35 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.416 -0.811 . . . . 0.89000000000000001 109.755 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.457 ' HB3' ' OG1' ' A' ' 183' ' ' THR . 0.1 OUTLIER -58.53 126.45 27.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.311 -1.366 . . . . 1.04 107.311 166.238 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.533 HG22 ' HB2' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.63 -33.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 O-C-N 120.939 -1.101 . . . . 1.02 110.55 178.798 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.0 mt-30 -63.85 -13.95 49.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.235 -0.893 . . . . 0.40000000000000002 111.449 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.457 ' OG1' ' HB3' ' A' ' 180' ' ' LEU . 60.3 p -130.62 -36.69 1.41 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.945 0.878 . . . . 1.03 110.26 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.418 ' CA ' HD12 ' A' ' 149' ' ' ILE . . . 87.08 24.35 37.81 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.334 -1.303 . . . . 0.17999999999999999 112.022 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 186' ' ' ILE . 0.2 OUTLIER -104.26 152.37 22.29 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.621 -0.29 . . . . 0.72999999999999998 110.658 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.472 ' N ' ' HG3' ' A' ' 185' ' ' GLU . 33.0 mm -87.85 113.6 25.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.811 0.815 . . . . 1.03 109.532 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.679 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.6 pp -101.8 -29.61 3.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 114.729 -1.123 . . . . 1.01 110.587 -173.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.624 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.4 t90 -136.82 152.47 50.31 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.304 -0.862 . . . . 0.070000000000000007 109.737 172.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 37.3 p -153.78 162.93 40.82 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.003 0.742 . . . . 0.64000000000000001 113.003 164.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -156.53 -178.24 30.46 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 110.985 -0.846 . . . . 0.12 110.985 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.823 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.1 mtmt -157.12 149.39 22.97 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.343 -1.725 . . . . 1.76 106.343 166.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -159.35 127.69 1.88 Allowed Glycine 0 C--N 1.285 -2.258 0 C-N-CA 119.973 -1.108 . . . . 0.13 112.258 -179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.09 114.45 12.43 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.547 0.689 . . . . 1.01 111.472 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.674 HG11 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -91.73 159.47 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 122.609 1.195 . . . . 1.01 111.065 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.781 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -99.68 173.78 6.54 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.319 -2.218 . . . . 0.92000000000000004 108.974 -173.051 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.474 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -102.94 130.3 49.95 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.64 -0.424 . . . . 0.91000000000000003 110.895 171.35 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.532 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 15.3 mm-40 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.609 -0.71 . . . . 1.24 110.722 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.801 -0.519 . . . . 88.920000000000002 111.801 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.6 p -82.32 114.27 20.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.84 0.353 . . . . 87.459999999999994 110.71 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -114.54 142.6 46.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.121 -0.49 . . . . 87.5 109.801 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.3 ptm 40.23 39.32 0.64 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.085 1.354 . . . . 85.340000000000003 113.725 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.81 -38.17 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.697 -0.683 . . . . 85.230000000000004 110.585 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.5 -110.26 0.23 Allowed Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 111.445 -0.662 . . . . 84.849999999999994 111.445 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 55.49 -100.84 0.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.949 0.5 . . . . 85.599999999999994 111.258 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 49.95 68.7 0.7 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.401 0.62 . . . . 85.310000000000002 111.055 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -123.85 99.34 38.49 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.654 -0.703 . . . . 82.170000000000002 110.409 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.01 78.74 3.08 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.462 2.108 . . . . 82.069999999999993 112.644 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 61.95 86.36 0.15 Allowed Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 115.077 -0.965 . . . . 79.709999999999994 111.7 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.73 145.51 75.62 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.354 2.036 . . . . 79.019999999999996 112.389 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -78.76 156.28 4.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.11 0.481 . . . . 77.260000000000005 111.507 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 39.3 tt0 -163.17 162.99 25.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.277 -0.874 . . . . 75.739999999999995 109.447 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.459 ' N ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 76.86 148.81 0.1 Allowed 'General case' 0 N--CA 1.463 0.182 0 O-C-N 124.192 0.932 . . . . 74.010000000000005 110.925 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.39 103.22 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.742 -0.663 . . . . 72.569999999999993 110.006 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -75.92 147.06 80.2 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.673 -0.694 . . . . 71.379999999999995 110.51 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.7 89.37 0.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.118 1.879 . . . . 70.189999999999998 111.695 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.43 ' HB2' ' HD3' ' A' ' 20' ' ' PRO . . . -101.45 -51.71 0.17 Allowed Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.208 -0.451 . . . . 67.769999999999996 111.955 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.43 ' HD3' ' HB2' ' A' ' 19' ' ' ALA . 5.9 Cg_exo -79.48 42.36 1.28 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.606 2.204 . . . . 67.180000000000007 112.833 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.16 127.85 33.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 65.200000000000003 110.09 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -136.71 133.22 18.85 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.149 -0.478 . . . . 63.460000000000001 109.975 -178.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_exo -57.27 143.19 94.29 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.952 2.435 . . . . 62.479999999999997 112.114 175.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.03 118.45 13.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.314 -0.403 . . . . 59.869999999999997 111.039 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -103.35 105.55 47.19 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.042 -0.526 . . . . 58.890000000000001 109.884 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.65 -137.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.831 2.354 . . . . 57.890000000000001 113.34 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -91.11 138.16 31.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.0 0.429 . . . . 55.729999999999997 110.441 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -143.59 144.41 27.41 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.469 -0.332 . . . . 54.079999999999998 110.233 178.138 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 28' ' ' GLN . 19.5 Cg_exo -66.67 107.95 1.35 Allowed 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.776 2.318 . . . . 53.299999999999997 112.305 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.4 m -98.36 148.8 35.02 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.926 -0.579 . . . . 51.130000000000003 109.785 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.82 88.8 0.15 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 123.039 2.493 . . . . 49.75 112.643 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 p -69.66 148.49 49.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.735 -0.666 . . . . 47.700000000000003 110.761 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -85.54 117.03 67.95 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.227 -0.442 . . . . 46.109999999999999 111.11 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.28 162.07 18.19 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.073 2.516 . . . . 45.890000000000001 113.066 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 p -89.02 144.13 26.37 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.445 -0.798 . . . . 43.0 111.233 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.427 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.5 p -67.48 128.2 93.56 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.428 -0.806 . . . . 40.789999999999999 110.495 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 34.4 Cg_exo -63.15 156.37 55.65 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.785 2.323 . . . . 40.450000000000003 112.677 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 m -77.51 135.95 38.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.9 -0.591 . . . . 37.729999999999997 110.914 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.0 mt -105.04 105.04 50.01 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.898 -0.592 . . . . 35.990000000000002 110.138 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -93.45 75.67 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.874 2.383 . . . . 34.350000000000001 112.572 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -125.24 73.01 1.27 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.111 0.481 . . . . 31.780000000000001 110.554 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.57 87.35 53.15 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.193 -0.458 . . . . 30.390000000000001 110.329 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.89 139.34 30.11 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.482 2.122 . . . . 29.940000000000001 111.137 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.63 153.8 52.37 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.754 -0.736 . . . . 26.75 112.656 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.7 129.06 20.18 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.031 2.487 . . . . 25.879999999999999 112.356 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.0 mt -74.86 -57.85 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.791 -0.641 . . . . 24.16 110.523 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 57.79 86.08 0.08 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.947 -0.569 . . . . 21.829999999999998 110.867 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -89.47 167.02 13.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.23 0.538 . . . . 20.620000000000001 110.684 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.14 173.08 6.77 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.312 -0.858 . . . . 16.559999999999999 110.496 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -103.66 56.78 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.473 0.654 . . . . 15.050000000000001 110.369 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -97.15 97.01 8.83 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.613 -0.721 . . . . 14.66 110.44 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.2 p -95.56 162.28 13.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.837 -0.619 . . . . 11.84 111.001 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.87 77.25 74.88 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.294 -0.866 . . . . 8.4399999999999995 111.368 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.81 146.8 21.13 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.868 2.378 . . . . 7.6600000000000001 110.827 175.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.62 140.52 47.5 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.847 1.698 . . . . 5.6600000000000001 112.499 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.18 92.07 6.86 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.786 -0.643 . . . . 2.8700000000000001 109.892 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.48 -175.98 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.673 2.249 . . . . 1.8300000000000001 112.819 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -130.99 146.23 52.31 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.991 -1.004 . . . . 4.2199999999999998 111.229 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.579 HG21 ' N ' ' A' ' 60' ' ' ARG . 11.4 mt -93.04 174.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.948 -1.024 . . . . 1.1299999999999999 111.421 -176.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.579 ' N ' HG21 ' A' ' 59' ' ' ILE . 25.4 mtt180 -65.05 -157.44 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.722 -1.581 . . . . 3.1400000000000001 112.06 176.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.812 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 18.6 t-160 -159.64 147.53 17.18 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 112.032 -2.349 . . . . 2.7400000000000002 106.238 177.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.812 ' HD1' ' C ' ' A' ' 61' ' ' HIS . 2.8 m-30 -125.21 158.3 34.37 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.866 -0.606 . . . . 0.76000000000000001 109.593 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 3.0 t70 -79.24 67.39 4.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 123.762 1.744 . . . . 0.34999999999999998 108.291 171.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.753 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 89.3 m95 -59.83 -44.43 94.07 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 111.478 -2.601 . . . . 0.10000000000000001 112.113 174.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.437 ' N ' HG23 ' A' ' 108' ' ' THR . 13.4 t-20 -51.04 -31.44 18.53 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.939 -1.482 . . . . 1.1100000000000001 111.35 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.35 -16.61 79.81 Favored Glycine 0 C--N 1.312 -0.754 0 CA-C-N 115.504 -0.771 . . . . 0.23000000000000001 111.318 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.435 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.57 -53.67 2.93 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.996 -1.102 . . . . 1.01 110.817 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.735 ' SD ' HD22 ' A' ' 109' ' ' LEU . 42.4 mtt -62.89 -59.61 4.61 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 114.206 -1.361 . . . . 0.089999999999999997 112.554 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.46 HE21 ' HA ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -38.53 -55.23 2.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 114.83 1.419 . . . . 0.63 114.83 -176.226 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.775 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.1 Cg_endo -65.46 -30.13 52.91 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.674 1.583 . . . . 0.17000000000000001 110.588 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.949 ' HE1' ' SD ' ' A' ' 176' ' ' MET . 13.7 mtm -83.35 -39.69 20.39 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 115.413 -0.812 . . . . 0.69999999999999996 111.205 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.678 HG21 ' O ' ' A' ' 68' ' ' MET . 58.9 t -56.82 -39.29 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 114.555 -1.202 . . . . 1.04 108.465 172.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -61.67 -35.33 77.65 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 113.176 -1.829 . . . . 1.1200000000000001 110.9 174.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.775 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.3 mtpt -81.31 -31.55 33.49 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.093 0.473 . . . . 1.8799999999999999 110.618 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.875 ' O ' HG13 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.26 -25.17 65.94 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.355 -0.839 . . . . 0.5 111.119 -173.086 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' HG ' ' HG2' ' A' ' 75' ' ' MET . 6.7 mt -95.2 -5.09 44.69 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.069 0.938 . . . . 1.29 110.762 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.92 17.46 41.7 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 108.888 -1.685 . . . . 0.17999999999999999 108.888 169.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.639 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -87.39 162.08 17.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.576 -0.812 . . . . 1.0 110.036 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -90.4 105.32 17.73 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.253 -0.885 . . . . 1.72 110.273 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.634 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.92 -22.2 3.47 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.978 -1.01 . . . . 0.13 110.807 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.875 HG13 ' O ' ' A' ' 75' ' ' MET . 10.7 p -102.08 153.88 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.678 0.752 . . . . 1.01 111.704 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.6 m -135.14 139.9 45.0 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.726 -1.124 . . . . 1.1000000000000001 110.796 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.496 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.81 126.89 29.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.332 -0.849 . . . . 1.1200000000000001 110.481 166.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.05 8.25 29.83 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.849 -0.691 . . . . 0.28000000000000003 112.56 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.31 153.2 19.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 120.721 -0.392 . . . . 1.55 110.52 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.628 HG12 ' N ' ' A' ' 158' ' ' HIS . 2.0 p -82.1 117.32 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 122.009 0.909 . . . . 1.03 108.956 166.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.643 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -105.42 110.23 22.5 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.301 -0.863 . . . . 1.03 109.267 -171.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.674 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -73.04 94.5 1.9 Allowed 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 114.446 -1.252 . . . . 1.01 109.133 178.044 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.442 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.4 m -73.39 116.78 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 107.542 -1.281 . . . . 1.6200000000000001 107.542 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.812 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 7.0 t0 -79.26 170.81 16.07 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.201 -1.036 . . . . 0.64000000000000001 108.201 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.633 ' HG ' ' HA ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -59.96 149.42 31.95 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 122.773 1.273 . . . . 1.05 108.937 171.548 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.581 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 36.7 t -74.34 138.55 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.476 0 CA-C-N 113.576 -1.647 . . . . 1.02 106.612 163.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.654 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.4 t-20 -84.45 158.97 20.87 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-O 121.888 0.852 . . . . 0.20000000000000001 109.875 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.747 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -122.81 84.8 2.32 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.281 -1.327 . . . . 0.12 107.938 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.428 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 15.0 mtp180 -107.67 -1.83 20.73 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 113.547 -1.66 . . . . 0.84999999999999998 108.574 -172.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.636 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 24.1 p -51.82 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.156 -1.838 . . . . 0.91000000000000003 114.216 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.3 OUTLIER -76.06 -2.99 33.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.233 -1.803 . . . . 0.62 110.33 174.692 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.516 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -149.66 -150.22 5.19 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.922 -0.656 . . . . 0.14000000000000001 112.905 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.603 ' N ' HG23 ' A' ' 169' ' ' VAL . 60.1 p -121.83 130.58 53.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.514 0.561 . . . . 1.76 112.514 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.747 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.6 157.38 47.02 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.855 0.836 . . . . 1.01 111.155 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.59 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -80.14 79.49 6.69 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.002 -1.454 . . . . 0.20999999999999999 107.993 175.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.581 ' HB2' ' O ' ' A' ' 92' ' ' VAL . . . -67.38 -15.57 63.75 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.285 -1.325 . . . . 1.0 109.997 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.57 -29.97 37.01 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.944 -0.762 . . . . 1.02 108.944 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.59 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.3 tp10 -66.46 -34.64 78.4 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 122.681 1.229 . . . . 1.73 109.131 170.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 102' ' ' ALA . . . -71.99 -43.4 65.17 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 113.203 -1.817 . . . . 1.04 109.664 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.624 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 55.7 m -63.77 -31.02 72.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.898 -1.501 . . . . 1.04 110.536 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -67.85 -42.45 81.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.609 -1.256 . . . . 1.47 107.609 172.436 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.646 HG23 ' HB2' ' A' ' 64' ' ' TRP . 57.2 m -63.56 -31.02 72.06 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.171 -0.922 . . . . 1.03 110.672 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.735 HD22 ' SD ' ' A' ' 68' ' ' MET . 8.3 mt -50.9 -70.47 0.08 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 115.776 -0.647 . . . . 1.3 109.278 171.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.427 ' O ' HD13 ' A' ' 121' ' ' LEU . 17.0 mtp180 -41.0 -38.78 1.04 Allowed 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.475 1.109 . . . . 1.8 111.197 176.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.531 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -68.37 -46.49 69.93 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.367 -1.288 . . . . 0.41999999999999998 112.358 -177.5 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.38 -33.4 65.01 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.299 1.047 . . . . 1.01 108.417 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.701 HD21 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -65.2 -31.89 73.28 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.186 -1.824 . . . . 1.01 110.131 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.513 ' CB ' HD12 ' A' ' 121' ' ' LEU . . . -72.85 -44.69 61.07 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 114.335 -1.302 . . . . 1.03 111.713 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -65.72 -28.75 69.28 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.54 -1.209 . . . . 1.55 110.832 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -81.43 -19.78 41.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.3 -0.864 . . . . 2.0499999999999998 111.885 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 59.24 11.05 11.53 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 115.586 0.995 . . . . 0.54000000000000004 115.586 163.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.496 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 56.2 mtpt -96.93 -3.96 40.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.35 0.575 . . . . 1.6000000000000001 109.759 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.643 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 29.0 m-85 -121.22 173.2 7.46 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.481 1.134 . . . . 0.27000000000000002 112.726 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.475 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 16.3 m -117.85 115.82 25.74 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 112.658 -2.065 . . . . 1.0800000000000001 107.776 170.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.582 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -83.07 137.57 34.05 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.152 -0.931 . . . . 1.1499999999999999 110.376 -172.473 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.534 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.7 OUTLIER -83.54 152.93 3.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.074 -1.084 . . . . 1.0900000000000001 108.074 171.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.639 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -101.4 163.19 12.4 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.023 0.916 . . . . 1.8200000000000001 109.827 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.59 71.06 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 113.65 -1.613 . . . . 1.1899999999999999 111.225 -170.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.663 ' O ' ' HG3' ' A' ' 129' ' ' MET . 3.7 pt20 -52.28 -28.35 18.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.656 -1.611 . . . . 2.04 110.973 173.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.553 ' HB2' HG22 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -96.94 -53.15 3.61 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.244 -1.344 . . . . 0.42999999999999999 110.404 170.458 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.729 HD13 ' NZ ' ' A' ' 131' ' ' LYS . 1.2 tm? -72.45 -63.9 1.06 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.94 -1.027 . . . . 2.04 113.574 -165.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.575 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -51.94 -37.56 53.22 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.582 1.658 . . . . 1.1499999999999999 108.407 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.663 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -62.89 -60.13 3.89 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 110.714 -2.948 . . . . 2.27 111.292 178.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.688 ' CB ' HG21 ' A' ' 151' ' ' ILE . . . -44.15 -43.03 6.77 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 124.304 1.003 . . . . 1.0700000000000001 112.148 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.729 ' NZ ' HD13 ' A' ' 127' ' ' LEU . 22.3 mttt -52.77 -55.52 22.25 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 120.326 -0.549 . . . . 2.1000000000000001 109.691 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 40.8 mt-30 -62.14 -41.74 98.57 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.021 -0.99 . . . . 0.42999999999999999 111.28 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.628 ' HG3' ' O ' ' A' ' 129' ' ' MET . 53.5 mt-30 -57.06 -36.45 70.56 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.257 -1.338 . . . . 0.38 110.034 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.527 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.06 -31.0 16.44 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.243 -1.344 . . . . 1.05 109.084 -176.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.52 -51.24 0.36 Allowed Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.015 -1.088 . . . . 0.33000000000000002 113.979 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.535 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 46.8 mt -67.41 -171.1 0.16 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 116.12 1.896 . . . . 1.0700000000000001 116.12 -169.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.553 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.8 m -115.58 152.55 47.31 Favored Pre-proline 0 N--CA 1.427 -1.62 0 CA-C-N 110.732 -2.94 . . . . 1.24 108.158 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.575 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 11.8 Cg_endo -59.2 -4.9 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.027 2.485 . . . . 0.39000000000000001 113.171 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.418 ' H ' ' C ' ' A' ' 137' ' ' SER . 2.2 tt0 -117.49 -30.41 5.53 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.826 0.822 . . . . 1.79 111.104 -176.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.553 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.4 t70 -58.28 -25.49 61.87 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.42 -1.718 . . . . 0.65000000000000002 109.065 -174.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.633 ' HA ' ' HG ' ' A' ' 91' ' ' SER . 5.5 m 72.9 161.37 0.24 Allowed 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 111.495 -2.593 . . . . 0.73999999999999999 111.822 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.812 ' HG ' ' CG ' ' A' ' 90' ' ' ASP . 8.5 mt -66.64 -38.76 87.58 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.25 -1.389 . . . . 1.48 107.25 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.34 -4.78 0.32 Allowed Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 112.576 -2.102 . . . . 0.34999999999999998 114.703 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.48 124.35 9.24 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 118.603 -0.713 . . . . 1.02 109.369 -174.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.58 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 16.6 mmt85 -41.66 -51.16 4.11 Favored 'General case' 0 C--O 1.212 -0.92 0 O-C-N 123.563 0.539 . . . . 2.21 111.046 -177.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.9 t -67.81 -29.16 68.27 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.493 0.663 . . . . 0.93000000000000005 111.21 -174.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.467 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 20.6 mttm -72.76 -31.17 64.72 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.355 1.074 . . . . 1.8899999999999999 108.519 177.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.672 ' HB3' ' OH ' ' A' ' 162' ' ' TYR . . . -76.97 -41.91 41.12 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 113.049 -1.887 . . . . 0.98999999999999999 110.746 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.529 ' HA ' HG21 ' A' ' 181' ' ' VAL . 43.0 mt -69.12 -42.21 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 113.393 -1.731 . . . . 1.03 110.189 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.66 -48.77 64.13 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.904 -1.044 . . . . 0.14999999999999999 111.27 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.688 HG21 ' CB ' ' A' ' 130' ' ' ALA . 67.2 mt -71.23 -48.08 56.58 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 N-CA-C 112.87 0.693 . . . . 1.05 112.87 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.638 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.57 -39.42 70.63 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.935 0.398 . . . . 1.03 110.633 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.402 ' HD2' ' CG2' ' A' ' 149' ' ' ILE . 28.7 mtp180 -81.01 -24.4 37.96 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.522 0.677 . . . . 1.29 110.672 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.501 HD22 ' CD ' ' A' ' 133' ' ' GLN . 32.3 t30 -79.28 -14.12 59.23 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.508 -1.293 . . . . 0.5 107.508 175.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.683 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.69 -29.98 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 113.196 -1.82 . . . . 1.05 110.967 -173.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.05 33.04 5.36 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.681 -0.771 . . . . 0.17000000000000001 112.437 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.674 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -106.89 159.75 16.02 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.92 0.711 . . . . 1.02 112.92 -170.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.628 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.9 m80 -99.65 -27.24 13.77 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.379 -0.828 . . . . 0.39000000000000001 109.686 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.564 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.6 m-85 -135.58 -173.02 3.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.262 -0.881 . . . . 0.81000000000000005 110.941 -175.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.716 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -137.63 138.6 44.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.941 -1.027 . . . . 1.03 108.897 166.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.555 HD21 ' HE1' ' A' ' 176' ' ' MET . 45.5 tp -107.93 101.36 10.63 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 119.715 -0.794 . . . . 1.02 109.038 165.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.672 ' OH ' ' HB3' ' A' ' 148' ' ' ALA . 2.4 m-85 -81.38 113.03 19.19 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.087 -1.415 . . . . 0.87 109.559 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.717 ' OG ' HD13 ' A' ' 109' ' ' LEU . 4.2 p -118.09 159.99 22.3 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.717 0.77 . . . . 1.45 110.749 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.815 ' O ' HD13 ' A' ' 174' ' ' LEU . 1.9 p -163.94 173.6 12.45 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 114.862 -1.063 . . . . 0.12 111.414 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.606 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.09 139.01 37.58 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 113.951 -1.477 . . . . 0.94999999999999996 108.464 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.636 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.4 t -147.2 -171.47 3.79 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.055 -0.658 . . . . 1.1499999999999999 110.073 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.05 -80.71 1.43 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.128 -1.034 . . . . 0.14999999999999999 111.773 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.441 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.5 t30 -144.52 125.47 14.4 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 107.99 -1.115 . . . . 0.58999999999999997 107.99 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.603 HG23 ' N ' ' A' ' 99' ' ' SER . 3.3 p -63.12 -42.97 98.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.479 -0.782 . . . . 1.0 112.934 -171.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.504 ' N ' HG12 ' A' ' 169' ' ' VAL . 9.7 m120 -61.66 -29.53 70.13 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.391 0.615 . . . . 1.9199999999999999 109.532 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.9 88.52 3.54 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.634 -1.167 . . . . 1.0600000000000001 108.508 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.653 ' HD2' HG21 ' A' ' 194' ' ' VAL . 44.3 Cg_endo -91.55 167.7 3.34 Favored 'Trans proline' 0 CA--C 1.497 -1.374 0 C-N-CA 124.927 3.751 . . . . 0.089999999999999997 115.015 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.606 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 14.5 m -85.73 118.0 24.96 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.041 -1.436 . . . . 1.0600000000000001 108.098 166.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.815 HD13 ' O ' ' A' ' 164' ' ' SER . 43.4 tp -84.49 98.66 10.23 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-O 122.057 0.932 . . . . 1.02 109.386 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.614 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.7 mt-30 -87.7 108.08 18.94 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.576 -1.193 . . . . 0.34000000000000002 109.088 -178.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.949 ' SD ' ' HE1' ' A' ' 71' ' ' MET . 80.9 mtp -105.74 162.42 13.55 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.059 -0.973 . . . . 1.0900000000000001 110.483 -176.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.485 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.7 tt0 -169.74 119.38 0.64 Allowed 'General case' 0 C--O 1.203 -1.39 0 CA-C-O 121.324 0.583 . . . . 0.68000000000000005 109.792 -170.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.716 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.6 OUTLIER -101.2 100.85 11.45 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.542 -0.91 . . . . 1.03 108.542 -172.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.58 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.9 ttp -90.47 120.06 31.26 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.764 -0.653 . . . . 0.89000000000000001 109.448 176.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.489 ' HB2' HG22 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.66 117.77 6.73 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.222 -1.399 . . . . 1.04 107.222 169.315 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.536 HG23 ' HB2' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -71.72 -35.71 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.162 0.892 . . . . 1.02 111.439 -176.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -61.38 -13.62 21.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.411 -0.813 . . . . 0.40000000000000002 111.581 -176.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 34.5 p -130.22 -37.96 1.42 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.176 0.989 . . . . 1.03 110.086 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.445 ' CA ' HD13 ' A' ' 149' ' ' ILE . . . 91.59 16.27 52.79 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 113.801 -1.545 . . . . 0.17999999999999999 112.138 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -98.09 156.34 16.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.94 0.4 . . . . 0.72999999999999998 110.619 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.485 HD12 ' HG2' ' A' ' 177' ' ' GLN . 31.6 mm -88.78 118.74 34.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.572 0.701 . . . . 1.03 109.404 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.664 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.7 pp -106.49 -29.08 2.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.804 -1.089 . . . . 1.01 110.123 -172.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.646 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.3 t90 -137.92 153.37 49.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.547 -0.751 . . . . 0.070000000000000007 110.135 171.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 54.9 p -153.52 164.4 38.29 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 113.379 0.881 . . . . 0.64000000000000001 113.379 164.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.93 -178.49 32.99 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.039 -0.825 . . . . 0.12 111.039 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.798 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.3 mtmt -157.86 146.5 19.22 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.446 -1.687 . . . . 1.76 106.446 166.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.466 ' N ' ' HE3' ' A' ' 71' ' ' MET . . . -157.45 128.02 2.04 Favored Glycine 0 C--N 1.284 -2.357 0 CA-C-N 114.677 -1.147 . . . . 0.13 112.064 -177.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.52 116.05 14.75 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.544 0.687 . . . . 1.01 111.343 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.696 HG13 ' CZ3' ' A' ' 64' ' ' TRP . 1.9 m -94.1 158.82 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 122.618 1.199 . . . . 1.01 110.979 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.745 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -100.89 171.98 7.32 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 112.527 -2.124 . . . . 0.92000000000000004 108.844 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.549 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 7.7 tt0 -101.56 131.6 47.65 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.121 -0.632 . . . . 0.91000000000000003 109.376 169.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.519 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 15.2 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.418 -0.801 . . . . 1.24 110.931 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.865 -0.494 . . . . 88.920000000000002 111.865 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -81.08 74.75 8.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.071 0.463 . . . . 87.459999999999994 111.706 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.455 ' HB2' ' OE1' ' A' ' 7' ' ' GLN . 31.7 m170 -121.1 82.04 1.87 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.351 -0.386 . . . . 87.5 110.201 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.7 tpt -55.95 114.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 85.340000000000003 110.803 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p 42.98 31.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 122.486 1.136 . . . . 85.230000000000004 111.628 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.49 11.42 7.13 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.056 -0.975 . . . . 84.849999999999994 111.282 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.455 ' OE1' ' HB2' ' A' ' 3' ' ' HIS . 17.3 mm-40 -68.2 -43.74 77.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.174 -0.513 . . . . 85.599999999999994 109.924 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 54.9 73.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.478 -0.783 . . . . 85.310000000000002 110.322 -176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -149.72 127.63 5.76 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.38 -0.827 . . . . 82.170000000000002 109.554 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -68.96 -179.84 2.81 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.046 1.831 . . . . 82.069999999999993 111.976 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 68.92 91.01 0.08 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 114.826 -1.079 . . . . 79.709999999999994 110.717 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -62.1 146.62 96.05 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.464 2.109 . . . . 79.019999999999996 112.46 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.08 145.79 9.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.537 -0.301 . . . . 77.260000000000005 110.611 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 49.52 63.56 2.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.453 -0.794 . . . . 75.739999999999995 111.04 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.69 148.62 52.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.545 . . . . 74.010000000000005 110.371 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.91 135.0 28.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.492 -0.776 . . . . 72.569999999999993 110.32 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -89.95 153.91 47.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.271 -0.422 . . . . 71.379999999999995 110.397 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.33 63.73 6.28 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.672 2.248 . . . . 70.189999999999998 111.946 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.17 112.2 65.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.114 -0.494 . . . . 67.769999999999996 111.146 -177.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.0 52.9 4.46 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.097 2.532 . . . . 67.180000000000007 111.847 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -75.47 83.83 2.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.379 -0.828 . . . . 65.200000000000003 111.021 -176.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -146.43 128.5 7.68 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.648 -0.705 . . . . 63.460000000000001 110.162 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -55.84 142.89 83.23 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.019 2.479 . . . . 62.479999999999997 112.45 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.18 119.65 13.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.285 -0.416 . . . . 59.869999999999997 110.995 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.58 155.81 87.17 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.982 -0.554 . . . . 58.890000000000001 110.266 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -50.99 -58.75 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.314 2.01 . . . . 57.890000000000001 111.361 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -139.32 -162.59 1.35 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.149 -0.478 . . . . 55.729999999999997 109.829 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 26.9 mm-40 -107.61 -49.15 0.1 OUTLIER Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 120.368 -0.533 . . . . 54.079999999999998 111.648 170.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HB2' ' A' ' 28' ' ' GLN . 50.6 Cg_exo -56.6 114.12 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.875 1.717 . . . . 53.299999999999997 112.033 175.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 m -95.05 126.82 45.14 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.808 -0.633 . . . . 51.130000000000003 110.569 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -59.88 134.66 58.31 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.674 2.249 . . . . 49.75 112.377 -178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.6 p -134.47 142.83 47.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.118 -0.492 . . . . 47.700000000000003 110.6 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.15 111.4 65.13 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.388 -0.369 . . . . 46.109999999999999 110.846 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.95 155.85 36.6 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.338 2.692 . . . . 45.890000000000001 112.426 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -144.32 114.23 7.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.453 -0.794 . . . . 43.0 110.533 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -111.92 118.0 47.22 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.737 -0.665 . . . . 40.789999999999999 110.625 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.34 162.55 40.06 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.474 2.116 . . . . 40.450000000000003 112.478 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.5 t -98.15 153.94 18.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.134 0.492 . . . . 37.729999999999997 110.677 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 mt -104.74 104.5 46.24 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.795 -0.639 . . . . 35.990000000000002 110.696 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.97 -179.06 4.5 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.901 2.401 . . . . 34.350000000000001 112.286 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.14 127.87 56.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.452 -0.34 . . . . 31.780000000000001 110.413 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -117.34 89.17 30.62 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 30.390000000000001 110.633 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.09 164.97 8.56 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.808 2.339 . . . . 29.940000000000001 112.585 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.48 174.22 23.62 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.811 -0.631 . . . . 26.75 112.106 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.21 131.75 22.69 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 123.119 2.546 . . . . 25.879999999999999 112.138 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mt -74.25 -54.26 15.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.736 -0.665 . . . . 24.16 110.766 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 56.76 83.04 0.1 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.823 0.702 . . . . 21.829999999999998 111.306 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -81.96 160.75 23.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.254 -0.43 . . . . 20.620000000000001 110.182 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -115.46 169.75 8.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.079 -0.51 . . . . 16.559999999999999 111.054 -176.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.32 26.79 8.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.959 0.885 . . . . 15.050000000000001 110.06 176.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 55.01 -107.13 0.36 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.327 -1.76 . . . . 14.66 111.286 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -142.87 150.84 40.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.105 0.479 . . . . 11.84 110.757 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.421 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -128.26 73.07 79.99 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.513 -0.767 . . . . 8.4399999999999995 110.5 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -95.18 107.18 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.449 2.766 . . . . 7.6600000000000001 112.221 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 52.9 Cg_exo -56.14 -68.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.889 2.393 . . . . 5.6600000000000001 111.348 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -167.01 92.32 0.72 Allowed Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.838 -0.619 . . . . 2.8700000000000001 110.104 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.21 -178.56 2.57 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 C-N-CA 123.235 2.624 . . . . 1.8300000000000001 111.639 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -99.65 135.74 40.61 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 113.908 -1.496 . . . . 4.2199999999999998 110.494 -175.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.626 HG23 ' N ' ' A' ' 60' ' ' ARG . 12.4 mt -83.19 168.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 122.124 0.964 . . . . 1.1299999999999999 111.994 -173.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.626 ' N ' HG23 ' A' ' 59' ' ' ILE . 48.2 mtt-85 -70.95 -157.36 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 113.57 -1.65 . . . . 3.1400000000000001 112.017 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.605 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 18.1 t-160 -155.35 147.71 23.88 Favored 'General case' 0 CA--C 1.473 -2.017 0 CA-C-N 112.486 -2.143 . . . . 2.7400000000000002 106.858 177.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.787 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.5 m-30 -125.54 159.27 32.48 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 115.351 -0.841 . . . . 0.76000000000000001 109.936 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.502 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 4.0 t70 -80.97 68.28 7.19 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 123.68 1.705 . . . . 0.34999999999999998 108.125 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.701 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.5 m95 -57.85 -41.52 82.53 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.599 -2.546 . . . . 0.10000000000000001 111.94 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.57 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 13.0 t-20 -52.98 -27.71 20.4 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.99 -1.459 . . . . 1.1100000000000001 111.496 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.57 -15.2 81.21 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.412 -0.813 . . . . 0.23000000000000001 111.129 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.96 -53.64 2.9 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.908 -1.146 . . . . 1.01 111.17 -176.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.77 ' SD ' HD23 ' A' ' 109' ' ' LEU . 38.5 mtt -65.27 -57.77 7.62 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.263 -1.335 . . . . 0.089999999999999997 112.132 -177.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.57 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.1 mm-40 -40.25 -55.88 3.8 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 114.348 1.24 . . . . 0.63 114.348 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.749 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.3 Cg_endo -63.88 -27.3 67.11 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.541 1.494 . . . . 0.17000000000000001 110.74 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.791 ' HE3' ' O ' ' A' ' 174' ' ' LEU . 12.7 mtm -85.56 -43.2 13.72 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.562 -0.745 . . . . 0.69999999999999996 112.174 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.709 HG23 ' O ' ' A' ' 68' ' ' MET . 31.5 t -59.0 -37.91 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 CA-C-N 115.011 -0.995 . . . . 1.04 108.826 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.447 ' HB3' ' O ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -57.11 -36.56 70.78 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.409 -1.723 . . . . 1.1200000000000001 110.396 174.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.749 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.7 mtpt -80.91 -37.3 29.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.087 -0.96 . . . . 1.8799999999999999 110.49 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.868 ' O ' HG11 ' A' ' 81' ' ' VAL . 2.5 ttp -57.65 -31.61 66.46 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.421 -1.263 . . . . 0.5 111.439 -175.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 22.5 mt -88.51 -5.31 58.3 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.917 0.865 . . . . 1.29 111.594 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.96 17.4 35.32 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.286 -1.525 . . . . 0.17999999999999999 109.286 172.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.702 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.03 161.76 16.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.807 -0.696 . . . . 1.0 109.733 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.431 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 9.7 p-10 -89.16 107.73 19.21 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.362 1.077 . . . . 1.72 111.443 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.646 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.73 -24.32 3.03 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 114.268 -1.333 . . . . 0.13 110.45 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.868 HG11 ' O ' ' A' ' 75' ' ' MET . 14.9 p -102.83 153.05 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.526 0.679 . . . . 1.01 111.762 -173.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.4 m -134.98 138.82 44.36 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.653 -1.158 . . . . 1.1000000000000001 110.577 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.59 131.26 50.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.757 -0.656 . . . . 1.1200000000000001 110.182 166.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.14 -1.47 31.35 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.026 -0.607 . . . . 0.28000000000000003 112.593 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.89 150.64 23.96 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.264 -0.575 . . . . 1.55 111.016 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.634 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.6 p -80.05 113.81 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-O 122.277 1.037 . . . . 1.03 109.01 164.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.834 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -100.88 107.21 18.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.814 -1.085 . . . . 1.03 108.722 -172.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.648 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -70.92 97.88 1.5 Allowed 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 114.169 -1.378 . . . . 1.01 108.019 177.713 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.457 HG12 ' CD1' ' A' ' 87' ' ' LEU . 2.2 m -71.37 118.27 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.243 0 N-CA-C 106.888 -1.523 . . . . 1.6200000000000001 106.888 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.769 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 0.8 OUTLIER -77.09 146.32 37.31 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 107.159 -1.422 . . . . 0.64000000000000001 107.159 178.098 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.519 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -55.36 134.43 50.19 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.448 -1.315 . . . . 1.05 107.448 175.9 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.607 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 22.0 t -61.46 138.4 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.011 0 N-CA-C 107.768 -1.197 . . . . 1.02 107.768 170.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.627 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.4 t-20 -84.95 163.02 19.19 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.156 -0.929 . . . . 0.20000000000000001 109.714 175.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.755 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.88 86.12 2.51 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.524 -1.216 . . . . 0.12 108.185 175.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -106.88 -4.22 19.43 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 113.97 -1.468 . . . . 0.84999999999999998 108.827 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 21.8 p -50.67 -177.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.516 -1.674 . . . . 0.91000000000000003 114.318 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.428 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 1.4 t30 -70.13 -10.7 59.62 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.476 -1.693 . . . . 0.62 110.325 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.483 ' HA3' HG12 ' A' ' 169' ' ' VAL . . . -140.55 -152.56 5.81 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.668 -0.696 . . . . 0.14000000000000001 112.564 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.597 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 70.7 m -122.44 129.36 51.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.071 0.462 . . . . 1.76 111.129 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.755 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.9 pp -132.5 160.1 37.47 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.786 0.803 . . . . 1.01 110.551 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.598 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -82.94 79.85 9.17 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.902 -1.499 . . . . 0.20999999999999999 107.889 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.607 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -68.28 -14.11 62.75 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.483 -1.235 . . . . 1.0 109.958 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.07 -32.23 39.34 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.545 -0.909 . . . . 1.02 108.545 -177.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.598 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 42.8 tp10 -66.43 -33.71 76.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 114.325 -1.307 . . . . 1.73 109.05 171.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.54 -43.91 65.55 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.113 -1.858 . . . . 1.04 109.509 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.602 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 62.9 m -63.34 -29.73 70.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.808 -1.542 . . . . 1.04 110.417 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -44.68 76.58 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.119 -1.067 . . . . 1.47 108.119 171.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.605 HG21 ' HB2' ' A' ' 64' ' ' TRP . 73.2 m -62.48 -30.79 71.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.412 -0.813 . . . . 1.03 110.718 178.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.77 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -50.99 -68.98 0.12 Allowed 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 109.326 -0.62 . . . . 1.3 109.326 171.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.449 ' O ' HD11 ' A' ' 121' ' ' LEU . 9.3 mtp180 -40.99 -37.61 0.84 Allowed 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.345 1.028 . . . . 1.8 111.411 175.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.564 HD21 ' N ' ' A' ' 111' ' ' ASN . 0.9 OUTLIER -71.54 -46.12 60.41 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.576 -1.193 . . . . 0.41999999999999998 111.968 -176.365 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.445 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . . . -73.56 -32.04 63.95 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 122.402 1.096 . . . . 1.01 108.701 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.716 HD22 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -65.79 -33.67 76.4 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.498 -1.683 . . . . 1.01 109.88 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.411 ' HB3' ' O ' ' A' ' 110' ' ' ARG . . . -72.93 -41.49 64.45 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 114.636 -1.166 . . . . 1.03 111.06 -176.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -64.21 -27.2 68.9 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.895 -1.048 . . . . 1.55 110.332 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -81.92 -21.76 37.15 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.466 -0.788 . . . . 2.0499999999999998 111.01 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 59.78 15.61 34.98 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 115.588 0.995 . . . . 0.54000000000000004 115.588 163.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.541 ' HE2' ' HB3' ' A' ' 76' ' ' LEU . 19.7 mtmt -101.81 -28.62 12.34 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 117.719 0.76 . . . . 1.6000000000000001 109.969 174.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.834 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 26.1 m-85 -92.23 173.81 7.63 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 122.152 0.977 . . . . 0.27000000000000002 112.447 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.577 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.7 m -118.4 123.19 44.63 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 113.31 -1.768 . . . . 1.0800000000000001 107.89 169.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.643 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -94.05 139.55 30.82 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 119.329 -0.949 . . . . 1.1499999999999999 111.865 -170.023 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.831 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.3 m -93.88 148.54 4.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.786 -1.19 . . . . 1.0900000000000001 107.786 170.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.407 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 12.3 t -101.59 -173.71 2.42 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.759 -0.777 . . . . 1.8200000000000001 110.222 177.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.498 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -64.69 -26.36 68.34 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.95 -1.13 . . . . 1.1899999999999999 107.95 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.603 ' O ' ' HG3' ' A' ' 129' ' ' MET . 35.0 mt-30 -50.88 -39.07 53.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 113.273 -1.785 . . . . 2.04 110.806 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.831 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 4.8 mt-30 -99.12 -52.78 3.44 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.141 0.972 . . . . 0.42999999999999999 110.212 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.641 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 35.3 tp -61.7 -63.14 1.36 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 113.585 -1.643 . . . . 2.04 113.456 -168.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.631 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 3.5 t -50.67 -47.35 58.82 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 123.396 1.57 . . . . 1.1499999999999999 109.374 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.663 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 16.7 mmt -54.0 -61.82 2.06 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 111.24 -2.709 . . . . 2.27 110.818 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.703 ' CB ' HG22 ' A' ' 151' ' ' ILE . . . -43.83 -44.97 7.16 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 124.124 0.89 . . . . 1.0700000000000001 112.626 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.746 ' NZ ' HD13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -55.94 -51.5 67.44 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 107.343 -1.354 . . . . 2.1000000000000001 107.343 -178.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.3 mt-30 -65.15 -41.03 95.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.672 -1.149 . . . . 0.42999999999999999 111.173 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.663 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.2 mt-30 -57.6 -32.56 67.31 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 114.628 -1.169 . . . . 0.38 109.574 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.53 HD22 ' N ' ' A' ' 134' ' ' LEU . 0.8 OUTLIER -93.96 -27.15 16.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 113.911 -1.495 . . . . 1.05 109.719 -177.455 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.38 -50.12 0.53 Allowed Glycine 0 CA--C 1.5 -0.904 0 CA-C-O 122.766 1.204 . . . . 0.33000000000000002 113.428 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.603 HD13 ' O ' ' A' ' 141' ' ' SER . 78.4 mt -66.58 -170.95 0.11 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 112.175 -2.012 . . . . 1.0700000000000001 116.025 -170.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.1 m -116.22 152.86 48.37 Favored Pre-proline 0 N--CA 1.431 -1.415 0 CA-C-N 111.129 -2.759 . . . . 1.24 108.56 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.631 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 18.1 Cg_endo -62.34 -2.0 2.86 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.086 2.524 . . . . 0.39000000000000001 112.993 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.424 ' H ' ' C ' ' A' ' 137' ' ' SER . 0.7 OUTLIER -118.74 -26.85 5.99 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.579 0.704 . . . . 1.79 110.746 -177.602 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.3 t70 -63.04 -21.89 66.47 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 113.895 -1.502 . . . . 0.65000000000000002 109.127 -173.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.603 ' O ' HD13 ' A' ' 136' ' ' LEU . 38.1 m 74.4 168.59 0.3 Allowed 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.666 -2.061 . . . . 0.73999999999999999 110.653 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.769 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 6.4 mt -64.78 -40.53 95.4 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.321 1.058 . . . . 1.48 108.331 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.7 -12.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 112.823 -1.99 . . . . 0.34999999999999998 114.507 177.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -151.32 125.11 9.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.073 -0.714 . . . . 1.02 109.073 -174.692 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.65 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.3 mmt180 -42.6 -47.33 5.2 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 118.047 0.385 . . . . 2.21 111.936 -176.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.9 t -71.22 -25.85 62.67 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.664 0.745 . . . . 0.93000000000000005 111.35 -175.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 27.2 mttm -75.84 -30.75 59.06 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 122.766 1.269 . . . . 1.8899999999999999 108.862 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.786 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -72.1 -46.77 55.4 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 112.184 -2.28 . . . . 0.98999999999999999 110.236 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.535 ' HA ' HG22 ' A' ' 181' ' ' VAL . 37.3 mt -68.07 -41.4 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 112.909 -1.95 . . . . 1.03 110.054 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.42 -54.83 27.82 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.51 -1.223 . . . . 0.14999999999999999 111.107 170.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.746 HD13 ' NZ ' ' A' ' 131' ' ' LYS . 12.4 mt -66.27 -46.6 86.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.062 0 N-CA-C 112.693 0.627 . . . . 1.05 112.693 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.636 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -57.73 -40.73 80.27 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 118.013 0.37 . . . . 1.03 111.015 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . 0.41 ' HD2' HG22 ' A' ' 149' ' ' ILE . 28.5 mtp-105 -81.49 -22.34 38.09 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.826 0.822 . . . . 1.29 110.346 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.472 HD22 ' CD ' ' A' ' 133' ' ' GLN . 12.7 t30 -82.01 -11.64 58.73 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 114.274 -1.33 . . . . 0.5 107.449 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.705 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.91 -29.13 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 113.267 -1.788 . . . . 1.05 110.794 -174.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.465 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.37 34.92 4.88 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.387 -0.911 . . . . 0.17000000000000001 112.362 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.648 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.98 160.57 16.31 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 113.138 0.792 . . . . 1.02 113.138 -169.591 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.634 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -99.78 -28.96 12.89 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.0 -1.0 . . . . 0.39000000000000001 109.744 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.664 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 11.6 m-85 -136.65 -175.43 4.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.96 -1.018 . . . . 0.81000000000000005 110.83 -174.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.667 ' O ' HD22 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -135.64 138.59 47.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.062 -0.972 . . . . 1.03 108.562 166.282 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.655 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 33.8 tp -108.26 99.59 8.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.281 -0.968 . . . . 1.02 109.483 166.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.786 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.64 112.54 17.01 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.784 -1.098 . . . . 0.87 109.322 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.887 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 13.0 t -124.37 158.88 31.63 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 122.157 0.979 . . . . 1.45 110.239 -177.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.646 ' O ' HD11 ' A' ' 174' ' ' LEU . 1.8 p -160.75 173.47 15.36 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.166 -1.379 . . . . 0.12 110.564 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.88 132.07 34.02 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-N 114.36 -1.291 . . . . 0.94999999999999996 108.613 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.623 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -140.89 -178.01 5.35 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.055 -0.658 . . . . 1.1499999999999999 109.73 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.43 -83.26 0.87 Allowed Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 119.774 -1.203 . . . . 0.14999999999999999 111.847 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.428 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 43.5 t-20 -140.08 127.18 20.97 Favored 'General case' 0 C--O 1.195 -1.794 0 N-CA-C 106.294 -1.743 . . . . 0.58999999999999997 106.294 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.483 HG12 ' HA3' ' A' ' 98' ' ' GLY . 2.3 p -60.64 -44.52 97.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 114.861 -1.063 . . . . 1.0 111.65 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.458 ' N ' HG13 ' A' ' 169' ' ' VAL . 43.2 m-80 -66.9 -24.92 66.15 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.338 0.59 . . . . 1.9199999999999999 109.777 -174.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.04 88.28 3.21 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 114.996 -1.002 . . . . 1.0600000000000001 108.474 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.661 ' HD2' HG21 ' A' ' 194' ' ' VAL . 44.1 Cg_endo -91.01 163.7 3.86 Favored 'Trans proline' 0 CA--C 1.492 -1.576 0 C-N-CA 124.652 3.568 . . . . 0.089999999999999997 115.253 -170.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.537 HG22 ' HB3' ' A' ' 191' ' ' LYS . 7.7 m -84.83 119.71 25.62 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 113.668 -1.605 . . . . 1.0600000000000001 107.998 170.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.956 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 21.8 tp -82.59 95.83 7.89 Favored 'General case' 0 CA--C 1.472 -2.043 0 C-N-CA 119.655 -0.818 . . . . 1.02 109.474 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.542 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 39.1 mt-30 -87.2 106.76 18.12 Favored 'General case' 0 C--N 1.253 -3.609 0 CA-C-O 122.415 1.102 . . . . 0.34000000000000002 108.663 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.887 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.3 mmm -110.97 162.97 14.3 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.516 -1.22 . . . . 1.0900000000000001 110.944 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 56.4 tt0 -171.41 118.92 0.46 Allowed 'General case' 0 C--O 1.205 -1.288 0 CA-C-O 121.165 0.507 . . . . 0.68000000000000005 110.702 -166.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.679 HD13 ' CD1' ' A' ' 187' ' ' ILE . 0.4 OUTLIER -100.36 100.9 11.76 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.853 -0.795 . . . . 1.03 108.853 -172.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.65 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.2 ttp -91.16 120.95 32.52 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.161 -0.927 . . . . 0.89000000000000001 109.398 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.409 HD22 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -58.49 126.76 28.93 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.066 -1.457 . . . . 1.04 107.066 166.38 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.535 HG22 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -81.18 -36.2 14.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 119.435 -0.906 . . . . 1.02 110.376 178.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 23.3 mt-30 -61.03 -16.26 41.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.093 -0.958 . . . . 0.40000000000000002 111.529 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 66.9 p -129.04 -37.0 1.73 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.769 0.795 . . . . 1.03 110.077 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.444 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.26 29.37 19.95 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 114.299 -1.319 . . . . 0.17999999999999999 112.205 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.73 154.3 23.1 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.674 0.273 . . . . 0.72999999999999998 110.6 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.474 HD11 ' HG2' ' A' ' 177' ' ' GLN . 29.5 mm -86.53 121.4 37.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.402 0.62 . . . . 1.03 109.365 177.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.679 ' CD1' HD13 ' A' ' 178' ' ' LEU . 1.4 pp -109.76 -33.06 2.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.095 -0.957 . . . . 1.01 110.45 -174.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.702 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 79.8 t90 -132.14 152.19 51.38 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.581 -0.736 . . . . 0.070000000000000007 109.356 172.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.477 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 27.0 p -153.79 162.8 40.93 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.265 0.839 . . . . 0.64000000000000001 113.265 164.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -157.69 -175.12 28.26 Favored Glycine 0 N--CA 1.427 -1.932 0 N-CA-C 110.817 -0.913 . . . . 0.12 110.817 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.956 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.2 mtmt -158.98 147.94 18.54 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.386 -1.709 . . . . 1.76 106.386 165.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.451 ' C ' ' H ' ' A' ' 174' ' ' LEU . . . -156.05 125.89 1.72 Allowed Glycine 0 C--N 1.289 -2.047 0 C-N-CA 118.638 -1.744 . . . . 0.13 114.021 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.75 112.59 7.98 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.619 0.723 . . . . 1.01 110.979 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.701 HG11 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -90.76 159.28 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 114.545 -1.207 . . . . 1.01 110.269 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.787 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -100.08 174.18 6.29 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 112.801 -2.0 . . . . 0.92000000000000004 108.825 -173.319 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -102.16 131.48 48.64 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.492 -0.483 . . . . 0.91000000000000003 110.532 171.23 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.509 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 17.4 mm-40 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.514 -0.755 . . . . 1.24 110.264 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 112.088 -0.405 . . . . 88.920000000000002 112.088 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 t -85.82 -15.48 41.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.684 0.278 . . . . 87.459999999999994 110.995 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -86.13 73.28 10.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.196 0.998 . . . . 87.5 111.212 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.6 mtt -83.68 -162.38 0.63 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.906 -1.043 . . . . 85.340000000000003 109.23 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.3 -11.19 12.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.254 0.549 . . . . 85.230000000000004 110.48 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.73 29.09 69.86 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.869 -0.605 . . . . 84.849999999999994 112.39 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -127.98 110.93 13.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.971 0.891 . . . . 85.599999999999994 110.978 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 66.05 76.5 0.31 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 113.535 -1.666 . . . . 85.310000000000002 112.444 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . 0.475 ' CD ' ' H ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -75.9 146.7 79.74 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.93 -0.577 . . . . 82.170000000000002 110.5 178.29 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.43 113.33 3.09 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.517 2.145 . . . . 82.069999999999993 112.072 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.52 113.7 62.34 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.378 -0.374 . . . . 79.709999999999994 110.968 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.1 138.47 2.33 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.955 2.436 . . . . 79.019999999999996 112.55 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 m -133.94 141.14 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.029 -0.532 . . . . 77.260000000000005 110.352 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -126.82 112.47 15.4 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.863 -0.608 . . . . 75.739999999999995 110.522 -174.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -109.36 140.55 42.91 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.849 -0.426 . . . . 74.010000000000005 109.849 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.4 111.63 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.818 0.818 . . . . 72.569999999999993 111.233 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.536 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 32.8 mmtp -87.85 -46.77 0.47 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 71.379999999999995 111.988 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 17' ' ' LYS . 19.9 Cg_endo -61.78 142.35 93.48 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.837 1.692 . . . . 70.189999999999998 111.841 174.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.22 85.97 59.13 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.351 -0.386 . . . . 67.769999999999996 110.798 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.88 104.18 1.79 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.828 2.352 . . . . 67.180000000000007 112.285 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.85 104.3 3.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.064 -0.517 . . . . 65.200000000000003 110.738 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.496 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 30.3 tt0 -69.78 -53.17 12.35 Favored Pre-proline 0 C--N 1.319 -0.744 0 C-N-CA 120.543 -0.463 . . . . 63.460000000000001 111.97 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.496 ' HD3' ' HB3' ' A' ' 22' ' ' GLN . 71.6 Cg_exo -56.85 143.54 90.89 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.663 2.242 . . . . 62.479999999999997 113.366 -175.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -143.12 133.19 24.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.702 -0.681 . . . . 59.869999999999997 110.286 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.5 mm-40 -89.64 109.8 34.72 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.667 -0.242 . . . . 58.890000000000001 110.7 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -91.57 94.73 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.936 2.424 . . . . 57.890000000000001 112.505 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -69.09 121.53 16.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.533 -0.303 . . . . 55.729999999999997 110.243 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -111.71 98.15 40.07 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 54.079999999999998 110.192 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.38 104.4 1.9 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.41 2.074 . . . . 53.299999999999997 112.013 -178.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -85.22 120.17 73.11 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.286 -0.416 . . . . 51.130000000000003 110.201 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.79 167.25 27.69 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.587 2.191 . . . . 49.75 112.655 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.45 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 5.8 p -99.59 152.89 19.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.013 -0.539 . . . . 47.700000000000003 110.073 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 33' ' ' VAL . 5.9 p -110.9 95.01 22.0 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.422 0.63 . . . . 46.109999999999999 111.074 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HD3' ' O ' ' A' ' 32' ' ' THR . 50.6 Cg_exo -61.52 174.93 1.85 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.298 2.666 . . . . 45.890000000000001 113.12 176.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 t 72.09 141.96 0.06 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.501 -1.227 . . . . 43.0 111.228 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 m -142.61 124.24 8.65 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.137 -0.938 . . . . 40.789999999999999 110.763 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.63 148.46 64.34 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.833 2.356 . . . . 40.450000000000003 112.252 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.4 m -148.13 131.5 16.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.727 -0.67 . . . . 37.729999999999997 109.94 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.8 mt -94.6 112.61 58.51 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.333 -0.394 . . . . 35.990000000000002 111.14 -174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -88.11 -177.19 1.81 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.953 2.435 . . . . 34.350000000000001 112.459 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 51.2 68.88 0.72 Allowed 'General case' 0 C--O 1.237 0.397 0 O-C-N 123.589 0.555 . . . . 31.780000000000001 112.08 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -116.63 87.65 21.95 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.379 -0.6 . . . . 30.390000000000001 109.379 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -89.12 168.18 5.37 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.792 2.328 . . . . 29.940000000000001 113.374 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.44 -174.68 19.95 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.73 -0.948 . . . . 26.75 110.73 172.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -78.04 130.45 10.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.333 2.022 . . . . 25.879999999999999 111.836 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.9 mt -80.17 -57.84 4.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.089 -0.505 . . . . 24.16 110.133 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.48 84.07 0.14 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.69 -0.686 . . . . 21.829999999999998 111.159 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -164.63 161.67 21.05 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.669 -0.696 . . . . 20.620000000000001 110.299 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -172.57 131.23 0.56 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.926 -1.034 . . . . 16.559999999999999 109.305 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -122.04 40.34 3.66 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.589 0.709 . . . . 15.050000000000001 109.99 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -99.64 168.8 9.71 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.386 -0.825 . . . . 14.66 110.674 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.9 p 61.46 142.93 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.769 1.293 . . . . 11.84 112.114 -172.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.657 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -144.56 66.23 13.46 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.631 -0.713 . . . . 8.4399999999999995 111.431 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.452 ' HD3' ' N ' ' A' ' 53' ' ' ALA . 60.0 Cg_endo -103.7 81.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.816 3.011 . . . . 7.6600000000000001 112.575 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.657 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 5.4 Cg_exo -75.01 -40.06 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.427 2.084 . . . . 5.6600000000000001 111.931 -177.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.05 59.45 16.52 Favored Pre-proline 0 C--O 1.234 0.264 0 O-C-N 123.874 0.734 . . . . 2.8700000000000001 111.688 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -77.85 -177.14 3.64 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.346 2.031 . . . . 1.8300000000000001 113.283 -176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -132.75 149.63 52.26 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.153 -1.385 . . . . 4.2199999999999998 109.403 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.6 HG23 ' N ' ' A' ' 60' ' ' ARG . 12.5 mt -84.06 166.6 2.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.805 0.812 . . . . 1.1299999999999999 111.92 -174.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.6 ' N ' HG23 ' A' ' 59' ' ' ILE . 31.5 mtt180 -73.17 -157.78 0.05 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 123.265 1.507 . . . . 3.1400000000000001 112.191 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.646 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 18.8 t-160 -159.4 149.04 18.57 Favored 'General case' 0 CA--C 1.475 -1.908 0 CA-C-N 111.914 -2.403 . . . . 2.7400000000000002 106.129 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.758 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.9 m-30 -125.33 159.3 32.09 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 123.768 0.667 . . . . 0.76000000000000001 109.638 -176.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.513 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 7.3 t70 -81.65 67.32 7.57 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 123.795 1.759 . . . . 0.34999999999999998 107.978 171.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . 0.713 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 92.9 m95 -58.17 -42.15 85.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 111.361 -2.654 . . . . 0.10000000000000001 111.847 173.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.562 ' N ' HG22 ' A' ' 108' ' ' THR . 0.2 OUTLIER -56.35 -27.76 56.9 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.138 -1.392 . . . . 1.1100000000000001 110.285 178.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.23 -14.47 76.65 Favored Glycine 0 CA--C 1.498 -1.013 0 N-CA-C 110.816 -0.914 . . . . 0.23000000000000001 110.816 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.451 ' O ' ' HD2' ' A' ' 70' ' ' PRO . . . -97.38 -54.56 3.11 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 113.966 -1.117 . . . . 1.01 110.32 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' MET . . . . . 0.841 ' HA ' ' SD ' ' A' ' 71' ' ' MET . 40.6 mtt -61.87 -49.65 75.39 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 124.545 1.153 . . . . 0.089999999999999997 112.454 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.421 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.7 mm-40 -41.39 -55.33 5.44 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 115.269 1.581 . . . . 0.63 115.269 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.789 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.8 Cg_endo -64.18 -29.22 64.73 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.063 1.842 . . . . 0.17000000000000001 111.353 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' MET . . . . . 0.841 ' SD ' ' HA ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -80.96 -45.15 17.09 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 114.98 -1.009 . . . . 0.69999999999999996 110.122 -178.343 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.707 HG23 ' O ' ' A' ' 68' ' ' MET . 61.3 t -56.29 -40.78 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 114.246 -1.343 . . . . 1.04 108.729 174.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -57.15 -35.25 69.31 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.075 -1.875 . . . . 1.1200000000000001 111.189 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.789 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 26.8 mtpt -85.96 -33.08 21.22 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.918 0.39 . . . . 1.8799999999999999 110.981 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . 0.823 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.98 -26.98 68.82 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.618 -0.719 . . . . 0.5 111.477 -170.3 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.498 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.3 mt -93.1 -7.17 46.28 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.971 0.891 . . . . 1.29 111.387 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.27 13.84 55.03 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.143 -1.583 . . . . 0.17999999999999999 109.143 172.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.59 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.11 164.33 19.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.428 -0.886 . . . . 1.0 110.348 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -86.39 106.87 17.73 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.324 -0.853 . . . . 1.72 109.844 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.632 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 132.92 -21.47 4.17 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 120.4 -0.905 . . . . 0.13 111.146 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.823 HG11 ' O ' ' A' ' 75' ' ' MET . 12.5 p -103.74 152.56 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.853 0.835 . . . . 1.01 112.243 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.469 HG21 ' O ' ' A' ' 83' ' ' ALA . 25.7 m -136.4 144.43 44.51 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.438 -1.256 . . . . 1.1000000000000001 110.823 175.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.514 ' HB1' ' CE ' ' A' ' 118' ' ' LYS . . . -61.92 142.68 57.27 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.254 -0.884 . . . . 1.1200000000000001 110.05 166.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.78 -0.34 69.94 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.847 -0.692 . . . . 0.28000000000000003 112.568 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . 0.485 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 63.1 m -94.57 145.83 24.54 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.552 -0.459 . . . . 1.55 109.977 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.645 HG12 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -76.44 126.67 37.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.685 0.755 . . . . 1.03 109.882 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.883 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -113.68 108.24 16.85 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.203 -0.908 . . . . 1.03 109.399 -170.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.649 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.9 OUTLIER -73.32 94.51 2.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.39 -1.277 . . . . 1.01 108.868 176.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.446 HG23 HD21 ' A' ' 109' ' ' LEU . 2.0 m -73.12 116.72 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 107.718 -1.215 . . . . 1.6200000000000001 107.718 176.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.74 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 5.5 t0 -79.06 171.25 15.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.517 -0.92 . . . . 0.64000000000000001 108.517 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.652 ' HG ' ' HA ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -59.73 148.38 34.38 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-O 122.544 1.164 . . . . 1.05 108.757 171.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.644 ' O ' ' HB2' ' A' ' 102' ' ' ALA . 24.7 t -73.97 138.25 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.498 0 N-CA-C 106.516 -1.661 . . . . 1.02 106.516 162.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.684 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.3 t-20 -85.23 163.73 18.5 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 121.744 0.783 . . . . 0.20000000000000001 110.108 174.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASN . . . . . 0.736 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.3 t-20 -124.82 86.23 2.53 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.633 -1.167 . . . . 0.12 108.384 175.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 11.3 mtp180 -107.72 -2.93 19.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.952 -1.476 . . . . 0.84999999999999998 108.731 -173.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.657 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 32.7 p -51.85 -172.18 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.232 -1.804 . . . . 0.91000000000000003 115.5 -176.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . 0.486 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.8 t30 -70.77 -8.91 55.81 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 112.537 -2.12 . . . . 0.62 110.562 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.514 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -153.26 -145.41 4.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.518 -0.849 . . . . 0.14000000000000001 113.045 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.61 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 58.1 p -121.43 130.58 53.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.626 0.602 . . . . 1.76 112.626 -176.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.736 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -136.17 153.5 51.24 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.626 0.727 . . . . 1.01 110.667 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.643 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -76.57 80.11 3.24 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.155 -1.384 . . . . 0.20999999999999999 107.771 175.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.644 ' HB2' ' O ' ' A' ' 92' ' ' VAL . . . -67.52 -15.23 63.55 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.155 -1.384 . . . . 1.0 110.07 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.07 -30.2 34.8 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.72 -0.845 . . . . 1.02 108.72 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.643 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 9.2 tp10 -66.07 -35.67 81.14 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.503 -1.226 . . . . 1.73 108.877 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.577 ' HB1' ' O ' ' A' ' 102' ' ' ALA . . . -70.66 -44.98 65.98 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 113.251 -1.795 . . . . 1.04 109.232 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.606 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 52.1 m -59.75 -32.03 70.2 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.965 -1.471 . . . . 1.04 110.947 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -43.87 71.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.476 -0.935 . . . . 1.47 108.476 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.645 ' O ' ' HB2' ' A' ' 111' ' ' ASN . 56.7 m -62.76 -29.48 70.72 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.328 -0.851 . . . . 1.03 110.54 176.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.693 ' O ' HD21 ' A' ' 113' ' ' LEU . 9.1 tp -56.27 -64.26 0.92 Allowed 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.937 -1.029 . . . . 1.3 109.185 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.726 ' O ' HD13 ' A' ' 121' ' ' LEU . 23.4 mtp180 -43.07 -37.38 1.95 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.172 0.987 . . . . 1.8 111.114 172.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.645 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -69.21 -46.9 66.26 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.25 -1.341 . . . . 0.41999999999999998 112.165 -175.584 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.19 -33.67 65.53 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.58 -0.896 . . . . 1.01 108.58 -179.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.693 HD21 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -59.21 -38.06 79.0 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.725 -1.579 . . . . 1.01 109.685 170.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.82 -40.68 60.94 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.177 -0.919 . . . . 1.03 110.926 -177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -56.47 -36.17 68.77 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.633 -1.167 . . . . 1.55 110.393 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -72.07 -47.61 50.28 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 113.636 -1.62 . . . . 2.0499999999999998 109.965 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.95 -11.96 63.28 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 114.947 0.739 . . . . 0.54000000000000004 114.947 172.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.514 ' CE ' ' HB1' ' A' ' 83' ' ' ALA . 53.9 mtpt -69.42 -36.68 76.95 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.515 1.157 . . . . 1.6000000000000001 111.081 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.883 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 20.6 m-85 -88.35 177.56 6.81 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 122.625 1.202 . . . . 0.27000000000000002 113.412 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 18.2 m -122.37 106.17 10.83 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 112.616 -2.083 . . . . 1.0800000000000001 108.041 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.726 HD13 ' O ' ' A' ' 110' ' ' ARG . 0.0 OUTLIER -94.42 128.6 41.07 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.563 -1.199 . . . . 1.1499999999999999 112.277 -168.5 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.725 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.7 OUTLIER -72.08 153.79 7.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.218 -1.356 . . . . 1.0900000000000001 108.066 174.101 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . 0.474 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 1.4 m -101.88 -179.05 3.89 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 119.598 -0.841 . . . . 1.8200000000000001 110.045 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -65.77 -29.53 70.05 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.602 -0.888 . . . . 1.1899999999999999 108.602 177.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.588 ' O ' ' HG3' ' A' ' 129' ' ' MET . 6.1 mt-30 -43.77 -38.96 3.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 113.444 -1.707 . . . . 2.04 111.541 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLN . . . . . 0.725 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 2.2 mt-30 -96.04 -55.42 2.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.69 1.233 . . . . 0.42999999999999999 108.561 172.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.754 HD12 ' NZ ' ' A' ' 131' ' ' LYS . 1.1 tm? -65.63 -58.62 5.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 112.671 -2.059 . . . . 2.04 113.721 -161.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.602 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -53.4 -38.99 63.92 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 123.547 1.642 . . . . 1.1499999999999999 108.437 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.684 ' HB2' ' O ' ' A' ' 126' ' ' GLN . 41.9 mmm -63.37 -60.31 3.54 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 110.923 -2.853 . . . . 2.27 111.18 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.708 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.45 -44.19 5.72 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 124.259 0.974 . . . . 1.0700000000000001 112.166 176.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.754 ' NZ ' HD12 ' A' ' 127' ' ' LEU . 26.3 mttt -52.47 -55.52 21.4 Favored 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 120.065 -0.654 . . . . 2.1000000000000001 109.589 176.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 42.4 mt-30 -61.49 -42.59 99.03 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.894 -1.048 . . . . 0.42999999999999999 111.469 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.677 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.5 mt-30 -57.55 -37.0 72.39 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.334 -1.303 . . . . 0.38 109.703 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.525 HD21 ' N ' ' A' ' 134' ' ' LEU . 0.4 OUTLIER -89.31 -31.36 17.86 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.804 -1.544 . . . . 1.05 109.063 -177.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 131' ' ' LYS . . . 159.64 -56.11 0.34 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-O 122.632 1.129 . . . . 0.33000000000000002 113.921 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 74.3 mt -61.88 -172.62 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 112.372 -1.914 . . . . 1.0700000000000001 116.025 -169.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.512 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.7 m -114.32 151.7 45.32 Favored Pre-proline 0 N--CA 1.428 -1.556 0 CA-C-N 110.846 -2.888 . . . . 1.24 108.581 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.602 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 10.2 Cg_endo -57.67 -7.56 3.31 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.177 2.585 . . . . 0.39000000000000001 113.423 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -116.98 -30.53 5.67 Favored 'General case' 0 CA--C 1.499 -1.008 0 O-C-N 123.709 0.63 . . . . 1.79 109.542 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 141' ' ' SER . 8.7 t70 -50.74 -36.11 34.91 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.506 1.146 . . . . 0.65000000000000002 108.778 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.652 ' HA ' ' HG ' ' A' ' 91' ' ' SER . 1.9 m 81.07 159.47 0.15 Allowed 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 110.747 -2.933 . . . . 0.73999999999999999 111.149 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.74 ' HG ' ' CG ' ' A' ' 90' ' ' ASP . 7.6 mt -66.27 -38.05 86.9 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.233 -1.395 . . . . 1.48 107.233 -172.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.17 0.16 0.68 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 112.545 -2.116 . . . . 0.34999999999999998 114.856 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' THR . . . . . 0.425 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -152.31 120.49 6.28 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.69 -0.855 . . . . 1.02 108.69 -174.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . 0.663 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.0 mmt180 -40.97 -48.08 3.12 Favored 'General case' 0 C--O 1.212 -0.874 0 O-C-N 123.691 0.619 . . . . 2.21 110.906 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 t -69.68 -29.77 67.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.23 0.538 . . . . 0.93000000000000005 111.817 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.425 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 23.9 mttm -72.36 -32.48 66.5 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.399 1.095 . . . . 1.8899999999999999 108.611 176.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ALA . . . . . 0.608 ' HA ' HD12 ' A' ' 142' ' ' LEU . . . -74.02 -43.06 59.29 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-N 112.761 -2.018 . . . . 0.98999999999999999 110.15 178.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.534 HG13 ' HE3' ' A' ' 179' ' ' MET . 40.2 mt -67.66 -42.66 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 CA-C-N 113.498 -1.683 . . . . 1.03 110.1 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.42 -51.99 44.08 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 114.955 -1.02 . . . . 0.14999999999999999 111.096 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ILE . . . . . 0.708 HG23 ' CB ' ' A' ' 130' ' ' ALA . 65.7 mt -68.25 -47.22 79.07 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 N-CA-C 113.01 0.744 . . . . 1.05 113.01 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . 0.638 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.24 -39.58 72.78 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.985 0.421 . . . . 1.03 110.816 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 23.6 mtp-105 -82.55 -19.9 37.66 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.526 0.679 . . . . 1.29 110.818 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.423 HD22 ' CD ' ' A' ' 133' ' ' GLN . 17.0 t30 -84.57 -11.22 56.46 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.344 -1.354 . . . . 0.5 107.344 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.703 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.08 -29.02 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 113.137 -1.847 . . . . 1.05 111.052 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.48 35.38 4.7 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.283 -0.96 . . . . 0.17000000000000001 112.485 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.83 156.24 21.42 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.249 0.833 . . . . 1.02 113.249 -169.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' HIS . . . . . 0.645 ' N ' HG12 ' A' ' 86' ' ' VAL . 1.6 m80 -96.53 -26.53 15.23 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.838 -1.074 . . . . 0.39000000000000001 109.751 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . 0.599 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 15.6 m-85 -135.99 -179.53 5.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.218 -0.901 . . . . 0.81000000000000005 111.064 -173.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.707 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -133.06 139.79 48.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.61 -0.885 . . . . 1.03 108.61 166.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.496 HD21 ' HE2' ' A' ' 176' ' ' MET . 46.4 tp -110.54 101.33 10.01 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 119.407 -0.917 . . . . 1.02 109.244 165.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . 0.466 ' CD2' HG13 ' A' ' 160' ' ' VAL . 4.5 m-85 -82.05 112.79 19.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.222 -1.354 . . . . 0.87 109.421 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.886 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 10.3 t -122.81 162.19 22.59 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.768 0.794 . . . . 1.45 110.613 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' SER . . . . . 0.775 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -162.85 175.09 11.59 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.522 -1.217 . . . . 0.12 111.101 -177.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.32 136.77 35.19 Favored 'General case' 0 N--CA 1.413 -2.317 0 CA-C-N 114.413 -1.267 . . . . 0.94999999999999996 108.853 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.657 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 3.5 m -144.97 -172.97 3.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 109.219 -0.66 . . . . 1.1499999999999999 109.219 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.14 -84.87 1.11 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.606 -1.283 . . . . 0.14999999999999999 110.834 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASN . . . . . 0.486 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 66.1 t30 -143.09 122.86 13.39 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.432 -0.884 . . . . 0.58999999999999997 109.923 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.521 HG22 ' N ' ' A' ' 99' ' ' SER . 2.4 p -54.32 -49.73 61.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 112.678 0.622 . . . . 1.0 112.678 -169.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASN . . . . . 0.438 ' N ' HG12 ' A' ' 169' ' ' VAL . 5.5 m-20 -56.83 -31.89 65.21 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.777 0.798 . . . . 1.9199999999999999 110.288 -174.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.49 87.51 4.15 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 114.263 -1.335 . . . . 1.0600000000000001 108.119 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.654 ' HD2' HG23 ' A' ' 194' ' ' VAL . 48.1 Cg_endo -90.64 165.48 4.17 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 124.712 3.608 . . . . 0.089999999999999997 114.999 -170.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' THR . . . . . 0.556 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 28.7 m -81.31 117.91 22.19 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.745 -1.571 . . . . 1.0600000000000001 107.098 165.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.836 HD13 ' OG ' ' A' ' 163' ' ' SER . 43.1 tp -83.83 100.12 10.76 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.256 -1.016 . . . . 1.02 108.256 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLN . . . . . 0.558 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 35.5 mt-30 -90.05 109.56 20.61 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 121.897 0.856 . . . . 0.34000000000000002 109.152 -177.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' MET . . . . . 0.886 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.0 OUTLIER -111.46 163.84 13.6 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.233 -0.894 . . . . 1.0900000000000001 111.356 -174.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLN . . . . . 0.465 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 57.8 tt0 -169.65 118.19 0.62 Allowed 'General case' 0 C--O 1.207 -1.171 0 CA-C-O 121.353 0.597 . . . . 0.68000000000000005 110.12 -165.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.707 HD23 ' O ' ' A' ' 160' ' ' VAL . 0.7 OUTLIER -101.16 102.29 13.18 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.038 -0.727 . . . . 1.03 109.038 -173.069 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.663 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.9 ttp -91.6 117.79 30.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.755 -0.657 . . . . 0.89000000000000001 109.491 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.447 ' HB2' HG22 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.48 113.0 2.7 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.655 -1.239 . . . . 1.04 107.655 170.616 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.525 HG23 ' HB1' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -67.53 -35.76 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.989 0.813 . . . . 1.02 111.611 -175.6 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -61.3 -12.52 13.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.726 -0.67 . . . . 0.40000000000000002 111.9 -177.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' THR . . . . . 0.473 ' HG1' ' HG2' ' A' ' 185' ' ' GLU . 43.4 p -130.46 -37.26 1.41 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.211 1.005 . . . . 1.03 110.333 177.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.437 ' CA ' HD13 ' A' ' 149' ' ' ILE . . . 88.91 21.05 44.14 Favored Glycine 0 N--CA 1.428 -1.88 0 CA-C-N 113.528 -1.669 . . . . 0.17999999999999999 111.596 -176.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.473 ' HG2' ' HG1' ' A' ' 183' ' ' THR . 14.1 pt-20 -99.62 154.31 18.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.906 0.384 . . . . 0.72999999999999998 110.537 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ILE . . . . . 0.435 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.7 mm -88.8 111.81 23.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.034 -0.728 . . . . 1.03 109.034 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.665 ' CD1' HD11 ' A' ' 178' ' ' LEU . 1.6 pp -98.49 -31.37 3.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.815 -1.084 . . . . 1.01 110.248 -173.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . 0.675 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 82.7 t90 -135.95 152.51 51.05 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.164 -0.925 . . . . 0.070000000000000007 109.914 173.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 64.9 p -154.01 162.71 41.01 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 112.172 0.434 . . . . 0.64000000000000001 112.172 163.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -162.15 -177.98 35.64 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.638 -0.985 . . . . 0.12 110.638 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' LYS . . . . . 0.833 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 13.2 mttt -151.78 153.77 34.94 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.537 -1.653 . . . . 1.76 106.537 166.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.52 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -159.82 128.22 1.95 Allowed Glycine 0 C--N 1.286 -2.236 0 CA-C-N 114.888 -1.051 . . . . 0.13 111.942 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -73.2 119.35 17.31 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.699 0.761 . . . . 1.01 111.286 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.708 HG12 ' CZ3' ' A' ' 64' ' ' TRP . 2.0 m -94.42 159.22 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 CA-C-N 114.682 -1.145 . . . . 1.01 110.708 -176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.758 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -99.34 172.84 7.08 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.648 -2.069 . . . . 0.92000000000000004 109.001 -174.408 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -102.47 130.93 49.42 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.733 -0.387 . . . . 0.91000000000000003 110.17 171.693 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.528 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 16.1 mm-40 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.408 -0.806 . . . . 1.24 110.391 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.717 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.7 m-30 . . . . . 0 N--CA 1.426 -1.672 0 CA-C-O 120.455 0.169 . . . . 0.20999999999999999 111.182 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 7.6 t70 -84.55 67.82 10.09 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 123.363 1.554 . . . . 0.34999999999999998 108.487 172.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.768 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.8 m95 -57.96 -42.5 85.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 112.219 -2.264 . . . . 0.10000000000000001 112.455 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 3.7 t30 -53.22 -26.14 16.61 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.13 -1.395 . . . . 1.1100000000000001 111.52 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.29 -15.61 79.81 Favored Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.279 -0.873 . . . . 0.20999999999999999 111.267 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.62 -53.19 3.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.104 -1.048 . . . . 0.13 110.991 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.704 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.2 mtt -65.43 -59.38 4.07 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 114.08 -1.418 . . . . 0.089999999999999997 112.035 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.5 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 5.1 mm100 -39.28 -54.98 3.34 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 114.679 1.362 . . . . 0.63 114.679 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.769 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.8 Cg_endo -63.61 -28.47 69.63 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.988 1.792 . . . . 0.14000000000000001 110.768 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.721 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 8.2 mtm -83.17 -44.47 15.02 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.088 -0.96 . . . . 0.69999999999999996 112.09 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 68' ' ' MET . 58.6 t -56.86 -39.14 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-N 114.312 -1.313 . . . . 0.12 108.715 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -60.13 -32.96 71.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.966 -1.924 . . . . 0.56000000000000005 110.974 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.769 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 5.0 mtpm? -83.79 -35.76 24.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.843 0.457 . . . . 1.3 111.159 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.871 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.85 -26.54 68.66 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.461 -0.791 . . . . 0.5 111.295 -172.238 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 118' ' ' LYS . 5.5 mt -93.46 -3.48 52.96 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.071 0.938 . . . . 0.65000000000000002 110.841 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.27 15.41 42.99 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 109.147 -1.581 . . . . 0.17000000000000001 109.147 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.629 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.89 160.95 19.28 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.526 -0.837 . . . . 0.10000000000000001 110.282 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.21 104.97 16.26 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.288 -0.869 . . . . 1.72 110.093 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.641 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.03 -23.83 3.16 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.842 -0.903 . . . . 0.12 110.842 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.871 HG11 ' O ' ' A' ' 75' ' ' MET . 11.9 p -103.07 150.67 6.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.635 0.731 . . . . 0.16 111.75 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.7 m -136.57 141.31 43.33 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.919 -1.037 . . . . 0.45000000000000001 111.102 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.631 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.12 132.95 48.57 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.779 -1.1 . . . . 0.28000000000000003 110.741 167.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.47 9.55 50.16 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 121.174 -0.536 . . . . 0.28000000000000003 112.8 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.66 149.64 21.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.327 -0.549 . . . . 1.2 110.647 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.712 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -80.84 116.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.168 0.985 . . . . 0.20000000000000001 108.925 166.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.743 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -105.16 109.51 21.53 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.044 -0.98 . . . . 0.14000000000000001 108.903 -172.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.792 HD21 HD13 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -71.78 94.42 1.39 Allowed 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 114.428 -1.26 . . . . 0.14999999999999999 108.32 177.267 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.452 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.7 m -72.58 119.18 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 106.978 -1.49 . . . . 0.94999999999999996 106.978 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.845 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 12.3 t0 -77.33 162.35 27.35 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.703 -1.221 . . . . 0.64000000000000001 107.703 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.567 ' H ' ' NZ ' ' A' ' 131' ' ' LYS . 1.1 m -62.17 143.21 57.06 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.59 -1.633 . . . . 0.37 106.59 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.56 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 27.3 t -71.73 139.76 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.118 0 N-CA-C 107.534 -1.284 . . . . 0.10000000000000001 107.534 168.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.78 ' H ' ' HA ' ' A' ' 164' ' ' SER . 8.0 t-20 -84.9 163.28 19.09 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.497 -0.774 . . . . 0.17999999999999999 110.07 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.77 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.14 85.22 2.38 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.96 -1.126 . . . . 0.12 107.96 175.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.535 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.9 mtp180 -107.02 -4.17 19.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.037 -1.438 . . . . 0.64000000000000001 108.764 -171.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 172' ' ' PRO . 19.1 p -51.05 -170.94 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.83 -1.986 . . . . 0.14000000000000001 115.499 -175.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 38.3 t30 -70.96 -6.35 38.05 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.718 -2.037 . . . . 0.47999999999999998 110.53 173.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.603 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -157.48 -144.05 3.83 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.396 -0.907 . . . . 0.12 113.297 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.629 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 94.8 p -121.42 130.31 53.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.612 0.597 . . . . 1.1599999999999999 112.612 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.77 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.2 pp -136.48 159.49 41.64 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-O 121.855 0.836 . . . . 0.10000000000000001 110.579 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.692 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -80.74 82.17 6.81 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 113.856 -1.52 . . . . 0.17000000000000001 107.975 175.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -70.84 -15.64 62.66 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.355 -1.293 . . . . 0.089999999999999997 109.81 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.663 ' HB2' ' CG ' ' A' ' 139' ' ' GLN . . . -78.66 -31.53 46.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.793 0.806 . . . . 0.14999999999999999 108.849 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.692 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 21.5 tt0 -62.83 -38.61 91.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 114.053 -1.43 . . . . 1.73 109.109 169.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -69.54 -44.62 70.57 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 112.867 -1.97 . . . . 0.12 109.005 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.592 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 60.6 m -64.89 -31.82 73.23 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.126 -1.397 . . . . 0.11 110.533 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.15 -51.24 59.74 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.972 -1.121 . . . . 1.47 107.972 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 64' ' ' TRP . 31.7 m -56.69 -33.15 66.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.532 -0.758 . . . . 0.12 111.436 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.704 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.3 mt -50.55 -68.69 0.15 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 109.61 -0.515 . . . . 0.56000000000000005 109.61 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.569 ' O ' HD13 ' A' ' 121' ' ' LEU . 19.0 mtp180 -42.81 -36.92 1.63 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.883 -1.053 . . . . 1.51 110.973 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.1 m-20 -71.9 -47.47 52.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.245 -1.343 . . . . 0.28000000000000003 111.854 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.5 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.21 -33.31 67.51 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.328 1.061 . . . . 0.089999999999999997 108.403 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.86 -32.9 74.58 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.514 -1.676 . . . . 0.12 109.918 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.693 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -76.28 -40.82 50.72 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.812 -1.086 . . . . 0.20000000000000001 111.364 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.05 -26.87 66.96 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.99 -1.005 . . . . 1.1699999999999999 110.682 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' A' ' 116' ' ' ASN . 1.3 t-20 -88.08 -17.94 29.98 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.147 -0.621 . . . . 2.0499999999999998 110.429 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.21 -12.83 2.99 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 116.048 1.179 . . . . 0.54000000000000004 116.048 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.72 ' HB2' HD13 ' A' ' 76' ' ' LEU . 57.8 mtpt -77.39 -14.3 59.74 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 117.802 0.801 . . . . 0.98999999999999999 111.463 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.743 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 23.2 m-85 -109.29 172.76 6.66 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 122.648 1.213 . . . . 0.20999999999999999 113.669 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.57 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 14.7 m -117.27 117.42 29.5 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 112.305 -2.225 . . . . 0.23000000000000001 108.031 169.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -88.52 139.02 30.9 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.437 -0.801 . . . . 0.38 110.517 -171.814 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.559 HG11 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.301 -1.52 0 N-CA-C 108.871 -0.788 . . . . 0.41999999999999998 108.871 172.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.792 HD13 HD21 ' A' ' 88' ' ' LEU . 26.5 tp . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 112.8 0.667 . . . . 1.3899999999999999 112.8 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.704 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 2.6 t -49.39 -44.56 45.19 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 123.308 1.528 . . . . 1.05 109.408 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.734 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 19.0 mmt -58.44 -61.61 2.46 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 111.064 -2.789 . . . . 1.6399999999999999 110.694 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.755 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.81 -46.15 5.13 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 124.484 1.115 . . . . 0.31 112.197 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.568 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -54.95 -51.36 66.39 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 108.624 -0.88 . . . . 1.53 108.624 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 128' ' ' SER . 39.1 mt-30 -65.68 -40.78 92.72 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.23 -0.895 . . . . 0.40999999999999998 111.162 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.734 ' HG3' ' O ' ' A' ' 129' ' ' MET . 54.5 mt-30 -57.81 -34.73 69.96 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 114.354 -1.294 . . . . 0.37 109.525 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.08 -28.93 17.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 113.754 -1.567 . . . . 0.23999999999999999 109.284 -176.939 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.62 -49.79 0.52 Allowed Glycine 0 CA--C 1.496 -1.137 0 CA-C-O 122.667 1.148 . . . . 0.33000000000000002 113.323 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 141' ' ' SER . 87.9 mt -64.92 -169.73 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 112.332 -1.934 . . . . 0.31 115.669 -171.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.0 m -116.3 155.05 48.82 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 110.858 -2.883 . . . . 0.81000000000000005 107.517 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.704 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 46.1 Cg_endo -67.26 1.35 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.661 2.241 . . . . 0.32000000000000001 110.866 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.663 ' CG ' ' HB2' ' A' ' 103' ' ' ALA . 31.4 mt-30 -118.27 -24.31 6.97 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.946 -1.479 . . . . 1.25 111.525 -173.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.621 ' O ' ' HB2' ' A' ' 141' ' ' SER . 7.1 t70 -72.92 -23.61 60.72 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 114.838 -1.073 . . . . 0.65000000000000002 108.793 -168.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 31.5 m 75.78 166.33 0.27 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.532 -2.122 . . . . 0.59999999999999998 110.56 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.944 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.2 mt -64.99 -40.4 94.91 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.581 1.182 . . . . 0.85999999999999999 108.777 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.71 -12.16 0.16 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 112.607 -2.088 . . . . 0.31 114.612 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -151.79 125.45 8.97 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 118.832 -0.604 . . . . 0.23999999999999999 109.57 -173.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 16.8 mmt85 -42.27 -48.13 4.9 Favored 'General case' 0 C--O 1.211 -0.944 0 O-C-N 123.413 0.446 . . . . 1.6499999999999999 111.915 -176.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 41.9 t -72.23 -26.33 61.98 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.595 0.712 . . . . 0.53000000000000003 111.236 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -74.37 -28.97 61.36 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.6 1.19 . . . . 1.3100000000000001 108.505 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.944 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -76.47 -47.92 21.32 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-N 112.471 -2.149 . . . . 0.12 110.427 177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.627 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.2 mt -66.51 -40.17 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 CA-C-N 112.856 -1.975 . . . . 0.11 110.073 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.46 -55.26 25.69 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 114.652 -1.158 . . . . 0.14999999999999999 110.965 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.755 HG23 ' CB ' ' A' ' 130' ' ' ALA . 92.1 mt -66.42 -48.55 80.4 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.07 0 N-CA-C 112.683 0.623 . . . . 0.17999999999999999 112.683 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.675 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.36 -41.2 72.22 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 123.227 0.329 . . . . 0.13 111.079 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.497 ' HD2' HG23 ' A' ' 149' ' ' ILE . 24.8 mtp180 -81.22 -23.02 38.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.597 0.713 . . . . 1.0800000000000001 110.459 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -82.84 -10.26 58.93 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.438 -1.319 . . . . 0.5 107.438 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.71 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.1 t -108.51 -29.47 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 113.18 -1.827 . . . . 0.17000000000000001 111.0 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.83 35.86 4.16 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.077 -1.058 . . . . 0.16 112.486 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.689 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.15 159.65 17.65 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.866 0.691 . . . . 0.12 112.866 -171.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.712 ' N ' HG13 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -99.85 -28.17 13.25 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 123.414 0.686 . . . . 0.20000000000000001 109.681 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.572 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.3 m-85 -135.44 -173.17 3.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.161 -0.927 . . . . 0.13 110.945 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.701 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -137.18 140.35 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.004 -0.998 . . . . 0.080000000000000002 108.786 166.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.633 HD21 ' SD ' ' A' ' 176' ' ' MET . 37.0 tp -109.31 100.95 10.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 119.417 -0.913 . . . . 0.16 109.3 165.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.4 m-85 -79.83 113.59 18.1 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 114.434 -1.257 . . . . 0.26000000000000001 109.027 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.855 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 6.4 t -126.64 161.25 28.51 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 122.143 0.973 . . . . 1.05 110.881 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.821 ' O ' HD12 ' A' ' 174' ' ' LEU . 2.2 p -164.51 174.55 10.79 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.949 -1.478 . . . . 0.10000000000000001 110.859 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.29 134.67 38.23 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 114.2 -1.363 . . . . 0.11 108.632 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.681 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.7 m -144.73 -175.96 4.87 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.185 -0.672 . . . . 1.0900000000000001 109.185 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.82 -84.53 0.8 Allowed Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 119.536 -1.316 . . . . 0.14999999999999999 111.325 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.7 t30 -144.23 127.22 16.45 Favored 'General case' 0 C--O 1.197 -1.676 0 N-CA-C 107.596 -1.261 . . . . 0.58999999999999997 107.596 175.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.603 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.5 p -63.34 -39.53 85.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.398 -0.819 . . . . 0.14999999999999999 112.364 -171.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.41 ' N ' HG13 ' A' ' 169' ' ' VAL . 4.4 m120 -60.72 -31.47 70.77 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 122.086 0.946 . . . . 1.26 109.753 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.55 88.89 3.29 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 113.169 -1.832 . . . . 0.13 108.307 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.799 ' HD2' HG22 ' A' ' 194' ' ' VAL . 52.4 Cg_endo -89.99 163.73 4.88 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 124.335 3.357 . . . . 0.089999999999999997 114.883 -169.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.617 HG22 ' HB3' ' A' ' 191' ' ' LYS . 63.8 m -82.93 117.97 23.14 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 106.965 -1.494 . . . . 0.14000000000000001 106.965 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 164' ' ' SER . 38.5 tp -83.9 97.49 9.26 Favored 'General case' 0 N--CA 1.413 -2.325 0 C-N-CA 119.294 -0.963 . . . . 0.16 108.402 177.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.582 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 7.4 mt-30 -87.87 109.47 19.8 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.098 -0.955 . . . . 0.34000000000000002 109.153 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.855 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -112.85 164.75 13.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.684 -1.144 . . . . 1.0900000000000001 111.481 -173.787 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.603 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.7 tt0 -170.57 118.16 0.52 Allowed 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 116.077 -0.51 . . . . 0.5 110.076 -166.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.066 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -100.37 100.56 11.36 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.741 -0.837 . . . . 0.10000000000000001 108.741 -172.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.627 ' HE1' HG13 ' A' ' 149' ' ' ILE . 18.2 ttp -90.52 121.93 32.9 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.445 -0.798 . . . . 0.070000000000000007 109.614 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.82 127.09 30.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.122 -1.436 . . . . 0.22 107.122 166.284 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.617 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.52 -34.4 13.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 119.33 0.968 . . . . 0.11 110.758 178.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.429 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.7 mt-30 -63.08 -14.69 51.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.265 -0.88 . . . . 0.34999999999999998 111.577 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.1 p -130.58 -36.97 1.4 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.677 0.751 . . . . 0.19 110.277 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.503 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.17 19.0 44.02 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.556 -1.202 . . . . 0.17999999999999999 112.25 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.7 156.79 16.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.529 -0.336 . . . . 0.72999999999999998 110.494 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.603 HD12 ' HG2' ' A' ' 177' ' ' GLN . 33.7 mm -91.58 115.85 31.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.637 0.732 . . . . 0.14000000000000001 109.52 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.066 HD11 HD13 ' A' ' 178' ' ' LEU . 1.5 pp -103.28 -29.61 2.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.019 -0.991 . . . . 0.13 110.681 -173.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.652 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.0 t90 -137.2 153.26 50.45 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.371 -0.831 . . . . 0.070000000000000007 109.508 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 79.9 p -153.47 165.47 35.75 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.822 0.675 . . . . 0.13 112.822 163.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -161.79 -175.91 33.32 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-O 121.718 0.621 . . . . 0.12 111.762 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.757 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 1.5 mttp -154.74 152.02 29.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.095 -1.817 . . . . 1.22 106.095 164.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -157.33 127.31 1.9 Allowed Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 119.612 -1.28 . . . . 0.12 111.833 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.42 115.2 10.32 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.391 0.615 . . . . 0.17000000000000001 110.487 -175.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.799 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -90.98 158.68 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-O 122.47 1.128 . . . . 0.11 109.647 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.657 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.23 171.58 7.52 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 112.848 -1.978 . . . . 0.17999999999999999 109.256 -172.612 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 6.8 tt0 -101.64 128.96 47.7 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.074 -0.713 . . . . 0.91000000000000003 109.074 168.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.497 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 19.3 mm-40 . . . . . 0 C--N 1.309 -1.177 0 CA-C-N 115.505 -0.771 . . . . 1.24 110.732 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.727 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.1 m-30 . . . . . 0 N--CA 1.426 -1.656 0 CA-C-O 120.252 0.072 . . . . 0.20999999999999999 110.973 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.528 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 15.8 t70 -85.05 67.75 10.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 123.538 1.637 . . . . 0.34999999999999998 108.444 173.334 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.772 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.1 m95 -55.64 -43.33 76.12 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 112.006 -2.361 . . . . 0.10000000000000001 112.752 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.438 ' N ' HG21 ' A' ' 108' ' ' THR . 4.1 t30 -50.8 -30.87 15.33 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.762 -1.563 . . . . 1.1100000000000001 111.643 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.28 -17.15 79.62 Favored Glycine 0 CA--C 1.503 -0.693 0 CA-C-N 115.506 -0.77 . . . . 0.20999999999999999 111.423 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.96 -51.51 3.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.114 -1.043 . . . . 0.13 110.806 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.74 ' SD ' HD23 ' A' ' 109' ' ' LEU . 37.6 mtt -65.69 -56.29 12.9 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 114.182 -1.372 . . . . 0.089999999999999997 112.473 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.465 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.6 mm100 -39.74 -54.29 4.15 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 114.804 1.409 . . . . 0.63 114.804 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.834 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 29.6 Cg_endo -63.55 -32.0 70.39 Favored 'Trans proline' 0 CA--C 1.508 -0.804 0 C-N-CA 121.919 1.746 . . . . 0.14000000000000001 110.799 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.758 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 7.7 mtm -79.64 -47.59 15.16 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 114.979 -1.01 . . . . 0.69999999999999996 111.515 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 68' ' ' MET . 53.3 t -54.52 -41.19 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 CA-C-N 114.089 -1.414 . . . . 0.12 108.955 176.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.9 t -60.0 -36.68 77.72 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.256 -1.793 . . . . 0.56000000000000005 110.791 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.834 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 20.0 mtpp -77.6 -35.36 52.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.303 0.573 . . . . 1.3 110.498 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.866 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.14 -29.81 71.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.765 -1.107 . . . . 0.5 111.44 -173.663 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.479 ' HG ' ' HB2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -83.68 -6.82 59.54 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.193 0.52 . . . . 0.65000000000000002 111.235 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -108.76 13.97 34.98 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.614 -1.395 . . . . 0.17000000000000001 109.614 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.657 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -81.58 161.36 23.56 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.663 -0.768 . . . . 0.10000000000000001 110.285 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.99 106.26 17.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.345 -0.843 . . . . 1.72 109.579 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.648 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.76 -24.68 3.46 Favored Glycine 0 N--CA 1.418 -2.542 0 C-N-CA 119.797 -1.192 . . . . 0.12 110.666 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.866 HG11 ' O ' ' A' ' 75' ' ' MET . 10.9 p -97.47 155.9 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.702 0.763 . . . . 0.16 111.541 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.405 ' HB ' ' OG ' ' A' ' 85' ' ' SER . 6.5 m -132.85 136.62 46.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 114.51 -1.223 . . . . 0.45000000000000001 110.901 -176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.654 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.6 130.21 45.74 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.864 -1.062 . . . . 0.28000000000000003 110.332 167.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.86 12.15 60.86 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.719 -0.753 . . . . 0.28000000000000003 113.233 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.462 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 61.9 m -97.56 147.73 23.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.124 0.462 . . . . 1.2 110.156 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.705 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.2 p -77.0 124.8 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 122.09 0.948 . . . . 0.20000000000000001 109.194 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.685 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.7 tm? -110.84 110.17 20.66 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.984 -1.007 . . . . 0.14000000000000001 108.58 -172.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.722 HD21 HD23 ' A' ' 127' ' ' LEU . 0.7 OUTLIER -71.34 92.85 1.08 Allowed 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.334 -1.358 . . . . 0.14999999999999999 107.334 176.336 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.5 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -73.68 113.41 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.416 -1.327 . . . . 0.94999999999999996 107.416 177.27 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.818 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 23.1 t0 -77.28 172.04 13.9 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 114.778 -1.101 . . . . 0.64000000000000001 108.815 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.556 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.7 OUTLIER -61.8 157.78 17.31 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 122.767 1.27 . . . . 0.37 108.371 168.234 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.559 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 39.3 t -86.87 139.63 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.202 0 CA-C-N 113.692 -1.595 . . . . 0.10000000000000001 107.047 165.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.824 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.6 t-20 -83.8 163.35 20.2 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.854 0.835 . . . . 0.17999999999999999 110.555 173.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.763 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.74 84.86 2.32 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.348 -1.296 . . . . 0.12 107.977 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.8 mtp180 -108.48 -2.6 18.85 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.847 -1.524 . . . . 0.64000000000000001 108.727 -171.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.738 HG21 ' HB3' ' A' ' 172' ' ' PRO . 22.6 p -51.4 -170.13 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 112.678 -2.055 . . . . 0.14000000000000001 115.156 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 29.8 t30 -70.49 -10.66 59.77 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.083 -1.871 . . . . 0.47999999999999998 110.531 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.559 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.37 -144.74 3.98 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.176 -1.011 . . . . 0.12 113.573 -176.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.639 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 16.5 m -121.27 130.75 53.83 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.8 0.44 . . . . 1.1599999999999999 110.935 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.763 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -136.8 157.48 46.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.962 0.887 . . . . 0.10000000000000001 110.735 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.723 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -77.17 80.74 3.68 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.628 -1.623 . . . . 0.17000000000000001 107.56 175.023 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -70.17 -14.71 62.76 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.863 -1.062 . . . . 0.089999999999999997 109.767 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.86 -29.6 35.74 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.413 -0.958 . . . . 0.14999999999999999 108.413 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.723 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 29.3 tt0 -61.62 -40.64 95.56 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.207 -1.36 . . . . 1.73 109.125 168.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -68.15 -45.29 73.94 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 112.826 -1.988 . . . . 0.12 108.845 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 47.2 m -63.78 -33.28 75.32 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 113.821 -1.536 . . . . 0.11 110.618 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -44.83 84.89 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.637 -1.245 . . . . 1.47 107.637 172.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.68 HG21 ' HB2' ' A' ' 64' ' ' TRP . 34.6 m -63.24 -30.11 71.32 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.234 -0.894 . . . . 0.12 110.867 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.74 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.57 -68.34 0.18 Allowed 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.589 -0.732 . . . . 0.56000000000000005 109.658 171.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.603 ' NH2' HD12 ' A' ' 127' ' ' LEU . 5.8 mpt_? -40.31 -36.63 0.56 Allowed 'General case' 0 C--O 1.213 -0.865 0 O-C-N 124.226 0.954 . . . . 1.51 110.888 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 108' ' ' THR . 5.5 m-20 -74.6 -46.35 39.12 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.665 -1.152 . . . . 0.28000000000000003 112.0 -174.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.55 63.36 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.471 -0.937 . . . . 0.089999999999999997 108.471 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.683 ' HB3' ' CD2' ' A' ' 121' ' ' LEU . 4.5 mm? -61.64 -35.21 77.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.649 -1.614 . . . . 0.12 109.442 172.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -73.46 -41.69 62.86 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 114.574 -1.194 . . . . 0.20000000000000001 110.937 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -71.85 -8.5 54.7 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.15 -0.932 . . . . 1.1699999999999999 110.281 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -77.81 -49.08 15.02 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.523 -0.917 . . . . 2.0499999999999998 108.523 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.87 -7.15 82.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.416 -0.811 . . . . 0.54000000000000004 113.735 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.654 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 58.7 mtpt -86.64 -33.13 20.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.289 0.545 . . . . 0.98999999999999999 111.322 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.685 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 6.5 m-85 -88.81 171.47 9.91 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.303 1.049 . . . . 0.20999999999999999 112.988 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 7.9 m -116.46 119.32 35.24 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.144 -1.844 . . . . 0.23000000000000001 108.222 168.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.683 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -89.01 140.82 29.05 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 119.466 -0.893 . . . . 0.38 111.368 -171.4 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.592 HG21 HD23 ' A' ' 88' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.299 -1.596 0 N-CA-C 108.42 -0.956 . . . . 0.41999999999999998 108.42 170.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.722 HD23 HD21 ' A' ' 88' ' ' LEU . 1.3 tm? . . . . . 0 C--O 1.222 -0.356 0 N-CA-C 112.998 0.74 . . . . 1.3899999999999999 112.998 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.684 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -48.75 -37.83 20.0 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 123.649 1.69 . . . . 1.05 108.946 -179.288 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.666 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 6.6 mmt -65.78 -61.52 2.02 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 110.731 -2.94 . . . . 1.6399999999999999 110.987 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.748 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.65 -43.61 3.92 Favored 'General case' 0 CA--C 1.503 -0.829 0 O-C-N 124.181 0.925 . . . . 0.31 112.384 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -55.24 -52.69 62.58 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 107.806 -1.183 . . . . 1.53 107.806 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.9 mt-30 -65.89 -41.05 92.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.064 -0.971 . . . . 0.40999999999999998 111.194 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.666 ' HG3' ' O ' ' A' ' 129' ' ' MET . 54.2 mt-30 -56.46 -34.72 67.14 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-N 114.365 -1.289 . . . . 0.37 109.617 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -92.57 -31.33 15.23 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.002 -1.454 . . . . 0.23999999999999999 109.45 -176.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.79 -51.95 0.39 Allowed Glycine 0 CA--C 1.499 -0.917 0 C-N-CA 120.149 -1.024 . . . . 0.33000000000000002 113.759 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 141' ' ' SER . 39.1 mt -67.25 -167.0 0.05 Allowed 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.499 -1.851 . . . . 0.31 115.778 -170.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -116.95 154.57 49.68 Favored Pre-proline 0 N--CA 1.421 -1.909 0 CA-C-N 110.994 -2.821 . . . . 0.81000000000000005 108.002 176.58 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.684 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 21.9 Cg_endo -62.56 -0.11 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.397 2.731 . . . . 0.32000000000000001 112.207 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.46 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.2 tt0 -119.51 -28.73 5.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.172 -0.922 . . . . 1.25 111.096 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.677 ' O ' ' HB2' ' A' ' 141' ' ' SER . 11.7 t70 -66.1 -25.4 66.99 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 113.779 -1.555 . . . . 0.65000000000000002 109.407 -172.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.677 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 5.7 m 75.66 171.75 0.26 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.146 -1.843 . . . . 0.59999999999999998 109.697 -173.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.01 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.0 mt -65.6 -39.24 91.35 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.398 1.094 . . . . 0.85999999999999999 108.36 -176.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.55 -12.4 0.33 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 112.871 -1.968 . . . . 0.31 114.646 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 124.88 7.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 118.719 -0.658 . . . . 0.23999999999999999 109.638 -174.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.668 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -40.89 -48.5 3.13 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 112.177 0.436 . . . . 1.6499999999999999 112.177 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.3 t -72.47 -26.16 61.7 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.443 0.64 . . . . 0.53000000000000003 111.186 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -73.97 -28.42 61.47 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.712 1.244 . . . . 1.3100000000000001 108.528 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 1.01 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -76.61 -47.25 22.93 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 112.27 -2.241 . . . . 0.12 110.253 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.635 HG13 ' HE1' ' A' ' 179' ' ' MET . 36.5 mt -66.75 -41.12 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 112.816 -1.993 . . . . 0.11 110.188 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.98 -54.94 26.3 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 114.613 -1.176 . . . . 0.14999999999999999 111.054 171.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.748 HG23 ' CB ' ' A' ' 130' ' ' ALA . 75.2 mt -65.63 -47.89 84.57 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 N-CA-C 112.748 0.647 . . . . 0.17999999999999999 112.748 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.671 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.27 -40.45 74.23 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.939 0.4 . . . . 0.13 110.939 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.46 ' HD2' HG23 ' A' ' 149' ' ' ILE . 30.9 mtp180 -82.13 -20.85 37.16 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.677 0.751 . . . . 1.0800000000000001 110.451 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 28.1 t-20 -83.28 -10.77 58.33 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.238 -1.393 . . . . 0.5 107.238 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.707 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.0 OUTLIER -109.59 -29.02 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 113.444 -1.707 . . . . 0.17000000000000001 111.42 -173.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.26 35.92 4.3 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.213 -0.994 . . . . 0.16 112.489 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.658 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.45 160.56 17.0 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.294 0.85 . . . . 0.12 113.294 -170.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.705 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.4 m80 -100.86 -26.21 13.84 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.121 -0.945 . . . . 0.20000000000000001 109.613 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.652 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 12.7 m-85 -135.49 -174.29 3.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.19 -0.914 . . . . 0.13 111.583 -174.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.692 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -136.57 140.02 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.094 -0.957 . . . . 0.080000000000000002 109.465 166.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 176' ' ' MET . 42.9 tp -109.61 100.73 9.73 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 119.61 -0.836 . . . . 0.16 109.144 165.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 142' ' ' LEU . 2.3 m-85 -80.53 112.48 17.92 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 114.464 -1.244 . . . . 0.26000000000000001 109.31 177.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.832 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.5 t -124.08 163.02 22.31 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 122.144 0.973 . . . . 1.05 111.335 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.83 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.1 p -164.65 173.71 11.62 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 114.037 -1.438 . . . . 0.10000000000000001 111.007 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -137.35 134.34 35.89 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 114.304 -1.316 . . . . 0.11 108.429 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -144.11 -176.19 4.91 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.305 -0.628 . . . . 1.0900000000000001 109.305 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.14 -83.91 0.92 Allowed Glycine 0 CA--C 1.491 -1.414 0 C-N-CA 119.567 -1.302 . . . . 0.14999999999999999 111.213 173.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.1 t30 -144.59 129.3 18.21 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-N 113.985 -1.108 . . . . 0.58999999999999997 108.149 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.559 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.6 p -63.65 -40.21 88.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.343 -0.844 . . . . 0.14999999999999999 112.168 -172.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -60.31 -32.1 70.9 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.982 0.896 . . . . 1.26 109.993 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.78 88.75 3.24 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 113.442 -1.708 . . . . 0.13 108.363 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 194' ' ' VAL . 45.9 Cg_endo -90.03 164.51 4.82 Favored 'Trans proline' 0 CA--C 1.49 -1.681 0 C-N-CA 124.028 3.152 . . . . 0.089999999999999997 114.626 -169.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.0 m -85.37 118.1 24.7 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 113.877 -1.51 . . . . 0.14000000000000001 107.586 167.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 164' ' ' SER . 42.7 tp -83.89 98.35 9.72 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 108.551 -0.907 . . . . 0.16 108.551 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.638 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 35.7 mt-30 -89.39 109.66 20.55 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-O 122.13 0.967 . . . . 0.34000000000000002 109.259 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.832 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.7 OUTLIER -113.37 163.66 14.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.736 -1.12 . . . . 1.0900000000000001 111.271 -173.859 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.61 ' HG2' HD12 ' A' ' 186' ' ' ILE . 37.6 tt0 -170.78 119.26 0.52 Allowed 'General case' 0 C--O 1.203 -1.349 0 CA-C-N 115.873 -0.603 . . . . 0.5 110.131 -166.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.142 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.94 102.01 12.94 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.716 -0.846 . . . . 0.10000000000000001 108.716 -172.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.668 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.9 ttp -91.71 122.95 34.73 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.656 -0.702 . . . . 0.070000000000000007 109.368 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -58.4 127.2 30.94 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.358 -1.349 . . . . 0.22 107.358 167.072 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.609 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.73 -34.22 11.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 119.151 -1.019 . . . . 0.11 110.758 178.415 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.468 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 27.6 mt-30 -62.94 -14.89 52.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.432 -0.804 . . . . 0.34999999999999998 111.379 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.2 p -130.64 -36.57 1.41 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.727 0.775 . . . . 0.19 110.365 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.479 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 86.05 32.51 17.28 Favored Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 114.319 -1.309 . . . . 0.17999999999999999 112.213 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.2 155.21 22.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.59 -0.305 . . . . 0.72999999999999998 110.4 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 177' ' ' GLN . 29.3 mm -88.23 119.13 35.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.967 -0.753 . . . . 0.14000000000000001 108.967 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.142 HD11 HD13 ' A' ' 178' ' ' LEU . 1.3 pp -107.12 -33.04 2.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.277 -0.874 . . . . 0.13 110.514 -174.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.657 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.8 t90 -133.53 151.52 51.75 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.438 -0.801 . . . . 0.070000000000000007 109.24 172.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 22.1 p -153.99 160.84 42.22 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.664 0.616 . . . . 0.13 112.664 165.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -157.81 -177.06 30.55 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.536 -1.025 . . . . 0.12 110.536 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.768 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 12.9 mtmt -157.43 150.37 23.36 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 105.508 -2.034 . . . . 1.22 105.508 167.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -157.96 126.9 1.79 Allowed Glycine 0 C--N 1.279 -2.598 0 C-N-CA 119.51 -1.329 . . . . 0.12 112.243 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.28 114.07 10.0 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.337 0.589 . . . . 0.17000000000000001 110.946 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.777 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -91.12 158.49 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 122.583 1.182 . . . . 0.11 110.125 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.662 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -98.8 172.16 7.63 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 112.69 -2.05 . . . . 0.17999999999999999 109.727 -173.37 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.9 tt0 -103.36 127.71 50.64 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.127 -0.694 . . . . 0.91000000000000003 109.127 167.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.55 ' HG2' ' C ' ' A' ' 62' ' ' TYR . 19.8 mm-40 . . . . . 0 C--N 1.306 -1.304 0 CA-C-N 115.513 -0.767 . . . . 1.24 110.585 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.752 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.7 m-30 . . . . . 0 N--CA 1.416 -2.128 0 N-CA-C 109.627 -0.509 . . . . 0.20999999999999999 109.627 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 2.1 t70 -79.66 68.02 5.59 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 123.785 1.755 . . . . 0.34999999999999998 108.167 170.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.716 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.9 m95 -60.08 -44.53 94.71 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 111.594 -2.548 . . . . 0.10000000000000001 112.199 174.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 2.6 t30 -50.03 -30.48 10.83 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.844 -1.525 . . . . 1.1100000000000001 111.607 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.65 -18.3 80.01 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-N 115.503 -0.772 . . . . 0.20999999999999999 111.266 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.58 -52.22 3.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.965 -1.118 . . . . 0.13 110.895 -175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.719 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.1 mtt -64.32 -58.49 6.36 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 114.136 -1.393 . . . . 0.089999999999999997 112.198 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.474 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.5 mm100 -40.11 -53.59 4.97 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 114.912 1.449 . . . . 0.63 114.912 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.811 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.1 Cg_endo -64.19 -30.79 64.75 Favored 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 122.164 1.91 . . . . 0.14000000000000001 110.654 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.769 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 9.3 mtm -80.97 -46.87 14.45 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 115.006 -0.997 . . . . 0.69999999999999996 111.7 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 68' ' ' MET . 57.5 t -54.6 -40.73 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 CA-C-N 114.091 -1.413 . . . . 0.12 108.841 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 t -58.97 -36.81 75.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.028 -1.896 . . . . 0.56000000000000005 110.909 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.811 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.9 mtpt -80.39 -34.1 36.6 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.091 0.472 . . . . 1.3 110.775 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.84 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.09 -29.56 70.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.305 -0.862 . . . . 0.5 111.685 -171.667 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.569 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.3 mt -91.79 -6.18 52.21 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.939 0.876 . . . . 0.65000000000000002 111.23 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.55 15.35 49.64 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 109.156 -1.578 . . . . 0.17000000000000001 109.156 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.616 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.48 165.48 18.06 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.42 -0.89 . . . . 0.10000000000000001 110.316 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -88.32 107.6 18.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.066 -0.97 . . . . 1.72 109.787 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.629 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 130.98 -22.88 4.46 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.991 -0.843 . . . . 0.12 110.991 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.84 HG11 ' O ' ' A' ' 75' ' ' MET . 10.1 p -99.27 152.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.861 0.838 . . . . 0.16 111.496 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -134.33 138.73 45.15 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.159 -1.382 . . . . 0.45000000000000001 109.835 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.59 ' HB2' ' HD2' ' A' ' 118' ' ' LYS . . . -65.3 137.82 57.8 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.871 -0.604 . . . . 0.28000000000000003 110.239 169.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.2 -1.41 54.39 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.799 -0.715 . . . . 0.28000000000000003 112.69 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.14 153.07 22.91 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.993 0.425 . . . . 1.2 110.972 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.658 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.0 p -81.86 116.43 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.122 0.963 . . . . 0.20000000000000001 109.221 166.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.722 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -103.93 109.67 21.52 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.964 -1.017 . . . . 0.14000000000000001 108.971 -173.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.673 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -71.76 94.29 1.37 Allowed 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 114.545 -1.207 . . . . 0.14999999999999999 107.932 176.804 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.499 HG11 ' HG3' ' A' ' 110' ' ' ARG . 1.7 m -73.12 117.71 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 N-CA-C 107.476 -1.305 . . . . 0.94999999999999996 107.476 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.831 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 8.7 t0 -77.52 156.41 31.0 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.659 -1.155 . . . . 0.64000000000000001 108.134 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.556 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.54 135.89 57.81 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.473 -1.306 . . . . 0.37 107.473 171.075 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.525 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 23.2 t -63.4 140.08 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.836 0 CA-C-N 114.783 -1.099 . . . . 0.10000000000000001 108.065 169.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.803 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.6 t-20 -85.56 163.22 18.5 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.248 -0.887 . . . . 0.17999999999999999 109.913 174.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.765 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.98 85.34 2.4 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.604 -1.18 . . . . 0.12 108.487 175.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -108.14 -1.98 19.86 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.969 -1.469 . . . . 0.64000000000000001 108.995 -172.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.719 HG21 ' HB3' ' A' ' 172' ' ' PRO . 24.5 p -52.0 -170.96 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 112.715 -2.039 . . . . 0.14000000000000001 114.975 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 32.7 t30 -72.48 -4.05 28.05 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 112.992 -1.913 . . . . 0.47999999999999998 110.558 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.615 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -157.42 -144.46 3.94 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.052 -1.071 . . . . 0.12 113.368 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.648 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 53.8 p -122.09 129.46 52.4 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 112.278 0.473 . . . . 1.1599999999999999 112.278 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.12 157.37 47.1 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 121.97 0.89 . . . . 0.10000000000000001 110.678 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.646 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.6 t-20 -80.48 79.99 7.0 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.053 -1.43 . . . . 0.17000000000000001 107.846 175.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.0 -14.2 62.66 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.479 -1.237 . . . . 0.089999999999999997 109.988 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.584 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.19 -32.17 44.04 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.721 -0.844 . . . . 0.14999999999999999 108.721 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.646 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.4 tp10 -66.63 -31.96 72.97 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 122.951 1.358 . . . . 1.73 109.064 172.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -73.75 -44.18 56.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.036 -1.893 . . . . 0.12 109.657 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.616 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 60.0 m -63.98 -31.6 72.84 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.986 -1.461 . . . . 0.11 110.626 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 1.5 pt-20 -66.97 -43.34 83.32 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.701 -1.222 . . . . 1.47 107.701 172.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.675 HG21 ' HB2' ' A' ' 64' ' ' TRP . 56.8 m -63.06 -30.46 71.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.234 -0.894 . . . . 0.12 110.672 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.719 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.74 -69.56 0.11 Allowed 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.205 -0.665 . . . . 0.56000000000000005 109.205 171.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.1 mtp180 -40.22 -38.22 0.74 Allowed 'General case' 0 C--N 1.313 -0.982 0 O-C-N 124.405 1.065 . . . . 1.51 111.29 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 108' ' ' THR . 5.0 m-20 -70.71 -47.51 59.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.517 -1.22 . . . . 0.28000000000000003 111.897 -176.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.4 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.15 -33.72 65.64 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.223 1.011 . . . . 0.089999999999999997 108.647 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.696 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -62.92 -34.65 77.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.416 -1.72 . . . . 0.12 109.976 172.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.615 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -74.78 -42.58 57.88 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 114.752 -1.113 . . . . 0.20000000000000001 111.097 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -63.2 -29.26 70.64 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.769 -1.105 . . . . 1.1699999999999999 110.43 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -82.26 -23.89 35.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.535 -0.757 . . . . 2.0499999999999998 110.159 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.71 4.28 57.51 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.975 -1.011 . . . . 0.54000000000000004 114.927 159.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.59 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 13.5 mtmm -91.18 -34.27 15.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.279 0.539 . . . . 0.98999999999999999 111.156 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.722 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 14.6 m-85 -89.44 175.56 7.26 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 122.355 1.074 . . . . 0.20999999999999999 112.458 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.5 m -118.92 121.13 39.25 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 113.012 -1.904 . . . . 0.23000000000000001 108.289 169.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.674 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -91.72 141.76 28.34 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 119.389 -0.924 . . . . 0.38 111.159 -170.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 88' ' ' LEU . 1.3 m . . . . . 0 C--N 1.299 -1.592 0 N-CA-C 107.892 -1.151 . . . . 0.41999999999999998 107.892 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.639 HD13 HD21 ' A' ' 88' ' ' LEU . 31.2 tp . . . . . 0 C--O 1.219 -0.524 0 N-CA-C 113.271 0.841 . . . . 1.3899999999999999 113.271 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.644 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 3.0 t -50.31 -46.26 55.33 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 123.365 1.555 . . . . 1.05 109.105 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.743 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 17.2 mmt -54.31 -63.36 1.17 Allowed 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 110.745 -2.934 . . . . 1.6399999999999999 110.706 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.77 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.91 -46.47 5.37 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.346 1.029 . . . . 0.31 112.15 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.523 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -54.45 -52.35 62.1 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 108.744 -0.836 . . . . 1.53 108.744 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 128' ' ' SER . 37.8 mt-30 -65.18 -39.88 93.49 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.402 -0.817 . . . . 0.40999999999999998 111.034 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.743 ' HG3' ' O ' ' A' ' 129' ' ' MET . 52.1 mt-30 -58.72 -34.74 71.69 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.516 -1.22 . . . . 0.37 109.568 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.495 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -90.21 -28.94 18.53 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 113.942 -1.481 . . . . 0.23999999999999999 109.733 -176.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.96 -45.06 0.69 Allowed Glycine 0 CA--C 1.494 -1.263 0 CA-C-O 122.534 1.075 . . . . 0.33000000000000002 113.094 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 141' ' ' SER . 91.3 mt -66.93 -171.44 0.14 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 112.416 -1.892 . . . . 0.31 115.43 -170.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 63.1 m -115.55 152.9 47.64 Favored Pre-proline 0 N--CA 1.425 -1.684 0 CA-C-N 110.641 -2.982 . . . . 0.81000000000000005 107.661 175.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.644 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 36.9 Cg_endo -66.26 0.44 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.49 2.127 . . . . 0.32000000000000001 112.138 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.584 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.6 tt0 -118.65 -27.06 5.97 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.997 0.903 . . . . 1.25 110.418 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 141' ' ' SER . 15.0 t70 -57.87 -25.89 61.36 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-N 113.207 -1.815 . . . . 0.65000000000000002 109.35 -173.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 21.3 m 73.52 168.95 0.31 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 112.668 -2.06 . . . . 0.59999999999999998 109.186 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.996 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.5 mt -66.03 -40.12 90.75 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.24 1.019 . . . . 0.85999999999999999 108.386 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 64.81 -9.18 0.45 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 112.95 -1.932 . . . . 0.31 114.332 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.56 124.64 6.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.065 -0.717 . . . . 0.23999999999999999 109.065 -175.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.687 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.4 mmt180 -42.27 -45.31 4.14 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 118.072 0.396 . . . . 1.6499999999999999 112.001 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.8 t -74.13 -25.77 59.95 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.601 0.715 . . . . 0.53000000000000003 111.255 -174.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -73.64 -29.6 62.44 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.625 1.203 . . . . 1.3100000000000001 108.421 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.996 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -76.27 -47.79 22.54 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 112.403 -2.18 . . . . 0.12 110.223 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.649 HG13 ' HE1' ' A' ' 179' ' ' MET . 42.1 mt -65.39 -41.52 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 112.794 -2.003 . . . . 0.11 109.865 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.59 -54.56 27.03 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 114.864 -1.062 . . . . 0.14999999999999999 111.082 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.77 HG23 ' CB ' ' A' ' 130' ' ' ALA . 89.9 mt -66.85 -48.14 80.65 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 N-CA-C 112.5 0.556 . . . . 0.17999999999999999 112.5 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.673 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.22 -41.01 71.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.939 0.399 . . . . 0.13 111.099 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.556 ' HD2' HG23 ' A' ' 149' ' ' ILE . 58.3 mtp180 -81.84 -21.51 37.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.614 0.721 . . . . 1.0800000000000001 110.618 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -84.76 -11.44 55.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.314 -1.365 . . . . 0.5 107.314 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.721 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.07 -29.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-N 113.184 -1.826 . . . . 0.17000000000000001 110.932 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.7 34.17 5.05 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.267 -0.968 . . . . 0.16 112.424 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.6 161.45 14.85 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.873 0.694 . . . . 0.12 112.873 -170.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.658 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.0 m80 -100.87 -27.72 13.17 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.24 -0.891 . . . . 0.20000000000000001 109.796 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.622 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 7.5 m-85 -136.15 -174.26 3.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.187 -0.915 . . . . 0.13 111.318 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.711 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -137.06 139.2 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.939 -1.028 . . . . 0.080000000000000002 108.883 166.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.607 HD21 ' SD ' ' A' ' 176' ' ' MET . 33.9 tp -107.98 100.57 9.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.318 -0.953 . . . . 0.16 109.351 165.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.574 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.2 m-85 -79.8 112.94 17.56 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 114.606 -1.179 . . . . 0.26000000000000001 108.897 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.845 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 10.2 t -124.45 160.58 27.9 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 121.922 0.867 . . . . 1.05 110.564 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.817 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.4 p -162.73 172.96 14.47 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 114.334 -1.303 . . . . 0.10000000000000001 111.076 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.32 135.33 40.7 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 114.005 -1.452 . . . . 0.11 108.633 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.668 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.8 m -144.09 -176.12 4.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.254 -0.647 . . . . 1.0900000000000001 109.254 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.11 -84.08 0.92 Allowed Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 119.768 -1.206 . . . . 0.14999999999999999 111.416 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.4 t30 -143.74 131.47 21.35 Favored 'General case' 0 C--O 1.196 -1.762 0 N-CA-C 107.821 -1.178 . . . . 0.58999999999999997 107.821 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.615 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.6 p -65.57 -41.34 90.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.14 -0.936 . . . . 0.14999999999999999 112.426 -171.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.404 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.3 m-20 -60.99 -31.15 70.77 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.732 0.777 . . . . 1.26 109.478 -177.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.23 89.07 3.37 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 113.874 -1.512 . . . . 0.13 108.16 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.86 ' HD2' HG22 ' A' ' 194' ' ' VAL . 42.6 Cg_endo -91.36 166.61 3.53 Favored 'Trans proline' 0 CA--C 1.494 -1.48 0 C-N-CA 124.551 3.501 . . . . 0.089999999999999997 114.846 -170.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.58 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.3 m -85.76 119.6 26.26 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 113.745 -1.57 . . . . 0.14000000000000001 107.551 166.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 164' ' ' SER . 50.4 tp -84.56 97.74 9.75 Favored 'General case' 0 N--CA 1.412 -2.326 0 C-N-CA 119.492 -0.883 . . . . 0.16 108.709 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.602 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 34.1 mt-30 -89.26 109.33 20.23 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 122.052 0.929 . . . . 0.34000000000000002 109.053 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.845 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.7 OUTLIER -112.87 164.17 13.74 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.004 -0.998 . . . . 1.0900000000000001 111.638 -173.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.609 ' HG2' HD12 ' A' ' 186' ' ' ILE . 9.3 tt0 -170.78 118.22 0.5 Allowed 'General case' 0 C--O 1.201 -1.476 0 CA-C-N 115.972 -0.558 . . . . 0.5 110.236 -166.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.104 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.19 101.99 13.16 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.609 -0.885 . . . . 0.10000000000000001 108.609 -172.801 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.687 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.5 ttp -90.43 121.62 32.57 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.462 -0.79 . . . . 0.070000000000000007 109.504 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.424 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.91 127.97 34.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.149 -1.426 . . . . 0.22 107.149 166.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -83.69 -34.18 10.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 118.912 -1.115 . . . . 0.11 110.965 178.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.462 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 28.7 mt-30 -61.6 -15.57 40.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.372 -0.831 . . . . 0.34999999999999998 111.424 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.8 p -130.2 -36.61 1.5 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.745 0.783 . . . . 0.19 110.294 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.51 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 87.59 27.91 25.79 Favored Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 114.316 -1.311 . . . . 0.17999999999999999 112.003 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.81 155.91 19.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.648 0.261 . . . . 0.72999999999999998 110.52 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.609 HD12 ' HG2' ' A' ' 177' ' ' GLN . 30.3 mm -89.85 115.64 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.502 0.668 . . . . 0.14000000000000001 109.494 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.104 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -103.1 -32.3 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.903 -1.044 . . . . 0.13 110.54 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.8 t90 -134.81 152.02 51.41 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.245 -0.889 . . . . 0.070000000000000007 109.403 173.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 30.0 p -153.57 162.78 40.94 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.881 0.697 . . . . 0.13 112.881 164.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.51 -173.64 27.18 Favored Glycine 0 N--CA 1.427 -1.94 0 N-CA-C 110.721 -0.951 . . . . 0.12 110.721 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 15.1 mtmm -158.93 154.08 25.33 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.273 -2.121 . . . . 1.22 105.273 166.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -161.22 127.79 1.81 Allowed Glycine 0 C--N 1.281 -2.484 0 C-N-CA 119.245 -1.455 . . . . 0.12 112.568 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 173' ' ' THR . . . -72.55 112.6 8.75 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.72 0.771 . . . . 0.17000000000000001 111.329 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.86 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -91.77 158.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-O 122.758 1.266 . . . . 0.11 110.816 -176.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.752 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.2 173.43 6.46 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 112.352 -2.203 . . . . 0.17999999999999999 108.652 -173.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.1 tt0 -102.34 133.78 46.71 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.14 -0.624 . . . . 0.91000000000000003 109.758 171.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.517 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 12.3 mm-40 . . . . . 0 C--N 1.315 -0.933 0 CA-C-O 118.804 -0.617 . . . . 1.24 110.906 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.718 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 3.5 m-30 . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 110.633 -0.136 . . . . 0.20999999999999999 110.633 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.567 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 4.4 t0 -82.74 68.15 9.1 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 123.756 1.741 . . . . 0.34999999999999998 108.404 171.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.773 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.4 m95 -59.75 -42.94 94.35 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 111.511 -2.586 . . . . 0.10000000000000001 112.288 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.428 ' N ' HG21 ' A' ' 108' ' ' THR . 4.0 t-20 -52.77 -31.79 40.21 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.609 -1.632 . . . . 1.1100000000000001 111.077 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.64 -15.88 78.69 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 121.781 0.656 . . . . 0.20999999999999999 111.67 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -94.5 -48.55 6.06 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.18 -1.01 . . . . 0.13 110.15 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.721 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.4 mtt -66.43 -55.64 14.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.134 -1.394 . . . . 0.089999999999999997 111.715 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.416 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.9 mm100 -38.81 -56.01 2.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 115.233 1.568 . . . . 0.63 115.233 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.818 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 40.3 Cg_endo -65.37 -29.37 54.17 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 121.728 1.619 . . . . 0.14000000000000001 110.418 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.648 ' HE2' ' N ' ' A' ' 192' ' ' GLY . 9.6 mtm -83.65 -40.23 19.23 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.312 -0.858 . . . . 0.69999999999999996 111.446 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 68' ' ' MET . 52.4 t -57.46 -39.91 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-N 114.85 -1.068 . . . . 0.12 108.339 171.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -61.17 -32.76 72.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.238 -1.801 . . . . 0.56000000000000005 111.19 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.818 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 34.2 mtpt -84.66 -32.2 23.76 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.086 0.47 . . . . 1.3 110.891 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.885 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.23 -29.77 69.51 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.332 -0.849 . . . . 0.5 111.413 -172.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.3 mt -92.07 -4.14 54.81 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 122.26 1.028 . . . . 0.65000000000000002 110.644 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.23 17.64 40.38 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 108.984 -1.646 . . . . 0.17000000000000001 108.984 170.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.625 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -88.04 161.8 17.16 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.693 -0.754 . . . . 0.10000000000000001 110.282 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.94 107.92 18.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.384 -0.825 . . . . 1.72 109.432 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.664 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.58 -24.66 3.33 Favored Glycine 0 N--CA 1.415 -2.716 0 C-N-CA 119.739 -1.219 . . . . 0.12 110.466 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.885 HG11 ' O ' ' A' ' 75' ' ' MET . 11.1 p -102.66 152.32 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.675 -0.762 . . . . 0.16 111.068 -175.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.3 m -135.82 139.64 43.62 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.922 -1.036 . . . . 0.45000000000000001 110.697 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.632 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.08 136.01 48.52 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.033 -0.985 . . . . 0.28000000000000003 110.414 167.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.04 3.95 55.6 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.903 -0.665 . . . . 0.28000000000000003 112.936 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.94 149.24 22.68 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.168 -0.613 . . . . 1.2 111.002 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -80.41 120.58 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 CA-C-O 121.933 0.873 . . . . 0.20000000000000001 108.802 165.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.875 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.7 tm? -108.77 111.58 23.41 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.416 -0.811 . . . . 0.14000000000000001 109.047 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.695 HD23 HG11 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -72.19 93.72 1.48 Allowed 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.833 -1.076 . . . . 0.14999999999999999 108.158 177.362 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.481 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.2 m -73.5 115.79 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 107.061 -1.459 . . . . 0.94999999999999996 107.061 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.768 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 16.7 t0 -77.57 170.62 16.25 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-N 115.063 -0.971 . . . . 0.64000000000000001 108.905 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.567 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.8 OUTLIER -61.77 152.59 30.92 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.93 -1.137 . . . . 0.37 107.93 168.038 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.536 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 38.6 t -81.95 140.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.151 0 N-CA-C 107.024 -1.473 . . . . 0.10000000000000001 107.024 167.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.831 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.7 t-20 -84.01 162.5 20.37 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.967 0.889 . . . . 0.17999999999999999 110.307 174.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.757 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -124.81 85.9 2.48 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.229 -1.35 . . . . 0.12 108.087 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 14.1 mtp180 -108.74 -0.95 19.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.077 -1.42 . . . . 0.64000000000000001 108.758 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 172' ' ' PRO . 30.2 p -53.21 -172.62 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.026 -1.897 . . . . 0.14000000000000001 115.348 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 34.2 t30 -68.37 -13.54 62.35 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 112.637 -2.074 . . . . 0.47999999999999998 110.522 173.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.549 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -148.16 -145.93 4.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.387 -0.911 . . . . 0.12 113.004 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.603 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 19.2 m -121.27 129.6 53.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.959 0.409 . . . . 1.1599999999999999 110.825 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.757 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.6 pp -135.18 157.63 46.43 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.921 0.867 . . . . 0.10000000000000001 110.627 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.777 ' ND2' ' HB2' ' A' ' 104' ' ' GLU . 57.9 t30 -81.57 81.46 7.64 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.954 -1.476 . . . . 0.17000000000000001 107.713 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.619 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -69.72 -14.77 62.96 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 114.278 -1.328 . . . . 0.089999999999999997 109.912 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.59 -29.8 46.32 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.734 -0.839 . . . . 0.14999999999999999 108.734 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.777 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 15.6 tp10 -67.91 -32.39 72.82 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 123.123 1.44 . . . . 1.73 109.15 170.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.5 -44.75 61.82 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.999 -1.91 . . . . 0.12 109.233 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.9 m -63.92 -34.3 77.65 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.936 -1.484 . . . . 0.11 111.104 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 13.1 pt-20 -68.0 -42.83 80.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 118.368 -1.333 . . . . 1.47 107.651 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.654 HG21 ' HB2' ' A' ' 64' ' ' TRP . 58.7 m -61.5 -29.09 69.76 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.226 -0.897 . . . . 0.12 111.176 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.721 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.3 mt -53.69 -68.12 0.2 Allowed 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 115.794 -0.639 . . . . 0.56000000000000005 109.471 170.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.581 ' O ' HD13 ' A' ' 121' ' ' LEU . 14.2 mtp180 -40.26 -38.08 0.73 Allowed 'General case' 0 C--N 1.31 -1.116 0 O-C-N 124.413 1.071 . . . . 1.51 111.395 174.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 108' ' ' THR . 16.1 m-80 -68.36 -47.41 67.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.675 -1.148 . . . . 0.28000000000000003 112.4 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.93 -35.79 59.62 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.364 -0.976 . . . . 0.089999999999999997 108.364 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -58.96 -35.67 73.55 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.61 -1.632 . . . . 0.12 109.784 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -69.46 -41.96 75.51 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.297 -1.32 . . . . 0.20000000000000001 111.294 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -65.21 -27.21 68.52 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.99 -1.005 . . . . 1.1699999999999999 111.224 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -86.86 -16.73 35.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.967 -0.56 . . . . 2.0499999999999998 111.237 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.91 -12.32 0.83 Allowed Glycine 0 C--N 1.334 0.427 0 N-CA-C 115.896 1.118 . . . . 0.54000000000000004 115.896 162.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 54.4 mtpt -73.28 -33.47 65.25 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 117.579 0.689 . . . . 0.98999999999999999 110.783 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.875 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 23.4 m-85 -90.4 177.43 6.39 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.54 1.162 . . . . 0.20999999999999999 112.677 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 5.4 m -121.92 119.96 33.06 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 112.651 -2.068 . . . . 0.23000000000000001 108.069 168.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.633 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -89.4 140.74 29.21 Favored 'General case' 0 N--CA 1.414 -2.235 0 C-N-CA 119.337 -0.945 . . . . 0.38 111.774 -169.892 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.536 HG21 HD23 ' A' ' 88' ' ' LEU . 1.5 m . . . . . 0 C--N 1.298 -1.659 0 N-CA-C 107.605 -1.258 . . . . 0.41999999999999998 107.605 167.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.612 HD23 HD21 ' A' ' 88' ' ' LEU . 1.4 tm? . . . . . 0 C--O 1.223 -0.335 0 N-CA-C 112.572 0.582 . . . . 1.3899999999999999 112.572 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.697 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.2 t -49.31 -39.05 29.79 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 123.573 1.654 . . . . 1.05 109.047 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.657 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 24.2 mmm -64.46 -62.07 1.82 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 110.72 -2.945 . . . . 1.6399999999999999 110.656 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.753 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.28 -43.48 7.4 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 124.106 0.878 . . . . 0.31 112.326 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.815 ' HZ1' HD23 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -51.28 -55.5 17.92 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.293 -1.003 . . . . 1.53 108.293 176.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.3 mt-30 -65.33 -41.28 94.11 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 123.951 0.782 . . . . 0.40999999999999998 111.42 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.657 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.3 mt-30 -56.26 -34.25 66.23 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.391 -1.277 . . . . 0.37 109.616 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -92.87 -31.19 15.06 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.905 -1.498 . . . . 0.23999999999999999 109.561 -177.678 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.06 -52.13 0.4 Allowed Glycine 0 CA--C 1.497 -1.091 0 CA-C-O 122.594 1.108 . . . . 0.33000000000000002 113.45 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 141' ' ' SER . 70.7 mt -63.51 -171.75 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 112.352 -1.924 . . . . 0.31 115.717 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 139' ' ' GLN . 6.3 m -116.14 152.29 47.62 Favored Pre-proline 0 N--CA 1.427 -1.621 0 CA-C-N 110.765 -2.925 . . . . 0.81000000000000005 107.931 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.697 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 30.3 Cg_endo -65.44 2.67 1.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.751 2.301 . . . . 0.32000000000000001 111.146 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.539 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.7 mm100 -115.17 -19.91 10.63 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 114.098 -1.41 . . . . 1.25 110.091 -174.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.694 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.7 t70 -80.63 -27.72 37.17 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 114.336 -1.302 . . . . 0.65000000000000002 109.839 -169.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.721 ' O ' HD13 ' A' ' 136' ' ' LEU . 4.0 m 76.02 175.23 0.22 Allowed 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 125.33 1.644 . . . . 0.59999999999999998 109.053 -168.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.998 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.5 mt -69.41 -39.13 78.11 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.368 1.08 . . . . 0.85999999999999999 108.701 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.18 -12.03 0.29 Allowed Glycine 0 C--N 1.317 -0.488 0 CA-C-N 112.96 -1.927 . . . . 0.31 114.809 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.54 125.78 8.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 117.548 0.674 . . . . 0.23999999999999999 109.324 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.4 mmt180 -41.45 -48.11 3.77 Favored 'General case' 0 C--O 1.213 -0.842 0 O-C-N 123.378 0.424 . . . . 1.6499999999999999 111.868 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.5 t -72.05 -27.5 62.73 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.58 0.705 . . . . 0.53000000000000003 111.296 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -73.06 -28.25 62.21 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.632 1.206 . . . . 1.3100000000000001 108.587 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.998 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -77.49 -46.0 23.85 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 112.293 -2.23 . . . . 0.12 110.304 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.649 HG13 ' HE1' ' A' ' 179' ' ' MET . 35.4 mt -67.33 -42.43 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-N 113.069 -1.878 . . . . 0.11 110.237 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.47 -53.59 31.27 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.955 -1.021 . . . . 0.14999999999999999 111.072 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.753 HG23 ' CB ' ' A' ' 130' ' ' ALA . 70.2 mt -66.32 -47.53 83.93 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 112.747 0.647 . . . . 0.17999999999999999 112.747 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.01 -39.98 72.7 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.017 0.437 . . . . 0.13 110.767 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -81.56 -23.01 37.45 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.676 0.751 . . . . 1.0800000000000001 110.635 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -82.18 -12.72 57.97 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.332 -1.358 . . . . 0.5 107.332 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.717 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.73 -28.53 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 113.245 -1.798 . . . . 0.17000000000000001 110.838 -174.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.67 35.45 4.89 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.35 -0.929 . . . . 0.16 112.282 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.76 156.38 21.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 113.27 0.841 . . . . 0.12 113.27 -170.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.671 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.9 m80 -95.3 -27.87 15.26 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.194 -0.912 . . . . 0.20000000000000001 109.807 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.557 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 9.2 m-85 -136.38 -179.1 5.47 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.476 -0.784 . . . . 0.13 111.049 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.697 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -131.97 140.75 47.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.438 -0.801 . . . . 0.080000000000000002 109.232 167.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 38.2 tp -110.4 101.06 9.81 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.708 -0.797 . . . . 0.16 108.946 164.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.679 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.23 116.72 19.67 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.21 -1.359 . . . . 0.26000000000000001 108.269 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.677 ' OG ' HD11 ' A' ' 174' ' ' LEU . 27.6 t -126.68 163.44 23.49 Favored 'General case' 0 C--N 1.279 -2.493 0 C-N-CA 119.495 -0.882 . . . . 1.05 111.015 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.848 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.9 p -164.23 178.27 7.7 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 114.264 -1.334 . . . . 0.10000000000000001 111.065 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -141.91 141.34 32.99 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 114.155 -1.384 . . . . 0.11 108.673 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 t -149.44 -171.35 3.87 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.208 -0.597 . . . . 1.0900000000000001 110.115 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.66 -80.69 1.25 Allowed Glycine 0 C--N 1.288 -2.138 0 CA-C-N 115.179 -0.919 . . . . 0.14999999999999999 111.567 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 59.1 t30 -145.58 127.5 15.46 Favored 'General case' 0 C--O 1.195 -1.767 0 N-CA-C 108.108 -1.071 . . . . 0.58999999999999997 108.108 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.549 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.4 p -61.76 -43.9 97.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.14 -0.936 . . . . 0.14999999999999999 113.008 -172.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -61.48 -29.71 70.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.49 0.662 . . . . 1.26 109.635 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.44 88.16 3.73 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 114.588 -1.187 . . . . 0.13 108.021 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.818 ' HD2' HG22 ' A' ' 194' ' ' VAL . 51.3 Cg_endo -91.29 163.56 3.69 Favored 'Trans proline' 0 CA--C 1.49 -1.697 0 C-N-CA 124.596 3.531 . . . . 0.089999999999999997 114.731 -170.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' ' 191' ' ' LYS . 18.8 m -81.77 117.17 21.86 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 113.854 -1.521 . . . . 0.14000000000000001 107.693 166.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 164' ' ' SER . 38.8 tp -83.73 98.94 9.95 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-O 121.885 0.85 . . . . 0.16 109.126 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.647 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.0 mt-30 -89.09 107.81 19.25 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.909 -1.041 . . . . 0.34000000000000002 109.048 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 34.7 mtp -108.25 162.84 13.71 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.848 -1.069 . . . . 1.0900000000000001 110.203 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.618 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.8 tt0 -169.49 119.99 0.68 Allowed 'General case' 0 C--O 1.204 -1.315 0 CA-C-O 121.377 0.608 . . . . 0.5 109.908 -167.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.119 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.44 102.38 13.17 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.934 -0.765 . . . . 0.10000000000000001 108.934 -172.202 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.704 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.1 ttp -92.48 122.91 35.38 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.533 -0.758 . . . . 0.070000000000000007 109.402 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.435 HD22 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -58.83 127.46 32.29 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.161 -1.422 . . . . 0.22 107.161 166.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.2 -33.63 11.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 119.35 0.977 . . . . 0.11 110.718 178.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.424 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.9 mt-30 -64.25 -14.77 57.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.291 -0.868 . . . . 0.34999999999999998 111.498 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 76.9 p -130.52 -36.96 1.41 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.766 0.794 . . . . 0.19 110.251 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.538 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.36 24.09 29.82 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.481 -1.236 . . . . 0.17999999999999999 112.496 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.92 155.61 18.5 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.684 0.278 . . . . 0.72999999999999998 110.682 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 177' ' ' GLN . 34.2 mm -87.95 119.25 35.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.433 0.635 . . . . 0.14000000000000001 109.507 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.119 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -108.28 -30.56 2.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.966 -1.016 . . . . 0.13 110.536 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.625 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.1 t90 -135.38 151.83 50.84 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 115.206 -0.906 . . . . 0.070000000000000007 109.351 171.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 57.0 p -154.06 161.85 41.62 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.768 0.655 . . . . 0.13 112.768 163.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -156.68 -178.91 31.25 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 110.68 -0.968 . . . . 0.12 110.68 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.741 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.7 mtmt -156.75 148.38 22.56 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.326 -1.731 . . . . 1.22 106.326 167.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.648 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -159.33 127.29 1.8 Allowed Glycine 0 C--N 1.282 -2.42 0 C-N-CA 119.907 -1.14 . . . . 0.12 112.542 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.83 113.05 9.43 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.543 0.687 . . . . 0.17000000000000001 111.455 -173.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.818 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -88.38 159.18 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.518 1.151 . . . . 0.11 110.298 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.683 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -98.86 172.84 7.18 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 112.781 -2.009 . . . . 0.17999999999999999 109.132 -172.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -102.85 127.65 49.95 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.873 -0.417 . . . . 0.91000000000000003 109.873 169.799 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.544 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 17.9 mm-40 . . . . . 0 C--N 1.313 -1.017 0 CA-C-O 118.524 -0.75 . . . . 1.24 110.838 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.759 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.2 m-30 . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 109.565 -0.532 . . . . 0.20999999999999999 109.565 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.556 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 5.0 t70 -80.91 67.0 6.65 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 123.707 1.718 . . . . 0.34999999999999998 108.065 172.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.737 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 90.0 m95 -56.94 -44.45 82.53 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 111.591 -2.55 . . . . 0.10000000000000001 112.389 175.032 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 3.8 t30 -51.05 -30.72 16.46 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.832 -1.531 . . . . 1.1100000000000001 111.687 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.81 -15.38 81.36 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-O 121.868 0.704 . . . . 0.20999999999999999 111.469 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.86 -52.06 3.4 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.076 -1.062 . . . . 0.13 110.782 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.726 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.7 mtt -64.13 -58.06 7.73 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 114.127 -1.397 . . . . 0.089999999999999997 111.952 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.463 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.7 mm100 -39.52 -54.66 3.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 114.856 1.428 . . . . 0.63 114.856 -176.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.634 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.1 Cg_endo -64.45 -28.78 62.35 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.004 1.802 . . . . 0.14000000000000001 110.667 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.849 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 6.4 mtm -82.4 -46.26 13.77 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 114.874 -1.057 . . . . 0.69999999999999996 111.902 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 68' ' ' MET . 57.7 t -54.34 -40.29 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-N 114.031 -1.44 . . . . 0.12 108.633 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -59.28 -37.72 78.35 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.167 -1.833 . . . . 0.56000000000000005 110.798 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.634 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 25.1 mtmt -77.08 -36.06 56.08 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 120.821 0.343 . . . . 1.3 111.649 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.811 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.0 -29.33 70.49 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.715 -0.675 . . . . 0.5 111.557 -170.594 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.632 HD22 ' HE2' ' A' ' 118' ' ' LYS . 5.2 mt -93.14 -6.78 47.14 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.102 0.953 . . . . 0.65000000000000002 111.012 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.49 17.79 46.02 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.02 -1.632 . . . . 0.17000000000000001 109.02 171.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.59 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -87.02 162.08 17.82 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.626 -0.787 . . . . 0.10000000000000001 110.355 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.54 108.04 17.76 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.057 -0.974 . . . . 1.72 109.235 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.633 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 131.04 -21.2 4.67 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.699 -1.239 . . . . 0.12 110.955 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.811 HG11 ' O ' ' A' ' 75' ' ' MET . 14.8 p -101.75 152.78 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.77 -0.715 . . . . 0.16 110.887 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 83' ' ' ALA . 26.5 m -135.75 140.28 44.22 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.011 -0.995 . . . . 0.45000000000000001 110.625 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.543 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -58.59 140.13 54.82 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.123 -0.944 . . . . 0.28000000000000003 110.484 167.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.3 10.08 54.61 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.88 -0.676 . . . . 0.28000000000000003 112.753 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.9 149.65 21.31 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 120.569 -0.452 . . . . 1.2 110.689 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.673 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.6 p -79.09 114.75 20.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-O 122.218 1.008 . . . . 0.20000000000000001 109.304 164.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.672 ' HG ' ' CE2' ' A' ' 119' ' ' PHE . 2.6 tm? -102.9 106.99 17.66 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.965 -1.016 . . . . 0.14000000000000001 109.065 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.666 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.7 OUTLIER -71.88 96.76 1.72 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 114.226 -1.352 . . . . 0.14999999999999999 108.039 176.537 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.936 ' O ' HD11 ' A' ' 127' ' ' LEU . 1.1 m -71.66 118.06 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.158 -1.423 . . . . 0.94999999999999996 107.158 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.852 ' HB2' HD11 ' A' ' 142' ' ' LEU . 1.1 t70 -76.65 146.1 38.37 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.656 -1.239 . . . . 0.64000000000000001 107.656 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.574 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.1 m -50.97 132.38 27.2 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.582 -1.266 . . . . 0.37 107.582 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.524 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 22.7 t -60.66 138.35 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.959 0 N-CA-C 107.79 -1.189 . . . . 0.10000000000000001 107.79 171.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.777 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.6 t-20 -83.51 162.03 21.04 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.202 -0.908 . . . . 0.17999999999999999 109.589 174.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.746 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.99 86.01 2.49 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.54 -1.209 . . . . 0.12 107.861 175.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 9.7 mtp180 -108.61 -3.71 17.74 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.847 -1.524 . . . . 0.64000000000000001 108.893 -172.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.6 p -49.99 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.067 -1.878 . . . . 0.14000000000000001 114.36 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.5 OUTLIER -76.53 -3.8 39.37 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.309 -1.769 . . . . 0.47999999999999998 110.36 174.637 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.614 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -146.54 -153.07 5.79 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.692 -0.685 . . . . 0.12 112.634 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.548 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 50.7 m -121.31 130.32 53.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 1.1599999999999999 111.457 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.746 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.9 pp -134.01 157.44 46.08 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.824 0.821 . . . . 0.10000000000000001 110.746 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.636 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -80.75 80.06 7.29 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.162 -1.381 . . . . 0.17000000000000001 107.803 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.14 -15.0 63.44 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.481 -1.236 . . . . 0.089999999999999997 110.167 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.64 -29.65 41.06 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.576 -0.898 . . . . 0.14999999999999999 108.576 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.636 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 16.1 tp10 -67.67 -33.38 74.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.283 -1.326 . . . . 1.73 109.143 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.74 -43.5 62.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.24 -1.8 . . . . 0.12 109.505 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.64 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.3 m -63.41 -30.52 71.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.838 -1.528 . . . . 0.11 110.564 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 2.0 pt-20 -69.43 -42.97 74.3 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.849 -1.167 . . . . 1.47 107.849 173.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 64' ' ' TRP . 85.2 m -62.58 -29.96 70.97 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.241 -0.891 . . . . 0.12 110.465 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.726 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.5 mt -51.98 -70.27 0.09 Allowed 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 109.13 -0.693 . . . . 0.56000000000000005 109.13 170.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 121' ' ' LEU . 19.0 mtp180 -40.21 -38.66 0.8 Allowed 'General case' 0 C--N 1.312 -1.032 0 O-C-N 124.465 1.103 . . . . 1.51 111.413 175.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 108' ' ' THR . 4.0 m-20 -70.27 -46.07 65.09 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.754 -1.112 . . . . 0.28000000000000003 112.244 -176.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.05 -33.06 65.46 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.2 1.0 . . . . 0.089999999999999997 108.437 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.713 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -64.5 -33.88 76.92 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 113.413 -1.721 . . . . 0.12 110.194 173.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.522 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -70.49 -37.16 74.18 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.789 -1.096 . . . . 0.20000000000000001 111.164 -175.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -57.48 -31.87 66.42 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.629 -1.169 . . . . 1.1699999999999999 110.997 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.479 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -77.03 -36.12 56.39 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.681 -1.145 . . . . 2.0499999999999998 110.211 -177.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.53 -4.56 8.92 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.313 -0.47 . . . . 0.54000000000000004 113.93 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HE2' HD22 ' A' ' 76' ' ' LEU . 11.7 ptmt -83.93 -30.27 26.44 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 122.328 -0.513 . . . . 0.98999999999999999 111.462 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.672 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 4.1 m-85 -89.39 168.74 11.98 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.708 0.766 . . . . 0.20999999999999999 111.285 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.586 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.1 m -116.5 121.18 41.06 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 114.063 -1.426 . . . . 0.23000000000000001 108.154 171.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.613 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -91.01 139.47 30.74 Favored 'General case' 0 N--CA 1.416 -2.151 0 C-N-CA 119.307 -0.957 . . . . 0.38 110.647 -171.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.562 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.9 m . . . . . 0 C--N 1.3 -1.576 0 N-CA-C 107.919 -1.141 . . . . 0.41999999999999998 107.919 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.936 HD11 ' O ' ' A' ' 89' ' ' VAL . 6.2 tt . . . . . 0 CA--C 1.516 -0.353 0 N-CA-C 113.349 0.87 . . . . 1.3899999999999999 113.349 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.598 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 15.4 m -57.16 -35.75 69.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 123.245 1.498 . . . . 1.05 108.786 -175.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.621 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -59.47 -60.34 4.01 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 111.811 -2.449 . . . . 1.6399999999999999 112.205 173.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.763 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.95 -44.02 4.42 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 124.308 1.043 . . . . 0.31 112.23 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.541 ' HZ3' ' N ' ' A' ' 142' ' ' LEU . 3.4 mttt -52.59 -54.7 29.4 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.172 -0.677 . . . . 1.53 109.172 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -62.81 -41.75 99.43 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.398 -0.819 . . . . 0.40999999999999998 111.0 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 129' ' ' MET . 47.6 mt-30 -57.06 -35.02 68.86 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 114.215 -1.357 . . . . 0.37 109.668 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.492 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.46 -30.39 16.49 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.95 -1.477 . . . . 0.23999999999999999 109.738 -176.792 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.42 -46.57 0.56 Allowed Glycine 0 CA--C 1.494 -1.224 0 C-N-CA 119.845 -1.169 . . . . 0.33000000000000002 113.569 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 141' ' ' SER . 98.3 mt -65.92 -169.64 0.07 Allowed 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 112.437 -1.882 . . . . 0.31 115.395 -170.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 6.7 m -114.76 149.32 42.17 Favored Pre-proline 0 N--CA 1.416 -2.153 0 CA-C-N 110.49 -3.05 . . . . 0.81000000000000005 107.676 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 59.0 Cg_endo -66.28 0.57 3.21 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 122.774 2.316 . . . . 0.32000000000000001 112.285 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -118.23 -26.52 6.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.825 0.821 . . . . 1.25 110.286 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.676 ' O ' ' HB2' ' A' ' 141' ' ' SER . 15.2 t70 -58.26 -23.45 56.16 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-N 113.346 -1.752 . . . . 0.65000000000000002 109.168 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.676 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 20.8 m 76.05 171.23 0.25 Allowed 'General case' 0 N--CA 1.42 -1.933 0 O-C-N 125.817 1.948 . . . . 0.59999999999999998 108.385 -173.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.912 HD22 ' HA ' ' A' ' 148' ' ' ALA . 6.9 mt -63.95 -39.06 93.29 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.724 -1.213 . . . . 0.85999999999999999 107.724 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.25 -11.85 1.39 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 113.059 -1.882 . . . . 0.31 114.334 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 1.2 m -155.42 128.06 7.94 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.076 -0.713 . . . . 0.23999999999999999 109.076 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.667 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.0 mmt180 -42.92 -46.87 5.54 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 117.995 0.361 . . . . 1.6499999999999999 111.556 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.1 t -72.3 -26.21 61.87 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.511 0.672 . . . . 0.53000000000000003 111.431 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 31.4 mttm -74.38 -32.17 62.63 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.661 1.219 . . . . 1.3100000000000001 108.797 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.912 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -71.11 -46.43 61.7 Favored 'General case' 0 CA--C 1.483 -1.627 0 CA-C-N 112.299 -2.228 . . . . 0.12 109.976 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.648 HG13 ' HE1' ' A' ' 179' ' ' MET . 36.6 mt -67.22 -41.79 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-N 112.764 -2.016 . . . . 0.11 109.974 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.53 -54.39 30.43 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 114.769 -1.105 . . . . 0.14999999999999999 111.297 171.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.763 HG23 ' CB ' ' A' ' 130' ' ' ALA . 79.1 mt -66.61 -47.77 82.38 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.029 0 N-CA-C 112.729 0.64 . . . . 0.17999999999999999 112.729 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.634 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.76 -41.66 74.31 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.809 0.338 . . . . 0.13 110.9 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.474 ' HD2' HG23 ' A' ' 149' ' ' ILE . 26.8 mtp180 -79.97 -23.98 41.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.48 0.657 . . . . 1.0800000000000001 110.53 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 27.4 t-20 -80.0 -12.83 59.68 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.337 -1.357 . . . . 0.5 107.337 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.68 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.39 -29.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 113.018 -1.901 . . . . 0.17000000000000001 110.79 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.82 34.21 5.28 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.586 -0.816 . . . . 0.16 112.632 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.06 161.24 14.92 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.031 0.752 . . . . 0.12 113.031 -169.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.673 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -100.31 -28.69 12.84 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.065 -0.97 . . . . 0.20000000000000001 109.348 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.583 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.3 m-85 -136.89 -177.96 4.98 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.935 -1.03 . . . . 0.13 110.936 -175.027 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.718 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -133.65 140.24 47.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.077 -0.965 . . . . 0.080000000000000002 108.823 167.58 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.627 HD21 ' SD ' ' A' ' 176' ' ' MET . 24.9 tp -110.46 99.05 8.12 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.333 -0.947 . . . . 0.16 109.725 166.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.784 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -78.75 112.59 16.03 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.893 -1.049 . . . . 0.26000000000000001 109.143 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.865 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.3 t -123.69 163.24 21.49 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 121.875 0.845 . . . . 1.05 110.275 -177.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.831 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -163.87 176.28 9.62 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 114.397 -1.274 . . . . 0.10000000000000001 111.33 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.57 132.52 29.39 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 113.844 -1.526 . . . . 0.11 108.531 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -142.34 -176.94 5.03 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.21 -0.596 . . . . 1.0900000000000001 109.492 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.09 -81.82 0.88 Allowed Glycine 0 C--N 1.303 -1.258 0 C-N-CA 119.649 -1.262 . . . . 0.14999999999999999 111.615 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.2 t30 -146.78 126.6 13.5 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 107.705 -1.221 . . . . 0.58999999999999997 107.705 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.614 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.2 p -58.75 -44.09 89.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 114.502 -1.226 . . . . 0.14999999999999999 112.723 -173.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -61.99 -29.91 70.58 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.776 0.798 . . . . 1.26 109.788 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.99 88.11 3.56 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 114.387 -1.279 . . . . 0.13 108.224 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.857 ' HD2' HG22 ' A' ' 194' ' ' VAL . 45.9 Cg_endo -90.06 165.54 4.74 Favored 'Trans proline' 0 CA--C 1.491 -1.631 0 C-N-CA 124.644 3.562 . . . . 0.089999999999999997 114.412 -170.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.6 m -83.3 118.27 23.55 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.942 -1.481 . . . . 0.14000000000000001 107.513 166.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.849 ' O ' ' HE1' ' A' ' 71' ' ' MET . 45.3 tp -83.76 99.51 10.32 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.367 -0.975 . . . . 0.16 108.367 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.624 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -91.34 109.02 20.29 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-O 122.09 0.948 . . . . 0.34000000000000002 109.196 -176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.865 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.1 mmm -111.87 163.54 14.09 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.983 -1.008 . . . . 1.0900000000000001 111.487 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.599 ' HG2' HD12 ' A' ' 186' ' ' ILE . 58.6 tt0 -171.15 116.91 0.44 Allowed 'General case' 0 C--O 1.203 -1.366 0 CA-C-N 116.019 -0.537 . . . . 0.5 110.404 -165.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.087 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -99.39 102.27 13.8 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.743 -0.836 . . . . 0.10000000000000001 108.743 -172.309 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.667 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 17.2 ttp -91.62 121.88 33.68 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.070000000000000007 109.534 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.6 128.04 35.04 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.159 -1.423 . . . . 0.22 107.159 166.195 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -83.09 -35.04 11.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 119.303 0.956 . . . . 0.11 110.747 178.5 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.4 mt-30 -61.45 -16.55 48.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.335 -0.848 . . . . 0.34999999999999998 111.358 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.7 p -130.08 -37.34 1.48 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.794 0.807 . . . . 0.19 110.224 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.558 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.48 25.29 26.2 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 114.449 -1.25 . . . . 0.17999999999999999 112.528 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.43 156.81 17.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.679 0.276 . . . . 0.72999999999999998 110.672 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.599 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.3 mm -91.46 112.8 25.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.454 0.645 . . . . 0.14000000000000001 109.679 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.087 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -101.11 -31.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.018 -0.992 . . . . 0.13 110.597 -173.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.653 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.6 t90 -134.06 152.62 51.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.359 -0.837 . . . . 0.070000000000000007 109.752 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 51.8 p -153.8 164.17 38.79 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.399 0.888 . . . . 0.13 113.399 164.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.47 -177.06 33.23 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 110.876 -0.889 . . . . 0.12 110.876 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.1 mtmt -157.46 152.8 26.16 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.645 -1.983 . . . . 1.22 105.645 166.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -163.76 128.18 1.79 Allowed Glycine 0 C--N 1.281 -2.498 0 C-N-CA 119.749 -1.215 . . . . 0.12 112.477 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.64 118.76 14.87 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.298 0.571 . . . . 0.17000000000000001 110.854 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.857 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -94.62 158.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.569 1.176 . . . . 0.11 110.621 -177.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -98.02 172.98 7.28 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 112.667 -2.061 . . . . 0.17999999999999999 108.861 -173.311 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -102.45 130.97 49.4 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.501 -0.48 . . . . 0.91000000000000003 109.962 170.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.514 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 15.4 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.844 -0.598 . . . . 1.24 110.744 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.744 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.9 m-30 . . . . . 0 N--CA 1.421 -1.899 0 N-CA-C 109.911 -0.403 . . . . 0.20999999999999999 109.911 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 4.3 t70 -81.73 67.91 7.89 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 123.595 1.664 . . . . 0.34999999999999998 108.292 171.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.707 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.0 m95 -58.29 -43.1 87.87 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 111.682 -2.508 . . . . 0.10000000000000001 112.547 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.453 ' N ' HG21 ' A' ' 108' ' ' THR . 3.2 t30 -51.82 -28.86 17.04 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.962 -1.472 . . . . 1.1100000000000001 111.598 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.44 -17.6 80.12 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.137 -0.938 . . . . 0.20999999999999999 111.104 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.1 -53.18 3.09 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.036 -1.082 . . . . 0.13 110.949 -176.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.703 ' SD ' HD23 ' A' ' 109' ' ' LEU . 42.2 mtt -64.24 -59.57 4.25 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.241 -1.345 . . . . 0.089999999999999997 112.593 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.444 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -39.34 -54.66 3.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 114.624 1.342 . . . . 0.63 114.624 -175.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.802 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.0 Cg_endo -64.21 -28.84 64.49 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 121.788 1.658 . . . . 0.14000000000000001 110.614 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.643 ' HE2' ' N ' ' A' ' 192' ' ' GLY . 11.8 mtm -84.99 -41.25 16.01 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.16 -0.927 . . . . 0.69999999999999996 111.476 -177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 68' ' ' MET . 61.2 t -55.91 -39.96 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 CA-C-N 114.629 -1.169 . . . . 0.12 108.697 172.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.7 t -60.93 -32.27 71.78 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.32 -1.764 . . . . 0.56000000000000005 111.085 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 16.6 mtpp -84.71 -33.48 23.13 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.147 0.498 . . . . 1.3 110.736 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.87 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -65.36 -27.91 68.91 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.169 -0.923 . . . . 0.5 111.334 -172.969 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.557 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.2 mt -92.92 -2.93 55.38 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.97 0.89 . . . . 0.65000000000000002 110.917 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.79 15.36 37.61 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.236 -1.546 . . . . 0.17000000000000001 109.236 170.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.27 165.0 17.69 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.679 -0.761 . . . . 0.10000000000000001 110.276 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -91.08 104.49 17.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.22 -0.9 . . . . 1.72 110.046 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.635 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.77 -21.78 3.72 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.097 -0.956 . . . . 0.12 110.735 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.87 HG11 ' O ' ' A' ' 75' ' ' MET . 12.4 p -100.0 153.62 4.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.605 0.716 . . . . 0.16 111.002 -177.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -135.15 136.39 41.84 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 114.838 -1.074 . . . . 0.45000000000000001 110.592 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.47 131.06 45.08 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.467 -0.788 . . . . 0.28000000000000003 110.179 166.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.96 9.91 44.25 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.79 -0.719 . . . . 0.28000000000000003 113.113 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.92 153.08 18.99 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 120.6 -0.44 . . . . 1.2 110.956 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.693 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -81.87 114.91 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 122.116 0.96 . . . . 0.20000000000000001 109.128 166.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.756 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -102.1 108.97 20.55 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.024 -0.989 . . . . 0.14000000000000001 109.264 -172.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.716 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -72.25 95.05 1.64 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 114.471 -1.24 . . . . 0.14999999999999999 108.272 175.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.495 HG11 ' HG3' ' A' ' 110' ' ' ARG . 1.6 m -73.01 118.21 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 107.83 -1.174 . . . . 0.94999999999999996 107.83 176.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.783 ' HB2' HD11 ' A' ' 142' ' ' LEU . 7.9 t0 -77.47 156.95 30.72 Favored 'General case' 0 CA--C 1.489 -1.397 0 CA-C-N 114.385 -1.28 . . . . 0.64000000000000001 107.856 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.538 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -58.38 136.98 57.55 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 108.075 -1.083 . . . . 0.37 108.075 171.234 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.513 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.2 t -64.0 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.982 0 N-CA-C 107.778 -1.193 . . . . 0.10000000000000001 107.778 167.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.818 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.8 t-20 -86.2 163.26 17.9 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.006 -0.997 . . . . 0.17999999999999999 110.069 174.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.754 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.57 84.65 2.3 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.303 -1.317 . . . . 0.12 108.134 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.52 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 7.2 mtp180 -109.09 -1.04 19.12 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 113.783 -1.553 . . . . 0.64000000000000001 108.627 -172.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.721 HG21 ' HB3' ' A' ' 172' ' ' PRO . 18.5 p -52.83 -171.97 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 112.73 -2.032 . . . . 0.14000000000000001 115.034 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.1 t30 -71.3 -9.39 58.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.759 -2.019 . . . . 0.47999999999999998 110.476 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.6 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.94 -146.33 4.32 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.472 -0.871 . . . . 0.12 112.903 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.588 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 54.8 p -121.87 131.02 53.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.245 0.461 . . . . 1.1599999999999999 112.245 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.91 156.72 48.34 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.802 0.81 . . . . 0.10000000000000001 110.629 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.656 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -79.79 79.6 6.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.978 -1.465 . . . . 0.17000000000000001 107.742 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.571 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.35 -14.44 62.99 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.307 -1.315 . . . . 0.089999999999999997 109.749 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.518 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.45 -31.38 37.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.747 -0.834 . . . . 0.14999999999999999 108.747 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.656 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 4.8 tp10 -66.32 -34.37 77.83 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.392 -1.277 . . . . 1.73 108.933 171.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.56 -43.57 66.09 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.236 -1.802 . . . . 0.12 109.551 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 81.0 m -62.92 -30.61 71.68 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 113.776 -1.556 . . . . 0.11 110.162 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.6 -49.68 70.14 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.722 -0.844 . . . . 1.47 108.722 169.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.681 HG21 ' HB2' ' A' ' 64' ' ' TRP . 53.1 m -59.38 -31.08 68.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.43 -0.804 . . . . 0.12 110.789 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.703 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.6 mt -51.2 -69.22 0.12 Allowed 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 115.902 -0.59 . . . . 0.56000000000000005 109.874 172.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.608 ' O ' HD13 ' A' ' 121' ' ' LEU . 4.9 mtp180 -41.85 -38.8 1.61 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.615 1.198 . . . . 1.51 110.886 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.2 m-20 -68.56 -49.04 62.53 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.32 -1.763 . . . . 0.28000000000000003 112.107 -176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.93 -32.89 69.94 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.357 1.075 . . . . 0.089999999999999997 108.446 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.825 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.4 mm? -64.14 -32.53 74.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.091 -1.868 . . . . 0.12 109.969 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.504 ' HA ' HD21 ' A' ' 121' ' ' LEU . . . -74.88 -38.53 61.88 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 114.749 -1.114 . . . . 0.20000000000000001 111.802 -174.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -67.31 -23.29 65.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.518 -0.764 . . . . 1.1699999999999999 111.449 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -89.27 -13.22 38.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 2.0499999999999998 111.877 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.95 -12.05 0.59 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 115.936 1.135 . . . . 0.54000000000000004 115.936 163.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.64 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 58.7 mtpt -75.81 -34.33 60.15 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 117.529 0.665 . . . . 0.98999999999999999 111.116 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.756 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 13.9 m-85 -91.42 177.67 6.17 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.889 1.328 . . . . 0.20999999999999999 113.823 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.55 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 12.7 m -125.02 114.17 18.75 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 112.244 -2.253 . . . . 0.23000000000000001 107.818 167.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.825 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -99.13 128.02 45.18 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.712 -0.795 . . . . 0.38 112.216 -168.095 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.523 HG21 HD23 ' A' ' 88' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.306 -1.32 0 N-CA-C 108.068 -1.086 . . . . 0.41999999999999998 108.068 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.756 HD21 ' HE3' ' A' ' 131' ' ' LYS . 2.0 tm? . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 113.331 0.863 . . . . 1.3899999999999999 113.331 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.7 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.1 t -50.49 -39.4 48.29 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 123.648 1.689 . . . . 1.05 109.028 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.699 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -63.59 -63.18 1.25 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 110.644 -2.98 . . . . 1.6399999999999999 110.688 178.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.754 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.31 -44.54 3.91 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 124.363 1.04 . . . . 0.31 111.646 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.756 ' HE3' HD21 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -49.47 -60.81 2.52 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 123.435 0.46 . . . . 1.53 110.044 176.016 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.2 mt-30 -58.79 -43.96 90.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.665 -1.152 . . . . 0.40999999999999998 111.46 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.699 ' HG3' ' O ' ' A' ' 129' ' ' MET . 49.4 mt-30 -56.14 -34.83 66.49 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.779 -1.1 . . . . 0.37 109.895 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.4 OUTLIER -90.67 -30.98 16.8 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 113.89 -1.504 . . . . 0.23999999999999999 109.487 -177.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.6 -50.69 0.44 Allowed Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 120.095 -1.05 . . . . 0.33000000000000002 113.64 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 141' ' ' SER . 86.1 mt -64.13 -173.02 0.08 Allowed 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 115.841 1.793 . . . . 0.31 115.841 -169.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.8 m -110.5 150.29 41.45 Favored Pre-proline 0 N--CA 1.421 -1.907 0 CA-C-N 111.005 -2.816 . . . . 0.81000000000000005 108.9 169.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.7 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 28.6 Cg_endo -64.13 1.12 1.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.003 2.469 . . . . 0.32000000000000001 112.831 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.518 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -118.33 -22.96 7.43 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.123 0.963 . . . . 1.25 110.487 -178.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 141' ' ' SER . 10.6 t70 -63.61 -21.94 66.63 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 113.062 -1.881 . . . . 0.65000000000000002 109.375 -174.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.64 ' O ' HD13 ' A' ' 136' ' ' LEU . 17.6 m 72.86 169.97 0.31 Allowed 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.42 -1.718 . . . . 0.59999999999999998 109.517 -173.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.012 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.7 mt -64.44 -39.58 94.11 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 122.349 1.071 . . . . 0.85999999999999999 108.268 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.97 -5.98 2.3 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 113.025 -1.898 . . . . 0.31 114.421 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 m -159.78 127.8 4.83 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.913 -0.773 . . . . 0.23999999999999999 108.913 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.726 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.5 mmt180 -42.42 -47.94 5.08 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 118.182 0.446 . . . . 1.6499999999999999 111.256 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.7 t -70.92 -25.79 62.92 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.503 0.668 . . . . 0.53000000000000003 111.591 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 26.8 mttm -75.21 -30.36 60.58 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 122.626 1.203 . . . . 1.3100000000000001 108.675 176.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 1.012 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -75.46 -46.57 31.73 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 112.472 -2.149 . . . . 0.12 110.288 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.614 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.5 mt -66.78 -41.71 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-N 112.811 -1.995 . . . . 0.11 110.004 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.11 -54.5 28.82 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.747 -1.115 . . . . 0.14999999999999999 111.134 171.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.754 HG23 ' CB ' ' A' ' 130' ' ' ALA . 72.2 mt -66.2 -47.86 83.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 N-CA-C 112.831 0.678 . . . . 0.17999999999999999 112.831 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.677 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.88 -40.36 72.85 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.926 0.393 . . . . 0.13 110.975 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.493 ' HD2' HG23 ' A' ' 149' ' ' ILE . 39.7 mtp180 -81.44 -22.67 38.01 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.745 0.783 . . . . 1.0800000000000001 110.48 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 28.7 t-20 -81.74 -12.04 58.76 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.199 -1.408 . . . . 0.5 107.199 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.698 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -107.4 -29.14 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 113.247 -1.797 . . . . 0.17000000000000001 110.918 -174.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.44 35.84 4.81 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.313 -0.946 . . . . 0.16 112.483 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.716 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.59 159.16 17.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.131 0.789 . . . . 0.12 113.131 -169.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.693 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -98.0 -27.06 14.41 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.18 -0.918 . . . . 0.20000000000000001 109.569 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.649 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 9.5 m-85 -136.65 -173.42 3.42 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.354 -0.839 . . . . 0.13 111.586 -174.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.696 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -137.76 138.43 44.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.803 -1.089 . . . . 0.080000000000000002 109.145 166.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.569 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 34.7 tp -107.82 99.43 8.9 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.379 -0.928 . . . . 0.16 109.281 165.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.69 ' CE1' HD12 ' A' ' 142' ' ' LEU . 2.0 m-85 -78.78 111.99 15.47 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.56 -1.2 . . . . 0.26000000000000001 108.743 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.729 ' OG ' HD11 ' A' ' 174' ' ' LEU . 26.8 t -123.6 159.22 29.72 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 121.776 0.798 . . . . 1.05 110.123 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.818 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.4 p -163.38 170.06 18.07 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-N 114.497 -1.229 . . . . 0.10000000000000001 111.18 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -133.86 135.93 44.05 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.143 -1.39 . . . . 0.11 108.636 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.676 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -144.23 -176.96 5.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.192 -0.67 . . . . 1.0900000000000001 109.192 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 96.08 -86.18 0.92 Allowed Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 119.628 -1.272 . . . . 0.14999999999999999 111.006 174.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.9 t30 -143.75 127.76 17.47 Favored 'General case' 0 C--O 1.191 -1.982 0 N-CA-C 107.375 -1.343 . . . . 0.58999999999999997 107.375 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.6 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.9 p -61.36 -49.71 83.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 114.061 -1.427 . . . . 0.14999999999999999 112.916 -170.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.447 ' N ' HG13 ' A' ' 169' ' ' VAL . 89.8 m-20 -58.83 -26.83 64.52 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.222 0.534 . . . . 1.26 110.904 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.13 88.18 3.51 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 114.903 -1.044 . . . . 0.13 108.394 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.831 ' HD2' HG22 ' A' ' 194' ' ' VAL . 43.3 Cg_endo -91.44 167.26 3.44 Favored 'Trans proline' 0 CA--C 1.493 -1.55 0 C-N-CA 124.947 3.765 . . . . 0.089999999999999997 114.854 -170.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.568 HG22 ' HB3' ' A' ' 191' ' ' LYS . 16.9 m -86.13 118.13 25.39 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 113.755 -1.566 . . . . 0.14000000000000001 107.694 166.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 164' ' ' SER . 54.1 tp -84.46 97.89 9.78 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-O 121.988 0.899 . . . . 0.16 109.337 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.63 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 34.9 mt-30 -87.64 107.66 18.72 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 114.567 -1.197 . . . . 0.34000000000000002 108.685 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.544 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 35.1 mtp -108.26 163.0 13.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.235 -0.893 . . . . 1.0900000000000001 110.063 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.608 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.5 tt0 -169.91 117.85 0.58 Allowed 'General case' 0 C--O 1.202 -1.438 0 CA-C-O 121.256 0.551 . . . . 0.5 110.136 -167.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.1 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.34 101.76 12.83 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.818 -0.808 . . . . 0.10000000000000001 108.818 -172.109 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.726 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.2 ttp -91.3 123.13 34.5 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.479 -0.782 . . . . 0.070000000000000007 109.533 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.77 127.37 31.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.075 -1.454 . . . . 0.22 107.075 166.425 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.05 -35.8 13.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.192 -1.003 . . . . 0.11 110.645 178.242 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.438 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.5 mt-30 -61.72 -15.5 41.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.259 -0.882 . . . . 0.34999999999999998 111.37 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p -130.08 -37.54 1.47 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.514 0.674 . . . . 0.19 110.127 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.512 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.15 26.13 24.66 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 114.631 -1.168 . . . . 0.17999999999999999 112.429 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.23 156.76 17.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.605 0.24 . . . . 0.72999999999999998 110.946 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.608 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.8 mm -91.25 110.59 22.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.792 0.806 . . . . 0.14000000000000001 109.706 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.1 HD11 HD13 ' A' ' 178' ' ' LEU . 1.5 pp -98.11 -32.39 3.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.695 -1.139 . . . . 0.13 110.514 -173.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.636 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.6 t90 -135.49 151.78 50.7 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.383 -0.826 . . . . 0.070000000000000007 109.541 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 33.0 p -153.84 163.17 40.48 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.742 0.645 . . . . 0.13 112.742 164.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.29 -178.41 32.29 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 110.841 -0.903 . . . . 0.12 110.841 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.743 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 16.3 mtmm -156.91 148.19 22.13 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.433 -1.692 . . . . 1.22 106.433 167.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.643 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -157.59 127.06 1.84 Allowed Glycine 0 C--N 1.283 -2.38 0 C-N-CA 119.682 -1.247 . . . . 0.12 112.293 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.94 116.05 12.98 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.413 0.625 . . . . 0.17000000000000001 111.069 -174.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.831 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -93.39 159.46 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 122.604 1.192 . . . . 0.11 110.716 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.744 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -100.82 172.55 6.99 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.485 -2.143 . . . . 0.17999999999999999 108.682 -174.175 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.1 tt0 -101.25 133.24 46.13 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 120.103 -0.639 . . . . 0.91000000000000003 109.601 171.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.547 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 36.7 mm-40 . . . . . 0 C--N 1.313 -1.02 0 CA-C-O 118.467 -0.778 . . . . 1.24 110.257 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.762 ' OH ' ' HB3' ' A' ' 100' ' ' LEU . 1.2 m-30 . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 110.032 -0.358 . . . . 0.20999999999999999 110.032 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.556 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 0.9 OUTLIER -81.73 67.46 7.71 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 123.578 1.656 . . . . 0.34999999999999998 107.949 170.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.707 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.8 m95 -60.03 -44.11 94.86 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 111.994 -2.366 . . . . 0.10000000000000001 112.256 174.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 4.3 t30 -51.65 -27.12 10.52 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.163 -1.38 . . . . 1.1100000000000001 111.269 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.15 -18.21 76.9 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.033 -0.985 . . . . 0.20999999999999999 111.292 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.22 -53.9 2.91 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.026 -1.087 . . . . 0.13 111.157 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.711 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.5 mtt -63.06 -60.49 3.37 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 114.052 -1.431 . . . . 0.089999999999999997 111.967 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 5.2 mm100 -38.36 -54.09 2.87 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 114.984 1.476 . . . . 0.63 114.984 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.805 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 39.2 Cg_endo -66.16 -29.14 47.85 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.702 1.601 . . . . 0.14000000000000001 110.57 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.727 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 15.6 mtm -84.48 -41.86 16.14 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.428 -0.806 . . . . 0.69999999999999996 111.818 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 68' ' ' MET . 60.7 t -57.0 -37.45 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 114.578 -1.192 . . . . 0.12 108.471 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -63.16 -33.12 74.79 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.961 -1.927 . . . . 0.56000000000000005 111.096 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.805 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.4 mtpt -83.42 -32.47 26.1 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.028 0.442 . . . . 1.3 110.632 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.846 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -66.03 -27.0 67.78 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.225 -0.898 . . . . 0.5 111.202 -173.05 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.647 HD13 ' HB2' ' A' ' 118' ' ' LYS . 5.9 mt -93.45 -7.29 44.9 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.951 0.882 . . . . 0.65000000000000002 110.669 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.0 16.97 53.69 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 108.885 -1.686 . . . . 0.17000000000000001 108.885 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.653 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -88.07 164.57 15.67 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.523 -0.838 . . . . 0.10000000000000001 110.307 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -89.2 106.66 18.59 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.978 -1.01 . . . . 1.72 109.407 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.642 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.19 -23.7 3.65 Favored Glycine 0 N--CA 1.417 -2.626 0 C-N-CA 119.69 -1.243 . . . . 0.12 110.791 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.846 HG11 ' O ' ' A' ' 75' ' ' MET . 11.4 p -100.06 153.75 4.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.787 0.803 . . . . 0.16 111.875 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -135.14 137.91 43.23 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.48 -1.236 . . . . 0.45000000000000001 110.639 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.667 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.35 130.78 48.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.462 -0.79 . . . . 0.28000000000000003 110.335 167.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.91 -3.92 33.94 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.966 -0.635 . . . . 0.28000000000000003 112.77 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.98 152.03 25.62 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 120.91 0.386 . . . . 1.2 111.122 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.655 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.7 p -80.67 117.84 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-O 121.978 0.894 . . . . 0.20000000000000001 109.05 165.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.77 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.3 tm? -106.16 109.57 21.55 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.166 -0.925 . . . . 0.14000000000000001 108.91 -172.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.683 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -71.92 96.12 1.65 Allowed 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.124 -1.398 . . . . 0.14999999999999999 108.163 177.387 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.537 HG12 ' CD1' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -71.88 120.04 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 N-CA-C 106.878 -1.527 . . . . 0.94999999999999996 106.878 177.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.777 ' HB2' HD11 ' A' ' 142' ' ' LEU . 10.5 t0 -77.71 155.58 31.19 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.08 -1.452 . . . . 0.64000000000000001 107.08 177.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.523 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.0 OUTLIER -59.2 136.95 58.12 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.584 -1.265 . . . . 0.37 107.584 171.728 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 21.7 t -63.15 139.04 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.831 0 N-CA-C 107.78 -1.193 . . . . 0.10000000000000001 107.78 168.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.802 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -86.03 163.52 17.89 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.239 -0.891 . . . . 0.17999999999999999 110.083 174.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.06 85.5 2.42 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.55 -1.204 . . . . 0.12 108.22 175.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.1 mtp180 -108.92 -0.24 19.79 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.027 -1.442 . . . . 0.64000000000000001 108.746 -172.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 172' ' ' PRO . 21.7 p -52.18 -177.01 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.21 -1.814 . . . . 0.14000000000000001 113.681 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.3 OUTLIER -73.92 -9.36 58.56 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.375 -1.738 . . . . 0.47999999999999998 110.133 173.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.609 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -139.9 -151.63 5.69 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.852 -0.69 . . . . 0.12 112.846 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 65.7 p -122.03 130.62 53.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.512 0.56 . . . . 1.1599999999999999 112.512 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.762 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 1.8 pp -136.2 156.9 48.01 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.009 0.909 . . . . 0.10000000000000001 111.604 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.622 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.6 t-20 -80.9 79.77 7.5 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.817 -1.538 . . . . 0.17000000000000001 107.867 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.52 -13.08 61.74 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.469 -1.242 . . . . 0.089999999999999997 110.038 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.534 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.41 -32.72 37.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.643 -0.873 . . . . 0.14999999999999999 108.643 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.622 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 6.1 tp10 -65.45 -33.81 76.82 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 122.804 1.288 . . . . 1.73 109.076 171.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.02 -44.08 63.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.928 -1.942 . . . . 0.12 109.51 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 61.4 m -63.65 -29.07 70.36 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.124 -1.398 . . . . 0.11 110.292 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.64 -52.37 52.39 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.185 -1.043 . . . . 1.47 108.185 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 64' ' ' TRP . 39.3 m -55.44 -33.93 64.03 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.671 -0.695 . . . . 0.12 111.144 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.711 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.0 mt -49.45 -69.22 0.12 Allowed 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 116.2 -0.455 . . . . 0.56000000000000005 109.862 172.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.527 ' O ' HD13 ' A' ' 121' ' ' LEU . 13.9 mtp180 -43.31 -36.95 2.03 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.442 1.089 . . . . 1.51 110.82 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 108' ' ' THR . 7.5 m-20 -70.83 -47.61 58.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.009 -1.451 . . . . 0.28000000000000003 111.561 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.485 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.36 -34.72 68.19 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 122.168 0.985 . . . . 0.089999999999999997 108.631 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -62.34 -33.94 75.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.56 -1.655 . . . . 0.12 109.954 173.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -75.15 -42.33 56.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 114.717 -1.129 . . . . 0.20000000000000001 111.053 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -63.63 -19.28 64.74 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.825 -1.08 . . . . 1.1699999999999999 110.667 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.42 -19.43 18.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.567 -0.742 . . . . 2.0499999999999998 111.565 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.04 14.19 10.26 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 115.357 0.903 . . . . 0.54000000000000004 115.357 164.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 56.8 mtpt -98.42 -2.35 39.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.268 0.534 . . . . 0.98999999999999999 109.913 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.77 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 34.8 m-85 -122.2 174.98 6.63 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.144 0.973 . . . . 0.20999999999999999 112.674 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.564 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 5.4 m -118.08 121.14 39.82 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 112.935 -1.939 . . . . 0.23000000000000001 107.742 170.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.662 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -92.31 139.47 30.58 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 119.164 -1.014 . . . . 0.38 111.837 -169.408 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.487 HG11 HD23 ' A' ' 88' ' ' LEU . 1.8 m . . . . . 0 C--N 1.3 -1.567 0 N-CA-C 108.047 -1.094 . . . . 0.41999999999999998 108.047 170.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.629 HD13 HD21 ' A' ' 88' ' ' LEU . 31.7 tp . . . . . 0 C--O 1.218 -0.563 0 N-CA-C 113.253 0.834 . . . . 1.3899999999999999 113.253 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.665 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 5.6 t -50.39 -46.56 56.18 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 123.275 1.512 . . . . 1.05 109.203 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.755 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -52.84 -63.75 1.04 Allowed 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 111.053 -2.794 . . . . 1.6399999999999999 110.374 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.768 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.77 -46.15 10.38 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 124.574 1.171 . . . . 0.31 112.195 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.532 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -54.39 -51.83 63.61 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 108.835 -0.802 . . . . 1.53 108.835 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.2 mt-30 -65.75 -38.86 90.25 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.313 -0.858 . . . . 0.40999999999999998 111.136 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.755 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.3 mt-30 -59.46 -33.84 71.8 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-N 114.486 -1.234 . . . . 0.37 109.678 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.522 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.43 -27.31 18.38 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.079 -1.418 . . . . 0.23999999999999999 109.552 -177.241 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.78 -48.79 0.58 Allowed Glycine 0 CA--C 1.495 -1.16 0 CA-C-O 122.598 1.11 . . . . 0.33000000000000002 113.259 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 141' ' ' SER . 96.6 mt -64.89 -171.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.102 -2.049 . . . . 0.31 115.716 -170.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.3 m -116.17 153.34 48.51 Favored Pre-proline 0 N--CA 1.428 -1.557 0 CA-C-N 110.705 -2.952 . . . . 0.81000000000000005 107.932 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.665 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 37.1 Cg_endo -65.81 -0.37 3.81 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.611 2.207 . . . . 0.32000000000000001 112.561 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.534 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 2.8 tt0 -118.41 -26.61 6.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.864 0.84 . . . . 1.25 110.704 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.1 t70 -56.86 -24.45 51.64 Favored 'General case' 0 CA--C 1.489 -1.366 0 CA-C-N 113.217 -1.81 . . . . 0.65000000000000002 109.677 -173.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.597 ' O ' HD13 ' A' ' 136' ' ' LEU . 13.0 m 73.47 170.26 0.31 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 112.964 -1.926 . . . . 0.59999999999999998 109.434 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.073 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.1 mt -69.19 -39.97 78.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.369 1.08 . . . . 0.85999999999999999 108.609 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.56 -12.11 0.52 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 112.94 -1.936 . . . . 0.31 114.099 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.77 128.65 10.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.775 -0.631 . . . . 0.23999999999999999 109.482 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.684 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 22.5 mmt-85 -42.82 -50.1 5.7 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 118.043 0.383 . . . . 1.6499999999999999 111.36 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.5 t -69.32 -27.28 65.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.456 0.646 . . . . 0.53000000000000003 111.365 -175.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 24.1 mttm -73.92 -27.63 61.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.666 1.222 . . . . 1.3100000000000001 108.663 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 1.073 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -79.61 -46.75 16.66 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 112.351 -2.204 . . . . 0.12 110.586 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.652 HG13 ' HE1' ' A' ' 179' ' ' MET . 44.4 mt -65.78 -41.66 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 112.946 -1.934 . . . . 0.11 110.099 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.25 -52.37 40.94 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.743 -1.117 . . . . 0.14999999999999999 111.243 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.768 HG23 ' CB ' ' A' ' 130' ' ' ALA . 89.1 mt -68.24 -48.43 73.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 N-CA-C 112.358 0.503 . . . . 0.17999999999999999 112.358 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.683 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.0 -41.31 71.12 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.948 0.404 . . . . 0.13 111.218 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.545 ' HD2' HG23 ' A' ' 149' ' ' ILE . 45.8 mtp180 -80.4 -24.26 39.82 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.597 0.713 . . . . 1.0800000000000001 110.506 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -80.89 -14.35 58.09 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 107.641 -1.244 . . . . 0.5 107.641 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.692 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -103.2 -28.64 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.188 -1.824 . . . . 0.17000000000000001 110.629 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.443 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 98.5 35.03 5.08 Favored Glycine 0 CA--C 1.5 -0.886 0 C-N-CA 120.153 -1.023 . . . . 0.16 112.16 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.682 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.39 158.58 17.38 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.756 0.65 . . . . 0.12 112.756 -170.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.655 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.1 m80 -98.2 -28.52 13.67 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.144 -0.934 . . . . 0.20000000000000001 109.392 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 6.2 m-85 -136.12 -174.89 3.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.089 -0.959 . . . . 0.13 111.235 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.694 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -135.67 140.23 44.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.091 -0.959 . . . . 0.080000000000000002 108.71 166.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.533 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 37.6 tp -109.31 101.75 10.72 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.292 -0.963 . . . . 0.16 109.45 165.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.617 ' CE1' HD12 ' A' ' 142' ' ' LEU . 2.2 m-85 -79.11 113.87 17.6 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.405 -1.27 . . . . 0.26000000000000001 108.673 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.711 ' OG ' HD11 ' A' ' 109' ' ' LEU . 4.2 p -121.33 157.73 29.77 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.444 -0.798 . . . . 1.05 109.791 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.802 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.7 p -164.62 173.24 12.17 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.985 -1.007 . . . . 0.10000000000000001 111.202 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.49 136.82 41.56 Favored 'General case' 0 N--CA 1.412 -2.334 0 CA-C-N 114.156 -1.384 . . . . 0.11 108.795 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.676 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.7 t -146.06 -171.29 3.68 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.882 -0.727 . . . . 1.0900000000000001 110.345 176.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.41 -78.0 1.51 Allowed Glycine 0 C--N 1.288 -2.099 0 CA-C-N 115.283 -0.871 . . . . 0.14999999999999999 111.713 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.2 t30 -148.85 131.56 15.97 Favored 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 107.62 -1.252 . . . . 0.58999999999999997 107.62 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.609 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.7 p -64.38 -41.8 93.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.102 -0.953 . . . . 0.14999999999999999 112.863 -172.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.481 ' HA ' ' NE2' ' A' ' 196' ' ' GLN . 5.2 m-20 -63.91 -28.85 70.11 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.293 1.045 . . . . 1.26 109.338 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.5 88.41 3.68 Favored Pre-proline 0 C--N 1.304 -1.374 0 CA-C-N 114.279 -1.328 . . . . 0.13 108.456 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.806 ' HD2' HG22 ' A' ' 194' ' ' VAL . 41.3 Cg_endo -92.0 166.25 3.15 Favored 'Trans proline' 0 CA--C 1.495 -1.447 0 C-N-CA 124.341 3.361 . . . . 0.089999999999999997 114.612 -171.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.605 HG22 ' HB3' ' A' ' 191' ' ' LYS . 49.2 m -85.02 118.8 24.81 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 113.793 -1.549 . . . . 0.14000000000000001 107.888 166.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 164' ' ' SER . 43.9 tp -84.11 96.72 9.01 Favored 'General case' 0 N--CA 1.414 -2.239 0 C-N-CA 119.26 -0.976 . . . . 0.16 108.66 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.678 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 31.9 mt-30 -85.83 108.94 18.35 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 114.638 -1.165 . . . . 0.34000000000000002 108.558 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.591 ' SD ' ' HB3' ' A' ' 163' ' ' SER . 2.9 mmm -112.06 163.52 14.19 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.655 -1.157 . . . . 1.0900000000000001 111.047 -174.103 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.645 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.4 tt0 -171.48 118.75 0.45 Allowed 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 115.917 -0.583 . . . . 0.5 109.949 -167.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.054 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.74 99.35 9.87 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.524 -0.917 . . . . 0.10000000000000001 108.524 -173.313 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.684 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.9 ttp -88.35 118.47 28.0 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.462 -0.79 . . . . 0.070000000000000007 109.22 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.527 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.17 115.65 4.31 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.067 -1.457 . . . . 0.22 107.067 169.708 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -71.28 -36.21 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.063 0.847 . . . . 0.11 111.348 -176.006 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.457 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 32.2 mt-30 -58.78 -15.53 12.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.525 -0.761 . . . . 0.34999999999999998 111.897 -177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 39.8 p -128.97 -37.28 1.72 Allowed 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.076 0.941 . . . . 0.19 110.02 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.522 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.28 23.79 36.28 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 113.663 -1.608 . . . . 0.17999999999999999 111.793 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -104.4 154.29 20.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.893 0.377 . . . . 0.72999999999999998 110.423 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.645 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.1 mm -87.6 116.19 29.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.53 0.681 . . . . 0.14000000000000001 109.358 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.054 HD11 HD13 ' A' ' 178' ' ' LEU . 1.7 pp -103.49 -31.34 2.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.93 -1.032 . . . . 0.13 110.476 -173.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.656 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 79.0 t90 -135.16 153.41 51.99 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.325 -0.852 . . . . 0.070000000000000007 109.314 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 77.8 p -153.73 164.0 39.05 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.085 -0.646 . . . . 0.13 112.697 163.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.61 -177.53 32.78 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.573 -1.011 . . . . 0.12 110.573 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.748 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 18.7 mtmm -157.98 148.2 20.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.488 -2.042 . . . . 1.22 105.488 166.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -155.65 126.89 1.92 Allowed Glycine 0 C--N 1.282 -2.445 0 C-N-CA 119.405 -1.379 . . . . 0.12 112.306 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.14 110.88 8.79 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.579 0.704 . . . . 0.17000000000000001 111.094 -173.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.806 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -89.91 157.73 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.583 -1.189 . . . . 0.11 110.581 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.717 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -97.83 172.77 7.45 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 112.612 -2.085 . . . . 0.17999999999999999 108.982 -175.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 2.2 tt0 -107.48 132.38 53.28 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.933 -1.107 . . . . 0.91000000000000003 110.79 171.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.552 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 35.9 mm-40 . . . . . 0 C--O 1.247 0.957 0 CA-C-N 114.811 -1.086 . . . . 1.24 110.948 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.732 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 . . . . . 0 N--CA 1.42 -1.944 0 N-CA-C 109.914 -0.402 . . . . 0.20999999999999999 109.914 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 10.9 t70 -84.05 67.35 9.64 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 123.492 1.615 . . . . 0.34999999999999998 108.125 170.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.75 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 91.1 m95 -58.96 -43.91 91.38 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 111.678 -2.51 . . . . 0.10000000000000001 112.437 175.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 4.1 t30 -50.56 -28.59 8.93 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.879 -1.51 . . . . 1.1100000000000001 111.415 174.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.08 -17.78 79.81 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.341 -0.845 . . . . 0.20999999999999999 111.215 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.62 -54.31 2.78 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.863 -1.168 . . . . 0.13 111.125 -175.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.72 ' SD ' HD23 ' A' ' 109' ' ' LEU . 40.1 mtt -62.59 -59.5 4.85 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 114.177 -1.374 . . . . 0.089999999999999997 112.105 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 5.8 mm100 -37.33 -55.31 1.86 Allowed Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 115.276 1.584 . . . . 0.63 115.276 -177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.796 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.3 Cg_endo -65.73 -29.74 50.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.648 1.565 . . . . 0.14000000000000001 110.458 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.691 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 13.0 mtm -83.91 -41.43 17.4 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 115.447 -0.797 . . . . 0.69999999999999996 111.541 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 68' ' ' MET . 58.8 t -55.97 -39.1 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 CA-C-N 114.718 -1.128 . . . . 0.12 108.812 171.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.2 t -61.74 -34.35 75.68 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.393 -1.73 . . . . 0.56000000000000005 110.813 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.796 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.2 mtpt -81.67 -33.93 31.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.073 -0.512 . . . . 1.3 110.464 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.867 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.72 -28.67 69.74 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.406 -0.815 . . . . 0.5 111.637 -171.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.561 ' N ' ' HG2' ' A' ' 75' ' ' MET . 5.5 mt -92.81 -4.84 52.31 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.081 0.943 . . . . 0.65000000000000002 111.133 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.68 15.9 44.65 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 108.914 -1.674 . . . . 0.17000000000000001 108.914 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.647 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.47 165.62 17.0 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.386 -0.907 . . . . 0.10000000000000001 109.869 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -92.97 104.91 17.09 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.277 -0.874 . . . . 1.72 110.303 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.654 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.82 -23.72 3.36 Favored Glycine 0 N--CA 1.428 -1.886 0 CA-C-N 115.018 -0.992 . . . . 0.12 110.69 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.867 HG11 ' O ' ' A' ' 75' ' ' MET . 9.9 p -98.76 155.46 3.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.748 0.785 . . . . 0.16 111.444 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.8 m -134.54 135.75 42.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.604 -1.18 . . . . 0.45000000000000001 111.034 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.575 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -60.23 129.31 41.07 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.222 -0.899 . . . . 0.28000000000000003 109.728 165.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.32 6.0 53.8 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.78 -0.724 . . . . 0.28000000000000003 112.938 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.493 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 65.7 m -98.12 146.93 25.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 120.719 -0.392 . . . . 1.2 110.51 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.692 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -76.8 132.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.029 -0.73 . . . . 0.20000000000000001 109.029 172.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.811 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.6 tm? -119.12 110.01 16.56 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.603 -0.726 . . . . 0.14000000000000001 109.084 -170.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.756 HD21 HD23 ' A' ' 127' ' ' LEU . 0.7 OUTLIER -71.77 93.99 1.34 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.815 -1.18 . . . . 0.14999999999999999 107.815 175.991 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -73.23 115.29 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.435 -1.32 . . . . 0.94999999999999996 107.435 176.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.817 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 12.3 t0 -77.74 170.92 15.76 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 114.997 -1.001 . . . . 0.64000000000000001 109.009 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.584 ' OG ' ' HE3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -62.48 152.92 33.16 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 122.42 1.105 . . . . 0.37 108.668 168.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.561 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 33.9 t -81.64 139.31 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.067 0 N-CA-C 106.985 -1.487 . . . . 0.10000000000000001 106.985 166.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.836 ' H ' ' HA ' ' A' ' 164' ' ' SER . 8.0 t-20 -83.65 163.35 20.37 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.922 0.867 . . . . 0.17999999999999999 110.498 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.762 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.2 t-20 -125.71 86.27 2.51 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.208 -1.36 . . . . 0.12 108.124 175.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.412 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.6 mtp180 -108.72 -2.03 18.94 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.124 -1.398 . . . . 0.64000000000000001 108.724 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.741 HG21 ' HB3' ' A' ' 172' ' ' PRO . 27.5 p -52.18 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 112.998 -1.91 . . . . 0.14000000000000001 115.39 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.517 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 35.4 t30 -69.9 -9.71 55.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 112.762 -2.017 . . . . 0.47999999999999998 110.492 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.601 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -153.27 -144.77 3.99 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.519 -0.848 . . . . 0.12 113.123 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.608 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 86.7 p -121.81 129.89 52.98 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.444 0.64 . . . . 1.1599999999999999 112.725 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.762 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.4 pp -135.52 156.51 48.78 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.923 0.868 . . . . 0.10000000000000001 110.852 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.635 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -80.95 79.44 7.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.961 -1.472 . . . . 0.17000000000000001 107.889 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.73 -14.28 62.81 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.433 -1.258 . . . . 0.089999999999999997 109.96 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.5 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.73 -30.48 36.25 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.555 -0.906 . . . . 0.14999999999999999 108.555 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.635 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.4 tp10 -66.21 -35.11 79.59 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.378 -1.283 . . . . 1.73 109.153 170.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.82 -43.86 67.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.107 -1.861 . . . . 0.12 109.369 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.657 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 63.0 m -61.77 -31.84 72.07 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 113.532 -1.667 . . . . 0.11 110.135 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.73 -46.77 77.64 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.843 -0.799 . . . . 1.47 108.843 171.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.69 HG21 ' HB2' ' A' ' 64' ' ' TRP . 50.9 m -60.19 -31.04 69.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.345 -0.843 . . . . 0.12 110.91 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.72 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -51.96 -68.15 0.19 Allowed 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.749 -0.66 . . . . 0.56000000000000005 110.361 172.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.528 ' O ' HD13 ' A' ' 121' ' ' LEU . 6.1 mpt_? -40.55 -37.36 0.7 Allowed 'General case' 0 C--O 1.213 -0.844 0 O-C-N 124.387 1.054 . . . . 1.51 110.456 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.589 ' HB2' ' O ' ' A' ' 108' ' ' THR . 5.5 m-20 -72.49 -46.8 53.07 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.304 -1.316 . . . . 0.28000000000000003 111.79 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.439 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.21 -33.51 65.41 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.069 0.938 . . . . 0.089999999999999997 108.718 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.69 -34.62 78.27 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.746 -1.57 . . . . 0.12 109.886 172.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.554 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.99 -40.51 65.17 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.696 -1.138 . . . . 0.20000000000000001 111.096 -176.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -61.89 -25.53 67.62 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.854 -1.067 . . . . 1.1699999999999999 110.69 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -92.52 -20.24 21.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.003 -0.544 . . . . 2.0499999999999998 111.467 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.9 0.78 4.38 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 115.693 1.037 . . . . 0.54000000000000004 115.693 162.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.575 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 53.0 mtpt -78.84 -33.99 45.52 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 117.395 0.598 . . . . 0.98999999999999999 109.812 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 19.0 m-85 -89.44 177.81 6.48 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-O 122.23 1.014 . . . . 0.20999999999999999 112.298 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.485 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.4 m -122.41 119.28 30.56 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 113.103 -1.862 . . . . 0.23000000000000001 108.31 167.162 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.676 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -86.92 145.43 26.55 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.448 -0.796 . . . . 0.38 111.317 -170.928 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.556 HG11 HD23 ' A' ' 88' ' ' LEU . 1.9 m . . . . . 0 C--N 1.298 -1.633 0 CA-C-N 115.364 -0.835 . . . . 0.41999999999999998 109.175 169.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.892 HD21 ' HE2' ' A' ' 131' ' ' LYS . 1.5 tm? . . . . . 0 C--O 1.225 -0.234 0 N-CA-C 113.205 0.817 . . . . 1.3899999999999999 113.205 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.673 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.3 t -49.54 -38.39 30.68 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 123.645 1.688 . . . . 1.05 109.189 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.667 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 33.7 mmm -64.02 -63.08 1.25 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 110.705 -2.952 . . . . 1.6399999999999999 111.191 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.748 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.26 -43.49 3.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 124.31 1.006 . . . . 0.31 111.442 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.892 ' HE2' HD21 ' A' ' 127' ' ' LEU . 3.7 mptp? -48.38 -65.57 0.54 Allowed 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.541 -0.541 . . . . 1.53 109.541 174.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 37.5 mt-30 -55.2 -44.61 75.52 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.828 -1.078 . . . . 0.40999999999999998 111.71 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.0 mt-30 -55.67 -36.0 66.62 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 114.745 -1.116 . . . . 0.37 110.022 -177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -91.18 -31.34 16.23 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.118 -1.401 . . . . 0.23999999999999999 109.285 -176.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.33 -48.32 0.43 Allowed Glycine 0 CA--C 1.496 -1.136 0 C-N-CA 119.801 -1.19 . . . . 0.33000000000000002 113.632 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.665 HD13 ' O ' ' A' ' 141' ' ' SER . 35.4 mt -66.24 -174.2 0.25 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 123.923 1.82 . . . . 0.31 115.781 -168.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.6 m -110.03 148.64 38.7 Favored Pre-proline 0 N--CA 1.421 -1.924 0 CA-C-N 110.791 -2.913 . . . . 0.81000000000000005 108.33 169.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.673 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 17.9 Cg_endo -61.38 0.4 1.03 Allowed 'Trans proline' 0 C--N 1.333 -0.255 0 C-N-CA 123.163 2.575 . . . . 0.32000000000000001 112.801 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.5 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.7 tt0 -117.9 -24.11 7.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.185 0.993 . . . . 1.25 110.424 -177.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.624 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.8 t70 -64.61 -22.56 67.0 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 113.213 -1.812 . . . . 0.65000000000000002 109.719 -174.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.665 ' O ' HD13 ' A' ' 136' ' ' LEU . 2.0 m 74.83 173.24 0.27 Allowed 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 125.322 1.639 . . . . 0.59999999999999998 109.652 -173.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.085 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.3 mt -64.72 -38.85 92.38 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.281 -1.007 . . . . 0.85999999999999999 108.281 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.38 -11.82 1.48 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 113.327 -1.76 . . . . 0.31 114.417 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 0.8 OUTLIER -157.19 130.22 7.73 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 118.672 -0.68 . . . . 0.23999999999999999 109.276 -178.036 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.63 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.1 mmt85 -43.29 -48.68 6.8 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 118.008 0.367 . . . . 1.6499999999999999 111.554 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 16.6 t -72.13 -24.93 61.54 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.531 0.681 . . . . 0.53000000000000003 111.202 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.413 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 25.3 mttm -74.6 -30.68 61.76 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.66 1.219 . . . . 1.3100000000000001 108.773 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 1.085 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -74.82 -46.2 38.2 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-N 112.411 -2.177 . . . . 0.12 110.236 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.639 HG13 ' HE1' ' A' ' 179' ' ' MET . 38.8 mt -67.53 -41.96 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 112.633 -2.076 . . . . 0.11 109.821 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.48 -53.85 30.06 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.71 -1.132 . . . . 0.14999999999999999 111.012 171.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.748 HG23 ' CB ' ' A' ' 130' ' ' ALA . 76.2 mt -66.96 -47.85 81.18 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 N-CA-C 112.641 0.608 . . . . 0.17999999999999999 112.641 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.672 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.29 -39.95 73.53 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.984 0.421 . . . . 0.13 111.02 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.536 ' HD2' HG23 ' A' ' 149' ' ' ILE . 45.5 mtp180 -82.59 -21.8 35.05 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.827 0.822 . . . . 1.0800000000000001 110.343 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.41 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 28.1 t-20 -82.82 -11.27 58.38 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.267 -1.382 . . . . 0.5 107.267 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.721 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.15 -29.66 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-N 113.143 -1.844 . . . . 0.17000000000000001 111.111 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.23 35.88 4.32 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.414 -0.898 . . . . 0.16 112.767 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.637 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.19 157.98 19.45 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.192 0.812 . . . . 0.12 113.192 -170.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.692 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.9 m80 -97.32 -25.97 15.06 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.27 -0.877 . . . . 0.20000000000000001 109.861 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.653 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 15.4 m-85 -136.12 -178.32 5.1 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.312 -0.858 . . . . 0.13 111.584 -174.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.673 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -133.37 141.53 44.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.1 -0.955 . . . . 0.080000000000000002 109.202 167.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 46.7 tp -111.43 102.26 10.64 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.628 -0.829 . . . . 0.16 109.255 164.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.681 ' CE1' HD12 ' A' ' 142' ' ' LEU . 1.8 m-85 -80.21 112.64 17.72 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.241 -1.345 . . . . 0.26000000000000001 109.198 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.692 ' OG ' HD11 ' A' ' 109' ' ' LEU . 3.8 p -119.15 158.12 26.57 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.959 0.885 . . . . 1.05 111.489 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.836 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.4 p -164.22 171.64 14.69 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-N 114.251 -1.341 . . . . 0.10000000000000001 111.255 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.14 134.91 33.49 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 114.118 -1.401 . . . . 0.11 108.658 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.9 m -144.74 -173.79 4.16 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.295 -0.631 . . . . 1.0900000000000001 109.295 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.54 -82.43 0.94 Allowed Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.616 -1.278 . . . . 0.14999999999999999 111.279 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.517 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 59.8 t30 -145.78 129.16 16.86 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 107.653 -1.24 . . . . 0.58999999999999997 107.653 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.601 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.3 p -65.03 -42.51 94.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.447 -0.797 . . . . 0.14999999999999999 112.552 -171.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.424 ' N ' HG13 ' A' ' 169' ' ' VAL . 7.4 m120 -60.66 -30.28 69.8 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.784 0.802 . . . . 1.26 110.087 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.01 89.26 3.41 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 113.645 -1.616 . . . . 0.13 108.557 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.817 ' HD2' HG22 ' A' ' 194' ' ' VAL . 43.1 Cg_endo -91.85 165.53 3.27 Favored 'Trans proline' 0 CA--C 1.496 -1.402 0 C-N-CA 124.678 3.586 . . . . 0.089999999999999997 115.301 -170.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.5 m -84.11 116.96 23.15 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 113.88 -1.509 . . . . 0.14000000000000001 107.83 166.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.813 HD12 ' O ' ' A' ' 164' ' ' SER . 43.9 tp -84.22 98.12 9.78 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.988 0.899 . . . . 0.16 109.25 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.635 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 35.4 mt-30 -87.11 108.32 18.84 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 114.586 -1.188 . . . . 0.34000000000000002 108.925 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.554 ' HG3' ' HG ' ' A' ' 174' ' ' LEU . 76.6 mtp -107.29 162.63 13.72 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.827 -1.079 . . . . 1.0900000000000001 110.357 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.592 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.4 tt0 -169.71 119.54 0.65 Allowed 'General case' 0 C--O 1.202 -1.411 0 CA-C-O 121.309 0.576 . . . . 0.5 109.904 -169.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.124 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.11 101.98 12.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.001 -0.74 . . . . 0.10000000000000001 109.001 -172.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.639 ' HE1' HG13 ' A' ' 149' ' ' ILE . 12.7 ttp -92.47 121.98 34.46 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.557 -0.747 . . . . 0.070000000000000007 109.407 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.3 128.44 37.0 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.285 -1.376 . . . . 0.22 107.285 166.506 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.625 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -84.66 -34.09 9.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 119.096 -1.042 . . . . 0.11 110.738 178.247 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.467 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 27.3 mt-30 -61.2 -16.31 43.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.371 -0.832 . . . . 0.34999999999999998 111.388 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.7 p -130.53 -37.49 1.38 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.505 0.669 . . . . 0.19 110.247 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.516 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.95 24.59 27.0 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.641 -1.163 . . . . 0.17999999999999999 112.479 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 179' ' ' MET . 10.4 pt-20 -103.81 157.78 16.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.654 -0.273 . . . . 0.72999999999999998 110.863 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.592 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.3 mm -93.04 114.19 29.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.574 0.702 . . . . 0.14000000000000001 109.375 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.124 HD11 HD13 ' A' ' 178' ' ' LEU . 1.3 pp -102.38 -30.75 2.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.996 -1.002 . . . . 0.13 110.816 -174.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.647 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.3 t90 -135.43 152.11 51.07 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.274 -0.876 . . . . 0.070000000000000007 109.547 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 61.9 p -153.71 164.21 38.7 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.915 0.709 . . . . 0.13 112.915 163.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.18 -178.69 32.44 Favored Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 110.927 -0.869 . . . . 0.12 110.927 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.734 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 12.0 mtmt -157.05 148.02 21.76 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.207 -1.775 . . . . 1.22 106.207 166.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.691 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -159.29 127.51 1.85 Allowed Glycine 0 C--N 1.28 -2.529 0 C-N-CA 119.769 -1.205 . . . . 0.12 112.343 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.82 114.79 11.35 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.659 0.742 . . . . 0.17000000000000001 111.108 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.817 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -90.6 158.96 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 122.718 1.247 . . . . 0.11 110.476 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -101.43 172.08 7.19 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.399 -2.182 . . . . 0.17999999999999999 108.445 -175.014 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.3 tt0 -101.26 135.79 42.15 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.201 -0.6 . . . . 0.91000000000000003 109.633 172.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.566 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 7.0 mt-30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.424 -0.798 . . . . 1.24 110.927 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.758 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.4 m-30 . . . . . 0 N--CA 1.42 -1.931 0 N-CA-C 109.73 -0.47 . . . . 0.20999999999999999 109.73 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.507 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 1.7 t70 -80.68 67.92 6.72 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 123.593 1.663 . . . . 0.34999999999999998 107.95 171.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.71 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 90.9 m95 -59.51 -44.5 93.12 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 111.643 -2.526 . . . . 0.10000000000000001 112.497 175.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 4.0 t30 -51.92 -28.99 18.24 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.055 -1.43 . . . . 1.1100000000000001 111.281 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.19 -16.91 80.35 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.326 -0.852 . . . . 0.20999999999999999 111.144 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.31 -52.78 3.17 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.109 -1.046 . . . . 0.13 111.008 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.676 ' SD ' HD23 ' A' ' 109' ' ' LEU . 43.3 mtt -62.36 -60.32 3.73 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 114.213 -1.358 . . . . 0.089999999999999997 112.179 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.499 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 5.3 mm100 -38.76 -53.19 3.47 Favored Pre-proline 0 C--O 1.225 -0.211 0 N-CA-C 115.554 1.687 . . . . 0.63 115.554 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.538 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 49.8 Cg_endo -66.98 -25.91 44.14 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.784 1.656 . . . . 0.14000000000000001 110.746 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.632 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 12.4 mtm -88.05 -43.26 11.84 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.956 -1.02 . . . . 0.69999999999999996 111.978 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 68' ' ' MET . 65.6 t -53.63 -40.43 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 CA-C-N 114.439 -1.255 . . . . 0.12 108.71 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.4 t -57.29 -39.6 76.05 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.005 -1.907 . . . . 0.56000000000000005 110.954 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 25.4 mtmt -77.49 -31.79 53.86 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.024 0.379 . . . . 1.3 112.024 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.871 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -65.26 -26.68 68.2 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.545 -0.752 . . . . 0.5 111.559 -169.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 118' ' ' LYS . 4.6 mt -94.48 -5.52 45.96 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 122.052 0.93 . . . . 0.65000000000000002 111.157 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.43 15.18 50.33 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 109.004 -1.638 . . . . 0.17000000000000001 109.004 170.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.63 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.74 165.54 17.74 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.426 -0.887 . . . . 0.10000000000000001 110.235 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -91.4 103.33 15.97 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.06 -0.973 . . . . 1.72 110.601 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.628 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.96 -21.97 3.48 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.56 -1.016 . . . . 0.12 110.56 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.871 HG11 ' O ' ' A' ' 75' ' ' MET . 11.9 p -101.36 152.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.746 0.784 . . . . 0.16 110.993 -176.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.3 m -135.93 141.0 44.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.724 -1.125 . . . . 0.45000000000000001 110.653 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.727 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -57.2 129.46 41.87 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.122 -0.944 . . . . 0.28000000000000003 110.838 168.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.52 14.16 24.41 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.101 -0.571 . . . . 0.28000000000000003 112.943 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.21 152.42 18.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.515 -0.474 . . . . 1.2 110.941 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.7 p -81.32 115.2 23.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.981 0.896 . . . . 0.20000000000000001 109.081 166.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.704 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -102.77 109.11 20.58 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.236 -0.893 . . . . 0.14000000000000001 109.099 -172.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.687 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.61 96.38 1.55 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.21 -1.359 . . . . 0.14999999999999999 108.318 176.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -71.8 121.16 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 106.852 -1.536 . . . . 0.94999999999999996 106.852 177.459 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.816 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 9.5 t0 -77.54 156.5 30.91 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.268 -1.382 . . . . 0.64000000000000001 107.268 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.534 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.57 138.04 57.83 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.061 -1.459 . . . . 0.37 107.061 171.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.543 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.8 t -64.49 137.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.073 0 N-CA-C 107.658 -1.238 . . . . 0.10000000000000001 107.658 168.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.781 ' H ' ' HA ' ' A' ' 164' ' ' SER . 5.1 t-20 -83.97 161.33 20.81 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.234 -0.894 . . . . 0.17999999999999999 109.614 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.77 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 1.9 t-20 -124.52 85.13 2.37 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.675 -1.148 . . . . 0.12 108.083 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.543 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.8 mtp180 -108.6 -1.96 19.17 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 113.756 -1.565 . . . . 0.64000000000000001 108.502 -172.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 172' ' ' PRO . 18.1 p -52.94 -172.77 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.044 -1.889 . . . . 0.14000000000000001 115.074 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 167' ' ' GLY . 58.8 t30 -71.59 -5.19 31.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.643 -2.072 . . . . 0.47999999999999998 110.828 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.596 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -156.38 -143.95 3.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.671 -0.776 . . . . 0.12 112.807 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.548 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 55.6 p -122.19 130.56 53.32 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.178 0.436 . . . . 1.1599999999999999 112.178 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.77 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.2 pp -136.22 157.37 46.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.858 0.837 . . . . 0.10000000000000001 110.863 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.15 79.44 7.81 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.85 -1.523 . . . . 0.17000000000000001 107.631 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.33 -14.07 62.73 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.511 -1.222 . . . . 0.089999999999999997 109.915 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.549 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.66 -32.74 41.6 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.672 -0.862 . . . . 0.14999999999999999 108.672 -178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.9 tp10 -65.94 -33.27 75.45 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 122.767 1.27 . . . . 1.73 108.943 171.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.46 -43.92 63.06 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 113.078 -1.874 . . . . 0.12 109.5 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.629 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 67.1 m -64.01 -31.43 72.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.115 -1.402 . . . . 0.11 110.476 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -42.69 81.2 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.895 -1.15 . . . . 1.47 107.895 172.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.677 HG21 ' HB2' ' A' ' 64' ' ' TRP . 30.1 m -63.34 -31.36 72.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.994 -1.003 . . . . 0.12 110.816 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.702 ' O ' HD23 ' A' ' 113' ' ' LEU . 9.4 mt -50.88 -69.83 0.1 Allowed 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 115.691 -0.686 . . . . 0.56000000000000005 109.518 171.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.542 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.2 mtp180 -40.71 -39.4 1.08 Allowed 'General case' 0 C--N 1.314 -0.942 0 O-C-N 124.539 1.15 . . . . 1.51 111.122 175.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 108' ' ' THR . 7.5 m-20 -69.7 -45.43 68.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.604 -1.18 . . . . 0.28000000000000003 111.948 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.499 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.95 -32.91 63.69 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.289 1.043 . . . . 0.089999999999999997 108.605 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -65.71 -32.1 73.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.608 -1.633 . . . . 0.12 110.26 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.592 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -73.58 -40.68 63.7 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 114.671 -1.149 . . . . 0.20000000000000001 111.489 -174.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -59.92 -27.96 67.2 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.562 -1.199 . . . . 1.1699999999999999 110.755 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -82.16 -35.51 28.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.54 -1.209 . . . . 2.0499999999999998 110.554 -174.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.28 0.64 30.6 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 114.626 0.61 . . . . 0.54000000000000004 114.626 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.771 ' HB2' HD13 ' A' ' 76' ' ' LEU . 58.5 mtpt -86.92 -8.12 57.55 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.935 -0.744 . . . . 0.98999999999999999 110.814 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.73 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 29.5 m-85 -119.09 175.37 5.81 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 122.159 0.98 . . . . 0.20999999999999999 112.497 171.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.512 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.5 m -119.7 123.73 44.52 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 112.987 -1.915 . . . . 0.23000000000000001 107.862 169.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.604 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -93.02 138.47 31.46 Favored 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 119.43 -0.908 . . . . 0.38 111.651 -170.158 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.518 HG21 HD23 ' A' ' 88' ' ' LEU . 1.7 m . . . . . 0 C--N 1.299 -1.629 0 N-CA-C 107.333 -1.358 . . . . 0.41999999999999998 107.333 169.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.612 HD13 HD21 ' A' ' 88' ' ' LEU . 30.8 tp . . . . . 0 C--O 1.221 -0.439 0 N-CA-C 113.34 0.867 . . . . 1.3899999999999999 113.34 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.667 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 4.3 t -49.97 -46.1 52.16 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 123.336 1.541 . . . . 1.05 109.289 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.716 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 52.0 mmm -55.4 -61.66 2.19 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 111.125 -2.761 . . . . 1.6399999999999999 110.64 175.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.769 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.79 -45.57 10.12 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 124.382 1.051 . . . . 0.31 112.472 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.552 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -55.14 -51.36 66.71 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 107.963 -1.125 . . . . 1.53 107.963 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.8 mt-30 -64.56 -40.87 96.36 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.047 -0.979 . . . . 0.40999999999999998 111.325 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.716 ' HG3' ' O ' ' A' ' 129' ' ' MET . 49.5 mt-30 -58.3 -34.21 70.3 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 114.429 -1.26 . . . . 0.37 109.383 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.514 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.14 -26.92 18.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.764 -1.562 . . . . 0.23999999999999999 109.381 -177.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.44 -52.05 0.52 Allowed Glycine 0 CA--C 1.497 -1.041 0 CA-C-O 122.677 1.154 . . . . 0.33000000000000002 113.039 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 141' ' ' SER . 77.7 mt -62.65 -171.15 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 111.761 -2.22 . . . . 0.31 116.046 -171.051 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.5 m -117.21 153.21 49.8 Favored Pre-proline 0 N--CA 1.428 -1.551 0 CA-C-N 110.929 -2.851 . . . . 0.81000000000000005 108.307 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.667 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 24.5 Cg_endo -63.14 -2.07 3.48 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.026 2.484 . . . . 0.32000000000000001 112.676 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.549 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.6 tt0 -118.15 -27.67 6.02 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.781 0.8 . . . . 1.25 110.463 -177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.2 t70 -60.54 -23.83 64.89 Favored 'General case' 0 CA--C 1.487 -1.442 0 CA-C-N 113.604 -1.635 . . . . 0.65000000000000002 109.483 -174.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.62 ' O ' HD13 ' A' ' 136' ' ' LEU . 17.8 m 74.8 169.49 0.29 Allowed 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 112.785 -2.007 . . . . 0.59999999999999998 110.455 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.831 HD22 ' HA ' ' A' ' 148' ' ' ALA . 6.7 mt -64.4 -40.25 95.42 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.336 1.065 . . . . 0.85999999999999999 108.477 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 64.49 -11.13 0.25 Allowed Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 112.978 -1.919 . . . . 0.31 114.666 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 142' ' ' LEU . 1.5 m -152.86 125.53 8.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.081 -0.711 . . . . 0.23999999999999999 109.081 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.735 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 12.3 mmt180 -41.66 -45.95 3.57 Favored 'General case' 0 C--O 1.213 -0.84 0 O-C-N 123.279 0.362 . . . . 1.6499999999999999 111.792 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.9 t -73.43 -25.59 60.58 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.628 0.728 . . . . 0.53000000000000003 111.505 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 29.7 mttm -75.0 -32.05 61.55 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.744 1.259 . . . . 1.3100000000000001 108.684 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.831 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -71.32 -46.99 59.33 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-N 112.217 -2.265 . . . . 0.12 110.044 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.622 HG13 ' HE1' ' A' ' 179' ' ' MET . 38.2 mt -67.07 -40.86 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 CA-C-N 112.678 -2.056 . . . . 0.11 109.839 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.08 -56.3 19.68 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 114.737 -1.119 . . . . 0.14999999999999999 111.129 171.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.769 HG23 ' CB ' ' A' ' 130' ' ' ALA . 85.3 mt -65.43 -47.98 84.78 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 N-CA-C 112.733 0.642 . . . . 0.17999999999999999 112.733 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.684 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.23 -40.49 74.19 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.845 0.355 . . . . 0.13 111.14 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.518 ' HD2' HG23 ' A' ' 149' ' ' ILE . 61.6 mtp180 -81.92 -21.75 37.16 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.695 0.759 . . . . 1.0800000000000001 110.533 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -84.06 -11.12 57.22 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.323 -1.362 . . . . 0.5 107.323 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.719 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -107.08 -29.11 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 113.143 -1.844 . . . . 0.17000000000000001 110.917 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.59 34.2 5.34 Favored Glycine 0 CA--C 1.504 -0.602 0 C-N-CA 120.403 -0.904 . . . . 0.16 112.553 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.687 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.34 161.83 14.45 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.637 0.606 . . . . 0.12 112.637 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.67 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.2 m80 -99.82 -28.16 13.27 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.561 -0.745 . . . . 0.20000000000000001 109.586 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.573 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.7 m-85 -136.67 -172.9 3.28 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.223 -0.899 . . . . 0.13 111.141 -174.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.678 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -137.44 139.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.835 -1.075 . . . . 0.080000000000000002 108.645 166.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.537 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 29.4 tp -108.35 100.56 9.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.584 -0.846 . . . . 0.16 109.329 165.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.665 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -79.25 112.56 16.59 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.831 -1.077 . . . . 0.26000000000000001 108.723 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.727 ' OG ' HD11 ' A' ' 174' ' ' LEU . 23.3 t -124.86 159.75 30.37 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-O 121.828 0.823 . . . . 1.05 110.052 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.826 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.5 p -163.75 173.03 13.34 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 114.505 -1.225 . . . . 0.10000000000000001 111.154 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.73 134.33 37.03 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 114.071 -1.422 . . . . 0.11 108.477 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -143.9 -176.72 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.373 -0.602 . . . . 1.0900000000000001 109.373 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 95.16 -82.68 0.88 Allowed Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 119.389 -1.386 . . . . 0.14999999999999999 111.856 172.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.44 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.4 t30 -143.07 123.82 14.18 Favored 'General case' 0 C--O 1.195 -1.782 0 N-CA-C 107.125 -1.435 . . . . 0.58999999999999997 107.125 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.596 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.1 p -63.04 -44.59 99.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 112.944 0.72 . . . . 0.14999999999999999 112.944 -172.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.44 ' N ' HG13 ' A' ' 169' ' ' VAL . 72.5 m-20 -61.28 -27.93 68.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 118.59 0.632 . . . . 1.26 109.891 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.4 88.74 3.35 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 114.855 -1.066 . . . . 0.13 108.436 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.816 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.8 Cg_endo -91.48 166.37 3.47 Favored 'Trans proline' 0 CA--C 1.492 -1.585 0 C-N-CA 124.996 3.797 . . . . 0.089999999999999997 115.183 -169.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.601 HG22 ' HB3' ' A' ' 191' ' ' LYS . 12.7 m -84.58 117.35 23.67 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.689 -1.596 . . . . 0.14000000000000001 107.672 167.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 164' ' ' SER . 48.2 tp -84.39 98.19 9.9 Favored 'General case' 0 N--CA 1.412 -2.326 0 C-N-CA 119.589 -0.844 . . . . 0.16 109.183 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.664 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.8 mt-30 -88.06 107.87 18.96 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 114.665 -1.152 . . . . 0.34000000000000002 109.092 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 36.0 mtp -108.15 162.06 14.41 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.012 -0.995 . . . . 1.0900000000000001 110.266 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.595 ' HG2' HD12 ' A' ' 186' ' ' ILE . 55.5 tt0 -169.72 117.59 0.6 Allowed 'General case' 0 C--O 1.205 -1.275 0 CA-C-O 121.308 0.575 . . . . 0.5 109.927 -168.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.04 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -99.84 101.41 12.53 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.695 -0.854 . . . . 0.10000000000000001 108.695 -170.972 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.735 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 16.9 ttp -91.39 122.63 34.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.373 -0.83 . . . . 0.070000000000000007 109.625 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -59.14 127.57 32.83 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.201 -1.407 . . . . 0.22 107.201 166.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -82.18 -34.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 119.065 -1.054 . . . . 0.11 110.865 178.529 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.437 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.4 mt-30 -62.54 -14.43 42.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.446 -0.797 . . . . 0.34999999999999998 111.592 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 79.3 p -130.65 -36.41 1.41 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.862 0.839 . . . . 0.19 110.416 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.541 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 87.9 27.6 25.92 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.397 -1.274 . . . . 0.17999999999999999 112.313 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -106.77 155.93 19.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.624 -0.288 . . . . 0.72999999999999998 110.624 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.595 HD12 ' HG2' ' A' ' 177' ' ' GLN . 33.1 mm -89.01 120.09 37.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.665 0.745 . . . . 0.14000000000000001 109.375 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.04 HD11 HD13 ' A' ' 178' ' ' LEU . 1.3 pp -108.18 -30.33 2.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.904 -1.043 . . . . 0.13 110.422 -173.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.63 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.2 t90 -136.96 152.89 50.69 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.177 -0.92 . . . . 0.070000000000000007 109.385 172.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.499 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 62.1 p -153.53 164.49 38.14 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.938 0.718 . . . . 0.13 112.938 164.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.71 179.84 35.01 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.671 -0.971 . . . . 0.12 110.671 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.6 mtmt -156.91 147.45 21.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.181 -1.785 . . . . 1.22 106.181 168.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.632 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -157.64 127.38 1.9 Allowed Glycine 0 C--N 1.283 -2.399 0 C-N-CA 119.674 -1.25 . . . . 0.12 112.43 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.65 110.96 9.37 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.787 0.803 . . . . 0.17000000000000001 111.503 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.816 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -88.53 159.5 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 122.797 1.284 . . . . 0.11 110.9 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.758 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -99.73 173.03 6.9 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 112.254 -2.248 . . . . 0.17999999999999999 108.895 -174.543 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.0 tt0 -104.34 133.52 49.1 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.936 -0.705 . . . . 0.91000000000000003 110.107 173.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.553 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 14.4 mm-40 . . . . . 0 C--N 1.313 -1.004 0 CA-C-O 118.551 -0.737 . . . . 1.24 110.617 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.718 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.2 m-30 . . . . . 0 N--CA 1.428 -1.571 0 CA-C-O 120.308 0.099 . . . . 0.20999999999999999 110.878 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.491 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 23.4 t70 -87.11 67.02 9.58 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 123.401 1.572 . . . . 0.34999999999999998 108.399 172.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.781 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.9 m95 -54.25 -43.58 71.05 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.089 -2.323 . . . . 0.10000000000000001 112.997 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.424 ' N ' HG21 ' A' ' 108' ' ' THR . 3.3 t30 -50.15 -30.56 11.51 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.806 -1.543 . . . . 1.1100000000000001 111.743 177.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.48 -16.41 80.64 Favored Glycine 0 CA--C 1.501 -0.801 0 N-CA-C 111.358 -0.697 . . . . 0.20999999999999999 111.358 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.73 -49.77 4.26 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.118 -1.041 . . . . 0.13 110.736 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.732 ' O ' HG23 ' A' ' 72' ' ' VAL . 39.0 mtt -66.56 -57.65 6.83 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.089 -1.414 . . . . 0.089999999999999997 111.94 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.8 mm100 -38.75 -54.96 2.88 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 114.958 1.466 . . . . 0.63 114.958 -177.0 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.82 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 31.9 Cg_endo -63.46 -30.77 72.09 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 121.908 1.739 . . . . 0.14000000000000001 110.45 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.744 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 7.6 mtm -81.59 -45.63 15.57 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 115.123 -0.944 . . . . 0.69999999999999996 111.851 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 68' ' ' MET . 46.8 t -56.54 -39.86 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-N 114.217 -1.356 . . . . 0.12 108.751 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -59.39 -34.39 72.37 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.064 -1.88 . . . . 0.56000000000000005 111.052 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.82 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 17.2 mtpp -83.41 -33.86 25.64 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.069 0.461 . . . . 1.3 110.912 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.83 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.81 -26.35 68.31 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.291 -0.868 . . . . 0.5 111.295 -173.186 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.676 HD13 ' HB2' ' A' ' 118' ' ' LYS . 6.4 mt -94.11 -6.35 45.19 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.205 1.002 . . . . 0.65000000000000002 110.788 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.64 16.05 52.19 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 108.934 -1.666 . . . . 0.17000000000000001 108.934 170.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.653 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -86.36 165.7 16.18 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.598 -0.801 . . . . 0.10000000000000001 109.925 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -92.87 105.52 17.63 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.255 -0.884 . . . . 1.72 110.195 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.637 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.05 -22.48 3.59 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 115.138 -0.937 . . . . 0.12 111.051 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.83 HG11 ' O ' ' A' ' 75' ' ' MET . 9.9 p -99.53 154.77 4.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.519 0.676 . . . . 0.16 111.617 -174.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.6 m -135.0 135.01 41.05 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.692 -1.14 . . . . 0.45000000000000001 110.897 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.601 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -60.59 121.41 12.12 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.394 -0.821 . . . . 0.28000000000000003 110.66 168.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.1 4.6 23.96 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.979 -0.629 . . . . 0.28000000000000003 112.55 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.3 152.46 21.93 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.804 -0.359 . . . . 1.2 110.526 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.5 p -80.02 120.71 31.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.819 0.819 . . . . 0.20000000000000001 108.906 165.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.77 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -109.36 107.7 17.98 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.821 0.82 . . . . 0.14000000000000001 109.154 -172.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.668 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -72.11 97.35 1.91 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.228 -1.351 . . . . 0.14999999999999999 107.679 174.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.837 ' O ' HD11 ' A' ' 127' ' ' LEU . 1.2 m -70.88 125.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 105.82 -1.919 . . . . 0.94999999999999996 105.82 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.879 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 10.0 t0 -78.26 157.7 29.16 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.401 -1.333 . . . . 0.64000000000000001 107.401 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.641 ' OG ' ' HE3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -57.7 135.39 56.75 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 106.842 -1.54 . . . . 0.37 106.842 170.423 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.567 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 28.3 t -64.9 139.68 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.951 0 N-CA-C 107.777 -1.194 . . . . 0.10000000000000001 107.777 169.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.798 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.5 t-20 -84.11 162.45 20.28 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.016 -0.993 . . . . 0.17999999999999999 109.778 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.36 85.02 2.35 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.683 -1.144 . . . . 0.12 108.004 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.467 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.2 mtp180 -107.09 -3.16 20.25 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 113.9 -1.5 . . . . 0.64000000000000001 108.653 -172.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.748 HG21 ' HB3' ' A' ' 172' ' ' PRO . 28.6 p -50.57 -175.36 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.24 -1.8 . . . . 0.14000000000000001 114.271 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.4 OUTLIER -72.3 -8.56 55.54 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.206 -1.816 . . . . 0.47999999999999998 110.599 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.595 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -146.47 -148.91 4.87 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.751 -0.738 . . . . 0.12 112.843 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.635 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.3 p -121.45 130.3 53.49 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.329 0.492 . . . . 1.1599999999999999 112.329 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.758 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -135.16 157.81 45.97 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.954 0.883 . . . . 0.10000000000000001 111.028 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.704 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -77.74 80.4 4.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.579 -1.646 . . . . 0.17000000000000001 107.86 175.144 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -69.41 -15.43 63.29 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.873 -1.058 . . . . 0.089999999999999997 109.77 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.57 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.84 -29.19 40.07 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.609 -0.886 . . . . 0.14999999999999999 108.609 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.704 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 20.9 tt0 -63.61 -39.71 95.07 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.054 -1.43 . . . . 1.73 109.32 168.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -68.48 -44.64 74.33 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.005 -1.907 . . . . 0.12 108.928 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 51.1 m -64.88 -31.44 72.68 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 113.946 -1.479 . . . . 0.11 110.61 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -44.79 78.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.695 -1.224 . . . . 1.47 107.695 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.686 HG21 ' HB2' ' A' ' 64' ' ' TRP . 40.1 m -64.01 -31.7 72.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.173 -0.921 . . . . 0.12 110.945 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.707 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.7 mt -49.86 -69.7 0.11 Allowed 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.277 -0.638 . . . . 0.56000000000000005 109.277 171.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.548 ' O ' HD13 ' A' ' 121' ' ' LEU . 16.4 mtp180 -41.05 -39.75 1.29 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.508 1.13 . . . . 1.51 111.394 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.0 m-20 -68.89 -45.97 69.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.65 -1.159 . . . . 0.28000000000000003 112.012 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.99 66.94 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.467 -0.938 . . . . 0.089999999999999997 108.467 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.69 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -59.58 -34.4 72.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.715 -1.584 . . . . 0.12 110.131 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.53 -39.11 67.8 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 114.662 -1.154 . . . . 0.20000000000000001 110.717 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -64.69 -24.58 67.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.709 -1.132 . . . . 1.1699999999999999 110.832 -176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -89.55 -25.18 21.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.648 -0.705 . . . . 2.0499999999999998 110.576 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 58.29 27.98 61.14 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.743 -0.662 . . . . 0.54000000000000004 114.147 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HB2' HD13 ' A' ' 76' ' ' LEU . 58.2 mtpt -110.87 -1.35 16.53 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.61 -0.515 . . . . 0.98999999999999999 109.61 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.77 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 40.1 m-85 -124.44 173.6 8.33 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.085 0.945 . . . . 0.20999999999999999 112.571 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.553 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.2 m -116.62 120.78 39.75 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 113.206 -1.815 . . . . 0.23000000000000001 107.532 169.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -89.85 146.23 24.58 Favored 'General case' 0 N--CA 1.415 -2.203 0 C-N-CA 119.344 -0.943 . . . . 0.38 111.223 -170.495 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.535 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.6 m . . . . . 0 C--N 1.303 -1.455 0 N-CA-C 107.765 -1.198 . . . . 0.41999999999999998 107.765 170.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.837 HD11 ' O ' ' A' ' 89' ' ' VAL . 5.8 tt . . . . . 0 CA--C 1.519 -0.223 0 N-CA-C 113.284 0.846 . . . . 1.3899999999999999 113.284 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.639 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.0 OUTLIER -53.17 -42.9 66.64 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 123.618 1.675 . . . . 1.05 109.208 -178.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.71 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 6.3 mmt -55.29 -62.85 1.4 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 110.942 -2.845 . . . . 1.6399999999999999 111.13 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.758 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.27 -44.4 5.37 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.106 0.879 . . . . 0.31 111.833 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.641 ' HE3' ' OG ' ' A' ' 91' ' ' SER . 4.0 mptp? -49.28 -65.02 0.64 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.287 -0.634 . . . . 1.53 109.287 175.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -54.06 -45.49 71.71 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.895 -1.048 . . . . 0.40999999999999998 112.001 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.71 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.4 mt-30 -55.65 -36.37 66.97 Favored 'General case' 0 CA--C 1.488 -1.424 0 CA-C-N 114.843 -1.071 . . . . 0.37 109.916 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -90.47 -29.39 17.96 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.172 -1.376 . . . . 0.23999999999999999 109.57 -176.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.07 -38.68 0.73 Allowed Glycine 0 CA--C 1.497 -1.069 0 C-N-CA 119.558 -1.306 . . . . 0.33000000000000002 113.933 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 141' ' ' SER . 92.1 mt -73.12 -173.49 1.3 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 123.94 1.829 . . . . 0.31 115.275 -167.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 15.3 m -109.4 147.85 36.86 Favored Pre-proline 0 N--CA 1.42 -1.944 0 CA-C-N 110.72 -2.945 . . . . 0.81000000000000005 107.984 168.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.639 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 34.3 Cg_endo -63.78 1.2 1.54 Allowed 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 123.058 2.505 . . . . 0.32000000000000001 112.176 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.57 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -117.1 -22.25 8.47 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.136 0.969 . . . . 1.25 110.251 -178.187 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 141' ' ' SER . 17.2 t70 -61.0 -24.29 66.04 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 112.963 -1.926 . . . . 0.65000000000000002 109.211 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.68 ' O ' HD13 ' A' ' 136' ' ' LEU . 14.0 m 74.42 174.83 0.26 Allowed 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 125.942 2.026 . . . . 0.59999999999999998 108.468 -170.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.1 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.4 mt -69.76 -39.72 76.52 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.21 -1.033 . . . . 0.85999999999999999 108.21 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.41 -12.0 0.73 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 113.276 -1.783 . . . . 0.31 114.41 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.96 125.11 7.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.605 -0.712 . . . . 0.23999999999999999 109.118 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.711 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -40.86 -47.95 3.01 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 118.075 0.398 . . . . 1.6499999999999999 111.81 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 149' ' ' ILE . 32.3 t -71.25 -29.22 64.83 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.391 0.615 . . . . 0.53000000000000003 111.592 -175.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -71.15 -27.57 63.64 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.681 1.229 . . . . 1.3100000000000001 108.374 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 1.1 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -78.6 -47.88 16.26 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 112.287 -2.233 . . . . 0.12 110.395 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.648 HG13 ' HE1' ' A' ' 179' ' ' MET . 36.7 mt -65.28 -42.12 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 112.837 -1.983 . . . . 0.11 110.252 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.3 -56.76 15.69 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.778 -1.101 . . . . 0.14999999999999999 110.964 171.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.758 HG23 ' CB ' ' A' ' 130' ' ' ALA . 70.8 mt -63.99 -47.73 89.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 N-CA-C 112.458 0.54 . . . . 0.17999999999999999 112.458 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.635 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.13 -42.01 76.24 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 123.241 0.338 . . . . 0.13 110.682 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.469 ' HD2' HG23 ' A' ' 149' ' ' ILE . 29.5 mtp180 -80.5 -23.05 40.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.643 0.735 . . . . 1.0800000000000001 110.795 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -80.9 -12.99 59.31 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.424 -1.324 . . . . 0.5 107.424 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.699 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.49 -29.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 112.987 -1.915 . . . . 0.17000000000000001 110.741 -175.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.46 34.19 5.11 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.59 -0.814 . . . . 0.16 112.612 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.668 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.66 159.81 16.44 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.912 0.708 . . . . 0.12 112.912 -169.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.687 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.5 m80 -99.29 -28.21 13.42 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.212 -0.904 . . . . 0.20000000000000001 109.323 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.575 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.6 m-85 -136.26 -176.91 4.48 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.963 -1.017 . . . . 0.13 111.008 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.687 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -134.06 141.34 44.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.665 -1.152 . . . . 0.080000000000000002 108.609 167.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.66 HD21 ' SD ' ' A' ' 176' ' ' MET . 29.9 tp -110.21 100.39 9.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.666 -0.814 . . . . 0.16 109.441 165.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.545 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.0 m-85 -79.06 112.45 16.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.579 -1.192 . . . . 0.26000000000000001 108.899 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.855 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 5.5 t -126.09 161.91 26.54 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-O 121.956 0.884 . . . . 1.05 110.691 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.853 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.7 p -162.83 177.59 9.16 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.23 -1.35 . . . . 0.10000000000000001 111.141 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -140.85 133.77 29.13 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.175 -1.375 . . . . 0.11 108.551 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -143.36 -176.61 5.01 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.307 -0.557 . . . . 1.0900000000000001 109.592 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.39 -81.37 0.94 Allowed Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.669 -1.253 . . . . 0.14999999999999999 111.873 172.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 53.1 t-20 -142.2 127.37 18.58 Favored 'General case' 0 C--O 1.197 -1.681 0 N-CA-C 106.747 -1.575 . . . . 0.58999999999999997 106.747 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.595 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.9 p -63.25 -41.13 91.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-N 115.438 -0.801 . . . . 0.14999999999999999 112.125 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.426 ' N ' HG13 ' A' ' 169' ' ' VAL . 91.9 m-20 -65.14 -28.45 69.43 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.317 0.579 . . . . 1.26 110.496 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.51 88.47 3.35 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 114.571 -1.195 . . . . 0.13 108.138 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.79 ' HD2' HG22 ' A' ' 194' ' ' VAL . 50.9 Cg_endo -90.09 164.96 4.75 Favored 'Trans proline' 0 CA--C 1.491 -1.658 0 C-N-CA 124.56 3.507 . . . . 0.089999999999999997 114.998 -170.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 191' ' ' LYS . 20.6 m -84.4 117.83 23.87 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.898 -1.501 . . . . 0.14000000000000001 107.628 166.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 164' ' ' SER . 40.4 tp -84.23 99.47 10.58 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.58 -0.896 . . . . 0.16 108.58 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.624 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.3 mt-30 -90.69 109.41 20.59 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-O 122.063 0.935 . . . . 0.34000000000000002 109.634 -175.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.855 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -112.84 164.36 13.5 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.958 -1.019 . . . . 1.0900000000000001 111.789 -172.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.61 ' HG2' HD12 ' A' ' 186' ' ' ILE . 55.9 tt0 -171.56 116.84 0.41 Allowed 'General case' 0 C--O 1.202 -1.395 0 CA-C-N 115.98 -0.555 . . . . 0.5 109.967 -166.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.03 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -99.23 101.53 12.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.554 -0.906 . . . . 0.10000000000000001 108.554 -171.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.711 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 18.4 ttp -91.18 122.69 34.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.404 -0.816 . . . . 0.070000000000000007 109.87 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.81 126.35 27.29 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.234 -1.395 . . . . 0.22 107.234 165.936 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.62 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -80.91 -35.68 14.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 119.303 -0.959 . . . . 0.11 110.72 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.428 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.8 mt-30 -60.57 -16.99 43.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.328 -0.851 . . . . 0.34999999999999998 111.603 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.8 p -129.33 -37.37 1.64 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.969 0.89 . . . . 0.19 110.155 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.546 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.5 23.67 28.15 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 114.402 -1.272 . . . . 0.17999999999999999 112.293 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.81 156.88 17.11 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.607 0.241 . . . . 0.72999999999999998 110.672 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 177' ' ' GLN . 37.9 mm -92.87 114.94 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.543 0.687 . . . . 0.14000000000000001 109.597 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.03 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -102.22 -31.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.878 -1.055 . . . . 0.13 110.603 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.656 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.9 t90 -135.59 153.33 51.71 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.487 -0.779 . . . . 0.070000000000000007 109.87 173.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 28.0 p -153.61 163.4 40.05 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.157 0.799 . . . . 0.13 113.157 164.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.38 -175.47 31.41 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 110.839 -0.904 . . . . 0.12 110.839 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.4 mtmt -158.25 151.14 22.59 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.421 -2.066 . . . . 1.22 105.421 166.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -160.88 127.75 1.81 Allowed Glycine 0 C--N 1.281 -2.515 0 C-N-CA 119.879 -1.153 . . . . 0.12 112.195 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.39 118.16 14.93 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.444 0.64 . . . . 0.17000000000000001 111.199 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.79 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -93.34 158.5 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-O 122.42 1.105 . . . . 0.11 109.868 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.673 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -97.98 171.46 8.26 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 112.879 -1.964 . . . . 0.17999999999999999 109.581 -173.042 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.1 tt0 -103.09 127.48 50.35 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.984 -0.747 . . . . 0.91000000000000003 108.984 166.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 14.2 mm-40 . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 118.724 -0.655 . . . . 1.24 110.817 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.771 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 1.8 m-30 . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 120.388 0.137 . . . . 0.20999999999999999 110.919 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 11.5 t70 -82.66 67.98 8.94 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 123.481 1.61 . . . . 0.34999999999999998 108.627 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.771 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 93.3 m95 -60.51 -43.75 96.73 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 112.14 -2.3 . . . . 0.10000000000000001 112.312 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 4.2 t30 -52.3 -29.0 21.23 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.064 -1.425 . . . . 1.1100000000000001 111.211 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.37 -16.48 80.69 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 115.35 -0.841 . . . . 0.20999999999999999 111.295 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.97 -51.64 3.49 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.183 -1.009 . . . . 0.13 110.959 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.718 ' SD ' HD23 ' A' ' 109' ' ' LEU . 38.5 mtt -65.61 -56.63 11.21 Favored 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 114.086 -1.415 . . . . 0.089999999999999997 112.517 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.6 mm100 -40.21 -54.57 4.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 114.732 1.382 . . . . 0.63 114.732 -176.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.802 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.2 Cg_endo -64.27 -30.09 63.95 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 121.916 1.744 . . . . 0.14000000000000001 110.664 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.673 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 7.7 mtm -81.62 -44.59 17.0 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 115.165 -0.925 . . . . 0.69999999999999996 111.826 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 68' ' ' MET . 49.0 t -56.74 -39.54 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-N 114.279 -1.328 . . . . 0.12 108.443 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.6 t -59.67 -32.62 70.64 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.049 -1.887 . . . . 0.56000000000000005 111.177 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.2 mtpt -85.98 -33.29 21.14 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.929 0.395 . . . . 1.3 111.046 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.851 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.65 -27.64 69.07 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.484 -0.78 . . . . 0.5 111.786 -171.319 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.548 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.0 mt -93.05 -5.68 49.94 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.94 0.876 . . . . 0.65000000000000002 111.257 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.14 15.29 47.56 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.201 -1.559 . . . . 0.17000000000000001 109.201 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.641 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -83.47 165.99 18.69 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.409 -0.895 . . . . 0.10000000000000001 111.148 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.52 105.68 14.65 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.876 -1.056 . . . . 1.72 110.382 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.606 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 129.25 -21.12 5.22 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.151 -1.023 . . . . 0.12 111.175 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.851 HG11 ' O ' ' A' ' 75' ' ' MET . 11.2 p -100.81 149.42 6.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.896 0.855 . . . . 0.16 110.837 -176.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.3 m -136.19 142.27 44.1 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.197 -1.365 . . . . 0.45000000000000001 109.701 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.736 ' HB2' ' HD2' ' A' ' 118' ' ' LYS . . . -62.37 136.21 57.81 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.54 -0.755 . . . . 0.28000000000000003 110.754 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.08 9.54 39.14 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.957 -0.64 . . . . 0.28000000000000003 112.777 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.37 152.03 18.75 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.742 -0.383 . . . . 1.2 110.711 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.685 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -80.95 120.12 31.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 122.015 0.912 . . . . 0.20000000000000001 109.103 165.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.666 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -107.45 110.57 22.55 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.137 -0.938 . . . . 0.14000000000000001 108.799 -172.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.715 HD21 HD13 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -70.67 99.39 1.67 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 114.786 -1.097 . . . . 0.14999999999999999 108.419 179.484 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.454 HG11 ' HG3' ' A' ' 110' ' ' ARG . 85.3 t -72.82 108.93 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 114.324 -1.307 . . . . 0.94999999999999996 108.416 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.806 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 6.8 t0 -77.79 154.56 31.8 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.982 -1.118 . . . . 0.64000000000000001 107.982 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.556 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.37 138.14 57.75 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.588 -1.264 . . . . 0.37 107.588 171.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.505 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 26.3 t -66.5 141.08 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.633 0 N-CA-C 107.904 -1.147 . . . . 0.10000000000000001 107.904 168.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.789 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.8 t-20 -86.2 163.08 18.0 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.459 -0.792 . . . . 0.17999999999999999 109.917 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.763 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 1.8 t-20 -126.01 84.84 2.32 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.669 -1.15 . . . . 0.12 108.29 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 13.7 mtp180 -108.97 -2.1 18.51 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.076 -1.42 . . . . 0.64000000000000001 108.705 -171.106 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.748 HG21 ' HB3' ' A' ' 172' ' ' PRO . 17.6 p -50.7 -172.07 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 112.608 -2.087 . . . . 0.14000000000000001 115.483 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.0 t30 -67.71 -13.1 61.81 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.028 -1.896 . . . . 0.47999999999999998 110.558 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.579 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -148.86 -146.26 4.29 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.592 -0.813 . . . . 0.12 112.884 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.618 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 49.2 m -122.15 129.0 51.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.943 0.402 . . . . 1.1599999999999999 111.134 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.763 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -132.12 159.29 39.34 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.525 0.678 . . . . 0.10000000000000001 110.054 -177.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.709 ' ND2' ' HB2' ' A' ' 104' ' ' GLU . 56.8 t30 -81.37 82.25 7.26 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.317 -1.311 . . . . 0.17000000000000001 108.229 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.608 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -69.25 -15.13 63.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.205 -1.361 . . . . 0.089999999999999997 109.907 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.463 ' HB2' ' CG ' ' A' ' 139' ' ' GLN . . . -78.28 -30.33 48.42 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.999 -0.741 . . . . 0.14999999999999999 108.999 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.709 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 14.2 tp10 -65.64 -35.2 80.12 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.784 1.278 . . . . 1.73 108.936 170.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.9 -45.9 63.48 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 112.832 -1.985 . . . . 0.12 109.366 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.6 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 55.9 m -63.87 -34.13 77.26 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.064 -1.426 . . . . 0.11 110.527 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -42.03 85.39 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.884 -1.154 . . . . 1.47 107.884 173.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.659 HG21 ' HB2' ' A' ' 64' ' ' TRP . 60.0 m -65.45 -30.99 71.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.252 -0.885 . . . . 0.12 110.984 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.718 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.21 -69.54 0.11 Allowed 'General case' 0 CA--C 1.492 -1.265 0 CA-C-N 115.781 -0.645 . . . . 0.56000000000000005 109.282 172.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.543 ' O ' HD13 ' A' ' 121' ' ' LEU . 60.1 mtp180 -40.64 -37.61 0.76 Allowed 'General case' 0 C--N 1.311 -1.073 0 O-C-N 124.3 1.0 . . . . 1.51 111.499 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 108' ' ' THR . 5.4 m-20 -70.79 -46.24 63.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.716 -1.129 . . . . 0.28000000000000003 112.067 -177.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.4 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.47 -33.52 64.89 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.156 0.979 . . . . 0.089999999999999997 108.532 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -63.58 -33.95 76.74 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.454 -1.703 . . . . 0.12 109.918 172.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.642 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -76.09 -43.51 43.11 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.763 -1.108 . . . . 0.20000000000000001 111.226 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.28 -38.49 65.94 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.562 -1.199 . . . . 1.1699999999999999 110.414 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.528 ' OD1' ' HG3' ' A' ' 118' ' ' LYS . 12.2 t-20 -69.11 -47.59 64.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 113.382 -1.736 . . . . 2.0499999999999998 109.398 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.53 -8.39 68.81 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 116.033 -0.531 . . . . 0.54000000000000004 113.762 171.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.736 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 15.6 mtmm -72.67 -33.93 66.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.096 -0.642 . . . . 0.98999999999999999 111.154 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.704 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 15.1 m-85 -90.92 176.91 6.44 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 122.328 1.061 . . . . 0.20999999999999999 112.526 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.508 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.8 m -120.8 117.61 27.86 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 112.85 -1.977 . . . . 0.23000000000000001 108.151 168.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.676 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -88.63 132.85 34.38 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 115.362 -0.836 . . . . 0.38 110.367 -171.525 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.584 HG11 HD23 ' A' ' 88' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.301 -1.517 0 N-CA-C 109.057 -0.72 . . . . 0.41999999999999998 109.057 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.715 HD13 HD21 ' A' ' 88' ' ' LEU . 17.7 tp . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 113.603 0.964 . . . . 1.3899999999999999 113.603 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 56.8 m -52.09 -40.58 61.46 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 123.37 1.557 . . . . 1.05 109.116 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.702 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 13.6 mmt -57.26 -62.63 1.63 Allowed 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 111.177 -2.738 . . . . 1.6399999999999999 111.002 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.776 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.22 -45.43 4.12 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 124.38 1.05 . . . . 0.31 111.875 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.571 ' HA ' HD11 ' A' ' 151' ' ' ILE . 1.0 OUTLIER -53.55 -53.6 49.26 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 108.954 -0.758 . . . . 1.53 108.954 178.658 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 128' ' ' SER . 37.5 mt-30 -64.23 -39.77 94.67 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.466 -0.788 . . . . 0.40999999999999998 111.128 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.702 ' HG3' ' O ' ' A' ' 129' ' ' MET . 53.0 mt-30 -59.0 -34.66 72.11 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 114.354 -1.294 . . . . 0.37 109.83 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -91.7 -28.79 17.21 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 114.243 -1.344 . . . . 0.23999999999999999 109.644 -176.259 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.58 -42.92 0.7 Allowed Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 119.894 -1.146 . . . . 0.33000000000000002 113.426 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 141' ' ' SER . 94.0 mt -69.9 -171.46 0.42 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 124.102 1.906 . . . . 0.31 115.472 -169.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 32.1 m -114.89 153.93 46.99 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 110.353 -3.112 . . . . 0.81000000000000005 107.194 174.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.623 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 64.6 Cg_endo -68.91 1.22 4.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.416 2.077 . . . . 0.32000000000000001 110.91 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.463 ' CG ' ' HB2' ' A' ' 103' ' ' ALA . 20.8 mt-30 -117.56 -23.35 7.72 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.132 -1.395 . . . . 1.25 111.031 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 14.3 t70 -69.05 -22.14 64.05 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 114.515 -1.22 . . . . 0.65000000000000002 108.879 -169.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.588 ' O ' HD13 ' A' ' 136' ' ' LEU . 32.3 m 71.76 166.94 0.3 Allowed 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 112.485 -2.143 . . . . 0.59999999999999998 109.578 -170.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.982 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.6 mt -65.48 -40.15 92.78 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 122.191 0.996 . . . . 0.85999999999999999 108.317 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.14 -12.18 0.27 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 113.047 -1.888 . . . . 0.31 114.476 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.25 123.3 7.57 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.023 -0.732 . . . . 0.23999999999999999 109.023 -173.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.664 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -42.43 -45.56 4.43 Favored 'General case' 0 C--O 1.213 -0.843 0 O-C-N 123.394 0.434 . . . . 1.6499999999999999 111.73 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -73.93 -25.49 60.01 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.676 0.751 . . . . 0.53000000000000003 111.407 -174.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -73.55 -30.47 63.07 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.634 1.207 . . . . 1.3100000000000001 108.331 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.982 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -75.41 -47.72 26.09 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 112.577 -2.102 . . . . 0.12 110.36 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.62 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.6 mt -65.49 -41.46 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-N 112.88 -1.964 . . . . 0.11 110.44 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.12 -53.53 36.8 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.67 -1.15 . . . . 0.14999999999999999 111.25 171.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.776 HG23 ' CB ' ' A' ' 130' ' ' ALA . 83.9 mt -66.67 -48.3 80.58 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 N-CA-C 112.172 0.434 . . . . 0.17999999999999999 112.172 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.682 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -54.43 -44.46 72.46 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 123.603 0.565 . . . . 0.13 111.248 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.459 ' NE ' HG23 ' A' ' 149' ' ' ILE . 49.7 mtt180 -78.76 -23.14 45.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.295 0.569 . . . . 1.0800000000000001 110.882 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -81.6 -13.66 57.72 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.641 -1.244 . . . . 0.5 107.641 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.703 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.01 -28.91 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 113.313 -1.767 . . . . 0.17000000000000001 111.041 -173.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.423 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.88 34.85 4.76 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.261 -0.971 . . . . 0.16 112.365 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.619 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.91 157.34 19.34 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.886 0.698 . . . . 0.12 112.886 -170.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.685 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.8 m80 -98.92 -28.63 13.35 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.137 -0.938 . . . . 0.20000000000000001 109.425 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.567 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.1 m-85 -135.13 -173.97 3.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.063 -0.971 . . . . 0.13 110.856 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.703 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -136.97 139.97 43.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.13 -0.941 . . . . 0.080000000000000002 108.93 166.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 40.1 tp -107.8 100.12 9.52 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.237 -0.985 . . . . 0.16 109.318 165.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.7 m-85 -80.39 116.65 20.57 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.226 -1.352 . . . . 0.26000000000000001 108.577 176.485 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.868 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 4.7 t -129.01 162.55 27.36 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.948 0.88 . . . . 1.05 110.607 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.831 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.4 p -162.4 176.24 10.7 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.4 -1.273 . . . . 0.10000000000000001 110.971 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -137.91 134.76 35.38 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.086 -1.416 . . . . 0.11 108.513 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.4 m -144.19 -176.0 4.84 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.278 -0.638 . . . . 1.0900000000000001 109.278 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -84.21 0.92 Allowed Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.824 -1.179 . . . . 0.14999999999999999 111.407 173.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.3 t30 -144.49 128.19 17.2 Favored 'General case' 0 C--O 1.197 -1.665 0 N-CA-C 107.921 -1.141 . . . . 0.58999999999999997 107.921 176.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.579 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.7 p -63.22 -41.77 94.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.136 -0.938 . . . . 0.14999999999999999 112.334 -172.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.41 ' N ' HG13 ' A' ' 169' ' ' VAL . 42.4 m-20 -59.17 -31.67 69.2 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.49 0.662 . . . . 1.26 109.552 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.05 89.2 3.11 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 114.329 -1.305 . . . . 0.13 108.351 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.8 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.5 Cg_endo -90.49 166.98 4.23 Favored 'Trans proline' 0 CA--C 1.494 -1.492 0 C-N-CA 124.481 3.454 . . . . 0.089999999999999997 114.815 -169.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.3 m -85.75 120.19 26.91 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 113.904 -1.498 . . . . 0.14000000000000001 107.369 165.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 164' ' ' SER . 44.4 tp -84.68 98.66 10.34 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 108.714 -0.847 . . . . 0.16 108.714 176.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.576 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -89.93 109.39 20.41 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 122.097 0.951 . . . . 0.34000000000000002 109.265 -176.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.868 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.9 OUTLIER -112.48 163.83 14.0 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.76 -1.109 . . . . 1.0900000000000001 111.538 -173.286 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.609 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.5 tt0 -170.67 119.02 0.53 Allowed 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.89 -0.596 . . . . 0.5 109.98 -166.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.049 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.25 100.15 10.64 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.671 -0.863 . . . . 0.10000000000000001 108.671 -173.268 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.664 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.8 ttp -89.42 123.06 33.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.433 -0.803 . . . . 0.070000000000000007 109.548 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.2 OUTLIER -59.63 127.36 31.64 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.892 -1.522 . . . . 0.22 106.892 166.491 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.93 -35.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 O-C-N 121.131 -0.981 . . . . 0.11 110.904 179.214 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.458 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 28.9 mt-30 -61.68 -16.2 46.79 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 0.34999999999999998 111.087 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 73.9 p -129.66 -37.05 1.59 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.752 0.786 . . . . 0.19 110.199 178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.552 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.82 24.88 26.51 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 114.701 -1.136 . . . . 0.17999999999999999 112.387 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -103.85 156.4 17.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.679 0.276 . . . . 0.72999999999999998 110.481 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.609 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.1 mm -89.22 117.0 31.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.552 0.692 . . . . 0.14000000000000001 109.335 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.049 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -104.99 -30.54 2.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.098 -0.955 . . . . 0.13 110.341 -174.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.661 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.0 t90 -136.42 152.22 50.36 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.397 -0.819 . . . . 0.070000000000000007 109.417 172.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 77.2 p -153.59 163.32 40.18 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.891 -0.724 . . . . 0.13 112.926 163.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.44 -174.93 28.78 Favored Glycine 0 N--CA 1.425 -2.047 0 N-CA-C 110.885 -0.886 . . . . 0.12 110.885 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.8 mtmt -158.96 151.28 21.4 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.383 -2.08 . . . . 1.22 105.383 165.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -159.43 127.24 1.79 Allowed Glycine 0 C--N 1.278 -2.676 0 C-N-CA 119.623 -1.275 . . . . 0.12 112.108 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.17 115.08 10.98 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.404 0.621 . . . . 0.17000000000000001 111.065 -174.535 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.8 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -91.87 158.45 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-O 122.59 1.186 . . . . 0.11 110.181 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.85 172.26 7.04 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 112.564 -2.107 . . . . 0.17999999999999999 109.166 -174.265 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.9 tt0 -100.42 130.65 46.53 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.261 -0.644 . . . . 0.91000000000000003 109.261 169.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.494 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 26.7 mm-40 . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 115.883 -0.599 . . . . 1.24 110.138 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.743 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.6 m-30 . . . . . 0 N--CA 1.417 -2.079 0 N-CA-C 109.662 -0.496 . . . . 0.20999999999999999 109.662 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 15.7 t70 -80.15 67.06 5.85 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 123.289 1.519 . . . . 0.34999999999999998 108.257 172.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.718 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.6 m95 -59.01 -44.17 91.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 111.77 -2.468 . . . . 0.10000000000000001 112.109 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 4.8 t30 -51.51 -29.33 16.29 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.04 -1.436 . . . . 1.1100000000000001 111.37 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.5 -16.49 80.69 Favored Glycine 0 C--N 1.314 -0.683 0 CA-C-N 115.385 -0.825 . . . . 0.20999999999999999 111.254 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.73 -53.16 3.03 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.062 -1.069 . . . . 0.13 111.091 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.69 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.8 mtt -63.56 -57.94 8.55 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 114.229 -1.35 . . . . 0.089999999999999997 112.139 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 5.7 mm100 -38.61 -55.31 2.67 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 115.172 1.545 . . . . 0.63 115.172 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.754 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.6 Cg_endo -65.04 -28.85 57.22 Favored 'Trans proline' 0 CA--C 1.51 -0.716 0 C-N-CA 121.673 1.582 . . . . 0.14000000000000001 110.649 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.637 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 11.3 mtm -84.47 -40.73 17.35 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.198 -0.91 . . . . 0.69999999999999996 111.452 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 68' ' ' MET . 60.4 t -57.73 -38.32 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 CA-C-O 122.353 1.073 . . . . 0.12 108.506 172.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 t -60.52 -35.41 75.9 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.014 -1.903 . . . . 0.56000000000000005 111.11 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.754 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 27.6 mtpt -81.37 -38.82 26.01 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.577 -0.527 . . . . 1.3 109.577 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.833 ' SD ' ' HE2' ' A' ' 119' ' ' PHE . 1.2 ttm -47.19 -54.6 10.29 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 123.901 0.751 . . . . 0.5 110.355 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.632 ' N ' ' HG2' ' A' ' 75' ' ' MET . 4.7 mt -80.03 7.62 8.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.525 -1.216 . . . . 0.65000000000000002 112.285 -169.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.96 17.33 8.68 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 113.941 -1.481 . . . . 0.17000000000000001 109.88 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -81.83 165.15 21.11 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.404 0.621 . . . . 0.10000000000000001 110.252 176.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -87.06 107.6 18.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.281 -0.872 . . . . 1.72 109.797 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.664 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 133.96 -24.89 3.58 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 110.763 -0.935 . . . . 0.12 110.763 -178.104 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.762 HG11 ' O ' ' A' ' 75' ' ' MET . 10.8 p -102.92 151.08 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.777 0.799 . . . . 0.16 111.164 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.5 m -135.91 142.73 44.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.43 -1.259 . . . . 0.45000000000000001 110.211 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.665 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -56.14 142.84 35.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.585 -0.734 . . . . 0.28000000000000003 110.469 166.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.32 11.33 58.55 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.778 -0.725 . . . . 0.28000000000000003 113.17 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.55 153.14 18.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.148 0.474 . . . . 1.2 110.552 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.696 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -82.28 120.47 33.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 108.772 -0.825 . . . . 0.20000000000000001 108.772 166.191 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.64 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -108.45 109.78 21.14 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.542 -0.754 . . . . 0.14000000000000001 109.308 -171.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.787 HD21 HD23 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -73.13 94.5 1.94 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.504 -1.225 . . . . 0.14999999999999999 108.945 177.378 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 2.0 m -73.04 115.93 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 106.902 -1.518 . . . . 0.94999999999999996 106.902 174.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.873 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 13.3 t0 -79.97 170.4 16.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.331 -0.989 . . . . 0.64000000000000001 108.331 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.525 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.5 OUTLIER -55.5 148.72 14.94 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-O 122.774 1.273 . . . . 0.37 109.375 170.278 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.515 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 34.6 t -77.62 140.5 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.172 0 N-CA-C 106.81 -1.552 . . . . 0.10000000000000001 106.81 165.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.81 ' H ' ' HA ' ' A' ' 164' ' ' SER . 5.5 t-20 -85.55 160.91 19.54 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 122.031 0.919 . . . . 0.17999999999999999 110.344 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.749 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -124.27 84.63 2.3 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 113.939 -1.482 . . . . 0.12 107.575 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.465 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 13.2 mtp180 -107.18 -2.07 21.24 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 113.66 -1.609 . . . . 0.64000000000000001 108.411 -172.785 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.726 HG21 ' HB3' ' A' ' 172' ' ' PRO . 22.3 p -50.96 -177.73 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.36 -1.745 . . . . 0.14000000000000001 113.799 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 1.5 t30 -73.49 -7.62 52.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.065 -1.88 . . . . 0.47999999999999998 110.263 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.618 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -142.37 -151.43 5.51 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.944 -0.645 . . . . 0.12 112.869 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.596 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 51.8 m -121.92 130.58 53.45 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.955 0.407 . . . . 1.1599999999999999 111.728 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.749 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.0 pp -134.84 158.19 44.85 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.876 0.846 . . . . 0.10000000000000001 110.795 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -80.64 79.69 7.23 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.019 -1.446 . . . . 0.17000000000000001 108.08 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.57 -15.77 63.83 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.376 -1.284 . . . . 0.089999999999999997 109.846 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.55 -31.56 42.02 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.888 -0.782 . . . . 0.14999999999999999 108.888 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.614 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.6 tp10 -66.04 -33.98 77.03 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.697 1.237 . . . . 1.73 108.876 171.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.29 -43.42 64.25 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 113.118 -1.855 . . . . 0.12 109.656 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 63.7 m -63.91 -32.2 73.65 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.107 -1.406 . . . . 0.11 110.537 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -40.99 80.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.997 -1.112 . . . . 1.47 107.997 173.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.683 HG21 ' HB2' ' A' ' 64' ' ' TRP . 54.7 m -64.5 -31.06 72.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.21 -0.904 . . . . 0.12 110.693 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.719 ' O ' HD23 ' A' ' 113' ' ' LEU . 8.4 mt -51.74 -70.05 0.1 Allowed 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.296 -0.631 . . . . 0.56000000000000005 109.296 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.635 ' O ' HD13 ' A' ' 121' ' ' LEU . 21.2 mtp180 -39.72 -38.46 0.64 Allowed 'General case' 0 C--N 1.315 -0.933 0 O-C-N 124.436 1.085 . . . . 1.51 111.331 174.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.3 m-20 -70.86 -46.89 61.87 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.578 -1.192 . . . . 0.28000000000000003 112.313 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.57 -31.0 64.89 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.227 1.013 . . . . 0.089999999999999997 108.471 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -66.15 -32.55 74.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.511 -1.677 . . . . 0.12 109.906 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.591 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.31 -39.39 68.27 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.48 -1.236 . . . . 0.20000000000000001 111.565 -175.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -66.97 -21.69 65.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.061 -0.972 . . . . 1.1699999999999999 111.265 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.69 -14.41 28.08 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.053 -0.521 . . . . 2.0499999999999998 111.753 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.24 -11.89 0.69 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 116.164 1.226 . . . . 0.54000000000000004 116.164 163.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 51.7 mtpt -74.51 -33.03 62.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.819 0.81 . . . . 0.98999999999999999 111.139 -177.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.833 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 20.8 m-85 -93.6 178.2 5.77 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 122.391 1.091 . . . . 0.20999999999999999 112.678 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 6.2 m -121.25 116.95 25.83 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 112.901 -1.954 . . . . 0.23000000000000001 107.822 168.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.702 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -87.54 135.49 33.33 Favored 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 119.477 -0.889 . . . . 0.38 110.751 -171.781 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.581 HG11 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.296 -1.759 0 N-CA-C 108.923 -0.769 . . . . 0.41999999999999998 108.923 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.787 HD23 HD21 ' A' ' 88' ' ' LEU . 1.9 tm? . . . . . 0 C--O 1.236 0.354 0 N-CA-C 113.218 0.822 . . . . 1.3899999999999999 113.218 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.648 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.5 OUTLIER -52.34 -39.89 61.26 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 123.712 1.72 . . . . 1.05 108.753 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.627 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -62.9 -59.85 4.28 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 110.694 -2.957 . . . . 1.6399999999999999 110.783 179.167 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.756 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.86 -40.01 5.85 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 124.098 0.874 . . . . 0.31 112.006 175.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.723 ' NZ ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -51.52 -60.46 3.12 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.825 -0.75 . . . . 1.53 109.215 175.329 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 37.2 mt-30 -58.74 -44.66 90.58 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.379 -1.282 . . . . 0.40999999999999998 111.7 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 129' ' ' MET . 43.5 mt-30 -55.33 -34.2 64.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.986 -1.006 . . . . 0.37 110.151 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.528 ' CD1' HG13 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -93.59 -30.56 14.91 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.991 -1.459 . . . . 0.23999999999999999 109.364 -178.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 161.43 -54.9 0.32 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.929 -1.129 . . . . 0.33000000000000002 114.086 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.508 ' CD1' ' HA ' ' A' ' 142' ' ' LEU . 43.8 mt -64.05 -172.36 0.06 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 116.385 1.994 . . . . 0.31 116.385 -168.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.5 m -111.16 150.7 42.37 Favored Pre-proline 0 N--CA 1.428 -1.54 0 CA-C-N 110.954 -2.839 . . . . 0.81000000000000005 108.777 170.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.648 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 15.1 Cg_endo -60.08 -2.49 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 123.357 2.705 . . . . 0.32000000000000001 113.107 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 101' ' ' ASN . 0.8 OUTLIER -117.44 -26.41 6.68 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.911 0.862 . . . . 1.25 110.647 -177.022 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 4.6 t70 -64.8 -24.56 67.59 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 113.696 -1.593 . . . . 0.65000000000000002 109.359 -171.138 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 22.6 m 66.33 161.56 0.15 Allowed 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 112.689 -2.05 . . . . 0.59999999999999998 109.995 -175.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.881 HD13 ' HA ' ' A' ' 148' ' ' ALA . 9.2 mt -73.19 -35.63 66.4 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.148 -1.842 . . . . 0.85999999999999999 109.204 -169.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.36 2.98 0.31 Allowed Glycine 0 C--N 1.318 -0.464 0 CA-C-N 113.164 -1.835 . . . . 0.31 114.949 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 118.14 5.27 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 109.07 -0.715 . . . . 0.23999999999999999 109.07 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.69 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 13.0 mmt180 -40.23 -47.87 2.5 Favored 'General case' 0 C--O 1.214 -0.783 0 O-C-N 123.696 0.623 . . . . 1.6499999999999999 111.448 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -69.77 -28.24 65.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.477 0.656 . . . . 0.53000000000000003 111.461 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.545 ' O ' HD12 ' A' ' 151' ' ' ILE . 21.2 mttm -72.82 -31.32 64.72 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.38 1.086 . . . . 1.3100000000000001 108.276 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.881 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -77.75 -38.94 45.86 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 113.15 -1.841 . . . . 0.12 110.798 178.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.605 ' HA ' HG23 ' A' ' 181' ' ' VAL . 33.0 mt -69.78 -43.17 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 CA-C-N 113.821 -1.536 . . . . 0.11 109.978 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.73 -53.57 35.43 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.177 -0.919 . . . . 0.14999999999999999 110.979 171.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.756 HG23 ' CB ' ' A' ' 130' ' ' ALA . 7.6 mt -67.14 -44.92 87.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.028 0 N-CA-C 113.069 0.766 . . . . 0.17999999999999999 113.069 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.65 -37.9 76.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 118.447 0.567 . . . . 0.13 110.513 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 149' ' ' ILE . 46.8 mtp180 -83.18 -21.7 33.44 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.799 0.809 . . . . 1.0800000000000001 110.407 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 28.3 t-20 -82.58 -10.32 59.02 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.187 -1.412 . . . . 0.5 107.187 175.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.734 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -109.79 -29.24 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 113.294 -1.775 . . . . 0.17000000000000001 111.107 -174.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.76 35.38 4.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.563 -0.827 . . . . 0.16 112.642 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.73 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -112.09 159.28 18.66 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.416 0.895 . . . . 0.12 113.416 -169.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.696 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.1 m80 -100.32 -25.99 14.05 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.486 -0.779 . . . . 0.20000000000000001 110.068 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.571 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.5 m-85 -135.57 -172.62 3.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.234 -0.894 . . . . 0.13 110.959 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.82 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -138.81 136.72 43.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.013 -0.994 . . . . 0.080000000000000002 108.964 167.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 48.6 tp -106.96 99.44 9.01 Favored 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 119.637 -0.825 . . . . 0.16 108.995 165.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.601 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -81.54 111.97 18.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.103 -1.408 . . . . 0.26000000000000001 109.448 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.726 ' OG ' HD11 ' A' ' 174' ' ' LEU . 31.4 t -121.31 166.33 14.2 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 121.699 0.761 . . . . 1.05 110.753 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.868 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.5 p -164.87 176.34 8.79 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-N 114.625 -1.17 . . . . 0.10000000000000001 111.351 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -142.64 135.36 28.03 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.294 -1.321 . . . . 0.11 108.499 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 3.1 m -144.42 -175.79 4.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.516 -0.55 . . . . 1.0900000000000001 109.516 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.6 -80.12 0.82 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 119.463 -1.351 . . . . 0.14999999999999999 112.025 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.5 t30 -148.92 123.2 9.58 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 106.917 -1.512 . . . . 0.58999999999999997 106.917 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.618 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.3 p -59.49 -45.65 93.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.121 -0.945 . . . . 0.14999999999999999 113.287 -172.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -60.02 -29.57 68.59 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.452 0.644 . . . . 1.26 109.703 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.91 88.03 3.6 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.441 -1.254 . . . . 0.13 108.512 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.813 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.6 Cg_endo -91.22 166.47 3.63 Favored 'Trans proline' 0 CA--C 1.496 -1.407 0 C-N-CA 124.835 3.69 . . . . 0.089999999999999997 114.98 -170.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.2 m -83.19 117.95 23.27 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.856 -1.52 . . . . 0.14000000000000001 107.638 166.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.868 HD12 ' O ' ' A' ' 164' ' ' SER . 46.4 tp -84.46 99.25 10.57 Favored 'General case' 0 N--CA 1.412 -2.325 0 C-N-CA 119.747 -0.781 . . . . 0.16 109.289 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.677 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.2 mt-30 -89.51 107.36 19.03 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 114.966 -1.015 . . . . 0.34000000000000002 109.291 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 37.5 mtp -106.52 161.83 14.26 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.212 -0.904 . . . . 1.0900000000000001 110.382 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.611 ' HG2' HD12 ' A' ' 186' ' ' ILE . 53.2 tt0 -167.47 119.03 0.88 Allowed 'General case' 0 C--O 1.207 -1.183 0 CA-C-O 121.165 0.507 . . . . 0.5 110.025 -168.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.087 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -101.01 101.34 12.1 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.826 -0.805 . . . . 0.10000000000000001 108.826 -172.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.69 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.0 ttp -91.14 118.95 30.86 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.603 -0.726 . . . . 0.070000000000000007 109.318 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.549 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -61.85 118.49 7.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.273 -1.38 . . . . 0.22 107.273 169.618 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -73.2 -32.88 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 119.516 1.053 . . . . 0.11 111.408 -176.393 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.437 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.1 mt-30 -64.1 -12.84 43.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.34999999999999998 111.538 -177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 33.1 p -130.12 -37.56 1.46 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.079 0.943 . . . . 0.19 109.892 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.594 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.82 19.47 51.25 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 113.756 -1.565 . . . . 0.17999999999999999 112.08 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.66 156.56 17.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.055 0.455 . . . . 0.72999999999999998 110.677 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.611 HD12 ' HG2' ' A' ' 177' ' ' GLN . 37.9 mm -88.4 117.48 32.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.679 0.752 . . . . 0.14000000000000001 109.424 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.087 HD11 HD13 ' A' ' 178' ' ' LEU . 1.8 pp -104.79 -30.1 2.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.527 -1.215 . . . . 0.13 110.353 -172.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.588 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.3 t90 -137.43 152.33 49.48 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.191 -0.913 . . . . 0.070000000000000007 109.338 172.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.46 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 61.2 p -153.58 165.52 35.65 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.865 0.691 . . . . 0.13 112.865 164.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.16 -179.43 33.99 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.892 -0.883 . . . . 0.12 110.892 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.745 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.8 mtmt -156.78 147.08 21.26 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.33 -1.73 . . . . 1.22 106.33 167.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.637 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -158.04 127.45 1.9 Allowed Glycine 0 C--N 1.283 -2.387 0 C-N-CA 119.94 -1.124 . . . . 0.12 112.266 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.72 117.02 13.9 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.425 0.631 . . . . 0.17000000000000001 111.003 -174.376 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.813 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -93.99 159.25 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 122.589 1.185 . . . . 0.11 110.736 -177.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -101.8 172.08 7.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 112.501 -2.136 . . . . 0.17999999999999999 108.861 -174.695 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.8 tt0 -100.77 133.2 45.59 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.075 -0.65 . . . . 0.91000000000000003 109.411 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.525 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 35.1 mm-40 . . . . . 0 C--N 1.316 -0.89 0 CA-C-O 118.656 -0.688 . . . . 1.24 110.518 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.772 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.9 m-30 . . . . . 0 N--CA 1.434 -1.243 0 CA-C-O 120.207 0.051 . . . . 0.20999999999999999 110.878 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.54 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 10.6 t0 -85.16 67.64 10.25 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 123.395 1.569 . . . . 0.34999999999999998 108.473 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.781 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 94.9 m95 -57.44 -41.9 81.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.008 -2.36 . . . . 0.10000000000000001 112.769 175.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.404 ' N ' HG21 ' A' ' 108' ' ' THR . 6.1 t30 -51.95 -25.43 8.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.197 -1.365 . . . . 1.1100000000000001 111.696 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.69 -16.58 78.97 Favored Glycine 0 C--N 1.312 -0.763 0 CA-C-N 115.147 -0.933 . . . . 0.20999999999999999 111.278 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.41 -52.84 3.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.118 -1.041 . . . . 0.13 111.199 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.723 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.4 mtt -64.59 -58.67 5.7 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 114.122 -1.399 . . . . 0.089999999999999997 112.507 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.484 HE21 ' HA ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -39.42 -54.78 3.56 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 114.794 1.405 . . . . 0.63 114.794 -176.343 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.807 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 37.4 Cg_endo -64.64 -28.97 60.64 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.532 1.488 . . . . 0.14000000000000001 110.16 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.719 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 10.9 mtm -83.09 -42.04 17.88 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.358 -0.837 . . . . 0.69999999999999996 112.108 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 68' ' ' MET . 58.2 t -57.01 -40.13 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 CA-C-N 114.26 -1.336 . . . . 0.12 108.802 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.68 -36.09 73.64 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.152 -1.84 . . . . 0.56000000000000005 111.054 173.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.807 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.1 mtpt -82.08 -32.91 30.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.011 -0.541 . . . . 1.3 111.207 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.833 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.82 -26.16 68.22 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.39 -0.823 . . . . 0.5 111.677 -172.19 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.657 HD13 ' HB2' ' A' ' 118' ' ' LYS . 3.9 mt -94.21 -8.02 40.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.124 0.964 . . . . 0.65000000000000002 110.997 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.82 14.67 60.17 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.664 -1.774 . . . . 0.17000000000000001 108.664 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.664 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -86.46 165.72 16.08 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.159 -1.02 . . . . 0.10000000000000001 109.818 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -94.46 105.38 17.35 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.252 -0.886 . . . . 1.72 109.914 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.651 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 136.23 -23.4 3.32 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.722 -0.951 . . . . 0.12 110.722 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.833 HG11 ' O ' ' A' ' 75' ' ' MET . 10.7 p -101.21 153.76 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.431 0.634 . . . . 0.16 111.197 -175.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.8 m -135.35 141.84 45.64 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.923 -1.035 . . . . 0.45000000000000001 110.441 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.654 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.38 130.25 45.98 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.346 -0.843 . . . . 0.28000000000000003 110.272 168.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.17 3.23 38.77 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.006 -0.616 . . . . 0.28000000000000003 112.876 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.0 151.89 22.87 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 120.488 -0.485 . . . . 1.2 110.97 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.676 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -80.73 119.14 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 121.988 0.899 . . . . 0.20000000000000001 109.031 165.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.763 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -108.38 107.56 18.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.28 -0.873 . . . . 0.14000000000000001 109.108 -171.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.692 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -71.43 97.9 1.71 Allowed 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.141 -1.39 . . . . 0.14999999999999999 107.847 175.575 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.894 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.5 m -71.08 121.91 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 106.608 -1.627 . . . . 0.94999999999999996 106.608 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.794 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 5.0 t0 -76.86 151.04 36.0 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.17 -1.419 . . . . 0.64000000000000001 107.17 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.544 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.1 m -57.53 132.78 54.21 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 106.947 -1.501 . . . . 0.37 106.947 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.548 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 23.1 t -60.55 138.31 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.988 0 N-CA-C 107.88 -1.155 . . . . 0.10000000000000001 107.88 170.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.8 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -84.19 162.95 20.03 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.337 -0.847 . . . . 0.17999999999999999 109.704 174.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.784 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.1 85.19 2.37 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.748 -1.114 . . . . 0.12 108.114 175.608 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.477 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.3 mtp180 -108.18 -4.09 17.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.852 -1.522 . . . . 0.64000000000000001 108.77 -171.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 172' ' ' PRO . 21.4 p -50.59 -171.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.854 -1.975 . . . . 0.14000000000000001 115.547 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 33.3 t30 -68.89 -10.66 58.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.883 -1.962 . . . . 0.47999999999999998 110.739 173.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.586 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -152.48 -143.93 3.8 Favored Glycine 0 C--O 1.236 0.244 0 C-N-CA 120.258 -0.972 . . . . 0.12 113.153 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.61 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 51.5 p -122.36 131.61 53.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.148 0.499 . . . . 1.1599999999999999 111.949 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.784 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.4 pp -137.43 156.43 48.19 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.846 0.831 . . . . 0.10000000000000001 110.633 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -79.87 81.09 6.19 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.787 -1.551 . . . . 0.17000000000000001 107.852 176.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.93 -14.72 63.21 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.193 -1.367 . . . . 0.089999999999999997 109.929 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.405 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.74 -30.23 40.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.685 -0.857 . . . . 0.14999999999999999 108.685 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 28.2 tp10 -66.0 -34.57 78.4 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.78 1.276 . . . . 1.73 109.068 170.245 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.03 -45.22 64.3 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.049 -1.887 . . . . 0.12 109.227 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 49.1 m -64.8 -30.58 71.59 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.029 -1.441 . . . . 0.11 110.5 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -67.2 -44.04 80.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.749 -1.204 . . . . 1.47 107.749 171.737 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.717 HG21 ' HB2' ' A' ' 64' ' ' TRP . 37.7 m -63.24 -31.46 72.61 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.237 -0.892 . . . . 0.12 110.783 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.723 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.3 mt -50.16 -70.47 0.09 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.05 -0.722 . . . . 0.56000000000000005 109.05 170.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.503 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.9 mtp180 -40.08 -40.32 1.05 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.487 1.117 . . . . 1.51 111.358 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.3 m-20 -67.26 -48.18 68.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.556 -1.202 . . . . 0.28000000000000003 112.137 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.2 -34.97 68.8 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.315 1.055 . . . . 0.089999999999999997 108.524 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -63.91 -32.33 73.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.158 -1.837 . . . . 0.12 110.064 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -76.01 -47.5 24.62 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 114.523 -1.217 . . . . 0.20000000000000001 111.302 -174.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -55.99 -33.13 64.56 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.336 -1.302 . . . . 1.1699999999999999 110.11 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -70.17 -43.77 70.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.244 -1.798 . . . . 2.0499999999999998 110.784 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.12 -3.39 66.04 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 114.749 0.659 . . . . 0.54000000000000004 114.749 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.657 ' HB2' HD13 ' A' ' 76' ' ' LEU . 58.7 mtpt -87.36 -8.2 56.89 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.066 0.933 . . . . 0.98999999999999999 111.192 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.763 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 27.0 m-85 -118.12 174.42 6.22 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 122.421 1.105 . . . . 0.20999999999999999 113.303 173.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.0 m -118.47 123.88 46.25 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 112.672 -2.058 . . . . 0.23000000000000001 108.021 170.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.673 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -95.66 141.33 29.27 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 119.291 -0.964 . . . . 0.38 111.519 -169.645 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.2 m . . . . . 0 C--N 1.306 -1.314 0 N-CA-C 107.802 -1.184 . . . . 0.41999999999999998 107.802 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.894 HD11 ' O ' ' A' ' 89' ' ' VAL . 6.3 tt . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 113.268 0.84 . . . . 1.3899999999999999 113.268 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.707 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -53.92 -43.72 70.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 123.389 1.566 . . . . 1.05 109.116 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.694 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -55.59 -60.85 2.85 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 111.226 -2.715 . . . . 1.6399999999999999 111.3 175.592 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.735 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.49 -46.22 6.77 Favored 'General case' 0 CA--C 1.497 -1.083 0 O-C-N 124.493 1.121 . . . . 0.31 111.807 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.605 ' HA ' HD11 ' A' ' 151' ' ' ILE . 5.8 mttt -53.32 -52.13 60.15 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.39 -0.596 . . . . 1.53 109.39 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -66.9 -38.63 86.6 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.542 -0.754 . . . . 0.40999999999999998 110.878 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.694 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.2 mt-30 -59.04 -32.3 69.63 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 114.551 -1.204 . . . . 0.37 109.845 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.51 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.7 OUTLIER -94.3 -30.49 14.51 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.123 -1.399 . . . . 0.23999999999999999 109.929 -177.423 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.06 -50.72 0.46 Allowed Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 120.012 -1.089 . . . . 0.33000000000000002 113.664 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 141' ' ' SER . 92.9 mt -65.36 -171.03 0.07 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 112.496 -1.852 . . . . 0.31 115.954 -171.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.1 m -115.72 151.67 46.5 Favored Pre-proline 0 N--CA 1.424 -1.736 0 CA-C-N 110.65 -2.977 . . . . 0.81000000000000005 107.985 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.707 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 36.2 Cg_endo -65.4 0.07 3.13 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.871 2.381 . . . . 0.32000000000000001 112.651 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.1 tt0 -118.74 -25.33 6.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.869 0.843 . . . . 1.25 110.519 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 141' ' ' SER . 9.1 t70 -60.98 -23.09 65.09 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.364 -1.744 . . . . 0.65000000000000002 109.079 -173.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 32.6 m 73.91 167.37 0.3 Allowed 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 112.848 -1.978 . . . . 0.59999999999999998 109.393 -174.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.063 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.3 mt -64.46 -39.49 93.92 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-O 122.439 1.114 . . . . 0.85999999999999999 108.421 -175.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.37 -7.29 1.39 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 113.062 -1.881 . . . . 0.31 114.163 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.49 126.35 6.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.995 -0.743 . . . . 0.23999999999999999 108.995 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.675 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.2 mmt180 -41.83 -49.19 4.44 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 118.039 0.381 . . . . 1.6499999999999999 110.995 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.6 t -69.34 -28.16 65.98 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.368 0.604 . . . . 0.53000000000000003 111.658 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 24.3 mttm -73.78 -29.95 62.49 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.618 1.199 . . . . 1.3100000000000001 108.668 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 1.063 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -75.25 -46.27 34.84 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-N 112.358 -2.201 . . . . 0.12 110.358 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.612 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.7 mt -65.97 -42.22 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 112.71 -2.041 . . . . 0.11 110.046 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.0 -52.63 41.99 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.849 -1.069 . . . . 0.14999999999999999 111.433 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.735 HG23 ' CB ' ' A' ' 130' ' ' ALA . 16.7 mt -68.34 -46.95 79.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 N-CA-C 112.346 0.498 . . . . 0.17999999999999999 112.346 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.64 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.71 -39.7 74.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.954 0.407 . . . . 0.13 110.693 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.529 ' HD2' HG23 ' A' ' 149' ' ' ILE . 34.5 mtp180 -81.41 -23.13 37.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.52 0.676 . . . . 1.0800000000000001 110.894 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -81.09 -13.18 58.98 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.627 -1.249 . . . . 0.5 107.627 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.682 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.92 -29.11 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 113.196 -1.82 . . . . 0.17000000000000001 110.772 -174.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.41 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 98.59 34.6 5.21 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 120.198 -1.001 . . . . 0.16 112.408 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.692 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.92 157.27 18.79 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 112.693 0.627 . . . . 0.12 112.693 -170.227 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.676 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.7 m80 -96.74 -27.16 14.88 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.362 -0.835 . . . . 0.20000000000000001 109.445 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.581 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.1 m-85 -137.29 -174.53 3.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.061 -0.972 . . . . 0.13 111.325 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.686 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -136.48 140.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.583 -1.19 . . . . 0.080000000000000002 108.553 166.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.62 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 26.2 tp -110.02 99.89 8.92 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.466 -0.893 . . . . 0.16 109.704 166.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 90' ' ' ASP . 2.3 m-85 -77.92 112.03 14.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.914 -1.039 . . . . 0.26000000000000001 108.785 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.69 ' OG ' HD11 ' A' ' 109' ' ' LEU . 4.0 p -120.06 158.93 25.81 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 115.093 -0.958 . . . . 1.05 109.56 -175.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.8 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.2 p -163.75 172.56 13.99 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 115.154 -0.93 . . . . 0.10000000000000001 110.875 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.67 131.81 36.18 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 113.956 -1.475 . . . . 0.11 108.536 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.681 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -142.5 -176.39 4.83 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.158 -0.682 . . . . 1.0900000000000001 109.158 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -86.05 0.98 Allowed Glycine 0 CA--C 1.49 -1.492 0 C-N-CA 119.55 -1.309 . . . . 0.14999999999999999 111.101 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.504 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.3 t30 -141.59 129.06 21.31 Favored 'General case' 0 C--O 1.198 -1.629 0 CA-C-N 113.867 -1.167 . . . . 0.58999999999999997 107.963 175.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.586 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.7 p -64.7 -39.39 85.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.226 -0.897 . . . . 0.14999999999999999 111.991 -172.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.428 ' N ' HG13 ' A' ' 169' ' ' VAL . 14.4 m-20 -61.3 -31.15 70.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.696 0.76 . . . . 1.26 109.411 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.99 88.79 3.17 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 113.916 -1.493 . . . . 0.13 107.962 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.797 ' HD2' HG22 ' A' ' 194' ' ' VAL . 51.3 Cg_endo -90.21 165.32 4.61 Favored 'Trans proline' 0 CA--C 1.491 -1.645 0 C-N-CA 124.315 3.343 . . . . 0.089999999999999997 114.837 -169.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 191' ' ' LYS . 23.8 m -85.39 117.84 24.55 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 113.715 -1.584 . . . . 0.14000000000000001 107.769 167.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 164' ' ' SER . 38.6 tp -84.31 97.77 9.63 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 119.485 -0.886 . . . . 0.16 108.88 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.648 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -87.48 109.0 19.29 Favored 'General case' 0 C--N 1.277 -2.587 0 CA-C-N 114.64 -1.163 . . . . 0.34000000000000002 109.053 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.582 ' SD ' ' HB3' ' A' ' 163' ' ' SER . 2.6 mmm -111.03 163.57 13.71 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.51 -1.223 . . . . 1.0900000000000001 111.464 -173.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.619 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.4 tt0 -172.08 117.59 0.38 Allowed 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 115.978 -0.556 . . . . 0.5 110.114 -166.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.038 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -100.05 101.54 12.64 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.53 -0.915 . . . . 0.10000000000000001 108.53 -172.34 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.675 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 17.0 ttp -90.66 122.86 33.8 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.468 -0.787 . . . . 0.070000000000000007 109.639 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -59.19 127.19 30.91 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.268 -1.382 . . . . 0.22 107.268 166.466 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.16 -34.4 12.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.172 -1.011 . . . . 0.11 110.701 178.382 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.441 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.5 mt-30 -61.88 -15.95 46.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.333 -0.848 . . . . 0.34999999999999998 111.604 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.7 p -130.38 -36.74 1.45 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.826 0.822 . . . . 0.19 110.202 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.551 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.89 23.84 29.18 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 114.528 -1.214 . . . . 0.17999999999999999 112.272 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -103.63 156.72 17.57 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.656 0.265 . . . . 0.72999999999999998 110.653 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.619 HD12 ' HG2' ' A' ' 177' ' ' GLN . 35.0 mm -90.07 120.02 38.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.616 0.722 . . . . 0.14000000000000001 109.379 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.038 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -108.62 -30.19 2.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.942 -1.026 . . . . 0.13 110.495 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.671 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.9 t90 -136.36 152.85 51.09 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 115.108 -0.951 . . . . 0.070000000000000007 109.501 172.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 35.6 p -153.32 163.19 40.35 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 113.253 0.834 . . . . 0.13 113.253 164.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.42 -175.55 29.47 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 110.967 -0.853 . . . . 0.12 110.967 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.4 mtmt -159.51 149.74 18.98 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 105.704 -1.961 . . . . 1.22 105.704 165.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -161.13 128.02 1.85 Allowed Glycine 0 C--N 1.28 -2.542 0 C-N-CA 119.601 -1.285 . . . . 0.12 112.142 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.3 120.2 17.57 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.58 0.705 . . . . 0.17000000000000001 111.116 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.797 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -94.96 158.91 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-N 114.65 -1.159 . . . . 0.11 109.753 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.68 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -100.35 171.34 7.83 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 112.981 -1.918 . . . . 0.17999999999999999 109.292 -174.161 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.3 tt0 -101.5 130.35 47.74 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.253 -0.647 . . . . 0.91000000000000003 109.253 169.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.54 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 19.5 mm-40 . . . . . 0 C--N 1.31 -1.146 0 CA-C-O 118.431 -0.795 . . . . 1.24 110.383 176.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.73 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.0 m-30 . . . . . 0 N--CA 1.415 -2.219 0 N-CA-C 109.41 -0.589 . . . . 0.20999999999999999 109.41 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.561 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 6.1 t70 -81.49 67.51 7.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.499 1.619 . . . . 0.34999999999999998 107.931 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.734 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.3 m95 -59.64 -42.34 92.55 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 111.933 -2.394 . . . . 0.10000000000000001 111.911 174.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.487 ' N ' HG21 ' A' ' 108' ' ' THR . 3.1 t30 -52.53 -24.88 8.94 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.062 -1.426 . . . . 1.1100000000000001 111.452 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.49 -16.73 77.34 Favored Glycine 0 C--N 1.312 -0.773 0 CA-C-N 115.129 -0.941 . . . . 0.20999999999999999 111.175 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.16 -55.11 2.55 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.897 -1.152 . . . . 0.13 111.41 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.729 ' O ' HG23 ' A' ' 72' ' ' VAL . 40.9 mtt -64.05 -57.21 10.34 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.117 -1.401 . . . . 0.089999999999999997 112.893 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.45 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 15.7 mm-40 -38.85 -54.93 2.96 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 114.53 1.307 . . . . 0.63 114.53 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.803 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.7 Cg_endo -64.71 -31.64 58.39 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 121.949 1.766 . . . . 0.14000000000000001 110.956 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.754 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 10.2 mtm -79.58 -44.04 21.81 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.433 -0.803 . . . . 0.69999999999999996 111.54 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 68' ' ' MET . 40.5 t -57.17 -39.09 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 114.366 -1.288 . . . . 0.12 108.509 175.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.7 t -59.19 -36.44 75.35 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.153 -1.839 . . . . 0.56000000000000005 110.811 174.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.803 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 32.8 mtpt -81.55 -34.13 31.3 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.168 0.508 . . . . 1.3 110.823 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.85 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.54 -29.07 70.38 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.235 -0.893 . . . . 0.5 111.563 -171.785 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.564 HD13 ' HB2' ' A' ' 118' ' ' LYS . 6.0 mt -90.77 -8.07 50.7 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.922 0.867 . . . . 0.65000000000000002 111.118 -177.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.38 13.09 58.49 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 109.182 -1.567 . . . . 0.17000000000000001 109.182 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.639 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -83.54 160.25 21.5 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.441 -0.879 . . . . 0.10000000000000001 110.245 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.47 106.29 16.71 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.062 -0.972 . . . . 1.72 110.115 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.636 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.52 -22.8 3.67 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 110.766 -0.933 . . . . 0.12 110.766 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 75' ' ' MET . 11.3 p -102.95 150.0 6.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.639 0.733 . . . . 0.16 111.514 -176.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.0 m -137.61 141.33 41.26 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.695 -1.139 . . . . 0.45000000000000001 111.135 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.66 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.97 132.36 49.69 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.745 -1.116 . . . . 0.28000000000000003 111.285 169.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.57 2.27 37.52 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.859 -0.686 . . . . 0.28000000000000003 112.709 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.26 149.91 22.86 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 120.233 -0.587 . . . . 1.2 110.923 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -79.48 117.55 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 122.196 0.998 . . . . 0.20000000000000001 108.871 164.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.784 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -104.92 109.75 21.85 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.521 -0.918 . . . . 0.14000000000000001 108.521 -172.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.693 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -71.27 94.06 1.16 Allowed 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.788 -1.19 . . . . 0.14999999999999999 107.788 176.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.519 HG11 ' HG3' ' A' ' 110' ' ' ARG . 1.1 m -72.87 116.14 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 107.124 -1.436 . . . . 0.94999999999999996 107.124 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.847 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 8.3 t0 -76.98 154.77 33.2 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.723 -1.214 . . . . 0.64000000000000001 107.723 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.0 OUTLIER -58.05 136.38 57.15 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 107.527 -1.286 . . . . 0.37 107.527 171.648 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.509 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.8 t -64.0 139.0 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 107.835 -1.172 . . . . 0.10000000000000001 107.835 168.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.818 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.6 t-20 -85.61 163.24 18.45 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.128 -0.942 . . . . 0.17999999999999999 110.063 174.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.751 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.31 85.25 2.38 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.407 -1.27 . . . . 0.12 108.187 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.476 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 9.7 mtp180 -108.88 -1.12 19.37 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.056 -1.429 . . . . 0.64000000000000001 108.644 -172.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.732 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.6 p -53.36 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.991 -1.913 . . . . 0.14000000000000001 115.106 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.528 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 22.4 t30 -67.45 -13.31 61.92 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.712 -2.04 . . . . 0.47999999999999998 110.479 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.579 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -149.71 -145.02 4.05 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.259 -0.972 . . . . 0.12 113.109 -176.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.619 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.4 p -121.89 132.65 54.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.18 0.514 . . . . 1.1599999999999999 111.747 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.751 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.0 pp -137.75 157.01 47.36 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.827 0.822 . . . . 0.10000000000000001 110.641 -178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -80.57 79.43 7.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 113.959 -1.473 . . . . 0.17000000000000001 107.647 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.16 -14.26 62.85 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.545 -1.207 . . . . 0.089999999999999997 109.836 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.586 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.17 -30.01 38.78 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.632 -0.877 . . . . 0.14999999999999999 108.632 -178.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.1 tp10 -67.93 -34.01 75.78 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.304 -1.317 . . . . 1.73 109.104 171.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.44 -43.69 66.23 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 113.213 -1.812 . . . . 0.12 109.613 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.551 ' CG2' ' HA ' ' A' ' 91' ' ' SER . 63.5 m -63.56 -28.13 69.73 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.73 -1.577 . . . . 0.11 110.159 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 104' ' ' GLU . 3.7 tp10 -66.04 -52.06 52.5 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.16 -1.052 . . . . 1.47 108.16 169.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.665 HG21 ' HB2' ' A' ' 64' ' ' TRP . 32.2 m -56.36 -33.93 66.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.669 -0.696 . . . . 0.12 111.319 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.723 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.7 mt -50.46 -68.02 0.21 Allowed 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 116.12 -0.491 . . . . 0.56000000000000005 109.799 172.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.55 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.7 mtp180 -43.04 -35.47 1.28 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.129 0.966 . . . . 1.51 111.194 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.604 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.2 m-20 -72.56 -45.62 58.36 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.49 -1.232 . . . . 0.28000000000000003 112.101 -175.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.56 -33.59 60.66 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.309 -0.997 . . . . 0.089999999999999997 108.309 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -62.99 -34.45 77.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 113.651 -1.613 . . . . 0.12 110.064 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -69.84 -38.28 76.45 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.521 -1.218 . . . . 0.20000000000000001 111.208 -175.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.97 -29.21 69.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.736 -1.12 . . . . 1.1699999999999999 111.179 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -81.31 -30.25 33.98 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.746 -0.661 . . . . 2.0499999999999998 111.141 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.28 3.82 10.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.049 -0.596 . . . . 0.54000000000000004 113.228 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.66 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 54.2 mtpt -88.28 -6.31 57.84 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.963 0.411 . . . . 0.98999999999999999 110.092 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.784 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 27.8 m-85 -122.49 175.32 6.52 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 122.491 1.139 . . . . 0.20999999999999999 113.099 172.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 7.1 m -121.11 119.26 31.9 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 112.621 -2.081 . . . . 0.23000000000000001 107.947 168.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -89.6 139.44 30.55 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.345 -0.942 . . . . 0.38 111.319 -170.279 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.499 HG11 HD23 ' A' ' 88' ' ' LEU . 1.6 m . . . . . 0 C--N 1.3 -1.568 0 N-CA-C 108.222 -1.029 . . . . 0.41999999999999998 108.222 170.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.67 HD13 HD21 ' A' ' 88' ' ' LEU . 26.1 tp . . . . . 0 CA--C 1.514 -0.429 0 N-CA-C 113.104 0.779 . . . . 1.3899999999999999 113.104 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.66 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.8 t -50.47 -43.73 55.49 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 123.365 1.555 . . . . 1.05 109.117 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.737 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -57.69 -61.42 2.52 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 111.145 -2.752 . . . . 1.6399999999999999 110.521 177.361 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.759 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.76 -45.79 7.35 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 124.564 1.165 . . . . 0.31 112.169 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.513 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.4 OUTLIER -54.44 -53.23 56.96 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 108.701 -0.851 . . . . 1.53 108.701 179.138 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.3 mt-30 -63.83 -39.89 95.29 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.563 -0.744 . . . . 0.40999999999999998 111.287 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.737 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.9 mt-30 -58.89 -35.07 72.42 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 114.471 -1.24 . . . . 0.37 109.548 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -90.06 -30.67 17.57 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 113.798 -1.546 . . . . 0.23999999999999999 109.502 -176.726 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.27 -45.89 0.6 Allowed Glycine 0 CA--C 1.495 -1.162 0 CA-C-O 122.422 1.012 . . . . 0.33000000000000002 113.376 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.602 HD13 ' O ' ' A' ' 141' ' ' SER . 92.3 mt -66.38 -171.09 0.11 Allowed 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.362 -1.919 . . . . 0.31 115.613 -170.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.1 m -115.78 151.45 46.33 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 110.716 -2.947 . . . . 0.81000000000000005 107.924 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.66 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 34.0 Cg_endo -64.81 0.2 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.526 2.151 . . . . 0.32000000000000001 112.638 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.586 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -119.13 -23.9 6.66 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.871 0.843 . . . . 1.25 110.811 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 14.4 t70 -61.4 -21.5 64.15 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.471 -1.695 . . . . 0.65000000000000002 109.359 -173.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.602 ' O ' HD13 ' A' ' 136' ' ' LEU . 26.3 m 70.56 167.84 0.3 Allowed 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 112.641 -2.072 . . . . 0.59999999999999998 110.12 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.947 HD22 ' HA ' ' A' ' 148' ' ' ALA . 5.4 mt -64.97 -40.29 94.77 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.257 -1.016 . . . . 0.85999999999999999 108.257 -177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 62.39 -10.16 0.12 Allowed Glycine 0 C--N 1.32 -0.357 0 CA-C-N 113.098 -1.864 . . . . 0.31 114.586 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.427 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.7 OUTLIER -153.8 124.51 7.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.026 -0.731 . . . . 0.23999999999999999 109.026 -175.358 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.686 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.3 mmt180 -41.28 -45.69 3.02 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 112.101 0.408 . . . . 1.6499999999999999 112.101 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 31.3 t -75.04 -25.58 58.81 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.791 0.805 . . . . 0.53000000000000003 111.247 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.551 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 48.2 mttt -72.77 -29.28 63.18 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.755 1.264 . . . . 1.3100000000000001 108.156 175.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.947 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -77.57 -49.02 15.52 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 112.31 -2.223 . . . . 0.12 110.273 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.629 HG13 ' HE1' ' A' ' 179' ' ' MET . 38.3 mt -65.26 -41.19 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-N 113.016 -1.902 . . . . 0.11 110.151 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.84 -55.0 25.61 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.745 -1.116 . . . . 0.14999999999999999 111.09 171.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.759 HG23 ' CB ' ' A' ' 130' ' ' ALA . 87.6 mt -66.78 -47.34 83.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 N-CA-C 112.637 0.606 . . . . 0.17999999999999999 112.637 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.693 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.0 -41.14 74.4 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.046 0.45 . . . . 0.13 111.133 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.518 ' HD2' HG23 ' A' ' 149' ' ' ILE . 54.3 mtp180 -81.01 -23.15 38.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.852 0.835 . . . . 1.0800000000000001 110.242 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -82.73 -10.7 58.78 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.323 -1.362 . . . . 0.5 107.323 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.723 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.14 -28.8 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 113.148 -1.842 . . . . 0.17000000000000001 110.965 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.403 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.74 35.26 4.66 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.443 -0.884 . . . . 0.16 112.6 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.684 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.4 159.5 16.96 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.02 0.748 . . . . 0.12 113.02 -169.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.671 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -98.64 -29.11 13.23 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.211 -0.904 . . . . 0.20000000000000001 109.434 178.816 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.577 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.4 m-85 -135.51 -173.17 3.27 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.055 -0.975 . . . . 0.13 111.037 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.691 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -136.74 138.54 46.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.645 -1.161 . . . . 0.080000000000000002 108.921 166.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.598 HD21 ' SD ' ' A' ' 176' ' ' MET . 35.1 tp -107.85 100.96 10.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.435 -0.906 . . . . 0.16 109.137 165.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.625 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.4 m-85 -78.5 119.04 21.24 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.401 -1.272 . . . . 0.26000000000000001 108.131 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.864 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 13.3 t -130.69 158.76 39.19 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 122.12 0.962 . . . . 1.05 110.413 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.818 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.5 p -162.03 170.67 18.86 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.038 -1.437 . . . . 0.10000000000000001 110.718 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -132.27 135.73 46.46 Favored 'General case' 0 N--CA 1.406 -2.666 0 CA-C-N 114.044 -1.434 . . . . 0.11 108.766 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.7 t -144.52 -170.69 3.44 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.608 -0.837 . . . . 1.0900000000000001 110.376 176.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 89.84 -83.23 1.38 Allowed Glycine 0 C--N 1.289 -2.065 0 CA-C-N 114.906 -1.043 . . . . 0.14999999999999999 111.062 175.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.528 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 57.7 t30 -141.67 129.37 21.6 Favored 'General case' 0 C--O 1.199 -1.602 0 CA-C-N 113.872 -1.164 . . . . 0.58999999999999997 108.205 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.579 HG11 ' HA3' ' A' ' 98' ' ' GLY . 4.2 p -65.28 -41.88 92.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 115.378 -0.828 . . . . 0.14999999999999999 112.63 -171.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.425 ' N ' HG13 ' A' ' 169' ' ' VAL . 50.8 m-20 -61.56 -29.44 70.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.378 0.608 . . . . 1.26 109.462 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.35 88.93 3.35 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 114.592 -1.185 . . . . 0.13 108.9 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.812 ' HD2' HG22 ' A' ' 194' ' ' VAL . 40.7 Cg_endo -92.24 163.88 3.08 Favored 'Trans proline' 0 CA--C 1.501 -1.147 0 C-N-CA 124.858 3.705 . . . . 0.089999999999999997 115.458 -170.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.743 HG22 ' HB3' ' A' ' 191' ' ' LYS . 14.3 m -82.73 120.54 25.72 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.837 -1.529 . . . . 0.14000000000000001 107.563 168.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.889 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 22.1 tp -82.78 95.16 7.8 Favored 'General case' 0 CA--C 1.476 -1.901 0 C-N-CA 119.434 -0.906 . . . . 0.16 109.11 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.503 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 16.0 mt-30 -86.18 107.74 18.02 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-O 122.044 0.926 . . . . 0.34000000000000002 108.61 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.864 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.0 OUTLIER -111.85 163.18 14.48 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.893 -1.048 . . . . 1.0900000000000001 111.245 -174.428 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 55.4 tt0 -170.48 117.81 0.53 Allowed 'General case' 0 C--O 1.204 -1.332 0 CA-C-N 115.87 -0.604 . . . . 0.5 110.327 -167.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.032 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.1 100.51 11.38 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.414 -0.958 . . . . 0.10000000000000001 108.414 -173.315 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.686 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.6 ttp -90.61 123.39 34.2 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.492 -0.776 . . . . 0.070000000000000007 109.608 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -59.96 126.65 28.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.096 -1.446 . . . . 0.22 107.096 166.689 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -81.6 -35.06 13.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 119.103 -1.039 . . . . 0.11 110.81 179.279 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.426 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.9 mt-30 -62.81 -15.06 52.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.377 -0.828 . . . . 0.34999999999999998 111.58 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.1 p -130.05 -34.89 1.64 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.724 0.773 . . . . 0.19 110.276 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.478 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 84.6 29.83 28.65 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.462 -1.244 . . . . 0.17999999999999999 112.12 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 179' ' ' MET . 9.8 pt-20 -105.3 158.19 16.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.42 -0.39 . . . . 0.72999999999999998 110.447 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.619 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.0 mm -93.58 112.07 25.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.623 0.725 . . . . 0.14000000000000001 109.659 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.032 HD11 HD13 ' A' ' 178' ' ' LEU . 1.2 pp -99.48 -30.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.067 -0.969 . . . . 0.13 110.853 -173.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.648 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 82.0 t90 -136.76 152.82 50.76 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.403 -0.817 . . . . 0.070000000000000007 109.743 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 35.9 p -153.99 163.9 39.31 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.107 0.78 . . . . 0.13 113.107 165.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.01 -173.65 27.69 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 111.125 -0.79 . . . . 0.12 111.125 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.889 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.5 mttt -158.8 148.96 19.54 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.409 -1.7 . . . . 1.22 106.409 165.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 174' ' ' LEU . . . -154.13 125.38 1.72 Allowed Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 118.574 -1.774 . . . . 0.12 113.905 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.75 107.93 5.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.648 0.737 . . . . 0.17000000000000001 110.862 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.812 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -88.57 158.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-N 114.224 -1.353 . . . . 0.11 110.586 -175.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.73 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -100.47 171.99 7.4 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 112.573 -2.103 . . . . 0.17999999999999999 108.751 -175.016 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.0 tt0 -101.82 132.86 47.35 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.086 -0.646 . . . . 0.91000000000000003 109.621 172.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.54 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 36.0 mm-40 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.496 -0.764 . . . . 1.24 110.672 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.742 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 . . . . . 0 N--CA 1.418 -2.046 0 N-CA-C 109.499 -0.556 . . . . 0.20999999999999999 109.499 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.512 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 5.1 t70 -82.49 67.47 8.54 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 123.618 1.675 . . . . 0.34999999999999998 108.144 171.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.732 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 91.9 m95 -57.58 -42.98 84.19 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 111.678 -2.51 . . . . 0.10000000000000001 112.026 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.428 ' N ' HG21 ' A' ' 108' ' ' THR . 13.4 t-20 -51.21 -28.3 11.08 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.914 -1.494 . . . . 1.1100000000000001 111.331 174.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 -18.56 79.06 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.096 -0.956 . . . . 0.20999999999999999 111.258 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.84 -54.35 2.84 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.868 -1.166 . . . . 0.13 110.879 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.712 ' SD ' HD23 ' A' ' 109' ' ' LEU . 40.8 mtt -60.2 -62.54 1.79 Allowed 'General case' 0 C--O 1.21 -0.998 0 CA-C-N 113.878 -1.51 . . . . 0.089999999999999997 111.61 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.462 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -37.22 -54.89 1.87 Allowed Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 114.593 1.331 . . . . 0.63 114.593 -172.259 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.745 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 34.4 Cg_endo -64.14 -31.56 64.54 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.355 2.036 . . . . 0.14000000000000001 111.001 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.718 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 8.1 mtm -78.24 -43.96 26.86 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 114.988 -1.005 . . . . 0.69999999999999996 111.271 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 68' ' ' MET . 42.4 t -58.57 -38.94 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-N 114.284 -1.326 . . . . 0.12 108.716 176.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.2 t -58.71 -37.25 75.72 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.956 -1.929 . . . . 0.56000000000000005 111.026 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.745 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 4.8 mtpm? -78.57 -41.92 30.63 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.627 -0.509 . . . . 1.3 109.627 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.841 ' SD ' ' HE2' ' A' ' 119' ' ' PHE . 1.0 OUTLIER -45.88 -53.53 9.64 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.724 0.809 . . . . 0.5 110.099 -175.207 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.64 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.9 mt -80.29 7.41 9.58 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.288 -1.324 . . . . 0.65000000000000002 112.249 -170.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.55 15.62 9.82 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.075 -1.421 . . . . 0.17000000000000001 109.805 170.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.595 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -80.54 165.25 22.29 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.235 0.54 . . . . 0.10000000000000001 110.423 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -87.8 105.81 17.65 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 115.597 -0.729 . . . . 1.72 109.124 175.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.673 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.29 -25.37 3.02 Favored Glycine 0 N--CA 1.415 -2.731 0 C-N-CA 119.623 -1.275 . . . . 0.12 110.437 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.763 HG11 ' O ' ' A' ' 75' ' ' MET . 12.8 p -103.21 149.35 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.86 0.838 . . . . 0.16 111.365 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.1 m -135.52 140.33 44.66 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.692 -1.14 . . . . 0.45000000000000001 110.744 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.594 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -54.77 131.49 43.95 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.07 -0.968 . . . . 0.28000000000000003 110.698 168.426 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.04 0.2 38.62 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.951 -0.642 . . . . 0.28000000000000003 113.271 176.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.87 151.22 23.52 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 120.537 -0.465 . . . . 1.2 111.081 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.712 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -81.16 120.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-O 121.865 0.84 . . . . 0.20000000000000001 109.074 165.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.725 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -108.42 111.02 22.7 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.412 -0.813 . . . . 0.14000000000000001 109.061 -171.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.762 HD21 HD23 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -72.31 101.09 2.78 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 114.849 -1.069 . . . . 0.14999999999999999 109.329 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.548 HG21 ' HG3' ' A' ' 110' ' ' ARG . 53.1 t -74.34 106.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 114.495 -1.229 . . . . 0.94999999999999996 109.511 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.912 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 2.3 t70 -78.29 158.39 28.89 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.592 -1.186 . . . . 0.64000000000000001 108.344 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.622 ' OG ' ' HA ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -62.32 135.28 57.39 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 115.378 -0.828 . . . . 0.37 109.325 175.448 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.599 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 33.4 t -62.28 138.49 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 106.983 -1.488 . . . . 0.10000000000000001 106.983 167.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.842 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.0 t-20 -85.01 161.49 19.73 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.836 0.827 . . . . 0.17999999999999999 110.114 174.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.766 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.95 84.94 2.34 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.368 -1.287 . . . . 0.12 108.261 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 14.1 mtp180 -108.51 -2.75 18.68 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 113.912 -1.495 . . . . 0.64000000000000001 108.572 -172.07 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.5 p -51.1 -170.94 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.683 -2.053 . . . . 0.14000000000000001 115.107 -176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 36.5 t30 -70.43 -10.45 59.14 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.134 -1.848 . . . . 0.47999999999999998 110.567 173.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.595 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -152.22 -144.45 3.92 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.414 -0.898 . . . . 0.12 113.128 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.609 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 54.6 p -122.14 131.73 54.11 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.165 0.432 . . . . 1.1599999999999999 112.165 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.766 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.8 pp -136.84 156.76 48.06 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.772 0.796 . . . . 0.10000000000000001 110.947 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.589 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -79.81 81.18 6.11 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.814 -1.539 . . . . 0.17000000000000001 107.961 175.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -67.97 -15.1 63.45 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.933 -1.485 . . . . 0.089999999999999997 110.112 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.796 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.92 -32.79 40.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.73 -0.841 . . . . 0.14999999999999999 108.73 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.589 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 12.8 tp10 -65.22 -34.48 78.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.432 -1.258 . . . . 1.73 108.929 171.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.06 -43.41 64.95 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 113.243 -1.798 . . . . 0.12 109.367 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.617 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 76.5 m -64.73 -28.8 69.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.062 -1.426 . . . . 0.11 110.405 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -43.53 67.31 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.05 -1.093 . . . . 1.47 108.05 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.687 HG21 ' HB2' ' A' ' 64' ' ' TRP . 75.9 m -61.96 -31.6 71.96 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.327 -0.852 . . . . 0.12 110.613 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.716 ' O ' HD23 ' A' ' 113' ' ' LEU . 9.0 mt -51.43 -69.48 0.11 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 109.209 -0.663 . . . . 0.56000000000000005 109.209 171.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.692 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.9 mtp180 -40.09 -38.86 0.79 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.424 1.078 . . . . 1.51 111.182 175.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 108' ' ' THR . 8.2 m-20 -70.88 -47.33 59.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.473 -1.24 . . . . 0.28000000000000003 112.159 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.8 -33.08 68.25 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.107 0.956 . . . . 0.089999999999999997 108.424 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.8 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.1 mm? -61.99 -32.98 73.5 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.437 -1.71 . . . . 0.12 109.894 173.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -74.43 -41.5 60.74 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.484 -1.234 . . . . 0.20000000000000001 111.604 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -64.93 -25.64 67.97 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.4 -0.818 . . . . 1.1699999999999999 111.199 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 30.2 m-80 -84.15 -16.53 43.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.529 -0.76 . . . . 2.0499999999999998 110.844 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.6 17.2 19.17 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 115.432 0.933 . . . . 0.54000000000000004 115.432 164.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.594 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 53.3 mtpt -98.16 -34.4 10.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.541 0.67 . . . . 0.98999999999999999 109.997 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.841 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 13.7 m-85 -89.32 177.85 6.49 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 122.728 1.251 . . . . 0.20999999999999999 113.095 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 21.2 m -123.67 111.07 15.75 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 112.299 -2.228 . . . . 0.23000000000000001 107.84 168.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.8 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -89.37 123.66 33.74 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.719 -1.128 . . . . 0.38 110.734 -170.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.535 HG11 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.3 -1.579 0 CA-C-N 115.354 -0.839 . . . . 0.41999999999999998 109.102 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.762 HD23 HD21 ' A' ' 88' ' ' LEU . 1.1 tm? . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 113.514 0.931 . . . . 1.3899999999999999 113.514 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.561 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -50.8 -37.97 45.72 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 123.684 1.707 . . . . 1.05 108.637 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.698 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 29.2 mmm -62.82 -62.09 1.96 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 110.417 -3.083 . . . . 1.6399999999999999 111.403 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.775 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -40.99 -45.12 2.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 124.478 1.111 . . . . 0.31 111.905 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.806 ' HE2' HD21 ' A' ' 142' ' ' LEU . 95.3 mttt -52.38 -58.09 7.77 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.847 -0.615 . . . . 1.53 109.845 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.9 mt-30 -58.12 -44.72 87.89 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.566 -1.197 . . . . 0.40999999999999998 111.622 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.698 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.5 mt-30 -56.47 -36.37 68.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.627 -1.17 . . . . 0.37 109.871 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.51 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -88.49 -29.38 20.18 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.972 -1.467 . . . . 0.23999999999999999 109.431 -177.368 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.8 -41.46 0.58 Allowed Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 119.36 -1.4 . . . . 0.33000000000000002 114.328 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 91.2 mt -73.75 -172.89 1.36 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 123.868 1.794 . . . . 0.31 115.262 -168.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 52.4 m -111.44 151.4 43.23 Favored Pre-proline 0 N--CA 1.425 -1.675 0 CA-C-N 110.783 -2.917 . . . . 0.81000000000000005 107.964 169.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.652 ' HA ' ' HD2' ' A' ' 131' ' ' LYS . 14.3 Cg_endo -60.6 -3.27 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.736 2.29 . . . . 0.32000000000000001 112.782 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.796 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -118.6 -20.88 8.18 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 123.132 0.573 . . . . 1.25 109.954 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.6 t70 -60.44 -33.55 72.71 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.699 -1.223 . . . . 0.65000000000000002 107.699 -174.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.622 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 18.4 m 78.92 156.64 0.16 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 110.441 -3.072 . . . . 0.59999999999999998 111.059 -173.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.912 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 7.2 mt -63.82 -39.34 94.0 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.15 -1.426 . . . . 0.85999999999999999 107.15 -172.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.1 -3.6 0.16 Allowed Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 112.849 -1.978 . . . . 0.31 115.166 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 m -149.66 121.67 8.25 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.881 -0.785 . . . . 0.23999999999999999 108.881 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.59 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.3 mmt180 -41.91 -45.06 3.62 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 123.61 0.569 . . . . 1.6499999999999999 111.366 -175.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.3 t -73.17 -26.55 61.23 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.541 0.686 . . . . 0.53000000000000003 111.525 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.559 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 49.1 mttt -73.15 -33.04 65.26 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.138 -1.06 . . . . 1.3100000000000001 108.138 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.863 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -74.98 -43.46 53.85 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-N 113.019 -1.901 . . . . 0.12 110.465 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.609 ' HA ' HG23 ' A' ' 181' ' ' VAL . 43.4 mt -67.1 -42.69 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 113.589 -1.641 . . . . 0.11 110.159 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.31 -52.33 41.4 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.856 -1.065 . . . . 0.14999999999999999 111.287 171.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.775 HG23 ' CB ' ' A' ' 130' ' ' ALA . 71.8 mt -68.5 -47.25 78.14 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 N-CA-C 112.891 0.7 . . . . 0.17999999999999999 112.891 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.695 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.28 -38.34 71.07 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.001 0.429 . . . . 0.13 111.23 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.479 ' HD2' HG23 ' A' ' 149' ' ' ILE . 30.4 mtp180 -84.04 -20.01 33.43 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.666 0.746 . . . . 1.0800000000000001 110.443 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 27.9 t-20 -84.36 -10.38 57.63 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.307 -1.368 . . . . 0.5 107.307 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.745 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -109.69 -29.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 113.262 -1.79 . . . . 0.17000000000000001 111.094 -173.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.13 34.74 4.73 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.391 -0.909 . . . . 0.16 112.833 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.624 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.64 161.29 15.53 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.15 0.796 . . . . 0.12 113.15 -169.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.712 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -101.91 -28.14 12.57 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.375 -0.829 . . . . 0.20000000000000001 109.78 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.56 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.4 m-85 -135.39 -172.57 3.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.261 -0.881 . . . . 0.13 110.959 -175.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.769 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -138.85 139.62 40.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.098 -0.955 . . . . 0.080000000000000002 109.221 167.464 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.594 HD21 ' SD ' ' A' ' 176' ' ' MET . 43.9 tp -107.62 99.84 9.29 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 119.386 -0.925 . . . . 0.16 109.395 165.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.594 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 3.0 m-85 -81.69 112.81 19.21 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.234 -1.348 . . . . 0.26000000000000001 109.556 176.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.859 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 4.9 t -123.08 166.12 15.68 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-O 121.77 0.795 . . . . 1.05 111.033 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.848 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -162.79 176.18 10.52 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 114.548 -1.205 . . . . 0.10000000000000001 111.313 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.65 133.4 30.58 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 113.865 -1.516 . . . . 0.11 108.279 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.67 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -143.14 -177.17 5.23 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.354 -0.61 . . . . 1.0900000000000001 109.354 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.76 -83.72 0.86 Allowed Glycine 0 CA--C 1.493 -1.336 0 C-N-CA 119.62 -1.276 . . . . 0.14999999999999999 111.355 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.7 t30 -144.17 130.5 19.8 Favored 'General case' 0 C--O 1.199 -1.598 0 N-CA-C 107.972 -1.121 . . . . 0.58999999999999997 107.972 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.595 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.2 p -64.48 -41.56 92.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.123 -0.944 . . . . 0.14999999999999999 112.36 -171.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.417 ' N ' HG13 ' A' ' 169' ' ' VAL . 10.9 m-20 -61.19 -30.76 70.61 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.793 0.806 . . . . 1.26 109.509 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.11 88.39 3.49 Favored Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 113.868 -1.514 . . . . 0.13 108.376 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.814 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.0 Cg_endo -90.72 167.0 4.01 Favored 'Trans proline' 0 CA--C 1.492 -1.579 0 C-N-CA 124.579 3.52 . . . . 0.089999999999999997 114.72 -170.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 23.7 m -86.39 119.41 26.63 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 113.732 -1.577 . . . . 0.14000000000000001 107.643 166.51 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 164' ' ' SER . 42.2 tp -84.13 98.67 10.03 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 108.643 -0.873 . . . . 0.16 108.643 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.627 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.0 mt-30 -90.49 109.02 20.17 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 122.089 0.947 . . . . 0.34000000000000002 109.276 -176.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.859 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -111.73 164.54 12.93 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.936 -1.029 . . . . 1.0900000000000001 111.795 -172.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.614 ' HG2' HD12 ' A' ' 186' ' ' ILE . 9.1 tt0 -170.64 119.5 0.54 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 115.813 -0.63 . . . . 0.5 110.245 -166.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.064 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.32 101.84 12.58 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.929 -0.767 . . . . 0.10000000000000001 108.929 -173.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.599 ' HE1' HG13 ' A' ' 149' ' ' ILE . 14.4 ttp -90.88 118.35 30.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.755 -0.657 . . . . 0.070000000000000007 109.675 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.498 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -61.7 117.89 6.41 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.936 -1.505 . . . . 0.22 106.936 168.881 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -71.9 -36.35 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.05 0.841 . . . . 0.11 111.485 -176.409 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.0 mt-30 -60.85 -15.25 28.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.364 -0.835 . . . . 0.34999999999999998 111.685 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 185' ' ' GLU . 40.5 p -127.91 -37.02 1.95 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.308 1.051 . . . . 0.19 109.896 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.552 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 86.83 24.32 38.73 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 113.765 -1.561 . . . . 0.17999999999999999 111.733 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.43 ' HG2' ' OG1' ' A' ' 183' ' ' THR . 11.0 pt-20 -105.22 158.03 16.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.882 0.372 . . . . 0.72999999999999998 110.248 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.614 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.0 mm -91.5 117.14 34.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.498 0.666 . . . . 0.14000000000000001 109.391 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.064 HD11 HD13 ' A' ' 178' ' ' LEU . 1.8 pp -105.02 -29.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 114.777 -1.101 . . . . 0.13 110.44 -171.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.595 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.4 t90 -136.95 152.2 49.9 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.145 -0.934 . . . . 0.070000000000000007 109.621 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 53.9 p -153.41 163.46 39.9 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.963 0.727 . . . . 0.13 112.963 164.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.69 -173.82 27.6 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 111.214 -0.755 . . . . 0.12 111.214 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.768 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.4 mtmt -158.91 151.44 21.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.668 -1.975 . . . . 1.22 105.668 165.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -161.02 127.74 1.81 Allowed Glycine 0 C--N 1.282 -2.43 0 C-N-CA 119.866 -1.159 . . . . 0.12 112.235 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.63 117.85 14.83 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.518 0.675 . . . . 0.17000000000000001 111.528 -173.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.814 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -95.53 158.16 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-O 122.633 1.206 . . . . 0.11 110.676 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.742 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -99.56 172.2 7.44 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.531 -2.122 . . . . 0.17999999999999999 108.966 -175.126 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.607 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.0 tt0 -102.67 134.04 46.69 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.19 -0.604 . . . . 0.91000000000000003 109.877 171.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.539 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 15.2 mm-40 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.477 -0.773 . . . . 1.24 110.524 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.752 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 . . . . . 0 N--CA 1.415 -2.186 0 N-CA-C 109.264 -0.643 . . . . 0.20999999999999999 109.264 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 2.8 t70 -80.01 68.09 6.02 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 123.692 1.711 . . . . 0.34999999999999998 108.36 171.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.726 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 90.3 m95 -59.41 -44.53 92.83 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 111.407 -2.633 . . . . 0.10000000000000001 112.312 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -51.36 -30.26 18.18 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.036 -1.438 . . . . 1.1100000000000001 111.524 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.79 -16.31 80.74 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 115.601 -0.727 . . . . 0.20999999999999999 111.385 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.96 -51.12 3.62 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 113.95 -1.125 . . . . 0.13 110.908 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.718 ' O ' HG23 ' A' ' 72' ' ' VAL . 40.7 mtt -65.33 -55.62 17.21 Favored 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 114.094 -1.412 . . . . 0.089999999999999997 112.224 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.486 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 6.1 mm100 -41.23 -54.76 5.68 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 114.558 1.318 . . . . 0.63 114.558 -176.229 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.824 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 23.7 Cg_endo -62.29 -31.61 81.91 Favored 'Trans proline' 0 CA--C 1.506 -0.891 0 C-N-CA 122.159 1.906 . . . . 0.14000000000000001 110.478 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.799 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 6.7 mtm -79.62 -46.5 17.1 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 114.863 -1.062 . . . . 0.69999999999999996 111.587 -176.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 68' ' ' MET . 61.1 t -55.92 -41.13 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 CA-C-N 114.025 -1.443 . . . . 0.12 108.869 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 t -59.43 -35.26 73.68 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.248 -1.796 . . . . 0.56000000000000005 110.952 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.824 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 21.0 mtpp -81.45 -34.67 31.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.926 0.49 . . . . 1.3 111.392 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.85 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.68 -27.66 69.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.693 -0.685 . . . . 0.5 111.592 -171.159 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.79 HD13 ' HB2' ' A' ' 118' ' ' LYS . 5.7 mt -92.92 -6.16 49.2 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.059 0.933 . . . . 0.65000000000000002 110.817 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.72 18.02 51.41 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 108.726 -1.75 . . . . 0.17000000000000001 108.726 170.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.669 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.17 163.15 15.56 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.318 -0.941 . . . . 0.10000000000000001 110.279 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.55 106.14 18.26 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.8 -1.091 . . . . 1.72 109.855 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.628 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.27 -23.85 3.62 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.201 -0.999 . . . . 0.12 111.056 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 75' ' ' MET . 10.4 p -100.22 152.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.661 0.743 . . . . 0.16 111.388 -174.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.5 m -135.25 139.45 44.45 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.643 -1.162 . . . . 0.45000000000000001 111.011 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.735 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.07 140.52 37.73 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.624 -1.171 . . . . 0.28000000000000003 111.155 167.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.91 2.95 68.64 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 121.262 -0.494 . . . . 0.28000000000000003 113.007 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.31 148.84 25.43 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 120.053 -0.659 . . . . 1.2 111.06 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.667 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -79.59 116.18 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-O 122.196 0.998 . . . . 0.20000000000000001 109.517 166.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.907 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -104.69 109.63 21.63 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.118 -0.946 . . . . 0.14000000000000001 109.427 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 1.026 HD21 HD13 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -72.16 99.28 2.3 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.832 -1.531 . . . . 0.14999999999999999 108.421 177.1 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.678 ' O ' HD21 ' A' ' 127' ' ' LEU . 3.0 m -72.02 117.6 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.699 -1.223 . . . . 0.94999999999999996 107.699 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.739 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -77.65 137.4 38.51 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.846 -1.168 . . . . 0.64000000000000001 107.846 -178.013 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.517 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.2 m -53.51 127.98 27.22 Favored 'General case' 0 CA--C 1.49 -1.356 0 CA-C-O 122.064 0.935 . . . . 0.37 108.579 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.596 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 19.8 t -55.53 134.97 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 107.695 -1.224 . . . . 0.10000000000000001 107.695 173.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.817 ' H ' ' HA ' ' A' ' 164' ' ' SER . 10.2 t-20 -85.62 163.59 18.23 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 114.842 -1.072 . . . . 0.17999999999999999 109.96 175.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.754 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.11 86.19 2.52 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.383 -1.281 . . . . 0.12 107.894 176.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.421 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 15.1 mtp180 -109.5 -3.51 16.93 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.048 -1.433 . . . . 0.64000000000000001 108.628 -172.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.734 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.5 p -50.81 -171.47 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.942 -1.935 . . . . 0.14000000000000001 115.491 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.541 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 37.5 t30 -71.27 -4.46 25.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.776 -2.011 . . . . 0.47999999999999998 110.719 173.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.597 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -157.85 -145.99 4.38 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.428 -0.892 . . . . 0.12 113.062 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.647 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 59.9 p -121.39 131.97 54.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.347 0.594 . . . . 1.1599999999999999 112.274 -178.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -137.21 158.31 44.72 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.015 0.912 . . . . 0.10000000000000001 110.808 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -81.4 79.76 7.94 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.821 -1.536 . . . . 0.17000000000000001 108.067 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -68.98 -14.38 63.0 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.377 -1.283 . . . . 0.089999999999999997 109.991 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.77 -30.22 36.05 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.726 -0.842 . . . . 0.14999999999999999 108.726 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.613 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 14.1 tp10 -67.62 -33.84 75.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 114.451 -1.25 . . . . 1.73 108.96 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.45 -44.19 65.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.186 -1.824 . . . . 0.12 109.567 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 77.6 m -64.0 -30.97 72.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.013 -1.448 . . . . 0.11 110.372 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -43.32 76.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.077 -1.083 . . . . 1.47 108.077 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 64' ' ' TRP . 79.2 m -63.14 -30.6 71.72 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.317 -0.856 . . . . 0.12 110.714 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.716 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.1 mt -51.5 -69.04 0.12 Allowed 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 109.404 -0.591 . . . . 0.56000000000000005 109.404 172.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 121' ' ' LEU . 18.5 mtp180 -41.06 -39.2 1.17 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.644 -1.162 . . . . 1.51 110.989 175.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 108' ' ' THR . 5.7 m-20 -70.0 -46.51 64.97 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.476 -1.238 . . . . 0.28000000000000003 112.038 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.81 -32.84 65.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 122.149 0.976 . . . . 0.089999999999999997 108.594 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.701 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -64.17 -34.38 77.95 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.588 -1.642 . . . . 0.12 110.1 174.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.655 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -70.97 -38.47 72.77 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.83 -1.077 . . . . 0.20000000000000001 111.45 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.82 -28.66 68.97 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.403 -1.271 . . . . 1.1699999999999999 111.041 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -83.24 -36.25 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.913 -1.04 . . . . 2.0499999999999998 110.19 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.18 -5.23 35.35 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.62 -0.8 . . . . 0.54000000000000004 114.35 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.79 ' HB2' HD13 ' A' ' 76' ' ' LEU . 53.7 mtpt -81.6 -9.89 59.56 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 117.774 0.787 . . . . 0.98999999999999999 110.787 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.907 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 28.5 m-85 -115.73 176.08 5.24 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.505 1.145 . . . . 0.20999999999999999 113.272 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.577 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.9 m -121.83 120.53 34.83 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 112.474 -2.148 . . . . 0.23000000000000001 107.896 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -88.1 140.01 29.92 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 119.512 -0.875 . . . . 0.38 109.929 -171.912 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.562 HG11 HD23 ' A' ' 88' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.429 -1.477 0 N-CA-C 108.56 -0.904 . . . . 0.41999999999999998 108.56 177.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 1.026 HD13 HD21 ' A' ' 88' ' ' LEU . 13.6 tp . . . . . 0 C--O 1.236 0.381 0 N-CA-C 114.58 1.326 . . . . 1.3899999999999999 114.58 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.585 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 66.6 m -56.23 -36.95 69.07 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 123.227 1.489 . . . . 1.05 108.456 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.616 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 9.3 mmt -62.98 -58.66 6.55 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 111.614 -2.539 . . . . 1.6399999999999999 110.997 174.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.744 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.63 -41.66 3.16 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 124.224 0.953 . . . . 0.31 111.91 176.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.821 ' HZ2' HD13 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -52.46 -57.61 9.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.153 -0.619 . . . . 1.53 109.912 175.846 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.0 mt-30 -61.4 -43.0 99.62 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.636 -1.166 . . . . 0.40999999999999998 111.445 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 129' ' ' MET . 47.8 mt-30 -56.29 -35.99 68.13 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 114.434 -1.257 . . . . 0.37 109.683 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.501 HD12 HG13 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -90.34 -29.95 17.75 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.029 -1.442 . . . . 0.23999999999999999 109.408 -178.052 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.62 -53.62 0.38 Allowed Glycine 0 CA--C 1.498 -0.976 0 C-N-CA 119.657 -1.259 . . . . 0.33000000000000002 114.174 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 141' ' ' SER . 14.9 mt -62.36 -171.07 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 112.254 -1.973 . . . . 0.31 116.226 -169.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 27.5 m -109.41 150.89 41.73 Favored Pre-proline 0 N--CA 1.421 -1.893 0 CA-C-N 110.759 -2.928 . . . . 0.81000000000000005 108.146 171.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 57.2 Cg_endo -66.06 0.19 3.45 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 122.991 2.461 . . . . 0.32000000000000001 112.139 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.472 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.5 tt0 -117.62 -31.01 5.32 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 114.717 -1.129 . . . . 1.25 109.39 -175.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 25.7 t0 -61.71 -27.01 68.4 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 113.028 -1.896 . . . . 0.65000000000000002 107.889 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.794 ' O ' HD13 ' A' ' 136' ' ' LEU . 0.4 OUTLIER 73.28 -170.29 0.13 Allowed 'General case' 0 CA--C 1.477 -1.854 0 CA-C-N 112.233 -2.258 . . . . 0.59999999999999998 109.933 -177.77 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.827 HD22 ' HA ' ' A' ' 148' ' ' ALA . 10.1 mt -65.25 -37.97 88.89 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.148 -1.387 . . . . 0.85999999999999999 107.707 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.37 -12.04 0.13 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 112.701 -2.045 . . . . 0.31 115.186 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.34 131.68 10.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 118.708 -0.663 . . . . 0.23999999999999999 109.226 -175.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.689 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 18.6 mmt180 -45.21 -50.07 11.82 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 118.069 0.395 . . . . 1.6499999999999999 111.446 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' A' ' 149' ' ' ILE . 71.1 m -71.13 -28.13 64.07 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.384 0.611 . . . . 0.53000000000000003 111.55 -175.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -72.43 -32.17 66.08 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 122.777 1.275 . . . . 1.3100000000000001 108.803 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.827 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -68.11 -44.82 75.33 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.218 -2.265 . . . . 0.12 109.906 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.605 HG13 ' HE1' ' A' ' 179' ' ' MET . 37.3 mt -68.72 -43.75 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 CA-C-N 112.958 -1.928 . . . . 0.11 110.411 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.41 -53.22 32.85 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.935 -1.03 . . . . 0.14999999999999999 111.036 172.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.821 HD13 ' HZ2' ' A' ' 131' ' ' LYS . 79.1 mt -66.98 -47.7 81.54 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 112.845 0.683 . . . . 0.17999999999999999 112.845 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.647 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.37 -39.28 72.66 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.878 0.37 . . . . 0.13 110.506 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.474 ' HD2' HG23 ' A' ' 149' ' ' ILE . 21.7 mtp180 -82.74 -21.78 34.6 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.464 0.649 . . . . 1.0800000000000001 110.664 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 27.7 t-20 -82.16 -11.2 58.86 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 107.116 -1.438 . . . . 0.5 107.116 176.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.713 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.65 -29.74 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 113.13 -1.85 . . . . 0.17000000000000001 110.978 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.48 35.75 4.57 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.226 -0.988 . . . . 0.16 112.64 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.645 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.54 155.11 22.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.353 0.872 . . . . 0.12 113.353 -170.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.667 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.2 m80 -94.03 -28.93 15.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.784 0.833 . . . . 0.20000000000000001 109.852 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.594 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 10.3 m-85 -136.59 -178.16 5.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.342 -0.845 . . . . 0.13 111.15 -173.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.696 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -135.31 139.21 47.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.103 -0.953 . . . . 0.080000000000000002 109.012 166.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.739 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 22.6 tp -109.96 98.92 8.12 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.607 -0.837 . . . . 0.16 109.932 167.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.0 m-85 -78.42 112.22 15.23 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.252 -0.885 . . . . 0.26000000000000001 109.367 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.868 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.0 t -124.07 159.62 29.53 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 122.397 1.094 . . . . 1.05 110.323 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.817 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.4 p -164.44 171.97 13.98 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.016 -1.447 . . . . 0.10000000000000001 111.098 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -133.28 133.96 43.3 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.082 -1.417 . . . . 0.11 108.714 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.1 m -143.67 -176.33 4.93 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.025 -0.732 . . . . 1.0900000000000001 109.025 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.93 -83.21 0.91 Allowed Glycine 0 C--N 1.301 -1.387 0 C-N-CA 119.698 -1.239 . . . . 0.14999999999999999 111.454 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.541 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 60.2 t30 -144.7 126.67 15.45 Favored 'General case' 0 C--O 1.196 -1.748 0 N-CA-C 108.066 -1.087 . . . . 0.58999999999999997 108.066 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.597 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.0 p -62.43 -44.12 98.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.316 -0.856 . . . . 0.14999999999999999 113.217 -170.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.428 ' N ' HG13 ' A' ' 169' ' ' VAL . 70.8 m-20 -62.1 -28.59 69.73 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.398 0.618 . . . . 1.26 109.728 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.86 88.2 3.59 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 114.681 -1.145 . . . . 0.13 108.436 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.839 ' HD2' HG22 ' A' ' 194' ' ' VAL . 42.9 Cg_endo -91.69 167.7 3.26 Favored 'Trans proline' 0 CA--C 1.498 -1.321 0 C-N-CA 125.045 3.83 . . . . 0.089999999999999997 115.151 -169.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 191' ' ' LYS . 32.3 m -84.35 118.96 24.55 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 113.796 -1.547 . . . . 0.14000000000000001 107.381 165.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.801 HD12 ' O ' ' A' ' 164' ' ' SER . 48.8 tp -84.43 98.11 9.89 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 108.378 -0.971 . . . . 0.16 108.378 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.555 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 31.4 mt-30 -88.96 109.3 20.13 Favored 'General case' 0 C--N 1.272 -2.761 0 CA-C-O 121.891 0.853 . . . . 0.34000000000000002 109.239 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.868 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.6 OUTLIER -112.34 164.28 13.42 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.109 -0.951 . . . . 1.0900000000000001 111.495 -174.556 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.629 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 60.1 tt0 -171.71 116.92 0.4 Allowed 'General case' 0 C--O 1.202 -1.446 0 CA-C-N 116.027 -0.533 . . . . 0.5 110.588 -166.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.053 HD13 HD11 ' A' ' 187' ' ' ILE . 0.8 OUTLIER -98.85 103.23 15.16 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.353 -0.842 . . . . 0.10000000000000001 108.851 -170.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.662 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 16.3 ttp -92.12 122.29 34.48 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.261 -0.882 . . . . 0.070000000000000007 109.713 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.433 HD22 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -59.45 126.75 28.89 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.215 -1.402 . . . . 0.22 107.215 166.287 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.596 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -80.45 -35.56 15.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.433 -0.907 . . . . 0.11 110.682 178.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.43 ' N ' HD12 ' A' ' 180' ' ' LEU . 29.4 mt-30 -64.02 -13.98 50.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.282 -0.872 . . . . 0.34999999999999998 111.527 -178.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 180' ' ' LEU . 80.6 p -131.12 -32.62 1.58 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.902 0.858 . . . . 0.19 110.623 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.454 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 82.95 28.03 39.12 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.357 -1.292 . . . . 0.17999999999999999 112.136 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.43 152.38 24.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.64 -0.28 . . . . 0.72999999999999998 110.502 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.588 HD12 ' HG2' ' A' ' 177' ' ' GLN . 30.4 mm -86.48 121.34 37.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.368 0.604 . . . . 0.14000000000000001 109.464 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.053 HD11 HD13 ' A' ' 178' ' ' LEU . 1.2 pp -109.28 -29.93 2.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.112 -0.949 . . . . 0.13 110.402 -174.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.669 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 80.6 t90 -136.48 153.43 51.04 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.056 -0.975 . . . . 0.070000000000000007 109.562 173.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 58.1 p -153.36 164.34 38.31 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.235 0.828 . . . . 0.13 113.235 164.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.2 -173.78 28.07 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 111.244 -0.742 . . . . 0.12 111.244 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.77 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 18.1 mttt -157.69 153.73 27.15 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.221 -2.14 . . . . 1.22 105.221 165.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.19 126.89 1.78 Allowed Glycine 0 C--N 1.279 -2.585 0 C-N-CA 119.525 -1.321 . . . . 0.12 111.663 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -73.94 111.87 9.52 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.508 0.67 . . . . 0.17000000000000001 110.774 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.839 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -91.3 158.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 122.693 1.235 . . . . 0.11 111.051 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.752 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -98.67 172.38 7.52 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 112.38 -2.191 . . . . 0.17999999999999999 108.722 -174.548 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.4 tt0 -102.61 133.16 48.06 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.997 -0.681 . . . . 0.91000000000000003 109.505 169.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.523 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 14.8 mm-40 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.795 -0.622 . . . . 1.24 110.602 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.768 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.0 m-30 . . . . . 0 N--CA 1.421 -1.88 0 N-CA-C 109.821 -0.437 . . . . 0.20999999999999999 109.821 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.541 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 4.4 t70 -80.73 67.54 6.65 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 123.761 1.743 . . . . 0.34999999999999998 108.25 171.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.715 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.1 m95 -56.23 -42.28 77.05 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 111.361 -2.654 . . . . 0.10000000000000001 112.345 174.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.429 ' OD1' ' HG3' ' A' ' 69' ' ' GLN . 3.7 t30 -49.55 -31.14 9.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.537 -1.665 . . . . 1.1100000000000001 112.183 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.2 -16.58 80.52 Favored Glycine 0 CA--C 1.505 -0.547 0 CA-C-O 122.091 0.828 . . . . 0.20999999999999999 111.193 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -100.89 -54.14 2.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.846 -1.177 . . . . 0.13 110.874 -176.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.716 ' O ' HG23 ' A' ' 72' ' ' VAL . 41.8 mtt -64.33 -59.12 4.75 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 114.256 -1.338 . . . . 0.089999999999999997 112.798 -176.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.429 ' HG3' ' OD1' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -39.47 -55.12 3.47 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 114.548 1.314 . . . . 0.63 114.548 -175.94 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.812 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 43.1 Cg_endo -66.14 -29.68 47.52 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.708 1.605 . . . . 0.14000000000000001 110.471 -177.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.656 ' HE2' ' N ' ' A' ' 192' ' ' GLY . 11.1 mtm -82.19 -40.46 21.7 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.292 -0.867 . . . . 0.69999999999999996 111.397 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 68' ' ' MET . 47.9 t -57.44 -39.06 66.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 114.608 -1.178 . . . . 0.12 108.382 172.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -62.12 -33.6 74.76 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.204 -1.816 . . . . 0.56000000000000005 110.94 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.812 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 32.9 mtpt -82.4 -31.57 29.55 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.203 0.525 . . . . 1.3 110.886 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.849 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.32 -28.52 68.06 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.255 -0.884 . . . . 0.5 111.425 -172.168 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.659 HD13 ' HD3' ' A' ' 118' ' ' LYS . 5.6 mt -93.53 -4.18 51.5 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.412 1.101 . . . . 0.65000000000000002 110.588 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.49 17.93 42.31 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 108.837 -1.705 . . . . 0.17000000000000001 108.837 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.614 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.33 163.98 15.1 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.615 -0.792 . . . . 0.10000000000000001 109.897 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -92.26 106.42 18.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.517 -0.765 . . . . 1.72 109.732 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.639 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.21 -24.69 3.07 Favored Glycine 0 N--CA 1.418 -2.519 0 C-N-CA 119.998 -1.096 . . . . 0.12 110.373 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.849 HG11 ' O ' ' A' ' 75' ' ' MET . 11.4 p -99.59 153.57 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 114.738 -0.731 . . . . 0.16 111.153 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.6 m -134.55 139.27 45.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.795 -1.093 . . . . 0.45000000000000001 110.267 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -58.89 143.9 46.24 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.432 -0.804 . . . . 0.28000000000000003 110.514 168.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.62 69.64 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.89 -0.672 . . . . 0.28000000000000003 113.141 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.95 153.65 22.03 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 117.078 0.439 . . . . 1.2 110.658 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.722 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.2 p -81.91 116.49 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 122.051 0.929 . . . . 0.20000000000000001 109.301 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.589 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -104.37 110.06 22.16 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.173 -0.922 . . . . 0.14000000000000001 109.106 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.75 HD23 HG11 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -71.65 101.09 2.45 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.954 -1.021 . . . . 0.14999999999999999 108.65 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.669 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 73.0 t -73.66 111.18 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.863 -1.062 . . . . 0.94999999999999996 109.048 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.792 ' HB2' HD11 ' A' ' 142' ' ' LEU . 6.1 t0 -77.35 152.87 34.25 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 114.735 -1.12 . . . . 0.64000000000000001 108.167 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.541 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.7 OUTLIER -61.39 137.24 58.24 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.718 -1.128 . . . . 0.37 107.999 173.253 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.56 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 20.6 t -63.58 138.84 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.88 0 N-CA-C 107.903 -1.147 . . . . 0.10000000000000001 107.903 167.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.815 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -84.21 162.81 20.06 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.123 -0.944 . . . . 0.17999999999999999 110.138 173.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.22 85.7 2.44 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.37 -1.287 . . . . 0.12 108.241 175.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.462 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.4 mtp180 -108.73 -1.69 19.19 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.029 -1.441 . . . . 0.64000000000000001 108.823 -172.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.712 HG21 ' HB3' ' A' ' 172' ' ' PRO . 24.6 p -52.46 -171.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 112.927 -1.942 . . . . 0.14000000000000001 115.281 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.448 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 30.5 t30 -71.24 -9.39 58.03 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.107 -1.861 . . . . 0.47999999999999998 110.539 173.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.547 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.73 -146.34 4.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.358 -0.925 . . . . 0.12 112.841 -177.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.587 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.1 p -121.19 129.7 53.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.119 0.485 . . . . 1.1599999999999999 112.147 -177.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.758 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -134.73 156.76 48.24 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-O 121.876 0.846 . . . . 0.10000000000000001 110.855 -177.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -80.44 80.7 6.84 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 113.845 -1.525 . . . . 0.17000000000000001 107.977 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.04 -14.71 63.19 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.261 -1.336 . . . . 0.089999999999999997 110.027 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.754 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.33 -32.63 37.86 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.812 -0.81 . . . . 0.14999999999999999 108.812 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.62 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.0 tp10 -65.5 -32.84 74.66 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.384 -1.28 . . . . 1.73 108.901 172.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -73.58 -45.18 54.84 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 112.96 -1.927 . . . . 0.12 109.683 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.62 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 73.1 m -62.84 -31.49 72.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.155 -1.384 . . . . 0.11 110.228 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -66.85 -44.09 81.91 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.136 -1.061 . . . . 1.47 108.136 172.715 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 64' ' ' TRP . 51.7 m -62.79 -31.73 72.77 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.4 -0.818 . . . . 0.12 110.584 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.689 ' O ' HD23 ' A' ' 113' ' ' LEU . 10.3 mt -52.67 -69.66 0.11 Allowed 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.737 -0.665 . . . . 0.56000000000000005 109.283 171.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.539 ' HG3' HG21 ' A' ' 89' ' ' VAL . 9.4 mtp180 -40.05 -36.57 0.5 Allowed 'General case' 0 C--N 1.313 -0.991 0 O-C-N 124.365 1.041 . . . . 1.51 111.606 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.9 m-20 -73.4 -46.98 45.55 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.501 -1.227 . . . . 0.28000000000000003 111.97 -176.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.415 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . . . -72.2 -31.99 66.39 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.261 1.029 . . . . 0.089999999999999997 108.455 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.866 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.5 mm? -63.23 -35.75 81.38 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.213 -1.812 . . . . 0.12 109.579 172.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.557 ' HA ' HD21 ' A' ' 121' ' ' LEU . . . -73.61 -39.93 64.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 114.855 -1.066 . . . . 0.20000000000000001 111.383 -175.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -61.01 -32.03 71.63 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.623 -0.717 . . . . 1.1699999999999999 110.85 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -76.46 -21.34 56.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.412 -0.813 . . . . 2.0499999999999998 111.076 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 60.91 11.83 26.23 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 115.492 0.957 . . . . 0.54000000000000004 115.492 162.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.659 ' HD3' HD13 ' A' ' 76' ' ' LEU . 8.6 ptmt -108.47 -23.64 11.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.413 0.606 . . . . 0.98999999999999999 111.225 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.654 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 3.2 m-85 -87.87 170.15 11.42 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.924 0.869 . . . . 0.20999999999999999 111.676 172.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 23.5 m -120.66 105.44 10.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 113.425 -1.716 . . . . 0.23000000000000001 108.064 170.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.866 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -98.17 130.67 44.91 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 114.379 -1.282 . . . . 0.38 112.249 -168.023 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.594 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.297 -1.711 0 CA-C-N 113.973 -1.467 . . . . 0.41999999999999998 107.77 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.675 HD23 HD21 ' A' ' 88' ' ' LEU . 1.8 tm? . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 112.906 0.706 . . . . 1.3899999999999999 112.906 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.726 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -50.89 -39.15 53.45 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 123.62 1.676 . . . . 1.05 109.248 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.705 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -63.87 -61.81 2.04 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 110.904 -2.862 . . . . 1.6399999999999999 110.837 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.782 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.82 -44.78 4.61 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 124.496 1.122 . . . . 0.31 112.134 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.53 ' HZ3' ' N ' ' A' ' 142' ' ' LEU . 13.3 mmtt -49.32 -60.37 2.88 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.471 -0.566 . . . . 1.53 109.471 175.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -59.16 -43.11 92.09 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.234 -0.894 . . . . 0.40999999999999998 111.059 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.705 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.1 mt-30 -56.41 -36.3 68.76 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 114.238 -1.346 . . . . 0.37 109.69 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -89.94 -31.36 17.3 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.162 -1.381 . . . . 0.23999999999999999 109.622 -176.441 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.53 -45.41 0.55 Allowed Glycine 0 CA--C 1.495 -1.207 0 C-N-CA 120.096 -1.05 . . . . 0.33000000000000002 113.278 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 141' ' ' SER . 95.7 mt -67.95 -171.16 0.2 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 112.448 -1.876 . . . . 0.31 115.486 -169.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 9.5 m -115.1 149.91 43.38 Favored Pre-proline 0 N--CA 1.422 -1.875 0 CA-C-N 110.7 -2.954 . . . . 0.81000000000000005 107.765 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.726 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 28.8 Cg_endo -64.5 1.02 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.534 2.156 . . . . 0.32000000000000001 112.034 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.754 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -117.36 -21.62 8.61 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.382 -0.826 . . . . 1.25 110.862 -177.776 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 16.3 t70 -71.42 -20.32 62.13 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.222 -1.354 . . . . 0.65000000000000002 108.932 -171.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.585 ' O ' HD13 ' A' ' 136' ' ' LEU . 26.3 m 72.84 169.05 0.32 Allowed 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 113.005 -1.907 . . . . 0.59999999999999998 109.338 -174.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.002 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.9 mt -63.48 -39.12 93.62 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.685 -1.228 . . . . 0.85999999999999999 107.685 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.43 -11.84 2.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 113.369 -1.741 . . . . 0.31 114.402 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 1.5 m -157.04 128.76 7.09 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.068 -0.716 . . . . 0.23999999999999999 109.068 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.658 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.3 mmt180 -43.93 -46.46 8.14 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 117.991 0.359 . . . . 1.6499999999999999 111.385 -178.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.404 ' HA ' ' HB ' ' A' ' 149' ' ' ILE . 40.7 t -71.27 -25.81 62.62 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.68 0.753 . . . . 0.53000000000000003 111.459 -175.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 22.8 mttm -75.04 -32.21 61.5 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.588 1.185 . . . . 1.3100000000000001 108.678 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 1.002 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -72.57 -46.02 56.37 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 112.385 -2.189 . . . . 0.12 110.017 177.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.598 HG13 ' HE1' ' A' ' 179' ' ' MET . 41.5 mt -67.14 -42.38 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 112.768 -2.015 . . . . 0.11 109.995 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.92 -52.72 37.48 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 114.74 -1.118 . . . . 0.14999999999999999 111.301 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.782 HG23 ' CB ' ' A' ' 130' ' ' ALA . 69.5 mt -67.12 -48.44 78.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.072 0 N-CA-C 112.7 0.63 . . . . 0.17999999999999999 112.7 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.696 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.94 -40.39 73.09 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.826 0.345 . . . . 0.13 111.344 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.524 ' HD2' HG23 ' A' ' 149' ' ' ILE . 43.0 mtp180 -81.64 -22.26 37.71 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.625 0.726 . . . . 1.0800000000000001 110.321 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -81.83 -12.95 58.27 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 107.16 -1.422 . . . . 0.5 107.16 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.75 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -106.05 -29.17 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 113.231 -1.804 . . . . 0.17000000000000001 110.898 -174.024 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.99 35.63 4.75 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.357 -0.925 . . . . 0.16 112.466 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.669 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.68 158.13 19.65 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.275 0.842 . . . . 0.12 113.275 -169.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.722 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.5 m80 -98.66 -27.79 13.83 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.322 -0.854 . . . . 0.20000000000000001 109.757 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.624 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 9.3 m-85 -135.58 -173.35 3.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.049 -0.978 . . . . 0.13 111.281 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.697 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -138.42 139.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.9 -1.045 . . . . 0.080000000000000002 109.231 167.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.735 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 40.8 tp -108.5 97.27 6.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.468 -0.893 . . . . 0.16 109.505 165.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.704 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 1.4 m-85 -78.82 112.45 15.99 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.687 -1.142 . . . . 0.26000000000000001 108.959 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.719 ' OG ' HD11 ' A' ' 174' ' ' LEU . 27.0 t -122.26 163.19 20.08 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 122.002 0.906 . . . . 1.05 110.515 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.823 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -164.33 173.15 12.59 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 114.37 -1.286 . . . . 0.10000000000000001 111.049 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.73 139.72 42.09 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 114.14 -1.391 . . . . 0.11 108.758 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.68 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 t -146.42 -172.54 3.98 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.954 -0.698 . . . . 1.0900000000000001 110.267 176.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 90.3 -84.49 1.34 Allowed Glycine 0 N--CA 1.424 -2.16 0 CA-C-N 114.883 -1.053 . . . . 0.14999999999999999 111.593 174.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.448 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 49.2 t-20 -135.29 128.04 31.05 Favored 'General case' 0 C--O 1.196 -1.719 0 N-CA-C 106.925 -1.509 . . . . 0.58999999999999997 106.925 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.547 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.9 p -64.03 -41.51 92.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.553 -0.749 . . . . 0.14999999999999999 112.37 -177.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.42 ' N ' HG13 ' A' ' 169' ' ' VAL . 78.8 m-20 -67.56 -26.45 66.31 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.468 0.651 . . . . 1.26 109.461 -175.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.52 89.21 3.26 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 114.887 -1.051 . . . . 0.13 108.304 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.852 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.6 Cg_endo -90.27 165.0 4.56 Favored 'Trans proline' 0 CA--C 1.488 -1.804 0 C-N-CA 124.519 3.479 . . . . 0.089999999999999997 114.97 -171.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.597 HG22 ' HB3' ' A' ' 191' ' ' LYS . 19.4 m -83.24 117.32 22.87 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.548 -1.66 . . . . 0.14000000000000001 107.602 166.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 164' ' ' SER . 49.1 tp -84.09 98.53 9.93 Favored 'General case' 0 N--CA 1.411 -2.381 0 C-N-CA 119.641 -0.824 . . . . 0.16 109.055 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.623 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.8 mt-30 -89.13 107.21 18.92 Favored 'General case' 0 C--N 1.273 -2.749 0 CA-C-N 114.811 -1.086 . . . . 0.34000000000000002 108.95 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 37.0 mtp -107.08 163.73 12.74 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.138 -0.937 . . . . 1.0900000000000001 110.393 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.592 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.9 tt0 -170.09 117.41 0.55 Allowed 'General case' 0 C--O 1.202 -1.445 0 CA-C-O 121.179 0.514 . . . . 0.5 110.208 -167.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.101 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -100.12 102.06 13.28 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.705 -0.85 . . . . 0.10000000000000001 108.705 -172.447 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.658 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.8 ttp -91.67 122.57 34.35 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.416 -0.811 . . . . 0.070000000000000007 109.755 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.467 ' HB3' ' OG1' ' A' ' 183' ' ' THR . 0.1 OUTLIER -58.53 126.45 27.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.311 -1.366 . . . . 0.22 107.311 166.238 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.63 -33.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 O-C-N 120.939 -1.101 . . . . 0.11 110.55 178.798 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.418 ' N ' HD12 ' A' ' 180' ' ' LEU . 29.0 mt-30 -63.85 -13.95 49.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.235 -0.893 . . . . 0.34999999999999998 111.449 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 180' ' ' LEU . 60.3 p -130.62 -36.69 1.41 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.945 0.878 . . . . 0.19 110.26 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.531 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 87.08 24.35 37.81 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.334 -1.303 . . . . 0.17999999999999999 112.022 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 186' ' ' ILE . 0.2 OUTLIER -104.26 152.37 22.29 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.621 -0.29 . . . . 0.72999999999999998 110.658 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.592 HD12 ' HG2' ' A' ' 177' ' ' GLN . 33.0 mm -87.85 113.6 25.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.811 0.815 . . . . 0.14000000000000001 109.532 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.101 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -101.8 -29.61 3.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 114.729 -1.123 . . . . 0.13 110.587 -173.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.637 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.4 t90 -136.82 152.47 50.31 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.304 -0.862 . . . . 0.070000000000000007 109.737 172.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 37.3 p -153.78 162.93 40.82 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.003 0.742 . . . . 0.13 113.003 164.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -156.53 -178.24 30.46 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 110.985 -0.846 . . . . 0.12 110.985 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.748 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.1 mtmt -157.12 149.39 22.97 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.343 -1.725 . . . . 1.22 106.343 166.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.656 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -159.35 127.69 1.88 Allowed Glycine 0 C--N 1.285 -2.258 0 C-N-CA 119.973 -1.108 . . . . 0.12 112.258 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.09 114.45 12.43 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.547 0.689 . . . . 0.17000000000000001 111.472 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.852 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -91.73 159.47 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 122.609 1.195 . . . . 0.11 111.065 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.768 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -99.68 173.78 6.54 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.319 -2.218 . . . . 0.17999999999999999 108.974 -173.051 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -102.94 130.3 49.95 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.64 -0.424 . . . . 0.91000000000000003 110.895 171.35 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.541 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 15.3 mm-40 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.609 -0.71 . . . . 1.24 110.722 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.75 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.8 m-30 . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 109.593 -0.521 . . . . 0.20999999999999999 109.593 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.525 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 3.0 t70 -79.24 67.39 4.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 123.762 1.744 . . . . 0.34999999999999998 108.291 171.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.75 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 89.3 m95 -59.83 -44.43 94.07 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 111.478 -2.601 . . . . 0.10000000000000001 112.113 174.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -51.04 -31.44 18.53 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.939 -1.482 . . . . 1.1100000000000001 111.35 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.35 -16.61 79.81 Favored Glycine 0 C--N 1.312 -0.754 0 CA-C-N 115.504 -0.771 . . . . 0.20999999999999999 111.318 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.57 -53.67 2.93 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.996 -1.102 . . . . 0.13 110.817 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.697 ' SD ' HD23 ' A' ' 109' ' ' LEU . 42.4 mtt -62.89 -59.61 4.61 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 114.206 -1.361 . . . . 0.089999999999999997 112.554 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.448 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 16.0 mm-40 -38.53 -55.23 2.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 114.83 1.419 . . . . 0.63 114.83 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.795 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.1 Cg_endo -65.46 -30.13 52.91 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.674 1.583 . . . . 0.14000000000000001 110.588 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.672 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 13.7 mtm -83.35 -39.69 20.39 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 115.413 -0.812 . . . . 0.69999999999999996 111.205 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 68' ' ' MET . 58.9 t -56.82 -39.29 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 114.555 -1.202 . . . . 0.12 108.465 172.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -61.67 -35.33 77.65 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 113.176 -1.829 . . . . 0.56000000000000005 110.9 174.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.795 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.3 mtpt -81.31 -31.55 33.49 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.093 0.473 . . . . 1.3 110.618 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.874 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.26 -25.17 65.94 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.355 -0.839 . . . . 0.5 111.119 -173.086 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' A' ' 118' ' ' LYS . 6.7 mt -95.2 -5.09 44.69 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.069 0.938 . . . . 0.65000000000000002 110.762 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.92 17.46 41.7 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 108.888 -1.685 . . . . 0.17000000000000001 108.888 169.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.648 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -87.39 162.08 17.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.576 -0.812 . . . . 0.10000000000000001 110.036 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -90.4 105.32 17.73 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.253 -0.885 . . . . 1.72 110.273 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.647 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.92 -22.2 3.47 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.978 -1.01 . . . . 0.12 110.807 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.874 HG11 ' O ' ' A' ' 75' ' ' MET . 10.7 p -102.08 153.88 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.678 0.752 . . . . 0.16 111.704 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.6 m -135.14 139.9 45.0 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.726 -1.124 . . . . 0.45000000000000001 110.796 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.664 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.81 126.89 29.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.332 -0.849 . . . . 0.28000000000000003 110.481 166.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.05 8.25 29.83 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.849 -0.691 . . . . 0.28000000000000003 112.56 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.31 153.2 19.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 120.721 -0.392 . . . . 1.2 110.52 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.0 p -82.1 117.32 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 122.009 0.909 . . . . 0.20000000000000001 108.956 166.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.662 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -105.42 110.23 22.5 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.301 -0.863 . . . . 0.14000000000000001 109.267 -171.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.724 HD21 HD23 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -73.04 94.5 1.9 Allowed 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 114.446 -1.252 . . . . 0.14999999999999999 109.133 178.044 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.4 m -73.39 116.78 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 107.542 -1.281 . . . . 0.94999999999999996 107.542 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.813 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 7.0 t0 -79.26 170.81 16.07 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.201 -1.036 . . . . 0.64000000000000001 108.201 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.59 ' OG ' ' HA ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -59.96 149.42 31.95 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 122.773 1.273 . . . . 0.37 108.937 171.548 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.559 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 36.7 t -74.34 138.55 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.476 0 CA-C-N 113.576 -1.647 . . . . 0.10000000000000001 106.612 163.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.828 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.4 t-20 -84.45 158.97 20.87 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-O 121.888 0.852 . . . . 0.17999999999999999 109.875 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.748 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -122.81 84.8 2.32 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.281 -1.327 . . . . 0.12 107.938 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.448 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 15.0 mtp180 -107.67 -1.83 20.73 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 113.547 -1.66 . . . . 0.64000000000000001 108.574 -172.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.747 HG21 ' HB3' ' A' ' 172' ' ' PRO . 24.1 p -51.82 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.156 -1.838 . . . . 0.14000000000000001 114.216 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.3 OUTLIER -76.06 -2.99 33.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.233 -1.803 . . . . 0.47999999999999998 110.33 174.692 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.638 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -149.66 -150.22 5.19 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.922 -0.656 . . . . 0.12 112.905 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.6 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.1 p -121.83 130.58 53.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.514 0.561 . . . . 1.1599999999999999 112.514 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.748 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.6 157.38 47.02 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.855 0.836 . . . . 0.10000000000000001 111.155 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.605 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -80.14 79.49 6.69 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.002 -1.454 . . . . 0.17000000000000001 107.993 175.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.38 -15.57 63.75 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.285 -1.325 . . . . 0.089999999999999997 109.997 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.57 -29.97 37.01 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.944 -0.762 . . . . 0.14999999999999999 108.944 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.605 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.3 tp10 -66.46 -34.64 78.4 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 122.681 1.229 . . . . 1.73 109.131 170.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.99 -43.4 65.17 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 113.203 -1.817 . . . . 0.12 109.664 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 55.7 m -63.77 -31.02 72.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.898 -1.501 . . . . 0.11 110.536 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -67.85 -42.45 81.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.609 -1.256 . . . . 1.47 107.609 172.436 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.692 HG21 ' HB2' ' A' ' 64' ' ' TRP . 57.2 m -63.56 -31.02 72.06 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.171 -0.922 . . . . 0.12 110.672 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.735 HD11 ' OG ' ' A' ' 163' ' ' SER . 8.3 mt -50.9 -70.47 0.08 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 115.776 -0.647 . . . . 0.56000000000000005 109.278 171.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.52 ' O ' HD13 ' A' ' 121' ' ' LEU . 17.0 mtp180 -41.0 -38.78 1.04 Allowed 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.475 1.109 . . . . 1.51 111.197 176.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 108' ' ' THR . 5.8 m-20 -68.37 -46.49 69.93 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.367 -1.288 . . . . 0.28000000000000003 112.358 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.448 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.38 -33.4 65.01 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.299 1.047 . . . . 0.089999999999999997 108.417 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -65.2 -31.89 73.28 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.186 -1.824 . . . . 0.12 110.131 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.65 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.85 -44.69 61.07 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 114.335 -1.302 . . . . 0.20000000000000001 111.713 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -65.72 -28.75 69.28 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.54 -1.209 . . . . 1.1699999999999999 110.832 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -81.43 -19.78 41.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.3 -0.864 . . . . 2.0499999999999998 111.885 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 59.24 11.05 11.53 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 115.586 0.995 . . . . 0.54000000000000004 115.586 163.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.664 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 56.2 mtpt -96.93 -3.96 40.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.35 0.575 . . . . 0.98999999999999999 109.759 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.662 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 29.0 m-85 -121.22 173.2 7.46 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.481 1.134 . . . . 0.20999999999999999 112.726 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 16.3 m -117.85 115.82 25.74 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 112.658 -2.065 . . . . 0.23000000000000001 107.776 170.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.3 OUTLIER -83.07 137.57 34.05 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.152 -0.931 . . . . 0.38 110.376 -172.473 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.551 HG21 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.295 -1.782 0 N-CA-C 108.074 -1.084 . . . . 0.41999999999999998 108.074 171.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.724 HD23 HD21 ' A' ' 88' ' ' LEU . 1.2 tm? . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 113.574 0.953 . . . . 1.3899999999999999 113.574 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.595 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -51.94 -37.56 53.22 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.582 1.658 . . . . 1.05 108.407 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.651 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.4 OUTLIER -62.89 -60.13 3.89 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 110.714 -2.948 . . . . 1.6399999999999999 111.292 178.183 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.778 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.15 -43.03 6.77 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 124.304 1.003 . . . . 0.31 112.148 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.703 ' HE3' ' CD2' ' A' ' 127' ' ' LEU . 22.3 mttt -52.77 -55.52 22.25 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 120.326 -0.549 . . . . 1.53 109.691 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.4 mt-30 -62.14 -41.74 98.57 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.021 -0.99 . . . . 0.40999999999999998 111.28 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 129' ' ' MET . 53.5 mt-30 -57.06 -36.45 70.56 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.257 -1.338 . . . . 0.37 110.034 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -91.06 -31.0 16.44 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.243 -1.344 . . . . 0.23999999999999999 109.084 -176.807 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.52 -51.24 0.36 Allowed Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.015 -1.088 . . . . 0.33000000000000002 113.979 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 141' ' ' SER . 46.8 mt -67.41 -171.1 0.16 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 116.12 1.896 . . . . 0.31 116.12 -169.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.8 m -115.58 152.55 47.31 Favored Pre-proline 0 N--CA 1.427 -1.62 0 CA-C-N 110.732 -2.94 . . . . 0.81000000000000005 108.158 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.686 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 11.8 Cg_endo -59.2 -4.9 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.027 2.485 . . . . 0.32000000000000001 113.171 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -117.49 -30.41 5.53 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.826 0.822 . . . . 1.25 111.104 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.591 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.4 t70 -58.28 -25.49 61.87 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.42 -1.718 . . . . 0.65000000000000002 109.065 -174.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.59 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 5.5 m 72.9 161.37 0.24 Allowed 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 111.495 -2.593 . . . . 0.59999999999999998 111.822 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.909 HD13 ' HA ' ' A' ' 148' ' ' ALA . 8.5 mt -66.64 -38.76 87.58 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.25 -1.389 . . . . 0.85999999999999999 107.25 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.34 -4.78 0.32 Allowed Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 112.576 -2.102 . . . . 0.31 114.703 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.48 124.35 9.24 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 118.603 -0.713 . . . . 0.23999999999999999 109.369 -174.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.586 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 16.6 mmt85 -41.66 -51.16 4.11 Favored 'General case' 0 C--O 1.212 -0.92 0 O-C-N 123.563 0.539 . . . . 1.6499999999999999 111.046 -177.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.9 t -67.81 -29.16 68.27 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.493 0.663 . . . . 0.53000000000000003 111.21 -174.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 20.6 mttm -72.76 -31.17 64.72 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.355 1.074 . . . . 1.3100000000000001 108.519 177.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.909 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -76.97 -41.91 41.12 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 113.049 -1.887 . . . . 0.12 110.746 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.609 ' HA ' HG23 ' A' ' 181' ' ' VAL . 43.0 mt -69.12 -42.21 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 113.393 -1.731 . . . . 0.11 110.189 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.66 -48.77 64.13 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.904 -1.044 . . . . 0.14999999999999999 111.27 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.778 HG23 ' CB ' ' A' ' 130' ' ' ALA . 67.2 mt -71.23 -48.08 56.58 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 N-CA-C 112.87 0.693 . . . . 0.17999999999999999 112.87 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.666 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.57 -39.42 70.63 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.935 0.398 . . . . 0.13 110.633 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.487 ' HD2' HG23 ' A' ' 149' ' ' ILE . 28.7 mtp180 -81.01 -24.4 37.96 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.522 0.677 . . . . 1.0800000000000001 110.672 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.28 -14.12 59.23 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.508 -1.293 . . . . 0.5 107.508 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.71 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -104.69 -29.98 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 113.196 -1.82 . . . . 0.17000000000000001 110.967 -173.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.05 33.04 5.36 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.681 -0.771 . . . . 0.16 112.437 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.689 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -106.89 159.75 16.02 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.92 0.711 . . . . 0.12 112.92 -170.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.67 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.9 m80 -99.65 -27.24 13.77 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.379 -0.828 . . . . 0.20000000000000001 109.686 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 5.6 m-85 -135.58 -173.02 3.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.262 -0.881 . . . . 0.13 110.941 -175.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.776 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -137.63 138.6 44.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.941 -1.027 . . . . 0.080000000000000002 108.897 166.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.479 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 45.5 tp -107.93 101.36 10.63 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 119.715 -0.794 . . . . 0.16 109.038 165.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.605 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.4 m-85 -81.38 113.03 19.19 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.087 -1.415 . . . . 0.26000000000000001 109.559 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.735 ' OG ' HD11 ' A' ' 109' ' ' LEU . 4.2 p -118.09 159.99 22.3 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.717 0.77 . . . . 1.05 110.749 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.828 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.9 p -163.94 173.6 12.45 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 114.862 -1.063 . . . . 0.10000000000000001 111.414 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.09 139.01 37.58 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 113.951 -1.477 . . . . 0.11 108.464 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.4 t -147.2 -171.47 3.79 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.055 -0.658 . . . . 1.0900000000000001 110.073 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.05 -80.71 1.43 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.128 -1.034 . . . . 0.14999999999999999 111.773 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.5 t30 -144.52 125.47 14.4 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 107.99 -1.115 . . . . 0.58999999999999997 107.99 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.638 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.3 p -63.12 -42.97 98.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.479 -0.782 . . . . 0.14999999999999999 112.934 -171.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.441 ' N ' HG13 ' A' ' 169' ' ' VAL . 50.0 m-20 -61.66 -29.53 70.13 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.391 0.615 . . . . 1.26 109.532 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.9 88.52 3.54 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.634 -1.167 . . . . 0.13 108.508 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.844 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.3 Cg_endo -91.55 167.7 3.34 Favored 'Trans proline' 0 CA--C 1.497 -1.374 0 C-N-CA 124.927 3.751 . . . . 0.089999999999999997 115.015 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.631 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 14.5 m -85.73 118.0 24.96 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.041 -1.436 . . . . 0.14000000000000001 108.098 166.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 164' ' ' SER . 43.4 tp -84.49 98.66 10.23 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-O 122.057 0.932 . . . . 0.16 109.386 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.682 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 17.9 mt-30 -87.7 108.08 18.94 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.576 -1.193 . . . . 0.34000000000000002 109.088 -178.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.56 ' HG3' ' HG ' ' A' ' 174' ' ' LEU . 80.9 mtp -105.74 162.42 13.55 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.059 -0.973 . . . . 1.0900000000000001 110.483 -176.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.612 ' HG2' HD12 ' A' ' 186' ' ' ILE . 9.3 tt0 -169.74 119.38 0.64 Allowed 'General case' 0 C--O 1.203 -1.39 0 CA-C-O 121.324 0.583 . . . . 0.5 109.792 -170.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.084 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -101.2 100.85 11.45 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.542 -0.91 . . . . 0.10000000000000001 108.542 -172.86 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.586 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.9 ttp -90.47 120.06 31.26 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.764 -0.653 . . . . 0.070000000000000007 109.448 176.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.544 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.66 117.77 6.73 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.222 -1.399 . . . . 0.22 107.222 169.315 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -71.72 -35.71 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.162 0.892 . . . . 0.11 111.439 -176.704 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.437 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 32.5 mt-30 -61.38 -13.62 21.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.411 -0.813 . . . . 0.34999999999999998 111.581 -176.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 34.5 p -130.22 -37.96 1.42 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.176 0.989 . . . . 0.19 110.086 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.572 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.59 16.27 52.79 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 113.801 -1.545 . . . . 0.17999999999999999 112.138 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -98.09 156.34 16.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.94 0.4 . . . . 0.72999999999999998 110.619 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.612 HD12 ' HG2' ' A' ' 177' ' ' GLN . 31.6 mm -88.78 118.74 34.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.572 0.701 . . . . 0.14000000000000001 109.404 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.084 HD11 HD13 ' A' ' 178' ' ' LEU . 1.7 pp -106.49 -29.08 2.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.804 -1.089 . . . . 0.13 110.123 -172.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.661 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.3 t90 -137.92 153.37 49.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.547 -0.751 . . . . 0.070000000000000007 110.135 171.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 54.9 p -153.52 164.4 38.29 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 113.379 0.881 . . . . 0.13 113.379 164.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.93 -178.49 32.99 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.039 -0.825 . . . . 0.12 111.039 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.3 mtmt -157.86 146.5 19.22 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.446 -1.687 . . . . 1.22 106.446 166.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.672 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -157.45 128.02 2.04 Favored Glycine 0 C--N 1.284 -2.357 0 CA-C-N 114.677 -1.147 . . . . 0.12 112.064 -177.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.52 116.05 14.75 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.544 0.687 . . . . 0.17000000000000001 111.343 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.844 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -94.1 158.82 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 122.618 1.199 . . . . 0.11 110.979 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.729 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -100.89 171.98 7.32 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 112.527 -2.124 . . . . 0.17999999999999999 108.844 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.3 tt0 -101.56 131.6 47.65 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.121 -0.632 . . . . 0.91000000000000003 109.376 169.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.525 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 15.2 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.418 -0.801 . . . . 1.24 110.931 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.774 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.5 m-30 . . . . . 0 N--CA 1.418 -2.041 0 N-CA-C 109.936 -0.394 . . . . 0.20999999999999999 109.936 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.521 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 4.0 t70 -80.97 68.28 7.19 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 123.68 1.705 . . . . 0.34999999999999998 108.125 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.731 ' HZ3' HD13 ' A' ' 174' ' ' LEU . 93.5 m95 -57.85 -41.52 82.53 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.599 -2.546 . . . . 0.10000000000000001 111.94 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 5.0 t30 -52.98 -27.71 20.4 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.99 -1.459 . . . . 1.1100000000000001 111.496 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.57 -15.2 81.21 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.412 -0.813 . . . . 0.20999999999999999 111.129 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.96 -53.64 2.9 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.908 -1.146 . . . . 0.13 111.17 -176.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.726 ' SD ' HD23 ' A' ' 109' ' ' LEU . 38.5 mtt -65.27 -57.77 7.62 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.263 -1.335 . . . . 0.089999999999999997 112.132 -177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.505 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 5.3 mm100 -40.25 -55.88 3.8 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 114.348 1.24 . . . . 0.63 114.348 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.775 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.3 Cg_endo -63.88 -27.3 67.11 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.541 1.494 . . . . 0.14000000000000001 110.74 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.666 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 12.7 mtm -85.56 -43.2 13.72 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.562 -0.745 . . . . 0.69999999999999996 112.174 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 68' ' ' MET . 31.5 t -59.0 -37.91 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 CA-C-N 115.011 -0.995 . . . . 0.12 108.826 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -57.11 -36.56 70.78 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.409 -1.723 . . . . 0.56000000000000005 110.396 174.348 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.775 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.7 mtpt -80.91 -37.3 29.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.087 -0.96 . . . . 1.3 110.49 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.872 ' O ' HG11 ' A' ' 81' ' ' VAL . 2.5 ttp -57.65 -31.61 66.46 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.421 -1.263 . . . . 0.5 111.439 -175.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.615 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 22.5 mt -88.51 -5.31 58.3 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.917 0.865 . . . . 0.65000000000000002 111.594 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.96 17.4 35.32 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.286 -1.525 . . . . 0.17000000000000001 109.286 172.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.711 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.03 161.76 16.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.807 -0.696 . . . . 0.10000000000000001 109.733 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.446 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 9.7 p-10 -89.16 107.73 19.21 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.362 1.077 . . . . 1.72 111.443 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.666 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.73 -24.32 3.03 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 114.268 -1.333 . . . . 0.12 110.45 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 75' ' ' MET . 14.9 p -102.83 153.05 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.526 0.679 . . . . 0.16 111.762 -173.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.4 m -134.98 138.82 44.36 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.653 -1.158 . . . . 0.45000000000000001 110.577 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.59 131.26 50.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.757 -0.656 . . . . 0.28000000000000003 110.182 166.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.14 -1.47 31.35 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.026 -0.607 . . . . 0.28000000000000003 112.593 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.89 150.64 23.96 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.264 -0.575 . . . . 1.2 111.016 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.65 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.6 p -80.05 113.81 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-O 122.277 1.037 . . . . 0.20000000000000001 109.01 164.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.855 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -100.88 107.21 18.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.814 -1.085 . . . . 0.14000000000000001 108.722 -172.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.683 HD23 HG11 ' A' ' 155' ' ' VAL . 0.8 OUTLIER -70.92 97.88 1.5 Allowed 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 114.169 -1.378 . . . . 0.14999999999999999 108.019 177.713 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 87' ' ' LEU . 2.2 m -71.37 118.27 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.243 0 N-CA-C 106.888 -1.523 . . . . 0.94999999999999996 106.888 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.79 ' HB2' HD11 ' A' ' 142' ' ' LEU . 0.8 OUTLIER -77.09 146.32 37.31 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 107.159 -1.422 . . . . 0.64000000000000001 107.159 178.098 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.497 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -55.36 134.43 50.19 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.448 -1.315 . . . . 0.37 107.448 175.9 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.54 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 22.0 t -61.46 138.4 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.011 0 N-CA-C 107.768 -1.197 . . . . 0.10000000000000001 107.768 170.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.784 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.4 t-20 -84.95 163.02 19.19 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.156 -0.929 . . . . 0.17999999999999999 109.714 175.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.757 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.88 86.12 2.51 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.524 -1.216 . . . . 0.12 108.185 175.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -106.88 -4.22 19.43 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 113.97 -1.468 . . . . 0.64000000000000001 108.827 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.76 HG21 ' HB3' ' A' ' 172' ' ' PRO . 21.8 p -50.67 -177.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.516 -1.674 . . . . 0.14000000000000001 114.318 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 1.4 t30 -70.13 -10.7 59.62 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.476 -1.693 . . . . 0.47999999999999998 110.325 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.572 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -140.55 -152.56 5.81 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.668 -0.696 . . . . 0.12 112.564 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.609 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 70.7 m -122.44 129.36 51.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.071 0.462 . . . . 1.1599999999999999 111.129 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.757 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.9 pp -132.5 160.1 37.47 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.786 0.803 . . . . 0.10000000000000001 110.551 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.616 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -82.94 79.85 9.17 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.902 -1.499 . . . . 0.17000000000000001 107.889 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.28 -14.11 62.75 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.483 -1.235 . . . . 0.089999999999999997 109.958 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ALA . . . . . 0.631 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.07 -32.23 39.34 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.545 -0.909 . . . . 0.14999999999999999 108.545 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.616 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 42.8 tp10 -66.43 -33.71 76.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 114.325 -1.307 . . . . 1.73 109.05 171.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.54 -43.91 65.55 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.113 -1.858 . . . . 0.12 109.509 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 62.9 m -63.34 -29.73 70.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.808 -1.542 . . . . 0.11 110.417 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -44.68 76.58 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.119 -1.067 . . . . 1.47 108.119 171.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.683 HG21 ' HB2' ' A' ' 64' ' ' TRP . 73.2 m -62.48 -30.79 71.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.412 -0.813 . . . . 0.12 110.718 178.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.726 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -50.99 -68.98 0.12 Allowed 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 109.326 -0.62 . . . . 0.56000000000000005 109.326 171.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.555 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.3 mtp180 -40.99 -37.61 0.84 Allowed 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.345 1.028 . . . . 1.51 111.411 175.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.2 m-20 -71.54 -46.12 60.41 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.576 -1.193 . . . . 0.28000000000000003 111.968 -176.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.505 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.56 -32.04 63.95 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 122.402 1.096 . . . . 0.089999999999999997 108.701 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -65.79 -33.67 76.4 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.498 -1.683 . . . . 0.12 109.88 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.93 -41.49 64.45 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 114.636 -1.166 . . . . 0.20000000000000001 111.06 -176.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -64.21 -27.2 68.9 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.895 -1.048 . . . . 1.1699999999999999 110.332 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -81.92 -21.76 37.15 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.466 -0.788 . . . . 2.0499999999999998 111.01 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 59.78 15.61 34.98 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 115.588 0.995 . . . . 0.54000000000000004 115.588 163.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.615 ' HE2' ' HB3' ' A' ' 76' ' ' LEU . 19.7 mtmt -101.81 -28.62 12.34 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 117.719 0.76 . . . . 0.98999999999999999 109.969 174.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.855 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 26.1 m-85 -92.23 173.81 7.63 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 122.152 0.977 . . . . 0.20999999999999999 112.447 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.606 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.7 m -118.4 123.19 44.63 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 113.31 -1.768 . . . . 0.23000000000000001 107.89 169.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.659 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -94.05 139.55 30.82 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 119.329 -0.949 . . . . 0.38 111.865 -170.023 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.474 HG11 HD23 ' A' ' 88' ' ' LEU . 1.3 m . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 107.786 -1.19 . . . . 0.41999999999999998 107.786 170.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.679 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 35.3 tp . . . . . 0 CA--C 1.518 -0.27 0 N-CA-C 113.456 0.91 . . . . 1.3899999999999999 113.456 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.655 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 3.5 t -50.67 -47.35 58.82 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 123.396 1.57 . . . . 1.05 109.374 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.693 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 16.7 mmt -54.0 -61.82 2.06 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 111.24 -2.709 . . . . 1.6399999999999999 110.818 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.77 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.83 -44.97 7.16 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 124.124 0.89 . . . . 0.31 112.626 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.702 ' NZ ' HD13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -55.94 -51.5 67.44 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 107.343 -1.354 . . . . 1.53 107.343 -178.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 128' ' ' SER . 36.8 mt-30 -65.15 -41.03 95.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.672 -1.149 . . . . 0.40999999999999998 111.173 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.693 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.2 mt-30 -57.6 -32.56 67.31 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 114.628 -1.169 . . . . 0.37 109.574 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -93.96 -27.15 16.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 113.911 -1.495 . . . . 0.23999999999999999 109.719 -177.455 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.38 -50.12 0.53 Allowed Glycine 0 CA--C 1.5 -0.904 0 CA-C-O 122.766 1.204 . . . . 0.33000000000000002 113.428 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.634 HD13 ' O ' ' A' ' 141' ' ' SER . 78.4 mt -66.58 -170.95 0.11 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 112.175 -2.012 . . . . 0.31 116.025 -170.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.1 m -116.22 152.86 48.37 Favored Pre-proline 0 N--CA 1.431 -1.415 0 CA-C-N 111.129 -2.759 . . . . 0.81000000000000005 108.56 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.655 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 18.1 Cg_endo -62.34 -2.0 2.86 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.086 2.524 . . . . 0.32000000000000001 112.993 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.631 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -118.74 -26.85 5.99 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.579 0.704 . . . . 1.25 110.746 -177.602 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.3 t70 -63.04 -21.89 66.47 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 113.895 -1.502 . . . . 0.65000000000000002 109.127 -173.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.634 ' O ' HD13 ' A' ' 136' ' ' LEU . 38.1 m 74.4 168.59 0.3 Allowed 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.666 -2.061 . . . . 0.59999999999999998 110.653 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 90' ' ' ASP . 6.4 mt -64.78 -40.53 95.4 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.321 1.058 . . . . 0.85999999999999999 108.331 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.7 -12.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 112.823 -1.99 . . . . 0.31 114.507 177.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.417 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -151.32 125.11 9.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.073 -0.714 . . . . 0.23999999999999999 109.073 -174.692 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.657 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.3 mmt180 -42.6 -47.33 5.2 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 118.047 0.385 . . . . 1.6499999999999999 111.936 -176.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.9 t -71.22 -25.85 62.67 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.664 0.745 . . . . 0.53000000000000003 111.35 -175.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.406 ' HD3' HD11 ' A' ' 136' ' ' LEU . 27.2 mttm -75.84 -30.75 59.06 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 122.766 1.269 . . . . 1.3100000000000001 108.862 176.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.776 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -72.1 -46.77 55.4 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 112.184 -2.28 . . . . 0.12 110.236 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.607 HG13 ' HE1' ' A' ' 179' ' ' MET . 37.3 mt -68.07 -41.4 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 112.909 -1.95 . . . . 0.11 110.054 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.42 -54.83 27.82 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.51 -1.223 . . . . 0.14999999999999999 111.107 170.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.77 HG23 ' CB ' ' A' ' 130' ' ' ALA . 12.4 mt -66.27 -46.6 86.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.062 0 N-CA-C 112.693 0.627 . . . . 0.17999999999999999 112.693 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.665 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -57.73 -40.73 80.27 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 118.013 0.37 . . . . 0.13 111.015 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.482 ' HD2' HG23 ' A' ' 149' ' ' ILE . 28.5 mtp-105 -81.49 -22.34 38.09 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.826 0.822 . . . . 1.0800000000000001 110.346 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -82.01 -11.64 58.73 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 114.274 -1.33 . . . . 0.5 107.449 176.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.7 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.91 -29.13 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 113.267 -1.788 . . . . 0.17000000000000001 110.794 -174.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.47 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.37 34.92 4.88 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.387 -0.911 . . . . 0.16 112.362 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.663 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.98 160.57 16.31 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 113.138 0.792 . . . . 0.12 113.138 -169.591 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.65 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -99.78 -28.96 12.89 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.0 -1.0 . . . . 0.20000000000000001 109.744 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.672 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 11.6 m-85 -136.65 -175.43 4.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.96 -1.018 . . . . 0.13 110.83 -174.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.676 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -135.64 138.59 47.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.062 -0.972 . . . . 0.080000000000000002 108.562 166.282 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.669 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 33.8 tp -108.26 99.59 8.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.281 -0.968 . . . . 0.16 109.483 166.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.776 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.64 112.54 17.01 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.784 -1.098 . . . . 0.26000000000000001 109.322 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.872 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 13.0 t -124.37 158.88 31.63 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 122.157 0.979 . . . . 1.05 110.239 -177.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.831 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.8 p -160.75 173.47 15.36 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.166 -1.379 . . . . 0.10000000000000001 110.564 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.88 132.07 34.02 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-N 114.36 -1.291 . . . . 0.11 108.613 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -140.89 -178.01 5.35 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.055 -0.658 . . . . 1.0900000000000001 109.73 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.43 -83.26 0.87 Allowed Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 119.774 -1.203 . . . . 0.14999999999999999 111.847 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 43.5 t-20 -140.08 127.18 20.97 Favored 'General case' 0 C--O 1.195 -1.794 0 N-CA-C 106.294 -1.743 . . . . 0.58999999999999997 106.294 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.572 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.3 p -60.64 -44.52 97.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 114.861 -1.063 . . . . 0.14999999999999999 111.65 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.408 ' N ' HG13 ' A' ' 169' ' ' VAL . 17.2 m120 -66.9 -24.92 66.15 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.338 0.59 . . . . 1.26 109.777 -174.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.04 88.28 3.21 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 114.996 -1.002 . . . . 0.13 108.474 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.826 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.1 Cg_endo -91.01 163.7 3.86 Favored 'Trans proline' 0 CA--C 1.492 -1.576 0 C-N-CA 124.652 3.568 . . . . 0.089999999999999997 115.253 -170.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.632 HG22 ' HB3' ' A' ' 191' ' ' LYS . 7.7 m -84.83 119.71 25.62 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 113.668 -1.605 . . . . 0.14000000000000001 107.998 170.133 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.893 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 21.8 tp -82.59 95.83 7.89 Favored 'General case' 0 CA--C 1.472 -2.043 0 C-N-CA 119.655 -0.818 . . . . 0.16 109.474 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.58 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 39.1 mt-30 -87.2 106.76 18.12 Favored 'General case' 0 C--N 1.253 -3.609 0 CA-C-O 122.415 1.102 . . . . 0.34000000000000002 108.663 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.872 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.3 mmm -110.97 162.97 14.3 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.516 -1.22 . . . . 1.0900000000000001 110.944 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.637 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.4 tt0 -171.41 118.92 0.46 Allowed 'General case' 0 C--O 1.205 -1.288 0 CA-C-O 121.165 0.507 . . . . 0.5 110.702 -166.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.061 HD13 HD11 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -100.36 100.9 11.76 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.853 -0.795 . . . . 0.10000000000000001 108.853 -172.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.657 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.2 ttp -91.16 120.95 32.52 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.161 -0.927 . . . . 0.070000000000000007 109.398 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -58.49 126.76 28.93 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.066 -1.457 . . . . 0.22 107.066 166.38 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.612 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.18 -36.2 14.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 119.435 -0.906 . . . . 0.11 110.376 178.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.475 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 23.3 mt-30 -61.03 -16.26 41.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.093 -0.958 . . . . 0.34999999999999998 111.529 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 66.9 p -129.04 -37.0 1.73 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.769 0.795 . . . . 0.19 110.077 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.568 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.26 29.37 19.95 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 114.299 -1.319 . . . . 0.17999999999999999 112.205 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.73 154.3 23.1 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.674 0.273 . . . . 0.72999999999999998 110.6 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.637 HD12 ' HG2' ' A' ' 177' ' ' GLN . 29.5 mm -86.53 121.4 37.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.402 0.62 . . . . 0.14000000000000001 109.365 177.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.061 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -109.76 -33.06 2.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.095 -0.957 . . . . 0.13 110.45 -174.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.711 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 79.8 t90 -132.14 152.19 51.38 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.581 -0.736 . . . . 0.070000000000000007 109.356 172.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 27.0 p -153.79 162.8 40.93 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.265 0.839 . . . . 0.13 113.265 164.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -157.69 -175.12 28.26 Favored Glycine 0 N--CA 1.427 -1.932 0 N-CA-C 110.817 -0.913 . . . . 0.12 110.817 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.893 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.2 mtmt -158.98 147.94 18.54 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.386 -1.709 . . . . 1.22 106.386 165.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 174' ' ' LEU . . . -156.05 125.89 1.72 Allowed Glycine 0 C--N 1.289 -2.047 0 C-N-CA 118.638 -1.744 . . . . 0.12 114.021 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.75 112.59 7.98 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.619 0.723 . . . . 0.17000000000000001 110.979 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.826 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -90.76 159.28 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 114.545 -1.207 . . . . 0.11 110.269 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.774 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -100.08 174.18 6.29 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 112.801 -2.0 . . . . 0.17999999999999999 108.825 -173.319 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -102.16 131.48 48.64 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.492 -0.483 . . . . 0.91000000000000003 110.532 171.23 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.532 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 17.4 mm-40 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.514 -0.755 . . . . 1.24 110.264 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.745 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.9 m-30 . . . . . 0 N--CA 1.421 -1.907 0 N-CA-C 109.638 -0.504 . . . . 0.20999999999999999 109.638 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 7.3 t70 -81.65 67.32 7.57 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 123.795 1.759 . . . . 0.34999999999999998 107.978 171.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.754 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.9 m95 -58.17 -42.15 85.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 111.361 -2.654 . . . . 0.10000000000000001 111.847 173.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.497 ' N ' HG21 ' A' ' 108' ' ' THR . 5.4 t-20 -56.35 -27.76 56.9 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.138 -1.392 . . . . 1.1100000000000001 110.285 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.23 -14.47 76.65 Favored Glycine 0 CA--C 1.498 -1.013 0 N-CA-C 110.816 -0.914 . . . . 0.20999999999999999 110.816 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.436 ' O ' ' HD2' ' A' ' 70' ' ' PRO . . . -97.38 -54.56 3.11 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 113.966 -1.117 . . . . 0.13 110.32 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' MET . . . . . 0.856 ' HA ' ' SD ' ' A' ' 71' ' ' MET . 40.6 mtt -61.87 -49.65 75.39 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 124.545 1.153 . . . . 0.089999999999999997 112.454 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.449 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 5.7 mm100 -41.39 -55.33 5.44 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 115.269 1.581 . . . . 0.63 115.269 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.806 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.8 Cg_endo -64.18 -29.22 64.73 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.063 1.842 . . . . 0.14000000000000001 111.353 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' MET . . . . . 0.856 ' SD ' ' HA ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -80.96 -45.15 17.09 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 114.98 -1.009 . . . . 0.69999999999999996 110.122 -178.343 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 68' ' ' MET . 61.3 t -56.29 -40.78 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 114.246 -1.343 . . . . 0.12 108.729 174.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -57.15 -35.25 69.31 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.075 -1.875 . . . . 0.56000000000000005 111.189 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.806 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 26.8 mtpt -85.96 -33.08 21.22 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.918 0.39 . . . . 1.3 110.981 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . 0.828 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.98 -26.98 68.82 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.618 -0.719 . . . . 0.5 111.477 -170.3 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.583 HD13 ' HB2' ' A' ' 118' ' ' LYS . 3.3 mt -93.1 -7.17 46.28 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.971 0.891 . . . . 0.65000000000000002 111.387 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.27 13.84 55.03 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.143 -1.583 . . . . 0.17000000000000001 109.143 172.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.598 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.11 164.33 19.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.428 -0.886 . . . . 0.10000000000000001 110.348 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -86.39 106.87 17.73 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.324 -0.853 . . . . 1.72 109.844 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.655 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 132.92 -21.47 4.17 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 120.4 -0.905 . . . . 0.12 111.146 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.828 HG11 ' O ' ' A' ' 75' ' ' MET . 12.5 p -103.74 152.56 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.853 0.835 . . . . 0.16 112.243 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 83' ' ' ALA . 25.7 m -136.4 144.43 44.51 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.438 -1.256 . . . . 0.45000000000000001 110.823 175.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB2' ' CE ' ' A' ' 118' ' ' LYS . . . -61.92 142.68 57.27 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.254 -0.884 . . . . 0.28000000000000003 110.05 166.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.78 -0.34 69.94 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.847 -0.692 . . . . 0.28000000000000003 112.568 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' SER . . . . . 0.487 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 63.1 m -94.57 145.83 24.54 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.552 -0.459 . . . . 1.2 109.977 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -76.44 126.67 37.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.685 0.755 . . . . 0.20000000000000001 109.882 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.9 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -113.68 108.24 16.85 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.203 -0.908 . . . . 0.14000000000000001 109.399 -170.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.753 HD23 HG11 ' A' ' 155' ' ' VAL . 0.9 OUTLIER -73.32 94.51 2.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.39 -1.277 . . . . 0.14999999999999999 108.868 176.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.536 HG23 HD23 ' A' ' 109' ' ' LEU . 2.0 m -73.12 116.72 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 107.718 -1.215 . . . . 0.94999999999999996 107.718 176.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.743 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 5.5 t0 -79.06 171.25 15.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.517 -0.92 . . . . 0.64000000000000001 108.517 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.624 ' OG ' ' HA ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -59.73 148.38 34.38 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-O 122.544 1.164 . . . . 0.37 108.757 171.624 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.638 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 24.7 t -73.97 138.25 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.498 0 N-CA-C 106.516 -1.661 . . . . 0.10000000000000001 106.516 162.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.841 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.3 t-20 -85.23 163.73 18.5 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 121.744 0.783 . . . . 0.17999999999999999 110.108 174.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASN . . . . . 0.738 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.3 t-20 -124.82 86.23 2.53 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.633 -1.167 . . . . 0.12 108.384 175.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.413 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.3 mtp180 -107.72 -2.93 19.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.952 -1.476 . . . . 0.64000000000000001 108.731 -173.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.701 HG21 ' HB3' ' A' ' 172' ' ' PRO . 32.7 p -51.85 -172.18 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.232 -1.804 . . . . 0.14000000000000001 115.5 -176.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.8 t30 -70.77 -8.91 55.81 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 112.537 -2.12 . . . . 0.47999999999999998 110.562 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . 0.566 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -153.26 -145.41 4.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.518 -0.849 . . . . 0.12 113.045 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.632 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 58.1 p -121.43 130.58 53.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.626 0.602 . . . . 1.1599999999999999 112.626 -176.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.738 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -136.17 153.5 51.24 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.626 0.727 . . . . 0.10000000000000001 110.667 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -76.57 80.11 3.24 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.155 -1.384 . . . . 0.17000000000000001 107.771 175.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -67.52 -15.23 63.55 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.155 -1.384 . . . . 0.089999999999999997 110.07 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.07 -30.2 34.8 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.72 -0.845 . . . . 0.14999999999999999 108.72 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.655 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 9.2 tp10 -66.07 -35.67 81.14 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.503 -1.226 . . . . 1.73 108.877 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.66 -44.98 65.98 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 113.251 -1.795 . . . . 0.12 109.232 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.59 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 52.1 m -59.75 -32.03 70.2 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.965 -1.471 . . . . 0.11 110.947 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -43.87 71.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.476 -0.935 . . . . 1.47 108.476 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.664 HG21 ' HB2' ' A' ' 64' ' ' TRP . 56.7 m -62.76 -29.48 70.72 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.328 -0.851 . . . . 0.12 110.54 176.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.728 ' O ' HD23 ' A' ' 113' ' ' LEU . 9.1 tp -56.27 -64.26 0.92 Allowed 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.937 -1.029 . . . . 0.56000000000000005 109.185 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.601 ' O ' HD13 ' A' ' 121' ' ' LEU . 23.4 mtp180 -43.07 -37.38 1.95 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.172 0.987 . . . . 1.51 111.114 172.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.641 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.9 m-20 -69.21 -46.9 66.26 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.25 -1.341 . . . . 0.28000000000000003 112.165 -175.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.449 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.19 -33.67 65.53 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.58 -0.896 . . . . 0.089999999999999997 108.58 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.805 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.2 mm? -59.21 -38.06 79.0 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.725 -1.579 . . . . 0.12 109.685 170.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.508 ' HA ' HD21 ' A' ' 121' ' ' LEU . . . -74.82 -40.68 60.94 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.177 -0.919 . . . . 0.20000000000000001 110.926 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -56.47 -36.17 68.77 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.633 -1.167 . . . . 1.1699999999999999 110.393 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -72.07 -47.61 50.28 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 113.636 -1.62 . . . . 2.0499999999999998 109.965 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.95 -11.96 63.28 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 114.947 0.739 . . . . 0.54000000000000004 114.947 172.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.655 ' CE ' ' HB2' ' A' ' 83' ' ' ALA . 53.9 mtpt -69.42 -36.68 76.95 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.515 1.157 . . . . 0.98999999999999999 111.081 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.9 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 20.6 m-85 -88.35 177.56 6.81 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 122.625 1.202 . . . . 0.20999999999999999 113.412 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.543 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 18.2 m -122.37 106.17 10.83 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 112.616 -2.083 . . . . 0.23000000000000001 108.041 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -94.42 128.6 41.07 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.563 -1.199 . . . . 0.38 112.277 -168.5 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.578 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.301 -1.542 0 CA-C-N 114.218 -1.356 . . . . 0.41999999999999998 108.066 174.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.766 HD11 ' HZ1' ' A' ' 131' ' ' LYS . 1.1 tm? . . . . . 0 C--O 1.233 0.207 0 N-CA-C 113.721 1.008 . . . . 1.3899999999999999 113.721 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.622 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -53.4 -38.99 63.92 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 123.547 1.642 . . . . 1.05 108.437 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.7 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 41.9 mmm -63.37 -60.31 3.54 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 110.923 -2.853 . . . . 1.6399999999999999 111.18 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.809 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.45 -44.19 5.72 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 124.259 0.974 . . . . 0.31 112.166 176.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.766 ' HZ1' HD11 ' A' ' 127' ' ' LEU . 26.3 mttt -52.47 -55.52 21.4 Favored 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 120.065 -0.654 . . . . 1.53 109.589 176.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.1 mt-30 -61.49 -42.59 99.03 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.894 -1.048 . . . . 0.40999999999999998 111.469 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.5 mt-30 -57.55 -37.0 72.39 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.334 -1.303 . . . . 0.37 109.703 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.4 OUTLIER -89.31 -31.36 17.86 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.804 -1.544 . . . . 0.23999999999999999 109.063 -177.94 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 131' ' ' LYS . . . 159.64 -56.11 0.34 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-O 122.632 1.129 . . . . 0.33000000000000002 113.921 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 74.3 mt -61.88 -172.62 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 112.372 -1.914 . . . . 0.31 116.025 -169.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.7 m -114.32 151.7 45.32 Favored Pre-proline 0 N--CA 1.428 -1.556 0 CA-C-N 110.846 -2.888 . . . . 0.81000000000000005 108.581 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.642 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 10.2 Cg_endo -57.67 -7.56 3.31 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.177 2.585 . . . . 0.32000000000000001 113.423 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -116.98 -30.53 5.67 Favored 'General case' 0 CA--C 1.499 -1.008 0 O-C-N 123.709 0.63 . . . . 1.25 109.542 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 141' ' ' SER . 8.7 t70 -50.74 -36.11 34.91 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.506 1.146 . . . . 0.65000000000000002 108.778 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.624 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 1.9 m 81.07 159.47 0.15 Allowed 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 110.747 -2.933 . . . . 0.59999999999999998 111.149 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.854 HD13 ' HA ' ' A' ' 148' ' ' ALA . 7.6 mt -66.27 -38.05 86.9 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.233 -1.395 . . . . 0.85999999999999999 107.233 -172.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.17 0.16 0.68 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 112.545 -2.116 . . . . 0.31 114.856 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -152.31 120.49 6.28 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.69 -0.855 . . . . 0.23999999999999999 108.69 -174.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . 0.671 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.0 mmt180 -40.97 -48.08 3.12 Favored 'General case' 0 C--O 1.212 -0.874 0 O-C-N 123.691 0.619 . . . . 1.6499999999999999 110.906 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 t -69.68 -29.77 67.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.23 0.538 . . . . 0.53000000000000003 111.817 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 23.9 mttm -72.36 -32.48 66.5 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.399 1.095 . . . . 1.3100000000000001 108.611 176.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ALA . . . . . 0.854 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -74.02 -43.06 59.29 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-N 112.761 -2.018 . . . . 0.12 110.15 178.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.609 HG13 ' HE1' ' A' ' 179' ' ' MET . 40.2 mt -67.66 -42.66 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 CA-C-N 113.498 -1.683 . . . . 0.11 110.1 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.42 -51.99 44.08 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 114.955 -1.02 . . . . 0.14999999999999999 111.096 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ILE . . . . . 0.809 HG23 ' CB ' ' A' ' 130' ' ' ALA . 65.7 mt -68.25 -47.22 79.07 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 N-CA-C 113.01 0.744 . . . . 0.17999999999999999 113.01 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ALA . . . . . 0.678 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.24 -39.58 72.78 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.985 0.421 . . . . 0.13 110.816 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ARG . . . . . 0.428 ' HD2' HG23 ' A' ' 149' ' ' ILE . 23.6 mtp-105 -82.55 -19.9 37.66 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.526 0.679 . . . . 1.0800000000000001 110.818 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.432 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 28.0 t-20 -84.57 -11.22 56.46 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.344 -1.354 . . . . 0.5 107.344 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.753 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -108.08 -29.02 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 113.137 -1.847 . . . . 0.17000000000000001 111.052 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.48 35.38 4.7 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.283 -0.96 . . . . 0.16 112.485 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.664 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.83 156.24 21.42 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.249 0.833 . . . . 0.12 113.249 -169.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' HIS . . . . . 0.687 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -96.53 -26.53 15.23 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.838 -1.074 . . . . 0.20000000000000001 109.751 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 15.6 m-85 -135.99 -179.53 5.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.218 -0.901 . . . . 0.13 111.064 -173.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.771 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.1 t -133.06 139.79 48.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.61 -0.885 . . . . 0.080000000000000002 108.61 166.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.62 HD21 ' HE1' ' A' ' 176' ' ' MET . 46.4 tp -110.54 101.33 10.01 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 119.407 -0.917 . . . . 0.16 109.244 165.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TYR . . . . . 0.639 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 4.5 m-85 -82.05 112.79 19.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.222 -1.354 . . . . 0.26000000000000001 109.421 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.874 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 10.3 t -122.81 162.19 22.59 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.768 0.794 . . . . 1.05 110.613 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' SER . . . . . 0.853 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -162.85 175.09 11.59 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.522 -1.217 . . . . 0.10000000000000001 111.101 -177.459 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.32 136.77 35.19 Favored 'General case' 0 N--CA 1.413 -2.317 0 CA-C-N 114.413 -1.267 . . . . 0.11 108.853 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 3.5 m -144.97 -172.97 3.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 109.219 -0.66 . . . . 1.0900000000000001 109.219 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.14 -84.87 1.11 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.606 -1.283 . . . . 0.14999999999999999 110.834 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASN . . . . . 0.518 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 66.1 t30 -143.09 122.86 13.39 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.432 -0.884 . . . . 0.58999999999999997 109.923 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.566 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.4 p -54.32 -49.73 61.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 112.678 0.622 . . . . 0.14999999999999999 112.678 -169.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASN . . . . . 0.413 ' N ' HG13 ' A' ' 169' ' ' VAL . 5.5 m-20 -56.83 -31.89 65.21 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.777 0.798 . . . . 1.26 110.288 -174.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.49 87.51 4.15 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 114.263 -1.335 . . . . 0.13 108.119 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PRO . . . . . 0.813 ' HD2' HG22 ' A' ' 194' ' ' VAL . 48.1 Cg_endo -90.64 165.48 4.17 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 124.712 3.608 . . . . 0.089999999999999997 114.999 -170.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 191' ' ' LYS . 28.7 m -81.31 117.91 22.19 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.745 -1.571 . . . . 0.14000000000000001 107.098 165.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 164' ' ' SER . 43.1 tp -83.83 100.12 10.76 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.256 -1.016 . . . . 0.16 108.256 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLN . . . . . 0.598 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 35.5 mt-30 -90.05 109.56 20.61 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 121.897 0.856 . . . . 0.34000000000000002 109.152 -177.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' MET . . . . . 0.874 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.0 OUTLIER -111.46 163.84 13.6 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.233 -0.894 . . . . 1.0900000000000001 111.356 -174.787 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLN . . . . . 0.555 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.8 tt0 -169.65 118.19 0.62 Allowed 'General case' 0 C--O 1.207 -1.171 0 CA-C-O 121.353 0.597 . . . . 0.5 110.12 -165.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 1.07 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.16 102.29 13.18 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.038 -0.727 . . . . 0.10000000000000001 109.038 -173.069 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' MET . . . . . 0.671 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.9 ttp -91.6 117.79 30.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.755 -0.657 . . . . 0.070000000000000007 109.491 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.48 113.0 2.7 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.655 -1.239 . . . . 0.22 107.655 170.616 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.59 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -67.53 -35.76 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.989 0.813 . . . . 0.11 111.611 -175.6 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLN . . . . . 0.456 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.5 mt-30 -61.3 -12.52 13.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.726 -0.67 . . . . 0.34999999999999998 111.9 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 43.4 p -130.46 -37.26 1.41 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.211 1.005 . . . . 0.19 110.333 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . 0.558 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.91 21.05 44.14 Favored Glycine 0 N--CA 1.428 -1.88 0 CA-C-N 113.528 -1.669 . . . . 0.17999999999999999 111.596 -176.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -99.62 154.31 18.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.906 0.384 . . . . 0.72999999999999998 110.537 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ILE . . . . . 0.555 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.7 mm -88.8 111.81 23.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.034 -0.728 . . . . 0.14000000000000001 109.034 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -98.49 -31.37 3.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.815 -1.084 . . . . 0.13 110.248 -173.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' TRP . . . . . 0.687 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 82.7 t90 -135.95 152.51 51.05 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.164 -0.925 . . . . 0.070000000000000007 109.914 173.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 64.9 p -154.01 162.71 41.01 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 112.172 0.434 . . . . 0.13 112.172 163.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -162.15 -177.98 35.64 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.638 -0.985 . . . . 0.12 110.638 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' LYS . . . . . 0.766 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 13.2 mttt -151.78 153.77 34.94 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.537 -1.653 . . . . 1.22 106.537 166.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -159.82 128.22 1.95 Allowed Glycine 0 C--N 1.286 -2.236 0 CA-C-N 114.888 -1.051 . . . . 0.12 111.942 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -73.2 119.35 17.31 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.699 0.761 . . . . 0.17000000000000001 111.286 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.813 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -94.42 159.22 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 CA-C-N 114.682 -1.145 . . . . 0.11 110.708 -176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' SER . . . . . 0.745 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -99.34 172.84 7.08 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.648 -2.069 . . . . 0.17999999999999999 109.001 -174.408 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -102.47 130.93 49.42 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.733 -0.387 . . . . 0.91000000000000003 110.17 171.693 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.544 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 16.1 mm-40 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.408 -0.806 . . . . 1.24 110.391 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.802 0 N-CA-C 112.269 -0.332 . . . . 88.609999999999999 112.269 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -74.01 105.66 5.35 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.792 -0.24 . . . . 87.430000000000007 110.382 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 62.32 -166.73 0.21 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.66 0.743 . . . . 87.159999999999997 111.174 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.3 ttm 68.05 34.2 4.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.038 -1.437 . . . . 85.340000000000003 111.625 167.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -109.73 -50.01 6.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.597 -1.183 . . . . 85.049999999999997 110.212 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.71 56.03 25.23 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.693 -0.765 . . . . 84.680000000000007 111.893 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -67.74 134.03 50.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.549 -0.326 . . . . 85.569999999999993 110.584 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 61.31 76.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.196 0.522 . . . . 85.040000000000006 111.566 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.78 159.3 85.68 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.737 -0.665 . . . . 82.170000000000002 109.863 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HB2' ' H ' ' A' ' 11' ' ' ALA . 35.7 Cg_exo -58.48 -89.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.081 2.521 . . . . 81.510000000000005 112.166 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' H ' ' HB2' ' A' ' 10' ' ' PRO . . . -179.04 -50.47 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.236 0 C-N-CA 122.748 0.419 . . . . 79.560000000000002 110.23 -175.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.79 143.64 46.42 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.481 1.454 . . . . 78.5 110.853 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.2 m -61.87 142.2 16.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.89 0.376 . . . . 77.0 110.871 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -168.26 143.35 3.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.806 -0.634 . . . . 75.739999999999995 110.613 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -75.14 149.44 39.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.352 -0.61 . . . . 73.909999999999997 109.352 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.52 105.38 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.926 -0.579 . . . . 72.299999999999997 110.705 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 19' ' ' ALA . 26.4 mtpp -80.17 -37.45 1.07 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.933 0.716 . . . . 71.219999999999999 112.933 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.38 42.19 0.45 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.754 1.636 . . . . 69.670000000000002 112.224 172.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -168.96 101.73 0.5 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.501 -0.772 . . . . 67.549999999999997 109.126 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.14 -62.65 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.262 2.641 . . . . 66.700000000000003 112.412 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -137.1 -68.06 0.48 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.605 . . . . 65.010000000000005 111.176 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 41.0 67.59 2.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 O-C-N 123.747 0.654 . . . . 63.409999999999997 111.495 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -62.4 159.32 36.34 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.272 2.648 . . . . 61.93 112.619 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.64 113.0 6.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.684 -0.689 . . . . 59.869999999999997 110.091 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 38.3 mt-10 -66.6 137.92 95.34 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.596 . . . . 58.469999999999999 110.951 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 25' ' ' GLU . 33.7 Cg_exo -59.59 130.1 33.93 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.536 2.158 . . . . 57.359999999999999 112.158 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -71.2 -38.81 72.07 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.584 -0.525 . . . . 55.509999999999998 109.584 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -140.54 127.62 12.17 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.753 -0.658 . . . . 53.869999999999997 110.348 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.5 -21.47 25.92 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 121.635 1.557 . . . . 52.759999999999998 112.428 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 m -85.82 124.7 70.54 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-O 121.062 0.458 . . . . 50.93 111.378 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -90.14 37.21 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.86 2.374 . . . . 49.210000000000001 111.236 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 p -83.47 153.58 24.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.489 -0.778 . . . . 47.490000000000002 111.911 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.0 109.57 10.72 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.368 -0.833 . . . . 45.969999999999999 110.25 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.26 156.32 17.21 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.024 2.483 . . . . 45.280000000000001 112.437 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.0 m -155.49 122.04 5.28 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.447 -0.797 . . . . 42.789999999999999 110.327 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.19 115.55 42.71 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.991 -0.549 . . . . 40.789999999999999 110.401 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -79.24 151.95 23.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.636 2.224 . . . . 39.810000000000002 112.483 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 m -72.31 140.42 48.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.007 -0.542 . . . . 37.5 110.533 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.0 mt -87.82 117.49 68.55 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.918 -0.583 . . . . 35.649999999999999 110.082 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.91 161.94 14.44 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.792 2.328 . . . . 33.719999999999999 112.304 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -80.79 97.31 7.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.229 0.538 . . . . 31.510000000000002 111.073 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -85.21 131.66 47.7 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.73 -0.668 . . . . 30.129999999999999 109.844 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.69 164.94 31.25 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.41 2.074 . . . . 29.52 112.422 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.76 173.29 19.99 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.941 -0.647 . . . . 26.75 112.017 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.32 134.52 33.81 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.073 2.515 . . . . 25.079999999999998 112.257 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.0 mt -81.92 -57.28 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.148 -0.478 . . . . 23.899999999999999 109.974 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 56.77 81.09 0.14 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.508 -0.769 . . . . 21.23 111.486 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -77.68 164.85 24.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.905 -0.589 . . . . 19.920000000000002 110.211 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.26 178.44 4.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.716 -0.675 . . . . 16.559999999999999 110.556 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -121.66 69.4 0.92 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.87 -0.15 . . . . 15.050000000000001 111.086 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 66.41 132.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.437 0.46 . . . . 14.19 111.677 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.3 p -67.97 148.92 50.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.511 0.672 . . . . 11.380000000000001 111.392 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.65 109.71 18.9 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.138 -0.937 . . . . 8.2899999999999991 109.637 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.39 114.76 2.82 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.743 2.296 . . . . 6.8700000000000001 112.453 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.36 -43.11 61.66 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.445 2.097 . . . . 5.04 111.653 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 65.03 110.36 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.283 0 O-C-N 124.036 0.835 . . . . 2.5899999999999999 111.35 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.95 -177.0 1.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.968 2.446 . . . . 1.6399999999999999 112.316 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -120.48 141.5 50.13 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.002 -0.999 . . . . 3.3900000000000001 110.485 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.596 HG22 ' N ' ' A' ' 60' ' ' ARG . 9.0 mt -89.3 174.49 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.268 -0.878 . . . . 0.44 111.049 -177.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.596 ' N ' HG22 ' A' ' 59' ' ' ILE . 36.7 mtt85 -61.46 -150.32 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.77 -1.559 . . . . 2.3399999999999999 111.826 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.594 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 23.5 t-160 -159.6 137.01 9.78 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-N 112.899 -1.955 . . . . 2.2200000000000002 106.588 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.717 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.7 m-30 -121.26 156.11 33.2 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.587 -0.733 . . . . 0.20999999999999999 111.182 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 7.6 t70 -84.55 67.82 10.09 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 123.363 1.554 . . . . 0.34999999999999998 108.487 172.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.768 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.8 m95 -57.96 -42.5 85.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 112.219 -2.264 . . . . 0.10000000000000001 112.455 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 3.7 t30 -53.22 -26.14 16.61 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.13 -1.395 . . . . 1.1100000000000001 111.52 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.29 -15.61 79.81 Favored Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.279 -0.873 . . . . 0.20999999999999999 111.267 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.62 -53.19 3.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.104 -1.048 . . . . 0.13 110.991 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.704 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.2 mtt -65.43 -59.38 4.07 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 114.08 -1.418 . . . . 0.089999999999999997 112.035 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.5 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 5.1 mm100 -39.28 -54.98 3.34 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 114.679 1.362 . . . . 0.63 114.679 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.769 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.8 Cg_endo -63.61 -28.47 69.63 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.988 1.792 . . . . 0.14000000000000001 110.768 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.721 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 8.2 mtm -83.17 -44.47 15.02 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.088 -0.96 . . . . 0.69999999999999996 112.09 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 68' ' ' MET . 58.6 t -56.86 -39.14 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-N 114.312 -1.313 . . . . 0.12 108.715 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -60.13 -32.96 71.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.966 -1.924 . . . . 0.56000000000000005 110.974 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.769 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 5.0 mtpm? -83.79 -35.76 24.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.843 0.457 . . . . 1.3 111.159 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.871 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.85 -26.54 68.66 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.461 -0.791 . . . . 0.5 111.295 -172.238 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 118' ' ' LYS . 5.5 mt -93.46 -3.48 52.96 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.071 0.938 . . . . 0.65000000000000002 110.841 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.27 15.41 42.99 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 109.147 -1.581 . . . . 0.17000000000000001 109.147 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.629 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.89 160.95 19.28 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.526 -0.837 . . . . 0.10000000000000001 110.282 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.21 104.97 16.26 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.288 -0.869 . . . . 1.72 110.093 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.641 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.03 -23.83 3.16 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.842 -0.903 . . . . 0.12 110.842 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.871 HG11 ' O ' ' A' ' 75' ' ' MET . 11.9 p -103.07 150.67 6.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.635 0.731 . . . . 0.16 111.75 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.7 m -136.57 141.31 43.33 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.919 -1.037 . . . . 0.45000000000000001 111.102 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.631 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.12 132.95 48.57 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.779 -1.1 . . . . 0.28000000000000003 110.741 167.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.47 9.55 50.16 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 121.174 -0.536 . . . . 0.28000000000000003 112.8 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.66 149.64 21.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.327 -0.549 . . . . 1.2 110.647 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.712 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -80.84 116.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.168 0.985 . . . . 0.20000000000000001 108.925 166.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.743 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -105.16 109.51 21.53 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.044 -0.98 . . . . 0.14000000000000001 108.903 -172.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.792 HD21 HD13 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -71.78 94.42 1.39 Allowed 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 114.428 -1.26 . . . . 0.14999999999999999 108.32 177.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.452 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.7 m -72.58 119.18 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 106.978 -1.49 . . . . 0.94999999999999996 106.978 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.845 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 12.3 t0 -77.33 162.35 27.35 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.703 -1.221 . . . . 0.64000000000000001 107.703 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.567 ' H ' ' NZ ' ' A' ' 131' ' ' LYS . 1.1 m -62.17 143.21 57.06 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.59 -1.633 . . . . 0.37 106.59 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.56 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 27.3 t -71.73 139.76 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.118 0 N-CA-C 107.534 -1.284 . . . . 0.10000000000000001 107.534 168.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.78 ' H ' ' HA ' ' A' ' 164' ' ' SER . 8.0 t-20 -84.9 163.28 19.09 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.497 -0.774 . . . . 0.17999999999999999 110.07 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.77 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.14 85.22 2.38 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.96 -1.126 . . . . 0.12 107.96 175.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.535 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.9 mtp180 -107.02 -4.17 19.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.037 -1.438 . . . . 0.64000000000000001 108.764 -171.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 172' ' ' PRO . 19.1 p -51.05 -170.94 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.83 -1.986 . . . . 0.14000000000000001 115.499 -175.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 38.3 t30 -70.96 -6.35 38.05 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.718 -2.037 . . . . 0.47999999999999998 110.53 173.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.603 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -157.48 -144.05 3.83 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.396 -0.907 . . . . 0.12 113.297 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.629 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 94.8 p -121.42 130.31 53.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.612 0.597 . . . . 1.1599999999999999 112.612 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.77 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.2 pp -136.48 159.49 41.64 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-O 121.855 0.836 . . . . 0.10000000000000001 110.579 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.692 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -80.74 82.17 6.81 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 113.856 -1.52 . . . . 0.17000000000000001 107.975 175.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -70.84 -15.64 62.66 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.355 -1.293 . . . . 0.089999999999999997 109.81 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.663 ' HB2' ' CG ' ' A' ' 139' ' ' GLN . . . -78.66 -31.53 46.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.793 0.806 . . . . 0.14999999999999999 108.849 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.692 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 21.5 tt0 -62.83 -38.61 91.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 114.053 -1.43 . . . . 1.73 109.109 169.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -69.54 -44.62 70.57 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 112.867 -1.97 . . . . 0.12 109.005 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.592 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 60.6 m -64.89 -31.82 73.23 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.126 -1.397 . . . . 0.11 110.533 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.15 -51.24 59.74 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.972 -1.121 . . . . 1.47 107.972 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 64' ' ' TRP . 31.7 m -56.69 -33.15 66.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.532 -0.758 . . . . 0.12 111.436 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.704 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.3 mt -50.55 -68.69 0.15 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 109.61 -0.515 . . . . 0.56000000000000005 109.61 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.569 ' O ' HD13 ' A' ' 121' ' ' LEU . 19.0 mtp180 -42.81 -36.92 1.63 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.883 -1.053 . . . . 1.51 110.973 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.1 m-20 -71.9 -47.47 52.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.245 -1.343 . . . . 0.28000000000000003 111.854 -175.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.5 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.21 -33.31 67.51 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.328 1.061 . . . . 0.089999999999999997 108.403 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.86 -32.9 74.58 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.514 -1.676 . . . . 0.12 109.918 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.693 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -76.28 -40.82 50.72 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.812 -1.086 . . . . 0.20000000000000001 111.364 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.05 -26.87 66.96 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.99 -1.005 . . . . 1.1699999999999999 110.682 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.436 HD21 ' HA ' ' A' ' 116' ' ' ASN . 1.3 t-20 -88.08 -17.94 29.98 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.147 -0.621 . . . . 2.0499999999999998 110.429 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.21 -12.83 2.99 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 116.048 1.179 . . . . 0.54000000000000004 116.048 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.72 ' HB2' HD13 ' A' ' 76' ' ' LEU . 57.8 mtpt -77.39 -14.3 59.74 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 117.802 0.801 . . . . 0.98999999999999999 111.463 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.743 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 23.2 m-85 -109.29 172.76 6.66 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 122.648 1.213 . . . . 0.20999999999999999 113.669 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.57 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 14.7 m -117.27 117.42 29.5 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 112.305 -2.225 . . . . 0.23000000000000001 108.031 169.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -88.52 139.02 30.9 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.437 -0.801 . . . . 0.38 110.517 -171.814 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.559 HG11 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -84.59 155.03 3.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.871 -0.788 . . . . 0.41999999999999998 108.871 172.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.26 152.57 19.27 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.602 0.715 . . . . 1.7 109.427 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.66 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -64.32 -19.43 65.43 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 114.502 -1.227 . . . . 0.55000000000000004 110.121 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.618 ' O ' ' HG3' ' A' ' 129' ' ' MET . 0.4 OUTLIER -57.22 -29.89 64.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.022 -0.99 . . . . 2.04 109.612 172.114 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.616 ' HB2' HG22 ' A' ' 155' ' ' VAL . 12.7 mt-30 -98.82 -54.66 2.94 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 122.427 1.108 . . . . 0.40999999999999998 110.101 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.792 HD13 HD21 ' A' ' 88' ' ' LEU . 26.5 tp -60.79 -63.22 1.37 Allowed 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 113.165 -1.834 . . . . 1.3899999999999999 112.8 -169.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.704 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 2.6 t -49.39 -44.56 45.19 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 123.308 1.528 . . . . 1.05 109.408 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.734 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 19.0 mmt -58.44 -61.61 2.46 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 111.064 -2.789 . . . . 1.6399999999999999 110.694 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.755 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.81 -46.15 5.13 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 124.484 1.115 . . . . 0.31 112.197 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.568 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -54.95 -51.36 66.39 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 108.624 -0.88 . . . . 1.53 108.624 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 128' ' ' SER . 39.1 mt-30 -65.68 -40.78 92.72 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.23 -0.895 . . . . 0.40999999999999998 111.162 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.734 ' HG3' ' O ' ' A' ' 129' ' ' MET . 54.5 mt-30 -57.81 -34.73 69.96 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 114.354 -1.294 . . . . 0.37 109.525 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.08 -28.93 17.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 113.754 -1.567 . . . . 0.23999999999999999 109.284 -176.939 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.62 -49.79 0.52 Allowed Glycine 0 CA--C 1.496 -1.137 0 CA-C-O 122.667 1.148 . . . . 0.33000000000000002 113.323 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 141' ' ' SER . 87.9 mt -64.92 -169.73 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 112.332 -1.934 . . . . 0.31 115.669 -171.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.0 m -116.3 155.05 48.82 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 110.858 -2.883 . . . . 0.81000000000000005 107.517 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.704 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 46.1 Cg_endo -67.26 1.35 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.661 2.241 . . . . 0.32000000000000001 110.866 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.663 ' CG ' ' HB2' ' A' ' 103' ' ' ALA . 31.4 mt-30 -118.27 -24.31 6.97 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.946 -1.479 . . . . 1.25 111.525 -173.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.621 ' O ' ' HB2' ' A' ' 141' ' ' SER . 7.1 t70 -72.92 -23.61 60.72 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 114.838 -1.073 . . . . 0.65000000000000002 108.793 -168.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 31.5 m 75.78 166.33 0.27 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.532 -2.122 . . . . 0.59999999999999998 110.56 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.944 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.2 mt -64.99 -40.4 94.91 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.581 1.182 . . . . 0.85999999999999999 108.777 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.71 -12.16 0.16 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 112.607 -2.088 . . . . 0.31 114.612 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -151.79 125.45 8.97 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 118.832 -0.604 . . . . 0.23999999999999999 109.57 -173.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 16.8 mmt85 -42.27 -48.13 4.9 Favored 'General case' 0 C--O 1.211 -0.944 0 O-C-N 123.413 0.446 . . . . 1.6499999999999999 111.915 -176.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 41.9 t -72.23 -26.33 61.98 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.595 0.712 . . . . 0.53000000000000003 111.236 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -74.37 -28.97 61.36 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.6 1.19 . . . . 1.3100000000000001 108.505 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.944 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -76.47 -47.92 21.32 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-N 112.471 -2.149 . . . . 0.12 110.427 177.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.627 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.2 mt -66.51 -40.17 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 CA-C-N 112.856 -1.975 . . . . 0.11 110.073 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.46 -55.26 25.69 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 114.652 -1.158 . . . . 0.14999999999999999 110.965 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.755 HG23 ' CB ' ' A' ' 130' ' ' ALA . 92.1 mt -66.42 -48.55 80.4 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.07 0 N-CA-C 112.683 0.623 . . . . 0.17999999999999999 112.683 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.675 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.36 -41.2 72.22 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 123.227 0.329 . . . . 0.13 111.079 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.497 ' HD2' HG23 ' A' ' 149' ' ' ILE . 24.8 mtp180 -81.22 -23.02 38.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.597 0.713 . . . . 1.0800000000000001 110.459 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -82.84 -10.26 58.93 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.438 -1.319 . . . . 0.5 107.438 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.71 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.1 t -108.51 -29.47 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 113.18 -1.827 . . . . 0.17000000000000001 111.0 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.83 35.86 4.16 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.077 -1.058 . . . . 0.16 112.486 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.689 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.15 159.65 17.65 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.866 0.691 . . . . 0.12 112.866 -171.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.712 ' N ' HG13 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -99.85 -28.17 13.25 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 123.414 0.686 . . . . 0.20000000000000001 109.681 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.572 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.3 m-85 -135.44 -173.17 3.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.161 -0.927 . . . . 0.13 110.945 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.701 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -137.18 140.35 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.004 -0.998 . . . . 0.080000000000000002 108.786 166.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.633 HD21 ' SD ' ' A' ' 176' ' ' MET . 37.0 tp -109.31 100.95 10.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 119.417 -0.913 . . . . 0.16 109.3 165.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.4 m-85 -79.83 113.59 18.1 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 114.434 -1.257 . . . . 0.26000000000000001 109.027 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.855 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 6.4 t -126.64 161.25 28.51 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 122.143 0.973 . . . . 1.05 110.881 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.821 ' O ' HD12 ' A' ' 174' ' ' LEU . 2.2 p -164.51 174.55 10.79 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.949 -1.478 . . . . 0.10000000000000001 110.859 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.29 134.67 38.23 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 114.2 -1.363 . . . . 0.11 108.632 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.681 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.7 m -144.73 -175.96 4.87 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.185 -0.672 . . . . 1.0900000000000001 109.185 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.82 -84.53 0.8 Allowed Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 119.536 -1.316 . . . . 0.14999999999999999 111.325 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.7 t30 -144.23 127.22 16.45 Favored 'General case' 0 C--O 1.197 -1.676 0 N-CA-C 107.596 -1.261 . . . . 0.58999999999999997 107.596 175.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.603 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.5 p -63.34 -39.53 85.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.398 -0.819 . . . . 0.14999999999999999 112.364 -171.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.41 ' N ' HG13 ' A' ' 169' ' ' VAL . 4.4 m120 -60.72 -31.47 70.77 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 122.086 0.946 . . . . 1.26 109.753 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.55 88.89 3.29 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 113.169 -1.832 . . . . 0.13 108.307 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.799 ' HD2' HG22 ' A' ' 194' ' ' VAL . 52.4 Cg_endo -89.99 163.73 4.88 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 124.335 3.357 . . . . 0.089999999999999997 114.883 -169.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.617 HG22 ' HB3' ' A' ' 191' ' ' LYS . 63.8 m -82.93 117.97 23.14 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 106.965 -1.494 . . . . 0.14000000000000001 106.965 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 164' ' ' SER . 38.5 tp -83.9 97.49 9.26 Favored 'General case' 0 N--CA 1.413 -2.325 0 C-N-CA 119.294 -0.963 . . . . 0.16 108.402 177.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.582 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 7.4 mt-30 -87.87 109.47 19.8 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.098 -0.955 . . . . 0.34000000000000002 109.153 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.855 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -112.85 164.75 13.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.684 -1.144 . . . . 1.0900000000000001 111.481 -173.787 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.603 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.7 tt0 -170.57 118.16 0.52 Allowed 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 116.077 -0.51 . . . . 0.5 110.076 -166.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.066 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -100.37 100.56 11.36 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.741 -0.837 . . . . 0.10000000000000001 108.741 -172.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.627 ' HE1' HG13 ' A' ' 149' ' ' ILE . 18.2 ttp -90.52 121.93 32.9 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.445 -0.798 . . . . 0.070000000000000007 109.614 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.82 127.09 30.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.122 -1.436 . . . . 0.22 107.122 166.284 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.617 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.52 -34.4 13.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 119.33 0.968 . . . . 0.11 110.758 178.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.429 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.7 mt-30 -63.08 -14.69 51.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.265 -0.88 . . . . 0.34999999999999998 111.577 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.1 p -130.58 -36.97 1.4 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.677 0.751 . . . . 0.19 110.277 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.503 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.17 19.0 44.02 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.556 -1.202 . . . . 0.17999999999999999 112.25 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.7 156.79 16.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.529 -0.336 . . . . 0.72999999999999998 110.494 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.603 HD12 ' HG2' ' A' ' 177' ' ' GLN . 33.7 mm -91.58 115.85 31.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.637 0.732 . . . . 0.14000000000000001 109.52 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.066 HD11 HD13 ' A' ' 178' ' ' LEU . 1.5 pp -103.28 -29.61 2.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.019 -0.991 . . . . 0.13 110.681 -173.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.652 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.0 t90 -137.2 153.26 50.45 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.371 -0.831 . . . . 0.070000000000000007 109.508 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 79.9 p -153.47 165.47 35.75 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.822 0.675 . . . . 0.13 112.822 163.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -161.79 -175.91 33.32 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-O 121.718 0.621 . . . . 0.12 111.762 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.757 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 1.5 mttp -154.74 152.02 29.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.095 -1.817 . . . . 1.22 106.095 164.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -157.33 127.31 1.9 Allowed Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 119.612 -1.28 . . . . 0.12 111.833 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.42 115.2 10.32 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.391 0.615 . . . . 0.17000000000000001 110.487 -175.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.799 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -90.98 158.68 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-O 122.47 1.128 . . . . 0.11 109.647 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.657 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.23 171.58 7.52 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 112.848 -1.978 . . . . 0.17999999999999999 109.256 -172.612 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 6.8 tt0 -101.64 128.96 47.7 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.074 -0.713 . . . . 0.91000000000000003 109.074 168.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.497 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 19.3 mm-40 . . . . . 0 C--N 1.309 -1.177 0 CA-C-N 115.505 -0.771 . . . . 1.24 110.732 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.853 0 N-CA-C 111.977 -0.449 . . . . 88.609999999999999 111.977 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -71.37 -41.15 70.07 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 122.323 0.249 . . . . 87.430000000000007 111.281 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 56.27 71.3 0.57 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.815 0.341 . . . . 87.159999999999997 110.293 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.8 ttt -129.73 57.59 1.67 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.694 0.759 . . . . 85.340000000000003 109.763 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.69 -15.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.477 -0.783 . . . . 85.049999999999997 111.155 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.55 55.3 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.957 -0.64 . . . . 84.680000000000007 111.846 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 57.6 tt0 -89.21 117.63 28.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.699 0.761 . . . . 85.569999999999993 110.738 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 55.33 66.22 1.28 Allowed 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 113.695 -1.593 . . . . 85.040000000000006 111.945 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 10.0 mm-40 -58.79 128.79 84.63 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-O 120.972 0.415 . . . . 82.170000000000002 111.039 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 22.7 Cg_exo -65.43 -33.28 47.69 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.657 2.238 . . . . 81.510000000000005 111.794 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.95 133.87 10.0 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.648 -0.705 . . . . 79.560000000000002 109.988 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.15 164.91 28.77 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.948 2.432 . . . . 78.5 112.475 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.0 m -95.84 156.47 3.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.812 -0.631 . . . . 77.0 111.303 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 59.6 97.51 0.03 OUTLIER 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.91 -1.041 . . . . 75.739999999999995 112.716 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -82.4 89.19 6.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.378 0.609 . . . . 73.909999999999997 109.575 172.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.427 HG22 ' HD3' ' A' ' 18' ' ' PRO . 6.4 p -69.83 107.53 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.286 -0.87 . . . . 72.299999999999997 111.307 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -125.45 84.06 60.61 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.505 -0.771 . . . . 71.219999999999999 109.66 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD3' HG22 ' A' ' 16' ' ' VAL . 98.8 Cg_endo -82.47 166.47 15.8 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.591 2.194 . . . . 69.670000000000002 112.505 -177.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.07 110.64 27.37 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.112 -0.495 . . . . 67.549999999999997 110.337 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.62 62.04 5.44 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.047 2.498 . . . . 66.700000000000003 112.14 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -129.44 174.78 9.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.886 -0.597 . . . . 65.010000000000005 109.685 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 58.4 tt0 -115.65 121.73 33.9 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.899 -0.408 . . . . 63.409999999999997 109.899 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 52.0 Cg_exo -62.87 173.71 3.59 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.894 2.396 . . . . 61.93 112.907 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 54.14 60.68 3.45 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 112.496 -2.138 . . . . 59.869999999999997 112.542 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.56 104.19 2.15 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.711 -1.131 . . . . 58.469999999999999 110.29 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -82.4 13.57 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.898 2.399 . . . . 57.359999999999999 112.424 -175.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 6.1 tp60 -139.15 148.97 43.92 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.111 -0.699 . . . . 55.509999999999998 109.111 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -72.05 115.58 39.86 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 110.279 -0.267 . . . . 53.869999999999997 110.279 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.72 -43.01 41.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.684 2.256 . . . . 52.759999999999998 111.316 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.82 106.14 26.13 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.441 -0.8 . . . . 50.93 110.217 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.66 37.27 0.67 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.799 2.333 . . . . 49.210000000000001 112.249 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.39 166.25 15.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.549 0.69 . . . . 47.490000000000002 110.423 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.0 m -110.99 142.05 25.45 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-N 114.864 -1.062 . . . . 45.969999999999999 109.645 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -55.63 154.04 27.11 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.562 2.175 . . . . 45.280000000000001 111.994 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -70.29 129.11 38.44 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.354 -0.839 . . . . 42.789999999999999 111.586 -172.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.77 81.63 69.9 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.356 -0.838 . . . . 40.789999999999999 111.01 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.85 -21.98 69.07 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.771 2.314 . . . . 39.810000000000002 111.607 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -172.3 150.7 2.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.213 -0.903 . . . . 37.5 109.558 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.2 mt -98.56 105.06 27.64 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.888 -0.596 . . . . 35.649999999999999 109.576 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.15 60.16 3.84 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.986 2.457 . . . . 33.719999999999999 112.827 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -132.0 174.97 9.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.088 -0.505 . . . . 31.510000000000002 110.219 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 29.5 tt0 70.14 129.43 0.03 OUTLIER Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 114.765 -1.107 . . . . 30.129999999999999 111.313 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 42' ' ' GLN . 27.8 Cg_exo -62.8 146.46 95.06 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 121.919 1.746 . . . . 29.52 111.666 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.72 -169.97 38.0 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.713 -0.756 . . . . 26.75 112.034 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.12 125.45 10.33 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.675 2.25 . . . . 25.079999999999998 111.599 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.8 mm -67.85 -54.29 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.876 -0.602 . . . . 23.899999999999999 110.715 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 50.55 76.96 0.13 Allowed 'General case' 0 C--O 1.235 0.324 0 O-C-N 124.137 0.898 . . . . 21.23 111.213 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -86.58 174.72 8.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.262 0.554 . . . . 19.920000000000002 110.823 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.63 164.54 22.67 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.361 -0.836 . . . . 16.559999999999999 109.349 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -101.5 17.37 22.94 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.673 0.749 . . . . 15.050000000000001 110.963 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 58.6 -85.7 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.508 -1.678 . . . . 14.19 110.772 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.673 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 41.1 p -88.35 158.48 18.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.388 -0.369 . . . . 11.380000000000001 110.237 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.43 95.58 6.18 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.813 -0.631 . . . . 8.2899999999999991 111.877 -174.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 52' ' ' THR . 36.0 Cg_endo -96.68 131.22 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.432 2.755 . . . . 6.8700000000000001 112.528 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.65 -34.62 83.81 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.393 2.062 . . . . 5.04 111.618 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.12 122.83 7.03 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.501 -0.772 . . . . 2.5899999999999999 109.146 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.4 -177.84 1.94 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 123.198 2.599 . . . . 1.6399999999999999 112.928 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -115.56 141.71 47.69 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 113.798 -1.546 . . . . 3.3900000000000001 109.544 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 60' ' ' ARG . 10.0 mt -84.43 167.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.875 0.845 . . . . 0.44 112.162 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.579 ' N ' HG22 ' A' ' 59' ' ' ILE . 35.8 mtt85 -71.81 -150.28 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.516 -1.675 . . . . 2.3399999999999999 111.435 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.731 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 1.9 t60 -158.74 136.35 10.21 Favored 'General case' 0 CA--C 1.476 -1.869 0 CA-C-N 112.948 -1.933 . . . . 2.2200000000000002 107.001 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.731 ' HD1' ' C ' ' A' ' 61' ' ' HIS . 2.1 m-30 -122.17 154.19 37.78 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.322 -0.854 . . . . 0.20999999999999999 110.973 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.528 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 15.8 t70 -85.05 67.75 10.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 123.538 1.637 . . . . 0.34999999999999998 108.444 173.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.772 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.1 m95 -55.64 -43.33 76.12 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 112.006 -2.361 . . . . 0.10000000000000001 112.752 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.438 ' N ' HG21 ' A' ' 108' ' ' THR . 4.1 t30 -50.8 -30.87 15.33 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.762 -1.563 . . . . 1.1100000000000001 111.643 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.28 -17.15 79.62 Favored Glycine 0 CA--C 1.503 -0.693 0 CA-C-N 115.506 -0.77 . . . . 0.20999999999999999 111.423 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.96 -51.51 3.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.114 -1.043 . . . . 0.13 110.806 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.74 ' SD ' HD23 ' A' ' 109' ' ' LEU . 37.6 mtt -65.69 -56.29 12.9 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 114.182 -1.372 . . . . 0.089999999999999997 112.473 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.465 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.6 mm100 -39.74 -54.29 4.15 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 114.804 1.409 . . . . 0.63 114.804 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.834 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 29.6 Cg_endo -63.55 -32.0 70.39 Favored 'Trans proline' 0 CA--C 1.508 -0.804 0 C-N-CA 121.919 1.746 . . . . 0.14000000000000001 110.799 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.758 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 7.7 mtm -79.64 -47.59 15.16 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 114.979 -1.01 . . . . 0.69999999999999996 111.515 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 68' ' ' MET . 53.3 t -54.52 -41.19 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 CA-C-N 114.089 -1.414 . . . . 0.12 108.955 176.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.9 t -60.0 -36.68 77.72 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.256 -1.793 . . . . 0.56000000000000005 110.791 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.834 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 20.0 mtpp -77.6 -35.36 52.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.303 0.573 . . . . 1.3 110.498 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.866 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.14 -29.81 71.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.765 -1.107 . . . . 0.5 111.44 -173.663 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.479 ' HG ' ' HB2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -83.68 -6.82 59.54 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.193 0.52 . . . . 0.65000000000000002 111.235 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -108.76 13.97 34.98 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.614 -1.395 . . . . 0.17000000000000001 109.614 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.657 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -81.58 161.36 23.56 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.663 -0.768 . . . . 0.10000000000000001 110.285 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.99 106.26 17.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.345 -0.843 . . . . 1.72 109.579 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.648 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.76 -24.68 3.46 Favored Glycine 0 N--CA 1.418 -2.542 0 C-N-CA 119.797 -1.192 . . . . 0.12 110.666 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.866 HG11 ' O ' ' A' ' 75' ' ' MET . 10.9 p -97.47 155.9 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.702 0.763 . . . . 0.16 111.541 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.405 ' HB ' ' OG ' ' A' ' 85' ' ' SER . 6.5 m -132.85 136.62 46.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 114.51 -1.223 . . . . 0.45000000000000001 110.901 -176.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.654 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.6 130.21 45.74 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.864 -1.062 . . . . 0.28000000000000003 110.332 167.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.86 12.15 60.86 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.719 -0.753 . . . . 0.28000000000000003 113.233 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.462 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 61.9 m -97.56 147.73 23.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.124 0.462 . . . . 1.2 110.156 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.705 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.2 p -77.0 124.8 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 122.09 0.948 . . . . 0.20000000000000001 109.194 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.685 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.7 tm? -110.84 110.17 20.66 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.984 -1.007 . . . . 0.14000000000000001 108.58 -172.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.722 HD21 HD23 ' A' ' 127' ' ' LEU . 0.7 OUTLIER -71.34 92.85 1.08 Allowed 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.334 -1.358 . . . . 0.14999999999999999 107.334 176.336 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.5 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -73.68 113.41 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.416 -1.327 . . . . 0.94999999999999996 107.416 177.27 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.818 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 23.1 t0 -77.28 172.04 13.9 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 114.778 -1.101 . . . . 0.64000000000000001 108.815 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.556 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.7 OUTLIER -61.8 157.78 17.31 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 122.767 1.27 . . . . 0.37 108.371 168.234 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.559 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 39.3 t -86.87 139.63 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.202 0 CA-C-N 113.692 -1.595 . . . . 0.10000000000000001 107.047 165.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.824 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.6 t-20 -83.8 163.35 20.2 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.854 0.835 . . . . 0.17999999999999999 110.555 173.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.763 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.74 84.86 2.32 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.348 -1.296 . . . . 0.12 107.977 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.8 mtp180 -108.48 -2.6 18.85 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.847 -1.524 . . . . 0.64000000000000001 108.727 -171.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.738 HG21 ' HB3' ' A' ' 172' ' ' PRO . 22.6 p -51.4 -170.13 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 112.678 -2.055 . . . . 0.14000000000000001 115.156 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 29.8 t30 -70.49 -10.66 59.77 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.083 -1.871 . . . . 0.47999999999999998 110.531 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.559 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.37 -144.74 3.98 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.176 -1.011 . . . . 0.12 113.573 -176.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.639 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 16.5 m -121.27 130.75 53.83 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.8 0.44 . . . . 1.1599999999999999 110.935 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.763 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -136.8 157.48 46.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.962 0.887 . . . . 0.10000000000000001 110.735 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.723 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -77.17 80.74 3.68 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.628 -1.623 . . . . 0.17000000000000001 107.56 175.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -70.17 -14.71 62.76 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.863 -1.062 . . . . 0.089999999999999997 109.767 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.86 -29.6 35.74 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.413 -0.958 . . . . 0.14999999999999999 108.413 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.723 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 29.3 tt0 -61.62 -40.64 95.56 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.207 -1.36 . . . . 1.73 109.125 168.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -68.15 -45.29 73.94 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 112.826 -1.988 . . . . 0.12 108.845 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 47.2 m -63.78 -33.28 75.32 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 113.821 -1.536 . . . . 0.11 110.618 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -44.83 84.89 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.637 -1.245 . . . . 1.47 107.637 172.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.68 HG21 ' HB2' ' A' ' 64' ' ' TRP . 34.6 m -63.24 -30.11 71.32 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.234 -0.894 . . . . 0.12 110.867 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.74 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.57 -68.34 0.18 Allowed 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.589 -0.732 . . . . 0.56000000000000005 109.658 171.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.603 ' NH2' HD12 ' A' ' 127' ' ' LEU . 5.8 mpt_? -40.31 -36.63 0.56 Allowed 'General case' 0 C--O 1.213 -0.865 0 O-C-N 124.226 0.954 . . . . 1.51 110.888 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.517 ' HB2' ' O ' ' A' ' 108' ' ' THR . 5.5 m-20 -74.6 -46.35 39.12 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.665 -1.152 . . . . 0.28000000000000003 112.0 -174.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.55 63.36 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.471 -0.937 . . . . 0.089999999999999997 108.471 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.683 ' HB3' ' CD2' ' A' ' 121' ' ' LEU . 4.5 mm? -61.64 -35.21 77.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.649 -1.614 . . . . 0.12 109.442 172.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -73.46 -41.69 62.86 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 114.574 -1.194 . . . . 0.20000000000000001 110.937 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -71.85 -8.5 54.7 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.15 -0.932 . . . . 1.1699999999999999 110.281 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -77.81 -49.08 15.02 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.523 -0.917 . . . . 2.0499999999999998 108.523 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.87 -7.15 82.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.416 -0.811 . . . . 0.54000000000000004 113.735 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.654 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 58.7 mtpt -86.64 -33.13 20.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.289 0.545 . . . . 0.98999999999999999 111.322 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.685 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 6.5 m-85 -88.81 171.47 9.91 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.303 1.049 . . . . 0.20999999999999999 112.988 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 7.9 m -116.46 119.32 35.24 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.144 -1.844 . . . . 0.23000000000000001 108.222 168.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.683 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -89.01 140.82 29.05 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 119.466 -0.893 . . . . 0.38 111.368 -171.4 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.592 HG21 HD23 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -89.42 147.81 4.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.42 -0.956 . . . . 0.41999999999999998 108.42 170.055 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.707 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 1.4 m -102.0 164.63 11.61 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.326 1.06 . . . . 1.7 110.06 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 128' ' ' SER . . . -64.26 -34.62 78.54 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 112.939 -1.937 . . . . 0.55000000000000004 111.348 -171.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.707 ' HG2' ' HB2' ' A' ' 123' ' ' SER . 10.2 pt20 -50.12 -30.13 10.49 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.501 -1.681 . . . . 2.04 110.966 172.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.583 ' HB2' HG22 ' A' ' 155' ' ' VAL . 4.4 mt-30 -97.24 -55.04 2.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.648 -1.16 . . . . 0.40999999999999998 110.586 171.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.722 HD23 HD21 ' A' ' 88' ' ' LEU . 1.3 tm? -69.62 -64.76 0.82 Allowed 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 114.679 -1.146 . . . . 1.3899999999999999 112.998 -168.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.684 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -48.75 -37.83 20.0 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 123.649 1.69 . . . . 1.05 108.946 -179.288 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.68 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 6.6 mmt -65.78 -61.52 2.02 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 110.731 -2.94 . . . . 1.6399999999999999 110.987 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.748 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.65 -43.61 3.92 Favored 'General case' 0 CA--C 1.503 -0.829 0 O-C-N 124.181 0.925 . . . . 0.31 112.384 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -55.24 -52.69 62.58 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 107.806 -1.183 . . . . 1.53 107.806 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.9 mt-30 -65.89 -41.05 92.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.064 -0.971 . . . . 0.40999999999999998 111.194 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.666 ' HG3' ' O ' ' A' ' 129' ' ' MET . 54.2 mt-30 -56.46 -34.72 67.14 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-N 114.365 -1.289 . . . . 0.37 109.617 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -92.57 -31.33 15.23 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.002 -1.454 . . . . 0.23999999999999999 109.45 -176.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.79 -51.95 0.39 Allowed Glycine 0 CA--C 1.499 -0.917 0 C-N-CA 120.149 -1.024 . . . . 0.33000000000000002 113.759 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 141' ' ' SER . 39.1 mt -67.25 -167.0 0.05 Allowed 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.499 -1.851 . . . . 0.31 115.778 -170.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -116.95 154.57 49.68 Favored Pre-proline 0 N--CA 1.421 -1.909 0 CA-C-N 110.994 -2.821 . . . . 0.81000000000000005 108.002 176.58 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.684 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 21.9 Cg_endo -62.56 -0.11 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.397 2.731 . . . . 0.32000000000000001 112.207 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.46 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.2 tt0 -119.51 -28.73 5.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.172 -0.922 . . . . 1.25 111.096 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.677 ' O ' ' HB2' ' A' ' 141' ' ' SER . 11.7 t70 -66.1 -25.4 66.99 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 113.779 -1.555 . . . . 0.65000000000000002 109.407 -172.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.677 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 5.7 m 75.66 171.75 0.26 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.146 -1.843 . . . . 0.59999999999999998 109.697 -173.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.01 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.0 mt -65.6 -39.24 91.35 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.398 1.094 . . . . 0.85999999999999999 108.36 -176.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.55 -12.4 0.33 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 112.871 -1.968 . . . . 0.31 114.646 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 124.88 7.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 118.719 -0.658 . . . . 0.23999999999999999 109.638 -174.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.668 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -40.89 -48.5 3.13 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 112.177 0.436 . . . . 1.6499999999999999 112.177 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.3 t -72.47 -26.16 61.7 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.443 0.64 . . . . 0.53000000000000003 111.186 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -73.97 -28.42 61.47 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.712 1.244 . . . . 1.3100000000000001 108.528 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 1.01 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -76.61 -47.25 22.93 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 112.27 -2.241 . . . . 0.12 110.253 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.635 HG13 ' HE1' ' A' ' 179' ' ' MET . 36.5 mt -66.75 -41.12 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 112.816 -1.993 . . . . 0.11 110.188 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.98 -54.94 26.3 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 114.613 -1.176 . . . . 0.14999999999999999 111.054 171.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.748 HG23 ' CB ' ' A' ' 130' ' ' ALA . 75.2 mt -65.63 -47.89 84.57 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 N-CA-C 112.748 0.647 . . . . 0.17999999999999999 112.748 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.671 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.27 -40.45 74.23 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.939 0.4 . . . . 0.13 110.939 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.46 ' HD2' HG23 ' A' ' 149' ' ' ILE . 30.9 mtp180 -82.13 -20.85 37.16 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.677 0.751 . . . . 1.0800000000000001 110.451 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 28.1 t-20 -83.28 -10.77 58.33 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.238 -1.393 . . . . 0.5 107.238 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.707 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.0 OUTLIER -109.59 -29.02 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 113.444 -1.707 . . . . 0.17000000000000001 111.42 -173.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.26 35.92 4.3 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.213 -0.994 . . . . 0.16 112.489 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.658 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.45 160.56 17.0 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.294 0.85 . . . . 0.12 113.294 -170.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.705 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.4 m80 -100.86 -26.21 13.84 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.121 -0.945 . . . . 0.20000000000000001 109.613 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.652 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 12.7 m-85 -135.49 -174.29 3.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.19 -0.914 . . . . 0.13 111.583 -174.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.692 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -136.57 140.02 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.094 -0.957 . . . . 0.080000000000000002 109.465 166.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 176' ' ' MET . 42.9 tp -109.61 100.73 9.73 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 119.61 -0.836 . . . . 0.16 109.144 165.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 142' ' ' LEU . 2.3 m-85 -80.53 112.48 17.92 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 114.464 -1.244 . . . . 0.26000000000000001 109.31 177.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.832 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.5 t -124.08 163.02 22.31 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 122.144 0.973 . . . . 1.05 111.335 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.83 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.1 p -164.65 173.71 11.62 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 114.037 -1.438 . . . . 0.10000000000000001 111.007 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -137.35 134.34 35.89 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 114.304 -1.316 . . . . 0.11 108.429 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -144.11 -176.19 4.91 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.305 -0.628 . . . . 1.0900000000000001 109.305 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.14 -83.91 0.92 Allowed Glycine 0 CA--C 1.491 -1.414 0 C-N-CA 119.567 -1.302 . . . . 0.14999999999999999 111.213 173.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.1 t30 -144.59 129.3 18.21 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-N 113.985 -1.108 . . . . 0.58999999999999997 108.149 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.559 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.6 p -63.65 -40.21 88.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.343 -0.844 . . . . 0.14999999999999999 112.168 -172.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -60.31 -32.1 70.9 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.982 0.896 . . . . 1.26 109.993 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.78 88.75 3.24 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 113.442 -1.708 . . . . 0.13 108.363 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 194' ' ' VAL . 45.9 Cg_endo -90.03 164.51 4.82 Favored 'Trans proline' 0 CA--C 1.49 -1.681 0 C-N-CA 124.028 3.152 . . . . 0.089999999999999997 114.626 -169.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.0 m -85.37 118.1 24.7 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 113.877 -1.51 . . . . 0.14000000000000001 107.586 167.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 164' ' ' SER . 42.7 tp -83.89 98.35 9.72 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 108.551 -0.907 . . . . 0.16 108.551 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.638 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 35.7 mt-30 -89.39 109.66 20.55 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-O 122.13 0.967 . . . . 0.34000000000000002 109.259 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.832 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.7 OUTLIER -113.37 163.66 14.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.736 -1.12 . . . . 1.0900000000000001 111.271 -173.859 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.61 ' HG2' HD12 ' A' ' 186' ' ' ILE . 37.6 tt0 -170.78 119.26 0.52 Allowed 'General case' 0 C--O 1.203 -1.349 0 CA-C-N 115.873 -0.603 . . . . 0.5 110.131 -166.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.142 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.94 102.01 12.94 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.716 -0.846 . . . . 0.10000000000000001 108.716 -172.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.668 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.9 ttp -91.71 122.95 34.73 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.656 -0.702 . . . . 0.070000000000000007 109.368 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -58.4 127.2 30.94 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.358 -1.349 . . . . 0.22 107.358 167.072 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.609 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.73 -34.22 11.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 119.151 -1.019 . . . . 0.11 110.758 178.415 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.468 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 27.6 mt-30 -62.94 -14.89 52.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.432 -0.804 . . . . 0.34999999999999998 111.379 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.2 p -130.64 -36.57 1.41 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.727 0.775 . . . . 0.19 110.365 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.479 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 86.05 32.51 17.28 Favored Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 114.319 -1.309 . . . . 0.17999999999999999 112.213 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.2 155.21 22.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.59 -0.305 . . . . 0.72999999999999998 110.4 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 177' ' ' GLN . 29.3 mm -88.23 119.13 35.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.967 -0.753 . . . . 0.14000000000000001 108.967 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.142 HD11 HD13 ' A' ' 178' ' ' LEU . 1.3 pp -107.12 -33.04 2.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.277 -0.874 . . . . 0.13 110.514 -174.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.657 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.8 t90 -133.53 151.52 51.75 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.438 -0.801 . . . . 0.070000000000000007 109.24 172.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 22.1 p -153.99 160.84 42.22 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.664 0.616 . . . . 0.13 112.664 165.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -157.81 -177.06 30.55 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.536 -1.025 . . . . 0.12 110.536 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.768 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 12.9 mtmt -157.43 150.37 23.36 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 105.508 -2.034 . . . . 1.22 105.508 167.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -157.96 126.9 1.79 Allowed Glycine 0 C--N 1.279 -2.598 0 C-N-CA 119.51 -1.329 . . . . 0.12 112.243 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.28 114.07 10.0 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.337 0.589 . . . . 0.17000000000000001 110.946 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.777 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -91.12 158.49 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 122.583 1.182 . . . . 0.11 110.125 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.662 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -98.8 172.16 7.63 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 112.69 -2.05 . . . . 0.17999999999999999 109.727 -173.37 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.9 tt0 -103.36 127.71 50.64 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.127 -0.694 . . . . 0.91000000000000003 109.127 167.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.55 ' HG2' ' C ' ' A' ' 62' ' ' TYR . 19.8 mm-40 . . . . . 0 C--N 1.306 -1.304 0 CA-C-N 115.513 -0.767 . . . . 1.24 110.585 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.564 -0.614 . . . . 88.609999999999999 111.564 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 t -91.53 -7.28 50.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.107 0.48 . . . . 87.430000000000007 110.596 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 73.06 132.75 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.815 -1.084 . . . . 87.159999999999997 111.684 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.1 mtt 46.44 48.36 13.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.705 0.765 . . . . 85.340000000000003 111.504 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.4 p -111.94 -9.11 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.534 -1.212 . . . . 85.049999999999997 108.59 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.87 -68.03 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.725 -1.125 . . . . 84.680000000000007 111.164 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 63.56 109.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.181 0.991 . . . . 85.569999999999993 111.709 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 57.63 56.12 5.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 113.893 -1.503 . . . . 85.040000000000006 110.937 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.614 ' OE1' ' HA ' ' A' ' 12' ' ' PRO . 24.2 tt0 -120.04 116.15 32.83 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 114.863 -1.062 . . . . 82.170000000000002 109.157 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.66 -41.19 79.93 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.279 2.652 . . . . 81.510000000000005 112.658 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.61 93.53 24.32 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.003 -0.544 . . . . 79.560000000000002 109.59 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.614 ' HA ' ' OE1' ' A' ' 9' ' ' GLU . 15.2 Cg_endo -59.06 138.31 84.65 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.46 2.107 . . . . 78.5 112.014 -177.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -63.08 156.79 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 115.797 -0.638 . . . . 77.0 111.705 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 67.95 89.91 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.928 -1.033 . . . . 75.739999999999995 110.69 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -70.17 104.49 2.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.705 -0.68 . . . . 73.909999999999997 110.876 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.11 110.86 22.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.212 0.53 . . . . 72.299999999999997 110.987 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -127.55 145.56 55.15 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.922 -0.581 . . . . 71.219999999999999 110.109 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.03 118.52 5.56 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.603 2.202 . . . . 69.670000000000002 112.059 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.97 107.79 51.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.09 -0.505 . . . . 67.549999999999997 110.673 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.35 -73.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.376 2.051 . . . . 66.700000000000003 112.449 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -167.49 63.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.698 0.761 . . . . 65.010000000000005 109.799 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.492 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 71.4 mt-30 -64.0 -48.16 78.61 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.161 -0.927 . . . . 63.409999999999997 112.291 -177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 22' ' ' GLN . 33.8 Cg_exo -65.83 146.78 84.22 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.983 1.788 . . . . 61.93 112.503 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -146.04 112.31 5.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.234 -0.439 . . . . 59.869999999999997 110.6 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -123.92 97.56 40.91 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.521 -0.309 . . . . 58.469999999999999 110.798 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.17 85.65 1.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.508 2.139 . . . . 57.359999999999999 111.504 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -64.93 142.57 58.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.04 0.448 . . . . 55.509999999999998 110.825 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -146.94 83.59 7.92 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.649 -0.705 . . . . 53.869999999999997 109.718 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.13 131.7 35.75 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.865 2.377 . . . . 52.759999999999998 111.908 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.8 m -122.77 133.76 24.63 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 50.93 110.876 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.98 148.84 70.98 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.894 2.396 . . . . 49.210000000000001 112.228 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -80.2 167.84 19.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.5 0.667 . . . . 47.490000000000002 110.613 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.446 ' H ' HG22 ' A' ' 32' ' ' THR . 11.5 m -118.24 107.76 42.98 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 114.853 -1.067 . . . . 45.969999999999999 111.252 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -55.84 160.2 10.32 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.628 2.886 . . . . 45.280000000000001 112.847 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 p -79.92 141.8 35.73 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.953 -1.021 . . . . 42.789999999999999 111.315 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.97 121.71 77.35 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.567 -0.742 . . . . 40.789999999999999 110.795 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.07 159.7 33.31 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.841 2.36 . . . . 39.810000000000002 112.16 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -76.58 120.79 22.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.14 0.495 . . . . 37.5 111.471 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -82.99 128.58 64.85 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.45 -0.796 . . . . 35.649999999999999 109.69 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.48 ' HG2' ' OE1' ' A' ' 42' ' ' GLN . 36.7 Cg_endo -67.22 -175.91 0.73 Allowed 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.565 2.177 . . . . 33.719999999999999 113.66 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -115.53 94.45 4.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.503 1.144 . . . . 31.510000000000002 111.204 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 2.2 mp0 -70.77 -39.14 8.5 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 114.039 -1.437 . . . . 30.129999999999999 113.301 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.92 149.84 20.54 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 121.841 1.694 . . . . 29.52 111.096 171.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.26 171.17 41.88 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.027 -1.082 . . . . 26.75 113.086 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.53 134.55 33.39 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.574 2.85 . . . . 25.079999999999998 111.979 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.2 mt -73.91 -58.81 4.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.243 -0.89 . . . . 23.899999999999999 110.04 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 56.53 80.63 0.15 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.005 0.742 . . . . 21.23 113.005 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -154.85 164.26 39.09 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.99 -0.55 . . . . 19.920000000000002 111.1 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.67 170.91 13.21 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.576 -0.738 . . . . 16.559999999999999 110.179 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.43 73.15 10.57 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.035 -0.728 . . . . 15.050000000000001 109.035 173.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 52' ' ' THR . 24.0 pt20 -50.03 -57.75 6.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.155 -0.93 . . . . 14.19 112.342 -172.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.4 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 36.3 p -119.76 134.27 55.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.469 . . . . 11.380000000000001 111.801 -173.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.45 100.91 4.38 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.383 -0.826 . . . . 8.2899999999999991 110.52 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.16 120.61 8.0 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.754 2.303 . . . . 6.8700000000000001 112.032 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -79.35 -93.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.438 2.092 . . . . 5.04 113.106 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.32 62.01 12.48 Favored Pre-proline 0 C--O 1.236 0.383 0 C-N-CA 122.729 0.411 . . . . 2.5899999999999999 111.632 -177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.31 -176.43 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.029 2.486 . . . . 1.6399999999999999 112.986 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -127.39 148.72 50.27 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.311 -1.313 . . . . 3.3900000000000001 110.252 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 60' ' ' ARG . 9.6 mt -90.35 168.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.0 0.905 . . . . 0.44 112.087 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.633 ' N ' HG22 ' A' ' 59' ' ' ILE . 42.8 mtt180 -71.14 -158.84 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.557 -1.656 . . . . 2.3399999999999999 112.222 178.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.67 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 4.5 t60 -157.85 150.28 22.49 Favored 'General case' 0 CA--C 1.47 -2.116 0 CA-C-N 111.885 -2.416 . . . . 2.2200000000000002 105.771 176.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.752 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.7 m-30 -125.44 160.05 30.38 Favored 'General case' 0 N--CA 1.416 -2.128 0 O-C-N 123.736 0.648 . . . . 0.20999999999999999 109.627 -176.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 2.1 t70 -79.66 68.02 5.59 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 123.785 1.755 . . . . 0.34999999999999998 108.167 170.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.716 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.9 m95 -60.08 -44.53 94.71 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 111.594 -2.548 . . . . 0.10000000000000001 112.199 174.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 2.6 t30 -50.03 -30.48 10.83 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.844 -1.525 . . . . 1.1100000000000001 111.607 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.65 -18.3 80.01 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-N 115.503 -0.772 . . . . 0.20999999999999999 111.266 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.58 -52.22 3.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.965 -1.118 . . . . 0.13 110.895 -175.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.719 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.1 mtt -64.32 -58.49 6.36 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 114.136 -1.393 . . . . 0.089999999999999997 112.198 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.474 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.5 mm100 -40.11 -53.59 4.97 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 114.912 1.449 . . . . 0.63 114.912 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.811 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.1 Cg_endo -64.19 -30.79 64.75 Favored 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 122.164 1.91 . . . . 0.14000000000000001 110.654 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.769 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 9.3 mtm -80.97 -46.87 14.45 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 115.006 -0.997 . . . . 0.69999999999999996 111.7 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 68' ' ' MET . 57.5 t -54.6 -40.73 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 CA-C-N 114.091 -1.413 . . . . 0.12 108.841 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 t -58.97 -36.81 75.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.028 -1.896 . . . . 0.56000000000000005 110.909 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.811 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.9 mtpt -80.39 -34.1 36.6 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.091 0.472 . . . . 1.3 110.775 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.84 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.09 -29.56 70.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.305 -0.862 . . . . 0.5 111.685 -171.667 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.569 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.3 mt -91.79 -6.18 52.21 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.939 0.876 . . . . 0.65000000000000002 111.23 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.55 15.35 49.64 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 109.156 -1.578 . . . . 0.17000000000000001 109.156 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.616 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.48 165.48 18.06 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.42 -0.89 . . . . 0.10000000000000001 110.316 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -88.32 107.6 18.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.066 -0.97 . . . . 1.72 109.787 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.629 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 130.98 -22.88 4.46 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.991 -0.843 . . . . 0.12 110.991 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.84 HG11 ' O ' ' A' ' 75' ' ' MET . 10.1 p -99.27 152.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.861 0.838 . . . . 0.16 111.496 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -134.33 138.73 45.15 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.159 -1.382 . . . . 0.45000000000000001 109.835 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.59 ' HB2' ' HD2' ' A' ' 118' ' ' LYS . . . -65.3 137.82 57.8 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.871 -0.604 . . . . 0.28000000000000003 110.239 169.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.2 -1.41 54.39 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.799 -0.715 . . . . 0.28000000000000003 112.69 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.14 153.07 22.91 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.993 0.425 . . . . 1.2 110.972 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.658 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.0 p -81.86 116.43 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.122 0.963 . . . . 0.20000000000000001 109.221 166.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.722 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -103.93 109.67 21.52 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.964 -1.017 . . . . 0.14000000000000001 108.971 -173.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.673 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -71.76 94.29 1.37 Allowed 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 114.545 -1.207 . . . . 0.14999999999999999 107.932 176.804 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.499 HG11 ' HG3' ' A' ' 110' ' ' ARG . 1.7 m -73.12 117.71 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 N-CA-C 107.476 -1.305 . . . . 0.94999999999999996 107.476 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.831 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 8.7 t0 -77.52 156.41 31.0 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.659 -1.155 . . . . 0.64000000000000001 108.134 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.556 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.54 135.89 57.81 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.473 -1.306 . . . . 0.37 107.473 171.075 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.525 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 23.2 t -63.4 140.08 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.836 0 CA-C-N 114.783 -1.099 . . . . 0.10000000000000001 108.065 169.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.803 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.6 t-20 -85.56 163.22 18.5 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.248 -0.887 . . . . 0.17999999999999999 109.913 174.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.765 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.98 85.34 2.4 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.604 -1.18 . . . . 0.12 108.487 175.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -108.14 -1.98 19.86 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.969 -1.469 . . . . 0.64000000000000001 108.995 -172.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.719 HG21 ' HB3' ' A' ' 172' ' ' PRO . 24.5 p -52.0 -170.96 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 112.715 -2.039 . . . . 0.14000000000000001 114.975 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 32.7 t30 -72.48 -4.05 28.05 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 112.992 -1.913 . . . . 0.47999999999999998 110.558 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.615 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -157.42 -144.46 3.94 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.052 -1.071 . . . . 0.12 113.368 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.648 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 53.8 p -122.09 129.46 52.4 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 112.278 0.473 . . . . 1.1599999999999999 112.278 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.12 157.37 47.1 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 121.97 0.89 . . . . 0.10000000000000001 110.678 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.646 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.6 t-20 -80.48 79.99 7.0 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.053 -1.43 . . . . 0.17000000000000001 107.846 175.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.0 -14.2 62.66 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.479 -1.237 . . . . 0.089999999999999997 109.988 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.584 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.19 -32.17 44.04 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.721 -0.844 . . . . 0.14999999999999999 108.721 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.646 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.4 tp10 -66.63 -31.96 72.97 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 122.951 1.358 . . . . 1.73 109.064 172.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -73.75 -44.18 56.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.036 -1.893 . . . . 0.12 109.657 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.616 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 60.0 m -63.98 -31.6 72.84 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.986 -1.461 . . . . 0.11 110.626 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 1.5 pt-20 -66.97 -43.34 83.32 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.701 -1.222 . . . . 1.47 107.701 172.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.675 HG21 ' HB2' ' A' ' 64' ' ' TRP . 56.8 m -63.06 -30.46 71.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.234 -0.894 . . . . 0.12 110.672 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.719 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.74 -69.56 0.11 Allowed 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.205 -0.665 . . . . 0.56000000000000005 109.205 171.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.1 mtp180 -40.22 -38.22 0.74 Allowed 'General case' 0 C--N 1.313 -0.982 0 O-C-N 124.405 1.065 . . . . 1.51 111.29 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.493 ' HB2' ' O ' ' A' ' 108' ' ' THR . 5.0 m-20 -70.71 -47.51 59.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.517 -1.22 . . . . 0.28000000000000003 111.897 -176.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.4 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.15 -33.72 65.64 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.223 1.011 . . . . 0.089999999999999997 108.647 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.696 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -62.92 -34.65 77.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.416 -1.72 . . . . 0.12 109.976 172.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.615 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -74.78 -42.58 57.88 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 114.752 -1.113 . . . . 0.20000000000000001 111.097 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -63.2 -29.26 70.64 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.769 -1.105 . . . . 1.1699999999999999 110.43 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -82.26 -23.89 35.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.535 -0.757 . . . . 2.0499999999999998 110.159 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.71 4.28 57.51 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.975 -1.011 . . . . 0.54000000000000004 114.927 159.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.59 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 13.5 mtmm -91.18 -34.27 15.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.279 0.539 . . . . 0.98999999999999999 111.156 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.722 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 14.6 m-85 -89.44 175.56 7.26 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 122.355 1.074 . . . . 0.20999999999999999 112.458 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.5 m -118.92 121.13 39.25 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 113.012 -1.904 . . . . 0.23000000000000001 108.289 169.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.674 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -91.72 141.76 28.34 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 119.389 -0.924 . . . . 0.38 111.159 -170.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.646 ' HB ' ' OE1' ' A' ' 126' ' ' GLN . 1.3 m -91.74 150.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.892 -1.151 . . . . 0.41999999999999998 107.892 169.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.507 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 1.4 m -101.88 -177.1 3.32 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 119.893 -0.723 . . . . 1.7 110.271 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.4 ' HA ' ' H ' ' A' ' 128' ' ' SER . . . -66.0 -29.98 70.46 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.34 -0.985 . . . . 0.55000000000000004 108.34 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 129' ' ' MET . 43.2 mt-30 -44.13 -40.81 5.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.091 -1.868 . . . . 2.04 111.212 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.646 ' OE1' ' HB ' ' A' ' 122' ' ' VAL . 36.2 mt-30 -98.05 -53.29 3.42 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 122.105 0.955 . . . . 0.40999999999999998 109.982 173.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.639 HD13 HD21 ' A' ' 88' ' ' LEU . 31.2 tp -62.94 -65.81 0.63 Allowed 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 113.303 -1.772 . . . . 1.3899999999999999 113.271 -166.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.644 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 3.0 t -50.31 -46.26 55.33 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 123.365 1.555 . . . . 1.05 109.105 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.743 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 17.2 mmt -54.31 -63.36 1.17 Allowed 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 110.745 -2.934 . . . . 1.6399999999999999 110.706 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.77 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.91 -46.47 5.37 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.346 1.029 . . . . 0.31 112.15 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.523 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -54.45 -52.35 62.1 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 108.744 -0.836 . . . . 1.53 108.744 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 128' ' ' SER . 37.8 mt-30 -65.18 -39.88 93.49 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.402 -0.817 . . . . 0.40999999999999998 111.034 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.743 ' HG3' ' O ' ' A' ' 129' ' ' MET . 52.1 mt-30 -58.72 -34.74 71.69 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.516 -1.22 . . . . 0.37 109.568 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.495 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -90.21 -28.94 18.53 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 113.942 -1.481 . . . . 0.23999999999999999 109.733 -176.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.96 -45.06 0.69 Allowed Glycine 0 CA--C 1.494 -1.263 0 CA-C-O 122.534 1.075 . . . . 0.33000000000000002 113.094 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 141' ' ' SER . 91.3 mt -66.93 -171.44 0.14 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 112.416 -1.892 . . . . 0.31 115.43 -170.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 63.1 m -115.55 152.9 47.64 Favored Pre-proline 0 N--CA 1.425 -1.684 0 CA-C-N 110.641 -2.982 . . . . 0.81000000000000005 107.661 175.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.644 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 36.9 Cg_endo -66.26 0.44 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.49 2.127 . . . . 0.32000000000000001 112.138 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.584 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.6 tt0 -118.65 -27.06 5.97 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.997 0.903 . . . . 1.25 110.418 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 141' ' ' SER . 15.0 t70 -57.87 -25.89 61.36 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-N 113.207 -1.815 . . . . 0.65000000000000002 109.35 -173.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 21.3 m 73.52 168.95 0.31 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 112.668 -2.06 . . . . 0.59999999999999998 109.186 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.996 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.5 mt -66.03 -40.12 90.75 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.24 1.019 . . . . 0.85999999999999999 108.386 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 64.81 -9.18 0.45 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 112.95 -1.932 . . . . 0.31 114.332 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.56 124.64 6.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.065 -0.717 . . . . 0.23999999999999999 109.065 -175.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.687 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.4 mmt180 -42.27 -45.31 4.14 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 118.072 0.396 . . . . 1.6499999999999999 112.001 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.8 t -74.13 -25.77 59.95 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.601 0.715 . . . . 0.53000000000000003 111.255 -174.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -73.64 -29.6 62.44 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.625 1.203 . . . . 1.3100000000000001 108.421 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.996 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -76.27 -47.79 22.54 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 112.403 -2.18 . . . . 0.12 110.223 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.649 HG13 ' HE1' ' A' ' 179' ' ' MET . 42.1 mt -65.39 -41.52 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 112.794 -2.003 . . . . 0.11 109.865 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.59 -54.56 27.03 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 114.864 -1.062 . . . . 0.14999999999999999 111.082 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.77 HG23 ' CB ' ' A' ' 130' ' ' ALA . 89.9 mt -66.85 -48.14 80.65 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 N-CA-C 112.5 0.556 . . . . 0.17999999999999999 112.5 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.673 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.22 -41.01 71.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.939 0.399 . . . . 0.13 111.099 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.556 ' HD2' HG23 ' A' ' 149' ' ' ILE . 58.3 mtp180 -81.84 -21.51 37.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.614 0.721 . . . . 1.0800000000000001 110.618 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -84.76 -11.44 55.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.314 -1.365 . . . . 0.5 107.314 176.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.721 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.07 -29.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-N 113.184 -1.826 . . . . 0.17000000000000001 110.932 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.7 34.17 5.05 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.267 -0.968 . . . . 0.16 112.424 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.6 161.45 14.85 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.873 0.694 . . . . 0.12 112.873 -170.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.658 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.0 m80 -100.87 -27.72 13.17 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.24 -0.891 . . . . 0.20000000000000001 109.796 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.622 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 7.5 m-85 -136.15 -174.26 3.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.187 -0.915 . . . . 0.13 111.318 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.711 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -137.06 139.2 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.939 -1.028 . . . . 0.080000000000000002 108.883 166.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.607 HD21 ' SD ' ' A' ' 176' ' ' MET . 33.9 tp -107.98 100.57 9.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.318 -0.953 . . . . 0.16 109.351 165.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.574 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.2 m-85 -79.8 112.94 17.56 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 114.606 -1.179 . . . . 0.26000000000000001 108.897 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.845 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 10.2 t -124.45 160.58 27.9 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 121.922 0.867 . . . . 1.05 110.564 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.817 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.4 p -162.73 172.96 14.47 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 114.334 -1.303 . . . . 0.10000000000000001 111.076 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.32 135.33 40.7 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 114.005 -1.452 . . . . 0.11 108.633 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.668 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.8 m -144.09 -176.12 4.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.254 -0.647 . . . . 1.0900000000000001 109.254 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.11 -84.08 0.92 Allowed Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 119.768 -1.206 . . . . 0.14999999999999999 111.416 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.4 t30 -143.74 131.47 21.35 Favored 'General case' 0 C--O 1.196 -1.762 0 N-CA-C 107.821 -1.178 . . . . 0.58999999999999997 107.821 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.615 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.6 p -65.57 -41.34 90.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.14 -0.936 . . . . 0.14999999999999999 112.426 -171.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.404 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.3 m-20 -60.99 -31.15 70.77 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.732 0.777 . . . . 1.26 109.478 -177.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.23 89.07 3.37 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 113.874 -1.512 . . . . 0.13 108.16 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.86 ' HD2' HG22 ' A' ' 194' ' ' VAL . 42.6 Cg_endo -91.36 166.61 3.53 Favored 'Trans proline' 0 CA--C 1.494 -1.48 0 C-N-CA 124.551 3.501 . . . . 0.089999999999999997 114.846 -170.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.58 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.3 m -85.76 119.6 26.26 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 113.745 -1.57 . . . . 0.14000000000000001 107.551 166.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 164' ' ' SER . 50.4 tp -84.56 97.74 9.75 Favored 'General case' 0 N--CA 1.412 -2.326 0 C-N-CA 119.492 -0.883 . . . . 0.16 108.709 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.602 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 34.1 mt-30 -89.26 109.33 20.23 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 122.052 0.929 . . . . 0.34000000000000002 109.053 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.845 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.7 OUTLIER -112.87 164.17 13.74 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.004 -0.998 . . . . 1.0900000000000001 111.638 -173.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.609 ' HG2' HD12 ' A' ' 186' ' ' ILE . 9.3 tt0 -170.78 118.22 0.5 Allowed 'General case' 0 C--O 1.201 -1.476 0 CA-C-N 115.972 -0.558 . . . . 0.5 110.236 -166.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.104 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.19 101.99 13.16 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.609 -0.885 . . . . 0.10000000000000001 108.609 -172.801 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.687 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.5 ttp -90.43 121.62 32.57 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.462 -0.79 . . . . 0.070000000000000007 109.504 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.424 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.91 127.97 34.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.149 -1.426 . . . . 0.22 107.149 166.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -83.69 -34.18 10.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 118.912 -1.115 . . . . 0.11 110.965 178.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.462 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 28.7 mt-30 -61.6 -15.57 40.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.372 -0.831 . . . . 0.34999999999999998 111.424 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.8 p -130.2 -36.61 1.5 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.745 0.783 . . . . 0.19 110.294 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.51 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 87.59 27.91 25.79 Favored Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 114.316 -1.311 . . . . 0.17999999999999999 112.003 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.81 155.91 19.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.648 0.261 . . . . 0.72999999999999998 110.52 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.609 HD12 ' HG2' ' A' ' 177' ' ' GLN . 30.3 mm -89.85 115.64 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.502 0.668 . . . . 0.14000000000000001 109.494 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.104 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -103.1 -32.3 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.903 -1.044 . . . . 0.13 110.54 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.8 t90 -134.81 152.02 51.41 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.245 -0.889 . . . . 0.070000000000000007 109.403 173.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 30.0 p -153.57 162.78 40.94 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.881 0.697 . . . . 0.13 112.881 164.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.51 -173.64 27.18 Favored Glycine 0 N--CA 1.427 -1.94 0 N-CA-C 110.721 -0.951 . . . . 0.12 110.721 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 15.1 mtmm -158.93 154.08 25.33 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.273 -2.121 . . . . 1.22 105.273 166.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -161.22 127.79 1.81 Allowed Glycine 0 C--N 1.281 -2.484 0 C-N-CA 119.245 -1.455 . . . . 0.12 112.568 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 173' ' ' THR . . . -72.55 112.6 8.75 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.72 0.771 . . . . 0.17000000000000001 111.329 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.86 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -91.77 158.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-O 122.758 1.266 . . . . 0.11 110.816 -176.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.752 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.2 173.43 6.46 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 112.352 -2.203 . . . . 0.17999999999999999 108.652 -173.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.1 tt0 -102.34 133.78 46.71 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.14 -0.624 . . . . 0.91000000000000003 109.758 171.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.517 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 12.3 mm-40 . . . . . 0 C--N 1.315 -0.933 0 CA-C-O 118.804 -0.617 . . . . 1.24 110.906 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.943 0 N-CA-C 112.297 -0.321 . . . . 88.609999999999999 112.297 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 p -100.18 177.47 5.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.058 -0.349 . . . . 87.430000000000007 110.058 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -100.36 59.29 0.99 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.532 0.682 . . . . 87.159999999999997 110.309 176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.5 ttp -119.56 49.28 1.38 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.042 0.925 . . . . 85.340000000000003 109.438 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.58 -18.66 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.229 -0.896 . . . . 85.049999999999997 110.936 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.0 22.76 4.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.067 -0.587 . . . . 84.680000000000007 111.995 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' HG3' ' N ' ' A' ' 8' ' ' ARG . 6.3 pt20 -60.49 -42.93 97.33 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.061 -0.569 . . . . 85.569999999999993 111.005 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.482 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 34.6 mmt180 64.31 113.58 0.03 OUTLIER 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.142 0.496 . . . . 85.040000000000006 111.652 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 73.46 119.55 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 114.86 -1.064 . . . . 82.170000000000002 111.668 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.42 -34.67 92.92 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.257 1.971 . . . . 81.510000000000005 110.564 172.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.34 93.15 10.16 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.116 -0.947 . . . . 79.560000000000002 109.369 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.03 133.87 60.52 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.829 2.353 . . . . 78.5 112.553 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.52 149.58 33.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.732 -0.667 . . . . 77.0 111.065 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -96.88 50.2 1.1 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.557 -0.747 . . . . 75.739999999999995 110.106 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.86 84.02 7.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.574 . . . . 73.909999999999997 110.374 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.19 133.25 32.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.185 -0.916 . . . . 72.299999999999997 109.852 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 44.7 mmtm -83.76 134.41 44.54 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.311 -0.404 . . . . 71.219999999999999 110.133 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 17' ' ' LYS . 33.8 Cg_exo -58.73 128.91 29.86 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.648 2.232 . . . . 69.670000000000002 112.89 -177.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.22 99.94 53.08 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.971 -0.559 . . . . 67.549999999999997 109.859 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.43 62.44 4.41 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.694 2.263 . . . . 66.700000000000003 112.854 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -80.48 -61.4 1.99 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.982 -0.377 . . . . 65.010000000000005 109.982 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 44.91 73.78 0.91 Allowed Pre-proline 0 C--O 1.24 0.579 0 O-C-N 123.786 0.678 . . . . 63.409999999999997 111.76 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -61.12 143.17 98.75 Favored 'Trans proline' 0 CA--C 1.519 -0.229 0 C-N-CA 123.411 2.74 . . . . 61.93 112.924 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.55 59.86 1.35 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.988 0.899 . . . . 59.869999999999997 109.125 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -115.11 95.35 41.88 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 113.629 -1.623 . . . . 58.469999999999999 110.055 -172.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.68 105.71 1.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.281 1.987 . . . . 57.359999999999999 112.063 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.612 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 90.4 mt-30 -95.65 -5.68 41.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.378 -0.374 . . . . 55.509999999999998 110.913 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -104.09 96.26 9.29 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.371 -0.377 . . . . 53.869999999999997 111.118 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.612 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 2.4 Cg_endo -82.01 135.73 8.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.079 2.519 . . . . 52.759999999999998 111.383 175.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -118.76 87.65 33.25 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.907 0.384 . . . . 50.93 110.83 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -91.34 174.07 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.388 2.725 . . . . 49.210000000000001 111.805 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 p -107.05 150.29 26.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.99 0.424 . . . . 47.490000000000002 110.877 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.4 t -98.81 108.37 48.4 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.695 -0.684 . . . . 45.969999999999999 110.462 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.69 156.02 39.7 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.673 2.249 . . . . 45.280000000000001 112.084 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.4 m -160.92 127.23 3.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.532 -0.758 . . . . 42.789999999999999 110.407 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -121.73 121.95 28.03 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.722 -0.672 . . . . 40.789999999999999 110.233 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.76 146.85 64.24 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 122.549 2.166 . . . . 39.810000000000002 112.151 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.8 m -141.24 106.38 4.99 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.31 0.576 . . . . 37.5 110.744 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -96.23 115.32 65.53 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.489 -0.778 . . . . 35.649999999999999 110.311 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.18 122.4 8.69 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.28 1.987 . . . . 33.719999999999999 111.966 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -135.77 -178.37 5.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.041 -0.527 . . . . 31.510000000000002 110.333 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -116.77 87.7 22.68 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.354 -0.61 . . . . 30.129999999999999 109.354 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.65 121.21 9.05 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.346 2.031 . . . . 29.52 111.433 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.86 161.95 8.91 Favored Glycine 0 N--CA 1.437 -1.233 0 N-CA-C 111.161 -0.776 . . . . 26.75 111.161 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.1 125.81 11.81 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.444 2.096 . . . . 25.079999999999998 112.391 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.07 -55.14 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.147 -0.478 . . . . 23.899999999999999 109.725 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 59.4 85.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.234 -0.893 . . . . 21.23 111.179 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -86.97 157.13 19.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.957 0.408 . . . . 19.920000000000002 110.807 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -175.62 131.31 0.27 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.371 -0.831 . . . . 16.559999999999999 109.444 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -106.03 75.44 1.11 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.286 -0.87 . . . . 15.050000000000001 110.267 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -51.59 132.85 30.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.531 -1.213 . . . . 14.19 110.634 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.4 p -69.58 160.35 31.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.663 0.744 . . . . 11.380000000000001 112.084 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.562 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -130.78 84.81 57.44 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 114.748 -1.114 . . . . 8.2899999999999991 110.203 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -85.63 105.61 0.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.745 2.296 . . . . 6.8700000000000001 112.732 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 72.2 Cg_endo -87.91 137.37 3.91 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.286 1.991 . . . . 5.04 112.287 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.75 78.61 72.98 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.309 -0.405 . . . . 2.5899999999999999 110.663 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.34 -177.22 3.14 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 123.441 2.76 . . . . 1.6399999999999999 113.028 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -109.64 139.2 44.95 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.522 -1.672 . . . . 3.3900000000000001 109.056 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.601 HG22 ' N ' ' A' ' 60' ' ' ARG . 12.4 mt -76.47 164.99 3.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.106 0.955 . . . . 0.44 112.436 -169.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.601 ' N ' HG22 ' A' ' 59' ' ' ILE . 37.4 mtt85 -75.95 -158.57 0.09 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.651 -1.613 . . . . 2.3399999999999999 112.114 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.595 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 95.6 m-70 -152.14 141.09 21.13 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 112.211 -2.268 . . . . 2.2200000000000002 107.161 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.718 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 3.5 m-30 -127.02 156.23 41.97 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.59 -0.732 . . . . 0.20999999999999999 110.633 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.567 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 4.4 t0 -82.74 68.15 9.1 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 123.756 1.741 . . . . 0.34999999999999998 108.404 171.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.773 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.4 m95 -59.75 -42.94 94.35 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 111.511 -2.586 . . . . 0.10000000000000001 112.288 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.428 ' N ' HG21 ' A' ' 108' ' ' THR . 4.0 t-20 -52.77 -31.79 40.21 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.609 -1.632 . . . . 1.1100000000000001 111.077 -178.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.64 -15.88 78.69 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 121.781 0.656 . . . . 0.20999999999999999 111.67 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -94.5 -48.55 6.06 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.18 -1.01 . . . . 0.13 110.15 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.721 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.4 mtt -66.43 -55.64 14.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.134 -1.394 . . . . 0.089999999999999997 111.715 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.416 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.9 mm100 -38.81 -56.01 2.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 115.233 1.568 . . . . 0.63 115.233 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.818 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 40.3 Cg_endo -65.37 -29.37 54.17 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 121.728 1.619 . . . . 0.14000000000000001 110.418 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.648 ' HE2' ' N ' ' A' ' 192' ' ' GLY . 9.6 mtm -83.65 -40.23 19.23 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.312 -0.858 . . . . 0.69999999999999996 111.446 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 68' ' ' MET . 52.4 t -57.46 -39.91 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-N 114.85 -1.068 . . . . 0.12 108.339 171.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -61.17 -32.76 72.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.238 -1.801 . . . . 0.56000000000000005 111.19 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.818 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 34.2 mtpt -84.66 -32.2 23.76 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.086 0.47 . . . . 1.3 110.891 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.885 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.23 -29.77 69.51 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.332 -0.849 . . . . 0.5 111.413 -172.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.3 mt -92.07 -4.14 54.81 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 122.26 1.028 . . . . 0.65000000000000002 110.644 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.23 17.64 40.38 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 108.984 -1.646 . . . . 0.17000000000000001 108.984 170.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.625 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -88.04 161.8 17.16 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.693 -0.754 . . . . 0.10000000000000001 110.282 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.94 107.92 18.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.384 -0.825 . . . . 1.72 109.432 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.664 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.58 -24.66 3.33 Favored Glycine 0 N--CA 1.415 -2.716 0 C-N-CA 119.739 -1.219 . . . . 0.12 110.466 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.885 HG11 ' O ' ' A' ' 75' ' ' MET . 11.1 p -102.66 152.32 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.675 -0.762 . . . . 0.16 111.068 -175.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.3 m -135.82 139.64 43.62 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.922 -1.036 . . . . 0.45000000000000001 110.697 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.632 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.08 136.01 48.52 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.033 -0.985 . . . . 0.28000000000000003 110.414 167.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.04 3.95 55.6 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.903 -0.665 . . . . 0.28000000000000003 112.936 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.94 149.24 22.68 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.168 -0.613 . . . . 1.2 111.002 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -80.41 120.58 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 CA-C-O 121.933 0.873 . . . . 0.20000000000000001 108.802 165.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.875 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.7 tm? -108.77 111.58 23.41 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.416 -0.811 . . . . 0.14000000000000001 109.047 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.695 HD23 HG11 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -72.19 93.72 1.48 Allowed 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.833 -1.076 . . . . 0.14999999999999999 108.158 177.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.481 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.2 m -73.5 115.79 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 107.061 -1.459 . . . . 0.94999999999999996 107.061 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.768 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 16.7 t0 -77.57 170.62 16.25 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-N 115.063 -0.971 . . . . 0.64000000000000001 108.905 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.567 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.8 OUTLIER -61.77 152.59 30.92 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.93 -1.137 . . . . 0.37 107.93 168.038 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.536 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 38.6 t -81.95 140.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.151 0 N-CA-C 107.024 -1.473 . . . . 0.10000000000000001 107.024 167.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.831 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.7 t-20 -84.01 162.5 20.37 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.967 0.889 . . . . 0.17999999999999999 110.307 174.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.757 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -124.81 85.9 2.48 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.229 -1.35 . . . . 0.12 108.087 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 14.1 mtp180 -108.74 -0.95 19.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.077 -1.42 . . . . 0.64000000000000001 108.758 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 172' ' ' PRO . 30.2 p -53.21 -172.62 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.026 -1.897 . . . . 0.14000000000000001 115.348 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 34.2 t30 -68.37 -13.54 62.35 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 112.637 -2.074 . . . . 0.47999999999999998 110.522 173.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.549 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -148.16 -145.93 4.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.387 -0.911 . . . . 0.12 113.004 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.603 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 19.2 m -121.27 129.6 53.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.959 0.409 . . . . 1.1599999999999999 110.825 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.757 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.6 pp -135.18 157.63 46.43 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.921 0.867 . . . . 0.10000000000000001 110.627 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.777 ' ND2' ' HB2' ' A' ' 104' ' ' GLU . 57.9 t30 -81.57 81.46 7.64 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.954 -1.476 . . . . 0.17000000000000001 107.713 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.619 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -69.72 -14.77 62.96 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 114.278 -1.328 . . . . 0.089999999999999997 109.912 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.59 -29.8 46.32 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.734 -0.839 . . . . 0.14999999999999999 108.734 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.777 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 15.6 tp10 -67.91 -32.39 72.82 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 123.123 1.44 . . . . 1.73 109.15 170.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.5 -44.75 61.82 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.999 -1.91 . . . . 0.12 109.233 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.9 m -63.92 -34.3 77.65 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.936 -1.484 . . . . 0.11 111.104 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 13.1 pt-20 -68.0 -42.83 80.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 118.368 -1.333 . . . . 1.47 107.651 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.654 HG21 ' HB2' ' A' ' 64' ' ' TRP . 58.7 m -61.5 -29.09 69.76 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.226 -0.897 . . . . 0.12 111.176 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.721 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.3 mt -53.69 -68.12 0.2 Allowed 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 115.794 -0.639 . . . . 0.56000000000000005 109.471 170.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.581 ' O ' HD13 ' A' ' 121' ' ' LEU . 14.2 mtp180 -40.26 -38.08 0.73 Allowed 'General case' 0 C--N 1.31 -1.116 0 O-C-N 124.413 1.071 . . . . 1.51 111.395 174.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 108' ' ' THR . 16.1 m-80 -68.36 -47.41 67.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.675 -1.148 . . . . 0.28000000000000003 112.4 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.93 -35.79 59.62 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.364 -0.976 . . . . 0.089999999999999997 108.364 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -58.96 -35.67 73.55 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.61 -1.632 . . . . 0.12 109.784 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -69.46 -41.96 75.51 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.297 -1.32 . . . . 0.20000000000000001 111.294 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -65.21 -27.21 68.52 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.99 -1.005 . . . . 1.1699999999999999 111.224 -175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 29.3 m-80 -86.86 -16.73 35.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.967 -0.56 . . . . 2.0499999999999998 111.237 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.91 -12.32 0.83 Allowed Glycine 0 C--N 1.334 0.427 0 N-CA-C 115.896 1.118 . . . . 0.54000000000000004 115.896 162.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 54.4 mtpt -73.28 -33.47 65.25 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 117.579 0.689 . . . . 0.98999999999999999 110.783 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.875 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 23.4 m-85 -90.4 177.43 6.39 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.54 1.162 . . . . 0.20999999999999999 112.677 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 5.4 m -121.92 119.96 33.06 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 112.651 -2.068 . . . . 0.23000000000000001 108.069 168.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.633 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -89.4 140.74 29.21 Favored 'General case' 0 N--CA 1.414 -2.235 0 C-N-CA 119.337 -0.945 . . . . 0.38 111.774 -169.892 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.606 ' HB ' ' OE1' ' A' ' 126' ' ' GLN . 1.5 m -90.32 150.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.605 -1.258 . . . . 0.41999999999999998 107.605 167.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.41 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -102.51 170.45 8.03 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.019 -0.672 . . . . 1.7 110.844 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 128' ' ' SER . . . -56.48 -35.02 67.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.27 0.557 . . . . 0.55000000000000004 110.059 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.68 ' O ' ' HG3' ' A' ' 129' ' ' MET . 6.8 pt20 -47.1 -33.1 4.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.49 -1.232 . . . . 2.04 111.04 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.606 ' OE1' ' HB ' ' A' ' 122' ' ' VAL . 33.7 mt-30 -98.21 -53.78 3.26 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-O 121.784 0.802 . . . . 0.40999999999999998 110.632 172.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.612 HD23 HD21 ' A' ' 88' ' ' LEU . 1.4 tm? -67.29 -64.07 0.93 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 113.916 -1.493 . . . . 1.3899999999999999 112.572 -168.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.697 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.2 t -49.31 -39.05 29.79 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 123.573 1.654 . . . . 1.05 109.047 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.68 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 24.2 mmm -64.46 -62.07 1.82 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 110.72 -2.945 . . . . 1.6399999999999999 110.656 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.753 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.28 -43.48 7.4 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 124.106 0.878 . . . . 0.31 112.326 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.815 ' HZ1' HD23 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -51.28 -55.5 17.92 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.293 -1.003 . . . . 1.53 108.293 176.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.3 mt-30 -65.33 -41.28 94.11 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 123.951 0.782 . . . . 0.40999999999999998 111.42 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.657 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.3 mt-30 -56.26 -34.25 66.23 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.391 -1.277 . . . . 0.37 109.616 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -92.87 -31.19 15.06 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.905 -1.498 . . . . 0.23999999999999999 109.561 -177.678 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.06 -52.13 0.4 Allowed Glycine 0 CA--C 1.497 -1.091 0 CA-C-O 122.594 1.108 . . . . 0.33000000000000002 113.45 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 141' ' ' SER . 70.7 mt -63.51 -171.75 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 112.352 -1.924 . . . . 0.31 115.717 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 139' ' ' GLN . 6.3 m -116.14 152.29 47.62 Favored Pre-proline 0 N--CA 1.427 -1.621 0 CA-C-N 110.765 -2.925 . . . . 0.81000000000000005 107.931 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.697 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 30.3 Cg_endo -65.44 2.67 1.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.751 2.301 . . . . 0.32000000000000001 111.146 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.539 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.7 mm100 -115.17 -19.91 10.63 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 114.098 -1.41 . . . . 1.25 110.091 -174.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.694 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.7 t70 -80.63 -27.72 37.17 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 114.336 -1.302 . . . . 0.65000000000000002 109.839 -169.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.721 ' O ' HD13 ' A' ' 136' ' ' LEU . 4.0 m 76.02 175.23 0.22 Allowed 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 125.33 1.644 . . . . 0.59999999999999998 109.053 -168.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.998 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.5 mt -69.41 -39.13 78.11 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.368 1.08 . . . . 0.85999999999999999 108.701 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.18 -12.03 0.29 Allowed Glycine 0 C--N 1.317 -0.488 0 CA-C-N 112.96 -1.927 . . . . 0.31 114.809 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.54 125.78 8.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 117.548 0.674 . . . . 0.23999999999999999 109.324 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.4 mmt180 -41.45 -48.11 3.77 Favored 'General case' 0 C--O 1.213 -0.842 0 O-C-N 123.378 0.424 . . . . 1.6499999999999999 111.868 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.5 t -72.05 -27.5 62.73 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.58 0.705 . . . . 0.53000000000000003 111.296 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -73.06 -28.25 62.21 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.632 1.206 . . . . 1.3100000000000001 108.587 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.998 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -77.49 -46.0 23.85 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 112.293 -2.23 . . . . 0.12 110.304 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.649 HG13 ' HE1' ' A' ' 179' ' ' MET . 35.4 mt -67.33 -42.43 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-N 113.069 -1.878 . . . . 0.11 110.237 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.47 -53.59 31.27 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.955 -1.021 . . . . 0.14999999999999999 111.072 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.753 HG23 ' CB ' ' A' ' 130' ' ' ALA . 70.2 mt -66.32 -47.53 83.93 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 112.747 0.647 . . . . 0.17999999999999999 112.747 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.01 -39.98 72.7 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.017 0.437 . . . . 0.13 110.767 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -81.56 -23.01 37.45 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.676 0.751 . . . . 1.0800000000000001 110.635 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -82.18 -12.72 57.97 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.332 -1.358 . . . . 0.5 107.332 176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.717 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.73 -28.53 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 113.245 -1.798 . . . . 0.17000000000000001 110.838 -174.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.67 35.45 4.89 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.35 -0.929 . . . . 0.16 112.282 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.76 156.38 21.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 113.27 0.841 . . . . 0.12 113.27 -170.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.671 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.9 m80 -95.3 -27.87 15.26 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.194 -0.912 . . . . 0.20000000000000001 109.807 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.557 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 9.2 m-85 -136.38 -179.1 5.47 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.476 -0.784 . . . . 0.13 111.049 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.697 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -131.97 140.75 47.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.438 -0.801 . . . . 0.080000000000000002 109.232 167.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 38.2 tp -110.4 101.06 9.81 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.708 -0.797 . . . . 0.16 108.946 164.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.679 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.23 116.72 19.67 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.21 -1.359 . . . . 0.26000000000000001 108.269 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.677 ' OG ' HD11 ' A' ' 174' ' ' LEU . 27.6 t -126.68 163.44 23.49 Favored 'General case' 0 C--N 1.279 -2.493 0 C-N-CA 119.495 -0.882 . . . . 1.05 111.015 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.848 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.9 p -164.23 178.27 7.7 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 114.264 -1.334 . . . . 0.10000000000000001 111.065 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -141.91 141.34 32.99 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 114.155 -1.384 . . . . 0.11 108.673 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 t -149.44 -171.35 3.87 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.208 -0.597 . . . . 1.0900000000000001 110.115 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.66 -80.69 1.25 Allowed Glycine 0 C--N 1.288 -2.138 0 CA-C-N 115.179 -0.919 . . . . 0.14999999999999999 111.567 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 59.1 t30 -145.58 127.5 15.46 Favored 'General case' 0 C--O 1.195 -1.767 0 N-CA-C 108.108 -1.071 . . . . 0.58999999999999997 108.108 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.549 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.4 p -61.76 -43.9 97.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.14 -0.936 . . . . 0.14999999999999999 113.008 -172.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 60.4 m-20 -61.48 -29.71 70.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.49 0.662 . . . . 1.26 109.635 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.44 88.16 3.73 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 114.588 -1.187 . . . . 0.13 108.021 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.818 ' HD2' HG22 ' A' ' 194' ' ' VAL . 51.3 Cg_endo -91.29 163.56 3.69 Favored 'Trans proline' 0 CA--C 1.49 -1.697 0 C-N-CA 124.596 3.531 . . . . 0.089999999999999997 114.731 -170.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' ' 191' ' ' LYS . 18.8 m -81.77 117.17 21.86 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 113.854 -1.521 . . . . 0.14000000000000001 107.693 166.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 164' ' ' SER . 38.8 tp -83.73 98.94 9.95 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-O 121.885 0.85 . . . . 0.16 109.126 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.647 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.0 mt-30 -89.09 107.81 19.25 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.909 -1.041 . . . . 0.34000000000000002 109.048 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 34.7 mtp -108.25 162.84 13.71 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.848 -1.069 . . . . 1.0900000000000001 110.203 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.618 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.8 tt0 -169.49 119.99 0.68 Allowed 'General case' 0 C--O 1.204 -1.315 0 CA-C-O 121.377 0.608 . . . . 0.5 109.908 -167.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.119 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.44 102.38 13.17 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.934 -0.765 . . . . 0.10000000000000001 108.934 -172.202 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.704 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.1 ttp -92.48 122.91 35.38 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.533 -0.758 . . . . 0.070000000000000007 109.402 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.435 HD22 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -58.83 127.46 32.29 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.161 -1.422 . . . . 0.22 107.161 166.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.2 -33.63 11.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 119.35 0.977 . . . . 0.11 110.718 178.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.424 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.9 mt-30 -64.25 -14.77 57.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.291 -0.868 . . . . 0.34999999999999998 111.498 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 76.9 p -130.52 -36.96 1.41 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.766 0.794 . . . . 0.19 110.251 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.538 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.36 24.09 29.82 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.481 -1.236 . . . . 0.17999999999999999 112.496 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.92 155.61 18.5 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.684 0.278 . . . . 0.72999999999999998 110.682 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 177' ' ' GLN . 34.2 mm -87.95 119.25 35.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.433 0.635 . . . . 0.14000000000000001 109.507 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.119 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -108.28 -30.56 2.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.966 -1.016 . . . . 0.13 110.536 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.625 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.1 t90 -135.38 151.83 50.84 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 115.206 -0.906 . . . . 0.070000000000000007 109.351 171.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 57.0 p -154.06 161.85 41.62 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.768 0.655 . . . . 0.13 112.768 163.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -156.68 -178.91 31.25 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 110.68 -0.968 . . . . 0.12 110.68 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.741 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.7 mtmt -156.75 148.38 22.56 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.326 -1.731 . . . . 1.22 106.326 167.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.648 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -159.33 127.29 1.8 Allowed Glycine 0 C--N 1.282 -2.42 0 C-N-CA 119.907 -1.14 . . . . 0.12 112.542 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.83 113.05 9.43 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.543 0.687 . . . . 0.17000000000000001 111.455 -173.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.818 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -88.38 159.18 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.518 1.151 . . . . 0.11 110.298 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.683 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -98.86 172.84 7.18 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 112.781 -2.009 . . . . 0.17999999999999999 109.132 -172.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -102.85 127.65 49.95 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.873 -0.417 . . . . 0.91000000000000003 109.873 169.799 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.544 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 17.9 mm-40 . . . . . 0 C--N 1.313 -1.017 0 CA-C-O 118.524 -0.75 . . . . 1.24 110.838 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.995 -0.442 . . . . 88.609999999999999 111.995 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.4 p 40.88 -103.09 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.966 0.906 . . . . 87.430000000000007 112.601 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -148.15 139.05 23.15 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.256 -0.646 . . . . 87.159999999999997 109.256 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.47 ' O ' HG12 ' A' ' 5' ' ' VAL . 25.2 ptm -69.41 142.59 53.85 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.442 -0.577 . . . . 85.340000000000003 109.442 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 4' ' ' MET . 3.2 p 50.85 13.79 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.208 1.403 . . . . 85.049999999999997 112.971 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.01 -46.73 5.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.125 -0.559 . . . . 84.680000000000007 112.058 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -76.0 -31.74 59.08 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.765 -0.457 . . . . 85.569999999999993 109.765 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 33.05 69.75 0.12 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.618 1.199 . . . . 85.040000000000006 112.557 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -71.02 158.46 88.12 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 116.05 -0.523 . . . . 82.170000000000002 110.378 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -49.56 -44.5 34.98 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.124 1.882 . . . . 81.510000000000005 111.298 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.57 101.61 20.91 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.486 -0.779 . . . . 79.560000000000002 109.707 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.36 139.9 92.38 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.397 2.064 . . . . 78.5 112.154 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -64.97 153.97 7.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.511 0.672 . . . . 77.0 111.911 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -106.45 -136.27 0.35 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.116 -0.947 . . . . 75.739999999999995 109.247 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -78.02 89.81 4.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.162 0.506 . . . . 73.909999999999997 110.191 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.73 127.61 30.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.462 -0.79 . . . . 72.299999999999997 110.334 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 12.5 mmmm -60.39 133.89 91.06 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.706 -0.679 . . . . 71.219999999999999 111.768 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 17' ' ' LYS . 38.6 Cg_exo -61.44 141.37 91.88 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.614 2.209 . . . . 69.670000000000002 111.424 174.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.5 -39.38 66.77 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 113.831 1.048 . . . . 67.549999999999997 113.831 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.79 49.02 0.87 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.358 2.039 . . . . 66.700000000000003 113.651 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -84.04 90.03 7.37 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.117 -0.697 . . . . 65.010000000000005 109.117 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -154.29 81.65 4.5 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.79 -0.641 . . . . 63.409999999999997 110.501 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.82 132.52 42.94 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 122.865 2.377 . . . . 61.93 112.489 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.16 75.03 1.33 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.228 -0.896 . . . . 59.869999999999997 110.653 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.688 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 48.4 mt-10 -133.69 -50.56 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.741 -1.118 . . . . 58.469999999999999 111.905 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.688 ' HD2' ' H ' ' A' ' 25' ' ' GLU . 77.8 Cg_endo -78.93 177.51 8.62 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.136 1.224 . . . . 57.359999999999999 111.883 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 22.2 tm0? -112.0 143.28 43.26 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.126 -0.694 . . . . 55.509999999999998 109.126 178.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -66.45 107.88 1.93 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 53.869999999999997 110.754 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 93.3 Cg_endo -83.34 61.78 7.25 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.491 2.128 . . . . 52.759999999999998 112.294 -176.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 20.1 m -121.19 147.8 47.76 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.911 -0.586 . . . . 50.93 110.466 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 30' ' ' VAL . 2.9 Cg_exo -75.08 149.98 37.15 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.603 2.202 . . . . 49.210000000000001 111.446 176.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p -73.14 145.85 46.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.88 0.371 . . . . 47.490000000000002 110.439 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -92.62 120.43 67.37 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.255 -0.429 . . . . 45.969999999999999 111.551 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.77 157.34 28.54 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.932 2.422 . . . . 45.280000000000001 111.695 173.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.6 m -155.04 120.7 5.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.74 -0.664 . . . . 42.789999999999999 110.512 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.5 t -105.13 101.65 31.66 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.636 -0.711 . . . . 40.789999999999999 109.465 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.34 156.44 55.98 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.322 2.015 . . . . 39.810000000000002 112.9 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.1 m -85.74 124.72 32.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.504 0.669 . . . . 37.5 110.73 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.9 mt -94.49 136.33 23.34 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.362 -0.835 . . . . 35.649999999999999 109.039 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.59 91.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.447 2.098 . . . . 33.719999999999999 111.752 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -96.06 -40.19 9.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.007 -0.542 . . . . 31.510000000000002 110.35 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.5 mm-40 58.23 79.66 0.31 Allowed Pre-proline 0 C--O 1.235 0.314 0 O-C-N 123.475 0.484 . . . . 30.129999999999999 110.678 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -53.95 122.79 12.03 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.126 2.551 . . . . 29.52 111.792 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.59 144.98 0.57 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.922 -0.581 . . . . 26.75 112.154 -172.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.61 128.81 19.78 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 122.914 2.409 . . . . 25.079999999999998 112.268 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.6 mt -68.94 -48.35 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.312 0.577 . . . . 23.899999999999999 109.585 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.98 77.74 0.48 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.616 -1.175 . . . . 21.23 109.039 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.446 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 3.9 t-160 -71.7 176.41 4.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.01 -0.996 . . . . 19.920000000000002 111.99 -175.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' H ' ' CG ' ' A' ' 48' ' ' HIS . 15.1 pt-20 -59.35 179.53 0.1 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.115 -0.948 . . . . 16.559999999999999 112.729 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -112.67 80.77 1.38 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.685 -0.689 . . . . 15.050000000000001 110.26 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -53.15 -61.91 1.99 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.936 0.147 . . . . 14.19 110.745 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.5 p 60.95 157.87 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.259 1.023 . . . . 11.380000000000001 113.188 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.27 93.52 29.56 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.904 -1.044 . . . . 8.2899999999999991 110.76 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.78 141.14 44.33 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.787 2.325 . . . . 6.8700000000000001 112.423 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -85.23 -168.3 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.77 2.313 . . . . 5.04 112.881 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 60.6 70.41 0.98 Allowed Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 114.833 -1.076 . . . . 2.5899999999999999 111.6 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.34 -176.7 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.28 2.654 . . . . 1.6399999999999999 112.51 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -117.01 145.22 43.8 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.505 -1.225 . . . . 3.3900000000000001 109.868 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.624 HG22 ' N ' ' A' ' 60' ' ' ARG . 11.4 mt -86.38 168.86 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.716 0.77 . . . . 0.44 112.115 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.624 ' N ' HG22 ' A' ' 59' ' ' ILE . 34.6 mtt-85 -69.6 -157.13 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.875 -1.511 . . . . 2.3399999999999999 112.194 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.66 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 5.0 t60 -158.83 147.99 18.82 Favored 'General case' 0 CA--C 1.473 -1.988 0 CA-C-N 112.245 -2.252 . . . . 2.2200000000000002 107.074 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.759 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.2 m-30 -125.38 158.97 32.98 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.291 -0.868 . . . . 0.20999999999999999 109.565 -176.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.556 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 5.0 t70 -80.91 67.0 6.65 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 123.707 1.718 . . . . 0.34999999999999998 108.065 172.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.737 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 90.0 m95 -56.94 -44.45 82.53 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 111.591 -2.55 . . . . 0.10000000000000001 112.389 175.032 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 3.8 t30 -51.05 -30.72 16.46 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.832 -1.531 . . . . 1.1100000000000001 111.687 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.81 -15.38 81.36 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-O 121.868 0.704 . . . . 0.20999999999999999 111.469 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.86 -52.06 3.4 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.076 -1.062 . . . . 0.13 110.782 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.726 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.7 mtt -64.13 -58.06 7.73 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 114.127 -1.397 . . . . 0.089999999999999997 111.952 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.463 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.7 mm100 -39.52 -54.66 3.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 114.856 1.428 . . . . 0.63 114.856 -176.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.634 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.1 Cg_endo -64.45 -28.78 62.35 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.004 1.802 . . . . 0.14000000000000001 110.667 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.849 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 6.4 mtm -82.4 -46.26 13.77 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 114.874 -1.057 . . . . 0.69999999999999996 111.902 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 68' ' ' MET . 57.7 t -54.34 -40.29 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-N 114.031 -1.44 . . . . 0.12 108.633 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -59.28 -37.72 78.35 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.167 -1.833 . . . . 0.56000000000000005 110.798 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.634 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 25.1 mtmt -77.08 -36.06 56.08 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 120.821 0.343 . . . . 1.3 111.649 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.811 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.0 -29.33 70.49 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.715 -0.675 . . . . 0.5 111.557 -170.594 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.632 HD22 ' HE2' ' A' ' 118' ' ' LYS . 5.2 mt -93.14 -6.78 47.14 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.102 0.953 . . . . 0.65000000000000002 111.012 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.49 17.79 46.02 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.02 -1.632 . . . . 0.17000000000000001 109.02 171.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.59 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -87.02 162.08 17.82 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.626 -0.787 . . . . 0.10000000000000001 110.355 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.54 108.04 17.76 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.057 -0.974 . . . . 1.72 109.235 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.633 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 131.04 -21.2 4.67 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.699 -1.239 . . . . 0.12 110.955 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.811 HG11 ' O ' ' A' ' 75' ' ' MET . 14.8 p -101.75 152.78 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.77 -0.715 . . . . 0.16 110.887 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 83' ' ' ALA . 26.5 m -135.75 140.28 44.22 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.011 -0.995 . . . . 0.45000000000000001 110.625 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.543 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -58.59 140.13 54.82 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.123 -0.944 . . . . 0.28000000000000003 110.484 167.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.3 10.08 54.61 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.88 -0.676 . . . . 0.28000000000000003 112.753 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.9 149.65 21.31 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 120.569 -0.452 . . . . 1.2 110.689 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.673 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.6 p -79.09 114.75 20.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-O 122.218 1.008 . . . . 0.20000000000000001 109.304 164.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.672 ' HG ' ' CE2' ' A' ' 119' ' ' PHE . 2.6 tm? -102.9 106.99 17.66 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.965 -1.016 . . . . 0.14000000000000001 109.065 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.666 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.7 OUTLIER -71.88 96.76 1.72 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 114.226 -1.352 . . . . 0.14999999999999999 108.039 176.537 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.936 ' O ' HD11 ' A' ' 127' ' ' LEU . 1.1 m -71.66 118.06 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.158 -1.423 . . . . 0.94999999999999996 107.158 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.852 ' HB2' HD11 ' A' ' 142' ' ' LEU . 1.1 t70 -76.65 146.1 38.37 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.656 -1.239 . . . . 0.64000000000000001 107.656 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.574 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.1 m -50.97 132.38 27.2 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.582 -1.266 . . . . 0.37 107.582 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.524 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 22.7 t -60.66 138.35 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.959 0 N-CA-C 107.79 -1.189 . . . . 0.10000000000000001 107.79 171.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.777 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.6 t-20 -83.51 162.03 21.04 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.202 -0.908 . . . . 0.17999999999999999 109.589 174.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.746 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.99 86.01 2.49 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.54 -1.209 . . . . 0.12 107.861 175.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 9.7 mtp180 -108.61 -3.71 17.74 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.847 -1.524 . . . . 0.64000000000000001 108.893 -172.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.6 p -49.99 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.067 -1.878 . . . . 0.14000000000000001 114.36 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.5 OUTLIER -76.53 -3.8 39.37 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.309 -1.769 . . . . 0.47999999999999998 110.36 174.637 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.614 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -146.54 -153.07 5.79 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.692 -0.685 . . . . 0.12 112.634 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 50.7 m -121.31 130.32 53.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 1.1599999999999999 111.457 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.746 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.9 pp -134.01 157.44 46.08 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.824 0.821 . . . . 0.10000000000000001 110.746 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.636 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -80.75 80.06 7.29 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.162 -1.381 . . . . 0.17000000000000001 107.803 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.14 -15.0 63.44 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.481 -1.236 . . . . 0.089999999999999997 110.167 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.64 -29.65 41.06 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.576 -0.898 . . . . 0.14999999999999999 108.576 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.636 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 16.1 tp10 -67.67 -33.38 74.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.283 -1.326 . . . . 1.73 109.143 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.74 -43.5 62.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.24 -1.8 . . . . 0.12 109.505 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.64 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.3 m -63.41 -30.52 71.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.838 -1.528 . . . . 0.11 110.564 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 2.0 pt-20 -69.43 -42.97 74.3 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.849 -1.167 . . . . 1.47 107.849 173.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 64' ' ' TRP . 85.2 m -62.58 -29.96 70.97 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.241 -0.891 . . . . 0.12 110.465 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.726 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.5 mt -51.98 -70.27 0.09 Allowed 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 109.13 -0.693 . . . . 0.56000000000000005 109.13 170.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 121' ' ' LEU . 19.0 mtp180 -40.21 -38.66 0.8 Allowed 'General case' 0 C--N 1.312 -1.032 0 O-C-N 124.465 1.103 . . . . 1.51 111.413 175.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 108' ' ' THR . 4.0 m-20 -70.27 -46.07 65.09 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.754 -1.112 . . . . 0.28000000000000003 112.244 -176.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.05 -33.06 65.46 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.2 1.0 . . . . 0.089999999999999997 108.437 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.713 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -64.5 -33.88 76.92 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 113.413 -1.721 . . . . 0.12 110.194 173.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.522 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -70.49 -37.16 74.18 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.789 -1.096 . . . . 0.20000000000000001 111.164 -175.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -57.48 -31.87 66.42 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.629 -1.169 . . . . 1.1699999999999999 110.997 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.479 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -77.03 -36.12 56.39 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.681 -1.145 . . . . 2.0499999999999998 110.211 -177.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.53 -4.56 8.92 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.313 -0.47 . . . . 0.54000000000000004 113.93 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HE2' HD22 ' A' ' 76' ' ' LEU . 11.7 ptmt -83.93 -30.27 26.44 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 122.328 -0.513 . . . . 0.98999999999999999 111.462 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.672 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 4.1 m-85 -89.39 168.74 11.98 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.708 0.766 . . . . 0.20999999999999999 111.285 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.586 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.1 m -116.5 121.18 41.06 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 114.063 -1.426 . . . . 0.23000000000000001 108.154 171.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.613 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -91.01 139.47 30.74 Favored 'General case' 0 N--CA 1.416 -2.151 0 C-N-CA 119.307 -0.957 . . . . 0.38 110.647 -171.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.562 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.9 m -92.54 143.01 12.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.919 -1.141 . . . . 0.41999999999999998 107.919 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.408 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 6.3 t -95.23 171.03 8.98 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 123.066 1.413 . . . . 1.7 109.608 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.29 -16.75 64.29 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 111.264 -2.698 . . . . 0.55000000000000004 109.09 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.571 ' O ' ' HG3' ' A' ' 129' ' ' MET . 27.1 mt-30 -59.51 -36.76 76.7 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 112.705 -2.043 . . . . 2.04 109.824 175.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.547 ' HB2' HG22 ' A' ' 155' ' ' VAL . 37.4 mt-30 -99.01 -51.87 3.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.981 0.896 . . . . 0.40999999999999998 110.205 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.936 HD11 ' O ' ' A' ' 89' ' ' VAL . 6.2 tt -64.01 -67.25 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.407 -1.724 . . . . 1.3899999999999999 113.349 -167.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.598 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 15.4 m -57.16 -35.75 69.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 123.245 1.498 . . . . 1.05 108.786 -175.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.621 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -59.47 -60.34 4.01 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 111.811 -2.449 . . . . 1.6399999999999999 112.205 173.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.763 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.95 -44.02 4.42 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 124.308 1.043 . . . . 0.31 112.23 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.541 ' HZ3' ' N ' ' A' ' 142' ' ' LEU . 3.4 mttt -52.59 -54.7 29.4 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.172 -0.677 . . . . 1.53 109.172 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -62.81 -41.75 99.43 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.398 -0.819 . . . . 0.40999999999999998 111.0 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 129' ' ' MET . 47.6 mt-30 -57.06 -35.02 68.86 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 114.215 -1.357 . . . . 0.37 109.668 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.492 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.46 -30.39 16.49 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.95 -1.477 . . . . 0.23999999999999999 109.738 -176.792 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.42 -46.57 0.56 Allowed Glycine 0 CA--C 1.494 -1.224 0 C-N-CA 119.845 -1.169 . . . . 0.33000000000000002 113.569 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 141' ' ' SER . 98.3 mt -65.92 -169.64 0.07 Allowed 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 112.437 -1.882 . . . . 0.31 115.395 -170.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 6.7 m -114.76 149.32 42.17 Favored Pre-proline 0 N--CA 1.416 -2.153 0 CA-C-N 110.49 -3.05 . . . . 0.81000000000000005 107.676 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 59.0 Cg_endo -66.28 0.57 3.21 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 122.774 2.316 . . . . 0.32000000000000001 112.285 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -118.23 -26.52 6.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.825 0.821 . . . . 1.25 110.286 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.676 ' O ' ' HB2' ' A' ' 141' ' ' SER . 15.2 t70 -58.26 -23.45 56.16 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-N 113.346 -1.752 . . . . 0.65000000000000002 109.168 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.676 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 20.8 m 76.05 171.23 0.25 Allowed 'General case' 0 N--CA 1.42 -1.933 0 O-C-N 125.817 1.948 . . . . 0.59999999999999998 108.385 -173.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.912 HD22 ' HA ' ' A' ' 148' ' ' ALA . 6.9 mt -63.95 -39.06 93.29 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.724 -1.213 . . . . 0.85999999999999999 107.724 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.25 -11.85 1.39 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 113.059 -1.882 . . . . 0.31 114.334 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 1.2 m -155.42 128.06 7.94 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.076 -0.713 . . . . 0.23999999999999999 109.076 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.667 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.0 mmt180 -42.92 -46.87 5.54 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 117.995 0.361 . . . . 1.6499999999999999 111.556 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.1 t -72.3 -26.21 61.87 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.511 0.672 . . . . 0.53000000000000003 111.431 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 31.4 mttm -74.38 -32.17 62.63 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.661 1.219 . . . . 1.3100000000000001 108.797 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.912 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -71.11 -46.43 61.7 Favored 'General case' 0 CA--C 1.483 -1.627 0 CA-C-N 112.299 -2.228 . . . . 0.12 109.976 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.648 HG13 ' HE1' ' A' ' 179' ' ' MET . 36.6 mt -67.22 -41.79 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-N 112.764 -2.016 . . . . 0.11 109.974 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.53 -54.39 30.43 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 114.769 -1.105 . . . . 0.14999999999999999 111.297 171.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.763 HG23 ' CB ' ' A' ' 130' ' ' ALA . 79.1 mt -66.61 -47.77 82.38 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.029 0 N-CA-C 112.729 0.64 . . . . 0.17999999999999999 112.729 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.634 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.76 -41.66 74.31 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.809 0.338 . . . . 0.13 110.9 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.474 ' HD2' HG23 ' A' ' 149' ' ' ILE . 26.8 mtp180 -79.97 -23.98 41.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.48 0.657 . . . . 1.0800000000000001 110.53 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.401 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 27.4 t-20 -80.0 -12.83 59.68 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.337 -1.357 . . . . 0.5 107.337 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.68 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.39 -29.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 113.018 -1.901 . . . . 0.17000000000000001 110.79 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.82 34.21 5.28 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.586 -0.816 . . . . 0.16 112.632 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.06 161.24 14.92 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.031 0.752 . . . . 0.12 113.031 -169.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.673 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -100.31 -28.69 12.84 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.065 -0.97 . . . . 0.20000000000000001 109.348 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.583 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.3 m-85 -136.89 -177.96 4.98 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.935 -1.03 . . . . 0.13 110.936 -175.027 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.718 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -133.65 140.24 47.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.077 -0.965 . . . . 0.080000000000000002 108.823 167.58 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.627 HD21 ' SD ' ' A' ' 176' ' ' MET . 24.9 tp -110.46 99.05 8.12 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.333 -0.947 . . . . 0.16 109.725 166.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.784 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -78.75 112.59 16.03 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.893 -1.049 . . . . 0.26000000000000001 109.143 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.865 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.3 t -123.69 163.24 21.49 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 121.875 0.845 . . . . 1.05 110.275 -177.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.831 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -163.87 176.28 9.62 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 114.397 -1.274 . . . . 0.10000000000000001 111.33 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.57 132.52 29.39 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 113.844 -1.526 . . . . 0.11 108.531 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -142.34 -176.94 5.03 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.21 -0.596 . . . . 1.0900000000000001 109.492 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.09 -81.82 0.88 Allowed Glycine 0 C--N 1.303 -1.258 0 C-N-CA 119.649 -1.262 . . . . 0.14999999999999999 111.615 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.2 t30 -146.78 126.6 13.5 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 107.705 -1.221 . . . . 0.58999999999999997 107.705 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.614 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.2 p -58.75 -44.09 89.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 114.502 -1.226 . . . . 0.14999999999999999 112.723 -173.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -61.99 -29.91 70.58 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.776 0.798 . . . . 1.26 109.788 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.99 88.11 3.56 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 114.387 -1.279 . . . . 0.13 108.224 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.857 ' HD2' HG22 ' A' ' 194' ' ' VAL . 45.9 Cg_endo -90.06 165.54 4.74 Favored 'Trans proline' 0 CA--C 1.491 -1.631 0 C-N-CA 124.644 3.562 . . . . 0.089999999999999997 114.412 -170.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.6 m -83.3 118.27 23.55 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.942 -1.481 . . . . 0.14000000000000001 107.513 166.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.849 ' O ' ' HE1' ' A' ' 71' ' ' MET . 45.3 tp -83.76 99.51 10.32 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.367 -0.975 . . . . 0.16 108.367 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.624 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -91.34 109.02 20.29 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-O 122.09 0.948 . . . . 0.34000000000000002 109.196 -176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.865 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.1 mmm -111.87 163.54 14.09 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.983 -1.008 . . . . 1.0900000000000001 111.487 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.599 ' HG2' HD12 ' A' ' 186' ' ' ILE . 58.6 tt0 -171.15 116.91 0.44 Allowed 'General case' 0 C--O 1.203 -1.366 0 CA-C-N 116.019 -0.537 . . . . 0.5 110.404 -165.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.087 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -99.39 102.27 13.8 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.743 -0.836 . . . . 0.10000000000000001 108.743 -172.309 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.667 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 17.2 ttp -91.62 121.88 33.68 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.070000000000000007 109.534 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.6 128.04 35.04 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.159 -1.423 . . . . 0.22 107.159 166.195 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -83.09 -35.04 11.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 119.303 0.956 . . . . 0.11 110.747 178.5 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.4 mt-30 -61.45 -16.55 48.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.335 -0.848 . . . . 0.34999999999999998 111.358 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.7 p -130.08 -37.34 1.48 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.794 0.807 . . . . 0.19 110.224 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.558 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.48 25.29 26.2 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 114.449 -1.25 . . . . 0.17999999999999999 112.528 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.43 156.81 17.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.679 0.276 . . . . 0.72999999999999998 110.672 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.599 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.3 mm -91.46 112.8 25.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.454 0.645 . . . . 0.14000000000000001 109.679 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.087 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -101.11 -31.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.018 -0.992 . . . . 0.13 110.597 -173.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.653 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.6 t90 -134.06 152.62 51.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.359 -0.837 . . . . 0.070000000000000007 109.752 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 51.8 p -153.8 164.17 38.79 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.399 0.888 . . . . 0.13 113.399 164.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.47 -177.06 33.23 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 110.876 -0.889 . . . . 0.12 110.876 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.1 mtmt -157.46 152.8 26.16 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.645 -1.983 . . . . 1.22 105.645 166.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -163.76 128.18 1.79 Allowed Glycine 0 C--N 1.281 -2.498 0 C-N-CA 119.749 -1.215 . . . . 0.12 112.477 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.64 118.76 14.87 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.298 0.571 . . . . 0.17000000000000001 110.854 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.857 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -94.62 158.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.569 1.176 . . . . 0.11 110.621 -177.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -98.02 172.98 7.28 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 112.667 -2.061 . . . . 0.17999999999999999 108.861 -173.311 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -102.45 130.97 49.4 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.501 -0.48 . . . . 0.91000000000000003 109.962 170.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.514 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 15.4 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.844 -0.598 . . . . 1.24 110.744 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.828 -0.509 . . . . 88.609999999999999 111.828 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m 61.65 69.29 0.65 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.292 0.567 . . . . 87.430000000000007 111.253 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -125.96 84.53 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.592 0.71 . . . . 87.159999999999997 109.815 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.536 ' O ' HG12 ' A' ' 5' ' ' VAL . 1.4 pmm? -71.89 135.33 46.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.702 -0.681 . . . . 85.340000000000003 110.621 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 4' ' ' MET . 1.4 p 54.7 5.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.329 1.452 . . . . 85.049999999999997 113.724 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.27 -7.65 64.25 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.975 -0.631 . . . . 84.680000000000007 112.596 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 36.4 tt0 54.1 99.97 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.537 0.735 . . . . 85.569999999999993 111.586 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 7' ' ' GLN . 84.8 mtp180 73.56 150.33 0.11 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.726 -1.124 . . . . 85.040000000000006 110.404 -175.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -74.19 137.43 75.46 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.872 -0.603 . . . . 82.170000000000002 109.756 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.4 -2.03 7.54 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.112 1.875 . . . . 81.510000000000005 112.132 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.54 98.07 10.19 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.937 -0.574 . . . . 79.560000000000002 109.996 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.54 133.99 16.43 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.971 1.78 . . . . 78.5 111.842 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.494 HG21 HG23 ' A' ' 16' ' ' VAL . 15.5 m -148.16 170.43 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.853 -0.612 . . . . 77.0 110.79 -176.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -63.55 -72.18 0.15 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.701 -0.682 . . . . 75.739999999999995 109.604 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -171.6 103.29 0.19 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.819 -0.628 . . . . 73.909999999999997 110.086 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.494 HG23 HG21 ' A' ' 13' ' ' VAL . 40.2 t -89.57 100.8 11.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.041 0.448 . . . . 72.299999999999997 109.793 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.47 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 39.0 mtmm -66.08 -46.98 63.43 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.956 -0.565 . . . . 71.219999999999999 111.851 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 17' ' ' LYS . 17.1 Cg_exo -67.43 160.01 49.77 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.625 1.55 . . . . 69.670000000000002 111.458 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.29 158.28 37.37 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.293 -0.412 . . . . 67.549999999999997 110.238 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.46 142.79 37.52 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.497 2.131 . . . . 66.700000000000003 111.165 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.59 133.97 46.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.703 -0.681 . . . . 65.010000000000005 111.982 -172.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -129.51 78.47 75.55 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.302 -0.863 . . . . 63.409999999999997 110.688 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.95 155.42 55.32 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.248 2.632 . . . . 61.93 112.489 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' HB1' ' CB ' ' A' ' 27' ' ' GLN . . . -70.12 85.84 0.55 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.451 0.643 . . . . 59.869999999999997 111.291 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.457 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 5.8 mm-40 -89.99 -44.57 0.41 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.418 -0.81 . . . . 58.469999999999999 112.202 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 23.2 Cg_exo -67.14 -12.0 34.34 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.121 1.881 . . . . 57.359999999999999 111.717 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.41 ' CB ' ' HB1' ' A' ' 24' ' ' ALA . 6.0 tp-100 -73.1 81.56 1.26 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.293 -0.867 . . . . 55.509999999999998 110.105 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 28' ' ' GLN . 6.9 tp60 -129.71 65.93 76.08 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.685 -0.689 . . . . 53.869999999999997 109.309 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HD3' ' C ' ' A' ' 27' ' ' GLN . 50.8 Cg_endo -94.85 38.33 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.742 2.961 . . . . 52.759999999999998 112.584 -170.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.1 t -66.28 127.18 93.12 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.72 -0.673 . . . . 50.93 109.268 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.44 92.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.928 2.419 . . . . 49.210000000000001 112.352 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.9 p -73.98 145.09 44.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.768 -0.651 . . . . 47.490000000000002 110.646 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.12 120.61 81.27 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.75 -0.659 . . . . 45.969999999999999 109.973 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.38 148.26 52.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.183 2.589 . . . . 45.280000000000001 112.001 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -132.48 136.78 46.91 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.057 -0.974 . . . . 42.789999999999999 110.559 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.24 121.48 56.36 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.814 -0.63 . . . . 40.789999999999999 111.091 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.75 156.59 47.27 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.939 2.426 . . . . 39.810000000000002 112.116 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.0 t -78.92 144.53 34.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.289 -0.414 . . . . 37.5 110.03 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.8 mt -89.22 115.07 62.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.844 -0.616 . . . . 35.649999999999999 110.355 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.15 -175.67 2.65 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.7 2.267 . . . . 33.719999999999999 112.33 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -105.95 77.45 1.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.605 0.717 . . . . 31.510000000000002 110.585 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.594 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 54.2 tp60 -60.9 -39.85 69.15 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 114.606 -1.179 . . . . 30.129999999999999 112.526 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 18.4 Cg_endo -60.26 123.16 12.55 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.493 1.462 . . . . 29.52 111.43 172.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.96 165.19 19.24 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 116.024 -0.534 . . . . 26.75 111.958 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.79 158.8 40.58 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.789 2.326 . . . . 25.079999999999998 112.47 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.04 -57.64 10.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 120.853 0.359 . . . . 23.899999999999999 110.431 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 60.2 82.08 0.16 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.122 -0.945 . . . . 21.23 111.594 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -170.76 159.09 6.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.397 -0.82 . . . . 19.920000000000002 109.238 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -129.86 -87.71 0.51 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.642 -0.708 . . . . 16.559999999999999 110.716 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.5 t70 45.08 70.01 0.39 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.833 0.825 . . . . 15.050000000000001 111.566 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -75.85 -54.68 6.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.91 -1.041 . . . . 14.19 110.196 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.1 p -131.18 139.47 49.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.206 -0.452 . . . . 11.380000000000001 110.416 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.92 78.74 19.37 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.132 -0.486 . . . . 8.2899999999999991 111.345 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -84.39 155.9 12.49 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.215 1.943 . . . . 6.8700000000000001 112.595 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.84 15.87 1.97 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.344 2.029 . . . . 5.04 111.961 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 59.44 66.12 2.34 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 115.556 -0.747 . . . . 2.5899999999999999 111.62 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -72.11 -175.96 1.94 Allowed 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 123.173 2.582 . . . . 1.6399999999999999 111.989 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -116.66 142.5 46.81 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.597 -1.183 . . . . 3.3900000000000001 110.688 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 60' ' ' ARG . 8.0 mt -95.11 170.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.992 0.901 . . . . 0.44 111.969 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.625 ' N ' HG22 ' A' ' 59' ' ' ILE . 56.7 mtt-85 -76.51 -156.81 0.07 Allowed 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 113.79 -1.55 . . . . 2.3399999999999999 111.727 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.63 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 3.9 t60 -157.28 147.96 21.33 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 112.404 -2.18 . . . . 2.2200000000000002 106.363 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.744 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.9 m-30 -125.34 160.34 29.57 Favored 'General case' 0 N--CA 1.421 -1.899 0 O-C-N 123.856 0.723 . . . . 0.20999999999999999 109.911 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 4.3 t70 -81.73 67.91 7.89 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 123.595 1.664 . . . . 0.34999999999999998 108.292 171.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.707 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.0 m95 -58.29 -43.1 87.87 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 111.682 -2.508 . . . . 0.10000000000000001 112.547 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.453 ' N ' HG21 ' A' ' 108' ' ' THR . 3.2 t30 -51.82 -28.86 17.04 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.962 -1.472 . . . . 1.1100000000000001 111.598 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.44 -17.6 80.12 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.137 -0.938 . . . . 0.20999999999999999 111.104 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.1 -53.18 3.09 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.036 -1.082 . . . . 0.13 110.949 -176.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.703 ' SD ' HD23 ' A' ' 109' ' ' LEU . 42.2 mtt -64.24 -59.57 4.25 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.241 -1.345 . . . . 0.089999999999999997 112.593 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.444 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -39.34 -54.66 3.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 114.624 1.342 . . . . 0.63 114.624 -175.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.802 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.0 Cg_endo -64.21 -28.84 64.49 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 121.788 1.658 . . . . 0.14000000000000001 110.614 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.643 ' HE2' ' N ' ' A' ' 192' ' ' GLY . 11.8 mtm -84.99 -41.25 16.01 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.16 -0.927 . . . . 0.69999999999999996 111.476 -177.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 68' ' ' MET . 61.2 t -55.91 -39.96 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 CA-C-N 114.629 -1.169 . . . . 0.12 108.697 172.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.7 t -60.93 -32.27 71.78 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.32 -1.764 . . . . 0.56000000000000005 111.085 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 16.6 mtpp -84.71 -33.48 23.13 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.147 0.498 . . . . 1.3 110.736 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.87 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -65.36 -27.91 68.91 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.169 -0.923 . . . . 0.5 111.334 -172.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.557 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.2 mt -92.92 -2.93 55.38 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.97 0.89 . . . . 0.65000000000000002 110.917 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.79 15.36 37.61 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.236 -1.546 . . . . 0.17000000000000001 109.236 170.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.27 165.0 17.69 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.679 -0.761 . . . . 0.10000000000000001 110.276 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -91.08 104.49 17.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.22 -0.9 . . . . 1.72 110.046 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.635 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.77 -21.78 3.72 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.097 -0.956 . . . . 0.12 110.735 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.87 HG11 ' O ' ' A' ' 75' ' ' MET . 12.4 p -100.0 153.62 4.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.605 0.716 . . . . 0.16 111.002 -177.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -135.15 136.39 41.84 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 114.838 -1.074 . . . . 0.45000000000000001 110.592 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.47 131.06 45.08 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.467 -0.788 . . . . 0.28000000000000003 110.179 166.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.96 9.91 44.25 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.79 -0.719 . . . . 0.28000000000000003 113.113 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.92 153.08 18.99 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 120.6 -0.44 . . . . 1.2 110.956 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.693 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -81.87 114.91 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 122.116 0.96 . . . . 0.20000000000000001 109.128 166.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.756 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -102.1 108.97 20.55 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.024 -0.989 . . . . 0.14000000000000001 109.264 -172.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.716 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -72.25 95.05 1.64 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 114.471 -1.24 . . . . 0.14999999999999999 108.272 175.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.495 HG11 ' HG3' ' A' ' 110' ' ' ARG . 1.6 m -73.01 118.21 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 107.83 -1.174 . . . . 0.94999999999999996 107.83 176.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.783 ' HB2' HD11 ' A' ' 142' ' ' LEU . 7.9 t0 -77.47 156.95 30.72 Favored 'General case' 0 CA--C 1.489 -1.397 0 CA-C-N 114.385 -1.28 . . . . 0.64000000000000001 107.856 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.538 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -58.38 136.98 57.55 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 108.075 -1.083 . . . . 0.37 108.075 171.234 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.513 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.2 t -64.0 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.982 0 N-CA-C 107.778 -1.193 . . . . 0.10000000000000001 107.778 167.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.818 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.8 t-20 -86.2 163.26 17.9 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.006 -0.997 . . . . 0.17999999999999999 110.069 174.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.754 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.57 84.65 2.3 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.303 -1.317 . . . . 0.12 108.134 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.52 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 7.2 mtp180 -109.09 -1.04 19.12 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 113.783 -1.553 . . . . 0.64000000000000001 108.627 -172.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.721 HG21 ' HB3' ' A' ' 172' ' ' PRO . 18.5 p -52.83 -171.97 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 112.73 -2.032 . . . . 0.14000000000000001 115.034 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.1 t30 -71.3 -9.39 58.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.759 -2.019 . . . . 0.47999999999999998 110.476 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.6 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.94 -146.33 4.32 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.472 -0.871 . . . . 0.12 112.903 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.588 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 54.8 p -121.87 131.02 53.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.245 0.461 . . . . 1.1599999999999999 112.245 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.91 156.72 48.34 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.802 0.81 . . . . 0.10000000000000001 110.629 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.656 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -79.79 79.6 6.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.978 -1.465 . . . . 0.17000000000000001 107.742 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.571 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.35 -14.44 62.99 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.307 -1.315 . . . . 0.089999999999999997 109.749 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.518 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.45 -31.38 37.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.747 -0.834 . . . . 0.14999999999999999 108.747 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.656 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 4.8 tp10 -66.32 -34.37 77.83 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.392 -1.277 . . . . 1.73 108.933 171.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.56 -43.57 66.09 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.236 -1.802 . . . . 0.12 109.551 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 81.0 m -62.92 -30.61 71.68 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 113.776 -1.556 . . . . 0.11 110.162 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.6 -49.68 70.14 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.722 -0.844 . . . . 1.47 108.722 169.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.681 HG21 ' HB2' ' A' ' 64' ' ' TRP . 53.1 m -59.38 -31.08 68.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.43 -0.804 . . . . 0.12 110.789 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.703 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.6 mt -51.2 -69.22 0.12 Allowed 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 115.902 -0.59 . . . . 0.56000000000000005 109.874 172.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.608 ' O ' HD13 ' A' ' 121' ' ' LEU . 4.9 mtp180 -41.85 -38.8 1.61 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.615 1.198 . . . . 1.51 110.886 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.2 m-20 -68.56 -49.04 62.53 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.32 -1.763 . . . . 0.28000000000000003 112.107 -176.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.93 -32.89 69.94 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.357 1.075 . . . . 0.089999999999999997 108.446 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.825 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.4 mm? -64.14 -32.53 74.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.091 -1.868 . . . . 0.12 109.969 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.504 ' HA ' HD21 ' A' ' 121' ' ' LEU . . . -74.88 -38.53 61.88 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 114.749 -1.114 . . . . 0.20000000000000001 111.802 -174.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -67.31 -23.29 65.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.518 -0.764 . . . . 1.1699999999999999 111.449 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -89.27 -13.22 38.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 2.0499999999999998 111.877 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.95 -12.05 0.59 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 115.936 1.135 . . . . 0.54000000000000004 115.936 163.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.64 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 58.7 mtpt -75.81 -34.33 60.15 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 117.529 0.665 . . . . 0.98999999999999999 111.116 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.756 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 13.9 m-85 -91.42 177.67 6.17 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.889 1.328 . . . . 0.20999999999999999 113.823 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.55 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 12.7 m -125.02 114.17 18.75 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 112.244 -2.253 . . . . 0.23000000000000001 107.818 167.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.825 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -99.13 128.02 45.18 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.712 -0.795 . . . . 0.38 112.216 -168.095 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.648 ' HB ' ' OE1' ' A' ' 126' ' ' GLN . 0.8 OUTLIER -75.03 153.17 6.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.068 -1.086 . . . . 0.41999999999999998 108.068 173.943 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.1 t -101.29 -175.32 2.83 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.416 -0.914 . . . . 1.7 110.349 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.434 ' HA ' ' H ' ' A' ' 128' ' ' SER . . . -65.91 -26.41 67.6 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.703 -1.221 . . . . 0.55000000000000004 107.703 174.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.663 ' O ' ' HG3' ' A' ' 129' ' ' MET . 59.7 mt-30 -48.84 -39.67 26.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 113.182 -1.826 . . . . 2.04 110.715 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.648 ' OE1' ' HB ' ' A' ' 122' ' ' VAL . 28.5 mt-30 -98.33 -50.06 4.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.68 0.752 . . . . 0.40999999999999998 110.136 173.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.756 HD21 ' HE3' ' A' ' 131' ' ' LYS . 2.0 tm? -66.47 -63.07 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.008 -1.451 . . . . 1.3899999999999999 113.331 -167.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.7 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.1 t -50.49 -39.4 48.29 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 123.648 1.689 . . . . 1.05 109.028 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.699 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -63.59 -63.18 1.25 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 110.644 -2.98 . . . . 1.6399999999999999 110.688 178.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.754 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.31 -44.54 3.91 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 124.363 1.04 . . . . 0.31 111.646 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.756 ' HE3' HD21 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -49.47 -60.81 2.52 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 123.435 0.46 . . . . 1.53 110.044 176.016 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.2 mt-30 -58.79 -43.96 90.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.665 -1.152 . . . . 0.40999999999999998 111.46 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.699 ' HG3' ' O ' ' A' ' 129' ' ' MET . 49.4 mt-30 -56.14 -34.83 66.49 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.779 -1.1 . . . . 0.37 109.895 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.4 OUTLIER -90.67 -30.98 16.8 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 113.89 -1.504 . . . . 0.23999999999999999 109.487 -177.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.6 -50.69 0.44 Allowed Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 120.095 -1.05 . . . . 0.33000000000000002 113.64 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 141' ' ' SER . 86.1 mt -64.13 -173.02 0.08 Allowed 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 115.841 1.793 . . . . 0.31 115.841 -169.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.8 m -110.5 150.29 41.45 Favored Pre-proline 0 N--CA 1.421 -1.907 0 CA-C-N 111.005 -2.816 . . . . 0.81000000000000005 108.9 169.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.7 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 28.6 Cg_endo -64.13 1.12 1.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.003 2.469 . . . . 0.32000000000000001 112.831 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.518 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -118.33 -22.96 7.43 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.123 0.963 . . . . 1.25 110.487 -178.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 141' ' ' SER . 10.6 t70 -63.61 -21.94 66.63 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 113.062 -1.881 . . . . 0.65000000000000002 109.375 -174.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.64 ' O ' HD13 ' A' ' 136' ' ' LEU . 17.6 m 72.86 169.97 0.31 Allowed 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.42 -1.718 . . . . 0.59999999999999998 109.517 -173.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.012 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.7 mt -64.44 -39.58 94.11 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 122.349 1.071 . . . . 0.85999999999999999 108.268 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.97 -5.98 2.3 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 113.025 -1.898 . . . . 0.31 114.421 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 m -159.78 127.8 4.83 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.913 -0.773 . . . . 0.23999999999999999 108.913 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.726 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.5 mmt180 -42.42 -47.94 5.08 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 118.182 0.446 . . . . 1.6499999999999999 111.256 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.7 t -70.92 -25.79 62.92 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.503 0.668 . . . . 0.53000000000000003 111.591 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 26.8 mttm -75.21 -30.36 60.58 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 122.626 1.203 . . . . 1.3100000000000001 108.675 176.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 1.012 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -75.46 -46.57 31.73 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 112.472 -2.149 . . . . 0.12 110.288 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.614 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.5 mt -66.78 -41.71 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-N 112.811 -1.995 . . . . 0.11 110.004 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.11 -54.5 28.82 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.747 -1.115 . . . . 0.14999999999999999 111.134 171.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.754 HG23 ' CB ' ' A' ' 130' ' ' ALA . 72.2 mt -66.2 -47.86 83.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 N-CA-C 112.831 0.678 . . . . 0.17999999999999999 112.831 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.677 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.88 -40.36 72.85 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.926 0.393 . . . . 0.13 110.975 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.493 ' HD2' HG23 ' A' ' 149' ' ' ILE . 39.7 mtp180 -81.44 -22.67 38.01 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.745 0.783 . . . . 1.0800000000000001 110.48 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.404 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 28.7 t-20 -81.74 -12.04 58.76 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.199 -1.408 . . . . 0.5 107.199 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.698 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -107.4 -29.14 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 113.247 -1.797 . . . . 0.17000000000000001 110.918 -174.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.44 35.84 4.81 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.313 -0.946 . . . . 0.16 112.483 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.716 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.59 159.16 17.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.131 0.789 . . . . 0.12 113.131 -169.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.693 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -98.0 -27.06 14.41 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.18 -0.918 . . . . 0.20000000000000001 109.569 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.649 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 9.5 m-85 -136.65 -173.42 3.42 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.354 -0.839 . . . . 0.13 111.586 -174.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.696 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -137.76 138.43 44.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.803 -1.089 . . . . 0.080000000000000002 109.145 166.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.569 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 34.7 tp -107.82 99.43 8.9 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.379 -0.928 . . . . 0.16 109.281 165.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.69 ' CE1' HD12 ' A' ' 142' ' ' LEU . 2.0 m-85 -78.78 111.99 15.47 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.56 -1.2 . . . . 0.26000000000000001 108.743 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.729 ' OG ' HD11 ' A' ' 174' ' ' LEU . 26.8 t -123.6 159.22 29.72 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 121.776 0.798 . . . . 1.05 110.123 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.818 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.4 p -163.38 170.06 18.07 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-N 114.497 -1.229 . . . . 0.10000000000000001 111.18 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -133.86 135.93 44.05 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.143 -1.39 . . . . 0.11 108.636 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.676 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -144.23 -176.96 5.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.192 -0.67 . . . . 1.0900000000000001 109.192 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 96.08 -86.18 0.92 Allowed Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 119.628 -1.272 . . . . 0.14999999999999999 111.006 174.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.9 t30 -143.75 127.76 17.47 Favored 'General case' 0 C--O 1.191 -1.982 0 N-CA-C 107.375 -1.343 . . . . 0.58999999999999997 107.375 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.6 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.9 p -61.36 -49.71 83.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 114.061 -1.427 . . . . 0.14999999999999999 112.916 -170.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.447 ' N ' HG13 ' A' ' 169' ' ' VAL . 89.8 m-20 -58.83 -26.83 64.52 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.222 0.534 . . . . 1.26 110.904 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.13 88.18 3.51 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 114.903 -1.044 . . . . 0.13 108.394 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.831 ' HD2' HG22 ' A' ' 194' ' ' VAL . 43.3 Cg_endo -91.44 167.26 3.44 Favored 'Trans proline' 0 CA--C 1.493 -1.55 0 C-N-CA 124.947 3.765 . . . . 0.089999999999999997 114.854 -170.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.568 HG22 ' HB3' ' A' ' 191' ' ' LYS . 16.9 m -86.13 118.13 25.39 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 113.755 -1.566 . . . . 0.14000000000000001 107.694 166.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 164' ' ' SER . 54.1 tp -84.46 97.89 9.78 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-O 121.988 0.899 . . . . 0.16 109.337 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.63 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 34.9 mt-30 -87.64 107.66 18.72 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 114.567 -1.197 . . . . 0.34000000000000002 108.685 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.544 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 35.1 mtp -108.26 163.0 13.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.235 -0.893 . . . . 1.0900000000000001 110.063 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.608 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.5 tt0 -169.91 117.85 0.58 Allowed 'General case' 0 C--O 1.202 -1.438 0 CA-C-O 121.256 0.551 . . . . 0.5 110.136 -167.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.1 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.34 101.76 12.83 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.818 -0.808 . . . . 0.10000000000000001 108.818 -172.109 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.726 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.2 ttp -91.3 123.13 34.5 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.479 -0.782 . . . . 0.070000000000000007 109.533 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.77 127.37 31.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.075 -1.454 . . . . 0.22 107.075 166.425 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.05 -35.8 13.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.192 -1.003 . . . . 0.11 110.645 178.242 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.438 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.5 mt-30 -61.72 -15.5 41.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.259 -0.882 . . . . 0.34999999999999998 111.37 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p -130.08 -37.54 1.47 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.514 0.674 . . . . 0.19 110.127 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.512 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.15 26.13 24.66 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 114.631 -1.168 . . . . 0.17999999999999999 112.429 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.23 156.76 17.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.605 0.24 . . . . 0.72999999999999998 110.946 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.608 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.8 mm -91.25 110.59 22.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.792 0.806 . . . . 0.14000000000000001 109.706 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.1 HD11 HD13 ' A' ' 178' ' ' LEU . 1.5 pp -98.11 -32.39 3.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.695 -1.139 . . . . 0.13 110.514 -173.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.636 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.6 t90 -135.49 151.78 50.7 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.383 -0.826 . . . . 0.070000000000000007 109.541 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 33.0 p -153.84 163.17 40.48 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.742 0.645 . . . . 0.13 112.742 164.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.29 -178.41 32.29 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 110.841 -0.903 . . . . 0.12 110.841 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.743 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 16.3 mtmm -156.91 148.19 22.13 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.433 -1.692 . . . . 1.22 106.433 167.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.643 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -157.59 127.06 1.84 Allowed Glycine 0 C--N 1.283 -2.38 0 C-N-CA 119.682 -1.247 . . . . 0.12 112.293 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.94 116.05 12.98 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.413 0.625 . . . . 0.17000000000000001 111.069 -174.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.831 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -93.39 159.46 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 122.604 1.192 . . . . 0.11 110.716 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.744 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -100.82 172.55 6.99 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.485 -2.143 . . . . 0.17999999999999999 108.682 -174.175 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.1 tt0 -101.25 133.24 46.13 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 120.103 -0.639 . . . . 0.91000000000000003 109.601 171.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.547 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 36.7 mm-40 . . . . . 0 C--N 1.313 -1.02 0 CA-C-O 118.467 -0.778 . . . . 1.24 110.257 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.874 -0.49 . . . . 88.609999999999999 111.874 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.5 m -106.02 -79.42 0.56 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.015 -0.365 . . . . 87.430000000000007 110.015 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.0 t60 44.13 74.63 0.12 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.745 0.818 . . . . 87.159999999999997 112.306 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.8 ttp -72.93 164.24 26.95 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.622 -0.881 . . . . 85.340000000000003 108.622 172.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.422 HG13 ' O ' ' A' ' 5' ' ' VAL . 14.6 p -77.31 55.89 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.843 1.306 . . . . 85.049999999999997 110.672 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -144.13 72.14 0.36 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 114.584 -1.189 . . . . 84.680000000000007 111.399 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -87.64 -175.61 5.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.592 -0.304 . . . . 85.569999999999993 110.993 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 61.01 62.69 1.38 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.417 0.627 . . . . 85.040000000000006 109.899 -175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.29 101.08 53.12 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.18 -0.918 . . . . 82.170000000000002 110.246 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.0 97.69 0.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.261 1.974 . . . . 81.510000000000005 111.969 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.94 119.4 77.0 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.235 -0.439 . . . . 79.560000000000002 110.311 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.466 ' O ' HG22 ' A' ' 13' ' ' VAL . 22.6 Cg_exo -62.91 127.51 20.63 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.11 1.873 . . . . 78.5 111.734 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 12' ' ' PRO . 5.9 m 50.47 161.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.313 1.445 . . . . 77.0 113.646 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -166.27 78.92 0.25 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.803 -1.089 . . . . 75.739999999999995 108.967 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -153.53 146.74 24.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.161 -0.472 . . . . 73.909999999999997 111.251 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.4 p -77.53 138.79 19.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.79 -0.641 . . . . 72.299999999999997 110.369 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -82.97 129.97 59.37 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.104 -0.498 . . . . 71.219999999999999 109.978 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.97 -170.97 0.77 Allowed 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.967 2.445 . . . . 69.670000000000002 112.699 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.88 73.05 0.64 Allowed Pre-proline 0 C--N 1.338 0.07 0 CA-C-N 115.073 -0.967 . . . . 67.549999999999997 110.729 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.73 118.25 5.11 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.764 2.309 . . . . 66.700000000000003 112.007 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -68.1 -55.36 12.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.935 -0.394 . . . . 65.010000000000005 109.935 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 67.9 119.85 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 O-C-N 123.96 0.787 . . . . 63.409999999999997 111.663 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -55.97 162.35 7.25 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 123.097 2.532 . . . . 61.93 112.528 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.64 86.75 0.48 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.725 -0.671 . . . . 59.869999999999997 110.957 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.505 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 76.9 mm-40 -102.51 -53.15 0.13 Allowed Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.275 -0.875 . . . . 58.469999999999999 111.697 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 91.3 Cg_endo -83.08 -156.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.53 1.486 . . . . 57.359999999999999 112.395 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 65.69 -97.67 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.209 -0.905 . . . . 55.509999999999998 110.609 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 56.26 128.19 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 123.703 0.801 . . . . 53.869999999999997 113.051 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.91 133.73 46.12 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.249 1.966 . . . . 52.759999999999998 112.611 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.56 123.57 21.38 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.136 -0.484 . . . . 50.93 110.175 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.25 143.37 35.3 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.054 1.836 . . . . 49.210000000000001 112.02 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 p -76.76 154.78 33.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.613 0.244 . . . . 47.490000000000002 111.574 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 m 37.99 84.62 0.18 Allowed Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.574 1.15 . . . . 45.969999999999999 113.9 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -54.42 160.24 7.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.444 2.762 . . . . 45.280000000000001 112.516 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -71.26 130.7 42.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.809 -1.087 . . . . 42.789999999999999 111.298 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.41 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 31.6 m -61.84 160.45 28.28 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.484 -0.78 . . . . 40.789999999999999 111.024 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 36' ' ' VAL . 83.9 Cg_exo -46.9 148.12 4.25 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.825 2.35 . . . . 39.810000000000002 113.269 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 t -68.31 129.51 40.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.525 0.679 . . . . 37.5 111.567 -175.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 mt -107.76 128.13 26.43 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.471 -0.786 . . . . 35.649999999999999 110.124 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.68 -179.52 4.61 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.43 2.087 . . . . 33.719999999999999 112.595 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -117.85 17.48 14.23 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 31.510000000000002 111.644 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 29.7 pt20 -160.34 151.06 15.44 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.79 -0.448 . . . . 30.129999999999999 109.79 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 42' ' ' GLN . 13.2 Cg_exo -71.47 120.61 7.06 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.223 1.949 . . . . 29.52 111.26 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.11 -164.49 9.88 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.021 -0.609 . . . . 26.75 112.954 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.71 169.34 10.68 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.252 2.635 . . . . 25.079999999999998 112.669 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 54.8 mt -63.88 -69.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.409 -0.36 . . . . 23.899999999999999 110.639 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.75 119.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.758 -1.11 . . . . 21.23 111.508 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -63.43 168.49 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.409 0.623 . . . . 19.920000000000002 111.054 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -100.67 133.98 44.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.359 -0.837 . . . . 16.559999999999999 109.568 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -109.62 78.66 1.15 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.683 -0.69 . . . . 15.050000000000001 110.203 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -59.92 -26.75 66.18 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 114.806 -1.088 . . . . 14.19 110.737 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.8 p -84.81 140.31 31.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.899 -0.591 . . . . 11.380000000000001 110.446 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.36 79.26 70.32 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.251 -0.431 . . . . 8.2899999999999991 111.815 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.68 -39.02 94.27 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.521 2.147 . . . . 6.8700000000000001 113.771 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -59.74 107.98 0.43 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 121.305 1.337 . . . . 5.04 111.99 170.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.86 130.76 37.47 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.019 -0.537 . . . . 2.5899999999999999 110.007 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.97 -177.17 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.186 2.591 . . . . 1.6399999999999999 112.965 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -121.19 146.81 46.39 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.591 -1.186 . . . . 3.3900000000000001 111.423 -174.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.635 ' HB ' ' HB2' ' A' ' 101' ' ' ASN . 12.0 mt -85.19 170.88 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.423 -1.262 . . . . 0.44 111.402 -177.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.61 ' N ' HG22 ' A' ' 59' ' ' ILE . 29.1 mtt-85 -69.22 -157.94 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 113.954 -1.475 . . . . 2.3399999999999999 111.651 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.787 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 6.4 t60 -156.46 150.6 25.25 Favored 'General case' 0 CA--C 1.467 -2.229 0 CA-C-N 112.778 -2.01 . . . . 2.2200000000000002 106.891 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.787 ' HD1' ' C ' ' A' ' 61' ' ' HIS . 1.2 m-30 -125.79 161.18 27.94 Favored 'General case' 0 N--CA 1.42 -1.94 0 O-C-N 124.005 0.816 . . . . 0.20999999999999999 110.032 -173.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.556 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 0.9 OUTLIER -81.73 67.46 7.71 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 123.578 1.656 . . . . 0.34999999999999998 107.949 170.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.707 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.8 m95 -60.03 -44.11 94.86 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 111.994 -2.366 . . . . 0.10000000000000001 112.256 174.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.494 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 4.3 t30 -51.65 -27.12 10.52 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.163 -1.38 . . . . 1.1100000000000001 111.269 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.15 -18.21 76.9 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.033 -0.985 . . . . 0.20999999999999999 111.292 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.22 -53.9 2.91 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.026 -1.087 . . . . 0.13 111.157 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.711 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.5 mtt -63.06 -60.49 3.37 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 114.052 -1.431 . . . . 0.089999999999999997 111.967 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 5.2 mm100 -38.36 -54.09 2.87 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 114.984 1.476 . . . . 0.63 114.984 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.805 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 39.2 Cg_endo -66.16 -29.14 47.85 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.702 1.601 . . . . 0.14000000000000001 110.57 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.727 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 15.6 mtm -84.48 -41.86 16.14 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.428 -0.806 . . . . 0.69999999999999996 111.818 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 68' ' ' MET . 60.7 t -57.0 -37.45 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 114.578 -1.192 . . . . 0.12 108.471 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -63.16 -33.12 74.79 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.961 -1.927 . . . . 0.56000000000000005 111.096 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.805 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.4 mtpt -83.42 -32.47 26.1 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.028 0.442 . . . . 1.3 110.632 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.846 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -66.03 -27.0 67.78 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.225 -0.898 . . . . 0.5 111.202 -173.05 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.647 HD13 ' HB2' ' A' ' 118' ' ' LYS . 5.9 mt -93.45 -7.29 44.9 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.951 0.882 . . . . 0.65000000000000002 110.669 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.0 16.97 53.69 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 108.885 -1.686 . . . . 0.17000000000000001 108.885 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.653 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -88.07 164.57 15.67 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.523 -0.838 . . . . 0.10000000000000001 110.307 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -89.2 106.66 18.59 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.978 -1.01 . . . . 1.72 109.407 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.642 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.19 -23.7 3.65 Favored Glycine 0 N--CA 1.417 -2.626 0 C-N-CA 119.69 -1.243 . . . . 0.12 110.791 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.846 HG11 ' O ' ' A' ' 75' ' ' MET . 11.4 p -100.06 153.75 4.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.787 0.803 . . . . 0.16 111.875 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -135.14 137.91 43.23 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.48 -1.236 . . . . 0.45000000000000001 110.639 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.667 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.35 130.78 48.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.462 -0.79 . . . . 0.28000000000000003 110.335 167.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.91 -3.92 33.94 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.966 -0.635 . . . . 0.28000000000000003 112.77 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.98 152.03 25.62 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 120.91 0.386 . . . . 1.2 111.122 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.655 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.7 p -80.67 117.84 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-O 121.978 0.894 . . . . 0.20000000000000001 109.05 165.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.77 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.3 tm? -106.16 109.57 21.55 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.166 -0.925 . . . . 0.14000000000000001 108.91 -172.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.683 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -71.92 96.12 1.65 Allowed 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.124 -1.398 . . . . 0.14999999999999999 108.163 177.387 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.537 HG12 ' CD1' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -71.88 120.04 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 N-CA-C 106.878 -1.527 . . . . 0.94999999999999996 106.878 177.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.777 ' HB2' HD11 ' A' ' 142' ' ' LEU . 10.5 t0 -77.71 155.58 31.19 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.08 -1.452 . . . . 0.64000000000000001 107.08 177.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.523 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.0 OUTLIER -59.2 136.95 58.12 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.584 -1.265 . . . . 0.37 107.584 171.728 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 21.7 t -63.15 139.04 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.831 0 N-CA-C 107.78 -1.193 . . . . 0.10000000000000001 107.78 168.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.802 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -86.03 163.52 17.89 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.239 -0.891 . . . . 0.17999999999999999 110.083 174.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.06 85.5 2.42 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.55 -1.204 . . . . 0.12 108.22 175.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.1 mtp180 -108.92 -0.24 19.79 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.027 -1.442 . . . . 0.64000000000000001 108.746 -172.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 172' ' ' PRO . 21.7 p -52.18 -177.01 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.21 -1.814 . . . . 0.14000000000000001 113.681 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.3 OUTLIER -73.92 -9.36 58.56 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.375 -1.738 . . . . 0.47999999999999998 110.133 173.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.609 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -139.9 -151.63 5.69 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.852 -0.69 . . . . 0.12 112.846 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 65.7 p -122.03 130.62 53.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.512 0.56 . . . . 1.1599999999999999 112.512 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.762 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 1.8 pp -136.2 156.9 48.01 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.009 0.909 . . . . 0.10000000000000001 111.604 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.635 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 1.6 t-20 -80.9 79.77 7.5 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.817 -1.538 . . . . 0.17000000000000001 107.867 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.52 -13.08 61.74 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.469 -1.242 . . . . 0.089999999999999997 110.038 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.534 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.41 -32.72 37.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.643 -0.873 . . . . 0.14999999999999999 108.643 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.622 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 6.1 tp10 -65.45 -33.81 76.82 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 122.804 1.288 . . . . 1.73 109.076 171.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.02 -44.08 63.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.928 -1.942 . . . . 0.12 109.51 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 61.4 m -63.65 -29.07 70.36 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.124 -1.398 . . . . 0.11 110.292 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.64 -52.37 52.39 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.185 -1.043 . . . . 1.47 108.185 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 64' ' ' TRP . 39.3 m -55.44 -33.93 64.03 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.671 -0.695 . . . . 0.12 111.144 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.711 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.0 mt -49.45 -69.22 0.12 Allowed 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 116.2 -0.455 . . . . 0.56000000000000005 109.862 172.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.527 ' O ' HD13 ' A' ' 121' ' ' LEU . 13.9 mtp180 -43.31 -36.95 2.03 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.442 1.089 . . . . 1.51 110.82 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 108' ' ' THR . 7.5 m-20 -70.83 -47.61 58.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.009 -1.451 . . . . 0.28000000000000003 111.561 -175.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.485 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.36 -34.72 68.19 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 122.168 0.985 . . . . 0.089999999999999997 108.631 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -62.34 -33.94 75.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.56 -1.655 . . . . 0.12 109.954 173.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -75.15 -42.33 56.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 114.717 -1.129 . . . . 0.20000000000000001 111.053 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -63.63 -19.28 64.74 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.825 -1.08 . . . . 1.1699999999999999 110.667 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.42 -19.43 18.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.567 -0.742 . . . . 2.0499999999999998 111.565 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.04 14.19 10.26 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 115.357 0.903 . . . . 0.54000000000000004 115.357 164.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 56.8 mtpt -98.42 -2.35 39.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.268 0.534 . . . . 0.98999999999999999 109.913 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.77 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 34.8 m-85 -122.2 174.98 6.63 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.144 0.973 . . . . 0.20999999999999999 112.674 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.564 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 5.4 m -118.08 121.14 39.82 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 112.935 -1.939 . . . . 0.23000000000000001 107.742 170.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.662 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -92.31 139.47 30.58 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 119.164 -1.014 . . . . 0.38 111.837 -169.408 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.657 ' HB ' ' OE1' ' A' ' 126' ' ' GLN . 1.8 m -92.71 146.97 5.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.047 -1.094 . . . . 0.41999999999999998 108.047 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.8 t -101.31 -173.84 2.46 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.896 -0.722 . . . . 1.7 110.234 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -66.02 -25.2 66.96 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.901 -1.148 . . . . 0.55000000000000004 107.901 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 129' ' ' MET . 34.3 mt-30 -51.32 -39.67 57.46 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.235 -1.802 . . . . 2.04 110.525 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.657 ' OE1' ' HB ' ' A' ' 122' ' ' VAL . 37.1 mt-30 -98.47 -53.63 3.27 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 122.265 1.031 . . . . 0.40999999999999998 109.819 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.629 HD13 HD21 ' A' ' 88' ' ' LEU . 31.7 tp -60.37 -65.0 0.76 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 113.122 -1.854 . . . . 1.3899999999999999 113.253 -168.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.665 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 5.6 t -50.39 -46.56 56.18 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 123.275 1.512 . . . . 1.05 109.203 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.755 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -52.84 -63.75 1.04 Allowed 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 111.053 -2.794 . . . . 1.6399999999999999 110.374 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.768 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.77 -46.15 10.38 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 124.574 1.171 . . . . 0.31 112.195 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.532 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -54.39 -51.83 63.61 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 108.835 -0.802 . . . . 1.53 108.835 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.2 mt-30 -65.75 -38.86 90.25 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.313 -0.858 . . . . 0.40999999999999998 111.136 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.755 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.3 mt-30 -59.46 -33.84 71.8 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-N 114.486 -1.234 . . . . 0.37 109.678 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.522 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.43 -27.31 18.38 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.079 -1.418 . . . . 0.23999999999999999 109.552 -177.241 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.78 -48.79 0.58 Allowed Glycine 0 CA--C 1.495 -1.16 0 CA-C-O 122.598 1.11 . . . . 0.33000000000000002 113.259 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 141' ' ' SER . 96.6 mt -64.89 -171.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.102 -2.049 . . . . 0.31 115.716 -170.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.3 m -116.17 153.34 48.51 Favored Pre-proline 0 N--CA 1.428 -1.557 0 CA-C-N 110.705 -2.952 . . . . 0.81000000000000005 107.932 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.665 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 37.1 Cg_endo -65.81 -0.37 3.81 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.611 2.207 . . . . 0.32000000000000001 112.561 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.534 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 2.8 tt0 -118.41 -26.61 6.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.864 0.84 . . . . 1.25 110.704 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.1 t70 -56.86 -24.45 51.64 Favored 'General case' 0 CA--C 1.489 -1.366 0 CA-C-N 113.217 -1.81 . . . . 0.65000000000000002 109.677 -173.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.597 ' O ' HD13 ' A' ' 136' ' ' LEU . 13.0 m 73.47 170.26 0.31 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 112.964 -1.926 . . . . 0.59999999999999998 109.434 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.073 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.1 mt -69.19 -39.97 78.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.369 1.08 . . . . 0.85999999999999999 108.609 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.56 -12.11 0.52 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 112.94 -1.936 . . . . 0.31 114.099 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.77 128.65 10.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.775 -0.631 . . . . 0.23999999999999999 109.482 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.684 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 22.5 mmt-85 -42.82 -50.1 5.7 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 118.043 0.383 . . . . 1.6499999999999999 111.36 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.5 t -69.32 -27.28 65.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.456 0.646 . . . . 0.53000000000000003 111.365 -175.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 24.1 mttm -73.92 -27.63 61.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.666 1.222 . . . . 1.3100000000000001 108.663 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 1.073 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -79.61 -46.75 16.66 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 112.351 -2.204 . . . . 0.12 110.586 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.652 HG13 ' HE1' ' A' ' 179' ' ' MET . 44.4 mt -65.78 -41.66 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 112.946 -1.934 . . . . 0.11 110.099 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.25 -52.37 40.94 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.743 -1.117 . . . . 0.14999999999999999 111.243 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.768 HG23 ' CB ' ' A' ' 130' ' ' ALA . 89.1 mt -68.24 -48.43 73.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 N-CA-C 112.358 0.503 . . . . 0.17999999999999999 112.358 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.683 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.0 -41.31 71.12 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.948 0.404 . . . . 0.13 111.218 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.545 ' HD2' HG23 ' A' ' 149' ' ' ILE . 45.8 mtp180 -80.4 -24.26 39.82 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.597 0.713 . . . . 1.0800000000000001 110.506 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -80.89 -14.35 58.09 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 107.641 -1.244 . . . . 0.5 107.641 176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.692 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -103.2 -28.64 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.188 -1.824 . . . . 0.17000000000000001 110.629 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.443 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 98.5 35.03 5.08 Favored Glycine 0 CA--C 1.5 -0.886 0 C-N-CA 120.153 -1.023 . . . . 0.16 112.16 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.682 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.39 158.58 17.38 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.756 0.65 . . . . 0.12 112.756 -170.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.655 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.1 m80 -98.2 -28.52 13.67 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.144 -0.934 . . . . 0.20000000000000001 109.392 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 6.2 m-85 -136.12 -174.89 3.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.089 -0.959 . . . . 0.13 111.235 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.694 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -135.67 140.23 44.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.091 -0.959 . . . . 0.080000000000000002 108.71 166.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.533 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 37.6 tp -109.31 101.75 10.72 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.292 -0.963 . . . . 0.16 109.45 165.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.617 ' CE1' HD12 ' A' ' 142' ' ' LEU . 2.2 m-85 -79.11 113.87 17.6 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.405 -1.27 . . . . 0.26000000000000001 108.673 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.711 ' OG ' HD11 ' A' ' 109' ' ' LEU . 4.2 p -121.33 157.73 29.77 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.444 -0.798 . . . . 1.05 109.791 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.802 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.7 p -164.62 173.24 12.17 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.985 -1.007 . . . . 0.10000000000000001 111.202 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.49 136.82 41.56 Favored 'General case' 0 N--CA 1.412 -2.334 0 CA-C-N 114.156 -1.384 . . . . 0.11 108.795 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.676 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.7 t -146.06 -171.29 3.68 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.882 -0.727 . . . . 1.0900000000000001 110.345 176.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.41 -78.0 1.51 Allowed Glycine 0 C--N 1.288 -2.099 0 CA-C-N 115.283 -0.871 . . . . 0.14999999999999999 111.713 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.2 t30 -148.85 131.56 15.97 Favored 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 107.62 -1.252 . . . . 0.58999999999999997 107.62 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.609 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.7 p -64.38 -41.8 93.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.102 -0.953 . . . . 0.14999999999999999 112.863 -172.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 5.2 m-20 -63.91 -28.85 70.11 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.293 1.045 . . . . 1.26 109.338 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.5 88.41 3.68 Favored Pre-proline 0 C--N 1.304 -1.374 0 CA-C-N 114.279 -1.328 . . . . 0.13 108.456 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.806 ' HD2' HG22 ' A' ' 194' ' ' VAL . 41.3 Cg_endo -92.0 166.25 3.15 Favored 'Trans proline' 0 CA--C 1.495 -1.447 0 C-N-CA 124.341 3.361 . . . . 0.089999999999999997 114.612 -171.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.605 HG22 ' HB3' ' A' ' 191' ' ' LYS . 49.2 m -85.02 118.8 24.81 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 113.793 -1.549 . . . . 0.14000000000000001 107.888 166.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 164' ' ' SER . 43.9 tp -84.11 96.72 9.01 Favored 'General case' 0 N--CA 1.414 -2.239 0 C-N-CA 119.26 -0.976 . . . . 0.16 108.66 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.678 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 31.9 mt-30 -85.83 108.94 18.35 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 114.638 -1.165 . . . . 0.34000000000000002 108.558 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.591 ' SD ' ' HB3' ' A' ' 163' ' ' SER . 2.9 mmm -112.06 163.52 14.19 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.655 -1.157 . . . . 1.0900000000000001 111.047 -174.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.645 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.4 tt0 -171.48 118.75 0.45 Allowed 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 115.917 -0.583 . . . . 0.5 109.949 -167.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.054 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.74 99.35 9.87 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.524 -0.917 . . . . 0.10000000000000001 108.524 -173.313 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.684 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.9 ttp -88.35 118.47 28.0 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.462 -0.79 . . . . 0.070000000000000007 109.22 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.527 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.17 115.65 4.31 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.067 -1.457 . . . . 0.22 107.067 169.708 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -71.28 -36.21 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.063 0.847 . . . . 0.11 111.348 -176.006 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.457 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 32.2 mt-30 -58.78 -15.53 12.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.525 -0.761 . . . . 0.34999999999999998 111.897 -177.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 39.8 p -128.97 -37.28 1.72 Allowed 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.076 0.941 . . . . 0.19 110.02 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.522 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.28 23.79 36.28 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 113.663 -1.608 . . . . 0.17999999999999999 111.793 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -104.4 154.29 20.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.893 0.377 . . . . 0.72999999999999998 110.423 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.645 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.1 mm -87.6 116.19 29.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.53 0.681 . . . . 0.14000000000000001 109.358 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.054 HD11 HD13 ' A' ' 178' ' ' LEU . 1.7 pp -103.49 -31.34 2.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.93 -1.032 . . . . 0.13 110.476 -173.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.656 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 79.0 t90 -135.16 153.41 51.99 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.325 -0.852 . . . . 0.070000000000000007 109.314 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 77.8 p -153.73 164.0 39.05 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.085 -0.646 . . . . 0.13 112.697 163.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.61 -177.53 32.78 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.573 -1.011 . . . . 0.12 110.573 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.748 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 18.7 mtmm -157.98 148.2 20.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.488 -2.042 . . . . 1.22 105.488 166.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -155.65 126.89 1.92 Allowed Glycine 0 C--N 1.282 -2.445 0 C-N-CA 119.405 -1.379 . . . . 0.12 112.306 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.14 110.88 8.79 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.579 0.704 . . . . 0.17000000000000001 111.094 -173.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.806 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -89.91 157.73 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.583 -1.189 . . . . 0.11 110.581 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.717 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -97.83 172.77 7.45 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 112.612 -2.085 . . . . 0.17999999999999999 108.982 -175.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 1.9 tt0 -107.48 132.38 53.28 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.933 -1.107 . . . . 0.91000000000000003 110.79 171.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.552 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 35.9 mm-40 . . . . . 0 C--O 1.247 0.957 0 CA-C-N 114.811 -1.086 . . . . 1.24 110.948 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 111.803 -0.519 . . . . 88.609999999999999 111.803 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 t 60.19 60.65 2.01 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.589 0.355 . . . . 87.430000000000007 110.733 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.2 t60 73.06 129.5 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.352 0.596 . . . . 87.159999999999997 111.962 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.456 ' O ' HG12 ' A' ' 5' ' ' VAL . 26.6 ptt? -61.03 148.98 38.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.668 -0.696 . . . . 85.340000000000003 110.928 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 4' ' ' MET . 0.4 OUTLIER 64.88 -4.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 123.877 0.871 . . . . 85.049999999999997 112.322 -175.439 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 4' ' ' MET . . . 63.96 30.58 78.14 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 116.085 -0.507 . . . . 84.680000000000007 113.661 172.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.603 ' HG2' ' H ' ' A' ' 8' ' ' ARG . 52.5 tt0 69.11 -179.77 0.23 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 110.149 -0.315 . . . . 85.569999999999993 110.149 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.603 ' H ' ' HG2' ' A' ' 7' ' ' GLN . 62.4 mtp85 64.62 56.71 1.17 Allowed 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.939 0.876 . . . . 85.040000000000006 109.106 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.499 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 8.4 pt-20 -116.2 138.08 23.96 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 114.163 -1.381 . . . . 82.170000000000002 110.425 -175.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 3.4 Cg_exo -79.6 172.87 13.76 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.526 2.15 . . . . 81.510000000000005 112.723 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.36 166.64 11.53 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.639 -0.709 . . . . 79.560000000000002 109.351 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.84 141.86 34.65 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.246 1.964 . . . . 78.5 112.126 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.51 148.54 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.341 0.591 . . . . 77.0 111.745 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.79 -15.75 16.16 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.326 -0.852 . . . . 75.739999999999995 110.202 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -80.64 94.08 6.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.356 -0.838 . . . . 73.909999999999997 110.85 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -77.62 111.59 14.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.536 -0.756 . . . . 72.299999999999997 109.866 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -76.21 112.32 20.26 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.939 -0.573 . . . . 71.219999999999999 109.474 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.53 33.19 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.064 2.509 . . . . 69.670000000000002 113.102 -172.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.35 85.46 0.19 Allowed Pre-proline 0 C--O 1.233 0.237 0 O-C-N 123.755 0.659 . . . . 67.549999999999997 111.954 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.75 46.95 2.02 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.625 2.217 . . . . 66.700000000000003 111.749 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -96.1 149.79 21.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.771 -0.649 . . . . 65.010000000000005 110.69 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 97.4 mt-30 -79.69 134.32 57.68 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.051 -0.522 . . . . 63.409999999999997 110.246 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 76.3 Cg_exo -56.75 144.19 87.73 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.472 2.781 . . . . 61.93 113.53 -176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -145.29 136.47 24.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.663 -0.699 . . . . 59.869999999999997 110.297 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 60.28 89.75 0.1 Allowed Pre-proline 0 N--CA 1.465 0.303 0 O-C-N 123.86 0.725 . . . . 58.469999999999999 111.825 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.23 -9.18 16.47 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.547 2.165 . . . . 57.359999999999999 112.667 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.568 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 15.5 mm100 62.57 46.61 5.43 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.981 -1.009 . . . . 55.509999999999998 112.53 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -97.43 103.89 17.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.013 0.435 . . . . 53.869999999999997 111.228 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 1.6 Cg_endo -82.36 81.85 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.616 2.211 . . . . 52.759999999999998 111.048 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.53 132.66 85.49 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.912 -0.586 . . . . 50.93 111.74 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.61 94.89 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.582 2.188 . . . . 49.210000000000001 111.86 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 p -87.32 158.05 19.14 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.094 -0.503 . . . . 47.490000000000002 111.847 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p 44.26 92.34 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 124.853 1.261 . . . . 45.969999999999999 113.43 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -57.56 165.02 6.55 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.546 2.831 . . . . 45.280000000000001 113.13 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.2 t -92.16 153.99 18.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.202 -0.908 . . . . 42.789999999999999 109.78 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 m -81.67 116.59 64.01 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-N 115.938 -0.573 . . . . 40.789999999999999 111.405 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.17 -27.0 7.08 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.024 2.483 . . . . 39.810000000000002 111.328 174.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 m -67.55 139.48 56.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.113 -0.949 . . . . 37.5 111.294 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 mt -97.36 107.35 38.18 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.719 -0.673 . . . . 35.649999999999999 110.169 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.78 -71.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.873 2.382 . . . . 33.719999999999999 112.395 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 89.7 mm-40 46.54 75.95 0.11 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.548 0.53 . . . . 31.510000000000002 112.017 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -64.25 141.37 98.12 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.751 -0.659 . . . . 30.129999999999999 111.216 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.68 158.75 39.4 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.416 2.077 . . . . 29.52 111.481 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.95 172.38 29.53 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.498 -0.858 . . . . 26.75 112.093 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.85 160.39 49.53 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.028 2.486 . . . . 25.079999999999998 112.007 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.4 mm -58.25 -61.15 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.759 0.314 . . . . 23.899999999999999 110.85 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 53.18 82.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.959 -1.019 . . . . 21.23 111.198 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -84.17 174.39 10.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.218 0.532 . . . . 19.920000000000002 110.439 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -121.64 138.82 54.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.559 -0.746 . . . . 16.559999999999999 109.456 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -111.47 70.47 0.71 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.428 0.632 . . . . 15.050000000000001 110.439 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -133.96 76.05 1.63 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.441 -1.254 . . . . 14.19 108.81 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.2 p -62.49 149.96 41.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.686 -0.688 . . . . 11.380000000000001 111.515 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.79 110.64 15.9 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.715 -0.675 . . . . 8.2899999999999991 111.728 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.79 141.95 87.0 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.884 2.389 . . . . 6.8700000000000001 110.655 172.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.14 116.74 2.63 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.827 2.352 . . . . 5.04 113.297 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.523 ' N ' ' HD2' ' A' ' 57' ' ' PRO . . . -64.62 -50.19 66.31 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.664 -0.244 . . . . 2.5899999999999999 111.157 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 56' ' ' ALA . 74.1 Cg_endo -68.26 -177.72 1.51 Allowed 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.366 2.044 . . . . 1.6399999999999999 112.337 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -115.1 142.68 46.32 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.723 -1.126 . . . . 3.3900000000000001 111.082 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 101' ' ' ASN . 10.7 mt -87.01 170.36 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.148 -0.933 . . . . 0.44 111.844 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.611 ' N ' HG22 ' A' ' 59' ' ' ILE . 31.2 mtt85 -66.5 -158.22 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.462 -1.699 . . . . 2.3399999999999999 112.218 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.673 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 2.2 t60 -157.66 148.35 21.05 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 112.43 -2.168 . . . . 2.2200000000000002 106.567 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.732 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 -125.51 162.4 24.99 Favored 'General case' 0 N--CA 1.42 -1.944 0 O-C-N 123.616 0.572 . . . . 0.20999999999999999 109.914 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 10.9 t70 -84.05 67.35 9.64 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 123.492 1.615 . . . . 0.34999999999999998 108.125 170.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.75 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 91.1 m95 -58.96 -43.91 91.38 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 111.678 -2.51 . . . . 0.10000000000000001 112.437 175.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 4.1 t30 -50.56 -28.59 8.93 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.879 -1.51 . . . . 1.1100000000000001 111.415 174.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.08 -17.78 79.81 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.341 -0.845 . . . . 0.20999999999999999 111.215 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.62 -54.31 2.78 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.863 -1.168 . . . . 0.13 111.125 -175.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.72 ' SD ' HD23 ' A' ' 109' ' ' LEU . 40.1 mtt -62.59 -59.5 4.85 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 114.177 -1.374 . . . . 0.089999999999999997 112.105 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' ASN . 5.8 mm100 -37.33 -55.31 1.86 Allowed Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 115.276 1.584 . . . . 0.63 115.276 -177.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.796 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.3 Cg_endo -65.73 -29.74 50.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.648 1.565 . . . . 0.14000000000000001 110.458 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.691 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 13.0 mtm -83.91 -41.43 17.4 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 115.447 -0.797 . . . . 0.69999999999999996 111.541 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 68' ' ' MET . 58.8 t -55.97 -39.1 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 CA-C-N 114.718 -1.128 . . . . 0.12 108.812 171.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.2 t -61.74 -34.35 75.68 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.393 -1.73 . . . . 0.56000000000000005 110.813 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.796 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.2 mtpt -81.67 -33.93 31.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.073 -0.512 . . . . 1.3 110.464 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.867 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.72 -28.67 69.74 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.406 -0.815 . . . . 0.5 111.637 -171.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.561 ' N ' ' HG2' ' A' ' 75' ' ' MET . 5.5 mt -92.81 -4.84 52.31 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.081 0.943 . . . . 0.65000000000000002 111.133 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.68 15.9 44.65 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 108.914 -1.674 . . . . 0.17000000000000001 108.914 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.647 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.47 165.62 17.0 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.386 -0.907 . . . . 0.10000000000000001 109.869 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -92.97 104.91 17.09 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.277 -0.874 . . . . 1.72 110.303 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.654 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.82 -23.72 3.36 Favored Glycine 0 N--CA 1.428 -1.886 0 CA-C-N 115.018 -0.992 . . . . 0.12 110.69 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.867 HG11 ' O ' ' A' ' 75' ' ' MET . 9.9 p -98.76 155.46 3.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.748 0.785 . . . . 0.16 111.444 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.8 m -134.54 135.75 42.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.604 -1.18 . . . . 0.45000000000000001 111.034 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.575 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -60.23 129.31 41.07 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.222 -0.899 . . . . 0.28000000000000003 109.728 165.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.32 6.0 53.8 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.78 -0.724 . . . . 0.28000000000000003 112.938 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.493 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 65.7 m -98.12 146.93 25.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 120.719 -0.392 . . . . 1.2 110.51 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.692 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -76.8 132.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.029 -0.73 . . . . 0.20000000000000001 109.029 172.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.811 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.6 tm? -119.12 110.01 16.56 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.603 -0.726 . . . . 0.14000000000000001 109.084 -170.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.756 HD21 HD23 ' A' ' 127' ' ' LEU . 0.7 OUTLIER -71.77 93.99 1.34 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.815 -1.18 . . . . 0.14999999999999999 107.815 175.991 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -73.23 115.29 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.435 -1.32 . . . . 0.94999999999999996 107.435 176.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.817 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 12.3 t0 -77.74 170.92 15.76 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 114.997 -1.001 . . . . 0.64000000000000001 109.009 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.584 ' OG ' ' HE3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -62.48 152.92 33.16 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 122.42 1.105 . . . . 0.37 108.668 168.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.561 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 33.9 t -81.64 139.31 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.067 0 N-CA-C 106.985 -1.487 . . . . 0.10000000000000001 106.985 166.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.836 ' H ' ' HA ' ' A' ' 164' ' ' SER . 8.0 t-20 -83.65 163.35 20.37 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.922 0.867 . . . . 0.17999999999999999 110.498 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.762 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.2 t-20 -125.71 86.27 2.51 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.208 -1.36 . . . . 0.12 108.124 175.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.412 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.6 mtp180 -108.72 -2.03 18.94 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.124 -1.398 . . . . 0.64000000000000001 108.724 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.741 HG21 ' HB3' ' A' ' 172' ' ' PRO . 27.5 p -52.18 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 112.998 -1.91 . . . . 0.14000000000000001 115.39 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.517 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 35.4 t30 -69.9 -9.71 55.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 112.762 -2.017 . . . . 0.47999999999999998 110.492 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.601 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -153.27 -144.77 3.99 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.519 -0.848 . . . . 0.12 113.123 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.608 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 86.7 p -121.81 129.89 52.98 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.444 0.64 . . . . 1.1599999999999999 112.725 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.762 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.4 pp -135.52 156.51 48.78 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.923 0.868 . . . . 0.10000000000000001 110.852 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.652 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 1.4 t-20 -80.95 79.44 7.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.961 -1.472 . . . . 0.17000000000000001 107.889 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.73 -14.28 62.81 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.433 -1.258 . . . . 0.089999999999999997 109.96 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.5 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.73 -30.48 36.25 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.555 -0.906 . . . . 0.14999999999999999 108.555 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.635 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.4 tp10 -66.21 -35.11 79.59 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.378 -1.283 . . . . 1.73 109.153 170.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.82 -43.86 67.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.107 -1.861 . . . . 0.12 109.369 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.657 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 63.0 m -61.77 -31.84 72.07 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 113.532 -1.667 . . . . 0.11 110.135 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.73 -46.77 77.64 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.843 -0.799 . . . . 1.47 108.843 171.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.69 HG21 ' HB2' ' A' ' 64' ' ' TRP . 50.9 m -60.19 -31.04 69.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.345 -0.843 . . . . 0.12 110.91 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.72 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -51.96 -68.15 0.19 Allowed 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.749 -0.66 . . . . 0.56000000000000005 110.361 172.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.528 ' O ' HD13 ' A' ' 121' ' ' LEU . 6.1 mpt_? -40.55 -37.36 0.7 Allowed 'General case' 0 C--O 1.213 -0.844 0 O-C-N 124.387 1.054 . . . . 1.51 110.456 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.589 ' HB2' ' O ' ' A' ' 108' ' ' THR . 5.5 m-20 -72.49 -46.8 53.07 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.304 -1.316 . . . . 0.28000000000000003 111.79 -174.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.439 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.21 -33.51 65.41 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.069 0.938 . . . . 0.089999999999999997 108.718 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.69 -34.62 78.27 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.746 -1.57 . . . . 0.12 109.886 172.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.554 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.99 -40.51 65.17 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.696 -1.138 . . . . 0.20000000000000001 111.096 -176.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -61.89 -25.53 67.62 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.854 -1.067 . . . . 1.1699999999999999 110.69 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -92.52 -20.24 21.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.003 -0.544 . . . . 2.0499999999999998 111.467 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.9 0.78 4.38 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 115.693 1.037 . . . . 0.54000000000000004 115.693 162.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.575 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 53.0 mtpt -78.84 -33.99 45.52 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 117.395 0.598 . . . . 0.98999999999999999 109.812 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 19.0 m-85 -89.44 177.81 6.48 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-O 122.23 1.014 . . . . 0.20999999999999999 112.298 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.485 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.4 m -122.41 119.28 30.56 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 113.103 -1.862 . . . . 0.23000000000000001 108.31 167.162 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.676 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -86.92 145.43 26.55 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.448 -0.796 . . . . 0.38 111.317 -170.928 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.556 HG11 HD23 ' A' ' 88' ' ' LEU . 1.9 m -92.74 152.42 3.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.364 -0.835 . . . . 0.41999999999999998 109.175 169.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.463 ' CB ' ' HG2' ' A' ' 125' ' ' GLN . 4.8 m -101.2 163.15 12.42 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.32 1.057 . . . . 1.7 110.416 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.403 ' HA ' ' H ' ' A' ' 128' ' ' SER . . . -67.15 -22.92 65.75 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 113.027 -1.897 . . . . 0.55000000000000004 110.545 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 129' ' ' MET . 4.4 pt20 -53.74 -32.06 50.73 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 125.039 1.462 . . . . 2.04 109.668 170.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.498 ' CB ' HG22 ' A' ' 155' ' ' VAL . 40.7 mt-30 -98.05 -53.79 3.27 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 114.593 -1.185 . . . . 0.40999999999999998 110.976 172.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.892 HD21 ' HE2' ' A' ' 131' ' ' LYS . 1.5 tm? -69.49 -64.6 0.85 Allowed 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 114.572 -1.195 . . . . 1.3899999999999999 113.205 -166.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.673 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.3 t -49.54 -38.39 30.68 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 123.645 1.688 . . . . 1.05 109.189 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.667 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 33.7 mmm -64.02 -63.08 1.25 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 110.705 -2.952 . . . . 1.6399999999999999 111.191 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.748 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.26 -43.49 3.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 124.31 1.006 . . . . 0.31 111.442 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.892 ' HE2' HD21 ' A' ' 127' ' ' LEU . 3.7 mptp? -48.38 -65.57 0.54 Allowed 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.541 -0.541 . . . . 1.53 109.541 174.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 37.5 mt-30 -55.2 -44.61 75.52 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.828 -1.078 . . . . 0.40999999999999998 111.71 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.0 mt-30 -55.67 -36.0 66.62 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 114.745 -1.116 . . . . 0.37 110.022 -177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -91.18 -31.34 16.23 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.118 -1.401 . . . . 0.23999999999999999 109.285 -176.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.33 -48.32 0.43 Allowed Glycine 0 CA--C 1.496 -1.136 0 C-N-CA 119.801 -1.19 . . . . 0.33000000000000002 113.632 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.665 HD13 ' O ' ' A' ' 141' ' ' SER . 35.4 mt -66.24 -174.2 0.25 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 123.923 1.82 . . . . 0.31 115.781 -168.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.6 m -110.03 148.64 38.7 Favored Pre-proline 0 N--CA 1.421 -1.924 0 CA-C-N 110.791 -2.913 . . . . 0.81000000000000005 108.33 169.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.673 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 17.9 Cg_endo -61.38 0.4 1.03 Allowed 'Trans proline' 0 C--N 1.333 -0.255 0 C-N-CA 123.163 2.575 . . . . 0.32000000000000001 112.801 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.5 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.7 tt0 -117.9 -24.11 7.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.185 0.993 . . . . 1.25 110.424 -177.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.624 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.8 t70 -64.61 -22.56 67.0 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 113.213 -1.812 . . . . 0.65000000000000002 109.719 -174.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.665 ' O ' HD13 ' A' ' 136' ' ' LEU . 2.0 m 74.83 173.24 0.27 Allowed 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 125.322 1.639 . . . . 0.59999999999999998 109.652 -173.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.085 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.3 mt -64.72 -38.85 92.38 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.281 -1.007 . . . . 0.85999999999999999 108.281 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.38 -11.82 1.48 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 113.327 -1.76 . . . . 0.31 114.417 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 0.8 OUTLIER -157.19 130.22 7.73 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 118.672 -0.68 . . . . 0.23999999999999999 109.276 -178.036 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.63 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.1 mmt85 -43.29 -48.68 6.8 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 118.008 0.367 . . . . 1.6499999999999999 111.554 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 16.6 t -72.13 -24.93 61.54 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.531 0.681 . . . . 0.53000000000000003 111.202 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.413 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 25.3 mttm -74.6 -30.68 61.76 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.66 1.219 . . . . 1.3100000000000001 108.773 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 1.085 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -74.82 -46.2 38.2 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-N 112.411 -2.177 . . . . 0.12 110.236 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.639 HG13 ' HE1' ' A' ' 179' ' ' MET . 38.8 mt -67.53 -41.96 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 112.633 -2.076 . . . . 0.11 109.821 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.48 -53.85 30.06 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.71 -1.132 . . . . 0.14999999999999999 111.012 171.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.748 HG23 ' CB ' ' A' ' 130' ' ' ALA . 76.2 mt -66.96 -47.85 81.18 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 N-CA-C 112.641 0.608 . . . . 0.17999999999999999 112.641 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.672 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.29 -39.95 73.53 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.984 0.421 . . . . 0.13 111.02 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.536 ' HD2' HG23 ' A' ' 149' ' ' ILE . 45.5 mtp180 -82.59 -21.8 35.05 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.827 0.822 . . . . 1.0800000000000001 110.343 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.41 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 28.1 t-20 -82.82 -11.27 58.38 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.267 -1.382 . . . . 0.5 107.267 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.721 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.15 -29.66 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-N 113.143 -1.844 . . . . 0.17000000000000001 111.111 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.23 35.88 4.32 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.414 -0.898 . . . . 0.16 112.767 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.637 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.19 157.98 19.45 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.192 0.812 . . . . 0.12 113.192 -170.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.692 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.9 m80 -97.32 -25.97 15.06 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.27 -0.877 . . . . 0.20000000000000001 109.861 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.653 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 15.4 m-85 -136.12 -178.32 5.1 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.312 -0.858 . . . . 0.13 111.584 -174.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.673 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -133.37 141.53 44.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.1 -0.955 . . . . 0.080000000000000002 109.202 167.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 46.7 tp -111.43 102.26 10.64 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.628 -0.829 . . . . 0.16 109.255 164.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.681 ' CE1' HD12 ' A' ' 142' ' ' LEU . 1.8 m-85 -80.21 112.64 17.72 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.241 -1.345 . . . . 0.26000000000000001 109.198 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.692 ' OG ' HD11 ' A' ' 109' ' ' LEU . 3.8 p -119.15 158.12 26.57 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.959 0.885 . . . . 1.05 111.489 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.836 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.4 p -164.22 171.64 14.69 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-N 114.251 -1.341 . . . . 0.10000000000000001 111.255 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.14 134.91 33.49 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 114.118 -1.401 . . . . 0.11 108.658 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.9 m -144.74 -173.79 4.16 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.295 -0.631 . . . . 1.0900000000000001 109.295 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.54 -82.43 0.94 Allowed Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.616 -1.278 . . . . 0.14999999999999999 111.279 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.517 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 59.8 t30 -145.78 129.16 16.86 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 107.653 -1.24 . . . . 0.58999999999999997 107.653 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.601 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.3 p -65.03 -42.51 94.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.447 -0.797 . . . . 0.14999999999999999 112.552 -171.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.424 ' N ' HG13 ' A' ' 169' ' ' VAL . 7.4 m120 -60.66 -30.28 69.8 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.784 0.802 . . . . 1.26 110.087 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.01 89.26 3.41 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 113.645 -1.616 . . . . 0.13 108.557 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.817 ' HD2' HG22 ' A' ' 194' ' ' VAL . 43.1 Cg_endo -91.85 165.53 3.27 Favored 'Trans proline' 0 CA--C 1.496 -1.402 0 C-N-CA 124.678 3.586 . . . . 0.089999999999999997 115.301 -170.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.5 m -84.11 116.96 23.15 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 113.88 -1.509 . . . . 0.14000000000000001 107.83 166.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.813 HD12 ' O ' ' A' ' 164' ' ' SER . 43.9 tp -84.22 98.12 9.78 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.988 0.899 . . . . 0.16 109.25 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.635 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 35.4 mt-30 -87.11 108.32 18.84 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 114.586 -1.188 . . . . 0.34000000000000002 108.925 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.554 ' HG3' ' HG ' ' A' ' 174' ' ' LEU . 76.6 mtp -107.29 162.63 13.72 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.827 -1.079 . . . . 1.0900000000000001 110.357 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.592 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.4 tt0 -169.71 119.54 0.65 Allowed 'General case' 0 C--O 1.202 -1.411 0 CA-C-O 121.309 0.576 . . . . 0.5 109.904 -169.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.124 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.11 101.98 12.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.001 -0.74 . . . . 0.10000000000000001 109.001 -172.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.639 ' HE1' HG13 ' A' ' 149' ' ' ILE . 12.7 ttp -92.47 121.98 34.46 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.557 -0.747 . . . . 0.070000000000000007 109.407 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.3 128.44 37.0 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.285 -1.376 . . . . 0.22 107.285 166.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.625 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -84.66 -34.09 9.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 119.096 -1.042 . . . . 0.11 110.738 178.247 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.467 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 27.3 mt-30 -61.2 -16.31 43.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.371 -0.832 . . . . 0.34999999999999998 111.388 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.7 p -130.53 -37.49 1.38 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.505 0.669 . . . . 0.19 110.247 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.516 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.95 24.59 27.0 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.641 -1.163 . . . . 0.17999999999999999 112.479 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 179' ' ' MET . 10.4 pt-20 -103.81 157.78 16.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.654 -0.273 . . . . 0.72999999999999998 110.863 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.592 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.3 mm -93.04 114.19 29.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.574 0.702 . . . . 0.14000000000000001 109.375 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.124 HD11 HD13 ' A' ' 178' ' ' LEU . 1.3 pp -102.38 -30.75 2.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.996 -1.002 . . . . 0.13 110.816 -174.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.647 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.3 t90 -135.43 152.11 51.07 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.274 -0.876 . . . . 0.070000000000000007 109.547 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 61.9 p -153.71 164.21 38.7 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.915 0.709 . . . . 0.13 112.915 163.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.18 -178.69 32.44 Favored Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 110.927 -0.869 . . . . 0.12 110.927 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.734 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 12.0 mtmt -157.05 148.02 21.76 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.207 -1.775 . . . . 1.22 106.207 166.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.691 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -159.29 127.51 1.85 Allowed Glycine 0 C--N 1.28 -2.529 0 C-N-CA 119.769 -1.205 . . . . 0.12 112.343 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.82 114.79 11.35 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.659 0.742 . . . . 0.17000000000000001 111.108 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.817 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -90.6 158.96 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 122.718 1.247 . . . . 0.11 110.476 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -101.43 172.08 7.19 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.399 -2.182 . . . . 0.17999999999999999 108.445 -175.014 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.3 tt0 -101.26 135.79 42.15 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.201 -0.6 . . . . 0.91000000000000003 109.633 172.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.566 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 23.0 mt-30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.424 -0.798 . . . . 1.24 110.927 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.933 -0.467 . . . . 88.609999999999999 111.933 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.1 m 57.11 61.8 2.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.475 0.655 . . . . 87.430000000000007 111.258 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.9 m80 56.08 62.71 2.26 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 114.566 -1.197 . . . . 87.159999999999997 110.572 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.503 ' O ' HG12 ' A' ' 5' ' ' VAL . 16.9 tpt -58.06 142.42 46.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.564 -0.289 . . . . 85.340000000000003 111.136 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 4' ' ' MET . 0.3 OUTLIER 59.83 0.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.481 1.112 . . . . 85.049999999999997 113.111 179.049 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.07 20.01 51.19 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.851 -0.69 . . . . 84.680000000000007 111.903 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 64.25 -166.6 0.22 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 122.797 0.439 . . . . 85.569999999999993 111.074 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 59.3 66.29 1.05 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.376 0.608 . . . . 85.040000000000006 111.058 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.487 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 18.6 mm-40 -62.66 -42.91 81.85 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.051 -0.977 . . . . 82.170000000000002 111.373 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 9' ' ' GLU . 43.7 Cg_endo -71.64 122.01 8.19 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.198 1.265 . . . . 81.510000000000005 110.964 167.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 12' ' ' PRO . . . -153.18 -60.16 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.726 -0.39 . . . . 79.560000000000002 111.927 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 11' ' ' ALA . 73.7 Cg_endo -74.75 150.54 39.6 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.284 1.322 . . . . 78.5 112.196 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.6 153.82 4.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.862 0.363 . . . . 77.0 110.227 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -82.83 74.1 9.81 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.155 -0.683 . . . . 75.739999999999995 109.155 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.44 140.83 57.05 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.383 -0.826 . . . . 73.909999999999997 110.978 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.47 149.42 7.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.687 -0.688 . . . . 72.299999999999997 110.61 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -60.95 103.4 0.37 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.675 -0.693 . . . . 71.219999999999999 109.772 174.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -85.87 137.24 5.46 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.702 2.268 . . . . 69.670000000000002 113.605 -169.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.07 127.92 19.33 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.687 -0.688 . . . . 67.549999999999997 109.708 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.38 140.18 39.76 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.262 1.975 . . . . 66.700000000000003 112.166 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -85.05 -164.55 1.01 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.254 -0.43 . . . . 65.010000000000005 110.588 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 49.33 73.23 1.03 Allowed Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 113.029 0.751 . . . . 63.409999999999997 113.029 169.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -66.09 162.87 33.72 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.053 2.502 . . . . 61.93 111.089 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . -68.45 85.61 0.28 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.001 0.429 . . . . 59.869999999999997 110.327 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -114.59 88.39 16.03 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.414 -0.812 . . . . 58.469999999999999 110.796 -174.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 24' ' ' ALA . 9.7 Cg_endo -91.13 -172.43 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.849 2.366 . . . . 57.359999999999999 112.497 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -134.09 22.74 3.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.586 0.708 . . . . 55.509999999999998 110.008 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.5 tp60 -154.97 120.93 2.66 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.411 -0.813 . . . . 53.869999999999997 109.974 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.81 -145.9 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.577 2.185 . . . . 52.759999999999998 110.924 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.48 111.46 5.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.743 0.306 . . . . 50.93 110.352 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.51 72.73 5.9 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.881 2.387 . . . . 49.210000000000001 112.38 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 p -133.6 152.38 51.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.05 -0.523 . . . . 47.490000000000002 110.985 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 t -115.06 85.5 12.32 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.878 -0.601 . . . . 45.969999999999999 109.743 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.39 162.14 18.34 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.989 2.459 . . . . 45.280000000000001 113.334 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.8 p -94.57 151.88 18.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.219 -0.901 . . . . 42.789999999999999 110.654 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 43.1 t -76.24 115.71 49.51 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.516 -0.766 . . . . 40.789999999999999 109.909 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 3.6 Cg_exo -73.09 -33.76 7.08 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.338 2.025 . . . . 39.810000000000002 112.695 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -75.42 140.8 43.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.403 0.62 . . . . 37.5 110.9 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.9 mt -105.94 130.78 22.46 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.532 -0.758 . . . . 35.649999999999999 109.922 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.88 64.96 6.84 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.457 2.105 . . . . 33.719999999999999 111.82 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -67.59 -46.9 71.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.245 -0.434 . . . . 31.510000000000002 110.67 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 61.53 84.91 0.19 Allowed Pre-proline 0 C--O 1.237 0.405 0 CA-C-N 115.987 -0.551 . . . . 30.129999999999999 110.527 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.47 133.38 25.94 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.016 2.477 . . . . 29.52 111.781 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.56 174.08 23.61 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.939 -0.648 . . . . 26.75 111.931 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.22 136.11 36.43 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.113 2.542 . . . . 25.079999999999998 112.284 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.2 mt -90.04 -70.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.293 -0.412 . . . . 23.899999999999999 110.13 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 54.35 86.96 0.05 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.569 -0.741 . . . . 21.23 112.598 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -94.68 173.27 7.69 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.411 -0.516 . . . . 19.920000000000002 110.172 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -138.97 177.31 7.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.853 -0.612 . . . . 16.559999999999999 110.731 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -123.18 32.49 5.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.806 0.812 . . . . 15.050000000000001 110.96 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 64.55 -171.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.788 -1.551 . . . . 14.19 110.715 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.585 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 27.0 p -136.53 153.01 51.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.172 -0.467 . . . . 11.380000000000001 110.025 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -112.32 89.47 12.41 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 8.2899999999999991 111.356 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 52' ' ' THR . 55.3 Cg_endo -103.06 89.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.079 3.186 . . . . 6.8700000000000001 112.373 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 83.9 Cg_endo -85.9 -154.88 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.702 2.268 . . . . 5.04 111.198 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.75 112.56 3.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 2.5899999999999999 110.447 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.33 -176.48 2.95 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.209 2.606 . . . . 1.6399999999999999 113.496 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -122.11 146.7 46.96 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.906 -1.497 . . . . 3.3900000000000001 108.668 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.612 HG22 ' N ' ' A' ' 60' ' ' ARG . 11.7 mt -81.0 165.51 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.77 0.795 . . . . 0.44 111.673 -174.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.612 ' N ' HG22 ' A' ' 59' ' ' ILE . 50.9 mtt-85 -74.6 -155.95 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.736 -1.575 . . . . 2.3399999999999999 112.187 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.638 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 4.0 t60 -157.63 147.46 20.33 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-N 111.887 -2.415 . . . . 2.2200000000000002 106.174 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.758 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.4 m-30 -125.46 160.86 28.42 Favored 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 123.812 0.695 . . . . 0.20999999999999999 109.73 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.507 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 1.7 t70 -80.68 67.92 6.72 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 123.593 1.663 . . . . 0.34999999999999998 107.95 171.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.71 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 90.9 m95 -59.51 -44.5 93.12 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 111.643 -2.526 . . . . 0.10000000000000001 112.497 175.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 4.0 t30 -51.92 -28.99 18.24 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.055 -1.43 . . . . 1.1100000000000001 111.281 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.19 -16.91 80.35 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.326 -0.852 . . . . 0.20999999999999999 111.144 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.31 -52.78 3.17 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.109 -1.046 . . . . 0.13 111.008 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.676 ' SD ' HD23 ' A' ' 109' ' ' LEU . 43.3 mtt -62.36 -60.32 3.73 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 114.213 -1.358 . . . . 0.089999999999999997 112.179 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.499 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 5.3 mm100 -38.76 -53.19 3.47 Favored Pre-proline 0 C--O 1.225 -0.211 0 N-CA-C 115.554 1.687 . . . . 0.63 115.554 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 49.8 Cg_endo -66.98 -25.91 44.14 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.784 1.656 . . . . 0.14000000000000001 110.746 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.632 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 12.4 mtm -88.05 -43.26 11.84 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.956 -1.02 . . . . 0.69999999999999996 111.978 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 68' ' ' MET . 65.6 t -53.63 -40.43 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 CA-C-N 114.439 -1.255 . . . . 0.12 108.71 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.4 t -57.29 -39.6 76.05 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.005 -1.907 . . . . 0.56000000000000005 110.954 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 25.4 mtmt -77.49 -31.79 53.86 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.024 0.379 . . . . 1.3 112.024 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.871 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -65.26 -26.68 68.2 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.545 -0.752 . . . . 0.5 111.559 -169.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 118' ' ' LYS . 4.6 mt -94.48 -5.52 45.96 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 122.052 0.93 . . . . 0.65000000000000002 111.157 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.43 15.18 50.33 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 109.004 -1.638 . . . . 0.17000000000000001 109.004 170.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.63 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.74 165.54 17.74 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.426 -0.887 . . . . 0.10000000000000001 110.235 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -91.4 103.33 15.97 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.06 -0.973 . . . . 1.72 110.601 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.628 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.96 -21.97 3.48 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.56 -1.016 . . . . 0.12 110.56 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.871 HG11 ' O ' ' A' ' 75' ' ' MET . 11.9 p -101.36 152.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.746 0.784 . . . . 0.16 110.993 -176.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.3 m -135.93 141.0 44.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.724 -1.125 . . . . 0.45000000000000001 110.653 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.727 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -57.2 129.46 41.87 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.122 -0.944 . . . . 0.28000000000000003 110.838 168.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.52 14.16 24.41 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.101 -0.571 . . . . 0.28000000000000003 112.943 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.21 152.42 18.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.515 -0.474 . . . . 1.2 110.941 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.7 p -81.32 115.2 23.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.981 0.896 . . . . 0.20000000000000001 109.081 166.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.704 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -102.77 109.11 20.58 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.236 -0.893 . . . . 0.14000000000000001 109.099 -172.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.687 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.61 96.38 1.55 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.21 -1.359 . . . . 0.14999999999999999 108.318 176.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -71.8 121.16 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 106.852 -1.536 . . . . 0.94999999999999996 106.852 177.459 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.816 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 9.5 t0 -77.54 156.5 30.91 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.268 -1.382 . . . . 0.64000000000000001 107.268 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.534 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.57 138.04 57.83 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.061 -1.459 . . . . 0.37 107.061 171.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.543 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.8 t -64.49 137.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.073 0 N-CA-C 107.658 -1.238 . . . . 0.10000000000000001 107.658 168.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.781 ' H ' ' HA ' ' A' ' 164' ' ' SER . 5.1 t-20 -83.97 161.33 20.81 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.234 -0.894 . . . . 0.17999999999999999 109.614 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.77 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 1.9 t-20 -124.52 85.13 2.37 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.675 -1.148 . . . . 0.12 108.083 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.543 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.8 mtp180 -108.6 -1.96 19.17 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 113.756 -1.565 . . . . 0.64000000000000001 108.502 -172.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 172' ' ' PRO . 18.1 p -52.94 -172.77 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.044 -1.889 . . . . 0.14000000000000001 115.074 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 167' ' ' GLY . 58.8 t30 -71.59 -5.19 31.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.643 -2.072 . . . . 0.47999999999999998 110.828 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.596 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -156.38 -143.95 3.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.671 -0.776 . . . . 0.12 112.807 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 55.6 p -122.19 130.56 53.32 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.178 0.436 . . . . 1.1599999999999999 112.178 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.77 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.2 pp -136.22 157.37 46.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.858 0.837 . . . . 0.10000000000000001 110.863 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.15 79.44 7.81 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.85 -1.523 . . . . 0.17000000000000001 107.631 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.33 -14.07 62.73 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.511 -1.222 . . . . 0.089999999999999997 109.915 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.549 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.66 -32.74 41.6 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.672 -0.862 . . . . 0.14999999999999999 108.672 -178.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.9 tp10 -65.94 -33.27 75.45 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 122.767 1.27 . . . . 1.73 108.943 171.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.46 -43.92 63.06 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 113.078 -1.874 . . . . 0.12 109.5 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.629 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 67.1 m -64.01 -31.43 72.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.115 -1.402 . . . . 0.11 110.476 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -42.69 81.2 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.895 -1.15 . . . . 1.47 107.895 172.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.677 HG21 ' HB2' ' A' ' 64' ' ' TRP . 30.1 m -63.34 -31.36 72.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.994 -1.003 . . . . 0.12 110.816 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.702 ' O ' HD23 ' A' ' 113' ' ' LEU . 9.4 mt -50.88 -69.83 0.1 Allowed 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 115.691 -0.686 . . . . 0.56000000000000005 109.518 171.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.542 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.2 mtp180 -40.71 -39.4 1.08 Allowed 'General case' 0 C--N 1.314 -0.942 0 O-C-N 124.539 1.15 . . . . 1.51 111.122 175.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 108' ' ' THR . 7.5 m-20 -69.7 -45.43 68.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.604 -1.18 . . . . 0.28000000000000003 111.948 -176.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.499 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.95 -32.91 63.69 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.289 1.043 . . . . 0.089999999999999997 108.605 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -65.71 -32.1 73.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.608 -1.633 . . . . 0.12 110.26 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.592 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -73.58 -40.68 63.7 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 114.671 -1.149 . . . . 0.20000000000000001 111.489 -174.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -59.92 -27.96 67.2 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.562 -1.199 . . . . 1.1699999999999999 110.755 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -82.16 -35.51 28.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.54 -1.209 . . . . 2.0499999999999998 110.554 -174.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.28 0.64 30.6 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 114.626 0.61 . . . . 0.54000000000000004 114.626 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.771 ' HB2' HD13 ' A' ' 76' ' ' LEU . 58.5 mtpt -86.92 -8.12 57.55 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.935 -0.744 . . . . 0.98999999999999999 110.814 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.73 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 29.5 m-85 -119.09 175.37 5.81 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 122.159 0.98 . . . . 0.20999999999999999 112.497 171.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.512 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.5 m -119.7 123.73 44.52 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 112.987 -1.915 . . . . 0.23000000000000001 107.862 169.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.604 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -93.02 138.47 31.46 Favored 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 119.43 -0.908 . . . . 0.38 111.651 -170.158 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.656 ' HB ' ' OE1' ' A' ' 126' ' ' GLN . 1.7 m -92.11 146.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.333 -1.358 . . . . 0.41999999999999998 107.333 169.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.437 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 9.5 t -101.31 -174.23 2.55 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 119.712 -0.795 . . . . 1.7 110.18 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -66.29 -24.77 66.61 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.909 -1.145 . . . . 0.55000000000000004 107.909 175.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.577 ' O ' ' HG3' ' A' ' 129' ' ' MET . 60.7 mt-30 -51.27 -40.05 58.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.219 -1.81 . . . . 2.04 110.51 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.656 ' OE1' ' HB ' ' A' ' 122' ' ' VAL . 35.6 mt-30 -98.14 -52.46 3.68 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 122.066 0.936 . . . . 0.40999999999999998 110.094 173.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.612 HD13 HD21 ' A' ' 88' ' ' LEU . 30.8 tp -61.13 -63.7 1.2 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 113.302 -1.772 . . . . 1.3899999999999999 113.34 -168.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.667 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 4.3 t -49.97 -46.1 52.16 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 123.336 1.541 . . . . 1.05 109.289 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.716 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 52.0 mmm -55.4 -61.66 2.19 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 111.125 -2.761 . . . . 1.6399999999999999 110.64 175.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.769 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.79 -45.57 10.12 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 124.382 1.051 . . . . 0.31 112.472 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.552 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -55.14 -51.36 66.71 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 107.963 -1.125 . . . . 1.53 107.963 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.8 mt-30 -64.56 -40.87 96.36 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.047 -0.979 . . . . 0.40999999999999998 111.325 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.716 ' HG3' ' O ' ' A' ' 129' ' ' MET . 49.5 mt-30 -58.3 -34.21 70.3 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 114.429 -1.26 . . . . 0.37 109.383 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.514 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.14 -26.92 18.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.764 -1.562 . . . . 0.23999999999999999 109.381 -177.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.44 -52.05 0.52 Allowed Glycine 0 CA--C 1.497 -1.041 0 CA-C-O 122.677 1.154 . . . . 0.33000000000000002 113.039 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 141' ' ' SER . 77.7 mt -62.65 -171.15 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 111.761 -2.22 . . . . 0.31 116.046 -171.051 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.5 m -117.21 153.21 49.8 Favored Pre-proline 0 N--CA 1.428 -1.551 0 CA-C-N 110.929 -2.851 . . . . 0.81000000000000005 108.307 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.667 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 24.5 Cg_endo -63.14 -2.07 3.48 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.026 2.484 . . . . 0.32000000000000001 112.676 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.549 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.6 tt0 -118.15 -27.67 6.02 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.781 0.8 . . . . 1.25 110.463 -177.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.2 t70 -60.54 -23.83 64.89 Favored 'General case' 0 CA--C 1.487 -1.442 0 CA-C-N 113.604 -1.635 . . . . 0.65000000000000002 109.483 -174.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.62 ' O ' HD13 ' A' ' 136' ' ' LEU . 17.8 m 74.8 169.49 0.29 Allowed 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 112.785 -2.007 . . . . 0.59999999999999998 110.455 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.831 HD22 ' HA ' ' A' ' 148' ' ' ALA . 6.7 mt -64.4 -40.25 95.42 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.336 1.065 . . . . 0.85999999999999999 108.477 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 64.49 -11.13 0.25 Allowed Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 112.978 -1.919 . . . . 0.31 114.666 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 142' ' ' LEU . 1.5 m -152.86 125.53 8.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.081 -0.711 . . . . 0.23999999999999999 109.081 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.735 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 12.3 mmt180 -41.66 -45.95 3.57 Favored 'General case' 0 C--O 1.213 -0.84 0 O-C-N 123.279 0.362 . . . . 1.6499999999999999 111.792 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.9 t -73.43 -25.59 60.58 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.628 0.728 . . . . 0.53000000000000003 111.505 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 29.7 mttm -75.0 -32.05 61.55 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.744 1.259 . . . . 1.3100000000000001 108.684 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.831 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -71.32 -46.99 59.33 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-N 112.217 -2.265 . . . . 0.12 110.044 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.622 HG13 ' HE1' ' A' ' 179' ' ' MET . 38.2 mt -67.07 -40.86 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 CA-C-N 112.678 -2.056 . . . . 0.11 109.839 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.08 -56.3 19.68 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 114.737 -1.119 . . . . 0.14999999999999999 111.129 171.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.769 HG23 ' CB ' ' A' ' 130' ' ' ALA . 85.3 mt -65.43 -47.98 84.78 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 N-CA-C 112.733 0.642 . . . . 0.17999999999999999 112.733 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.684 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.23 -40.49 74.19 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.845 0.355 . . . . 0.13 111.14 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.518 ' HD2' HG23 ' A' ' 149' ' ' ILE . 61.6 mtp180 -81.92 -21.75 37.16 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.695 0.759 . . . . 1.0800000000000001 110.533 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -84.06 -11.12 57.22 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.323 -1.362 . . . . 0.5 107.323 176.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.719 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -107.08 -29.11 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 113.143 -1.844 . . . . 0.17000000000000001 110.917 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.59 34.2 5.34 Favored Glycine 0 CA--C 1.504 -0.602 0 C-N-CA 120.403 -0.904 . . . . 0.16 112.553 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.687 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.34 161.83 14.45 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.637 0.606 . . . . 0.12 112.637 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.67 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.2 m80 -99.82 -28.16 13.27 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.561 -0.745 . . . . 0.20000000000000001 109.586 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.573 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.7 m-85 -136.67 -172.9 3.28 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.223 -0.899 . . . . 0.13 111.141 -174.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.678 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -137.44 139.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.835 -1.075 . . . . 0.080000000000000002 108.645 166.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.537 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 29.4 tp -108.35 100.56 9.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.584 -0.846 . . . . 0.16 109.329 165.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.665 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -79.25 112.56 16.59 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.831 -1.077 . . . . 0.26000000000000001 108.723 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.727 ' OG ' HD11 ' A' ' 174' ' ' LEU . 23.3 t -124.86 159.75 30.37 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-O 121.828 0.823 . . . . 1.05 110.052 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.826 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.5 p -163.75 173.03 13.34 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 114.505 -1.225 . . . . 0.10000000000000001 111.154 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.73 134.33 37.03 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 114.071 -1.422 . . . . 0.11 108.477 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -143.9 -176.72 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.373 -0.602 . . . . 1.0900000000000001 109.373 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 95.16 -82.68 0.88 Allowed Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 119.389 -1.386 . . . . 0.14999999999999999 111.856 172.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.44 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.4 t30 -143.07 123.82 14.18 Favored 'General case' 0 C--O 1.195 -1.782 0 N-CA-C 107.125 -1.435 . . . . 0.58999999999999997 107.125 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.596 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.1 p -63.04 -44.59 99.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 112.944 0.72 . . . . 0.14999999999999999 112.944 -172.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.44 ' N ' HG13 ' A' ' 169' ' ' VAL . 72.5 m-20 -61.28 -27.93 68.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 118.59 0.632 . . . . 1.26 109.891 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.4 88.74 3.35 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 114.855 -1.066 . . . . 0.13 108.436 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.816 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.8 Cg_endo -91.48 166.37 3.47 Favored 'Trans proline' 0 CA--C 1.492 -1.585 0 C-N-CA 124.996 3.797 . . . . 0.089999999999999997 115.183 -169.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.601 HG22 ' HB3' ' A' ' 191' ' ' LYS . 12.7 m -84.58 117.35 23.67 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.689 -1.596 . . . . 0.14000000000000001 107.672 167.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 164' ' ' SER . 48.2 tp -84.39 98.19 9.9 Favored 'General case' 0 N--CA 1.412 -2.326 0 C-N-CA 119.589 -0.844 . . . . 0.16 109.183 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.664 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.8 mt-30 -88.06 107.87 18.96 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 114.665 -1.152 . . . . 0.34000000000000002 109.092 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 36.0 mtp -108.15 162.06 14.41 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.012 -0.995 . . . . 1.0900000000000001 110.266 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.595 ' HG2' HD12 ' A' ' 186' ' ' ILE . 55.5 tt0 -169.72 117.59 0.6 Allowed 'General case' 0 C--O 1.205 -1.275 0 CA-C-O 121.308 0.575 . . . . 0.5 109.927 -168.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.04 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -99.84 101.41 12.53 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.695 -0.854 . . . . 0.10000000000000001 108.695 -170.972 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.735 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 16.9 ttp -91.39 122.63 34.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.373 -0.83 . . . . 0.070000000000000007 109.625 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -59.14 127.57 32.83 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.201 -1.407 . . . . 0.22 107.201 166.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -82.18 -34.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 119.065 -1.054 . . . . 0.11 110.865 178.529 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.437 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.4 mt-30 -62.54 -14.43 42.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.446 -0.797 . . . . 0.34999999999999998 111.592 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 79.3 p -130.65 -36.41 1.41 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.862 0.839 . . . . 0.19 110.416 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.541 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 87.9 27.6 25.92 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.397 -1.274 . . . . 0.17999999999999999 112.313 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -106.77 155.93 19.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.624 -0.288 . . . . 0.72999999999999998 110.624 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.595 HD12 ' HG2' ' A' ' 177' ' ' GLN . 33.1 mm -89.01 120.09 37.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.665 0.745 . . . . 0.14000000000000001 109.375 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.04 HD11 HD13 ' A' ' 178' ' ' LEU . 1.3 pp -108.18 -30.33 2.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.904 -1.043 . . . . 0.13 110.422 -173.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.63 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.2 t90 -136.96 152.89 50.69 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.177 -0.92 . . . . 0.070000000000000007 109.385 172.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.499 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 62.1 p -153.53 164.49 38.14 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.938 0.718 . . . . 0.13 112.938 164.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.71 179.84 35.01 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.671 -0.971 . . . . 0.12 110.671 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.6 mtmt -156.91 147.45 21.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.181 -1.785 . . . . 1.22 106.181 168.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.632 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -157.64 127.38 1.9 Allowed Glycine 0 C--N 1.283 -2.399 0 C-N-CA 119.674 -1.25 . . . . 0.12 112.43 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.65 110.96 9.37 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.787 0.803 . . . . 0.17000000000000001 111.503 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.816 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -88.53 159.5 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 122.797 1.284 . . . . 0.11 110.9 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.758 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -99.73 173.03 6.9 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 112.254 -2.248 . . . . 0.17999999999999999 108.895 -174.543 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.3 tt0 -104.34 133.52 49.1 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.936 -0.705 . . . . 0.91000000000000003 110.107 173.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.553 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 14.4 mm-40 . . . . . 0 C--N 1.313 -1.004 0 CA-C-O 118.551 -0.737 . . . . 1.24 110.617 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.851 -0.499 . . . . 88.609999999999999 111.851 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m -140.97 160.58 39.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.575 0.226 . . . . 87.430000000000007 110.804 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -87.79 107.27 18.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.312 -0.625 . . . . 87.159999999999997 109.312 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.532 ' O ' HG12 ' A' ' 5' ' ' VAL . 62.2 ttp -97.17 78.43 2.76 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.829 -0.349 . . . . 85.340000000000003 110.228 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 4' ' ' MET . 3.5 p 56.78 -36.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.114 1.766 . . . . 85.049999999999997 114.791 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.69 105.76 0.19 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 111.165 -0.774 . . . . 84.680000000000007 111.165 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -118.72 -84.58 0.65 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 119.465 -0.303 . . . . 85.569999999999993 111.249 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 46.94 68.4 0.63 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.405 0.621 . . . . 85.040000000000006 110.646 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -154.21 170.59 8.21 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.295 -0.866 . . . . 82.170000000000002 109.822 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.07 -42.07 67.87 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.728 1.618 . . . . 81.510000000000005 111.531 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 62.78 92.81 0.06 OUTLIER Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 115.288 -0.869 . . . . 79.560000000000002 111.266 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.44 143.51 99.47 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.846 2.364 . . . . 78.5 111.832 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.24 156.62 5.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 77.0 110.82 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.07 88.42 1.42 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.672 -0.694 . . . . 75.739999999999995 110.562 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.471 ' HG2' ' H ' ' A' ' 16' ' ' VAL . 33.9 tt0 -81.59 172.8 13.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.274 -0.876 . . . . 73.909999999999997 109.127 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.471 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 8.8 p -37.45 127.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 O-C-N 123.84 0.712 . . . . 72.299999999999997 111.753 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 54.6 mtmt -93.37 152.63 41.21 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.894 -0.594 . . . . 71.219999999999999 110.588 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 17' ' ' LYS . 20.6 Cg_exo -65.96 80.96 0.27 Allowed 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.062 2.508 . . . . 69.670000000000002 112.7 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -132.28 76.97 71.7 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.941 -0.572 . . . . 67.549999999999997 110.441 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.23 121.44 6.86 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.194 1.929 . . . . 66.700000000000003 111.889 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -108.01 116.08 31.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.234 0.54 . . . . 65.010000000000005 110.55 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -115.54 130.95 23.9 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.757 -0.656 . . . . 63.409999999999997 109.913 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.97 141.83 93.82 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.027 2.484 . . . . 61.93 112.956 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.33 65.33 1.59 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.187 -0.915 . . . . 59.869999999999997 108.918 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -80.06 151.21 72.83 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 114.145 -1.388 . . . . 58.469999999999999 110.312 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 55.6 Cg_endo -70.31 1.33 4.9 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.909 2.406 . . . . 57.359999999999999 112.949 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 55.68 -166.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.041 0.537 . . . . 55.509999999999998 111.553 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.547 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 2.6 mp0 -94.55 -64.56 0.12 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 118.845 -0.598 . . . . 53.869999999999997 111.196 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' A' ' 28' ' ' GLN . 23.6 Cg_exo -59.5 -56.37 1.31 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.496 1.464 . . . . 52.759999999999998 113.392 -167.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.23 150.74 70.0 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.702 -0.481 . . . . 50.93 109.702 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 26' ' ' PRO . 16.2 Cg_exo -67.86 -40.78 8.92 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.253 1.969 . . . . 49.210000000000001 112.077 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -144.63 143.38 30.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.655 -0.702 . . . . 47.490000000000002 110.188 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.576 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 26.3 t -102.28 -51.34 0.15 Allowed Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.044 -0.525 . . . . 45.969999999999999 111.447 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 52.1 Cg_exo -61.19 164.32 14.98 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.399 2.066 . . . . 45.280000000000001 113.372 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 m -89.02 140.55 29.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.983 -1.008 . . . . 42.789999999999999 109.926 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.9 m -68.17 146.62 98.14 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.583 . . . . 40.789999999999999 111.224 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -50.88 -55.71 3.79 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.513 2.142 . . . . 39.810000000000002 112.678 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.2 m -113.95 123.69 50.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.179 0.514 . . . . 37.5 111.246 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.58 107.97 59.55 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.407 -0.815 . . . . 35.649999999999999 109.443 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.66 -49.56 16.37 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.092 2.528 . . . . 33.719999999999999 112.423 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 68.32 123.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.992 0.808 . . . . 31.510000000000002 111.748 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.8 mp0 -116.28 88.85 24.34 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 30.129999999999999 110.46 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.14 121.71 6.28 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.683 2.255 . . . . 29.52 111.644 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.23 -176.94 4.61 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.082 -0.58 . . . . 26.75 113.107 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.01 133.51 27.13 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.74 2.293 . . . . 25.079999999999998 111.821 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.9 mt -76.16 -50.75 21.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.027 -0.533 . . . . 23.899999999999999 110.661 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.61 84.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.003 -0.999 . . . . 21.23 111.051 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -88.24 177.06 6.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.505 0.669 . . . . 19.920000000000002 111.264 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -141.66 170.83 14.98 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.836 -1.074 . . . . 16.559999999999999 109.848 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -103.23 29.33 5.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.982 0.896 . . . . 15.050000000000001 111.247 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.473 ' HB3' ' HG3' ' A' ' 54' ' ' PRO . 59.8 tp60 179.7 156.05 0.58 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.78 -1.1 . . . . 14.19 108.065 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.2 p -80.75 119.02 22.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.323 0.583 . . . . 11.380000000000001 111.395 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 56' ' ' ALA . . . 49.47 60.51 15.34 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.141 -1.391 . . . . 8.2899999999999991 113.24 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HG3' ' HB3' ' A' ' 51' ' ' GLN . 24.3 Cg_exo -59.8 -47.49 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.584 2.189 . . . . 6.8700000000000001 114.239 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.94 -16.63 36.86 Favored 'Trans proline' 0 C--N 1.356 0.925 0 CA-C-N 120.92 1.364 . . . . 5.04 112.654 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -86.91 111.2 38.68 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.802 0.334 . . . . 2.5899999999999999 111.109 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.62 -176.52 3.32 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.231 2.621 . . . . 1.6399999999999999 112.065 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -112.41 137.25 50.85 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.785 -1.098 . . . . 3.3900000000000001 109.612 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 60' ' ' ARG . 13.6 mt -77.64 171.75 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.964 -1.016 . . . . 0.44 111.579 -172.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.588 ' N ' HG22 ' A' ' 59' ' ' ILE . 46.9 mtt85 -60.64 -149.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.956 -1.474 . . . . 2.3399999999999999 112.214 176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.629 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 2.7 t60 -159.43 137.73 10.51 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-N 112.634 -2.076 . . . . 2.2200000000000002 107.017 177.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.718 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.2 m-30 -122.09 156.4 33.66 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.364 -0.834 . . . . 0.20999999999999999 110.878 -177.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.491 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 23.4 t70 -87.11 67.02 9.58 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 123.401 1.572 . . . . 0.34999999999999998 108.399 172.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.781 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.9 m95 -54.25 -43.58 71.05 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.089 -2.323 . . . . 0.10000000000000001 112.997 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.424 ' N ' HG21 ' A' ' 108' ' ' THR . 3.3 t30 -50.15 -30.56 11.51 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.806 -1.543 . . . . 1.1100000000000001 111.743 177.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.48 -16.41 80.64 Favored Glycine 0 CA--C 1.501 -0.801 0 N-CA-C 111.358 -0.697 . . . . 0.20999999999999999 111.358 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.73 -49.77 4.26 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.118 -1.041 . . . . 0.13 110.736 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.732 ' O ' HG23 ' A' ' 72' ' ' VAL . 39.0 mtt -66.56 -57.65 6.83 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.089 -1.414 . . . . 0.089999999999999997 111.94 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.8 mm100 -38.75 -54.96 2.88 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 114.958 1.466 . . . . 0.63 114.958 -177.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.82 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 31.9 Cg_endo -63.46 -30.77 72.09 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 121.908 1.739 . . . . 0.14000000000000001 110.45 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.744 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 7.6 mtm -81.59 -45.63 15.57 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 115.123 -0.944 . . . . 0.69999999999999996 111.851 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 68' ' ' MET . 46.8 t -56.54 -39.86 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-N 114.217 -1.356 . . . . 0.12 108.751 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -59.39 -34.39 72.37 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.064 -1.88 . . . . 0.56000000000000005 111.052 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.82 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 17.2 mtpp -83.41 -33.86 25.64 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.069 0.461 . . . . 1.3 110.912 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.83 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.81 -26.35 68.31 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.291 -0.868 . . . . 0.5 111.295 -173.186 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.676 HD13 ' HB2' ' A' ' 118' ' ' LYS . 6.4 mt -94.11 -6.35 45.19 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.205 1.002 . . . . 0.65000000000000002 110.788 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.64 16.05 52.19 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 108.934 -1.666 . . . . 0.17000000000000001 108.934 170.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.653 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -86.36 165.7 16.18 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.598 -0.801 . . . . 0.10000000000000001 109.925 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -92.87 105.52 17.63 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.255 -0.884 . . . . 1.72 110.195 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.637 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.05 -22.48 3.59 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 115.138 -0.937 . . . . 0.12 111.051 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.83 HG11 ' O ' ' A' ' 75' ' ' MET . 9.9 p -99.53 154.77 4.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.519 0.676 . . . . 0.16 111.617 -174.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.6 m -135.0 135.01 41.05 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.692 -1.14 . . . . 0.45000000000000001 110.897 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.601 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -60.59 121.41 12.12 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.394 -0.821 . . . . 0.28000000000000003 110.66 168.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.1 4.6 23.96 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.979 -0.629 . . . . 0.28000000000000003 112.55 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.3 152.46 21.93 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.804 -0.359 . . . . 1.2 110.526 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.5 p -80.02 120.71 31.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.819 0.819 . . . . 0.20000000000000001 108.906 165.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.77 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -109.36 107.7 17.98 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.821 0.82 . . . . 0.14000000000000001 109.154 -172.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.668 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -72.11 97.35 1.91 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.228 -1.351 . . . . 0.14999999999999999 107.679 174.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.837 ' O ' HD11 ' A' ' 127' ' ' LEU . 1.2 m -70.88 125.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 105.82 -1.919 . . . . 0.94999999999999996 105.82 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.879 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 10.0 t0 -78.26 157.7 29.16 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.401 -1.333 . . . . 0.64000000000000001 107.401 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.641 ' OG ' ' HE3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -57.7 135.39 56.75 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 106.842 -1.54 . . . . 0.37 106.842 170.423 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.567 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 28.3 t -64.9 139.68 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.951 0 N-CA-C 107.777 -1.194 . . . . 0.10000000000000001 107.777 169.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.798 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.5 t-20 -84.11 162.45 20.28 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.016 -0.993 . . . . 0.17999999999999999 109.778 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.36 85.02 2.35 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.683 -1.144 . . . . 0.12 108.004 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.467 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.2 mtp180 -107.09 -3.16 20.25 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 113.9 -1.5 . . . . 0.64000000000000001 108.653 -172.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.748 HG21 ' HB3' ' A' ' 172' ' ' PRO . 28.6 p -50.57 -175.36 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.24 -1.8 . . . . 0.14000000000000001 114.271 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.4 OUTLIER -72.3 -8.56 55.54 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.206 -1.816 . . . . 0.47999999999999998 110.599 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.595 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -146.47 -148.91 4.87 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.751 -0.738 . . . . 0.12 112.843 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.635 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.3 p -121.45 130.3 53.49 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.329 0.492 . . . . 1.1599999999999999 112.329 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.758 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -135.16 157.81 45.97 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.954 0.883 . . . . 0.10000000000000001 111.028 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.704 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -77.74 80.4 4.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.579 -1.646 . . . . 0.17000000000000001 107.86 175.144 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -69.41 -15.43 63.29 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.873 -1.058 . . . . 0.089999999999999997 109.77 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.57 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.84 -29.19 40.07 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.609 -0.886 . . . . 0.14999999999999999 108.609 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.704 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 20.9 tt0 -63.61 -39.71 95.07 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.054 -1.43 . . . . 1.73 109.32 168.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -68.48 -44.64 74.33 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.005 -1.907 . . . . 0.12 108.928 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 51.1 m -64.88 -31.44 72.68 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 113.946 -1.479 . . . . 0.11 110.61 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -44.79 78.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.695 -1.224 . . . . 1.47 107.695 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.686 HG21 ' HB2' ' A' ' 64' ' ' TRP . 40.1 m -64.01 -31.7 72.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.173 -0.921 . . . . 0.12 110.945 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.707 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.7 mt -49.86 -69.7 0.11 Allowed 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.277 -0.638 . . . . 0.56000000000000005 109.277 171.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.548 ' O ' HD13 ' A' ' 121' ' ' LEU . 16.4 mtp180 -41.05 -39.75 1.29 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.508 1.13 . . . . 1.51 111.394 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.51 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.0 m-20 -68.89 -45.97 69.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.65 -1.159 . . . . 0.28000000000000003 112.012 -176.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.99 66.94 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.467 -0.938 . . . . 0.089999999999999997 108.467 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.69 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -59.58 -34.4 72.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.715 -1.584 . . . . 0.12 110.131 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.53 -39.11 67.8 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 114.662 -1.154 . . . . 0.20000000000000001 110.717 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -64.69 -24.58 67.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.709 -1.132 . . . . 1.1699999999999999 110.832 -176.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 m-80 -89.55 -25.18 21.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.648 -0.705 . . . . 2.0499999999999998 110.576 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 58.29 27.98 61.14 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.743 -0.662 . . . . 0.54000000000000004 114.147 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HB2' HD13 ' A' ' 76' ' ' LEU . 58.2 mtpt -110.87 -1.35 16.53 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.61 -0.515 . . . . 0.98999999999999999 109.61 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.77 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 40.1 m-85 -124.44 173.6 8.33 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.085 0.945 . . . . 0.20999999999999999 112.571 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.553 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.2 m -116.62 120.78 39.75 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 113.206 -1.815 . . . . 0.23000000000000001 107.532 169.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -89.85 146.23 24.58 Favored 'General case' 0 N--CA 1.415 -2.203 0 C-N-CA 119.344 -0.943 . . . . 0.38 111.223 -170.495 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.557 ' HB ' ' OE1' ' A' ' 126' ' ' GLN . 1.6 m -100.62 141.2 17.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.765 -1.198 . . . . 0.41999999999999998 107.765 170.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.409 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 1.4 m -96.04 -179.99 4.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.805 -0.758 . . . . 1.7 110.55 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.77 -30.37 69.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.785 0.802 . . . . 0.55000000000000004 109.035 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.631 ' O ' ' HG3' ' A' ' 129' ' ' MET . 31.9 mt-30 -44.48 -41.5 6.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.188 -1.823 . . . . 2.04 111.771 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.557 ' OE1' ' HB ' ' A' ' 122' ' ' VAL . 47.7 mt-30 -98.52 -48.02 5.16 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.79 0.805 . . . . 0.40999999999999998 110.283 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.837 HD11 ' O ' ' A' ' 89' ' ' VAL . 5.8 tt -64.97 -66.37 0.55 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.4 -1.727 . . . . 1.3899999999999999 113.284 -166.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.639 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.0 OUTLIER -53.17 -42.9 66.64 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 123.618 1.675 . . . . 1.05 109.208 -178.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.71 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 6.3 mmt -55.29 -62.85 1.4 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 110.942 -2.845 . . . . 1.6399999999999999 111.13 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.758 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.27 -44.4 5.37 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.106 0.879 . . . . 0.31 111.833 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.641 ' HE3' ' OG ' ' A' ' 91' ' ' SER . 4.0 mptp? -49.28 -65.02 0.64 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.287 -0.634 . . . . 1.53 109.287 175.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 37.2 mt-30 -54.06 -45.49 71.71 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.895 -1.048 . . . . 0.40999999999999998 112.001 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.71 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.4 mt-30 -55.65 -36.37 66.97 Favored 'General case' 0 CA--C 1.488 -1.424 0 CA-C-N 114.843 -1.071 . . . . 0.37 109.916 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -90.47 -29.39 17.96 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.172 -1.376 . . . . 0.23999999999999999 109.57 -176.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.07 -38.68 0.73 Allowed Glycine 0 CA--C 1.497 -1.069 0 C-N-CA 119.558 -1.306 . . . . 0.33000000000000002 113.933 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 141' ' ' SER . 92.1 mt -73.12 -173.49 1.3 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 123.94 1.829 . . . . 0.31 115.275 -167.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 15.3 m -109.4 147.85 36.86 Favored Pre-proline 0 N--CA 1.42 -1.944 0 CA-C-N 110.72 -2.945 . . . . 0.81000000000000005 107.984 168.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.639 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 34.3 Cg_endo -63.78 1.2 1.54 Allowed 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 123.058 2.505 . . . . 0.32000000000000001 112.176 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.57 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -117.1 -22.25 8.47 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.136 0.969 . . . . 1.25 110.251 -178.187 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 141' ' ' SER . 17.2 t70 -61.0 -24.29 66.04 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 112.963 -1.926 . . . . 0.65000000000000002 109.211 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.68 ' O ' HD13 ' A' ' 136' ' ' LEU . 14.0 m 74.42 174.83 0.26 Allowed 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 125.942 2.026 . . . . 0.59999999999999998 108.468 -170.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.1 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.4 mt -69.76 -39.72 76.52 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.21 -1.033 . . . . 0.85999999999999999 108.21 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.41 -12.0 0.73 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 113.276 -1.783 . . . . 0.31 114.41 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.96 125.11 7.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.605 -0.712 . . . . 0.23999999999999999 109.118 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.711 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -40.86 -47.95 3.01 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 118.075 0.398 . . . . 1.6499999999999999 111.81 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 149' ' ' ILE . 32.3 t -71.25 -29.22 64.83 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.391 0.615 . . . . 0.53000000000000003 111.592 -175.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -71.15 -27.57 63.64 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.681 1.229 . . . . 1.3100000000000001 108.374 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 1.1 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -78.6 -47.88 16.26 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 112.287 -2.233 . . . . 0.12 110.395 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.648 HG13 ' HE1' ' A' ' 179' ' ' MET . 36.7 mt -65.28 -42.12 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 112.837 -1.983 . . . . 0.11 110.252 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.3 -56.76 15.69 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.778 -1.101 . . . . 0.14999999999999999 110.964 171.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.758 HG23 ' CB ' ' A' ' 130' ' ' ALA . 70.8 mt -63.99 -47.73 89.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 N-CA-C 112.458 0.54 . . . . 0.17999999999999999 112.458 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.635 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.13 -42.01 76.24 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 123.241 0.338 . . . . 0.13 110.682 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.469 ' HD2' HG23 ' A' ' 149' ' ' ILE . 29.5 mtp180 -80.5 -23.05 40.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.643 0.735 . . . . 1.0800000000000001 110.795 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -80.9 -12.99 59.31 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.424 -1.324 . . . . 0.5 107.424 176.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.699 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.49 -29.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 112.987 -1.915 . . . . 0.17000000000000001 110.741 -175.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.46 34.19 5.11 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.59 -0.814 . . . . 0.16 112.612 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.668 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.66 159.81 16.44 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.912 0.708 . . . . 0.12 112.912 -169.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.687 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.5 m80 -99.29 -28.21 13.42 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.212 -0.904 . . . . 0.20000000000000001 109.323 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.575 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.6 m-85 -136.26 -176.91 4.48 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.963 -1.017 . . . . 0.13 111.008 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.687 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -134.06 141.34 44.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.665 -1.152 . . . . 0.080000000000000002 108.609 167.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.66 HD21 ' SD ' ' A' ' 176' ' ' MET . 29.9 tp -110.21 100.39 9.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.666 -0.814 . . . . 0.16 109.441 165.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.545 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.0 m-85 -79.06 112.45 16.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.579 -1.192 . . . . 0.26000000000000001 108.899 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.855 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 5.5 t -126.09 161.91 26.54 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-O 121.956 0.884 . . . . 1.05 110.691 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.853 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.7 p -162.83 177.59 9.16 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.23 -1.35 . . . . 0.10000000000000001 111.141 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -140.85 133.77 29.13 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.175 -1.375 . . . . 0.11 108.551 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -143.36 -176.61 5.01 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.307 -0.557 . . . . 1.0900000000000001 109.592 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.39 -81.37 0.94 Allowed Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.669 -1.253 . . . . 0.14999999999999999 111.873 172.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 53.1 t-20 -142.2 127.37 18.58 Favored 'General case' 0 C--O 1.197 -1.681 0 N-CA-C 106.747 -1.575 . . . . 0.58999999999999997 106.747 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.595 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.9 p -63.25 -41.13 91.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-N 115.438 -0.801 . . . . 0.14999999999999999 112.125 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.426 ' N ' HG13 ' A' ' 169' ' ' VAL . 91.9 m-20 -65.14 -28.45 69.43 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.317 0.579 . . . . 1.26 110.496 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.51 88.47 3.35 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 114.571 -1.195 . . . . 0.13 108.138 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.79 ' HD2' HG22 ' A' ' 194' ' ' VAL . 50.9 Cg_endo -90.09 164.96 4.75 Favored 'Trans proline' 0 CA--C 1.491 -1.658 0 C-N-CA 124.56 3.507 . . . . 0.089999999999999997 114.998 -170.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 191' ' ' LYS . 20.6 m -84.4 117.83 23.87 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.898 -1.501 . . . . 0.14000000000000001 107.628 166.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 164' ' ' SER . 40.4 tp -84.23 99.47 10.58 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.58 -0.896 . . . . 0.16 108.58 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.624 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.3 mt-30 -90.69 109.41 20.59 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-O 122.063 0.935 . . . . 0.34000000000000002 109.634 -175.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.855 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -112.84 164.36 13.5 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.958 -1.019 . . . . 1.0900000000000001 111.789 -172.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.61 ' HG2' HD12 ' A' ' 186' ' ' ILE . 55.9 tt0 -171.56 116.84 0.41 Allowed 'General case' 0 C--O 1.202 -1.395 0 CA-C-N 115.98 -0.555 . . . . 0.5 109.967 -166.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.03 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -99.23 101.53 12.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.554 -0.906 . . . . 0.10000000000000001 108.554 -171.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.711 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 18.4 ttp -91.18 122.69 34.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.404 -0.816 . . . . 0.070000000000000007 109.87 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.81 126.35 27.29 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.234 -1.395 . . . . 0.22 107.234 165.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.62 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -80.91 -35.68 14.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 119.303 -0.959 . . . . 0.11 110.72 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.428 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.8 mt-30 -60.57 -16.99 43.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.328 -0.851 . . . . 0.34999999999999998 111.603 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.8 p -129.33 -37.37 1.64 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.969 0.89 . . . . 0.19 110.155 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.546 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.5 23.67 28.15 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 114.402 -1.272 . . . . 0.17999999999999999 112.293 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.81 156.88 17.11 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.607 0.241 . . . . 0.72999999999999998 110.672 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 177' ' ' GLN . 37.9 mm -92.87 114.94 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.543 0.687 . . . . 0.14000000000000001 109.597 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.03 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -102.22 -31.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.878 -1.055 . . . . 0.13 110.603 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.656 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.9 t90 -135.59 153.33 51.71 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.487 -0.779 . . . . 0.070000000000000007 109.87 173.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 28.0 p -153.61 163.4 40.05 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.157 0.799 . . . . 0.13 113.157 164.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.38 -175.47 31.41 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 110.839 -0.904 . . . . 0.12 110.839 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.4 mtmt -158.25 151.14 22.59 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.421 -2.066 . . . . 1.22 105.421 166.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -160.88 127.75 1.81 Allowed Glycine 0 C--N 1.281 -2.515 0 C-N-CA 119.879 -1.153 . . . . 0.12 112.195 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.39 118.16 14.93 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.444 0.64 . . . . 0.17000000000000001 111.199 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.79 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -93.34 158.5 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-O 122.42 1.105 . . . . 0.11 109.868 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.673 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -97.98 171.46 8.26 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 112.879 -1.964 . . . . 0.17999999999999999 109.581 -173.042 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.1 tt0 -103.09 127.48 50.35 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.984 -0.747 . . . . 0.91000000000000003 108.984 166.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 14.2 mm-40 . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 118.724 -0.655 . . . . 1.24 110.817 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 112.147 -0.381 . . . . 88.609999999999999 112.147 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 t -147.34 149.73 33.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.18 -0.674 . . . . 87.430000000000007 109.18 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -84.19 158.21 21.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.679 0.276 . . . . 87.159999999999997 110.686 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.1 ptp 48.29 34.91 4.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.559 1.144 . . . . 85.340000000000003 112.734 176.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -112.3 -30.51 2.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.007 -0.997 . . . . 85.049999999999997 109.286 175.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.68 -98.39 0.35 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.191 -1.163 . . . . 84.680000000000007 110.191 173.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 53.5 mt-30 51.59 98.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.169 0.587 . . . . 85.569999999999993 112.582 175.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.517 ' NE ' ' HA ' ' A' ' 8' ' ' ARG . 4.2 mmp_? 70.93 41.32 0.84 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.086 -0.961 . . . . 85.040000000000006 110.7 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 175.36 140.04 0.2 Allowed Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.714 -1.584 . . . . 82.170000000000002 109.341 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.67 122.48 10.6 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.569 2.179 . . . . 81.510000000000005 111.683 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.11 105.83 50.6 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.101 -0.499 . . . . 79.560000000000002 110.159 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -71.74 -178.04 2.86 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.7 2.266 . . . . 78.5 113.891 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -52.45 162.48 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.912 -1.04 . . . . 77.0 112.728 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -87.56 51.72 2.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.176 -0.92 . . . . 75.739999999999995 110.622 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -111.25 146.64 36.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 73.909999999999997 110.293 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.77 128.53 23.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.993 -1.003 . . . . 72.299999999999997 110.07 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -71.82 130.99 86.21 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.166 -0.47 . . . . 71.219999999999999 110.92 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.5 142.54 95.38 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.477 2.118 . . . . 69.670000000000002 110.75 171.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.13 86.71 0.14 Allowed Pre-proline 0 C--O 1.234 0.278 0 CA-C-O 121.133 0.492 . . . . 67.549999999999997 110.644 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.27 27.79 0.41 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.55 2.833 . . . . 66.700000000000003 112.451 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 73.1 -44.78 0.6 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.451 0.7 . . . . 65.010000000000005 110.893 -175.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 4.5 pp0? -140.66 128.73 12.56 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.799 -0.445 . . . . 63.409999999999997 109.799 173.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 60.6 Cg_exo -60.96 148.12 93.59 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.144 2.563 . . . . 61.93 113.043 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -141.64 79.77 1.69 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.38 0.609 . . . . 59.869999999999997 110.419 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -135.78 136.0 22.74 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.343 -0.844 . . . . 58.469999999999999 110.97 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.2 -61.55 0.59 Allowed 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 122.652 2.234 . . . . 57.359999999999999 112.116 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.446 ' HG2' ' N ' ' A' ' 28' ' ' GLN . 34.7 tt0 69.76 163.02 0.24 Allowed 'General case' 0 CA--C 1.532 0.26 0 O-C-N 124.158 0.911 . . . . 55.509999999999998 110.693 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.446 ' N ' ' HG2' ' A' ' 27' ' ' GLN . 79.3 mt-30 66.88 67.19 0.64 Allowed Pre-proline 0 C--O 1.225 -0.222 0 CA-C-N 114.115 -1.402 . . . . 53.869999999999997 110.914 -176.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.05 131.19 35.68 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 121.887 1.725 . . . . 52.759999999999998 112.296 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t 52.56 70.38 1.9 Allowed Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 113.62 -1.627 . . . . 50.93 111.209 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.84 -9.75 26.83 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.588 2.192 . . . . 49.210000000000001 112.606 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 p -103.38 146.19 28.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 47.490000000000002 110.948 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 p -163.1 95.93 1.09 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 121.367 0.604 . . . . 45.969999999999999 110.703 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -56.92 155.59 27.27 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.869 2.38 . . . . 45.280000000000001 111.824 176.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.5 m -157.34 132.02 8.64 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.819 -0.628 . . . . 42.789999999999999 110.536 -175.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.0 t 61.38 84.4 0.19 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.327 -0.851 . . . . 40.789999999999999 110.727 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.32 -29.28 54.63 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.144 2.563 . . . . 39.810000000000002 112.43 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 12.8 t -78.14 158.65 29.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.038 -0.528 . . . . 37.5 109.766 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.2 mt -91.99 106.99 19.57 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.895 -0.593 . . . . 35.649999999999999 110.443 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 38' ' ' THR . 73.9 Cg_endo -76.52 -10.04 18.74 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.464 2.11 . . . . 33.719999999999999 111.849 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -85.91 93.92 9.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.744 -0.662 . . . . 31.510000000000002 109.595 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -81.91 135.78 48.2 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.16 -0.473 . . . . 30.129999999999999 110.625 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.64 164.74 34.71 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.376 2.051 . . . . 29.52 112.235 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.19 179.82 19.58 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.694 -0.765 . . . . 26.75 111.617 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.86 133.26 28.78 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.648 2.232 . . . . 25.079999999999998 111.132 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.5 mt -61.06 -42.49 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.274 -0.875 . . . . 23.899999999999999 110.498 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -51.46 104.29 0.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.935 -1.03 . . . . 21.23 111.26 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -123.54 175.08 7.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.843 -0.617 . . . . 19.920000000000002 110.265 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -126.42 166.49 17.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.987 -0.551 . . . . 16.559999999999999 111.182 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -99.43 74.42 1.91 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 15.050000000000001 110.424 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -66.1 162.6 19.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.621 -0.718 . . . . 14.19 111.517 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.5 p 66.09 160.43 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.065 1.346 . . . . 11.380000000000001 111.925 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.01 87.23 50.99 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 115.171 -0.922 . . . . 8.2899999999999991 110.827 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 9.2 Cg_exo -71.3 158.01 55.54 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.892 2.395 . . . . 6.8700000000000001 112.03 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.22 -49.4 17.6 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.35 2.033 . . . . 5.04 112.891 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -119.49 80.17 22.06 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.223 -0.444 . . . . 2.5899999999999999 110.434 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 98.1 Cg_endo -75.15 -176.3 2.83 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.155 2.57 . . . . 1.6399999999999999 113.134 -176.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -126.98 148.57 50.09 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.418 -1.265 . . . . 3.3900000000000001 109.43 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 60' ' ' ARG . 8.9 mt -88.84 167.91 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.767 0.794 . . . . 0.44 111.239 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 59' ' ' ILE . 29.9 mtt-85 -69.79 -159.9 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 113.717 -1.583 . . . . 2.3399999999999999 111.709 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.646 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 38.7 m80 -147.58 141.07 25.4 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 112.535 -2.12 . . . . 2.2200000000000002 107.215 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.771 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 1.8 m-30 -126.36 155.62 41.78 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.76 -0.654 . . . . 0.20999999999999999 110.919 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 11.5 t70 -82.66 67.98 8.94 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 123.481 1.61 . . . . 0.34999999999999998 108.627 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.771 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 93.3 m95 -60.51 -43.75 96.73 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 112.14 -2.3 . . . . 0.10000000000000001 112.312 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 4.2 t30 -52.3 -29.0 21.23 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.064 -1.425 . . . . 1.1100000000000001 111.211 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.37 -16.48 80.69 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 115.35 -0.841 . . . . 0.20999999999999999 111.295 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.97 -51.64 3.49 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.183 -1.009 . . . . 0.13 110.959 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.718 ' SD ' HD23 ' A' ' 109' ' ' LEU . 38.5 mtt -65.61 -56.63 11.21 Favored 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 114.086 -1.415 . . . . 0.089999999999999997 112.517 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.459 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.6 mm100 -40.21 -54.57 4.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 114.732 1.382 . . . . 0.63 114.732 -176.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.802 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.2 Cg_endo -64.27 -30.09 63.95 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 121.916 1.744 . . . . 0.14000000000000001 110.664 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.673 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 7.7 mtm -81.62 -44.59 17.0 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 115.165 -0.925 . . . . 0.69999999999999996 111.826 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 68' ' ' MET . 49.0 t -56.74 -39.54 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-N 114.279 -1.328 . . . . 0.12 108.443 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.6 t -59.67 -32.62 70.64 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.049 -1.887 . . . . 0.56000000000000005 111.177 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.2 mtpt -85.98 -33.29 21.14 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.929 0.395 . . . . 1.3 111.046 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.851 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.65 -27.64 69.07 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.484 -0.78 . . . . 0.5 111.786 -171.319 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.548 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.0 mt -93.05 -5.68 49.94 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.94 0.876 . . . . 0.65000000000000002 111.257 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.14 15.29 47.56 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.201 -1.559 . . . . 0.17000000000000001 109.201 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.641 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -83.47 165.99 18.69 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.409 -0.895 . . . . 0.10000000000000001 111.148 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.52 105.68 14.65 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.876 -1.056 . . . . 1.72 110.382 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.606 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 129.25 -21.12 5.22 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.151 -1.023 . . . . 0.12 111.175 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.851 HG11 ' O ' ' A' ' 75' ' ' MET . 11.2 p -100.81 149.42 6.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.896 0.855 . . . . 0.16 110.837 -176.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.3 m -136.19 142.27 44.1 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.197 -1.365 . . . . 0.45000000000000001 109.701 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.736 ' HB2' ' HD2' ' A' ' 118' ' ' LYS . . . -62.37 136.21 57.81 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.54 -0.755 . . . . 0.28000000000000003 110.754 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.08 9.54 39.14 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.957 -0.64 . . . . 0.28000000000000003 112.777 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.37 152.03 18.75 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.742 -0.383 . . . . 1.2 110.711 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.685 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -80.95 120.12 31.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 122.015 0.912 . . . . 0.20000000000000001 109.103 165.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.666 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -107.45 110.57 22.55 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.137 -0.938 . . . . 0.14000000000000001 108.799 -172.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.715 HD21 HD13 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -70.67 99.39 1.67 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 114.786 -1.097 . . . . 0.14999999999999999 108.419 179.484 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.454 HG11 ' HG3' ' A' ' 110' ' ' ARG . 85.3 t -72.82 108.93 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 114.324 -1.307 . . . . 0.94999999999999996 108.416 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.806 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 6.8 t0 -77.79 154.56 31.8 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.982 -1.118 . . . . 0.64000000000000001 107.982 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.556 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.37 138.14 57.75 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.588 -1.264 . . . . 0.37 107.588 171.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.505 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 26.3 t -66.5 141.08 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.633 0 N-CA-C 107.904 -1.147 . . . . 0.10000000000000001 107.904 168.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.789 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.8 t-20 -86.2 163.08 18.0 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.459 -0.792 . . . . 0.17999999999999999 109.917 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.763 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 1.8 t-20 -126.01 84.84 2.32 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.669 -1.15 . . . . 0.12 108.29 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 13.7 mtp180 -108.97 -2.1 18.51 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.076 -1.42 . . . . 0.64000000000000001 108.705 -171.106 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.748 HG21 ' HB3' ' A' ' 172' ' ' PRO . 17.6 p -50.7 -172.07 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 112.608 -2.087 . . . . 0.14000000000000001 115.483 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.0 t30 -67.71 -13.1 61.81 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.028 -1.896 . . . . 0.47999999999999998 110.558 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.579 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -148.86 -146.26 4.29 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.592 -0.813 . . . . 0.12 112.884 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.618 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 49.2 m -122.15 129.0 51.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.943 0.402 . . . . 1.1599999999999999 111.134 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.763 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -132.12 159.29 39.34 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.525 0.678 . . . . 0.10000000000000001 110.054 -177.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.709 ' ND2' ' HB2' ' A' ' 104' ' ' GLU . 56.8 t30 -81.37 82.25 7.26 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.317 -1.311 . . . . 0.17000000000000001 108.229 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.608 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -69.25 -15.13 63.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.205 -1.361 . . . . 0.089999999999999997 109.907 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.463 ' HB2' ' CG ' ' A' ' 139' ' ' GLN . . . -78.28 -30.33 48.42 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.999 -0.741 . . . . 0.14999999999999999 108.999 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.709 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 14.2 tp10 -65.64 -35.2 80.12 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.784 1.278 . . . . 1.73 108.936 170.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.9 -45.9 63.48 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 112.832 -1.985 . . . . 0.12 109.366 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.6 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 55.9 m -63.87 -34.13 77.26 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.064 -1.426 . . . . 0.11 110.527 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -42.03 85.39 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.884 -1.154 . . . . 1.47 107.884 173.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.659 HG21 ' HB2' ' A' ' 64' ' ' TRP . 60.0 m -65.45 -30.99 71.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.252 -0.885 . . . . 0.12 110.984 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.718 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.21 -69.54 0.11 Allowed 'General case' 0 CA--C 1.492 -1.265 0 CA-C-N 115.781 -0.645 . . . . 0.56000000000000005 109.282 172.04 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.543 ' O ' HD13 ' A' ' 121' ' ' LEU . 60.1 mtp180 -40.64 -37.61 0.76 Allowed 'General case' 0 C--N 1.311 -1.073 0 O-C-N 124.3 1.0 . . . . 1.51 111.499 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 108' ' ' THR . 5.4 m-20 -70.79 -46.24 63.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.716 -1.129 . . . . 0.28000000000000003 112.067 -177.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.4 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.47 -33.52 64.89 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.156 0.979 . . . . 0.089999999999999997 108.532 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -63.58 -33.95 76.74 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.454 -1.703 . . . . 0.12 109.918 172.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.642 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -76.09 -43.51 43.11 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.763 -1.108 . . . . 0.20000000000000001 111.226 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.28 -38.49 65.94 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.562 -1.199 . . . . 1.1699999999999999 110.414 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.528 ' OD1' ' HG3' ' A' ' 118' ' ' LYS . 12.2 t-20 -69.11 -47.59 64.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 113.382 -1.736 . . . . 2.0499999999999998 109.398 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.53 -8.39 68.81 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 116.033 -0.531 . . . . 0.54000000000000004 113.762 171.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.736 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 15.6 mtmm -72.67 -33.93 66.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.096 -0.642 . . . . 0.98999999999999999 111.154 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.704 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 15.1 m-85 -90.92 176.91 6.44 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 122.328 1.061 . . . . 0.20999999999999999 112.526 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.508 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.8 m -120.8 117.61 27.86 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 112.85 -1.977 . . . . 0.23000000000000001 108.151 168.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.676 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -88.63 132.85 34.38 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 115.362 -0.836 . . . . 0.38 110.367 -171.525 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.584 HG11 HD23 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -78.33 155.37 5.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 109.057 -0.72 . . . . 0.41999999999999998 109.057 177.04 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.597 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 57.7 m -100.38 160.85 14.01 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.079 0.942 . . . . 1.7 110.55 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.08 -27.99 65.06 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 113.322 -1.763 . . . . 0.55000000000000004 110.453 -173.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.691 ' O ' ' HG3' ' A' ' 129' ' ' MET . 9.4 pt20 -55.22 -27.9 49.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.363 -1.744 . . . . 2.04 110.518 172.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.617 ' HB2' HG22 ' A' ' 155' ' ' VAL . 17.9 mt-30 -97.73 -57.0 2.34 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.206 -1.361 . . . . 0.40999999999999998 110.106 172.236 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.715 HD13 HD21 ' A' ' 88' ' ' LEU . 17.7 tp -65.57 -67.4 0.44 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.063 -1.426 . . . . 1.3899999999999999 113.603 -168.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 56.8 m -52.09 -40.58 61.46 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 123.37 1.557 . . . . 1.05 109.116 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.702 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 13.6 mmt -57.26 -62.63 1.63 Allowed 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 111.177 -2.738 . . . . 1.6399999999999999 111.002 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.776 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.22 -45.43 4.12 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 124.38 1.05 . . . . 0.31 111.875 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.571 ' HA ' HD11 ' A' ' 151' ' ' ILE . 1.0 OUTLIER -53.55 -53.6 49.26 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 108.954 -0.758 . . . . 1.53 108.954 178.658 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 128' ' ' SER . 37.5 mt-30 -64.23 -39.77 94.67 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.466 -0.788 . . . . 0.40999999999999998 111.128 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.702 ' HG3' ' O ' ' A' ' 129' ' ' MET . 53.0 mt-30 -59.0 -34.66 72.11 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 114.354 -1.294 . . . . 0.37 109.83 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -91.7 -28.79 17.21 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 114.243 -1.344 . . . . 0.23999999999999999 109.644 -176.259 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.58 -42.92 0.7 Allowed Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 119.894 -1.146 . . . . 0.33000000000000002 113.426 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 141' ' ' SER . 94.0 mt -69.9 -171.46 0.42 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 124.102 1.906 . . . . 0.31 115.472 -169.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 32.1 m -114.89 153.93 46.99 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 110.353 -3.112 . . . . 0.81000000000000005 107.194 174.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.623 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 64.6 Cg_endo -68.91 1.22 4.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.416 2.077 . . . . 0.32000000000000001 110.91 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.463 ' CG ' ' HB2' ' A' ' 103' ' ' ALA . 20.8 mt-30 -117.56 -23.35 7.72 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.132 -1.395 . . . . 1.25 111.031 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 14.3 t70 -69.05 -22.14 64.05 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 114.515 -1.22 . . . . 0.65000000000000002 108.879 -169.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.588 ' O ' HD13 ' A' ' 136' ' ' LEU . 32.3 m 71.76 166.94 0.3 Allowed 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 112.485 -2.143 . . . . 0.59999999999999998 109.578 -170.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.982 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.6 mt -65.48 -40.15 92.78 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 122.191 0.996 . . . . 0.85999999999999999 108.317 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.14 -12.18 0.27 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 113.047 -1.888 . . . . 0.31 114.476 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.25 123.3 7.57 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.023 -0.732 . . . . 0.23999999999999999 109.023 -173.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.664 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -42.43 -45.56 4.43 Favored 'General case' 0 C--O 1.213 -0.843 0 O-C-N 123.394 0.434 . . . . 1.6499999999999999 111.73 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -73.93 -25.49 60.01 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.676 0.751 . . . . 0.53000000000000003 111.407 -174.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -73.55 -30.47 63.07 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.634 1.207 . . . . 1.3100000000000001 108.331 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.982 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -75.41 -47.72 26.09 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 112.577 -2.102 . . . . 0.12 110.36 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.62 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.6 mt -65.49 -41.46 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-N 112.88 -1.964 . . . . 0.11 110.44 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.12 -53.53 36.8 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.67 -1.15 . . . . 0.14999999999999999 111.25 171.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.776 HG23 ' CB ' ' A' ' 130' ' ' ALA . 83.9 mt -66.67 -48.3 80.58 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 N-CA-C 112.172 0.434 . . . . 0.17999999999999999 112.172 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.682 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -54.43 -44.46 72.46 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 123.603 0.565 . . . . 0.13 111.248 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.459 ' NE ' HG23 ' A' ' 149' ' ' ILE . 49.7 mtt180 -78.76 -23.14 45.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.295 0.569 . . . . 1.0800000000000001 110.882 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -81.6 -13.66 57.72 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.641 -1.244 . . . . 0.5 107.641 175.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.703 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.01 -28.91 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 113.313 -1.767 . . . . 0.17000000000000001 111.041 -173.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.423 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.88 34.85 4.76 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.261 -0.971 . . . . 0.16 112.365 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.619 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.91 157.34 19.34 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.886 0.698 . . . . 0.12 112.886 -170.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.685 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.8 m80 -98.92 -28.63 13.35 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.137 -0.938 . . . . 0.20000000000000001 109.425 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.567 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.1 m-85 -135.13 -173.97 3.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.063 -0.971 . . . . 0.13 110.856 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.703 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -136.97 139.97 43.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.13 -0.941 . . . . 0.080000000000000002 108.93 166.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 40.1 tp -107.8 100.12 9.52 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.237 -0.985 . . . . 0.16 109.318 165.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.7 m-85 -80.39 116.65 20.57 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.226 -1.352 . . . . 0.26000000000000001 108.577 176.485 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.868 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 4.7 t -129.01 162.55 27.36 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.948 0.88 . . . . 1.05 110.607 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.831 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.4 p -162.4 176.24 10.7 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.4 -1.273 . . . . 0.10000000000000001 110.971 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -137.91 134.76 35.38 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.086 -1.416 . . . . 0.11 108.513 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.4 m -144.19 -176.0 4.84 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.278 -0.638 . . . . 1.0900000000000001 109.278 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -84.21 0.92 Allowed Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.824 -1.179 . . . . 0.14999999999999999 111.407 173.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.3 t30 -144.49 128.19 17.2 Favored 'General case' 0 C--O 1.197 -1.665 0 N-CA-C 107.921 -1.141 . . . . 0.58999999999999997 107.921 176.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.579 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.7 p -63.22 -41.77 94.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.136 -0.938 . . . . 0.14999999999999999 112.334 -172.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.41 ' N ' HG13 ' A' ' 169' ' ' VAL . 42.4 m-20 -59.17 -31.67 69.2 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.49 0.662 . . . . 1.26 109.552 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.05 89.2 3.11 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 114.329 -1.305 . . . . 0.13 108.351 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.8 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.5 Cg_endo -90.49 166.98 4.23 Favored 'Trans proline' 0 CA--C 1.494 -1.492 0 C-N-CA 124.481 3.454 . . . . 0.089999999999999997 114.815 -169.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.3 m -85.75 120.19 26.91 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 113.904 -1.498 . . . . 0.14000000000000001 107.369 165.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 164' ' ' SER . 44.4 tp -84.68 98.66 10.34 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 108.714 -0.847 . . . . 0.16 108.714 176.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.576 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -89.93 109.39 20.41 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 122.097 0.951 . . . . 0.34000000000000002 109.265 -176.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.868 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.9 OUTLIER -112.48 163.83 14.0 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.76 -1.109 . . . . 1.0900000000000001 111.538 -173.286 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.609 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.5 tt0 -170.67 119.02 0.53 Allowed 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.89 -0.596 . . . . 0.5 109.98 -166.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.049 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.25 100.15 10.64 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.671 -0.863 . . . . 0.10000000000000001 108.671 -173.268 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.664 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.8 ttp -89.42 123.06 33.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.433 -0.803 . . . . 0.070000000000000007 109.548 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.2 OUTLIER -59.63 127.36 31.64 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.892 -1.522 . . . . 0.22 106.892 166.491 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.93 -35.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 O-C-N 121.131 -0.981 . . . . 0.11 110.904 179.214 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.458 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 28.9 mt-30 -61.68 -16.2 46.79 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 0.34999999999999998 111.087 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 73.9 p -129.66 -37.05 1.59 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.752 0.786 . . . . 0.19 110.199 178.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.552 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.82 24.88 26.51 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 114.701 -1.136 . . . . 0.17999999999999999 112.387 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -103.85 156.4 17.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.679 0.276 . . . . 0.72999999999999998 110.481 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.609 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.1 mm -89.22 117.0 31.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.552 0.692 . . . . 0.14000000000000001 109.335 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.049 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -104.99 -30.54 2.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.098 -0.955 . . . . 0.13 110.341 -174.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.661 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.0 t90 -136.42 152.22 50.36 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.397 -0.819 . . . . 0.070000000000000007 109.417 172.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 77.2 p -153.59 163.32 40.18 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.891 -0.724 . . . . 0.13 112.926 163.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.44 -174.93 28.78 Favored Glycine 0 N--CA 1.425 -2.047 0 N-CA-C 110.885 -0.886 . . . . 0.12 110.885 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.8 mtmt -158.96 151.28 21.4 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.383 -2.08 . . . . 1.22 105.383 165.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -159.43 127.24 1.79 Allowed Glycine 0 C--N 1.278 -2.676 0 C-N-CA 119.623 -1.275 . . . . 0.12 112.108 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.17 115.08 10.98 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.404 0.621 . . . . 0.17000000000000001 111.065 -174.535 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.8 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -91.87 158.45 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-O 122.59 1.186 . . . . 0.11 110.181 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.85 172.26 7.04 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 112.564 -2.107 . . . . 0.17999999999999999 109.166 -174.265 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.9 tt0 -100.42 130.65 46.53 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.261 -0.644 . . . . 0.91000000000000003 109.261 169.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.494 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 26.7 mm-40 . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 115.883 -0.599 . . . . 1.24 110.138 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.674 0 N-CA-C 111.884 -0.486 . . . . 88.609999999999999 111.884 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.494 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 44.9 m -142.43 28.11 1.67 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.61 -0.347 . . . . 87.430000000000007 111.446 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.441 ' O ' HG23 ' A' ' 5' ' ' VAL . 96.6 m-70 -71.34 116.78 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 87.159999999999997 110.247 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.2 ttp 51.58 44.02 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.897 0.856 . . . . 85.340000000000003 110.127 -171.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 2' ' ' SER . 97.3 t -130.73 -46.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.831 -1.077 . . . . 85.049999999999997 109.897 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.35 -112.47 1.34 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.625 -0.798 . . . . 84.680000000000007 112.151 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -118.27 -168.46 1.53 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 123.013 -0.11 . . . . 85.569999999999993 111.085 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 0.1 OUTLIER 53.29 63.85 2.07 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.773 0.671 . . . . 85.040000000000006 111.663 -176.665 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 44.0 tt0 175.05 -52.97 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 114.822 -1.081 . . . . 82.170000000000002 110.903 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 9' ' ' GLU . 10.2 Cg_endo -51.76 105.67 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.543 2.162 . . . . 81.510000000000005 112.618 177.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.13 77.07 1.19 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.23 -0.441 . . . . 79.560000000000002 110.087 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.68 140.54 81.4 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.159 1.906 . . . . 78.5 112.318 -176.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.05 160.26 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.439 0.638 . . . . 77.0 111.233 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.89 133.34 41.37 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.206 -0.906 . . . . 75.739999999999995 109.774 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -135.63 92.79 2.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.134 0.492 . . . . 73.909999999999997 111.08 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 p -69.12 109.03 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.488 -0.778 . . . . 72.299999999999997 109.994 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -112.16 101.05 51.19 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.847 -0.615 . . . . 71.219999999999999 110.32 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.23 -48.51 17.48 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.076 1.85 . . . . 69.670000000000002 111.899 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.05 65.69 4.63 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-N 114.714 -1.13 . . . . 67.549999999999997 111.709 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.79 155.86 39.43 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.078 1.852 . . . . 66.700000000000003 112.169 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -173.03 137.78 0.73 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.076 -0.511 . . . . 65.010000000000005 110.207 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -138.02 125.64 13.82 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.149 -0.686 . . . . 63.409999999999997 109.149 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -49.81 137.13 35.25 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.95 2.434 . . . . 61.93 112.826 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -119.5 98.11 5.98 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.223 -0.899 . . . . 59.869999999999997 110.207 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -112.16 139.48 22.51 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.978 -0.555 . . . . 58.469999999999999 110.374 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.17 129.02 20.68 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.958 1.772 . . . . 57.359999999999999 111.834 177.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -115.44 68.21 0.71 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.698 0.761 . . . . 55.509999999999998 109.94 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -120.32 84.34 34.67 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.511 -0.768 . . . . 53.869999999999997 110.096 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.48 157.27 28.88 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.285 1.99 . . . . 52.759999999999998 112.161 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.5 p -158.71 76.74 3.33 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 122.089 0.947 . . . . 50.93 110.365 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -86.78 102.77 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.212 2.608 . . . . 49.210000000000001 111.287 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.4 p -85.53 141.48 29.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.177 -0.465 . . . . 47.490000000000002 111.592 -175.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.36 82.31 68.18 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.976 -0.557 . . . . 45.969999999999999 110.185 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -64.13 156.28 60.06 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.175 2.584 . . . . 45.280000000000001 112.749 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.0 m -157.21 120.78 4.15 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.413 -0.812 . . . . 42.789999999999999 109.988 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.51 103.9 55.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.101 -0.499 . . . . 40.789999999999999 110.658 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -59.29 150.33 75.18 Favored 'Trans proline' 0 CA--C 1.52 -0.194 0 C-N-CA 122.67 2.246 . . . . 39.810000000000002 111.962 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 93.1 m -145.55 124.39 12.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.238 -0.437 . . . . 37.5 110.459 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.7 mt -96.26 115.03 65.37 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.767 -0.651 . . . . 35.649999999999999 110.905 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.81 144.54 93.79 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.865 2.377 . . . . 33.719999999999999 111.842 177.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -144.13 141.14 29.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.813 -0.439 . . . . 31.510000000000002 109.813 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 10.5 pt20 -131.59 88.28 43.51 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.103 0.478 . . . . 30.129999999999999 111.116 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.31 134.99 19.82 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.607 2.205 . . . . 29.52 111.806 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.18 156.71 26.63 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.624 -0.798 . . . . 26.75 112.124 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.68 129.03 8.97 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.339 2.692 . . . . 25.079999999999998 113.052 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.3 mt -84.64 -70.52 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.613 -0.514 . . . . 23.899999999999999 109.613 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 60.56 101.85 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.918 -1.037 . . . . 21.23 112.989 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -120.06 173.54 7.02 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.157 -0.474 . . . . 19.920000000000002 110.207 169.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.02 -176.16 5.8 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.083 -0.508 . . . . 16.559999999999999 110.021 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.7 87.22 2.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.003 -0.544 . . . . 15.050000000000001 110.419 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -86.48 170.02 12.32 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.999 -0.546 . . . . 14.19 110.92 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.5 p -115.52 133.93 55.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.355 0.597 . . . . 11.380000000000001 110.117 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.531 ' HB3' ' HD3' ' A' ' 54' ' ' PRO . . . -85.75 -52.36 0.47 Allowed Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.252 -0.885 . . . . 8.2899999999999991 112.222 -175.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 53' ' ' ALA . 87.7 Cg_endo -88.54 131.02 2.38 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.347 1.365 . . . . 6.8700000000000001 112.446 176.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 54' ' ' PRO . 7.9 Cg_exo -73.21 -172.78 1.09 Allowed 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.186 1.924 . . . . 5.04 111.901 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 60.91 68.34 1.29 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 114.693 -1.139 . . . . 2.5899999999999999 111.933 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -71.1 -177.13 2.14 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.959 2.439 . . . . 1.6399999999999999 112.177 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -114.79 146.66 40.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.737 -1.12 . . . . 3.3900000000000001 109.979 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 60' ' ' ARG . 10.3 mt -88.75 170.44 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.459 -0.791 . . . . 0.44 111.615 -177.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.625 ' N ' HG22 ' A' ' 59' ' ' ILE . 30.4 mtt85 -69.79 -156.67 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.763 -1.562 . . . . 2.3399999999999999 112.575 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.638 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 3.1 t60 -158.41 145.62 17.82 Favored 'General case' 0 CA--C 1.473 -2.0 0 CA-C-N 111.904 -2.407 . . . . 2.2200000000000002 106.595 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.743 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.6 m-30 -124.27 159.6 29.85 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.459 -0.791 . . . . 0.20999999999999999 109.662 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 15.7 t70 -80.15 67.06 5.85 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 123.289 1.519 . . . . 0.34999999999999998 108.257 172.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.718 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.6 m95 -59.01 -44.17 91.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 111.77 -2.468 . . . . 0.10000000000000001 112.109 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.435 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 4.8 t30 -51.51 -29.33 16.29 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.04 -1.436 . . . . 1.1100000000000001 111.37 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.5 -16.49 80.69 Favored Glycine 0 C--N 1.314 -0.683 0 CA-C-N 115.385 -0.825 . . . . 0.20999999999999999 111.254 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.73 -53.16 3.03 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.062 -1.069 . . . . 0.13 111.091 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.69 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.8 mtt -63.56 -57.94 8.55 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 114.229 -1.35 . . . . 0.089999999999999997 112.139 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 5.7 mm100 -38.61 -55.31 2.67 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 115.172 1.545 . . . . 0.63 115.172 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.754 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.6 Cg_endo -65.04 -28.85 57.22 Favored 'Trans proline' 0 CA--C 1.51 -0.716 0 C-N-CA 121.673 1.582 . . . . 0.14000000000000001 110.649 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.637 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 11.3 mtm -84.47 -40.73 17.35 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.198 -0.91 . . . . 0.69999999999999996 111.452 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 68' ' ' MET . 60.4 t -57.73 -38.32 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 CA-C-O 122.353 1.073 . . . . 0.12 108.506 172.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 t -60.52 -35.41 75.9 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.014 -1.903 . . . . 0.56000000000000005 111.11 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.754 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 27.6 mtpt -81.37 -38.82 26.01 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.577 -0.527 . . . . 1.3 109.577 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.833 ' SD ' ' HE2' ' A' ' 119' ' ' PHE . 1.2 ttm -47.19 -54.6 10.29 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 123.901 0.751 . . . . 0.5 110.355 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.632 ' N ' ' HG2' ' A' ' 75' ' ' MET . 4.7 mt -80.03 7.62 8.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.525 -1.216 . . . . 0.65000000000000002 112.285 -169.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.96 17.33 8.68 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 113.941 -1.481 . . . . 0.17000000000000001 109.88 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -81.83 165.15 21.11 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.404 0.621 . . . . 0.10000000000000001 110.252 176.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -87.06 107.6 18.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.281 -0.872 . . . . 1.72 109.797 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.664 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 133.96 -24.89 3.58 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 110.763 -0.935 . . . . 0.12 110.763 -178.104 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.762 HG11 ' O ' ' A' ' 75' ' ' MET . 10.8 p -102.92 151.08 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.777 0.799 . . . . 0.16 111.164 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.5 m -135.91 142.73 44.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.43 -1.259 . . . . 0.45000000000000001 110.211 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.665 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -56.14 142.84 35.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.585 -0.734 . . . . 0.28000000000000003 110.469 166.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.32 11.33 58.55 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.778 -0.725 . . . . 0.28000000000000003 113.17 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.55 153.14 18.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.148 0.474 . . . . 1.2 110.552 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.696 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -82.28 120.47 33.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 108.772 -0.825 . . . . 0.20000000000000001 108.772 166.191 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.64 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -108.45 109.78 21.14 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.542 -0.754 . . . . 0.14000000000000001 109.308 -171.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.787 HD21 HD23 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -73.13 94.5 1.94 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.504 -1.225 . . . . 0.14999999999999999 108.945 177.378 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 2.0 m -73.04 115.93 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 106.902 -1.518 . . . . 0.94999999999999996 106.902 174.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.873 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 13.3 t0 -79.97 170.4 16.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.331 -0.989 . . . . 0.64000000000000001 108.331 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.525 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.5 OUTLIER -55.5 148.72 14.94 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-O 122.774 1.273 . . . . 0.37 109.375 170.278 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.515 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 34.6 t -77.62 140.5 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.172 0 N-CA-C 106.81 -1.552 . . . . 0.10000000000000001 106.81 165.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.81 ' H ' ' HA ' ' A' ' 164' ' ' SER . 5.5 t-20 -85.55 160.91 19.54 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 122.031 0.919 . . . . 0.17999999999999999 110.344 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.749 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -124.27 84.63 2.3 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 113.939 -1.482 . . . . 0.12 107.575 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.465 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 13.2 mtp180 -107.18 -2.07 21.24 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 113.66 -1.609 . . . . 0.64000000000000001 108.411 -172.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.726 HG21 ' HB3' ' A' ' 172' ' ' PRO . 22.3 p -50.96 -177.73 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.36 -1.745 . . . . 0.14000000000000001 113.799 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 1.5 t30 -73.49 -7.62 52.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.065 -1.88 . . . . 0.47999999999999998 110.263 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.618 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -142.37 -151.43 5.51 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.944 -0.645 . . . . 0.12 112.869 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.596 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 51.8 m -121.92 130.58 53.45 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.955 0.407 . . . . 1.1599999999999999 111.728 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.749 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.0 pp -134.84 158.19 44.85 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.876 0.846 . . . . 0.10000000000000001 110.795 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -80.64 79.69 7.23 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.019 -1.446 . . . . 0.17000000000000001 108.08 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.57 -15.77 63.83 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.376 -1.284 . . . . 0.089999999999999997 109.846 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.55 -31.56 42.02 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.888 -0.782 . . . . 0.14999999999999999 108.888 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.614 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.6 tp10 -66.04 -33.98 77.03 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.697 1.237 . . . . 1.73 108.876 171.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.29 -43.42 64.25 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 113.118 -1.855 . . . . 0.12 109.656 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 63.7 m -63.91 -32.2 73.65 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.107 -1.406 . . . . 0.11 110.537 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -40.99 80.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.997 -1.112 . . . . 1.47 107.997 173.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.683 HG21 ' HB2' ' A' ' 64' ' ' TRP . 54.7 m -64.5 -31.06 72.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.21 -0.904 . . . . 0.12 110.693 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.719 ' O ' HD23 ' A' ' 113' ' ' LEU . 8.4 mt -51.74 -70.05 0.1 Allowed 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.296 -0.631 . . . . 0.56000000000000005 109.296 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.635 ' O ' HD13 ' A' ' 121' ' ' LEU . 21.2 mtp180 -39.72 -38.46 0.64 Allowed 'General case' 0 C--N 1.315 -0.933 0 O-C-N 124.436 1.085 . . . . 1.51 111.331 174.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.3 m-20 -70.86 -46.89 61.87 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.578 -1.192 . . . . 0.28000000000000003 112.313 -177.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.57 -31.0 64.89 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.227 1.013 . . . . 0.089999999999999997 108.471 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -66.15 -32.55 74.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.511 -1.677 . . . . 0.12 109.906 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.591 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.31 -39.39 68.27 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.48 -1.236 . . . . 0.20000000000000001 111.565 -175.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -66.97 -21.69 65.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.061 -0.972 . . . . 1.1699999999999999 111.265 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.69 -14.41 28.08 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.053 -0.521 . . . . 2.0499999999999998 111.753 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.24 -11.89 0.69 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 116.164 1.226 . . . . 0.54000000000000004 116.164 163.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 51.7 mtpt -74.51 -33.03 62.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.819 0.81 . . . . 0.98999999999999999 111.139 -177.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.833 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 20.8 m-85 -93.6 178.2 5.77 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 122.391 1.091 . . . . 0.20999999999999999 112.678 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 6.2 m -121.25 116.95 25.83 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 112.901 -1.954 . . . . 0.23000000000000001 107.822 168.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.702 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -87.54 135.49 33.33 Favored 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 119.477 -0.889 . . . . 0.38 110.751 -171.781 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.581 HG11 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -79.59 154.88 4.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 108.923 -0.769 . . . . 0.41999999999999998 108.923 173.556 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.551 ' CB ' ' HG2' ' A' ' 125' ' ' GLN . 35.0 m -95.52 160.11 14.67 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.713 0.768 . . . . 1.7 109.89 176.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . . . -73.58 -21.09 60.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.129 -1.396 . . . . 0.55000000000000004 109.907 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.657 ' O ' ' HG3' ' A' ' 129' ' ' MET . 9.5 pt20 -57.13 -26.82 61.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.442 -1.254 . . . . 2.04 109.491 170.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.558 ' HB2' HG22 ' A' ' 155' ' ' VAL . 15.4 mt-30 -98.41 -52.48 3.63 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 114.292 -1.322 . . . . 0.40999999999999998 110.598 171.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.787 HD23 HD21 ' A' ' 88' ' ' LEU . 1.9 tm? -70.26 -62.85 1.23 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.692 -1.14 . . . . 1.3899999999999999 113.218 -167.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.648 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.5 OUTLIER -52.34 -39.89 61.26 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 123.712 1.72 . . . . 1.05 108.753 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.657 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -62.9 -59.85 4.28 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 110.694 -2.957 . . . . 1.6399999999999999 110.783 179.167 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.756 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.86 -40.01 5.85 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 124.098 0.874 . . . . 0.31 112.006 175.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.723 ' NZ ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -51.52 -60.46 3.12 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.825 -0.75 . . . . 1.53 109.215 175.329 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 37.2 mt-30 -58.74 -44.66 90.58 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.379 -1.282 . . . . 0.40999999999999998 111.7 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 129' ' ' MET . 43.5 mt-30 -55.33 -34.2 64.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.986 -1.006 . . . . 0.37 110.151 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.528 ' CD1' HG13 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -93.59 -30.56 14.91 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.991 -1.459 . . . . 0.23999999999999999 109.364 -178.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 161.43 -54.9 0.32 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.929 -1.129 . . . . 0.33000000000000002 114.086 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.508 ' CD1' ' HA ' ' A' ' 142' ' ' LEU . 43.8 mt -64.05 -172.36 0.06 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 116.385 1.994 . . . . 0.31 116.385 -168.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.5 m -111.16 150.7 42.37 Favored Pre-proline 0 N--CA 1.428 -1.54 0 CA-C-N 110.954 -2.839 . . . . 0.81000000000000005 108.777 170.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.648 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 15.1 Cg_endo -60.08 -2.49 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 123.357 2.705 . . . . 0.32000000000000001 113.107 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 101' ' ' ASN . 0.8 OUTLIER -117.44 -26.41 6.68 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.911 0.862 . . . . 1.25 110.647 -177.022 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 4.6 t70 -64.8 -24.56 67.59 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 113.696 -1.593 . . . . 0.65000000000000002 109.359 -171.138 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 22.6 m 66.33 161.56 0.15 Allowed 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 112.689 -2.05 . . . . 0.59999999999999998 109.995 -175.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.881 HD13 ' HA ' ' A' ' 148' ' ' ALA . 9.2 mt -73.19 -35.63 66.4 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.148 -1.842 . . . . 0.85999999999999999 109.204 -169.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.36 2.98 0.31 Allowed Glycine 0 C--N 1.318 -0.464 0 CA-C-N 113.164 -1.835 . . . . 0.31 114.949 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 118.14 5.27 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 109.07 -0.715 . . . . 0.23999999999999999 109.07 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.69 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 13.0 mmt180 -40.23 -47.87 2.5 Favored 'General case' 0 C--O 1.214 -0.783 0 O-C-N 123.696 0.623 . . . . 1.6499999999999999 111.448 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -69.77 -28.24 65.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.477 0.656 . . . . 0.53000000000000003 111.461 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.545 ' O ' HD12 ' A' ' 151' ' ' ILE . 21.2 mttm -72.82 -31.32 64.72 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.38 1.086 . . . . 1.3100000000000001 108.276 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.881 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -77.75 -38.94 45.86 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 113.15 -1.841 . . . . 0.12 110.798 178.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.605 ' HA ' HG23 ' A' ' 181' ' ' VAL . 33.0 mt -69.78 -43.17 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 CA-C-N 113.821 -1.536 . . . . 0.11 109.978 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.73 -53.57 35.43 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.177 -0.919 . . . . 0.14999999999999999 110.979 171.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.756 HG23 ' CB ' ' A' ' 130' ' ' ALA . 7.6 mt -67.14 -44.92 87.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.028 0 N-CA-C 113.069 0.766 . . . . 0.17999999999999999 113.069 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.65 -37.9 76.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 118.447 0.567 . . . . 0.13 110.513 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 149' ' ' ILE . 46.8 mtp180 -83.18 -21.7 33.44 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.799 0.809 . . . . 1.0800000000000001 110.407 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 28.3 t-20 -82.58 -10.32 59.02 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.187 -1.412 . . . . 0.5 107.187 175.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.734 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -109.79 -29.24 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 113.294 -1.775 . . . . 0.17000000000000001 111.107 -174.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.76 35.38 4.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.563 -0.827 . . . . 0.16 112.642 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.73 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -112.09 159.28 18.66 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.416 0.895 . . . . 0.12 113.416 -169.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.696 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.1 m80 -100.32 -25.99 14.05 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.486 -0.779 . . . . 0.20000000000000001 110.068 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.571 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.5 m-85 -135.57 -172.62 3.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.234 -0.894 . . . . 0.13 110.959 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.82 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -138.81 136.72 43.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.013 -0.994 . . . . 0.080000000000000002 108.964 167.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 48.6 tp -106.96 99.44 9.01 Favored 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 119.637 -0.825 . . . . 0.16 108.995 165.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.601 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -81.54 111.97 18.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.103 -1.408 . . . . 0.26000000000000001 109.448 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.726 ' OG ' HD11 ' A' ' 174' ' ' LEU . 31.4 t -121.31 166.33 14.2 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 121.699 0.761 . . . . 1.05 110.753 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.868 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.5 p -164.87 176.34 8.79 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-N 114.625 -1.17 . . . . 0.10000000000000001 111.351 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -142.64 135.36 28.03 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.294 -1.321 . . . . 0.11 108.499 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 3.1 m -144.42 -175.79 4.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.516 -0.55 . . . . 1.0900000000000001 109.516 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.6 -80.12 0.82 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 119.463 -1.351 . . . . 0.14999999999999999 112.025 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.5 t30 -148.92 123.2 9.58 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 106.917 -1.512 . . . . 0.58999999999999997 106.917 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.618 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.3 p -59.49 -45.65 93.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.121 -0.945 . . . . 0.14999999999999999 113.287 -172.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 43.2 m-20 -60.02 -29.57 68.59 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.452 0.644 . . . . 1.26 109.703 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.91 88.03 3.6 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.441 -1.254 . . . . 0.13 108.512 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.813 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.6 Cg_endo -91.22 166.47 3.63 Favored 'Trans proline' 0 CA--C 1.496 -1.407 0 C-N-CA 124.835 3.69 . . . . 0.089999999999999997 114.98 -170.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.2 m -83.19 117.95 23.27 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.856 -1.52 . . . . 0.14000000000000001 107.638 166.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.868 HD12 ' O ' ' A' ' 164' ' ' SER . 46.4 tp -84.46 99.25 10.57 Favored 'General case' 0 N--CA 1.412 -2.325 0 C-N-CA 119.747 -0.781 . . . . 0.16 109.289 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.677 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.2 mt-30 -89.51 107.36 19.03 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 114.966 -1.015 . . . . 0.34000000000000002 109.291 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 37.5 mtp -106.52 161.83 14.26 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.212 -0.904 . . . . 1.0900000000000001 110.382 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.611 ' HG2' HD12 ' A' ' 186' ' ' ILE . 53.2 tt0 -167.47 119.03 0.88 Allowed 'General case' 0 C--O 1.207 -1.183 0 CA-C-O 121.165 0.507 . . . . 0.5 110.025 -168.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.087 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -101.01 101.34 12.1 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.826 -0.805 . . . . 0.10000000000000001 108.826 -172.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.69 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.0 ttp -91.14 118.95 30.86 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.603 -0.726 . . . . 0.070000000000000007 109.318 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.549 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -61.85 118.49 7.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.273 -1.38 . . . . 0.22 107.273 169.618 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -73.2 -32.88 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 119.516 1.053 . . . . 0.11 111.408 -176.393 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.437 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.1 mt-30 -64.1 -12.84 43.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.34999999999999998 111.538 -177.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 33.1 p -130.12 -37.56 1.46 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.079 0.943 . . . . 0.19 109.892 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.594 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.82 19.47 51.25 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 113.756 -1.565 . . . . 0.17999999999999999 112.08 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.66 156.56 17.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.055 0.455 . . . . 0.72999999999999998 110.677 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.611 HD12 ' HG2' ' A' ' 177' ' ' GLN . 37.9 mm -88.4 117.48 32.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.679 0.752 . . . . 0.14000000000000001 109.424 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.087 HD11 HD13 ' A' ' 178' ' ' LEU . 1.8 pp -104.79 -30.1 2.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.527 -1.215 . . . . 0.13 110.353 -172.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.588 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.3 t90 -137.43 152.33 49.48 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.191 -0.913 . . . . 0.070000000000000007 109.338 172.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.46 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 61.2 p -153.58 165.52 35.65 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.865 0.691 . . . . 0.13 112.865 164.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.16 -179.43 33.99 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.892 -0.883 . . . . 0.12 110.892 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.745 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.8 mtmt -156.78 147.08 21.26 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.33 -1.73 . . . . 1.22 106.33 167.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.637 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -158.04 127.45 1.9 Allowed Glycine 0 C--N 1.283 -2.387 0 C-N-CA 119.94 -1.124 . . . . 0.12 112.266 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.72 117.02 13.9 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.425 0.631 . . . . 0.17000000000000001 111.003 -174.376 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.813 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -93.99 159.25 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 122.589 1.185 . . . . 0.11 110.736 -177.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -101.8 172.08 7.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 112.501 -2.136 . . . . 0.17999999999999999 108.861 -174.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.8 tt0 -100.77 133.2 45.59 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.075 -0.65 . . . . 0.91000000000000003 109.411 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.525 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 35.1 mm-40 . . . . . 0 C--N 1.316 -0.89 0 CA-C-O 118.656 -0.688 . . . . 1.24 110.518 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 N-CA-C 111.761 -0.535 . . . . 88.609999999999999 111.761 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 t -115.71 124.78 51.71 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.902 -0.407 . . . . 87.430000000000007 109.902 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -113.51 63.19 0.65 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.578 -0.527 . . . . 87.159999999999997 109.578 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 ptm -110.76 39.26 2.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.383 0.611 . . . . 85.340000000000003 111.32 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.54 -68.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.267 -0.879 . . . . 85.049999999999997 109.715 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.57 74.65 0.42 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.021 -0.609 . . . . 84.680000000000007 112.342 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.24 139.36 38.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.903 0.382 . . . . 85.569999999999993 110.154 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -143.71 100.17 3.54 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.493 0.663 . . . . 85.040000000000006 110.735 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.489 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -94.99 126.84 45.18 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.559 -0.746 . . . . 82.170000000000002 110.563 -178.265 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.74 -176.35 2.77 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.108 1.872 . . . . 81.510000000000005 111.95 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.84 124.97 29.58 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.238 -0.437 . . . . 79.560000000000002 110.074 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.401 ' O ' HG22 ' A' ' 13' ' ' VAL . 24.7 Cg_exo -63.27 137.55 61.55 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.467 2.112 . . . . 78.5 111.955 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 12' ' ' PRO . 26.4 m 51.71 138.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 125.628 1.571 . . . . 77.0 113.931 -177.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -87.07 -33.94 19.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.917 -1.038 . . . . 75.739999999999995 110.714 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 54.17 94.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.944 0.778 . . . . 73.909999999999997 112.319 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.51 116.14 19.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.507 -0.769 . . . . 72.299999999999997 110.334 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -70.25 138.6 86.93 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.469 . . . . 71.219999999999999 110.401 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.52 121.5 9.97 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.491 2.127 . . . . 69.670000000000002 112.647 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . . . -115.94 135.98 22.84 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.814 -0.63 . . . . 67.549999999999997 109.616 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 19' ' ' ALA . 27.8 Cg_exo -60.43 114.71 2.24 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.242 1.962 . . . . 66.700000000000003 112.012 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.537 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 10.9 pt-20 -119.41 5.86 11.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.806 0.336 . . . . 65.010000000000005 110.816 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.9 tp60 -114.59 84.43 9.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.504 -0.316 . . . . 63.409999999999997 110.618 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 26.9 Cg_exo -71.4 146.99 51.64 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.374 2.716 . . . . 61.93 112.306 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.56 80.36 1.9 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.37 0.605 . . . . 59.869999999999997 110.346 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -70.56 134.49 86.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.066 -0.97 . . . . 58.469999999999999 111.138 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.16 158.13 55.65 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.282 1.988 . . . . 57.359999999999999 111.483 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -88.93 152.21 21.86 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.908 -0.317 . . . . 55.509999999999998 110.425 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 2.4 mp0 -89.31 138.55 28.64 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.32 -0.4 . . . . 53.869999999999997 110.152 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 28' ' ' GLN . 16.9 Cg_exo -65.9 136.89 46.94 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.197 1.931 . . . . 52.759999999999998 111.237 175.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.15 96.0 32.43 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-O 121.392 0.615 . . . . 50.93 110.886 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.53 95.21 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.66 2.24 . . . . 49.210000000000001 111.854 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 p -83.08 142.71 31.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.21 -0.45 . . . . 47.490000000000002 110.601 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.5 t 63.32 94.2 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 45.969999999999999 110.621 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -56.98 161.25 10.93 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.494 2.796 . . . . 45.280000000000001 112.985 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.0 m -76.13 132.45 40.03 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.892 -1.049 . . . . 42.789999999999999 110.092 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.7 m -58.0 147.76 63.12 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.93 -0.577 . . . . 40.789999999999999 111.041 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -48.42 -47.5 19.97 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.163 2.575 . . . . 39.810000000000002 113.961 -172.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.8 t -54.96 135.24 48.78 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.368 0.604 . . . . 37.5 110.955 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.9 mt -75.83 128.57 83.19 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.795 -0.639 . . . . 35.649999999999999 110.422 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.16 75.76 0.94 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.055 2.504 . . . . 33.719999999999999 112.011 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -157.74 -44.99 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.614 -0.721 . . . . 31.510000000000002 110.121 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 58.26 81.49 0.25 Allowed Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 115.213 -0.903 . . . . 30.129999999999999 111.492 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.43 123.59 10.7 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.0 1.8 . . . . 29.52 111.447 175.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.92 -168.7 12.47 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.45 -0.66 . . . . 26.75 111.45 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.02 131.99 19.04 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.531 2.154 . . . . 25.079999999999998 112.01 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.9 mt -79.17 -51.26 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.03 -0.532 . . . . 23.899999999999999 110.031 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 67.78 76.26 0.27 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.293 -0.867 . . . . 21.23 110.668 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 146.76 35.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.431 -0.804 . . . . 19.920000000000002 110.202 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -169.35 164.08 10.72 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.193 -0.912 . . . . 16.559999999999999 110.256 -175.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -86.71 77.92 9.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.778 0.799 . . . . 15.050000000000001 110.005 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -60.56 136.94 58.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.381 -0.827 . . . . 14.19 110.118 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.1 p -68.28 145.17 54.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.795 0.807 . . . . 11.380000000000001 111.973 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 54' ' ' PRO . . . -100.5 -177.61 0.59 Allowed Pre-proline 0 N--CA 1.436 -1.138 0 CA-C-N 114.545 -1.207 . . . . 8.2899999999999991 108.071 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 53' ' ' ALA . 5.6 Cg_exo -30.65 103.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.34 3.36 . . . . 6.8700000000000001 112.886 170.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.73 -58.16 0.66 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.025 2.483 . . . . 5.04 113.633 -171.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.424 ' HA ' ' HD2' ' A' ' 57' ' ' PRO . . . -107.78 109.8 62.35 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.058 0.392 . . . . 2.5899999999999999 112.058 -174.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 90.5 Cg_endo -76.02 -177.3 3.55 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 123.04 2.493 . . . . 1.6399999999999999 110.61 167.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -104.7 132.51 50.86 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.461 -0.79 . . . . 3.3900000000000001 110.122 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.62 HG22 ' N ' ' A' ' 60' ' ' ARG . 10.4 mt -93.21 172.79 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 122.24 1.019 . . . . 0.44 112.842 -172.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.62 ' N ' HG22 ' A' ' 59' ' ' ILE . 25.3 mtt85 -72.3 -158.05 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.399 -1.728 . . . . 2.3399999999999999 111.655 175.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.631 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 41.7 m80 -150.56 142.72 24.11 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.761 -2.018 . . . . 2.2200000000000002 107.128 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.772 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.9 m-30 -126.6 155.53 42.35 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 123.665 0.603 . . . . 0.20999999999999999 110.878 -175.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.54 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 10.6 t0 -85.16 67.64 10.25 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 123.395 1.569 . . . . 0.34999999999999998 108.473 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.781 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 94.9 m95 -57.44 -41.9 81.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.008 -2.36 . . . . 0.10000000000000001 112.769 175.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.404 ' N ' HG21 ' A' ' 108' ' ' THR . 6.1 t30 -51.95 -25.43 8.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.197 -1.365 . . . . 1.1100000000000001 111.696 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.69 -16.58 78.97 Favored Glycine 0 C--N 1.312 -0.763 0 CA-C-N 115.147 -0.933 . . . . 0.20999999999999999 111.278 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.41 -52.84 3.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.118 -1.041 . . . . 0.13 111.199 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.723 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.4 mtt -64.59 -58.67 5.7 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 114.122 -1.399 . . . . 0.089999999999999997 112.507 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.484 HE21 ' HA ' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -39.42 -54.78 3.56 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 114.794 1.405 . . . . 0.63 114.794 -176.343 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.807 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 37.4 Cg_endo -64.64 -28.97 60.64 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.532 1.488 . . . . 0.14000000000000001 110.16 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.719 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 10.9 mtm -83.09 -42.04 17.88 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.358 -0.837 . . . . 0.69999999999999996 112.108 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 68' ' ' MET . 58.2 t -57.01 -40.13 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 CA-C-N 114.26 -1.336 . . . . 0.12 108.802 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.68 -36.09 73.64 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.152 -1.84 . . . . 0.56000000000000005 111.054 173.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.807 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.1 mtpt -82.08 -32.91 30.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.011 -0.541 . . . . 1.3 111.207 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.833 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.82 -26.16 68.22 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.39 -0.823 . . . . 0.5 111.677 -172.19 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.657 HD13 ' HB2' ' A' ' 118' ' ' LYS . 3.9 mt -94.21 -8.02 40.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.124 0.964 . . . . 0.65000000000000002 110.997 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.82 14.67 60.17 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.664 -1.774 . . . . 0.17000000000000001 108.664 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.664 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -86.46 165.72 16.08 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.159 -1.02 . . . . 0.10000000000000001 109.818 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -94.46 105.38 17.35 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.252 -0.886 . . . . 1.72 109.914 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.651 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 136.23 -23.4 3.32 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.722 -0.951 . . . . 0.12 110.722 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.833 HG11 ' O ' ' A' ' 75' ' ' MET . 10.7 p -101.21 153.76 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.431 0.634 . . . . 0.16 111.197 -175.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.8 m -135.35 141.84 45.64 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.923 -1.035 . . . . 0.45000000000000001 110.441 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.654 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.38 130.25 45.98 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.346 -0.843 . . . . 0.28000000000000003 110.272 168.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.17 3.23 38.77 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.006 -0.616 . . . . 0.28000000000000003 112.876 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.0 151.89 22.87 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 120.488 -0.485 . . . . 1.2 110.97 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.676 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -80.73 119.14 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 121.988 0.899 . . . . 0.20000000000000001 109.031 165.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.763 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -108.38 107.56 18.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.28 -0.873 . . . . 0.14000000000000001 109.108 -171.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.692 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -71.43 97.9 1.71 Allowed 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.141 -1.39 . . . . 0.14999999999999999 107.847 175.575 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.894 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.5 m -71.08 121.91 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 106.608 -1.627 . . . . 0.94999999999999996 106.608 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.794 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 5.0 t0 -76.86 151.04 36.0 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.17 -1.419 . . . . 0.64000000000000001 107.17 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.544 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.1 m -57.53 132.78 54.21 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 106.947 -1.501 . . . . 0.37 106.947 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.548 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 23.1 t -60.55 138.31 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.988 0 N-CA-C 107.88 -1.155 . . . . 0.10000000000000001 107.88 170.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.8 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -84.19 162.95 20.03 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.337 -0.847 . . . . 0.17999999999999999 109.704 174.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.784 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.1 85.19 2.37 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.748 -1.114 . . . . 0.12 108.114 175.608 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.477 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.3 mtp180 -108.18 -4.09 17.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.852 -1.522 . . . . 0.64000000000000001 108.77 -171.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 172' ' ' PRO . 21.4 p -50.59 -171.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.854 -1.975 . . . . 0.14000000000000001 115.547 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 33.3 t30 -68.89 -10.66 58.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.883 -1.962 . . . . 0.47999999999999998 110.739 173.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.586 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -152.48 -143.93 3.8 Favored Glycine 0 C--O 1.236 0.244 0 C-N-CA 120.258 -0.972 . . . . 0.12 113.153 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.61 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 51.5 p -122.36 131.61 53.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.148 0.499 . . . . 1.1599999999999999 111.949 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.784 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.4 pp -137.43 156.43 48.19 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.846 0.831 . . . . 0.10000000000000001 110.633 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -79.87 81.09 6.19 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.787 -1.551 . . . . 0.17000000000000001 107.852 176.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.93 -14.72 63.21 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.193 -1.367 . . . . 0.089999999999999997 109.929 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.405 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.74 -30.23 40.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.685 -0.857 . . . . 0.14999999999999999 108.685 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 28.2 tp10 -66.0 -34.57 78.4 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.78 1.276 . . . . 1.73 109.068 170.245 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.03 -45.22 64.3 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.049 -1.887 . . . . 0.12 109.227 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 49.1 m -64.8 -30.58 71.59 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.029 -1.441 . . . . 0.11 110.5 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -67.2 -44.04 80.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.749 -1.204 . . . . 1.47 107.749 171.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.717 HG21 ' HB2' ' A' ' 64' ' ' TRP . 37.7 m -63.24 -31.46 72.61 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.237 -0.892 . . . . 0.12 110.783 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.723 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.3 mt -50.16 -70.47 0.09 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.05 -0.722 . . . . 0.56000000000000005 109.05 170.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.503 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.9 mtp180 -40.08 -40.32 1.05 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.487 1.117 . . . . 1.51 111.358 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.3 m-20 -67.26 -48.18 68.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.556 -1.202 . . . . 0.28000000000000003 112.137 -177.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.2 -34.97 68.8 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.315 1.055 . . . . 0.089999999999999997 108.524 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -63.91 -32.33 73.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.158 -1.837 . . . . 0.12 110.064 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -76.01 -47.5 24.62 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 114.523 -1.217 . . . . 0.20000000000000001 111.302 -174.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -55.99 -33.13 64.56 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.336 -1.302 . . . . 1.1699999999999999 110.11 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -70.17 -43.77 70.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.244 -1.798 . . . . 2.0499999999999998 110.784 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.12 -3.39 66.04 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 114.749 0.659 . . . . 0.54000000000000004 114.749 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.657 ' HB2' HD13 ' A' ' 76' ' ' LEU . 58.7 mtpt -87.36 -8.2 56.89 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.066 0.933 . . . . 0.98999999999999999 111.192 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.763 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 27.0 m-85 -118.12 174.42 6.22 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 122.421 1.105 . . . . 0.20999999999999999 113.303 173.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.0 m -118.47 123.88 46.25 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 112.672 -2.058 . . . . 0.23000000000000001 108.021 170.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.673 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -95.66 141.33 29.27 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 119.291 -0.964 . . . . 0.38 111.519 -169.645 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.2 m -97.46 140.55 17.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.802 -1.184 . . . . 0.41999999999999998 107.802 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.415 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 8.7 t -93.93 -177.76 4.44 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 119.274 -0.971 . . . . 1.7 111.316 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.428 ' HA ' ' H ' ' A' ' 128' ' ' SER . . . -63.33 -25.88 68.51 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.295 -1.002 . . . . 0.55000000000000004 108.295 177.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.667 ' O ' ' HG3' ' A' ' 129' ' ' MET . 32.8 mt-30 -51.6 -39.56 58.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.185 -1.825 . . . . 2.04 110.907 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.522 ' HB2' HG22 ' A' ' 155' ' ' VAL . 50.9 mt-30 -98.62 -50.39 4.28 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.964 0.888 . . . . 0.40999999999999998 110.098 172.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.894 HD11 ' O ' ' A' ' 89' ' ' VAL . 6.3 tt -62.43 -64.98 0.76 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.474 -1.693 . . . . 1.3899999999999999 113.268 -168.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.707 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -53.92 -43.72 70.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 123.389 1.566 . . . . 1.05 109.116 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.694 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -55.59 -60.85 2.85 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 111.226 -2.715 . . . . 1.6399999999999999 111.3 175.592 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.735 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.49 -46.22 6.77 Favored 'General case' 0 CA--C 1.497 -1.083 0 O-C-N 124.493 1.121 . . . . 0.31 111.807 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.605 ' HA ' HD11 ' A' ' 151' ' ' ILE . 5.8 mttt -53.32 -52.13 60.15 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.39 -0.596 . . . . 1.53 109.39 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 -66.9 -38.63 86.6 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.542 -0.754 . . . . 0.40999999999999998 110.878 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.694 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.2 mt-30 -59.04 -32.3 69.63 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 114.551 -1.204 . . . . 0.37 109.845 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.51 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.7 OUTLIER -94.3 -30.49 14.51 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.123 -1.399 . . . . 0.23999999999999999 109.929 -177.423 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.06 -50.72 0.46 Allowed Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 120.012 -1.089 . . . . 0.33000000000000002 113.664 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 141' ' ' SER . 92.9 mt -65.36 -171.03 0.07 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 112.496 -1.852 . . . . 0.31 115.954 -171.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.1 m -115.72 151.67 46.5 Favored Pre-proline 0 N--CA 1.424 -1.736 0 CA-C-N 110.65 -2.977 . . . . 0.81000000000000005 107.985 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.707 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 36.2 Cg_endo -65.4 0.07 3.13 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.871 2.381 . . . . 0.32000000000000001 112.651 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.1 tt0 -118.74 -25.33 6.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.869 0.843 . . . . 1.25 110.519 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 141' ' ' SER . 9.1 t70 -60.98 -23.09 65.09 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.364 -1.744 . . . . 0.65000000000000002 109.079 -173.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 32.6 m 73.91 167.37 0.3 Allowed 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 112.848 -1.978 . . . . 0.59999999999999998 109.393 -174.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.063 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.3 mt -64.46 -39.49 93.92 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-O 122.439 1.114 . . . . 0.85999999999999999 108.421 -175.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.37 -7.29 1.39 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 113.062 -1.881 . . . . 0.31 114.163 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.49 126.35 6.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.995 -0.743 . . . . 0.23999999999999999 108.995 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.675 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.2 mmt180 -41.83 -49.19 4.44 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 118.039 0.381 . . . . 1.6499999999999999 110.995 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.6 t -69.34 -28.16 65.98 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.368 0.604 . . . . 0.53000000000000003 111.658 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 24.3 mttm -73.78 -29.95 62.49 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.618 1.199 . . . . 1.3100000000000001 108.668 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 1.063 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -75.25 -46.27 34.84 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-N 112.358 -2.201 . . . . 0.12 110.358 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.612 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.7 mt -65.97 -42.22 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 112.71 -2.041 . . . . 0.11 110.046 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.0 -52.63 41.99 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.849 -1.069 . . . . 0.14999999999999999 111.433 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.735 HG23 ' CB ' ' A' ' 130' ' ' ALA . 16.7 mt -68.34 -46.95 79.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 N-CA-C 112.346 0.498 . . . . 0.17999999999999999 112.346 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.64 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.71 -39.7 74.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.954 0.407 . . . . 0.13 110.693 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.529 ' HD2' HG23 ' A' ' 149' ' ' ILE . 34.5 mtp180 -81.41 -23.13 37.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.52 0.676 . . . . 1.0800000000000001 110.894 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -81.09 -13.18 58.98 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.627 -1.249 . . . . 0.5 107.627 175.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.682 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.92 -29.11 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 113.196 -1.82 . . . . 0.17000000000000001 110.772 -174.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.41 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 98.59 34.6 5.21 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 120.198 -1.001 . . . . 0.16 112.408 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.692 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.92 157.27 18.79 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 112.693 0.627 . . . . 0.12 112.693 -170.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.676 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.7 m80 -96.74 -27.16 14.88 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.362 -0.835 . . . . 0.20000000000000001 109.445 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.581 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.1 m-85 -137.29 -174.53 3.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.061 -0.972 . . . . 0.13 111.325 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.686 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -136.48 140.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.583 -1.19 . . . . 0.080000000000000002 108.553 166.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.62 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 26.2 tp -110.02 99.89 8.92 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.466 -0.893 . . . . 0.16 109.704 166.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 90' ' ' ASP . 2.3 m-85 -77.92 112.03 14.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.914 -1.039 . . . . 0.26000000000000001 108.785 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.69 ' OG ' HD11 ' A' ' 109' ' ' LEU . 4.0 p -120.06 158.93 25.81 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 115.093 -0.958 . . . . 1.05 109.56 -175.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.8 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.2 p -163.75 172.56 13.99 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 115.154 -0.93 . . . . 0.10000000000000001 110.875 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.67 131.81 36.18 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 113.956 -1.475 . . . . 0.11 108.536 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.681 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -142.5 -176.39 4.83 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.158 -0.682 . . . . 1.0900000000000001 109.158 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -86.05 0.98 Allowed Glycine 0 CA--C 1.49 -1.492 0 C-N-CA 119.55 -1.309 . . . . 0.14999999999999999 111.101 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.504 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.3 t30 -141.59 129.06 21.31 Favored 'General case' 0 C--O 1.198 -1.629 0 CA-C-N 113.867 -1.167 . . . . 0.58999999999999997 107.963 175.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.586 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.7 p -64.7 -39.39 85.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.226 -0.897 . . . . 0.14999999999999999 111.991 -172.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.428 ' N ' HG13 ' A' ' 169' ' ' VAL . 14.4 m-20 -61.3 -31.15 70.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.696 0.76 . . . . 1.26 109.411 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.99 88.79 3.17 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 113.916 -1.493 . . . . 0.13 107.962 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.797 ' HD2' HG22 ' A' ' 194' ' ' VAL . 51.3 Cg_endo -90.21 165.32 4.61 Favored 'Trans proline' 0 CA--C 1.491 -1.645 0 C-N-CA 124.315 3.343 . . . . 0.089999999999999997 114.837 -169.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 191' ' ' LYS . 23.8 m -85.39 117.84 24.55 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 113.715 -1.584 . . . . 0.14000000000000001 107.769 167.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 164' ' ' SER . 38.6 tp -84.31 97.77 9.63 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 119.485 -0.886 . . . . 0.16 108.88 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.648 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -87.48 109.0 19.29 Favored 'General case' 0 C--N 1.277 -2.587 0 CA-C-N 114.64 -1.163 . . . . 0.34000000000000002 109.053 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.582 ' SD ' ' HB3' ' A' ' 163' ' ' SER . 2.6 mmm -111.03 163.57 13.71 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.51 -1.223 . . . . 1.0900000000000001 111.464 -173.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.619 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.4 tt0 -172.08 117.59 0.38 Allowed 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 115.978 -0.556 . . . . 0.5 110.114 -166.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.038 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -100.05 101.54 12.64 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.53 -0.915 . . . . 0.10000000000000001 108.53 -172.34 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.675 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 17.0 ttp -90.66 122.86 33.8 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.468 -0.787 . . . . 0.070000000000000007 109.639 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -59.19 127.19 30.91 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.268 -1.382 . . . . 0.22 107.268 166.466 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.16 -34.4 12.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.172 -1.011 . . . . 0.11 110.701 178.382 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.441 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.5 mt-30 -61.88 -15.95 46.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.333 -0.848 . . . . 0.34999999999999998 111.604 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.7 p -130.38 -36.74 1.45 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.826 0.822 . . . . 0.19 110.202 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.551 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.89 23.84 29.18 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 114.528 -1.214 . . . . 0.17999999999999999 112.272 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -103.63 156.72 17.57 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.656 0.265 . . . . 0.72999999999999998 110.653 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.619 HD12 ' HG2' ' A' ' 177' ' ' GLN . 35.0 mm -90.07 120.02 38.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.616 0.722 . . . . 0.14000000000000001 109.379 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.038 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -108.62 -30.19 2.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.942 -1.026 . . . . 0.13 110.495 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.671 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.9 t90 -136.36 152.85 51.09 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 115.108 -0.951 . . . . 0.070000000000000007 109.501 172.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 35.6 p -153.32 163.19 40.35 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 113.253 0.834 . . . . 0.13 113.253 164.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.42 -175.55 29.47 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 110.967 -0.853 . . . . 0.12 110.967 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.4 mtmt -159.51 149.74 18.98 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 105.704 -1.961 . . . . 1.22 105.704 165.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -161.13 128.02 1.85 Allowed Glycine 0 C--N 1.28 -2.542 0 C-N-CA 119.601 -1.285 . . . . 0.12 112.142 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.3 120.2 17.57 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.58 0.705 . . . . 0.17000000000000001 111.116 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.797 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -94.96 158.91 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-N 114.65 -1.159 . . . . 0.11 109.753 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.68 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -100.35 171.34 7.83 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 112.981 -1.918 . . . . 0.17999999999999999 109.292 -174.161 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.3 tt0 -101.5 130.35 47.74 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.253 -0.647 . . . . 0.91000000000000003 109.253 169.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.54 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 19.5 mm-40 . . . . . 0 C--N 1.31 -1.146 0 CA-C-O 118.431 -0.795 . . . . 1.24 110.383 176.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.089 -0.404 . . . . 88.609999999999999 112.089 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 p -88.26 -5.89 58.1 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 122.137 0.175 . . . . 87.430000000000007 111.158 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 67.57 172.32 0.27 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.177 0.513 . . . . 87.159999999999997 110.692 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.4 ptp 40.88 44.94 2.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.591 -1.186 . . . . 85.340000000000003 111.868 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -128.41 -26.04 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.326 -0.852 . . . . 85.049999999999997 111.098 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.01 84.37 0.44 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.692 -0.766 . . . . 84.680000000000007 112.383 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -146.65 23.02 1.27 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.651 -0.5 . . . . 85.569999999999993 109.651 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 54.07 73.44 0.39 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.879 -0.6 . . . . 85.040000000000006 110.811 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.81 145.43 96.83 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.821 -0.627 . . . . 82.170000000000002 110.407 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.81 129.53 29.43 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.985 2.456 . . . . 81.510000000000005 112.012 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.79 93.56 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.968 0.729 . . . . 79.560000000000002 112.968 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.99 130.44 32.67 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.465 1.444 . . . . 78.5 112.119 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.18 158.42 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.427 -0.806 . . . . 77.0 109.968 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -96.38 85.1 3.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.322 0.582 . . . . 75.739999999999995 109.94 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.3 152.77 34.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.561 -0.745 . . . . 73.909999999999997 110.436 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.32 102.46 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.459 -0.791 . . . . 72.299999999999997 110.368 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -87.63 -34.3 0.44 Allowed Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 113.393 0.886 . . . . 71.219999999999999 113.393 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 17' ' ' LYS . 39.4 Cg_endo -65.92 102.03 0.51 Allowed 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 121.424 1.416 . . . . 69.670000000000002 112.259 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.03 150.07 54.5 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.715 -0.675 . . . . 67.549999999999997 110.743 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.39 -57.67 2.15 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.124 2.549 . . . . 66.700000000000003 112.263 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 66.52 161.36 0.15 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.517 0.675 . . . . 65.010000000000005 111.915 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 16.2 mm100 -97.99 132.39 24.8 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.661 -0.7 . . . . 63.409999999999997 110.945 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 51.5 Cg_exo -62.66 150.89 86.41 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.939 2.426 . . . . 61.93 112.389 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.95 82.57 1.5 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.722 -0.672 . . . . 59.869999999999997 109.301 174.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 43.1 mt-10 -80.64 140.99 51.58 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.58 -0.736 . . . . 58.469999999999999 111.418 -175.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 25' ' ' GLU . 38.3 Cg_exo -62.53 98.61 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.927 2.418 . . . . 57.359999999999999 111.987 175.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.477 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 84.4 mt-30 -88.88 173.66 8.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.247 -0.433 . . . . 55.509999999999998 110.55 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -112.91 93.92 26.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.938 0.399 . . . . 53.869999999999997 111.12 -178.196 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 4.8 Cg_exo -78.73 137.22 14.11 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.734 2.29 . . . . 52.759999999999998 111.542 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t 64.27 97.31 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.253 0 O-C-N 123.523 0.515 . . . . 50.93 110.664 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.05 -157.04 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.63 2.22 . . . . 49.210000000000001 112.406 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p -62.44 142.42 57.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.224 0.535 . . . . 47.490000000000002 111.602 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.5 t -136.0 106.2 9.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.67 -0.695 . . . . 45.969999999999999 109.58 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -55.36 162.91 5.37 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.27 2.647 . . . . 45.280000000000001 113.46 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 m -86.31 124.57 32.83 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.422 -0.808 . . . . 42.789999999999999 110.675 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.6 t -115.14 99.39 52.26 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.081 -0.509 . . . . 40.789999999999999 110.257 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.54 -172.31 1.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.752 2.301 . . . . 39.810000000000002 112.191 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.8 m -132.25 144.8 50.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.893 0.378 . . . . 37.5 110.795 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -105.2 105.21 51.0 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.087 -0.506 . . . . 35.649999999999999 109.959 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -70.97 102.46 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.493 2.129 . . . . 33.719999999999999 112.243 -179.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -61.85 -51.3 68.75 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.916 -0.314 . . . . 31.510000000000002 110.169 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.9 mt-30 61.09 75.33 0.46 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.284 -0.871 . . . . 30.129999999999999 111.071 -178.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.72 141.62 50.27 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.686 2.258 . . . . 29.52 111.564 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.48 158.35 27.69 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.635 -0.793 . . . . 26.75 111.841 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.34 126.25 9.63 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.848 2.366 . . . . 25.079999999999998 113.02 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.0 mt -74.65 -54.3 14.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.679 -0.489 . . . . 23.899999999999999 109.679 175.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 58.69 79.41 0.22 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.83 0.706 . . . . 21.23 109.734 175.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -133.93 149.33 51.27 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.816 -0.629 . . . . 19.920000000000002 111.862 -173.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -166.18 139.19 4.05 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.617 -1.174 . . . . 16.559999999999999 109.554 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -121.75 45.1 2.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.679 0.752 . . . . 15.050000000000001 109.955 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -87.5 131.34 34.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.955 -1.021 . . . . 14.19 110.19 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.9 p -64.66 148.73 50.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.591 0.71 . . . . 11.380000000000001 111.304 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.14 -46.41 0.34 Allowed Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.044 -0.98 . . . . 8.2899999999999991 113.397 -173.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -85.98 111.9 1.17 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.232 1.955 . . . . 6.8700000000000001 112.574 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -85.53 76.71 2.91 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.706 2.271 . . . . 5.04 111.751 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 66.23 106.96 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.338 0 O-C-N 123.668 0.605 . . . . 2.5899999999999999 110.683 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.16 -177.18 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.858 2.372 . . . . 1.6399999999999999 113.372 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.4 153.46 50.78 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.623 -1.171 . . . . 3.3900000000000001 110.925 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 60' ' ' ARG . 8.5 mt -90.03 168.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.86 -1.064 . . . . 0.44 110.665 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 59' ' ' ILE . 20.6 mtt85 -67.29 -158.92 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.34 1.543 . . . . 2.3399999999999999 111.743 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.717 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 4.3 t60 -160.09 149.07 17.39 Favored 'General case' 0 CA--C 1.468 -2.191 0 CA-C-N 112.105 -2.316 . . . . 2.2200000000000002 105.911 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.73 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.0 m-30 -125.3 160.94 28.07 Favored 'General case' 0 N--CA 1.415 -2.219 0 O-C-N 123.671 0.607 . . . . 0.20999999999999999 109.41 -175.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.561 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 6.1 t70 -81.49 67.51 7.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.499 1.619 . . . . 0.34999999999999998 107.931 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.734 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.3 m95 -59.64 -42.34 92.55 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 111.933 -2.394 . . . . 0.10000000000000001 111.911 174.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.487 ' N ' HG21 ' A' ' 108' ' ' THR . 3.1 t30 -52.53 -24.88 8.94 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.062 -1.426 . . . . 1.1100000000000001 111.452 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.49 -16.73 77.34 Favored Glycine 0 C--N 1.312 -0.773 0 CA-C-N 115.129 -0.941 . . . . 0.20999999999999999 111.175 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.16 -55.11 2.55 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.897 -1.152 . . . . 0.13 111.41 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.729 ' O ' HG23 ' A' ' 72' ' ' VAL . 40.9 mtt -64.05 -57.21 10.34 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.117 -1.401 . . . . 0.089999999999999997 112.893 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.45 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 15.7 mm-40 -38.85 -54.93 2.96 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 114.53 1.307 . . . . 0.63 114.53 -176.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.803 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.7 Cg_endo -64.71 -31.64 58.39 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 121.949 1.766 . . . . 0.14000000000000001 110.956 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.754 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 10.2 mtm -79.58 -44.04 21.81 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.433 -0.803 . . . . 0.69999999999999996 111.54 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 68' ' ' MET . 40.5 t -57.17 -39.09 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 114.366 -1.288 . . . . 0.12 108.509 175.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.7 t -59.19 -36.44 75.35 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.153 -1.839 . . . . 0.56000000000000005 110.811 174.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.803 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 32.8 mtpt -81.55 -34.13 31.3 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.168 0.508 . . . . 1.3 110.823 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.85 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.54 -29.07 70.38 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.235 -0.893 . . . . 0.5 111.563 -171.785 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.564 HD13 ' HB2' ' A' ' 118' ' ' LYS . 6.0 mt -90.77 -8.07 50.7 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.922 0.867 . . . . 0.65000000000000002 111.118 -177.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.38 13.09 58.49 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 109.182 -1.567 . . . . 0.17000000000000001 109.182 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.639 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -83.54 160.25 21.5 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.441 -0.879 . . . . 0.10000000000000001 110.245 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.47 106.29 16.71 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.062 -0.972 . . . . 1.72 110.115 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.636 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.52 -22.8 3.67 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 110.766 -0.933 . . . . 0.12 110.766 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 75' ' ' MET . 11.3 p -102.95 150.0 6.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.639 0.733 . . . . 0.16 111.514 -176.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.0 m -137.61 141.33 41.26 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.695 -1.139 . . . . 0.45000000000000001 111.135 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.66 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.97 132.36 49.69 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.745 -1.116 . . . . 0.28000000000000003 111.285 169.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.57 2.27 37.52 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.859 -0.686 . . . . 0.28000000000000003 112.709 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.26 149.91 22.86 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 120.233 -0.587 . . . . 1.2 110.923 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -79.48 117.55 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 122.196 0.998 . . . . 0.20000000000000001 108.871 164.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.784 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -104.92 109.75 21.85 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.521 -0.918 . . . . 0.14000000000000001 108.521 -172.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.693 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -71.27 94.06 1.16 Allowed 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.788 -1.19 . . . . 0.14999999999999999 107.788 176.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.519 HG11 ' HG3' ' A' ' 110' ' ' ARG . 1.1 m -72.87 116.14 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 107.124 -1.436 . . . . 0.94999999999999996 107.124 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.847 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 8.3 t0 -76.98 154.77 33.2 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.723 -1.214 . . . . 0.64000000000000001 107.723 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.0 OUTLIER -58.05 136.38 57.15 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 107.527 -1.286 . . . . 0.37 107.527 171.648 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.509 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.8 t -64.0 139.0 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 107.835 -1.172 . . . . 0.10000000000000001 107.835 168.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.818 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.6 t-20 -85.61 163.24 18.45 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.128 -0.942 . . . . 0.17999999999999999 110.063 174.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.751 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.31 85.25 2.38 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.407 -1.27 . . . . 0.12 108.187 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.476 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 9.7 mtp180 -108.88 -1.12 19.37 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.056 -1.429 . . . . 0.64000000000000001 108.644 -172.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.732 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.6 p -53.36 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.991 -1.913 . . . . 0.14000000000000001 115.106 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.528 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 22.4 t30 -67.45 -13.31 61.92 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.712 -2.04 . . . . 0.47999999999999998 110.479 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.579 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -149.71 -145.02 4.05 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.259 -0.972 . . . . 0.12 113.109 -176.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.619 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.4 p -121.89 132.65 54.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.18 0.514 . . . . 1.1599999999999999 111.747 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.751 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.0 pp -137.75 157.01 47.36 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.827 0.822 . . . . 0.10000000000000001 110.641 -178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -80.57 79.43 7.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 113.959 -1.473 . . . . 0.17000000000000001 107.647 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.16 -14.26 62.85 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.545 -1.207 . . . . 0.089999999999999997 109.836 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.586 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.17 -30.01 38.78 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.632 -0.877 . . . . 0.14999999999999999 108.632 -178.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.1 tp10 -67.93 -34.01 75.78 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.304 -1.317 . . . . 1.73 109.104 171.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.44 -43.69 66.23 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 113.213 -1.812 . . . . 0.12 109.613 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.551 ' CG2' ' HA ' ' A' ' 91' ' ' SER . 63.5 m -63.56 -28.13 69.73 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.73 -1.577 . . . . 0.11 110.159 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 104' ' ' GLU . 3.7 tp10 -66.04 -52.06 52.5 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.16 -1.052 . . . . 1.47 108.16 169.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.665 HG21 ' HB2' ' A' ' 64' ' ' TRP . 32.2 m -56.36 -33.93 66.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.669 -0.696 . . . . 0.12 111.319 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.723 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.7 mt -50.46 -68.02 0.21 Allowed 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 116.12 -0.491 . . . . 0.56000000000000005 109.799 172.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.55 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.7 mtp180 -43.04 -35.47 1.28 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.129 0.966 . . . . 1.51 111.194 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.604 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.2 m-20 -72.56 -45.62 58.36 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.49 -1.232 . . . . 0.28000000000000003 112.101 -175.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.56 -33.59 60.66 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.309 -0.997 . . . . 0.089999999999999997 108.309 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -62.99 -34.45 77.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 113.651 -1.613 . . . . 0.12 110.064 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -69.84 -38.28 76.45 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.521 -1.218 . . . . 0.20000000000000001 111.208 -175.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -60.97 -29.21 69.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.736 -1.12 . . . . 1.1699999999999999 111.179 -175.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -81.31 -30.25 33.98 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.746 -0.661 . . . . 2.0499999999999998 111.141 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.28 3.82 10.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.049 -0.596 . . . . 0.54000000000000004 113.228 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.66 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 54.2 mtpt -88.28 -6.31 57.84 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.963 0.411 . . . . 0.98999999999999999 110.092 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.784 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 27.8 m-85 -122.49 175.32 6.52 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 122.491 1.139 . . . . 0.20999999999999999 113.099 172.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 7.1 m -121.11 119.26 31.9 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 112.621 -2.081 . . . . 0.23000000000000001 107.947 168.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -89.6 139.44 30.55 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.345 -0.942 . . . . 0.38 111.319 -170.279 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.615 ' HB ' ' OE1' ' A' ' 126' ' ' GLN . 1.6 m -91.38 147.09 5.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.222 -1.029 . . . . 0.41999999999999998 108.222 170.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.538 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -103.12 178.22 4.62 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.188 -0.605 . . . . 1.7 110.574 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.23 -33.34 72.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.422 0.63 . . . . 0.55000000000000004 110.414 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.683 ' O ' ' HG3' ' A' ' 129' ' ' MET . 9.6 pt20 -47.47 -35.88 9.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.285 -1.325 . . . . 2.04 111.374 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.615 ' OE1' ' HB ' ' A' ' 122' ' ' VAL . 25.7 mt-30 -97.93 -54.08 3.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 122.052 0.93 . . . . 0.40999999999999998 110.107 173.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.67 HD13 HD21 ' A' ' 88' ' ' LEU . 26.1 tp -63.86 -65.23 0.71 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 113.367 -1.742 . . . . 1.3899999999999999 113.104 -168.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.66 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.8 t -50.47 -43.73 55.49 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 123.365 1.555 . . . . 1.05 109.117 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.737 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -57.69 -61.42 2.52 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 111.145 -2.752 . . . . 1.6399999999999999 110.521 177.361 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.759 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.76 -45.79 7.35 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 124.564 1.165 . . . . 0.31 112.169 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.513 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.4 OUTLIER -54.44 -53.23 56.96 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 108.701 -0.851 . . . . 1.53 108.701 179.138 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.3 mt-30 -63.83 -39.89 95.29 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.563 -0.744 . . . . 0.40999999999999998 111.287 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.737 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.9 mt-30 -58.89 -35.07 72.42 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 114.471 -1.24 . . . . 0.37 109.548 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -90.06 -30.67 17.57 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 113.798 -1.546 . . . . 0.23999999999999999 109.502 -176.726 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.27 -45.89 0.6 Allowed Glycine 0 CA--C 1.495 -1.162 0 CA-C-O 122.422 1.012 . . . . 0.33000000000000002 113.376 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.602 HD13 ' O ' ' A' ' 141' ' ' SER . 92.3 mt -66.38 -171.09 0.11 Allowed 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.362 -1.919 . . . . 0.31 115.613 -170.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.1 m -115.78 151.45 46.33 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 110.716 -2.947 . . . . 0.81000000000000005 107.924 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.66 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 34.0 Cg_endo -64.81 0.2 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.526 2.151 . . . . 0.32000000000000001 112.638 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.586 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -119.13 -23.9 6.66 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.871 0.843 . . . . 1.25 110.811 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 14.4 t70 -61.4 -21.5 64.15 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.471 -1.695 . . . . 0.65000000000000002 109.359 -173.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.602 ' O ' HD13 ' A' ' 136' ' ' LEU . 26.3 m 70.56 167.84 0.3 Allowed 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 112.641 -2.072 . . . . 0.59999999999999998 110.12 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.947 HD22 ' HA ' ' A' ' 148' ' ' ALA . 5.4 mt -64.97 -40.29 94.77 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.257 -1.016 . . . . 0.85999999999999999 108.257 -177.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 62.39 -10.16 0.12 Allowed Glycine 0 C--N 1.32 -0.357 0 CA-C-N 113.098 -1.864 . . . . 0.31 114.586 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.427 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.7 OUTLIER -153.8 124.51 7.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.026 -0.731 . . . . 0.23999999999999999 109.026 -175.358 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.686 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.3 mmt180 -41.28 -45.69 3.02 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 112.101 0.408 . . . . 1.6499999999999999 112.101 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 31.3 t -75.04 -25.58 58.81 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.791 0.805 . . . . 0.53000000000000003 111.247 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.551 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 48.2 mttt -72.77 -29.28 63.18 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.755 1.264 . . . . 1.3100000000000001 108.156 175.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.947 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -77.57 -49.02 15.52 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 112.31 -2.223 . . . . 0.12 110.273 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.629 HG13 ' HE1' ' A' ' 179' ' ' MET . 38.3 mt -65.26 -41.19 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-N 113.016 -1.902 . . . . 0.11 110.151 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.84 -55.0 25.61 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.745 -1.116 . . . . 0.14999999999999999 111.09 171.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.759 HG23 ' CB ' ' A' ' 130' ' ' ALA . 87.6 mt -66.78 -47.34 83.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 N-CA-C 112.637 0.606 . . . . 0.17999999999999999 112.637 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.693 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.0 -41.14 74.4 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.046 0.45 . . . . 0.13 111.133 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.518 ' HD2' HG23 ' A' ' 149' ' ' ILE . 54.3 mtp180 -81.01 -23.15 38.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.852 0.835 . . . . 1.0800000000000001 110.242 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -82.73 -10.7 58.78 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.323 -1.362 . . . . 0.5 107.323 177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.723 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.14 -28.8 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 113.148 -1.842 . . . . 0.17000000000000001 110.965 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.403 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.74 35.26 4.66 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.443 -0.884 . . . . 0.16 112.6 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.684 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.4 159.5 16.96 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.02 0.748 . . . . 0.12 113.02 -169.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.671 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -98.64 -29.11 13.23 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.211 -0.904 . . . . 0.20000000000000001 109.434 178.816 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.577 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.4 m-85 -135.51 -173.17 3.27 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.055 -0.975 . . . . 0.13 111.037 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.691 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -136.74 138.54 46.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.645 -1.161 . . . . 0.080000000000000002 108.921 166.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.598 HD21 ' SD ' ' A' ' 176' ' ' MET . 35.1 tp -107.85 100.96 10.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.435 -0.906 . . . . 0.16 109.137 165.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.625 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.4 m-85 -78.5 119.04 21.24 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.401 -1.272 . . . . 0.26000000000000001 108.131 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.864 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 13.3 t -130.69 158.76 39.19 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 122.12 0.962 . . . . 1.05 110.413 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.818 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.5 p -162.03 170.67 18.86 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.038 -1.437 . . . . 0.10000000000000001 110.718 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -132.27 135.73 46.46 Favored 'General case' 0 N--CA 1.406 -2.666 0 CA-C-N 114.044 -1.434 . . . . 0.11 108.766 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.7 t -144.52 -170.69 3.44 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.608 -0.837 . . . . 1.0900000000000001 110.376 176.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 89.84 -83.23 1.38 Allowed Glycine 0 C--N 1.289 -2.065 0 CA-C-N 114.906 -1.043 . . . . 0.14999999999999999 111.062 175.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.528 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 57.7 t30 -141.67 129.37 21.6 Favored 'General case' 0 C--O 1.199 -1.602 0 CA-C-N 113.872 -1.164 . . . . 0.58999999999999997 108.205 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.579 HG11 ' HA3' ' A' ' 98' ' ' GLY . 4.2 p -65.28 -41.88 92.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 115.378 -0.828 . . . . 0.14999999999999999 112.63 -171.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.425 ' N ' HG13 ' A' ' 169' ' ' VAL . 50.8 m-20 -61.56 -29.44 70.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.378 0.608 . . . . 1.26 109.462 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.35 88.93 3.35 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 114.592 -1.185 . . . . 0.13 108.9 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.812 ' HD2' HG22 ' A' ' 194' ' ' VAL . 40.7 Cg_endo -92.24 163.88 3.08 Favored 'Trans proline' 0 CA--C 1.501 -1.147 0 C-N-CA 124.858 3.705 . . . . 0.089999999999999997 115.458 -170.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.743 HG22 ' HB3' ' A' ' 191' ' ' LYS . 14.3 m -82.73 120.54 25.72 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.837 -1.529 . . . . 0.14000000000000001 107.563 168.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.889 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 22.1 tp -82.78 95.16 7.8 Favored 'General case' 0 CA--C 1.476 -1.901 0 C-N-CA 119.434 -0.906 . . . . 0.16 109.11 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.503 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 16.0 mt-30 -86.18 107.74 18.02 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-O 122.044 0.926 . . . . 0.34000000000000002 108.61 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.864 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.0 OUTLIER -111.85 163.18 14.48 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.893 -1.048 . . . . 1.0900000000000001 111.245 -174.428 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 55.4 tt0 -170.48 117.81 0.53 Allowed 'General case' 0 C--O 1.204 -1.332 0 CA-C-N 115.87 -0.604 . . . . 0.5 110.327 -167.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.032 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.1 100.51 11.38 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.414 -0.958 . . . . 0.10000000000000001 108.414 -173.315 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.686 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.6 ttp -90.61 123.39 34.2 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.492 -0.776 . . . . 0.070000000000000007 109.608 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -59.96 126.65 28.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.096 -1.446 . . . . 0.22 107.096 166.689 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -81.6 -35.06 13.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 119.103 -1.039 . . . . 0.11 110.81 179.279 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.426 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.9 mt-30 -62.81 -15.06 52.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.377 -0.828 . . . . 0.34999999999999998 111.58 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.1 p -130.05 -34.89 1.64 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.724 0.773 . . . . 0.19 110.276 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.478 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 84.6 29.83 28.65 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.462 -1.244 . . . . 0.17999999999999999 112.12 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 179' ' ' MET . 9.8 pt-20 -105.3 158.19 16.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.42 -0.39 . . . . 0.72999999999999998 110.447 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.619 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.0 mm -93.58 112.07 25.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.623 0.725 . . . . 0.14000000000000001 109.659 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.032 HD11 HD13 ' A' ' 178' ' ' LEU . 1.2 pp -99.48 -30.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.067 -0.969 . . . . 0.13 110.853 -173.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.648 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 82.0 t90 -136.76 152.82 50.76 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.403 -0.817 . . . . 0.070000000000000007 109.743 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 35.9 p -153.99 163.9 39.31 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.107 0.78 . . . . 0.13 113.107 165.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.01 -173.65 27.69 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 111.125 -0.79 . . . . 0.12 111.125 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.889 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.5 mttt -158.8 148.96 19.54 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.409 -1.7 . . . . 1.22 106.409 165.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 174' ' ' LEU . . . -154.13 125.38 1.72 Allowed Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 118.574 -1.774 . . . . 0.12 113.905 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.75 107.93 5.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.648 0.737 . . . . 0.17000000000000001 110.862 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.812 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -88.57 158.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-N 114.224 -1.353 . . . . 0.11 110.586 -175.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.73 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -100.47 171.99 7.4 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 112.573 -2.103 . . . . 0.17999999999999999 108.751 -175.016 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.0 tt0 -101.82 132.86 47.35 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.086 -0.646 . . . . 0.91000000000000003 109.621 172.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.54 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 36.0 mm-40 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.496 -0.764 . . . . 1.24 110.672 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.646 -0.582 . . . . 88.609999999999999 111.646 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -121.87 -57.66 1.78 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.639 0.257 . . . . 87.430000000000007 110.545 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.3 m80 67.52 114.02 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.477 -0.783 . . . . 87.159999999999997 110.847 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.8 mtp -120.5 147.73 44.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.128 -0.487 . . . . 85.340000000000003 110.436 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p 48.91 15.75 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.183 1.393 . . . . 85.049999999999997 113.411 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.38 -60.05 0.87 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.652 -0.785 . . . . 84.680000000000007 111.584 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -87.81 43.69 1.13 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.553 1.168 . . . . 85.569999999999993 110.573 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.462 ' C ' ' HD3' ' A' ' 10' ' ' PRO . 97.9 mtt180 59.93 63.59 1.43 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 113.15 -1.841 . . . . 85.040000000000006 111.785 -175.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -125.86 69.2 64.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.166 -0.925 . . . . 82.170000000000002 110.324 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HD3' ' C ' ' A' ' 8' ' ' ARG . 3.5 Cg_exo -81.55 -71.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.417 2.745 . . . . 81.510000000000005 111.566 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.35 109.66 0.99 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.082 -0.508 . . . . 79.560000000000002 110.28 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.03 137.7 69.63 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.947 2.432 . . . . 78.5 112.043 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.7 m -139.67 157.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.835 -0.62 . . . . 77.0 110.677 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -103.71 139.3 39.15 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.738 -0.838 . . . . 75.739999999999995 108.738 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -58.9 137.74 57.69 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.368 -0.378 . . . . 73.909999999999997 111.59 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.21 118.5 7.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.275 0.56 . . . . 72.299999999999997 109.531 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 48.5 mttp -76.78 -45.9 3.05 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.631 -0.713 . . . . 71.219999999999999 111.816 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 17' ' ' LYS . 72.0 Cg_endo -76.61 177.03 9.34 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.454 1.436 . . . . 69.670000000000002 111.679 171.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.539 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . . . -153.24 -61.58 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 119.369 -0.348 . . . . 67.549999999999997 111.858 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 19' ' ' ALA . 94.5 Cg_endo -77.82 -7.6 16.57 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.521 1.481 . . . . 66.700000000000003 112.896 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 64.48 -171.46 0.18 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.78 -0.646 . . . . 65.010000000000005 110.563 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -128.28 75.32 79.1 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.477 -0.564 . . . . 63.409999999999997 109.477 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.61 139.0 83.66 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.971 2.447 . . . . 61.93 113.058 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . -126.54 92.44 3.56 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.328 -0.851 . . . . 59.869999999999997 110.0 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 25' ' ' GLU . 1.2 tt0 -93.21 110.83 48.81 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 115.627 -0.715 . . . . 58.469999999999999 109.671 -177.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 24' ' ' ALA . 70.9 Cg_endo -93.5 102.68 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.057 2.505 . . . . 57.359999999999999 112.31 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -127.98 -62.39 1.06 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.531 0.681 . . . . 55.509999999999998 110.659 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 49.7 tt0 56.96 71.55 1.12 Allowed Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 114.065 -1.425 . . . . 53.869999999999997 110.974 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.89 -26.91 59.05 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.52 2.147 . . . . 52.759999999999998 112.768 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.02 123.37 89.21 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.853 0.359 . . . . 50.93 111.115 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.7 152.26 32.87 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.551 2.167 . . . . 49.210000000000001 112.588 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.58 170.73 10.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.398 0.618 . . . . 47.490000000000002 110.723 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.55 121.34 9.06 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.177 -0.919 . . . . 45.969999999999999 110.504 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -57.66 159.37 17.19 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.287 2.658 . . . . 45.280000000000001 112.648 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 p -74.05 130.29 39.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.173 -0.922 . . . . 42.789999999999999 111.287 -176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.4 p -143.19 130.7 10.91 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.727 -0.67 . . . . 40.789999999999999 110.338 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 11.0 Cg_exo -71.24 -170.47 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.609 2.206 . . . . 39.810000000000002 111.22 174.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.5 t -128.26 140.87 51.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.251 0.548 . . . . 37.5 110.733 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.9 mt -103.53 127.88 28.62 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.625 -0.716 . . . . 35.649999999999999 110.335 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.1 113.72 2.73 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.183 1.922 . . . . 33.719999999999999 111.759 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.478 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 14.8 mm100 -97.74 59.53 1.48 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.117 0.484 . . . . 31.510000000000002 110.172 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -109.65 92.47 12.24 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.109 -0.496 . . . . 30.129999999999999 110.637 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 41' ' ' GLN . 83.5 Cg_endo -91.86 154.91 3.38 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.899 2.399 . . . . 29.52 112.118 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' HA2' ' HD3' ' A' ' 45' ' ' PRO . . . -167.92 162.32 36.11 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.457 -0.878 . . . . 26.75 112.059 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 48.7 Cg_endo -97.17 135.32 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.911 3.074 . . . . 25.079999999999998 112.988 -175.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.2 mm -73.78 -50.03 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 23.899999999999999 110.21 172.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 36.16 74.51 0.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.61 1.164 . . . . 21.23 113.246 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -76.07 164.94 25.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.143 0.497 . . . . 19.920000000000002 110.858 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.36 174.92 6.07 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.542 -0.754 . . . . 16.559999999999999 109.305 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -95.22 88.23 5.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.25 -0.648 . . . . 15.050000000000001 109.25 173.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -64.95 82.14 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.853 0.72 . . . . 14.19 110.462 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.3 p -137.07 127.62 26.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.311 -0.404 . . . . 11.380000000000001 111.347 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 106.89 3.79 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 115.183 -0.917 . . . . 8.2899999999999991 110.367 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -68.55 124.49 11.64 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.334 2.023 . . . . 6.8700000000000001 111.957 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.77 -38.84 7.22 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 121.963 1.775 . . . . 5.04 111.636 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.05 148.45 32.39 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.814 -0.63 . . . . 2.5899999999999999 110.351 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.78 -177.73 2.02 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 123.389 2.726 . . . . 1.6399999999999999 111.297 174.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -104.72 133.58 49.3 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.727 -1.124 . . . . 3.3900000000000001 111.098 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.677 ' HB ' ' HB2' ' A' ' 101' ' ' ASN . 14.1 mt -79.15 174.38 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.571 -1.195 . . . . 0.44 112.213 -171.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.627 ' N ' HG22 ' A' ' 59' ' ' ILE . 45.9 mtt180 -62.76 -158.0 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.12 -1.855 . . . . 2.3399999999999999 112.432 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.686 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 5.4 t60 -155.56 150.97 27.04 Favored 'General case' 0 CA--C 1.471 -2.08 0 CA-C-N 112.126 -2.306 . . . . 2.2200000000000002 106.114 176.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.742 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 -125.24 160.13 29.97 Favored 'General case' 0 N--CA 1.418 -2.046 0 O-C-N 123.827 0.705 . . . . 0.20999999999999999 109.499 -176.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.512 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 5.1 t70 -82.49 67.47 8.54 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 123.618 1.675 . . . . 0.34999999999999998 108.144 171.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.732 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 91.9 m95 -57.58 -42.98 84.19 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 111.678 -2.51 . . . . 0.10000000000000001 112.026 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.428 ' N ' HG21 ' A' ' 108' ' ' THR . 13.4 t-20 -51.21 -28.3 11.08 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.914 -1.494 . . . . 1.1100000000000001 111.331 174.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 -18.56 79.06 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.096 -0.956 . . . . 0.20999999999999999 111.258 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.84 -54.35 2.84 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.868 -1.166 . . . . 0.13 110.879 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.712 ' SD ' HD23 ' A' ' 109' ' ' LEU . 40.8 mtt -60.2 -62.54 1.79 Allowed 'General case' 0 C--O 1.21 -0.998 0 CA-C-N 113.878 -1.51 . . . . 0.089999999999999997 111.61 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.462 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -37.22 -54.89 1.87 Allowed Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 114.593 1.331 . . . . 0.63 114.593 -172.259 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.745 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 34.4 Cg_endo -64.14 -31.56 64.54 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.355 2.036 . . . . 0.14000000000000001 111.001 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.718 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 8.1 mtm -78.24 -43.96 26.86 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 114.988 -1.005 . . . . 0.69999999999999996 111.271 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 68' ' ' MET . 42.4 t -58.57 -38.94 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-N 114.284 -1.326 . . . . 0.12 108.716 176.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.2 t -58.71 -37.25 75.72 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.956 -1.929 . . . . 0.56000000000000005 111.026 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.745 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 4.8 mtpm? -78.57 -41.92 30.63 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.627 -0.509 . . . . 1.3 109.627 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.841 ' SD ' ' HE2' ' A' ' 119' ' ' PHE . 1.0 OUTLIER -45.88 -53.53 9.64 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.724 0.809 . . . . 0.5 110.099 -175.207 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.64 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.9 mt -80.29 7.41 9.58 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.288 -1.324 . . . . 0.65000000000000002 112.249 -170.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.55 15.62 9.82 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.075 -1.421 . . . . 0.17000000000000001 109.805 170.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.595 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -80.54 165.25 22.29 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.235 0.54 . . . . 0.10000000000000001 110.423 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -87.8 105.81 17.65 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 115.597 -0.729 . . . . 1.72 109.124 175.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.673 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.29 -25.37 3.02 Favored Glycine 0 N--CA 1.415 -2.731 0 C-N-CA 119.623 -1.275 . . . . 0.12 110.437 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.763 HG11 ' O ' ' A' ' 75' ' ' MET . 12.8 p -103.21 149.35 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.86 0.838 . . . . 0.16 111.365 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.1 m -135.52 140.33 44.66 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.692 -1.14 . . . . 0.45000000000000001 110.744 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.594 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -54.77 131.49 43.95 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.07 -0.968 . . . . 0.28000000000000003 110.698 168.426 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.04 0.2 38.62 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.951 -0.642 . . . . 0.28000000000000003 113.271 176.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.87 151.22 23.52 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 120.537 -0.465 . . . . 1.2 111.081 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.712 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -81.16 120.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-O 121.865 0.84 . . . . 0.20000000000000001 109.074 165.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.725 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -108.42 111.02 22.7 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.412 -0.813 . . . . 0.14000000000000001 109.061 -171.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.762 HD21 HD23 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -72.31 101.09 2.78 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 114.849 -1.069 . . . . 0.14999999999999999 109.329 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.548 HG21 ' HG3' ' A' ' 110' ' ' ARG . 53.1 t -74.34 106.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 114.495 -1.229 . . . . 0.94999999999999996 109.511 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.912 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 2.3 t70 -78.29 158.39 28.89 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.592 -1.186 . . . . 0.64000000000000001 108.344 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.622 ' OG ' ' HA ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -62.32 135.28 57.39 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 115.378 -0.828 . . . . 0.37 109.325 175.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.599 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 33.4 t -62.28 138.49 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 106.983 -1.488 . . . . 0.10000000000000001 106.983 167.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.842 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.0 t-20 -85.01 161.49 19.73 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.836 0.827 . . . . 0.17999999999999999 110.114 174.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.766 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.95 84.94 2.34 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.368 -1.287 . . . . 0.12 108.261 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 14.1 mtp180 -108.51 -2.75 18.68 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 113.912 -1.495 . . . . 0.64000000000000001 108.572 -172.07 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.5 p -51.1 -170.94 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.683 -2.053 . . . . 0.14000000000000001 115.107 -176.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 36.5 t30 -70.43 -10.45 59.14 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.134 -1.848 . . . . 0.47999999999999998 110.567 173.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.595 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -152.22 -144.45 3.92 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.414 -0.898 . . . . 0.12 113.128 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.609 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 54.6 p -122.14 131.73 54.11 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.165 0.432 . . . . 1.1599999999999999 112.165 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.766 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.8 pp -136.84 156.76 48.06 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.772 0.796 . . . . 0.10000000000000001 110.947 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.677 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 1.4 t-20 -79.81 81.18 6.11 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.814 -1.539 . . . . 0.17000000000000001 107.961 175.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -67.97 -15.1 63.45 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.933 -1.485 . . . . 0.089999999999999997 110.112 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.796 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.92 -32.79 40.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.73 -0.841 . . . . 0.14999999999999999 108.73 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.589 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 12.8 tp10 -65.22 -34.48 78.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.432 -1.258 . . . . 1.73 108.929 171.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.06 -43.41 64.95 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 113.243 -1.798 . . . . 0.12 109.367 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.617 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 76.5 m -64.73 -28.8 69.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.062 -1.426 . . . . 0.11 110.405 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -43.53 67.31 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.05 -1.093 . . . . 1.47 108.05 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.687 HG21 ' HB2' ' A' ' 64' ' ' TRP . 75.9 m -61.96 -31.6 71.96 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.327 -0.852 . . . . 0.12 110.613 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.716 ' O ' HD23 ' A' ' 113' ' ' LEU . 9.0 mt -51.43 -69.48 0.11 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 109.209 -0.663 . . . . 0.56000000000000005 109.209 171.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.692 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.9 mtp180 -40.09 -38.86 0.79 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.424 1.078 . . . . 1.51 111.182 175.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 108' ' ' THR . 8.2 m-20 -70.88 -47.33 59.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.473 -1.24 . . . . 0.28000000000000003 112.159 -176.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.8 -33.08 68.25 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.107 0.956 . . . . 0.089999999999999997 108.424 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.8 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.1 mm? -61.99 -32.98 73.5 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.437 -1.71 . . . . 0.12 109.894 173.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -74.43 -41.5 60.74 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.484 -1.234 . . . . 0.20000000000000001 111.604 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -64.93 -25.64 67.97 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.4 -0.818 . . . . 1.1699999999999999 111.199 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 30.2 m-80 -84.15 -16.53 43.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.529 -0.76 . . . . 2.0499999999999998 110.844 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.6 17.2 19.17 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 115.432 0.933 . . . . 0.54000000000000004 115.432 164.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.594 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 53.3 mtpt -98.16 -34.4 10.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.541 0.67 . . . . 0.98999999999999999 109.997 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.841 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 13.7 m-85 -89.32 177.85 6.49 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 122.728 1.251 . . . . 0.20999999999999999 113.095 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 21.2 m -123.67 111.07 15.75 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 112.299 -2.228 . . . . 0.23000000000000001 107.84 168.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.8 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -89.37 123.66 33.74 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.719 -1.128 . . . . 0.38 110.734 -170.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.535 HG11 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -65.8 155.21 7.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.354 -0.839 . . . . 0.41999999999999998 109.102 176.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.499 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 67.3 m -93.7 155.77 17.07 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.737 0.78 . . . . 1.7 110.029 175.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.566 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . . . -72.91 -19.75 61.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.218 -1.355 . . . . 0.55000000000000004 109.596 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.726 ' O ' ' HG3' ' A' ' 129' ' ' MET . 5.7 pt20 -57.36 -29.09 63.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.11 -1.405 . . . . 2.04 109.993 172.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.646 ' HB2' HG22 ' A' ' 155' ' ' VAL . 0.2 OUTLIER -99.18 -46.75 5.45 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.154 -0.93 . . . . 0.40999999999999998 110.625 171.792 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.762 HD23 HD21 ' A' ' 88' ' ' LEU . 1.1 tm? -73.47 -62.39 1.5 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.682 -1.144 . . . . 1.3899999999999999 113.514 -167.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.561 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -50.8 -37.97 45.72 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 123.684 1.707 . . . . 1.05 108.637 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.726 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 29.2 mmm -62.82 -62.09 1.96 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 110.417 -3.083 . . . . 1.6399999999999999 111.403 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.775 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -40.99 -45.12 2.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 124.478 1.111 . . . . 0.31 111.905 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.806 ' HE2' HD21 ' A' ' 142' ' ' LEU . 95.3 mttt -52.38 -58.09 7.77 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.847 -0.615 . . . . 1.53 109.845 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.9 mt-30 -58.12 -44.72 87.89 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.566 -1.197 . . . . 0.40999999999999998 111.622 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.698 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.5 mt-30 -56.47 -36.37 68.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.627 -1.17 . . . . 0.37 109.871 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.51 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -88.49 -29.38 20.18 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.972 -1.467 . . . . 0.23999999999999999 109.431 -177.368 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.8 -41.46 0.58 Allowed Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 119.36 -1.4 . . . . 0.33000000000000002 114.328 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 91.2 mt -73.75 -172.89 1.36 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 123.868 1.794 . . . . 0.31 115.262 -168.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 52.4 m -111.44 151.4 43.23 Favored Pre-proline 0 N--CA 1.425 -1.675 0 CA-C-N 110.783 -2.917 . . . . 0.81000000000000005 107.964 169.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.652 ' HA ' ' HD2' ' A' ' 131' ' ' LYS . 14.3 Cg_endo -60.6 -3.27 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.736 2.29 . . . . 0.32000000000000001 112.782 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.796 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -118.6 -20.88 8.18 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 123.132 0.573 . . . . 1.25 109.954 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.6 t70 -60.44 -33.55 72.71 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.699 -1.223 . . . . 0.65000000000000002 107.699 -174.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.622 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 18.4 m 78.92 156.64 0.16 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 110.441 -3.072 . . . . 0.59999999999999998 111.059 -173.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.912 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 7.2 mt -63.82 -39.34 94.0 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.15 -1.426 . . . . 0.85999999999999999 107.15 -172.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.1 -3.6 0.16 Allowed Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 112.849 -1.978 . . . . 0.31 115.166 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 m -149.66 121.67 8.25 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.881 -0.785 . . . . 0.23999999999999999 108.881 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.59 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.3 mmt180 -41.91 -45.06 3.62 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 123.61 0.569 . . . . 1.6499999999999999 111.366 -175.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.3 t -73.17 -26.55 61.23 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.541 0.686 . . . . 0.53000000000000003 111.525 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.559 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 49.1 mttt -73.15 -33.04 65.26 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.138 -1.06 . . . . 1.3100000000000001 108.138 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.863 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -74.98 -43.46 53.85 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-N 113.019 -1.901 . . . . 0.12 110.465 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.609 ' HA ' HG23 ' A' ' 181' ' ' VAL . 43.4 mt -67.1 -42.69 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 113.589 -1.641 . . . . 0.11 110.159 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.31 -52.33 41.4 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.856 -1.065 . . . . 0.14999999999999999 111.287 171.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.775 HG23 ' CB ' ' A' ' 130' ' ' ALA . 71.8 mt -68.5 -47.25 78.14 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 N-CA-C 112.891 0.7 . . . . 0.17999999999999999 112.891 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.695 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.28 -38.34 71.07 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.001 0.429 . . . . 0.13 111.23 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.479 ' HD2' HG23 ' A' ' 149' ' ' ILE . 30.4 mtp180 -84.04 -20.01 33.43 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.666 0.746 . . . . 1.0800000000000001 110.443 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.419 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 27.9 t-20 -84.36 -10.38 57.63 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.307 -1.368 . . . . 0.5 107.307 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.745 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -109.69 -29.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 113.262 -1.79 . . . . 0.17000000000000001 111.094 -173.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.13 34.74 4.73 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.391 -0.909 . . . . 0.16 112.833 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.624 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.64 161.29 15.53 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.15 0.796 . . . . 0.12 113.15 -169.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.712 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -101.91 -28.14 12.57 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.375 -0.829 . . . . 0.20000000000000001 109.78 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.56 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.4 m-85 -135.39 -172.57 3.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.261 -0.881 . . . . 0.13 110.959 -175.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.769 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -138.85 139.62 40.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.098 -0.955 . . . . 0.080000000000000002 109.221 167.464 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.594 HD21 ' SD ' ' A' ' 176' ' ' MET . 43.9 tp -107.62 99.84 9.29 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 119.386 -0.925 . . . . 0.16 109.395 165.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.594 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 3.0 m-85 -81.69 112.81 19.21 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.234 -1.348 . . . . 0.26000000000000001 109.556 176.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.859 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 4.9 t -123.08 166.12 15.68 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-O 121.77 0.795 . . . . 1.05 111.033 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.848 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -162.79 176.18 10.52 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 114.548 -1.205 . . . . 0.10000000000000001 111.313 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.65 133.4 30.58 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 113.865 -1.516 . . . . 0.11 108.279 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.67 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -143.14 -177.17 5.23 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.354 -0.61 . . . . 1.0900000000000001 109.354 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.76 -83.72 0.86 Allowed Glycine 0 CA--C 1.493 -1.336 0 C-N-CA 119.62 -1.276 . . . . 0.14999999999999999 111.355 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.7 t30 -144.17 130.5 19.8 Favored 'General case' 0 C--O 1.199 -1.598 0 N-CA-C 107.972 -1.121 . . . . 0.58999999999999997 107.972 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.595 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.2 p -64.48 -41.56 92.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.123 -0.944 . . . . 0.14999999999999999 112.36 -171.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.417 ' N ' HG13 ' A' ' 169' ' ' VAL . 10.9 m-20 -61.19 -30.76 70.61 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.793 0.806 . . . . 1.26 109.509 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.11 88.39 3.49 Favored Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 113.868 -1.514 . . . . 0.13 108.376 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.814 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.0 Cg_endo -90.72 167.0 4.01 Favored 'Trans proline' 0 CA--C 1.492 -1.579 0 C-N-CA 124.579 3.52 . . . . 0.089999999999999997 114.72 -170.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 23.7 m -86.39 119.41 26.63 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 113.732 -1.577 . . . . 0.14000000000000001 107.643 166.51 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 164' ' ' SER . 42.2 tp -84.13 98.67 10.03 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 108.643 -0.873 . . . . 0.16 108.643 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.627 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.0 mt-30 -90.49 109.02 20.17 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 122.089 0.947 . . . . 0.34000000000000002 109.276 -176.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.859 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -111.73 164.54 12.93 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.936 -1.029 . . . . 1.0900000000000001 111.795 -172.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.614 ' HG2' HD12 ' A' ' 186' ' ' ILE . 9.1 tt0 -170.64 119.5 0.54 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 115.813 -0.63 . . . . 0.5 110.245 -166.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.064 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.32 101.84 12.58 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.929 -0.767 . . . . 0.10000000000000001 108.929 -173.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.599 ' HE1' HG13 ' A' ' 149' ' ' ILE . 14.4 ttp -90.88 118.35 30.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.755 -0.657 . . . . 0.070000000000000007 109.675 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.498 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -61.7 117.89 6.41 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.936 -1.505 . . . . 0.22 106.936 168.881 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -71.9 -36.35 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.05 0.841 . . . . 0.11 111.485 -176.409 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.0 mt-30 -60.85 -15.25 28.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.364 -0.835 . . . . 0.34999999999999998 111.685 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 185' ' ' GLU . 40.5 p -127.91 -37.02 1.95 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.308 1.051 . . . . 0.19 109.896 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.552 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 86.83 24.32 38.73 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 113.765 -1.561 . . . . 0.17999999999999999 111.733 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.43 ' HG2' ' OG1' ' A' ' 183' ' ' THR . 11.0 pt-20 -105.22 158.03 16.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.882 0.372 . . . . 0.72999999999999998 110.248 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.614 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.0 mm -91.5 117.14 34.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.498 0.666 . . . . 0.14000000000000001 109.391 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.064 HD11 HD13 ' A' ' 178' ' ' LEU . 1.8 pp -105.02 -29.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 114.777 -1.101 . . . . 0.13 110.44 -171.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.595 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.4 t90 -136.95 152.2 49.9 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.145 -0.934 . . . . 0.070000000000000007 109.621 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 53.9 p -153.41 163.46 39.9 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.963 0.727 . . . . 0.13 112.963 164.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.69 -173.82 27.6 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 111.214 -0.755 . . . . 0.12 111.214 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.768 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.4 mtmt -158.91 151.44 21.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.668 -1.975 . . . . 1.22 105.668 165.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -161.02 127.74 1.81 Allowed Glycine 0 C--N 1.282 -2.43 0 C-N-CA 119.866 -1.159 . . . . 0.12 112.235 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.63 117.85 14.83 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.518 0.675 . . . . 0.17000000000000001 111.528 -173.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.814 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -95.53 158.16 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-O 122.633 1.206 . . . . 0.11 110.676 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.742 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -99.56 172.2 7.44 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.531 -2.122 . . . . 0.17999999999999999 108.966 -175.126 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.607 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.0 tt0 -102.67 134.04 46.69 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.19 -0.604 . . . . 0.91000000000000003 109.877 171.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.539 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 15.2 mm-40 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.477 -0.773 . . . . 1.24 110.524 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 111.828 -0.509 . . . . 88.609999999999999 111.828 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.9 m -92.12 171.08 9.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.698 0.285 . . . . 87.430000000000007 110.451 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -132.78 -172.61 2.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.632 -0.258 . . . . 87.159999999999997 110.416 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.47 ' O ' HG12 ' A' ' 5' ' ' VAL . 1.4 pmm? -56.57 150.33 15.7 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.613 0.571 . . . . 85.340000000000003 110.235 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 4' ' ' MET . 4.3 p 49.75 17.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.864 1.266 . . . . 85.049999999999997 112.667 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.41 -101.15 0.86 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.75 -0.738 . . . . 84.680000000000007 111.473 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -142.53 37.7 1.5 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.755 0.788 . . . . 85.569999999999993 110.274 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 65.7 178.59 0.2 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 114.389 -1.278 . . . . 85.040000000000006 111.402 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 58.34 71.16 1.06 Allowed Pre-proline 0 C--O 1.225 -0.194 0 CA-C-N 113.487 -1.688 . . . . 82.170000000000002 112.004 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -45.97 -72.17 0.05 OUTLIER 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.289 2.659 . . . . 81.510000000000005 112.346 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.453 ' O ' HG13 ' A' ' 13' ' ' VAL . . . -155.44 114.32 2.27 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.218 -0.446 . . . . 79.560000000000002 110.477 -175.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.68 132.34 16.57 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.506 2.804 . . . . 78.5 112.966 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 11' ' ' ALA . 16.9 m -134.12 172.09 16.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.291 -0.868 . . . . 77.0 110.982 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 70.8 60.23 0.2 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.727 -1.124 . . . . 75.739999999999995 109.911 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -114.05 107.62 15.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.408 -0.815 . . . . 73.909999999999997 110.671 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.51 135.8 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.197 0.522 . . . . 72.299999999999997 111.445 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -97.5 119.26 63.16 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.037 -0.528 . . . . 71.219999999999999 109.893 174.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.39 -168.55 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.663 1.575 . . . . 69.670000000000002 112.209 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.65 98.82 0.04 OUTLIER Pre-proline 0 C--N 1.339 0.137 0 CA-C-N 114.691 -1.141 . . . . 67.549999999999997 111.771 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.22 161.55 39.85 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.135 1.89 . . . . 66.700000000000003 111.419 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.57 -5.98 30.95 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.382 -0.527 . . . . 65.010000000000005 111.932 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 72.15 124.08 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.242 0 O-C-N 124.051 0.845 . . . . 63.409999999999997 110.28 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -51.6 141.31 43.39 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.907 2.404 . . . . 61.93 112.567 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.86 111.49 12.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 59.869999999999997 110.446 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -121.4 83.86 40.85 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 58.469999999999999 110.85 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.76 -19.51 41.07 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.113 2.542 . . . . 57.359999999999999 111.519 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 58.7 -105.8 0.27 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.348 -0.842 . . . . 55.509999999999998 110.69 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' VAL . 19.4 mm-40 -144.56 156.01 56.72 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.895 -0.409 . . . . 53.869999999999997 109.895 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.93 35.88 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.952 2.435 . . . . 52.759999999999998 112.534 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' GLN . 3.0 p -160.32 96.54 1.49 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.288 0.566 . . . . 50.93 109.997 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.81 123.18 11.84 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.525 2.15 . . . . 49.210000000000001 111.551 177.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.3 p -118.21 141.95 47.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.6 -0.273 . . . . 47.490000000000002 111.046 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.5 t 57.38 93.85 0.05 OUTLIER Pre-proline 0 C--O 1.235 0.325 0 O-C-N 123.72 0.637 . . . . 45.969999999999999 111.222 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.92 159.37 12.07 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.045 2.497 . . . . 45.280000000000001 112.572 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -75.94 120.61 21.52 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.458 -0.792 . . . . 42.789999999999999 110.741 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.82 108.15 33.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.966 -0.561 . . . . 40.789999999999999 109.97 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.88 -41.75 59.32 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.041 2.494 . . . . 39.810000000000002 112.239 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.9 m -125.34 97.74 5.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 37.5 110.281 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 4.8 mt -67.99 123.59 87.54 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.279 -0.873 . . . . 35.649999999999999 110.789 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 39' ' ' ILE . 32.4 Cg_exo -57.73 97.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.029 2.486 . . . . 33.719999999999999 112.812 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -164.68 118.12 1.31 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.899 -0.591 . . . . 31.510000000000002 109.723 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.662 ' H ' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -150.92 -55.56 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 119.111 -0.471 . . . . 30.129999999999999 111.294 -175.549 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.662 ' HD2' ' H ' ' A' ' 42' ' ' GLN . 5.0 Cg_endo -46.49 123.47 6.87 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.712 2.275 . . . . 29.52 113.444 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.57 171.98 18.25 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.557 -0.747 . . . . 26.75 111.273 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -61.74 129.86 29.24 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.556 2.17 . . . . 25.079999999999998 112.284 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.5 mt -88.16 -66.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.471 -0.331 . . . . 23.899999999999999 110.896 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 61.82 92.32 0.06 Allowed 'General case' 0 C--O 1.233 0.188 0 O-C-N 123.712 0.633 . . . . 21.23 110.482 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -99.01 161.24 13.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.164 -0.471 . . . . 19.920000000000002 111.234 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -179.01 134.5 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.261 -0.881 . . . . 16.559999999999999 109.658 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.02 64.39 1.22 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.55 -0.75 . . . . 15.050000000000001 109.355 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -118.9 25.64 10.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.781 -1.099 . . . . 14.19 110.244 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.2 p -64.43 133.6 52.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.946 -0.57 . . . . 11.380000000000001 111.715 -174.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.66 73.65 40.74 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.32 -0.855 . . . . 8.2899999999999991 111.387 -176.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.38 143.31 24.72 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.364 2.043 . . . . 6.8700000000000001 111.737 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.84 130.27 39.65 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.751 2.3 . . . . 5.04 111.399 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.65 95.26 0.05 OUTLIER Pre-proline 0 C--O 1.233 0.231 0 O-C-N 123.995 0.809 . . . . 2.5899999999999999 109.735 -169.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.7 -177.0 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.458 2.772 . . . . 1.6399999999999999 113.439 -172.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -120.64 146.4 46.43 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.45 -1.25 . . . . 3.3900000000000001 110.901 -173.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 60' ' ' ARG . 11.0 mt -84.26 169.51 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.187 -0.915 . . . . 0.44 111.355 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.614 ' N ' HG22 ' A' ' 59' ' ' ILE . 29.4 mtt85 -66.2 -157.67 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 123.565 1.65 . . . . 2.3399999999999999 112.301 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.676 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 3.9 t60 -158.82 147.56 18.54 Favored 'General case' 0 CA--C 1.471 -2.072 0 CA-C-N 111.741 -2.481 . . . . 2.2200000000000002 106.344 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.752 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 -125.03 159.87 30.32 Favored 'General case' 0 N--CA 1.415 -2.186 0 O-C-N 123.934 0.771 . . . . 0.20999999999999999 109.264 -176.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 2.8 t70 -80.01 68.09 6.02 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 123.692 1.711 . . . . 0.34999999999999998 108.36 171.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.726 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 90.3 m95 -59.41 -44.53 92.83 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 111.407 -2.633 . . . . 0.10000000000000001 112.312 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -51.36 -30.26 18.18 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.036 -1.438 . . . . 1.1100000000000001 111.524 176.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.79 -16.31 80.74 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 115.601 -0.727 . . . . 0.20999999999999999 111.385 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.96 -51.12 3.62 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 113.95 -1.125 . . . . 0.13 110.908 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.718 ' O ' HG23 ' A' ' 72' ' ' VAL . 40.7 mtt -65.33 -55.62 17.21 Favored 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 114.094 -1.412 . . . . 0.089999999999999997 112.224 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.486 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 6.1 mm100 -41.23 -54.76 5.68 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 114.558 1.318 . . . . 0.63 114.558 -176.229 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.824 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 23.7 Cg_endo -62.29 -31.61 81.91 Favored 'Trans proline' 0 CA--C 1.506 -0.891 0 C-N-CA 122.159 1.906 . . . . 0.14000000000000001 110.478 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.799 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 6.7 mtm -79.62 -46.5 17.1 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 114.863 -1.062 . . . . 0.69999999999999996 111.587 -176.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 68' ' ' MET . 61.1 t -55.92 -41.13 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 CA-C-N 114.025 -1.443 . . . . 0.12 108.869 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 t -59.43 -35.26 73.68 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.248 -1.796 . . . . 0.56000000000000005 110.952 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.824 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 21.0 mtpp -81.45 -34.67 31.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.926 0.49 . . . . 1.3 111.392 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.85 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.68 -27.66 69.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.693 -0.685 . . . . 0.5 111.592 -171.159 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.79 HD13 ' HB2' ' A' ' 118' ' ' LYS . 5.7 mt -92.92 -6.16 49.2 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.059 0.933 . . . . 0.65000000000000002 110.817 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.72 18.02 51.41 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 108.726 -1.75 . . . . 0.17000000000000001 108.726 170.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.669 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.17 163.15 15.56 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.318 -0.941 . . . . 0.10000000000000001 110.279 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.55 106.14 18.26 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.8 -1.091 . . . . 1.72 109.855 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.628 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.27 -23.85 3.62 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.201 -0.999 . . . . 0.12 111.056 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 75' ' ' MET . 10.4 p -100.22 152.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.661 0.743 . . . . 0.16 111.388 -174.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.5 m -135.25 139.45 44.45 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.643 -1.162 . . . . 0.45000000000000001 111.011 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.735 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.07 140.52 37.73 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.624 -1.171 . . . . 0.28000000000000003 111.155 167.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.91 2.95 68.64 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 121.262 -0.494 . . . . 0.28000000000000003 113.007 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.31 148.84 25.43 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 120.053 -0.659 . . . . 1.2 111.06 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.667 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -79.59 116.18 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-O 122.196 0.998 . . . . 0.20000000000000001 109.517 166.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.907 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -104.69 109.63 21.63 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.118 -0.946 . . . . 0.14000000000000001 109.427 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 1.026 HD21 HD13 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -72.16 99.28 2.3 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.832 -1.531 . . . . 0.14999999999999999 108.421 177.1 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.678 ' O ' HD21 ' A' ' 127' ' ' LEU . 3.0 m -72.02 117.6 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.699 -1.223 . . . . 0.94999999999999996 107.699 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.739 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -77.65 137.4 38.51 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.846 -1.168 . . . . 0.64000000000000001 107.846 -178.013 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.517 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.2 m -53.51 127.98 27.22 Favored 'General case' 0 CA--C 1.49 -1.356 0 CA-C-O 122.064 0.935 . . . . 0.37 108.579 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.596 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 19.8 t -55.53 134.97 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 107.695 -1.224 . . . . 0.10000000000000001 107.695 173.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.817 ' H ' ' HA ' ' A' ' 164' ' ' SER . 10.2 t-20 -85.62 163.59 18.23 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 114.842 -1.072 . . . . 0.17999999999999999 109.96 175.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.754 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.11 86.19 2.52 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.383 -1.281 . . . . 0.12 107.894 176.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.421 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 15.1 mtp180 -109.5 -3.51 16.93 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.048 -1.433 . . . . 0.64000000000000001 108.628 -172.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.734 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.5 p -50.81 -171.47 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.942 -1.935 . . . . 0.14000000000000001 115.491 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.541 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 37.5 t30 -71.27 -4.46 25.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.776 -2.011 . . . . 0.47999999999999998 110.719 173.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.597 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -157.85 -145.99 4.38 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.428 -0.892 . . . . 0.12 113.062 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.647 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 59.9 p -121.39 131.97 54.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.347 0.594 . . . . 1.1599999999999999 112.274 -178.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -137.21 158.31 44.72 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.015 0.912 . . . . 0.10000000000000001 110.808 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -81.4 79.76 7.94 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.821 -1.536 . . . . 0.17000000000000001 108.067 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -68.98 -14.38 63.0 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.377 -1.283 . . . . 0.089999999999999997 109.991 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.77 -30.22 36.05 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.726 -0.842 . . . . 0.14999999999999999 108.726 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.613 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 14.1 tp10 -67.62 -33.84 75.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 114.451 -1.25 . . . . 1.73 108.96 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.45 -44.19 65.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.186 -1.824 . . . . 0.12 109.567 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 77.6 m -64.0 -30.97 72.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.013 -1.448 . . . . 0.11 110.372 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -43.32 76.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.077 -1.083 . . . . 1.47 108.077 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 64' ' ' TRP . 79.2 m -63.14 -30.6 71.72 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.317 -0.856 . . . . 0.12 110.714 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.716 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.1 mt -51.5 -69.04 0.12 Allowed 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 109.404 -0.591 . . . . 0.56000000000000005 109.404 172.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 121' ' ' LEU . 18.5 mtp180 -41.06 -39.2 1.17 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.644 -1.162 . . . . 1.51 110.989 175.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.49 ' HB2' ' O ' ' A' ' 108' ' ' THR . 5.7 m-20 -70.0 -46.51 64.97 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.476 -1.238 . . . . 0.28000000000000003 112.038 -176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.81 -32.84 65.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 122.149 0.976 . . . . 0.089999999999999997 108.594 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.701 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -64.17 -34.38 77.95 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.588 -1.642 . . . . 0.12 110.1 174.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.655 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -70.97 -38.47 72.77 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.83 -1.077 . . . . 0.20000000000000001 111.45 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.82 -28.66 68.97 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.403 -1.271 . . . . 1.1699999999999999 111.041 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -83.24 -36.25 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.913 -1.04 . . . . 2.0499999999999998 110.19 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.18 -5.23 35.35 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.62 -0.8 . . . . 0.54000000000000004 114.35 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.79 ' HB2' HD13 ' A' ' 76' ' ' LEU . 53.7 mtpt -81.6 -9.89 59.56 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 117.774 0.787 . . . . 0.98999999999999999 110.787 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.907 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 28.5 m-85 -115.73 176.08 5.24 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.505 1.145 . . . . 0.20999999999999999 113.272 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.577 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.9 m -121.83 120.53 34.83 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 112.474 -2.148 . . . . 0.23000000000000001 107.896 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -88.1 140.01 29.92 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 119.512 -0.875 . . . . 0.38 109.929 -171.912 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.562 HG11 HD23 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -88.07 155.11 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.56 -0.904 . . . . 0.41999999999999998 108.56 177.266 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.525 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 73.3 m -91.29 154.3 19.35 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.136 0.97 . . . . 1.7 110.773 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.95 -22.07 61.51 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.539 -1.664 . . . . 0.55000000000000004 109.795 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.631 ' O ' ' HG3' ' A' ' 129' ' ' MET . 12.9 pt20 -54.63 -29.68 52.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.504 -1.225 . . . . 2.04 109.37 171.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' A' ' 129' ' ' MET . 19.1 mt-30 -96.29 -56.49 2.61 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 114.358 -1.292 . . . . 0.40999999999999998 109.585 174.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 1.026 HD13 HD21 ' A' ' 88' ' ' LEU . 13.6 tp -72.6 -58.21 3.54 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 113.685 -1.598 . . . . 1.3899999999999999 114.58 -159.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.585 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 66.6 m -56.23 -36.95 69.07 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 123.227 1.489 . . . . 1.05 108.456 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.631 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 9.3 mmt -62.98 -58.66 6.55 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 111.614 -2.539 . . . . 1.6399999999999999 110.997 174.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.744 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.63 -41.66 3.16 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 124.224 0.953 . . . . 0.31 111.91 176.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.821 ' HZ2' HD13 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -52.46 -57.61 9.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.153 -0.619 . . . . 1.53 109.912 175.846 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.0 mt-30 -61.4 -43.0 99.62 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.636 -1.166 . . . . 0.40999999999999998 111.445 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 129' ' ' MET . 47.8 mt-30 -56.29 -35.99 68.13 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 114.434 -1.257 . . . . 0.37 109.683 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.501 HD12 HG13 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -90.34 -29.95 17.75 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.029 -1.442 . . . . 0.23999999999999999 109.408 -178.052 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.62 -53.62 0.38 Allowed Glycine 0 CA--C 1.498 -0.976 0 C-N-CA 119.657 -1.259 . . . . 0.33000000000000002 114.174 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 141' ' ' SER . 14.9 mt -62.36 -171.07 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 112.254 -1.973 . . . . 0.31 116.226 -169.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 27.5 m -109.41 150.89 41.73 Favored Pre-proline 0 N--CA 1.421 -1.893 0 CA-C-N 110.759 -2.928 . . . . 0.81000000000000005 108.146 171.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 57.2 Cg_endo -66.06 0.19 3.45 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 122.991 2.461 . . . . 0.32000000000000001 112.139 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.472 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.5 tt0 -117.62 -31.01 5.32 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 114.717 -1.129 . . . . 1.25 109.39 -175.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 25.7 t0 -61.71 -27.01 68.4 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 113.028 -1.896 . . . . 0.65000000000000002 107.889 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.794 ' O ' HD13 ' A' ' 136' ' ' LEU . 0.4 OUTLIER 73.28 -170.29 0.13 Allowed 'General case' 0 CA--C 1.477 -1.854 0 CA-C-N 112.233 -2.258 . . . . 0.59999999999999998 109.933 -177.77 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.827 HD22 ' HA ' ' A' ' 148' ' ' ALA . 10.1 mt -65.25 -37.97 88.89 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.148 -1.387 . . . . 0.85999999999999999 107.707 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.37 -12.04 0.13 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 112.701 -2.045 . . . . 0.31 115.186 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.34 131.68 10.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 118.708 -0.663 . . . . 0.23999999999999999 109.226 -175.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.689 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 18.6 mmt180 -45.21 -50.07 11.82 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 118.069 0.395 . . . . 1.6499999999999999 111.446 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' A' ' 149' ' ' ILE . 71.1 m -71.13 -28.13 64.07 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.384 0.611 . . . . 0.53000000000000003 111.55 -175.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -72.43 -32.17 66.08 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 122.777 1.275 . . . . 1.3100000000000001 108.803 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.827 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -68.11 -44.82 75.33 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.218 -2.265 . . . . 0.12 109.906 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.605 HG13 ' HE1' ' A' ' 179' ' ' MET . 37.3 mt -68.72 -43.75 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 CA-C-N 112.958 -1.928 . . . . 0.11 110.411 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.41 -53.22 32.85 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.935 -1.03 . . . . 0.14999999999999999 111.036 172.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.821 HD13 ' HZ2' ' A' ' 131' ' ' LYS . 79.1 mt -66.98 -47.7 81.54 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 112.845 0.683 . . . . 0.17999999999999999 112.845 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.647 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.37 -39.28 72.66 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.878 0.37 . . . . 0.13 110.506 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.474 ' HD2' HG23 ' A' ' 149' ' ' ILE . 21.7 mtp180 -82.74 -21.78 34.6 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.464 0.649 . . . . 1.0800000000000001 110.664 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 27.7 t-20 -82.16 -11.2 58.86 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 107.116 -1.438 . . . . 0.5 107.116 176.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.713 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.65 -29.74 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 113.13 -1.85 . . . . 0.17000000000000001 110.978 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.48 35.75 4.57 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.226 -0.988 . . . . 0.16 112.64 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.645 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.54 155.11 22.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.353 0.872 . . . . 0.12 113.353 -170.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.667 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.2 m80 -94.03 -28.93 15.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.784 0.833 . . . . 0.20000000000000001 109.852 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.594 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 10.3 m-85 -136.59 -178.16 5.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.342 -0.845 . . . . 0.13 111.15 -173.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.696 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -135.31 139.21 47.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.103 -0.953 . . . . 0.080000000000000002 109.012 166.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.739 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 22.6 tp -109.96 98.92 8.12 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.607 -0.837 . . . . 0.16 109.932 167.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.0 m-85 -78.42 112.22 15.23 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.252 -0.885 . . . . 0.26000000000000001 109.367 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.868 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.0 t -124.07 159.62 29.53 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 122.397 1.094 . . . . 1.05 110.323 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.817 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.4 p -164.44 171.97 13.98 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.016 -1.447 . . . . 0.10000000000000001 111.098 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -133.28 133.96 43.3 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.082 -1.417 . . . . 0.11 108.714 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.1 m -143.67 -176.33 4.93 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.025 -0.732 . . . . 1.0900000000000001 109.025 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.93 -83.21 0.91 Allowed Glycine 0 C--N 1.301 -1.387 0 C-N-CA 119.698 -1.239 . . . . 0.14999999999999999 111.454 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.541 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 60.2 t30 -144.7 126.67 15.45 Favored 'General case' 0 C--O 1.196 -1.748 0 N-CA-C 108.066 -1.087 . . . . 0.58999999999999997 108.066 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.597 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.0 p -62.43 -44.12 98.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.316 -0.856 . . . . 0.14999999999999999 113.217 -170.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.428 ' N ' HG13 ' A' ' 169' ' ' VAL . 70.8 m-20 -62.1 -28.59 69.73 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.398 0.618 . . . . 1.26 109.728 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.86 88.2 3.59 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 114.681 -1.145 . . . . 0.13 108.436 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.839 ' HD2' HG22 ' A' ' 194' ' ' VAL . 42.9 Cg_endo -91.69 167.7 3.26 Favored 'Trans proline' 0 CA--C 1.498 -1.321 0 C-N-CA 125.045 3.83 . . . . 0.089999999999999997 115.151 -169.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 191' ' ' LYS . 32.3 m -84.35 118.96 24.55 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 113.796 -1.547 . . . . 0.14000000000000001 107.381 165.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.801 HD12 ' O ' ' A' ' 164' ' ' SER . 48.8 tp -84.43 98.11 9.89 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 108.378 -0.971 . . . . 0.16 108.378 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.555 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 31.4 mt-30 -88.96 109.3 20.13 Favored 'General case' 0 C--N 1.272 -2.761 0 CA-C-O 121.891 0.853 . . . . 0.34000000000000002 109.239 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.868 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.6 OUTLIER -112.34 164.28 13.42 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.109 -0.951 . . . . 1.0900000000000001 111.495 -174.556 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.629 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 60.1 tt0 -171.71 116.92 0.4 Allowed 'General case' 0 C--O 1.202 -1.446 0 CA-C-N 116.027 -0.533 . . . . 0.5 110.588 -166.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.053 HD13 HD11 ' A' ' 187' ' ' ILE . 0.8 OUTLIER -98.85 103.23 15.16 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.353 -0.842 . . . . 0.10000000000000001 108.851 -170.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.662 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 16.3 ttp -92.12 122.29 34.48 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.261 -0.882 . . . . 0.070000000000000007 109.713 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.433 HD22 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -59.45 126.75 28.89 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.215 -1.402 . . . . 0.22 107.215 166.287 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.596 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -80.45 -35.56 15.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.433 -0.907 . . . . 0.11 110.682 178.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.43 ' N ' HD12 ' A' ' 180' ' ' LEU . 29.4 mt-30 -64.02 -13.98 50.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.282 -0.872 . . . . 0.34999999999999998 111.527 -178.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 180' ' ' LEU . 80.6 p -131.12 -32.62 1.58 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.902 0.858 . . . . 0.19 110.623 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.454 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 82.95 28.03 39.12 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.357 -1.292 . . . . 0.17999999999999999 112.136 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.43 152.38 24.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.64 -0.28 . . . . 0.72999999999999998 110.502 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.588 HD12 ' HG2' ' A' ' 177' ' ' GLN . 30.4 mm -86.48 121.34 37.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.368 0.604 . . . . 0.14000000000000001 109.464 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.053 HD11 HD13 ' A' ' 178' ' ' LEU . 1.2 pp -109.28 -29.93 2.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.112 -0.949 . . . . 0.13 110.402 -174.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.669 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 80.6 t90 -136.48 153.43 51.04 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.056 -0.975 . . . . 0.070000000000000007 109.562 173.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 58.1 p -153.36 164.34 38.31 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.235 0.828 . . . . 0.13 113.235 164.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.2 -173.78 28.07 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 111.244 -0.742 . . . . 0.12 111.244 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.77 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 18.1 mttt -157.69 153.73 27.15 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.221 -2.14 . . . . 1.22 105.221 165.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.19 126.89 1.78 Allowed Glycine 0 C--N 1.279 -2.585 0 C-N-CA 119.525 -1.321 . . . . 0.12 111.663 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -73.94 111.87 9.52 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.508 0.67 . . . . 0.17000000000000001 110.774 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.839 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -91.3 158.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 122.693 1.235 . . . . 0.11 111.051 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.752 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -98.67 172.38 7.52 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 112.38 -2.191 . . . . 0.17999999999999999 108.722 -174.548 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.4 tt0 -102.61 133.16 48.06 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.997 -0.681 . . . . 0.91000000000000003 109.505 169.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.523 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 14.8 mm-40 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.795 -0.622 . . . . 1.24 110.602 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.556 -0.218 . . . . 88.609999999999999 112.556 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 33.7 t -160.94 125.11 3.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.76 -0.459 . . . . 87.430000000000007 109.76 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 2' ' ' SER . 53.0 m80 70.26 122.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.662 0.601 . . . . 87.159999999999997 111.63 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 ttt 61.3 48.97 5.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.888 0.851 . . . . 85.340000000000003 110.264 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -127.35 -38.14 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.697 -1.138 . . . . 85.049999999999997 110.177 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.99 -25.62 48.36 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.618 -0.801 . . . . 84.680000000000007 112.149 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 10.2 pt20 -87.85 -145.8 0.14 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.652 -0.129 . . . . 85.569999999999993 110.652 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.556 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 67.8 mtm180 71.32 178.2 0.26 Allowed 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.075 0.55 . . . . 85.040000000000006 110.456 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -104.07 90.38 3.01 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.55 -0.75 . . . . 82.170000000000002 109.545 172.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 5.0 Cg_exo -73.83 123.57 8.56 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.707 2.271 . . . . 81.510000000000005 112.412 -177.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.46 99.93 39.32 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.027 -0.533 . . . . 79.560000000000002 109.632 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.75 130.98 27.73 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.012 1.808 . . . . 78.5 112.201 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 m -138.28 156.55 30.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.465 -0.789 . . . . 77.0 110.493 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -139.17 -71.05 0.4 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.593 -0.73 . . . . 75.739999999999995 109.646 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -95.21 90.0 5.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.11 0.481 . . . . 73.909999999999997 110.403 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.5 t -78.07 113.99 18.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.72 -0.673 . . . . 72.299999999999997 109.666 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -119.91 136.1 24.7 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.468 -0.333 . . . . 71.219999999999999 110.538 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.88 140.12 65.33 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.913 1.742 . . . . 69.670000000000002 110.613 170.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.26 73.23 81.49 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 121.092 -0.243 . . . . 67.549999999999997 110.954 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.29 -49.47 9.2 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.329 2.019 . . . . 66.700000000000003 111.596 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 66.85 132.03 0.02 OUTLIER 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.785 0.678 . . . . 65.010000000000005 111.358 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -127.9 78.85 74.61 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.008 -0.542 . . . . 63.409999999999997 110.63 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.61 143.65 81.97 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.443 2.762 . . . . 61.93 112.673 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.86 82.51 2.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.403 0.62 . . . . 59.869999999999997 110.24 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -112.2 87.39 9.02 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 114.954 -1.021 . . . . 58.469999999999999 109.965 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.18 155.03 42.08 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.301 2.001 . . . . 57.359999999999999 112.644 -175.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -90.93 141.36 28.92 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.138 0.494 . . . . 55.509999999999998 110.803 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -143.36 125.09 8.41 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.732 -0.667 . . . . 53.869999999999997 109.609 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.24 -154.79 0.05 OUTLIER 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.532 2.155 . . . . 52.759999999999998 111.872 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.9 m -61.38 127.97 89.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.142 0.496 . . . . 50.93 111.283 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.94 -10.37 19.7 Favored 'Trans proline' 0 CA--C 1.527 0.143 0 C-N-CA 122.629 2.219 . . . . 49.210000000000001 111.85 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 p -94.43 143.04 26.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.947 -0.57 . . . . 47.490000000000002 110.979 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.96 119.2 15.67 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.726 -0.67 . . . . 45.969999999999999 110.068 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.03 152.64 81.68 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.755 2.303 . . . . 45.280000000000001 112.47 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 p 45.16 100.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.845 -1.07 . . . . 42.789999999999999 113.072 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HB ' ' HD3' ' A' ' 37' ' ' PRO . 88.7 t -127.83 -51.26 0.03 OUTLIER Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 115.346 -0.843 . . . . 40.789999999999999 111.983 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.519 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 10.9 Cg_exo -72.7 -159.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.097 1.865 . . . . 39.810000000000002 112.539 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 m -57.63 130.79 47.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.998 0.428 . . . . 37.5 110.865 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -73.49 112.49 16.26 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.837 -0.62 . . . . 35.649999999999999 110.0 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.08 79.02 3.51 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.541 2.161 . . . . 33.719999999999999 113.354 -173.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -145.21 133.57 21.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 31.510000000000002 109.986 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -134.82 79.92 50.83 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.554 -0.294 . . . . 30.129999999999999 111.017 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.39 147.5 65.42 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.173 1.916 . . . . 29.52 111.54 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.96 -173.09 43.09 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.915 -0.659 . . . . 26.75 111.609 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.68 132.5 23.58 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.484 2.122 . . . . 25.079999999999998 111.663 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.7 mt -87.44 -62.39 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 116.369 -0.378 . . . . 23.899999999999999 110.154 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 53.23 73.2 0.38 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.564 -0.744 . . . . 21.23 110.883 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -73.28 164.48 26.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.668 -0.696 . . . . 19.920000000000002 110.841 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -111.36 177.08 4.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.408 -0.815 . . . . 16.559999999999999 110.49 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -118.94 45.93 1.98 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.75 0.786 . . . . 15.050000000000001 110.043 178.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -81.35 53.05 1.97 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.495 -0.775 . . . . 14.19 110.418 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.2 p -109.25 144.97 36.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.963 -0.562 . . . . 11.380000000000001 111.109 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.32 67.34 46.09 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.52 -0.764 . . . . 8.2899999999999991 110.383 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 22.7 Cg_exo -64.63 130.45 26.46 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.503 2.135 . . . . 6.8700000000000001 111.759 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 54' ' ' PRO . 9.5 Cg_exo -71.7 -149.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.932 2.421 . . . . 5.04 110.912 173.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.41 107.61 0.95 Allowed Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 109.942 -0.392 . . . . 2.5899999999999999 109.942 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.38 -176.59 3.01 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.319 2.679 . . . . 1.6399999999999999 113.145 -172.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -118.35 139.56 51.17 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.174 -1.375 . . . . 3.3900000000000001 110.168 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 60' ' ' ARG . 9.7 mt -88.02 171.42 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.968 0.889 . . . . 0.44 111.574 -176.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.623 ' N ' HG22 ' A' ' 59' ' ' ILE . 50.1 mtt-85 -72.04 -157.16 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 113.746 -1.57 . . . . 2.3399999999999999 112.232 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.627 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 4.2 t60 -158.09 146.96 19.22 Favored 'General case' 0 CA--C 1.476 -1.904 0 CA-C-N 112.237 -2.256 . . . . 2.2200000000000002 106.616 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.768 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.0 m-30 -125.62 158.58 34.33 Favored 'General case' 0 N--CA 1.421 -1.88 0 O-C-N 123.967 0.792 . . . . 0.20999999999999999 109.821 -175.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.541 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 4.4 t70 -80.73 67.54 6.65 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 123.761 1.743 . . . . 0.34999999999999998 108.25 171.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.715 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.1 m95 -56.23 -42.28 77.05 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 111.361 -2.654 . . . . 0.10000000000000001 112.345 174.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.429 ' OD1' ' HG3' ' A' ' 69' ' ' GLN . 3.7 t30 -49.55 -31.14 9.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.537 -1.665 . . . . 1.1100000000000001 112.183 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.2 -16.58 80.52 Favored Glycine 0 CA--C 1.505 -0.547 0 CA-C-O 122.091 0.828 . . . . 0.20999999999999999 111.193 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -100.89 -54.14 2.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.846 -1.177 . . . . 0.13 110.874 -176.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.716 ' O ' HG23 ' A' ' 72' ' ' VAL . 41.8 mtt -64.33 -59.12 4.75 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 114.256 -1.338 . . . . 0.089999999999999997 112.798 -176.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.429 ' HG3' ' OD1' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -39.47 -55.12 3.47 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 114.548 1.314 . . . . 0.63 114.548 -175.94 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.812 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 43.1 Cg_endo -66.14 -29.68 47.52 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.708 1.605 . . . . 0.14000000000000001 110.471 -177.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.656 ' HE2' ' N ' ' A' ' 192' ' ' GLY . 11.1 mtm -82.19 -40.46 21.7 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.292 -0.867 . . . . 0.69999999999999996 111.397 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 68' ' ' MET . 47.9 t -57.44 -39.06 66.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 114.608 -1.178 . . . . 0.12 108.382 172.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -62.12 -33.6 74.76 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.204 -1.816 . . . . 0.56000000000000005 110.94 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.812 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 32.9 mtpt -82.4 -31.57 29.55 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.203 0.525 . . . . 1.3 110.886 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.849 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.32 -28.52 68.06 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.255 -0.884 . . . . 0.5 111.425 -172.168 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.659 HD13 ' HD3' ' A' ' 118' ' ' LYS . 5.6 mt -93.53 -4.18 51.5 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.412 1.101 . . . . 0.65000000000000002 110.588 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.49 17.93 42.31 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 108.837 -1.705 . . . . 0.17000000000000001 108.837 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.614 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.33 163.98 15.1 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.615 -0.792 . . . . 0.10000000000000001 109.897 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -92.26 106.42 18.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.517 -0.765 . . . . 1.72 109.732 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.639 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.21 -24.69 3.07 Favored Glycine 0 N--CA 1.418 -2.519 0 C-N-CA 119.998 -1.096 . . . . 0.12 110.373 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.849 HG11 ' O ' ' A' ' 75' ' ' MET . 11.4 p -99.59 153.57 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 114.738 -0.731 . . . . 0.16 111.153 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.6 m -134.55 139.27 45.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.795 -1.093 . . . . 0.45000000000000001 110.267 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -58.89 143.9 46.24 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.432 -0.804 . . . . 0.28000000000000003 110.514 168.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.62 69.64 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.89 -0.672 . . . . 0.28000000000000003 113.141 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.95 153.65 22.03 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 117.078 0.439 . . . . 1.2 110.658 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.722 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.2 p -81.91 116.49 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 122.051 0.929 . . . . 0.20000000000000001 109.301 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.589 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -104.37 110.06 22.16 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.173 -0.922 . . . . 0.14000000000000001 109.106 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.75 HD23 HG11 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -71.65 101.09 2.45 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.954 -1.021 . . . . 0.14999999999999999 108.65 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.669 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 73.0 t -73.66 111.18 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.863 -1.062 . . . . 0.94999999999999996 109.048 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.792 ' HB2' HD11 ' A' ' 142' ' ' LEU . 6.1 t0 -77.35 152.87 34.25 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 114.735 -1.12 . . . . 0.64000000000000001 108.167 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.541 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.7 OUTLIER -61.39 137.24 58.24 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.718 -1.128 . . . . 0.37 107.999 173.253 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.56 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 20.6 t -63.58 138.84 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.88 0 N-CA-C 107.903 -1.147 . . . . 0.10000000000000001 107.903 167.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.815 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -84.21 162.81 20.06 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.123 -0.944 . . . . 0.17999999999999999 110.138 173.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.22 85.7 2.44 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.37 -1.287 . . . . 0.12 108.241 175.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.462 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.4 mtp180 -108.73 -1.69 19.19 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.029 -1.441 . . . . 0.64000000000000001 108.823 -172.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.712 HG21 ' HB3' ' A' ' 172' ' ' PRO . 24.6 p -52.46 -171.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 112.927 -1.942 . . . . 0.14000000000000001 115.281 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.448 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 30.5 t30 -71.24 -9.39 58.03 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.107 -1.861 . . . . 0.47999999999999998 110.539 173.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.547 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.73 -146.34 4.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.358 -0.925 . . . . 0.12 112.841 -177.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.587 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.1 p -121.19 129.7 53.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.119 0.485 . . . . 1.1599999999999999 112.147 -177.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.758 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -134.73 156.76 48.24 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-O 121.876 0.846 . . . . 0.10000000000000001 110.855 -177.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -80.44 80.7 6.84 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 113.845 -1.525 . . . . 0.17000000000000001 107.977 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.04 -14.71 63.19 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.261 -1.336 . . . . 0.089999999999999997 110.027 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.754 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.33 -32.63 37.86 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.812 -0.81 . . . . 0.14999999999999999 108.812 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.62 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.0 tp10 -65.5 -32.84 74.66 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.384 -1.28 . . . . 1.73 108.901 172.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -73.58 -45.18 54.84 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 112.96 -1.927 . . . . 0.12 109.683 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.62 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 73.1 m -62.84 -31.49 72.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.155 -1.384 . . . . 0.11 110.228 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -66.85 -44.09 81.91 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.136 -1.061 . . . . 1.47 108.136 172.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 64' ' ' TRP . 51.7 m -62.79 -31.73 72.77 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.4 -0.818 . . . . 0.12 110.584 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.689 ' O ' HD23 ' A' ' 113' ' ' LEU . 10.3 mt -52.67 -69.66 0.11 Allowed 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.737 -0.665 . . . . 0.56000000000000005 109.283 171.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.539 ' HG3' HG21 ' A' ' 89' ' ' VAL . 9.4 mtp180 -40.05 -36.57 0.5 Allowed 'General case' 0 C--N 1.313 -0.991 0 O-C-N 124.365 1.041 . . . . 1.51 111.606 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.9 m-20 -73.4 -46.98 45.55 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.501 -1.227 . . . . 0.28000000000000003 111.97 -176.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.415 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . . . -72.2 -31.99 66.39 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.261 1.029 . . . . 0.089999999999999997 108.455 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.866 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.5 mm? -63.23 -35.75 81.38 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.213 -1.812 . . . . 0.12 109.579 172.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.557 ' HA ' HD21 ' A' ' 121' ' ' LEU . . . -73.61 -39.93 64.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 114.855 -1.066 . . . . 0.20000000000000001 111.383 -175.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -61.01 -32.03 71.63 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.623 -0.717 . . . . 1.1699999999999999 110.85 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -76.46 -21.34 56.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.412 -0.813 . . . . 2.0499999999999998 111.076 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 60.91 11.83 26.23 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 115.492 0.957 . . . . 0.54000000000000004 115.492 162.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.659 ' HD3' HD13 ' A' ' 76' ' ' LEU . 8.6 ptmt -108.47 -23.64 11.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.413 0.606 . . . . 0.98999999999999999 111.225 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.654 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 3.2 m-85 -87.87 170.15 11.42 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.924 0.869 . . . . 0.20999999999999999 111.676 172.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 23.5 m -120.66 105.44 10.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 113.425 -1.716 . . . . 0.23000000000000001 108.064 170.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.866 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -98.17 130.67 44.91 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 114.379 -1.282 . . . . 0.38 112.249 -168.023 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.63 ' HB ' ' OE1' ' A' ' 126' ' ' GLN . 0.7 OUTLIER -75.48 150.86 6.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 113.973 -1.467 . . . . 0.41999999999999998 107.77 174.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.6 t -101.24 -173.07 2.28 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 119.803 -0.759 . . . . 1.7 109.765 176.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -63.32 -25.28 68.23 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.1 -1.074 . . . . 0.55000000000000004 108.1 174.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.618 ' O ' ' HG3' ' A' ' 129' ' ' MET . 36.2 mt-30 -52.52 -39.09 60.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.392 -1.731 . . . . 2.04 110.79 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.63 ' OE1' ' HB ' ' A' ' 122' ' ' VAL . 30.1 mt-30 -99.15 -51.16 3.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.774 0.797 . . . . 0.40999999999999998 110.316 172.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.675 HD23 HD21 ' A' ' 88' ' ' LEU . 1.8 tm? -64.26 -62.5 1.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.801 -1.545 . . . . 1.3899999999999999 112.906 -167.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.726 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -50.89 -39.15 53.45 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 123.62 1.676 . . . . 1.05 109.248 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.705 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -63.87 -61.81 2.04 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 110.904 -2.862 . . . . 1.6399999999999999 110.837 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.782 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.82 -44.78 4.61 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 124.496 1.122 . . . . 0.31 112.134 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.53 ' HZ3' ' N ' ' A' ' 142' ' ' LEU . 13.3 mmtt -49.32 -60.37 2.88 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.471 -0.566 . . . . 1.53 109.471 175.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -59.16 -43.11 92.09 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.234 -0.894 . . . . 0.40999999999999998 111.059 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.705 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.1 mt-30 -56.41 -36.3 68.76 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 114.238 -1.346 . . . . 0.37 109.69 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -89.94 -31.36 17.3 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.162 -1.381 . . . . 0.23999999999999999 109.622 -176.441 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.53 -45.41 0.55 Allowed Glycine 0 CA--C 1.495 -1.207 0 C-N-CA 120.096 -1.05 . . . . 0.33000000000000002 113.278 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 141' ' ' SER . 95.7 mt -67.95 -171.16 0.2 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 112.448 -1.876 . . . . 0.31 115.486 -169.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 9.5 m -115.1 149.91 43.38 Favored Pre-proline 0 N--CA 1.422 -1.875 0 CA-C-N 110.7 -2.954 . . . . 0.81000000000000005 107.765 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.726 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 28.8 Cg_endo -64.5 1.02 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.534 2.156 . . . . 0.32000000000000001 112.034 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.754 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -117.36 -21.62 8.61 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.382 -0.826 . . . . 1.25 110.862 -177.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 16.3 t70 -71.42 -20.32 62.13 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.222 -1.354 . . . . 0.65000000000000002 108.932 -171.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.585 ' O ' HD13 ' A' ' 136' ' ' LEU . 26.3 m 72.84 169.05 0.32 Allowed 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 113.005 -1.907 . . . . 0.59999999999999998 109.338 -174.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.002 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.9 mt -63.48 -39.12 93.62 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.685 -1.228 . . . . 0.85999999999999999 107.685 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.43 -11.84 2.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 113.369 -1.741 . . . . 0.31 114.402 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 1.5 m -157.04 128.76 7.09 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.068 -0.716 . . . . 0.23999999999999999 109.068 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.658 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.3 mmt180 -43.93 -46.46 8.14 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 117.991 0.359 . . . . 1.6499999999999999 111.385 -178.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.404 ' HA ' ' HB ' ' A' ' 149' ' ' ILE . 40.7 t -71.27 -25.81 62.62 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.68 0.753 . . . . 0.53000000000000003 111.459 -175.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 22.8 mttm -75.04 -32.21 61.5 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.588 1.185 . . . . 1.3100000000000001 108.678 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 1.002 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -72.57 -46.02 56.37 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 112.385 -2.189 . . . . 0.12 110.017 177.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.598 HG13 ' HE1' ' A' ' 179' ' ' MET . 41.5 mt -67.14 -42.38 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 112.768 -2.015 . . . . 0.11 109.995 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.92 -52.72 37.48 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 114.74 -1.118 . . . . 0.14999999999999999 111.301 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.782 HG23 ' CB ' ' A' ' 130' ' ' ALA . 69.5 mt -67.12 -48.44 78.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.072 0 N-CA-C 112.7 0.63 . . . . 0.17999999999999999 112.7 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.696 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.94 -40.39 73.09 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.826 0.345 . . . . 0.13 111.344 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.524 ' HD2' HG23 ' A' ' 149' ' ' ILE . 43.0 mtp180 -81.64 -22.26 37.71 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.625 0.726 . . . . 1.0800000000000001 110.321 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -81.83 -12.95 58.27 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 107.16 -1.422 . . . . 0.5 107.16 175.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.75 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -106.05 -29.17 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 113.231 -1.804 . . . . 0.17000000000000001 110.898 -174.024 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.99 35.63 4.75 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.357 -0.925 . . . . 0.16 112.466 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.669 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.68 158.13 19.65 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.275 0.842 . . . . 0.12 113.275 -169.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.722 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.5 m80 -98.66 -27.79 13.83 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.322 -0.854 . . . . 0.20000000000000001 109.757 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.624 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 9.3 m-85 -135.58 -173.35 3.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.049 -0.978 . . . . 0.13 111.281 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.697 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -138.42 139.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.9 -1.045 . . . . 0.080000000000000002 109.231 167.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.735 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 40.8 tp -108.5 97.27 6.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.468 -0.893 . . . . 0.16 109.505 165.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.704 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 1.4 m-85 -78.82 112.45 15.99 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.687 -1.142 . . . . 0.26000000000000001 108.959 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.719 ' OG ' HD11 ' A' ' 174' ' ' LEU . 27.0 t -122.26 163.19 20.08 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 122.002 0.906 . . . . 1.05 110.515 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.823 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -164.33 173.15 12.59 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 114.37 -1.286 . . . . 0.10000000000000001 111.049 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.73 139.72 42.09 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 114.14 -1.391 . . . . 0.11 108.758 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.68 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 t -146.42 -172.54 3.98 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.954 -0.698 . . . . 1.0900000000000001 110.267 176.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 90.3 -84.49 1.34 Allowed Glycine 0 N--CA 1.424 -2.16 0 CA-C-N 114.883 -1.053 . . . . 0.14999999999999999 111.593 174.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.448 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 49.2 t-20 -135.29 128.04 31.05 Favored 'General case' 0 C--O 1.196 -1.719 0 N-CA-C 106.925 -1.509 . . . . 0.58999999999999997 106.925 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.547 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.9 p -64.03 -41.51 92.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.553 -0.749 . . . . 0.14999999999999999 112.37 -177.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.42 ' N ' HG13 ' A' ' 169' ' ' VAL . 78.8 m-20 -67.56 -26.45 66.31 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.468 0.651 . . . . 1.26 109.461 -175.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.52 89.21 3.26 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 114.887 -1.051 . . . . 0.13 108.304 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.852 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.6 Cg_endo -90.27 165.0 4.56 Favored 'Trans proline' 0 CA--C 1.488 -1.804 0 C-N-CA 124.519 3.479 . . . . 0.089999999999999997 114.97 -171.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.597 HG22 ' HB3' ' A' ' 191' ' ' LYS . 19.4 m -83.24 117.32 22.87 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.548 -1.66 . . . . 0.14000000000000001 107.602 166.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 164' ' ' SER . 49.1 tp -84.09 98.53 9.93 Favored 'General case' 0 N--CA 1.411 -2.381 0 C-N-CA 119.641 -0.824 . . . . 0.16 109.055 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.623 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.8 mt-30 -89.13 107.21 18.92 Favored 'General case' 0 C--N 1.273 -2.749 0 CA-C-N 114.811 -1.086 . . . . 0.34000000000000002 108.95 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 37.0 mtp -107.08 163.73 12.74 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.138 -0.937 . . . . 1.0900000000000001 110.393 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.592 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.9 tt0 -170.09 117.41 0.55 Allowed 'General case' 0 C--O 1.202 -1.445 0 CA-C-O 121.179 0.514 . . . . 0.5 110.208 -167.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.101 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -100.12 102.06 13.28 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.705 -0.85 . . . . 0.10000000000000001 108.705 -172.447 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.658 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.8 ttp -91.67 122.57 34.35 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.416 -0.811 . . . . 0.070000000000000007 109.755 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.467 ' HB3' ' OG1' ' A' ' 183' ' ' THR . 0.1 OUTLIER -58.53 126.45 27.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.311 -1.366 . . . . 0.22 107.311 166.238 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.63 -33.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 O-C-N 120.939 -1.101 . . . . 0.11 110.55 178.798 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.418 ' N ' HD12 ' A' ' 180' ' ' LEU . 29.0 mt-30 -63.85 -13.95 49.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.235 -0.893 . . . . 0.34999999999999998 111.449 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 180' ' ' LEU . 60.3 p -130.62 -36.69 1.41 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.945 0.878 . . . . 0.19 110.26 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.531 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 87.08 24.35 37.81 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.334 -1.303 . . . . 0.17999999999999999 112.022 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 186' ' ' ILE . 0.2 OUTLIER -104.26 152.37 22.29 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.621 -0.29 . . . . 0.72999999999999998 110.658 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.592 HD12 ' HG2' ' A' ' 177' ' ' GLN . 33.0 mm -87.85 113.6 25.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.811 0.815 . . . . 0.14000000000000001 109.532 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.101 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -101.8 -29.61 3.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 114.729 -1.123 . . . . 0.13 110.587 -173.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.637 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.4 t90 -136.82 152.47 50.31 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.304 -0.862 . . . . 0.070000000000000007 109.737 172.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 37.3 p -153.78 162.93 40.82 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.003 0.742 . . . . 0.13 113.003 164.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -156.53 -178.24 30.46 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 110.985 -0.846 . . . . 0.12 110.985 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.748 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.1 mtmt -157.12 149.39 22.97 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.343 -1.725 . . . . 1.22 106.343 166.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.656 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -159.35 127.69 1.88 Allowed Glycine 0 C--N 1.285 -2.258 0 C-N-CA 119.973 -1.108 . . . . 0.12 112.258 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.09 114.45 12.43 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.547 0.689 . . . . 0.17000000000000001 111.472 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.852 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -91.73 159.47 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 122.609 1.195 . . . . 0.11 111.065 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.768 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -99.68 173.78 6.54 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.319 -2.218 . . . . 0.17999999999999999 108.974 -173.051 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -102.94 130.3 49.95 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.64 -0.424 . . . . 0.91000000000000003 110.895 171.35 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.541 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 15.3 mm-40 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.609 -0.71 . . . . 1.24 110.722 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.801 -0.519 . . . . 88.609999999999999 111.801 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.6 p -82.32 114.27 20.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.84 0.353 . . . . 87.430000000000007 110.71 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -114.54 142.6 46.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.121 -0.49 . . . . 87.159999999999997 109.801 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.3 ptm 40.23 39.32 0.64 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.085 1.354 . . . . 85.340000000000003 113.725 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.81 -38.17 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.697 -0.683 . . . . 85.049999999999997 110.585 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.5 -110.26 0.23 Allowed Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 111.445 -0.662 . . . . 84.680000000000007 111.445 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 55.49 -100.84 0.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.949 0.5 . . . . 85.569999999999993 111.258 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 49.95 68.7 0.7 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.401 0.62 . . . . 85.040000000000006 111.055 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -123.85 99.34 38.49 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.654 -0.703 . . . . 82.170000000000002 110.409 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.01 78.74 3.08 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.462 2.108 . . . . 81.510000000000005 112.644 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 61.95 86.36 0.15 Allowed Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 115.077 -0.965 . . . . 79.560000000000002 111.7 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.73 145.51 75.62 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.354 2.036 . . . . 78.5 112.389 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -78.76 156.28 4.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.11 0.481 . . . . 77.0 111.507 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 39.3 tt0 -163.17 162.99 25.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.277 -0.874 . . . . 75.739999999999995 109.447 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.473 ' N ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 76.86 148.81 0.1 Allowed 'General case' 0 N--CA 1.463 0.182 0 O-C-N 124.192 0.932 . . . . 73.909999999999997 110.925 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.39 103.22 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.742 -0.663 . . . . 72.299999999999997 110.006 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -75.92 147.06 80.2 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.673 -0.694 . . . . 71.219999999999999 110.51 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.7 89.37 0.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.118 1.879 . . . . 69.670000000000002 111.695 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.455 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . . . -101.45 -51.71 0.17 Allowed Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.208 -0.451 . . . . 67.549999999999997 111.955 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 19' ' ' ALA . 5.9 Cg_exo -79.48 42.36 1.28 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.606 2.204 . . . . 66.700000000000003 112.833 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.16 127.85 33.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 65.010000000000005 110.09 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 53.1 tt0 -136.71 133.22 18.85 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.149 -0.478 . . . . 63.409999999999997 109.975 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 83.7 Cg_exo -57.27 143.19 94.29 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.952 2.435 . . . . 61.93 112.114 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.03 118.45 13.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.314 -0.403 . . . . 59.869999999999997 111.039 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -103.35 105.55 47.19 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.042 -0.526 . . . . 58.469999999999999 109.884 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.65 -137.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.831 2.354 . . . . 57.359999999999999 113.34 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -91.11 138.16 31.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.0 0.429 . . . . 55.509999999999998 110.441 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 4.9 pm0 -143.59 144.41 27.41 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.469 -0.332 . . . . 53.869999999999997 110.233 178.138 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 28' ' ' GLN . 19.5 Cg_exo -66.67 107.95 1.35 Allowed 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.776 2.318 . . . . 52.759999999999998 112.305 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.4 m -98.36 148.8 35.02 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.926 -0.579 . . . . 50.93 109.785 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.82 88.8 0.15 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 123.039 2.493 . . . . 49.210000000000001 112.643 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 p -69.66 148.49 49.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.735 -0.666 . . . . 47.490000000000002 110.761 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -85.54 117.03 67.95 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.227 -0.442 . . . . 45.969999999999999 111.11 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.28 162.07 18.19 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.073 2.516 . . . . 45.280000000000001 113.066 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 p -89.02 144.13 26.37 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.445 -0.798 . . . . 42.789999999999999 111.233 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.451 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.5 p -67.48 128.2 93.56 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.428 -0.806 . . . . 40.789999999999999 110.495 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 34.4 Cg_exo -63.15 156.37 55.65 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.785 2.323 . . . . 39.810000000000002 112.677 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 m -77.51 135.95 38.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.9 -0.591 . . . . 37.5 110.914 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.0 mt -105.04 105.04 50.01 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.898 -0.592 . . . . 35.649999999999999 110.138 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -93.45 75.67 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.874 2.383 . . . . 33.719999999999999 112.572 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -125.24 73.01 1.27 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.111 0.481 . . . . 31.510000000000002 110.554 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.57 87.35 53.15 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.193 -0.458 . . . . 30.129999999999999 110.329 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.89 139.34 30.11 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.482 2.122 . . . . 29.52 111.137 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.63 153.8 52.37 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.754 -0.736 . . . . 26.75 112.656 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.7 129.06 20.18 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.031 2.487 . . . . 25.079999999999998 112.356 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.0 mt -74.86 -57.85 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.791 -0.641 . . . . 23.899999999999999 110.523 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 57.79 86.08 0.08 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.947 -0.569 . . . . 21.23 110.867 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -89.47 167.02 13.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.23 0.538 . . . . 19.920000000000002 110.684 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.14 173.08 6.77 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.312 -0.858 . . . . 16.559999999999999 110.496 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -103.66 56.78 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.473 0.654 . . . . 15.050000000000001 110.369 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -97.15 97.01 8.83 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.613 -0.721 . . . . 14.19 110.44 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.2 p -95.56 162.28 13.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.837 -0.619 . . . . 11.380000000000001 111.001 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.87 77.25 74.88 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.294 -0.866 . . . . 8.2899999999999991 111.368 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.81 146.8 21.13 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.868 2.378 . . . . 6.8700000000000001 110.827 175.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.62 140.52 47.5 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.847 1.698 . . . . 5.04 112.499 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.18 92.07 6.86 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.786 -0.643 . . . . 2.5899999999999999 109.892 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.48 -175.98 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.673 2.249 . . . . 1.6399999999999999 112.819 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -130.99 146.23 52.31 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.991 -1.004 . . . . 3.3900000000000001 111.229 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.632 HG22 ' N ' ' A' ' 60' ' ' ARG . 11.4 mt -93.04 174.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.948 -1.024 . . . . 0.44 111.421 -176.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.632 ' N ' HG22 ' A' ' 59' ' ' ILE . 25.4 mtt180 -65.05 -157.44 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.722 -1.581 . . . . 2.3399999999999999 112.06 176.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.792 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 4.6 t60 -159.64 147.53 17.18 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 112.032 -2.349 . . . . 2.2200000000000002 106.238 177.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.792 ' HD1' ' C ' ' A' ' 61' ' ' HIS . 2.8 m-30 -125.21 158.3 34.37 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.866 -0.606 . . . . 0.20999999999999999 109.593 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.525 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 3.0 t70 -79.24 67.39 4.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 123.762 1.744 . . . . 0.34999999999999998 108.291 171.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.75 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 89.3 m95 -59.83 -44.43 94.07 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 111.478 -2.601 . . . . 0.10000000000000001 112.113 174.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.5 t30 -51.04 -31.44 18.53 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.939 -1.482 . . . . 1.1100000000000001 111.35 175.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.35 -16.61 79.81 Favored Glycine 0 C--N 1.312 -0.754 0 CA-C-N 115.504 -0.771 . . . . 0.20999999999999999 111.318 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.57 -53.67 2.93 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.996 -1.102 . . . . 0.13 110.817 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.697 ' SD ' HD23 ' A' ' 109' ' ' LEU . 42.4 mtt -62.89 -59.61 4.61 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 114.206 -1.361 . . . . 0.089999999999999997 112.554 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.448 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 16.0 mm-40 -38.53 -55.23 2.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 114.83 1.419 . . . . 0.63 114.83 -176.226 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.795 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.1 Cg_endo -65.46 -30.13 52.91 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.674 1.583 . . . . 0.14000000000000001 110.588 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.672 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 13.7 mtm -83.35 -39.69 20.39 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 115.413 -0.812 . . . . 0.69999999999999996 111.205 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 68' ' ' MET . 58.9 t -56.82 -39.29 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 114.555 -1.202 . . . . 0.12 108.465 172.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -61.67 -35.33 77.65 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 113.176 -1.829 . . . . 0.56000000000000005 110.9 174.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.795 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.3 mtpt -81.31 -31.55 33.49 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.093 0.473 . . . . 1.3 110.618 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.874 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.26 -25.17 65.94 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.355 -0.839 . . . . 0.5 111.119 -173.086 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' A' ' 118' ' ' LYS . 6.7 mt -95.2 -5.09 44.69 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.069 0.938 . . . . 0.65000000000000002 110.762 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.92 17.46 41.7 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 108.888 -1.685 . . . . 0.17000000000000001 108.888 169.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.648 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -87.39 162.08 17.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.576 -0.812 . . . . 0.10000000000000001 110.036 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -90.4 105.32 17.73 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.253 -0.885 . . . . 1.72 110.273 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.647 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.92 -22.2 3.47 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.978 -1.01 . . . . 0.12 110.807 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.874 HG11 ' O ' ' A' ' 75' ' ' MET . 10.7 p -102.08 153.88 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.678 0.752 . . . . 0.16 111.704 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.6 m -135.14 139.9 45.0 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.726 -1.124 . . . . 0.45000000000000001 110.796 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.664 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.81 126.89 29.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.332 -0.849 . . . . 0.28000000000000003 110.481 166.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.05 8.25 29.83 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.849 -0.691 . . . . 0.28000000000000003 112.56 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.31 153.2 19.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 120.721 -0.392 . . . . 1.2 110.52 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.0 p -82.1 117.32 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 122.009 0.909 . . . . 0.20000000000000001 108.956 166.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.662 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -105.42 110.23 22.5 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.301 -0.863 . . . . 0.14000000000000001 109.267 -171.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.724 HD21 HD23 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -73.04 94.5 1.9 Allowed 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 114.446 -1.252 . . . . 0.14999999999999999 109.133 178.044 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.4 m -73.39 116.78 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 107.542 -1.281 . . . . 0.94999999999999996 107.542 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.813 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 7.0 t0 -79.26 170.81 16.07 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.201 -1.036 . . . . 0.64000000000000001 108.201 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.59 ' OG ' ' HA ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -59.96 149.42 31.95 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 122.773 1.273 . . . . 0.37 108.937 171.548 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.559 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 36.7 t -74.34 138.55 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.476 0 CA-C-N 113.576 -1.647 . . . . 0.10000000000000001 106.612 163.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.828 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.4 t-20 -84.45 158.97 20.87 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-O 121.888 0.852 . . . . 0.17999999999999999 109.875 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.748 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -122.81 84.8 2.32 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.281 -1.327 . . . . 0.12 107.938 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.448 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 15.0 mtp180 -107.67 -1.83 20.73 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 113.547 -1.66 . . . . 0.64000000000000001 108.574 -172.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.747 HG21 ' HB3' ' A' ' 172' ' ' PRO . 24.1 p -51.82 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.156 -1.838 . . . . 0.14000000000000001 114.216 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.3 OUTLIER -76.06 -2.99 33.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.233 -1.803 . . . . 0.47999999999999998 110.33 174.692 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.638 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -149.66 -150.22 5.19 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.922 -0.656 . . . . 0.12 112.905 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.6 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.1 p -121.83 130.58 53.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.514 0.561 . . . . 1.1599999999999999 112.514 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.748 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.6 157.38 47.02 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.855 0.836 . . . . 0.10000000000000001 111.155 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.605 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -80.14 79.49 6.69 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.002 -1.454 . . . . 0.17000000000000001 107.993 175.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.38 -15.57 63.75 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.285 -1.325 . . . . 0.089999999999999997 109.997 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.57 -29.97 37.01 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.944 -0.762 . . . . 0.14999999999999999 108.944 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.605 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.3 tp10 -66.46 -34.64 78.4 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 122.681 1.229 . . . . 1.73 109.131 170.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.99 -43.4 65.17 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 113.203 -1.817 . . . . 0.12 109.664 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 55.7 m -63.77 -31.02 72.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.898 -1.501 . . . . 0.11 110.536 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -67.85 -42.45 81.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.609 -1.256 . . . . 1.47 107.609 172.436 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.692 HG21 ' HB2' ' A' ' 64' ' ' TRP . 57.2 m -63.56 -31.02 72.06 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.171 -0.922 . . . . 0.12 110.672 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.735 HD11 ' OG ' ' A' ' 163' ' ' SER . 8.3 mt -50.9 -70.47 0.08 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 115.776 -0.647 . . . . 0.56000000000000005 109.278 171.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.52 ' O ' HD13 ' A' ' 121' ' ' LEU . 17.0 mtp180 -41.0 -38.78 1.04 Allowed 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.475 1.109 . . . . 1.51 111.197 176.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 108' ' ' THR . 5.8 m-20 -68.37 -46.49 69.93 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.367 -1.288 . . . . 0.28000000000000003 112.358 -177.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.448 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.38 -33.4 65.01 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.299 1.047 . . . . 0.089999999999999997 108.417 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -65.2 -31.89 73.28 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.186 -1.824 . . . . 0.12 110.131 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.65 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.85 -44.69 61.07 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 114.335 -1.302 . . . . 0.20000000000000001 111.713 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -65.72 -28.75 69.28 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.54 -1.209 . . . . 1.1699999999999999 110.832 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -81.43 -19.78 41.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.3 -0.864 . . . . 2.0499999999999998 111.885 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 59.24 11.05 11.53 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 115.586 0.995 . . . . 0.54000000000000004 115.586 163.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.664 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 56.2 mtpt -96.93 -3.96 40.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.35 0.575 . . . . 0.98999999999999999 109.759 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.662 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 29.0 m-85 -121.22 173.2 7.46 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.481 1.134 . . . . 0.20999999999999999 112.726 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 16.3 m -117.85 115.82 25.74 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 112.658 -2.065 . . . . 0.23000000000000001 107.776 170.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.3 OUTLIER -83.07 137.57 34.05 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.152 -0.931 . . . . 0.38 110.376 -172.473 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.551 HG21 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -83.54 152.93 3.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.074 -1.084 . . . . 0.41999999999999998 108.074 171.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.712 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -101.4 163.19 12.4 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.023 0.916 . . . . 1.7 109.827 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.59 71.06 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 113.65 -1.613 . . . . 0.55000000000000004 111.225 -170.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.712 ' HG2' ' HB2' ' A' ' 123' ' ' SER . 11.0 pt20 -52.28 -28.35 18.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.656 -1.611 . . . . 2.04 110.973 173.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.618 ' HB2' HG22 ' A' ' 155' ' ' VAL . 4.9 mt-30 -96.94 -53.15 3.61 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.244 -1.344 . . . . 0.40999999999999998 110.404 170.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.724 HD23 HD21 ' A' ' 88' ' ' LEU . 1.2 tm? -72.45 -63.9 1.06 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.94 -1.027 . . . . 1.3899999999999999 113.574 -165.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.595 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -51.94 -37.56 53.22 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.582 1.658 . . . . 1.05 108.407 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.667 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -62.89 -60.13 3.89 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 110.714 -2.948 . . . . 1.6399999999999999 111.292 178.183 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.778 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.15 -43.03 6.77 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 124.304 1.003 . . . . 0.31 112.148 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.703 ' HE3' ' CD2' ' A' ' 127' ' ' LEU . 22.3 mttt -52.77 -55.52 22.25 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 120.326 -0.549 . . . . 1.53 109.691 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.4 mt-30 -62.14 -41.74 98.57 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.021 -0.99 . . . . 0.40999999999999998 111.28 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 129' ' ' MET . 53.5 mt-30 -57.06 -36.45 70.56 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.257 -1.338 . . . . 0.37 110.034 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -91.06 -31.0 16.44 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.243 -1.344 . . . . 0.23999999999999999 109.084 -176.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.52 -51.24 0.36 Allowed Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.015 -1.088 . . . . 0.33000000000000002 113.979 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 141' ' ' SER . 46.8 mt -67.41 -171.1 0.16 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 116.12 1.896 . . . . 0.31 116.12 -169.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.8 m -115.58 152.55 47.31 Favored Pre-proline 0 N--CA 1.427 -1.62 0 CA-C-N 110.732 -2.94 . . . . 0.81000000000000005 108.158 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.686 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 11.8 Cg_endo -59.2 -4.9 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.027 2.485 . . . . 0.32000000000000001 113.171 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -117.49 -30.41 5.53 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.826 0.822 . . . . 1.25 111.104 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.591 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.4 t70 -58.28 -25.49 61.87 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.42 -1.718 . . . . 0.65000000000000002 109.065 -174.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.59 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 5.5 m 72.9 161.37 0.24 Allowed 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 111.495 -2.593 . . . . 0.59999999999999998 111.822 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.909 HD13 ' HA ' ' A' ' 148' ' ' ALA . 8.5 mt -66.64 -38.76 87.58 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.25 -1.389 . . . . 0.85999999999999999 107.25 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.34 -4.78 0.32 Allowed Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 112.576 -2.102 . . . . 0.31 114.703 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.48 124.35 9.24 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 118.603 -0.713 . . . . 0.23999999999999999 109.369 -174.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.586 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 16.6 mmt85 -41.66 -51.16 4.11 Favored 'General case' 0 C--O 1.212 -0.92 0 O-C-N 123.563 0.539 . . . . 1.6499999999999999 111.046 -177.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.9 t -67.81 -29.16 68.27 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.493 0.663 . . . . 0.53000000000000003 111.21 -174.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 20.6 mttm -72.76 -31.17 64.72 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.355 1.074 . . . . 1.3100000000000001 108.519 177.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.909 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -76.97 -41.91 41.12 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 113.049 -1.887 . . . . 0.12 110.746 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.609 ' HA ' HG23 ' A' ' 181' ' ' VAL . 43.0 mt -69.12 -42.21 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 113.393 -1.731 . . . . 0.11 110.189 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.66 -48.77 64.13 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.904 -1.044 . . . . 0.14999999999999999 111.27 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.778 HG23 ' CB ' ' A' ' 130' ' ' ALA . 67.2 mt -71.23 -48.08 56.58 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 N-CA-C 112.87 0.693 . . . . 0.17999999999999999 112.87 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.666 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.57 -39.42 70.63 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.935 0.398 . . . . 0.13 110.633 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.487 ' HD2' HG23 ' A' ' 149' ' ' ILE . 28.7 mtp180 -81.01 -24.4 37.96 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.522 0.677 . . . . 1.0800000000000001 110.672 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -79.28 -14.12 59.23 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.508 -1.293 . . . . 0.5 107.508 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.71 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -104.69 -29.98 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 113.196 -1.82 . . . . 0.17000000000000001 110.967 -173.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.05 33.04 5.36 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.681 -0.771 . . . . 0.16 112.437 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.689 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -106.89 159.75 16.02 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.92 0.711 . . . . 0.12 112.92 -170.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.67 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.9 m80 -99.65 -27.24 13.77 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.379 -0.828 . . . . 0.20000000000000001 109.686 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 5.6 m-85 -135.58 -173.02 3.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.262 -0.881 . . . . 0.13 110.941 -175.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.776 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -137.63 138.6 44.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.941 -1.027 . . . . 0.080000000000000002 108.897 166.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.479 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 45.5 tp -107.93 101.36 10.63 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 119.715 -0.794 . . . . 0.16 109.038 165.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.605 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.4 m-85 -81.38 113.03 19.19 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.087 -1.415 . . . . 0.26000000000000001 109.559 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.735 ' OG ' HD11 ' A' ' 109' ' ' LEU . 4.2 p -118.09 159.99 22.3 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.717 0.77 . . . . 1.05 110.749 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.828 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.9 p -163.94 173.6 12.45 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 114.862 -1.063 . . . . 0.10000000000000001 111.414 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.09 139.01 37.58 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 113.951 -1.477 . . . . 0.11 108.464 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.4 t -147.2 -171.47 3.79 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.055 -0.658 . . . . 1.0900000000000001 110.073 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.05 -80.71 1.43 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.128 -1.034 . . . . 0.14999999999999999 111.773 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.5 t30 -144.52 125.47 14.4 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 107.99 -1.115 . . . . 0.58999999999999997 107.99 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.638 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.3 p -63.12 -42.97 98.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.479 -0.782 . . . . 0.14999999999999999 112.934 -171.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.441 ' N ' HG13 ' A' ' 169' ' ' VAL . 50.0 m-20 -61.66 -29.53 70.13 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.391 0.615 . . . . 1.26 109.532 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.9 88.52 3.54 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.634 -1.167 . . . . 0.13 108.508 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.844 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.3 Cg_endo -91.55 167.7 3.34 Favored 'Trans proline' 0 CA--C 1.497 -1.374 0 C-N-CA 124.927 3.751 . . . . 0.089999999999999997 115.015 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.631 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 14.5 m -85.73 118.0 24.96 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.041 -1.436 . . . . 0.14000000000000001 108.098 166.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 164' ' ' SER . 43.4 tp -84.49 98.66 10.23 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-O 122.057 0.932 . . . . 0.16 109.386 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.682 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 17.9 mt-30 -87.7 108.08 18.94 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.576 -1.193 . . . . 0.34000000000000002 109.088 -178.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.56 ' HG3' ' HG ' ' A' ' 174' ' ' LEU . 80.9 mtp -105.74 162.42 13.55 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.059 -0.973 . . . . 1.0900000000000001 110.483 -176.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.612 ' HG2' HD12 ' A' ' 186' ' ' ILE . 9.3 tt0 -169.74 119.38 0.64 Allowed 'General case' 0 C--O 1.203 -1.39 0 CA-C-O 121.324 0.583 . . . . 0.5 109.792 -170.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.084 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -101.2 100.85 11.45 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.542 -0.91 . . . . 0.10000000000000001 108.542 -172.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.586 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.9 ttp -90.47 120.06 31.26 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.764 -0.653 . . . . 0.070000000000000007 109.448 176.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.544 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.66 117.77 6.73 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.222 -1.399 . . . . 0.22 107.222 169.315 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -71.72 -35.71 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.162 0.892 . . . . 0.11 111.439 -176.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.437 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 32.5 mt-30 -61.38 -13.62 21.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.411 -0.813 . . . . 0.34999999999999998 111.581 -176.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 34.5 p -130.22 -37.96 1.42 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.176 0.989 . . . . 0.19 110.086 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.572 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.59 16.27 52.79 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 113.801 -1.545 . . . . 0.17999999999999999 112.138 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -98.09 156.34 16.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.94 0.4 . . . . 0.72999999999999998 110.619 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.612 HD12 ' HG2' ' A' ' 177' ' ' GLN . 31.6 mm -88.78 118.74 34.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.572 0.701 . . . . 0.14000000000000001 109.404 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.084 HD11 HD13 ' A' ' 178' ' ' LEU . 1.7 pp -106.49 -29.08 2.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.804 -1.089 . . . . 0.13 110.123 -172.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.661 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.3 t90 -137.92 153.37 49.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.547 -0.751 . . . . 0.070000000000000007 110.135 171.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 54.9 p -153.52 164.4 38.29 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 113.379 0.881 . . . . 0.13 113.379 164.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.93 -178.49 32.99 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.039 -0.825 . . . . 0.12 111.039 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.3 mtmt -157.86 146.5 19.22 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.446 -1.687 . . . . 1.22 106.446 166.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.672 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -157.45 128.02 2.04 Favored Glycine 0 C--N 1.284 -2.357 0 CA-C-N 114.677 -1.147 . . . . 0.12 112.064 -177.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.52 116.05 14.75 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.544 0.687 . . . . 0.17000000000000001 111.343 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.844 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -94.1 158.82 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 122.618 1.199 . . . . 0.11 110.979 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.729 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -100.89 171.98 7.32 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 112.527 -2.124 . . . . 0.17999999999999999 108.844 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.3 tt0 -101.56 131.6 47.65 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.121 -0.632 . . . . 0.91000000000000003 109.376 169.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.525 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 15.2 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.418 -0.801 . . . . 1.24 110.931 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.865 -0.494 . . . . 88.609999999999999 111.865 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -81.08 74.75 8.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.071 0.463 . . . . 87.430000000000007 111.706 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.457 ' HB2' ' OE1' ' A' ' 7' ' ' GLN . 31.7 m170 -121.1 82.04 1.87 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.351 -0.386 . . . . 87.159999999999997 110.201 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.7 tpt -55.95 114.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 85.340000000000003 110.803 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p 42.98 31.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 122.486 1.136 . . . . 85.049999999999997 111.628 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.49 11.42 7.13 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.056 -0.975 . . . . 84.680000000000007 111.282 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.457 ' OE1' ' HB2' ' A' ' 3' ' ' HIS . 17.3 mm-40 -68.2 -43.74 77.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.174 -0.513 . . . . 85.569999999999993 109.924 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 54.9 73.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.478 -0.783 . . . . 85.040000000000006 110.322 -176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 37.0 tt0 -149.72 127.63 5.76 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.38 -0.827 . . . . 82.170000000000002 109.554 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 13.2 Cg_exo -68.96 -179.84 2.81 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.046 1.831 . . . . 81.510000000000005 111.976 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 68.92 91.01 0.08 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 114.826 -1.079 . . . . 79.560000000000002 110.717 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -62.1 146.62 96.05 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.464 2.109 . . . . 78.5 112.46 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.08 145.79 9.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.537 -0.301 . . . . 77.0 110.611 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 49.52 63.56 2.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.453 -0.794 . . . . 75.739999999999995 111.04 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.69 148.62 52.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.545 . . . . 73.909999999999997 110.371 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.91 135.0 28.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.492 -0.776 . . . . 72.299999999999997 110.32 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -89.95 153.91 47.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.271 -0.422 . . . . 71.219999999999999 110.397 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.33 63.73 6.28 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.672 2.248 . . . . 69.670000000000002 111.946 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' HB1' ' HG2' ' A' ' 21' ' ' GLU . . . -104.17 112.2 65.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.114 -0.494 . . . . 67.549999999999997 111.146 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.0 52.9 4.46 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.097 2.532 . . . . 66.700000000000003 111.847 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HG2' ' HB1' ' A' ' 19' ' ' ALA . 13.6 mm-40 -75.47 83.83 2.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.379 -0.828 . . . . 65.010000000000005 111.021 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 14.3 pt20 -146.43 128.5 7.68 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.648 -0.705 . . . . 63.409999999999997 110.162 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 88.2 Cg_exo -55.84 142.89 83.23 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.019 2.479 . . . . 61.93 112.45 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.18 119.65 13.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.285 -0.416 . . . . 59.869999999999997 110.995 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.58 155.81 87.17 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.982 -0.554 . . . . 58.469999999999999 110.266 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -50.99 -58.75 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.314 2.01 . . . . 57.359999999999999 111.361 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -139.32 -162.59 1.35 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.149 -0.478 . . . . 55.509999999999998 109.829 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 26.9 mm-40 -107.61 -49.15 0.1 OUTLIER Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 120.368 -0.533 . . . . 53.869999999999997 111.648 170.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' A' ' 28' ' ' GLN . 50.6 Cg_exo -56.6 114.12 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.875 1.717 . . . . 52.759999999999998 112.033 175.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 13.2 m -95.05 126.82 45.14 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.808 -0.633 . . . . 50.93 110.569 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 30' ' ' VAL . 38.1 Cg_exo -59.88 134.66 58.31 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.674 2.249 . . . . 49.210000000000001 112.377 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.6 p -134.47 142.83 47.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.118 -0.492 . . . . 47.490000000000002 110.6 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.15 111.4 65.13 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.388 -0.369 . . . . 45.969999999999999 110.846 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.95 155.85 36.6 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.338 2.692 . . . . 45.280000000000001 112.426 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -144.32 114.23 7.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.453 -0.794 . . . . 42.789999999999999 110.533 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -111.92 118.0 47.22 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.737 -0.665 . . . . 40.789999999999999 110.625 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.34 162.55 40.06 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.474 2.116 . . . . 39.810000000000002 112.478 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.5 t -98.15 153.94 18.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.134 0.492 . . . . 37.5 110.677 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 mt -104.74 104.5 46.24 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.795 -0.639 . . . . 35.649999999999999 110.696 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.97 -179.06 4.5 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.901 2.401 . . . . 33.719999999999999 112.286 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.4 pp0? -114.14 127.87 56.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.452 -0.34 . . . . 31.510000000000002 110.413 178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -117.34 89.17 30.62 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 30.129999999999999 110.633 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.09 164.97 8.56 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.808 2.339 . . . . 29.52 112.585 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.48 174.22 23.62 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.811 -0.631 . . . . 26.75 112.106 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.21 131.75 22.69 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 123.119 2.546 . . . . 25.079999999999998 112.138 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mt -74.25 -54.26 15.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.736 -0.665 . . . . 23.899999999999999 110.766 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 56.76 83.04 0.1 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.823 0.702 . . . . 21.23 111.306 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -81.96 160.75 23.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.254 -0.43 . . . . 19.920000000000002 110.182 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 51' ' ' GLN . 12.6 pt-20 -115.46 169.75 8.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.079 -0.51 . . . . 16.559999999999999 111.054 -176.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.32 26.79 8.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.959 0.885 . . . . 15.050000000000001 110.06 176.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 23.7 mp0 55.01 -107.13 0.36 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.327 -1.76 . . . . 14.19 111.286 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -142.87 150.84 40.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.105 0.479 . . . . 11.380000000000001 110.757 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -128.26 73.07 79.99 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.513 -0.767 . . . . 8.2899999999999991 110.5 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -95.18 107.18 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.449 2.766 . . . . 6.8700000000000001 112.221 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 52.9 Cg_exo -56.14 -68.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.889 2.393 . . . . 5.04 111.348 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -167.01 92.32 0.72 Allowed Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.838 -0.619 . . . . 2.5899999999999999 110.104 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.21 -178.56 2.57 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 C-N-CA 123.235 2.624 . . . . 1.6399999999999999 111.639 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -99.65 135.74 40.61 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 113.908 -1.496 . . . . 3.3900000000000001 110.494 -175.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 101' ' ' ASN . 12.4 mt -83.19 168.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 122.124 0.964 . . . . 0.44 111.994 -173.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 59' ' ' ILE . 48.2 mtt-85 -70.95 -157.36 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 113.57 -1.65 . . . . 2.3399999999999999 112.017 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.598 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 4.9 t60 -155.35 147.71 23.88 Favored 'General case' 0 CA--C 1.473 -2.017 0 CA-C-N 112.486 -2.143 . . . . 2.2200000000000002 106.858 177.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.774 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.5 m-30 -125.54 159.27 32.48 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 115.351 -0.841 . . . . 0.20999999999999999 109.936 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.521 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 4.0 t70 -80.97 68.28 7.19 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 123.68 1.705 . . . . 0.34999999999999998 108.125 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.731 ' HZ3' HD13 ' A' ' 174' ' ' LEU . 93.5 m95 -57.85 -41.52 82.53 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.599 -2.546 . . . . 0.10000000000000001 111.94 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 69' ' ' GLN . 5.0 t30 -52.98 -27.71 20.4 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.99 -1.459 . . . . 1.1100000000000001 111.496 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.57 -15.2 81.21 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.412 -0.813 . . . . 0.20999999999999999 111.129 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.96 -53.64 2.9 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.908 -1.146 . . . . 0.13 111.17 -176.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.726 ' SD ' HD23 ' A' ' 109' ' ' LEU . 38.5 mtt -65.27 -57.77 7.62 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.263 -1.335 . . . . 0.089999999999999997 112.132 -177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.505 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 5.3 mm100 -40.25 -55.88 3.8 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 114.348 1.24 . . . . 0.63 114.348 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.775 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.3 Cg_endo -63.88 -27.3 67.11 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.541 1.494 . . . . 0.14000000000000001 110.74 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.666 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 12.7 mtm -85.56 -43.2 13.72 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.562 -0.745 . . . . 0.69999999999999996 112.174 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 68' ' ' MET . 31.5 t -59.0 -37.91 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 CA-C-N 115.011 -0.995 . . . . 0.12 108.826 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -57.11 -36.56 70.78 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.409 -1.723 . . . . 0.56000000000000005 110.396 174.348 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.775 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.7 mtpt -80.91 -37.3 29.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.087 -0.96 . . . . 1.3 110.49 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.872 ' O ' HG11 ' A' ' 81' ' ' VAL . 2.5 ttp -57.65 -31.61 66.46 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.421 -1.263 . . . . 0.5 111.439 -175.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.615 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 22.5 mt -88.51 -5.31 58.3 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.917 0.865 . . . . 0.65000000000000002 111.594 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.96 17.4 35.32 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.286 -1.525 . . . . 0.17000000000000001 109.286 172.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.711 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.03 161.76 16.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.807 -0.696 . . . . 0.10000000000000001 109.733 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.446 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 9.7 p-10 -89.16 107.73 19.21 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.362 1.077 . . . . 1.72 111.443 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.666 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.73 -24.32 3.03 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 114.268 -1.333 . . . . 0.12 110.45 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 75' ' ' MET . 14.9 p -102.83 153.05 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.526 0.679 . . . . 0.16 111.762 -173.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.4 m -134.98 138.82 44.36 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.653 -1.158 . . . . 0.45000000000000001 110.577 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.59 131.26 50.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.757 -0.656 . . . . 0.28000000000000003 110.182 166.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.14 -1.47 31.35 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.026 -0.607 . . . . 0.28000000000000003 112.593 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.89 150.64 23.96 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.264 -0.575 . . . . 1.2 111.016 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.65 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.6 p -80.05 113.81 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-O 122.277 1.037 . . . . 0.20000000000000001 109.01 164.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.855 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -100.88 107.21 18.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.814 -1.085 . . . . 0.14000000000000001 108.722 -172.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.683 HD23 HG11 ' A' ' 155' ' ' VAL . 0.8 OUTLIER -70.92 97.88 1.5 Allowed 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 114.169 -1.378 . . . . 0.14999999999999999 108.019 177.713 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 87' ' ' LEU . 2.2 m -71.37 118.27 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.243 0 N-CA-C 106.888 -1.523 . . . . 0.94999999999999996 106.888 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.79 ' HB2' HD11 ' A' ' 142' ' ' LEU . 0.8 OUTLIER -77.09 146.32 37.31 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 107.159 -1.422 . . . . 0.64000000000000001 107.159 178.098 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.497 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -55.36 134.43 50.19 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.448 -1.315 . . . . 0.37 107.448 175.9 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.54 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 22.0 t -61.46 138.4 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.011 0 N-CA-C 107.768 -1.197 . . . . 0.10000000000000001 107.768 170.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.784 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.4 t-20 -84.95 163.02 19.19 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.156 -0.929 . . . . 0.17999999999999999 109.714 175.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.757 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.88 86.12 2.51 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.524 -1.216 . . . . 0.12 108.185 175.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -106.88 -4.22 19.43 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 113.97 -1.468 . . . . 0.64000000000000001 108.827 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.76 HG21 ' HB3' ' A' ' 172' ' ' PRO . 21.8 p -50.67 -177.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.516 -1.674 . . . . 0.14000000000000001 114.318 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 1.4 t30 -70.13 -10.7 59.62 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.476 -1.693 . . . . 0.47999999999999998 110.325 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.572 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -140.55 -152.56 5.81 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.668 -0.696 . . . . 0.12 112.564 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.609 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 70.7 m -122.44 129.36 51.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.071 0.462 . . . . 1.1599999999999999 111.129 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.757 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.9 pp -132.5 160.1 37.47 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.786 0.803 . . . . 0.10000000000000001 110.551 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.643 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 1.2 t-20 -82.94 79.85 9.17 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.902 -1.499 . . . . 0.17000000000000001 107.889 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.28 -14.11 62.75 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.483 -1.235 . . . . 0.089999999999999997 109.958 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ALA . . . . . 0.631 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.07 -32.23 39.34 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.545 -0.909 . . . . 0.14999999999999999 108.545 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.616 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 42.8 tp10 -66.43 -33.71 76.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 114.325 -1.307 . . . . 1.73 109.05 171.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.54 -43.91 65.55 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.113 -1.858 . . . . 0.12 109.509 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 62.9 m -63.34 -29.73 70.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.808 -1.542 . . . . 0.11 110.417 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -44.68 76.58 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.119 -1.067 . . . . 1.47 108.119 171.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.683 HG21 ' HB2' ' A' ' 64' ' ' TRP . 73.2 m -62.48 -30.79 71.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.412 -0.813 . . . . 0.12 110.718 178.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.726 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -50.99 -68.98 0.12 Allowed 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 109.326 -0.62 . . . . 0.56000000000000005 109.326 171.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.555 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.3 mtp180 -40.99 -37.61 0.84 Allowed 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.345 1.028 . . . . 1.51 111.411 175.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.536 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.2 m-20 -71.54 -46.12 60.41 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.576 -1.193 . . . . 0.28000000000000003 111.968 -176.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.505 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.56 -32.04 63.95 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 122.402 1.096 . . . . 0.089999999999999997 108.701 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -65.79 -33.67 76.4 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.498 -1.683 . . . . 0.12 109.88 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.93 -41.49 64.45 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 114.636 -1.166 . . . . 0.20000000000000001 111.06 -176.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -64.21 -27.2 68.9 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.895 -1.048 . . . . 1.1699999999999999 110.332 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -81.92 -21.76 37.15 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.466 -0.788 . . . . 2.0499999999999998 111.01 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 59.78 15.61 34.98 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 115.588 0.995 . . . . 0.54000000000000004 115.588 163.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.615 ' HE2' ' HB3' ' A' ' 76' ' ' LEU . 19.7 mtmt -101.81 -28.62 12.34 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 117.719 0.76 . . . . 0.98999999999999999 109.969 174.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.855 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 26.1 m-85 -92.23 173.81 7.63 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 122.152 0.977 . . . . 0.20999999999999999 112.447 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.606 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.7 m -118.4 123.19 44.63 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 113.31 -1.768 . . . . 0.23000000000000001 107.89 169.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.659 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -94.05 139.55 30.82 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 119.329 -0.949 . . . . 0.38 111.865 -170.023 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.7 ' HB ' ' OE1' ' A' ' 126' ' ' GLN . 1.3 m -93.88 148.54 4.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.786 -1.19 . . . . 0.41999999999999998 107.786 170.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.3 t -101.59 -173.71 2.42 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.759 -0.777 . . . . 1.7 110.222 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -64.69 -26.36 68.34 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.95 -1.13 . . . . 0.55000000000000004 107.95 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.62 ' O ' ' HG3' ' A' ' 129' ' ' MET . 35.0 mt-30 -50.88 -39.07 53.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 113.273 -1.785 . . . . 2.04 110.806 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.7 ' OE1' ' HB ' ' A' ' 122' ' ' VAL . 28.4 mt-30 -99.12 -52.78 3.44 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.141 0.972 . . . . 0.40999999999999998 110.212 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.679 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 35.3 tp -61.7 -63.14 1.36 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 113.585 -1.643 . . . . 1.3899999999999999 113.456 -168.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.655 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 3.5 t -50.67 -47.35 58.82 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 123.396 1.57 . . . . 1.05 109.374 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.693 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 16.7 mmt -54.0 -61.82 2.06 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 111.24 -2.709 . . . . 1.6399999999999999 110.818 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.77 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.83 -44.97 7.16 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 124.124 0.89 . . . . 0.31 112.626 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.702 ' NZ ' HD13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -55.94 -51.5 67.44 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 107.343 -1.354 . . . . 1.53 107.343 -178.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 128' ' ' SER . 36.8 mt-30 -65.15 -41.03 95.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.672 -1.149 . . . . 0.40999999999999998 111.173 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.693 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.2 mt-30 -57.6 -32.56 67.31 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 114.628 -1.169 . . . . 0.37 109.574 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -93.96 -27.15 16.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 113.911 -1.495 . . . . 0.23999999999999999 109.719 -177.455 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.38 -50.12 0.53 Allowed Glycine 0 CA--C 1.5 -0.904 0 CA-C-O 122.766 1.204 . . . . 0.33000000000000002 113.428 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.634 HD13 ' O ' ' A' ' 141' ' ' SER . 78.4 mt -66.58 -170.95 0.11 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 112.175 -2.012 . . . . 0.31 116.025 -170.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.1 m -116.22 152.86 48.37 Favored Pre-proline 0 N--CA 1.431 -1.415 0 CA-C-N 111.129 -2.759 . . . . 0.81000000000000005 108.56 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.655 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 18.1 Cg_endo -62.34 -2.0 2.86 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.086 2.524 . . . . 0.32000000000000001 112.993 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.631 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -118.74 -26.85 5.99 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.579 0.704 . . . . 1.25 110.746 -177.602 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.3 t70 -63.04 -21.89 66.47 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 113.895 -1.502 . . . . 0.65000000000000002 109.127 -173.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.634 ' O ' HD13 ' A' ' 136' ' ' LEU . 38.1 m 74.4 168.59 0.3 Allowed 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.666 -2.061 . . . . 0.59999999999999998 110.653 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 90' ' ' ASP . 6.4 mt -64.78 -40.53 95.4 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.321 1.058 . . . . 0.85999999999999999 108.331 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.7 -12.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 112.823 -1.99 . . . . 0.31 114.507 177.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.417 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -151.32 125.11 9.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.073 -0.714 . . . . 0.23999999999999999 109.073 -174.692 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.657 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.3 mmt180 -42.6 -47.33 5.2 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 118.047 0.385 . . . . 1.6499999999999999 111.936 -176.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.9 t -71.22 -25.85 62.67 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.664 0.745 . . . . 0.53000000000000003 111.35 -175.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.406 ' HD3' HD11 ' A' ' 136' ' ' LEU . 27.2 mttm -75.84 -30.75 59.06 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 122.766 1.269 . . . . 1.3100000000000001 108.862 176.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.776 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -72.1 -46.77 55.4 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 112.184 -2.28 . . . . 0.12 110.236 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.607 HG13 ' HE1' ' A' ' 179' ' ' MET . 37.3 mt -68.07 -41.4 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 112.909 -1.95 . . . . 0.11 110.054 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.42 -54.83 27.82 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.51 -1.223 . . . . 0.14999999999999999 111.107 170.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.77 HG23 ' CB ' ' A' ' 130' ' ' ALA . 12.4 mt -66.27 -46.6 86.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.062 0 N-CA-C 112.693 0.627 . . . . 0.17999999999999999 112.693 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.665 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -57.73 -40.73 80.27 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 118.013 0.37 . . . . 0.13 111.015 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.482 ' HD2' HG23 ' A' ' 149' ' ' ILE . 28.5 mtp-105 -81.49 -22.34 38.09 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.826 0.822 . . . . 1.0800000000000001 110.346 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -82.01 -11.64 58.73 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 114.274 -1.33 . . . . 0.5 107.449 176.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.7 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.91 -29.13 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 113.267 -1.788 . . . . 0.17000000000000001 110.794 -174.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.47 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.37 34.92 4.88 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.387 -0.911 . . . . 0.16 112.362 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.663 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.98 160.57 16.31 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 113.138 0.792 . . . . 0.12 113.138 -169.591 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.65 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -99.78 -28.96 12.89 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.0 -1.0 . . . . 0.20000000000000001 109.744 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.672 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 11.6 m-85 -136.65 -175.43 4.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.96 -1.018 . . . . 0.13 110.83 -174.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.676 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -135.64 138.59 47.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.062 -0.972 . . . . 0.080000000000000002 108.562 166.282 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.669 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 33.8 tp -108.26 99.59 8.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.281 -0.968 . . . . 0.16 109.483 166.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.776 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.64 112.54 17.01 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.784 -1.098 . . . . 0.26000000000000001 109.322 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.872 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 13.0 t -124.37 158.88 31.63 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 122.157 0.979 . . . . 1.05 110.239 -177.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.831 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.8 p -160.75 173.47 15.36 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.166 -1.379 . . . . 0.10000000000000001 110.564 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.88 132.07 34.02 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-N 114.36 -1.291 . . . . 0.11 108.613 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -140.89 -178.01 5.35 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.055 -0.658 . . . . 1.0900000000000001 109.73 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.43 -83.26 0.87 Allowed Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 119.774 -1.203 . . . . 0.14999999999999999 111.847 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 43.5 t-20 -140.08 127.18 20.97 Favored 'General case' 0 C--O 1.195 -1.794 0 N-CA-C 106.294 -1.743 . . . . 0.58999999999999997 106.294 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.572 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.3 p -60.64 -44.52 97.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 114.861 -1.063 . . . . 0.14999999999999999 111.65 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.408 ' N ' HG13 ' A' ' 169' ' ' VAL . 17.2 m120 -66.9 -24.92 66.15 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.338 0.59 . . . . 1.26 109.777 -174.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.04 88.28 3.21 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 114.996 -1.002 . . . . 0.13 108.474 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.826 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.1 Cg_endo -91.01 163.7 3.86 Favored 'Trans proline' 0 CA--C 1.492 -1.576 0 C-N-CA 124.652 3.568 . . . . 0.089999999999999997 115.253 -170.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.632 HG22 ' HB3' ' A' ' 191' ' ' LYS . 7.7 m -84.83 119.71 25.62 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 113.668 -1.605 . . . . 0.14000000000000001 107.998 170.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.893 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 21.8 tp -82.59 95.83 7.89 Favored 'General case' 0 CA--C 1.472 -2.043 0 C-N-CA 119.655 -0.818 . . . . 0.16 109.474 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.58 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 39.1 mt-30 -87.2 106.76 18.12 Favored 'General case' 0 C--N 1.253 -3.609 0 CA-C-O 122.415 1.102 . . . . 0.34000000000000002 108.663 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.872 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.3 mmm -110.97 162.97 14.3 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.516 -1.22 . . . . 1.0900000000000001 110.944 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.637 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.4 tt0 -171.41 118.92 0.46 Allowed 'General case' 0 C--O 1.205 -1.288 0 CA-C-O 121.165 0.507 . . . . 0.5 110.702 -166.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.061 HD13 HD11 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -100.36 100.9 11.76 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.853 -0.795 . . . . 0.10000000000000001 108.853 -172.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.657 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.2 ttp -91.16 120.95 32.52 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.161 -0.927 . . . . 0.070000000000000007 109.398 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -58.49 126.76 28.93 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.066 -1.457 . . . . 0.22 107.066 166.38 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.612 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.18 -36.2 14.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 119.435 -0.906 . . . . 0.11 110.376 178.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.475 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 23.3 mt-30 -61.03 -16.26 41.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.093 -0.958 . . . . 0.34999999999999998 111.529 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 66.9 p -129.04 -37.0 1.73 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.769 0.795 . . . . 0.19 110.077 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.568 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.26 29.37 19.95 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 114.299 -1.319 . . . . 0.17999999999999999 112.205 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.73 154.3 23.1 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.674 0.273 . . . . 0.72999999999999998 110.6 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.637 HD12 ' HG2' ' A' ' 177' ' ' GLN . 29.5 mm -86.53 121.4 37.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.402 0.62 . . . . 0.14000000000000001 109.365 177.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.061 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -109.76 -33.06 2.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.095 -0.957 . . . . 0.13 110.45 -174.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.711 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 79.8 t90 -132.14 152.19 51.38 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.581 -0.736 . . . . 0.070000000000000007 109.356 172.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 27.0 p -153.79 162.8 40.93 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.265 0.839 . . . . 0.13 113.265 164.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -157.69 -175.12 28.26 Favored Glycine 0 N--CA 1.427 -1.932 0 N-CA-C 110.817 -0.913 . . . . 0.12 110.817 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.893 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.2 mtmt -158.98 147.94 18.54 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.386 -1.709 . . . . 1.22 106.386 165.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 174' ' ' LEU . . . -156.05 125.89 1.72 Allowed Glycine 0 C--N 1.289 -2.047 0 C-N-CA 118.638 -1.744 . . . . 0.12 114.021 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.75 112.59 7.98 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.619 0.723 . . . . 0.17000000000000001 110.979 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.826 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -90.76 159.28 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 114.545 -1.207 . . . . 0.11 110.269 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.774 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -100.08 174.18 6.29 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 112.801 -2.0 . . . . 0.17999999999999999 108.825 -173.319 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.0 OUTLIER -102.16 131.48 48.64 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.492 -0.483 . . . . 0.91000000000000003 110.532 171.23 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.532 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 17.4 mm-40 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.514 -0.755 . . . . 1.24 110.264 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 112.088 -0.405 . . . . 88.609999999999999 112.088 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 t -85.82 -15.48 41.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.684 0.278 . . . . 87.430000000000007 110.995 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -86.13 73.28 10.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.196 0.998 . . . . 87.159999999999997 111.212 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.6 mtt -83.68 -162.38 0.63 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.906 -1.043 . . . . 85.340000000000003 109.23 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.3 -11.19 12.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.254 0.549 . . . . 85.049999999999997 110.48 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.73 29.09 69.86 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.869 -0.605 . . . . 84.680000000000007 112.39 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -127.98 110.93 13.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.971 0.891 . . . . 85.569999999999993 110.978 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 66.05 76.5 0.31 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 113.535 -1.666 . . . . 85.040000000000006 112.444 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -75.9 146.7 79.74 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.93 -0.577 . . . . 82.170000000000002 110.5 178.29 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.43 113.33 3.09 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.517 2.145 . . . . 81.510000000000005 112.072 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.52 113.7 62.34 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.378 -0.374 . . . . 79.560000000000002 110.968 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.1 138.47 2.33 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.955 2.436 . . . . 78.5 112.55 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 m -133.94 141.14 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.029 -0.532 . . . . 77.0 110.352 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -126.82 112.47 15.4 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.863 -0.608 . . . . 75.739999999999995 110.522 -174.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -109.36 140.55 42.91 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.849 -0.426 . . . . 73.909999999999997 109.849 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.4 111.63 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.818 0.818 . . . . 72.299999999999997 111.233 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 32.8 mmtp -87.85 -46.77 0.47 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 71.219999999999999 111.988 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 17' ' ' LYS . 19.9 Cg_endo -61.78 142.35 93.48 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.837 1.692 . . . . 69.670000000000002 111.841 174.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.22 85.97 59.13 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.351 -0.386 . . . . 67.549999999999997 110.798 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.88 104.18 1.79 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.828 2.352 . . . . 66.700000000000003 112.285 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.85 104.3 3.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.064 -0.517 . . . . 65.010000000000005 110.738 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 30.3 tt0 -69.78 -53.17 12.35 Favored Pre-proline 0 C--N 1.319 -0.744 0 C-N-CA 120.543 -0.463 . . . . 63.409999999999997 111.97 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 22' ' ' GLN . 71.6 Cg_exo -56.85 143.54 90.89 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.663 2.242 . . . . 61.93 113.366 -175.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -143.12 133.19 24.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.702 -0.681 . . . . 59.869999999999997 110.286 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.5 mm-40 -89.64 109.8 34.72 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.667 -0.242 . . . . 58.469999999999999 110.7 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 25' ' ' GLU . 15.2 Cg_endo -91.57 94.73 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.936 2.424 . . . . 57.359999999999999 112.505 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -69.09 121.53 16.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.533 -0.303 . . . . 55.509999999999998 110.243 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -111.71 98.15 40.07 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 53.869999999999997 110.192 -178.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.38 104.4 1.9 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.41 2.074 . . . . 52.759999999999998 112.013 -178.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -85.22 120.17 73.11 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.286 -0.416 . . . . 50.93 110.201 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.79 167.25 27.69 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.587 2.191 . . . . 49.210000000000001 112.655 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.473 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 5.8 p -99.59 152.89 19.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.013 -0.539 . . . . 47.490000000000002 110.073 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 33' ' ' VAL . 5.9 p -110.9 95.01 22.0 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.422 0.63 . . . . 45.969999999999999 111.074 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 32' ' ' THR . 50.6 Cg_exo -61.52 174.93 1.85 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.298 2.666 . . . . 45.280000000000001 113.12 176.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 t 72.09 141.96 0.06 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.501 -1.227 . . . . 42.789999999999999 111.228 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 m -142.61 124.24 8.65 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.137 -0.938 . . . . 40.789999999999999 110.763 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.63 148.46 64.34 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.833 2.356 . . . . 39.810000000000002 112.252 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.4 m -148.13 131.5 16.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.727 -0.67 . . . . 37.5 109.94 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.8 mt -94.6 112.61 58.51 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.333 -0.394 . . . . 35.649999999999999 111.14 -174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -88.11 -177.19 1.81 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.953 2.435 . . . . 33.719999999999999 112.459 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 51.2 68.88 0.72 Allowed 'General case' 0 C--O 1.237 0.397 0 O-C-N 123.589 0.555 . . . . 31.510000000000002 112.08 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -116.63 87.65 21.95 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.379 -0.6 . . . . 30.129999999999999 109.379 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -89.12 168.18 5.37 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.792 2.328 . . . . 29.52 113.374 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.44 -174.68 19.95 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.73 -0.948 . . . . 26.75 110.73 172.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -78.04 130.45 10.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.333 2.022 . . . . 25.079999999999998 111.836 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.9 mt -80.17 -57.84 4.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.089 -0.505 . . . . 23.899999999999999 110.133 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.48 84.07 0.14 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.69 -0.686 . . . . 21.23 111.159 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -164.63 161.67 21.05 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.669 -0.696 . . . . 19.920000000000002 110.299 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -172.57 131.23 0.56 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.926 -1.034 . . . . 16.559999999999999 109.305 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -122.04 40.34 3.66 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.589 0.709 . . . . 15.050000000000001 109.99 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -99.64 168.8 9.71 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.386 -0.825 . . . . 14.19 110.674 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.9 p 61.46 142.93 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.769 1.293 . . . . 11.380000000000001 112.114 -172.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.673 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -144.56 66.23 13.46 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.631 -0.713 . . . . 8.2899999999999991 111.431 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 53' ' ' ALA . 60.0 Cg_endo -103.7 81.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.816 3.011 . . . . 6.8700000000000001 112.575 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 5.4 Cg_exo -75.01 -40.06 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.427 2.084 . . . . 5.04 111.931 -177.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.05 59.45 16.52 Favored Pre-proline 0 C--O 1.234 0.264 0 O-C-N 123.874 0.734 . . . . 2.5899999999999999 111.688 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 55' ' ' PRO . 63.6 Cg_endo -77.85 -177.14 3.64 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.346 2.031 . . . . 1.6399999999999999 113.283 -176.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -132.75 149.63 52.26 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.153 -1.385 . . . . 3.3900000000000001 109.403 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 60' ' ' ARG . 12.5 mt -84.06 166.6 2.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.805 0.812 . . . . 0.44 111.92 -174.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.611 ' N ' HG22 ' A' ' 59' ' ' ILE . 31.5 mtt180 -73.17 -157.78 0.05 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 123.265 1.507 . . . . 2.3399999999999999 112.191 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.644 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 4.5 t60 -159.4 149.04 18.57 Favored 'General case' 0 CA--C 1.475 -1.908 0 CA-C-N 111.914 -2.403 . . . . 2.2200000000000002 106.129 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.745 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.9 m-30 -125.33 159.3 32.09 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 123.768 0.667 . . . . 0.20999999999999999 109.638 -176.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 7.3 t70 -81.65 67.32 7.57 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 123.795 1.759 . . . . 0.34999999999999998 107.978 171.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.754 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.9 m95 -58.17 -42.15 85.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 111.361 -2.654 . . . . 0.10000000000000001 111.847 173.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.497 ' N ' HG21 ' A' ' 108' ' ' THR . 5.4 t-20 -56.35 -27.76 56.9 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.138 -1.392 . . . . 1.1100000000000001 110.285 178.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.23 -14.47 76.65 Favored Glycine 0 CA--C 1.498 -1.013 0 N-CA-C 110.816 -0.914 . . . . 0.20999999999999999 110.816 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.436 ' O ' ' HD2' ' A' ' 70' ' ' PRO . . . -97.38 -54.56 3.11 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 113.966 -1.117 . . . . 0.13 110.32 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' MET . . . . . 0.856 ' HA ' ' SD ' ' A' ' 71' ' ' MET . 40.6 mtt -61.87 -49.65 75.39 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 124.545 1.153 . . . . 0.089999999999999997 112.454 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.449 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 5.7 mm100 -41.39 -55.33 5.44 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 115.269 1.581 . . . . 0.63 115.269 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.806 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.8 Cg_endo -64.18 -29.22 64.73 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.063 1.842 . . . . 0.14000000000000001 111.353 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' MET . . . . . 0.856 ' SD ' ' HA ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -80.96 -45.15 17.09 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 114.98 -1.009 . . . . 0.69999999999999996 110.122 -178.343 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 68' ' ' MET . 61.3 t -56.29 -40.78 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 114.246 -1.343 . . . . 0.12 108.729 174.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -57.15 -35.25 69.31 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.075 -1.875 . . . . 0.56000000000000005 111.189 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.806 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 26.8 mtpt -85.96 -33.08 21.22 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.918 0.39 . . . . 1.3 110.981 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.828 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.98 -26.98 68.82 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.618 -0.719 . . . . 0.5 111.477 -170.3 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.583 HD13 ' HB2' ' A' ' 118' ' ' LYS . 3.3 mt -93.1 -7.17 46.28 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.971 0.891 . . . . 0.65000000000000002 111.387 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.27 13.84 55.03 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.143 -1.583 . . . . 0.17000000000000001 109.143 172.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.598 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.11 164.33 19.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.428 -0.886 . . . . 0.10000000000000001 110.348 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -86.39 106.87 17.73 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.324 -0.853 . . . . 1.72 109.844 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.655 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 132.92 -21.47 4.17 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 120.4 -0.905 . . . . 0.12 111.146 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.828 HG11 ' O ' ' A' ' 75' ' ' MET . 12.5 p -103.74 152.56 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.853 0.835 . . . . 0.16 112.243 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 83' ' ' ALA . 25.7 m -136.4 144.43 44.51 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.438 -1.256 . . . . 0.45000000000000001 110.823 175.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB2' ' CE ' ' A' ' 118' ' ' LYS . . . -61.92 142.68 57.27 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.254 -0.884 . . . . 0.28000000000000003 110.05 166.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.78 -0.34 69.94 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.847 -0.692 . . . . 0.28000000000000003 112.568 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . 0.487 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 63.1 m -94.57 145.83 24.54 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.552 -0.459 . . . . 1.2 109.977 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -76.44 126.67 37.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.685 0.755 . . . . 0.20000000000000001 109.882 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.9 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -113.68 108.24 16.85 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.203 -0.908 . . . . 0.14000000000000001 109.399 -170.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.753 HD23 HG11 ' A' ' 155' ' ' VAL . 0.9 OUTLIER -73.32 94.51 2.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.39 -1.277 . . . . 0.14999999999999999 108.868 176.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.536 HG23 HD23 ' A' ' 109' ' ' LEU . 2.0 m -73.12 116.72 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 107.718 -1.215 . . . . 0.94999999999999996 107.718 176.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.743 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 5.5 t0 -79.06 171.25 15.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.517 -0.92 . . . . 0.64000000000000001 108.517 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.624 ' OG ' ' HA ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -59.73 148.38 34.38 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-O 122.544 1.164 . . . . 0.37 108.757 171.624 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.638 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 24.7 t -73.97 138.25 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.498 0 N-CA-C 106.516 -1.661 . . . . 0.10000000000000001 106.516 162.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.841 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.3 t-20 -85.23 163.73 18.5 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 121.744 0.783 . . . . 0.17999999999999999 110.108 174.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASN . . . . . 0.738 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.3 t-20 -124.82 86.23 2.53 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.633 -1.167 . . . . 0.12 108.384 175.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.413 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.3 mtp180 -107.72 -2.93 19.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.952 -1.476 . . . . 0.64000000000000001 108.731 -173.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.701 HG21 ' HB3' ' A' ' 172' ' ' PRO . 32.7 p -51.85 -172.18 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.232 -1.804 . . . . 0.14000000000000001 115.5 -176.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.8 t30 -70.77 -8.91 55.81 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 112.537 -2.12 . . . . 0.47999999999999998 110.562 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . 0.566 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -153.26 -145.41 4.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.518 -0.849 . . . . 0.12 113.045 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.632 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 58.1 p -121.43 130.58 53.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.626 0.602 . . . . 1.1599999999999999 112.626 -176.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.738 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -136.17 153.5 51.24 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.626 0.727 . . . . 0.10000000000000001 110.667 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -76.57 80.11 3.24 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.155 -1.384 . . . . 0.17000000000000001 107.771 175.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -67.52 -15.23 63.55 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.155 -1.384 . . . . 0.089999999999999997 110.07 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.07 -30.2 34.8 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.72 -0.845 . . . . 0.14999999999999999 108.72 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.655 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 9.2 tp10 -66.07 -35.67 81.14 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.503 -1.226 . . . . 1.73 108.877 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.66 -44.98 65.98 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 113.251 -1.795 . . . . 0.12 109.232 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.59 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 52.1 m -59.75 -32.03 70.2 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.965 -1.471 . . . . 0.11 110.947 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -43.87 71.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.476 -0.935 . . . . 1.47 108.476 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.664 HG21 ' HB2' ' A' ' 64' ' ' TRP . 56.7 m -62.76 -29.48 70.72 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.328 -0.851 . . . . 0.12 110.54 176.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.728 ' O ' HD23 ' A' ' 113' ' ' LEU . 9.1 tp -56.27 -64.26 0.92 Allowed 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.937 -1.029 . . . . 0.56000000000000005 109.185 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.601 ' O ' HD13 ' A' ' 121' ' ' LEU . 23.4 mtp180 -43.07 -37.38 1.95 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.172 0.987 . . . . 1.51 111.114 172.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.641 ' HB2' ' O ' ' A' ' 108' ' ' THR . 6.9 m-20 -69.21 -46.9 66.26 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.25 -1.341 . . . . 0.28000000000000003 112.165 -175.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.449 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.19 -33.67 65.53 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.58 -0.896 . . . . 0.089999999999999997 108.58 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.805 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.2 mm? -59.21 -38.06 79.0 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.725 -1.579 . . . . 0.12 109.685 170.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.508 ' HA ' HD21 ' A' ' 121' ' ' LEU . . . -74.82 -40.68 60.94 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.177 -0.919 . . . . 0.20000000000000001 110.926 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -56.47 -36.17 68.77 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.633 -1.167 . . . . 1.1699999999999999 110.393 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -72.07 -47.61 50.28 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 113.636 -1.62 . . . . 2.0499999999999998 109.965 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.95 -11.96 63.28 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 114.947 0.739 . . . . 0.54000000000000004 114.947 172.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.655 ' CE ' ' HB2' ' A' ' 83' ' ' ALA . 53.9 mtpt -69.42 -36.68 76.95 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.515 1.157 . . . . 0.98999999999999999 111.081 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.9 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 20.6 m-85 -88.35 177.56 6.81 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 122.625 1.202 . . . . 0.20999999999999999 113.412 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.543 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 18.2 m -122.37 106.17 10.83 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 112.616 -2.083 . . . . 0.23000000000000001 108.041 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -94.42 128.6 41.07 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.563 -1.199 . . . . 0.38 112.277 -168.5 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.596 ' HB ' ' OE1' ' A' ' 126' ' ' GLN . 0.7 OUTLIER -72.08 153.79 7.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.218 -1.356 . . . . 0.41999999999999998 108.066 174.101 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . 0.497 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 1.4 m -101.88 -179.05 3.89 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 119.598 -0.841 . . . . 1.7 110.045 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 128' ' ' SER . . . -65.77 -29.53 70.05 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.602 -0.888 . . . . 0.55000000000000004 108.602 177.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.606 ' O ' ' HG3' ' A' ' 129' ' ' MET . 6.1 mt-30 -43.77 -38.96 3.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 113.444 -1.707 . . . . 2.04 111.541 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLN . . . . . 0.68 ' O ' ' HB2' ' A' ' 129' ' ' MET . 13.6 mt-30 -96.04 -55.42 2.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.69 1.233 . . . . 0.40999999999999998 108.561 172.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.766 HD11 ' HZ1' ' A' ' 131' ' ' LYS . 1.1 tm? -65.63 -58.62 5.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 112.671 -2.059 . . . . 1.3899999999999999 113.721 -161.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.622 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -53.4 -38.99 63.92 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 123.547 1.642 . . . . 1.05 108.437 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.7 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 41.9 mmm -63.37 -60.31 3.54 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 110.923 -2.853 . . . . 1.6399999999999999 111.18 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.809 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.45 -44.19 5.72 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 124.259 0.974 . . . . 0.31 112.166 176.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.766 ' HZ1' HD11 ' A' ' 127' ' ' LEU . 26.3 mttt -52.47 -55.52 21.4 Favored 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 120.065 -0.654 . . . . 1.53 109.589 176.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.1 mt-30 -61.49 -42.59 99.03 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.894 -1.048 . . . . 0.40999999999999998 111.469 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.5 mt-30 -57.55 -37.0 72.39 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.334 -1.303 . . . . 0.37 109.703 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.507 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.4 OUTLIER -89.31 -31.36 17.86 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.804 -1.544 . . . . 0.23999999999999999 109.063 -177.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 131' ' ' LYS . . . 159.64 -56.11 0.34 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-O 122.632 1.129 . . . . 0.33000000000000002 113.921 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 74.3 mt -61.88 -172.62 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 112.372 -1.914 . . . . 0.31 116.025 -169.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.7 m -114.32 151.7 45.32 Favored Pre-proline 0 N--CA 1.428 -1.556 0 CA-C-N 110.846 -2.888 . . . . 0.81000000000000005 108.581 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.642 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 10.2 Cg_endo -57.67 -7.56 3.31 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.177 2.585 . . . . 0.32000000000000001 113.423 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -116.98 -30.53 5.67 Favored 'General case' 0 CA--C 1.499 -1.008 0 O-C-N 123.709 0.63 . . . . 1.25 109.542 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 141' ' ' SER . 8.7 t70 -50.74 -36.11 34.91 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.506 1.146 . . . . 0.65000000000000002 108.778 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.624 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 1.9 m 81.07 159.47 0.15 Allowed 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 110.747 -2.933 . . . . 0.59999999999999998 111.149 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.854 HD13 ' HA ' ' A' ' 148' ' ' ALA . 7.6 mt -66.27 -38.05 86.9 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.233 -1.395 . . . . 0.85999999999999999 107.233 -172.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.17 0.16 0.68 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 112.545 -2.116 . . . . 0.31 114.856 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -152.31 120.49 6.28 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.69 -0.855 . . . . 0.23999999999999999 108.69 -174.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . 0.671 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.0 mmt180 -40.97 -48.08 3.12 Favored 'General case' 0 C--O 1.212 -0.874 0 O-C-N 123.691 0.619 . . . . 1.6499999999999999 110.906 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 t -69.68 -29.77 67.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.23 0.538 . . . . 0.53000000000000003 111.817 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 23.9 mttm -72.36 -32.48 66.5 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.399 1.095 . . . . 1.3100000000000001 108.611 176.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ALA . . . . . 0.854 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -74.02 -43.06 59.29 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-N 112.761 -2.018 . . . . 0.12 110.15 178.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.609 HG13 ' HE1' ' A' ' 179' ' ' MET . 40.2 mt -67.66 -42.66 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 CA-C-N 113.498 -1.683 . . . . 0.11 110.1 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.42 -51.99 44.08 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 114.955 -1.02 . . . . 0.14999999999999999 111.096 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ILE . . . . . 0.809 HG23 ' CB ' ' A' ' 130' ' ' ALA . 65.7 mt -68.25 -47.22 79.07 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 N-CA-C 113.01 0.744 . . . . 0.17999999999999999 113.01 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ALA . . . . . 0.678 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.24 -39.58 72.78 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.985 0.421 . . . . 0.13 110.816 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ARG . . . . . 0.428 ' HD2' HG23 ' A' ' 149' ' ' ILE . 23.6 mtp-105 -82.55 -19.9 37.66 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.526 0.679 . . . . 1.0800000000000001 110.818 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.432 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 28.0 t-20 -84.57 -11.22 56.46 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.344 -1.354 . . . . 0.5 107.344 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.753 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -108.08 -29.02 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 113.137 -1.847 . . . . 0.17000000000000001 111.052 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.48 35.38 4.7 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.283 -0.96 . . . . 0.16 112.485 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.664 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.83 156.24 21.42 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.249 0.833 . . . . 0.12 113.249 -169.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' HIS . . . . . 0.687 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -96.53 -26.53 15.23 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.838 -1.074 . . . . 0.20000000000000001 109.751 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 15.6 m-85 -135.99 -179.53 5.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.218 -0.901 . . . . 0.13 111.064 -173.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.771 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.1 t -133.06 139.79 48.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.61 -0.885 . . . . 0.080000000000000002 108.61 166.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.62 HD21 ' HE1' ' A' ' 176' ' ' MET . 46.4 tp -110.54 101.33 10.01 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 119.407 -0.917 . . . . 0.16 109.244 165.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TYR . . . . . 0.639 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 4.5 m-85 -82.05 112.79 19.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.222 -1.354 . . . . 0.26000000000000001 109.421 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.874 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 10.3 t -122.81 162.19 22.59 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.768 0.794 . . . . 1.05 110.613 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' SER . . . . . 0.853 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -162.85 175.09 11.59 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.522 -1.217 . . . . 0.10000000000000001 111.101 -177.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.32 136.77 35.19 Favored 'General case' 0 N--CA 1.413 -2.317 0 CA-C-N 114.413 -1.267 . . . . 0.11 108.853 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 3.5 m -144.97 -172.97 3.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 109.219 -0.66 . . . . 1.0900000000000001 109.219 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.14 -84.87 1.11 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.606 -1.283 . . . . 0.14999999999999999 110.834 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASN . . . . . 0.518 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 66.1 t30 -143.09 122.86 13.39 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.432 -0.884 . . . . 0.58999999999999997 109.923 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.566 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.4 p -54.32 -49.73 61.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 112.678 0.622 . . . . 0.14999999999999999 112.678 -169.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASN . . . . . 0.413 ' N ' HG13 ' A' ' 169' ' ' VAL . 5.5 m-20 -56.83 -31.89 65.21 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.777 0.798 . . . . 1.26 110.288 -174.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.49 87.51 4.15 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 114.263 -1.335 . . . . 0.13 108.119 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.813 ' HD2' HG22 ' A' ' 194' ' ' VAL . 48.1 Cg_endo -90.64 165.48 4.17 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 124.712 3.608 . . . . 0.089999999999999997 114.999 -170.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 191' ' ' LYS . 28.7 m -81.31 117.91 22.19 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.745 -1.571 . . . . 0.14000000000000001 107.098 165.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 164' ' ' SER . 43.1 tp -83.83 100.12 10.76 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.256 -1.016 . . . . 0.16 108.256 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLN . . . . . 0.598 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 35.5 mt-30 -90.05 109.56 20.61 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 121.897 0.856 . . . . 0.34000000000000002 109.152 -177.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' MET . . . . . 0.874 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.0 OUTLIER -111.46 163.84 13.6 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.233 -0.894 . . . . 1.0900000000000001 111.356 -174.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLN . . . . . 0.555 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.8 tt0 -169.65 118.19 0.62 Allowed 'General case' 0 C--O 1.207 -1.171 0 CA-C-O 121.353 0.597 . . . . 0.5 110.12 -165.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 1.07 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.16 102.29 13.18 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.038 -0.727 . . . . 0.10000000000000001 109.038 -173.069 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' MET . . . . . 0.671 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.9 ttp -91.6 117.79 30.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.755 -0.657 . . . . 0.070000000000000007 109.491 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.48 113.0 2.7 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.655 -1.239 . . . . 0.22 107.655 170.616 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.59 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -67.53 -35.76 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.989 0.813 . . . . 0.11 111.611 -175.6 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.456 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.5 mt-30 -61.3 -12.52 13.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.726 -0.67 . . . . 0.34999999999999998 111.9 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 43.4 p -130.46 -37.26 1.41 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.211 1.005 . . . . 0.19 110.333 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.558 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.91 21.05 44.14 Favored Glycine 0 N--CA 1.428 -1.88 0 CA-C-N 113.528 -1.669 . . . . 0.17999999999999999 111.596 -176.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -99.62 154.31 18.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.906 0.384 . . . . 0.72999999999999998 110.537 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ILE . . . . . 0.555 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.7 mm -88.8 111.81 23.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.034 -0.728 . . . . 0.14000000000000001 109.034 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -98.49 -31.37 3.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.815 -1.084 . . . . 0.13 110.248 -173.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' TRP . . . . . 0.687 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 82.7 t90 -135.95 152.51 51.05 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.164 -0.925 . . . . 0.070000000000000007 109.914 173.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 64.9 p -154.01 162.71 41.01 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 112.172 0.434 . . . . 0.13 112.172 163.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -162.15 -177.98 35.64 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.638 -0.985 . . . . 0.12 110.638 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' LYS . . . . . 0.766 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 13.2 mttt -151.78 153.77 34.94 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.537 -1.653 . . . . 1.22 106.537 166.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -159.82 128.22 1.95 Allowed Glycine 0 C--N 1.286 -2.236 0 CA-C-N 114.888 -1.051 . . . . 0.12 111.942 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -73.2 119.35 17.31 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.699 0.761 . . . . 0.17000000000000001 111.286 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.813 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -94.42 159.22 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 CA-C-N 114.682 -1.145 . . . . 0.11 110.708 -176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.745 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -99.34 172.84 7.08 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.648 -2.069 . . . . 0.17999999999999999 109.001 -174.408 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -102.47 130.93 49.42 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.733 -0.387 . . . . 0.91000000000000003 110.17 171.693 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.544 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 16.1 mm-40 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.408 -0.806 . . . . 1.24 110.391 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.717 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.7 m-30 . . . . . 0 N--CA 1.426 -1.672 0 CA-C-O 120.455 0.169 . . . . 0.21 111.182 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 7.6 t70 -84.55 67.82 10.09 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 123.363 1.554 . . . . 0.35 108.487 172.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.768 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.8 m95 -57.96 -42.5 85.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 112.219 -2.264 . . . . 0.1 112.455 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.597 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 9.5 t-20 -53.22 -26.14 16.61 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.13 -1.395 . . . . 1.11 111.52 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.29 -15.61 79.81 Favored Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.279 -0.873 . . . . 0.21 111.267 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.62 -53.19 3.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.104 -1.048 . . . . 0.13 110.991 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.704 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.2 mtt -65.43 -59.38 4.07 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 114.08 -1.418 . . . . 0.09 112.035 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.597 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.9 mm-40 -39.28 -54.98 3.34 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 114.679 1.362 . . . . 0.63 114.679 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.769 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.8 Cg_endo -63.61 -28.47 69.63 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.988 1.792 . . . . 0.14 110.768 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.721 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 8.2 mtm -83.17 -44.47 15.02 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.088 -0.96 . . . . 0.7 112.09 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 68' ' ' MET . 58.6 t -56.86 -39.14 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-N 114.312 -1.313 . . . . 0.12 108.715 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -60.13 -32.96 71.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.966 -1.924 . . . . 0.56 110.974 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.769 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 5.0 mtpm? -83.79 -35.76 24.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.843 0.457 . . . . 1.3 111.159 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.871 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.85 -26.54 68.66 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.461 -0.791 . . . . 0.5 111.295 -172.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 118' ' ' LYS . 5.5 mt -93.46 -3.48 52.96 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.071 0.938 . . . . 0.65 110.841 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.27 15.41 42.99 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 109.147 -1.581 . . . . 0.17 109.147 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.629 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.89 160.95 19.28 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.526 -0.837 . . . . 0.1 110.282 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.21 104.97 16.26 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.288 -0.869 . . . . 1.72 110.093 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.641 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.03 -23.83 3.16 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.842 -0.903 . . . . 0.12 110.842 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.871 HG11 ' O ' ' A' ' 75' ' ' MET . 11.9 p -103.07 150.67 6.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.635 0.731 . . . . 0.16 111.75 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.7 m -136.57 141.31 43.33 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.919 -1.037 . . . . 0.45 111.102 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.631 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.12 132.95 48.57 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.779 -1.1 . . . . 0.28 110.741 167.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.47 9.55 50.16 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 121.174 -0.536 . . . . 0.28 112.8 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.66 149.64 21.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.327 -0.549 . . . . 1.2 110.647 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.712 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -80.84 116.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.168 0.985 . . . . 0.2 108.925 166.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.743 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -105.16 109.51 21.53 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.044 -0.98 . . . . 0.14 108.903 -172.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.792 HD21 HD13 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -71.78 94.42 1.39 Allowed 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 114.428 -1.26 . . . . 0.15 108.32 177.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.452 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.7 m -72.58 119.18 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 106.978 -1.49 . . . . 0.95 106.978 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.845 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 12.3 t0 -77.33 162.35 27.35 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.703 -1.221 . . . . 0.64 107.703 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.567 ' H ' ' NZ ' ' A' ' 131' ' ' LYS . 1.1 m -62.17 143.21 57.06 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.59 -1.633 . . . . 0.37 106.59 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.56 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 27.3 t -71.73 139.76 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.118 0 N-CA-C 107.534 -1.284 . . . . 0.1 107.534 168.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.78 ' H ' ' HA ' ' A' ' 164' ' ' SER . 8.0 t-20 -84.9 163.28 19.09 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.497 -0.774 . . . . 0.18 110.07 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.77 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.14 85.22 2.38 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.96 -1.126 . . . . 0.12 107.96 175.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.535 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.9 mtp180 -107.02 -4.17 19.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.037 -1.438 . . . . 0.64 108.764 -171.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 172' ' ' PRO . 19.1 p -51.05 -170.94 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.83 -1.986 . . . . 0.14 115.499 -175.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 38.3 t30 -70.96 -6.35 38.05 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.718 -2.037 . . . . 0.48 110.53 173.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.603 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -157.48 -144.05 3.83 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.396 -0.907 . . . . 0.12 113.297 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.629 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 94.8 p -121.42 130.31 53.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.612 0.597 . . . . 1.16 112.612 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.77 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.2 pp -136.48 159.49 41.64 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-O 121.855 0.836 . . . . 0.1 110.579 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.692 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -80.74 82.17 6.81 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 113.856 -1.52 . . . . 0.17 107.975 175.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -70.84 -15.64 62.66 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.355 -1.293 . . . . 0.09 109.81 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.663 ' HB2' ' CG ' ' A' ' 139' ' ' GLN . . . -78.66 -31.53 46.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.793 0.806 . . . . 0.15 108.849 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.692 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 21.5 tt0 -62.83 -38.61 91.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 114.053 -1.43 . . . . 1.73 109.109 169.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -69.54 -44.62 70.57 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 112.867 -1.97 . . . . 0.12 109.005 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.592 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 60.6 m -64.89 -31.82 73.23 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.126 -1.397 . . . . 0.11 110.533 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.15 -51.24 59.74 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.972 -1.121 . . . . 1.47 107.972 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 64' ' ' TRP . 31.7 m -56.69 -33.15 66.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.532 -0.758 . . . . 0.12 111.436 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.704 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.3 mt -50.55 -68.69 0.15 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 109.61 -0.515 . . . . 0.56 109.61 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.569 ' O ' HD13 ' A' ' 121' ' ' LEU . 19.0 mtp180 -42.81 -36.92 1.63 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.883 -1.053 . . . . 1.51 110.973 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -71.9 -47.47 52.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.245 -1.343 . . . . 0.28 111.854 -175.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.5 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.21 -33.31 67.51 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.328 1.061 . . . . 0.09 108.403 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.86 -32.9 74.58 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.514 -1.676 . . . . 0.12 109.918 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.693 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -76.28 -40.82 50.72 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.812 -1.086 . . . . 0.2 111.364 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.05 -26.87 66.96 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.99 -1.005 . . . . 1.17 110.682 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.494 HD22 HD12 ' A' ' 76' ' ' LEU . 51.6 t30 -88.08 -17.94 29.98 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.147 -0.621 . . . . 2.05 110.429 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.21 -12.83 2.99 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 116.048 1.179 . . . . 0.54 116.048 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.72 ' HB2' HD13 ' A' ' 76' ' ' LEU . 57.8 mtpt -77.39 -14.3 59.74 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 117.802 0.801 . . . . 0.99 111.463 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.743 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 23.2 m-85 -109.29 172.76 6.66 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 122.648 1.213 . . . . 0.21 113.669 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.57 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 14.7 m -117.27 117.42 29.5 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 112.305 -2.225 . . . . 0.23 108.031 169.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -88.52 139.02 30.9 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.437 -0.801 . . . . 0.38 110.517 -171.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.559 HG11 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.301 -1.52 0 N-CA-C 108.871 -0.788 . . . . 0.42 108.871 172.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.792 HD13 HD21 ' A' ' 88' ' ' LEU . 26.5 tp . . . . . 0 C--O 1.218 -0.599 0 N-CA-C 112.8 0.667 . . . . 1.39 112.8 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.704 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 2.6 t -49.39 -44.56 45.19 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 123.308 1.528 . . . . 1.05 109.408 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.734 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 19.0 mmt -58.44 -61.61 2.46 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 111.064 -2.789 . . . . 1.64 110.694 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.755 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.81 -46.15 5.13 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 124.484 1.115 . . . . 0.31 112.197 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.568 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -54.95 -51.36 66.39 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 108.624 -0.88 . . . . 1.53 108.624 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 128' ' ' SER . 40.9 mt-30 -65.68 -40.78 92.72 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.23 -0.895 . . . . 0.41 111.162 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.734 ' HG3' ' O ' ' A' ' 129' ' ' MET . 54.5 mt-30 -57.81 -34.73 69.96 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 114.354 -1.294 . . . . 0.37 109.525 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.08 -28.93 17.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 113.754 -1.567 . . . . 0.24 109.284 -176.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.62 -49.79 0.52 Allowed Glycine 0 CA--C 1.496 -1.137 0 CA-C-O 122.667 1.148 . . . . 0.33 113.323 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 141' ' ' SER . 87.9 mt -64.92 -169.73 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 112.332 -1.934 . . . . 0.31 115.669 -171.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.0 m -116.3 155.05 48.82 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 110.858 -2.883 . . . . 0.81 107.517 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.704 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 46.1 Cg_endo -67.26 1.35 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.661 2.241 . . . . 0.32 110.866 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.663 ' CG ' ' HB2' ' A' ' 103' ' ' ALA . 31.4 mt-30 -118.27 -24.31 6.97 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.946 -1.479 . . . . 1.25 111.525 -173.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.621 ' O ' ' HB2' ' A' ' 141' ' ' SER . 7.1 t70 -72.92 -23.61 60.72 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 114.838 -1.073 . . . . 0.65 108.793 -168.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 31.5 m 75.78 166.33 0.27 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.532 -2.122 . . . . 0.6 110.56 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.944 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.2 mt -64.99 -40.4 94.91 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.581 1.182 . . . . 0.86 108.777 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.71 -12.16 0.16 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 112.607 -2.088 . . . . 0.31 114.612 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -151.79 125.45 8.97 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 118.832 -0.604 . . . . 0.24 109.57 -173.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 16.8 mmt85 -42.27 -48.13 4.9 Favored 'General case' 0 C--O 1.211 -0.944 0 O-C-N 123.413 0.446 . . . . 1.65 111.915 -176.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 41.9 t -72.23 -26.33 61.98 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.595 0.712 . . . . 0.53 111.236 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -74.37 -28.97 61.36 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.6 1.19 . . . . 1.31 108.505 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.944 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -76.47 -47.92 21.32 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-N 112.471 -2.149 . . . . 0.12 110.427 177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.627 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.2 mt -66.51 -40.17 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 CA-C-N 112.856 -1.975 . . . . 0.11 110.073 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.46 -55.26 25.69 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 114.652 -1.158 . . . . 0.15 110.965 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.755 HG23 ' CB ' ' A' ' 130' ' ' ALA . 92.1 mt -66.42 -48.55 80.4 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.07 0 N-CA-C 112.683 0.623 . . . . 0.18 112.683 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.675 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.36 -41.2 72.22 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 123.227 0.329 . . . . 0.13 111.079 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.497 ' HD2' HG23 ' A' ' 149' ' ' ILE . 24.8 mtp180 -81.22 -23.02 38.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.597 0.713 . . . . 1.08 110.459 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.502 HD22 ' CB ' ' A' ' 130' ' ' ALA . 21.4 t30 -82.84 -10.26 58.93 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.438 -1.319 . . . . 0.5 107.438 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.71 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.1 t -108.51 -29.47 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 113.18 -1.827 . . . . 0.17 111.0 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.83 35.86 4.16 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.077 -1.058 . . . . 0.16 112.486 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.689 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.15 159.65 17.65 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.866 0.691 . . . . 0.12 112.866 -171.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.712 ' N ' HG13 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -99.85 -28.17 13.25 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 123.414 0.686 . . . . 0.2 109.681 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.572 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.3 m-85 -135.44 -173.17 3.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.161 -0.927 . . . . 0.13 110.945 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.701 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -137.18 140.35 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.004 -0.998 . . . . 0.08 108.786 166.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.633 HD21 ' SD ' ' A' ' 176' ' ' MET . 37.0 tp -109.31 100.95 10.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 119.417 -0.913 . . . . 0.16 109.3 165.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.4 m-85 -79.83 113.59 18.1 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 114.434 -1.257 . . . . 0.26 109.027 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.855 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 6.4 t -126.64 161.25 28.51 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 122.143 0.973 . . . . 1.05 110.881 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.821 ' O ' HD12 ' A' ' 174' ' ' LEU . 2.2 p -164.51 174.55 10.79 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.949 -1.478 . . . . 0.1 110.859 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.29 134.67 38.23 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 114.2 -1.363 . . . . 0.11 108.632 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.681 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.7 m -144.73 -175.96 4.87 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.185 -0.672 . . . . 1.09 109.185 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.82 -84.53 0.8 Allowed Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 119.536 -1.316 . . . . 0.15 111.325 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.7 t30 -144.23 127.22 16.45 Favored 'General case' 0 C--O 1.197 -1.676 0 N-CA-C 107.596 -1.261 . . . . 0.59 107.596 175.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.603 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.5 p -63.34 -39.53 85.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.398 -0.819 . . . . 0.15 112.364 -171.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.41 ' N ' HG13 ' A' ' 169' ' ' VAL . 4.4 m120 -60.72 -31.47 70.77 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 122.086 0.946 . . . . 1.26 109.753 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.55 88.89 3.29 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 113.169 -1.832 . . . . 0.13 108.307 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.799 ' HD2' HG22 ' A' ' 194' ' ' VAL . 52.4 Cg_endo -89.99 163.73 4.88 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 124.335 3.357 . . . . 0.09 114.883 -169.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.617 HG22 ' HB3' ' A' ' 191' ' ' LYS . 63.8 m -82.93 117.97 23.14 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 106.965 -1.494 . . . . 0.14 106.965 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 164' ' ' SER . 38.5 tp -83.9 97.49 9.26 Favored 'General case' 0 N--CA 1.413 -2.325 0 C-N-CA 119.294 -0.963 . . . . 0.16 108.402 177.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.582 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 6.3 mt-30 -87.87 109.47 19.8 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.098 -0.955 . . . . 0.34 109.153 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.855 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -112.85 164.75 13.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.684 -1.144 . . . . 1.09 111.481 -173.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.603 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.7 tt0 -170.57 118.16 0.52 Allowed 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 116.077 -0.51 . . . . 0.5 110.076 -166.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.066 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -100.37 100.56 11.36 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.741 -0.837 . . . . 0.1 108.741 -172.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.627 ' HE1' HG13 ' A' ' 149' ' ' ILE . 18.2 ttp -90.52 121.93 32.9 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.445 -0.798 . . . . 0.07 109.614 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.82 127.09 30.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.122 -1.436 . . . . 0.22 107.122 166.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.617 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.52 -34.4 13.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 119.33 0.968 . . . . 0.11 110.758 178.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.429 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.7 mt-30 -63.08 -14.69 51.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.265 -0.88 . . . . 0.35 111.577 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.1 p -130.58 -36.97 1.4 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.677 0.751 . . . . 0.19 110.277 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.503 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.17 19.0 44.02 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.556 -1.202 . . . . 0.18 112.25 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.7 156.79 16.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.529 -0.336 . . . . 0.73 110.494 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.603 HD12 ' HG2' ' A' ' 177' ' ' GLN . 33.7 mm -91.58 115.85 31.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.637 0.732 . . . . 0.14 109.52 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.066 HD11 HD13 ' A' ' 178' ' ' LEU . 1.5 pp -103.28 -29.61 2.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.019 -0.991 . . . . 0.13 110.681 -173.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.652 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.0 t90 -137.2 153.26 50.45 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.371 -0.831 . . . . 0.07 109.508 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 79.9 p -153.47 165.47 35.75 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.822 0.675 . . . . 0.13 112.822 163.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -161.79 -175.91 33.32 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-O 121.718 0.621 . . . . 0.12 111.762 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.757 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 1.5 mttp -154.74 152.02 29.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.095 -1.817 . . . . 1.22 106.095 164.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -157.33 127.31 1.9 Allowed Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 119.612 -1.28 . . . . 0.12 111.833 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.42 115.2 10.32 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.391 0.615 . . . . 0.17 110.487 -175.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.799 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -90.98 158.68 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-O 122.47 1.128 . . . . 0.11 109.647 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.657 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.23 171.58 7.52 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 112.848 -1.978 . . . . 0.18 109.256 -172.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 6.8 tt0 -101.64 128.96 47.7 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.074 -0.713 . . . . 0.91 109.074 168.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.497 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 19.3 mm-40 . . . . . 0 C--N 1.309 -1.177 0 CA-C-N 115.505 -0.771 . . . . 1.24 110.732 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.727 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.1 m-30 . . . . . 0 N--CA 1.426 -1.656 0 CA-C-O 120.252 0.072 . . . . 0.21 110.973 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.528 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 15.8 t70 -85.05 67.75 10.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 123.538 1.637 . . . . 0.35 108.444 173.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.772 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.1 m95 -55.64 -43.33 76.12 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 112.006 -2.361 . . . . 0.1 112.752 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.503 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 11.1 t-20 -50.8 -30.87 15.33 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.762 -1.563 . . . . 1.11 111.643 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.28 -17.15 79.62 Favored Glycine 0 CA--C 1.503 -0.693 0 CA-C-N 115.506 -0.77 . . . . 0.21 111.423 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.96 -51.51 3.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.114 -1.043 . . . . 0.13 110.806 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.74 ' SD ' HD23 ' A' ' 109' ' ' LEU . 37.6 mtt -65.69 -56.29 12.9 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 114.182 -1.372 . . . . 0.09 112.473 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.503 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 7.0 mm-40 -39.74 -54.29 4.15 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 114.804 1.409 . . . . 0.63 114.804 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.834 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 29.6 Cg_endo -63.55 -32.0 70.39 Favored 'Trans proline' 0 CA--C 1.508 -0.804 0 C-N-CA 121.919 1.746 . . . . 0.14 110.799 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.758 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 7.7 mtm -79.64 -47.59 15.16 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 114.979 -1.01 . . . . 0.7 111.515 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 68' ' ' MET . 53.3 t -54.52 -41.19 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 CA-C-N 114.089 -1.414 . . . . 0.12 108.955 176.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.9 t -60.0 -36.68 77.72 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.256 -1.793 . . . . 0.56 110.791 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.834 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 20.0 mtpp -77.6 -35.36 52.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.303 0.573 . . . . 1.3 110.498 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.866 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.14 -29.81 71.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.765 -1.107 . . . . 0.5 111.44 -173.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.479 ' HG ' ' HB2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -83.68 -6.82 59.54 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.193 0.52 . . . . 0.65 111.235 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -108.76 13.97 34.98 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.614 -1.395 . . . . 0.17 109.614 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.657 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -81.58 161.36 23.56 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.663 -0.768 . . . . 0.1 110.285 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.99 106.26 17.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.345 -0.843 . . . . 1.72 109.579 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.648 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.76 -24.68 3.46 Favored Glycine 0 N--CA 1.418 -2.542 0 C-N-CA 119.797 -1.192 . . . . 0.12 110.666 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.866 HG11 ' O ' ' A' ' 75' ' ' MET . 10.9 p -97.47 155.9 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.702 0.763 . . . . 0.16 111.541 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.405 ' HB ' ' OG ' ' A' ' 85' ' ' SER . 6.5 m -132.85 136.62 46.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 114.51 -1.223 . . . . 0.45 110.901 -176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.654 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.6 130.21 45.74 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.864 -1.062 . . . . 0.28 110.332 167.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.86 12.15 60.86 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.719 -0.753 . . . . 0.28 113.233 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.462 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 61.9 m -97.56 147.73 23.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.124 0.462 . . . . 1.2 110.156 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.705 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.2 p -77.0 124.8 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 122.09 0.948 . . . . 0.2 109.194 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.685 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.7 tm? -110.84 110.17 20.66 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.984 -1.007 . . . . 0.14 108.58 -172.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.722 HD21 HD23 ' A' ' 127' ' ' LEU . 0.7 OUTLIER -71.34 92.85 1.08 Allowed 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.334 -1.358 . . . . 0.15 107.334 176.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.5 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -73.68 113.41 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.416 -1.327 . . . . 0.95 107.416 177.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.818 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 23.1 t0 -77.28 172.04 13.9 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 114.778 -1.101 . . . . 0.64 108.815 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.556 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.7 OUTLIER -61.8 157.78 17.31 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 122.767 1.27 . . . . 0.37 108.371 168.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.559 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 39.3 t -86.87 139.63 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.202 0 CA-C-N 113.692 -1.595 . . . . 0.1 107.047 165.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.824 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.6 t-20 -83.8 163.35 20.2 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.854 0.835 . . . . 0.18 110.555 173.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.763 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.74 84.86 2.32 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.348 -1.296 . . . . 0.12 107.977 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.8 mtp180 -108.48 -2.6 18.85 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.847 -1.524 . . . . 0.64 108.727 -171.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.738 HG21 ' HB3' ' A' ' 172' ' ' PRO . 22.6 p -51.4 -170.13 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 112.678 -2.055 . . . . 0.14 115.156 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 29.8 t30 -70.49 -10.66 59.77 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.083 -1.871 . . . . 0.48 110.531 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.559 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.37 -144.74 3.98 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.176 -1.011 . . . . 0.12 113.573 -176.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.639 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 16.5 m -121.27 130.75 53.83 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.8 0.44 . . . . 1.16 110.935 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.763 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -136.8 157.48 46.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.962 0.887 . . . . 0.1 110.735 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.723 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -77.17 80.74 3.68 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.628 -1.623 . . . . 0.17 107.56 175.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -70.17 -14.71 62.76 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.863 -1.062 . . . . 0.09 109.767 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.86 -29.6 35.74 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.413 -0.958 . . . . 0.15 108.413 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.723 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 29.3 tt0 -61.62 -40.64 95.56 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.207 -1.36 . . . . 1.73 109.125 168.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -68.15 -45.29 73.94 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 112.826 -1.988 . . . . 0.12 108.845 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 47.2 m -63.78 -33.28 75.32 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 113.821 -1.536 . . . . 0.11 110.618 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -44.83 84.89 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.637 -1.245 . . . . 1.47 107.637 172.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.68 HG21 ' HB2' ' A' ' 64' ' ' TRP . 34.6 m -63.24 -30.11 71.32 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.234 -0.894 . . . . 0.12 110.867 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.74 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.57 -68.34 0.18 Allowed 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.589 -0.732 . . . . 0.56 109.658 171.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.603 ' NH2' HD12 ' A' ' 127' ' ' LEU . 5.8 mpt_? -40.31 -36.63 0.56 Allowed 'General case' 0 C--O 1.213 -0.865 0 O-C-N 124.226 0.954 . . . . 1.51 110.888 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.543 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -74.6 -46.35 39.12 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.665 -1.152 . . . . 0.28 112.0 -174.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.55 63.36 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.471 -0.937 . . . . 0.09 108.471 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.683 ' HB3' ' CD2' ' A' ' 121' ' ' LEU . 4.5 mm? -61.64 -35.21 77.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.649 -1.614 . . . . 0.12 109.442 172.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -73.46 -41.69 62.86 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 114.574 -1.194 . . . . 0.2 110.937 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.85 -8.5 54.7 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.15 -0.932 . . . . 1.17 110.281 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -77.81 -49.08 15.02 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.523 -0.917 . . . . 2.05 108.523 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.87 -7.15 82.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.416 -0.811 . . . . 0.54 113.735 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.654 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 58.7 mtpt -86.64 -33.13 20.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.289 0.545 . . . . 0.99 111.322 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.685 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 6.5 m-85 -88.81 171.47 9.91 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.303 1.049 . . . . 0.21 112.988 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 7.9 m -116.46 119.32 35.24 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.144 -1.844 . . . . 0.23 108.222 168.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.683 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -89.01 140.82 29.05 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 119.466 -0.893 . . . . 0.38 111.368 -171.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.592 HG21 HD23 ' A' ' 88' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.299 -1.596 0 N-CA-C 108.42 -0.956 . . . . 0.42 108.42 170.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.722 HD23 HD21 ' A' ' 88' ' ' LEU . 1.3 tm? . . . . . 0 C--O 1.222 -0.356 0 N-CA-C 112.998 0.74 . . . . 1.39 112.998 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.684 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -48.75 -37.83 20.0 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 123.649 1.69 . . . . 1.05 108.946 -179.288 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.666 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 6.6 mmt -65.78 -61.52 2.02 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 110.731 -2.94 . . . . 1.64 110.987 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.748 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.65 -43.61 3.92 Favored 'General case' 0 CA--C 1.503 -0.829 0 O-C-N 124.181 0.925 . . . . 0.31 112.384 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -55.24 -52.69 62.58 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 107.806 -1.183 . . . . 1.53 107.806 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.9 mt-30 -65.89 -41.05 92.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.064 -0.971 . . . . 0.41 111.194 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.666 ' HG3' ' O ' ' A' ' 129' ' ' MET . 54.2 mt-30 -56.46 -34.72 67.14 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-N 114.365 -1.289 . . . . 0.37 109.617 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -92.57 -31.33 15.23 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.002 -1.454 . . . . 0.24 109.45 -176.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.79 -51.95 0.39 Allowed Glycine 0 CA--C 1.499 -0.917 0 C-N-CA 120.149 -1.024 . . . . 0.33 113.759 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 141' ' ' SER . 39.1 mt -67.25 -167.0 0.05 Allowed 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.499 -1.851 . . . . 0.31 115.778 -170.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -116.95 154.57 49.68 Favored Pre-proline 0 N--CA 1.421 -1.909 0 CA-C-N 110.994 -2.821 . . . . 0.81 108.002 176.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.684 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 21.9 Cg_endo -62.56 -0.11 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.397 2.731 . . . . 0.32 112.207 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.46 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.2 tt0 -119.51 -28.73 5.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.172 -0.922 . . . . 1.25 111.096 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.677 ' O ' ' HB2' ' A' ' 141' ' ' SER . 11.7 t70 -66.1 -25.4 66.99 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 113.779 -1.555 . . . . 0.65 109.407 -172.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.677 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 5.7 m 75.66 171.75 0.26 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.146 -1.843 . . . . 0.6 109.697 -173.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.01 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.0 mt -65.6 -39.24 91.35 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.398 1.094 . . . . 0.86 108.36 -176.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.55 -12.4 0.33 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 112.871 -1.968 . . . . 0.31 114.646 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 124.88 7.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 118.719 -0.658 . . . . 0.24 109.638 -174.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.668 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -40.89 -48.5 3.13 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 112.177 0.436 . . . . 1.65 112.177 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.3 t -72.47 -26.16 61.7 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.443 0.64 . . . . 0.53 111.186 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -73.97 -28.42 61.47 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.712 1.244 . . . . 1.31 108.528 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 1.01 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -76.61 -47.25 22.93 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 112.27 -2.241 . . . . 0.12 110.253 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.635 HG13 ' HE1' ' A' ' 179' ' ' MET . 36.5 mt -66.75 -41.12 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 112.816 -1.993 . . . . 0.11 110.188 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.98 -54.94 26.3 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 114.613 -1.176 . . . . 0.15 111.054 171.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.748 HG23 ' CB ' ' A' ' 130' ' ' ALA . 75.2 mt -65.63 -47.89 84.57 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 N-CA-C 112.748 0.647 . . . . 0.18 112.748 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.671 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.27 -40.45 74.23 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.939 0.4 . . . . 0.13 110.939 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.46 ' HD2' HG23 ' A' ' 149' ' ' ILE . 30.9 mtp180 -82.13 -20.85 37.16 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.677 0.751 . . . . 1.08 110.451 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 14.8 t30 -83.28 -10.77 58.33 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.238 -1.393 . . . . 0.5 107.238 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.707 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.0 OUTLIER -109.59 -29.02 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 113.444 -1.707 . . . . 0.17 111.42 -173.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.26 35.92 4.3 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.213 -0.994 . . . . 0.16 112.489 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.658 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.45 160.56 17.0 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.294 0.85 . . . . 0.12 113.294 -170.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.705 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.4 m80 -100.86 -26.21 13.84 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.121 -0.945 . . . . 0.2 109.613 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.652 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 12.7 m-85 -135.49 -174.29 3.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.19 -0.914 . . . . 0.13 111.583 -174.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.692 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -136.57 140.02 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.094 -0.957 . . . . 0.08 109.465 166.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 176' ' ' MET . 42.9 tp -109.61 100.73 9.73 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 119.61 -0.836 . . . . 0.16 109.144 165.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 142' ' ' LEU . 2.3 m-85 -80.53 112.48 17.92 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 114.464 -1.244 . . . . 0.26 109.31 177.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.832 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.5 t -124.08 163.02 22.31 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 122.144 0.973 . . . . 1.05 111.335 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.83 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.1 p -164.65 173.71 11.62 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 114.037 -1.438 . . . . 0.1 111.007 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -137.35 134.34 35.89 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 114.304 -1.316 . . . . 0.11 108.429 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -144.11 -176.19 4.91 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.305 -0.628 . . . . 1.09 109.305 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.14 -83.91 0.92 Allowed Glycine 0 CA--C 1.491 -1.414 0 C-N-CA 119.567 -1.302 . . . . 0.15 111.213 173.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.1 t30 -144.59 129.3 18.21 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-N 113.985 -1.108 . . . . 0.59 108.149 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.559 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.6 p -63.65 -40.21 88.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.343 -0.844 . . . . 0.15 112.168 -172.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -60.31 -32.1 70.9 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.982 0.896 . . . . 1.26 109.993 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.78 88.75 3.24 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 113.442 -1.708 . . . . 0.13 108.363 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 194' ' ' VAL . 45.9 Cg_endo -90.03 164.51 4.82 Favored 'Trans proline' 0 CA--C 1.49 -1.681 0 C-N-CA 124.028 3.152 . . . . 0.09 114.626 -169.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.0 m -85.37 118.1 24.7 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 113.877 -1.51 . . . . 0.14 107.586 167.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 164' ' ' SER . 42.7 tp -83.89 98.35 9.72 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 108.551 -0.907 . . . . 0.16 108.551 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.638 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 35.7 mt-30 -89.39 109.66 20.55 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-O 122.13 0.967 . . . . 0.34 109.259 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.832 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.7 OUTLIER -113.37 163.66 14.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.736 -1.12 . . . . 1.09 111.271 -173.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.61 ' HG2' HD12 ' A' ' 186' ' ' ILE . 37.6 tt0 -170.78 119.26 0.52 Allowed 'General case' 0 C--O 1.203 -1.349 0 CA-C-N 115.873 -0.603 . . . . 0.5 110.131 -166.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.142 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.94 102.01 12.94 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.716 -0.846 . . . . 0.1 108.716 -172.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.668 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.9 ttp -91.71 122.95 34.73 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.656 -0.702 . . . . 0.07 109.368 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -58.4 127.2 30.94 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.358 -1.349 . . . . 0.22 107.358 167.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.609 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.73 -34.22 11.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 119.151 -1.019 . . . . 0.11 110.758 178.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.468 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 27.6 mt-30 -62.94 -14.89 52.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.432 -0.804 . . . . 0.35 111.379 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.2 p -130.64 -36.57 1.41 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.727 0.775 . . . . 0.19 110.365 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.479 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 86.05 32.51 17.28 Favored Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 114.319 -1.309 . . . . 0.18 112.213 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.2 155.21 22.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.59 -0.305 . . . . 0.73 110.4 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 177' ' ' GLN . 29.3 mm -88.23 119.13 35.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.967 -0.753 . . . . 0.14 108.967 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.142 HD11 HD13 ' A' ' 178' ' ' LEU . 1.3 pp -107.12 -33.04 2.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.277 -0.874 . . . . 0.13 110.514 -174.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.657 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.8 t90 -133.53 151.52 51.75 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.438 -0.801 . . . . 0.07 109.24 172.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 22.1 p -153.99 160.84 42.22 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.664 0.616 . . . . 0.13 112.664 165.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -157.81 -177.06 30.55 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.536 -1.025 . . . . 0.12 110.536 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.768 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 12.9 mtmt -157.43 150.37 23.36 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 105.508 -2.034 . . . . 1.22 105.508 167.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -157.96 126.9 1.79 Allowed Glycine 0 C--N 1.279 -2.598 0 C-N-CA 119.51 -1.329 . . . . 0.12 112.243 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.28 114.07 10.0 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.337 0.589 . . . . 0.17 110.946 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.777 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -91.12 158.49 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 122.583 1.182 . . . . 0.11 110.125 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.662 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -98.8 172.16 7.63 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 112.69 -2.05 . . . . 0.18 109.727 -173.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.9 tt0 -103.36 127.71 50.64 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.127 -0.694 . . . . 0.91 109.127 167.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.55 ' HG2' ' C ' ' A' ' 62' ' ' TYR . 19.8 mm-40 . . . . . 0 C--N 1.306 -1.304 0 CA-C-N 115.513 -0.767 . . . . 1.24 110.585 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.752 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.7 m-30 . . . . . 0 N--CA 1.416 -2.128 0 N-CA-C 109.627 -0.509 . . . . 0.21 109.627 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 2.1 t70 -79.66 68.02 5.59 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 123.785 1.755 . . . . 0.35 108.167 170.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.716 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.9 m95 -60.08 -44.53 94.71 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 111.594 -2.548 . . . . 0.1 112.199 174.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.562 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 7.1 t-20 -50.03 -30.48 10.83 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.844 -1.525 . . . . 1.11 111.607 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.65 -18.3 80.01 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-N 115.503 -0.772 . . . . 0.21 111.266 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.58 -52.22 3.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.965 -1.118 . . . . 0.13 110.895 -175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.719 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.1 mtt -64.32 -58.49 6.36 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 114.136 -1.393 . . . . 0.09 112.198 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.562 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 6.0 mm-40 -40.11 -53.59 4.97 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 114.912 1.449 . . . . 0.63 114.912 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.811 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.1 Cg_endo -64.19 -30.79 64.75 Favored 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 122.164 1.91 . . . . 0.14 110.654 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.769 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 9.3 mtm -80.97 -46.87 14.45 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 115.006 -0.997 . . . . 0.7 111.7 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 68' ' ' MET . 57.5 t -54.6 -40.73 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 CA-C-N 114.091 -1.413 . . . . 0.12 108.841 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 t -58.97 -36.81 75.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.028 -1.896 . . . . 0.56 110.909 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.811 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.9 mtpt -80.39 -34.1 36.6 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.091 0.472 . . . . 1.3 110.775 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.84 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.09 -29.56 70.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.305 -0.862 . . . . 0.5 111.685 -171.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.569 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.3 mt -91.79 -6.18 52.21 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.939 0.876 . . . . 0.65 111.23 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.55 15.35 49.64 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 109.156 -1.578 . . . . 0.17 109.156 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.616 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.48 165.48 18.06 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.42 -0.89 . . . . 0.1 110.316 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -88.32 107.6 18.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.066 -0.97 . . . . 1.72 109.787 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.629 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 130.98 -22.88 4.46 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.991 -0.843 . . . . 0.12 110.991 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.84 HG11 ' O ' ' A' ' 75' ' ' MET . 10.1 p -99.27 152.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.861 0.838 . . . . 0.16 111.496 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -134.33 138.73 45.15 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.159 -1.382 . . . . 0.45 109.835 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.59 ' HB2' ' HD2' ' A' ' 118' ' ' LYS . . . -65.3 137.82 57.8 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.871 -0.604 . . . . 0.28 110.239 169.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.2 -1.41 54.39 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.799 -0.715 . . . . 0.28 112.69 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.14 153.07 22.91 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.993 0.425 . . . . 1.2 110.972 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.658 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.0 p -81.86 116.43 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.122 0.963 . . . . 0.2 109.221 166.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.722 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -103.93 109.67 21.52 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.964 -1.017 . . . . 0.14 108.971 -173.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.673 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -71.76 94.29 1.37 Allowed 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 114.545 -1.207 . . . . 0.15 107.932 176.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.499 HG11 ' HG3' ' A' ' 110' ' ' ARG . 1.7 m -73.12 117.71 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 N-CA-C 107.476 -1.305 . . . . 0.95 107.476 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.831 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 8.7 t0 -77.52 156.41 31.0 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.659 -1.155 . . . . 0.64 108.134 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.556 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.54 135.89 57.81 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.473 -1.306 . . . . 0.37 107.473 171.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.525 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 23.2 t -63.4 140.08 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.836 0 CA-C-N 114.783 -1.099 . . . . 0.1 108.065 169.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.803 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.6 t-20 -85.56 163.22 18.5 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.248 -0.887 . . . . 0.18 109.913 174.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.765 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.98 85.34 2.4 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.604 -1.18 . . . . 0.12 108.487 175.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -108.14 -1.98 19.86 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.969 -1.469 . . . . 0.64 108.995 -172.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.719 HG21 ' HB3' ' A' ' 172' ' ' PRO . 24.5 p -52.0 -170.96 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 112.715 -2.039 . . . . 0.14 114.975 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 32.7 t30 -72.48 -4.05 28.05 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 112.992 -1.913 . . . . 0.48 110.558 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.615 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -157.42 -144.46 3.94 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.052 -1.071 . . . . 0.12 113.368 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.648 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 53.8 p -122.09 129.46 52.4 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 112.278 0.473 . . . . 1.16 112.278 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.12 157.37 47.1 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 121.97 0.89 . . . . 0.1 110.678 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.646 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.6 t-20 -80.48 79.99 7.0 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.053 -1.43 . . . . 0.17 107.846 175.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.0 -14.2 62.66 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.479 -1.237 . . . . 0.09 109.988 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.584 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.19 -32.17 44.04 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.721 -0.844 . . . . 0.15 108.721 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.646 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.4 tp10 -66.63 -31.96 72.97 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 122.951 1.358 . . . . 1.73 109.064 172.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -73.75 -44.18 56.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.036 -1.893 . . . . 0.12 109.657 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.616 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 60.0 m -63.98 -31.6 72.84 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.986 -1.461 . . . . 0.11 110.626 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 1.5 pt-20 -66.97 -43.34 83.32 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.701 -1.222 . . . . 1.47 107.701 172.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.675 HG21 ' HB2' ' A' ' 64' ' ' TRP . 56.8 m -63.06 -30.46 71.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.234 -0.894 . . . . 0.12 110.672 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.719 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.74 -69.56 0.11 Allowed 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.205 -0.665 . . . . 0.56 109.205 171.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.1 mtp180 -40.22 -38.22 0.74 Allowed 'General case' 0 C--N 1.313 -0.982 0 O-C-N 124.405 1.065 . . . . 1.51 111.29 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.514 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.71 -47.51 59.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.517 -1.22 . . . . 0.28 111.897 -176.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.4 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.15 -33.72 65.64 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.223 1.011 . . . . 0.09 108.647 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.696 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -62.92 -34.65 77.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.416 -1.72 . . . . 0.12 109.976 172.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.615 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -74.78 -42.58 57.88 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 114.752 -1.113 . . . . 0.2 111.097 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -63.2 -29.26 70.64 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.769 -1.105 . . . . 1.17 110.43 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -82.26 -23.89 35.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.535 -0.757 . . . . 2.05 110.159 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.71 4.28 57.51 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.975 -1.011 . . . . 0.54 114.927 159.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.59 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 13.5 mtmm -91.18 -34.27 15.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.279 0.539 . . . . 0.99 111.156 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.722 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 14.6 m-85 -89.44 175.56 7.26 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 122.355 1.074 . . . . 0.21 112.458 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.5 m -118.92 121.13 39.25 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 113.012 -1.904 . . . . 0.23 108.289 169.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.674 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -91.72 141.76 28.34 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 119.389 -0.924 . . . . 0.38 111.159 -170.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 88' ' ' LEU . 1.3 m . . . . . 0 C--N 1.299 -1.592 0 N-CA-C 107.892 -1.151 . . . . 0.42 107.892 169.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.639 HD13 HD21 ' A' ' 88' ' ' LEU . 31.2 tp . . . . . 0 C--O 1.219 -0.524 0 N-CA-C 113.271 0.841 . . . . 1.39 113.271 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.644 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 3.0 t -50.31 -46.26 55.33 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 123.365 1.555 . . . . 1.05 109.105 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.743 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 17.2 mmt -54.31 -63.36 1.17 Allowed 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 110.745 -2.934 . . . . 1.64 110.706 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.77 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.91 -46.47 5.37 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.346 1.029 . . . . 0.31 112.15 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.523 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -54.45 -52.35 62.1 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 108.744 -0.836 . . . . 1.53 108.744 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.7 mt-30 -65.18 -39.88 93.49 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.402 -0.817 . . . . 0.41 111.034 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.743 ' HG3' ' O ' ' A' ' 129' ' ' MET . 52.1 mt-30 -58.72 -34.74 71.69 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.516 -1.22 . . . . 0.37 109.568 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.495 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -90.21 -28.94 18.53 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 113.942 -1.481 . . . . 0.24 109.733 -176.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.96 -45.06 0.69 Allowed Glycine 0 CA--C 1.494 -1.263 0 CA-C-O 122.534 1.075 . . . . 0.33 113.094 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 141' ' ' SER . 91.3 mt -66.93 -171.44 0.14 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 112.416 -1.892 . . . . 0.31 115.43 -170.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 63.1 m -115.55 152.9 47.64 Favored Pre-proline 0 N--CA 1.425 -1.684 0 CA-C-N 110.641 -2.982 . . . . 0.81 107.661 175.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.644 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 36.9 Cg_endo -66.26 0.44 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.49 2.127 . . . . 0.32 112.138 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.584 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.6 tt0 -118.65 -27.06 5.97 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.997 0.903 . . . . 1.25 110.418 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 141' ' ' SER . 15.0 t70 -57.87 -25.89 61.36 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-N 113.207 -1.815 . . . . 0.65 109.35 -173.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 21.3 m 73.52 168.95 0.31 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 112.668 -2.06 . . . . 0.6 109.186 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.996 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.5 mt -66.03 -40.12 90.75 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.24 1.019 . . . . 0.86 108.386 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 64.81 -9.18 0.45 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 112.95 -1.932 . . . . 0.31 114.332 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.56 124.64 6.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.065 -0.717 . . . . 0.24 109.065 -175.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.687 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.4 mmt180 -42.27 -45.31 4.14 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 118.072 0.396 . . . . 1.65 112.001 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.8 t -74.13 -25.77 59.95 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.601 0.715 . . . . 0.53 111.255 -174.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -73.64 -29.6 62.44 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.625 1.203 . . . . 1.31 108.421 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.996 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -76.27 -47.79 22.54 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 112.403 -2.18 . . . . 0.12 110.223 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.649 HG13 ' HE1' ' A' ' 179' ' ' MET . 42.1 mt -65.39 -41.52 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 112.794 -2.003 . . . . 0.11 109.865 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.59 -54.56 27.03 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 114.864 -1.062 . . . . 0.15 111.082 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.77 HG23 ' CB ' ' A' ' 130' ' ' ALA . 89.9 mt -66.85 -48.14 80.65 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 N-CA-C 112.5 0.556 . . . . 0.18 112.5 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.673 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.22 -41.01 71.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.939 0.399 . . . . 0.13 111.099 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.556 ' HD2' HG23 ' A' ' 149' ' ' ILE . 58.3 mtp180 -81.84 -21.51 37.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.614 0.721 . . . . 1.08 110.618 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.501 HD22 ' CB ' ' A' ' 130' ' ' ALA . 22.8 t30 -84.76 -11.44 55.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.314 -1.365 . . . . 0.5 107.314 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.721 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.07 -29.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-N 113.184 -1.826 . . . . 0.17 110.932 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.7 34.17 5.05 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.267 -0.968 . . . . 0.16 112.424 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.6 161.45 14.85 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.873 0.694 . . . . 0.12 112.873 -170.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.658 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.0 m80 -100.87 -27.72 13.17 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.24 -0.891 . . . . 0.2 109.796 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.622 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 7.5 m-85 -136.15 -174.26 3.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.187 -0.915 . . . . 0.13 111.318 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.711 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -137.06 139.2 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.939 -1.028 . . . . 0.08 108.883 166.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.607 HD21 ' SD ' ' A' ' 176' ' ' MET . 33.9 tp -107.98 100.57 9.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.318 -0.953 . . . . 0.16 109.351 165.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.574 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.2 m-85 -79.8 112.94 17.56 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 114.606 -1.179 . . . . 0.26 108.897 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.845 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 10.2 t -124.45 160.58 27.9 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 121.922 0.867 . . . . 1.05 110.564 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.817 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.4 p -162.73 172.96 14.47 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 114.334 -1.303 . . . . 0.1 111.076 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.32 135.33 40.7 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 114.005 -1.452 . . . . 0.11 108.633 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.668 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.8 m -144.09 -176.12 4.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.254 -0.647 . . . . 1.09 109.254 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.11 -84.08 0.92 Allowed Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 119.768 -1.206 . . . . 0.15 111.416 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.4 t30 -143.74 131.47 21.35 Favored 'General case' 0 C--O 1.196 -1.762 0 N-CA-C 107.821 -1.178 . . . . 0.59 107.821 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.615 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.6 p -65.57 -41.34 90.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.14 -0.936 . . . . 0.15 112.426 -171.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.404 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.3 m-20 -60.99 -31.15 70.77 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.732 0.777 . . . . 1.26 109.478 -177.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.23 89.07 3.37 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 113.874 -1.512 . . . . 0.13 108.16 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.86 ' HD2' HG22 ' A' ' 194' ' ' VAL . 42.6 Cg_endo -91.36 166.61 3.53 Favored 'Trans proline' 0 CA--C 1.494 -1.48 0 C-N-CA 124.551 3.501 . . . . 0.09 114.846 -170.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.58 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.3 m -85.76 119.6 26.26 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 113.745 -1.57 . . . . 0.14 107.551 166.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 164' ' ' SER . 50.4 tp -84.56 97.74 9.75 Favored 'General case' 0 N--CA 1.412 -2.326 0 C-N-CA 119.492 -0.883 . . . . 0.16 108.709 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.602 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 34.1 mt-30 -89.26 109.33 20.23 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 122.052 0.929 . . . . 0.34 109.053 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.845 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.7 OUTLIER -112.87 164.17 13.74 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.004 -0.998 . . . . 1.09 111.638 -173.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.609 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.0 tt0 -170.78 118.22 0.5 Allowed 'General case' 0 C--O 1.201 -1.476 0 CA-C-N 115.972 -0.558 . . . . 0.5 110.236 -166.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.104 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.19 101.99 13.16 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.609 -0.885 . . . . 0.1 108.609 -172.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.687 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.5 ttp -90.43 121.62 32.57 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.462 -0.79 . . . . 0.07 109.504 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.424 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.91 127.97 34.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.149 -1.426 . . . . 0.22 107.149 166.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -83.69 -34.18 10.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 118.912 -1.115 . . . . 0.11 110.965 178.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.462 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 28.7 mt-30 -61.6 -15.57 40.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.372 -0.831 . . . . 0.35 111.424 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.8 p -130.2 -36.61 1.5 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.745 0.783 . . . . 0.19 110.294 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.51 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 87.59 27.91 25.79 Favored Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 114.316 -1.311 . . . . 0.18 112.003 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.81 155.91 19.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.648 0.261 . . . . 0.73 110.52 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.609 HD12 ' HG2' ' A' ' 177' ' ' GLN . 30.3 mm -89.85 115.64 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.502 0.668 . . . . 0.14 109.494 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.104 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -103.1 -32.3 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.903 -1.044 . . . . 0.13 110.54 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.8 t90 -134.81 152.02 51.41 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.245 -0.889 . . . . 0.07 109.403 173.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 30.0 p -153.57 162.78 40.94 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.881 0.697 . . . . 0.13 112.881 164.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.51 -173.64 27.18 Favored Glycine 0 N--CA 1.427 -1.94 0 N-CA-C 110.721 -0.951 . . . . 0.12 110.721 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 15.1 mtmm -158.93 154.08 25.33 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.273 -2.121 . . . . 1.22 105.273 166.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -161.22 127.79 1.81 Allowed Glycine 0 C--N 1.281 -2.484 0 C-N-CA 119.245 -1.455 . . . . 0.12 112.568 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 173' ' ' THR . . . -72.55 112.6 8.75 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.72 0.771 . . . . 0.17 111.329 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.86 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -91.77 158.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-O 122.758 1.266 . . . . 0.11 110.816 -176.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.752 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.2 173.43 6.46 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 112.352 -2.203 . . . . 0.18 108.652 -173.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.1 tt0 -102.34 133.78 46.71 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.14 -0.624 . . . . 0.91 109.758 171.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.517 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 12.3 mm-40 . . . . . 0 C--N 1.315 -0.933 0 CA-C-O 118.804 -0.617 . . . . 1.24 110.906 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.718 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 3.5 m-30 . . . . . 0 N--CA 1.433 -1.284 0 N-CA-C 110.633 -0.136 . . . . 0.21 110.633 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.567 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 4.4 t0 -82.74 68.15 9.1 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 123.756 1.741 . . . . 0.35 108.404 171.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.773 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.4 m95 -59.75 -42.94 94.35 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 111.511 -2.586 . . . . 0.1 112.288 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.428 ' N ' HG21 ' A' ' 108' ' ' THR . 0.1 OUTLIER -52.77 -31.79 40.21 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.609 -1.632 . . . . 1.11 111.077 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.64 -15.88 78.69 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 121.781 0.656 . . . . 0.21 111.67 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -94.5 -48.55 6.06 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.18 -1.01 . . . . 0.13 110.15 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.721 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.4 mtt -66.43 -55.64 14.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.134 -1.394 . . . . 0.09 111.715 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.416 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 6.1 mm-40 -38.81 -56.01 2.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 115.233 1.568 . . . . 0.63 115.233 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.818 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 40.3 Cg_endo -65.37 -29.37 54.17 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 121.728 1.619 . . . . 0.14 110.418 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.648 ' HE2' ' N ' ' A' ' 192' ' ' GLY . 9.6 mtm -83.65 -40.23 19.23 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.312 -0.858 . . . . 0.7 111.446 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 68' ' ' MET . 52.4 t -57.46 -39.91 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-N 114.85 -1.068 . . . . 0.12 108.339 171.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -61.17 -32.76 72.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.238 -1.801 . . . . 0.56 111.19 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.818 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 34.2 mtpt -84.66 -32.2 23.76 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.086 0.47 . . . . 1.3 110.891 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.885 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.23 -29.77 69.51 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.332 -0.849 . . . . 0.5 111.413 -172.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.3 mt -92.07 -4.14 54.81 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 122.26 1.028 . . . . 0.65 110.644 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.23 17.64 40.38 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 108.984 -1.646 . . . . 0.17 108.984 170.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.625 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -88.04 161.8 17.16 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.693 -0.754 . . . . 0.1 110.282 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.94 107.92 18.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.384 -0.825 . . . . 1.72 109.432 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.664 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.58 -24.66 3.33 Favored Glycine 0 N--CA 1.415 -2.716 0 C-N-CA 119.739 -1.219 . . . . 0.12 110.466 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.885 HG11 ' O ' ' A' ' 75' ' ' MET . 11.1 p -102.66 152.32 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.675 -0.762 . . . . 0.16 111.068 -175.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.3 m -135.82 139.64 43.62 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.922 -1.036 . . . . 0.45 110.697 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.632 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.08 136.01 48.52 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.033 -0.985 . . . . 0.28 110.414 167.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.04 3.95 55.6 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.903 -0.665 . . . . 0.28 112.936 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.94 149.24 22.68 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.168 -0.613 . . . . 1.2 111.002 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -80.41 120.58 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 CA-C-O 121.933 0.873 . . . . 0.2 108.802 165.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.875 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.7 tm? -108.77 111.58 23.41 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.416 -0.811 . . . . 0.14 109.047 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.695 HD23 HG11 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -72.19 93.72 1.48 Allowed 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.833 -1.076 . . . . 0.15 108.158 177.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.481 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.2 m -73.5 115.79 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 107.061 -1.459 . . . . 0.95 107.061 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.768 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 16.7 t0 -77.57 170.62 16.25 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-N 115.063 -0.971 . . . . 0.64 108.905 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.567 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.8 OUTLIER -61.77 152.59 30.92 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.93 -1.137 . . . . 0.37 107.93 168.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.536 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 38.6 t -81.95 140.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.151 0 N-CA-C 107.024 -1.473 . . . . 0.1 107.024 167.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.831 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.7 t-20 -84.01 162.5 20.37 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.967 0.889 . . . . 0.18 110.307 174.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.757 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -124.81 85.9 2.48 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.229 -1.35 . . . . 0.12 108.087 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 14.1 mtp180 -108.74 -0.95 19.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.077 -1.42 . . . . 0.64 108.758 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 172' ' ' PRO . 30.2 p -53.21 -172.62 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.026 -1.897 . . . . 0.14 115.348 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 34.2 t30 -68.37 -13.54 62.35 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 112.637 -2.074 . . . . 0.48 110.522 173.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.549 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -148.16 -145.93 4.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.387 -0.911 . . . . 0.12 113.004 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.603 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 19.2 m -121.27 129.6 53.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.959 0.409 . . . . 1.16 110.825 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.757 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.6 pp -135.18 157.63 46.43 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.921 0.867 . . . . 0.1 110.627 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.57 81.46 7.64 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.954 -1.476 . . . . 0.17 107.713 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.619 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -69.72 -14.77 62.96 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 114.278 -1.328 . . . . 0.09 109.912 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.59 -29.8 46.32 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.734 -0.839 . . . . 0.15 108.734 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 15.6 tp10 -67.91 -32.39 72.82 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 123.123 1.44 . . . . 1.73 109.15 170.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.5 -44.75 61.82 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.999 -1.91 . . . . 0.12 109.233 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.9 m -63.92 -34.3 77.65 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.936 -1.484 . . . . 0.11 111.104 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 13.1 pt-20 -68.0 -42.83 80.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 118.368 -1.333 . . . . 1.47 107.651 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.654 HG21 ' HB2' ' A' ' 64' ' ' TRP . 58.7 m -61.5 -29.09 69.76 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.226 -0.897 . . . . 0.12 111.176 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.721 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.3 mt -53.69 -68.12 0.2 Allowed 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 115.794 -0.639 . . . . 0.56 109.471 170.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.581 ' O ' HD13 ' A' ' 121' ' ' LEU . 14.2 mtp180 -40.26 -38.08 0.73 Allowed 'General case' 0 C--N 1.31 -1.116 0 O-C-N 124.413 1.071 . . . . 1.51 111.395 174.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 108' ' ' THR . 16.1 m-80 -68.36 -47.41 67.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.675 -1.148 . . . . 0.28 112.4 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.93 -35.79 59.62 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.364 -0.976 . . . . 0.09 108.364 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -58.96 -35.67 73.55 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.61 -1.632 . . . . 0.12 109.784 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -69.46 -41.96 75.51 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.297 -1.32 . . . . 0.2 111.294 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.406 ' HB2' ' NE2' ' A' ' 69' ' ' GLN . 11.2 m-80 -65.21 -27.21 68.52 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.99 -1.005 . . . . 1.17 111.224 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.86 -16.73 35.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.967 -0.56 . . . . 2.05 111.237 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.91 -12.32 0.83 Allowed Glycine 0 C--N 1.334 0.427 0 N-CA-C 115.896 1.118 . . . . 0.54 115.896 162.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 54.4 mtpt -73.28 -33.47 65.25 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 117.579 0.689 . . . . 0.99 110.783 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.875 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 23.4 m-85 -90.4 177.43 6.39 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.54 1.162 . . . . 0.21 112.677 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 5.4 m -121.92 119.96 33.06 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 112.651 -2.068 . . . . 0.23 108.069 168.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.633 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -89.4 140.74 29.21 Favored 'General case' 0 N--CA 1.414 -2.235 0 C-N-CA 119.337 -0.945 . . . . 0.38 111.774 -169.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.536 HG21 HD23 ' A' ' 88' ' ' LEU . 1.5 m . . . . . 0 C--N 1.298 -1.659 0 N-CA-C 107.605 -1.258 . . . . 0.42 107.605 167.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.612 HD23 HD21 ' A' ' 88' ' ' LEU . 1.4 tm? . . . . . 0 C--O 1.223 -0.335 0 N-CA-C 112.572 0.582 . . . . 1.39 112.572 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.697 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.2 t -49.31 -39.05 29.79 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 123.573 1.654 . . . . 1.05 109.047 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.657 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 24.2 mmm -64.46 -62.07 1.82 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 110.72 -2.945 . . . . 1.64 110.656 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.753 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.28 -43.48 7.4 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 124.106 0.878 . . . . 0.31 112.326 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.815 ' HZ1' HD23 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -51.28 -55.5 17.92 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.293 -1.003 . . . . 1.53 108.293 176.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.3 mt-30 -65.33 -41.28 94.11 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 123.951 0.782 . . . . 0.41 111.42 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.657 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.3 mt-30 -56.26 -34.25 66.23 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.391 -1.277 . . . . 0.37 109.616 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -92.87 -31.19 15.06 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.905 -1.498 . . . . 0.24 109.561 -177.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.06 -52.13 0.4 Allowed Glycine 0 CA--C 1.497 -1.091 0 CA-C-O 122.594 1.108 . . . . 0.33 113.45 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 141' ' ' SER . 70.7 mt -63.51 -171.75 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 112.352 -1.924 . . . . 0.31 115.717 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 139' ' ' GLN . 6.3 m -116.14 152.29 47.62 Favored Pre-proline 0 N--CA 1.427 -1.621 0 CA-C-N 110.765 -2.925 . . . . 0.81 107.931 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.697 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 30.3 Cg_endo -65.44 2.67 1.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.751 2.301 . . . . 0.32 111.146 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.539 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.7 mm100 -115.17 -19.91 10.63 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 114.098 -1.41 . . . . 1.25 110.091 -174.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.694 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.7 t70 -80.63 -27.72 37.17 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 114.336 -1.302 . . . . 0.65 109.839 -169.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.721 ' O ' HD13 ' A' ' 136' ' ' LEU . 4.0 m 76.02 175.23 0.22 Allowed 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 125.33 1.644 . . . . 0.6 109.053 -168.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.998 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.5 mt -69.41 -39.13 78.11 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.368 1.08 . . . . 0.86 108.701 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.18 -12.03 0.29 Allowed Glycine 0 C--N 1.317 -0.488 0 CA-C-N 112.96 -1.927 . . . . 0.31 114.809 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.54 125.78 8.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 117.548 0.674 . . . . 0.24 109.324 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.4 mmt180 -41.45 -48.11 3.77 Favored 'General case' 0 C--O 1.213 -0.842 0 O-C-N 123.378 0.424 . . . . 1.65 111.868 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.5 t -72.05 -27.5 62.73 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.58 0.705 . . . . 0.53 111.296 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -73.06 -28.25 62.21 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.632 1.206 . . . . 1.31 108.587 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.998 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -77.49 -46.0 23.85 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 112.293 -2.23 . . . . 0.12 110.304 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.649 HG13 ' HE1' ' A' ' 179' ' ' MET . 35.4 mt -67.33 -42.43 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-N 113.069 -1.878 . . . . 0.11 110.237 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.47 -53.59 31.27 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.955 -1.021 . . . . 0.15 111.072 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.753 HG23 ' CB ' ' A' ' 130' ' ' ALA . 70.2 mt -66.32 -47.53 83.93 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 112.747 0.647 . . . . 0.18 112.747 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.01 -39.98 72.7 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.017 0.437 . . . . 0.13 110.767 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -81.56 -23.01 37.45 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.676 0.751 . . . . 1.08 110.635 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.46 HD21 ' CD ' ' A' ' 133' ' ' GLN . 19.1 t30 -82.18 -12.72 57.97 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.332 -1.358 . . . . 0.5 107.332 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.717 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.73 -28.53 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 113.245 -1.798 . . . . 0.17 110.838 -174.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.67 35.45 4.89 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.35 -0.929 . . . . 0.16 112.282 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.76 156.38 21.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 113.27 0.841 . . . . 0.12 113.27 -170.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.671 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.9 m80 -95.3 -27.87 15.26 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.194 -0.912 . . . . 0.2 109.807 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.557 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 9.2 m-85 -136.38 -179.1 5.47 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.476 -0.784 . . . . 0.13 111.049 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.697 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -131.97 140.75 47.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.438 -0.801 . . . . 0.08 109.232 167.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 38.2 tp -110.4 101.06 9.81 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.708 -0.797 . . . . 0.16 108.946 164.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.679 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.23 116.72 19.67 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.21 -1.359 . . . . 0.26 108.269 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.677 ' OG ' HD11 ' A' ' 174' ' ' LEU . 27.6 t -126.68 163.44 23.49 Favored 'General case' 0 C--N 1.279 -2.493 0 C-N-CA 119.495 -0.882 . . . . 1.05 111.015 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.848 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.9 p -164.23 178.27 7.7 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 114.264 -1.334 . . . . 0.1 111.065 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -141.91 141.34 32.99 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 114.155 -1.384 . . . . 0.11 108.673 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 t -149.44 -171.35 3.87 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.208 -0.597 . . . . 1.09 110.115 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.66 -80.69 1.25 Allowed Glycine 0 C--N 1.288 -2.138 0 CA-C-N 115.179 -0.919 . . . . 0.15 111.567 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 59.1 t30 -145.58 127.5 15.46 Favored 'General case' 0 C--O 1.195 -1.767 0 N-CA-C 108.108 -1.071 . . . . 0.59 108.108 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.549 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.4 p -61.76 -43.9 97.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.14 -0.936 . . . . 0.15 113.008 -172.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -61.48 -29.71 70.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.49 0.662 . . . . 1.26 109.635 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.44 88.16 3.73 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 114.588 -1.187 . . . . 0.13 108.021 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.818 ' HD2' HG22 ' A' ' 194' ' ' VAL . 51.3 Cg_endo -91.29 163.56 3.69 Favored 'Trans proline' 0 CA--C 1.49 -1.697 0 C-N-CA 124.596 3.531 . . . . 0.09 114.731 -170.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' ' 191' ' ' LYS . 18.8 m -81.77 117.17 21.86 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 113.854 -1.521 . . . . 0.14 107.693 166.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 164' ' ' SER . 38.8 tp -83.73 98.94 9.95 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-O 121.885 0.85 . . . . 0.16 109.126 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.647 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.0 mt-30 -89.09 107.81 19.25 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.909 -1.041 . . . . 0.34 109.048 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 34.7 mtp -108.25 162.84 13.71 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.848 -1.069 . . . . 1.09 110.203 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.618 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.8 tt0 -169.49 119.99 0.68 Allowed 'General case' 0 C--O 1.204 -1.315 0 CA-C-O 121.377 0.608 . . . . 0.5 109.908 -167.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.119 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.44 102.38 13.17 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.934 -0.765 . . . . 0.1 108.934 -172.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.704 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.1 ttp -92.48 122.91 35.38 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.533 -0.758 . . . . 0.07 109.402 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.435 HD22 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -58.83 127.46 32.29 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.161 -1.422 . . . . 0.22 107.161 166.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.2 -33.63 11.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 119.35 0.977 . . . . 0.11 110.718 178.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.424 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.9 mt-30 -64.25 -14.77 57.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.291 -0.868 . . . . 0.35 111.498 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 76.9 p -130.52 -36.96 1.41 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.766 0.794 . . . . 0.19 110.251 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.538 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.36 24.09 29.82 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.481 -1.236 . . . . 0.18 112.496 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.92 155.61 18.5 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.684 0.278 . . . . 0.73 110.682 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 177' ' ' GLN . 34.2 mm -87.95 119.25 35.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.433 0.635 . . . . 0.14 109.507 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.119 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -108.28 -30.56 2.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.966 -1.016 . . . . 0.13 110.536 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.625 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.1 t90 -135.38 151.83 50.84 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 115.206 -0.906 . . . . 0.07 109.351 171.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 57.0 p -154.06 161.85 41.62 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.768 0.655 . . . . 0.13 112.768 163.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -156.68 -178.91 31.25 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 110.68 -0.968 . . . . 0.12 110.68 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.741 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.7 mtmt -156.75 148.38 22.56 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.326 -1.731 . . . . 1.22 106.326 167.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.648 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -159.33 127.29 1.8 Allowed Glycine 0 C--N 1.282 -2.42 0 C-N-CA 119.907 -1.14 . . . . 0.12 112.542 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.83 113.05 9.43 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.543 0.687 . . . . 0.17 111.455 -173.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.818 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -88.38 159.18 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.518 1.151 . . . . 0.11 110.298 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.683 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -98.86 172.84 7.18 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 112.781 -2.009 . . . . 0.18 109.132 -172.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -102.85 127.65 49.95 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.873 -0.417 . . . . 0.91 109.873 169.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.544 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 17.9 mm-40 . . . . . 0 C--N 1.313 -1.017 0 CA-C-O 118.524 -0.75 . . . . 1.24 110.838 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.759 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.2 m-30 . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 109.565 -0.532 . . . . 0.21 109.565 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.556 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 5.0 t70 -80.91 67.0 6.65 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 123.707 1.718 . . . . 0.35 108.065 172.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.737 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 90.0 m95 -56.94 -44.45 82.53 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 111.591 -2.55 . . . . 0.1 112.389 175.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.449 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 10.2 t-20 -51.05 -30.72 16.46 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.832 -1.531 . . . . 1.11 111.687 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.81 -15.38 81.36 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-O 121.868 0.704 . . . . 0.21 111.469 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.86 -52.06 3.4 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.076 -1.062 . . . . 0.13 110.782 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.726 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.7 mtt -64.13 -58.06 7.73 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 114.127 -1.397 . . . . 0.09 111.952 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.463 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.8 mm-40 -39.52 -54.66 3.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 114.856 1.428 . . . . 0.63 114.856 -176.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.634 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.1 Cg_endo -64.45 -28.78 62.35 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.004 1.802 . . . . 0.14 110.667 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.849 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 6.4 mtm -82.4 -46.26 13.77 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 114.874 -1.057 . . . . 0.7 111.902 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 68' ' ' MET . 57.7 t -54.34 -40.29 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-N 114.031 -1.44 . . . . 0.12 108.633 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -59.28 -37.72 78.35 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.167 -1.833 . . . . 0.56 110.798 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.634 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 25.1 mtmt -77.08 -36.06 56.08 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 120.821 0.343 . . . . 1.3 111.649 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.811 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.0 -29.33 70.49 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.715 -0.675 . . . . 0.5 111.557 -170.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.632 HD22 ' HE2' ' A' ' 118' ' ' LYS . 5.2 mt -93.14 -6.78 47.14 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.102 0.953 . . . . 0.65 111.012 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.49 17.79 46.02 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.02 -1.632 . . . . 0.17 109.02 171.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.59 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -87.02 162.08 17.82 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.626 -0.787 . . . . 0.1 110.355 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.54 108.04 17.76 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.057 -0.974 . . . . 1.72 109.235 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.633 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 131.04 -21.2 4.67 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.699 -1.239 . . . . 0.12 110.955 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.811 HG11 ' O ' ' A' ' 75' ' ' MET . 14.8 p -101.75 152.78 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.77 -0.715 . . . . 0.16 110.887 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 83' ' ' ALA . 26.5 m -135.75 140.28 44.22 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.011 -0.995 . . . . 0.45 110.625 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.543 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -58.59 140.13 54.82 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.123 -0.944 . . . . 0.28 110.484 167.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.3 10.08 54.61 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.88 -0.676 . . . . 0.28 112.753 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.9 149.65 21.31 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 120.569 -0.452 . . . . 1.2 110.689 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.673 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.6 p -79.09 114.75 20.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-O 122.218 1.008 . . . . 0.2 109.304 164.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.672 ' HG ' ' CE2' ' A' ' 119' ' ' PHE . 2.6 tm? -102.9 106.99 17.66 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.965 -1.016 . . . . 0.14 109.065 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.666 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.7 OUTLIER -71.88 96.76 1.72 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 114.226 -1.352 . . . . 0.15 108.039 176.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.936 ' O ' HD11 ' A' ' 127' ' ' LEU . 1.1 m -71.66 118.06 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.158 -1.423 . . . . 0.95 107.158 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.852 ' HB2' HD11 ' A' ' 142' ' ' LEU . 1.1 t70 -76.65 146.1 38.37 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.656 -1.239 . . . . 0.64 107.656 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.574 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.1 m -50.97 132.38 27.2 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.582 -1.266 . . . . 0.37 107.582 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.524 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 22.7 t -60.66 138.35 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.959 0 N-CA-C 107.79 -1.189 . . . . 0.1 107.79 171.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.777 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.6 t-20 -83.51 162.03 21.04 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.202 -0.908 . . . . 0.18 109.589 174.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.746 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.99 86.01 2.49 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.54 -1.209 . . . . 0.12 107.861 175.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 9.7 mtp180 -108.61 -3.71 17.74 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.847 -1.524 . . . . 0.64 108.893 -172.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.6 p -49.99 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.067 -1.878 . . . . 0.14 114.36 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.5 OUTLIER -76.53 -3.8 39.37 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.309 -1.769 . . . . 0.48 110.36 174.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.614 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -146.54 -153.07 5.79 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.692 -0.685 . . . . 0.12 112.634 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.548 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 50.7 m -121.31 130.32 53.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 1.16 111.457 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.746 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.9 pp -134.01 157.44 46.08 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.824 0.821 . . . . 0.1 110.746 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.636 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -80.75 80.06 7.29 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.162 -1.381 . . . . 0.17 107.803 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.14 -15.0 63.44 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.481 -1.236 . . . . 0.09 110.167 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.64 -29.65 41.06 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.576 -0.898 . . . . 0.15 108.576 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.636 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 16.1 tp10 -67.67 -33.38 74.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.283 -1.326 . . . . 1.73 109.143 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.74 -43.5 62.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.24 -1.8 . . . . 0.12 109.505 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.64 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.3 m -63.41 -30.52 71.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.838 -1.528 . . . . 0.11 110.564 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 2.0 pt-20 -69.43 -42.97 74.3 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.849 -1.167 . . . . 1.47 107.849 173.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 64' ' ' TRP . 85.2 m -62.58 -29.96 70.97 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.241 -0.891 . . . . 0.12 110.465 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.726 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.5 mt -51.98 -70.27 0.09 Allowed 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 109.13 -0.693 . . . . 0.56 109.13 170.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 121' ' ' LEU . 19.0 mtp180 -40.21 -38.66 0.8 Allowed 'General case' 0 C--N 1.312 -1.032 0 O-C-N 124.465 1.103 . . . . 1.51 111.413 175.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.502 ' N ' HD22 ' A' ' 111' ' ' ASN . 1.0 OUTLIER -70.27 -46.07 65.09 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.754 -1.112 . . . . 0.28 112.244 -176.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.05 -33.06 65.46 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.2 1.0 . . . . 0.09 108.437 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.713 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -64.5 -33.88 76.92 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 113.413 -1.721 . . . . 0.12 110.194 173.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.522 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -70.49 -37.16 74.18 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.789 -1.096 . . . . 0.2 111.164 -175.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -57.48 -31.87 66.42 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.629 -1.169 . . . . 1.17 110.997 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.479 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -77.03 -36.12 56.39 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.681 -1.145 . . . . 2.05 110.211 -177.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.53 -4.56 8.92 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.313 -0.47 . . . . 0.54 113.93 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HE2' HD22 ' A' ' 76' ' ' LEU . 11.7 ptmt -83.93 -30.27 26.44 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 122.328 -0.513 . . . . 0.99 111.462 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.672 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 4.1 m-85 -89.39 168.74 11.98 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.708 0.766 . . . . 0.21 111.285 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.586 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.1 m -116.5 121.18 41.06 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 114.063 -1.426 . . . . 0.23 108.154 171.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.613 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -91.01 139.47 30.74 Favored 'General case' 0 N--CA 1.416 -2.151 0 C-N-CA 119.307 -0.957 . . . . 0.38 110.647 -171.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.562 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.9 m . . . . . 0 C--N 1.3 -1.576 0 N-CA-C 107.919 -1.141 . . . . 0.42 107.919 173.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.936 HD11 ' O ' ' A' ' 89' ' ' VAL . 6.2 tt . . . . . 0 CA--C 1.516 -0.353 0 N-CA-C 113.349 0.87 . . . . 1.39 113.349 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.598 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 15.4 m -57.16 -35.75 69.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 123.245 1.498 . . . . 1.05 108.786 -175.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.621 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -59.47 -60.34 4.01 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 111.811 -2.449 . . . . 1.64 112.205 173.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.763 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.95 -44.02 4.42 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 124.308 1.043 . . . . 0.31 112.23 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.541 ' HZ3' ' N ' ' A' ' 142' ' ' LEU . 3.4 mttt -52.59 -54.7 29.4 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.172 -0.677 . . . . 1.53 109.172 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -62.81 -41.75 99.43 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.398 -0.819 . . . . 0.41 111.0 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 129' ' ' MET . 47.6 mt-30 -57.06 -35.02 68.86 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 114.215 -1.357 . . . . 0.37 109.668 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.492 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.46 -30.39 16.49 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.95 -1.477 . . . . 0.24 109.738 -176.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.42 -46.57 0.56 Allowed Glycine 0 CA--C 1.494 -1.224 0 C-N-CA 119.845 -1.169 . . . . 0.33 113.569 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 141' ' ' SER . 98.3 mt -65.92 -169.64 0.07 Allowed 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 112.437 -1.882 . . . . 0.31 115.395 -170.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 6.7 m -114.76 149.32 42.17 Favored Pre-proline 0 N--CA 1.416 -2.153 0 CA-C-N 110.49 -3.05 . . . . 0.81 107.676 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 59.0 Cg_endo -66.28 0.57 3.21 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 122.774 2.316 . . . . 0.32 112.285 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -118.23 -26.52 6.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.825 0.821 . . . . 1.25 110.286 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.676 ' O ' ' HB2' ' A' ' 141' ' ' SER . 15.2 t70 -58.26 -23.45 56.16 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-N 113.346 -1.752 . . . . 0.65 109.168 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.676 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 20.8 m 76.05 171.23 0.25 Allowed 'General case' 0 N--CA 1.42 -1.933 0 O-C-N 125.817 1.948 . . . . 0.6 108.385 -173.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.912 HD22 ' HA ' ' A' ' 148' ' ' ALA . 6.9 mt -63.95 -39.06 93.29 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.724 -1.213 . . . . 0.86 107.724 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.25 -11.85 1.39 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 113.059 -1.882 . . . . 0.31 114.334 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 1.2 m -155.42 128.06 7.94 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.076 -0.713 . . . . 0.24 109.076 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.667 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.0 mmt180 -42.92 -46.87 5.54 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 117.995 0.361 . . . . 1.65 111.556 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.1 t -72.3 -26.21 61.87 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.511 0.672 . . . . 0.53 111.431 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 31.4 mttm -74.38 -32.17 62.63 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.661 1.219 . . . . 1.31 108.797 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.912 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -71.11 -46.43 61.7 Favored 'General case' 0 CA--C 1.483 -1.627 0 CA-C-N 112.299 -2.228 . . . . 0.12 109.976 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.648 HG13 ' HE1' ' A' ' 179' ' ' MET . 36.6 mt -67.22 -41.79 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-N 112.764 -2.016 . . . . 0.11 109.974 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.53 -54.39 30.43 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 114.769 -1.105 . . . . 0.15 111.297 171.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.763 HG23 ' CB ' ' A' ' 130' ' ' ALA . 79.1 mt -66.61 -47.77 82.38 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.029 0 N-CA-C 112.729 0.64 . . . . 0.18 112.729 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.634 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.76 -41.66 74.31 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.809 0.338 . . . . 0.13 110.9 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.474 ' HD2' HG23 ' A' ' 149' ' ' ILE . 26.8 mtp180 -79.97 -23.98 41.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.48 0.657 . . . . 1.08 110.53 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.476 HD21 ' CD ' ' A' ' 133' ' ' GLN . 17.6 t30 -80.0 -12.83 59.68 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.337 -1.357 . . . . 0.5 107.337 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.68 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.39 -29.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 113.018 -1.901 . . . . 0.17 110.79 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.82 34.21 5.28 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.586 -0.816 . . . . 0.16 112.632 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.06 161.24 14.92 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.031 0.752 . . . . 0.12 113.031 -169.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.673 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -100.31 -28.69 12.84 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.065 -0.97 . . . . 0.2 109.348 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.583 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.3 m-85 -136.89 -177.96 4.98 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.935 -1.03 . . . . 0.13 110.936 -175.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.718 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -133.65 140.24 47.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.077 -0.965 . . . . 0.08 108.823 167.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.627 HD21 ' SD ' ' A' ' 176' ' ' MET . 24.9 tp -110.46 99.05 8.12 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.333 -0.947 . . . . 0.16 109.725 166.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.784 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -78.75 112.59 16.03 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.893 -1.049 . . . . 0.26 109.143 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.865 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.3 t -123.69 163.24 21.49 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 121.875 0.845 . . . . 1.05 110.275 -177.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.831 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -163.87 176.28 9.62 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 114.397 -1.274 . . . . 0.1 111.33 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.57 132.52 29.39 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 113.844 -1.526 . . . . 0.11 108.531 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -142.34 -176.94 5.03 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.21 -0.596 . . . . 1.09 109.492 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.09 -81.82 0.88 Allowed Glycine 0 C--N 1.303 -1.258 0 C-N-CA 119.649 -1.262 . . . . 0.15 111.615 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.2 t30 -146.78 126.6 13.5 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 107.705 -1.221 . . . . 0.59 107.705 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.614 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.2 p -58.75 -44.09 89.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 114.502 -1.226 . . . . 0.15 112.723 -173.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -61.99 -29.91 70.58 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.776 0.798 . . . . 1.26 109.788 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.99 88.11 3.56 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 114.387 -1.279 . . . . 0.13 108.224 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.857 ' HD2' HG22 ' A' ' 194' ' ' VAL . 45.9 Cg_endo -90.06 165.54 4.74 Favored 'Trans proline' 0 CA--C 1.491 -1.631 0 C-N-CA 124.644 3.562 . . . . 0.09 114.412 -170.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.6 m -83.3 118.27 23.55 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.942 -1.481 . . . . 0.14 107.513 166.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.849 ' O ' ' HE1' ' A' ' 71' ' ' MET . 45.3 tp -83.76 99.51 10.32 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.367 -0.975 . . . . 0.16 108.367 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.624 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -91.34 109.02 20.29 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-O 122.09 0.948 . . . . 0.34 109.196 -176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.865 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.1 mmm -111.87 163.54 14.09 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.983 -1.008 . . . . 1.09 111.487 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.599 ' HG2' HD12 ' A' ' 186' ' ' ILE . 58.6 tt0 -171.15 116.91 0.44 Allowed 'General case' 0 C--O 1.203 -1.366 0 CA-C-N 116.019 -0.537 . . . . 0.5 110.404 -165.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.087 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -99.39 102.27 13.8 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.743 -0.836 . . . . 0.1 108.743 -172.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.667 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 17.2 ttp -91.62 121.88 33.68 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.07 109.534 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.6 128.04 35.04 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.159 -1.423 . . . . 0.22 107.159 166.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -83.09 -35.04 11.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 119.303 0.956 . . . . 0.11 110.747 178.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.4 mt-30 -61.45 -16.55 48.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.335 -0.848 . . . . 0.35 111.358 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.7 p -130.08 -37.34 1.48 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.794 0.807 . . . . 0.19 110.224 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.558 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.48 25.29 26.2 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 114.449 -1.25 . . . . 0.18 112.528 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.43 156.81 17.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.679 0.276 . . . . 0.73 110.672 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.599 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.3 mm -91.46 112.8 25.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.454 0.645 . . . . 0.14 109.679 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.087 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -101.11 -31.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.018 -0.992 . . . . 0.13 110.597 -173.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.653 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.6 t90 -134.06 152.62 51.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.359 -0.837 . . . . 0.07 109.752 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 51.8 p -153.8 164.17 38.79 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.399 0.888 . . . . 0.13 113.399 164.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.47 -177.06 33.23 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 110.876 -0.889 . . . . 0.12 110.876 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.1 mtmt -157.46 152.8 26.16 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.645 -1.983 . . . . 1.22 105.645 166.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -163.76 128.18 1.79 Allowed Glycine 0 C--N 1.281 -2.498 0 C-N-CA 119.749 -1.215 . . . . 0.12 112.477 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.64 118.76 14.87 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.298 0.571 . . . . 0.17 110.854 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.857 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -94.62 158.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.569 1.176 . . . . 0.11 110.621 -177.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -98.02 172.98 7.28 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 112.667 -2.061 . . . . 0.18 108.861 -173.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -102.45 130.97 49.4 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.501 -0.48 . . . . 0.91 109.962 170.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.514 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 15.4 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.844 -0.598 . . . . 1.24 110.744 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.744 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.9 m-30 . . . . . 0 N--CA 1.421 -1.899 0 N-CA-C 109.911 -0.403 . . . . 0.21 109.911 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 4.3 t70 -81.73 67.91 7.89 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 123.595 1.664 . . . . 0.35 108.292 171.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.707 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.0 m95 -58.29 -43.1 87.87 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 111.682 -2.508 . . . . 0.1 112.547 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.499 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 8.6 t-20 -51.82 -28.86 17.04 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.962 -1.472 . . . . 1.11 111.598 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.44 -17.6 80.12 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.137 -0.938 . . . . 0.21 111.104 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.1 -53.18 3.09 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.036 -1.082 . . . . 0.13 110.949 -176.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.703 ' SD ' HD23 ' A' ' 109' ' ' LEU . 42.2 mtt -64.24 -59.57 4.25 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.241 -1.345 . . . . 0.09 112.593 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.499 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -39.34 -54.66 3.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 114.624 1.342 . . . . 0.63 114.624 -175.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.802 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.0 Cg_endo -64.21 -28.84 64.49 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 121.788 1.658 . . . . 0.14 110.614 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.643 ' HE2' ' N ' ' A' ' 192' ' ' GLY . 11.8 mtm -84.99 -41.25 16.01 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.16 -0.927 . . . . 0.7 111.476 -177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 68' ' ' MET . 61.2 t -55.91 -39.96 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 CA-C-N 114.629 -1.169 . . . . 0.12 108.697 172.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.7 t -60.93 -32.27 71.78 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.32 -1.764 . . . . 0.56 111.085 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 16.6 mtpp -84.71 -33.48 23.13 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.147 0.498 . . . . 1.3 110.736 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.87 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -65.36 -27.91 68.91 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.169 -0.923 . . . . 0.5 111.334 -172.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.557 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.2 mt -92.92 -2.93 55.38 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.97 0.89 . . . . 0.65 110.917 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.79 15.36 37.61 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.236 -1.546 . . . . 0.17 109.236 170.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.27 165.0 17.69 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.679 -0.761 . . . . 0.1 110.276 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -91.08 104.49 17.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.22 -0.9 . . . . 1.72 110.046 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.635 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.77 -21.78 3.72 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.097 -0.956 . . . . 0.12 110.735 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.87 HG11 ' O ' ' A' ' 75' ' ' MET . 12.4 p -100.0 153.62 4.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.605 0.716 . . . . 0.16 111.002 -177.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -135.15 136.39 41.84 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 114.838 -1.074 . . . . 0.45 110.592 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.47 131.06 45.08 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.467 -0.788 . . . . 0.28 110.179 166.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.96 9.91 44.25 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.79 -0.719 . . . . 0.28 113.113 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.92 153.08 18.99 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 120.6 -0.44 . . . . 1.2 110.956 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.693 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -81.87 114.91 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 122.116 0.96 . . . . 0.2 109.128 166.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.756 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -102.1 108.97 20.55 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.024 -0.989 . . . . 0.14 109.264 -172.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.716 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -72.25 95.05 1.64 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 114.471 -1.24 . . . . 0.15 108.272 175.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.495 HG11 ' HG3' ' A' ' 110' ' ' ARG . 1.6 m -73.01 118.21 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 107.83 -1.174 . . . . 0.95 107.83 176.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.783 ' HB2' HD11 ' A' ' 142' ' ' LEU . 7.9 t0 -77.47 156.95 30.72 Favored 'General case' 0 CA--C 1.489 -1.397 0 CA-C-N 114.385 -1.28 . . . . 0.64 107.856 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.538 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -58.38 136.98 57.55 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 108.075 -1.083 . . . . 0.37 108.075 171.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.513 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.2 t -64.0 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.982 0 N-CA-C 107.778 -1.193 . . . . 0.1 107.778 167.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.818 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.8 t-20 -86.2 163.26 17.9 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.006 -0.997 . . . . 0.18 110.069 174.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.754 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.57 84.65 2.3 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.303 -1.317 . . . . 0.12 108.134 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.52 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 7.2 mtp180 -109.09 -1.04 19.12 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 113.783 -1.553 . . . . 0.64 108.627 -172.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.721 HG21 ' HB3' ' A' ' 172' ' ' PRO . 18.5 p -52.83 -171.97 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 112.73 -2.032 . . . . 0.14 115.034 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.1 t30 -71.3 -9.39 58.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.759 -2.019 . . . . 0.48 110.476 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.6 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.94 -146.33 4.32 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.472 -0.871 . . . . 0.12 112.903 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.588 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 54.8 p -121.87 131.02 53.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.245 0.461 . . . . 1.16 112.245 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.91 156.72 48.34 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.802 0.81 . . . . 0.1 110.629 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.656 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -79.79 79.6 6.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.978 -1.465 . . . . 0.17 107.742 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.571 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.35 -14.44 62.99 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.307 -1.315 . . . . 0.09 109.749 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.518 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.45 -31.38 37.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.747 -0.834 . . . . 0.15 108.747 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.656 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 4.8 tp10 -66.32 -34.37 77.83 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.392 -1.277 . . . . 1.73 108.933 171.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.56 -43.57 66.09 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.236 -1.802 . . . . 0.12 109.551 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 81.0 m -62.92 -30.61 71.68 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 113.776 -1.556 . . . . 0.11 110.162 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.6 -49.68 70.14 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.722 -0.844 . . . . 1.47 108.722 169.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.681 HG21 ' HB2' ' A' ' 64' ' ' TRP . 53.1 m -59.38 -31.08 68.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.43 -0.804 . . . . 0.12 110.789 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.703 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.6 mt -51.2 -69.22 0.12 Allowed 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 115.902 -0.59 . . . . 0.56 109.874 172.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.608 ' O ' HD13 ' A' ' 121' ' ' LEU . 4.9 mtp180 -41.85 -38.8 1.61 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.615 1.198 . . . . 1.51 110.886 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -68.56 -49.04 62.53 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.32 -1.763 . . . . 0.28 112.107 -176.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.93 -32.89 69.94 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.357 1.075 . . . . 0.09 108.446 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.825 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.4 mm? -64.14 -32.53 74.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.091 -1.868 . . . . 0.12 109.969 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.504 ' HA ' HD21 ' A' ' 121' ' ' LEU . . . -74.88 -38.53 61.88 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 114.749 -1.114 . . . . 0.2 111.802 -174.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -67.31 -23.29 65.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.518 -0.764 . . . . 1.17 111.449 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -89.27 -13.22 38.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 2.05 111.877 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.95 -12.05 0.59 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 115.936 1.135 . . . . 0.54 115.936 163.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.64 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 58.7 mtpt -75.81 -34.33 60.15 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 117.529 0.665 . . . . 0.99 111.116 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.756 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 13.9 m-85 -91.42 177.67 6.17 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.889 1.328 . . . . 0.21 113.823 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.55 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 12.7 m -125.02 114.17 18.75 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 112.244 -2.253 . . . . 0.23 107.818 167.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.825 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -99.13 128.02 45.18 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.712 -0.795 . . . . 0.38 112.216 -168.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.523 HG21 HD23 ' A' ' 88' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.306 -1.32 0 N-CA-C 108.068 -1.086 . . . . 0.42 108.068 173.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.756 HD21 ' HE3' ' A' ' 131' ' ' LYS . 2.0 tm? . . . . . 0 N--CA 1.456 -0.135 0 N-CA-C 113.331 0.863 . . . . 1.39 113.331 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.7 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.1 t -50.49 -39.4 48.29 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 123.648 1.689 . . . . 1.05 109.028 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.699 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -63.59 -63.18 1.25 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 110.644 -2.98 . . . . 1.64 110.688 178.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.754 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.31 -44.54 3.91 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 124.363 1.04 . . . . 0.31 111.646 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.756 ' HE3' HD21 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -49.47 -60.81 2.52 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 123.435 0.46 . . . . 1.53 110.044 176.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.9 mt-30 -58.79 -43.96 90.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.665 -1.152 . . . . 0.41 111.46 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.699 ' HG3' ' O ' ' A' ' 129' ' ' MET . 49.4 mt-30 -56.14 -34.83 66.49 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.779 -1.1 . . . . 0.37 109.895 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.4 OUTLIER -90.67 -30.98 16.8 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 113.89 -1.504 . . . . 0.24 109.487 -177.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.6 -50.69 0.44 Allowed Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 120.095 -1.05 . . . . 0.33 113.64 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 141' ' ' SER . 86.1 mt -64.13 -173.02 0.08 Allowed 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 115.841 1.793 . . . . 0.31 115.841 -169.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.8 m -110.5 150.29 41.45 Favored Pre-proline 0 N--CA 1.421 -1.907 0 CA-C-N 111.005 -2.816 . . . . 0.81 108.9 169.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.7 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 28.6 Cg_endo -64.13 1.12 1.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.003 2.469 . . . . 0.32 112.831 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.518 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -118.33 -22.96 7.43 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.123 0.963 . . . . 1.25 110.487 -178.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 141' ' ' SER . 10.6 t70 -63.61 -21.94 66.63 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 113.062 -1.881 . . . . 0.65 109.375 -174.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.64 ' O ' HD13 ' A' ' 136' ' ' LEU . 17.6 m 72.86 169.97 0.31 Allowed 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.42 -1.718 . . . . 0.6 109.517 -173.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.012 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.7 mt -64.44 -39.58 94.11 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 122.349 1.071 . . . . 0.86 108.268 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.97 -5.98 2.3 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 113.025 -1.898 . . . . 0.31 114.421 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 m -159.78 127.8 4.83 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.913 -0.773 . . . . 0.24 108.913 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.726 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.5 mmt180 -42.42 -47.94 5.08 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 118.182 0.446 . . . . 1.65 111.256 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.7 t -70.92 -25.79 62.92 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.503 0.668 . . . . 0.53 111.591 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 26.8 mttm -75.21 -30.36 60.58 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 122.626 1.203 . . . . 1.31 108.675 176.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 1.012 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -75.46 -46.57 31.73 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 112.472 -2.149 . . . . 0.12 110.288 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.614 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.5 mt -66.78 -41.71 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-N 112.811 -1.995 . . . . 0.11 110.004 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.11 -54.5 28.82 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.747 -1.115 . . . . 0.15 111.134 171.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.754 HG23 ' CB ' ' A' ' 130' ' ' ALA . 72.2 mt -66.2 -47.86 83.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 N-CA-C 112.831 0.678 . . . . 0.18 112.831 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.677 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.88 -40.36 72.85 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.926 0.393 . . . . 0.13 110.975 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.493 ' HD2' HG23 ' A' ' 149' ' ' ILE . 39.7 mtp180 -81.44 -22.67 38.01 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.745 0.783 . . . . 1.08 110.48 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.415 HD22 ' CB ' ' A' ' 130' ' ' ALA . 12.2 t30 -81.74 -12.04 58.76 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.199 -1.408 . . . . 0.5 107.199 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.698 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -107.4 -29.14 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 113.247 -1.797 . . . . 0.17 110.918 -174.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.44 35.84 4.81 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.313 -0.946 . . . . 0.16 112.483 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.716 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.59 159.16 17.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.131 0.789 . . . . 0.12 113.131 -169.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.693 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -98.0 -27.06 14.41 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.18 -0.918 . . . . 0.2 109.569 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.649 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 9.5 m-85 -136.65 -173.42 3.42 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.354 -0.839 . . . . 0.13 111.586 -174.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.696 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -137.76 138.43 44.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.803 -1.089 . . . . 0.08 109.145 166.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.569 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 34.7 tp -107.82 99.43 8.9 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.379 -0.928 . . . . 0.16 109.281 165.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.69 ' CE1' HD12 ' A' ' 142' ' ' LEU . 2.0 m-85 -78.78 111.99 15.47 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.56 -1.2 . . . . 0.26 108.743 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.729 ' OG ' HD11 ' A' ' 174' ' ' LEU . 26.8 t -123.6 159.22 29.72 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 121.776 0.798 . . . . 1.05 110.123 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.818 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.4 p -163.38 170.06 18.07 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-N 114.497 -1.229 . . . . 0.1 111.18 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -133.86 135.93 44.05 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.143 -1.39 . . . . 0.11 108.636 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.676 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -144.23 -176.96 5.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.192 -0.67 . . . . 1.09 109.192 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 96.08 -86.18 0.92 Allowed Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 119.628 -1.272 . . . . 0.15 111.006 174.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.9 t30 -143.75 127.76 17.47 Favored 'General case' 0 C--O 1.191 -1.982 0 N-CA-C 107.375 -1.343 . . . . 0.59 107.375 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.6 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.9 p -61.36 -49.71 83.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 114.061 -1.427 . . . . 0.15 112.916 -170.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.447 ' N ' HG13 ' A' ' 169' ' ' VAL . 89.8 m-20 -58.83 -26.83 64.52 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.222 0.534 . . . . 1.26 110.904 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.13 88.18 3.51 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 114.903 -1.044 . . . . 0.13 108.394 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.831 ' HD2' HG22 ' A' ' 194' ' ' VAL . 43.3 Cg_endo -91.44 167.26 3.44 Favored 'Trans proline' 0 CA--C 1.493 -1.55 0 C-N-CA 124.947 3.765 . . . . 0.09 114.854 -170.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.568 HG22 ' HB3' ' A' ' 191' ' ' LYS . 16.9 m -86.13 118.13 25.39 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 113.755 -1.566 . . . . 0.14 107.694 166.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 164' ' ' SER . 54.1 tp -84.46 97.89 9.78 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-O 121.988 0.899 . . . . 0.16 109.337 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.63 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 34.9 mt-30 -87.64 107.66 18.72 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 114.567 -1.197 . . . . 0.34 108.685 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.544 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 35.1 mtp -108.26 163.0 13.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.235 -0.893 . . . . 1.09 110.063 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.608 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.5 tt0 -169.91 117.85 0.58 Allowed 'General case' 0 C--O 1.202 -1.438 0 CA-C-O 121.256 0.551 . . . . 0.5 110.136 -167.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.1 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.34 101.76 12.83 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.818 -0.808 . . . . 0.1 108.818 -172.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.726 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.2 ttp -91.3 123.13 34.5 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.479 -0.782 . . . . 0.07 109.533 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.77 127.37 31.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.075 -1.454 . . . . 0.22 107.075 166.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.05 -35.8 13.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.192 -1.003 . . . . 0.11 110.645 178.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.438 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.5 mt-30 -61.72 -15.5 41.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.259 -0.882 . . . . 0.35 111.37 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p -130.08 -37.54 1.47 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.514 0.674 . . . . 0.19 110.127 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.512 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.15 26.13 24.66 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 114.631 -1.168 . . . . 0.18 112.429 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.23 156.76 17.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.605 0.24 . . . . 0.73 110.946 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.608 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.8 mm -91.25 110.59 22.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.792 0.806 . . . . 0.14 109.706 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.1 HD11 HD13 ' A' ' 178' ' ' LEU . 1.5 pp -98.11 -32.39 3.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.695 -1.139 . . . . 0.13 110.514 -173.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.636 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.6 t90 -135.49 151.78 50.7 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.383 -0.826 . . . . 0.07 109.541 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 33.0 p -153.84 163.17 40.48 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.742 0.645 . . . . 0.13 112.742 164.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.29 -178.41 32.29 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 110.841 -0.903 . . . . 0.12 110.841 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.743 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 16.3 mtmm -156.91 148.19 22.13 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.433 -1.692 . . . . 1.22 106.433 167.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.643 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -157.59 127.06 1.84 Allowed Glycine 0 C--N 1.283 -2.38 0 C-N-CA 119.682 -1.247 . . . . 0.12 112.293 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.94 116.05 12.98 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.413 0.625 . . . . 0.17 111.069 -174.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.831 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -93.39 159.46 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 122.604 1.192 . . . . 0.11 110.716 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.744 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -100.82 172.55 6.99 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.485 -2.143 . . . . 0.18 108.682 -174.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.1 tt0 -101.25 133.24 46.13 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 120.103 -0.639 . . . . 0.91 109.601 171.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.547 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 36.7 mm-40 . . . . . 0 C--N 1.313 -1.02 0 CA-C-O 118.467 -0.778 . . . . 1.24 110.257 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.762 ' OH ' ' HB3' ' A' ' 100' ' ' LEU . 1.2 m-30 . . . . . 0 N--CA 1.42 -1.94 0 N-CA-C 110.032 -0.358 . . . . 0.21 110.032 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.556 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 0.9 OUTLIER -81.73 67.46 7.71 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 123.578 1.656 . . . . 0.35 107.949 170.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.707 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.8 m95 -60.03 -44.11 94.86 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 111.994 -2.366 . . . . 0.1 112.256 174.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.549 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 12.0 t-20 -51.65 -27.12 10.52 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.163 -1.38 . . . . 1.11 111.269 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.15 -18.21 76.9 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.033 -0.985 . . . . 0.21 111.292 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.22 -53.9 2.91 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.026 -1.087 . . . . 0.13 111.157 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.711 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.5 mtt -63.06 -60.49 3.37 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 114.052 -1.431 . . . . 0.09 111.967 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.549 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.6 mm-40 -38.36 -54.09 2.87 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 114.984 1.476 . . . . 0.63 114.984 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.805 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 39.2 Cg_endo -66.16 -29.14 47.85 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.702 1.601 . . . . 0.14 110.57 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.727 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 15.6 mtm -84.48 -41.86 16.14 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.428 -0.806 . . . . 0.7 111.818 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 68' ' ' MET . 60.7 t -57.0 -37.45 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 114.578 -1.192 . . . . 0.12 108.471 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -63.16 -33.12 74.79 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.961 -1.927 . . . . 0.56 111.096 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.805 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.4 mtpt -83.42 -32.47 26.1 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.028 0.442 . . . . 1.3 110.632 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.846 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -66.03 -27.0 67.78 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.225 -0.898 . . . . 0.5 111.202 -173.05 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.647 HD13 ' HB2' ' A' ' 118' ' ' LYS . 5.9 mt -93.45 -7.29 44.9 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.951 0.882 . . . . 0.65 110.669 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.0 16.97 53.69 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 108.885 -1.686 . . . . 0.17 108.885 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.653 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -88.07 164.57 15.67 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.523 -0.838 . . . . 0.1 110.307 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -89.2 106.66 18.59 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.978 -1.01 . . . . 1.72 109.407 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.642 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.19 -23.7 3.65 Favored Glycine 0 N--CA 1.417 -2.626 0 C-N-CA 119.69 -1.243 . . . . 0.12 110.791 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.846 HG11 ' O ' ' A' ' 75' ' ' MET . 11.4 p -100.06 153.75 4.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.787 0.803 . . . . 0.16 111.875 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -135.14 137.91 43.23 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.48 -1.236 . . . . 0.45 110.639 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.667 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.35 130.78 48.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.462 -0.79 . . . . 0.28 110.335 167.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.91 -3.92 33.94 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.966 -0.635 . . . . 0.28 112.77 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.98 152.03 25.62 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 120.91 0.386 . . . . 1.2 111.122 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.655 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.7 p -80.67 117.84 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-O 121.978 0.894 . . . . 0.2 109.05 165.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.77 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.3 tm? -106.16 109.57 21.55 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.166 -0.925 . . . . 0.14 108.91 -172.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.683 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -71.92 96.12 1.65 Allowed 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.124 -1.398 . . . . 0.15 108.163 177.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.537 HG12 ' CD1' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -71.88 120.04 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 N-CA-C 106.878 -1.527 . . . . 0.95 106.878 177.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.777 ' HB2' HD11 ' A' ' 142' ' ' LEU . 10.5 t0 -77.71 155.58 31.19 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.08 -1.452 . . . . 0.64 107.08 177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.523 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.0 OUTLIER -59.2 136.95 58.12 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.584 -1.265 . . . . 0.37 107.584 171.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 21.7 t -63.15 139.04 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.831 0 N-CA-C 107.78 -1.193 . . . . 0.1 107.78 168.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.802 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -86.03 163.52 17.89 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.239 -0.891 . . . . 0.18 110.083 174.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.06 85.5 2.42 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.55 -1.204 . . . . 0.12 108.22 175.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.1 mtp180 -108.92 -0.24 19.79 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.027 -1.442 . . . . 0.64 108.746 -172.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 172' ' ' PRO . 21.7 p -52.18 -177.01 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.21 -1.814 . . . . 0.14 113.681 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.3 OUTLIER -73.92 -9.36 58.56 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.375 -1.738 . . . . 0.48 110.133 173.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.609 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -139.9 -151.63 5.69 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.852 -0.69 . . . . 0.12 112.846 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 65.7 p -122.03 130.62 53.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.512 0.56 . . . . 1.16 112.512 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.762 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 1.8 pp -136.2 156.9 48.01 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.009 0.909 . . . . 0.1 111.604 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.622 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.6 t-20 -80.9 79.77 7.5 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.817 -1.538 . . . . 0.17 107.867 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.52 -13.08 61.74 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.469 -1.242 . . . . 0.09 110.038 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.534 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.41 -32.72 37.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.643 -0.873 . . . . 0.15 108.643 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.622 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 6.1 tp10 -65.45 -33.81 76.82 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 122.804 1.288 . . . . 1.73 109.076 171.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.02 -44.08 63.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.928 -1.942 . . . . 0.12 109.51 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 61.4 m -63.65 -29.07 70.36 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.124 -1.398 . . . . 0.11 110.292 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.64 -52.37 52.39 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.185 -1.043 . . . . 1.47 108.185 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 64' ' ' TRP . 39.3 m -55.44 -33.93 64.03 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.671 -0.695 . . . . 0.12 111.144 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.711 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.0 mt -49.45 -69.22 0.12 Allowed 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 116.2 -0.455 . . . . 0.56 109.862 172.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.527 ' O ' HD13 ' A' ' 121' ' ' LEU . 13.9 mtp180 -43.31 -36.95 2.03 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.442 1.089 . . . . 1.51 110.82 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -70.83 -47.61 58.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.009 -1.451 . . . . 0.28 111.561 -175.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.485 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.36 -34.72 68.19 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 122.168 0.985 . . . . 0.09 108.631 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -62.34 -33.94 75.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.56 -1.655 . . . . 0.12 109.954 173.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -75.15 -42.33 56.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 114.717 -1.129 . . . . 0.2 111.053 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -63.63 -19.28 64.74 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.825 -1.08 . . . . 1.17 110.667 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.42 -19.43 18.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.567 -0.742 . . . . 2.05 111.565 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.04 14.19 10.26 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 115.357 0.903 . . . . 0.54 115.357 164.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 56.8 mtpt -98.42 -2.35 39.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.268 0.534 . . . . 0.99 109.913 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.77 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 34.8 m-85 -122.2 174.98 6.63 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.144 0.973 . . . . 0.21 112.674 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.564 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 5.4 m -118.08 121.14 39.82 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 112.935 -1.939 . . . . 0.23 107.742 170.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.662 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -92.31 139.47 30.58 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 119.164 -1.014 . . . . 0.38 111.837 -169.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.487 HG11 HD23 ' A' ' 88' ' ' LEU . 1.8 m . . . . . 0 C--N 1.3 -1.567 0 N-CA-C 108.047 -1.094 . . . . 0.42 108.047 170.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.629 HD13 HD21 ' A' ' 88' ' ' LEU . 31.7 tp . . . . . 0 C--O 1.218 -0.563 0 N-CA-C 113.253 0.834 . . . . 1.39 113.253 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.665 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 5.6 t -50.39 -46.56 56.18 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 123.275 1.512 . . . . 1.05 109.203 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.755 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -52.84 -63.75 1.04 Allowed 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 111.053 -2.794 . . . . 1.64 110.374 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.768 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.77 -46.15 10.38 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 124.574 1.171 . . . . 0.31 112.195 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.532 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -54.39 -51.83 63.61 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 108.835 -0.802 . . . . 1.53 108.835 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.3 mt-30 -65.75 -38.86 90.25 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.313 -0.858 . . . . 0.41 111.136 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.755 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.3 mt-30 -59.46 -33.84 71.8 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-N 114.486 -1.234 . . . . 0.37 109.678 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -91.43 -27.31 18.38 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.079 -1.418 . . . . 0.24 109.552 -177.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.78 -48.79 0.58 Allowed Glycine 0 CA--C 1.495 -1.16 0 CA-C-O 122.598 1.11 . . . . 0.33 113.259 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 141' ' ' SER . 96.6 mt -64.89 -171.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.102 -2.049 . . . . 0.31 115.716 -170.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.3 m -116.17 153.34 48.51 Favored Pre-proline 0 N--CA 1.428 -1.557 0 CA-C-N 110.705 -2.952 . . . . 0.81 107.932 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.665 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 37.1 Cg_endo -65.81 -0.37 3.81 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.611 2.207 . . . . 0.32 112.561 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.534 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 2.8 tt0 -118.41 -26.61 6.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.864 0.84 . . . . 1.25 110.704 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.1 t70 -56.86 -24.45 51.64 Favored 'General case' 0 CA--C 1.489 -1.366 0 CA-C-N 113.217 -1.81 . . . . 0.65 109.677 -173.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.597 ' O ' HD13 ' A' ' 136' ' ' LEU . 13.0 m 73.47 170.26 0.31 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 112.964 -1.926 . . . . 0.6 109.434 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.073 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.1 mt -69.19 -39.97 78.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.369 1.08 . . . . 0.86 108.609 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.56 -12.11 0.52 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 112.94 -1.936 . . . . 0.31 114.099 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.77 128.65 10.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.775 -0.631 . . . . 0.24 109.482 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.684 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 22.5 mmt-85 -42.82 -50.1 5.7 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 118.043 0.383 . . . . 1.65 111.36 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.5 t -69.32 -27.28 65.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.456 0.646 . . . . 0.53 111.365 -175.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 24.1 mttm -73.92 -27.63 61.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.666 1.222 . . . . 1.31 108.663 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 1.073 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -79.61 -46.75 16.66 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 112.351 -2.204 . . . . 0.12 110.586 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.652 HG13 ' HE1' ' A' ' 179' ' ' MET . 44.4 mt -65.78 -41.66 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 112.946 -1.934 . . . . 0.11 110.099 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.25 -52.37 40.94 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.743 -1.117 . . . . 0.15 111.243 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.768 HG23 ' CB ' ' A' ' 130' ' ' ALA . 89.1 mt -68.24 -48.43 73.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 N-CA-C 112.358 0.503 . . . . 0.18 112.358 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.683 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.0 -41.31 71.12 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.948 0.404 . . . . 0.13 111.218 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.545 ' HD2' HG23 ' A' ' 149' ' ' ILE . 45.8 mtp180 -80.4 -24.26 39.82 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.597 0.713 . . . . 1.08 110.506 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.471 HD21 ' CD ' ' A' ' 133' ' ' GLN . 39.2 t30 -80.89 -14.35 58.09 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 107.641 -1.244 . . . . 0.5 107.641 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.692 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -103.2 -28.64 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.188 -1.824 . . . . 0.17 110.629 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.443 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 98.5 35.03 5.08 Favored Glycine 0 CA--C 1.5 -0.886 0 C-N-CA 120.153 -1.023 . . . . 0.16 112.16 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.682 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.39 158.58 17.38 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.756 0.65 . . . . 0.12 112.756 -170.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.655 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.1 m80 -98.2 -28.52 13.67 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.144 -0.934 . . . . 0.2 109.392 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 6.2 m-85 -136.12 -174.89 3.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.089 -0.959 . . . . 0.13 111.235 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.694 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -135.67 140.23 44.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.091 -0.959 . . . . 0.08 108.71 166.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.533 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 37.6 tp -109.31 101.75 10.72 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.292 -0.963 . . . . 0.16 109.45 165.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.617 ' CE1' HD12 ' A' ' 142' ' ' LEU . 2.2 m-85 -79.11 113.87 17.6 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.405 -1.27 . . . . 0.26 108.673 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.711 ' OG ' HD11 ' A' ' 109' ' ' LEU . 4.2 p -121.33 157.73 29.77 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.444 -0.798 . . . . 1.05 109.791 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.802 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.7 p -164.62 173.24 12.17 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.985 -1.007 . . . . 0.1 111.202 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.49 136.82 41.56 Favored 'General case' 0 N--CA 1.412 -2.334 0 CA-C-N 114.156 -1.384 . . . . 0.11 108.795 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.676 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.7 t -146.06 -171.29 3.68 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.882 -0.727 . . . . 1.09 110.345 176.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.41 -78.0 1.51 Allowed Glycine 0 C--N 1.288 -2.099 0 CA-C-N 115.283 -0.871 . . . . 0.15 111.713 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.2 t30 -148.85 131.56 15.97 Favored 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 107.62 -1.252 . . . . 0.59 107.62 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.609 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.7 p -64.38 -41.8 93.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.102 -0.953 . . . . 0.15 112.863 -172.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 5.2 m-20 -63.91 -28.85 70.11 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.293 1.045 . . . . 1.26 109.338 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.5 88.41 3.68 Favored Pre-proline 0 C--N 1.304 -1.374 0 CA-C-N 114.279 -1.328 . . . . 0.13 108.456 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.806 ' HD2' HG22 ' A' ' 194' ' ' VAL . 41.3 Cg_endo -92.0 166.25 3.15 Favored 'Trans proline' 0 CA--C 1.495 -1.447 0 C-N-CA 124.341 3.361 . . . . 0.09 114.612 -171.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.605 HG22 ' HB3' ' A' ' 191' ' ' LYS . 49.2 m -85.02 118.8 24.81 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 113.793 -1.549 . . . . 0.14 107.888 166.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 164' ' ' SER . 43.9 tp -84.11 96.72 9.01 Favored 'General case' 0 N--CA 1.414 -2.239 0 C-N-CA 119.26 -0.976 . . . . 0.16 108.66 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.678 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 31.9 mt-30 -85.83 108.94 18.35 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 114.638 -1.165 . . . . 0.34 108.558 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.591 ' SD ' ' HB3' ' A' ' 163' ' ' SER . 2.9 mmm -112.06 163.52 14.19 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.655 -1.157 . . . . 1.09 111.047 -174.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.645 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.4 tt0 -171.48 118.75 0.45 Allowed 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 115.917 -0.583 . . . . 0.5 109.949 -167.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.054 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.74 99.35 9.87 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.524 -0.917 . . . . 0.1 108.524 -173.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.684 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.9 ttp -88.35 118.47 28.0 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.462 -0.79 . . . . 0.07 109.22 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.527 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.17 115.65 4.31 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.067 -1.457 . . . . 0.22 107.067 169.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -71.28 -36.21 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.063 0.847 . . . . 0.11 111.348 -176.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.457 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 32.2 mt-30 -58.78 -15.53 12.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.525 -0.761 . . . . 0.35 111.897 -177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 39.8 p -128.97 -37.28 1.72 Allowed 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.076 0.941 . . . . 0.19 110.02 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.522 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.28 23.79 36.28 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 113.663 -1.608 . . . . 0.18 111.793 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -104.4 154.29 20.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.893 0.377 . . . . 0.73 110.423 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.645 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.1 mm -87.6 116.19 29.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.53 0.681 . . . . 0.14 109.358 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.054 HD11 HD13 ' A' ' 178' ' ' LEU . 1.7 pp -103.49 -31.34 2.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.93 -1.032 . . . . 0.13 110.476 -173.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.656 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 79.0 t90 -135.16 153.41 51.99 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.325 -0.852 . . . . 0.07 109.314 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 77.8 p -153.73 164.0 39.05 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.085 -0.646 . . . . 0.13 112.697 163.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.61 -177.53 32.78 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.573 -1.011 . . . . 0.12 110.573 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.748 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 18.7 mtmm -157.98 148.2 20.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.488 -2.042 . . . . 1.22 105.488 166.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -155.65 126.89 1.92 Allowed Glycine 0 C--N 1.282 -2.445 0 C-N-CA 119.405 -1.379 . . . . 0.12 112.306 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.14 110.88 8.79 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.579 0.704 . . . . 0.17 111.094 -173.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.806 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -89.91 157.73 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.583 -1.189 . . . . 0.11 110.581 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.717 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -97.83 172.77 7.45 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 112.612 -2.085 . . . . 0.18 108.982 -175.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 1.9 tt0 -107.48 132.38 53.28 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.933 -1.107 . . . . 0.91 110.79 171.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.552 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 35.9 mm-40 . . . . . 0 C--O 1.247 0.957 0 CA-C-N 114.811 -1.086 . . . . 1.24 110.948 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.732 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 . . . . . 0 N--CA 1.42 -1.944 0 N-CA-C 109.914 -0.402 . . . . 0.21 109.914 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 10.9 t70 -84.05 67.35 9.64 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 123.492 1.615 . . . . 0.35 108.125 170.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.75 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 91.1 m95 -58.96 -43.91 91.38 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 111.678 -2.51 . . . . 0.1 112.437 175.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.514 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 11.8 t-20 -50.56 -28.59 8.93 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.879 -1.51 . . . . 1.11 111.415 174.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.08 -17.78 79.81 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.341 -0.845 . . . . 0.21 111.215 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.62 -54.31 2.78 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.863 -1.168 . . . . 0.13 111.125 -175.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.72 ' SD ' HD23 ' A' ' 109' ' ' LEU . 40.1 mtt -62.59 -59.5 4.85 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 114.177 -1.374 . . . . 0.09 112.105 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.514 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 6.2 mm-40 -37.33 -55.31 1.86 Allowed Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 115.276 1.584 . . . . 0.63 115.276 -177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.796 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.3 Cg_endo -65.73 -29.74 50.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.648 1.565 . . . . 0.14 110.458 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.691 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 13.0 mtm -83.91 -41.43 17.4 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 115.447 -0.797 . . . . 0.7 111.541 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 68' ' ' MET . 58.8 t -55.97 -39.1 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 CA-C-N 114.718 -1.128 . . . . 0.12 108.812 171.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.2 t -61.74 -34.35 75.68 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.393 -1.73 . . . . 0.56 110.813 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.796 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.2 mtpt -81.67 -33.93 31.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.073 -0.512 . . . . 1.3 110.464 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.867 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.72 -28.67 69.74 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.406 -0.815 . . . . 0.5 111.637 -171.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.561 ' N ' ' HG2' ' A' ' 75' ' ' MET . 5.5 mt -92.81 -4.84 52.31 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.081 0.943 . . . . 0.65 111.133 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.68 15.9 44.65 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 108.914 -1.674 . . . . 0.17 108.914 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.647 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.47 165.62 17.0 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.386 -0.907 . . . . 0.1 109.869 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -92.97 104.91 17.09 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.277 -0.874 . . . . 1.72 110.303 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.654 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.82 -23.72 3.36 Favored Glycine 0 N--CA 1.428 -1.886 0 CA-C-N 115.018 -0.992 . . . . 0.12 110.69 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.867 HG11 ' O ' ' A' ' 75' ' ' MET . 9.9 p -98.76 155.46 3.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.748 0.785 . . . . 0.16 111.444 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.8 m -134.54 135.75 42.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.604 -1.18 . . . . 0.45 111.034 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.575 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -60.23 129.31 41.07 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.222 -0.899 . . . . 0.28 109.728 165.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.32 6.0 53.8 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.78 -0.724 . . . . 0.28 112.938 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.493 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 65.7 m -98.12 146.93 25.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 120.719 -0.392 . . . . 1.2 110.51 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.692 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -76.8 132.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.029 -0.73 . . . . 0.2 109.029 172.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.811 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.6 tm? -119.12 110.01 16.56 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.603 -0.726 . . . . 0.14 109.084 -170.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.756 HD21 HD23 ' A' ' 127' ' ' LEU . 0.7 OUTLIER -71.77 93.99 1.34 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.815 -1.18 . . . . 0.15 107.815 175.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -73.23 115.29 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.435 -1.32 . . . . 0.95 107.435 176.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.817 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 12.3 t0 -77.74 170.92 15.76 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 114.997 -1.001 . . . . 0.64 109.009 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.584 ' OG ' ' HE3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -62.48 152.92 33.16 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 122.42 1.105 . . . . 0.37 108.668 168.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.561 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 33.9 t -81.64 139.31 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.067 0 N-CA-C 106.985 -1.487 . . . . 0.1 106.985 166.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.836 ' H ' ' HA ' ' A' ' 164' ' ' SER . 8.0 t-20 -83.65 163.35 20.37 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.922 0.867 . . . . 0.18 110.498 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.762 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.2 t-20 -125.71 86.27 2.51 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.208 -1.36 . . . . 0.12 108.124 175.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.412 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.6 mtp180 -108.72 -2.03 18.94 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.124 -1.398 . . . . 0.64 108.724 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.741 HG21 ' HB3' ' A' ' 172' ' ' PRO . 27.5 p -52.18 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 112.998 -1.91 . . . . 0.14 115.39 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.517 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 35.4 t30 -69.9 -9.71 55.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 112.762 -2.017 . . . . 0.48 110.492 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.601 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -153.27 -144.77 3.99 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.519 -0.848 . . . . 0.12 113.123 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.608 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 86.7 p -121.81 129.89 52.98 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.444 0.64 . . . . 1.16 112.725 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.762 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.4 pp -135.52 156.51 48.78 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.923 0.868 . . . . 0.1 110.852 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.635 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -80.95 79.44 7.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.961 -1.472 . . . . 0.17 107.889 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.73 -14.28 62.81 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.433 -1.258 . . . . 0.09 109.96 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.5 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.73 -30.48 36.25 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.555 -0.906 . . . . 0.15 108.555 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.635 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.4 tp10 -66.21 -35.11 79.59 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.378 -1.283 . . . . 1.73 109.153 170.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.82 -43.86 67.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.107 -1.861 . . . . 0.12 109.369 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.657 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 63.0 m -61.77 -31.84 72.07 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 113.532 -1.667 . . . . 0.11 110.135 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.73 -46.77 77.64 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.843 -0.799 . . . . 1.47 108.843 171.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.69 HG21 ' HB2' ' A' ' 64' ' ' TRP . 50.9 m -60.19 -31.04 69.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.345 -0.843 . . . . 0.12 110.91 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.72 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -51.96 -68.15 0.19 Allowed 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.749 -0.66 . . . . 0.56 110.361 172.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.528 ' O ' HD13 ' A' ' 121' ' ' LEU . 6.1 mpt_? -40.55 -37.36 0.7 Allowed 'General case' 0 C--O 1.213 -0.844 0 O-C-N 124.387 1.054 . . . . 1.51 110.456 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.589 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -72.49 -46.8 53.07 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.304 -1.316 . . . . 0.28 111.79 -174.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.439 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.21 -33.51 65.41 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.069 0.938 . . . . 0.09 108.718 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.69 -34.62 78.27 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.746 -1.57 . . . . 0.12 109.886 172.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.554 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.99 -40.51 65.17 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.696 -1.138 . . . . 0.2 111.096 -176.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -61.89 -25.53 67.62 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.854 -1.067 . . . . 1.17 110.69 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -92.52 -20.24 21.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.003 -0.544 . . . . 2.05 111.467 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.9 0.78 4.38 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 115.693 1.037 . . . . 0.54 115.693 162.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.575 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 53.0 mtpt -78.84 -33.99 45.52 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 117.395 0.598 . . . . 0.99 109.812 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 19.0 m-85 -89.44 177.81 6.48 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-O 122.23 1.014 . . . . 0.21 112.298 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.485 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.4 m -122.41 119.28 30.56 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 113.103 -1.862 . . . . 0.23 108.31 167.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.676 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -86.92 145.43 26.55 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.448 -0.796 . . . . 0.38 111.317 -170.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.556 HG11 HD23 ' A' ' 88' ' ' LEU . 1.9 m . . . . . 0 C--N 1.298 -1.633 0 CA-C-N 115.364 -0.835 . . . . 0.42 109.175 169.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.892 HD21 ' HE2' ' A' ' 131' ' ' LYS . 1.5 tm? . . . . . 0 C--O 1.225 -0.234 0 N-CA-C 113.205 0.817 . . . . 1.39 113.205 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.673 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.3 t -49.54 -38.39 30.68 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 123.645 1.688 . . . . 1.05 109.189 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.667 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 33.7 mmm -64.02 -63.08 1.25 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 110.705 -2.952 . . . . 1.64 111.191 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.748 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.26 -43.49 3.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 124.31 1.006 . . . . 0.31 111.442 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.892 ' HE2' HD21 ' A' ' 127' ' ' LEU . 3.7 mptp? -48.38 -65.57 0.54 Allowed 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.541 -0.541 . . . . 1.53 109.541 174.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.1 mt-30 -55.2 -44.61 75.52 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.828 -1.078 . . . . 0.41 111.71 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.0 mt-30 -55.67 -36.0 66.62 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 114.745 -1.116 . . . . 0.37 110.022 -177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -91.18 -31.34 16.23 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.118 -1.401 . . . . 0.24 109.285 -176.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.33 -48.32 0.43 Allowed Glycine 0 CA--C 1.496 -1.136 0 C-N-CA 119.801 -1.19 . . . . 0.33 113.632 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.665 HD13 ' O ' ' A' ' 141' ' ' SER . 35.4 mt -66.24 -174.2 0.25 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 123.923 1.82 . . . . 0.31 115.781 -168.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.6 m -110.03 148.64 38.7 Favored Pre-proline 0 N--CA 1.421 -1.924 0 CA-C-N 110.791 -2.913 . . . . 0.81 108.33 169.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.673 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 17.9 Cg_endo -61.38 0.4 1.03 Allowed 'Trans proline' 0 C--N 1.333 -0.255 0 C-N-CA 123.163 2.575 . . . . 0.32 112.801 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.5 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.7 tt0 -117.9 -24.11 7.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.185 0.993 . . . . 1.25 110.424 -177.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.624 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.8 t70 -64.61 -22.56 67.0 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 113.213 -1.812 . . . . 0.65 109.719 -174.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.665 ' O ' HD13 ' A' ' 136' ' ' LEU . 2.0 m 74.83 173.24 0.27 Allowed 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 125.322 1.639 . . . . 0.6 109.652 -173.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.085 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.3 mt -64.72 -38.85 92.38 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.281 -1.007 . . . . 0.86 108.281 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.38 -11.82 1.48 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 113.327 -1.76 . . . . 0.31 114.417 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 0.8 OUTLIER -157.19 130.22 7.73 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 118.672 -0.68 . . . . 0.24 109.276 -178.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.63 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.1 mmt85 -43.29 -48.68 6.8 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 118.008 0.367 . . . . 1.65 111.554 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 16.6 t -72.13 -24.93 61.54 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.531 0.681 . . . . 0.53 111.202 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.413 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 25.3 mttm -74.6 -30.68 61.76 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.66 1.219 . . . . 1.31 108.773 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 1.085 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -74.82 -46.2 38.2 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-N 112.411 -2.177 . . . . 0.12 110.236 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.639 HG13 ' HE1' ' A' ' 179' ' ' MET . 38.8 mt -67.53 -41.96 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 112.633 -2.076 . . . . 0.11 109.821 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.48 -53.85 30.06 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.71 -1.132 . . . . 0.15 111.012 171.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.748 HG23 ' CB ' ' A' ' 130' ' ' ALA . 76.2 mt -66.96 -47.85 81.18 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 N-CA-C 112.641 0.608 . . . . 0.18 112.641 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.672 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.29 -39.95 73.53 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.984 0.421 . . . . 0.13 111.02 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.536 ' HD2' HG23 ' A' ' 149' ' ' ILE . 45.5 mtp180 -82.59 -21.8 35.05 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.827 0.822 . . . . 1.08 110.343 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.416 HD21 ' CD ' ' A' ' 133' ' ' GLN . 14.7 t30 -82.82 -11.27 58.38 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.267 -1.382 . . . . 0.5 107.267 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.721 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.15 -29.66 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-N 113.143 -1.844 . . . . 0.17 111.111 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.23 35.88 4.32 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.414 -0.898 . . . . 0.16 112.767 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.637 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.19 157.98 19.45 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.192 0.812 . . . . 0.12 113.192 -170.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.692 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.9 m80 -97.32 -25.97 15.06 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.27 -0.877 . . . . 0.2 109.861 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.653 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 15.4 m-85 -136.12 -178.32 5.1 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.312 -0.858 . . . . 0.13 111.584 -174.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.673 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -133.37 141.53 44.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.1 -0.955 . . . . 0.08 109.202 167.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 46.7 tp -111.43 102.26 10.64 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.628 -0.829 . . . . 0.16 109.255 164.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.681 ' CE1' HD12 ' A' ' 142' ' ' LEU . 1.8 m-85 -80.21 112.64 17.72 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.241 -1.345 . . . . 0.26 109.198 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.692 ' OG ' HD11 ' A' ' 109' ' ' LEU . 3.8 p -119.15 158.12 26.57 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.959 0.885 . . . . 1.05 111.489 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.836 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.4 p -164.22 171.64 14.69 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-N 114.251 -1.341 . . . . 0.1 111.255 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.14 134.91 33.49 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 114.118 -1.401 . . . . 0.11 108.658 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.9 m -144.74 -173.79 4.16 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.295 -0.631 . . . . 1.09 109.295 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.54 -82.43 0.94 Allowed Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.616 -1.278 . . . . 0.15 111.279 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.517 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 59.8 t30 -145.78 129.16 16.86 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 107.653 -1.24 . . . . 0.59 107.653 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.601 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.3 p -65.03 -42.51 94.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.447 -0.797 . . . . 0.15 112.552 -171.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.424 ' N ' HG13 ' A' ' 169' ' ' VAL . 7.4 m120 -60.66 -30.28 69.8 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.784 0.802 . . . . 1.26 110.087 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.01 89.26 3.41 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 113.645 -1.616 . . . . 0.13 108.557 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.817 ' HD2' HG22 ' A' ' 194' ' ' VAL . 43.1 Cg_endo -91.85 165.53 3.27 Favored 'Trans proline' 0 CA--C 1.496 -1.402 0 C-N-CA 124.678 3.586 . . . . 0.09 115.301 -170.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.5 m -84.11 116.96 23.15 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 113.88 -1.509 . . . . 0.14 107.83 166.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.813 HD12 ' O ' ' A' ' 164' ' ' SER . 43.9 tp -84.22 98.12 9.78 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.988 0.899 . . . . 0.16 109.25 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.635 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 35.4 mt-30 -87.11 108.32 18.84 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 114.586 -1.188 . . . . 0.34 108.925 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.554 ' HG3' ' HG ' ' A' ' 174' ' ' LEU . 76.6 mtp -107.29 162.63 13.72 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.827 -1.079 . . . . 1.09 110.357 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.592 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.4 tt0 -169.71 119.54 0.65 Allowed 'General case' 0 C--O 1.202 -1.411 0 CA-C-O 121.309 0.576 . . . . 0.5 109.904 -169.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.124 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.11 101.98 12.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.001 -0.74 . . . . 0.1 109.001 -172.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.639 ' HE1' HG13 ' A' ' 149' ' ' ILE . 12.7 ttp -92.47 121.98 34.46 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.557 -0.747 . . . . 0.07 109.407 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.3 128.44 37.0 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.285 -1.376 . . . . 0.22 107.285 166.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.625 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -84.66 -34.09 9.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 119.096 -1.042 . . . . 0.11 110.738 178.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.467 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 27.3 mt-30 -61.2 -16.31 43.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.371 -0.832 . . . . 0.35 111.388 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.7 p -130.53 -37.49 1.38 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.505 0.669 . . . . 0.19 110.247 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.516 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.95 24.59 27.0 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.641 -1.163 . . . . 0.18 112.479 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 179' ' ' MET . 10.4 pt-20 -103.81 157.78 16.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.654 -0.273 . . . . 0.73 110.863 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.592 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.3 mm -93.04 114.19 29.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.574 0.702 . . . . 0.14 109.375 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.124 HD11 HD13 ' A' ' 178' ' ' LEU . 1.3 pp -102.38 -30.75 2.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.996 -1.002 . . . . 0.13 110.816 -174.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.647 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.3 t90 -135.43 152.11 51.07 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.274 -0.876 . . . . 0.07 109.547 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 61.9 p -153.71 164.21 38.7 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.915 0.709 . . . . 0.13 112.915 163.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.18 -178.69 32.44 Favored Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 110.927 -0.869 . . . . 0.12 110.927 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.734 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 12.0 mtmt -157.05 148.02 21.76 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.207 -1.775 . . . . 1.22 106.207 166.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.691 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -159.29 127.51 1.85 Allowed Glycine 0 C--N 1.28 -2.529 0 C-N-CA 119.769 -1.205 . . . . 0.12 112.343 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.82 114.79 11.35 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.659 0.742 . . . . 0.17 111.108 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.817 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -90.6 158.96 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 122.718 1.247 . . . . 0.11 110.476 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -101.43 172.08 7.19 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.399 -2.182 . . . . 0.18 108.445 -175.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.3 tt0 -101.26 135.79 42.15 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.201 -0.6 . . . . 0.91 109.633 172.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.566 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 23.0 mt-30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.424 -0.798 . . . . 1.24 110.927 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.758 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.4 m-30 . . . . . 0 N--CA 1.42 -1.931 0 N-CA-C 109.73 -0.47 . . . . 0.21 109.73 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.507 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 1.7 t70 -80.68 67.92 6.72 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 123.593 1.663 . . . . 0.35 107.95 171.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.71 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 90.9 m95 -59.51 -44.5 93.12 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 111.643 -2.526 . . . . 0.1 112.497 175.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.526 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 10.3 t-20 -51.92 -28.99 18.24 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.055 -1.43 . . . . 1.11 111.281 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.19 -16.91 80.35 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.326 -0.852 . . . . 0.21 111.144 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.31 -52.78 3.17 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.109 -1.046 . . . . 0.13 111.008 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.676 ' SD ' HD23 ' A' ' 109' ' ' LEU . 43.3 mtt -62.36 -60.32 3.73 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 114.213 -1.358 . . . . 0.09 112.179 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.526 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 6.2 mm-40 -38.76 -53.19 3.47 Favored Pre-proline 0 C--O 1.225 -0.211 0 N-CA-C 115.554 1.687 . . . . 0.63 115.554 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.538 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 49.8 Cg_endo -66.98 -25.91 44.14 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.784 1.656 . . . . 0.14 110.746 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.632 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 12.4 mtm -88.05 -43.26 11.84 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.956 -1.02 . . . . 0.7 111.978 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 68' ' ' MET . 65.6 t -53.63 -40.43 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 CA-C-N 114.439 -1.255 . . . . 0.12 108.71 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.4 t -57.29 -39.6 76.05 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.005 -1.907 . . . . 0.56 110.954 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 25.4 mtmt -77.49 -31.79 53.86 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.024 0.379 . . . . 1.3 112.024 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.871 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -65.26 -26.68 68.2 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.545 -0.752 . . . . 0.5 111.559 -169.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 118' ' ' LYS . 4.6 mt -94.48 -5.52 45.96 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 122.052 0.93 . . . . 0.65 111.157 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.43 15.18 50.33 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 109.004 -1.638 . . . . 0.17 109.004 170.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.63 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.74 165.54 17.74 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.426 -0.887 . . . . 0.1 110.235 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -91.4 103.33 15.97 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.06 -0.973 . . . . 1.72 110.601 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.628 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.96 -21.97 3.48 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.56 -1.016 . . . . 0.12 110.56 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.871 HG11 ' O ' ' A' ' 75' ' ' MET . 11.9 p -101.36 152.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.746 0.784 . . . . 0.16 110.993 -176.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.3 m -135.93 141.0 44.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.724 -1.125 . . . . 0.45 110.653 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.727 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -57.2 129.46 41.87 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.122 -0.944 . . . . 0.28 110.838 168.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.52 14.16 24.41 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.101 -0.571 . . . . 0.28 112.943 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.21 152.42 18.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.515 -0.474 . . . . 1.2 110.941 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.7 p -81.32 115.2 23.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.981 0.896 . . . . 0.2 109.081 166.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.704 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -102.77 109.11 20.58 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.236 -0.893 . . . . 0.14 109.099 -172.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.687 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.61 96.38 1.55 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.21 -1.359 . . . . 0.15 108.318 176.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -71.8 121.16 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 106.852 -1.536 . . . . 0.95 106.852 177.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.816 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 9.5 t0 -77.54 156.5 30.91 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.268 -1.382 . . . . 0.64 107.268 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.534 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.57 138.04 57.83 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.061 -1.459 . . . . 0.37 107.061 171.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.543 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.8 t -64.49 137.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.073 0 N-CA-C 107.658 -1.238 . . . . 0.1 107.658 168.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.781 ' H ' ' HA ' ' A' ' 164' ' ' SER . 5.1 t-20 -83.97 161.33 20.81 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.234 -0.894 . . . . 0.18 109.614 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.77 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 1.9 t-20 -124.52 85.13 2.37 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.675 -1.148 . . . . 0.12 108.083 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.543 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.8 mtp180 -108.6 -1.96 19.17 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 113.756 -1.565 . . . . 0.64 108.502 -172.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 172' ' ' PRO . 18.1 p -52.94 -172.77 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.044 -1.889 . . . . 0.14 115.074 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 167' ' ' GLY . 58.8 t30 -71.59 -5.19 31.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.643 -2.072 . . . . 0.48 110.828 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.596 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -156.38 -143.95 3.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.671 -0.776 . . . . 0.12 112.807 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.548 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 55.6 p -122.19 130.56 53.32 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.178 0.436 . . . . 1.16 112.178 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.77 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.2 pp -136.22 157.37 46.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.858 0.837 . . . . 0.1 110.863 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.15 79.44 7.81 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.85 -1.523 . . . . 0.17 107.631 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.33 -14.07 62.73 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.511 -1.222 . . . . 0.09 109.915 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.549 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.66 -32.74 41.6 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.672 -0.862 . . . . 0.15 108.672 -178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.9 tp10 -65.94 -33.27 75.45 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 122.767 1.27 . . . . 1.73 108.943 171.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.46 -43.92 63.06 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 113.078 -1.874 . . . . 0.12 109.5 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.629 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 67.1 m -64.01 -31.43 72.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.115 -1.402 . . . . 0.11 110.476 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -42.69 81.2 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.895 -1.15 . . . . 1.47 107.895 172.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.677 HG21 ' HB2' ' A' ' 64' ' ' TRP . 30.1 m -63.34 -31.36 72.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.994 -1.003 . . . . 0.12 110.816 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.702 ' O ' HD23 ' A' ' 113' ' ' LEU . 9.4 mt -50.88 -69.83 0.1 Allowed 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 115.691 -0.686 . . . . 0.56 109.518 171.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.542 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.2 mtp180 -40.71 -39.4 1.08 Allowed 'General case' 0 C--N 1.314 -0.942 0 O-C-N 124.539 1.15 . . . . 1.51 111.122 175.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.532 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -69.7 -45.43 68.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.604 -1.18 . . . . 0.28 111.948 -176.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.499 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.95 -32.91 63.69 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.289 1.043 . . . . 0.09 108.605 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -65.71 -32.1 73.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.608 -1.633 . . . . 0.12 110.26 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.592 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -73.58 -40.68 63.7 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 114.671 -1.149 . . . . 0.2 111.489 -174.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -59.92 -27.96 67.2 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.562 -1.199 . . . . 1.17 110.755 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -82.16 -35.51 28.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.54 -1.209 . . . . 2.05 110.554 -174.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.28 0.64 30.6 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 114.626 0.61 . . . . 0.54 114.626 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.771 ' HB2' HD13 ' A' ' 76' ' ' LEU . 58.5 mtpt -86.92 -8.12 57.55 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.935 -0.744 . . . . 0.99 110.814 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.73 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 29.5 m-85 -119.09 175.37 5.81 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 122.159 0.98 . . . . 0.21 112.497 171.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.512 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.5 m -119.7 123.73 44.52 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 112.987 -1.915 . . . . 0.23 107.862 169.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.604 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -93.02 138.47 31.46 Favored 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 119.43 -0.908 . . . . 0.38 111.651 -170.158 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.518 HG21 HD23 ' A' ' 88' ' ' LEU . 1.7 m . . . . . 0 C--N 1.299 -1.629 0 N-CA-C 107.333 -1.358 . . . . 0.42 107.333 169.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.612 HD13 HD21 ' A' ' 88' ' ' LEU . 30.8 tp . . . . . 0 C--O 1.221 -0.439 0 N-CA-C 113.34 0.867 . . . . 1.39 113.34 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.667 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 4.3 t -49.97 -46.1 52.16 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 123.336 1.541 . . . . 1.05 109.289 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.716 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 52.0 mmm -55.4 -61.66 2.19 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 111.125 -2.761 . . . . 1.64 110.64 175.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.769 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.79 -45.57 10.12 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 124.382 1.051 . . . . 0.31 112.472 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.552 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -55.14 -51.36 66.71 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 107.963 -1.125 . . . . 1.53 107.963 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 128' ' ' SER . 40.2 mt-30 -64.56 -40.87 96.36 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.047 -0.979 . . . . 0.41 111.325 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.716 ' HG3' ' O ' ' A' ' 129' ' ' MET . 49.5 mt-30 -58.3 -34.21 70.3 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 114.429 -1.26 . . . . 0.37 109.383 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.514 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.14 -26.92 18.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.764 -1.562 . . . . 0.24 109.381 -177.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.44 -52.05 0.52 Allowed Glycine 0 CA--C 1.497 -1.041 0 CA-C-O 122.677 1.154 . . . . 0.33 113.039 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 141' ' ' SER . 77.7 mt -62.65 -171.15 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 111.761 -2.22 . . . . 0.31 116.046 -171.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.5 m -117.21 153.21 49.8 Favored Pre-proline 0 N--CA 1.428 -1.551 0 CA-C-N 110.929 -2.851 . . . . 0.81 108.307 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.667 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 24.5 Cg_endo -63.14 -2.07 3.48 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.026 2.484 . . . . 0.32 112.676 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.549 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.6 tt0 -118.15 -27.67 6.02 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.781 0.8 . . . . 1.25 110.463 -177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.2 t70 -60.54 -23.83 64.89 Favored 'General case' 0 CA--C 1.487 -1.442 0 CA-C-N 113.604 -1.635 . . . . 0.65 109.483 -174.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.62 ' O ' HD13 ' A' ' 136' ' ' LEU . 17.8 m 74.8 169.49 0.29 Allowed 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 112.785 -2.007 . . . . 0.6 110.455 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.831 HD22 ' HA ' ' A' ' 148' ' ' ALA . 6.7 mt -64.4 -40.25 95.42 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.336 1.065 . . . . 0.86 108.477 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 64.49 -11.13 0.25 Allowed Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 112.978 -1.919 . . . . 0.31 114.666 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 142' ' ' LEU . 1.5 m -152.86 125.53 8.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.081 -0.711 . . . . 0.24 109.081 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.735 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 12.3 mmt180 -41.66 -45.95 3.57 Favored 'General case' 0 C--O 1.213 -0.84 0 O-C-N 123.279 0.362 . . . . 1.65 111.792 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.9 t -73.43 -25.59 60.58 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.628 0.728 . . . . 0.53 111.505 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 29.7 mttm -75.0 -32.05 61.55 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.744 1.259 . . . . 1.31 108.684 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.831 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -71.32 -46.99 59.33 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-N 112.217 -2.265 . . . . 0.12 110.044 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.622 HG13 ' HE1' ' A' ' 179' ' ' MET . 38.2 mt -67.07 -40.86 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 CA-C-N 112.678 -2.056 . . . . 0.11 109.839 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.08 -56.3 19.68 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 114.737 -1.119 . . . . 0.15 111.129 171.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.769 HG23 ' CB ' ' A' ' 130' ' ' ALA . 85.3 mt -65.43 -47.98 84.78 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 N-CA-C 112.733 0.642 . . . . 0.18 112.733 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.684 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.23 -40.49 74.19 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.845 0.355 . . . . 0.13 111.14 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.518 ' HD2' HG23 ' A' ' 149' ' ' ILE . 61.6 mtp180 -81.92 -21.75 37.16 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.695 0.759 . . . . 1.08 110.533 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.481 HD21 ' CD ' ' A' ' 133' ' ' GLN . 17.8 t30 -84.06 -11.12 57.22 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.323 -1.362 . . . . 0.5 107.323 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.719 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -107.08 -29.11 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 113.143 -1.844 . . . . 0.17 110.917 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.59 34.2 5.34 Favored Glycine 0 CA--C 1.504 -0.602 0 C-N-CA 120.403 -0.904 . . . . 0.16 112.553 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.687 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.34 161.83 14.45 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.637 0.606 . . . . 0.12 112.637 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.67 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.2 m80 -99.82 -28.16 13.27 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.561 -0.745 . . . . 0.2 109.586 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.573 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.7 m-85 -136.67 -172.9 3.28 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.223 -0.899 . . . . 0.13 111.141 -174.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.678 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -137.44 139.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.835 -1.075 . . . . 0.08 108.645 166.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.537 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 29.4 tp -108.35 100.56 9.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.584 -0.846 . . . . 0.16 109.329 165.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.665 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -79.25 112.56 16.59 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.831 -1.077 . . . . 0.26 108.723 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.727 ' OG ' HD11 ' A' ' 174' ' ' LEU . 23.3 t -124.86 159.75 30.37 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-O 121.828 0.823 . . . . 1.05 110.052 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.826 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.5 p -163.75 173.03 13.34 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 114.505 -1.225 . . . . 0.1 111.154 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.73 134.33 37.03 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 114.071 -1.422 . . . . 0.11 108.477 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -143.9 -176.72 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.373 -0.602 . . . . 1.09 109.373 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 95.16 -82.68 0.88 Allowed Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 119.389 -1.386 . . . . 0.15 111.856 172.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.44 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.4 t30 -143.07 123.82 14.18 Favored 'General case' 0 C--O 1.195 -1.782 0 N-CA-C 107.125 -1.435 . . . . 0.59 107.125 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.596 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.1 p -63.04 -44.59 99.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 112.944 0.72 . . . . 0.15 112.944 -172.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.44 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.1 m120 -61.28 -27.93 68.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 118.59 0.632 . . . . 1.26 109.891 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.4 88.74 3.35 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 114.855 -1.066 . . . . 0.13 108.436 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.816 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.8 Cg_endo -91.48 166.37 3.47 Favored 'Trans proline' 0 CA--C 1.492 -1.585 0 C-N-CA 124.996 3.797 . . . . 0.09 115.183 -169.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.601 HG22 ' HB3' ' A' ' 191' ' ' LYS . 12.7 m -84.58 117.35 23.67 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.689 -1.596 . . . . 0.14 107.672 167.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 164' ' ' SER . 48.2 tp -84.39 98.19 9.9 Favored 'General case' 0 N--CA 1.412 -2.326 0 C-N-CA 119.589 -0.844 . . . . 0.16 109.183 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.664 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.8 mt-30 -88.06 107.87 18.96 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 114.665 -1.152 . . . . 0.34 109.092 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 36.0 mtp -108.15 162.06 14.41 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.012 -0.995 . . . . 1.09 110.266 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.595 ' HG2' HD12 ' A' ' 186' ' ' ILE . 55.5 tt0 -169.72 117.59 0.6 Allowed 'General case' 0 C--O 1.205 -1.275 0 CA-C-O 121.308 0.575 . . . . 0.5 109.927 -168.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.04 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -99.84 101.41 12.53 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.695 -0.854 . . . . 0.1 108.695 -170.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.735 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 16.9 ttp -91.39 122.63 34.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.373 -0.83 . . . . 0.07 109.625 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -59.14 127.57 32.83 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.201 -1.407 . . . . 0.22 107.201 166.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -82.18 -34.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 119.065 -1.054 . . . . 0.11 110.865 178.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.437 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.4 mt-30 -62.54 -14.43 42.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.446 -0.797 . . . . 0.35 111.592 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 79.3 p -130.65 -36.41 1.41 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.862 0.839 . . . . 0.19 110.416 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.541 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 87.9 27.6 25.92 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.397 -1.274 . . . . 0.18 112.313 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -106.77 155.93 19.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.624 -0.288 . . . . 0.73 110.624 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.595 HD12 ' HG2' ' A' ' 177' ' ' GLN . 33.1 mm -89.01 120.09 37.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.665 0.745 . . . . 0.14 109.375 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.04 HD11 HD13 ' A' ' 178' ' ' LEU . 1.3 pp -108.18 -30.33 2.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.904 -1.043 . . . . 0.13 110.422 -173.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.63 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.2 t90 -136.96 152.89 50.69 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.177 -0.92 . . . . 0.07 109.385 172.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.499 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 62.1 p -153.53 164.49 38.14 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.938 0.718 . . . . 0.13 112.938 164.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.71 179.84 35.01 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.671 -0.971 . . . . 0.12 110.671 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.6 mtmt -156.91 147.45 21.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.181 -1.785 . . . . 1.22 106.181 168.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.632 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -157.64 127.38 1.9 Allowed Glycine 0 C--N 1.283 -2.399 0 C-N-CA 119.674 -1.25 . . . . 0.12 112.43 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.65 110.96 9.37 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.787 0.803 . . . . 0.17 111.503 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.816 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -88.53 159.5 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 122.797 1.284 . . . . 0.11 110.9 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.758 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -99.73 173.03 6.9 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 112.254 -2.248 . . . . 0.18 108.895 -174.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.3 tt0 -104.34 133.52 49.1 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.936 -0.705 . . . . 0.91 110.107 173.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.553 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 14.4 mm-40 . . . . . 0 C--N 1.313 -1.004 0 CA-C-O 118.551 -0.737 . . . . 1.24 110.617 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.718 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.2 m-30 . . . . . 0 N--CA 1.428 -1.571 0 CA-C-O 120.308 0.099 . . . . 0.21 110.878 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.491 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 23.4 t70 -87.11 67.02 9.58 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 123.401 1.572 . . . . 0.35 108.399 172.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.781 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.9 m95 -54.25 -43.58 71.05 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.089 -2.323 . . . . 0.1 112.997 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.47 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 8.6 t-20 -50.15 -30.56 11.51 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.806 -1.543 . . . . 1.11 111.743 177.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.48 -16.41 80.64 Favored Glycine 0 CA--C 1.501 -0.801 0 N-CA-C 111.358 -0.697 . . . . 0.21 111.358 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.73 -49.77 4.26 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.118 -1.041 . . . . 0.13 110.736 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.732 ' O ' HG23 ' A' ' 72' ' ' VAL . 39.0 mtt -66.56 -57.65 6.83 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.089 -1.414 . . . . 0.09 111.94 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.47 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 7.0 mm-40 -38.75 -54.96 2.88 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 114.958 1.466 . . . . 0.63 114.958 -177.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.82 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 31.9 Cg_endo -63.46 -30.77 72.09 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 121.908 1.739 . . . . 0.14 110.45 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.744 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 7.6 mtm -81.59 -45.63 15.57 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 115.123 -0.944 . . . . 0.7 111.851 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 68' ' ' MET . 46.8 t -56.54 -39.86 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-N 114.217 -1.356 . . . . 0.12 108.751 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -59.39 -34.39 72.37 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.064 -1.88 . . . . 0.56 111.052 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.82 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 17.2 mtpp -83.41 -33.86 25.64 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.069 0.461 . . . . 1.3 110.912 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.83 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.81 -26.35 68.31 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.291 -0.868 . . . . 0.5 111.295 -173.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.676 HD13 ' HB2' ' A' ' 118' ' ' LYS . 6.4 mt -94.11 -6.35 45.19 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.205 1.002 . . . . 0.65 110.788 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.64 16.05 52.19 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 108.934 -1.666 . . . . 0.17 108.934 170.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.653 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -86.36 165.7 16.18 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.598 -0.801 . . . . 0.1 109.925 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -92.87 105.52 17.63 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.255 -0.884 . . . . 1.72 110.195 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.637 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.05 -22.48 3.59 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 115.138 -0.937 . . . . 0.12 111.051 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.83 HG11 ' O ' ' A' ' 75' ' ' MET . 9.9 p -99.53 154.77 4.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.519 0.676 . . . . 0.16 111.617 -174.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.6 m -135.0 135.01 41.05 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.692 -1.14 . . . . 0.45 110.897 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.601 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -60.59 121.41 12.12 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.394 -0.821 . . . . 0.28 110.66 168.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.1 4.6 23.96 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.979 -0.629 . . . . 0.28 112.55 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.3 152.46 21.93 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.804 -0.359 . . . . 1.2 110.526 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.5 p -80.02 120.71 31.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.819 0.819 . . . . 0.2 108.906 165.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.77 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -109.36 107.7 17.98 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.821 0.82 . . . . 0.14 109.154 -172.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.668 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -72.11 97.35 1.91 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.228 -1.351 . . . . 0.15 107.679 174.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.837 ' O ' HD11 ' A' ' 127' ' ' LEU . 1.2 m -70.88 125.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 105.82 -1.919 . . . . 0.95 105.82 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.879 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 10.0 t0 -78.26 157.7 29.16 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.401 -1.333 . . . . 0.64 107.401 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.641 ' OG ' ' HE3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -57.7 135.39 56.75 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 106.842 -1.54 . . . . 0.37 106.842 170.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.567 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 28.3 t -64.9 139.68 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.951 0 N-CA-C 107.777 -1.194 . . . . 0.1 107.777 169.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.798 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.5 t-20 -84.11 162.45 20.28 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.016 -0.993 . . . . 0.18 109.778 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.36 85.02 2.35 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.683 -1.144 . . . . 0.12 108.004 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.467 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.2 mtp180 -107.09 -3.16 20.25 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 113.9 -1.5 . . . . 0.64 108.653 -172.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.748 HG21 ' HB3' ' A' ' 172' ' ' PRO . 28.6 p -50.57 -175.36 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.24 -1.8 . . . . 0.14 114.271 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.4 OUTLIER -72.3 -8.56 55.54 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.206 -1.816 . . . . 0.48 110.599 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.595 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -146.47 -148.91 4.87 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.751 -0.738 . . . . 0.12 112.843 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.635 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.3 p -121.45 130.3 53.49 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.329 0.492 . . . . 1.16 112.329 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.758 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -135.16 157.81 45.97 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.954 0.883 . . . . 0.1 111.028 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.704 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -77.74 80.4 4.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.579 -1.646 . . . . 0.17 107.86 175.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -69.41 -15.43 63.29 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.873 -1.058 . . . . 0.09 109.77 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.57 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.84 -29.19 40.07 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.609 -0.886 . . . . 0.15 108.609 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.704 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 20.9 tt0 -63.61 -39.71 95.07 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.054 -1.43 . . . . 1.73 109.32 168.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -68.48 -44.64 74.33 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.005 -1.907 . . . . 0.12 108.928 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 51.1 m -64.88 -31.44 72.68 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 113.946 -1.479 . . . . 0.11 110.61 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -44.79 78.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.695 -1.224 . . . . 1.47 107.695 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.686 HG21 ' HB2' ' A' ' 64' ' ' TRP . 40.1 m -64.01 -31.7 72.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.173 -0.921 . . . . 0.12 110.945 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.707 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.7 mt -49.86 -69.7 0.11 Allowed 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.277 -0.638 . . . . 0.56 109.277 171.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.548 ' O ' HD13 ' A' ' 121' ' ' LEU . 16.4 mtp180 -41.05 -39.75 1.29 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.508 1.13 . . . . 1.51 111.394 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.534 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -68.89 -45.97 69.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.65 -1.159 . . . . 0.28 112.012 -176.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.99 66.94 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.467 -0.938 . . . . 0.09 108.467 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.69 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -59.58 -34.4 72.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.715 -1.584 . . . . 0.12 110.131 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.53 -39.11 67.8 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 114.662 -1.154 . . . . 0.2 110.717 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.426 ' HB2' ' NE2' ' A' ' 69' ' ' GLN . 1.0 OUTLIER -64.69 -24.58 67.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.709 -1.132 . . . . 1.17 110.832 -176.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -89.55 -25.18 21.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.648 -0.705 . . . . 2.05 110.576 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 58.29 27.98 61.14 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.743 -0.662 . . . . 0.54 114.147 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HB2' HD13 ' A' ' 76' ' ' LEU . 58.2 mtpt -110.87 -1.35 16.53 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.61 -0.515 . . . . 0.99 109.61 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.77 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 40.1 m-85 -124.44 173.6 8.33 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.085 0.945 . . . . 0.21 112.571 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.553 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.2 m -116.62 120.78 39.75 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 113.206 -1.815 . . . . 0.23 107.532 169.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -89.85 146.23 24.58 Favored 'General case' 0 N--CA 1.415 -2.203 0 C-N-CA 119.344 -0.943 . . . . 0.38 111.223 -170.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.535 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.6 m . . . . . 0 C--N 1.303 -1.455 0 N-CA-C 107.765 -1.198 . . . . 0.42 107.765 170.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.837 HD11 ' O ' ' A' ' 89' ' ' VAL . 5.8 tt . . . . . 0 CA--C 1.519 -0.223 0 N-CA-C 113.284 0.846 . . . . 1.39 113.284 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.639 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.0 OUTLIER -53.17 -42.9 66.64 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 123.618 1.675 . . . . 1.05 109.208 -178.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.71 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 6.3 mmt -55.29 -62.85 1.4 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 110.942 -2.845 . . . . 1.64 111.13 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.758 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.27 -44.4 5.37 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.106 0.879 . . . . 0.31 111.833 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.641 ' HE3' ' OG ' ' A' ' 91' ' ' SER . 4.0 mptp? -49.28 -65.02 0.64 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.287 -0.634 . . . . 1.53 109.287 175.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.06 -45.49 71.71 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.895 -1.048 . . . . 0.41 112.001 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.71 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.4 mt-30 -55.65 -36.37 66.97 Favored 'General case' 0 CA--C 1.488 -1.424 0 CA-C-N 114.843 -1.071 . . . . 0.37 109.916 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -90.47 -29.39 17.96 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.172 -1.376 . . . . 0.24 109.57 -176.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.07 -38.68 0.73 Allowed Glycine 0 CA--C 1.497 -1.069 0 C-N-CA 119.558 -1.306 . . . . 0.33 113.933 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 141' ' ' SER . 92.1 mt -73.12 -173.49 1.3 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 123.94 1.829 . . . . 0.31 115.275 -167.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 15.3 m -109.4 147.85 36.86 Favored Pre-proline 0 N--CA 1.42 -1.944 0 CA-C-N 110.72 -2.945 . . . . 0.81 107.984 168.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.639 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 34.3 Cg_endo -63.78 1.2 1.54 Allowed 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 123.058 2.505 . . . . 0.32 112.176 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.57 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -117.1 -22.25 8.47 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.136 0.969 . . . . 1.25 110.251 -178.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 141' ' ' SER . 17.2 t70 -61.0 -24.29 66.04 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 112.963 -1.926 . . . . 0.65 109.211 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.68 ' O ' HD13 ' A' ' 136' ' ' LEU . 14.0 m 74.42 174.83 0.26 Allowed 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 125.942 2.026 . . . . 0.6 108.468 -170.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.1 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.4 mt -69.76 -39.72 76.52 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.21 -1.033 . . . . 0.86 108.21 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.41 -12.0 0.73 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 113.276 -1.783 . . . . 0.31 114.41 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.96 125.11 7.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.605 -0.712 . . . . 0.24 109.118 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.711 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -40.86 -47.95 3.01 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 118.075 0.398 . . . . 1.65 111.81 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 149' ' ' ILE . 32.3 t -71.25 -29.22 64.83 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.391 0.615 . . . . 0.53 111.592 -175.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -71.15 -27.57 63.64 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.681 1.229 . . . . 1.31 108.374 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 1.1 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -78.6 -47.88 16.26 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 112.287 -2.233 . . . . 0.12 110.395 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.648 HG13 ' HE1' ' A' ' 179' ' ' MET . 36.7 mt -65.28 -42.12 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 112.837 -1.983 . . . . 0.11 110.252 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.3 -56.76 15.69 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.778 -1.101 . . . . 0.15 110.964 171.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.758 HG23 ' CB ' ' A' ' 130' ' ' ALA . 70.8 mt -63.99 -47.73 89.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 N-CA-C 112.458 0.54 . . . . 0.18 112.458 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.635 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.13 -42.01 76.24 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 123.241 0.338 . . . . 0.13 110.682 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.469 ' HD2' HG23 ' A' ' 149' ' ' ILE . 29.5 mtp180 -80.5 -23.05 40.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.643 0.735 . . . . 1.08 110.795 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.423 HD21 ' CD ' ' A' ' 133' ' ' GLN . 12.9 t30 -80.9 -12.99 59.31 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.424 -1.324 . . . . 0.5 107.424 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.699 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.49 -29.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 112.987 -1.915 . . . . 0.17 110.741 -175.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.46 34.19 5.11 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.59 -0.814 . . . . 0.16 112.612 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.668 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.66 159.81 16.44 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.912 0.708 . . . . 0.12 112.912 -169.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.687 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.5 m80 -99.29 -28.21 13.42 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.212 -0.904 . . . . 0.2 109.323 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.575 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.6 m-85 -136.26 -176.91 4.48 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.963 -1.017 . . . . 0.13 111.008 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.687 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -134.06 141.34 44.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.665 -1.152 . . . . 0.08 108.609 167.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.66 HD21 ' SD ' ' A' ' 176' ' ' MET . 29.9 tp -110.21 100.39 9.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.666 -0.814 . . . . 0.16 109.441 165.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.545 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.0 m-85 -79.06 112.45 16.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.579 -1.192 . . . . 0.26 108.899 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.855 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 5.5 t -126.09 161.91 26.54 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-O 121.956 0.884 . . . . 1.05 110.691 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.853 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.7 p -162.83 177.59 9.16 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.23 -1.35 . . . . 0.1 111.141 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -140.85 133.77 29.13 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.175 -1.375 . . . . 0.11 108.551 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -143.36 -176.61 5.01 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.307 -0.557 . . . . 1.09 109.592 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.39 -81.37 0.94 Allowed Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.669 -1.253 . . . . 0.15 111.873 172.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 53.1 t-20 -142.2 127.37 18.58 Favored 'General case' 0 C--O 1.197 -1.681 0 N-CA-C 106.747 -1.575 . . . . 0.59 106.747 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.595 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.9 p -63.25 -41.13 91.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-N 115.438 -0.801 . . . . 0.15 112.125 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.426 ' N ' HG13 ' A' ' 169' ' ' VAL . 91.9 m-20 -65.14 -28.45 69.43 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.317 0.579 . . . . 1.26 110.496 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.51 88.47 3.35 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 114.571 -1.195 . . . . 0.13 108.138 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.79 ' HD2' HG22 ' A' ' 194' ' ' VAL . 50.9 Cg_endo -90.09 164.96 4.75 Favored 'Trans proline' 0 CA--C 1.491 -1.658 0 C-N-CA 124.56 3.507 . . . . 0.09 114.998 -170.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 191' ' ' LYS . 20.6 m -84.4 117.83 23.87 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.898 -1.501 . . . . 0.14 107.628 166.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 164' ' ' SER . 40.4 tp -84.23 99.47 10.58 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.58 -0.896 . . . . 0.16 108.58 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.624 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.3 mt-30 -90.69 109.41 20.59 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-O 122.063 0.935 . . . . 0.34 109.634 -175.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.855 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -112.84 164.36 13.5 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.958 -1.019 . . . . 1.09 111.789 -172.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.61 ' HG2' HD12 ' A' ' 186' ' ' ILE . 55.9 tt0 -171.56 116.84 0.41 Allowed 'General case' 0 C--O 1.202 -1.395 0 CA-C-N 115.98 -0.555 . . . . 0.5 109.967 -166.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.03 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -99.23 101.53 12.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.554 -0.906 . . . . 0.1 108.554 -171.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.711 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 18.4 ttp -91.18 122.69 34.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.404 -0.816 . . . . 0.07 109.87 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.81 126.35 27.29 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.234 -1.395 . . . . 0.22 107.234 165.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.62 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -80.91 -35.68 14.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 119.303 -0.959 . . . . 0.11 110.72 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.428 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.8 mt-30 -60.57 -16.99 43.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.328 -0.851 . . . . 0.35 111.603 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.8 p -129.33 -37.37 1.64 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.969 0.89 . . . . 0.19 110.155 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.546 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.5 23.67 28.15 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 114.402 -1.272 . . . . 0.18 112.293 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.81 156.88 17.11 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.607 0.241 . . . . 0.73 110.672 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 177' ' ' GLN . 37.9 mm -92.87 114.94 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.543 0.687 . . . . 0.14 109.597 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.03 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -102.22 -31.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.878 -1.055 . . . . 0.13 110.603 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.656 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.9 t90 -135.59 153.33 51.71 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.487 -0.779 . . . . 0.07 109.87 173.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 28.0 p -153.61 163.4 40.05 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.157 0.799 . . . . 0.13 113.157 164.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.38 -175.47 31.41 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 110.839 -0.904 . . . . 0.12 110.839 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.4 mtmt -158.25 151.14 22.59 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.421 -2.066 . . . . 1.22 105.421 166.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -160.88 127.75 1.81 Allowed Glycine 0 C--N 1.281 -2.515 0 C-N-CA 119.879 -1.153 . . . . 0.12 112.195 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.39 118.16 14.93 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.444 0.64 . . . . 0.17 111.199 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.79 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -93.34 158.5 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-O 122.42 1.105 . . . . 0.11 109.868 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.673 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -97.98 171.46 8.26 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 112.879 -1.964 . . . . 0.18 109.581 -173.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 7.4 tt0 -103.09 127.48 50.35 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.984 -0.747 . . . . 0.91 108.984 166.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 14.2 mm-40 . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 118.724 -0.655 . . . . 1.24 110.817 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.771 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 1.8 m-30 . . . . . 0 N--CA 1.429 -1.491 0 CA-C-O 120.388 0.137 . . . . 0.21 110.919 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 11.5 t70 -82.66 67.98 8.94 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 123.481 1.61 . . . . 0.35 108.627 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.771 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 93.3 m95 -60.51 -43.75 96.73 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 112.14 -2.3 . . . . 0.1 112.312 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.473 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 12.1 t-20 -52.3 -29.0 21.23 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.064 -1.425 . . . . 1.11 111.211 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.37 -16.48 80.69 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 115.35 -0.841 . . . . 0.21 111.295 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.97 -51.64 3.49 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.183 -1.009 . . . . 0.13 110.959 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.718 ' SD ' HD23 ' A' ' 109' ' ' LEU . 38.5 mtt -65.61 -56.63 11.21 Favored 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 114.086 -1.415 . . . . 0.09 112.517 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.473 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.6 mm-40 -40.21 -54.57 4.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 114.732 1.382 . . . . 0.63 114.732 -176.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.802 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.2 Cg_endo -64.27 -30.09 63.95 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 121.916 1.744 . . . . 0.14 110.664 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.673 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 7.7 mtm -81.62 -44.59 17.0 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 115.165 -0.925 . . . . 0.7 111.826 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 68' ' ' MET . 49.0 t -56.74 -39.54 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-N 114.279 -1.328 . . . . 0.12 108.443 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.6 t -59.67 -32.62 70.64 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.049 -1.887 . . . . 0.56 111.177 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.2 mtpt -85.98 -33.29 21.14 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.929 0.395 . . . . 1.3 111.046 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.851 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.65 -27.64 69.07 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.484 -0.78 . . . . 0.5 111.786 -171.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.548 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.0 mt -93.05 -5.68 49.94 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.94 0.876 . . . . 0.65 111.257 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.14 15.29 47.56 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.201 -1.559 . . . . 0.17 109.201 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.641 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -83.47 165.99 18.69 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.409 -0.895 . . . . 0.1 111.148 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.52 105.68 14.65 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.876 -1.056 . . . . 1.72 110.382 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.606 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 129.25 -21.12 5.22 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.151 -1.023 . . . . 0.12 111.175 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.851 HG11 ' O ' ' A' ' 75' ' ' MET . 11.2 p -100.81 149.42 6.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.896 0.855 . . . . 0.16 110.837 -176.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.3 m -136.19 142.27 44.1 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.197 -1.365 . . . . 0.45 109.701 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.736 ' HB2' ' HD2' ' A' ' 118' ' ' LYS . . . -62.37 136.21 57.81 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.54 -0.755 . . . . 0.28 110.754 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.08 9.54 39.14 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.957 -0.64 . . . . 0.28 112.777 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.37 152.03 18.75 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.742 -0.383 . . . . 1.2 110.711 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.685 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -80.95 120.12 31.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 122.015 0.912 . . . . 0.2 109.103 165.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.666 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -107.45 110.57 22.55 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.137 -0.938 . . . . 0.14 108.799 -172.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.715 HD21 HD13 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -70.67 99.39 1.67 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 114.786 -1.097 . . . . 0.15 108.419 179.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.454 HG11 ' HG3' ' A' ' 110' ' ' ARG . 85.3 t -72.82 108.93 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 114.324 -1.307 . . . . 0.95 108.416 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.806 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 6.8 t0 -77.79 154.56 31.8 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.982 -1.118 . . . . 0.64 107.982 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.556 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.37 138.14 57.75 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.588 -1.264 . . . . 0.37 107.588 171.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.505 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 26.3 t -66.5 141.08 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.633 0 N-CA-C 107.904 -1.147 . . . . 0.1 107.904 168.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.789 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.8 t-20 -86.2 163.08 18.0 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.459 -0.792 . . . . 0.18 109.917 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.763 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 1.8 t-20 -126.01 84.84 2.32 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.669 -1.15 . . . . 0.12 108.29 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 13.7 mtp180 -108.97 -2.1 18.51 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.076 -1.42 . . . . 0.64 108.705 -171.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.748 HG21 ' HB3' ' A' ' 172' ' ' PRO . 17.6 p -50.7 -172.07 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 112.608 -2.087 . . . . 0.14 115.483 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.0 t30 -67.71 -13.1 61.81 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.028 -1.896 . . . . 0.48 110.558 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.579 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -148.86 -146.26 4.29 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.592 -0.813 . . . . 0.12 112.884 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.618 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 49.2 m -122.15 129.0 51.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.943 0.402 . . . . 1.16 111.134 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.763 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -132.12 159.29 39.34 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.525 0.678 . . . . 0.1 110.054 -177.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.614 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.37 82.25 7.26 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.317 -1.311 . . . . 0.17 108.229 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.608 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -69.25 -15.13 63.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.205 -1.361 . . . . 0.09 109.907 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.463 ' HB2' ' CG ' ' A' ' 139' ' ' GLN . . . -78.28 -30.33 48.42 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.999 -0.741 . . . . 0.15 108.999 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.614 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 14.2 tp10 -65.64 -35.2 80.12 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.784 1.278 . . . . 1.73 108.936 170.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.9 -45.9 63.48 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 112.832 -1.985 . . . . 0.12 109.366 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.6 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 55.9 m -63.87 -34.13 77.26 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.064 -1.426 . . . . 0.11 110.527 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -42.03 85.39 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.884 -1.154 . . . . 1.47 107.884 173.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.659 HG21 ' HB2' ' A' ' 64' ' ' TRP . 60.0 m -65.45 -30.99 71.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.252 -0.885 . . . . 0.12 110.984 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.718 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.21 -69.54 0.11 Allowed 'General case' 0 CA--C 1.492 -1.265 0 CA-C-N 115.781 -0.645 . . . . 0.56 109.282 172.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.543 ' O ' HD13 ' A' ' 121' ' ' LEU . 60.1 mtp180 -40.64 -37.61 0.76 Allowed 'General case' 0 C--N 1.311 -1.073 0 O-C-N 124.3 1.0 . . . . 1.51 111.499 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -70.79 -46.24 63.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.716 -1.129 . . . . 0.28 112.067 -177.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.4 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.47 -33.52 64.89 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.156 0.979 . . . . 0.09 108.532 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -63.58 -33.95 76.74 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.454 -1.703 . . . . 0.12 109.918 172.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.642 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -76.09 -43.51 43.11 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.763 -1.108 . . . . 0.2 111.226 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.28 -38.49 65.94 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.562 -1.199 . . . . 1.17 110.414 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.528 ' OD1' ' HG3' ' A' ' 118' ' ' LYS . 12.2 t-20 -69.11 -47.59 64.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 113.382 -1.736 . . . . 2.05 109.398 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.53 -8.39 68.81 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 116.033 -0.531 . . . . 0.54 113.762 171.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.736 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 15.6 mtmm -72.67 -33.93 66.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.096 -0.642 . . . . 0.99 111.154 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.704 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 15.1 m-85 -90.92 176.91 6.44 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 122.328 1.061 . . . . 0.21 112.526 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.508 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.8 m -120.8 117.61 27.86 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 112.85 -1.977 . . . . 0.23 108.151 168.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.676 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -88.63 132.85 34.38 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 115.362 -0.836 . . . . 0.38 110.367 -171.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.584 HG11 HD23 ' A' ' 88' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.301 -1.517 0 N-CA-C 109.057 -0.72 . . . . 0.42 109.057 177.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.715 HD13 HD21 ' A' ' 88' ' ' LEU . 17.7 tp . . . . . 0 CA--C 1.511 -0.524 0 N-CA-C 113.603 0.964 . . . . 1.39 113.603 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 56.8 m -52.09 -40.58 61.46 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 123.37 1.557 . . . . 1.05 109.116 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.702 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 13.6 mmt -57.26 -62.63 1.63 Allowed 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 111.177 -2.738 . . . . 1.64 111.002 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.776 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.22 -45.43 4.12 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 124.38 1.05 . . . . 0.31 111.875 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.571 ' HA ' HD11 ' A' ' 151' ' ' ILE . 1.0 OUTLIER -53.55 -53.6 49.26 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 108.954 -0.758 . . . . 1.53 108.954 178.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 128' ' ' SER . 39.0 mt-30 -64.23 -39.77 94.67 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.466 -0.788 . . . . 0.41 111.128 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.702 ' HG3' ' O ' ' A' ' 129' ' ' MET . 53.0 mt-30 -59.0 -34.66 72.11 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 114.354 -1.294 . . . . 0.37 109.83 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -91.7 -28.79 17.21 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 114.243 -1.344 . . . . 0.24 109.644 -176.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.58 -42.92 0.7 Allowed Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 119.894 -1.146 . . . . 0.33 113.426 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 141' ' ' SER . 94.0 mt -69.9 -171.46 0.42 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 124.102 1.906 . . . . 0.31 115.472 -169.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 32.1 m -114.89 153.93 46.99 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 110.353 -3.112 . . . . 0.81 107.194 174.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.623 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 64.6 Cg_endo -68.91 1.22 4.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.416 2.077 . . . . 0.32 110.91 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.463 ' CG ' ' HB2' ' A' ' 103' ' ' ALA . 20.8 mt-30 -117.56 -23.35 7.72 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.132 -1.395 . . . . 1.25 111.031 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 14.3 t70 -69.05 -22.14 64.05 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 114.515 -1.22 . . . . 0.65 108.879 -169.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.588 ' O ' HD13 ' A' ' 136' ' ' LEU . 32.3 m 71.76 166.94 0.3 Allowed 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 112.485 -2.143 . . . . 0.6 109.578 -170.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.982 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.6 mt -65.48 -40.15 92.78 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 122.191 0.996 . . . . 0.86 108.317 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.14 -12.18 0.27 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 113.047 -1.888 . . . . 0.31 114.476 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.25 123.3 7.57 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.023 -0.732 . . . . 0.24 109.023 -173.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.664 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -42.43 -45.56 4.43 Favored 'General case' 0 C--O 1.213 -0.843 0 O-C-N 123.394 0.434 . . . . 1.65 111.73 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -73.93 -25.49 60.01 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.676 0.751 . . . . 0.53 111.407 -174.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -73.55 -30.47 63.07 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.634 1.207 . . . . 1.31 108.331 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.982 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -75.41 -47.72 26.09 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 112.577 -2.102 . . . . 0.12 110.36 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.62 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.6 mt -65.49 -41.46 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-N 112.88 -1.964 . . . . 0.11 110.44 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.12 -53.53 36.8 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.67 -1.15 . . . . 0.15 111.25 171.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.776 HG23 ' CB ' ' A' ' 130' ' ' ALA . 83.9 mt -66.67 -48.3 80.58 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 N-CA-C 112.172 0.434 . . . . 0.18 112.172 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.682 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -54.43 -44.46 72.46 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 123.603 0.565 . . . . 0.13 111.248 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.459 ' NE ' HG23 ' A' ' 149' ' ' ILE . 49.7 mtt180 -78.76 -23.14 45.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.295 0.569 . . . . 1.08 110.882 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.502 HD21 ' CD ' ' A' ' 133' ' ' GLN . 35.0 t30 -81.6 -13.66 57.72 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.641 -1.244 . . . . 0.5 107.641 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.703 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.01 -28.91 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 113.313 -1.767 . . . . 0.17 111.041 -173.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.423 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.88 34.85 4.76 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.261 -0.971 . . . . 0.16 112.365 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.619 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.91 157.34 19.34 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.886 0.698 . . . . 0.12 112.886 -170.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.685 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.8 m80 -98.92 -28.63 13.35 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.137 -0.938 . . . . 0.2 109.425 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.567 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.1 m-85 -135.13 -173.97 3.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.063 -0.971 . . . . 0.13 110.856 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.703 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -136.97 139.97 43.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.13 -0.941 . . . . 0.08 108.93 166.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 40.1 tp -107.8 100.12 9.52 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.237 -0.985 . . . . 0.16 109.318 165.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.7 m-85 -80.39 116.65 20.57 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.226 -1.352 . . . . 0.26 108.577 176.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.868 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 4.7 t -129.01 162.55 27.36 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.948 0.88 . . . . 1.05 110.607 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.831 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.4 p -162.4 176.24 10.7 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.4 -1.273 . . . . 0.1 110.971 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -137.91 134.76 35.38 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.086 -1.416 . . . . 0.11 108.513 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.4 m -144.19 -176.0 4.84 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.278 -0.638 . . . . 1.09 109.278 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -84.21 0.92 Allowed Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.824 -1.179 . . . . 0.15 111.407 173.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.3 t30 -144.49 128.19 17.2 Favored 'General case' 0 C--O 1.197 -1.665 0 N-CA-C 107.921 -1.141 . . . . 0.59 107.921 176.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.579 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.7 p -63.22 -41.77 94.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.136 -0.938 . . . . 0.15 112.334 -172.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.41 ' N ' HG13 ' A' ' 169' ' ' VAL . 8.7 m120 -59.17 -31.67 69.2 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.49 0.662 . . . . 1.26 109.552 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.05 89.2 3.11 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 114.329 -1.305 . . . . 0.13 108.351 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.8 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.5 Cg_endo -90.49 166.98 4.23 Favored 'Trans proline' 0 CA--C 1.494 -1.492 0 C-N-CA 124.481 3.454 . . . . 0.09 114.815 -169.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.3 m -85.75 120.19 26.91 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 113.904 -1.498 . . . . 0.14 107.369 165.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 164' ' ' SER . 44.4 tp -84.68 98.66 10.34 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 108.714 -0.847 . . . . 0.16 108.714 176.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.576 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -89.93 109.39 20.41 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 122.097 0.951 . . . . 0.34 109.265 -176.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.868 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.9 OUTLIER -112.48 163.83 14.0 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.76 -1.109 . . . . 1.09 111.538 -173.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.609 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.5 tt0 -170.67 119.02 0.53 Allowed 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.89 -0.596 . . . . 0.5 109.98 -166.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.049 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.25 100.15 10.64 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.671 -0.863 . . . . 0.1 108.671 -173.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.664 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.8 ttp -89.42 123.06 33.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.433 -0.803 . . . . 0.07 109.548 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.2 OUTLIER -59.63 127.36 31.64 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.892 -1.522 . . . . 0.22 106.892 166.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.93 -35.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 O-C-N 121.131 -0.981 . . . . 0.11 110.904 179.214 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.458 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 28.9 mt-30 -61.68 -16.2 46.79 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 0.35 111.087 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 73.9 p -129.66 -37.05 1.59 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.752 0.786 . . . . 0.19 110.199 178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.552 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.82 24.88 26.51 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 114.701 -1.136 . . . . 0.18 112.387 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -103.85 156.4 17.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.679 0.276 . . . . 0.73 110.481 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.609 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.1 mm -89.22 117.0 31.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.552 0.692 . . . . 0.14 109.335 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.049 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -104.99 -30.54 2.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.098 -0.955 . . . . 0.13 110.341 -174.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.661 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.0 t90 -136.42 152.22 50.36 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.397 -0.819 . . . . 0.07 109.417 172.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 77.2 p -153.59 163.32 40.18 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.891 -0.724 . . . . 0.13 112.926 163.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.44 -174.93 28.78 Favored Glycine 0 N--CA 1.425 -2.047 0 N-CA-C 110.885 -0.886 . . . . 0.12 110.885 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.8 mtmt -158.96 151.28 21.4 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.383 -2.08 . . . . 1.22 105.383 165.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -159.43 127.24 1.79 Allowed Glycine 0 C--N 1.278 -2.676 0 C-N-CA 119.623 -1.275 . . . . 0.12 112.108 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.17 115.08 10.98 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.404 0.621 . . . . 0.17 111.065 -174.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.8 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -91.87 158.45 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-O 122.59 1.186 . . . . 0.11 110.181 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.85 172.26 7.04 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 112.564 -2.107 . . . . 0.18 109.166 -174.265 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.9 tt0 -100.42 130.65 46.53 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.261 -0.644 . . . . 0.91 109.261 169.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.494 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 26.7 mm-40 . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 115.883 -0.599 . . . . 1.24 110.138 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.743 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.6 m-30 . . . . . 0 N--CA 1.417 -2.079 0 N-CA-C 109.662 -0.496 . . . . 0.21 109.662 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 15.7 t70 -80.15 67.06 5.85 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 123.289 1.519 . . . . 0.35 108.257 172.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.718 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.6 m95 -59.01 -44.17 91.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 111.77 -2.468 . . . . 0.1 112.109 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.461 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 13.3 t-20 -51.51 -29.33 16.29 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.04 -1.436 . . . . 1.11 111.37 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.5 -16.49 80.69 Favored Glycine 0 C--N 1.314 -0.683 0 CA-C-N 115.385 -0.825 . . . . 0.21 111.254 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.73 -53.16 3.03 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.062 -1.069 . . . . 0.13 111.091 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.69 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.8 mtt -63.56 -57.94 8.55 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 114.229 -1.35 . . . . 0.09 112.139 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.9 mm-40 -38.61 -55.31 2.67 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 115.172 1.545 . . . . 0.63 115.172 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.754 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.6 Cg_endo -65.04 -28.85 57.22 Favored 'Trans proline' 0 CA--C 1.51 -0.716 0 C-N-CA 121.673 1.582 . . . . 0.14 110.649 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.637 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 11.3 mtm -84.47 -40.73 17.35 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.198 -0.91 . . . . 0.7 111.452 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 68' ' ' MET . 60.4 t -57.73 -38.32 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 CA-C-O 122.353 1.073 . . . . 0.12 108.506 172.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 t -60.52 -35.41 75.9 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.014 -1.903 . . . . 0.56 111.11 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.754 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 27.6 mtpt -81.37 -38.82 26.01 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.577 -0.527 . . . . 1.3 109.577 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.833 ' SD ' ' HE2' ' A' ' 119' ' ' PHE . 1.2 ttm -47.19 -54.6 10.29 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 123.901 0.751 . . . . 0.5 110.355 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.632 ' N ' ' HG2' ' A' ' 75' ' ' MET . 4.7 mt -80.03 7.62 8.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.525 -1.216 . . . . 0.65 112.285 -169.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.96 17.33 8.68 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 113.941 -1.481 . . . . 0.17 109.88 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -81.83 165.15 21.11 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.404 0.621 . . . . 0.1 110.252 176.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -87.06 107.6 18.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.281 -0.872 . . . . 1.72 109.797 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.664 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 133.96 -24.89 3.58 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 110.763 -0.935 . . . . 0.12 110.763 -178.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.762 HG11 ' O ' ' A' ' 75' ' ' MET . 10.8 p -102.92 151.08 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.777 0.799 . . . . 0.16 111.164 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.5 m -135.91 142.73 44.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.43 -1.259 . . . . 0.45 110.211 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.665 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -56.14 142.84 35.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.585 -0.734 . . . . 0.28 110.469 166.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.32 11.33 58.55 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.778 -0.725 . . . . 0.28 113.17 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.55 153.14 18.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.148 0.474 . . . . 1.2 110.552 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.696 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -82.28 120.47 33.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 108.772 -0.825 . . . . 0.2 108.772 166.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.64 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -108.45 109.78 21.14 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.542 -0.754 . . . . 0.14 109.308 -171.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.787 HD21 HD23 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -73.13 94.5 1.94 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.504 -1.225 . . . . 0.15 108.945 177.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 2.0 m -73.04 115.93 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 106.902 -1.518 . . . . 0.95 106.902 174.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.873 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 13.3 t0 -79.97 170.4 16.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.331 -0.989 . . . . 0.64 108.331 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.525 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.5 OUTLIER -55.5 148.72 14.94 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-O 122.774 1.273 . . . . 0.37 109.375 170.278 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.515 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 34.6 t -77.62 140.5 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.172 0 N-CA-C 106.81 -1.552 . . . . 0.1 106.81 165.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.81 ' H ' ' HA ' ' A' ' 164' ' ' SER . 5.5 t-20 -85.55 160.91 19.54 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 122.031 0.919 . . . . 0.18 110.344 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.749 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -124.27 84.63 2.3 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 113.939 -1.482 . . . . 0.12 107.575 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.465 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 13.2 mtp180 -107.18 -2.07 21.24 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 113.66 -1.609 . . . . 0.64 108.411 -172.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.726 HG21 ' HB3' ' A' ' 172' ' ' PRO . 22.3 p -50.96 -177.73 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.36 -1.745 . . . . 0.14 113.799 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 1.5 t30 -73.49 -7.62 52.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.065 -1.88 . . . . 0.48 110.263 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.618 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -142.37 -151.43 5.51 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.944 -0.645 . . . . 0.12 112.869 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.596 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 51.8 m -121.92 130.58 53.45 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.955 0.407 . . . . 1.16 111.728 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.749 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.0 pp -134.84 158.19 44.85 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.876 0.846 . . . . 0.1 110.795 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -80.64 79.69 7.23 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.019 -1.446 . . . . 0.17 108.08 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.57 -15.77 63.83 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.376 -1.284 . . . . 0.09 109.846 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.55 -31.56 42.02 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.888 -0.782 . . . . 0.15 108.888 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.614 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.6 tp10 -66.04 -33.98 77.03 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.697 1.237 . . . . 1.73 108.876 171.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.29 -43.42 64.25 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 113.118 -1.855 . . . . 0.12 109.656 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 63.7 m -63.91 -32.2 73.65 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.107 -1.406 . . . . 0.11 110.537 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -40.99 80.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.997 -1.112 . . . . 1.47 107.997 173.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.683 HG21 ' HB2' ' A' ' 64' ' ' TRP . 54.7 m -64.5 -31.06 72.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.21 -0.904 . . . . 0.12 110.693 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.719 ' O ' HD23 ' A' ' 113' ' ' LEU . 8.4 mt -51.74 -70.05 0.1 Allowed 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.296 -0.631 . . . . 0.56 109.296 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.635 ' O ' HD13 ' A' ' 121' ' ' LEU . 21.2 mtp180 -39.72 -38.46 0.64 Allowed 'General case' 0 C--N 1.315 -0.933 0 O-C-N 124.436 1.085 . . . . 1.51 111.331 174.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.509 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.86 -46.89 61.87 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.578 -1.192 . . . . 0.28 112.313 -177.253 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.57 -31.0 64.89 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.227 1.013 . . . . 0.09 108.471 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -66.15 -32.55 74.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.511 -1.677 . . . . 0.12 109.906 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.591 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.31 -39.39 68.27 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.48 -1.236 . . . . 0.2 111.565 -175.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -66.97 -21.69 65.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.061 -0.972 . . . . 1.17 111.265 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.69 -14.41 28.08 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.053 -0.521 . . . . 2.05 111.753 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.24 -11.89 0.69 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 116.164 1.226 . . . . 0.54 116.164 163.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 51.7 mtpt -74.51 -33.03 62.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.819 0.81 . . . . 0.99 111.139 -177.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.833 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 20.8 m-85 -93.6 178.2 5.77 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 122.391 1.091 . . . . 0.21 112.678 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 6.2 m -121.25 116.95 25.83 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 112.901 -1.954 . . . . 0.23 107.822 168.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.702 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -87.54 135.49 33.33 Favored 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 119.477 -0.889 . . . . 0.38 110.751 -171.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.581 HG11 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.296 -1.759 0 N-CA-C 108.923 -0.769 . . . . 0.42 108.923 173.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.787 HD23 HD21 ' A' ' 88' ' ' LEU . 1.9 tm? . . . . . 0 C--O 1.236 0.354 0 N-CA-C 113.218 0.822 . . . . 1.39 113.218 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.648 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.5 OUTLIER -52.34 -39.89 61.26 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 123.712 1.72 . . . . 1.05 108.753 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.627 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -62.9 -59.85 4.28 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 110.694 -2.957 . . . . 1.64 110.783 179.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.756 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.86 -40.01 5.85 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 124.098 0.874 . . . . 0.31 112.006 175.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.723 ' NZ ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -51.52 -60.46 3.12 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.825 -0.75 . . . . 1.53 109.215 175.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 40.3 mt-30 -58.74 -44.66 90.58 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.379 -1.282 . . . . 0.41 111.7 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 129' ' ' MET . 43.5 mt-30 -55.33 -34.2 64.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.986 -1.006 . . . . 0.37 110.151 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.528 ' CD1' HG13 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -93.59 -30.56 14.91 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.991 -1.459 . . . . 0.24 109.364 -178.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 161.43 -54.9 0.32 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.929 -1.129 . . . . 0.33 114.086 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.508 ' CD1' ' HA ' ' A' ' 142' ' ' LEU . 43.8 mt -64.05 -172.36 0.06 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 116.385 1.994 . . . . 0.31 116.385 -168.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.5 m -111.16 150.7 42.37 Favored Pre-proline 0 N--CA 1.428 -1.54 0 CA-C-N 110.954 -2.839 . . . . 0.81 108.777 170.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.648 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 15.1 Cg_endo -60.08 -2.49 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 123.357 2.705 . . . . 0.32 113.107 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 101' ' ' ASN . 0.8 OUTLIER -117.44 -26.41 6.68 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.911 0.862 . . . . 1.25 110.647 -177.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 4.6 t70 -64.8 -24.56 67.59 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 113.696 -1.593 . . . . 0.65 109.359 -171.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 22.6 m 66.33 161.56 0.15 Allowed 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 112.689 -2.05 . . . . 0.6 109.995 -175.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.881 HD13 ' HA ' ' A' ' 148' ' ' ALA . 9.2 mt -73.19 -35.63 66.4 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.148 -1.842 . . . . 0.86 109.204 -169.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.36 2.98 0.31 Allowed Glycine 0 C--N 1.318 -0.464 0 CA-C-N 113.164 -1.835 . . . . 0.31 114.949 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 118.14 5.27 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 109.07 -0.715 . . . . 0.24 109.07 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.69 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 13.0 mmt180 -40.23 -47.87 2.5 Favored 'General case' 0 C--O 1.214 -0.783 0 O-C-N 123.696 0.623 . . . . 1.65 111.448 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -69.77 -28.24 65.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.477 0.656 . . . . 0.53 111.461 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.545 ' O ' HD12 ' A' ' 151' ' ' ILE . 21.2 mttm -72.82 -31.32 64.72 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.38 1.086 . . . . 1.31 108.276 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.881 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -77.75 -38.94 45.86 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 113.15 -1.841 . . . . 0.12 110.798 178.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.605 ' HA ' HG23 ' A' ' 181' ' ' VAL . 33.0 mt -69.78 -43.17 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 CA-C-N 113.821 -1.536 . . . . 0.11 109.978 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.73 -53.57 35.43 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.177 -0.919 . . . . 0.15 110.979 171.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.756 HG23 ' CB ' ' A' ' 130' ' ' ALA . 7.6 mt -67.14 -44.92 87.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.028 0 N-CA-C 113.069 0.766 . . . . 0.18 113.069 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.65 -37.9 76.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 118.447 0.567 . . . . 0.13 110.513 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 149' ' ' ILE . 46.8 mtp180 -83.18 -21.7 33.44 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.799 0.809 . . . . 1.08 110.407 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 13.8 t30 -82.58 -10.32 59.02 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.187 -1.412 . . . . 0.5 107.187 175.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.734 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -109.79 -29.24 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 113.294 -1.775 . . . . 0.17 111.107 -174.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.76 35.38 4.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.563 -0.827 . . . . 0.16 112.642 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.73 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -112.09 159.28 18.66 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.416 0.895 . . . . 0.12 113.416 -169.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.696 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.1 m80 -100.32 -25.99 14.05 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.486 -0.779 . . . . 0.2 110.068 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.571 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.5 m-85 -135.57 -172.62 3.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.234 -0.894 . . . . 0.13 110.959 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.82 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -138.81 136.72 43.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.013 -0.994 . . . . 0.08 108.964 167.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 48.6 tp -106.96 99.44 9.01 Favored 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 119.637 -0.825 . . . . 0.16 108.995 165.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.601 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -81.54 111.97 18.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.103 -1.408 . . . . 0.26 109.448 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.726 ' OG ' HD11 ' A' ' 174' ' ' LEU . 31.4 t -121.31 166.33 14.2 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 121.699 0.761 . . . . 1.05 110.753 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.868 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.5 p -164.87 176.34 8.79 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-N 114.625 -1.17 . . . . 0.1 111.351 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -142.64 135.36 28.03 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.294 -1.321 . . . . 0.11 108.499 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 3.1 m -144.42 -175.79 4.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.516 -0.55 . . . . 1.09 109.516 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.6 -80.12 0.82 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 119.463 -1.351 . . . . 0.15 112.025 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.5 t30 -148.92 123.2 9.58 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 106.917 -1.512 . . . . 0.59 106.917 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.618 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.3 p -59.49 -45.65 93.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.121 -0.945 . . . . 0.15 113.287 -172.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -60.02 -29.57 68.59 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.452 0.644 . . . . 1.26 109.703 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.91 88.03 3.6 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.441 -1.254 . . . . 0.13 108.512 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.813 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.6 Cg_endo -91.22 166.47 3.63 Favored 'Trans proline' 0 CA--C 1.496 -1.407 0 C-N-CA 124.835 3.69 . . . . 0.09 114.98 -170.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.2 m -83.19 117.95 23.27 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.856 -1.52 . . . . 0.14 107.638 166.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.868 HD12 ' O ' ' A' ' 164' ' ' SER . 46.4 tp -84.46 99.25 10.57 Favored 'General case' 0 N--CA 1.412 -2.325 0 C-N-CA 119.747 -0.781 . . . . 0.16 109.289 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.677 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.2 mt-30 -89.51 107.36 19.03 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 114.966 -1.015 . . . . 0.34 109.291 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 37.5 mtp -106.52 161.83 14.26 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.212 -0.904 . . . . 1.09 110.382 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.611 ' HG2' HD12 ' A' ' 186' ' ' ILE . 53.2 tt0 -167.47 119.03 0.88 Allowed 'General case' 0 C--O 1.207 -1.183 0 CA-C-O 121.165 0.507 . . . . 0.5 110.025 -168.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.087 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -101.01 101.34 12.1 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.826 -0.805 . . . . 0.1 108.826 -172.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.69 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.0 ttp -91.14 118.95 30.86 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.603 -0.726 . . . . 0.07 109.318 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.549 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -61.85 118.49 7.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.273 -1.38 . . . . 0.22 107.273 169.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -73.2 -32.88 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 119.516 1.053 . . . . 0.11 111.408 -176.393 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.437 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.1 mt-30 -64.1 -12.84 43.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.35 111.538 -177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 33.1 p -130.12 -37.56 1.46 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.079 0.943 . . . . 0.19 109.892 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.594 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.82 19.47 51.25 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 113.756 -1.565 . . . . 0.18 112.08 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.66 156.56 17.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.055 0.455 . . . . 0.73 110.677 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.611 HD12 ' HG2' ' A' ' 177' ' ' GLN . 37.9 mm -88.4 117.48 32.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.679 0.752 . . . . 0.14 109.424 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.087 HD11 HD13 ' A' ' 178' ' ' LEU . 1.8 pp -104.79 -30.1 2.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.527 -1.215 . . . . 0.13 110.353 -172.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.588 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.3 t90 -137.43 152.33 49.48 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.191 -0.913 . . . . 0.07 109.338 172.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.46 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 61.2 p -153.58 165.52 35.65 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.865 0.691 . . . . 0.13 112.865 164.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.16 -179.43 33.99 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.892 -0.883 . . . . 0.12 110.892 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.745 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.8 mtmt -156.78 147.08 21.26 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.33 -1.73 . . . . 1.22 106.33 167.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.637 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -158.04 127.45 1.9 Allowed Glycine 0 C--N 1.283 -2.387 0 C-N-CA 119.94 -1.124 . . . . 0.12 112.266 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.72 117.02 13.9 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.425 0.631 . . . . 0.17 111.003 -174.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.813 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -93.99 159.25 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 122.589 1.185 . . . . 0.11 110.736 -177.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -101.8 172.08 7.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 112.501 -2.136 . . . . 0.18 108.861 -174.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 8.3 tt0 -100.77 133.2 45.59 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.075 -0.65 . . . . 0.91 109.411 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.525 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 35.1 mm-40 . . . . . 0 C--N 1.316 -0.89 0 CA-C-O 118.656 -0.688 . . . . 1.24 110.518 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.772 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.9 m-30 . . . . . 0 N--CA 1.434 -1.243 0 CA-C-O 120.207 0.051 . . . . 0.21 110.878 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.54 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 10.6 t0 -85.16 67.64 10.25 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 123.395 1.569 . . . . 0.35 108.473 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.781 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 94.9 m95 -57.44 -41.9 81.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.008 -2.36 . . . . 0.1 112.769 175.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.486 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 14.7 t-20 -51.95 -25.43 8.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.197 -1.365 . . . . 1.11 111.696 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.69 -16.58 78.97 Favored Glycine 0 C--N 1.312 -0.763 0 CA-C-N 115.147 -0.933 . . . . 0.21 111.278 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.41 -52.84 3.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.118 -1.041 . . . . 0.13 111.199 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.723 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.4 mtt -64.59 -58.67 5.7 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 114.122 -1.399 . . . . 0.09 112.507 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.486 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -39.42 -54.78 3.56 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 114.794 1.405 . . . . 0.63 114.794 -176.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.807 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 37.4 Cg_endo -64.64 -28.97 60.64 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.532 1.488 . . . . 0.14 110.16 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.719 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 10.9 mtm -83.09 -42.04 17.88 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.358 -0.837 . . . . 0.7 112.108 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 68' ' ' MET . 58.2 t -57.01 -40.13 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 CA-C-N 114.26 -1.336 . . . . 0.12 108.802 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.68 -36.09 73.64 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.152 -1.84 . . . . 0.56 111.054 173.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.807 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.1 mtpt -82.08 -32.91 30.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.011 -0.541 . . . . 1.3 111.207 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.833 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.82 -26.16 68.22 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.39 -0.823 . . . . 0.5 111.677 -172.19 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.657 HD13 ' HB2' ' A' ' 118' ' ' LYS . 3.9 mt -94.21 -8.02 40.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.124 0.964 . . . . 0.65 110.997 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.82 14.67 60.17 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.664 -1.774 . . . . 0.17 108.664 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.664 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -86.46 165.72 16.08 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.159 -1.02 . . . . 0.1 109.818 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -94.46 105.38 17.35 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.252 -0.886 . . . . 1.72 109.914 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.651 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 136.23 -23.4 3.32 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.722 -0.951 . . . . 0.12 110.722 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.833 HG11 ' O ' ' A' ' 75' ' ' MET . 10.7 p -101.21 153.76 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.431 0.634 . . . . 0.16 111.197 -175.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.8 m -135.35 141.84 45.64 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.923 -1.035 . . . . 0.45 110.441 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.654 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.38 130.25 45.98 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.346 -0.843 . . . . 0.28 110.272 168.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.17 3.23 38.77 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.006 -0.616 . . . . 0.28 112.876 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.0 151.89 22.87 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 120.488 -0.485 . . . . 1.2 110.97 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.676 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -80.73 119.14 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 121.988 0.899 . . . . 0.2 109.031 165.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.763 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -108.38 107.56 18.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.28 -0.873 . . . . 0.14 109.108 -171.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.692 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -71.43 97.9 1.71 Allowed 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.141 -1.39 . . . . 0.15 107.847 175.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.894 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.5 m -71.08 121.91 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 106.608 -1.627 . . . . 0.95 106.608 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.794 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 5.0 t0 -76.86 151.04 36.0 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.17 -1.419 . . . . 0.64 107.17 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.544 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.1 m -57.53 132.78 54.21 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 106.947 -1.501 . . . . 0.37 106.947 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.548 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 23.1 t -60.55 138.31 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.988 0 N-CA-C 107.88 -1.155 . . . . 0.1 107.88 170.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.8 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -84.19 162.95 20.03 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.337 -0.847 . . . . 0.18 109.704 174.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.784 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.1 85.19 2.37 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.748 -1.114 . . . . 0.12 108.114 175.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.477 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.3 mtp180 -108.18 -4.09 17.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.852 -1.522 . . . . 0.64 108.77 -171.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 172' ' ' PRO . 21.4 p -50.59 -171.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.854 -1.975 . . . . 0.14 115.547 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 33.3 t30 -68.89 -10.66 58.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.883 -1.962 . . . . 0.48 110.739 173.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.586 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -152.48 -143.93 3.8 Favored Glycine 0 C--O 1.236 0.244 0 C-N-CA 120.258 -0.972 . . . . 0.12 113.153 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.61 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 51.5 p -122.36 131.61 53.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.148 0.499 . . . . 1.16 111.949 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.784 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.4 pp -137.43 156.43 48.19 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.846 0.831 . . . . 0.1 110.633 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -79.87 81.09 6.19 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.787 -1.551 . . . . 0.17 107.852 176.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.93 -14.72 63.21 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.193 -1.367 . . . . 0.09 109.929 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.405 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.74 -30.23 40.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.685 -0.857 . . . . 0.15 108.685 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 28.2 tp10 -66.0 -34.57 78.4 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.78 1.276 . . . . 1.73 109.068 170.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.03 -45.22 64.3 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.049 -1.887 . . . . 0.12 109.227 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 49.1 m -64.8 -30.58 71.59 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.029 -1.441 . . . . 0.11 110.5 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -67.2 -44.04 80.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.749 -1.204 . . . . 1.47 107.749 171.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.717 HG21 ' HB2' ' A' ' 64' ' ' TRP . 37.7 m -63.24 -31.46 72.61 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.237 -0.892 . . . . 0.12 110.783 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.723 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.3 mt -50.16 -70.47 0.09 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.05 -0.722 . . . . 0.56 109.05 170.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.503 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.9 mtp180 -40.08 -40.32 1.05 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.487 1.117 . . . . 1.51 111.358 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -67.26 -48.18 68.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.556 -1.202 . . . . 0.28 112.137 -177.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.2 -34.97 68.8 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.315 1.055 . . . . 0.09 108.524 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -63.91 -32.33 73.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.158 -1.837 . . . . 0.12 110.064 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -76.01 -47.5 24.62 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 114.523 -1.217 . . . . 0.2 111.302 -174.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -55.99 -33.13 64.56 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.336 -1.302 . . . . 1.17 110.11 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -70.17 -43.77 70.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.244 -1.798 . . . . 2.05 110.784 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.12 -3.39 66.04 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 114.749 0.659 . . . . 0.54 114.749 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.657 ' HB2' HD13 ' A' ' 76' ' ' LEU . 58.7 mtpt -87.36 -8.2 56.89 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.066 0.933 . . . . 0.99 111.192 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.763 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 27.0 m-85 -118.12 174.42 6.22 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 122.421 1.105 . . . . 0.21 113.303 173.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.0 m -118.47 123.88 46.25 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 112.672 -2.058 . . . . 0.23 108.021 170.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.673 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -95.66 141.33 29.27 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 119.291 -0.964 . . . . 0.38 111.519 -169.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.548 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 1.2 m . . . . . 0 C--N 1.306 -1.314 0 N-CA-C 107.802 -1.184 . . . . 0.42 107.802 172.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.894 HD11 ' O ' ' A' ' 89' ' ' VAL . 6.3 tt . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 113.268 0.84 . . . . 1.39 113.268 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.707 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -53.92 -43.72 70.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 123.389 1.566 . . . . 1.05 109.116 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.694 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -55.59 -60.85 2.85 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 111.226 -2.715 . . . . 1.64 111.3 175.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.735 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.49 -46.22 6.77 Favored 'General case' 0 CA--C 1.497 -1.083 0 O-C-N 124.493 1.121 . . . . 0.31 111.807 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.605 ' HA ' HD11 ' A' ' 151' ' ' ILE . 5.8 mttt -53.32 -52.13 60.15 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.39 -0.596 . . . . 1.53 109.39 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -66.9 -38.63 86.6 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.542 -0.754 . . . . 0.41 110.878 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.694 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.2 mt-30 -59.04 -32.3 69.63 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 114.551 -1.204 . . . . 0.37 109.845 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.51 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.7 OUTLIER -94.3 -30.49 14.51 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.123 -1.399 . . . . 0.24 109.929 -177.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.06 -50.72 0.46 Allowed Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 120.012 -1.089 . . . . 0.33 113.664 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 141' ' ' SER . 92.9 mt -65.36 -171.03 0.07 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 112.496 -1.852 . . . . 0.31 115.954 -171.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.1 m -115.72 151.67 46.5 Favored Pre-proline 0 N--CA 1.424 -1.736 0 CA-C-N 110.65 -2.977 . . . . 0.81 107.985 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.707 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 36.2 Cg_endo -65.4 0.07 3.13 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.871 2.381 . . . . 0.32 112.651 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.1 tt0 -118.74 -25.33 6.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.869 0.843 . . . . 1.25 110.519 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 141' ' ' SER . 9.1 t70 -60.98 -23.09 65.09 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.364 -1.744 . . . . 0.65 109.079 -173.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 32.6 m 73.91 167.37 0.3 Allowed 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 112.848 -1.978 . . . . 0.6 109.393 -174.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.063 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.3 mt -64.46 -39.49 93.92 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-O 122.439 1.114 . . . . 0.86 108.421 -175.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.37 -7.29 1.39 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 113.062 -1.881 . . . . 0.31 114.163 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.49 126.35 6.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.995 -0.743 . . . . 0.24 108.995 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.675 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.2 mmt180 -41.83 -49.19 4.44 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 118.039 0.381 . . . . 1.65 110.995 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.6 t -69.34 -28.16 65.98 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.368 0.604 . . . . 0.53 111.658 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 24.3 mttm -73.78 -29.95 62.49 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.618 1.199 . . . . 1.31 108.668 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 1.063 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -75.25 -46.27 34.84 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-N 112.358 -2.201 . . . . 0.12 110.358 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.612 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.7 mt -65.97 -42.22 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 112.71 -2.041 . . . . 0.11 110.046 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.0 -52.63 41.99 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.849 -1.069 . . . . 0.15 111.433 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.735 HG23 ' CB ' ' A' ' 130' ' ' ALA . 16.7 mt -68.34 -46.95 79.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 N-CA-C 112.346 0.498 . . . . 0.18 112.346 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.64 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.71 -39.7 74.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.954 0.407 . . . . 0.13 110.693 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.529 ' HD2' HG23 ' A' ' 149' ' ' ILE . 34.5 mtp180 -81.41 -23.13 37.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.52 0.676 . . . . 1.08 110.894 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.478 HD21 ' CD ' ' A' ' 133' ' ' GLN . 34.9 t30 -81.09 -13.18 58.98 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.627 -1.249 . . . . 0.5 107.627 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.682 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.92 -29.11 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 113.196 -1.82 . . . . 0.17 110.772 -174.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.41 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 98.59 34.6 5.21 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 120.198 -1.001 . . . . 0.16 112.408 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.692 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.92 157.27 18.79 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 112.693 0.627 . . . . 0.12 112.693 -170.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.676 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.7 m80 -96.74 -27.16 14.88 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.362 -0.835 . . . . 0.2 109.445 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.581 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.1 m-85 -137.29 -174.53 3.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.061 -0.972 . . . . 0.13 111.325 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.686 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -136.48 140.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.583 -1.19 . . . . 0.08 108.553 166.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.62 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 26.2 tp -110.02 99.89 8.92 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.466 -0.893 . . . . 0.16 109.704 166.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 90' ' ' ASP . 2.3 m-85 -77.92 112.03 14.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.914 -1.039 . . . . 0.26 108.785 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.69 ' OG ' HD11 ' A' ' 109' ' ' LEU . 4.0 p -120.06 158.93 25.81 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 115.093 -0.958 . . . . 1.05 109.56 -175.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.8 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.2 p -163.75 172.56 13.99 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 115.154 -0.93 . . . . 0.1 110.875 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.67 131.81 36.18 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 113.956 -1.475 . . . . 0.11 108.536 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.681 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -142.5 -176.39 4.83 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.158 -0.682 . . . . 1.09 109.158 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -86.05 0.98 Allowed Glycine 0 CA--C 1.49 -1.492 0 C-N-CA 119.55 -1.309 . . . . 0.15 111.101 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.504 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.3 t30 -141.59 129.06 21.31 Favored 'General case' 0 C--O 1.198 -1.629 0 CA-C-N 113.867 -1.167 . . . . 0.59 107.963 175.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.586 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.7 p -64.7 -39.39 85.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.226 -0.897 . . . . 0.15 111.991 -172.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.428 ' N ' HG13 ' A' ' 169' ' ' VAL . 14.4 m-20 -61.3 -31.15 70.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.696 0.76 . . . . 1.26 109.411 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.99 88.79 3.17 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 113.916 -1.493 . . . . 0.13 107.962 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.797 ' HD2' HG22 ' A' ' 194' ' ' VAL . 51.3 Cg_endo -90.21 165.32 4.61 Favored 'Trans proline' 0 CA--C 1.491 -1.645 0 C-N-CA 124.315 3.343 . . . . 0.09 114.837 -169.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 191' ' ' LYS . 23.8 m -85.39 117.84 24.55 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 113.715 -1.584 . . . . 0.14 107.769 167.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 164' ' ' SER . 38.6 tp -84.31 97.77 9.63 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 119.485 -0.886 . . . . 0.16 108.88 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.648 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -87.48 109.0 19.29 Favored 'General case' 0 C--N 1.277 -2.587 0 CA-C-N 114.64 -1.163 . . . . 0.34 109.053 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.582 ' SD ' ' HB3' ' A' ' 163' ' ' SER . 2.6 mmm -111.03 163.57 13.71 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.51 -1.223 . . . . 1.09 111.464 -173.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.619 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.4 tt0 -172.08 117.59 0.38 Allowed 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 115.978 -0.556 . . . . 0.5 110.114 -166.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.038 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -100.05 101.54 12.64 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.53 -0.915 . . . . 0.1 108.53 -172.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.675 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 17.0 ttp -90.66 122.86 33.8 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.468 -0.787 . . . . 0.07 109.639 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -59.19 127.19 30.91 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.268 -1.382 . . . . 0.22 107.268 166.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.16 -34.4 12.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.172 -1.011 . . . . 0.11 110.701 178.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.441 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.5 mt-30 -61.88 -15.95 46.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.333 -0.848 . . . . 0.35 111.604 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.7 p -130.38 -36.74 1.45 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.826 0.822 . . . . 0.19 110.202 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.551 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.89 23.84 29.18 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 114.528 -1.214 . . . . 0.18 112.272 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -103.63 156.72 17.57 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.656 0.265 . . . . 0.73 110.653 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.619 HD12 ' HG2' ' A' ' 177' ' ' GLN . 35.0 mm -90.07 120.02 38.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.616 0.722 . . . . 0.14 109.379 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.038 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -108.62 -30.19 2.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.942 -1.026 . . . . 0.13 110.495 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.671 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.9 t90 -136.36 152.85 51.09 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 115.108 -0.951 . . . . 0.07 109.501 172.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 35.6 p -153.32 163.19 40.35 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 113.253 0.834 . . . . 0.13 113.253 164.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.42 -175.55 29.47 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 110.967 -0.853 . . . . 0.12 110.967 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.4 mtmt -159.51 149.74 18.98 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 105.704 -1.961 . . . . 1.22 105.704 165.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -161.13 128.02 1.85 Allowed Glycine 0 C--N 1.28 -2.542 0 C-N-CA 119.601 -1.285 . . . . 0.12 112.142 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.3 120.2 17.57 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.58 0.705 . . . . 0.17 111.116 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.797 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -94.96 158.91 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-N 114.65 -1.159 . . . . 0.11 109.753 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.68 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -100.35 171.34 7.83 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 112.981 -1.918 . . . . 0.18 109.292 -174.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 7.6 tt0 -101.5 130.35 47.74 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.253 -0.647 . . . . 0.91 109.253 169.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.54 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 19.5 mm-40 . . . . . 0 C--N 1.31 -1.146 0 CA-C-O 118.431 -0.795 . . . . 1.24 110.383 176.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.73 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.0 m-30 . . . . . 0 N--CA 1.415 -2.219 0 N-CA-C 109.41 -0.589 . . . . 0.21 109.41 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.561 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 6.1 t70 -81.49 67.51 7.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.499 1.619 . . . . 0.35 107.931 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.734 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.3 m95 -59.64 -42.34 92.55 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 111.933 -2.394 . . . . 0.1 111.911 174.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.487 ' N ' HG21 ' A' ' 108' ' ' THR . 8.9 t-20 -52.53 -24.88 8.94 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.062 -1.426 . . . . 1.11 111.452 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.49 -16.73 77.34 Favored Glycine 0 C--N 1.312 -0.773 0 CA-C-N 115.129 -0.941 . . . . 0.21 111.175 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.16 -55.11 2.55 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.897 -1.152 . . . . 0.13 111.41 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.729 ' O ' HG23 ' A' ' 72' ' ' VAL . 40.9 mtt -64.05 -57.21 10.34 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.117 -1.401 . . . . 0.09 112.893 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.611 HE22 ' ND2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -38.85 -54.93 2.96 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 114.53 1.307 . . . . 0.63 114.53 -176.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.803 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.7 Cg_endo -64.71 -31.64 58.39 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 121.949 1.766 . . . . 0.14 110.956 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.754 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 10.2 mtm -79.58 -44.04 21.81 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.433 -0.803 . . . . 0.7 111.54 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 68' ' ' MET . 40.5 t -57.17 -39.09 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 114.366 -1.288 . . . . 0.12 108.509 175.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.7 t -59.19 -36.44 75.35 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.153 -1.839 . . . . 0.56 110.811 174.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.803 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 32.8 mtpt -81.55 -34.13 31.3 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.168 0.508 . . . . 1.3 110.823 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.85 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.54 -29.07 70.38 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.235 -0.893 . . . . 0.5 111.563 -171.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.564 HD13 ' HB2' ' A' ' 118' ' ' LYS . 6.0 mt -90.77 -8.07 50.7 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.922 0.867 . . . . 0.65 111.118 -177.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.38 13.09 58.49 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 109.182 -1.567 . . . . 0.17 109.182 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.639 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -83.54 160.25 21.5 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.441 -0.879 . . . . 0.1 110.245 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.47 106.29 16.71 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.062 -0.972 . . . . 1.72 110.115 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.636 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.52 -22.8 3.67 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 110.766 -0.933 . . . . 0.12 110.766 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 75' ' ' MET . 11.3 p -102.95 150.0 6.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.639 0.733 . . . . 0.16 111.514 -176.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.0 m -137.61 141.33 41.26 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.695 -1.139 . . . . 0.45 111.135 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.66 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.97 132.36 49.69 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.745 -1.116 . . . . 0.28 111.285 169.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.57 2.27 37.52 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.859 -0.686 . . . . 0.28 112.709 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.26 149.91 22.86 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 120.233 -0.587 . . . . 1.2 110.923 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -79.48 117.55 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 122.196 0.998 . . . . 0.2 108.871 164.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.784 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -104.92 109.75 21.85 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.521 -0.918 . . . . 0.14 108.521 -172.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.693 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -71.27 94.06 1.16 Allowed 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.788 -1.19 . . . . 0.15 107.788 176.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.519 HG11 ' HG3' ' A' ' 110' ' ' ARG . 1.1 m -72.87 116.14 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 107.124 -1.436 . . . . 0.95 107.124 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.847 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 8.3 t0 -76.98 154.77 33.2 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.723 -1.214 . . . . 0.64 107.723 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.0 OUTLIER -58.05 136.38 57.15 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 107.527 -1.286 . . . . 0.37 107.527 171.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.509 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.8 t -64.0 139.0 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 107.835 -1.172 . . . . 0.1 107.835 168.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.818 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.6 t-20 -85.61 163.24 18.45 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.128 -0.942 . . . . 0.18 110.063 174.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.751 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.31 85.25 2.38 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.407 -1.27 . . . . 0.12 108.187 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.476 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 9.7 mtp180 -108.88 -1.12 19.37 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.056 -1.429 . . . . 0.64 108.644 -172.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.732 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.6 p -53.36 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.991 -1.913 . . . . 0.14 115.106 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.528 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 22.4 t30 -67.45 -13.31 61.92 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.712 -2.04 . . . . 0.48 110.479 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.579 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -149.71 -145.02 4.05 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.259 -0.972 . . . . 0.12 113.109 -176.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.619 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.4 p -121.89 132.65 54.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.18 0.514 . . . . 1.16 111.747 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.751 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.0 pp -137.75 157.01 47.36 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.827 0.822 . . . . 0.1 110.641 -178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -80.57 79.43 7.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 113.959 -1.473 . . . . 0.17 107.647 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.16 -14.26 62.85 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.545 -1.207 . . . . 0.09 109.836 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.586 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.17 -30.01 38.78 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.632 -0.877 . . . . 0.15 108.632 -178.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.1 tp10 -67.93 -34.01 75.78 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.304 -1.317 . . . . 1.73 109.104 171.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.44 -43.69 66.23 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 113.213 -1.812 . . . . 0.12 109.613 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.551 ' CG2' ' HA ' ' A' ' 91' ' ' SER . 63.5 m -63.56 -28.13 69.73 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.73 -1.577 . . . . 0.11 110.159 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 104' ' ' GLU . 3.7 tp10 -66.04 -52.06 52.5 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.16 -1.052 . . . . 1.47 108.16 169.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.665 HG21 ' HB2' ' A' ' 64' ' ' TRP . 32.2 m -56.36 -33.93 66.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.669 -0.696 . . . . 0.12 111.319 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.723 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.7 mt -50.46 -68.02 0.21 Allowed 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 116.12 -0.491 . . . . 0.56 109.799 172.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.55 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.7 mtp180 -43.04 -35.47 1.28 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.129 0.966 . . . . 1.51 111.194 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.604 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -72.56 -45.62 58.36 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.49 -1.232 . . . . 0.28 112.101 -175.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.56 -33.59 60.66 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.309 -0.997 . . . . 0.09 108.309 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -62.99 -34.45 77.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 113.651 -1.613 . . . . 0.12 110.064 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -69.84 -38.28 76.45 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.521 -1.218 . . . . 0.2 111.208 -175.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . 0.611 ' ND2' HE22 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -60.97 -29.21 69.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.736 -1.12 . . . . 1.17 111.179 -175.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -81.31 -30.25 33.98 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.746 -0.661 . . . . 2.05 111.141 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.28 3.82 10.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.049 -0.596 . . . . 0.54 113.228 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.66 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 54.2 mtpt -88.28 -6.31 57.84 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.963 0.411 . . . . 0.99 110.092 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.784 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 27.8 m-85 -122.49 175.32 6.52 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 122.491 1.139 . . . . 0.21 113.099 172.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 7.1 m -121.11 119.26 31.9 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 112.621 -2.081 . . . . 0.23 107.947 168.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -89.6 139.44 30.55 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.345 -0.942 . . . . 0.38 111.319 -170.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.499 HG11 HD23 ' A' ' 88' ' ' LEU . 1.6 m . . . . . 0 C--N 1.3 -1.568 0 N-CA-C 108.222 -1.029 . . . . 0.42 108.222 170.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.67 HD13 HD21 ' A' ' 88' ' ' LEU . 26.1 tp . . . . . 0 CA--C 1.514 -0.429 0 N-CA-C 113.104 0.779 . . . . 1.39 113.104 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.66 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.8 t -50.47 -43.73 55.49 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 123.365 1.555 . . . . 1.05 109.117 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.737 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -57.69 -61.42 2.52 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 111.145 -2.752 . . . . 1.64 110.521 177.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.759 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.76 -45.79 7.35 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 124.564 1.165 . . . . 0.31 112.169 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.513 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.4 OUTLIER -54.44 -53.23 56.96 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 108.701 -0.851 . . . . 1.53 108.701 179.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 128' ' ' SER . 40.2 mt-30 -63.83 -39.89 95.29 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.563 -0.744 . . . . 0.41 111.287 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.737 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.9 mt-30 -58.89 -35.07 72.42 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 114.471 -1.24 . . . . 0.37 109.548 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -90.06 -30.67 17.57 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 113.798 -1.546 . . . . 0.24 109.502 -176.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.27 -45.89 0.6 Allowed Glycine 0 CA--C 1.495 -1.162 0 CA-C-O 122.422 1.012 . . . . 0.33 113.376 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.602 HD13 ' O ' ' A' ' 141' ' ' SER . 92.3 mt -66.38 -171.09 0.11 Allowed 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.362 -1.919 . . . . 0.31 115.613 -170.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.1 m -115.78 151.45 46.33 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 110.716 -2.947 . . . . 0.81 107.924 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.66 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 34.0 Cg_endo -64.81 0.2 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.526 2.151 . . . . 0.32 112.638 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.586 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -119.13 -23.9 6.66 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.871 0.843 . . . . 1.25 110.811 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 14.4 t70 -61.4 -21.5 64.15 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.471 -1.695 . . . . 0.65 109.359 -173.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.602 ' O ' HD13 ' A' ' 136' ' ' LEU . 26.3 m 70.56 167.84 0.3 Allowed 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 112.641 -2.072 . . . . 0.6 110.12 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.947 HD22 ' HA ' ' A' ' 148' ' ' ALA . 5.4 mt -64.97 -40.29 94.77 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.257 -1.016 . . . . 0.86 108.257 -177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 62.39 -10.16 0.12 Allowed Glycine 0 C--N 1.32 -0.357 0 CA-C-N 113.098 -1.864 . . . . 0.31 114.586 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.427 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.7 OUTLIER -153.8 124.51 7.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.026 -0.731 . . . . 0.24 109.026 -175.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.686 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.3 mmt180 -41.28 -45.69 3.02 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 112.101 0.408 . . . . 1.65 112.101 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 31.3 t -75.04 -25.58 58.81 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.791 0.805 . . . . 0.53 111.247 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.551 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 48.2 mttt -72.77 -29.28 63.18 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.755 1.264 . . . . 1.31 108.156 175.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.947 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -77.57 -49.02 15.52 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 112.31 -2.223 . . . . 0.12 110.273 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.629 HG13 ' HE1' ' A' ' 179' ' ' MET . 38.3 mt -65.26 -41.19 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-N 113.016 -1.902 . . . . 0.11 110.151 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.84 -55.0 25.61 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.745 -1.116 . . . . 0.15 111.09 171.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.759 HG23 ' CB ' ' A' ' 130' ' ' ALA . 87.6 mt -66.78 -47.34 83.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 N-CA-C 112.637 0.606 . . . . 0.18 112.637 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.693 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.0 -41.14 74.4 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.046 0.45 . . . . 0.13 111.133 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.518 ' HD2' HG23 ' A' ' 149' ' ' ILE . 54.3 mtp180 -81.01 -23.15 38.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.852 0.835 . . . . 1.08 110.242 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.463 HD21 ' CD ' ' A' ' 133' ' ' GLN . 12.7 t30 -82.73 -10.7 58.78 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.323 -1.362 . . . . 0.5 107.323 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.723 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.14 -28.8 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 113.148 -1.842 . . . . 0.17 110.965 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.403 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.74 35.26 4.66 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.443 -0.884 . . . . 0.16 112.6 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.684 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.4 159.5 16.96 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.02 0.748 . . . . 0.12 113.02 -169.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.671 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -98.64 -29.11 13.23 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.211 -0.904 . . . . 0.2 109.434 178.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.577 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.4 m-85 -135.51 -173.17 3.27 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.055 -0.975 . . . . 0.13 111.037 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.691 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -136.74 138.54 46.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.645 -1.161 . . . . 0.08 108.921 166.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.598 HD21 ' SD ' ' A' ' 176' ' ' MET . 35.1 tp -107.85 100.96 10.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.435 -0.906 . . . . 0.16 109.137 165.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.625 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.4 m-85 -78.5 119.04 21.24 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.401 -1.272 . . . . 0.26 108.131 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.864 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 13.3 t -130.69 158.76 39.19 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 122.12 0.962 . . . . 1.05 110.413 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.818 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.5 p -162.03 170.67 18.86 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.038 -1.437 . . . . 0.1 110.718 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -132.27 135.73 46.46 Favored 'General case' 0 N--CA 1.406 -2.666 0 CA-C-N 114.044 -1.434 . . . . 0.11 108.766 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.7 t -144.52 -170.69 3.44 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.608 -0.837 . . . . 1.09 110.376 176.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 89.84 -83.23 1.38 Allowed Glycine 0 C--N 1.289 -2.065 0 CA-C-N 114.906 -1.043 . . . . 0.15 111.062 175.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.528 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 57.7 t30 -141.67 129.37 21.6 Favored 'General case' 0 C--O 1.199 -1.602 0 CA-C-N 113.872 -1.164 . . . . 0.59 108.205 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.579 HG11 ' HA3' ' A' ' 98' ' ' GLY . 4.2 p -65.28 -41.88 92.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 115.378 -0.828 . . . . 0.15 112.63 -171.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.425 ' N ' HG13 ' A' ' 169' ' ' VAL . 9.7 m120 -61.56 -29.44 70.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.378 0.608 . . . . 1.26 109.462 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.35 88.93 3.35 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 114.592 -1.185 . . . . 0.13 108.9 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.812 ' HD2' HG22 ' A' ' 194' ' ' VAL . 40.7 Cg_endo -92.24 163.88 3.08 Favored 'Trans proline' 0 CA--C 1.501 -1.147 0 C-N-CA 124.858 3.705 . . . . 0.09 115.458 -170.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.743 HG22 ' HB3' ' A' ' 191' ' ' LYS . 14.3 m -82.73 120.54 25.72 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.837 -1.529 . . . . 0.14 107.563 168.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.889 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 22.1 tp -82.78 95.16 7.8 Favored 'General case' 0 CA--C 1.476 -1.901 0 C-N-CA 119.434 -0.906 . . . . 0.16 109.11 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.503 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 35.8 mt-30 -86.18 107.74 18.02 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-O 122.044 0.926 . . . . 0.34 108.61 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.864 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.0 OUTLIER -111.85 163.18 14.48 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.893 -1.048 . . . . 1.09 111.245 -174.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 55.4 tt0 -170.48 117.81 0.53 Allowed 'General case' 0 C--O 1.204 -1.332 0 CA-C-N 115.87 -0.604 . . . . 0.5 110.327 -167.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.032 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.1 100.51 11.38 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.414 -0.958 . . . . 0.1 108.414 -173.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.686 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.6 ttp -90.61 123.39 34.2 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.492 -0.776 . . . . 0.07 109.608 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -59.96 126.65 28.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.096 -1.446 . . . . 0.22 107.096 166.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -81.6 -35.06 13.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 119.103 -1.039 . . . . 0.11 110.81 179.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.426 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.9 mt-30 -62.81 -15.06 52.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.377 -0.828 . . . . 0.35 111.58 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.1 p -130.05 -34.89 1.64 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.724 0.773 . . . . 0.19 110.276 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.478 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 84.6 29.83 28.65 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.462 -1.244 . . . . 0.18 112.12 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 179' ' ' MET . 9.8 pt-20 -105.3 158.19 16.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.42 -0.39 . . . . 0.73 110.447 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.619 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.0 mm -93.58 112.07 25.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.623 0.725 . . . . 0.14 109.659 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.032 HD11 HD13 ' A' ' 178' ' ' LEU . 1.2 pp -99.48 -30.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.067 -0.969 . . . . 0.13 110.853 -173.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.648 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 82.0 t90 -136.76 152.82 50.76 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.403 -0.817 . . . . 0.07 109.743 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 35.9 p -153.99 163.9 39.31 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.107 0.78 . . . . 0.13 113.107 165.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.01 -173.65 27.69 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 111.125 -0.79 . . . . 0.12 111.125 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.889 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.5 mttt -158.8 148.96 19.54 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.409 -1.7 . . . . 1.22 106.409 165.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 174' ' ' LEU . . . -154.13 125.38 1.72 Allowed Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 118.574 -1.774 . . . . 0.12 113.905 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.75 107.93 5.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.648 0.737 . . . . 0.17 110.862 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.812 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -88.57 158.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-N 114.224 -1.353 . . . . 0.11 110.586 -175.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.73 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -100.47 171.99 7.4 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 112.573 -2.103 . . . . 0.18 108.751 -175.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 8.8 tt0 -101.82 132.86 47.35 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.086 -0.646 . . . . 0.91 109.621 172.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.54 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 36.0 mm-40 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.496 -0.764 . . . . 1.24 110.672 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.742 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 . . . . . 0 N--CA 1.418 -2.046 0 N-CA-C 109.499 -0.556 . . . . 0.21 109.499 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.512 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 5.1 t70 -82.49 67.47 8.54 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 123.618 1.675 . . . . 0.35 108.144 171.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.732 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 91.9 m95 -57.58 -42.98 84.19 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 111.678 -2.51 . . . . 0.1 112.026 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.428 ' N ' HG21 ' A' ' 108' ' ' THR . 13.4 t-20 -51.21 -28.3 11.08 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.914 -1.494 . . . . 1.11 111.331 174.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 -18.56 79.06 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.096 -0.956 . . . . 0.21 111.258 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.84 -54.35 2.84 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.868 -1.166 . . . . 0.13 110.879 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.712 ' SD ' HD23 ' A' ' 109' ' ' LEU . 40.8 mtt -60.2 -62.54 1.79 Allowed 'General case' 0 C--O 1.21 -0.998 0 CA-C-N 113.878 -1.51 . . . . 0.09 111.61 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.462 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -37.22 -54.89 1.87 Allowed Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 114.593 1.331 . . . . 0.63 114.593 -172.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.745 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 34.4 Cg_endo -64.14 -31.56 64.54 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.355 2.036 . . . . 0.14 111.001 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.718 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 8.1 mtm -78.24 -43.96 26.86 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 114.988 -1.005 . . . . 0.7 111.271 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 68' ' ' MET . 42.4 t -58.57 -38.94 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-N 114.284 -1.326 . . . . 0.12 108.716 176.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.2 t -58.71 -37.25 75.72 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.956 -1.929 . . . . 0.56 111.026 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.745 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 4.8 mtpm? -78.57 -41.92 30.63 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.627 -0.509 . . . . 1.3 109.627 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.841 ' SD ' ' HE2' ' A' ' 119' ' ' PHE . 1.0 OUTLIER -45.88 -53.53 9.64 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.724 0.809 . . . . 0.5 110.099 -175.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.64 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.9 mt -80.29 7.41 9.58 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.288 -1.324 . . . . 0.65 112.249 -170.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.55 15.62 9.82 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.075 -1.421 . . . . 0.17 109.805 170.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.595 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -80.54 165.25 22.29 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.235 0.54 . . . . 0.1 110.423 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -87.8 105.81 17.65 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 115.597 -0.729 . . . . 1.72 109.124 175.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.673 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.29 -25.37 3.02 Favored Glycine 0 N--CA 1.415 -2.731 0 C-N-CA 119.623 -1.275 . . . . 0.12 110.437 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.763 HG11 ' O ' ' A' ' 75' ' ' MET . 12.8 p -103.21 149.35 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.86 0.838 . . . . 0.16 111.365 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.1 m -135.52 140.33 44.66 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.692 -1.14 . . . . 0.45 110.744 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.594 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -54.77 131.49 43.95 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.07 -0.968 . . . . 0.28 110.698 168.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.04 0.2 38.62 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.951 -0.642 . . . . 0.28 113.271 176.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.87 151.22 23.52 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 120.537 -0.465 . . . . 1.2 111.081 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.712 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -81.16 120.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-O 121.865 0.84 . . . . 0.2 109.074 165.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.725 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -108.42 111.02 22.7 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.412 -0.813 . . . . 0.14 109.061 -171.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.762 HD21 HD23 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -72.31 101.09 2.78 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 114.849 -1.069 . . . . 0.15 109.329 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.548 HG21 ' HG3' ' A' ' 110' ' ' ARG . 53.1 t -74.34 106.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 114.495 -1.229 . . . . 0.95 109.511 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.912 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 2.3 t70 -78.29 158.39 28.89 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.592 -1.186 . . . . 0.64 108.344 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.622 ' OG ' ' HA ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -62.32 135.28 57.39 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 115.378 -0.828 . . . . 0.37 109.325 175.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.599 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 33.4 t -62.28 138.49 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 106.983 -1.488 . . . . 0.1 106.983 167.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.842 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.0 t-20 -85.01 161.49 19.73 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.836 0.827 . . . . 0.18 110.114 174.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.766 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.95 84.94 2.34 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.368 -1.287 . . . . 0.12 108.261 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 14.1 mtp180 -108.51 -2.75 18.68 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 113.912 -1.495 . . . . 0.64 108.572 -172.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.5 p -51.1 -170.94 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.683 -2.053 . . . . 0.14 115.107 -176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 36.5 t30 -70.43 -10.45 59.14 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.134 -1.848 . . . . 0.48 110.567 173.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.595 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -152.22 -144.45 3.92 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.414 -0.898 . . . . 0.12 113.128 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.609 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 54.6 p -122.14 131.73 54.11 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.165 0.432 . . . . 1.16 112.165 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.766 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.8 pp -136.84 156.76 48.06 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.772 0.796 . . . . 0.1 110.947 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.589 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -79.81 81.18 6.11 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.814 -1.539 . . . . 0.17 107.961 175.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -67.97 -15.1 63.45 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.933 -1.485 . . . . 0.09 110.112 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.796 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.92 -32.79 40.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.73 -0.841 . . . . 0.15 108.73 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.589 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 12.8 tp10 -65.22 -34.48 78.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.432 -1.258 . . . . 1.73 108.929 171.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.06 -43.41 64.95 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 113.243 -1.798 . . . . 0.12 109.367 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.617 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 76.5 m -64.73 -28.8 69.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.062 -1.426 . . . . 0.11 110.405 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -43.53 67.31 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.05 -1.093 . . . . 1.47 108.05 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.687 HG21 ' HB2' ' A' ' 64' ' ' TRP . 75.9 m -61.96 -31.6 71.96 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.327 -0.852 . . . . 0.12 110.613 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.716 ' O ' HD23 ' A' ' 113' ' ' LEU . 9.0 mt -51.43 -69.48 0.11 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 109.209 -0.663 . . . . 0.56 109.209 171.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.692 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.9 mtp180 -40.09 -38.86 0.79 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.424 1.078 . . . . 1.51 111.182 175.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.528 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.88 -47.33 59.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.473 -1.24 . . . . 0.28 112.159 -176.073 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.8 -33.08 68.25 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.107 0.956 . . . . 0.09 108.424 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.8 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.1 mm? -61.99 -32.98 73.5 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.437 -1.71 . . . . 0.12 109.894 173.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -74.43 -41.5 60.74 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.484 -1.234 . . . . 0.2 111.604 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -64.93 -25.64 67.97 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.4 -0.818 . . . . 1.17 111.199 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 10.7 m120 -84.15 -16.53 43.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.529 -0.76 . . . . 2.05 110.844 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.6 17.2 19.17 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 115.432 0.933 . . . . 0.54 115.432 164.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.594 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 53.3 mtpt -98.16 -34.4 10.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.541 0.67 . . . . 0.99 109.997 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.841 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 13.7 m-85 -89.32 177.85 6.49 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 122.728 1.251 . . . . 0.21 113.095 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 21.2 m -123.67 111.07 15.75 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 112.299 -2.228 . . . . 0.23 107.84 168.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.8 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -89.37 123.66 33.74 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.719 -1.128 . . . . 0.38 110.734 -170.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.535 HG11 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.3 -1.579 0 CA-C-N 115.354 -0.839 . . . . 0.42 109.102 176.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.762 HD23 HD21 ' A' ' 88' ' ' LEU . 1.1 tm? . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 113.514 0.931 . . . . 1.39 113.514 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.561 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -50.8 -37.97 45.72 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 123.684 1.707 . . . . 1.05 108.637 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.698 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 29.2 mmm -62.82 -62.09 1.96 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 110.417 -3.083 . . . . 1.64 111.403 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.775 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -40.99 -45.12 2.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 124.478 1.111 . . . . 0.31 111.905 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.806 ' HE2' HD21 ' A' ' 142' ' ' LEU . 95.3 mttt -52.38 -58.09 7.77 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.847 -0.615 . . . . 1.53 109.845 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 41.7 mt-30 -58.12 -44.72 87.89 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.566 -1.197 . . . . 0.41 111.622 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.698 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.5 mt-30 -56.47 -36.37 68.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.627 -1.17 . . . . 0.37 109.871 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.51 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -88.49 -29.38 20.18 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.972 -1.467 . . . . 0.24 109.431 -177.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.8 -41.46 0.58 Allowed Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 119.36 -1.4 . . . . 0.33 114.328 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 91.2 mt -73.75 -172.89 1.36 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 123.868 1.794 . . . . 0.31 115.262 -168.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 52.4 m -111.44 151.4 43.23 Favored Pre-proline 0 N--CA 1.425 -1.675 0 CA-C-N 110.783 -2.917 . . . . 0.81 107.964 169.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.652 ' HA ' ' HD2' ' A' ' 131' ' ' LYS . 14.3 Cg_endo -60.6 -3.27 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.736 2.29 . . . . 0.32 112.782 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.796 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -118.6 -20.88 8.18 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 123.132 0.573 . . . . 1.25 109.954 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.6 t70 -60.44 -33.55 72.71 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.699 -1.223 . . . . 0.65 107.699 -174.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.622 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 18.4 m 78.92 156.64 0.16 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 110.441 -3.072 . . . . 0.6 111.059 -173.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.912 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 7.2 mt -63.82 -39.34 94.0 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.15 -1.426 . . . . 0.86 107.15 -172.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.1 -3.6 0.16 Allowed Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 112.849 -1.978 . . . . 0.31 115.166 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 m -149.66 121.67 8.25 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.881 -0.785 . . . . 0.24 108.881 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.59 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.3 mmt180 -41.91 -45.06 3.62 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 123.61 0.569 . . . . 1.65 111.366 -175.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.3 t -73.17 -26.55 61.23 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.541 0.686 . . . . 0.53 111.525 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.559 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 49.1 mttt -73.15 -33.04 65.26 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.138 -1.06 . . . . 1.31 108.138 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.863 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -74.98 -43.46 53.85 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-N 113.019 -1.901 . . . . 0.12 110.465 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.609 ' HA ' HG23 ' A' ' 181' ' ' VAL . 43.4 mt -67.1 -42.69 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 113.589 -1.641 . . . . 0.11 110.159 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.31 -52.33 41.4 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.856 -1.065 . . . . 0.15 111.287 171.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.775 HG23 ' CB ' ' A' ' 130' ' ' ALA . 71.8 mt -68.5 -47.25 78.14 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 N-CA-C 112.891 0.7 . . . . 0.18 112.891 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.695 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.28 -38.34 71.07 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.001 0.429 . . . . 0.13 111.23 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.479 ' HD2' HG23 ' A' ' 149' ' ' ILE . 30.4 mtp180 -84.04 -20.01 33.43 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.666 0.746 . . . . 1.08 110.443 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.468 HD22 ' CB ' ' A' ' 130' ' ' ALA . 16.6 t30 -84.36 -10.38 57.63 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.307 -1.368 . . . . 0.5 107.307 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.745 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -109.69 -29.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 113.262 -1.79 . . . . 0.17 111.094 -173.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.13 34.74 4.73 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.391 -0.909 . . . . 0.16 112.833 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.624 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.64 161.29 15.53 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.15 0.796 . . . . 0.12 113.15 -169.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.712 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -101.91 -28.14 12.57 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.375 -0.829 . . . . 0.2 109.78 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.56 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.4 m-85 -135.39 -172.57 3.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.261 -0.881 . . . . 0.13 110.959 -175.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.769 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -138.85 139.62 40.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.098 -0.955 . . . . 0.08 109.221 167.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.594 HD21 ' SD ' ' A' ' 176' ' ' MET . 43.9 tp -107.62 99.84 9.29 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 119.386 -0.925 . . . . 0.16 109.395 165.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.594 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 3.0 m-85 -81.69 112.81 19.21 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.234 -1.348 . . . . 0.26 109.556 176.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.859 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 4.9 t -123.08 166.12 15.68 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-O 121.77 0.795 . . . . 1.05 111.033 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.848 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -162.79 176.18 10.52 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 114.548 -1.205 . . . . 0.1 111.313 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.65 133.4 30.58 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 113.865 -1.516 . . . . 0.11 108.279 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.67 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -143.14 -177.17 5.23 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.354 -0.61 . . . . 1.09 109.354 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.76 -83.72 0.86 Allowed Glycine 0 CA--C 1.493 -1.336 0 C-N-CA 119.62 -1.276 . . . . 0.15 111.355 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.7 t30 -144.17 130.5 19.8 Favored 'General case' 0 C--O 1.199 -1.598 0 N-CA-C 107.972 -1.121 . . . . 0.59 107.972 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.595 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.2 p -64.48 -41.56 92.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.123 -0.944 . . . . 0.15 112.36 -171.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.417 ' N ' HG13 ' A' ' 169' ' ' VAL . 10.9 m-20 -61.19 -30.76 70.61 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.793 0.806 . . . . 1.26 109.509 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.11 88.39 3.49 Favored Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 113.868 -1.514 . . . . 0.13 108.376 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.814 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.0 Cg_endo -90.72 167.0 4.01 Favored 'Trans proline' 0 CA--C 1.492 -1.579 0 C-N-CA 124.579 3.52 . . . . 0.09 114.72 -170.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 23.7 m -86.39 119.41 26.63 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 113.732 -1.577 . . . . 0.14 107.643 166.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 164' ' ' SER . 42.2 tp -84.13 98.67 10.03 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 108.643 -0.873 . . . . 0.16 108.643 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.627 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.0 mt-30 -90.49 109.02 20.17 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 122.089 0.947 . . . . 0.34 109.276 -176.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.859 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -111.73 164.54 12.93 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.936 -1.029 . . . . 1.09 111.795 -172.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.614 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.0 tt0 -170.64 119.5 0.54 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 115.813 -0.63 . . . . 0.5 110.245 -166.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.064 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.32 101.84 12.58 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.929 -0.767 . . . . 0.1 108.929 -173.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.599 ' HE1' HG13 ' A' ' 149' ' ' ILE . 14.4 ttp -90.88 118.35 30.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.755 -0.657 . . . . 0.07 109.675 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.498 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -61.7 117.89 6.41 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.936 -1.505 . . . . 0.22 106.936 168.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -71.9 -36.35 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.05 0.841 . . . . 0.11 111.485 -176.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.0 mt-30 -60.85 -15.25 28.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.364 -0.835 . . . . 0.35 111.685 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 185' ' ' GLU . 40.5 p -127.91 -37.02 1.95 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.308 1.051 . . . . 0.19 109.896 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.552 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 86.83 24.32 38.73 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 113.765 -1.561 . . . . 0.18 111.733 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.43 ' HG2' ' OG1' ' A' ' 183' ' ' THR . 11.0 pt-20 -105.22 158.03 16.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.882 0.372 . . . . 0.73 110.248 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.614 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.0 mm -91.5 117.14 34.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.498 0.666 . . . . 0.14 109.391 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.064 HD11 HD13 ' A' ' 178' ' ' LEU . 1.8 pp -105.02 -29.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 114.777 -1.101 . . . . 0.13 110.44 -171.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.595 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.4 t90 -136.95 152.2 49.9 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.145 -0.934 . . . . 0.07 109.621 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 53.9 p -153.41 163.46 39.9 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.963 0.727 . . . . 0.13 112.963 164.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.69 -173.82 27.6 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 111.214 -0.755 . . . . 0.12 111.214 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.768 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.4 mtmt -158.91 151.44 21.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.668 -1.975 . . . . 1.22 105.668 165.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -161.02 127.74 1.81 Allowed Glycine 0 C--N 1.282 -2.43 0 C-N-CA 119.866 -1.159 . . . . 0.12 112.235 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.63 117.85 14.83 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.518 0.675 . . . . 0.17 111.528 -173.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.814 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -95.53 158.16 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-O 122.633 1.206 . . . . 0.11 110.676 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.742 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -99.56 172.2 7.44 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.531 -2.122 . . . . 0.18 108.966 -175.126 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.607 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 8.9 tt0 -102.67 134.04 46.69 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.19 -0.604 . . . . 0.91 109.877 171.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.539 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 15.2 mm-40 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.477 -0.773 . . . . 1.24 110.524 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.752 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 . . . . . 0 N--CA 1.415 -2.186 0 N-CA-C 109.264 -0.643 . . . . 0.21 109.264 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 2.8 t70 -80.01 68.09 6.02 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 123.692 1.711 . . . . 0.35 108.36 171.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.726 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 90.3 m95 -59.41 -44.53 92.83 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 111.407 -2.633 . . . . 0.1 112.312 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.437 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 12.8 t-20 -51.36 -30.26 18.18 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.036 -1.438 . . . . 1.11 111.524 176.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.79 -16.31 80.74 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 115.601 -0.727 . . . . 0.21 111.385 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.96 -51.12 3.62 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 113.95 -1.125 . . . . 0.13 110.908 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.718 ' O ' HG23 ' A' ' 72' ' ' VAL . 40.7 mtt -65.33 -55.62 17.21 Favored 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 114.094 -1.412 . . . . 0.09 112.224 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.486 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.7 mm-40 -41.23 -54.76 5.68 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 114.558 1.318 . . . . 0.63 114.558 -176.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.824 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 23.7 Cg_endo -62.29 -31.61 81.91 Favored 'Trans proline' 0 CA--C 1.506 -0.891 0 C-N-CA 122.159 1.906 . . . . 0.14 110.478 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.799 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 6.7 mtm -79.62 -46.5 17.1 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 114.863 -1.062 . . . . 0.7 111.587 -176.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 68' ' ' MET . 61.1 t -55.92 -41.13 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 CA-C-N 114.025 -1.443 . . . . 0.12 108.869 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 t -59.43 -35.26 73.68 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.248 -1.796 . . . . 0.56 110.952 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.824 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 21.0 mtpp -81.45 -34.67 31.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.926 0.49 . . . . 1.3 111.392 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.85 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.68 -27.66 69.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.693 -0.685 . . . . 0.5 111.592 -171.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.79 HD13 ' HB2' ' A' ' 118' ' ' LYS . 5.7 mt -92.92 -6.16 49.2 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.059 0.933 . . . . 0.65 110.817 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.72 18.02 51.41 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 108.726 -1.75 . . . . 0.17 108.726 170.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.669 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.17 163.15 15.56 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.318 -0.941 . . . . 0.1 110.279 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.55 106.14 18.26 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.8 -1.091 . . . . 1.72 109.855 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.628 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.27 -23.85 3.62 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.201 -0.999 . . . . 0.12 111.056 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 75' ' ' MET . 10.4 p -100.22 152.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.661 0.743 . . . . 0.16 111.388 -174.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.5 m -135.25 139.45 44.45 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.643 -1.162 . . . . 0.45 111.011 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.735 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.07 140.52 37.73 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.624 -1.171 . . . . 0.28 111.155 167.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.91 2.95 68.64 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 121.262 -0.494 . . . . 0.28 113.007 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.31 148.84 25.43 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 120.053 -0.659 . . . . 1.2 111.06 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.667 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -79.59 116.18 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-O 122.196 0.998 . . . . 0.2 109.517 166.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.907 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -104.69 109.63 21.63 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.118 -0.946 . . . . 0.14 109.427 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 1.026 HD21 HD13 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -72.16 99.28 2.3 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.832 -1.531 . . . . 0.15 108.421 177.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.678 ' O ' HD21 ' A' ' 127' ' ' LEU . 3.0 m -72.02 117.6 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.699 -1.223 . . . . 0.95 107.699 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.739 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -77.65 137.4 38.51 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.846 -1.168 . . . . 0.64 107.846 -178.013 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.517 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.2 m -53.51 127.98 27.22 Favored 'General case' 0 CA--C 1.49 -1.356 0 CA-C-O 122.064 0.935 . . . . 0.37 108.579 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.596 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 19.8 t -55.53 134.97 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 107.695 -1.224 . . . . 0.1 107.695 173.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.817 ' H ' ' HA ' ' A' ' 164' ' ' SER . 10.2 t-20 -85.62 163.59 18.23 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 114.842 -1.072 . . . . 0.18 109.96 175.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.754 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.11 86.19 2.52 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.383 -1.281 . . . . 0.12 107.894 176.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.421 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 15.1 mtp180 -109.5 -3.51 16.93 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.048 -1.433 . . . . 0.64 108.628 -172.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.734 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.5 p -50.81 -171.47 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.942 -1.935 . . . . 0.14 115.491 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.541 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 37.5 t30 -71.27 -4.46 25.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.776 -2.011 . . . . 0.48 110.719 173.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.597 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -157.85 -145.99 4.38 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.428 -0.892 . . . . 0.12 113.062 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.647 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 59.9 p -121.39 131.97 54.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.347 0.594 . . . . 1.16 112.274 -178.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -137.21 158.31 44.72 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.015 0.912 . . . . 0.1 110.808 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -81.4 79.76 7.94 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.821 -1.536 . . . . 0.17 108.067 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -68.98 -14.38 63.0 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.377 -1.283 . . . . 0.09 109.991 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.77 -30.22 36.05 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.726 -0.842 . . . . 0.15 108.726 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.613 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 14.1 tp10 -67.62 -33.84 75.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 114.451 -1.25 . . . . 1.73 108.96 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.45 -44.19 65.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.186 -1.824 . . . . 0.12 109.567 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 77.6 m -64.0 -30.97 72.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.013 -1.448 . . . . 0.11 110.372 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -43.32 76.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.077 -1.083 . . . . 1.47 108.077 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 64' ' ' TRP . 79.2 m -63.14 -30.6 71.72 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.317 -0.856 . . . . 0.12 110.714 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.716 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.1 mt -51.5 -69.04 0.12 Allowed 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 109.404 -0.591 . . . . 0.56 109.404 172.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 121' ' ' LEU . 18.5 mtp180 -41.06 -39.2 1.17 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.644 -1.162 . . . . 1.51 110.989 175.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.534 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.0 -46.51 64.97 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.476 -1.238 . . . . 0.28 112.038 -176.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.81 -32.84 65.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 122.149 0.976 . . . . 0.09 108.594 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.701 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -64.17 -34.38 77.95 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.588 -1.642 . . . . 0.12 110.1 174.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.655 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -70.97 -38.47 72.77 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.83 -1.077 . . . . 0.2 111.45 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.82 -28.66 68.97 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.403 -1.271 . . . . 1.17 111.041 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -83.24 -36.25 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.913 -1.04 . . . . 2.05 110.19 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.18 -5.23 35.35 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.62 -0.8 . . . . 0.54 114.35 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.79 ' HB2' HD13 ' A' ' 76' ' ' LEU . 53.7 mtpt -81.6 -9.89 59.56 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 117.774 0.787 . . . . 0.99 110.787 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.907 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 28.5 m-85 -115.73 176.08 5.24 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.505 1.145 . . . . 0.21 113.272 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.577 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.9 m -121.83 120.53 34.83 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 112.474 -2.148 . . . . 0.23 107.896 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -88.1 140.01 29.92 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 119.512 -0.875 . . . . 0.38 109.929 -171.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.562 HG11 HD23 ' A' ' 88' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.429 -1.477 0 N-CA-C 108.56 -0.904 . . . . 0.42 108.56 177.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 1.026 HD13 HD21 ' A' ' 88' ' ' LEU . 13.6 tp . . . . . 0 C--O 1.236 0.381 0 N-CA-C 114.58 1.326 . . . . 1.39 114.58 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.585 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 66.6 m -56.23 -36.95 69.07 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 123.227 1.489 . . . . 1.05 108.456 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.616 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 9.3 mmt -62.98 -58.66 6.55 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 111.614 -2.539 . . . . 1.64 110.997 174.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.744 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.63 -41.66 3.16 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 124.224 0.953 . . . . 0.31 111.91 176.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.821 ' HZ2' HD13 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -52.46 -57.61 9.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.153 -0.619 . . . . 1.53 109.912 175.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 40.2 mt-30 -61.4 -43.0 99.62 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.636 -1.166 . . . . 0.41 111.445 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 129' ' ' MET . 47.8 mt-30 -56.29 -35.99 68.13 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 114.434 -1.257 . . . . 0.37 109.683 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.501 HD12 HG13 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -90.34 -29.95 17.75 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.029 -1.442 . . . . 0.24 109.408 -178.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.62 -53.62 0.38 Allowed Glycine 0 CA--C 1.498 -0.976 0 C-N-CA 119.657 -1.259 . . . . 0.33 114.174 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 141' ' ' SER . 14.9 mt -62.36 -171.07 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 112.254 -1.973 . . . . 0.31 116.226 -169.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 27.5 m -109.41 150.89 41.73 Favored Pre-proline 0 N--CA 1.421 -1.893 0 CA-C-N 110.759 -2.928 . . . . 0.81 108.146 171.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 57.2 Cg_endo -66.06 0.19 3.45 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 122.991 2.461 . . . . 0.32 112.139 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.472 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.5 tt0 -117.62 -31.01 5.32 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 114.717 -1.129 . . . . 1.25 109.39 -175.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 25.7 t0 -61.71 -27.01 68.4 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 113.028 -1.896 . . . . 0.65 107.889 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.794 ' O ' HD13 ' A' ' 136' ' ' LEU . 0.4 OUTLIER 73.28 -170.29 0.13 Allowed 'General case' 0 CA--C 1.477 -1.854 0 CA-C-N 112.233 -2.258 . . . . 0.6 109.933 -177.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.827 HD22 ' HA ' ' A' ' 148' ' ' ALA . 10.1 mt -65.25 -37.97 88.89 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.148 -1.387 . . . . 0.86 107.707 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.37 -12.04 0.13 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 112.701 -2.045 . . . . 0.31 115.186 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.34 131.68 10.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 118.708 -0.663 . . . . 0.24 109.226 -175.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.689 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 18.6 mmt180 -45.21 -50.07 11.82 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 118.069 0.395 . . . . 1.65 111.446 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' A' ' 149' ' ' ILE . 71.1 m -71.13 -28.13 64.07 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.384 0.611 . . . . 0.53 111.55 -175.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -72.43 -32.17 66.08 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 122.777 1.275 . . . . 1.31 108.803 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.827 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -68.11 -44.82 75.33 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.218 -2.265 . . . . 0.12 109.906 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.605 HG13 ' HE1' ' A' ' 179' ' ' MET . 37.3 mt -68.72 -43.75 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 CA-C-N 112.958 -1.928 . . . . 0.11 110.411 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.41 -53.22 32.85 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.935 -1.03 . . . . 0.15 111.036 172.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.821 HD13 ' HZ2' ' A' ' 131' ' ' LYS . 79.1 mt -66.98 -47.7 81.54 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 112.845 0.683 . . . . 0.18 112.845 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.647 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.37 -39.28 72.66 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.878 0.37 . . . . 0.13 110.506 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.474 ' HD2' HG23 ' A' ' 149' ' ' ILE . 21.7 mtp180 -82.74 -21.78 34.6 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.464 0.649 . . . . 1.08 110.664 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 17.0 t30 -82.16 -11.2 58.86 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 107.116 -1.438 . . . . 0.5 107.116 176.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.713 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.65 -29.74 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 113.13 -1.85 . . . . 0.17 110.978 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.48 35.75 4.57 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.226 -0.988 . . . . 0.16 112.64 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.645 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.54 155.11 22.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.353 0.872 . . . . 0.12 113.353 -170.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.667 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.2 m80 -94.03 -28.93 15.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.784 0.833 . . . . 0.2 109.852 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.594 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 10.3 m-85 -136.59 -178.16 5.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.342 -0.845 . . . . 0.13 111.15 -173.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.696 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -135.31 139.21 47.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.103 -0.953 . . . . 0.08 109.012 166.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.739 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 22.6 tp -109.96 98.92 8.12 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.607 -0.837 . . . . 0.16 109.932 167.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.0 m-85 -78.42 112.22 15.23 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.252 -0.885 . . . . 0.26 109.367 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.868 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.0 t -124.07 159.62 29.53 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 122.397 1.094 . . . . 1.05 110.323 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.817 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.4 p -164.44 171.97 13.98 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.016 -1.447 . . . . 0.1 111.098 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -133.28 133.96 43.3 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.082 -1.417 . . . . 0.11 108.714 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.1 m -143.67 -176.33 4.93 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.025 -0.732 . . . . 1.09 109.025 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.93 -83.21 0.91 Allowed Glycine 0 C--N 1.301 -1.387 0 C-N-CA 119.698 -1.239 . . . . 0.15 111.454 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.541 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 60.2 t30 -144.7 126.67 15.45 Favored 'General case' 0 C--O 1.196 -1.748 0 N-CA-C 108.066 -1.087 . . . . 0.59 108.066 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.597 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.0 p -62.43 -44.12 98.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.316 -0.856 . . . . 0.15 113.217 -170.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.428 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.9 m120 -62.1 -28.59 69.73 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.398 0.618 . . . . 1.26 109.728 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.86 88.2 3.59 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 114.681 -1.145 . . . . 0.13 108.436 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.839 ' HD2' HG22 ' A' ' 194' ' ' VAL . 42.9 Cg_endo -91.69 167.7 3.26 Favored 'Trans proline' 0 CA--C 1.498 -1.321 0 C-N-CA 125.045 3.83 . . . . 0.09 115.151 -169.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 191' ' ' LYS . 32.3 m -84.35 118.96 24.55 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 113.796 -1.547 . . . . 0.14 107.381 165.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.801 HD12 ' O ' ' A' ' 164' ' ' SER . 48.8 tp -84.43 98.11 9.89 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 108.378 -0.971 . . . . 0.16 108.378 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.555 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 31.4 mt-30 -88.96 109.3 20.13 Favored 'General case' 0 C--N 1.272 -2.761 0 CA-C-O 121.891 0.853 . . . . 0.34 109.239 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.868 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.6 OUTLIER -112.34 164.28 13.42 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.109 -0.951 . . . . 1.09 111.495 -174.556 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.629 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 60.1 tt0 -171.71 116.92 0.4 Allowed 'General case' 0 C--O 1.202 -1.446 0 CA-C-N 116.027 -0.533 . . . . 0.5 110.588 -166.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.053 HD13 HD11 ' A' ' 187' ' ' ILE . 0.8 OUTLIER -98.85 103.23 15.16 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.353 -0.842 . . . . 0.1 108.851 -170.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.662 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 16.3 ttp -92.12 122.29 34.48 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.261 -0.882 . . . . 0.07 109.713 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.433 HD22 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -59.45 126.75 28.89 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.215 -1.402 . . . . 0.22 107.215 166.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.596 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -80.45 -35.56 15.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.433 -0.907 . . . . 0.11 110.682 178.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.43 ' N ' HD12 ' A' ' 180' ' ' LEU . 29.4 mt-30 -64.02 -13.98 50.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.282 -0.872 . . . . 0.35 111.527 -178.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 180' ' ' LEU . 80.6 p -131.12 -32.62 1.58 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.902 0.858 . . . . 0.19 110.623 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.454 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 82.95 28.03 39.12 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.357 -1.292 . . . . 0.18 112.136 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.43 152.38 24.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.64 -0.28 . . . . 0.73 110.502 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.588 HD12 ' HG2' ' A' ' 177' ' ' GLN . 30.4 mm -86.48 121.34 37.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.368 0.604 . . . . 0.14 109.464 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.053 HD11 HD13 ' A' ' 178' ' ' LEU . 1.2 pp -109.28 -29.93 2.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.112 -0.949 . . . . 0.13 110.402 -174.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.669 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 80.6 t90 -136.48 153.43 51.04 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.056 -0.975 . . . . 0.07 109.562 173.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 58.1 p -153.36 164.34 38.31 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.235 0.828 . . . . 0.13 113.235 164.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.2 -173.78 28.07 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 111.244 -0.742 . . . . 0.12 111.244 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.77 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 18.1 mttt -157.69 153.73 27.15 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.221 -2.14 . . . . 1.22 105.221 165.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.19 126.89 1.78 Allowed Glycine 0 C--N 1.279 -2.585 0 C-N-CA 119.525 -1.321 . . . . 0.12 111.663 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -73.94 111.87 9.52 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.508 0.67 . . . . 0.17 110.774 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.839 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -91.3 158.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 122.693 1.235 . . . . 0.11 111.051 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.752 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -98.67 172.38 7.52 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 112.38 -2.191 . . . . 0.18 108.722 -174.548 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.6 tt0 -102.61 133.16 48.06 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.997 -0.681 . . . . 0.91 109.505 169.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.523 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 14.8 mm-40 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.795 -0.622 . . . . 1.24 110.602 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.768 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.0 m-30 . . . . . 0 N--CA 1.421 -1.88 0 N-CA-C 109.821 -0.437 . . . . 0.21 109.821 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.541 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 4.4 t70 -80.73 67.54 6.65 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 123.761 1.743 . . . . 0.35 108.25 171.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.715 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.1 m95 -56.23 -42.28 77.05 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 111.361 -2.654 . . . . 0.1 112.345 174.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.579 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 9.8 t-20 -49.55 -31.14 9.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.537 -1.665 . . . . 1.11 112.183 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.2 -16.58 80.52 Favored Glycine 0 CA--C 1.505 -0.547 0 CA-C-O 122.091 0.828 . . . . 0.21 111.193 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -100.89 -54.14 2.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.846 -1.177 . . . . 0.13 110.874 -176.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.716 ' O ' HG23 ' A' ' 72' ' ' VAL . 41.8 mtt -64.33 -59.12 4.75 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 114.256 -1.338 . . . . 0.09 112.798 -176.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.579 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -39.47 -55.12 3.47 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 114.548 1.314 . . . . 0.63 114.548 -175.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.812 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 43.1 Cg_endo -66.14 -29.68 47.52 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.708 1.605 . . . . 0.14 110.471 -177.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.656 ' HE2' ' N ' ' A' ' 192' ' ' GLY . 11.1 mtm -82.19 -40.46 21.7 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.292 -0.867 . . . . 0.7 111.397 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 68' ' ' MET . 47.9 t -57.44 -39.06 66.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 114.608 -1.178 . . . . 0.12 108.382 172.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -62.12 -33.6 74.76 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.204 -1.816 . . . . 0.56 110.94 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.812 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 32.9 mtpt -82.4 -31.57 29.55 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.203 0.525 . . . . 1.3 110.886 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.849 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.32 -28.52 68.06 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.255 -0.884 . . . . 0.5 111.425 -172.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.659 HD13 ' HD3' ' A' ' 118' ' ' LYS . 5.6 mt -93.53 -4.18 51.5 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.412 1.101 . . . . 0.65 110.588 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.49 17.93 42.31 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 108.837 -1.705 . . . . 0.17 108.837 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.614 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.33 163.98 15.1 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.615 -0.792 . . . . 0.1 109.897 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -92.26 106.42 18.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.517 -0.765 . . . . 1.72 109.732 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.639 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.21 -24.69 3.07 Favored Glycine 0 N--CA 1.418 -2.519 0 C-N-CA 119.998 -1.096 . . . . 0.12 110.373 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.849 HG11 ' O ' ' A' ' 75' ' ' MET . 11.4 p -99.59 153.57 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 114.738 -0.731 . . . . 0.16 111.153 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.6 m -134.55 139.27 45.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.795 -1.093 . . . . 0.45 110.267 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -58.89 143.9 46.24 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.432 -0.804 . . . . 0.28 110.514 168.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.62 69.64 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.89 -0.672 . . . . 0.28 113.141 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.95 153.65 22.03 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 117.078 0.439 . . . . 1.2 110.658 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.722 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.2 p -81.91 116.49 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 122.051 0.929 . . . . 0.2 109.301 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.589 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -104.37 110.06 22.16 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.173 -0.922 . . . . 0.14 109.106 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.75 HD23 HG11 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -71.65 101.09 2.45 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.954 -1.021 . . . . 0.15 108.65 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.669 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 73.0 t -73.66 111.18 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.863 -1.062 . . . . 0.95 109.048 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.792 ' HB2' HD11 ' A' ' 142' ' ' LEU . 6.1 t0 -77.35 152.87 34.25 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 114.735 -1.12 . . . . 0.64 108.167 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.541 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.7 OUTLIER -61.39 137.24 58.24 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.718 -1.128 . . . . 0.37 107.999 173.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.56 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 20.6 t -63.58 138.84 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.88 0 N-CA-C 107.903 -1.147 . . . . 0.1 107.903 167.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.815 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -84.21 162.81 20.06 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.123 -0.944 . . . . 0.18 110.138 173.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.22 85.7 2.44 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.37 -1.287 . . . . 0.12 108.241 175.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.462 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.4 mtp180 -108.73 -1.69 19.19 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.029 -1.441 . . . . 0.64 108.823 -172.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.712 HG21 ' HB3' ' A' ' 172' ' ' PRO . 24.6 p -52.46 -171.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 112.927 -1.942 . . . . 0.14 115.281 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.448 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 30.5 t30 -71.24 -9.39 58.03 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.107 -1.861 . . . . 0.48 110.539 173.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.547 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.73 -146.34 4.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.358 -0.925 . . . . 0.12 112.841 -177.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.587 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.1 p -121.19 129.7 53.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.119 0.485 . . . . 1.16 112.147 -177.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.758 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -134.73 156.76 48.24 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-O 121.876 0.846 . . . . 0.1 110.855 -177.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -80.44 80.7 6.84 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 113.845 -1.525 . . . . 0.17 107.977 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.04 -14.71 63.19 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.261 -1.336 . . . . 0.09 110.027 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.754 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.33 -32.63 37.86 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.812 -0.81 . . . . 0.15 108.812 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.62 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.0 tp10 -65.5 -32.84 74.66 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.384 -1.28 . . . . 1.73 108.901 172.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -73.58 -45.18 54.84 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 112.96 -1.927 . . . . 0.12 109.683 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.62 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 73.1 m -62.84 -31.49 72.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.155 -1.384 . . . . 0.11 110.228 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -66.85 -44.09 81.91 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.136 -1.061 . . . . 1.47 108.136 172.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 64' ' ' TRP . 51.7 m -62.79 -31.73 72.77 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.4 -0.818 . . . . 0.12 110.584 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.689 ' O ' HD23 ' A' ' 113' ' ' LEU . 10.3 mt -52.67 -69.66 0.11 Allowed 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.737 -0.665 . . . . 0.56 109.283 171.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.539 ' HG3' HG21 ' A' ' 89' ' ' VAL . 9.4 mtp180 -40.05 -36.57 0.5 Allowed 'General case' 0 C--N 1.313 -0.991 0 O-C-N 124.365 1.041 . . . . 1.51 111.606 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.516 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -73.4 -46.98 45.55 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.501 -1.227 . . . . 0.28 111.97 -176.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.415 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . . . -72.2 -31.99 66.39 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.261 1.029 . . . . 0.09 108.455 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.866 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.5 mm? -63.23 -35.75 81.38 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.213 -1.812 . . . . 0.12 109.579 172.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.557 ' HA ' HD21 ' A' ' 121' ' ' LEU . . . -73.61 -39.93 64.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 114.855 -1.066 . . . . 0.2 111.383 -175.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -61.01 -32.03 71.63 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.623 -0.717 . . . . 1.17 110.85 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -76.46 -21.34 56.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.412 -0.813 . . . . 2.05 111.076 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 60.91 11.83 26.23 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 115.492 0.957 . . . . 0.54 115.492 162.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.659 ' HD3' HD13 ' A' ' 76' ' ' LEU . 8.6 ptmt -108.47 -23.64 11.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.413 0.606 . . . . 0.99 111.225 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.654 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 3.2 m-85 -87.87 170.15 11.42 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.924 0.869 . . . . 0.21 111.676 172.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 23.5 m -120.66 105.44 10.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 113.425 -1.716 . . . . 0.23 108.064 170.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.866 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -98.17 130.67 44.91 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 114.379 -1.282 . . . . 0.38 112.249 -168.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.594 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.297 -1.711 0 CA-C-N 113.973 -1.467 . . . . 0.42 107.77 174.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.675 HD23 HD21 ' A' ' 88' ' ' LEU . 1.8 tm? . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 112.906 0.706 . . . . 1.39 112.906 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.726 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -50.89 -39.15 53.45 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 123.62 1.676 . . . . 1.05 109.248 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.705 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -63.87 -61.81 2.04 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 110.904 -2.862 . . . . 1.64 110.837 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.782 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.82 -44.78 4.61 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 124.496 1.122 . . . . 0.31 112.134 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.53 ' HZ3' ' N ' ' A' ' 142' ' ' LEU . 13.3 mmtt -49.32 -60.37 2.88 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.471 -0.566 . . . . 1.53 109.471 175.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -59.16 -43.11 92.09 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.234 -0.894 . . . . 0.41 111.059 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.705 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.1 mt-30 -56.41 -36.3 68.76 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 114.238 -1.346 . . . . 0.37 109.69 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -89.94 -31.36 17.3 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.162 -1.381 . . . . 0.24 109.622 -176.441 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.53 -45.41 0.55 Allowed Glycine 0 CA--C 1.495 -1.207 0 C-N-CA 120.096 -1.05 . . . . 0.33 113.278 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 141' ' ' SER . 95.7 mt -67.95 -171.16 0.2 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 112.448 -1.876 . . . . 0.31 115.486 -169.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 9.5 m -115.1 149.91 43.38 Favored Pre-proline 0 N--CA 1.422 -1.875 0 CA-C-N 110.7 -2.954 . . . . 0.81 107.765 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.726 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 28.8 Cg_endo -64.5 1.02 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.534 2.156 . . . . 0.32 112.034 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.754 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -117.36 -21.62 8.61 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.382 -0.826 . . . . 1.25 110.862 -177.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 16.3 t70 -71.42 -20.32 62.13 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.222 -1.354 . . . . 0.65 108.932 -171.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.585 ' O ' HD13 ' A' ' 136' ' ' LEU . 26.3 m 72.84 169.05 0.32 Allowed 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 113.005 -1.907 . . . . 0.6 109.338 -174.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.002 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.9 mt -63.48 -39.12 93.62 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.685 -1.228 . . . . 0.86 107.685 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.43 -11.84 2.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 113.369 -1.741 . . . . 0.31 114.402 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 1.5 m -157.04 128.76 7.09 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.068 -0.716 . . . . 0.24 109.068 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.658 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.3 mmt180 -43.93 -46.46 8.14 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 117.991 0.359 . . . . 1.65 111.385 -178.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.404 ' HA ' ' HB ' ' A' ' 149' ' ' ILE . 40.7 t -71.27 -25.81 62.62 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.68 0.753 . . . . 0.53 111.459 -175.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 22.8 mttm -75.04 -32.21 61.5 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.588 1.185 . . . . 1.31 108.678 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 1.002 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -72.57 -46.02 56.37 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 112.385 -2.189 . . . . 0.12 110.017 177.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.598 HG13 ' HE1' ' A' ' 179' ' ' MET . 41.5 mt -67.14 -42.38 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 112.768 -2.015 . . . . 0.11 109.995 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.92 -52.72 37.48 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 114.74 -1.118 . . . . 0.15 111.301 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.782 HG23 ' CB ' ' A' ' 130' ' ' ALA . 69.5 mt -67.12 -48.44 78.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.072 0 N-CA-C 112.7 0.63 . . . . 0.18 112.7 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.696 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.94 -40.39 73.09 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.826 0.345 . . . . 0.13 111.344 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.524 ' HD2' HG23 ' A' ' 149' ' ' ILE . 43.0 mtp180 -81.64 -22.26 37.71 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.625 0.726 . . . . 1.08 110.321 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.423 HD21 ' CD ' ' A' ' 133' ' ' GLN . 15.4 t30 -81.83 -12.95 58.27 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 107.16 -1.422 . . . . 0.5 107.16 175.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.75 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -106.05 -29.17 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 113.231 -1.804 . . . . 0.17 110.898 -174.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.99 35.63 4.75 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.357 -0.925 . . . . 0.16 112.466 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.669 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.68 158.13 19.65 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.275 0.842 . . . . 0.12 113.275 -169.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.722 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.5 m80 -98.66 -27.79 13.83 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.322 -0.854 . . . . 0.2 109.757 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.624 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 9.3 m-85 -135.58 -173.35 3.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.049 -0.978 . . . . 0.13 111.281 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.697 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -138.42 139.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.9 -1.045 . . . . 0.08 109.231 167.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.735 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 40.8 tp -108.5 97.27 6.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.468 -0.893 . . . . 0.16 109.505 165.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.704 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 1.4 m-85 -78.82 112.45 15.99 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.687 -1.142 . . . . 0.26 108.959 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.719 ' OG ' HD11 ' A' ' 174' ' ' LEU . 27.0 t -122.26 163.19 20.08 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 122.002 0.906 . . . . 1.05 110.515 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.823 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -164.33 173.15 12.59 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 114.37 -1.286 . . . . 0.1 111.049 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.73 139.72 42.09 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 114.14 -1.391 . . . . 0.11 108.758 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.68 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 t -146.42 -172.54 3.98 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.954 -0.698 . . . . 1.09 110.267 176.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 90.3 -84.49 1.34 Allowed Glycine 0 N--CA 1.424 -2.16 0 CA-C-N 114.883 -1.053 . . . . 0.15 111.593 174.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.448 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 49.2 t-20 -135.29 128.04 31.05 Favored 'General case' 0 C--O 1.196 -1.719 0 N-CA-C 106.925 -1.509 . . . . 0.59 106.925 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.547 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.9 p -64.03 -41.51 92.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.553 -0.749 . . . . 0.15 112.37 -177.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.42 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.9 m120 -67.56 -26.45 66.31 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.468 0.651 . . . . 1.26 109.461 -175.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.52 89.21 3.26 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 114.887 -1.051 . . . . 0.13 108.304 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.852 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.6 Cg_endo -90.27 165.0 4.56 Favored 'Trans proline' 0 CA--C 1.488 -1.804 0 C-N-CA 124.519 3.479 . . . . 0.09 114.97 -171.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.597 HG22 ' HB3' ' A' ' 191' ' ' LYS . 19.4 m -83.24 117.32 22.87 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.548 -1.66 . . . . 0.14 107.602 166.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 164' ' ' SER . 49.1 tp -84.09 98.53 9.93 Favored 'General case' 0 N--CA 1.411 -2.381 0 C-N-CA 119.641 -0.824 . . . . 0.16 109.055 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.623 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.8 mt-30 -89.13 107.21 18.92 Favored 'General case' 0 C--N 1.273 -2.749 0 CA-C-N 114.811 -1.086 . . . . 0.34 108.95 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 37.0 mtp -107.08 163.73 12.74 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.138 -0.937 . . . . 1.09 110.393 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.592 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.9 tt0 -170.09 117.41 0.55 Allowed 'General case' 0 C--O 1.202 -1.445 0 CA-C-O 121.179 0.514 . . . . 0.5 110.208 -167.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.101 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -100.12 102.06 13.28 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.705 -0.85 . . . . 0.1 108.705 -172.447 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.658 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.8 ttp -91.67 122.57 34.35 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.416 -0.811 . . . . 0.07 109.755 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.467 ' HB3' ' OG1' ' A' ' 183' ' ' THR . 0.1 OUTLIER -58.53 126.45 27.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.311 -1.366 . . . . 0.22 107.311 166.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.63 -33.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 O-C-N 120.939 -1.101 . . . . 0.11 110.55 178.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.418 ' N ' HD12 ' A' ' 180' ' ' LEU . 29.0 mt-30 -63.85 -13.95 49.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.235 -0.893 . . . . 0.35 111.449 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 180' ' ' LEU . 60.3 p -130.62 -36.69 1.41 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.945 0.878 . . . . 0.19 110.26 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.531 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 87.08 24.35 37.81 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.334 -1.303 . . . . 0.18 112.022 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 186' ' ' ILE . 0.2 OUTLIER -104.26 152.37 22.29 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.621 -0.29 . . . . 0.73 110.658 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.592 HD12 ' HG2' ' A' ' 177' ' ' GLN . 33.0 mm -87.85 113.6 25.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.811 0.815 . . . . 0.14 109.532 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.101 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -101.8 -29.61 3.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 114.729 -1.123 . . . . 0.13 110.587 -173.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.637 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.4 t90 -136.82 152.47 50.31 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.304 -0.862 . . . . 0.07 109.737 172.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 37.3 p -153.78 162.93 40.82 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.003 0.742 . . . . 0.13 113.003 164.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -156.53 -178.24 30.46 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 110.985 -0.846 . . . . 0.12 110.985 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.748 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.1 mtmt -157.12 149.39 22.97 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.343 -1.725 . . . . 1.22 106.343 166.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.656 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -159.35 127.69 1.88 Allowed Glycine 0 C--N 1.285 -2.258 0 C-N-CA 119.973 -1.108 . . . . 0.12 112.258 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.09 114.45 12.43 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.547 0.689 . . . . 0.17 111.472 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.852 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -91.73 159.47 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 122.609 1.195 . . . . 0.11 111.065 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.768 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -99.68 173.78 6.54 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.319 -2.218 . . . . 0.18 108.974 -173.051 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -102.94 130.3 49.95 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.64 -0.424 . . . . 0.91 110.895 171.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.541 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 15.3 mm-40 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.609 -0.71 . . . . 1.24 110.722 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.75 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.8 m-30 . . . . . 0 N--CA 1.418 -2.038 0 N-CA-C 109.593 -0.521 . . . . 0.21 109.593 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.525 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 3.0 t70 -79.24 67.39 4.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 123.762 1.744 . . . . 0.35 108.291 171.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.75 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 89.3 m95 -59.83 -44.43 94.07 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 111.478 -2.601 . . . . 0.1 112.113 174.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.415 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 13.4 t-20 -51.04 -31.44 18.53 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.939 -1.482 . . . . 1.11 111.35 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.35 -16.61 79.81 Favored Glycine 0 C--N 1.312 -0.754 0 CA-C-N 115.504 -0.771 . . . . 0.21 111.318 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.57 -53.67 2.93 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.996 -1.102 . . . . 0.13 110.817 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.697 ' SD ' HD23 ' A' ' 109' ' ' LEU . 42.4 mtt -62.89 -59.61 4.61 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 114.206 -1.361 . . . . 0.09 112.554 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.448 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -38.53 -55.23 2.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 114.83 1.419 . . . . 0.63 114.83 -176.226 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.795 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.1 Cg_endo -65.46 -30.13 52.91 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.674 1.583 . . . . 0.14 110.588 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.672 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 13.7 mtm -83.35 -39.69 20.39 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 115.413 -0.812 . . . . 0.7 111.205 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 68' ' ' MET . 58.9 t -56.82 -39.29 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 114.555 -1.202 . . . . 0.12 108.465 172.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -61.67 -35.33 77.65 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 113.176 -1.829 . . . . 0.56 110.9 174.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.795 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.3 mtpt -81.31 -31.55 33.49 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.093 0.473 . . . . 1.3 110.618 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.874 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.26 -25.17 65.94 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.355 -0.839 . . . . 0.5 111.119 -173.086 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' A' ' 118' ' ' LYS . 6.7 mt -95.2 -5.09 44.69 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.069 0.938 . . . . 0.65 110.762 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.92 17.46 41.7 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 108.888 -1.685 . . . . 0.17 108.888 169.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.648 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -87.39 162.08 17.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.576 -0.812 . . . . 0.1 110.036 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -90.4 105.32 17.73 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.253 -0.885 . . . . 1.72 110.273 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.647 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.92 -22.2 3.47 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.978 -1.01 . . . . 0.12 110.807 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.874 HG11 ' O ' ' A' ' 75' ' ' MET . 10.7 p -102.08 153.88 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.678 0.752 . . . . 0.16 111.704 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.6 m -135.14 139.9 45.0 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.726 -1.124 . . . . 0.45 110.796 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.664 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.81 126.89 29.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.332 -0.849 . . . . 0.28 110.481 166.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.05 8.25 29.83 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.849 -0.691 . . . . 0.28 112.56 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.31 153.2 19.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 120.721 -0.392 . . . . 1.2 110.52 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.0 p -82.1 117.32 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 122.009 0.909 . . . . 0.2 108.956 166.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.662 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -105.42 110.23 22.5 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.301 -0.863 . . . . 0.14 109.267 -171.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.724 HD21 HD23 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -73.04 94.5 1.9 Allowed 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 114.446 -1.252 . . . . 0.15 109.133 178.044 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.4 m -73.39 116.78 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 107.542 -1.281 . . . . 0.95 107.542 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.813 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 7.0 t0 -79.26 170.81 16.07 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.201 -1.036 . . . . 0.64 108.201 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.59 ' OG ' ' HA ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -59.96 149.42 31.95 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 122.773 1.273 . . . . 0.37 108.937 171.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.559 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 36.7 t -74.34 138.55 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.476 0 CA-C-N 113.576 -1.647 . . . . 0.1 106.612 163.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.828 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.4 t-20 -84.45 158.97 20.87 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-O 121.888 0.852 . . . . 0.18 109.875 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.748 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -122.81 84.8 2.32 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.281 -1.327 . . . . 0.12 107.938 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.448 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 15.0 mtp180 -107.67 -1.83 20.73 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 113.547 -1.66 . . . . 0.64 108.574 -172.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.747 HG21 ' HB3' ' A' ' 172' ' ' PRO . 24.1 p -51.82 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.156 -1.838 . . . . 0.14 114.216 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.3 OUTLIER -76.06 -2.99 33.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.233 -1.803 . . . . 0.48 110.33 174.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.638 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -149.66 -150.22 5.19 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.922 -0.656 . . . . 0.12 112.905 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.6 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.1 p -121.83 130.58 53.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.514 0.561 . . . . 1.16 112.514 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.748 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.6 157.38 47.02 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.855 0.836 . . . . 0.1 111.155 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.605 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -80.14 79.49 6.69 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.002 -1.454 . . . . 0.17 107.993 175.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.38 -15.57 63.75 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.285 -1.325 . . . . 0.09 109.997 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.57 -29.97 37.01 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.944 -0.762 . . . . 0.15 108.944 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.605 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.3 tp10 -66.46 -34.64 78.4 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 122.681 1.229 . . . . 1.73 109.131 170.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.99 -43.4 65.17 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 113.203 -1.817 . . . . 0.12 109.664 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 55.7 m -63.77 -31.02 72.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.898 -1.501 . . . . 0.11 110.536 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -67.85 -42.45 81.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.609 -1.256 . . . . 1.47 107.609 172.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.692 HG21 ' HB2' ' A' ' 64' ' ' TRP . 57.2 m -63.56 -31.02 72.06 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.171 -0.922 . . . . 0.12 110.672 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.735 HD11 ' OG ' ' A' ' 163' ' ' SER . 8.3 mt -50.9 -70.47 0.08 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 115.776 -0.647 . . . . 0.56 109.278 171.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.52 ' O ' HD13 ' A' ' 121' ' ' LEU . 17.0 mtp180 -41.0 -38.78 1.04 Allowed 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.475 1.109 . . . . 1.51 111.197 176.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -68.37 -46.49 69.93 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.367 -1.288 . . . . 0.28 112.358 -177.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.448 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.38 -33.4 65.01 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.299 1.047 . . . . 0.09 108.417 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -65.2 -31.89 73.28 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.186 -1.824 . . . . 0.12 110.131 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.65 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.85 -44.69 61.07 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 114.335 -1.302 . . . . 0.2 111.713 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -65.72 -28.75 69.28 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.54 -1.209 . . . . 1.17 110.832 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -81.43 -19.78 41.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.3 -0.864 . . . . 2.05 111.885 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 59.24 11.05 11.53 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 115.586 0.995 . . . . 0.54 115.586 163.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.664 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 56.2 mtpt -96.93 -3.96 40.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.35 0.575 . . . . 0.99 109.759 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.662 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 29.0 m-85 -121.22 173.2 7.46 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.481 1.134 . . . . 0.21 112.726 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 16.3 m -117.85 115.82 25.74 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 112.658 -2.065 . . . . 0.23 107.776 170.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.3 OUTLIER -83.07 137.57 34.05 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.152 -0.931 . . . . 0.38 110.376 -172.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.551 HG21 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.295 -1.782 0 N-CA-C 108.074 -1.084 . . . . 0.42 108.074 171.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.724 HD23 HD21 ' A' ' 88' ' ' LEU . 1.2 tm? . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 113.574 0.953 . . . . 1.39 113.574 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.595 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -51.94 -37.56 53.22 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.582 1.658 . . . . 1.05 108.407 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.651 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.4 OUTLIER -62.89 -60.13 3.89 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 110.714 -2.948 . . . . 1.64 111.292 178.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.778 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.15 -43.03 6.77 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 124.304 1.003 . . . . 0.31 112.148 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.703 ' HE3' ' CD2' ' A' ' 127' ' ' LEU . 22.3 mttt -52.77 -55.52 22.25 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 120.326 -0.549 . . . . 1.53 109.691 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 40.8 mt-30 -62.14 -41.74 98.57 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.021 -0.99 . . . . 0.41 111.28 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 129' ' ' MET . 53.5 mt-30 -57.06 -36.45 70.56 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.257 -1.338 . . . . 0.37 110.034 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -91.06 -31.0 16.44 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.243 -1.344 . . . . 0.24 109.084 -176.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.52 -51.24 0.36 Allowed Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.015 -1.088 . . . . 0.33 113.979 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 141' ' ' SER . 46.8 mt -67.41 -171.1 0.16 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 116.12 1.896 . . . . 0.31 116.12 -169.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.8 m -115.58 152.55 47.31 Favored Pre-proline 0 N--CA 1.427 -1.62 0 CA-C-N 110.732 -2.94 . . . . 0.81 108.158 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.686 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 11.8 Cg_endo -59.2 -4.9 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.027 2.485 . . . . 0.32 113.171 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -117.49 -30.41 5.53 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.826 0.822 . . . . 1.25 111.104 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.591 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.4 t70 -58.28 -25.49 61.87 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.42 -1.718 . . . . 0.65 109.065 -174.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.59 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 5.5 m 72.9 161.37 0.24 Allowed 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 111.495 -2.593 . . . . 0.6 111.822 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.909 HD13 ' HA ' ' A' ' 148' ' ' ALA . 8.5 mt -66.64 -38.76 87.58 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.25 -1.389 . . . . 0.86 107.25 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.34 -4.78 0.32 Allowed Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 112.576 -2.102 . . . . 0.31 114.703 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.48 124.35 9.24 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 118.603 -0.713 . . . . 0.24 109.369 -174.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.586 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 16.6 mmt85 -41.66 -51.16 4.11 Favored 'General case' 0 C--O 1.212 -0.92 0 O-C-N 123.563 0.539 . . . . 1.65 111.046 -177.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.9 t -67.81 -29.16 68.27 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.493 0.663 . . . . 0.53 111.21 -174.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 20.6 mttm -72.76 -31.17 64.72 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.355 1.074 . . . . 1.31 108.519 177.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.909 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -76.97 -41.91 41.12 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 113.049 -1.887 . . . . 0.12 110.746 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.609 ' HA ' HG23 ' A' ' 181' ' ' VAL . 43.0 mt -69.12 -42.21 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 113.393 -1.731 . . . . 0.11 110.189 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.66 -48.77 64.13 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.904 -1.044 . . . . 0.15 111.27 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.778 HG23 ' CB ' ' A' ' 130' ' ' ALA . 67.2 mt -71.23 -48.08 56.58 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 N-CA-C 112.87 0.693 . . . . 0.18 112.87 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.666 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.57 -39.42 70.63 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.935 0.398 . . . . 0.13 110.633 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.487 ' HD2' HG23 ' A' ' 149' ' ' ILE . 28.7 mtp180 -81.01 -24.4 37.96 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.522 0.677 . . . . 1.08 110.672 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.536 HD21 ' CD ' ' A' ' 133' ' ' GLN . 32.3 t30 -79.28 -14.12 59.23 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.508 -1.293 . . . . 0.5 107.508 175.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.71 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -104.69 -29.98 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 113.196 -1.82 . . . . 0.17 110.967 -173.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.05 33.04 5.36 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.681 -0.771 . . . . 0.16 112.437 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.689 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -106.89 159.75 16.02 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.92 0.711 . . . . 0.12 112.92 -170.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.67 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.9 m80 -99.65 -27.24 13.77 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.379 -0.828 . . . . 0.2 109.686 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 5.6 m-85 -135.58 -173.02 3.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.262 -0.881 . . . . 0.13 110.941 -175.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.776 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -137.63 138.6 44.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.941 -1.027 . . . . 0.08 108.897 166.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.479 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 45.5 tp -107.93 101.36 10.63 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 119.715 -0.794 . . . . 0.16 109.038 165.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.605 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.4 m-85 -81.38 113.03 19.19 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.087 -1.415 . . . . 0.26 109.559 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.735 ' OG ' HD11 ' A' ' 109' ' ' LEU . 4.2 p -118.09 159.99 22.3 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.717 0.77 . . . . 1.05 110.749 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.828 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.9 p -163.94 173.6 12.45 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 114.862 -1.063 . . . . 0.1 111.414 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.09 139.01 37.58 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 113.951 -1.477 . . . . 0.11 108.464 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.4 t -147.2 -171.47 3.79 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.055 -0.658 . . . . 1.09 110.073 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.05 -80.71 1.43 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.128 -1.034 . . . . 0.15 111.773 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.5 t30 -144.52 125.47 14.4 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 107.99 -1.115 . . . . 0.59 107.99 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.638 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.3 p -63.12 -42.97 98.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.479 -0.782 . . . . 0.15 112.934 -171.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.441 ' N ' HG13 ' A' ' 169' ' ' VAL . 9.7 m120 -61.66 -29.53 70.13 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.391 0.615 . . . . 1.26 109.532 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.9 88.52 3.54 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.634 -1.167 . . . . 0.13 108.508 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.844 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.3 Cg_endo -91.55 167.7 3.34 Favored 'Trans proline' 0 CA--C 1.497 -1.374 0 C-N-CA 124.927 3.751 . . . . 0.09 115.015 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.631 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 14.5 m -85.73 118.0 24.96 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.041 -1.436 . . . . 0.14 108.098 166.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 164' ' ' SER . 43.4 tp -84.49 98.66 10.23 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-O 122.057 0.932 . . . . 0.16 109.386 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.682 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.7 mt-30 -87.7 108.08 18.94 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.576 -1.193 . . . . 0.34 109.088 -178.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.56 ' HG3' ' HG ' ' A' ' 174' ' ' LEU . 80.9 mtp -105.74 162.42 13.55 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.059 -0.973 . . . . 1.09 110.483 -176.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.612 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.7 tt0 -169.74 119.38 0.64 Allowed 'General case' 0 C--O 1.203 -1.39 0 CA-C-O 121.324 0.583 . . . . 0.5 109.792 -170.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.084 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -101.2 100.85 11.45 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.542 -0.91 . . . . 0.1 108.542 -172.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.586 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.9 ttp -90.47 120.06 31.26 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.764 -0.653 . . . . 0.07 109.448 176.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.544 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.66 117.77 6.73 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.222 -1.399 . . . . 0.22 107.222 169.315 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -71.72 -35.71 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.162 0.892 . . . . 0.11 111.439 -176.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.437 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 32.5 mt-30 -61.38 -13.62 21.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.411 -0.813 . . . . 0.35 111.581 -176.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 34.5 p -130.22 -37.96 1.42 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.176 0.989 . . . . 0.19 110.086 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.572 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.59 16.27 52.79 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 113.801 -1.545 . . . . 0.18 112.138 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -98.09 156.34 16.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.94 0.4 . . . . 0.73 110.619 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.612 HD12 ' HG2' ' A' ' 177' ' ' GLN . 31.6 mm -88.78 118.74 34.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.572 0.701 . . . . 0.14 109.404 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.084 HD11 HD13 ' A' ' 178' ' ' LEU . 1.7 pp -106.49 -29.08 2.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.804 -1.089 . . . . 0.13 110.123 -172.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.661 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.3 t90 -137.92 153.37 49.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.547 -0.751 . . . . 0.07 110.135 171.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 54.9 p -153.52 164.4 38.29 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 113.379 0.881 . . . . 0.13 113.379 164.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.93 -178.49 32.99 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.039 -0.825 . . . . 0.12 111.039 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.3 mtmt -157.86 146.5 19.22 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.446 -1.687 . . . . 1.22 106.446 166.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.672 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -157.45 128.02 2.04 Favored Glycine 0 C--N 1.284 -2.357 0 CA-C-N 114.677 -1.147 . . . . 0.12 112.064 -177.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.52 116.05 14.75 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.544 0.687 . . . . 0.17 111.343 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.844 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -94.1 158.82 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 122.618 1.199 . . . . 0.11 110.979 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.729 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -100.89 171.98 7.32 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 112.527 -2.124 . . . . 0.18 108.844 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 7.7 tt0 -101.56 131.6 47.65 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.121 -0.632 . . . . 0.91 109.376 169.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.525 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 15.2 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.418 -0.801 . . . . 1.24 110.931 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.774 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.5 m-30 . . . . . 0 N--CA 1.418 -2.041 0 N-CA-C 109.936 -0.394 . . . . 0.21 109.936 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.521 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 4.0 t70 -80.97 68.28 7.19 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 123.68 1.705 . . . . 0.35 108.125 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.731 ' HZ3' HD13 ' A' ' 174' ' ' LEU . 93.5 m95 -57.85 -41.52 82.53 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.599 -2.546 . . . . 0.1 111.94 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.581 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 13.0 t-20 -52.98 -27.71 20.4 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.99 -1.459 . . . . 1.11 111.496 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.57 -15.2 81.21 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.412 -0.813 . . . . 0.21 111.129 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.96 -53.64 2.9 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.908 -1.146 . . . . 0.13 111.17 -176.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.726 ' SD ' HD23 ' A' ' 109' ' ' LEU . 38.5 mtt -65.27 -57.77 7.62 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.263 -1.335 . . . . 0.09 112.132 -177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.581 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.1 mm-40 -40.25 -55.88 3.8 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 114.348 1.24 . . . . 0.63 114.348 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.775 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.3 Cg_endo -63.88 -27.3 67.11 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.541 1.494 . . . . 0.14 110.74 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.666 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 12.7 mtm -85.56 -43.2 13.72 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.562 -0.745 . . . . 0.7 112.174 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 68' ' ' MET . 31.5 t -59.0 -37.91 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 CA-C-N 115.011 -0.995 . . . . 0.12 108.826 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -57.11 -36.56 70.78 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.409 -1.723 . . . . 0.56 110.396 174.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.775 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.7 mtpt -80.91 -37.3 29.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.087 -0.96 . . . . 1.3 110.49 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.872 ' O ' HG11 ' A' ' 81' ' ' VAL . 2.5 ttp -57.65 -31.61 66.46 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.421 -1.263 . . . . 0.5 111.439 -175.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.615 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 22.5 mt -88.51 -5.31 58.3 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.917 0.865 . . . . 0.65 111.594 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.96 17.4 35.32 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.286 -1.525 . . . . 0.17 109.286 172.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.711 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.03 161.76 16.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.807 -0.696 . . . . 0.1 109.733 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.446 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 9.7 p-10 -89.16 107.73 19.21 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.362 1.077 . . . . 1.72 111.443 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.666 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.73 -24.32 3.03 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 114.268 -1.333 . . . . 0.12 110.45 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 75' ' ' MET . 14.9 p -102.83 153.05 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.526 0.679 . . . . 0.16 111.762 -173.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.4 m -134.98 138.82 44.36 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.653 -1.158 . . . . 0.45 110.577 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.59 131.26 50.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.757 -0.656 . . . . 0.28 110.182 166.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.14 -1.47 31.35 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.026 -0.607 . . . . 0.28 112.593 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.89 150.64 23.96 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.264 -0.575 . . . . 1.2 111.016 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.65 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.6 p -80.05 113.81 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-O 122.277 1.037 . . . . 0.2 109.01 164.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.855 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -100.88 107.21 18.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.814 -1.085 . . . . 0.14 108.722 -172.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.683 HD23 HG11 ' A' ' 155' ' ' VAL . 0.8 OUTLIER -70.92 97.88 1.5 Allowed 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 114.169 -1.378 . . . . 0.15 108.019 177.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 87' ' ' LEU . 2.2 m -71.37 118.27 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.243 0 N-CA-C 106.888 -1.523 . . . . 0.95 106.888 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.79 ' HB2' HD11 ' A' ' 142' ' ' LEU . 0.8 OUTLIER -77.09 146.32 37.31 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 107.159 -1.422 . . . . 0.64 107.159 178.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.497 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -55.36 134.43 50.19 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.448 -1.315 . . . . 0.37 107.448 175.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.54 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 22.0 t -61.46 138.4 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.011 0 N-CA-C 107.768 -1.197 . . . . 0.1 107.768 170.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.784 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.4 t-20 -84.95 163.02 19.19 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.156 -0.929 . . . . 0.18 109.714 175.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.757 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.88 86.12 2.51 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.524 -1.216 . . . . 0.12 108.185 175.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -106.88 -4.22 19.43 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 113.97 -1.468 . . . . 0.64 108.827 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.76 HG21 ' HB3' ' A' ' 172' ' ' PRO . 21.8 p -50.67 -177.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.516 -1.674 . . . . 0.14 114.318 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 1.4 t30 -70.13 -10.7 59.62 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.476 -1.693 . . . . 0.48 110.325 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.572 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -140.55 -152.56 5.81 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.668 -0.696 . . . . 0.12 112.564 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.609 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 70.7 m -122.44 129.36 51.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.071 0.462 . . . . 1.16 111.129 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.757 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.9 pp -132.5 160.1 37.47 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.786 0.803 . . . . 0.1 110.551 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.616 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -82.94 79.85 9.17 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.902 -1.499 . . . . 0.17 107.889 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.28 -14.11 62.75 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.483 -1.235 . . . . 0.09 109.958 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . 0.631 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.07 -32.23 39.34 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.545 -0.909 . . . . 0.15 108.545 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.616 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 42.8 tp10 -66.43 -33.71 76.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 114.325 -1.307 . . . . 1.73 109.05 171.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.54 -43.91 65.55 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.113 -1.858 . . . . 0.12 109.509 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 62.9 m -63.34 -29.73 70.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.808 -1.542 . . . . 0.11 110.417 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -44.68 76.58 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.119 -1.067 . . . . 1.47 108.119 171.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.683 HG21 ' HB2' ' A' ' 64' ' ' TRP . 73.2 m -62.48 -30.79 71.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.412 -0.813 . . . . 0.12 110.718 178.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.726 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -50.99 -68.98 0.12 Allowed 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 109.326 -0.62 . . . . 0.56 109.326 171.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.555 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.3 mtp180 -40.99 -37.61 0.84 Allowed 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.345 1.028 . . . . 1.51 111.411 175.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.553 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -71.54 -46.12 60.41 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.576 -1.193 . . . . 0.28 111.968 -176.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.505 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.56 -32.04 63.95 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 122.402 1.096 . . . . 0.09 108.701 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -65.79 -33.67 76.4 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.498 -1.683 . . . . 0.12 109.88 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.93 -41.49 64.45 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 114.636 -1.166 . . . . 0.2 111.06 -176.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -64.21 -27.2 68.9 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.895 -1.048 . . . . 1.17 110.332 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -81.92 -21.76 37.15 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.466 -0.788 . . . . 2.05 111.01 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 59.78 15.61 34.98 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 115.588 0.995 . . . . 0.54 115.588 163.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.615 ' HE2' ' HB3' ' A' ' 76' ' ' LEU . 19.7 mtmt -101.81 -28.62 12.34 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 117.719 0.76 . . . . 0.99 109.969 174.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.855 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 26.1 m-85 -92.23 173.81 7.63 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 122.152 0.977 . . . . 0.21 112.447 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.606 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.7 m -118.4 123.19 44.63 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 113.31 -1.768 . . . . 0.23 107.89 169.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.659 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -94.05 139.55 30.82 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 119.329 -0.949 . . . . 0.38 111.865 -170.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.474 HG11 HD23 ' A' ' 88' ' ' LEU . 1.3 m . . . . . 0 C--N 1.301 -1.531 0 N-CA-C 107.786 -1.19 . . . . 0.42 107.786 170.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.679 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 35.3 tp . . . . . 0 CA--C 1.518 -0.27 0 N-CA-C 113.456 0.91 . . . . 1.39 113.456 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.655 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 3.5 t -50.67 -47.35 58.82 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 123.396 1.57 . . . . 1.05 109.374 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.693 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 16.7 mmt -54.0 -61.82 2.06 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 111.24 -2.709 . . . . 1.64 110.818 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.77 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.83 -44.97 7.16 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 124.124 0.89 . . . . 0.31 112.626 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.702 ' NZ ' HD13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -55.94 -51.5 67.44 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 107.343 -1.354 . . . . 1.53 107.343 -178.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.3 mt-30 -65.15 -41.03 95.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.672 -1.149 . . . . 0.41 111.173 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.693 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.2 mt-30 -57.6 -32.56 67.31 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 114.628 -1.169 . . . . 0.37 109.574 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -93.96 -27.15 16.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 113.911 -1.495 . . . . 0.24 109.719 -177.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.38 -50.12 0.53 Allowed Glycine 0 CA--C 1.5 -0.904 0 CA-C-O 122.766 1.204 . . . . 0.33 113.428 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.634 HD13 ' O ' ' A' ' 141' ' ' SER . 78.4 mt -66.58 -170.95 0.11 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 112.175 -2.012 . . . . 0.31 116.025 -170.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.1 m -116.22 152.86 48.37 Favored Pre-proline 0 N--CA 1.431 -1.415 0 CA-C-N 111.129 -2.759 . . . . 0.81 108.56 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.655 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 18.1 Cg_endo -62.34 -2.0 2.86 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.086 2.524 . . . . 0.32 112.993 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.631 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -118.74 -26.85 5.99 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.579 0.704 . . . . 1.25 110.746 -177.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.3 t70 -63.04 -21.89 66.47 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 113.895 -1.502 . . . . 0.65 109.127 -173.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.634 ' O ' HD13 ' A' ' 136' ' ' LEU . 38.1 m 74.4 168.59 0.3 Allowed 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.666 -2.061 . . . . 0.6 110.653 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 90' ' ' ASP . 6.4 mt -64.78 -40.53 95.4 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.321 1.058 . . . . 0.86 108.331 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.7 -12.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 112.823 -1.99 . . . . 0.31 114.507 177.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.417 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -151.32 125.11 9.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.073 -0.714 . . . . 0.24 109.073 -174.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.657 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.3 mmt180 -42.6 -47.33 5.2 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 118.047 0.385 . . . . 1.65 111.936 -176.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.9 t -71.22 -25.85 62.67 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.664 0.745 . . . . 0.53 111.35 -175.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.406 ' HD3' HD11 ' A' ' 136' ' ' LEU . 27.2 mttm -75.84 -30.75 59.06 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 122.766 1.269 . . . . 1.31 108.862 176.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.776 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -72.1 -46.77 55.4 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 112.184 -2.28 . . . . 0.12 110.236 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.607 HG13 ' HE1' ' A' ' 179' ' ' MET . 37.3 mt -68.07 -41.4 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 112.909 -1.95 . . . . 0.11 110.054 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.42 -54.83 27.82 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.51 -1.223 . . . . 0.15 111.107 170.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.77 HG23 ' CB ' ' A' ' 130' ' ' ALA . 12.4 mt -66.27 -46.6 86.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.062 0 N-CA-C 112.693 0.627 . . . . 0.18 112.693 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.665 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -57.73 -40.73 80.27 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 118.013 0.37 . . . . 0.13 111.015 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.482 ' HD2' HG23 ' A' ' 149' ' ' ILE . 28.5 mtp-105 -81.49 -22.34 38.09 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.826 0.822 . . . . 1.08 110.346 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.508 HD21 ' CD ' ' A' ' 133' ' ' GLN . 12.7 t30 -82.01 -11.64 58.73 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 114.274 -1.33 . . . . 0.5 107.449 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.7 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.91 -29.13 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 113.267 -1.788 . . . . 0.17 110.794 -174.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.47 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.37 34.92 4.88 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.387 -0.911 . . . . 0.16 112.362 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.663 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.98 160.57 16.31 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 113.138 0.792 . . . . 0.12 113.138 -169.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.65 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -99.78 -28.96 12.89 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.0 -1.0 . . . . 0.2 109.744 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.672 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 11.6 m-85 -136.65 -175.43 4.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.96 -1.018 . . . . 0.13 110.83 -174.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.676 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -135.64 138.59 47.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.062 -0.972 . . . . 0.08 108.562 166.282 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.669 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 33.8 tp -108.26 99.59 8.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.281 -0.968 . . . . 0.16 109.483 166.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.776 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.64 112.54 17.01 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.784 -1.098 . . . . 0.26 109.322 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.872 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 13.0 t -124.37 158.88 31.63 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 122.157 0.979 . . . . 1.05 110.239 -177.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.831 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.8 p -160.75 173.47 15.36 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.166 -1.379 . . . . 0.1 110.564 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.88 132.07 34.02 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-N 114.36 -1.291 . . . . 0.11 108.613 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -140.89 -178.01 5.35 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.055 -0.658 . . . . 1.09 109.73 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.43 -83.26 0.87 Allowed Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 119.774 -1.203 . . . . 0.15 111.847 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 43.5 t-20 -140.08 127.18 20.97 Favored 'General case' 0 C--O 1.195 -1.794 0 N-CA-C 106.294 -1.743 . . . . 0.59 106.294 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.572 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.3 p -60.64 -44.52 97.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 114.861 -1.063 . . . . 0.15 111.65 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.465 ' HA ' HE21 ' A' ' 196' ' ' GLN . 43.2 m-80 -66.9 -24.92 66.15 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.338 0.59 . . . . 1.26 109.777 -174.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.04 88.28 3.21 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 114.996 -1.002 . . . . 0.13 108.474 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.826 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.1 Cg_endo -91.01 163.7 3.86 Favored 'Trans proline' 0 CA--C 1.492 -1.576 0 C-N-CA 124.652 3.568 . . . . 0.09 115.253 -170.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.632 HG22 ' HB3' ' A' ' 191' ' ' LYS . 7.7 m -84.83 119.71 25.62 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 113.668 -1.605 . . . . 0.14 107.998 170.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.893 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 21.8 tp -82.59 95.83 7.89 Favored 'General case' 0 CA--C 1.472 -2.043 0 C-N-CA 119.655 -0.818 . . . . 0.16 109.474 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.58 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 39.1 mt-30 -87.2 106.76 18.12 Favored 'General case' 0 C--N 1.253 -3.609 0 CA-C-O 122.415 1.102 . . . . 0.34 108.663 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.872 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.3 mmm -110.97 162.97 14.3 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.516 -1.22 . . . . 1.09 110.944 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.637 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.4 tt0 -171.41 118.92 0.46 Allowed 'General case' 0 C--O 1.205 -1.288 0 CA-C-O 121.165 0.507 . . . . 0.5 110.702 -166.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.061 HD13 HD11 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -100.36 100.9 11.76 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.853 -0.795 . . . . 0.1 108.853 -172.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.657 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.2 ttp -91.16 120.95 32.52 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.161 -0.927 . . . . 0.07 109.398 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -58.49 126.76 28.93 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.066 -1.457 . . . . 0.22 107.066 166.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.612 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.18 -36.2 14.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 119.435 -0.906 . . . . 0.11 110.376 178.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.475 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 23.3 mt-30 -61.03 -16.26 41.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.093 -0.958 . . . . 0.35 111.529 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 66.9 p -129.04 -37.0 1.73 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.769 0.795 . . . . 0.19 110.077 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.568 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.26 29.37 19.95 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 114.299 -1.319 . . . . 0.18 112.205 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.73 154.3 23.1 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.674 0.273 . . . . 0.73 110.6 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.637 HD12 ' HG2' ' A' ' 177' ' ' GLN . 29.5 mm -86.53 121.4 37.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.402 0.62 . . . . 0.14 109.365 177.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.061 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -109.76 -33.06 2.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.095 -0.957 . . . . 0.13 110.45 -174.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.711 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 79.8 t90 -132.14 152.19 51.38 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.581 -0.736 . . . . 0.07 109.356 172.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 27.0 p -153.79 162.8 40.93 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.265 0.839 . . . . 0.13 113.265 164.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -157.69 -175.12 28.26 Favored Glycine 0 N--CA 1.427 -1.932 0 N-CA-C 110.817 -0.913 . . . . 0.12 110.817 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.893 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.2 mtmt -158.98 147.94 18.54 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.386 -1.709 . . . . 1.22 106.386 165.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 174' ' ' LEU . . . -156.05 125.89 1.72 Allowed Glycine 0 C--N 1.289 -2.047 0 C-N-CA 118.638 -1.744 . . . . 0.12 114.021 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.75 112.59 7.98 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.619 0.723 . . . . 0.17 110.979 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.826 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -90.76 159.28 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 114.545 -1.207 . . . . 0.11 110.269 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.774 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -100.08 174.18 6.29 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 112.801 -2.0 . . . . 0.18 108.825 -173.319 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -102.16 131.48 48.64 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.492 -0.483 . . . . 0.91 110.532 171.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.532 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 17.4 mm-40 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.514 -0.755 . . . . 1.24 110.264 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.745 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.9 m-30 . . . . . 0 N--CA 1.421 -1.907 0 N-CA-C 109.638 -0.504 . . . . 0.21 109.638 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 7.3 t70 -81.65 67.32 7.57 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 123.795 1.759 . . . . 0.35 107.978 171.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.754 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.9 m95 -58.17 -42.15 85.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 111.361 -2.654 . . . . 0.1 111.847 173.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.497 ' N ' HG21 ' A' ' 108' ' ' THR . 0.2 OUTLIER -56.35 -27.76 56.9 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.138 -1.392 . . . . 1.11 110.285 178.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.23 -14.47 76.65 Favored Glycine 0 CA--C 1.498 -1.013 0 N-CA-C 110.816 -0.914 . . . . 0.21 110.816 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.436 ' O ' ' HD2' ' A' ' 70' ' ' PRO . . . -97.38 -54.56 3.11 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 113.966 -1.117 . . . . 0.13 110.32 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' MET . . . . . 0.856 ' HA ' ' SD ' ' A' ' 71' ' ' MET . 40.6 mtt -61.87 -49.65 75.39 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 124.545 1.153 . . . . 0.09 112.454 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.449 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 5.7 mm-40 -41.39 -55.33 5.44 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 115.269 1.581 . . . . 0.63 115.269 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.806 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.8 Cg_endo -64.18 -29.22 64.73 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.063 1.842 . . . . 0.14 111.353 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' MET . . . . . 0.856 ' SD ' ' HA ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -80.96 -45.15 17.09 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 114.98 -1.009 . . . . 0.7 110.122 -178.343 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 68' ' ' MET . 61.3 t -56.29 -40.78 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 114.246 -1.343 . . . . 0.12 108.729 174.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -57.15 -35.25 69.31 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.075 -1.875 . . . . 0.56 111.189 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.806 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 26.8 mtpt -85.96 -33.08 21.22 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.918 0.39 . . . . 1.3 110.981 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . 0.828 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.98 -26.98 68.82 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.618 -0.719 . . . . 0.5 111.477 -170.3 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.583 HD13 ' HB2' ' A' ' 118' ' ' LYS . 3.3 mt -93.1 -7.17 46.28 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.971 0.891 . . . . 0.65 111.387 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.27 13.84 55.03 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.143 -1.583 . . . . 0.17 109.143 172.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.598 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.11 164.33 19.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.428 -0.886 . . . . 0.1 110.348 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -86.39 106.87 17.73 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.324 -0.853 . . . . 1.72 109.844 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.655 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 132.92 -21.47 4.17 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 120.4 -0.905 . . . . 0.12 111.146 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.828 HG11 ' O ' ' A' ' 75' ' ' MET . 12.5 p -103.74 152.56 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.853 0.835 . . . . 0.16 112.243 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 83' ' ' ALA . 25.7 m -136.4 144.43 44.51 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.438 -1.256 . . . . 0.45 110.823 175.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB2' ' CE ' ' A' ' 118' ' ' LYS . . . -61.92 142.68 57.27 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.254 -0.884 . . . . 0.28 110.05 166.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.78 -0.34 69.94 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.847 -0.692 . . . . 0.28 112.568 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' SER . . . . . 0.487 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 63.1 m -94.57 145.83 24.54 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.552 -0.459 . . . . 1.2 109.977 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -76.44 126.67 37.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.685 0.755 . . . . 0.2 109.882 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.9 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -113.68 108.24 16.85 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.203 -0.908 . . . . 0.14 109.399 -170.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.753 HD23 HG11 ' A' ' 155' ' ' VAL . 0.9 OUTLIER -73.32 94.51 2.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.39 -1.277 . . . . 0.15 108.868 176.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.536 HG23 HD23 ' A' ' 109' ' ' LEU . 2.0 m -73.12 116.72 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 107.718 -1.215 . . . . 0.95 107.718 176.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.743 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 5.5 t0 -79.06 171.25 15.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.517 -0.92 . . . . 0.64 108.517 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.624 ' OG ' ' HA ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -59.73 148.38 34.38 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-O 122.544 1.164 . . . . 0.37 108.757 171.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.638 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 24.7 t -73.97 138.25 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.498 0 N-CA-C 106.516 -1.661 . . . . 0.1 106.516 162.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.841 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.3 t-20 -85.23 163.73 18.5 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 121.744 0.783 . . . . 0.18 110.108 174.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASN . . . . . 0.738 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.3 t-20 -124.82 86.23 2.53 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.633 -1.167 . . . . 0.12 108.384 175.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.413 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.3 mtp180 -107.72 -2.93 19.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.952 -1.476 . . . . 0.64 108.731 -173.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.701 HG21 ' HB3' ' A' ' 172' ' ' PRO . 32.7 p -51.85 -172.18 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.232 -1.804 . . . . 0.14 115.5 -176.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.8 t30 -70.77 -8.91 55.81 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 112.537 -2.12 . . . . 0.48 110.562 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . 0.566 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -153.26 -145.41 4.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.518 -0.849 . . . . 0.12 113.045 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.632 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 58.1 p -121.43 130.58 53.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.626 0.602 . . . . 1.16 112.626 -176.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.738 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -136.17 153.5 51.24 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.626 0.727 . . . . 0.1 110.667 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -76.57 80.11 3.24 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.155 -1.384 . . . . 0.17 107.771 175.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -67.52 -15.23 63.55 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.155 -1.384 . . . . 0.09 110.07 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.07 -30.2 34.8 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.72 -0.845 . . . . 0.15 108.72 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.655 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 9.2 tp10 -66.07 -35.67 81.14 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.503 -1.226 . . . . 1.73 108.877 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.66 -44.98 65.98 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 113.251 -1.795 . . . . 0.12 109.232 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.59 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 52.1 m -59.75 -32.03 70.2 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.965 -1.471 . . . . 0.11 110.947 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -43.87 71.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.476 -0.935 . . . . 1.47 108.476 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.664 HG21 ' HB2' ' A' ' 64' ' ' TRP . 56.7 m -62.76 -29.48 70.72 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.328 -0.851 . . . . 0.12 110.54 176.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.728 ' O ' HD23 ' A' ' 113' ' ' LEU . 9.1 tp -56.27 -64.26 0.92 Allowed 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.937 -1.029 . . . . 0.56 109.185 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.601 ' O ' HD13 ' A' ' 121' ' ' LEU . 23.4 mtp180 -43.07 -37.38 1.95 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.172 0.987 . . . . 1.51 111.114 172.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.641 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -69.21 -46.9 66.26 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.25 -1.341 . . . . 0.28 112.165 -175.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.449 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.19 -33.67 65.53 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.58 -0.896 . . . . 0.09 108.58 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.805 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.2 mm? -59.21 -38.06 79.0 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.725 -1.579 . . . . 0.12 109.685 170.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.508 ' HA ' HD21 ' A' ' 121' ' ' LEU . . . -74.82 -40.68 60.94 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.177 -0.919 . . . . 0.2 110.926 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -56.47 -36.17 68.77 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.633 -1.167 . . . . 1.17 110.393 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -72.07 -47.61 50.28 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 113.636 -1.62 . . . . 2.05 109.965 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.95 -11.96 63.28 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 114.947 0.739 . . . . 0.54 114.947 172.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.655 ' CE ' ' HB2' ' A' ' 83' ' ' ALA . 53.9 mtpt -69.42 -36.68 76.95 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.515 1.157 . . . . 0.99 111.081 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.9 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 20.6 m-85 -88.35 177.56 6.81 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 122.625 1.202 . . . . 0.21 113.412 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.543 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 18.2 m -122.37 106.17 10.83 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 112.616 -2.083 . . . . 0.23 108.041 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -94.42 128.6 41.07 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.563 -1.199 . . . . 0.38 112.277 -168.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.578 ' CG2' ' HB2' ' A' ' 127' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.301 -1.542 0 CA-C-N 114.218 -1.356 . . . . 0.42 108.066 174.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.766 HD11 ' HZ1' ' A' ' 131' ' ' LYS . 1.1 tm? . . . . . 0 C--O 1.233 0.207 0 N-CA-C 113.721 1.008 . . . . 1.39 113.721 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.622 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -53.4 -38.99 63.92 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 123.547 1.642 . . . . 1.05 108.437 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.7 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 41.9 mmm -63.37 -60.31 3.54 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 110.923 -2.853 . . . . 1.64 111.18 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.809 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.45 -44.19 5.72 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 124.259 0.974 . . . . 0.31 112.166 176.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.766 ' HZ1' HD11 ' A' ' 127' ' ' LEU . 26.3 mttt -52.47 -55.52 21.4 Favored 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 120.065 -0.654 . . . . 1.53 109.589 176.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 42.4 mt-30 -61.49 -42.59 99.03 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.894 -1.048 . . . . 0.41 111.469 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.5 mt-30 -57.55 -37.0 72.39 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.334 -1.303 . . . . 0.37 109.703 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.507 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.4 OUTLIER -89.31 -31.36 17.86 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.804 -1.544 . . . . 0.24 109.063 -177.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 131' ' ' LYS . . . 159.64 -56.11 0.34 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-O 122.632 1.129 . . . . 0.33 113.921 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 74.3 mt -61.88 -172.62 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 112.372 -1.914 . . . . 0.31 116.025 -169.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.7 m -114.32 151.7 45.32 Favored Pre-proline 0 N--CA 1.428 -1.556 0 CA-C-N 110.846 -2.888 . . . . 0.81 108.581 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.642 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 10.2 Cg_endo -57.67 -7.56 3.31 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.177 2.585 . . . . 0.32 113.423 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -116.98 -30.53 5.67 Favored 'General case' 0 CA--C 1.499 -1.008 0 O-C-N 123.709 0.63 . . . . 1.25 109.542 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 141' ' ' SER . 8.7 t70 -50.74 -36.11 34.91 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.506 1.146 . . . . 0.65 108.778 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.624 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 1.9 m 81.07 159.47 0.15 Allowed 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 110.747 -2.933 . . . . 0.6 111.149 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.854 HD13 ' HA ' ' A' ' 148' ' ' ALA . 7.6 mt -66.27 -38.05 86.9 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.233 -1.395 . . . . 0.86 107.233 -172.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.17 0.16 0.68 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 112.545 -2.116 . . . . 0.31 114.856 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -152.31 120.49 6.28 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.69 -0.855 . . . . 0.24 108.69 -174.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . 0.671 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.0 mmt180 -40.97 -48.08 3.12 Favored 'General case' 0 C--O 1.212 -0.874 0 O-C-N 123.691 0.619 . . . . 1.65 110.906 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 t -69.68 -29.77 67.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.23 0.538 . . . . 0.53 111.817 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 23.9 mttm -72.36 -32.48 66.5 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.399 1.095 . . . . 1.31 108.611 176.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ALA . . . . . 0.854 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -74.02 -43.06 59.29 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-N 112.761 -2.018 . . . . 0.12 110.15 178.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.609 HG13 ' HE1' ' A' ' 179' ' ' MET . 40.2 mt -67.66 -42.66 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 CA-C-N 113.498 -1.683 . . . . 0.11 110.1 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.42 -51.99 44.08 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 114.955 -1.02 . . . . 0.15 111.096 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ILE . . . . . 0.809 HG23 ' CB ' ' A' ' 130' ' ' ALA . 65.7 mt -68.25 -47.22 79.07 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 N-CA-C 113.01 0.744 . . . . 0.18 113.01 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . 0.678 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.24 -39.58 72.78 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.985 0.421 . . . . 0.13 110.816 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ARG . . . . . 0.428 ' HD2' HG23 ' A' ' 149' ' ' ILE . 23.6 mtp-105 -82.55 -19.9 37.66 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.526 0.679 . . . . 1.08 110.818 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.462 HD21 ' CD ' ' A' ' 133' ' ' GLN . 17.0 t30 -84.57 -11.22 56.46 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.344 -1.354 . . . . 0.5 107.344 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.753 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -108.08 -29.02 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 113.137 -1.847 . . . . 0.17 111.052 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.48 35.38 4.7 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.283 -0.96 . . . . 0.16 112.485 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.664 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.83 156.24 21.42 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.249 0.833 . . . . 0.12 113.249 -169.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' HIS . . . . . 0.687 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -96.53 -26.53 15.23 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.838 -1.074 . . . . 0.2 109.751 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 15.6 m-85 -135.99 -179.53 5.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.218 -0.901 . . . . 0.13 111.064 -173.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.771 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.1 t -133.06 139.79 48.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.61 -0.885 . . . . 0.08 108.61 166.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.62 HD21 ' HE1' ' A' ' 176' ' ' MET . 46.4 tp -110.54 101.33 10.01 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 119.407 -0.917 . . . . 0.16 109.244 165.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . 0.639 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 4.5 m-85 -82.05 112.79 19.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.222 -1.354 . . . . 0.26 109.421 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.874 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 10.3 t -122.81 162.19 22.59 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.768 0.794 . . . . 1.05 110.613 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' SER . . . . . 0.853 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -162.85 175.09 11.59 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.522 -1.217 . . . . 0.1 111.101 -177.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.32 136.77 35.19 Favored 'General case' 0 N--CA 1.413 -2.317 0 CA-C-N 114.413 -1.267 . . . . 0.11 108.853 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 3.5 m -144.97 -172.97 3.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 109.219 -0.66 . . . . 1.09 109.219 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.14 -84.87 1.11 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.606 -1.283 . . . . 0.15 110.834 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASN . . . . . 0.518 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 66.1 t30 -143.09 122.86 13.39 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.432 -0.884 . . . . 0.59 109.923 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.566 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.4 p -54.32 -49.73 61.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 112.678 0.622 . . . . 0.15 112.678 -169.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASN . . . . . 0.413 ' N ' HG13 ' A' ' 169' ' ' VAL . 5.5 m-20 -56.83 -31.89 65.21 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.777 0.798 . . . . 1.26 110.288 -174.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.49 87.51 4.15 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 114.263 -1.335 . . . . 0.13 108.119 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . 0.813 ' HD2' HG22 ' A' ' 194' ' ' VAL . 48.1 Cg_endo -90.64 165.48 4.17 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 124.712 3.608 . . . . 0.09 114.999 -170.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 191' ' ' LYS . 28.7 m -81.31 117.91 22.19 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.745 -1.571 . . . . 0.14 107.098 165.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 164' ' ' SER . 43.1 tp -83.83 100.12 10.76 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.256 -1.016 . . . . 0.16 108.256 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLN . . . . . 0.598 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 35.5 mt-30 -90.05 109.56 20.61 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 121.897 0.856 . . . . 0.34 109.152 -177.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' MET . . . . . 0.874 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.0 OUTLIER -111.46 163.84 13.6 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.233 -0.894 . . . . 1.09 111.356 -174.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLN . . . . . 0.555 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.8 tt0 -169.65 118.19 0.62 Allowed 'General case' 0 C--O 1.207 -1.171 0 CA-C-O 121.353 0.597 . . . . 0.5 110.12 -165.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 1.07 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.16 102.29 13.18 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.038 -0.727 . . . . 0.1 109.038 -173.069 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . 0.671 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.9 ttp -91.6 117.79 30.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.755 -0.657 . . . . 0.07 109.491 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.48 113.0 2.7 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.655 -1.239 . . . . 0.22 107.655 170.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.59 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -67.53 -35.76 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.989 0.813 . . . . 0.11 111.611 -175.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLN . . . . . 0.456 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.5 mt-30 -61.3 -12.52 13.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.726 -0.67 . . . . 0.35 111.9 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 43.4 p -130.46 -37.26 1.41 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.211 1.005 . . . . 0.19 110.333 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . 0.558 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.91 21.05 44.14 Favored Glycine 0 N--CA 1.428 -1.88 0 CA-C-N 113.528 -1.669 . . . . 0.18 111.596 -176.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -99.62 154.31 18.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.906 0.384 . . . . 0.73 110.537 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ILE . . . . . 0.555 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.7 mm -88.8 111.81 23.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.034 -0.728 . . . . 0.14 109.034 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -98.49 -31.37 3.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.815 -1.084 . . . . 0.13 110.248 -173.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' TRP . . . . . 0.687 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 82.7 t90 -135.95 152.51 51.05 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.164 -0.925 . . . . 0.07 109.914 173.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 64.9 p -154.01 162.71 41.01 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 112.172 0.434 . . . . 0.13 112.172 163.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -162.15 -177.98 35.64 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.638 -0.985 . . . . 0.12 110.638 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' LYS . . . . . 0.766 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 13.2 mttt -151.78 153.77 34.94 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.537 -1.653 . . . . 1.22 106.537 166.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -159.82 128.22 1.95 Allowed Glycine 0 C--N 1.286 -2.236 0 CA-C-N 114.888 -1.051 . . . . 0.12 111.942 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -73.2 119.35 17.31 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.699 0.761 . . . . 0.17 111.286 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.813 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -94.42 159.22 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 CA-C-N 114.682 -1.145 . . . . 0.11 110.708 -176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . 0.745 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -99.34 172.84 7.08 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.648 -2.069 . . . . 0.18 109.001 -174.408 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -102.47 130.93 49.42 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.733 -0.387 . . . . 0.91 110.17 171.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.544 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 16.1 mm-40 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.408 -0.806 . . . . 1.24 110.391 177.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.802 0 N-CA-C 112.269 -0.332 . . . . 88.61 112.269 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -74.01 105.66 5.35 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 122.792 -0.24 . . . . 87.43 110.382 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 62.32 -166.73 0.21 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.66 0.743 . . . . 87.16 111.174 -177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 46.3 ttm 68.05 34.2 4.19 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 114.038 -1.437 . . . . 85.34 111.625 167.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.9 t -109.73 -50.01 6.86 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 114.597 -1.183 . . . . 85.05 110.212 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 61.71 56.03 25.23 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.693 -0.765 . . . . 84.68 111.893 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -67.74 134.03 50.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.549 -0.326 . . . . 85.57 110.584 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 19.8 mmm180 61.31 76.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.196 0.522 . . . . 85.04 111.566 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -72.78 159.3 85.68 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 115.737 -0.665 . . . . 82.17 109.863 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.408 ' HB2' ' H ' ' A' ' 11' ' ' ALA . 35.7 Cg_exo -58.48 -89.54 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.624 0 C-N-CA 123.081 2.521 . . . . 81.51 112.166 178.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.408 ' H ' ' HB2' ' A' ' 10' ' ' PRO . . . -179.04 -50.47 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.236 0 C-N-CA 122.748 0.419 . . . . 79.56 110.23 -175.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -70.79 143.64 46.42 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 121.481 1.454 . . . . 78.5 110.853 168.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.2 m -61.87 142.2 16.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.89 0.376 . . . . 77.0 110.871 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -168.26 143.35 3.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.806 -0.634 . . . . 75.74 110.613 -175.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -75.14 149.44 39.03 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.352 -0.61 . . . . 73.91 109.352 174.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 40.7 t -63.52 105.38 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.926 -0.579 . . . . 72.3 110.705 -177.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 19' ' ' ALA . 26.4 mtpp -80.17 -37.45 1.07 Allowed Pre-proline 0 C--N 1.326 -0.437 0 N-CA-C 112.933 0.716 . . . . 71.22 112.933 -177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.38 42.19 0.45 Allowed 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.754 1.636 . . . . 69.67 112.224 172.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 17' ' ' LYS . . . -168.96 101.73 0.5 Allowed Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.501 -0.772 . . . . 67.55 109.126 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.14 -62.65 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.262 2.641 . . . . 66.7 112.412 -177.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.0 mm-40 -137.1 -68.06 0.48 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.868 -0.605 . . . . 65.01 111.176 -175.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 41.0 67.59 2.87 Favored Pre-proline 0 CA--C 1.537 0.451 0 O-C-N 123.747 0.654 . . . . 63.41 111.495 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -62.4 159.32 36.34 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.272 2.648 . . . . 61.93 112.619 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.64 113.0 6.5 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.684 -0.689 . . . . 59.87 110.091 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 38.3 mt-10 -66.6 137.92 95.34 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.596 . . . . 58.47 110.951 -176.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 25' ' ' GLU . 33.7 Cg_exo -59.59 130.1 33.93 Favored 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.536 2.158 . . . . 57.36 112.158 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -71.2 -38.81 72.07 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.584 -0.525 . . . . 55.51 109.584 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -140.54 127.62 12.17 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.753 -0.658 . . . . 53.87 110.348 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -71.5 -21.47 25.92 Favored 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 121.635 1.557 . . . . 52.76 112.428 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.8 m -85.82 124.7 70.54 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-O 121.062 0.458 . . . . 50.93 111.378 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -90.14 37.21 0.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.86 2.374 . . . . 49.21 111.236 173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.0 p -83.47 153.58 24.37 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.489 -0.778 . . . . 47.49 111.911 -175.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 p -135.0 109.57 10.72 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.368 -0.833 . . . . 45.97 110.25 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -55.26 156.32 17.21 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.024 2.483 . . . . 45.28 112.437 178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.0 m -155.49 122.04 5.28 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 115.447 -0.797 . . . . 42.79 110.327 -176.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.19 115.55 42.71 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.991 -0.549 . . . . 40.79 110.401 178.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -79.24 151.95 23.61 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.636 2.224 . . . . 39.81 112.483 -179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.4 m -72.31 140.42 48.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.007 -0.542 . . . . 37.5 110.533 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.0 mt -87.82 117.49 68.55 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.918 -0.583 . . . . 35.65 110.082 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_exo -58.91 161.94 14.44 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.792 2.328 . . . . 33.72 112.304 178.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -80.79 97.31 7.28 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.229 0.538 . . . . 31.51 111.073 -176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 25.3 tt0 -85.21 131.66 47.7 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.73 -0.668 . . . . 30.13 109.844 178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.69 164.94 31.25 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.41 2.074 . . . . 29.52 112.422 -179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -105.76 173.29 19.99 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 120.941 -0.647 . . . . 26.75 112.017 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -67.32 134.52 33.81 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 123.073 2.515 . . . . 25.08 112.257 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 27.0 mt -81.92 -57.28 4.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.148 -0.478 . . . . 23.9 109.974 176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 56.77 81.09 0.14 Allowed 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.508 -0.769 . . . . 21.23 111.486 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.1 p-80 -77.68 164.85 24.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.905 -0.589 . . . . 19.92 110.211 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -110.26 178.44 4.39 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.716 -0.675 . . . . 16.56 110.556 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -121.66 69.4 0.92 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.87 -0.15 . . . . 15.05 111.086 -177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 66.41 132.61 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.437 0.46 . . . . 14.19 111.677 178.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.3 p -67.97 148.92 50.4 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.511 0.672 . . . . 11.38 111.392 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -128.65 109.71 18.9 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.138 -0.937 . . . . 8.29 109.637 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -64.39 114.76 2.82 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.743 2.296 . . . . 6.87 112.453 -177.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.36 -43.11 61.66 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.445 2.097 . . . . 5.04 111.653 176.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 65.03 110.36 0.03 OUTLIER Pre-proline 0 C--O 1.234 0.283 0 O-C-N 124.036 0.835 . . . . 2.59 111.35 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -68.95 -177.0 1.43 Allowed 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.968 2.446 . . . . 1.64 112.316 -179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 18.3 p80 -120.48 141.5 50.13 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.002 -0.999 . . . . 3.39 110.485 -177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.596 HG22 ' N ' ' A' ' 60' ' ' ARG . 9.0 mt -89.3 174.49 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.268 -0.878 . . . . 0.44 111.049 -177.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.596 ' N ' HG22 ' A' ' 59' ' ' ILE . 36.7 mtt85 -61.46 -150.32 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.77 -1.559 . . . . 2.34 111.826 175.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.594 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 23.5 t-160 -159.6 137.01 9.78 Favored 'General case' 0 CA--C 1.475 -1.933 0 CA-C-N 112.899 -1.955 . . . . 2.22 106.588 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.717 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.7 m-30 -121.26 156.11 33.2 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 115.587 -0.733 . . . . 0.21 111.182 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 7.6 t70 -84.55 67.82 10.09 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-O 123.363 1.554 . . . . 0.35 108.487 172.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.768 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.8 m95 -57.96 -42.5 85.11 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-N 112.219 -2.264 . . . . 0.1 112.455 174.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.597 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 9.5 t-20 -53.22 -26.14 16.61 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 114.13 -1.395 . . . . 1.11 111.52 175.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.29 -15.61 79.81 Favored Glycine 0 C--N 1.314 -0.658 0 CA-C-N 115.279 -0.873 . . . . 0.21 111.267 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.62 -53.19 3.03 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.104 -1.048 . . . . 0.13 110.991 -176.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.704 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.2 mtt -65.43 -59.38 4.07 Favored 'General case' 0 C--O 1.21 -0.986 0 CA-C-N 114.08 -1.418 . . . . 0.09 112.035 -177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.597 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.9 mm-40 -39.28 -54.98 3.34 Favored Pre-proline 0 C--N 1.319 -0.742 0 N-CA-C 114.679 1.362 . . . . 0.63 114.679 -176.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.769 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.8 Cg_endo -63.61 -28.47 69.63 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 121.988 1.792 . . . . 0.14 110.768 -178.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.721 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 8.2 mtm -83.17 -44.47 15.02 Favored 'General case' 0 C--O 1.212 -0.885 0 CA-C-N 115.088 -0.96 . . . . 0.7 112.09 -179.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 68' ' ' MET . 58.6 t -56.86 -39.14 62.82 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-N 114.312 -1.313 . . . . 0.12 108.715 175.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -60.13 -32.96 71.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 112.966 -1.924 . . . . 0.56 110.974 174.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.769 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 5.0 mtpm? -83.79 -35.76 24.07 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 122.843 0.457 . . . . 1.3 111.159 178.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.871 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.85 -26.54 68.66 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.461 -0.791 . . . . 0.5 111.295 -172.238 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.72 HD13 ' HB2' ' A' ' 118' ' ' LYS . 5.5 mt -93.46 -3.48 52.96 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.071 0.938 . . . . 0.65 110.841 -178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.27 15.41 42.99 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 109.147 -1.581 . . . . 0.17 109.147 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.629 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.89 160.95 19.28 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.526 -0.837 . . . . 0.1 110.282 -179.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -86.21 104.97 16.26 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 115.288 -0.869 . . . . 1.72 110.093 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.641 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.03 -23.83 3.16 Favored Glycine 0 N--CA 1.43 -1.748 0 N-CA-C 110.842 -0.903 . . . . 0.12 110.842 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.871 HG11 ' O ' ' A' ' 75' ' ' MET . 11.9 p -103.07 150.67 6.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.635 0.731 . . . . 0.16 111.75 -174.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.7 m -136.57 141.31 43.33 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.919 -1.037 . . . . 0.45 111.102 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.631 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.12 132.95 48.57 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.779 -1.1 . . . . 0.28 110.741 167.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.47 9.55 50.16 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 121.174 -0.536 . . . . 0.28 112.8 176.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -91.66 149.64 21.54 Favored 'General case' 0 CA--C 1.503 -0.828 0 C-N-CA 120.327 -0.549 . . . . 1.2 110.647 177.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.712 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -80.84 116.88 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 CA-C-O 122.168 0.985 . . . . 0.2 108.925 166.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.743 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -105.16 109.51 21.53 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.044 -0.98 . . . . 0.14 108.903 -172.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.792 HD21 HD13 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -71.78 94.42 1.39 Allowed 'General case' 0 CA--C 1.502 -0.873 0 CA-C-N 114.428 -1.26 . . . . 0.15 108.32 177.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.452 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.7 m -72.58 119.18 18.86 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.755 0 N-CA-C 106.978 -1.49 . . . . 0.95 106.978 178.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.845 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 12.3 t0 -77.33 162.35 27.35 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.703 -1.221 . . . . 0.64 107.703 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.567 ' H ' ' NZ ' ' A' ' 131' ' ' LYS . 1.1 m -62.17 143.21 57.06 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 106.59 -1.633 . . . . 0.37 106.59 170.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.56 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 27.3 t -71.73 139.76 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.118 0 N-CA-C 107.534 -1.284 . . . . 0.1 107.534 168.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.78 ' H ' ' HA ' ' A' ' 164' ' ' SER . 8.0 t-20 -84.9 163.28 19.09 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 115.497 -0.774 . . . . 0.18 110.07 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.77 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.14 85.22 2.38 Favored 'General case' 0 C--N 1.294 -1.835 0 N-CA-C 107.96 -1.126 . . . . 0.12 107.96 175.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.535 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.9 mtp180 -107.02 -4.17 19.28 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.037 -1.438 . . . . 0.64 108.764 -171.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 172' ' ' PRO . 19.1 p -51.05 -170.94 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 112.83 -1.986 . . . . 0.14 115.499 -175.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 38.3 t30 -70.96 -6.35 38.05 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.718 -2.037 . . . . 0.48 110.53 173.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.603 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -157.48 -144.05 3.83 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.396 -0.907 . . . . 0.12 113.297 -178.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.629 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 94.8 p -121.42 130.31 53.52 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 112.612 0.597 . . . . 1.16 112.612 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.77 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.2 pp -136.48 159.49 41.64 Favored 'General case' 0 CA--C 1.497 -1.092 0 CA-C-O 121.855 0.836 . . . . 0.1 110.579 -177.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.692 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -80.74 82.17 6.81 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 113.856 -1.52 . . . . 0.17 107.975 175.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.562 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -70.84 -15.64 62.66 Favored 'General case' 0 C--N 1.287 -2.125 0 CA-C-N 114.355 -1.293 . . . . 0.09 109.81 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.663 ' HB2' ' CG ' ' A' ' 139' ' ' GLN . . . -78.66 -31.53 46.81 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.793 0.806 . . . . 0.15 108.849 178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.692 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 21.5 tt0 -62.83 -38.61 91.44 Favored 'General case' 0 N--CA 1.431 -1.409 0 CA-C-N 114.053 -1.43 . . . . 1.73 109.109 169.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.562 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -69.54 -44.62 70.57 Favored 'General case' 0 N--CA 1.423 -1.82 0 CA-C-N 112.867 -1.97 . . . . 0.12 109.005 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.592 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 60.6 m -64.89 -31.82 73.23 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 114.126 -1.397 . . . . 0.11 110.533 -178.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -66.15 -51.24 59.74 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 107.972 -1.121 . . . . 1.47 107.972 171.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 64' ' ' TRP . 31.7 m -56.69 -33.15 66.15 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.532 -0.758 . . . . 0.12 111.436 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.704 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.3 mt -50.55 -68.69 0.15 Allowed 'General case' 0 CA--C 1.49 -1.333 0 N-CA-C 109.61 -0.515 . . . . 0.56 109.61 172.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.569 ' O ' HD13 ' A' ' 121' ' ' LEU . 19.0 mtp180 -42.81 -36.92 1.63 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 114.883 -1.053 . . . . 1.51 110.973 176.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.562 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -71.9 -47.47 52.48 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.245 -1.343 . . . . 0.28 111.854 -175.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.5 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.21 -33.31 67.51 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 122.328 1.061 . . . . 0.09 108.403 -179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.86 -32.9 74.58 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 113.514 -1.676 . . . . 0.12 109.918 173.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.693 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -76.28 -40.82 50.72 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 114.812 -1.086 . . . . 0.2 111.364 -176.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 19.1 m-80 -67.05 -26.87 66.96 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-N 114.99 -1.005 . . . . 1.17 110.682 -176.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.494 HD22 HD12 ' A' ' 76' ' ' LEU . 51.6 t30 -88.08 -17.94 29.98 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.147 -0.621 . . . . 2.05 110.429 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 72.21 -12.83 2.99 Favored Glycine 0 C--N 1.332 0.312 0 N-CA-C 116.048 1.179 . . . . 0.54 116.048 161.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.72 ' HB2' HD13 ' A' ' 76' ' ' LEU . 57.8 mtpt -77.39 -14.3 59.74 Favored 'General case' 0 C--O 1.218 -0.584 0 CA-C-N 117.802 0.801 . . . . 0.99 111.463 -177.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.743 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 23.2 m-85 -109.29 172.76 6.66 Favored 'General case' 0 CA--C 1.491 -1.298 0 CA-C-O 122.648 1.213 . . . . 0.21 113.669 177.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.57 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 14.7 m -117.27 117.42 29.5 Favored 'General case' 0 N--CA 1.414 -2.239 0 CA-C-N 112.305 -2.225 . . . . 0.23 108.031 169.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.693 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.2 OUTLIER -88.52 139.02 30.9 Favored 'General case' 0 N--CA 1.415 -2.19 0 CA-C-N 115.437 -0.801 . . . . 0.38 110.517 -171.814 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.559 HG11 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -84.59 155.03 3.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.871 -0.788 . . . . 0.42 108.871 172.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.26 152.57 19.27 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-O 121.602 0.715 . . . . 1.7 109.427 178.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.66 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -64.32 -19.43 65.43 Favored 'General case' 0 CA--C 1.511 -0.558 0 CA-C-N 114.502 -1.227 . . . . 0.55 110.121 176.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.618 ' O ' ' HG3' ' A' ' 129' ' ' MET . 0.4 OUTLIER -57.22 -29.89 64.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.022 -0.99 . . . . 2.04 109.612 172.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.616 ' HB2' HG22 ' A' ' 155' ' ' VAL . 1.7 mt-30 -98.82 -54.66 2.94 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 122.427 1.108 . . . . 0.41 110.101 174.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.792 HD13 HD21 ' A' ' 88' ' ' LEU . 26.5 tp -60.79 -63.22 1.37 Allowed 'General case' 0 C--O 1.218 -0.599 0 CA-C-N 113.165 -1.834 . . . . 1.39 112.8 -169.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.704 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 2.6 t -49.39 -44.56 45.19 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-O 123.308 1.528 . . . . 1.05 109.408 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.734 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 19.0 mmt -58.44 -61.61 2.46 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-N 111.064 -2.789 . . . . 1.64 110.694 177.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.755 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.81 -46.15 5.13 Favored 'General case' 0 CA--C 1.506 -0.744 0 O-C-N 124.484 1.115 . . . . 0.31 112.197 174.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.568 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -54.95 -51.36 66.39 Favored 'General case' 0 C--O 1.211 -0.943 0 N-CA-C 108.624 -0.88 . . . . 1.53 108.624 179.526 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 128' ' ' SER . 40.9 mt-30 -65.68 -40.78 92.72 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.23 -0.895 . . . . 0.41 111.162 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.734 ' HG3' ' O ' ' A' ' 129' ' ' MET . 54.5 mt-30 -57.81 -34.73 69.96 Favored 'General case' 0 CA--C 1.488 -1.409 0 CA-C-N 114.354 -1.294 . . . . 0.37 109.525 178.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.08 -28.93 17.61 Favored 'General case' 0 N--CA 1.423 -1.797 0 CA-C-N 113.754 -1.567 . . . . 0.24 109.284 -176.939 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.62 -49.79 0.52 Allowed Glycine 0 CA--C 1.496 -1.137 0 CA-C-O 122.667 1.148 . . . . 0.33 113.323 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.557 HD13 ' O ' ' A' ' 141' ' ' SER . 87.9 mt -64.92 -169.73 0.04 OUTLIER 'General case' 0 C--N 1.292 -1.91 0 CA-C-N 112.332 -1.934 . . . . 0.31 115.669 -171.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.605 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.0 m -116.3 155.05 48.82 Favored Pre-proline 0 N--CA 1.43 -1.443 0 CA-C-N 110.858 -2.883 . . . . 0.81 107.517 176.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.704 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 46.1 Cg_endo -67.26 1.35 3.04 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 122.661 2.241 . . . . 0.32 110.866 177.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.663 ' CG ' ' HB2' ' A' ' 103' ' ' ALA . 31.4 mt-30 -118.27 -24.31 6.97 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 113.946 -1.479 . . . . 1.25 111.525 -173.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.621 ' O ' ' HB2' ' A' ' 141' ' ' SER . 7.1 t70 -72.92 -23.61 60.72 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 114.838 -1.073 . . . . 0.65 108.793 -168.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.621 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 31.5 m 75.78 166.33 0.27 Allowed 'General case' 0 N--CA 1.427 -1.611 0 CA-C-N 112.532 -2.122 . . . . 0.6 110.56 -173.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.944 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.2 mt -64.99 -40.4 94.91 Favored 'General case' 0 C--N 1.295 -1.761 0 CA-C-O 122.581 1.182 . . . . 0.86 108.777 -176.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.71 -12.16 0.16 Allowed Glycine 0 N--CA 1.447 -0.596 0 CA-C-N 112.607 -2.088 . . . . 0.31 114.612 178.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -151.79 125.45 8.97 Favored 'General case' 0 CA--C 1.51 -0.583 0 CA-C-O 118.832 -0.604 . . . . 0.24 109.57 -173.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 16.8 mmt85 -42.27 -48.13 4.9 Favored 'General case' 0 C--O 1.211 -0.944 0 O-C-N 123.413 0.446 . . . . 1.65 111.915 -176.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 41.9 t -72.23 -26.33 61.98 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-O 121.595 0.712 . . . . 0.53 111.236 -174.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -74.37 -28.97 61.36 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 122.6 1.19 . . . . 1.31 108.505 176.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.944 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -76.47 -47.92 21.32 Favored 'General case' 0 CA--C 1.49 -1.357 0 CA-C-N 112.471 -2.149 . . . . 0.12 110.427 177.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.627 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.2 mt -66.51 -40.17 85.78 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.753 0 CA-C-N 112.856 -1.975 . . . . 0.11 110.073 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.46 -55.26 25.69 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 114.652 -1.158 . . . . 0.15 110.965 171.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.755 HG23 ' CB ' ' A' ' 130' ' ' ALA . 92.1 mt -66.42 -48.55 80.4 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.07 0 N-CA-C 112.683 0.623 . . . . 0.18 112.683 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.675 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.36 -41.2 72.22 Favored 'General case' 0 C--N 1.308 -1.233 0 O-C-N 123.227 0.329 . . . . 0.13 111.079 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.497 ' HD2' HG23 ' A' ' 149' ' ' ILE . 24.8 mtp180 -81.22 -23.02 38.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-O 121.597 0.713 . . . . 1.08 110.459 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.502 HD22 ' CB ' ' A' ' 130' ' ' ALA . 21.4 t30 -82.84 -10.26 58.93 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 107.438 -1.319 . . . . 0.5 107.438 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.71 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.1 t -108.51 -29.47 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.256 0 CA-C-N 113.18 -1.827 . . . . 0.17 111.0 -174.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.83 35.86 4.16 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.077 -1.058 . . . . 0.16 112.486 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.689 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.15 159.65 17.65 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.866 0.691 . . . . 0.12 112.866 -171.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.712 ' N ' HG13 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -99.85 -28.17 13.25 Favored 'General case' 0 CA--C 1.51 -0.583 0 C-N-CA 123.414 0.686 . . . . 0.2 109.681 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.572 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.3 m-85 -135.44 -173.17 3.27 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.161 -0.927 . . . . 0.13 110.945 -175.139 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.701 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -137.18 140.35 42.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-N 115.004 -0.998 . . . . 0.08 108.786 166.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.633 HD21 ' SD ' ' A' ' 176' ' ' MET . 37.0 tp -109.31 100.95 10.0 Favored 'General case' 0 N--CA 1.43 -1.452 0 C-N-CA 119.417 -0.913 . . . . 0.16 109.3 165.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.52 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.4 m-85 -79.83 113.59 18.1 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-N 114.434 -1.257 . . . . 0.26 109.027 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.855 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 6.4 t -126.64 161.25 28.51 Favored 'General case' 0 C--N 1.279 -2.469 0 CA-C-O 122.143 0.973 . . . . 1.05 110.881 -178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.821 ' O ' HD12 ' A' ' 174' ' ' LEU . 2.2 p -164.51 174.55 10.79 Favored 'General case' 0 N--CA 1.418 -2.035 0 CA-C-N 113.949 -1.478 . . . . 0.1 110.859 -177.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.29 134.67 38.23 Favored 'General case' 0 N--CA 1.41 -2.44 0 CA-C-N 114.2 -1.363 . . . . 0.11 108.632 178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.681 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.7 m -144.73 -175.96 4.87 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.185 -0.672 . . . . 1.09 109.185 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 96.82 -84.53 0.8 Allowed Glycine 0 N--CA 1.433 -1.554 0 C-N-CA 119.536 -1.316 . . . . 0.15 111.325 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.7 t30 -144.23 127.22 16.45 Favored 'General case' 0 C--O 1.197 -1.676 0 N-CA-C 107.596 -1.261 . . . . 0.59 107.596 175.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.603 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.5 p -63.34 -39.53 85.63 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 115.398 -0.819 . . . . 0.15 112.364 -171.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.41 ' N ' HG13 ' A' ' 169' ' ' VAL . 4.4 m120 -60.72 -31.47 70.77 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 122.086 0.946 . . . . 1.26 109.753 -177.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.55 88.89 3.29 Favored Pre-proline 0 C--N 1.306 -1.316 0 CA-C-N 113.169 -1.832 . . . . 0.13 108.307 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.799 ' HD2' HG22 ' A' ' 194' ' ' VAL . 52.4 Cg_endo -89.99 163.73 4.88 Favored 'Trans proline' 0 CA--C 1.494 -1.502 0 C-N-CA 124.335 3.357 . . . . 0.09 114.883 -169.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.617 HG22 ' HB3' ' A' ' 191' ' ' LYS . 63.8 m -82.93 117.97 23.14 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 106.965 -1.494 . . . . 0.14 106.965 166.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.821 HD12 ' O ' ' A' ' 164' ' ' SER . 38.5 tp -83.9 97.49 9.26 Favored 'General case' 0 N--CA 1.413 -2.325 0 C-N-CA 119.294 -0.963 . . . . 0.16 108.402 177.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.582 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 6.3 mt-30 -87.87 109.47 19.8 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 115.098 -0.955 . . . . 0.34 109.153 -176.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.855 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -112.85 164.75 13.02 Favored 'General case' 0 C--N 1.301 -1.516 0 CA-C-N 114.684 -1.144 . . . . 1.09 111.481 -173.787 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.603 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.7 tt0 -170.57 118.16 0.52 Allowed 'General case' 0 C--O 1.205 -1.251 0 CA-C-N 116.077 -0.51 . . . . 0.5 110.076 -166.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.066 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -100.37 100.56 11.36 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.741 -0.837 . . . . 0.1 108.741 -172.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.627 ' HE1' HG13 ' A' ' 149' ' ' ILE . 18.2 ttp -90.52 121.93 32.9 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-N 115.445 -0.798 . . . . 0.07 109.614 177.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.82 127.09 30.43 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.122 -1.436 . . . . 0.22 107.122 166.284 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.617 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.52 -34.4 13.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 CA-C-N 119.33 0.968 . . . . 0.11 110.758 178.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.429 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.7 mt-30 -63.08 -14.69 51.44 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.265 -0.88 . . . . 0.35 111.577 -177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.1 p -130.58 -36.97 1.4 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.677 0.751 . . . . 0.19 110.277 176.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.503 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.17 19.0 44.02 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.556 -1.202 . . . . 0.18 112.25 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -98.7 156.79 16.66 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.529 -0.336 . . . . 0.73 110.494 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.603 HD12 ' HG2' ' A' ' 177' ' ' GLN . 33.7 mm -91.58 115.85 31.52 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-O 121.637 0.732 . . . . 0.14 109.52 179.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.066 HD11 HD13 ' A' ' 178' ' ' LEU . 1.5 pp -103.28 -29.61 2.93 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.019 -0.991 . . . . 0.13 110.681 -173.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.652 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.0 t90 -137.2 153.26 50.45 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-N 115.371 -0.831 . . . . 0.07 109.508 171.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 79.9 p -153.47 165.47 35.75 Favored 'General case' 0 C--N 1.309 -1.184 0 N-CA-C 112.822 0.675 . . . . 0.13 112.822 163.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -161.79 -175.91 33.32 Favored Glycine 0 N--CA 1.425 -2.08 0 CA-C-O 121.718 0.621 . . . . 0.12 111.762 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.757 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 1.5 mttp -154.74 152.02 29.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 106.095 -1.817 . . . . 1.22 106.095 164.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -157.33 127.31 1.9 Allowed Glycine 0 N--CA 1.417 -2.571 0 C-N-CA 119.612 -1.28 . . . . 0.12 111.833 174.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.42 115.2 10.32 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-O 121.391 0.615 . . . . 0.17 110.487 -175.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.799 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -90.98 158.68 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.566 0 CA-C-O 122.47 1.128 . . . . 0.11 109.647 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.657 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.23 171.58 7.52 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 112.848 -1.978 . . . . 0.18 109.256 -172.612 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 6.8 tt0 -101.64 128.96 47.7 Favored 'General case' 0 C--N 1.292 -1.897 0 N-CA-C 109.074 -0.713 . . . . 0.91 109.074 168.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.497 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 19.3 mm-40 . . . . . 0 C--N 1.309 -1.177 0 CA-C-N 115.505 -0.771 . . . . 1.24 110.732 177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.853 0 N-CA-C 111.977 -0.449 . . . . 88.61 111.977 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.5 p -71.37 -41.15 70.07 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 122.323 0.249 . . . . 87.43 111.281 -177.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 56.27 71.3 0.57 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-O 120.815 0.341 . . . . 87.16 110.293 -176.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 27.8 ttt -129.73 57.59 1.67 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 121.694 0.759 . . . . 85.34 109.763 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.8 p -131.69 -15.72 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 115.477 -0.783 . . . . 85.05 111.155 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 138.55 55.3 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.957 -0.64 . . . . 84.68 111.846 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -89.21 117.63 28.32 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.699 0.761 . . . . 85.57 110.738 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 28.2 mmm180 55.33 66.22 1.28 Allowed 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 113.695 -1.593 . . . . 85.04 111.945 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.452 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 10.0 mm-40 -58.79 128.79 84.63 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-O 120.972 0.415 . . . . 82.17 111.039 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 22.7 Cg_exo -65.43 -33.28 47.69 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.657 2.238 . . . . 81.51 111.794 177.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -146.95 133.87 10.0 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.648 -0.705 . . . . 79.56 109.988 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.15 164.91 28.77 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.948 2.432 . . . . 78.5 112.475 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 36.0 m -95.84 156.47 3.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.812 -0.631 . . . . 77.0 111.303 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 59.6 97.51 0.03 OUTLIER 'General case' 0 C--O 1.236 0.348 0 CA-C-N 114.91 -1.041 . . . . 75.74 112.716 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -82.4 89.19 6.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.378 0.609 . . . . 73.91 109.575 172.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.427 HG22 ' HD3' ' A' ' 18' ' ' PRO . 6.4 p -69.83 107.53 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.286 -0.87 . . . . 72.3 111.307 -177.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -125.45 84.06 60.61 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.505 -0.771 . . . . 71.22 109.66 177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD3' HG22 ' A' ' 16' ' ' VAL . 98.8 Cg_endo -82.47 166.47 15.8 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.591 2.194 . . . . 69.67 112.505 -177.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.07 110.64 27.37 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.112 -0.495 . . . . 67.55 110.337 177.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.62 62.04 5.44 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 123.047 2.498 . . . . 66.7 112.14 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -129.44 174.78 9.32 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.886 -0.597 . . . . 65.01 109.685 179.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 58.4 tt0 -115.65 121.73 33.9 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.899 -0.408 . . . . 63.41 109.899 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 52.0 Cg_exo -62.87 173.71 3.59 Favored 'Trans proline' 0 C--O 1.236 0.404 0 C-N-CA 122.894 2.396 . . . . 61.93 112.907 177.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 54.14 60.68 3.45 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-N 112.496 -2.138 . . . . 59.87 112.542 175.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -79.56 104.19 2.15 Favored Pre-proline 0 C--N 1.316 -0.881 0 CA-C-N 114.711 -1.131 . . . . 58.47 110.29 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -82.4 13.57 2.52 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 122.898 2.399 . . . . 57.36 112.424 -175.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 27' ' ' GLN . 6.1 tp60 -139.15 148.97 43.92 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.111 -0.699 . . . . 55.51 109.111 177.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -72.05 115.58 39.86 Favored Pre-proline 0 C--N 1.324 -0.532 0 N-CA-C 110.279 -0.267 . . . . 53.87 110.279 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -59.72 -43.01 41.31 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.684 2.256 . . . . 52.76 111.316 178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 m -125.82 106.14 26.13 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 115.441 -0.8 . . . . 50.93 110.217 174.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -81.66 37.27 0.67 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.799 2.333 . . . . 49.21 112.249 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.39 166.25 15.72 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.549 0.69 . . . . 47.49 110.423 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.0 m -110.99 142.05 25.45 Favored Pre-proline 0 C--N 1.309 -1.177 0 CA-C-N 114.864 -1.062 . . . . 45.97 109.645 178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -55.63 154.04 27.11 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.562 2.175 . . . . 45.28 111.994 177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 2.9 p -70.29 129.11 38.44 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.354 -0.839 . . . . 42.79 111.586 -172.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -127.77 81.63 69.9 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.356 -0.838 . . . . 40.79 111.01 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.85 -21.98 69.07 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.771 2.314 . . . . 39.81 111.607 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.2 t -172.3 150.7 2.42 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.213 -0.903 . . . . 37.5 109.558 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.2 mt -98.56 105.06 27.64 Favored Pre-proline 0 C--N 1.318 -0.785 0 CA-C-N 115.888 -0.596 . . . . 35.65 109.576 177.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -73.15 60.16 3.84 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.986 2.457 . . . . 33.72 112.827 -177.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -132.0 174.97 9.63 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.088 -0.505 . . . . 31.51 110.219 176.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 29.5 tt0 70.14 129.43 0.03 OUTLIER Pre-proline 0 CA--C 1.529 0.141 0 CA-C-N 114.765 -1.107 . . . . 30.13 111.313 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 42' ' ' GLN . 27.8 Cg_exo -62.8 146.46 95.06 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 121.919 1.746 . . . . 29.52 111.666 176.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -175.72 -169.97 38.0 Favored Glycine 0 N--CA 1.443 -0.876 0 C-N-CA 120.713 -0.756 . . . . 26.75 112.034 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.12 125.45 10.33 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.675 2.25 . . . . 25.08 111.599 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 33.8 mm -67.85 -54.29 23.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.876 -0.602 . . . . 23.9 110.715 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 50.55 76.96 0.13 Allowed 'General case' 0 C--O 1.235 0.324 0 O-C-N 124.137 0.898 . . . . 21.23 111.213 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -86.58 174.72 8.73 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.262 0.554 . . . . 19.92 110.823 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -128.63 164.54 22.67 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.361 -0.836 . . . . 16.56 109.349 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -101.5 17.37 22.94 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 121.673 0.749 . . . . 15.05 110.963 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 58.6 -85.7 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 113.508 -1.678 . . . . 14.19 110.772 -178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.673 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 41.1 p -88.35 158.48 18.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.388 -0.369 . . . . 11.38 110.237 177.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -102.43 95.58 6.18 Favored Pre-proline 0 C--N 1.316 -0.853 0 CA-C-N 115.813 -0.631 . . . . 8.29 111.877 -174.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 52' ' ' THR . 36.0 Cg_endo -96.68 131.22 0.37 Allowed 'Trans proline' 0 N--CA 1.449 -1.091 0 C-N-CA 123.432 2.755 . . . . 6.87 112.528 178.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -61.65 -34.62 83.81 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.393 2.062 . . . . 5.04 111.618 175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -144.12 122.83 7.03 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.501 -0.772 . . . . 2.59 109.146 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -69.4 -177.84 1.94 Allowed 'Trans proline' 0 CA--C 1.511 -0.625 0 C-N-CA 123.198 2.599 . . . . 1.64 112.928 -176.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -115.56 141.71 47.69 Favored 'General case' 0 C--N 1.303 -1.437 0 CA-C-N 113.798 -1.546 . . . . 3.39 109.544 -176.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 60' ' ' ARG . 10.0 mt -84.43 167.14 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.875 0.845 . . . . 0.44 112.162 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.579 ' N ' HG22 ' A' ' 59' ' ' ILE . 35.8 mtt85 -71.81 -150.28 0.02 OUTLIER 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 113.516 -1.675 . . . . 2.34 111.435 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.731 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 23.6 t-160 -158.74 136.35 10.21 Favored 'General case' 0 CA--C 1.476 -1.869 0 CA-C-N 112.948 -1.933 . . . . 2.22 107.001 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.731 ' HD1' ' C ' ' A' ' 61' ' ' HIS . 2.1 m-30 -122.17 154.19 37.78 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-N 115.322 -0.854 . . . . 0.21 110.973 -177.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.528 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 15.8 t70 -85.05 67.75 10.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 123.538 1.637 . . . . 0.35 108.444 173.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.772 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.1 m95 -55.64 -43.33 76.12 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 112.006 -2.361 . . . . 0.1 112.752 175.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.503 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 11.1 t-20 -50.8 -30.87 15.33 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 113.762 -1.563 . . . . 1.11 111.643 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.28 -17.15 79.62 Favored Glycine 0 CA--C 1.503 -0.693 0 CA-C-N 115.506 -0.77 . . . . 0.21 111.423 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.96 -51.51 3.68 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 114.114 -1.043 . . . . 0.13 110.806 -176.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.74 ' SD ' HD23 ' A' ' 109' ' ' LEU . 37.6 mtt -65.69 -56.29 12.9 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 114.182 -1.372 . . . . 0.09 112.473 -177.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.503 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 7.0 mm-40 -39.74 -54.29 4.15 Favored Pre-proline 0 C--N 1.323 -0.584 0 N-CA-C 114.804 1.409 . . . . 0.63 114.804 -176.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.834 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 29.6 Cg_endo -63.55 -32.0 70.39 Favored 'Trans proline' 0 CA--C 1.508 -0.804 0 C-N-CA 121.919 1.746 . . . . 0.14 110.799 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.758 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 7.7 mtm -79.64 -47.59 15.16 Favored 'General case' 0 CA--C 1.504 -0.809 0 CA-C-N 114.979 -1.01 . . . . 0.7 111.515 -177.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 68' ' ' MET . 53.3 t -54.52 -41.19 53.25 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.082 0 CA-C-N 114.089 -1.414 . . . . 0.12 108.955 176.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.9 t -60.0 -36.68 77.72 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.256 -1.793 . . . . 0.56 110.791 175.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.834 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 20.0 mtpp -77.6 -35.36 52.91 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 121.303 0.573 . . . . 1.3 110.498 178.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.866 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.14 -29.81 71.09 Favored 'General case' 0 N--CA 1.431 -1.391 0 CA-C-N 114.765 -1.107 . . . . 0.5 111.44 -173.663 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.479 ' HG ' ' HB2' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -83.68 -6.82 59.54 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.193 0.52 . . . . 0.65 111.235 179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -108.76 13.97 34.98 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 109.614 -1.395 . . . . 0.17 109.614 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.657 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -81.58 161.36 23.56 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 114.663 -0.768 . . . . 0.1 110.285 -178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -86.99 106.26 17.71 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 115.345 -0.843 . . . . 1.72 109.579 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.648 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.76 -24.68 3.46 Favored Glycine 0 N--CA 1.418 -2.542 0 C-N-CA 119.797 -1.192 . . . . 0.12 110.666 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.866 HG11 ' O ' ' A' ' 75' ' ' MET . 10.9 p -97.47 155.9 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-O 121.702 0.763 . . . . 0.16 111.541 -174.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.405 ' HB ' ' OG ' ' A' ' 85' ' ' SER . 6.5 m -132.85 136.62 46.34 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 114.51 -1.223 . . . . 0.45 110.901 -176.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.654 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.6 130.21 45.74 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.864 -1.062 . . . . 0.28 110.332 167.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.86 12.15 60.86 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.719 -0.753 . . . . 0.28 113.233 174.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.462 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 61.9 m -97.56 147.73 23.98 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 117.124 0.462 . . . . 1.2 110.156 179.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.705 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.2 p -77.0 124.8 36.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 CA-C-O 122.09 0.948 . . . . 0.2 109.194 174.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.685 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.7 tm? -110.84 110.17 20.66 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 114.984 -1.007 . . . . 0.14 108.58 -172.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.722 HD21 HD23 ' A' ' 127' ' ' LEU . 0.7 OUTLIER -71.34 92.85 1.08 Allowed 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 107.334 -1.358 . . . . 0.15 107.334 176.336 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.5 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 0.2 OUTLIER -73.68 113.41 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 107.416 -1.327 . . . . 0.95 107.416 177.27 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.818 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 23.1 t0 -77.28 172.04 13.9 Favored 'General case' 0 CA--C 1.491 -1.295 0 CA-C-N 114.778 -1.101 . . . . 0.64 108.815 -175.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.556 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.7 OUTLIER -61.8 157.78 17.31 Favored 'General case' 0 N--CA 1.417 -2.112 0 CA-C-O 122.767 1.27 . . . . 0.37 108.371 168.234 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.559 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 39.3 t -86.87 139.63 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.395 -3.202 0 CA-C-N 113.692 -1.595 . . . . 0.1 107.047 165.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.824 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.6 t-20 -83.8 163.35 20.2 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.854 0.835 . . . . 0.18 110.555 173.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.763 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.74 84.86 2.32 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.348 -1.296 . . . . 0.12 107.977 176.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.401 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.8 mtp180 -108.48 -2.6 18.85 Favored 'General case' 0 CA--C 1.501 -0.913 0 CA-C-N 113.847 -1.524 . . . . 0.64 108.727 -171.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.738 HG21 ' HB3' ' A' ' 172' ' ' PRO . 22.6 p -51.4 -170.13 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 112.678 -2.055 . . . . 0.14 115.156 -176.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 29.8 t30 -70.49 -10.66 59.77 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 113.083 -1.871 . . . . 0.48 110.531 173.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.559 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.37 -144.74 3.98 Favored Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.176 -1.011 . . . . 0.12 113.573 -176.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.639 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 16.5 m -121.27 130.75 53.83 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 122.8 0.44 . . . . 1.16 110.935 -178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.763 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -136.8 157.48 46.65 Favored 'General case' 0 CA--C 1.5 -0.943 0 CA-C-O 121.962 0.887 . . . . 0.1 110.735 -178.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.723 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -77.17 80.74 3.68 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 113.628 -1.623 . . . . 0.17 107.56 175.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.564 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -70.17 -14.71 62.76 Favored 'General case' 0 C--N 1.288 -2.071 0 CA-C-N 114.863 -1.062 . . . . 0.09 109.767 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.86 -29.6 35.74 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.413 -0.958 . . . . 0.15 108.413 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.723 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 29.3 tt0 -61.62 -40.64 95.56 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.207 -1.36 . . . . 1.73 109.125 168.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.564 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -68.15 -45.29 73.94 Favored 'General case' 0 N--CA 1.421 -1.905 0 CA-C-N 112.826 -1.988 . . . . 0.12 108.845 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 47.2 m -63.78 -33.28 75.32 Favored 'General case' 0 N--CA 1.428 -1.568 0 CA-C-N 113.821 -1.536 . . . . 0.11 110.618 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.72 -44.83 84.89 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 107.637 -1.245 . . . . 1.47 107.637 172.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.68 HG21 ' HB2' ' A' ' 64' ' ' TRP . 34.6 m -63.24 -30.11 71.32 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.234 -0.894 . . . . 0.12 110.867 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.74 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.57 -68.34 0.18 Allowed 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.589 -0.732 . . . . 0.56 109.658 171.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.603 ' NH2' HD12 ' A' ' 127' ' ' LEU . 5.8 mpt_? -40.31 -36.63 0.56 Allowed 'General case' 0 C--O 1.213 -0.865 0 O-C-N 124.226 0.954 . . . . 1.51 110.888 174.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.543 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -74.6 -46.35 39.12 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 114.665 -1.152 . . . . 0.28 112.0 -174.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -74.38 -34.55 63.36 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 108.471 -0.937 . . . . 0.09 108.471 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.683 ' HB3' ' CD2' ' A' ' 121' ' ' LEU . 4.5 mm? -61.64 -35.21 77.26 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 113.649 -1.614 . . . . 0.12 109.442 172.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.528 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -73.46 -41.69 62.86 Favored 'General case' 0 CA--C 1.498 -1.042 0 CA-C-N 114.574 -1.194 . . . . 0.2 110.937 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.85 -8.5 54.7 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.15 -0.932 . . . . 1.17 110.281 -179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -77.81 -49.08 15.02 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.523 -0.917 . . . . 2.05 108.523 171.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 87.87 -7.15 82.17 Favored Glycine 0 N--CA 1.452 -0.292 0 CA-C-N 115.416 -0.811 . . . . 0.54 113.735 175.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.654 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 58.7 mtpt -86.64 -33.13 20.22 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 117.289 0.545 . . . . 0.99 111.322 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.685 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 6.5 m-85 -88.81 171.47 9.91 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.303 1.049 . . . . 0.21 112.988 -179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.59 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 7.9 m -116.46 119.32 35.24 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-N 113.144 -1.844 . . . . 0.23 108.222 168.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.683 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.7 OUTLIER -89.01 140.82 29.05 Favored 'General case' 0 N--CA 1.414 -2.273 0 C-N-CA 119.466 -0.893 . . . . 0.38 111.368 -171.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.592 HG21 HD23 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -89.42 147.81 4.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.42 -0.956 . . . . 0.42 108.42 170.055 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.707 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 1.4 m -102.0 164.63 11.61 Favored 'General case' 0 C--N 1.308 -1.231 0 CA-C-O 122.326 1.06 . . . . 1.7 110.06 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.413 ' HA ' ' H ' ' A' ' 128' ' ' SER . . . -64.26 -34.62 78.54 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 112.939 -1.937 . . . . 0.55 111.348 -171.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.707 ' HG2' ' HB2' ' A' ' 123' ' ' SER . 10.2 pt20 -50.12 -30.13 10.49 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 113.501 -1.681 . . . . 2.04 110.966 172.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.583 ' HB2' HG22 ' A' ' 155' ' ' VAL . 0.5 OUTLIER -97.24 -55.04 2.97 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.648 -1.16 . . . . 0.41 110.586 171.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.722 HD23 HD21 ' A' ' 88' ' ' LEU . 1.3 tm? -69.62 -64.76 0.82 Allowed 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 114.679 -1.146 . . . . 1.39 112.998 -168.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.684 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -48.75 -37.83 20.0 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-O 123.649 1.69 . . . . 1.05 108.946 -179.288 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.68 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 6.6 mmt -65.78 -61.52 2.02 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 110.731 -2.94 . . . . 1.64 110.987 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.748 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.65 -43.61 3.92 Favored 'General case' 0 CA--C 1.503 -0.829 0 O-C-N 124.181 0.925 . . . . 0.31 112.384 176.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 127' ' ' LEU . 0.0 OUTLIER -55.24 -52.69 62.58 Favored 'General case' 0 C--O 1.214 -0.777 0 N-CA-C 107.806 -1.183 . . . . 1.53 107.806 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.502 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.9 mt-30 -65.89 -41.05 92.01 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.064 -0.971 . . . . 0.41 111.194 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.666 ' HG3' ' O ' ' A' ' 129' ' ' MET . 54.2 mt-30 -56.46 -34.72 67.14 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-N 114.365 -1.289 . . . . 0.37 109.617 179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.509 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -92.57 -31.33 15.23 Favored 'General case' 0 N--CA 1.423 -1.821 0 CA-C-N 114.002 -1.454 . . . . 0.24 109.45 -176.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.79 -51.95 0.39 Allowed Glycine 0 CA--C 1.499 -0.917 0 C-N-CA 120.149 -1.024 . . . . 0.33 113.759 -178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.664 HD13 ' O ' ' A' ' 141' ' ' SER . 39.1 mt -67.25 -167.0 0.05 Allowed 'General case' 0 C--N 1.292 -1.899 0 CA-C-N 112.499 -1.851 . . . . 0.31 115.778 -170.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.46 ' C ' ' H ' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -116.95 154.57 49.68 Favored Pre-proline 0 N--CA 1.421 -1.909 0 CA-C-N 110.994 -2.821 . . . . 0.81 108.002 176.58 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.684 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 21.9 Cg_endo -62.56 -0.11 1.74 Allowed 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 123.397 2.731 . . . . 0.32 112.207 172.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.46 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.2 tt0 -119.51 -28.73 5.26 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 115.172 -0.922 . . . . 1.25 111.096 -176.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.677 ' O ' ' HB2' ' A' ' 141' ' ' SER . 11.7 t70 -66.1 -25.4 66.99 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 113.779 -1.555 . . . . 0.65 109.407 -172.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.677 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 5.7 m 75.66 171.75 0.26 Allowed 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 113.146 -1.843 . . . . 0.6 109.697 -173.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.01 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.0 mt -65.6 -39.24 91.35 Favored 'General case' 0 C--N 1.293 -1.855 0 CA-C-O 122.398 1.094 . . . . 0.86 108.36 -176.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.55 -12.4 0.33 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 112.871 -1.968 . . . . 0.31 114.646 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.13 124.88 7.79 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 118.719 -0.658 . . . . 0.24 109.638 -174.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.668 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -40.89 -48.5 3.13 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 112.177 0.436 . . . . 1.65 112.177 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 39.3 t -72.47 -26.16 61.7 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-O 121.443 0.64 . . . . 0.53 111.186 -174.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 24.0 mttm -73.97 -28.42 61.47 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 122.712 1.244 . . . . 1.31 108.528 176.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 1.01 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -76.61 -47.25 22.93 Favored 'General case' 0 CA--C 1.488 -1.411 0 CA-C-N 112.27 -2.241 . . . . 0.12 110.253 178.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.635 HG13 ' HE1' ' A' ' 179' ' ' MET . 36.5 mt -66.75 -41.12 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.766 0 CA-C-N 112.816 -1.993 . . . . 0.11 110.188 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.98 -54.94 26.3 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 114.613 -1.176 . . . . 0.15 111.054 171.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.748 HG23 ' CB ' ' A' ' 130' ' ' ALA . 75.2 mt -65.63 -47.89 84.57 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.067 0 N-CA-C 112.748 0.647 . . . . 0.18 112.748 -178.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.671 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.27 -40.45 74.23 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.939 0.4 . . . . 0.13 110.939 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.46 ' HD2' HG23 ' A' ' 149' ' ' ILE . 30.9 mtp180 -82.13 -20.85 37.16 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-O 121.677 0.751 . . . . 1.08 110.451 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 14.8 t30 -83.28 -10.77 58.33 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 107.238 -1.393 . . . . 0.5 107.238 176.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.707 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.0 OUTLIER -109.59 -29.02 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 113.444 -1.707 . . . . 0.17 111.42 -173.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.26 35.92 4.3 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.213 -0.994 . . . . 0.16 112.489 -178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.658 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.45 160.56 17.0 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 113.294 0.85 . . . . 0.12 113.294 -170.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.705 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.4 m80 -100.86 -26.21 13.84 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.121 -0.945 . . . . 0.2 109.613 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.652 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 12.7 m-85 -135.49 -174.29 3.59 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.19 -0.914 . . . . 0.13 111.583 -174.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.692 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -136.57 140.02 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.094 -0.957 . . . . 0.08 109.465 166.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.638 HD21 ' SD ' ' A' ' 176' ' ' MET . 42.9 tp -109.61 100.73 9.73 Favored 'General case' 0 N--CA 1.429 -1.509 0 C-N-CA 119.61 -0.836 . . . . 0.16 109.144 165.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.571 ' CE1' ' HB2' ' A' ' 142' ' ' LEU . 2.3 m-85 -80.53 112.48 17.92 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-N 114.464 -1.244 . . . . 0.26 109.31 177.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.832 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.5 t -124.08 163.02 22.31 Favored 'General case' 0 C--N 1.279 -2.481 0 CA-C-O 122.144 0.973 . . . . 1.05 111.335 -178.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.83 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.1 p -164.65 173.71 11.62 Favored 'General case' 0 N--CA 1.423 -1.776 0 CA-C-N 114.037 -1.438 . . . . 0.1 111.007 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -137.35 134.34 35.89 Favored 'General case' 0 N--CA 1.413 -2.278 0 CA-C-N 114.304 -1.316 . . . . 0.11 108.429 177.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -144.11 -176.19 4.91 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 109.305 -0.628 . . . . 1.09 109.305 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.14 -83.91 0.92 Allowed Glycine 0 CA--C 1.491 -1.414 0 C-N-CA 119.567 -1.302 . . . . 0.15 111.213 173.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.1 t30 -144.59 129.3 18.21 Favored 'General case' 0 C--O 1.198 -1.62 0 CA-C-N 113.985 -1.108 . . . . 0.59 108.149 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.559 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.6 p -63.65 -40.21 88.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-N 115.343 -0.844 . . . . 0.15 112.168 -172.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -60.31 -32.1 70.9 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.982 0.896 . . . . 1.26 109.993 -177.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.78 88.75 3.24 Favored Pre-proline 0 C--N 1.301 -1.504 0 CA-C-N 113.442 -1.708 . . . . 0.13 108.363 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 194' ' ' VAL . 45.9 Cg_endo -90.03 164.51 4.82 Favored 'Trans proline' 0 CA--C 1.49 -1.681 0 C-N-CA 124.028 3.152 . . . . 0.09 114.626 -169.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.0 m -85.37 118.1 24.7 Favored 'General case' 0 N--CA 1.415 -2.203 0 CA-C-N 113.877 -1.51 . . . . 0.14 107.586 167.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 164' ' ' SER . 42.7 tp -83.89 98.35 9.72 Favored 'General case' 0 N--CA 1.412 -2.371 0 N-CA-C 108.551 -0.907 . . . . 0.16 108.551 178.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.638 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 35.7 mt-30 -89.39 109.66 20.55 Favored 'General case' 0 C--N 1.273 -2.742 0 CA-C-O 122.13 0.967 . . . . 0.34 109.259 -176.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.832 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.7 OUTLIER -113.37 163.66 14.57 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 114.736 -1.12 . . . . 1.09 111.271 -173.859 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.61 ' HG2' HD12 ' A' ' 186' ' ' ILE . 37.6 tt0 -170.78 119.26 0.52 Allowed 'General case' 0 C--O 1.203 -1.349 0 CA-C-N 115.873 -0.603 . . . . 0.5 110.131 -166.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.142 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.94 102.01 12.94 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.716 -0.846 . . . . 0.1 108.716 -172.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.668 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.9 ttp -91.71 122.95 34.73 Favored 'General case' 0 CA--C 1.504 -0.81 0 CA-C-N 115.656 -0.702 . . . . 0.07 109.368 176.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.411 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -58.4 127.2 30.94 Favored 'General case' 0 N--CA 1.427 -1.596 0 N-CA-C 107.358 -1.349 . . . . 0.22 107.358 167.072 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.609 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.73 -34.22 11.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 119.151 -1.019 . . . . 0.11 110.758 178.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.468 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 27.6 mt-30 -62.94 -14.89 52.74 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.432 -0.804 . . . . 0.35 111.379 -178.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.2 p -130.64 -36.57 1.41 Allowed 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 121.727 0.775 . . . . 0.19 110.365 178.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.479 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 86.05 32.51 17.28 Favored Glycine 0 N--CA 1.433 -1.533 0 CA-C-N 114.319 -1.309 . . . . 0.18 112.213 -177.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -110.2 155.21 22.29 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.59 -0.305 . . . . 0.73 110.4 178.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 177' ' ' GLN . 29.3 mm -88.23 119.13 35.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 108.967 -0.753 . . . . 0.14 108.967 176.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.142 HD11 HD13 ' A' ' 178' ' ' LEU . 1.3 pp -107.12 -33.04 2.6 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.277 -0.874 . . . . 0.13 110.514 -174.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.657 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.8 t90 -133.53 151.52 51.75 Favored 'General case' 0 CA--C 1.499 -0.982 0 CA-C-N 115.438 -0.801 . . . . 0.07 109.24 172.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 22.1 p -153.99 160.84 42.22 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.664 0.616 . . . . 0.13 112.664 165.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -157.81 -177.06 30.55 Favored Glycine 0 N--CA 1.425 -2.048 0 N-CA-C 110.536 -1.025 . . . . 0.12 110.536 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.768 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 12.9 mtmt -157.43 150.37 23.36 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 105.508 -2.034 . . . . 1.22 105.508 167.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -157.96 126.9 1.79 Allowed Glycine 0 C--N 1.279 -2.598 0 C-N-CA 119.51 -1.329 . . . . 0.12 112.243 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.28 114.07 10.0 Favored 'General case' 0 C--N 1.299 -1.622 0 CA-C-O 121.337 0.589 . . . . 0.17 110.946 -175.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.777 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -91.12 158.49 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.521 0 CA-C-O 122.583 1.182 . . . . 0.11 110.125 -177.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.662 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -98.8 172.16 7.63 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-N 112.69 -2.05 . . . . 0.18 109.727 -173.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.568 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 4.9 tt0 -103.36 127.71 50.64 Favored 'General case' 0 C--N 1.292 -1.914 0 N-CA-C 109.127 -0.694 . . . . 0.91 109.127 167.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.55 ' HG2' ' C ' ' A' ' 62' ' ' TYR . 19.8 mm-40 . . . . . 0 C--N 1.306 -1.304 0 CA-C-N 115.513 -0.767 . . . . 1.24 110.585 178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.564 -0.614 . . . . 88.61 111.564 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.6 t -91.53 -7.28 50.78 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.107 0.48 . . . . 87.43 110.596 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.5 m-70 73.06 132.75 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 114.815 -1.084 . . . . 87.16 111.684 179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.1 mtt 46.44 48.36 13.79 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.705 0.765 . . . . 85.34 111.504 -178.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.4 p -111.94 -9.11 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.534 -1.212 . . . . 85.05 108.59 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.87 -68.03 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 114.725 -1.125 . . . . 84.68 111.164 175.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 63.56 109.53 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 122.181 0.991 . . . . 85.57 111.709 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 57.63 56.12 5.11 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-N 113.893 -1.503 . . . . 85.04 110.937 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.614 ' OE1' ' HA ' ' A' ' 12' ' ' PRO . 24.2 tt0 -120.04 116.15 32.83 Favored Pre-proline 0 C--N 1.313 -1.013 0 CA-C-N 114.863 -1.062 . . . . 82.17 109.157 178.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.66 -41.19 79.93 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.279 2.652 . . . . 81.51 112.658 -177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -132.61 93.53 24.32 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-N 116.003 -0.544 . . . . 79.56 109.59 175.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.614 ' HA ' ' OE1' ' A' ' 9' ' ' GLU . 15.2 Cg_endo -59.06 138.31 84.65 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.46 2.107 . . . . 78.5 112.014 -177.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.6 m -63.08 156.79 4.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 115.797 -0.638 . . . . 77.0 111.705 -177.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 67.95 89.91 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.928 -1.033 . . . . 75.74 110.69 -177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 62.1 mm-40 -70.17 104.49 2.63 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.705 -0.68 . . . . 73.91 110.876 178.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.2 t -89.11 110.86 22.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.212 0.53 . . . . 72.3 110.987 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -127.55 145.56 55.15 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.922 -0.581 . . . . 71.22 110.109 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -66.03 118.52 5.56 Favored 'Trans proline' 0 N--CA 1.463 -0.286 0 C-N-CA 122.603 2.202 . . . . 69.67 112.059 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -100.97 107.79 51.37 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.09 -0.505 . . . . 67.55 110.673 -178.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.35 -73.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.376 2.051 . . . . 66.7 112.449 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -167.49 63.17 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.698 0.761 . . . . 65.01 109.799 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.492 ' HB2' ' HD3' ' A' ' 23' ' ' PRO . 24.3 mt-30 -64.0 -48.16 78.61 Favored Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.161 -0.927 . . . . 63.41 112.291 -177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.492 ' HD3' ' HB2' ' A' ' 22' ' ' GLN . 33.8 Cg_exo -65.83 146.78 84.22 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 121.983 1.788 . . . . 61.93 112.503 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -146.04 112.31 5.8 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.234 -0.439 . . . . 59.87 110.6 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -123.92 97.56 40.91 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.521 -0.309 . . . . 58.47 110.798 178.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -81.17 85.65 1.75 Allowed 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.508 2.139 . . . . 57.36 111.504 175.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -64.93 142.57 58.39 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.04 0.448 . . . . 55.51 110.825 -176.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -146.94 83.59 7.92 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.649 -0.705 . . . . 53.87 109.718 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -62.13 131.7 35.75 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.865 2.377 . . . . 52.76 111.908 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.8 m -122.77 133.76 24.63 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 50.93 110.876 -178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -68.98 148.84 70.98 Favored 'Trans proline' 0 C--O 1.233 0.25 0 C-N-CA 122.894 2.396 . . . . 49.21 112.228 -178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.446 HG22 ' H ' ' A' ' 33' ' ' VAL . 0.8 OUTLIER -80.2 167.84 19.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.5 0.667 . . . . 47.49 110.613 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.446 ' H ' HG22 ' A' ' 32' ' ' THR . 11.5 m -118.24 107.76 42.98 Favored Pre-proline 0 C--N 1.311 -1.072 0 CA-C-N 114.853 -1.067 . . . . 45.97 111.252 -179.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -55.84 160.2 10.32 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.628 2.886 . . . . 45.28 112.847 177.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.9 p -79.92 141.8 35.73 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 114.953 -1.021 . . . . 42.79 111.315 -176.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.97 121.71 77.35 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.567 -0.742 . . . . 40.79 110.795 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -62.07 159.7 33.31 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.841 2.36 . . . . 39.81 112.16 177.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 4.1 p -76.58 120.79 22.26 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.14 0.495 . . . . 37.5 111.471 179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 8.9 mt -82.99 128.58 64.85 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.45 -0.796 . . . . 35.65 109.69 -178.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.48 ' HG2' ' OE1' ' A' ' 42' ' ' GLN . 36.7 Cg_endo -67.22 -175.91 0.73 Allowed 'Trans proline' 0 CA--C 1.531 0.341 0 C-N-CA 122.565 2.177 . . . . 33.72 113.66 -177.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -115.53 94.45 4.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.503 1.144 . . . . 31.51 111.204 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.48 ' OE1' ' HG2' ' A' ' 40' ' ' PRO . 2.2 mp0 -70.77 -39.14 8.5 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 114.039 -1.437 . . . . 30.13 113.301 -173.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -79.92 149.84 20.54 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 121.841 1.694 . . . . 29.52 111.096 171.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -167.26 171.17 41.88 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.027 -1.082 . . . . 26.75 113.086 -179.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -67.53 134.55 33.39 Favored 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 123.574 2.85 . . . . 25.08 111.979 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.2 mt -73.91 -58.81 4.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.243 -0.89 . . . . 23.9 110.04 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 56.53 80.63 0.15 Allowed 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 113.005 0.742 . . . . 21.23 113.005 171.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -154.85 164.26 39.09 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.99 -0.55 . . . . 19.92 111.1 171.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -129.67 170.91 13.21 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.576 -0.738 . . . . 16.56 110.179 -177.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -85.43 73.15 10.57 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.035 -0.728 . . . . 15.05 109.035 173.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.4 ' HG3' ' N ' ' A' ' 52' ' ' THR . 4.2 pt20 -50.03 -57.75 6.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.155 -0.93 . . . . 14.19 112.342 -172.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.4 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 36.3 p -119.76 134.27 55.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.086 0.469 . . . . 11.38 111.801 -173.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.45 100.91 4.38 Favored Pre-proline 0 N--CA 1.444 -0.754 0 CA-C-N 115.383 -0.826 . . . . 8.29 110.52 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -64.16 120.61 8.0 Favored 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.754 2.303 . . . . 6.87 112.032 179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -79.35 -93.06 0.0 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.524 0 C-N-CA 122.438 2.092 . . . . 5.04 113.106 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.32 62.01 12.48 Favored Pre-proline 0 C--O 1.236 0.383 0 C-N-CA 122.729 0.411 . . . . 2.59 111.632 -177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.31 -176.43 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.595 0 C-N-CA 123.029 2.486 . . . . 1.64 112.986 -178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 52.6 m80 -127.39 148.72 50.27 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.311 -1.313 . . . . 3.39 110.252 -176.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.633 HG22 ' N ' ' A' ' 60' ' ' ARG . 9.6 mt -90.35 168.42 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.0 0.905 . . . . 0.44 112.087 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.633 ' N ' HG22 ' A' ' 59' ' ' ILE . 42.8 mtt180 -71.14 -158.84 0.04 OUTLIER 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 113.557 -1.656 . . . . 2.34 112.222 178.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.67 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 17.3 t-160 -157.85 150.28 22.49 Favored 'General case' 0 CA--C 1.47 -2.116 0 CA-C-N 111.885 -2.416 . . . . 2.22 105.771 176.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.752 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.7 m-30 -125.44 160.05 30.38 Favored 'General case' 0 N--CA 1.416 -2.128 0 O-C-N 123.736 0.648 . . . . 0.21 109.627 -176.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.534 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 2.1 t70 -79.66 68.02 5.59 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 123.785 1.755 . . . . 0.35 108.167 170.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.716 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.9 m95 -60.08 -44.53 94.71 Favored 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 111.594 -2.548 . . . . 0.1 112.199 174.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.562 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 7.1 t-20 -50.03 -30.48 10.83 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 113.844 -1.525 . . . . 1.11 111.607 175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.65 -18.3 80.01 Favored Glycine 0 CA--C 1.502 -0.748 0 CA-C-N 115.503 -0.772 . . . . 0.21 111.266 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.58 -52.22 3.4 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.965 -1.118 . . . . 0.13 110.895 -175.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.719 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.1 mtt -64.32 -58.49 6.36 Favored 'General case' 0 C--O 1.209 -1.075 0 CA-C-N 114.136 -1.393 . . . . 0.09 112.198 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.562 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 6.0 mm-40 -40.11 -53.59 4.97 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 114.912 1.449 . . . . 0.63 114.912 -175.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.811 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.1 Cg_endo -64.19 -30.79 64.75 Favored 'Trans proline' 0 CA--C 1.511 -0.674 0 C-N-CA 122.164 1.91 . . . . 0.14 110.654 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.769 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 9.3 mtm -80.97 -46.87 14.45 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 115.006 -0.997 . . . . 0.7 111.7 -177.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.71 HG23 ' O ' ' A' ' 68' ' ' MET . 57.5 t -54.6 -40.73 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.14 0 CA-C-N 114.091 -1.413 . . . . 0.12 108.841 175.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 t -58.97 -36.81 75.47 Favored 'General case' 0 C--N 1.309 -1.165 0 CA-C-N 113.028 -1.896 . . . . 0.56 110.909 174.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.811 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.9 mtpt -80.39 -34.1 36.6 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 121.091 0.472 . . . . 1.3 110.775 179.092 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.84 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.09 -29.56 70.69 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-N 115.305 -0.862 . . . . 0.5 111.685 -171.667 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.569 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.3 mt -91.79 -6.18 52.21 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.939 0.876 . . . . 0.65 111.23 -178.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.55 15.35 49.64 Favored Glycine 0 N--CA 1.442 -0.945 0 N-CA-C 109.156 -1.578 . . . . 0.17 109.156 171.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.616 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.48 165.48 18.06 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.42 -0.89 . . . . 0.1 110.316 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -88.32 107.6 18.91 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 115.066 -0.97 . . . . 1.72 109.787 176.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.629 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 130.98 -22.88 4.46 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 110.991 -0.843 . . . . 0.12 110.991 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.84 HG11 ' O ' ' A' ' 75' ' ' MET . 10.1 p -99.27 152.44 4.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.861 0.838 . . . . 0.16 111.496 -175.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -134.33 138.73 45.15 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 114.159 -1.382 . . . . 0.45 109.835 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.59 ' HB2' ' HD2' ' A' ' 118' ' ' LYS . . . -65.3 137.82 57.8 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.871 -0.604 . . . . 0.28 110.239 169.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.2 -1.41 54.39 Favored Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.799 -0.715 . . . . 0.28 112.69 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.14 153.07 22.91 Favored 'General case' 0 CA--C 1.506 -0.729 0 CA-C-O 120.993 0.425 . . . . 1.2 110.972 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.658 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.0 p -81.86 116.43 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.091 0 CA-C-O 122.122 0.963 . . . . 0.2 109.221 166.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.722 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -103.93 109.67 21.52 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.964 -1.017 . . . . 0.14 108.971 -173.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.673 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -71.76 94.29 1.37 Allowed 'General case' 0 CA--C 1.503 -0.827 0 CA-C-N 114.545 -1.207 . . . . 0.15 107.932 176.804 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.499 HG11 ' HG3' ' A' ' 110' ' ' ARG . 1.7 m -73.12 117.71 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 N-CA-C 107.476 -1.305 . . . . 0.95 107.476 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.831 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 8.7 t0 -77.52 156.41 31.0 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-N 114.659 -1.155 . . . . 0.64 108.134 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.556 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.54 135.89 57.81 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 107.473 -1.306 . . . . 0.37 107.473 171.075 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.525 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 23.2 t -63.4 140.08 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.836 0 CA-C-N 114.783 -1.099 . . . . 0.1 108.065 169.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.803 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.6 t-20 -85.56 163.22 18.5 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 115.248 -0.887 . . . . 0.18 109.913 174.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.765 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.98 85.34 2.4 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 114.604 -1.18 . . . . 0.12 108.487 175.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 14.0 mtp180 -108.14 -1.98 19.86 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.969 -1.469 . . . . 0.64 108.995 -172.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.719 HG21 ' HB3' ' A' ' 172' ' ' PRO . 24.5 p -52.0 -170.96 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 112.715 -2.039 . . . . 0.14 114.975 -177.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 32.7 t30 -72.48 -4.05 28.05 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 112.992 -1.913 . . . . 0.48 110.558 173.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.615 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -157.42 -144.46 3.94 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.052 -1.071 . . . . 0.12 113.368 -177.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.648 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 53.8 p -122.09 129.46 52.4 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 112.278 0.473 . . . . 1.16 112.278 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.765 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.12 157.37 47.1 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 121.97 0.89 . . . . 0.1 110.678 -178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.646 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.6 t-20 -80.48 79.99 7.0 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.053 -1.43 . . . . 0.17 107.846 175.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.584 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.0 -14.2 62.66 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 114.479 -1.237 . . . . 0.09 109.988 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.584 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.19 -32.17 44.04 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.721 -0.844 . . . . 0.15 108.721 -178.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.646 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.4 tp10 -66.63 -31.96 72.97 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-O 122.951 1.358 . . . . 1.73 109.064 172.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -73.75 -44.18 56.92 Favored 'General case' 0 N--CA 1.429 -1.476 0 CA-C-N 113.036 -1.893 . . . . 0.12 109.657 177.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.616 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 60.0 m -63.98 -31.6 72.84 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 113.986 -1.461 . . . . 0.11 110.626 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 1.5 pt-20 -66.97 -43.34 83.32 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.701 -1.222 . . . . 1.47 107.701 172.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.675 HG21 ' HB2' ' A' ' 64' ' ' TRP . 56.8 m -63.06 -30.46 71.61 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 115.234 -0.894 . . . . 0.12 110.672 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.719 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.74 -69.56 0.11 Allowed 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.205 -0.665 . . . . 0.56 109.205 171.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.1 mtp180 -40.22 -38.22 0.74 Allowed 'General case' 0 C--N 1.313 -0.982 0 O-C-N 124.405 1.065 . . . . 1.51 111.29 174.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.514 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.71 -47.51 59.42 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 114.517 -1.22 . . . . 0.28 111.897 -176.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.4 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.15 -33.72 65.64 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.223 1.011 . . . . 0.09 108.647 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.696 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -62.92 -34.65 77.9 Favored 'General case' 0 N--CA 1.442 -0.869 0 CA-C-N 113.416 -1.72 . . . . 0.12 109.976 172.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.615 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -74.78 -42.58 57.88 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-N 114.752 -1.113 . . . . 0.2 111.097 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.3 m-80 -63.2 -29.26 70.64 Favored 'General case' 0 N--CA 1.439 -0.983 0 CA-C-N 114.769 -1.105 . . . . 1.17 110.43 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -82.26 -23.89 35.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.535 -0.757 . . . . 2.05 110.159 -176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 71.71 4.28 57.51 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.975 -1.011 . . . . 0.54 114.927 159.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.59 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 13.5 mtmm -91.18 -34.27 15.08 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.279 0.539 . . . . 0.99 111.156 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.722 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 14.6 m-85 -89.44 175.56 7.26 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 122.355 1.074 . . . . 0.21 112.458 -178.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.5 m -118.92 121.13 39.25 Favored 'General case' 0 N--CA 1.417 -2.119 0 CA-C-N 113.012 -1.904 . . . . 0.23 108.289 169.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.674 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -91.72 141.76 28.34 Favored 'General case' 0 N--CA 1.415 -2.186 0 C-N-CA 119.389 -0.924 . . . . 0.38 111.159 -170.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.796 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.3 m -91.74 150.08 3.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 107.892 -1.151 . . . . 0.42 107.892 169.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.507 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 1.4 m -101.88 -177.1 3.32 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 119.893 -0.723 . . . . 1.7 110.271 179.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.4 ' HA ' ' H ' ' A' ' 128' ' ' SER . . . -66.0 -29.98 70.46 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 108.34 -0.985 . . . . 0.55 108.34 176.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.625 ' O ' ' HG3' ' A' ' 129' ' ' MET . 10.0 mt-30 -44.13 -40.81 5.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 113.091 -1.868 . . . . 2.04 111.212 175.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.796 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 6.8 mt-30 -98.05 -53.29 3.42 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 122.105 0.955 . . . . 0.41 109.982 173.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.639 HD13 HD21 ' A' ' 88' ' ' LEU . 31.2 tp -62.94 -65.81 0.63 Allowed 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 113.303 -1.772 . . . . 1.39 113.271 -166.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.644 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 3.0 t -50.31 -46.26 55.33 Favored 'General case' 0 CA--C 1.497 -1.086 0 CA-C-O 123.365 1.555 . . . . 1.05 109.105 -177.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.743 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 17.2 mmt -54.31 -63.36 1.17 Allowed 'General case' 0 N--CA 1.432 -1.366 0 CA-C-N 110.745 -2.934 . . . . 1.64 110.706 176.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.77 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.91 -46.47 5.37 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 124.346 1.029 . . . . 0.31 112.15 175.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.523 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -54.45 -52.35 62.1 Favored 'General case' 0 C--O 1.212 -0.919 0 N-CA-C 108.744 -0.836 . . . . 1.53 108.744 179.439 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.559 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.7 mt-30 -65.18 -39.88 93.49 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.402 -0.817 . . . . 0.41 111.034 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.743 ' HG3' ' O ' ' A' ' 129' ' ' MET . 52.1 mt-30 -58.72 -34.74 71.69 Favored 'General case' 0 CA--C 1.491 -1.316 0 CA-C-N 114.516 -1.22 . . . . 0.37 109.568 178.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.495 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -90.21 -28.94 18.53 Favored 'General case' 0 N--CA 1.424 -1.756 0 CA-C-N 113.942 -1.481 . . . . 0.24 109.733 -176.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.96 -45.06 0.69 Allowed Glycine 0 CA--C 1.494 -1.263 0 CA-C-O 122.534 1.075 . . . . 0.33 113.094 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.612 HD13 ' O ' ' A' ' 141' ' ' SER . 91.3 mt -66.93 -171.44 0.14 Allowed 'General case' 0 C--N 1.291 -1.957 0 CA-C-N 112.416 -1.892 . . . . 0.31 115.43 -170.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.565 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 63.1 m -115.55 152.9 47.64 Favored Pre-proline 0 N--CA 1.425 -1.684 0 CA-C-N 110.641 -2.982 . . . . 0.81 107.661 175.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.644 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 36.9 Cg_endo -66.26 0.44 3.33 Favored 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 122.49 2.127 . . . . 0.32 112.138 178.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.584 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.6 tt0 -118.65 -27.06 5.97 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.997 0.903 . . . . 1.25 110.418 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.614 ' O ' ' HB2' ' A' ' 141' ' ' SER . 15.0 t70 -57.87 -25.89 61.36 Favored 'General case' 0 CA--C 1.486 -1.492 0 CA-C-N 113.207 -1.815 . . . . 0.65 109.35 -173.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 21.3 m 73.52 168.95 0.31 Allowed 'General case' 0 N--CA 1.422 -1.846 0 CA-C-N 112.668 -2.06 . . . . 0.6 109.186 -172.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.996 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.5 mt -66.03 -40.12 90.75 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.24 1.019 . . . . 0.86 108.386 -177.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 64.81 -9.18 0.45 Allowed Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 112.95 -1.932 . . . . 0.31 114.332 177.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.56 124.64 6.17 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.065 -0.717 . . . . 0.24 109.065 -175.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.687 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.4 mmt180 -42.27 -45.31 4.14 Favored 'General case' 0 C--O 1.214 -0.783 0 CA-C-N 118.072 0.396 . . . . 1.65 112.001 -177.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.8 t -74.13 -25.77 59.95 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-O 121.601 0.715 . . . . 0.53 111.255 -174.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 59.1 mttt -73.64 -29.6 62.44 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-O 122.625 1.203 . . . . 1.31 108.421 175.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.996 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -76.27 -47.79 22.54 Favored 'General case' 0 CA--C 1.487 -1.453 0 CA-C-N 112.403 -2.18 . . . . 0.12 110.223 178.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.649 HG13 ' HE1' ' A' ' 179' ' ' MET . 42.1 mt -65.39 -41.52 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 CA-C-N 112.794 -2.003 . . . . 0.11 109.865 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.59 -54.56 27.03 Favored Glycine 0 N--CA 1.437 -1.296 0 CA-C-N 114.864 -1.062 . . . . 0.15 111.082 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.77 HG23 ' CB ' ' A' ' 130' ' ' ALA . 89.9 mt -66.85 -48.14 80.65 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 N-CA-C 112.5 0.556 . . . . 0.18 112.5 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.673 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.22 -41.01 71.48 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-O 120.939 0.399 . . . . 0.13 111.099 -178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.556 ' HD2' HG23 ' A' ' 149' ' ' ILE . 58.3 mtp180 -81.84 -21.51 37.53 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.614 0.721 . . . . 1.08 110.618 -178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.501 HD22 ' CB ' ' A' ' 130' ' ' ALA . 22.8 t30 -84.76 -11.44 55.77 Favored 'General case' 0 CA--C 1.507 -0.709 0 N-CA-C 107.314 -1.365 . . . . 0.5 107.314 176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.721 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.07 -29.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 CA-C-N 113.184 -1.826 . . . . 0.17 110.932 -174.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.7 34.17 5.05 Favored Glycine 0 CA--C 1.503 -0.703 0 C-N-CA 120.267 -0.968 . . . . 0.16 112.424 -179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.6 161.45 14.85 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.873 0.694 . . . . 0.12 112.873 -170.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.658 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.0 m80 -100.87 -27.72 13.17 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.24 -0.891 . . . . 0.2 109.796 177.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.622 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 7.5 m-85 -136.15 -174.26 3.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.187 -0.915 . . . . 0.13 111.318 -174.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.711 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -137.06 139.2 44.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 114.939 -1.028 . . . . 0.08 108.883 166.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.607 HD21 ' SD ' ' A' ' 176' ' ' MET . 33.9 tp -107.98 100.57 9.9 Favored 'General case' 0 N--CA 1.431 -1.395 0 C-N-CA 119.318 -0.953 . . . . 0.16 109.351 165.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.574 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.2 m-85 -79.8 112.94 17.56 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-N 114.606 -1.179 . . . . 0.26 108.897 178.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.845 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 10.2 t -124.45 160.58 27.9 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-O 121.922 0.867 . . . . 1.05 110.564 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.817 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.4 p -162.73 172.96 14.47 Favored 'General case' 0 N--CA 1.42 -1.957 0 CA-C-N 114.334 -1.303 . . . . 0.1 111.076 -177.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.32 135.33 40.7 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 114.005 -1.452 . . . . 0.11 108.633 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.668 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.8 m -144.09 -176.12 4.88 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 109.254 -0.647 . . . . 1.09 109.254 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.11 -84.08 0.92 Allowed Glycine 0 CA--C 1.49 -1.489 0 C-N-CA 119.768 -1.206 . . . . 0.15 111.416 173.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.4 t30 -143.74 131.47 21.35 Favored 'General case' 0 C--O 1.196 -1.762 0 N-CA-C 107.821 -1.178 . . . . 0.59 107.821 174.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.615 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.6 p -65.57 -41.34 90.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-N 115.14 -0.936 . . . . 0.15 112.426 -171.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.404 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.3 m-20 -60.99 -31.15 70.77 Favored 'General case' 0 CA--C 1.509 -0.612 0 CA-C-O 121.732 0.777 . . . . 1.26 109.478 -177.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.23 89.07 3.37 Favored Pre-proline 0 C--N 1.312 -1.025 0 CA-C-N 113.874 -1.512 . . . . 0.13 108.16 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.86 ' HD2' HG22 ' A' ' 194' ' ' VAL . 42.6 Cg_endo -91.36 166.61 3.53 Favored 'Trans proline' 0 CA--C 1.494 -1.48 0 C-N-CA 124.551 3.501 . . . . 0.09 114.846 -170.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.58 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.3 m -85.76 119.6 26.26 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 113.745 -1.57 . . . . 0.14 107.551 166.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.817 HD12 ' O ' ' A' ' 164' ' ' SER . 50.4 tp -84.56 97.74 9.75 Favored 'General case' 0 N--CA 1.412 -2.326 0 C-N-CA 119.492 -0.883 . . . . 0.16 108.709 178.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.602 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 34.1 mt-30 -89.26 109.33 20.23 Favored 'General case' 0 C--N 1.273 -2.726 0 CA-C-O 122.052 0.929 . . . . 0.34 109.053 -176.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.845 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.7 OUTLIER -112.87 164.17 13.74 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-N 115.004 -0.998 . . . . 1.09 111.638 -173.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.609 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.0 tt0 -170.78 118.22 0.5 Allowed 'General case' 0 C--O 1.201 -1.476 0 CA-C-N 115.972 -0.558 . . . . 0.5 110.236 -166.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.104 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.19 101.99 13.16 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 108.609 -0.885 . . . . 0.1 108.609 -172.801 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.687 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.5 ttp -90.43 121.62 32.57 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-N 115.462 -0.79 . . . . 0.07 109.504 176.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.424 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.91 127.97 34.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.149 -1.426 . . . . 0.22 107.149 166.606 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.646 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -83.69 -34.18 10.26 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 118.912 -1.115 . . . . 0.11 110.965 178.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.462 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 28.7 mt-30 -61.6 -15.57 40.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.372 -0.831 . . . . 0.35 111.424 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 70.8 p -130.2 -36.61 1.5 Allowed 'General case' 0 CA--C 1.511 -0.539 0 CA-C-O 121.745 0.783 . . . . 0.19 110.294 178.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.51 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 87.59 27.91 25.79 Favored Glycine 0 N--CA 1.435 -1.413 0 CA-C-N 114.316 -1.311 . . . . 0.18 112.003 -178.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -106.81 155.91 19.22 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 120.648 0.261 . . . . 0.73 110.52 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.609 HD12 ' HG2' ' A' ' 177' ' ' GLN . 30.3 mm -89.85 115.64 29.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.502 0.668 . . . . 0.14 109.494 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.104 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -103.1 -32.3 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 CA-C-N 114.903 -1.044 . . . . 0.13 110.54 -173.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.697 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.8 t90 -134.81 152.02 51.41 Favored 'General case' 0 CA--C 1.504 -0.822 0 CA-C-N 115.245 -0.889 . . . . 0.07 109.403 173.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.501 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 30.0 p -153.57 162.78 40.94 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.881 0.697 . . . . 0.13 112.881 164.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.51 -173.64 27.18 Favored Glycine 0 N--CA 1.427 -1.94 0 N-CA-C 110.721 -0.951 . . . . 0.12 110.721 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 15.1 mtmm -158.93 154.08 25.33 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 105.273 -2.121 . . . . 1.22 105.273 166.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -161.22 127.79 1.81 Allowed Glycine 0 C--N 1.281 -2.484 0 C-N-CA 119.245 -1.455 . . . . 0.12 112.568 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.514 ' HA ' ' HA ' ' A' ' 173' ' ' THR . . . -72.55 112.6 8.75 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 121.72 0.771 . . . . 0.17 111.329 -174.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.86 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -91.77 158.8 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.612 0 CA-C-O 122.758 1.266 . . . . 0.11 110.816 -176.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.752 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.2 173.43 6.46 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 112.352 -2.203 . . . . 0.18 108.652 -173.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.1 tt0 -102.34 133.78 46.71 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 120.14 -0.624 . . . . 0.91 109.758 171.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.517 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 12.3 mm-40 . . . . . 0 C--N 1.315 -0.933 0 CA-C-O 118.804 -0.617 . . . . 1.24 110.906 177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.943 0 N-CA-C 112.297 -0.321 . . . . 88.61 112.297 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.6 p -100.18 177.47 5.06 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.058 -0.349 . . . . 87.43 110.058 179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 -100.36 59.29 0.99 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.532 0.682 . . . . 87.16 110.309 176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 51.5 ttp -119.56 49.28 1.38 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.042 0.925 . . . . 85.34 109.438 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.3 p -116.58 -18.66 6.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.229 -0.896 . . . . 85.05 110.936 -178.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -130.0 22.76 4.77 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.067 -0.587 . . . . 84.68 111.995 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.482 ' HG3' ' N ' ' A' ' 8' ' ' ARG . 2.8 pt20 -60.49 -42.93 97.33 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.061 -0.569 . . . . 85.57 111.005 -179.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.482 ' N ' ' HG3' ' A' ' 7' ' ' GLN . 34.6 mmt180 64.31 113.58 0.03 OUTLIER 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.142 0.496 . . . . 85.04 111.652 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 73.46 119.55 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.354 0 CA-C-N 114.86 -1.064 . . . . 82.17 111.668 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -60.42 -34.67 92.92 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.257 1.971 . . . . 81.51 110.564 172.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -139.34 93.15 10.16 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.116 -0.947 . . . . 79.56 109.369 174.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.03 133.87 60.52 Favored 'Trans proline' 0 C--O 1.234 0.276 0 C-N-CA 122.829 2.353 . . . . 78.5 112.553 -179.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 23.9 m -129.52 149.58 33.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.732 -0.667 . . . . 77.0 111.065 -179.043 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -96.88 50.2 1.1 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.557 -0.747 . . . . 75.74 110.106 -176.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.86 84.02 7.54 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.938 -0.574 . . . . 73.91 110.374 -178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.2 t -71.19 133.25 32.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.185 -0.916 . . . . 72.3 109.852 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 44.7 mmtm -83.76 134.41 44.54 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.311 -0.404 . . . . 71.22 110.133 -178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 17' ' ' LYS . 33.8 Cg_exo -58.73 128.91 29.86 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.648 2.232 . . . . 69.67 112.89 -177.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -116.22 99.94 53.08 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.971 -0.559 . . . . 67.55 109.859 176.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -73.43 62.44 4.41 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 122.694 2.263 . . . . 66.7 112.854 -176.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -80.48 -61.4 1.99 Allowed 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.982 -0.377 . . . . 65.01 109.982 176.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 44.91 73.78 0.91 Allowed Pre-proline 0 C--O 1.24 0.579 0 O-C-N 123.786 0.678 . . . . 63.41 111.76 176.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -61.12 143.17 98.75 Favored 'Trans proline' 0 CA--C 1.519 -0.229 0 C-N-CA 123.411 2.74 . . . . 61.93 112.924 -179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.55 59.86 1.35 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.988 0.899 . . . . 59.87 109.125 177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -115.11 95.35 41.88 Favored Pre-proline 0 C--N 1.314 -0.935 0 CA-C-N 113.629 -1.623 . . . . 58.47 110.055 -172.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -69.68 105.71 1.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 122.281 1.987 . . . . 57.36 112.063 -178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.612 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 90.4 mt-30 -95.65 -5.68 41.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.378 -0.374 . . . . 55.51 110.913 -179.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 58.0 tp60 -104.09 96.26 9.29 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 116.371 -0.377 . . . . 53.87 111.118 179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.612 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 2.4 Cg_endo -82.01 135.73 8.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.079 2.519 . . . . 52.76 111.383 175.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 40.8 t -118.76 87.65 33.25 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-O 120.907 0.384 . . . . 50.93 110.83 -178.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -91.34 174.07 2.58 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 123.388 2.725 . . . . 49.21 111.805 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 46.8 p -107.05 150.29 26.69 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.99 0.424 . . . . 47.49 110.877 176.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 65.4 t -98.81 108.37 48.4 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 115.695 -0.684 . . . . 45.97 110.462 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -59.69 156.02 39.7 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.673 2.249 . . . . 45.28 112.084 177.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 71.4 m -160.92 127.23 3.97 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.532 -0.758 . . . . 42.79 110.407 -177.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 5.6 p -121.73 121.95 28.03 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.722 -0.672 . . . . 40.79 110.233 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -55.76 146.85 64.24 Favored 'Trans proline' 0 CA--C 1.517 -0.329 0 C-N-CA 122.549 2.166 . . . . 39.81 112.151 177.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 65.8 m -141.24 106.38 4.99 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.31 0.576 . . . . 37.5 110.744 -177.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 4.5 mt -96.23 115.32 65.53 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.489 -0.778 . . . . 35.65 110.311 -179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -71.18 122.4 8.69 Favored 'Trans proline' 0 N--CA 1.459 -0.501 0 C-N-CA 122.28 1.987 . . . . 33.72 111.966 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -135.77 -178.37 5.1 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.041 -0.527 . . . . 31.51 110.333 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.1 mp0 -116.77 87.7 22.68 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 109.354 -0.61 . . . . 30.13 109.354 176.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -62.65 121.21 9.05 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.346 2.031 . . . . 29.52 111.433 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 140.86 161.95 8.91 Favored Glycine 0 N--CA 1.437 -1.233 0 N-CA-C 111.161 -0.776 . . . . 26.75 111.161 -174.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -71.1 125.81 11.81 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 122.444 2.096 . . . . 25.08 112.391 -179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 42.8 mt -73.07 -55.14 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.147 -0.478 . . . . 23.9 109.725 178.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 59.4 85.56 0.1 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.234 -0.893 . . . . 21.23 111.179 177.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.4 p-80 -86.97 157.13 19.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.957 0.408 . . . . 19.92 110.807 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -175.62 131.31 0.27 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.371 -0.831 . . . . 16.56 109.444 -179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -106.03 75.44 1.11 Allowed 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.286 -0.87 . . . . 15.05 110.267 -177.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -51.59 132.85 30.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.531 -1.213 . . . . 14.19 110.634 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 48.4 p -69.58 160.35 31.68 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.663 0.744 . . . . 11.38 112.084 -176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.562 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -130.78 84.81 57.44 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 114.748 -1.114 . . . . 8.29 110.203 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -85.63 105.61 0.86 Allowed 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.745 2.296 . . . . 6.87 112.732 -177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 72.2 Cg_endo -87.91 137.37 3.91 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.286 1.991 . . . . 5.04 112.287 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -126.75 78.61 72.98 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.309 -0.405 . . . . 2.59 110.663 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -74.34 -177.22 3.14 Favored 'Trans proline' 0 CA--C 1.514 -0.497 0 C-N-CA 123.441 2.76 . . . . 1.64 113.028 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -109.64 139.2 44.95 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 113.522 -1.672 . . . . 3.39 109.056 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.601 HG22 ' N ' ' A' ' 60' ' ' ARG . 12.4 mt -76.47 164.99 3.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.106 0.955 . . . . 0.44 112.436 -169.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.601 ' N ' HG22 ' A' ' 59' ' ' ILE . 37.4 mtt85 -75.95 -158.57 0.09 Allowed 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.651 -1.613 . . . . 2.34 112.114 -178.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.595 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 41.9 m80 -152.14 141.09 21.13 Favored 'General case' 0 CA--C 1.48 -1.715 0 CA-C-N 112.211 -2.268 . . . . 2.22 107.161 -177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.718 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 3.5 m-30 -127.02 156.23 41.97 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.59 -0.732 . . . . 0.21 110.633 -174.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.567 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 4.4 t0 -82.74 68.15 9.1 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 123.756 1.741 . . . . 0.35 108.404 171.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.773 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.4 m95 -59.75 -42.94 94.35 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 111.511 -2.586 . . . . 0.1 112.288 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.428 ' N ' HG21 ' A' ' 108' ' ' THR . 0.1 OUTLIER -52.77 -31.79 40.21 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 113.609 -1.632 . . . . 1.11 111.077 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.64 -15.88 78.69 Favored Glycine 0 N--CA 1.444 -0.807 0 CA-C-O 121.781 0.656 . . . . 0.21 111.67 -177.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.441 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -94.5 -48.55 6.06 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.18 -1.01 . . . . 0.13 110.15 -177.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.721 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.4 mtt -66.43 -55.64 14.77 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 114.134 -1.394 . . . . 0.09 111.715 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.416 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 6.1 mm-40 -38.81 -56.01 2.53 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 115.233 1.568 . . . . 0.63 115.233 -177.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.818 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 40.3 Cg_endo -65.37 -29.37 54.17 Favored 'Trans proline' 0 CA--C 1.506 -0.885 0 C-N-CA 121.728 1.619 . . . . 0.14 110.418 -176.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.648 ' HE2' ' N ' ' A' ' 192' ' ' GLY . 9.6 mtm -83.65 -40.23 19.23 Favored 'General case' 0 C--O 1.215 -0.729 0 CA-C-N 115.312 -0.858 . . . . 0.7 111.446 -177.105 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.704 HG23 ' O ' ' A' ' 68' ' ' MET . 52.4 t -57.46 -39.91 71.54 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.934 0 CA-C-N 114.85 -1.068 . . . . 0.12 108.339 171.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -61.17 -32.76 72.49 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.238 -1.801 . . . . 0.56 111.19 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.818 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 34.2 mtpt -84.66 -32.2 23.76 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-O 121.086 0.47 . . . . 1.3 110.891 178.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.885 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.23 -29.77 69.51 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-N 115.332 -0.849 . . . . 0.5 111.413 -172.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.58 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.3 mt -92.07 -4.14 54.81 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 122.26 1.028 . . . . 0.65 110.644 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.23 17.64 40.38 Favored Glycine 0 N--CA 1.436 -1.31 0 N-CA-C 108.984 -1.646 . . . . 0.17 108.984 170.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.625 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -88.04 161.8 17.16 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.693 -0.754 . . . . 0.1 110.282 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.94 107.92 18.94 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.384 -0.825 . . . . 1.72 109.432 175.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.664 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.58 -24.66 3.33 Favored Glycine 0 N--CA 1.415 -2.716 0 C-N-CA 119.739 -1.219 . . . . 0.12 110.466 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.885 HG11 ' O ' ' A' ' 75' ' ' MET . 11.1 p -102.66 152.32 5.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 114.675 -0.762 . . . . 0.16 111.068 -175.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.3 m -135.82 139.64 43.62 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.922 -1.036 . . . . 0.45 110.697 177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.632 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.08 136.01 48.52 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 115.033 -0.985 . . . . 0.28 110.414 167.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.04 3.95 55.6 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.903 -0.665 . . . . 0.28 112.936 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.94 149.24 22.68 Favored 'General case' 0 CA--C 1.502 -0.893 0 C-N-CA 120.168 -0.613 . . . . 1.2 111.002 178.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -80.41 120.58 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.32 0 CA-C-O 121.933 0.873 . . . . 0.2 108.802 165.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.875 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.7 tm? -108.77 111.58 23.41 Favored 'General case' 0 C--N 1.298 -1.647 0 CA-C-N 115.416 -0.811 . . . . 0.14 109.047 -171.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.695 HD23 HG11 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -72.19 93.72 1.48 Allowed 'General case' 0 CA--C 1.501 -0.918 0 CA-C-N 114.833 -1.076 . . . . 0.15 108.158 177.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.481 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.2 m -73.5 115.79 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.721 0 N-CA-C 107.061 -1.459 . . . . 0.95 107.061 176.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.768 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 16.7 t0 -77.57 170.62 16.25 Favored 'General case' 0 CA--C 1.493 -1.235 0 CA-C-N 115.063 -0.971 . . . . 0.64 108.905 -177.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.567 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.8 OUTLIER -61.77 152.59 30.92 Favored 'General case' 0 N--CA 1.42 -1.938 0 N-CA-C 107.93 -1.137 . . . . 0.37 107.93 168.038 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.536 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 38.6 t -81.95 140.77 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.151 0 N-CA-C 107.024 -1.473 . . . . 0.1 107.024 167.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.831 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.7 t-20 -84.01 162.5 20.37 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-O 121.967 0.889 . . . . 0.18 110.307 174.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.757 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -124.81 85.9 2.48 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 114.229 -1.35 . . . . 0.12 108.087 175.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 14.1 mtp180 -108.74 -0.95 19.73 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 114.077 -1.42 . . . . 0.64 108.758 -173.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.709 HG21 ' HB3' ' A' ' 172' ' ' PRO . 30.2 p -53.21 -172.62 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 113.026 -1.897 . . . . 0.14 115.348 -176.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 34.2 t30 -68.37 -13.54 62.35 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 112.637 -2.074 . . . . 0.48 110.522 173.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.549 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -148.16 -145.93 4.25 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.387 -0.911 . . . . 0.12 113.004 -176.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.603 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 19.2 m -121.27 129.6 53.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.959 0.409 . . . . 1.16 110.825 -177.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.757 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.6 pp -135.18 157.63 46.43 Favored 'General case' 0 CA--C 1.503 -0.848 0 CA-C-O 121.921 0.867 . . . . 0.1 110.627 -178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.57 81.46 7.64 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 113.954 -1.476 . . . . 0.17 107.713 175.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.619 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -69.72 -14.77 62.96 Favored 'General case' 0 C--N 1.287 -2.124 0 CA-C-N 114.278 -1.328 . . . . 0.09 109.912 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -78.59 -29.8 46.32 Favored 'General case' 0 C--N 1.315 -0.913 0 N-CA-C 108.734 -0.839 . . . . 0.15 108.734 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 15.6 tp10 -67.91 -32.39 72.82 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 123.123 1.44 . . . . 1.73 109.15 170.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.5 -44.75 61.82 Favored 'General case' 0 N--CA 1.427 -1.599 0 CA-C-N 112.999 -1.91 . . . . 0.12 109.233 177.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.67 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.9 m -63.92 -34.3 77.65 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-N 113.936 -1.484 . . . . 0.11 111.104 -178.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.56 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 13.1 pt-20 -68.0 -42.83 80.11 Favored 'General case' 0 N--CA 1.442 -0.873 0 C-N-CA 118.368 -1.333 . . . . 1.47 107.651 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.654 HG21 ' HB2' ' A' ' 64' ' ' TRP . 58.7 m -61.5 -29.09 69.76 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 115.226 -0.897 . . . . 0.12 111.176 177.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.721 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.3 mt -53.69 -68.12 0.2 Allowed 'General case' 0 CA--C 1.496 -1.113 0 CA-C-N 115.794 -0.639 . . . . 0.56 109.471 170.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.581 ' O ' HD13 ' A' ' 121' ' ' LEU . 14.2 mtp180 -40.26 -38.08 0.73 Allowed 'General case' 0 C--N 1.31 -1.116 0 O-C-N 124.413 1.071 . . . . 1.51 111.395 174.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.569 ' HB2' ' O ' ' A' ' 108' ' ' THR . 16.1 m-80 -68.36 -47.41 67.51 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.675 -1.148 . . . . 0.28 112.4 -179.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.93 -35.79 59.62 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 108.364 -0.976 . . . . 0.09 108.364 -175.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.655 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -58.96 -35.67 73.55 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 113.61 -1.632 . . . . 0.12 109.784 172.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -69.46 -41.96 75.51 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.297 -1.32 . . . . 0.2 111.294 -176.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.406 ' HB2' ' NE2' ' A' ' 69' ' ' GLN . 11.2 m-80 -65.21 -27.21 68.52 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.99 -1.005 . . . . 1.17 111.224 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.86 -16.73 35.21 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.967 -0.56 . . . . 2.05 111.237 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.91 -12.32 0.83 Allowed Glycine 0 C--N 1.334 0.427 0 N-CA-C 115.896 1.118 . . . . 0.54 115.896 162.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 54.4 mtpt -73.28 -33.47 65.25 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-N 117.579 0.689 . . . . 0.99 110.783 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.875 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 23.4 m-85 -90.4 177.43 6.39 Favored 'General case' 0 CA--C 1.495 -1.163 0 CA-C-O 122.54 1.162 . . . . 0.21 112.677 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 5.4 m -121.92 119.96 33.06 Favored 'General case' 0 N--CA 1.417 -2.125 0 CA-C-N 112.651 -2.068 . . . . 0.23 108.069 168.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.633 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -89.4 140.74 29.21 Favored 'General case' 0 N--CA 1.414 -2.235 0 C-N-CA 119.337 -0.945 . . . . 0.38 111.774 -169.892 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.755 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.5 m -90.32 150.59 3.69 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 107.605 -1.258 . . . . 0.42 107.605 167.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.41 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -102.51 170.45 8.03 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.019 -0.672 . . . . 1.7 110.844 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.423 ' HB1' ' HB3' ' A' ' 128' ' ' SER . . . -56.48 -35.02 67.48 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.27 0.557 . . . . 0.55 110.059 175.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.68 ' O ' ' HG3' ' A' ' 129' ' ' MET . 1.5 pt20 -47.1 -33.1 4.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.49 -1.232 . . . . 2.04 111.04 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.755 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 6.6 mt-30 -98.21 -53.78 3.26 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-O 121.784 0.802 . . . . 0.41 110.632 172.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.612 HD23 HD21 ' A' ' 88' ' ' LEU . 1.4 tm? -67.29 -64.07 0.93 Allowed 'General case' 0 C--O 1.223 -0.335 0 CA-C-N 113.916 -1.493 . . . . 1.39 112.572 -168.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.697 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.2 t -49.31 -39.05 29.79 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-O 123.573 1.654 . . . . 1.05 109.047 -178.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.68 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 24.2 mmm -64.46 -62.07 1.82 Allowed 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 110.72 -2.945 . . . . 1.64 110.656 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.753 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.28 -43.48 7.4 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 124.106 0.878 . . . . 0.31 112.326 176.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.815 ' HZ1' HD23 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -51.28 -55.5 17.92 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.293 -1.003 . . . . 1.53 108.293 176.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.525 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 38.3 mt-30 -65.33 -41.28 94.11 Favored 'General case' 0 C--N 1.313 -1.02 0 O-C-N 123.951 0.782 . . . . 0.41 111.42 -178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.657 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.3 mt-30 -56.26 -34.25 66.23 Favored 'General case' 0 CA--C 1.488 -1.436 0 CA-C-N 114.391 -1.277 . . . . 0.37 109.616 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.501 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -92.87 -31.19 15.06 Favored 'General case' 0 N--CA 1.425 -1.724 0 CA-C-N 113.905 -1.498 . . . . 0.24 109.561 -177.678 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.06 -52.13 0.4 Allowed Glycine 0 CA--C 1.497 -1.091 0 CA-C-O 122.594 1.108 . . . . 0.33 113.45 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.721 HD13 ' O ' ' A' ' 141' ' ' SER . 70.7 mt -63.51 -171.75 0.04 OUTLIER 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 112.352 -1.924 . . . . 0.31 115.717 -171.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.539 ' C ' ' H ' ' A' ' 139' ' ' GLN . 6.3 m -116.14 152.29 47.62 Favored Pre-proline 0 N--CA 1.427 -1.621 0 CA-C-N 110.765 -2.925 . . . . 0.81 107.931 176.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.697 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 30.3 Cg_endo -65.44 2.67 1.4 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.751 2.301 . . . . 0.32 111.146 174.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.539 ' H ' ' C ' ' A' ' 137' ' ' SER . 1.7 mm100 -115.17 -19.91 10.63 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 114.098 -1.41 . . . . 1.25 110.091 -174.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.694 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.7 t70 -80.63 -27.72 37.17 Favored 'General case' 0 CA--C 1.5 -0.97 0 CA-C-N 114.336 -1.302 . . . . 0.65 109.839 -169.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.721 ' O ' HD13 ' A' ' 136' ' ' LEU . 4.0 m 76.02 175.23 0.22 Allowed 'General case' 0 N--CA 1.438 -1.033 0 O-C-N 125.33 1.644 . . . . 0.6 109.053 -168.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.998 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.5 mt -69.41 -39.13 78.11 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.368 1.08 . . . . 0.86 108.701 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.18 -12.03 0.29 Allowed Glycine 0 C--N 1.317 -0.488 0 CA-C-N 112.96 -1.927 . . . . 0.31 114.809 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.54 125.78 8.65 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 117.548 0.674 . . . . 0.24 109.324 -175.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.704 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.4 mmt180 -41.45 -48.11 3.77 Favored 'General case' 0 C--O 1.213 -0.842 0 O-C-N 123.378 0.424 . . . . 1.65 111.868 -176.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.5 t -72.05 -27.5 62.73 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 121.58 0.705 . . . . 0.53 111.296 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -73.06 -28.25 62.21 Favored 'General case' 0 CA--C 1.507 -0.7 0 CA-C-O 122.632 1.206 . . . . 1.31 108.587 176.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.998 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -77.49 -46.0 23.85 Favored 'General case' 0 CA--C 1.49 -1.33 0 CA-C-N 112.293 -2.23 . . . . 0.12 110.304 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.649 HG13 ' HE1' ' A' ' 179' ' ' MET . 35.4 mt -67.33 -42.43 87.57 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.775 0 CA-C-N 113.069 -1.878 . . . . 0.11 110.237 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.47 -53.59 31.27 Favored Glycine 0 N--CA 1.438 -1.173 0 CA-C-N 114.955 -1.021 . . . . 0.15 111.072 171.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.753 HG23 ' CB ' ' A' ' 130' ' ' ALA . 70.2 mt -66.32 -47.53 83.93 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.013 0 N-CA-C 112.747 0.647 . . . . 0.18 112.747 -178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.01 -39.98 72.7 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 121.017 0.437 . . . . 0.13 110.767 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 27.7 mtp-105 -81.56 -23.01 37.45 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.676 0.751 . . . . 1.08 110.635 -179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.46 HD21 ' CD ' ' A' ' 133' ' ' GLN . 19.1 t30 -82.18 -12.72 57.97 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 107.332 -1.358 . . . . 0.5 107.332 176.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.717 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.73 -28.53 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.276 0 CA-C-N 113.245 -1.798 . . . . 0.17 110.838 -174.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.67 35.45 4.89 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.35 -0.929 . . . . 0.16 112.282 -179.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.649 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.76 156.38 21.16 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 113.27 0.841 . . . . 0.12 113.27 -170.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.671 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.9 m80 -95.3 -27.87 15.26 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 115.194 -0.912 . . . . 0.2 109.807 176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.557 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 9.2 m-85 -136.38 -179.1 5.47 Favored 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 115.476 -0.784 . . . . 0.13 111.049 -173.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.697 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -131.97 140.75 47.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.438 -0.801 . . . . 0.08 109.232 167.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.481 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 38.2 tp -110.4 101.06 9.81 Favored 'General case' 0 N--CA 1.429 -1.506 0 C-N-CA 119.708 -0.797 . . . . 0.16 108.946 164.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.679 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.23 116.72 19.67 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-N 114.21 -1.359 . . . . 0.26 108.269 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.677 ' OG ' HD11 ' A' ' 174' ' ' LEU . 27.6 t -126.68 163.44 23.49 Favored 'General case' 0 C--N 1.279 -2.493 0 C-N-CA 119.495 -0.882 . . . . 1.05 111.015 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.848 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.9 p -164.23 178.27 7.7 Favored 'General case' 0 N--CA 1.426 -1.669 0 CA-C-N 114.264 -1.334 . . . . 0.1 111.065 -176.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.618 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -141.91 141.34 32.99 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 114.155 -1.384 . . . . 0.11 108.673 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.702 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 t -149.44 -171.35 3.87 Favored 'General case' 0 C--N 1.302 -1.485 0 C-N-CA 120.208 -0.597 . . . . 1.09 110.115 176.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 91.66 -80.69 1.25 Allowed Glycine 0 C--N 1.288 -2.138 0 CA-C-N 115.179 -0.919 . . . . 0.15 111.567 173.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.509 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 59.1 t30 -145.58 127.5 15.46 Favored 'General case' 0 C--O 1.195 -1.767 0 N-CA-C 108.108 -1.071 . . . . 0.59 108.108 176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.549 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.4 p -61.76 -43.9 97.94 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.14 -0.936 . . . . 0.15 113.008 -172.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -61.48 -29.71 70.14 Favored 'General case' 0 CA--C 1.51 -0.575 0 CA-C-O 121.49 0.662 . . . . 1.26 109.635 -177.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.44 88.16 3.73 Favored Pre-proline 0 C--N 1.308 -1.203 0 CA-C-N 114.588 -1.187 . . . . 0.13 108.021 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.818 ' HD2' HG22 ' A' ' 194' ' ' VAL . 51.3 Cg_endo -91.29 163.56 3.69 Favored 'Trans proline' 0 CA--C 1.49 -1.697 0 C-N-CA 124.596 3.531 . . . . 0.09 114.731 -170.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' ' 191' ' ' LYS . 18.8 m -81.77 117.17 21.86 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 113.854 -1.521 . . . . 0.14 107.693 166.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 164' ' ' SER . 38.8 tp -83.73 98.94 9.95 Favored 'General case' 0 N--CA 1.412 -2.326 0 CA-C-O 121.885 0.85 . . . . 0.16 109.126 177.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.647 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.0 mt-30 -89.09 107.81 19.25 Favored 'General case' 0 C--N 1.275 -2.658 0 CA-C-N 114.909 -1.041 . . . . 0.34 109.048 -176.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.522 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 34.7 mtp -108.25 162.84 13.71 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 114.848 -1.069 . . . . 1.09 110.203 -177.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.618 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.8 tt0 -169.49 119.99 0.68 Allowed 'General case' 0 C--O 1.204 -1.315 0 CA-C-O 121.377 0.608 . . . . 0.5 109.908 -167.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.119 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.44 102.38 13.17 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 108.934 -0.765 . . . . 0.1 108.934 -172.202 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.704 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.1 ttp -92.48 122.91 35.38 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.533 -0.758 . . . . 0.07 109.402 176.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.435 HD22 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -58.83 127.46 32.29 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.161 -1.422 . . . . 0.22 107.161 166.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.61 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.2 -33.63 11.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 119.35 0.977 . . . . 0.11 110.718 178.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.424 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.9 mt-30 -64.25 -14.77 57.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.291 -0.868 . . . . 0.35 111.498 -177.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 76.9 p -130.52 -36.96 1.41 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.766 0.794 . . . . 0.19 110.251 176.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.538 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.36 24.09 29.82 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.481 -1.236 . . . . 0.18 112.496 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -103.92 155.61 18.5 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.684 0.278 . . . . 0.73 110.682 179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.618 HD12 ' HG2' ' A' ' 177' ' ' GLN . 34.2 mm -87.95 119.25 35.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.433 0.635 . . . . 0.14 109.507 177.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.119 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -108.28 -30.56 2.47 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.04 0 CA-C-N 114.966 -1.016 . . . . 0.13 110.536 -173.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.625 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.1 t90 -135.38 151.83 50.84 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-N 115.206 -0.906 . . . . 0.07 109.351 171.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 57.0 p -154.06 161.85 41.62 Favored 'General case' 0 C--N 1.307 -1.251 0 N-CA-C 112.768 0.655 . . . . 0.13 112.768 163.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -156.68 -178.91 31.25 Favored Glycine 0 N--CA 1.425 -2.066 0 N-CA-C 110.68 -0.968 . . . . 0.12 110.68 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.741 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.7 mtmt -156.75 148.38 22.56 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 106.326 -1.731 . . . . 1.22 106.326 167.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.648 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -159.33 127.29 1.8 Allowed Glycine 0 C--N 1.282 -2.42 0 C-N-CA 119.907 -1.14 . . . . 0.12 112.542 -178.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.83 113.05 9.43 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.543 0.687 . . . . 0.17 111.455 -173.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.818 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -88.38 159.18 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.472 0 CA-C-O 122.518 1.151 . . . . 0.11 110.298 -177.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.683 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -98.86 172.84 7.18 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 112.781 -2.009 . . . . 0.18 109.132 -172.763 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -102.85 127.65 49.95 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.873 -0.417 . . . . 0.91 109.873 169.799 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.544 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 17.9 mm-40 . . . . . 0 C--N 1.313 -1.017 0 CA-C-O 118.524 -0.75 . . . . 1.24 110.838 178.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.606 0 N-CA-C 111.995 -0.442 . . . . 88.61 111.995 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 61.4 p 40.88 -103.09 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 123.966 0.906 . . . . 87.43 112.601 179.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.7 m80 -148.15 139.05 23.15 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.256 -0.646 . . . . 87.16 109.256 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.47 ' O ' HG12 ' A' ' 5' ' ' VAL . 25.2 ptm -69.41 142.59 53.85 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.442 -0.577 . . . . 85.34 109.442 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 4' ' ' MET . 3.2 p 50.85 13.79 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 C-N-CA 125.208 1.403 . . . . 85.05 112.971 -178.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.01 -46.73 5.82 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.125 -0.559 . . . . 84.68 112.058 -179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -76.0 -31.74 59.08 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.765 -0.457 . . . . 85.57 109.765 178.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 15.1 ptm180 33.05 69.75 0.12 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.618 1.199 . . . . 85.04 112.557 176.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -71.02 158.46 88.12 Favored Pre-proline 0 C--N 1.318 -0.79 0 CA-C-N 116.05 -0.523 . . . . 82.17 110.378 -179.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 5.2 Cg_endo -49.56 -44.5 34.98 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.124 1.882 . . . . 81.51 111.298 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -128.57 101.61 20.91 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.486 -0.779 . . . . 79.56 109.707 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.36 139.9 92.38 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.397 2.064 . . . . 78.5 112.154 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 33.0 m -64.97 153.97 7.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.511 0.672 . . . . 77.0 111.911 -175.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -106.45 -136.27 0.35 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.116 -0.947 . . . . 75.74 109.247 176.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -78.02 89.81 4.18 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.162 0.506 . . . . 73.91 110.191 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.1 p -68.73 127.61 30.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.462 -0.79 . . . . 72.3 110.334 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.433 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 12.5 mmmm -60.39 133.89 91.06 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 115.706 -0.679 . . . . 71.22 111.768 -176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 17' ' ' LYS . 38.6 Cg_exo -61.44 141.37 91.88 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.614 2.209 . . . . 69.67 111.424 174.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.5 -39.38 66.77 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 113.831 1.048 . . . . 67.55 113.831 -176.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.79 49.02 0.87 Allowed 'Trans proline' 0 C--N 1.363 1.302 0 C-N-CA 122.358 2.039 . . . . 66.7 113.651 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -84.04 90.03 7.37 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.117 -0.697 . . . . 65.01 109.117 175.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.9 tp60 -154.29 81.65 4.5 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.79 -0.641 . . . . 63.41 110.501 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -60.82 132.52 42.94 Favored 'Trans proline' 0 CA--C 1.518 -0.28 0 C-N-CA 122.865 2.377 . . . . 61.93 112.489 176.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.16 75.03 1.33 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.228 -0.896 . . . . 59.87 110.653 -174.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.688 ' H ' ' HD2' ' A' ' 26' ' ' PRO . 48.4 mt-10 -133.69 -50.56 0.03 OUTLIER Pre-proline 0 C--N 1.318 -0.773 0 CA-C-N 114.741 -1.118 . . . . 58.47 111.905 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.688 ' HD2' ' H ' ' A' ' 25' ' ' GLU . 77.8 Cg_endo -78.93 177.51 8.62 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 121.136 1.224 . . . . 57.36 111.883 177.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.409 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -112.0 143.28 43.26 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.126 -0.694 . . . . 55.51 109.126 178.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -66.45 107.88 1.93 Allowed Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.679 0.276 . . . . 53.87 110.754 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 93.3 Cg_endo -83.34 61.78 7.25 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.491 2.128 . . . . 52.76 112.294 -176.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 20.1 m -121.19 147.8 47.76 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 115.911 -0.586 . . . . 50.93 110.466 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 30' ' ' VAL . 2.9 Cg_exo -75.08 149.98 37.15 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.603 2.202 . . . . 49.21 111.446 176.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.4 p -73.14 145.85 46.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.88 0.371 . . . . 47.49 110.439 178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 18.0 m -92.62 120.43 67.37 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.255 -0.429 . . . . 45.97 111.551 -176.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_exo -58.77 157.34 28.54 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.932 2.422 . . . . 45.28 111.695 173.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.6 m -155.04 120.7 5.07 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-N 115.74 -0.664 . . . . 42.79 110.512 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.5 t -105.13 101.65 31.66 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.636 -0.711 . . . . 40.79 109.465 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.34 156.44 55.98 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.322 2.015 . . . . 39.81 112.9 -176.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.1 m -85.74 124.72 32.56 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.504 0.669 . . . . 37.5 110.73 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.9 mt -94.49 136.33 23.34 Favored Pre-proline 0 C--N 1.317 -0.845 0 CA-C-N 115.362 -0.835 . . . . 35.65 109.039 177.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.59 91.09 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.447 2.098 . . . . 33.72 111.752 177.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.3 tp60 -96.06 -40.19 9.36 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.007 -0.542 . . . . 31.51 110.35 -178.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 58.23 79.66 0.31 Allowed Pre-proline 0 C--O 1.235 0.314 0 O-C-N 123.475 0.484 . . . . 30.13 110.678 -178.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_exo -53.95 122.79 12.03 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.126 2.551 . . . . 29.52 111.792 179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.59 144.98 0.57 Allowed Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.922 -0.581 . . . . 26.75 112.154 -172.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -66.61 128.81 19.78 Favored 'Trans proline' 0 C--N 1.329 -0.455 0 C-N-CA 122.914 2.409 . . . . 25.08 112.268 -177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 52.6 mt -68.94 -48.35 70.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.312 0.577 . . . . 23.9 109.585 174.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.98 77.74 0.48 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.616 -1.175 . . . . 21.23 109.039 175.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.446 ' CG ' ' H ' ' A' ' 49' ' ' GLU . 3.9 t-160 -71.7 176.41 4.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.01 -0.996 . . . . 19.92 111.99 -175.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.446 ' H ' ' CG ' ' A' ' 48' ' ' HIS . 15.1 pt-20 -59.35 179.53 0.1 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.115 -0.948 . . . . 16.56 112.729 -175.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -112.67 80.77 1.38 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.685 -0.689 . . . . 15.05 110.26 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.2 mt-30 -53.15 -61.91 1.99 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.936 0.147 . . . . 14.19 110.745 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 38.5 p 60.95 157.87 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.259 1.023 . . . . 11.38 113.188 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.27 93.52 29.56 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 114.904 -1.044 . . . . 8.29 110.76 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -69.78 141.14 44.33 Favored 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 122.787 2.325 . . . . 6.87 112.423 -179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -85.23 -168.3 0.49 Allowed 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.77 2.313 . . . . 5.04 112.881 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 60.6 70.41 0.98 Allowed Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 114.833 -1.076 . . . . 2.59 111.6 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -73.34 -176.7 2.6 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.28 2.654 . . . . 1.64 112.51 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -117.01 145.22 43.8 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 114.505 -1.225 . . . . 3.39 109.868 -178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.624 HG22 ' N ' ' A' ' 60' ' ' ARG . 11.4 mt -86.38 168.86 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.716 0.77 . . . . 0.44 112.115 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.624 ' N ' HG22 ' A' ' 59' ' ' ILE . 34.6 mtt-85 -69.6 -157.13 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 113.875 -1.511 . . . . 2.34 112.194 178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.66 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 17.9 t-160 -158.83 147.99 18.82 Favored 'General case' 0 CA--C 1.473 -1.988 0 CA-C-N 112.245 -2.252 . . . . 2.22 107.074 177.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.759 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.2 m-30 -125.38 158.97 32.98 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.291 -0.868 . . . . 0.21 109.565 -176.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.556 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 5.0 t70 -80.91 67.0 6.65 Favored 'General case' 0 N--CA 1.437 -1.099 0 CA-C-O 123.707 1.718 . . . . 0.35 108.065 172.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.737 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 90.0 m95 -56.94 -44.45 82.53 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 111.591 -2.55 . . . . 0.1 112.389 175.032 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.449 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 10.2 t-20 -51.05 -30.72 16.46 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 113.832 -1.531 . . . . 1.11 111.687 176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.81 -15.38 81.36 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-O 121.868 0.704 . . . . 0.21 111.469 -179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.86 -52.06 3.4 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.076 -1.062 . . . . 0.13 110.782 -177.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.726 ' SD ' HD23 ' A' ' 109' ' ' LEU . 39.7 mtt -64.13 -58.06 7.73 Favored 'General case' 0 C--O 1.21 -0.976 0 CA-C-N 114.127 -1.397 . . . . 0.09 111.952 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.463 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.8 mm-40 -39.52 -54.66 3.73 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 114.856 1.428 . . . . 0.63 114.856 -176.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.634 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.1 Cg_endo -64.45 -28.78 62.35 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.004 1.802 . . . . 0.14 110.667 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.849 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 6.4 mtm -82.4 -46.26 13.77 Favored 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 114.874 -1.057 . . . . 0.7 111.902 -178.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 68' ' ' MET . 57.7 t -54.34 -40.29 47.65 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.286 0 CA-C-N 114.031 -1.44 . . . . 0.12 108.633 175.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -59.28 -37.72 78.35 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-N 113.167 -1.833 . . . . 0.56 110.798 175.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.634 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 25.1 mtmt -77.08 -36.06 56.08 Favored 'General case' 0 C--N 1.347 0.493 0 CA-C-O 120.821 0.343 . . . . 1.3 111.649 176.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.811 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.0 -29.33 70.49 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.715 -0.675 . . . . 0.5 111.557 -170.594 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.632 HD22 ' HE2' ' A' ' 118' ' ' LYS . 5.2 mt -93.14 -6.78 47.14 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.102 0.953 . . . . 0.65 111.012 -179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.49 17.79 46.02 Favored Glycine 0 N--CA 1.437 -1.275 0 N-CA-C 109.02 -1.632 . . . . 0.17 109.02 171.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.59 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -87.02 162.08 17.82 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-N 114.626 -0.787 . . . . 0.1 110.355 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -85.54 108.04 17.76 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.057 -0.974 . . . . 1.72 109.235 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.633 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 131.04 -21.2 4.67 Favored Glycine 0 N--CA 1.419 -2.47 0 C-N-CA 119.699 -1.239 . . . . 0.12 110.955 178.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.811 HG11 ' O ' ' A' ' 75' ' ' MET . 14.8 p -101.75 152.78 5.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.77 -0.715 . . . . 0.16 110.887 -176.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 83' ' ' ALA . 26.5 m -135.75 140.28 44.22 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 115.011 -0.995 . . . . 0.45 110.625 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.543 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -58.59 140.13 54.82 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 115.123 -0.944 . . . . 0.28 110.484 167.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.3 10.08 54.61 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.88 -0.676 . . . . 0.28 112.753 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.9 149.65 21.31 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 120.569 -0.452 . . . . 1.2 110.689 178.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.673 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.6 p -79.09 114.75 20.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 CA-C-O 122.218 1.008 . . . . 0.2 109.304 164.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.672 ' HG ' ' CE2' ' A' ' 119' ' ' PHE . 2.6 tm? -102.9 106.99 17.66 Favored 'General case' 0 C--N 1.301 -1.522 0 CA-C-N 114.965 -1.016 . . . . 0.14 109.065 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.666 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.7 OUTLIER -71.88 96.76 1.72 Allowed 'General case' 0 CA--C 1.504 -0.792 0 CA-C-N 114.226 -1.352 . . . . 0.15 108.039 176.537 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.936 ' O ' HD11 ' A' ' 127' ' ' LEU . 1.1 m -71.66 118.06 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.839 0 N-CA-C 107.158 -1.423 . . . . 0.95 107.158 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.852 ' HB2' HD11 ' A' ' 142' ' ' LEU . 1.1 t70 -76.65 146.1 38.37 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.656 -1.239 . . . . 0.64 107.656 -178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.574 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.1 m -50.97 132.38 27.2 Favored 'General case' 0 CA--C 1.481 -1.688 0 N-CA-C 107.582 -1.266 . . . . 0.37 107.582 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.524 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 22.7 t -60.66 138.35 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.959 0 N-CA-C 107.79 -1.189 . . . . 0.1 107.79 171.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.777 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.6 t-20 -83.51 162.03 21.04 Favored 'General case' 0 C--N 1.287 -2.14 0 CA-C-N 115.202 -0.908 . . . . 0.18 109.589 174.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.746 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.99 86.01 2.49 Favored 'General case' 0 C--N 1.289 -2.053 0 CA-C-N 114.54 -1.209 . . . . 0.12 107.861 175.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.47 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 9.7 mtp180 -108.61 -3.71 17.74 Favored 'General case' 0 CA--C 1.502 -0.869 0 CA-C-N 113.847 -1.524 . . . . 0.64 108.893 -172.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.6 p -49.99 -175.42 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.067 -1.878 . . . . 0.14 114.36 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.5 OUTLIER -76.53 -3.8 39.37 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-N 113.309 -1.769 . . . . 0.48 110.36 174.637 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.614 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -146.54 -153.07 5.79 Favored Glycine 0 CA--C 1.519 0.33 0 CA-C-N 115.692 -0.685 . . . . 0.12 112.634 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 50.7 m -121.31 130.32 53.58 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.822 0.344 . . . . 1.16 111.457 -178.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.746 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.9 pp -134.01 157.44 46.08 Favored 'General case' 0 CA--C 1.506 -0.738 0 CA-C-O 121.824 0.821 . . . . 0.1 110.746 -177.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.636 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -80.75 80.06 7.29 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.162 -1.381 . . . . 0.17 107.803 175.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.569 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.14 -15.0 63.44 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 114.481 -1.236 . . . . 0.09 110.167 179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -79.64 -29.65 41.06 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 108.576 -0.898 . . . . 0.15 108.576 -177.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.636 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 16.1 tp10 -67.67 -33.38 74.82 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-N 114.283 -1.326 . . . . 1.73 109.143 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.74 -43.5 62.84 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-N 113.24 -1.8 . . . . 0.12 109.505 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.64 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 59.3 m -63.41 -30.52 71.63 Favored 'General case' 0 N--CA 1.43 -1.446 0 CA-C-N 113.838 -1.528 . . . . 0.11 110.564 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 2.0 pt-20 -69.43 -42.97 74.3 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.849 -1.167 . . . . 1.47 107.849 173.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 64' ' ' TRP . 85.2 m -62.58 -29.96 70.97 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-N 115.241 -0.891 . . . . 0.12 110.465 178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.726 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.5 mt -51.98 -70.27 0.09 Allowed 'General case' 0 CA--C 1.494 -1.196 0 N-CA-C 109.13 -0.693 . . . . 0.56 109.13 170.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 121' ' ' LEU . 19.0 mtp180 -40.21 -38.66 0.8 Allowed 'General case' 0 C--N 1.312 -1.032 0 O-C-N 124.465 1.103 . . . . 1.51 111.413 175.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.502 ' N ' HD22 ' A' ' 111' ' ' ASN . 1.0 OUTLIER -70.27 -46.07 65.09 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.754 -1.112 . . . . 0.28 112.244 -176.88 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.05 -33.06 65.46 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-O 122.2 1.0 . . . . 0.09 108.437 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.713 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -64.5 -33.88 76.92 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 113.413 -1.721 . . . . 0.12 110.194 173.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.522 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -70.49 -37.16 74.18 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-N 114.789 -1.096 . . . . 0.2 111.164 -175.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -57.48 -31.87 66.42 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 114.629 -1.169 . . . . 1.17 110.997 -176.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.479 ' HB3' ' HG2' ' A' ' 118' ' ' LYS . 1.0 OUTLIER -77.03 -36.12 56.39 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 114.681 -1.145 . . . . 2.05 110.211 -177.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.53 -4.56 8.92 Favored Glycine 0 CA--C 1.521 0.435 0 C-N-CA 121.313 -0.47 . . . . 0.54 113.93 176.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.632 ' HE2' HD22 ' A' ' 76' ' ' LEU . 11.7 ptmt -83.93 -30.27 26.44 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 122.328 -0.513 . . . . 0.99 111.462 178.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.672 ' CE2' ' HG ' ' A' ' 87' ' ' LEU . 4.1 m-85 -89.39 168.74 11.98 Favored 'General case' 0 CA--C 1.498 -1.05 0 CA-C-O 121.708 0.766 . . . . 0.21 111.285 173.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.586 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.1 m -116.5 121.18 41.06 Favored 'General case' 0 N--CA 1.418 -2.034 0 CA-C-N 114.063 -1.426 . . . . 0.23 108.154 171.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.613 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -91.01 139.47 30.74 Favored 'General case' 0 N--CA 1.416 -2.151 0 C-N-CA 119.307 -0.957 . . . . 0.38 110.647 -171.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.572 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.9 m -92.54 143.01 12.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 107.919 -1.141 . . . . 0.42 107.919 173.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.408 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 6.3 t -95.23 171.03 8.98 Favored 'General case' 0 N--CA 1.439 -0.978 0 CA-C-O 123.066 1.413 . . . . 1.7 109.608 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.29 -16.75 64.29 Favored 'General case' 0 CA--C 1.497 -1.081 0 CA-C-N 111.264 -2.698 . . . . 0.55 109.09 -175.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.571 ' O ' ' HG3' ' A' ' 129' ' ' MET . 27.1 mt-30 -59.51 -36.76 76.7 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 112.705 -2.043 . . . . 2.04 109.824 175.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.572 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 6.0 mt-30 -99.01 -51.87 3.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.981 0.896 . . . . 0.41 110.205 174.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.936 HD11 ' O ' ' A' ' 89' ' ' VAL . 6.2 tt -64.01 -67.25 0.45 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 113.407 -1.724 . . . . 1.39 113.349 -167.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.598 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 15.4 m -57.16 -35.75 69.94 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-O 123.245 1.498 . . . . 1.05 108.786 -175.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.621 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -59.47 -60.34 4.01 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 111.811 -2.449 . . . . 1.64 112.205 173.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.763 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.95 -44.02 4.42 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 124.308 1.043 . . . . 0.31 112.23 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.541 ' HZ3' ' N ' ' A' ' 142' ' ' LEU . 3.4 mttt -52.59 -54.7 29.4 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.172 -0.677 . . . . 1.53 109.172 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -62.81 -41.75 99.43 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.398 -0.819 . . . . 0.41 111.0 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.621 ' HG3' ' O ' ' A' ' 129' ' ' MET . 47.6 mt-30 -57.06 -35.02 68.86 Favored 'General case' 0 CA--C 1.49 -1.345 0 CA-C-N 114.215 -1.357 . . . . 0.37 109.668 -179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.492 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.5 OUTLIER -91.46 -30.39 16.49 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-N 113.95 -1.477 . . . . 0.24 109.738 -176.792 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.42 -46.57 0.56 Allowed Glycine 0 CA--C 1.494 -1.224 0 C-N-CA 119.845 -1.169 . . . . 0.33 113.569 -178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.624 HD13 ' O ' ' A' ' 141' ' ' SER . 98.3 mt -65.92 -169.64 0.07 Allowed 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 112.437 -1.882 . . . . 0.31 115.395 -170.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.541 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 6.7 m -114.76 149.32 42.17 Favored Pre-proline 0 N--CA 1.416 -2.153 0 CA-C-N 110.49 -3.05 . . . . 0.81 107.676 174.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.598 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 59.0 Cg_endo -66.28 0.57 3.21 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 C-N-CA 122.774 2.316 . . . . 0.32 112.285 -178.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -118.23 -26.52 6.3 Favored 'General case' 0 CA--C 1.507 -0.708 0 CA-C-O 121.825 0.821 . . . . 1.25 110.286 -177.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.676 ' O ' ' HB2' ' A' ' 141' ' ' SER . 15.2 t70 -58.26 -23.45 56.16 Favored 'General case' 0 CA--C 1.486 -1.508 0 CA-C-N 113.346 -1.752 . . . . 0.65 109.168 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.676 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 20.8 m 76.05 171.23 0.25 Allowed 'General case' 0 N--CA 1.42 -1.933 0 O-C-N 125.817 1.948 . . . . 0.6 108.385 -173.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.912 HD22 ' HA ' ' A' ' 148' ' ' ALA . 6.9 mt -63.95 -39.06 93.29 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 107.724 -1.213 . . . . 0.86 107.724 -177.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.25 -11.85 1.39 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 113.059 -1.882 . . . . 0.31 114.334 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 1.2 m -155.42 128.06 7.94 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.076 -0.713 . . . . 0.24 109.076 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.667 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.0 mmt180 -42.92 -46.87 5.54 Favored 'General case' 0 C--O 1.212 -0.872 0 CA-C-N 117.995 0.361 . . . . 1.65 111.556 -179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.1 t -72.3 -26.21 61.87 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.511 0.672 . . . . 0.53 111.431 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.407 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 31.4 mttm -74.38 -32.17 62.63 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.661 1.219 . . . . 1.31 108.797 175.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.912 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -71.11 -46.43 61.7 Favored 'General case' 0 CA--C 1.483 -1.627 0 CA-C-N 112.299 -2.228 . . . . 0.12 109.976 177.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.648 HG13 ' HE1' ' A' ' 179' ' ' MET . 36.6 mt -67.22 -41.79 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.896 0 CA-C-N 112.764 -2.016 . . . . 0.11 109.974 178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.53 -54.39 30.43 Favored Glycine 0 N--CA 1.438 -1.187 0 CA-C-N 114.769 -1.105 . . . . 0.15 111.297 171.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.763 HG23 ' CB ' ' A' ' 130' ' ' ALA . 79.1 mt -66.61 -47.77 82.38 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.029 0 N-CA-C 112.729 0.64 . . . . 0.18 112.729 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.634 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.76 -41.66 74.31 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.809 0.338 . . . . 0.13 110.9 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.474 ' HD2' HG23 ' A' ' 149' ' ' ILE . 26.8 mtp180 -79.97 -23.98 41.25 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.48 0.657 . . . . 1.08 110.53 -179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.476 HD21 ' CD ' ' A' ' 133' ' ' GLN . 17.6 t30 -80.0 -12.83 59.68 Favored 'General case' 0 CA--C 1.505 -0.784 0 N-CA-C 107.337 -1.357 . . . . 0.5 107.337 176.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.68 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.39 -29.23 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.499 0 CA-C-N 113.018 -1.901 . . . . 0.17 110.79 -175.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.82 34.21 5.28 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.586 -0.816 . . . . 0.16 112.632 -179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.666 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.06 161.24 14.92 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.031 0.752 . . . . 0.12 113.031 -169.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.673 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -100.31 -28.69 12.84 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-N 115.065 -0.97 . . . . 0.2 109.348 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.583 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.3 m-85 -136.89 -177.96 4.98 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 114.935 -1.03 . . . . 0.13 110.936 -175.027 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.718 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -133.65 140.24 47.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 115.077 -0.965 . . . . 0.08 108.823 167.58 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.627 HD21 ' SD ' ' A' ' 176' ' ' MET . 24.9 tp -110.46 99.05 8.12 Favored 'General case' 0 N--CA 1.431 -1.396 0 C-N-CA 119.333 -0.947 . . . . 0.16 109.725 166.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.784 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -78.75 112.59 16.03 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 114.893 -1.049 . . . . 0.26 109.143 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.865 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.3 t -123.69 163.24 21.49 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-O 121.875 0.845 . . . . 1.05 110.275 -177.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.831 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -163.87 176.28 9.62 Favored 'General case' 0 N--CA 1.417 -2.101 0 CA-C-N 114.397 -1.274 . . . . 0.1 111.33 -177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.57 132.52 29.39 Favored 'General case' 0 N--CA 1.412 -2.373 0 CA-C-N 113.844 -1.526 . . . . 0.11 108.531 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -142.34 -176.94 5.03 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 120.21 -0.596 . . . . 1.09 109.492 179.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.09 -81.82 0.88 Allowed Glycine 0 C--N 1.303 -1.258 0 C-N-CA 119.649 -1.262 . . . . 0.15 111.615 172.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.508 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.2 t30 -146.78 126.6 13.5 Favored 'General case' 0 C--O 1.196 -1.725 0 N-CA-C 107.705 -1.221 . . . . 0.59 107.705 176.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.614 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.2 p -58.75 -44.09 89.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-N 114.502 -1.226 . . . . 0.15 112.723 -173.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -61.99 -29.91 70.58 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-O 121.776 0.798 . . . . 1.26 109.788 -175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.99 88.11 3.56 Favored Pre-proline 0 C--N 1.309 -1.18 0 CA-C-N 114.387 -1.279 . . . . 0.13 108.224 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.857 ' HD2' HG22 ' A' ' 194' ' ' VAL . 45.9 Cg_endo -90.06 165.54 4.74 Favored 'Trans proline' 0 CA--C 1.491 -1.631 0 C-N-CA 124.644 3.562 . . . . 0.09 114.412 -170.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.573 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.6 m -83.3 118.27 23.55 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-N 113.942 -1.481 . . . . 0.14 107.513 166.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.849 ' O ' ' HE1' ' A' ' 71' ' ' MET . 45.3 tp -83.76 99.51 10.32 Favored 'General case' 0 N--CA 1.41 -2.463 0 N-CA-C 108.367 -0.975 . . . . 0.16 108.367 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.624 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -91.34 109.02 20.29 Favored 'General case' 0 C--N 1.272 -2.789 0 CA-C-O 122.09 0.948 . . . . 0.34 109.196 -176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.865 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.1 mmm -111.87 163.54 14.09 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.983 -1.008 . . . . 1.09 111.487 -173.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.599 ' HG2' HD12 ' A' ' 186' ' ' ILE . 58.6 tt0 -171.15 116.91 0.44 Allowed 'General case' 0 C--O 1.203 -1.366 0 CA-C-N 116.019 -0.537 . . . . 0.5 110.404 -165.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.087 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -99.39 102.27 13.8 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 108.743 -0.836 . . . . 0.1 108.743 -172.309 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.667 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 17.2 ttp -91.62 121.88 33.68 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-N 115.441 -0.8 . . . . 0.07 109.534 176.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.6 128.04 35.04 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 107.159 -1.423 . . . . 0.22 107.159 166.195 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.624 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -83.09 -35.04 11.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 119.303 0.956 . . . . 0.11 110.747 178.5 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.44 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.4 mt-30 -61.45 -16.55 48.12 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.335 -0.848 . . . . 0.35 111.358 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.7 p -130.08 -37.34 1.48 Allowed 'General case' 0 CA--C 1.514 -0.43 0 CA-C-O 121.794 0.807 . . . . 0.19 110.224 178.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.558 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.48 25.29 26.2 Favored Glycine 0 N--CA 1.437 -1.289 0 CA-C-N 114.449 -1.25 . . . . 0.18 112.528 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -104.43 156.81 17.61 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.679 0.276 . . . . 0.73 110.672 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.599 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.3 mm -91.46 112.8 25.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.454 0.645 . . . . 0.14 109.679 179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.087 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -101.11 -31.66 3.27 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-N 115.018 -0.992 . . . . 0.13 110.597 -173.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.653 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.6 t90 -134.06 152.62 51.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.359 -0.837 . . . . 0.07 109.752 172.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.498 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 51.8 p -153.8 164.17 38.79 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 113.399 0.888 . . . . 0.13 113.399 164.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.47 -177.06 33.23 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 110.876 -0.889 . . . . 0.12 110.876 -178.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.1 mtmt -157.46 152.8 26.16 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 105.645 -1.983 . . . . 1.22 105.645 166.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -163.76 128.18 1.79 Allowed Glycine 0 C--N 1.281 -2.498 0 C-N-CA 119.749 -1.215 . . . . 0.12 112.477 177.375 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.64 118.76 14.87 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.298 0.571 . . . . 0.17 110.854 -174.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.857 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -94.62 158.7 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.435 0 CA-C-O 122.569 1.176 . . . . 0.11 110.621 -177.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.759 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -98.02 172.98 7.28 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 112.667 -2.061 . . . . 0.18 108.861 -173.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.501 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -102.45 130.97 49.4 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.501 -0.48 . . . . 0.91 109.962 170.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.514 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 15.4 mm-40 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.844 -0.598 . . . . 1.24 110.744 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.652 0 N-CA-C 111.828 -0.509 . . . . 88.61 111.828 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m 61.65 69.29 0.65 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.292 0.567 . . . . 87.43 111.253 179.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -125.96 84.53 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.592 0.71 . . . . 87.16 109.815 176.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.536 ' O ' HG12 ' A' ' 5' ' ' VAL . 1.4 pmm? -71.89 135.33 46.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.702 -0.681 . . . . 85.34 110.621 -177.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.536 HG12 ' O ' ' A' ' 4' ' ' MET . 1.4 p 54.7 5.53 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 125.329 1.452 . . . . 85.05 113.724 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.27 -7.65 64.25 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.975 -0.631 . . . . 84.68 112.596 -178.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.448 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 36.4 tt0 54.1 99.97 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.537 0.735 . . . . 85.57 111.586 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.448 ' HB2' ' O ' ' A' ' 7' ' ' GLN . 84.8 mtp180 73.56 150.33 0.11 Allowed 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 114.726 -1.124 . . . . 85.04 110.404 -175.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -74.19 137.43 75.46 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.872 -0.603 . . . . 82.17 109.756 178.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -67.4 -2.03 7.54 Favored 'Trans proline' 0 CA--C 1.529 0.232 0 C-N-CA 122.112 1.875 . . . . 81.51 112.132 177.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -102.54 98.07 10.19 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.937 -0.574 . . . . 79.56 109.996 174.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -75.54 133.99 16.43 Favored 'Trans proline' 0 N--CA 1.455 -0.739 0 C-N-CA 121.971 1.78 . . . . 78.5 111.842 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.494 HG21 HG23 ' A' ' 16' ' ' VAL . 15.5 m -148.16 170.43 3.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 115.853 -0.612 . . . . 77.0 110.79 -176.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -63.55 -72.18 0.15 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.701 -0.682 . . . . 75.74 109.604 173.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -171.6 103.29 0.19 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.819 -0.628 . . . . 73.91 110.086 -177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.494 HG23 HG21 ' A' ' 13' ' ' VAL . 40.2 t -89.57 100.8 11.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.041 0.448 . . . . 72.3 109.793 177.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.47 ' HB2' ' HD3' ' A' ' 18' ' ' PRO . 39.0 mtmm -66.08 -46.98 63.43 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.956 -0.565 . . . . 71.22 111.851 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.47 ' HD3' ' HB2' ' A' ' 17' ' ' LYS . 17.1 Cg_exo -67.43 160.01 49.77 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.625 1.55 . . . . 69.67 111.458 174.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.29 158.28 37.37 Favored Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.293 -0.412 . . . . 67.55 110.238 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.46 142.79 37.52 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.497 2.131 . . . . 66.7 111.165 173.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.59 133.97 46.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.703 -0.681 . . . . 65.01 111.982 -172.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -129.51 78.47 75.55 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.302 -0.863 . . . . 63.41 110.688 -177.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -61.95 155.42 55.32 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.248 2.632 . . . . 61.93 112.489 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' HB1' ' CB ' ' A' ' 27' ' ' GLN . . . -70.12 85.84 0.55 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.451 0.643 . . . . 59.87 111.291 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.457 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 5.8 mm-40 -89.99 -44.57 0.41 Allowed Pre-proline 0 C--N 1.321 -0.666 0 CA-C-N 115.418 -0.81 . . . . 58.47 112.202 -178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.457 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 23.2 Cg_exo -67.14 -12.0 34.34 Favored 'Trans proline' 0 C--N 1.358 1.072 0 C-N-CA 122.121 1.881 . . . . 57.36 111.717 174.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.41 ' CB ' ' HB1' ' A' ' 24' ' ' ALA . 22.9 tp60 -73.1 81.56 1.26 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.293 -0.867 . . . . 55.51 110.105 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.401 ' HA ' ' OE1' ' A' ' 28' ' ' GLN . 6.9 tp60 -129.71 65.93 76.08 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.685 -0.689 . . . . 53.87 109.309 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.404 ' HD3' ' C ' ' A' ' 27' ' ' GLN . 50.8 Cg_endo -94.85 38.33 0.16 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.742 2.961 . . . . 52.76 112.584 -170.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 57.1 t -66.28 127.18 93.12 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.72 -0.673 . . . . 50.93 109.268 178.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.44 92.91 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.928 2.419 . . . . 49.21 112.352 -178.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.9 p -73.98 145.09 44.89 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.768 -0.651 . . . . 47.49 110.646 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.2 t -72.12 120.61 81.27 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.75 -0.659 . . . . 45.97 109.973 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.38 148.26 52.55 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 123.183 2.589 . . . . 45.28 112.001 179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.8 m -132.48 136.78 46.91 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.057 -0.974 . . . . 42.79 110.559 -172.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 7.3 p -59.24 121.48 56.36 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.814 -0.63 . . . . 40.79 111.091 178.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -61.75 156.59 47.27 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.939 2.426 . . . . 39.81 112.116 177.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.0 t -78.92 144.53 34.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.289 -0.414 . . . . 37.5 110.03 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 21.8 mt -89.22 115.07 62.7 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.844 -0.616 . . . . 35.65 110.355 -177.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.15 -175.67 2.65 Favored 'Trans proline' 0 N--CA 1.464 -0.221 0 C-N-CA 122.7 2.267 . . . . 33.72 112.33 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -105.95 77.45 1.25 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.605 0.717 . . . . 31.51 110.585 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.594 ' N ' ' HD2' ' A' ' 43' ' ' PRO . 7.4 tp-100 -60.9 -39.85 69.15 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 114.606 -1.179 . . . . 30.13 112.526 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 42' ' ' GLN . 18.4 Cg_endo -60.26 123.16 12.55 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 121.493 1.462 . . . . 29.52 111.43 172.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -125.96 165.19 19.24 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 116.024 -0.534 . . . . 26.75 111.958 -177.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -62.79 158.8 40.58 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.789 2.326 . . . . 25.08 112.47 177.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 58.3 mt -59.04 -57.64 10.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 120.853 0.359 . . . . 23.9 110.431 -176.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.8 mm-40 60.2 82.08 0.16 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.122 -0.945 . . . . 21.23 111.594 179.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -170.76 159.09 6.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.397 -0.82 . . . . 19.92 109.238 177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -129.86 -87.71 0.51 Allowed 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.642 -0.708 . . . . 16.56 110.716 -177.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 29.5 t70 45.08 70.01 0.39 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.833 0.825 . . . . 15.05 111.566 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -75.85 -54.68 6.54 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 114.91 -1.041 . . . . 14.19 110.196 179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.1 p -131.18 139.47 49.75 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.206 -0.452 . . . . 11.38 110.416 175.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.92 78.74 19.37 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-N 116.132 -0.486 . . . . 8.29 111.345 -176.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -84.39 155.9 12.49 Favored 'Trans proline' 0 N--CA 1.453 -0.876 0 C-N-CA 122.215 1.943 . . . . 6.87 112.595 177.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -82.84 15.87 1.97 Allowed 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.344 2.029 . . . . 5.04 111.961 174.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 59.44 66.12 2.34 Favored Pre-proline 0 N--CA 1.464 0.23 0 CA-C-N 115.556 -0.747 . . . . 2.59 111.62 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -72.11 -175.96 1.94 Allowed 'Trans proline' 0 CA--C 1.512 -0.624 0 C-N-CA 123.173 2.582 . . . . 1.64 111.989 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -116.66 142.5 46.81 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.597 -1.183 . . . . 3.39 110.688 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 60' ' ' ARG . 8.0 mt -95.11 170.23 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.992 0.901 . . . . 0.44 111.969 -177.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.625 ' N ' HG22 ' A' ' 59' ' ' ILE . 56.7 mtt-85 -76.51 -156.81 0.07 Allowed 'General case' 0 N--CA 1.436 -1.168 0 CA-C-N 113.79 -1.55 . . . . 2.34 111.727 176.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.63 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 19.4 t-160 -157.28 147.96 21.33 Favored 'General case' 0 CA--C 1.474 -1.949 0 CA-C-N 112.404 -2.18 . . . . 2.22 106.363 177.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.744 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.9 m-30 -125.34 160.34 29.57 Favored 'General case' 0 N--CA 1.421 -1.899 0 O-C-N 123.856 0.723 . . . . 0.21 109.911 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 4.3 t70 -81.73 67.91 7.89 Favored 'General case' 0 N--CA 1.436 -1.145 0 CA-C-O 123.595 1.664 . . . . 0.35 108.292 171.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.707 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.0 m95 -58.29 -43.1 87.87 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 111.682 -2.508 . . . . 0.1 112.547 174.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.499 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 8.6 t-20 -51.82 -28.86 17.04 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 113.962 -1.472 . . . . 1.11 111.598 176.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.44 -17.6 80.12 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-N 115.137 -0.938 . . . . 0.21 111.104 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.1 -53.18 3.09 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.036 -1.082 . . . . 0.13 110.949 -176.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.703 ' SD ' HD23 ' A' ' 109' ' ' LEU . 42.2 mtt -64.24 -59.57 4.25 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.241 -1.345 . . . . 0.09 112.593 -176.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.499 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -39.34 -54.66 3.53 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 114.624 1.342 . . . . 0.63 114.624 -175.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.802 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.0 Cg_endo -64.21 -28.84 64.49 Favored 'Trans proline' 0 CA--C 1.507 -0.839 0 C-N-CA 121.788 1.658 . . . . 0.14 110.614 -177.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.643 ' HE2' ' N ' ' A' ' 192' ' ' GLY . 11.8 mtm -84.99 -41.25 16.01 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-N 115.16 -0.927 . . . . 0.7 111.476 -177.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.67 HG23 ' O ' ' A' ' 68' ' ' MET . 61.2 t -55.91 -39.96 59.87 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 CA-C-N 114.629 -1.169 . . . . 0.12 108.697 172.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.7 t -60.93 -32.27 71.78 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.32 -1.764 . . . . 0.56 111.085 175.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 16.6 mtpp -84.71 -33.48 23.13 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.147 0.498 . . . . 1.3 110.736 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.87 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -65.36 -27.91 68.91 Favored 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.169 -0.923 . . . . 0.5 111.334 -172.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.557 ' N ' ' HG2' ' A' ' 75' ' ' MET . 6.2 mt -92.92 -2.93 55.38 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.97 0.89 . . . . 0.65 110.917 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.79 15.36 37.61 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 109.236 -1.546 . . . . 0.17 109.236 170.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.636 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.27 165.0 17.69 Favored 'General case' 0 N--CA 1.442 -0.846 0 CA-C-N 114.679 -0.761 . . . . 0.1 110.276 -178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -91.08 104.49 17.06 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.22 -0.9 . . . . 1.72 110.046 178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.635 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.77 -21.78 3.72 Favored Glycine 0 N--CA 1.429 -1.792 0 CA-C-N 115.097 -0.956 . . . . 0.12 110.735 -179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.87 HG11 ' O ' ' A' ' 75' ' ' MET . 12.4 p -100.0 153.62 4.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.605 0.716 . . . . 0.16 111.002 -177.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.1 m -135.15 136.39 41.84 Favored 'General case' 0 N--CA 1.432 -1.342 0 CA-C-N 114.838 -1.074 . . . . 0.45 110.592 179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.64 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.47 131.06 45.08 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.467 -0.788 . . . . 0.28 110.179 166.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.96 9.91 44.25 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.79 -0.719 . . . . 0.28 113.113 176.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.92 153.08 18.99 Favored 'General case' 0 CA--C 1.508 -0.643 0 C-N-CA 120.6 -0.44 . . . . 1.2 110.956 178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.693 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -81.87 114.91 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 122.116 0.96 . . . . 0.2 109.128 166.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.756 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -102.1 108.97 20.55 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 115.024 -0.989 . . . . 0.14 109.264 -172.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.716 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -72.25 95.05 1.64 Allowed 'General case' 0 CA--C 1.503 -0.86 0 CA-C-N 114.471 -1.24 . . . . 0.15 108.272 175.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.495 HG11 ' HG3' ' A' ' 110' ' ' ARG . 1.6 m -73.01 118.21 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.738 0 N-CA-C 107.83 -1.174 . . . . 0.95 107.83 176.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.783 ' HB2' HD11 ' A' ' 142' ' ' LEU . 7.9 t0 -77.47 156.95 30.72 Favored 'General case' 0 CA--C 1.489 -1.397 0 CA-C-N 114.385 -1.28 . . . . 0.64 107.856 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.538 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -58.38 136.98 57.55 Favored 'General case' 0 N--CA 1.42 -1.952 0 N-CA-C 108.075 -1.083 . . . . 0.37 108.075 171.234 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.513 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.2 t -64.0 139.72 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.982 0 N-CA-C 107.778 -1.193 . . . . 0.1 107.778 167.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.818 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.8 t-20 -86.2 163.26 17.9 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 115.006 -0.997 . . . . 0.18 110.069 174.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.754 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.57 84.65 2.3 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 114.303 -1.317 . . . . 0.12 108.134 176.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.52 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 7.2 mtp180 -109.09 -1.04 19.12 Favored 'General case' 0 CA--C 1.503 -0.863 0 CA-C-N 113.783 -1.553 . . . . 0.64 108.627 -172.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.721 HG21 ' HB3' ' A' ' 172' ' ' PRO . 18.5 p -52.83 -171.97 0.0 OUTLIER 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 112.73 -2.032 . . . . 0.14 115.034 -177.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.1 t30 -71.3 -9.39 58.04 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 112.759 -2.019 . . . . 0.48 110.476 173.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.6 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.94 -146.33 4.32 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.472 -0.871 . . . . 0.12 112.903 -177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.588 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 54.8 p -121.87 131.02 53.82 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 112.245 0.461 . . . . 1.16 112.245 -177.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.91 156.72 48.34 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-O 121.802 0.81 . . . . 0.1 110.629 -177.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.656 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -79.79 79.6 6.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 113.978 -1.465 . . . . 0.17 107.742 175.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.571 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.35 -14.44 62.99 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.307 -1.315 . . . . 0.09 109.749 179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.518 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.45 -31.38 37.48 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.747 -0.834 . . . . 0.15 108.747 -178.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.656 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 4.8 tp10 -66.32 -34.37 77.83 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 114.392 -1.277 . . . . 1.73 108.933 171.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.56 -43.57 66.09 Favored 'General case' 0 N--CA 1.432 -1.354 0 CA-C-N 113.236 -1.802 . . . . 0.12 109.551 178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.626 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 81.0 m -62.92 -30.61 71.68 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 113.776 -1.556 . . . . 0.11 110.162 178.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -64.6 -49.68 70.14 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 108.722 -0.844 . . . . 1.47 108.722 169.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.681 HG21 ' HB2' ' A' ' 64' ' ' TRP . 53.1 m -59.38 -31.08 68.9 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.43 -0.804 . . . . 0.12 110.789 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.703 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.6 mt -51.2 -69.22 0.12 Allowed 'General case' 0 CA--C 1.494 -1.178 0 CA-C-N 115.902 -0.59 . . . . 0.56 109.874 172.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.608 ' O ' HD13 ' A' ' 121' ' ' LEU . 4.9 mtp180 -41.85 -38.8 1.61 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 122.615 1.198 . . . . 1.51 110.886 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.556 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -68.56 -49.04 62.53 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.32 -1.763 . . . . 0.28 112.107 -176.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -70.93 -32.89 69.94 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-O 122.357 1.075 . . . . 0.09 108.446 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.825 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.4 mm? -64.14 -32.53 74.13 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 113.091 -1.868 . . . . 0.12 109.969 174.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.504 ' HA ' HD21 ' A' ' 121' ' ' LEU . . . -74.88 -38.53 61.88 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 114.749 -1.114 . . . . 0.2 111.802 -174.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -67.31 -23.29 65.63 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.518 -0.764 . . . . 1.17 111.449 -174.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -89.27 -13.22 38.59 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.973 -0.558 . . . . 2.05 111.877 -176.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.95 -12.05 0.59 Allowed Glycine 0 C--N 1.336 0.533 0 N-CA-C 115.936 1.135 . . . . 0.54 115.936 163.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.64 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 58.7 mtpt -75.81 -34.33 60.15 Favored 'General case' 0 C--O 1.219 -0.507 0 CA-C-N 117.529 0.665 . . . . 0.99 111.116 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.756 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 13.9 m-85 -91.42 177.67 6.17 Favored 'General case' 0 CA--C 1.498 -1.031 0 CA-C-O 122.889 1.328 . . . . 0.21 113.823 -178.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.55 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 12.7 m -125.02 114.17 18.75 Favored 'General case' 0 N--CA 1.419 -2.025 0 CA-C-N 112.244 -2.253 . . . . 0.23 107.818 167.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.825 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -99.13 128.02 45.18 Favored 'General case' 0 N--CA 1.427 -1.615 0 C-N-CA 119.712 -0.795 . . . . 0.38 112.216 -168.095 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.798 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.8 OUTLIER -75.03 153.17 6.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 108.068 -1.086 . . . . 0.42 108.068 173.943 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.1 t -101.29 -175.32 2.83 Favored 'General case' 0 N--CA 1.434 -1.228 0 C-N-CA 119.416 -0.914 . . . . 1.7 110.349 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.434 ' HA ' ' H ' ' A' ' 128' ' ' SER . . . -65.91 -26.41 67.6 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.703 -1.221 . . . . 0.55 107.703 174.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.663 ' O ' ' HG3' ' A' ' 129' ' ' MET . 15.3 mt-30 -48.84 -39.67 26.5 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 113.182 -1.826 . . . . 2.04 110.715 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.798 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 4.9 mt-30 -98.33 -50.06 4.46 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.68 0.752 . . . . 0.41 110.136 173.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.756 HD21 ' HE3' ' A' ' 131' ' ' LYS . 2.0 tm? -66.47 -63.07 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.008 -1.451 . . . . 1.39 113.331 -167.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.7 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.1 t -50.49 -39.4 48.29 Favored 'General case' 0 CA--C 1.501 -0.919 0 CA-C-O 123.648 1.689 . . . . 1.05 109.028 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.699 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -63.59 -63.18 1.25 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 110.644 -2.98 . . . . 1.64 110.688 178.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.754 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.31 -44.54 3.91 Favored 'General case' 0 CA--C 1.502 -0.869 0 O-C-N 124.363 1.04 . . . . 0.31 111.646 174.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.756 ' HE3' HD21 ' A' ' 127' ' ' LEU . 0.0 OUTLIER -49.47 -60.81 2.52 Favored 'General case' 0 N--CA 1.44 -0.948 0 O-C-N 123.435 0.46 . . . . 1.53 110.044 176.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.9 mt-30 -58.79 -43.96 90.59 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 114.665 -1.152 . . . . 0.41 111.46 178.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.699 ' HG3' ' O ' ' A' ' 129' ' ' MET . 49.4 mt-30 -56.14 -34.83 66.49 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.779 -1.1 . . . . 0.37 109.895 -178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.493 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.4 OUTLIER -90.67 -30.98 16.8 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 113.89 -1.504 . . . . 0.24 109.487 -177.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 156.6 -50.69 0.44 Allowed Glycine 0 CA--C 1.497 -1.088 0 C-N-CA 120.095 -1.05 . . . . 0.33 113.64 -179.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.64 HD13 ' O ' ' A' ' 141' ' ' SER . 86.1 mt -64.13 -173.02 0.08 Allowed 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 115.841 1.793 . . . . 0.31 115.841 -169.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.495 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.8 m -110.5 150.29 41.45 Favored Pre-proline 0 N--CA 1.421 -1.907 0 CA-C-N 111.005 -2.816 . . . . 0.81 108.9 169.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.7 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 28.6 Cg_endo -64.13 1.12 1.71 Allowed 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 123.003 2.469 . . . . 0.32 112.831 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.518 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -118.33 -22.96 7.43 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 122.123 0.963 . . . . 1.25 110.487 -178.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.607 ' O ' ' HB2' ' A' ' 141' ' ' SER . 10.6 t70 -63.61 -21.94 66.63 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 113.062 -1.881 . . . . 0.65 109.375 -174.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.64 ' O ' HD13 ' A' ' 136' ' ' LEU . 17.6 m 72.86 169.97 0.31 Allowed 'General case' 0 N--CA 1.426 -1.639 0 CA-C-N 113.42 -1.718 . . . . 0.6 109.517 -173.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.012 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.7 mt -64.44 -39.58 94.11 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-O 122.349 1.071 . . . . 0.86 108.268 -176.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.97 -5.98 2.3 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 113.025 -1.898 . . . . 0.31 114.421 176.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.1 m -159.78 127.8 4.83 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.913 -0.773 . . . . 0.24 108.913 -178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.726 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.5 mmt180 -42.42 -47.94 5.08 Favored 'General case' 0 C--O 1.21 -0.98 0 CA-C-N 118.182 0.446 . . . . 1.65 111.256 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 46.7 t -70.92 -25.79 62.92 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.503 0.668 . . . . 0.53 111.591 -174.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 26.8 mttm -75.21 -30.36 60.58 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-O 122.626 1.203 . . . . 1.31 108.675 176.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 1.012 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -75.46 -46.57 31.73 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 112.472 -2.149 . . . . 0.12 110.288 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.614 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.5 mt -66.78 -41.71 88.29 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 CA-C-N 112.811 -1.995 . . . . 0.11 110.004 178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.11 -54.5 28.82 Favored Glycine 0 N--CA 1.437 -1.238 0 CA-C-N 114.747 -1.115 . . . . 0.15 111.134 171.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.754 HG23 ' CB ' ' A' ' 130' ' ' ALA . 72.2 mt -66.2 -47.86 83.18 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.989 0 N-CA-C 112.831 0.678 . . . . 0.18 112.831 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.677 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.88 -40.36 72.85 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 120.926 0.393 . . . . 0.13 110.975 -178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.493 ' HD2' HG23 ' A' ' 149' ' ' ILE . 39.7 mtp180 -81.44 -22.67 38.01 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.745 0.783 . . . . 1.08 110.48 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.415 HD22 ' CB ' ' A' ' 130' ' ' ALA . 12.2 t30 -81.74 -12.04 58.76 Favored 'General case' 0 CA--C 1.507 -0.711 0 N-CA-C 107.199 -1.408 . . . . 0.5 107.199 176.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.698 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -107.4 -29.14 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 CA-C-N 113.247 -1.797 . . . . 0.17 110.918 -174.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.44 35.84 4.81 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.313 -0.946 . . . . 0.16 112.483 -178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.716 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.59 159.16 17.8 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 113.131 0.789 . . . . 0.12 113.131 -169.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.693 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -98.0 -27.06 14.41 Favored 'General case' 0 CA--C 1.508 -0.659 0 CA-C-N 115.18 -0.918 . . . . 0.2 109.569 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.649 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 9.5 m-85 -136.65 -173.42 3.42 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.354 -0.839 . . . . 0.13 111.586 -174.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.696 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -137.76 138.43 44.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 114.803 -1.089 . . . . 0.08 109.145 166.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.569 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 34.7 tp -107.82 99.43 8.9 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 119.379 -0.928 . . . . 0.16 109.281 165.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.69 ' CE1' HD12 ' A' ' 142' ' ' LEU . 2.0 m-85 -78.78 111.99 15.47 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 114.56 -1.2 . . . . 0.26 108.743 178.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.729 ' OG ' HD11 ' A' ' 174' ' ' LEU . 26.8 t -123.6 159.22 29.72 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-O 121.776 0.798 . . . . 1.05 110.123 -177.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.818 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.4 p -163.38 170.06 18.07 Favored 'General case' 0 CA--C 1.478 -1.817 0 CA-C-N 114.497 -1.229 . . . . 0.1 111.18 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.547 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -133.86 135.93 44.05 Favored 'General case' 0 C--N 1.28 -2.449 0 CA-C-N 114.143 -1.39 . . . . 0.11 108.636 177.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.676 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -144.23 -176.96 5.23 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 109.192 -0.67 . . . . 1.09 109.192 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 96.08 -86.18 0.92 Allowed Glycine 0 N--CA 1.432 -1.586 0 C-N-CA 119.628 -1.272 . . . . 0.15 111.006 174.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.9 t30 -143.75 127.76 17.47 Favored 'General case' 0 C--O 1.191 -1.982 0 N-CA-C 107.375 -1.343 . . . . 0.59 107.375 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.6 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.9 p -61.36 -49.71 83.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-N 114.061 -1.427 . . . . 0.15 112.916 -170.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.447 ' N ' HG13 ' A' ' 169' ' ' VAL . 89.8 m-20 -58.83 -26.83 64.52 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.222 0.534 . . . . 1.26 110.904 -177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.13 88.18 3.51 Favored Pre-proline 0 C--N 1.312 -1.059 0 CA-C-N 114.903 -1.044 . . . . 0.13 108.394 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.831 ' HD2' HG22 ' A' ' 194' ' ' VAL . 43.3 Cg_endo -91.44 167.26 3.44 Favored 'Trans proline' 0 CA--C 1.493 -1.55 0 C-N-CA 124.947 3.765 . . . . 0.09 114.854 -170.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.568 HG22 ' HB3' ' A' ' 191' ' ' LYS . 16.9 m -86.13 118.13 25.39 Favored 'General case' 0 N--CA 1.419 -1.997 0 CA-C-N 113.755 -1.566 . . . . 0.14 107.694 166.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 164' ' ' SER . 54.1 tp -84.46 97.89 9.78 Favored 'General case' 0 N--CA 1.413 -2.287 0 CA-C-O 121.988 0.899 . . . . 0.16 109.337 177.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.63 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 34.9 mt-30 -87.64 107.66 18.72 Favored 'General case' 0 C--N 1.274 -2.699 0 CA-C-N 114.567 -1.197 . . . . 0.34 108.685 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.544 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 35.1 mtp -108.26 163.0 13.57 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 115.235 -0.893 . . . . 1.09 110.063 -177.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.608 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.5 tt0 -169.91 117.85 0.58 Allowed 'General case' 0 C--O 1.202 -1.438 0 CA-C-O 121.256 0.551 . . . . 0.5 110.136 -167.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.1 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.34 101.76 12.83 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.818 -0.808 . . . . 0.1 108.818 -172.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.726 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.2 ttp -91.3 123.13 34.5 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.479 -0.782 . . . . 0.07 109.533 176.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.77 127.37 31.84 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 107.075 -1.454 . . . . 0.22 107.075 166.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.05 -35.8 13.54 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 C-N-CA 119.192 -1.003 . . . . 0.11 110.645 178.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.438 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.5 mt-30 -61.72 -15.5 41.12 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.259 -0.882 . . . . 0.35 111.37 -178.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 80.9 p -130.08 -37.54 1.47 Allowed 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 121.514 0.674 . . . . 0.19 110.127 177.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.512 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.15 26.13 24.66 Favored Glycine 0 N--CA 1.436 -1.337 0 CA-C-N 114.631 -1.168 . . . . 0.18 112.429 -179.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -105.23 156.76 17.81 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.605 0.24 . . . . 0.73 110.946 -179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.608 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.8 mm -91.25 110.59 22.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.792 0.806 . . . . 0.14 109.706 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.1 HD11 HD13 ' A' ' 178' ' ' LEU . 1.5 pp -98.11 -32.39 3.93 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 CA-C-N 114.695 -1.139 . . . . 0.13 110.514 -173.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.636 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.6 t90 -135.49 151.78 50.7 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-N 115.383 -0.826 . . . . 0.07 109.541 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.512 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 33.0 p -153.84 163.17 40.48 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 112.742 0.645 . . . . 0.13 112.742 164.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.29 -178.41 32.29 Favored Glycine 0 N--CA 1.425 -2.063 0 N-CA-C 110.841 -0.903 . . . . 0.12 110.841 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.743 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 16.3 mtmm -156.91 148.19 22.13 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 106.433 -1.692 . . . . 1.22 106.433 167.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.643 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -157.59 127.06 1.84 Allowed Glycine 0 C--N 1.283 -2.38 0 C-N-CA 119.682 -1.247 . . . . 0.12 112.293 -179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.94 116.05 12.98 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-O 121.413 0.625 . . . . 0.17 111.069 -174.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.831 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -93.39 159.46 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.444 0 CA-C-O 122.604 1.192 . . . . 0.11 110.716 -176.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.744 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -100.82 172.55 6.99 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 112.485 -2.143 . . . . 0.18 108.682 -174.175 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.1 tt0 -101.25 133.24 46.13 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 120.103 -0.639 . . . . 0.91 109.601 171.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.547 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 36.7 mm-40 . . . . . 0 C--N 1.313 -1.02 0 CA-C-O 118.467 -0.778 . . . . 1.24 110.257 176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.874 -0.49 . . . . 88.61 111.874 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.5 m -106.02 -79.42 0.56 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 110.015 -0.365 . . . . 87.43 110.015 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.0 t60 44.13 74.63 0.12 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.745 0.818 . . . . 87.16 112.306 178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.8 ttp -72.93 164.24 26.95 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.622 -0.881 . . . . 85.34 108.622 172.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.422 ' O ' HG13 ' A' ' 5' ' ' VAL . 14.6 p -77.31 55.89 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 122.843 1.306 . . . . 85.05 110.672 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -144.13 72.14 0.36 Allowed Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 114.584 -1.189 . . . . 84.68 111.399 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -87.64 -175.61 5.25 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.592 -0.304 . . . . 85.57 110.993 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 41.4 mtm180 61.01 62.69 1.38 Allowed 'General case' 0 CA--C 1.519 -0.243 0 CA-C-O 121.417 0.627 . . . . 85.04 109.899 -175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -117.29 101.08 53.12 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 115.18 -0.918 . . . . 82.17 110.246 -178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -86.0 97.69 0.57 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.261 1.974 . . . . 81.51 111.969 176.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.94 119.4 77.0 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.235 -0.439 . . . . 79.56 110.311 177.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.466 ' O ' HG22 ' A' ' 13' ' ' VAL . 22.6 Cg_exo -62.91 127.51 20.63 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.11 1.873 . . . . 78.5 111.734 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 12' ' ' PRO . 5.9 m 50.47 161.77 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 C-N-CA 125.313 1.445 . . . . 77.0 113.646 -174.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -166.27 78.92 0.25 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.803 -1.089 . . . . 75.74 108.967 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -153.53 146.74 24.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.161 -0.472 . . . . 73.91 111.251 -175.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.4 p -77.53 138.79 19.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.79 -0.641 . . . . 72.3 110.369 176.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -82.97 129.97 59.37 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.104 -0.498 . . . . 71.22 109.978 179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -73.97 -170.97 0.77 Allowed 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.967 2.445 . . . . 69.67 112.699 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 60.88 73.05 0.64 Allowed Pre-proline 0 C--N 1.338 0.07 0 CA-C-N 115.073 -0.967 . . . . 67.55 110.729 -175.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.73 118.25 5.11 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.764 2.309 . . . . 66.7 112.007 -177.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -68.1 -55.36 12.75 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.935 -0.394 . . . . 65.01 109.935 -179.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 67.9 119.85 0.03 OUTLIER Pre-proline 0 CA--C 1.533 0.29 0 O-C-N 123.96 0.787 . . . . 63.41 111.663 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_exo -55.97 162.35 7.25 Favored 'Trans proline' 0 C--O 1.238 0.49 0 C-N-CA 123.097 2.532 . . . . 61.93 112.528 175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.64 86.75 0.48 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.725 -0.671 . . . . 59.87 110.957 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.505 ' HB2' ' HD3' ' A' ' 26' ' ' PRO . 76.9 mm-40 -102.51 -53.15 0.13 Allowed Pre-proline 0 C--N 1.321 -0.672 0 CA-C-N 115.275 -0.875 . . . . 58.47 111.697 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 25' ' ' GLU . 91.3 Cg_endo -83.08 -156.43 0.07 OUTLIER 'Trans proline' 0 C--N 1.353 0.778 0 C-N-CA 121.53 1.486 . . . . 57.36 112.395 178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 65.69 -97.67 0.05 Allowed 'General case' 0 C--O 1.231 0.125 0 CA-C-N 115.209 -0.905 . . . . 55.51 110.609 178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 56.26 128.19 0.01 OUTLIER Pre-proline 0 N--CA 1.471 0.583 0 C-N-CA 123.703 0.801 . . . . 53.87 113.051 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.91 133.73 46.12 Favored 'Trans proline' 0 CA--C 1.531 0.351 0 C-N-CA 122.249 1.966 . . . . 52.76 112.611 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 63.0 t -129.56 123.57 21.38 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 116.136 -0.484 . . . . 50.93 110.175 178.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.25 143.37 35.3 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.054 1.836 . . . . 49.21 112.02 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.5 p -76.76 154.78 33.7 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.613 0.244 . . . . 47.49 111.574 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.8 m 37.99 84.62 0.18 Allowed Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.574 1.15 . . . . 45.97 113.9 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -54.42 160.24 7.14 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.444 2.762 . . . . 45.28 112.516 175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.7 p -71.26 130.7 42.08 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.809 -1.087 . . . . 42.79 111.298 -176.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.41 ' HB ' ' HD2' ' A' ' 37' ' ' PRO . 31.6 m -61.84 160.45 28.28 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.484 -0.78 . . . . 40.79 111.024 179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HD2' ' HB ' ' A' ' 36' ' ' VAL . 83.9 Cg_exo -46.9 148.12 4.25 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.825 2.35 . . . . 39.81 113.269 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.9 t -68.31 129.51 40.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.525 0.679 . . . . 37.5 111.567 -175.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.0 mt -107.76 128.13 26.43 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.471 -0.786 . . . . 35.65 110.124 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.68 -179.52 4.61 Favored 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.43 2.087 . . . . 33.72 112.595 178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -117.85 17.48 14.23 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.783 -0.367 . . . . 31.51 111.644 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.415 ' HA ' ' HD3' ' A' ' 43' ' ' PRO . 4.3 pt20 -160.34 151.06 15.44 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.79 -0.448 . . . . 30.13 109.79 177.058 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 42' ' ' GLN . 13.2 Cg_exo -71.47 120.61 7.06 Favored 'Trans proline' 0 C--O 1.236 0.384 0 C-N-CA 122.223 1.949 . . . . 29.52 111.26 175.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 59.11 -164.49 9.88 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 121.021 -0.609 . . . . 26.75 112.954 -177.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.71 169.34 10.68 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.252 2.635 . . . . 25.08 112.669 179.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 54.8 mt -63.88 -69.24 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.409 -0.36 . . . . 23.9 110.639 -179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.75 119.66 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.758 -1.11 . . . . 21.23 111.508 -174.204 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.2 p-80 -63.43 168.49 4.5 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.409 0.623 . . . . 19.92 111.054 178.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -100.67 133.98 44.31 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.359 -0.837 . . . . 16.56 109.568 178.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -109.62 78.66 1.15 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.683 -0.69 . . . . 15.05 110.203 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -59.92 -26.75 66.18 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 114.806 -1.088 . . . . 14.19 110.737 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.8 p -84.81 140.31 31.29 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.899 -0.591 . . . . 11.38 110.446 175.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -131.36 79.26 70.32 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.251 -0.431 . . . . 8.29 111.815 -175.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -56.68 -39.02 94.27 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.521 2.147 . . . . 6.87 113.771 174.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_exo -59.74 107.98 0.43 Allowed 'Trans proline' 0 C--N 1.358 1.054 0 C-N-CA 121.305 1.337 . . . . 5.04 111.99 170.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -91.86 130.76 37.47 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.019 -0.537 . . . . 2.59 110.007 178.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.97 -177.17 1.82 Allowed 'Trans proline' 0 N--CA 1.458 -0.566 0 C-N-CA 123.186 2.591 . . . . 1.64 112.965 -177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -121.19 146.81 46.39 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.591 -1.186 . . . . 3.39 111.423 -174.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.635 ' HB ' ' HB2' ' A' ' 101' ' ' ASN . 12.0 mt -85.19 170.88 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 114.423 -1.262 . . . . 0.44 111.402 -177.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.61 ' N ' HG22 ' A' ' 59' ' ' ILE . 29.1 mtt-85 -69.22 -157.94 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 113.954 -1.475 . . . . 2.34 111.651 177.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.787 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 16.2 t-160 -156.46 150.6 25.25 Favored 'General case' 0 CA--C 1.467 -2.229 0 CA-C-N 112.778 -2.01 . . . . 2.22 106.891 178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.787 ' HD1' ' C ' ' A' ' 61' ' ' HIS . 1.2 m-30 -125.79 161.18 27.94 Favored 'General case' 0 N--CA 1.42 -1.94 0 O-C-N 124.005 0.816 . . . . 0.21 110.032 -173.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.556 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 0.9 OUTLIER -81.73 67.46 7.71 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 123.578 1.656 . . . . 0.35 107.949 170.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.707 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.8 m95 -60.03 -44.11 94.86 Favored 'General case' 0 C--N 1.305 -1.342 0 CA-C-N 111.994 -2.366 . . . . 0.1 112.256 174.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.549 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 12.0 t-20 -51.65 -27.12 10.52 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.163 -1.38 . . . . 1.11 111.269 174.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.15 -18.21 76.9 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.033 -0.985 . . . . 0.21 111.292 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.22 -53.9 2.91 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.026 -1.087 . . . . 0.13 111.157 -176.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.711 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.5 mtt -63.06 -60.49 3.37 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 114.052 -1.431 . . . . 0.09 111.967 -178.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.549 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.6 mm-40 -38.36 -54.09 2.87 Favored Pre-proline 0 C--N 1.322 -0.627 0 N-CA-C 114.984 1.476 . . . . 0.63 114.984 -176.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.805 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 39.2 Cg_endo -66.16 -29.14 47.85 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.702 1.601 . . . . 0.14 110.57 -177.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.727 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 15.6 mtm -84.48 -41.86 16.14 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.428 -0.806 . . . . 0.7 111.818 -178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 68' ' ' MET . 60.7 t -57.0 -37.45 54.85 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 114.578 -1.192 . . . . 0.12 108.471 174.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -63.16 -33.12 74.79 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 112.961 -1.927 . . . . 0.56 111.096 174.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.805 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.4 mtpt -83.42 -32.47 26.1 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 121.028 0.442 . . . . 1.3 110.632 178.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.846 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -66.03 -27.0 67.78 Favored 'General case' 0 CA--C 1.501 -0.938 0 CA-C-N 115.225 -0.898 . . . . 0.5 111.202 -173.05 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.647 HD13 ' HB2' ' A' ' 118' ' ' LYS . 5.9 mt -93.45 -7.29 44.9 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.951 0.882 . . . . 0.65 110.669 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.0 16.97 53.69 Favored Glycine 0 N--CA 1.44 -1.056 0 N-CA-C 108.885 -1.686 . . . . 0.17 108.885 171.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.653 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -88.07 164.57 15.67 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.523 -0.838 . . . . 0.1 110.307 -178.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -89.2 106.66 18.59 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.978 -1.01 . . . . 1.72 109.407 177.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.642 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.19 -23.7 3.65 Favored Glycine 0 N--CA 1.417 -2.626 0 C-N-CA 119.69 -1.243 . . . . 0.12 110.791 179.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.846 HG11 ' O ' ' A' ' 75' ' ' MET . 11.4 p -100.06 153.75 4.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.787 0.803 . . . . 0.16 111.875 -174.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.9 m -135.14 137.91 43.23 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 114.48 -1.236 . . . . 0.45 110.639 179.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.667 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.35 130.78 48.58 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.462 -0.79 . . . . 0.28 110.335 167.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 107.91 -3.92 33.94 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.966 -0.635 . . . . 0.28 112.77 176.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.98 152.03 25.62 Favored 'General case' 0 CA--C 1.509 -0.618 0 CA-C-O 120.91 0.386 . . . . 1.2 111.122 -178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.655 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.7 p -80.67 117.84 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 CA-C-O 121.978 0.894 . . . . 0.2 109.05 165.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.77 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.3 tm? -106.16 109.57 21.55 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 115.166 -0.925 . . . . 0.14 108.91 -172.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.683 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -71.92 96.12 1.65 Allowed 'General case' 0 CA--C 1.502 -0.868 0 CA-C-N 114.124 -1.398 . . . . 0.15 108.163 177.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.537 HG12 ' CD1' ' A' ' 87' ' ' LEU . 0.9 OUTLIER -71.88 120.04 19.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.97 0 N-CA-C 106.878 -1.527 . . . . 0.95 106.878 177.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.777 ' HB2' HD11 ' A' ' 142' ' ' LEU . 10.5 t0 -77.71 155.58 31.19 Favored 'General case' 0 CA--C 1.489 -1.394 0 N-CA-C 107.08 -1.452 . . . . 0.64 107.08 177.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.523 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.0 OUTLIER -59.2 136.95 58.12 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 107.584 -1.265 . . . . 0.37 107.584 171.728 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.535 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 21.7 t -63.15 139.04 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.402 -2.831 0 N-CA-C 107.78 -1.193 . . . . 0.1 107.78 168.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.802 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -86.03 163.52 17.89 Favored 'General case' 0 C--N 1.288 -2.068 0 CA-C-N 115.239 -0.891 . . . . 0.18 110.083 174.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.06 85.5 2.42 Favored 'General case' 0 C--N 1.291 -1.954 0 CA-C-N 114.55 -1.204 . . . . 0.12 108.22 175.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.458 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.1 mtp180 -108.92 -0.24 19.79 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.027 -1.442 . . . . 0.64 108.746 -172.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 172' ' ' PRO . 21.7 p -52.18 -177.01 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 113.21 -1.814 . . . . 0.14 113.681 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.3 OUTLIER -73.92 -9.36 58.56 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.375 -1.738 . . . . 0.48 110.133 173.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.609 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -139.9 -151.63 5.69 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.852 -0.69 . . . . 0.12 112.846 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.571 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 65.7 p -122.03 130.62 53.44 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 112.512 0.56 . . . . 1.16 112.512 -176.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.762 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 1.8 pp -136.2 156.9 48.01 Favored 'General case' 0 CA--C 1.504 -0.796 0 CA-C-O 122.009 0.909 . . . . 0.1 111.604 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.635 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 1.6 t-20 -80.9 79.77 7.5 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.817 -1.538 . . . . 0.17 107.867 175.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.52 -13.08 61.74 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 114.469 -1.242 . . . . 0.09 110.038 179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.534 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.41 -32.72 37.39 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.643 -0.873 . . . . 0.15 108.643 -178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.622 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 6.1 tp10 -65.45 -33.81 76.82 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-O 122.804 1.288 . . . . 1.73 109.076 171.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.02 -44.08 63.99 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-N 112.928 -1.942 . . . . 0.12 109.51 179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.604 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 61.4 m -63.65 -29.07 70.36 Favored 'General case' 0 N--CA 1.433 -1.291 0 CA-C-N 114.124 -1.398 . . . . 0.11 110.292 178.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -65.64 -52.37 52.39 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 108.185 -1.043 . . . . 1.47 108.185 169.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.691 HG21 ' HB2' ' A' ' 64' ' ' TRP . 39.3 m -55.44 -33.93 64.03 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.671 -0.695 . . . . 0.12 111.144 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.711 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.0 mt -49.45 -69.22 0.12 Allowed 'General case' 0 CA--C 1.49 -1.348 0 CA-C-N 116.2 -0.455 . . . . 0.56 109.862 172.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.527 ' O ' HD13 ' A' ' 121' ' ' LEU . 13.9 mtp180 -43.31 -36.95 2.03 Favored 'General case' 0 C--N 1.312 -1.054 0 O-C-N 124.442 1.089 . . . . 1.51 110.82 177.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -70.83 -47.61 58.48 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.009 -1.451 . . . . 0.28 111.561 -175.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.485 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.36 -34.72 68.19 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-O 122.168 0.985 . . . . 0.09 108.631 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.678 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -62.34 -33.94 75.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 113.56 -1.655 . . . . 0.12 109.954 173.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -75.15 -42.33 56.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 114.717 -1.129 . . . . 0.2 111.053 -176.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -63.63 -19.28 64.74 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 114.825 -1.08 . . . . 1.17 110.667 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -97.42 -19.43 18.45 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.567 -0.742 . . . . 2.05 111.565 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 57.04 14.19 10.26 Favored Glycine 0 C--N 1.333 0.374 0 N-CA-C 115.357 0.903 . . . . 0.54 115.357 164.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.667 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 56.8 mtpt -98.42 -2.35 39.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 117.268 0.534 . . . . 0.99 109.913 177.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.77 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 34.8 m-85 -122.2 174.98 6.63 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 122.144 0.973 . . . . 0.21 112.674 173.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.564 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 5.4 m -118.08 121.14 39.82 Favored 'General case' 0 N--CA 1.419 -2.007 0 CA-C-N 112.935 -1.939 . . . . 0.23 107.742 170.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.662 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -92.31 139.47 30.58 Favored 'General case' 0 N--CA 1.416 -2.126 0 C-N-CA 119.164 -1.014 . . . . 0.38 111.837 -169.408 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.807 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.8 m -92.71 146.97 5.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.047 -1.094 . . . . 0.42 108.047 170.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 17.8 t -101.31 -173.84 2.46 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 119.896 -0.722 . . . . 1.7 110.234 178.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -66.02 -25.2 66.96 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.901 -1.148 . . . . 0.55 107.901 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 129' ' ' MET . 34.3 mt-30 -51.32 -39.67 57.46 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 113.235 -1.802 . . . . 2.04 110.525 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.807 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 6.6 mt-30 -98.47 -53.63 3.27 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-O 122.265 1.031 . . . . 0.41 109.819 173.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.629 HD13 HD21 ' A' ' 88' ' ' LEU . 31.7 tp -60.37 -65.0 0.76 Allowed 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 113.122 -1.854 . . . . 1.39 113.253 -168.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.665 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 5.6 t -50.39 -46.56 56.18 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 123.275 1.512 . . . . 1.05 109.203 -177.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.755 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -52.84 -63.75 1.04 Allowed 'General case' 0 CA--C 1.494 -1.177 0 CA-C-N 111.053 -2.794 . . . . 1.64 110.374 175.349 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.768 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.77 -46.15 10.38 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 124.574 1.171 . . . . 0.31 112.195 176.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.532 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.8 OUTLIER -54.39 -51.83 63.61 Favored 'General case' 0 C--O 1.212 -0.869 0 N-CA-C 108.835 -0.802 . . . . 1.53 108.835 179.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.564 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.3 mt-30 -65.75 -38.86 90.25 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.313 -0.858 . . . . 0.41 111.136 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.755 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.3 mt-30 -59.46 -33.84 71.8 Favored 'General case' 0 CA--C 1.491 -1.324 0 CA-C-N 114.486 -1.234 . . . . 0.37 109.678 178.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.522 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -91.43 -27.31 18.38 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.079 -1.418 . . . . 0.24 109.552 -177.241 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 149.78 -48.79 0.58 Allowed Glycine 0 CA--C 1.495 -1.16 0 CA-C-O 122.598 1.11 . . . . 0.33 113.259 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.597 HD13 ' O ' ' A' ' 141' ' ' SER . 96.6 mt -64.89 -171.77 0.07 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 112.102 -2.049 . . . . 0.31 115.716 -170.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.563 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.3 m -116.17 153.34 48.51 Favored Pre-proline 0 N--CA 1.428 -1.557 0 CA-C-N 110.705 -2.952 . . . . 0.81 107.932 175.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.665 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 37.1 Cg_endo -65.81 -0.37 3.81 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.611 2.207 . . . . 0.32 112.561 -179.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.534 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 2.8 tt0 -118.41 -26.61 6.19 Favored 'General case' 0 CA--C 1.508 -0.637 0 CA-C-O 121.864 0.84 . . . . 1.25 110.704 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.586 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.1 t70 -56.86 -24.45 51.64 Favored 'General case' 0 CA--C 1.489 -1.366 0 CA-C-N 113.217 -1.81 . . . . 0.65 109.677 -173.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.597 ' O ' HD13 ' A' ' 136' ' ' LEU . 13.0 m 73.47 170.26 0.31 Allowed 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 112.964 -1.926 . . . . 0.6 109.434 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.073 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.1 mt -69.19 -39.97 78.37 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-O 122.369 1.08 . . . . 0.86 108.609 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.56 -12.11 0.52 Allowed Glycine 0 N--CA 1.448 -0.546 0 CA-C-N 112.94 -1.936 . . . . 0.31 114.099 179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.77 128.65 10.25 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 118.775 -0.631 . . . . 0.24 109.482 -175.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.684 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 22.5 mmt-85 -42.82 -50.1 5.7 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 118.043 0.383 . . . . 1.65 111.36 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 38.5 t -69.32 -27.28 65.24 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-O 121.456 0.646 . . . . 0.53 111.365 -175.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.47 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 24.1 mttm -73.92 -27.63 61.13 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-O 122.666 1.222 . . . . 1.31 108.663 177.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 1.073 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -79.61 -46.75 16.66 Favored 'General case' 0 CA--C 1.49 -1.362 0 CA-C-N 112.351 -2.204 . . . . 0.12 110.586 178.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.652 HG13 ' HE1' ' A' ' 179' ' ' MET . 44.4 mt -65.78 -41.66 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.723 0 CA-C-N 112.946 -1.934 . . . . 0.11 110.099 178.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.25 -52.37 40.94 Favored Glycine 0 N--CA 1.439 -1.118 0 CA-C-N 114.743 -1.117 . . . . 0.15 111.243 172.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.768 HG23 ' CB ' ' A' ' 130' ' ' ALA . 89.1 mt -68.24 -48.43 73.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.042 0 N-CA-C 112.358 0.503 . . . . 0.18 112.358 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.683 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.0 -41.31 71.12 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 120.948 0.404 . . . . 0.13 111.218 -178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.545 ' HD2' HG23 ' A' ' 149' ' ' ILE . 45.8 mtp180 -80.4 -24.26 39.82 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 121.597 0.713 . . . . 1.08 110.506 -178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.471 HD21 ' CD ' ' A' ' 133' ' ' GLN . 39.2 t30 -80.89 -14.35 58.09 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 107.641 -1.244 . . . . 0.5 107.641 176.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.692 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -103.2 -28.64 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.26 0 CA-C-N 113.188 -1.824 . . . . 0.17 110.629 -174.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.443 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 98.5 35.03 5.08 Favored Glycine 0 CA--C 1.5 -0.886 0 C-N-CA 120.153 -1.023 . . . . 0.16 112.16 -179.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.682 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.39 158.58 17.38 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 112.756 0.65 . . . . 0.12 112.756 -170.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.655 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.1 m80 -98.2 -28.52 13.67 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.144 -0.934 . . . . 0.2 109.392 178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.589 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 6.2 m-85 -136.12 -174.89 3.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.089 -0.959 . . . . 0.13 111.235 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.694 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -135.67 140.23 44.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.091 -0.959 . . . . 0.08 108.71 166.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.533 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 37.6 tp -109.31 101.75 10.72 Favored 'General case' 0 N--CA 1.431 -1.4 0 C-N-CA 119.292 -0.963 . . . . 0.16 109.45 165.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.617 ' CE1' HD12 ' A' ' 142' ' ' LEU . 2.2 m-85 -79.11 113.87 17.6 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 114.405 -1.27 . . . . 0.26 108.673 177.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.711 ' OG ' HD11 ' A' ' 109' ' ' LEU . 4.2 p -121.33 157.73 29.77 Favored 'General case' 0 C--N 1.282 -2.351 0 CA-C-N 115.444 -0.798 . . . . 1.05 109.791 -176.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.802 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.7 p -164.62 173.24 12.17 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 114.985 -1.007 . . . . 0.1 111.202 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.49 136.82 41.56 Favored 'General case' 0 N--CA 1.412 -2.334 0 CA-C-N 114.156 -1.384 . . . . 0.11 108.795 178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.676 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.7 t -146.06 -171.29 3.68 Favored 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.882 -0.727 . . . . 1.09 110.345 176.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.41 -78.0 1.51 Allowed Glycine 0 C--N 1.288 -2.099 0 CA-C-N 115.283 -0.871 . . . . 0.15 111.713 174.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.484 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.2 t30 -148.85 131.56 15.97 Favored 'General case' 0 C--O 1.198 -1.642 0 N-CA-C 107.62 -1.252 . . . . 0.59 107.62 176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.609 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.7 p -64.38 -41.8 93.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.102 -0.953 . . . . 0.15 112.863 -172.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 196' ' ' GLN . 5.2 m-20 -63.91 -28.85 70.11 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-O 122.293 1.045 . . . . 1.26 109.338 -177.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.5 88.41 3.68 Favored Pre-proline 0 C--N 1.304 -1.374 0 CA-C-N 114.279 -1.328 . . . . 0.13 108.456 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.806 ' HD2' HG22 ' A' ' 194' ' ' VAL . 41.3 Cg_endo -92.0 166.25 3.15 Favored 'Trans proline' 0 CA--C 1.495 -1.447 0 C-N-CA 124.341 3.361 . . . . 0.09 114.612 -171.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.605 HG22 ' HB3' ' A' ' 191' ' ' LYS . 49.2 m -85.02 118.8 24.81 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 113.793 -1.549 . . . . 0.14 107.888 166.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.782 HD12 ' O ' ' A' ' 164' ' ' SER . 43.9 tp -84.11 96.72 9.01 Favored 'General case' 0 N--CA 1.414 -2.239 0 C-N-CA 119.26 -0.976 . . . . 0.16 108.66 176.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.678 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 31.9 mt-30 -85.83 108.94 18.35 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 114.638 -1.165 . . . . 0.34 108.558 -177.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.591 ' SD ' ' HB3' ' A' ' 163' ' ' SER . 2.9 mmm -112.06 163.52 14.19 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 114.655 -1.157 . . . . 1.09 111.047 -174.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.645 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.4 tt0 -171.48 118.75 0.45 Allowed 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 115.917 -0.583 . . . . 0.5 109.949 -167.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.054 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.74 99.35 9.87 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 108.524 -0.917 . . . . 0.1 108.524 -173.313 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.684 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.9 ttp -88.35 118.47 28.0 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.462 -0.79 . . . . 0.07 109.22 176.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.527 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.17 115.65 4.31 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.067 -1.457 . . . . 0.22 107.067 169.708 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.618 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -71.28 -36.21 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 CA-C-N 119.063 0.847 . . . . 0.11 111.348 -176.006 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.457 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 32.2 mt-30 -58.78 -15.53 12.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.525 -0.761 . . . . 0.35 111.897 -177.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 39.8 p -128.97 -37.28 1.72 Allowed 'General case' 0 CA--C 1.506 -0.719 0 CA-C-O 122.076 0.941 . . . . 0.19 110.02 178.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.522 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.28 23.79 36.28 Favored Glycine 0 N--CA 1.431 -1.663 0 CA-C-N 113.663 -1.608 . . . . 0.18 111.793 -177.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -104.4 154.29 20.03 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.893 0.377 . . . . 0.73 110.423 179.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.645 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.1 mm -87.6 116.19 29.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 CA-C-O 121.53 0.681 . . . . 0.14 109.358 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.054 HD11 HD13 ' A' ' 178' ' ' LEU . 1.7 pp -103.49 -31.34 2.89 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.93 -1.032 . . . . 0.13 110.476 -173.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.656 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 79.0 t90 -135.16 153.41 51.99 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 115.325 -0.852 . . . . 0.07 109.314 171.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.521 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 77.8 p -153.73 164.0 39.05 Favored 'General case' 0 C--N 1.308 -1.23 0 C-N-CA 120.085 -0.646 . . . . 0.13 112.697 163.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.61 -177.53 32.78 Favored Glycine 0 N--CA 1.424 -2.126 0 N-CA-C 110.573 -1.011 . . . . 0.12 110.573 -178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.748 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 18.7 mtmm -157.98 148.2 20.39 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 105.488 -2.042 . . . . 1.22 105.488 166.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -155.65 126.89 1.92 Allowed Glycine 0 C--N 1.282 -2.445 0 C-N-CA 119.405 -1.379 . . . . 0.12 112.306 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.53 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.14 110.88 8.79 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-O 121.579 0.704 . . . . 0.17 111.094 -173.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.806 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -89.91 157.73 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.457 0 CA-C-N 114.583 -1.189 . . . . 0.11 110.581 -176.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.717 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -97.83 172.77 7.45 Favored 'General case' 0 C--N 1.291 -1.97 0 CA-C-N 112.612 -2.085 . . . . 0.18 108.982 -175.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 1.9 tt0 -107.48 132.38 53.28 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.933 -1.107 . . . . 0.91 110.79 171.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.552 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 35.9 mm-40 . . . . . 0 C--O 1.247 0.957 0 CA-C-N 114.811 -1.086 . . . . 1.24 110.948 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 111.803 -0.519 . . . . 88.61 111.803 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.4 t 60.19 60.65 2.01 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 122.589 0.355 . . . . 87.43 110.733 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 86.2 t60 73.06 129.5 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.352 0.596 . . . . 87.16 111.962 176.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.456 ' O ' HG12 ' A' ' 5' ' ' VAL . 26.6 ptt? -61.03 148.98 38.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.668 -0.696 . . . . 85.34 110.928 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.456 HG12 ' O ' ' A' ' 4' ' ' MET . 0.4 OUTLIER 64.88 -4.35 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 C-N-CA 123.877 0.871 . . . . 85.05 112.322 -175.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 4' ' ' MET . . . 63.96 30.58 78.14 Favored Glycine 0 N--CA 1.452 -0.264 0 CA-C-N 116.085 -0.507 . . . . 84.68 113.661 172.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.603 ' HG2' ' H ' ' A' ' 8' ' ' ARG . 52.5 tt0 69.11 -179.77 0.23 Allowed 'General case' 0 C--O 1.236 0.346 0 N-CA-C 110.149 -0.315 . . . . 85.57 110.149 178.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.603 ' H ' ' HG2' ' A' ' 7' ' ' GLN . 62.4 mtp85 64.62 56.71 1.17 Allowed 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 121.939 0.876 . . . . 85.04 109.106 -175.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.499 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 8.4 pt-20 -116.2 138.08 23.96 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 114.163 -1.381 . . . . 82.17 110.425 -175.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.499 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 3.4 Cg_exo -79.6 172.87 13.76 Favored 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.526 2.15 . . . . 81.51 112.723 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -115.36 166.64 11.53 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.639 -0.709 . . . . 79.56 109.351 176.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.84 141.86 34.65 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 122.246 1.964 . . . . 78.5 112.126 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.5 m -66.51 148.54 12.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 121.341 0.591 . . . . 77.0 111.745 -176.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -102.79 -15.75 16.16 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.326 -0.852 . . . . 75.74 110.202 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -80.64 94.08 6.25 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.356 -0.838 . . . . 73.91 110.85 178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.9 t -77.62 111.59 14.6 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.536 -0.756 . . . . 72.3 109.866 178.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -76.21 112.32 20.26 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.939 -0.573 . . . . 71.22 109.474 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -78.53 33.19 0.46 Allowed 'Trans proline' 0 C--O 1.233 0.262 0 C-N-CA 123.064 2.509 . . . . 69.67 113.102 -172.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.35 85.46 0.19 Allowed Pre-proline 0 C--O 1.233 0.237 0 O-C-N 123.755 0.659 . . . . 67.55 111.954 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.75 46.95 2.02 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.625 2.217 . . . . 66.7 111.749 177.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -96.1 149.79 21.22 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.771 -0.649 . . . . 65.01 110.69 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 27.2 mt-30 -79.69 134.32 57.68 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 116.051 -0.522 . . . . 63.41 110.246 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 76.3 Cg_exo -56.75 144.19 87.73 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.472 2.781 . . . . 61.93 113.53 -176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -145.29 136.47 24.9 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.663 -0.699 . . . . 59.87 110.297 178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 60.28 89.75 0.1 Allowed Pre-proline 0 N--CA 1.465 0.303 0 O-C-N 123.86 0.725 . . . . 58.47 111.825 178.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -78.23 -9.18 16.47 Favored 'Trans proline' 0 C--O 1.236 0.414 0 C-N-CA 122.547 2.165 . . . . 57.36 112.667 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.568 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 15.5 mm100 62.57 46.61 5.43 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 114.981 -1.009 . . . . 55.51 112.53 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -97.43 103.89 17.98 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-O 121.013 0.435 . . . . 53.87 111.228 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 1.6 Cg_endo -82.36 81.85 2.4 Favored 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 122.616 2.211 . . . . 52.76 111.048 175.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.7 m -58.53 132.66 85.49 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.912 -0.586 . . . . 50.93 111.74 -177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -70.61 94.89 0.61 Allowed 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.582 2.188 . . . . 49.21 111.86 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.5 p -87.32 158.05 19.14 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.094 -0.503 . . . . 47.49 111.847 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 p 44.26 92.34 0.05 OUTLIER Pre-proline 0 N--CA 1.472 0.635 0 C-N-CA 124.853 1.261 . . . . 45.97 113.43 175.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -57.56 165.02 6.55 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.546 2.831 . . . . 45.28 113.13 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.2 t -92.16 153.99 18.97 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.202 -0.908 . . . . 42.79 109.78 177.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 31.5 m -81.67 116.59 64.01 Favored Pre-proline 0 C--N 1.316 -0.859 0 CA-C-N 115.938 -0.573 . . . . 40.79 111.405 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -77.17 -27.0 7.08 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.024 2.483 . . . . 39.81 111.328 174.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 5.7 m -67.55 139.48 56.94 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.113 -0.949 . . . . 37.5 111.294 -177.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 mt -97.36 107.35 38.18 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.719 -0.673 . . . . 35.65 110.169 -178.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.78 -71.05 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.873 2.382 . . . . 33.72 112.395 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 17.3 mm100 46.54 75.95 0.11 Allowed 'General case' 0 N--CA 1.469 0.484 0 O-C-N 123.548 0.53 . . . . 31.51 112.017 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -64.25 141.37 98.12 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.751 -0.659 . . . . 30.13 111.216 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.68 158.75 39.4 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 122.416 2.077 . . . . 29.52 111.481 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -95.95 172.38 29.53 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.498 -0.858 . . . . 26.75 112.093 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_exo -70.85 160.39 49.53 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.028 2.486 . . . . 25.08 112.007 179.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.4 mm -58.25 -61.15 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.759 0.314 . . . . 23.9 110.85 -176.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 53.18 82.87 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.959 -1.019 . . . . 21.23 111.198 -179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 39.0 p-80 -84.17 174.39 10.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.218 0.532 . . . . 19.92 110.439 178.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -121.64 138.82 54.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.559 -0.746 . . . . 16.56 109.456 178.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -111.47 70.47 0.71 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.428 0.632 . . . . 15.05 110.439 -178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -133.96 76.05 1.63 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.441 -1.254 . . . . 14.19 108.81 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 68.2 p -62.49 149.96 41.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.686 -0.688 . . . . 11.38 111.515 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.79 110.64 15.9 Favored Pre-proline 0 C--N 1.319 -0.723 0 CA-C-N 115.715 -0.675 . . . . 8.29 111.728 -172.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.79 141.95 87.0 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.884 2.389 . . . . 6.87 110.655 172.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -50.14 116.74 2.63 Favored 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.827 2.352 . . . . 5.04 113.297 -174.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.523 ' N ' ' HD2' ' A' ' 57' ' ' PRO . . . -64.62 -50.19 66.31 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.664 -0.244 . . . . 2.59 111.157 176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 56' ' ' ALA . 74.1 Cg_endo -68.26 -177.72 1.51 Allowed 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.366 2.044 . . . . 1.64 112.337 177.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -115.1 142.68 46.32 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 114.723 -1.126 . . . . 3.39 111.082 -173.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.652 ' HB ' ' HB2' ' A' ' 101' ' ' ASN . 10.7 mt -87.01 170.36 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.148 -0.933 . . . . 0.44 111.844 -175.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.611 ' N ' HG22 ' A' ' 59' ' ' ILE . 31.2 mtt85 -66.5 -158.22 0.02 OUTLIER 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 113.462 -1.699 . . . . 2.34 112.218 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.673 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 22.4 t-160 -157.66 148.35 21.05 Favored 'General case' 0 CA--C 1.476 -1.881 0 CA-C-N 112.43 -2.168 . . . . 2.22 106.567 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.732 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 -125.51 162.4 24.99 Favored 'General case' 0 N--CA 1.42 -1.944 0 O-C-N 123.616 0.572 . . . . 0.21 109.914 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.516 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 10.9 t70 -84.05 67.35 9.64 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 123.492 1.615 . . . . 0.35 108.125 170.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.75 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 91.1 m95 -58.96 -43.91 91.38 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 111.678 -2.51 . . . . 0.1 112.437 175.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.514 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 11.8 t-20 -50.56 -28.59 8.93 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 113.879 -1.51 . . . . 1.11 111.415 174.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.08 -17.78 79.81 Favored Glycine 0 C--N 1.312 -0.756 0 CA-C-N 115.341 -0.845 . . . . 0.21 111.215 -179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.414 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.62 -54.31 2.78 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 113.863 -1.168 . . . . 0.13 111.125 -175.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.72 ' SD ' HD23 ' A' ' 109' ' ' LEU . 40.1 mtt -62.59 -59.5 4.85 Favored 'General case' 0 C--O 1.211 -0.945 0 CA-C-N 114.177 -1.374 . . . . 0.09 112.105 -178.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.514 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 6.2 mm-40 -37.33 -55.31 1.86 Allowed Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 115.276 1.584 . . . . 0.63 115.276 -177.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.796 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.3 Cg_endo -65.73 -29.74 50.87 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 121.648 1.565 . . . . 0.14 110.458 -177.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.691 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 13.0 mtm -83.91 -41.43 17.4 Favored 'General case' 0 C--O 1.213 -0.83 0 CA-C-N 115.447 -0.797 . . . . 0.7 111.541 -177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.672 HG23 ' O ' ' A' ' 68' ' ' MET . 58.8 t -55.97 -39.1 55.66 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.038 0 CA-C-N 114.718 -1.128 . . . . 0.12 108.812 171.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.2 t -61.74 -34.35 75.68 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 113.393 -1.73 . . . . 0.56 110.813 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.796 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.2 mtpt -81.67 -33.93 31.0 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.073 -0.512 . . . . 1.3 110.464 178.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.867 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.72 -28.67 69.74 Favored 'General case' 0 N--CA 1.44 -0.959 0 CA-C-N 115.406 -0.815 . . . . 0.5 111.637 -171.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.561 ' N ' ' HG2' ' A' ' 75' ' ' MET . 5.5 mt -92.81 -4.84 52.31 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 122.081 0.943 . . . . 0.65 111.133 -178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.68 15.9 44.65 Favored Glycine 0 N--CA 1.441 -1.022 0 N-CA-C 108.914 -1.674 . . . . 0.17 108.914 170.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.647 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -85.47 165.62 17.0 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 114.386 -0.907 . . . . 0.1 109.869 -179.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -92.97 104.91 17.09 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 115.277 -0.874 . . . . 1.72 110.303 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.654 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.82 -23.72 3.36 Favored Glycine 0 N--CA 1.428 -1.886 0 CA-C-N 115.018 -0.992 . . . . 0.12 110.69 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.867 HG11 ' O ' ' A' ' 75' ' ' MET . 9.9 p -98.76 155.46 3.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.748 0.785 . . . . 0.16 111.444 -174.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 4.8 m -134.54 135.75 42.56 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-N 114.604 -1.18 . . . . 0.45 111.034 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.575 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -60.23 129.31 41.07 Favored 'General case' 0 C--N 1.309 -1.156 0 CA-C-N 115.222 -0.899 . . . . 0.28 109.728 165.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.32 6.0 53.8 Favored Glycine 0 N--CA 1.444 -0.793 0 C-N-CA 120.78 -0.724 . . . . 0.28 112.938 176.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.493 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 65.7 m -98.12 146.93 25.08 Favored 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 120.719 -0.392 . . . . 1.2 110.51 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.692 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -76.8 132.18 33.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 109.029 -0.73 . . . . 0.2 109.029 172.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.811 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 1.6 tm? -119.12 110.01 16.56 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.603 -0.726 . . . . 0.14 109.084 -170.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.756 HD21 HD23 ' A' ' 127' ' ' LEU . 0.7 OUTLIER -71.77 93.99 1.34 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.815 -1.18 . . . . 0.15 107.815 175.991 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.473 HG23 ' CD1' ' A' ' 109' ' ' LEU . 0.2 OUTLIER -73.23 115.29 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.642 0 N-CA-C 107.435 -1.32 . . . . 0.95 107.435 176.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.817 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 12.3 t0 -77.74 170.92 15.76 Favored 'General case' 0 CA--C 1.494 -1.191 0 CA-C-N 114.997 -1.001 . . . . 0.64 109.009 -176.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.584 ' OG ' ' HE3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -62.48 152.92 33.16 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-O 122.42 1.105 . . . . 0.37 108.668 168.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.561 ' HB ' ' HB1' ' A' ' 102' ' ' ALA . 33.9 t -81.64 139.31 18.16 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.067 0 N-CA-C 106.985 -1.487 . . . . 0.1 106.985 166.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.836 ' H ' ' HA ' ' A' ' 164' ' ' SER . 8.0 t-20 -83.65 163.35 20.37 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.922 0.867 . . . . 0.18 110.498 173.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.762 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.2 t-20 -125.71 86.27 2.51 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 114.208 -1.36 . . . . 0.12 108.124 175.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.412 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.6 mtp180 -108.72 -2.03 18.94 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.124 -1.398 . . . . 0.64 108.724 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.741 HG21 ' HB3' ' A' ' 172' ' ' PRO . 27.5 p -52.18 -171.9 0.0 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 112.998 -1.91 . . . . 0.14 115.39 -176.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.517 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 35.4 t30 -69.9 -9.71 55.89 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 112.762 -2.017 . . . . 0.48 110.492 174.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.601 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -153.27 -144.77 3.99 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.519 -0.848 . . . . 0.12 113.123 -176.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.608 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 86.7 p -121.81 129.89 52.98 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-O 121.444 0.64 . . . . 1.16 112.725 -177.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.762 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.4 pp -135.52 156.51 48.78 Favored 'General case' 0 CA--C 1.502 -0.867 0 CA-C-O 121.923 0.868 . . . . 0.1 110.852 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.652 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 1.4 t-20 -80.95 79.44 7.62 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 113.961 -1.472 . . . . 0.17 107.889 175.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.585 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.73 -14.28 62.81 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.433 -1.258 . . . . 0.09 109.96 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.5 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.73 -30.48 36.25 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.555 -0.906 . . . . 0.15 108.555 -177.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.635 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.4 tp10 -66.21 -35.11 79.59 Favored 'General case' 0 N--CA 1.432 -1.362 0 CA-C-N 114.378 -1.283 . . . . 1.73 109.153 170.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.82 -43.86 67.72 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 113.107 -1.861 . . . . 0.12 109.369 179.532 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.657 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 63.0 m -61.77 -31.84 72.07 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-N 113.532 -1.667 . . . . 0.11 110.135 178.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -65.73 -46.77 77.64 Favored 'General case' 0 N--CA 1.434 -1.246 0 N-CA-C 108.843 -0.799 . . . . 1.47 108.843 171.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.69 HG21 ' HB2' ' A' ' 64' ' ' TRP . 50.9 m -60.19 -31.04 69.76 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 115.345 -0.843 . . . . 0.12 110.91 177.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.72 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -51.96 -68.15 0.19 Allowed 'General case' 0 CA--C 1.496 -1.107 0 CA-C-N 115.749 -0.66 . . . . 0.56 110.361 172.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.528 ' O ' HD13 ' A' ' 121' ' ' LEU . 6.1 mpt_? -40.55 -37.36 0.7 Allowed 'General case' 0 C--O 1.213 -0.844 0 O-C-N 124.387 1.054 . . . . 1.51 110.456 175.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.589 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -72.49 -46.8 53.07 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 114.304 -1.316 . . . . 0.28 111.79 -174.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.439 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.21 -33.51 65.41 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 122.069 0.938 . . . . 0.09 108.718 -179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -63.69 -34.62 78.27 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.746 -1.57 . . . . 0.12 109.886 172.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.554 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.99 -40.51 65.17 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.696 -1.138 . . . . 0.2 111.096 -176.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -61.89 -25.53 67.62 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.854 -1.067 . . . . 1.17 110.69 -177.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -92.52 -20.24 21.15 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.003 -0.544 . . . . 2.05 111.467 -176.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 63.9 0.78 4.38 Favored Glycine 0 C--N 1.331 0.295 0 N-CA-C 115.693 1.037 . . . . 0.54 115.693 162.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.575 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 53.0 mtpt -78.84 -33.99 45.52 Favored 'General case' 0 C--O 1.221 -0.446 0 CA-C-N 117.395 0.598 . . . . 0.99 109.812 177.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.811 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 19.0 m-85 -89.44 177.81 6.48 Favored 'General case' 0 CA--C 1.491 -1.317 0 CA-C-O 122.23 1.014 . . . . 0.21 112.298 -179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.485 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.4 m -122.41 119.28 30.56 Favored 'General case' 0 N--CA 1.416 -2.152 0 CA-C-N 113.103 -1.862 . . . . 0.23 108.31 167.162 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.676 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.9 OUTLIER -86.92 145.43 26.55 Favored 'General case' 0 N--CA 1.413 -2.281 0 CA-C-N 115.448 -0.796 . . . . 0.38 111.317 -170.928 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.59 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.9 m -92.74 152.42 3.45 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 CA-C-N 115.364 -0.835 . . . . 0.42 109.175 169.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.463 ' CB ' ' HG2' ' A' ' 125' ' ' GLN . 4.8 m -101.2 163.15 12.42 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-O 122.32 1.057 . . . . 1.7 110.416 176.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.403 ' HA ' ' H ' ' A' ' 128' ' ' SER . . . -67.15 -22.92 65.75 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 113.027 -1.897 . . . . 0.55 110.545 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.643 ' O ' ' HG3' ' A' ' 129' ' ' MET . 4.4 pt20 -53.74 -32.06 50.73 Favored 'General case' 0 C--N 1.322 -0.625 0 O-C-N 125.039 1.462 . . . . 2.04 109.668 170.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.59 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 7.7 mt-30 -98.05 -53.79 3.27 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 114.593 -1.185 . . . . 0.41 110.976 172.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.892 HD21 ' HE2' ' A' ' 131' ' ' LYS . 1.5 tm? -69.49 -64.6 0.85 Allowed 'General case' 0 C--O 1.225 -0.234 0 CA-C-N 114.572 -1.195 . . . . 1.39 113.205 -166.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.673 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.3 t -49.54 -38.39 30.68 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-O 123.645 1.688 . . . . 1.05 109.189 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.667 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 33.7 mmm -64.02 -63.08 1.25 Allowed 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 110.705 -2.952 . . . . 1.64 111.191 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.748 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.26 -43.49 3.46 Favored 'General case' 0 CA--C 1.502 -0.867 0 O-C-N 124.31 1.006 . . . . 0.31 111.442 174.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.892 ' HE2' HD21 ' A' ' 127' ' ' LEU . 3.7 mptp? -48.38 -65.57 0.54 Allowed 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 109.541 -0.541 . . . . 1.53 109.541 174.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 39.1 mt-30 -55.2 -44.61 75.52 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 114.828 -1.078 . . . . 0.41 111.71 178.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.667 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.0 mt-30 -55.67 -36.0 66.62 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 114.745 -1.116 . . . . 0.37 110.022 -177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.511 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.6 OUTLIER -91.18 -31.34 16.23 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 114.118 -1.401 . . . . 0.24 109.285 -176.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.33 -48.32 0.43 Allowed Glycine 0 CA--C 1.496 -1.136 0 C-N-CA 119.801 -1.19 . . . . 0.33 113.632 -178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.665 HD13 ' O ' ' A' ' 141' ' ' SER . 35.4 mt -66.24 -174.2 0.25 Allowed 'General case' 0 C--N 1.294 -1.812 0 CA-C-O 123.923 1.82 . . . . 0.31 115.781 -168.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.534 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.6 m -110.03 148.64 38.7 Favored Pre-proline 0 N--CA 1.421 -1.924 0 CA-C-N 110.791 -2.913 . . . . 0.81 108.33 169.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.673 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 17.9 Cg_endo -61.38 0.4 1.03 Allowed 'Trans proline' 0 C--N 1.333 -0.255 0 C-N-CA 123.163 2.575 . . . . 0.32 112.801 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.5 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.7 tt0 -117.9 -24.11 7.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 122.185 0.993 . . . . 1.25 110.424 -177.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.624 ' O ' ' HB2' ' A' ' 141' ' ' SER . 5.8 t70 -64.61 -22.56 67.0 Favored 'General case' 0 CA--C 1.496 -1.109 0 CA-C-N 113.213 -1.812 . . . . 0.65 109.719 -174.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.665 ' O ' HD13 ' A' ' 136' ' ' LEU . 2.0 m 74.83 173.24 0.27 Allowed 'General case' 0 N--CA 1.432 -1.358 0 O-C-N 125.322 1.639 . . . . 0.6 109.652 -173.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.085 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.3 mt -64.72 -38.85 92.38 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.281 -1.007 . . . . 0.86 108.281 -176.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.38 -11.82 1.48 Allowed Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 113.327 -1.76 . . . . 0.31 114.417 176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.413 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 0.8 OUTLIER -157.19 130.22 7.73 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 118.672 -0.68 . . . . 0.24 109.276 -178.036 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.63 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.1 mmt85 -43.29 -48.68 6.8 Favored 'General case' 0 C--O 1.211 -0.933 0 CA-C-N 118.008 0.367 . . . . 1.65 111.554 -179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 16.6 t -72.13 -24.93 61.54 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.531 0.681 . . . . 0.53 111.202 -174.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.413 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 25.3 mttm -74.6 -30.68 61.76 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-O 122.66 1.219 . . . . 1.31 108.773 175.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 1.085 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -74.82 -46.2 38.2 Favored 'General case' 0 CA--C 1.485 -1.544 0 CA-C-N 112.411 -2.177 . . . . 0.12 110.236 178.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.639 HG13 ' HE1' ' A' ' 179' ' ' MET . 38.8 mt -67.53 -41.96 86.4 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.882 0 CA-C-N 112.633 -2.076 . . . . 0.11 109.821 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.48 -53.85 30.06 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.71 -1.132 . . . . 0.15 111.012 171.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.748 HG23 ' CB ' ' A' ' 130' ' ' ALA . 76.2 mt -66.96 -47.85 81.18 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.043 0 N-CA-C 112.641 0.608 . . . . 0.18 112.641 -178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.672 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.29 -39.95 73.53 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 120.984 0.421 . . . . 0.13 111.02 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.536 ' HD2' HG23 ' A' ' 149' ' ' ILE . 45.5 mtp180 -82.59 -21.8 35.05 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 121.827 0.822 . . . . 1.08 110.343 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.416 HD21 ' CD ' ' A' ' 133' ' ' GLN . 14.7 t30 -82.82 -11.27 58.38 Favored 'General case' 0 CA--C 1.507 -0.694 0 N-CA-C 107.267 -1.382 . . . . 0.5 107.267 176.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.721 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.15 -29.66 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.24 0 CA-C-N 113.143 -1.844 . . . . 0.17 111.111 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.23 35.88 4.32 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.414 -0.898 . . . . 0.16 112.767 -178.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.637 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.19 157.98 19.45 Favored 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 113.192 0.812 . . . . 0.12 113.192 -170.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.692 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.9 m80 -97.32 -25.97 15.06 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 115.27 -0.877 . . . . 0.2 109.861 176.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.653 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 15.4 m-85 -136.12 -178.32 5.1 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-N 115.312 -0.858 . . . . 0.13 111.584 -174.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.673 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -133.37 141.53 44.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 115.1 -0.955 . . . . 0.08 109.202 167.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.457 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 46.7 tp -111.43 102.26 10.64 Favored 'General case' 0 N--CA 1.43 -1.464 0 C-N-CA 119.628 -0.829 . . . . 0.16 109.255 164.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.681 ' CE1' HD12 ' A' ' 142' ' ' LEU . 1.8 m-85 -80.21 112.64 17.72 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.241 -1.345 . . . . 0.26 109.198 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.692 ' OG ' HD11 ' A' ' 109' ' ' LEU . 3.8 p -119.15 158.12 26.57 Favored 'General case' 0 C--N 1.281 -2.388 0 CA-C-O 121.959 0.885 . . . . 1.05 111.489 -176.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.836 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.4 p -164.22 171.64 14.69 Favored 'General case' 0 CA--C 1.484 -1.593 0 CA-C-N 114.251 -1.341 . . . . 0.1 111.255 179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.14 134.91 33.49 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-N 114.118 -1.401 . . . . 0.11 108.658 178.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.9 m -144.74 -173.79 4.16 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 109.295 -0.631 . . . . 1.09 109.295 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.54 -82.43 0.94 Allowed Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.616 -1.278 . . . . 0.15 111.279 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.517 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 59.8 t30 -145.78 129.16 16.86 Favored 'General case' 0 C--O 1.195 -1.772 0 N-CA-C 107.653 -1.24 . . . . 0.59 107.653 176.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.601 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.3 p -65.03 -42.51 94.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 CA-C-N 115.447 -0.797 . . . . 0.15 112.552 -171.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.424 ' N ' HG13 ' A' ' 169' ' ' VAL . 7.4 m120 -60.66 -30.28 69.8 Favored 'General case' 0 CA--C 1.508 -0.668 0 CA-C-O 121.784 0.802 . . . . 1.26 110.087 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.01 89.26 3.41 Favored Pre-proline 0 C--N 1.305 -1.349 0 CA-C-N 113.645 -1.616 . . . . 0.13 108.557 178.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.817 ' HD2' HG22 ' A' ' 194' ' ' VAL . 43.1 Cg_endo -91.85 165.53 3.27 Favored 'Trans proline' 0 CA--C 1.496 -1.402 0 C-N-CA 124.678 3.586 . . . . 0.09 115.301 -170.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.5 m -84.11 116.96 23.15 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 113.88 -1.509 . . . . 0.14 107.83 166.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.813 HD12 ' O ' ' A' ' 164' ' ' SER . 43.9 tp -84.22 98.12 9.78 Favored 'General case' 0 N--CA 1.415 -2.184 0 CA-C-O 121.988 0.899 . . . . 0.16 109.25 177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.635 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 35.4 mt-30 -87.11 108.32 18.84 Favored 'General case' 0 C--N 1.274 -2.701 0 CA-C-N 114.586 -1.188 . . . . 0.34 108.925 -178.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.554 ' HG3' ' HG ' ' A' ' 174' ' ' LEU . 76.6 mtp -107.29 162.63 13.72 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.827 -1.079 . . . . 1.09 110.357 -176.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.592 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.4 tt0 -169.71 119.54 0.65 Allowed 'General case' 0 C--O 1.202 -1.411 0 CA-C-O 121.309 0.576 . . . . 0.5 109.904 -169.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.124 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.11 101.98 12.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 109.001 -0.74 . . . . 0.1 109.001 -172.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.639 ' HE1' HG13 ' A' ' 149' ' ' ILE . 12.7 ttp -92.47 121.98 34.46 Favored 'General case' 0 N--CA 1.439 -1.019 0 CA-C-N 115.557 -0.747 . . . . 0.07 109.407 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -57.3 128.44 37.0 Favored 'General case' 0 N--CA 1.427 -1.592 0 N-CA-C 107.285 -1.376 . . . . 0.22 107.285 166.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.625 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -84.66 -34.09 9.02 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.967 0 C-N-CA 119.096 -1.042 . . . . 0.11 110.738 178.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.467 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 27.3 mt-30 -61.2 -16.31 43.47 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.371 -0.832 . . . . 0.35 111.388 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 82.7 p -130.53 -37.49 1.38 Allowed 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.505 0.669 . . . . 0.19 110.247 178.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.516 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.95 24.59 27.0 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-N 114.641 -1.163 . . . . 0.18 112.479 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.427 ' O ' ' HA ' ' A' ' 179' ' ' MET . 10.4 pt-20 -103.81 157.78 16.84 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.654 -0.273 . . . . 0.73 110.863 -178.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.592 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.3 mm -93.04 114.19 29.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.574 0.702 . . . . 0.14 109.375 177.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.124 HD11 HD13 ' A' ' 178' ' ' LEU . 1.3 pp -102.38 -30.75 2.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.996 -1.002 . . . . 0.13 110.816 -174.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.647 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.3 t90 -135.43 152.11 51.07 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-N 115.274 -0.876 . . . . 0.07 109.547 173.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 61.9 p -153.71 164.21 38.7 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 112.915 0.709 . . . . 0.13 112.915 163.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.18 -178.69 32.44 Favored Glycine 0 N--CA 1.429 -1.793 0 N-CA-C 110.927 -0.869 . . . . 0.12 110.927 179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.734 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 12.0 mtmt -157.05 148.02 21.76 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 106.207 -1.775 . . . . 1.22 106.207 166.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.691 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -159.29 127.51 1.85 Allowed Glycine 0 C--N 1.28 -2.529 0 C-N-CA 119.769 -1.205 . . . . 0.12 112.343 -178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.82 114.79 11.35 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.659 0.742 . . . . 0.17 111.108 -174.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.817 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -90.6 158.96 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.485 0 CA-C-O 122.718 1.247 . . . . 0.11 110.476 -177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.732 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -101.43 172.08 7.19 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 112.399 -2.182 . . . . 0.18 108.445 -175.014 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.609 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.3 tt0 -101.26 135.79 42.15 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 120.201 -0.6 . . . . 0.91 109.633 172.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.566 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 23.0 mt-30 . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.424 -0.798 . . . . 1.24 110.927 177.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.809 0 N-CA-C 111.933 -0.467 . . . . 88.61 111.933 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.1 m 57.11 61.8 2.44 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.475 0.655 . . . . 87.43 111.258 178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.9 m80 56.08 62.71 2.26 Favored 'General case' 0 CA--C 1.521 -0.155 0 CA-C-N 114.566 -1.197 . . . . 87.16 110.572 -177.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.503 ' O ' HG12 ' A' ' 5' ' ' VAL . 16.9 tpt -58.06 142.42 46.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.564 -0.289 . . . . 85.34 111.136 -175.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 4' ' ' MET . 0.3 OUTLIER 59.83 0.56 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.481 1.112 . . . . 85.05 113.111 179.049 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.07 20.01 51.19 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.851 -0.69 . . . . 84.68 111.903 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 64.25 -166.6 0.22 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 122.797 0.439 . . . . 85.57 111.074 179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 59.3 66.29 1.05 Allowed 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.376 0.608 . . . . 85.04 111.058 178.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.487 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 18.6 mm-40 -62.66 -42.91 81.85 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.051 -0.977 . . . . 82.17 111.373 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 9' ' ' GLU . 43.7 Cg_endo -71.64 122.01 8.19 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.198 1.265 . . . . 81.51 110.964 167.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 12' ' ' PRO . . . -153.18 -60.16 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.726 -0.39 . . . . 79.56 111.927 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.513 ' HD3' ' HB3' ' A' ' 11' ' ' ALA . 73.7 Cg_endo -74.75 150.54 39.6 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 121.284 1.322 . . . . 78.5 112.196 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 28.0 m -78.6 153.82 4.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.862 0.363 . . . . 77.0 110.227 174.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -82.83 74.1 9.81 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.155 -0.683 . . . . 75.74 109.155 177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -60.44 140.83 57.05 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.383 -0.826 . . . . 73.91 110.978 -176.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 11.8 p -74.47 149.42 7.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.687 -0.688 . . . . 72.3 110.61 179.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -60.95 103.4 0.37 Allowed Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.675 -0.693 . . . . 71.22 109.772 174.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -85.87 137.24 5.46 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.702 2.268 . . . . 69.67 113.605 -169.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.07 127.92 19.33 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 115.687 -0.688 . . . . 67.55 109.708 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -70.38 140.18 39.76 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.262 1.975 . . . . 66.7 112.166 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -85.05 -164.55 1.01 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.254 -0.43 . . . . 65.01 110.588 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 49.33 73.23 1.03 Allowed Pre-proline 0 C--O 1.236 0.366 0 N-CA-C 113.029 0.751 . . . . 63.41 113.029 169.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -66.09 162.87 33.72 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 123.053 2.502 . . . . 61.93 111.089 173.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.488 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . -68.45 85.61 0.28 Allowed 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.001 0.429 . . . . 59.87 110.327 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -114.59 88.39 16.03 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 115.414 -0.812 . . . . 58.47 110.796 -174.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 24' ' ' ALA . 9.7 Cg_endo -91.13 -172.43 0.48 Allowed 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.849 2.366 . . . . 57.36 112.497 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -134.09 22.74 3.82 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.586 0.708 . . . . 55.51 110.008 175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.586 ' HA ' HE21 ' A' ' 28' ' ' GLN . 0.0 OUTLIER -154.97 120.93 2.66 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.411 -0.813 . . . . 53.87 109.974 -179.204 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -73.81 -145.9 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.577 2.185 . . . . 52.76 110.924 172.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.48 111.46 5.18 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 120.743 0.306 . . . . 50.93 110.352 176.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -82.51 72.73 5.9 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.881 2.387 . . . . 49.21 112.38 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.0 p -133.6 152.38 51.88 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.05 -0.523 . . . . 47.49 110.985 -179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.3 t -115.06 85.5 12.32 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 115.878 -0.601 . . . . 45.97 109.743 176.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -60.39 162.14 18.34 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.989 2.459 . . . . 45.28 113.334 -179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.8 p -94.57 151.88 18.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.219 -0.901 . . . . 42.79 110.654 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 43.1 t -76.24 115.71 49.51 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.516 -0.766 . . . . 40.79 109.909 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 3.6 Cg_exo -73.09 -33.76 7.08 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 122.338 2.025 . . . . 39.81 112.695 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.7 t -75.42 140.8 43.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.403 0.62 . . . . 37.5 110.9 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.9 mt -105.94 130.78 22.46 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.532 -0.758 . . . . 35.65 109.922 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.88 64.96 6.84 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.457 2.105 . . . . 33.72 111.82 178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 -67.59 -46.9 71.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.245 -0.434 . . . . 31.51 110.67 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 61.53 84.91 0.19 Allowed Pre-proline 0 C--O 1.237 0.405 0 CA-C-N 115.987 -0.551 . . . . 30.13 110.527 -177.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.47 133.38 25.94 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 123.016 2.477 . . . . 29.52 111.781 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -142.56 174.08 23.61 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.939 -0.648 . . . . 26.75 111.931 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -68.22 136.11 36.43 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 123.113 2.542 . . . . 25.08 112.284 -178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.2 mt -90.04 -70.31 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.293 -0.412 . . . . 23.9 110.13 178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 54.35 86.96 0.05 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.569 -0.741 . . . . 21.23 112.598 176.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.6 p-80 -94.68 173.27 7.69 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.411 -0.516 . . . . 19.92 110.172 173.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -138.97 177.31 7.98 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 115.853 -0.612 . . . . 16.56 110.731 176.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -123.18 32.49 5.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.806 0.812 . . . . 15.05 110.96 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 64.55 -171.35 0.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 113.788 -1.551 . . . . 14.19 110.715 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.585 ' O ' ' HD3' ' A' ' 54' ' ' PRO . 27.0 p -136.53 153.01 51.12 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.172 -0.467 . . . . 11.38 110.025 174.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.462 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -112.32 89.47 12.41 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.761 -0.654 . . . . 8.29 111.356 -175.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.585 ' HD3' ' O ' ' A' ' 52' ' ' THR . 55.3 Cg_endo -103.06 89.79 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.935 0 C-N-CA 124.079 3.186 . . . . 6.87 112.373 177.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 83.9 Cg_endo -85.9 -154.88 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.702 2.268 . . . . 5.04 111.198 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -52.75 112.56 3.59 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.873 0.368 . . . . 2.59 110.447 177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -75.33 -176.48 2.95 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.209 2.606 . . . . 1.64 113.496 -173.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 35.4 p-80 -122.11 146.7 46.96 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 113.906 -1.497 . . . . 3.39 108.668 178.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.612 HG22 ' N ' ' A' ' 60' ' ' ARG . 11.7 mt -81.0 165.51 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 CA-C-O 121.77 0.795 . . . . 0.44 111.673 -174.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.612 ' N ' HG22 ' A' ' 59' ' ' ILE . 50.9 mtt-85 -74.6 -155.95 0.05 OUTLIER 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.736 -1.575 . . . . 2.34 112.187 -178.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.638 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 18.2 t-160 -157.63 147.46 20.33 Favored 'General case' 0 CA--C 1.473 -2.002 0 CA-C-N 111.887 -2.415 . . . . 2.22 106.174 179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.758 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.4 m-30 -125.46 160.86 28.42 Favored 'General case' 0 N--CA 1.42 -1.931 0 O-C-N 123.812 0.695 . . . . 0.21 109.73 -176.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.507 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 1.7 t70 -80.68 67.92 6.72 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 123.593 1.663 . . . . 0.35 107.95 171.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.71 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 90.9 m95 -59.51 -44.5 93.12 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 111.643 -2.526 . . . . 0.1 112.497 175.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.526 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 10.3 t-20 -51.92 -28.99 18.24 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.055 -1.43 . . . . 1.11 111.281 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.19 -16.91 80.35 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.326 -0.852 . . . . 0.21 111.144 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.468 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.31 -52.78 3.17 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 114.109 -1.046 . . . . 0.13 111.008 -176.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.676 ' SD ' HD23 ' A' ' 109' ' ' LEU . 43.3 mtt -62.36 -60.32 3.73 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 114.213 -1.358 . . . . 0.09 112.179 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.526 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 6.2 mm-40 -38.76 -53.19 3.47 Favored Pre-proline 0 C--O 1.225 -0.211 0 N-CA-C 115.554 1.687 . . . . 0.63 115.554 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 49.8 Cg_endo -66.98 -25.91 44.14 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 121.784 1.656 . . . . 0.14 110.746 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.632 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 12.4 mtm -88.05 -43.26 11.84 Favored 'General case' 0 C--O 1.22 -0.465 0 CA-C-N 114.956 -1.02 . . . . 0.7 111.978 -177.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 68' ' ' MET . 65.6 t -53.63 -40.43 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.185 0 CA-C-N 114.439 -1.255 . . . . 0.12 108.71 172.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.4 t -57.29 -39.6 76.05 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 113.005 -1.907 . . . . 0.56 110.954 174.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 25.4 mtmt -77.49 -31.79 53.86 Favored 'General case' 0 CA--C 1.51 -0.572 0 N-CA-C 112.024 0.379 . . . . 1.3 112.024 177.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.871 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -65.26 -26.68 68.2 Favored 'General case' 0 N--CA 1.439 -1.012 0 CA-C-N 115.545 -0.752 . . . . 0.5 111.559 -169.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.771 HD13 ' HB2' ' A' ' 118' ' ' LYS . 4.6 mt -94.48 -5.52 45.96 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-O 122.052 0.93 . . . . 0.65 111.157 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.43 15.18 50.33 Favored Glycine 0 N--CA 1.438 -1.185 0 N-CA-C 109.004 -1.638 . . . . 0.17 109.004 170.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.63 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.74 165.54 17.74 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.426 -0.887 . . . . 0.1 110.235 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -91.4 103.33 15.97 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-N 115.06 -0.973 . . . . 1.72 110.601 177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.628 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.96 -21.97 3.48 Favored Glycine 0 N--CA 1.43 -1.749 0 N-CA-C 110.56 -1.016 . . . . 0.12 110.56 -178.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.871 HG11 ' O ' ' A' ' 75' ' ' MET . 11.9 p -101.36 152.19 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-O 121.746 0.784 . . . . 0.16 110.993 -176.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.3 m -135.93 141.0 44.45 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-N 114.724 -1.125 . . . . 0.45 110.653 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.727 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -57.2 129.46 41.87 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.122 -0.944 . . . . 0.28 110.838 168.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 104.52 14.16 24.41 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 121.101 -0.571 . . . . 0.28 112.943 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.21 152.42 18.86 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.515 -0.474 . . . . 1.2 110.941 178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.7 p -81.32 115.2 23.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 CA-C-O 121.981 0.896 . . . . 0.2 109.081 166.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.704 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -102.77 109.11 20.58 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 115.236 -0.893 . . . . 0.14 109.099 -172.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.687 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.8 OUTLIER -71.61 96.38 1.55 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.21 -1.359 . . . . 0.15 108.318 176.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.515 HG12 ' CD1' ' A' ' 87' ' ' LEU . 1.0 OUTLIER -71.8 121.16 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.059 0 N-CA-C 106.852 -1.536 . . . . 0.95 106.852 177.459 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.816 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 9.5 t0 -77.54 156.5 30.91 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 107.268 -1.382 . . . . 0.64 107.268 177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.534 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.57 138.04 57.83 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.061 -1.459 . . . . 0.37 107.061 171.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.543 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.8 t -64.49 137.8 24.24 Favored 'Isoleucine or valine' 0 N--CA 1.398 -3.073 0 N-CA-C 107.658 -1.238 . . . . 0.1 107.658 168.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.781 ' H ' ' HA ' ' A' ' 164' ' ' SER . 5.1 t-20 -83.97 161.33 20.81 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 115.234 -0.894 . . . . 0.18 109.614 175.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.77 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 1.9 t-20 -124.52 85.13 2.37 Favored 'General case' 0 C--N 1.291 -1.96 0 CA-C-N 114.675 -1.148 . . . . 0.12 108.083 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.543 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 10.8 mtp180 -108.6 -1.96 19.17 Favored 'General case' 0 CA--C 1.505 -0.782 0 CA-C-N 113.756 -1.565 . . . . 0.64 108.502 -172.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.729 HG21 ' HB3' ' A' ' 172' ' ' PRO . 18.1 p -52.94 -172.77 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 113.044 -1.889 . . . . 0.14 115.074 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 167' ' ' GLY . 58.8 t30 -71.59 -5.19 31.59 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 112.643 -2.072 . . . . 0.48 110.828 174.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.596 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -156.38 -143.95 3.8 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.671 -0.776 . . . . 0.12 112.807 -178.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.548 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 55.6 p -122.19 130.56 53.32 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 112.178 0.436 . . . . 1.16 112.178 -177.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.77 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.2 pp -136.22 157.37 46.98 Favored 'General case' 0 CA--C 1.504 -0.827 0 CA-C-O 121.858 0.837 . . . . 0.1 110.863 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.15 79.44 7.81 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 113.85 -1.523 . . . . 0.17 107.631 176.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.33 -14.07 62.73 Favored 'General case' 0 C--N 1.289 -2.031 0 CA-C-N 114.511 -1.222 . . . . 0.09 109.915 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.549 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.66 -32.74 41.6 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 108.672 -0.862 . . . . 0.15 108.672 -178.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.9 tp10 -65.94 -33.27 75.45 Favored 'General case' 0 N--CA 1.433 -1.301 0 CA-C-O 122.767 1.27 . . . . 1.73 108.943 171.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.46 -43.92 63.06 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 113.078 -1.874 . . . . 0.12 109.5 179.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.629 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 67.1 m -64.01 -31.43 72.61 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 114.115 -1.402 . . . . 0.11 110.476 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -42.69 81.2 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 107.895 -1.15 . . . . 1.47 107.895 172.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.677 HG21 ' HB2' ' A' ' 64' ' ' TRP . 30.1 m -63.34 -31.36 72.49 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.994 -1.003 . . . . 0.12 110.816 178.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.702 ' O ' HD23 ' A' ' 113' ' ' LEU . 9.4 mt -50.88 -69.83 0.1 Allowed 'General case' 0 CA--C 1.495 -1.15 0 CA-C-N 115.691 -0.686 . . . . 0.56 109.518 171.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.542 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.2 mtp180 -40.71 -39.4 1.08 Allowed 'General case' 0 C--N 1.314 -0.942 0 O-C-N 124.539 1.15 . . . . 1.51 111.122 175.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.532 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -69.7 -45.43 68.27 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.604 -1.18 . . . . 0.28 111.948 -176.154 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.499 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.95 -32.91 63.69 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.289 1.043 . . . . 0.09 108.605 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -65.71 -32.1 73.46 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 113.608 -1.633 . . . . 0.12 110.26 174.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.592 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -73.58 -40.68 63.7 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 114.671 -1.149 . . . . 0.2 111.489 -174.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -59.92 -27.96 67.2 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.562 -1.199 . . . . 1.17 110.755 -177.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -82.16 -35.51 28.32 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 114.54 -1.209 . . . . 2.05 110.554 -174.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.28 0.64 30.6 Favored Glycine 0 CA--C 1.526 0.743 0 N-CA-C 114.626 0.61 . . . . 0.54 114.626 175.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.771 ' HB2' HD13 ' A' ' 76' ' ' LEU . 58.5 mtpt -86.92 -8.12 57.55 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 121.935 -0.744 . . . . 0.99 110.814 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.73 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 29.5 m-85 -119.09 175.37 5.81 Favored 'General case' 0 CA--C 1.5 -0.954 0 CA-C-O 122.159 0.98 . . . . 0.21 112.497 171.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.512 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.5 m -119.7 123.73 44.52 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 112.987 -1.915 . . . . 0.23 107.862 169.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.604 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -93.02 138.47 31.46 Favored 'General case' 0 N--CA 1.418 -2.051 0 C-N-CA 119.43 -0.908 . . . . 0.38 111.651 -170.158 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.806 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.7 m -92.11 146.83 5.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.629 0 N-CA-C 107.333 -1.358 . . . . 0.42 107.333 169.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.437 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 9.5 t -101.31 -174.23 2.55 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 119.712 -0.795 . . . . 1.7 110.18 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.492 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -66.29 -24.77 66.61 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 107.909 -1.145 . . . . 0.55 107.909 175.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.577 ' O ' ' HG3' ' A' ' 129' ' ' MET . 14.6 mt-30 -51.27 -40.05 58.06 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 113.219 -1.81 . . . . 2.04 110.51 179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.806 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 6.3 mt-30 -98.14 -52.46 3.68 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-O 122.066 0.936 . . . . 0.41 110.094 173.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.612 HD13 HD21 ' A' ' 88' ' ' LEU . 30.8 tp -61.13 -63.7 1.2 Allowed 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 113.302 -1.772 . . . . 1.39 113.34 -168.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.667 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 4.3 t -49.97 -46.1 52.16 Favored 'General case' 0 CA--C 1.498 -1.043 0 CA-C-O 123.336 1.541 . . . . 1.05 109.289 -177.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.716 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 52.0 mmm -55.4 -61.66 2.19 Favored 'General case' 0 N--CA 1.434 -1.266 0 CA-C-N 111.125 -2.761 . . . . 1.64 110.64 175.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.769 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.79 -45.57 10.12 Favored 'General case' 0 CA--C 1.506 -0.741 0 O-C-N 124.382 1.051 . . . . 0.31 112.472 176.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.552 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -55.14 -51.36 66.71 Favored 'General case' 0 C--O 1.213 -0.836 0 N-CA-C 107.963 -1.125 . . . . 1.53 107.963 179.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 128' ' ' SER . 40.2 mt-30 -64.56 -40.87 96.36 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.047 -0.979 . . . . 0.41 111.325 -179.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.716 ' HG3' ' O ' ' A' ' 129' ' ' MET . 49.5 mt-30 -58.3 -34.21 70.3 Favored 'General case' 0 CA--C 1.487 -1.444 0 CA-C-N 114.429 -1.26 . . . . 0.37 109.383 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.514 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -91.14 -26.92 18.86 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.764 -1.562 . . . . 0.24 109.381 -177.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 150.44 -52.05 0.52 Allowed Glycine 0 CA--C 1.497 -1.041 0 CA-C-O 122.677 1.154 . . . . 0.33 113.039 -179.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.62 HD13 ' O ' ' A' ' 141' ' ' SER . 77.7 mt -62.65 -171.15 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.824 0 CA-C-N 111.761 -2.22 . . . . 0.31 116.046 -171.051 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.596 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.5 m -117.21 153.21 49.8 Favored Pre-proline 0 N--CA 1.428 -1.551 0 CA-C-N 110.929 -2.851 . . . . 0.81 108.307 177.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.667 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 24.5 Cg_endo -63.14 -2.07 3.48 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 123.026 2.484 . . . . 0.32 112.676 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.549 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.6 tt0 -118.15 -27.67 6.02 Favored 'General case' 0 CA--C 1.507 -0.703 0 CA-C-O 121.781 0.8 . . . . 1.25 110.463 -177.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.596 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.2 t70 -60.54 -23.83 64.89 Favored 'General case' 0 CA--C 1.487 -1.442 0 CA-C-N 113.604 -1.635 . . . . 0.65 109.483 -174.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.62 ' O ' HD13 ' A' ' 136' ' ' LEU . 17.8 m 74.8 169.49 0.29 Allowed 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 112.785 -2.007 . . . . 0.6 110.455 -178.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.831 HD22 ' HA ' ' A' ' 148' ' ' ALA . 6.7 mt -64.4 -40.25 95.42 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-O 122.336 1.065 . . . . 0.86 108.477 -177.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 64.49 -11.13 0.25 Allowed Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 112.978 -1.919 . . . . 0.31 114.666 177.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.406 ' H ' ' C ' ' A' ' 142' ' ' LEU . 1.5 m -152.86 125.53 8.3 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.081 -0.711 . . . . 0.24 109.081 -176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.735 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 12.3 mmt180 -41.66 -45.95 3.57 Favored 'General case' 0 C--O 1.213 -0.84 0 O-C-N 123.279 0.362 . . . . 1.65 111.792 -179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 45.9 t -73.43 -25.59 60.58 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.628 0.728 . . . . 0.53 111.505 -174.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.423 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 29.7 mttm -75.0 -32.05 61.55 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 122.744 1.259 . . . . 1.31 108.684 175.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.831 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -71.32 -46.99 59.33 Favored 'General case' 0 CA--C 1.485 -1.555 0 CA-C-N 112.217 -2.265 . . . . 0.12 110.044 177.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.622 HG13 ' HE1' ' A' ' 179' ' ' MET . 38.2 mt -67.07 -40.86 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.015 0 CA-C-N 112.678 -2.056 . . . . 0.11 109.839 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.08 -56.3 19.68 Favored Glycine 0 N--CA 1.438 -1.214 0 CA-C-N 114.737 -1.119 . . . . 0.15 111.129 171.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.769 HG23 ' CB ' ' A' ' 130' ' ' ALA . 85.3 mt -65.43 -47.98 84.78 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.055 0 N-CA-C 112.733 0.642 . . . . 0.18 112.733 -178.05 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.684 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.23 -40.49 74.19 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-O 120.845 0.355 . . . . 0.13 111.14 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.518 ' HD2' HG23 ' A' ' 149' ' ' ILE . 61.6 mtp180 -81.92 -21.75 37.16 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 121.695 0.759 . . . . 1.08 110.533 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.481 HD21 ' CD ' ' A' ' 133' ' ' GLN . 17.8 t30 -84.06 -11.12 57.22 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.323 -1.362 . . . . 0.5 107.323 176.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.719 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -107.08 -29.11 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 113.143 -1.844 . . . . 0.17 110.917 -175.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.59 34.2 5.34 Favored Glycine 0 CA--C 1.504 -0.602 0 C-N-CA 120.403 -0.904 . . . . 0.16 112.553 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.687 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -107.34 161.83 14.45 Favored 'General case' 0 C--N 1.313 -0.989 0 N-CA-C 112.637 0.606 . . . . 0.12 112.637 -170.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.67 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.2 m80 -99.82 -28.16 13.27 Favored 'General case' 0 CA--C 1.512 -0.508 0 CA-C-N 115.561 -0.745 . . . . 0.2 109.586 178.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.573 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.7 m-85 -136.67 -172.9 3.28 Favored 'General case' 0 CA--C 1.514 -0.41 0 CA-C-N 115.223 -0.899 . . . . 0.13 111.141 -174.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.678 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -137.44 139.74 43.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.835 -1.075 . . . . 0.08 108.645 166.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.537 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 29.4 tp -108.35 100.56 9.84 Favored 'General case' 0 N--CA 1.433 -1.305 0 C-N-CA 119.584 -0.846 . . . . 0.16 109.329 165.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.665 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.1 m-85 -79.25 112.56 16.59 Favored 'General case' 0 C--N 1.308 -1.216 0 CA-C-N 114.831 -1.077 . . . . 0.26 108.723 178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.727 ' OG ' HD11 ' A' ' 174' ' ' LEU . 23.3 t -124.86 159.75 30.37 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-O 121.828 0.823 . . . . 1.05 110.052 -176.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.826 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.5 p -163.75 173.03 13.34 Favored 'General case' 0 N--CA 1.421 -1.9 0 CA-C-N 114.505 -1.225 . . . . 0.1 111.154 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.73 134.33 37.03 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 114.071 -1.422 . . . . 0.11 108.477 177.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -143.9 -176.72 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 109.373 -0.602 . . . . 1.09 109.373 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 95.16 -82.68 0.88 Allowed Glycine 0 N--CA 1.435 -1.394 0 C-N-CA 119.389 -1.386 . . . . 0.15 111.856 172.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.44 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.4 t30 -143.07 123.82 14.18 Favored 'General case' 0 C--O 1.195 -1.782 0 N-CA-C 107.125 -1.435 . . . . 0.59 107.125 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.596 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.1 p -63.04 -44.59 99.68 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 N-CA-C 112.944 0.72 . . . . 0.15 112.944 -172.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.44 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.1 m120 -61.28 -27.93 68.82 Favored 'General case' 0 CA--C 1.513 -0.469 0 CA-C-N 118.59 0.632 . . . . 1.26 109.891 -177.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.4 88.74 3.35 Favored Pre-proline 0 C--N 1.313 -0.983 0 CA-C-N 114.855 -1.066 . . . . 0.13 108.436 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.816 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.8 Cg_endo -91.48 166.37 3.47 Favored 'Trans proline' 0 CA--C 1.492 -1.585 0 C-N-CA 124.996 3.797 . . . . 0.09 115.183 -169.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.601 HG22 ' HB3' ' A' ' 191' ' ' LYS . 12.7 m -84.58 117.35 23.67 Favored 'General case' 0 N--CA 1.42 -1.943 0 CA-C-N 113.689 -1.596 . . . . 0.14 107.672 167.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 164' ' ' SER . 48.2 tp -84.39 98.19 9.9 Favored 'General case' 0 N--CA 1.412 -2.326 0 C-N-CA 119.589 -0.844 . . . . 0.16 109.183 177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.664 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.8 mt-30 -88.06 107.87 18.96 Favored 'General case' 0 C--N 1.273 -2.738 0 CA-C-N 114.665 -1.152 . . . . 0.34 109.092 -177.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 36.0 mtp -108.15 162.06 14.41 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 115.012 -0.995 . . . . 1.09 110.266 -177.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.595 ' HG2' HD12 ' A' ' 186' ' ' ILE . 55.5 tt0 -169.72 117.59 0.6 Allowed 'General case' 0 C--O 1.205 -1.275 0 CA-C-O 121.308 0.575 . . . . 0.5 109.927 -168.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.04 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -99.84 101.41 12.53 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 108.695 -0.854 . . . . 0.1 108.695 -170.972 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.735 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 16.9 ttp -91.39 122.63 34.16 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-N 115.373 -0.83 . . . . 0.07 109.625 176.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.434 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -59.14 127.57 32.83 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.201 -1.407 . . . . 0.22 107.201 166.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -82.18 -34.95 12.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 C-N-CA 119.065 -1.054 . . . . 0.11 110.865 178.529 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.437 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.4 mt-30 -62.54 -14.43 42.04 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.446 -0.797 . . . . 0.35 111.592 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 79.3 p -130.65 -36.41 1.41 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.862 0.839 . . . . 0.19 110.416 177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.541 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 87.9 27.6 25.92 Favored Glycine 0 N--CA 1.436 -1.328 0 CA-C-N 114.397 -1.274 . . . . 0.18 112.313 -179.155 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -106.77 155.93 19.19 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.624 -0.288 . . . . 0.73 110.624 179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.595 HD12 ' HG2' ' A' ' 177' ' ' GLN . 33.1 mm -89.01 120.09 37.13 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.665 0.745 . . . . 0.14 109.375 177.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.04 HD11 HD13 ' A' ' 178' ' ' LEU . 1.3 pp -108.18 -30.33 2.5 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 CA-C-N 114.904 -1.043 . . . . 0.13 110.422 -173.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.63 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 81.2 t90 -136.96 152.89 50.69 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.177 -0.92 . . . . 0.07 109.385 172.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.499 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 62.1 p -153.53 164.49 38.14 Favored 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 112.938 0.718 . . . . 0.13 112.938 164.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.71 179.84 35.01 Favored Glycine 0 N--CA 1.424 -2.123 0 N-CA-C 110.671 -0.971 . . . . 0.12 110.671 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.6 mtmt -156.91 147.45 21.44 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.181 -1.785 . . . . 1.22 106.181 168.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.632 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -157.64 127.38 1.9 Allowed Glycine 0 C--N 1.283 -2.399 0 C-N-CA 119.674 -1.25 . . . . 0.12 112.43 -178.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.582 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.65 110.96 9.37 Favored 'General case' 0 C--N 1.296 -1.74 0 CA-C-O 121.787 0.803 . . . . 0.17 111.503 -173.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.816 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -88.53 159.5 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.405 0 CA-C-O 122.797 1.284 . . . . 0.11 110.9 -175.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.758 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -99.73 173.03 6.9 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 112.254 -2.248 . . . . 0.18 108.895 -174.543 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.565 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.3 tt0 -104.34 133.52 49.1 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.936 -0.705 . . . . 0.91 110.107 173.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.553 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 14.4 mm-40 . . . . . 0 C--N 1.313 -1.004 0 CA-C-O 118.551 -0.737 . . . . 1.24 110.617 176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.716 0 N-CA-C 111.851 -0.499 . . . . 88.61 111.851 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 21.9 m -140.97 160.58 39.78 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.575 0.226 . . . . 87.43 110.804 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.6 t60 -87.79 107.27 18.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.312 -0.625 . . . . 87.16 109.312 175.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.532 ' O ' HG12 ' A' ' 5' ' ' VAL . 62.2 ttp -97.17 78.43 2.76 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.829 -0.349 . . . . 85.34 110.228 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 4' ' ' MET . 3.5 p 56.78 -36.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 126.114 1.766 . . . . 85.05 114.791 -178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 165.69 105.76 0.19 Allowed Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 111.165 -0.774 . . . . 84.68 111.165 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -118.72 -84.58 0.65 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 119.465 -0.303 . . . . 85.57 111.249 -177.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 39.0 mmt180 46.94 68.4 0.63 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.405 0.621 . . . . 85.04 110.646 -177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -154.21 170.59 8.21 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-N 115.295 -0.866 . . . . 82.17 109.822 -176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_exo -57.07 -42.07 67.87 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 121.728 1.618 . . . . 81.51 111.531 174.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 62.78 92.81 0.06 OUTLIER Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 115.288 -0.869 . . . . 79.56 111.266 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -60.44 143.51 99.47 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.846 2.364 . . . . 78.5 111.832 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.1 m -65.24 156.62 5.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.907 -0.588 . . . . 77.0 110.82 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.07 88.42 1.42 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.672 -0.694 . . . . 75.74 110.562 -178.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.471 ' HG2' ' H ' ' A' ' 16' ' ' VAL . 33.9 tt0 -81.59 172.8 13.02 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.274 -0.876 . . . . 73.91 109.127 175.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.471 ' H ' ' HG2' ' A' ' 15' ' ' GLU . 8.8 p -37.45 127.6 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 O-C-N 123.84 0.712 . . . . 72.3 111.753 178.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 54.6 mtmt -93.37 152.63 41.21 Favored Pre-proline 0 C--N 1.322 -0.618 0 CA-C-N 115.894 -0.594 . . . . 71.22 110.588 -178.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 17' ' ' LYS . 20.6 Cg_exo -65.96 80.96 0.27 Allowed 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.062 2.508 . . . . 69.67 112.7 -178.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -132.28 76.97 71.7 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.941 -0.572 . . . . 67.55 110.441 176.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -74.23 121.44 6.86 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.194 1.929 . . . . 66.7 111.889 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -108.01 116.08 31.3 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.234 0.54 . . . . 65.01 110.55 178.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 -115.54 130.95 23.9 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.757 -0.656 . . . . 63.41 109.913 178.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.97 141.83 93.82 Favored 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.027 2.484 . . . . 61.93 112.956 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -133.33 65.33 1.59 Allowed 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.187 -0.915 . . . . 59.87 108.918 176.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -80.06 151.21 72.83 Favored Pre-proline 0 C--N 1.314 -0.949 0 CA-C-N 114.145 -1.388 . . . . 58.47 110.312 -175.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 55.6 Cg_endo -70.31 1.33 4.9 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.909 2.406 . . . . 57.36 112.949 -179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 55.68 -166.52 0.11 Allowed 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.041 0.537 . . . . 55.51 111.553 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.547 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 2.6 mp0 -94.55 -64.56 0.12 Allowed Pre-proline 0 C--N 1.324 -0.515 0 CA-C-O 118.845 -0.598 . . . . 53.87 111.196 176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.547 ' HD3' ' HB2' ' A' ' 28' ' ' GLN . 23.6 Cg_exo -59.5 -56.37 1.31 Allowed 'Trans proline' 0 C--N 1.357 0.994 0 C-N-CA 121.496 1.464 . . . . 52.76 113.392 -167.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 29.4 m -137.23 150.74 70.0 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.702 -0.481 . . . . 50.93 109.702 176.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 26' ' ' PRO . 16.2 Cg_exo -67.86 -40.78 8.92 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.253 1.969 . . . . 49.21 112.077 179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.1 p -144.63 143.38 30.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.655 -0.702 . . . . 47.49 110.188 178.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.576 ' HB ' ' HD3' ' A' ' 34' ' ' PRO . 26.3 t -102.28 -51.34 0.15 Allowed Pre-proline 0 C--N 1.321 -0.631 0 CA-C-N 116.044 -0.525 . . . . 45.97 111.447 179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.576 ' HD3' ' HB ' ' A' ' 33' ' ' VAL . 52.1 Cg_exo -61.19 164.32 14.98 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.399 2.066 . . . . 45.28 113.372 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.1 m -89.02 140.55 29.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.983 -1.008 . . . . 42.79 109.926 176.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 26.9 m -68.17 146.62 98.14 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 115.916 -0.583 . . . . 40.79 111.224 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -50.88 -55.71 3.79 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.513 2.142 . . . . 39.81 112.678 -178.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 85.2 m -113.95 123.69 50.35 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.179 0.514 . . . . 37.5 111.246 -178.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.58 107.97 59.55 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.407 -0.815 . . . . 35.65 109.443 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.66 -49.56 16.37 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.092 2.528 . . . . 33.72 112.423 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 68.32 123.42 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 O-C-N 123.992 0.808 . . . . 31.51 111.748 176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -116.28 88.85 24.34 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.107 -0.497 . . . . 30.13 110.46 175.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.14 121.71 6.28 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.683 2.255 . . . . 29.52 111.644 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 61.23 -176.94 4.61 Favored Glycine 0 CA--C 1.522 0.523 0 C-N-CA 121.082 -0.58 . . . . 26.75 113.107 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 15.9 Cg_exo -69.01 133.51 27.13 Favored 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.74 2.293 . . . . 25.08 111.821 176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.9 mt -76.16 -50.75 21.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.027 -0.533 . . . . 23.9 110.661 177.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.61 84.68 0.07 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.003 -0.999 . . . . 21.23 111.051 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -88.24 177.06 6.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.505 0.669 . . . . 19.92 111.264 178.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -141.66 170.83 14.98 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 114.836 -1.074 . . . . 16.56 109.848 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -103.23 29.33 5.63 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.982 0.896 . . . . 15.05 111.247 -176.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.473 ' HB3' ' HG3' ' A' ' 54' ' ' PRO . 8.4 tp-100 179.7 156.05 0.58 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.78 -1.1 . . . . 14.19 108.065 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.2 p -80.75 119.02 22.8 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.323 0.583 . . . . 11.38 111.395 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.435 ' HB1' ' HB3' ' A' ' 56' ' ' ALA . . . 49.47 60.51 15.34 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 114.141 -1.391 . . . . 8.29 113.24 178.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.473 ' HG3' ' HB3' ' A' ' 51' ' ' GLN . 24.3 Cg_exo -59.8 -47.49 15.66 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.584 2.189 . . . . 6.87 114.239 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.94 -16.63 36.86 Favored 'Trans proline' 0 C--N 1.356 0.925 0 CA-C-N 120.92 1.364 . . . . 5.04 112.654 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' HB3' ' HB1' ' A' ' 53' ' ' ALA . . . -86.91 111.2 38.68 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-O 120.802 0.334 . . . . 2.59 111.109 -178.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -78.62 -176.52 3.32 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.231 2.621 . . . . 1.64 112.065 176.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 20.2 p80 -112.41 137.25 50.85 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 114.785 -1.098 . . . . 3.39 109.612 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.588 HG22 ' N ' ' A' ' 60' ' ' ARG . 13.6 mt -77.64 171.75 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 114.964 -1.016 . . . . 0.44 111.579 -172.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.588 ' N ' HG22 ' A' ' 59' ' ' ILE . 46.9 mtt85 -60.64 -149.98 0.0 OUTLIER 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.956 -1.474 . . . . 2.34 112.214 176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.629 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 21.1 t-160 -159.43 137.73 10.51 Favored 'General case' 0 CA--C 1.477 -1.829 0 CA-C-N 112.634 -2.076 . . . . 2.22 107.017 177.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.718 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.2 m-30 -122.09 156.4 33.66 Favored 'General case' 0 N--CA 1.428 -1.571 0 CA-C-N 115.364 -0.834 . . . . 0.21 110.878 -177.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.491 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 23.4 t70 -87.11 67.02 9.58 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 123.401 1.572 . . . . 0.35 108.399 172.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.781 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.9 m95 -54.25 -43.58 71.05 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.089 -2.323 . . . . 0.1 112.997 175.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.47 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 8.6 t-20 -50.15 -30.56 11.51 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 113.806 -1.543 . . . . 1.11 111.743 177.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.48 -16.41 80.64 Favored Glycine 0 CA--C 1.501 -0.801 0 N-CA-C 111.358 -0.697 . . . . 0.21 111.358 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.73 -49.77 4.26 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.118 -1.041 . . . . 0.13 110.736 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.732 ' O ' HG23 ' A' ' 72' ' ' VAL . 39.0 mtt -66.56 -57.65 6.83 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.089 -1.414 . . . . 0.09 111.94 -178.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.47 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 7.0 mm-40 -38.75 -54.96 2.88 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 114.958 1.466 . . . . 0.63 114.958 -177.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.82 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 31.9 Cg_endo -63.46 -30.77 72.09 Favored 'Trans proline' 0 CA--C 1.507 -0.847 0 C-N-CA 121.908 1.739 . . . . 0.14 110.45 -179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.744 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 7.6 mtm -81.59 -45.63 15.57 Favored 'General case' 0 CA--C 1.506 -0.741 0 CA-C-N 115.123 -0.944 . . . . 0.7 111.851 -177.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 68' ' ' MET . 46.8 t -56.54 -39.86 64.85 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-N 114.217 -1.356 . . . . 0.12 108.751 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.3 t -59.39 -34.39 72.37 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.064 -1.88 . . . . 0.56 111.052 174.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.82 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 17.2 mtpp -83.41 -33.86 25.64 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-O 121.069 0.461 . . . . 1.3 110.912 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.83 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.81 -26.35 68.31 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-N 115.291 -0.868 . . . . 0.5 111.295 -173.186 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.676 HD13 ' HB2' ' A' ' 118' ' ' LYS . 6.4 mt -94.11 -6.35 45.19 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-O 122.205 1.002 . . . . 0.65 110.788 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.64 16.05 52.19 Favored Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 108.934 -1.666 . . . . 0.17 108.934 170.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.653 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -86.36 165.7 16.18 Favored 'General case' 0 N--CA 1.44 -0.934 0 CA-C-N 114.598 -0.801 . . . . 0.1 109.925 -178.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -92.87 105.52 17.63 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 115.255 -0.884 . . . . 1.72 110.195 177.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.637 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.05 -22.48 3.59 Favored Glycine 0 N--CA 1.429 -1.802 0 CA-C-N 115.138 -0.937 . . . . 0.12 111.051 -178.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.83 HG11 ' O ' ' A' ' 75' ' ' MET . 9.9 p -99.53 154.77 4.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.519 0.676 . . . . 0.16 111.617 -174.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 3.6 m -135.0 135.01 41.05 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 114.692 -1.14 . . . . 0.45 110.897 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.601 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -60.59 121.41 12.12 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.394 -0.821 . . . . 0.28 110.66 168.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 113.1 4.6 23.96 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.979 -0.629 . . . . 0.28 112.55 177.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -88.3 152.46 21.93 Favored 'General case' 0 CA--C 1.509 -0.603 0 C-N-CA 120.804 -0.359 . . . . 1.2 110.526 179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.5 p -80.02 120.71 31.98 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 CA-C-O 121.819 0.819 . . . . 0.2 108.906 165.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.77 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -109.36 107.7 17.98 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.821 0.82 . . . . 0.14 109.154 -172.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.668 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -72.11 97.35 1.91 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.228 -1.351 . . . . 0.15 107.679 174.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.837 ' O ' HD11 ' A' ' 127' ' ' LEU . 1.2 m -70.88 125.22 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.955 0 N-CA-C 105.82 -1.919 . . . . 0.95 105.82 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.879 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 10.0 t0 -78.26 157.7 29.16 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 107.401 -1.333 . . . . 0.64 107.401 178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.641 ' OG ' ' HE3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -57.7 135.39 56.75 Favored 'General case' 0 N--CA 1.412 -2.347 0 N-CA-C 106.842 -1.54 . . . . 0.37 106.842 170.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.567 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 28.3 t -64.9 139.68 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.4 -2.951 0 N-CA-C 107.777 -1.194 . . . . 0.1 107.777 169.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.798 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.5 t-20 -84.11 162.45 20.28 Favored 'General case' 0 C--N 1.29 -1.99 0 CA-C-N 115.016 -0.993 . . . . 0.18 109.778 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.36 85.02 2.35 Favored 'General case' 0 C--N 1.291 -1.948 0 CA-C-N 114.683 -1.144 . . . . 0.12 108.004 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.467 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.2 mtp180 -107.09 -3.16 20.25 Favored 'General case' 0 CA--C 1.503 -0.854 0 CA-C-N 113.9 -1.5 . . . . 0.64 108.653 -172.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.748 HG21 ' HB3' ' A' ' 172' ' ' PRO . 28.6 p -50.57 -175.36 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 113.24 -1.8 . . . . 0.14 114.271 -177.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.4 OUTLIER -72.3 -8.56 55.54 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 113.206 -1.816 . . . . 0.48 110.599 174.656 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.595 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -146.47 -148.91 4.87 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.751 -0.738 . . . . 0.12 112.843 -179.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.635 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.3 p -121.45 130.3 53.49 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 112.329 0.492 . . . . 1.16 112.329 -177.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.758 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -135.16 157.81 45.97 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 121.954 0.883 . . . . 0.1 111.028 -177.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.704 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 1.0 OUTLIER -77.74 80.4 4.2 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 113.579 -1.646 . . . . 0.17 107.86 175.144 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -69.41 -15.43 63.29 Favored 'General case' 0 C--N 1.289 -2.059 0 CA-C-N 114.873 -1.058 . . . . 0.09 109.77 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.57 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.84 -29.19 40.07 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.609 -0.886 . . . . 0.15 108.609 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.704 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 20.9 tt0 -63.61 -39.71 95.07 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 114.054 -1.43 . . . . 1.73 109.32 168.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.544 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -68.48 -44.64 74.33 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.005 -1.907 . . . . 0.12 108.928 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.561 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 51.1 m -64.88 -31.44 72.68 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 113.946 -1.479 . . . . 0.11 110.61 -179.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.16 -44.79 78.86 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 107.695 -1.224 . . . . 1.47 107.695 172.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.686 HG21 ' HB2' ' A' ' 64' ' ' TRP . 40.1 m -64.01 -31.7 72.98 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.173 -0.921 . . . . 0.12 110.945 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.707 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.7 mt -49.86 -69.7 0.11 Allowed 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 109.277 -0.638 . . . . 0.56 109.277 171.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.548 ' O ' HD13 ' A' ' 121' ' ' LEU . 16.4 mtp180 -41.05 -39.75 1.29 Allowed 'General case' 0 C--N 1.31 -1.123 0 O-C-N 124.508 1.13 . . . . 1.51 111.394 175.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.534 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -68.89 -45.97 69.59 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 114.65 -1.159 . . . . 0.28 112.012 -176.053 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -73.08 -36.99 66.94 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 108.467 -0.938 . . . . 0.09 108.467 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.69 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -59.58 -34.4 72.67 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.715 -1.584 . . . . 0.12 110.131 173.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.652 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.53 -39.11 67.8 Favored 'General case' 0 CA--C 1.503 -0.865 0 CA-C-N 114.662 -1.154 . . . . 0.2 110.717 -177.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.426 ' HB2' ' NE2' ' A' ' 69' ' ' GLN . 1.0 OUTLIER -64.69 -24.58 67.62 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 114.709 -1.132 . . . . 1.17 110.832 -176.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -89.55 -25.18 21.51 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.648 -0.705 . . . . 2.05 110.576 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 58.29 27.98 61.14 Favored Glycine 0 C--N 1.332 0.308 0 CA-C-N 115.743 -0.662 . . . . 0.54 114.147 169.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.676 ' HB2' HD13 ' A' ' 76' ' ' LEU . 58.2 mtpt -110.87 -1.35 16.53 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.61 -0.515 . . . . 0.99 109.61 175.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.77 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 40.1 m-85 -124.44 173.6 8.33 Favored 'General case' 0 CA--C 1.498 -1.036 0 CA-C-O 122.085 0.945 . . . . 0.21 112.571 173.146 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.553 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.2 m -116.62 120.78 39.75 Favored 'General case' 0 N--CA 1.418 -2.067 0 CA-C-N 113.206 -1.815 . . . . 0.23 107.532 169.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.652 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -89.85 146.23 24.58 Favored 'General case' 0 N--CA 1.415 -2.203 0 C-N-CA 119.344 -0.943 . . . . 0.38 111.223 -170.495 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.707 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.6 m -100.62 141.2 17.86 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 N-CA-C 107.765 -1.198 . . . . 0.42 107.765 170.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.409 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 1.4 m -96.04 -179.99 4.87 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 119.805 -0.758 . . . . 1.7 110.55 -179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.77 -30.37 69.99 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.785 0.802 . . . . 0.55 109.035 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.631 ' O ' ' HG3' ' A' ' 129' ' ' MET . 31.9 mt-30 -44.48 -41.5 6.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 113.188 -1.823 . . . . 2.04 111.771 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.707 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 8.3 mt-30 -98.52 -48.02 5.16 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.79 0.805 . . . . 0.41 110.283 172.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.837 HD11 ' O ' ' A' ' 89' ' ' VAL . 5.8 tt -64.97 -66.37 0.55 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 113.4 -1.727 . . . . 1.39 113.284 -166.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.639 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.0 OUTLIER -53.17 -42.9 66.64 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 123.618 1.675 . . . . 1.05 109.208 -178.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.71 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 6.3 mmt -55.29 -62.85 1.4 Allowed 'General case' 0 N--CA 1.435 -1.22 0 CA-C-N 110.942 -2.845 . . . . 1.64 111.13 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.758 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.27 -44.4 5.37 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 124.106 0.879 . . . . 0.31 111.833 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.641 ' HE3' ' OG ' ' A' ' 91' ' ' SER . 4.0 mptp? -49.28 -65.02 0.64 Allowed 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 109.287 -0.634 . . . . 1.53 109.287 175.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.06 -45.49 71.71 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 114.895 -1.048 . . . . 0.41 112.001 177.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.71 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.4 mt-30 -55.65 -36.37 66.97 Favored 'General case' 0 CA--C 1.488 -1.424 0 CA-C-N 114.843 -1.071 . . . . 0.37 109.916 -177.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -90.47 -29.39 17.96 Favored 'General case' 0 N--CA 1.423 -1.795 0 CA-C-N 114.172 -1.376 . . . . 0.24 109.57 -176.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 153.07 -38.68 0.73 Allowed Glycine 0 CA--C 1.497 -1.069 0 C-N-CA 119.558 -1.306 . . . . 0.33 113.933 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.68 HD13 ' O ' ' A' ' 141' ' ' SER . 92.1 mt -73.12 -173.49 1.3 Allowed 'General case' 0 C--N 1.293 -1.848 0 CA-C-O 123.94 1.829 . . . . 0.31 115.275 -167.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.487 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 15.3 m -109.4 147.85 36.86 Favored Pre-proline 0 N--CA 1.42 -1.944 0 CA-C-N 110.72 -2.945 . . . . 0.81 107.984 168.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.639 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 34.3 Cg_endo -63.78 1.2 1.54 Allowed 'Trans proline' 0 C--N 1.33 -0.437 0 C-N-CA 123.058 2.505 . . . . 0.32 112.176 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.57 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.1 OUTLIER -117.1 -22.25 8.47 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-O 122.136 0.969 . . . . 1.25 110.251 -178.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.672 ' O ' ' HB2' ' A' ' 141' ' ' SER . 17.2 t70 -61.0 -24.29 66.04 Favored 'General case' 0 CA--C 1.487 -1.471 0 CA-C-N 112.963 -1.926 . . . . 0.65 109.211 -173.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.68 ' O ' HD13 ' A' ' 136' ' ' LEU . 14.0 m 74.42 174.83 0.26 Allowed 'General case' 0 N--CA 1.426 -1.65 0 O-C-N 125.942 2.026 . . . . 0.6 108.468 -170.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.1 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.4 mt -69.76 -39.72 76.52 Favored 'General case' 0 C--N 1.29 -2.013 0 N-CA-C 108.21 -1.033 . . . . 0.86 108.21 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.41 -12.0 0.73 Allowed Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 113.276 -1.783 . . . . 0.31 114.41 178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.96 125.11 7.36 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 118.605 -0.712 . . . . 0.24 109.118 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.711 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -40.86 -47.95 3.01 Favored 'General case' 0 C--O 1.212 -0.869 0 CA-C-N 118.075 0.398 . . . . 1.65 111.81 -178.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.4 ' HA ' ' HB ' ' A' ' 149' ' ' ILE . 32.3 t -71.25 -29.22 64.83 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-O 121.391 0.615 . . . . 0.53 111.592 -175.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 44.6 mttt -71.15 -27.57 63.64 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-O 122.681 1.229 . . . . 1.31 108.374 176.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 1.1 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -78.6 -47.88 16.26 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-N 112.287 -2.233 . . . . 0.12 110.395 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.648 HG13 ' HE1' ' A' ' 179' ' ' MET . 36.7 mt -65.28 -42.12 93.1 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-N 112.837 -1.983 . . . . 0.11 110.252 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.3 -56.76 15.69 Favored Glycine 0 N--CA 1.438 -1.179 0 CA-C-N 114.778 -1.101 . . . . 0.15 110.964 171.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.758 HG23 ' CB ' ' A' ' 130' ' ' ALA . 70.8 mt -63.99 -47.73 89.15 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.012 0 N-CA-C 112.458 0.54 . . . . 0.18 112.458 -177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.635 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.13 -42.01 76.24 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 123.241 0.338 . . . . 0.13 110.682 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.469 ' HD2' HG23 ' A' ' 149' ' ' ILE . 29.5 mtp180 -80.5 -23.05 40.37 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.643 0.735 . . . . 1.08 110.795 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.423 HD21 ' CD ' ' A' ' 133' ' ' GLN . 12.9 t30 -80.9 -12.99 59.31 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 107.424 -1.324 . . . . 0.5 107.424 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.699 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -105.49 -29.38 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.317 0 CA-C-N 112.987 -1.915 . . . . 0.17 110.741 -175.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.46 34.19 5.11 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.59 -0.814 . . . . 0.16 112.612 -179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.668 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.66 159.81 16.44 Favored 'General case' 0 C--N 1.317 -0.835 0 N-CA-C 112.912 0.708 . . . . 0.12 112.912 -169.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.687 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.5 m80 -99.29 -28.21 13.42 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.212 -0.904 . . . . 0.2 109.323 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.575 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.6 m-85 -136.26 -176.91 4.48 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-N 114.963 -1.017 . . . . 0.13 111.008 -175.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.687 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -134.06 141.34 44.1 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 114.665 -1.152 . . . . 0.08 108.609 167.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.66 HD21 ' SD ' ' A' ' 176' ' ' MET . 29.9 tp -110.21 100.39 9.29 Favored 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 119.666 -0.814 . . . . 0.16 109.441 165.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.545 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.0 m-85 -79.06 112.45 16.28 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 114.579 -1.192 . . . . 0.26 108.899 179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.855 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 5.5 t -126.09 161.91 26.54 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-O 121.956 0.884 . . . . 1.05 110.691 -176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.853 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.7 p -162.83 177.59 9.16 Favored 'General case' 0 N--CA 1.42 -1.928 0 CA-C-N 114.23 -1.35 . . . . 0.1 111.141 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -140.85 133.77 29.13 Favored 'General case' 0 N--CA 1.412 -2.33 0 CA-C-N 114.175 -1.375 . . . . 0.11 108.551 178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.689 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.7 m -143.36 -176.61 5.01 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.307 -0.557 . . . . 1.09 109.592 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.39 -81.37 0.94 Allowed Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 119.669 -1.253 . . . . 0.15 111.873 172.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.468 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 53.1 t-20 -142.2 127.37 18.58 Favored 'General case' 0 C--O 1.197 -1.681 0 N-CA-C 106.747 -1.575 . . . . 0.59 106.747 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.595 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.9 p -63.25 -41.13 91.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.017 0 CA-C-N 115.438 -0.801 . . . . 0.15 112.125 -177.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.426 ' N ' HG13 ' A' ' 169' ' ' VAL . 91.9 m-20 -65.14 -28.45 69.43 Favored 'General case' 0 CA--C 1.505 -0.755 0 CA-C-O 121.317 0.579 . . . . 1.26 110.496 -177.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.51 88.47 3.35 Favored Pre-proline 0 C--N 1.307 -1.251 0 CA-C-N 114.571 -1.195 . . . . 0.13 108.138 176.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.79 ' HD2' HG22 ' A' ' 194' ' ' VAL . 50.9 Cg_endo -90.09 164.96 4.75 Favored 'Trans proline' 0 CA--C 1.491 -1.658 0 C-N-CA 124.56 3.507 . . . . 0.09 114.998 -170.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 191' ' ' LYS . 20.6 m -84.4 117.83 23.87 Favored 'General case' 0 N--CA 1.417 -2.085 0 CA-C-N 113.898 -1.501 . . . . 0.14 107.628 166.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 164' ' ' SER . 40.4 tp -84.23 99.47 10.58 Favored 'General case' 0 N--CA 1.41 -2.435 0 N-CA-C 108.58 -0.896 . . . . 0.16 108.58 178.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.624 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.3 mt-30 -90.69 109.41 20.59 Favored 'General case' 0 C--N 1.273 -2.745 0 CA-C-O 122.063 0.935 . . . . 0.34 109.634 -175.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.855 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -112.84 164.36 13.5 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 114.958 -1.019 . . . . 1.09 111.789 -172.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.61 ' HG2' HD12 ' A' ' 186' ' ' ILE . 55.9 tt0 -171.56 116.84 0.41 Allowed 'General case' 0 C--O 1.202 -1.395 0 CA-C-N 115.98 -0.555 . . . . 0.5 109.967 -166.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.03 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -99.23 101.53 12.88 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.554 -0.906 . . . . 0.1 108.554 -171.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.711 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 18.4 ttp -91.18 122.69 34.03 Favored 'General case' 0 N--CA 1.442 -0.853 0 CA-C-N 115.404 -0.816 . . . . 0.07 109.87 177.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.419 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -58.81 126.35 27.29 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.234 -1.395 . . . . 0.22 107.234 165.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.62 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -80.91 -35.68 14.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 C-N-CA 119.303 -0.959 . . . . 0.11 110.72 178.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.428 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.8 mt-30 -60.57 -16.99 43.44 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.328 -0.851 . . . . 0.35 111.603 -178.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 67.8 p -129.33 -37.37 1.64 Allowed 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.969 0.89 . . . . 0.19 110.155 177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.546 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.5 23.67 28.15 Favored Glycine 0 N--CA 1.434 -1.456 0 CA-C-N 114.402 -1.272 . . . . 0.18 112.293 -178.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -100.81 156.88 17.11 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.607 0.241 . . . . 0.73 110.672 -179.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.61 HD12 ' HG2' ' A' ' 177' ' ' GLN . 37.9 mm -92.87 114.94 30.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 CA-C-O 121.543 0.687 . . . . 0.14 109.597 178.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.03 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -102.22 -31.29 3.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 CA-C-N 114.878 -1.055 . . . . 0.13 110.603 -173.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.656 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 81.9 t90 -135.59 153.33 51.71 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-N 115.487 -0.779 . . . . 0.07 109.87 173.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 28.0 p -153.61 163.4 40.05 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 113.157 0.799 . . . . 0.13 113.157 164.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -160.38 -175.47 31.41 Favored Glycine 0 N--CA 1.428 -1.845 0 N-CA-C 110.839 -0.904 . . . . 0.12 110.839 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.755 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.4 mtmt -158.25 151.14 22.59 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.421 -2.066 . . . . 1.22 105.421 166.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -160.88 127.75 1.81 Allowed Glycine 0 C--N 1.281 -2.515 0 C-N-CA 119.879 -1.153 . . . . 0.12 112.195 178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.601 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.39 118.16 14.93 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.444 0.64 . . . . 0.17 111.199 -174.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.79 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -93.34 158.5 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-O 122.42 1.105 . . . . 0.11 109.868 -178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.673 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -97.98 171.46 8.26 Favored 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 112.879 -1.964 . . . . 0.18 109.581 -173.042 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.532 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 7.4 tt0 -103.09 127.48 50.35 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 108.984 -0.747 . . . . 0.91 108.984 166.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.491 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 14.2 mm-40 . . . . . 0 C--N 1.307 -1.27 0 CA-C-O 118.724 -0.655 . . . . 1.24 110.817 178.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.734 0 N-CA-C 112.147 -0.381 . . . . 88.61 112.147 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 t -147.34 149.73 33.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.18 -0.674 . . . . 87.43 109.18 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -84.19 158.21 21.39 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.679 0.276 . . . . 87.16 110.686 178.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.1 ptp 48.29 34.91 4.93 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.559 1.144 . . . . 85.34 112.734 176.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.4 p -112.3 -30.51 2.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.007 -0.997 . . . . 85.05 109.286 175.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.68 -98.39 0.35 Allowed Glycine 0 N--CA 1.444 -0.807 0 N-CA-C 110.191 -1.163 . . . . 84.68 110.191 173.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.407 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 53.5 mt-30 51.59 98.75 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 123.169 0.587 . . . . 85.57 112.582 175.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.517 ' HA ' ' NE ' ' A' ' 8' ' ' ARG . 4.2 mmp_? 70.93 41.32 0.84 Allowed 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.086 -0.961 . . . . 85.04 110.7 -176.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 175.36 140.04 0.2 Allowed Pre-proline 0 C--N 1.316 -0.874 0 CA-C-N 113.714 -1.584 . . . . 82.17 109.341 177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.8 Cg_exo -63.67 122.48 10.6 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.569 2.179 . . . . 81.51 111.683 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -104.11 105.83 50.6 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 116.101 -0.499 . . . . 79.56 110.159 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -71.74 -178.04 2.86 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.7 2.266 . . . . 78.5 113.891 -176.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 29.9 m -52.45 162.48 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 114.912 -1.04 . . . . 77.0 112.728 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -87.56 51.72 2.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.176 -0.92 . . . . 75.74 110.622 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -111.25 146.64 36.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 73.91 110.293 -179.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.77 128.53 23.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 114.993 -1.003 . . . . 72.3 110.07 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -71.82 130.99 86.21 Favored Pre-proline 0 C--N 1.324 -0.534 0 CA-C-N 116.166 -0.47 . . . . 71.22 110.92 -179.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -57.5 142.54 95.38 Favored 'Trans proline' 0 C--O 1.237 0.431 0 C-N-CA 122.477 2.118 . . . . 69.67 110.75 171.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.13 86.71 0.14 Allowed Pre-proline 0 C--O 1.234 0.278 0 CA-C-O 121.133 0.492 . . . . 67.55 110.644 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.27 27.79 0.41 Allowed 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 123.55 2.833 . . . . 66.7 112.451 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 73.1 -44.78 0.6 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.451 0.7 . . . . 65.01 110.893 -175.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.417 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 0.0 OUTLIER -140.66 128.73 12.56 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.799 -0.445 . . . . 63.41 109.799 173.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 60.6 Cg_exo -60.96 148.12 93.59 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 123.144 2.563 . . . . 61.93 113.043 178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -141.64 79.77 1.69 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.38 0.609 . . . . 59.87 110.419 176.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -135.78 136.0 22.74 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.343 -0.844 . . . . 58.47 110.97 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -47.2 -61.55 0.59 Allowed 'Trans proline' 0 C--O 1.239 0.56 0 C-N-CA 122.652 2.234 . . . . 57.36 112.116 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.446 ' HG2' ' N ' ' A' ' 28' ' ' GLN . 34.7 tt0 69.76 163.02 0.24 Allowed 'General case' 0 CA--C 1.532 0.26 0 O-C-N 124.158 0.911 . . . . 55.51 110.693 -178.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.446 ' N ' ' HG2' ' A' ' 27' ' ' GLN . 79.3 mt-30 66.88 67.19 0.64 Allowed Pre-proline 0 C--O 1.225 -0.222 0 CA-C-N 114.115 -1.402 . . . . 53.87 110.914 -176.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -61.05 131.19 35.68 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 121.887 1.725 . . . . 52.76 112.296 -178.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.2 t 52.56 70.38 1.9 Allowed Pre-proline 0 CA--C 1.53 0.182 0 CA-C-N 113.62 -1.627 . . . . 50.93 111.209 -179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -69.84 -9.75 26.83 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.588 2.192 . . . . 49.21 112.606 -176.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 14.6 p -103.38 146.19 28.86 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.001 0.429 . . . . 47.49 110.948 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 p -163.1 95.93 1.09 Allowed Pre-proline 0 C--N 1.324 -0.51 0 CA-C-O 121.367 0.604 . . . . 45.97 110.703 179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -56.92 155.59 27.27 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.869 2.38 . . . . 45.28 111.824 176.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 57.5 m -157.34 132.02 8.64 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 115.819 -0.628 . . . . 42.79 110.536 -175.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 28.0 t 61.38 84.4 0.19 Allowed Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 115.327 -0.851 . . . . 40.79 110.727 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.32 -29.28 54.63 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.144 2.563 . . . . 39.81 112.43 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.415 ' O ' ' HD3' ' A' ' 40' ' ' PRO . 12.8 t -78.14 158.65 29.01 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.038 -0.528 . . . . 37.5 109.766 176.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 23.2 mt -91.99 106.99 19.57 Favored Pre-proline 0 C--N 1.316 -0.856 0 CA-C-N 115.895 -0.593 . . . . 35.65 110.443 -178.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 38' ' ' THR . 73.9 Cg_endo -76.52 -10.04 18.74 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.464 2.11 . . . . 33.72 111.849 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -85.91 93.92 9.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.744 -0.662 . . . . 31.51 109.595 178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -81.91 135.78 48.2 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.16 -0.473 . . . . 30.13 110.625 -176.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -72.64 164.74 34.71 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.376 2.051 . . . . 29.52 112.235 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.19 179.82 19.58 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.694 -0.765 . . . . 26.75 111.617 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.86 133.26 28.78 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.648 2.232 . . . . 25.08 111.132 176.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 62.5 mt -61.06 -42.49 93.35 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.457 0 CA-C-N 115.274 -0.875 . . . . 23.9 110.498 178.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -51.46 104.29 0.08 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 114.935 -1.03 . . . . 21.23 111.26 178.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -123.54 175.08 7.0 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.843 -0.617 . . . . 19.92 110.265 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -126.42 166.49 17.1 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.987 -0.551 . . . . 16.56 111.182 178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -99.43 74.42 1.91 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.179 0.514 . . . . 15.05 110.424 176.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.1 162.6 19.26 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.621 -0.718 . . . . 14.19 111.517 -177.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 27.5 p 66.09 160.43 0.14 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 125.065 1.346 . . . . 11.38 111.925 -176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -123.01 87.23 50.99 Favored Pre-proline 0 C--N 1.315 -0.929 0 CA-C-N 115.171 -0.922 . . . . 8.29 110.827 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.403 ' O ' ' HD3' ' A' ' 57' ' ' PRO . 9.2 Cg_exo -71.3 158.01 55.54 Favored 'Trans proline' 0 CA--C 1.531 0.326 0 C-N-CA 122.892 2.395 . . . . 6.87 112.03 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.22 -49.4 17.6 Favored 'Trans proline' 0 C--O 1.239 0.573 0 C-N-CA 122.35 2.033 . . . . 5.04 112.891 -177.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -119.49 80.17 22.06 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.223 -0.444 . . . . 2.59 110.434 177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 98.1 Cg_endo -75.15 -176.3 2.83 Favored 'Trans proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.155 2.57 . . . . 1.64 113.134 -176.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -126.98 148.57 50.09 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 114.418 -1.265 . . . . 3.39 109.43 178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 60' ' ' ARG . 8.9 mt -88.84 167.91 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-O 121.767 0.794 . . . . 0.44 111.239 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 59' ' ' ILE . 29.9 mtt-85 -69.79 -159.9 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.283 0 CA-C-N 113.717 -1.583 . . . . 2.34 111.709 178.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.646 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 38.7 m80 -147.58 141.07 25.4 Favored 'General case' 0 CA--C 1.479 -1.787 0 CA-C-N 112.535 -2.12 . . . . 2.22 107.215 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.771 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 1.8 m-30 -126.36 155.62 41.78 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.76 -0.654 . . . . 0.21 110.919 -174.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 11.5 t70 -82.66 67.98 8.94 Favored 'General case' 0 N--CA 1.437 -1.11 0 CA-C-O 123.481 1.61 . . . . 0.35 108.627 172.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.771 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 93.3 m95 -60.51 -43.75 96.73 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 112.14 -2.3 . . . . 0.1 112.312 175.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.473 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 12.1 t-20 -52.3 -29.0 21.23 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 114.064 -1.425 . . . . 1.11 111.211 175.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.37 -16.48 80.69 Favored Glycine 0 C--N 1.314 -0.692 0 CA-C-N 115.35 -0.841 . . . . 0.21 111.295 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.97 -51.64 3.49 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 114.183 -1.009 . . . . 0.13 110.959 -176.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.718 ' SD ' HD23 ' A' ' 109' ' ' LEU . 38.5 mtt -65.61 -56.63 11.21 Favored 'General case' 0 C--O 1.208 -1.108 0 CA-C-N 114.086 -1.415 . . . . 0.09 112.517 -177.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.473 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.6 mm-40 -40.21 -54.57 4.54 Favored Pre-proline 0 C--N 1.321 -0.644 0 N-CA-C 114.732 1.382 . . . . 0.63 114.732 -176.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.802 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.2 Cg_endo -64.27 -30.09 63.95 Favored 'Trans proline' 0 CA--C 1.511 -0.628 0 C-N-CA 121.916 1.744 . . . . 0.14 110.664 -179.225 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.673 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 7.7 mtm -81.62 -44.59 17.0 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 115.165 -0.925 . . . . 0.7 111.826 -177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 68' ' ' MET . 49.0 t -56.74 -39.54 64.45 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-N 114.279 -1.328 . . . . 0.12 108.443 175.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.6 t -59.67 -32.62 70.64 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 113.049 -1.887 . . . . 0.56 111.177 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.802 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.2 mtpt -85.98 -33.29 21.14 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.929 0.395 . . . . 1.3 111.046 178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.851 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.65 -27.64 69.07 Favored 'General case' 0 C--O 1.212 -0.902 0 CA-C-N 115.484 -0.78 . . . . 0.5 111.786 -171.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.548 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.0 mt -93.05 -5.68 49.94 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-O 121.94 0.876 . . . . 0.65 111.257 -178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.14 15.29 47.56 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.201 -1.559 . . . . 0.17 109.201 171.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.641 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -83.47 165.99 18.69 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-N 114.409 -0.895 . . . . 0.1 111.148 -178.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.52 105.68 14.65 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.876 -1.056 . . . . 1.72 110.382 174.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.606 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 129.25 -21.12 5.22 Favored Glycine 0 N--CA 1.429 -1.783 0 C-N-CA 120.151 -1.023 . . . . 0.12 111.175 177.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.851 HG11 ' O ' ' A' ' 75' ' ' MET . 11.2 p -100.81 149.42 6.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.896 0.855 . . . . 0.16 110.837 -176.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 34.3 m -136.19 142.27 44.1 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 114.197 -1.365 . . . . 0.45 109.701 175.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.736 ' HB2' ' HD2' ' A' ' 118' ' ' LYS . . . -62.37 136.21 57.81 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.54 -0.755 . . . . 0.28 110.754 171.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 103.08 9.54 39.14 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.957 -0.64 . . . . 0.28 112.777 178.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.37 152.03 18.75 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 120.742 -0.383 . . . . 1.2 110.711 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.685 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -80.95 120.12 31.95 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-O 122.015 0.912 . . . . 0.2 109.103 165.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.666 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -107.45 110.57 22.55 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 115.137 -0.938 . . . . 0.14 108.799 -172.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.715 HD21 HD13 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -70.67 99.39 1.67 Allowed 'General case' 0 CA--C 1.498 -1.038 0 CA-C-N 114.786 -1.097 . . . . 0.15 108.419 179.484 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.454 HG11 ' HG3' ' A' ' 110' ' ' ARG . 85.3 t -72.82 108.93 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.536 0 CA-C-N 114.324 -1.307 . . . . 0.95 108.416 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.806 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 6.8 t0 -77.79 154.56 31.8 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 107.982 -1.118 . . . . 0.64 107.982 179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.556 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.9 OUTLIER -59.37 138.14 57.75 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 107.588 -1.264 . . . . 0.37 107.588 171.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.505 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 26.3 t -66.5 141.08 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.633 0 N-CA-C 107.904 -1.147 . . . . 0.1 107.904 168.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.789 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.8 t-20 -86.2 163.08 18.0 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 115.459 -0.792 . . . . 0.18 109.917 174.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.763 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 1.8 t-20 -126.01 84.84 2.32 Favored 'General case' 0 C--N 1.294 -1.848 0 CA-C-N 114.669 -1.15 . . . . 0.12 108.29 177.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 13.7 mtp180 -108.97 -2.1 18.51 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-N 114.076 -1.42 . . . . 0.64 108.705 -171.106 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.748 HG21 ' HB3' ' A' ' 172' ' ' PRO . 17.6 p -50.7 -172.07 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 112.608 -2.087 . . . . 0.14 115.483 -177.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.0 t30 -67.71 -13.1 61.81 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.028 -1.896 . . . . 0.48 110.558 173.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.579 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -148.86 -146.26 4.29 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.592 -0.813 . . . . 0.12 112.884 -176.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.618 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 49.2 m -122.15 129.0 51.92 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.943 0.402 . . . . 1.16 111.134 179.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.763 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -132.12 159.29 39.34 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-O 121.525 0.678 . . . . 0.1 110.054 -177.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.614 ' O ' ' HB3' ' A' ' 104' ' ' GLU . 1.5 t-20 -81.37 82.25 7.26 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 114.317 -1.311 . . . . 0.17 108.229 175.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.608 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -69.25 -15.13 63.3 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-N 114.205 -1.361 . . . . 0.09 109.907 178.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.463 ' HB2' ' CG ' ' A' ' 139' ' ' GLN . . . -78.28 -30.33 48.42 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.999 -0.741 . . . . 0.15 108.999 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.614 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 14.2 tp10 -65.64 -35.2 80.12 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-O 122.784 1.278 . . . . 1.73 108.936 170.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.9 -45.9 63.48 Favored 'General case' 0 N--CA 1.427 -1.598 0 CA-C-N 112.832 -1.985 . . . . 0.12 109.366 178.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.6 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 55.9 m -63.87 -34.13 77.26 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.064 -1.426 . . . . 0.11 110.527 -178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.07 -42.03 85.39 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.884 -1.154 . . . . 1.47 107.884 173.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.659 HG21 ' HB2' ' A' ' 64' ' ' TRP . 60.0 m -65.45 -30.99 71.84 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.252 -0.885 . . . . 0.12 110.984 178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.718 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.8 mt -52.21 -69.54 0.11 Allowed 'General case' 0 CA--C 1.492 -1.265 0 CA-C-N 115.781 -0.645 . . . . 0.56 109.282 172.04 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.543 ' O ' HD13 ' A' ' 121' ' ' LEU . 60.1 mtp180 -40.64 -37.61 0.76 Allowed 'General case' 0 C--N 1.311 -1.073 0 O-C-N 124.3 1.0 . . . . 1.51 111.499 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.501 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -70.79 -46.24 63.21 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.716 -1.129 . . . . 0.28 112.067 -177.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.4 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.47 -33.52 64.89 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 122.156 0.979 . . . . 0.09 108.532 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -63.58 -33.95 76.74 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 113.454 -1.703 . . . . 0.12 109.918 172.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.642 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -76.09 -43.51 43.11 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-N 114.763 -1.108 . . . . 0.2 111.226 -176.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.28 -38.49 65.94 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 114.562 -1.199 . . . . 1.17 110.414 -179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.528 ' OD1' ' HG3' ' A' ' 118' ' ' LYS . 12.2 t-20 -69.11 -47.59 64.76 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 113.382 -1.736 . . . . 2.05 109.398 -178.48 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 84.53 -8.39 68.81 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 116.033 -0.531 . . . . 0.54 113.762 171.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.736 ' HD2' ' HB2' ' A' ' 83' ' ' ALA . 15.6 mtmm -72.67 -33.93 66.88 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.096 -0.642 . . . . 0.99 111.154 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.704 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 15.1 m-85 -90.92 176.91 6.44 Favored 'General case' 0 CA--C 1.493 -1.239 0 CA-C-O 122.328 1.061 . . . . 0.21 112.526 179.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.508 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.8 m -120.8 117.61 27.86 Favored 'General case' 0 N--CA 1.417 -2.089 0 CA-C-N 112.85 -1.977 . . . . 0.23 108.151 168.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.676 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -88.63 132.85 34.38 Favored 'General case' 0 N--CA 1.416 -2.173 0 CA-C-N 115.362 -0.836 . . . . 0.38 110.367 -171.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.584 HG11 HD23 ' A' ' 88' ' ' LEU . 0.9 OUTLIER -78.33 155.37 5.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 N-CA-C 109.057 -0.72 . . . . 0.42 109.057 177.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.597 ' HB3' ' HG2' ' A' ' 125' ' ' GLN . 57.7 m -100.38 160.85 14.01 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.079 0.942 . . . . 1.7 110.55 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.08 -27.99 65.06 Favored 'General case' 0 CA--C 1.505 -0.767 0 CA-C-N 113.322 -1.763 . . . . 0.55 110.453 -173.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.691 ' O ' ' HG3' ' A' ' 129' ' ' MET . 9.4 pt20 -55.22 -27.9 49.39 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 113.363 -1.744 . . . . 2.04 110.518 172.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.617 ' HB2' HG22 ' A' ' 155' ' ' VAL . 2.6 mt-30 -97.73 -57.0 2.34 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.206 -1.361 . . . . 0.41 110.106 172.236 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.715 HD13 HD21 ' A' ' 88' ' ' LEU . 17.7 tp -65.57 -67.4 0.44 Allowed 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 114.063 -1.426 . . . . 1.39 113.603 -168.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.623 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 56.8 m -52.09 -40.58 61.46 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 123.37 1.557 . . . . 1.05 109.116 -175.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.702 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 13.6 mmt -57.26 -62.63 1.63 Allowed 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 111.177 -2.738 . . . . 1.64 111.002 173.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.776 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.22 -45.43 4.12 Favored 'General case' 0 CA--C 1.504 -0.802 0 O-C-N 124.38 1.05 . . . . 0.31 111.875 175.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.571 ' HA ' HD11 ' A' ' 151' ' ' ILE . 1.0 OUTLIER -53.55 -53.6 49.26 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 108.954 -0.758 . . . . 1.53 108.954 178.658 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.408 ' HG3' ' O ' ' A' ' 128' ' ' SER . 39.0 mt-30 -64.23 -39.77 94.67 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.466 -0.788 . . . . 0.41 111.128 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.702 ' HG3' ' O ' ' A' ' 129' ' ' MET . 53.0 mt-30 -59.0 -34.66 72.11 Favored 'General case' 0 CA--C 1.49 -1.333 0 CA-C-N 114.354 -1.294 . . . . 0.37 109.83 178.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -91.7 -28.79 17.21 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 114.243 -1.344 . . . . 0.24 109.644 -176.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.58 -42.92 0.7 Allowed Glycine 0 CA--C 1.496 -1.135 0 C-N-CA 119.894 -1.146 . . . . 0.33 113.426 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.588 HD13 ' O ' ' A' ' 141' ' ' SER . 94.0 mt -69.9 -171.46 0.42 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 124.102 1.906 . . . . 0.31 115.472 -169.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.608 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 32.1 m -114.89 153.93 46.99 Favored Pre-proline 0 N--CA 1.422 -1.837 0 CA-C-N 110.353 -3.112 . . . . 0.81 107.194 174.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.623 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 64.6 Cg_endo -68.91 1.22 4.06 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.416 2.077 . . . . 0.32 110.91 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.463 ' CG ' ' HB2' ' A' ' 103' ' ' ALA . 20.8 mt-30 -117.56 -23.35 7.72 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-N 114.132 -1.395 . . . . 1.25 111.031 -175.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 14.3 t70 -69.05 -22.14 64.05 Favored 'General case' 0 CA--C 1.489 -1.393 0 CA-C-N 114.515 -1.22 . . . . 0.65 108.879 -169.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.588 ' O ' HD13 ' A' ' 136' ' ' LEU . 32.3 m 71.76 166.94 0.3 Allowed 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 112.485 -2.143 . . . . 0.6 109.578 -170.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.982 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.6 mt -65.48 -40.15 92.78 Favored 'General case' 0 C--N 1.295 -1.772 0 CA-C-O 122.191 0.996 . . . . 0.86 108.317 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.14 -12.18 0.27 Allowed Glycine 0 N--CA 1.45 -0.407 0 CA-C-N 113.047 -1.888 . . . . 0.31 114.476 178.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.25 123.3 7.57 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 109.023 -0.732 . . . . 0.24 109.023 -173.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.664 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.6 mmt180 -42.43 -45.56 4.43 Favored 'General case' 0 C--O 1.213 -0.843 0 O-C-N 123.394 0.434 . . . . 1.65 111.73 -176.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.0 t -73.93 -25.49 60.01 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-O 121.676 0.751 . . . . 0.53 111.407 -174.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -73.55 -30.47 63.07 Favored 'General case' 0 CA--C 1.508 -0.652 0 CA-C-O 122.634 1.207 . . . . 1.31 108.331 175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.982 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -75.41 -47.72 26.09 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 112.577 -2.102 . . . . 0.12 110.36 178.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.62 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.6 mt -65.49 -41.46 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.833 0 CA-C-N 112.88 -1.964 . . . . 0.11 110.44 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.12 -53.53 36.8 Favored Glycine 0 N--CA 1.438 -1.195 0 CA-C-N 114.67 -1.15 . . . . 0.15 111.25 171.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.776 HG23 ' CB ' ' A' ' 130' ' ' ALA . 83.9 mt -66.67 -48.3 80.58 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.103 0 N-CA-C 112.172 0.434 . . . . 0.18 112.172 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.682 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -54.43 -44.46 72.46 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 123.603 0.565 . . . . 0.13 111.248 -178.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.459 ' NE ' HG23 ' A' ' 149' ' ' ILE . 49.7 mtt180 -78.76 -23.14 45.53 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-O 121.295 0.569 . . . . 1.08 110.882 -178.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.502 HD21 ' CD ' ' A' ' 133' ' ' GLN . 35.0 t30 -81.6 -13.66 57.72 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.641 -1.244 . . . . 0.5 107.641 175.487 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.703 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.01 -28.91 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.335 0 CA-C-N 113.313 -1.767 . . . . 0.17 111.041 -173.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.423 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.88 34.85 4.76 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.261 -0.971 . . . . 0.16 112.365 -178.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.619 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.91 157.34 19.34 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 112.886 0.698 . . . . 0.12 112.886 -170.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.685 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.8 m80 -98.92 -28.63 13.35 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-N 115.137 -0.938 . . . . 0.2 109.425 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.567 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.1 m-85 -135.13 -173.97 3.48 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.063 -0.971 . . . . 0.13 110.856 -175.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.703 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.2 t -136.97 139.97 43.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 115.13 -0.941 . . . . 0.08 108.93 166.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.615 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 40.1 tp -107.8 100.12 9.52 Favored 'General case' 0 N--CA 1.428 -1.567 0 C-N-CA 119.237 -0.985 . . . . 0.16 109.318 165.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.558 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.7 m-85 -80.39 116.65 20.57 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.226 -1.352 . . . . 0.26 108.577 176.485 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.868 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 4.7 t -129.01 162.55 27.36 Favored 'General case' 0 C--N 1.283 -2.291 0 CA-C-O 121.948 0.88 . . . . 1.05 110.607 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.831 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.4 p -162.4 176.24 10.7 Favored 'General case' 0 N--CA 1.418 -2.037 0 CA-C-N 114.4 -1.273 . . . . 0.1 110.971 -177.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -137.91 134.76 35.38 Favored 'General case' 0 N--CA 1.409 -2.502 0 CA-C-N 114.086 -1.416 . . . . 0.11 108.513 178.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.685 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.4 m -144.19 -176.0 4.84 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 109.278 -0.638 . . . . 1.09 109.278 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -84.21 0.92 Allowed Glycine 0 N--CA 1.435 -1.378 0 C-N-CA 119.824 -1.179 . . . . 0.15 111.407 173.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.3 t30 -144.49 128.19 17.2 Favored 'General case' 0 C--O 1.197 -1.665 0 N-CA-C 107.921 -1.141 . . . . 0.59 107.921 176.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.579 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.7 p -63.22 -41.77 94.01 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-N 115.136 -0.938 . . . . 0.15 112.334 -172.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.41 ' N ' HG13 ' A' ' 169' ' ' VAL . 8.7 m120 -59.17 -31.67 69.2 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.49 0.662 . . . . 1.26 109.552 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.05 89.2 3.11 Favored Pre-proline 0 C--N 1.315 -0.912 0 CA-C-N 114.329 -1.305 . . . . 0.13 108.351 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.8 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.5 Cg_endo -90.49 166.98 4.23 Favored 'Trans proline' 0 CA--C 1.494 -1.492 0 C-N-CA 124.481 3.454 . . . . 0.09 114.815 -169.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.589 HG22 ' HB3' ' A' ' 191' ' ' LYS . 25.3 m -85.75 120.19 26.91 Favored 'General case' 0 N--CA 1.42 -1.926 0 CA-C-N 113.904 -1.498 . . . . 0.14 107.369 165.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.831 HD12 ' O ' ' A' ' 164' ' ' SER . 44.4 tp -84.68 98.66 10.34 Favored 'General case' 0 N--CA 1.412 -2.348 0 N-CA-C 108.714 -0.847 . . . . 0.16 108.714 176.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.576 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -89.93 109.39 20.41 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 122.097 0.951 . . . . 0.34 109.265 -176.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.868 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.9 OUTLIER -112.48 163.83 14.0 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.76 -1.109 . . . . 1.09 111.538 -173.286 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.609 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.5 tt0 -170.67 119.02 0.53 Allowed 'General case' 0 C--O 1.207 -1.149 0 CA-C-N 115.89 -0.596 . . . . 0.5 109.98 -166.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.049 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.25 100.15 10.64 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.671 -0.863 . . . . 0.1 108.671 -173.268 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.664 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.8 ttp -89.42 123.06 33.22 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.433 -0.803 . . . . 0.07 109.548 176.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.428 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.2 OUTLIER -59.63 127.36 31.64 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 106.892 -1.522 . . . . 0.22 106.892 166.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.664 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.93 -35.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 O-C-N 121.131 -0.981 . . . . 0.11 110.904 179.214 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.458 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 28.9 mt-30 -61.68 -16.2 46.79 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.281 -0.872 . . . . 0.35 111.087 -177.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 73.9 p -129.66 -37.05 1.59 Allowed 'General case' 0 CA--C 1.513 -0.465 0 CA-C-O 121.752 0.786 . . . . 0.19 110.199 178.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.552 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.82 24.88 26.51 Favored Glycine 0 N--CA 1.434 -1.444 0 CA-C-N 114.701 -1.136 . . . . 0.18 112.387 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -103.85 156.4 17.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.679 0.276 . . . . 0.73 110.481 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.609 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.1 mm -89.22 117.0 31.7 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 CA-C-O 121.552 0.692 . . . . 0.14 109.335 178.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.049 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -104.99 -30.54 2.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 115.098 -0.955 . . . . 0.13 110.341 -174.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.661 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.0 t90 -136.42 152.22 50.36 Favored 'General case' 0 CA--C 1.504 -0.819 0 CA-C-N 115.397 -0.819 . . . . 0.07 109.417 172.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 77.2 p -153.59 163.32 40.18 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 119.891 -0.724 . . . . 0.13 112.926 163.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.44 -174.93 28.78 Favored Glycine 0 N--CA 1.425 -2.047 0 N-CA-C 110.885 -0.886 . . . . 0.12 110.885 -178.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.756 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.8 mtmt -158.96 151.28 21.4 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 105.383 -2.08 . . . . 1.22 105.383 165.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -159.43 127.24 1.79 Allowed Glycine 0 C--N 1.278 -2.676 0 C-N-CA 119.623 -1.275 . . . . 0.12 112.108 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.509 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.17 115.08 10.98 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.404 0.621 . . . . 0.17 111.065 -174.535 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.8 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -91.87 158.45 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.522 0 CA-C-O 122.59 1.186 . . . . 0.11 110.181 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.656 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -101.85 172.26 7.04 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 112.564 -2.107 . . . . 0.18 109.166 -174.265 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 3.9 tt0 -100.42 130.65 46.53 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 109.261 -0.644 . . . . 0.91 109.261 169.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.494 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 26.7 mm-40 . . . . . 0 C--N 1.31 -1.109 0 CA-C-N 115.883 -0.599 . . . . 1.24 110.138 177.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.674 0 N-CA-C 111.884 -0.486 . . . . 88.61 111.884 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.494 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 44.9 m -142.43 28.11 1.67 Allowed 'General case' 0 C--N 1.324 -0.543 0 O-C-N 122.61 -0.347 . . . . 87.43 111.446 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.441 ' O ' HG23 ' A' ' 5' ' ' VAL . 96.6 m-70 -71.34 116.78 12.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 87.16 110.247 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 40.2 ttp 51.58 44.02 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.897 0.856 . . . . 85.34 110.127 -171.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 2' ' ' SER . 97.3 t -130.73 -46.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.831 -1.077 . . . . 85.05 109.897 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -133.35 -112.47 1.34 Allowed Glycine 0 N--CA 1.443 -0.837 0 C-N-CA 120.625 -0.798 . . . . 84.68 112.151 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -118.27 -168.46 1.53 Allowed 'General case' 0 C--N 1.321 -0.65 0 O-C-N 123.013 -0.11 . . . . 85.57 111.085 -177.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.409 ' O ' ' HB2' ' A' ' 9' ' ' GLU . 0.1 OUTLIER 53.29 63.85 2.07 Favored 'General case' 0 C--O 1.233 0.22 0 O-C-N 123.773 0.671 . . . . 85.04 111.663 -176.665 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 10' ' ' PRO . 44.0 tt0 175.05 -52.97 0.0 OUTLIER Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 114.822 -1.081 . . . . 82.17 110.903 173.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 9' ' ' GLU . 10.2 Cg_endo -51.76 105.67 0.12 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 122.543 2.162 . . . . 81.51 112.618 177.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -166.13 77.07 1.19 Allowed Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.23 -0.441 . . . . 79.56 110.087 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -62.68 140.54 81.4 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.159 1.906 . . . . 78.5 112.318 -176.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.7 m -76.05 160.26 5.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-O 121.439 0.638 . . . . 77.0 111.233 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -133.89 133.34 41.37 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.206 -0.906 . . . . 75.74 109.774 174.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -135.63 92.79 2.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.134 0.492 . . . . 73.91 111.08 179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 5.5 p -69.12 109.03 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.488 -0.778 . . . . 72.3 109.994 173.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -112.16 101.05 51.19 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 115.847 -0.615 . . . . 71.22 110.32 -177.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.23 -48.51 17.48 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 122.076 1.85 . . . . 69.67 111.899 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 55.05 65.69 4.63 Favored Pre-proline 0 C--O 1.232 0.147 0 CA-C-N 114.714 -1.13 . . . . 67.55 111.709 -178.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.79 155.86 39.43 Favored 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 122.078 1.852 . . . . 66.7 112.169 -178.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -173.03 137.78 0.73 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.076 -0.511 . . . . 65.01 110.207 -178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -138.02 125.64 13.82 Favored Pre-proline 0 C--N 1.319 -0.756 0 N-CA-C 109.149 -0.686 . . . . 63.41 109.149 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -49.81 137.13 35.25 Favored 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 122.95 2.434 . . . . 61.93 112.826 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -119.5 98.11 5.98 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.223 -0.899 . . . . 59.87 110.207 -178.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -112.16 139.48 22.51 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 115.978 -0.555 . . . . 58.47 110.374 -178.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -66.17 129.02 20.68 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.958 1.772 . . . . 57.36 111.834 177.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -115.44 68.21 0.71 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.698 0.761 . . . . 55.51 109.94 178.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -120.32 84.34 34.67 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.511 -0.768 . . . . 53.87 110.096 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.48 157.27 28.88 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.285 1.99 . . . . 52.76 112.161 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.5 p -158.71 76.74 3.33 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-O 122.089 0.947 . . . . 50.93 110.365 178.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -86.78 102.77 0.59 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.212 2.608 . . . . 49.21 111.287 178.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 33.4 p -85.53 141.48 29.85 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.177 -0.465 . . . . 47.49 111.592 -175.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.6 t -129.36 82.31 68.18 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.976 -0.557 . . . . 45.97 110.185 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -64.13 156.28 60.06 Favored 'Trans proline' 0 C--O 1.235 0.335 0 C-N-CA 123.175 2.584 . . . . 45.28 112.749 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 59.0 m -157.21 120.78 4.15 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.413 -0.812 . . . . 42.79 109.988 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 40.4 t -113.51 103.9 55.42 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.101 -0.499 . . . . 40.79 110.658 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -59.29 150.33 75.18 Favored 'Trans proline' 0 CA--C 1.52 -0.194 0 C-N-CA 122.67 2.246 . . . . 39.81 111.962 175.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 93.1 m -145.55 124.39 12.67 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.238 -0.437 . . . . 37.5 110.459 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.7 mt -96.26 115.03 65.37 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.767 -0.651 . . . . 35.65 110.905 -175.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.81 144.54 93.79 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.865 2.377 . . . . 33.72 111.842 177.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -144.13 141.14 29.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.813 -0.439 . . . . 31.51 109.813 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.406 ' O ' ' HG3' ' A' ' 42' ' ' GLN . 10.5 pt20 -131.59 88.28 43.51 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.103 0.478 . . . . 30.13 111.116 -176.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -74.31 134.99 19.82 Favored 'Trans proline' 0 N--CA 1.46 -0.458 0 C-N-CA 122.607 2.205 . . . . 29.52 111.806 178.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.18 156.71 26.63 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.624 -0.798 . . . . 26.75 112.124 177.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -78.68 129.03 8.97 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.339 2.692 . . . . 25.08 113.052 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 30.3 mt -84.64 -70.52 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.613 -0.514 . . . . 23.9 109.613 174.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 60.56 101.85 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.918 -1.037 . . . . 21.23 112.989 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -120.06 173.54 7.02 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.157 -0.474 . . . . 19.92 110.207 169.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.02 -176.16 5.8 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.083 -0.508 . . . . 16.56 110.021 174.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -118.7 87.22 2.69 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.003 -0.544 . . . . 15.05 110.419 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -86.48 170.02 12.32 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 115.999 -0.546 . . . . 14.19 110.92 175.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 54.5 p -115.52 133.93 55.56 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.355 0.597 . . . . 11.38 110.117 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.531 ' HB3' ' HD3' ' A' ' 54' ' ' PRO . . . -85.75 -52.36 0.47 Allowed Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.252 -0.885 . . . . 8.29 112.222 -175.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 53' ' ' ALA . 87.7 Cg_endo -88.54 131.02 2.38 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 121.347 1.365 . . . . 6.87 112.446 176.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 54' ' ' PRO . 7.9 Cg_exo -73.21 -172.78 1.09 Allowed 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.186 1.924 . . . . 5.04 111.901 175.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 60.91 68.34 1.29 Allowed Pre-proline 0 CA--C 1.53 0.202 0 CA-C-N 114.693 -1.139 . . . . 2.59 111.933 178.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -71.1 -177.13 2.14 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.959 2.439 . . . . 1.64 112.177 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.6 p80 -114.79 146.66 40.76 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.737 -1.12 . . . . 3.39 109.979 -177.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.625 HG22 ' N ' ' A' ' 60' ' ' ARG . 10.3 mt -88.75 170.44 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.459 -0.791 . . . . 0.44 111.615 -177.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.625 ' N ' HG22 ' A' ' 59' ' ' ILE . 30.4 mtt85 -69.79 -156.67 0.02 OUTLIER 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.763 -1.562 . . . . 2.34 112.575 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.638 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 21.5 t-160 -158.41 145.62 17.82 Favored 'General case' 0 CA--C 1.473 -2.0 0 CA-C-N 111.904 -2.407 . . . . 2.22 106.595 178.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.743 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.6 m-30 -124.27 159.6 29.85 Favored 'General case' 0 N--CA 1.417 -2.079 0 CA-C-N 115.459 -0.791 . . . . 0.21 109.662 -176.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.564 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 15.7 t70 -80.15 67.06 5.85 Favored 'General case' 0 N--CA 1.433 -1.321 0 CA-C-O 123.289 1.519 . . . . 0.35 108.257 172.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.718 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 90.6 m95 -59.01 -44.17 91.64 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 111.77 -2.468 . . . . 0.1 112.109 175.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.461 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 13.3 t-20 -51.51 -29.33 16.29 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.04 -1.436 . . . . 1.11 111.37 174.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.5 -16.49 80.69 Favored Glycine 0 C--N 1.314 -0.683 0 CA-C-N 115.385 -0.825 . . . . 0.21 111.254 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.73 -53.16 3.03 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.062 -1.069 . . . . 0.13 111.091 -176.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.69 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.8 mtt -63.56 -57.94 8.55 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 114.229 -1.35 . . . . 0.09 112.139 -177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.461 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.9 mm-40 -38.61 -55.31 2.67 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 115.172 1.545 . . . . 0.63 115.172 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.754 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.6 Cg_endo -65.04 -28.85 57.22 Favored 'Trans proline' 0 CA--C 1.51 -0.716 0 C-N-CA 121.673 1.582 . . . . 0.14 110.649 -177.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.637 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 11.3 mtm -84.47 -40.73 17.35 Favored 'General case' 0 C--O 1.21 -0.99 0 CA-C-N 115.198 -0.91 . . . . 0.7 111.452 -178.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 68' ' ' MET . 60.4 t -57.73 -38.32 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.98 0 CA-C-O 122.353 1.073 . . . . 0.12 108.506 172.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.0 t -60.52 -35.41 75.9 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.014 -1.903 . . . . 0.56 111.11 174.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.754 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 27.6 mtpt -81.37 -38.82 26.01 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 109.577 -0.527 . . . . 1.3 109.577 177.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.833 ' SD ' ' HE2' ' A' ' 119' ' ' PHE . 1.2 ttm -47.19 -54.6 10.29 Favored 'General case' 0 N--CA 1.434 -1.272 0 O-C-N 123.901 0.751 . . . . 0.5 110.355 -175.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.632 ' N ' ' HG2' ' A' ' 75' ' ' MET . 4.7 mt -80.03 7.62 8.7 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.525 -1.216 . . . . 0.65 112.285 -169.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -121.96 17.33 8.68 Favored Glycine 0 N--CA 1.439 -1.162 0 CA-C-N 113.941 -1.481 . . . . 0.17 109.88 169.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.588 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -81.83 165.15 21.11 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-O 121.404 0.621 . . . . 0.1 110.252 176.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -87.06 107.6 18.5 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.281 -0.872 . . . . 1.72 109.797 174.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.664 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 133.96 -24.89 3.58 Favored Glycine 0 N--CA 1.429 -1.785 0 N-CA-C 110.763 -0.935 . . . . 0.12 110.763 -178.104 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.762 HG11 ' O ' ' A' ' 75' ' ' MET . 10.8 p -102.92 151.08 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-O 121.777 0.799 . . . . 0.16 111.164 -177.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.5 m -135.91 142.73 44.71 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.43 -1.259 . . . . 0.45 110.211 177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.665 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -56.14 142.84 35.37 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.585 -0.734 . . . . 0.28 110.469 166.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 93.32 11.33 58.55 Favored Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.778 -0.725 . . . . 0.28 113.17 175.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -97.55 153.14 18.36 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.148 0.474 . . . . 1.2 110.552 177.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.696 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -82.28 120.47 33.81 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 N-CA-C 108.772 -0.825 . . . . 0.2 108.772 166.191 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.64 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -108.45 109.78 21.14 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 115.542 -0.754 . . . . 0.14 109.308 -171.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.787 HD21 HD23 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -73.13 94.5 1.94 Allowed 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.504 -1.225 . . . . 0.15 108.945 177.378 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.518 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 2.0 m -73.04 115.93 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.591 0 N-CA-C 106.902 -1.518 . . . . 0.95 106.902 174.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.873 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 13.3 t0 -79.97 170.4 16.53 Favored 'General case' 0 CA--C 1.504 -0.8 0 N-CA-C 108.331 -0.989 . . . . 0.64 108.331 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.525 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 0.5 OUTLIER -55.5 148.72 14.94 Favored 'General case' 0 N--CA 1.414 -2.263 0 CA-C-O 122.774 1.273 . . . . 0.37 109.375 170.278 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.515 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 34.6 t -77.62 140.5 16.95 Favored 'Isoleucine or valine' 0 N--CA 1.396 -3.172 0 N-CA-C 106.81 -1.552 . . . . 0.1 106.81 165.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.81 ' H ' ' HA ' ' A' ' 164' ' ' SER . 5.5 t-20 -85.55 160.91 19.54 Favored 'General case' 0 C--N 1.286 -2.154 0 CA-C-O 122.031 0.919 . . . . 0.18 110.344 174.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.749 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -124.27 84.63 2.3 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 113.939 -1.482 . . . . 0.12 107.575 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.465 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 13.2 mtp180 -107.18 -2.07 21.24 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 113.66 -1.609 . . . . 0.64 108.411 -172.785 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.726 HG21 ' HB3' ' A' ' 172' ' ' PRO . 22.3 p -50.96 -177.73 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.36 -1.745 . . . . 0.14 113.799 -178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.434 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 1.5 t30 -73.49 -7.62 52.57 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-N 113.065 -1.88 . . . . 0.48 110.263 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.618 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -142.37 -151.43 5.51 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 120.944 -0.645 . . . . 0.12 112.869 179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.596 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 51.8 m -121.92 130.58 53.45 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 120.955 0.407 . . . . 1.16 111.728 -179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.749 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.0 pp -134.84 158.19 44.85 Favored 'General case' 0 CA--C 1.504 -0.8 0 CA-C-O 121.876 0.846 . . . . 0.1 110.795 -177.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.614 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -80.64 79.69 7.23 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 114.019 -1.446 . . . . 0.17 108.08 176.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.591 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.57 -15.77 63.83 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 114.376 -1.284 . . . . 0.09 109.846 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.493 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.55 -31.56 42.02 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.888 -0.782 . . . . 0.15 108.888 -177.61 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.614 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.6 tp10 -66.04 -33.98 77.03 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.697 1.237 . . . . 1.73 108.876 171.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.591 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.29 -43.42 64.25 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 113.118 -1.855 . . . . 0.12 109.656 179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.621 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 63.7 m -63.91 -32.2 73.65 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 114.107 -1.406 . . . . 0.11 110.537 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -40.99 80.04 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.997 -1.112 . . . . 1.47 107.997 173.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.683 HG21 ' HB2' ' A' ' 64' ' ' TRP . 54.7 m -64.5 -31.06 72.12 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.21 -0.904 . . . . 0.12 110.693 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.719 ' O ' HD23 ' A' ' 113' ' ' LEU . 8.4 mt -51.74 -70.05 0.1 Allowed 'General case' 0 CA--C 1.496 -1.097 0 N-CA-C 109.296 -0.631 . . . . 0.56 109.296 171.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.635 ' O ' HD13 ' A' ' 121' ' ' LEU . 21.2 mtp180 -39.72 -38.46 0.64 Allowed 'General case' 0 C--N 1.315 -0.933 0 O-C-N 124.436 1.085 . . . . 1.51 111.331 174.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.509 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.86 -46.89 61.87 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.578 -1.192 . . . . 0.28 112.313 -177.253 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.461 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.57 -31.0 64.89 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-O 122.227 1.013 . . . . 0.09 108.471 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.719 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -66.15 -32.55 74.06 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 113.511 -1.677 . . . . 0.12 109.906 175.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.591 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.31 -39.39 68.27 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.48 -1.236 . . . . 0.2 111.565 -175.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -66.97 -21.69 65.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.061 -0.972 . . . . 1.17 111.265 -174.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -92.69 -14.41 28.08 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.053 -0.521 . . . . 2.05 111.753 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 67.24 -11.89 0.69 Allowed Glycine 0 C--N 1.334 0.426 0 N-CA-C 116.164 1.226 . . . . 0.54 116.164 163.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.665 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 51.7 mtpt -74.51 -33.03 62.69 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.819 0.81 . . . . 0.99 111.139 -177.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.833 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 20.8 m-85 -93.6 178.2 5.77 Favored 'General case' 0 CA--C 1.5 -0.959 0 CA-C-O 122.391 1.091 . . . . 0.21 112.678 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.487 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 6.2 m -121.25 116.95 25.83 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 112.901 -1.954 . . . . 0.23 107.822 168.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.702 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -87.54 135.49 33.33 Favored 'General case' 0 N--CA 1.418 -2.06 0 C-N-CA 119.477 -0.889 . . . . 0.38 110.751 -171.781 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.673 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.7 OUTLIER -79.59 154.88 4.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 N-CA-C 108.923 -0.769 . . . . 0.42 108.923 173.556 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.551 ' CB ' ' HG2' ' A' ' 125' ' ' GLN . 35.0 m -95.52 160.11 14.67 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.713 0.768 . . . . 1.7 109.89 176.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.531 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . . . -73.58 -21.09 60.44 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.129 -1.396 . . . . 0.55 109.907 -177.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.657 ' O ' ' HG3' ' A' ' 129' ' ' MET . 9.5 pt20 -57.13 -26.82 61.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.442 -1.254 . . . . 2.04 109.491 170.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.673 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 2.3 mt-30 -98.41 -52.48 3.63 Favored 'General case' 0 C--O 1.216 -0.71 0 CA-C-N 114.292 -1.322 . . . . 0.41 110.598 171.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.787 HD23 HD21 ' A' ' 88' ' ' LEU . 1.9 tm? -70.26 -62.85 1.23 Allowed 'General case' 0 C--O 1.236 0.354 0 CA-C-N 114.692 -1.14 . . . . 1.39 113.218 -167.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.648 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.5 OUTLIER -52.34 -39.89 61.26 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-O 123.712 1.72 . . . . 1.05 108.753 179.35 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.657 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 0.3 OUTLIER -62.9 -59.85 4.28 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 110.694 -2.957 . . . . 1.64 110.783 179.167 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.756 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.86 -40.01 5.85 Favored 'General case' 0 CA--C 1.502 -0.888 0 O-C-N 124.098 0.874 . . . . 0.31 112.006 175.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.723 ' NZ ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -51.52 -60.46 3.12 Favored 'General case' 0 N--CA 1.439 -0.999 0 C-N-CA 119.825 -0.75 . . . . 1.53 109.215 175.329 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 40.3 mt-30 -58.74 -44.66 90.58 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.379 -1.282 . . . . 0.41 111.7 178.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.627 ' HG3' ' O ' ' A' ' 129' ' ' MET . 43.5 mt-30 -55.33 -34.2 64.0 Favored 'General case' 0 CA--C 1.489 -1.382 0 CA-C-N 114.986 -1.006 . . . . 0.37 110.151 -178.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.528 ' CD1' HG13 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -93.59 -30.56 14.91 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 113.991 -1.459 . . . . 0.24 109.364 -178.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 161.43 -54.9 0.32 Allowed Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 119.929 -1.129 . . . . 0.33 114.086 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.508 ' CD1' ' HA ' ' A' ' 142' ' ' LEU . 43.8 mt -64.05 -172.36 0.06 Allowed 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 116.385 1.994 . . . . 0.31 116.385 -168.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.558 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.5 m -111.16 150.7 42.37 Favored Pre-proline 0 N--CA 1.428 -1.54 0 CA-C-N 110.954 -2.839 . . . . 0.81 108.777 170.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.648 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 15.1 Cg_endo -60.08 -2.49 1.76 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 123.357 2.705 . . . . 0.32 113.107 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.493 ' OE1' ' HA ' ' A' ' 101' ' ' ASN . 0.8 OUTLIER -117.44 -26.41 6.68 Favored 'General case' 0 CA--C 1.501 -0.927 0 CA-C-O 121.911 0.862 . . . . 1.25 110.647 -177.022 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.558 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 4.6 t70 -64.8 -24.56 67.59 Favored 'General case' 0 CA--C 1.491 -1.305 0 CA-C-N 113.696 -1.593 . . . . 0.65 109.359 -171.138 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 22.6 m 66.33 161.56 0.15 Allowed 'General case' 0 N--CA 1.429 -1.51 0 CA-C-N 112.689 -2.05 . . . . 0.6 109.995 -175.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.881 HD13 ' HA ' ' A' ' 148' ' ' ALA . 9.2 mt -73.19 -35.63 66.4 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.148 -1.842 . . . . 0.86 109.204 -169.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 55.36 2.98 0.31 Allowed Glycine 0 C--N 1.318 -0.464 0 CA-C-N 113.164 -1.835 . . . . 0.31 114.949 175.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.72 118.14 5.27 Favored 'General case' 0 CA--C 1.5 -0.947 0 N-CA-C 109.07 -0.715 . . . . 0.24 109.07 -174.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.69 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 13.0 mmt180 -40.23 -47.87 2.5 Favored 'General case' 0 C--O 1.214 -0.783 0 O-C-N 123.696 0.623 . . . . 1.65 111.448 -176.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 23.3 t -69.77 -28.24 65.59 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-O 121.477 0.656 . . . . 0.53 111.461 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.545 ' O ' HD12 ' A' ' 151' ' ' ILE . 21.2 mttm -72.82 -31.32 64.72 Favored 'General case' 0 CA--C 1.503 -0.835 0 CA-C-O 122.38 1.086 . . . . 1.31 108.276 176.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.881 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -77.75 -38.94 45.86 Favored 'General case' 0 CA--C 1.486 -1.486 0 CA-C-N 113.15 -1.841 . . . . 0.12 110.798 178.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.605 ' HA ' HG23 ' A' ' 181' ' ' VAL . 33.0 mt -69.78 -43.17 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.953 0 CA-C-N 113.821 -1.536 . . . . 0.11 109.978 177.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.73 -53.57 35.43 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.177 -0.919 . . . . 0.15 110.979 171.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.756 HG23 ' CB ' ' A' ' 130' ' ' ALA . 7.6 mt -67.14 -44.92 87.62 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.028 0 N-CA-C 113.069 0.766 . . . . 0.18 113.069 -179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.67 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -58.65 -37.9 76.97 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 118.447 0.567 . . . . 0.13 110.513 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.44 ' HD2' HG23 ' A' ' 149' ' ' ILE . 46.8 mtp180 -83.18 -21.7 33.44 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.799 0.809 . . . . 1.08 110.407 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.513 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 13.8 t30 -82.58 -10.32 59.02 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.187 -1.412 . . . . 0.5 107.187 175.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.734 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -109.79 -29.24 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 113.294 -1.775 . . . . 0.17 111.107 -174.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.76 35.38 4.62 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.563 -0.827 . . . . 0.16 112.642 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.73 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -112.09 159.28 18.66 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 113.416 0.895 . . . . 0.12 113.416 -169.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.696 ' N ' HG13 ' A' ' 86' ' ' VAL . 2.1 m80 -100.32 -25.99 14.05 Favored 'General case' 0 CA--C 1.51 -0.564 0 CA-C-N 115.486 -0.779 . . . . 0.2 110.068 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.571 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.5 m-85 -135.57 -172.62 3.13 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.234 -0.894 . . . . 0.13 110.959 -176.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.82 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -138.81 136.72 43.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 115.013 -0.994 . . . . 0.08 108.964 167.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.518 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 48.6 tp -106.96 99.44 9.01 Favored 'General case' 0 N--CA 1.426 -1.648 0 C-N-CA 119.637 -0.825 . . . . 0.16 108.995 165.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.601 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -81.54 111.97 18.34 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 114.103 -1.408 . . . . 0.26 109.448 177.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.726 ' OG ' HD11 ' A' ' 174' ' ' LEU . 31.4 t -121.31 166.33 14.2 Favored 'General case' 0 C--N 1.282 -2.33 0 CA-C-O 121.699 0.761 . . . . 1.05 110.753 -178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.868 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.5 p -164.87 176.34 8.79 Favored 'General case' 0 CA--C 1.485 -1.537 0 CA-C-N 114.625 -1.17 . . . . 0.1 111.351 -177.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -142.64 135.36 28.03 Favored 'General case' 0 N--CA 1.414 -2.265 0 CA-C-N 114.294 -1.321 . . . . 0.11 108.499 178.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.687 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 3.1 m -144.42 -175.79 4.78 Favored 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.516 -0.55 . . . . 1.09 109.516 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.6 -80.12 0.82 Allowed Glycine 0 N--CA 1.434 -1.446 0 C-N-CA 119.463 -1.351 . . . . 0.15 112.025 173.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.434 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.5 t30 -148.92 123.2 9.58 Favored 'General case' 0 C--O 1.198 -1.631 0 N-CA-C 106.917 -1.512 . . . . 0.59 106.917 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.618 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.3 p -59.49 -45.65 93.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-N 115.121 -0.945 . . . . 0.15 113.287 -172.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -60.02 -29.57 68.59 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.452 0.644 . . . . 1.26 109.703 -176.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.91 88.03 3.6 Favored Pre-proline 0 C--N 1.313 -0.997 0 CA-C-N 114.441 -1.254 . . . . 0.13 108.512 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.813 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.6 Cg_endo -91.22 166.47 3.63 Favored 'Trans proline' 0 CA--C 1.496 -1.407 0 C-N-CA 124.835 3.69 . . . . 0.09 114.98 -170.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.636 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 15.2 m -83.19 117.95 23.27 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 113.856 -1.52 . . . . 0.14 107.638 166.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.868 HD12 ' O ' ' A' ' 164' ' ' SER . 46.4 tp -84.46 99.25 10.57 Favored 'General case' 0 N--CA 1.412 -2.325 0 C-N-CA 119.747 -0.781 . . . . 0.16 109.289 177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.677 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.2 mt-30 -89.51 107.36 19.03 Favored 'General case' 0 C--N 1.274 -2.711 0 CA-C-N 114.966 -1.015 . . . . 0.34 109.291 -177.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.571 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 37.5 mtp -106.52 161.83 14.26 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-N 115.212 -0.904 . . . . 1.09 110.382 -177.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.611 ' HG2' HD12 ' A' ' 186' ' ' ILE . 53.2 tt0 -167.47 119.03 0.88 Allowed 'General case' 0 C--O 1.207 -1.183 0 CA-C-O 121.165 0.507 . . . . 0.5 110.025 -168.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.087 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -101.01 101.34 12.1 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.826 -0.805 . . . . 0.1 108.826 -172.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.69 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.0 ttp -91.14 118.95 30.86 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-N 115.603 -0.726 . . . . 0.07 109.318 176.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.549 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -61.85 118.49 7.27 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 107.273 -1.38 . . . . 0.22 107.273 169.618 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -73.2 -32.88 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 CA-C-N 119.516 1.053 . . . . 0.11 111.408 -176.393 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.437 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.1 mt-30 -64.1 -12.84 43.02 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.613 -0.721 . . . . 0.35 111.538 -177.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 33.1 p -130.12 -37.56 1.46 Allowed 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 122.079 0.943 . . . . 0.19 109.892 178.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.594 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.82 19.47 51.25 Favored Glycine 0 N--CA 1.43 -1.725 0 CA-C-N 113.756 -1.565 . . . . 0.18 112.08 -179.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -104.66 156.56 17.87 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.055 0.455 . . . . 0.73 110.677 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.611 HD12 ' HG2' ' A' ' 177' ' ' GLN . 37.9 mm -88.4 117.48 32.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-O 121.679 0.752 . . . . 0.14 109.424 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.087 HD11 HD13 ' A' ' 178' ' ' LEU . 1.8 pp -104.79 -30.1 2.77 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 CA-C-N 114.527 -1.215 . . . . 0.13 110.353 -172.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.588 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.3 t90 -137.43 152.33 49.48 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.191 -0.913 . . . . 0.07 109.338 172.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.46 ' HB3' ' HG3' ' A' ' 177' ' ' GLN . 61.2 p -153.58 165.52 35.65 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 112.865 0.691 . . . . 0.13 112.865 164.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.16 -179.43 33.99 Favored Glycine 0 N--CA 1.429 -1.82 0 N-CA-C 110.892 -0.883 . . . . 0.12 110.892 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.745 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.8 mtmt -156.78 147.08 21.26 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 106.33 -1.73 . . . . 1.22 106.33 167.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.637 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -158.04 127.45 1.9 Allowed Glycine 0 C--N 1.283 -2.387 0 C-N-CA 119.94 -1.124 . . . . 0.12 112.266 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.72 117.02 13.9 Favored 'General case' 0 C--N 1.297 -1.717 0 CA-C-O 121.425 0.631 . . . . 0.17 111.003 -174.376 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.813 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -93.99 159.25 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.323 0 CA-C-O 122.589 1.185 . . . . 0.11 110.736 -177.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.743 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -101.8 172.08 7.15 Favored 'General case' 0 C--N 1.291 -1.951 0 CA-C-N 112.501 -2.136 . . . . 0.18 108.861 -174.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.583 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 8.3 tt0 -100.77 133.2 45.59 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.075 -0.65 . . . . 0.91 109.411 171.458 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.525 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 35.1 mm-40 . . . . . 0 C--N 1.316 -0.89 0 CA-C-O 118.656 -0.688 . . . . 1.24 110.518 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.587 0 N-CA-C 111.761 -0.535 . . . . 88.61 111.761 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.5 t -115.71 124.78 51.71 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.902 -0.407 . . . . 87.43 109.902 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -113.51 63.19 0.65 Allowed 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.578 -0.527 . . . . 87.16 109.578 -178.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.6 ptm -110.76 39.26 2.27 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.383 0.611 . . . . 85.34 111.32 -175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 96.0 t -127.54 -68.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.267 -0.879 . . . . 85.05 109.715 177.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.57 74.65 0.42 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.021 -0.609 . . . . 84.68 112.342 179.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -78.24 139.36 38.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.903 0.382 . . . . 85.57 110.154 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -143.71 100.17 3.54 Favored 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.493 0.663 . . . . 85.04 110.735 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.489 ' H ' ' CD ' ' A' ' 9' ' ' GLU . 0.5 OUTLIER -94.99 126.84 45.18 Favored Pre-proline 0 C--N 1.315 -0.908 0 CA-C-N 115.559 -0.746 . . . . 82.17 110.563 -178.265 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -74.74 -176.35 2.77 Favored 'Trans proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.108 1.872 . . . . 81.51 111.95 176.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -114.84 124.97 29.58 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-N 116.238 -0.437 . . . . 79.56 110.074 178.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.401 ' O ' HG22 ' A' ' 13' ' ' VAL . 24.7 Cg_exo -63.27 137.55 61.55 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.467 2.112 . . . . 78.5 111.955 177.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.401 HG22 ' O ' ' A' ' 12' ' ' PRO . 26.4 m 51.71 138.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 125.628 1.571 . . . . 77.0 113.931 -177.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -87.07 -33.94 19.33 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 114.917 -1.038 . . . . 75.74 110.714 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 54.17 94.58 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.307 0 O-C-N 123.944 0.778 . . . . 73.91 112.319 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.1 t -76.51 116.14 19.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.507 -0.769 . . . . 72.3 110.334 178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 8.5 mtpm? -70.25 138.6 86.93 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 116.169 -0.469 . . . . 71.22 110.401 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.52 121.5 9.97 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.491 2.127 . . . . 69.67 112.647 -179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . . . -115.94 135.98 22.84 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.814 -0.63 . . . . 67.55 109.616 177.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 19' ' ' ALA . 27.8 Cg_exo -60.43 114.71 2.24 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.242 1.962 . . . . 66.7 112.012 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.537 ' O ' ' HD3' ' A' ' 23' ' ' PRO . 10.9 pt-20 -119.41 5.86 11.14 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.806 0.336 . . . . 65.01 110.816 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.492 HE21 ' HA ' ' A' ' 22' ' ' GLN . 0.1 OUTLIER -114.59 84.43 9.94 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 116.504 -0.316 . . . . 63.41 110.618 -178.368 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 21' ' ' GLU . 26.9 Cg_exo -71.4 146.99 51.64 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 123.374 2.716 . . . . 61.93 112.306 177.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.56 80.36 1.9 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.37 0.605 . . . . 59.87 110.346 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -70.56 134.49 86.46 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.066 -0.97 . . . . 58.47 111.138 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.16 158.13 55.65 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.282 1.988 . . . . 57.36 111.483 176.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -88.93 152.21 21.86 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.908 -0.317 . . . . 55.51 110.425 178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 2.4 mp0 -89.31 138.55 28.64 Favored Pre-proline 0 C--N 1.318 -0.778 0 CA-C-N 116.32 -0.4 . . . . 53.87 110.152 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 28' ' ' GLN . 16.9 Cg_exo -65.9 136.89 46.94 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.197 1.931 . . . . 52.76 111.237 175.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.4 p -128.15 96.0 32.43 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-O 121.392 0.615 . . . . 50.93 110.886 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -75.53 95.21 0.99 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.66 2.24 . . . . 49.21 111.854 178.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.8 p -83.08 142.71 31.08 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.21 -0.45 . . . . 47.49 110.601 177.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.5 t 63.32 94.2 0.05 OUTLIER Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.757 -0.656 . . . . 45.97 110.621 -176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -56.98 161.25 10.93 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 123.494 2.796 . . . . 45.28 112.985 177.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.0 m -76.13 132.45 40.03 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.892 -1.049 . . . . 42.79 110.092 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 29.7 m -58.0 147.76 63.12 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.93 -0.577 . . . . 40.79 111.041 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -48.42 -47.5 19.97 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 123.163 2.575 . . . . 39.81 113.961 -172.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.8 t -54.96 135.24 48.78 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.368 0.604 . . . . 37.5 110.955 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.9 mt -75.83 128.57 83.19 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.795 -0.639 . . . . 35.65 110.422 -176.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.16 75.76 0.94 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 123.055 2.504 . . . . 33.72 112.011 177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -157.74 -44.99 0.06 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.614 -0.721 . . . . 31.51 110.121 -176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 58.26 81.49 0.25 Allowed Pre-proline 0 N--CA 1.463 0.217 0 CA-C-N 115.213 -0.903 . . . . 30.13 111.492 179.463 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.43 123.59 10.7 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.0 1.8 . . . . 29.52 111.447 175.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.92 -168.7 12.47 Favored Glycine 0 N--CA 1.446 -0.644 0 N-CA-C 111.45 -0.66 . . . . 26.75 111.45 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 8.0 Cg_exo -72.02 131.99 19.04 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.531 2.154 . . . . 25.08 112.01 176.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 34.9 mt -79.17 -51.26 17.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-N 116.03 -0.532 . . . . 23.9 110.031 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 67.78 76.26 0.27 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.293 -0.867 . . . . 21.23 110.668 177.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -142.08 146.76 35.79 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.431 -0.804 . . . . 19.92 110.202 176.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -169.35 164.08 10.72 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.193 -0.912 . . . . 16.56 110.256 -175.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -86.71 77.92 9.22 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.778 0.799 . . . . 15.05 110.005 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -60.56 136.94 58.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.381 -0.827 . . . . 14.19 110.118 -178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.1 p -68.28 145.17 54.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.795 0.807 . . . . 11.38 111.973 -176.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.65 ' HB1' ' HD2' ' A' ' 54' ' ' PRO . . . -100.5 -177.61 0.59 Allowed Pre-proline 0 N--CA 1.436 -1.138 0 CA-C-N 114.545 -1.207 . . . . 8.29 108.071 177.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.65 ' HD2' ' HB1' ' A' ' 53' ' ' ALA . 5.6 Cg_exo -30.65 103.67 0.03 OUTLIER 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 124.34 3.36 . . . . 6.87 112.886 170.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -59.73 -58.16 0.66 Allowed 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.025 2.483 . . . . 5.04 113.633 -171.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.424 ' HA ' ' HD2' ' A' ' 57' ' ' PRO . . . -107.78 109.8 62.35 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 112.058 0.392 . . . . 2.59 112.058 -174.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 56' ' ' ALA . 90.5 Cg_endo -76.02 -177.3 3.55 Favored 'Trans proline' 0 CA--C 1.51 -0.701 0 C-N-CA 123.04 2.493 . . . . 1.64 110.61 167.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -104.7 132.51 50.86 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.461 -0.79 . . . . 3.39 110.122 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.62 HG22 ' N ' ' A' ' 60' ' ' ARG . 10.4 mt -93.21 172.79 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 CA-C-O 122.24 1.019 . . . . 0.44 112.842 -172.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.62 ' N ' HG22 ' A' ' 59' ' ' ILE . 25.3 mtt85 -72.3 -158.05 0.04 OUTLIER 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 113.399 -1.728 . . . . 2.34 111.655 175.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.631 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 41.7 m80 -150.56 142.72 24.11 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.761 -2.018 . . . . 2.22 107.128 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.772 ' HB2' ' NE1' ' A' ' 64' ' ' TRP . 2.9 m-30 -126.6 155.53 42.35 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 123.665 0.603 . . . . 0.21 110.878 -175.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.54 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 10.6 t0 -85.16 67.64 10.25 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 123.395 1.569 . . . . 0.35 108.473 173.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.781 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 94.9 m95 -57.44 -41.9 81.41 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.008 -2.36 . . . . 0.1 112.769 175.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.486 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 14.7 t-20 -51.95 -25.43 8.21 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 114.197 -1.365 . . . . 1.11 111.696 175.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.69 -16.58 78.97 Favored Glycine 0 C--N 1.312 -0.763 0 CA-C-N 115.147 -0.933 . . . . 0.21 111.278 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -101.41 -52.84 3.14 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 114.118 -1.041 . . . . 0.13 111.199 -177.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.723 ' SD ' HD23 ' A' ' 109' ' ' LEU . 41.4 mtt -64.59 -58.67 5.7 Favored 'General case' 0 C--O 1.212 -0.916 0 CA-C-N 114.122 -1.399 . . . . 0.09 112.507 -176.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.486 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -39.42 -54.78 3.56 Favored Pre-proline 0 C--N 1.321 -0.669 0 N-CA-C 114.794 1.405 . . . . 0.63 114.794 -176.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.807 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 37.4 Cg_endo -64.64 -28.97 60.64 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.532 1.488 . . . . 0.14 110.16 -177.065 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.719 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 10.9 mtm -83.09 -42.04 17.88 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-N 115.358 -0.837 . . . . 0.7 112.108 -178.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.696 HG23 ' O ' ' A' ' 68' ' ' MET . 58.2 t -57.01 -40.13 70.67 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 CA-C-N 114.26 -1.336 . . . . 0.12 108.802 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.68 -36.09 73.64 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.152 -1.84 . . . . 0.56 111.054 173.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.807 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.1 mtpt -82.08 -32.91 30.07 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.011 -0.541 . . . . 1.3 111.207 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.833 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.82 -26.16 68.22 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-N 115.39 -0.823 . . . . 0.5 111.677 -172.19 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.657 HD13 ' HB2' ' A' ' 118' ' ' LYS . 3.9 mt -94.21 -8.02 40.49 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-O 122.124 0.964 . . . . 0.65 110.997 -178.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -99.82 14.67 60.17 Favored Glycine 0 N--CA 1.438 -1.179 0 N-CA-C 108.664 -1.774 . . . . 0.17 108.664 171.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.664 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -86.46 165.72 16.08 Favored 'General case' 0 N--CA 1.436 -1.14 0 CA-C-N 114.159 -1.02 . . . . 0.1 109.818 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -94.46 105.38 17.35 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.252 -0.886 . . . . 1.72 109.914 178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.651 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 136.23 -23.4 3.32 Favored Glycine 0 N--CA 1.428 -1.86 0 N-CA-C 110.722 -0.951 . . . . 0.12 110.722 -177.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.833 HG11 ' O ' ' A' ' 75' ' ' MET . 10.7 p -101.21 153.76 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.431 0.634 . . . . 0.16 111.197 -175.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 15.8 m -135.35 141.84 45.64 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.923 -1.035 . . . . 0.45 110.441 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.654 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.38 130.25 45.98 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.346 -0.843 . . . . 0.28 110.272 168.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.17 3.23 38.77 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 121.006 -0.616 . . . . 0.28 112.876 175.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.0 151.89 22.87 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 120.488 -0.485 . . . . 1.2 110.97 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.676 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -80.73 119.14 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.124 0 CA-C-O 121.988 0.899 . . . . 0.2 109.031 165.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.763 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -108.38 107.56 18.17 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 115.28 -0.873 . . . . 0.14 109.108 -171.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.692 ' HB2' ' CB ' ' A' ' 157' ' ' ALA . 0.6 OUTLIER -71.43 97.9 1.71 Allowed 'General case' 0 CA--C 1.503 -0.859 0 CA-C-N 114.141 -1.39 . . . . 0.15 107.847 175.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.894 ' O ' HD11 ' A' ' 127' ' ' LEU . 2.5 m -71.08 121.91 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.013 0 N-CA-C 106.608 -1.627 . . . . 0.95 106.608 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.794 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 5.0 t0 -76.86 151.04 36.0 Favored 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.17 -1.419 . . . . 0.64 107.17 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.544 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 1.1 m -57.53 132.78 54.21 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 106.947 -1.501 . . . . 0.37 106.947 173.628 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.548 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 23.1 t -60.55 138.31 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.399 -2.988 0 N-CA-C 107.88 -1.155 . . . . 0.1 107.88 170.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.8 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -84.19 162.95 20.03 Favored 'General case' 0 C--N 1.288 -2.105 0 CA-C-N 115.337 -0.847 . . . . 0.18 109.704 174.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.784 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -125.1 85.19 2.37 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-N 114.748 -1.114 . . . . 0.12 108.114 175.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.477 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.3 mtp180 -108.18 -4.09 17.94 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.852 -1.522 . . . . 0.64 108.77 -171.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.763 HG21 ' HB3' ' A' ' 172' ' ' PRO . 21.4 p -50.59 -171.4 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 112.854 -1.975 . . . . 0.14 115.547 -176.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 33.3 t30 -68.89 -10.66 58.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 112.883 -1.962 . . . . 0.48 110.739 173.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.586 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -152.48 -143.93 3.8 Favored Glycine 0 C--O 1.236 0.244 0 C-N-CA 120.258 -0.972 . . . . 0.12 113.153 -176.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.61 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 51.5 p -122.36 131.61 53.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 121.148 0.499 . . . . 1.16 111.949 -178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.784 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.4 pp -137.43 156.43 48.19 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.846 0.831 . . . . 0.1 110.633 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -79.87 81.09 6.19 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-N 113.787 -1.551 . . . . 0.17 107.852 176.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.598 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.93 -14.72 63.21 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 114.193 -1.367 . . . . 0.09 109.929 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.405 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.74 -30.23 40.77 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.685 -0.857 . . . . 0.15 108.685 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 28.2 tp10 -66.0 -34.57 78.4 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-O 122.78 1.276 . . . . 1.73 109.068 170.245 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.03 -45.22 64.3 Favored 'General case' 0 N--CA 1.428 -1.542 0 CA-C-N 113.049 -1.887 . . . . 0.12 109.227 178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.609 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 49.1 m -64.8 -30.58 71.59 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 114.029 -1.441 . . . . 0.11 110.5 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.57 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.8 OUTLIER -67.2 -44.04 80.61 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.749 -1.204 . . . . 1.47 107.749 171.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.717 HG21 ' HB2' ' A' ' 64' ' ' TRP . 37.7 m -63.24 -31.46 72.61 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 115.237 -0.892 . . . . 0.12 110.783 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.723 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.3 mt -50.16 -70.47 0.09 Allowed 'General case' 0 CA--C 1.491 -1.301 0 N-CA-C 109.05 -0.722 . . . . 0.56 109.05 170.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.503 ' O ' HD13 ' A' ' 121' ' ' LEU . 10.9 mtp180 -40.08 -40.32 1.05 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 124.487 1.117 . . . . 1.51 111.358 175.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.521 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -67.26 -48.18 68.51 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.556 -1.202 . . . . 0.28 112.137 -177.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.2 -34.97 68.8 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 122.315 1.055 . . . . 0.09 108.524 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.3 mm? -63.91 -32.33 73.83 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 113.158 -1.837 . . . . 0.12 110.064 174.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.608 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -76.01 -47.5 24.62 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-N 114.523 -1.217 . . . . 0.2 111.302 -174.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -55.99 -33.13 64.56 Favored 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 114.336 -1.302 . . . . 1.17 110.11 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -70.17 -43.77 70.13 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 113.244 -1.798 . . . . 2.05 110.784 -177.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 79.12 -3.39 66.04 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 114.749 0.659 . . . . 0.54 114.749 173.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.657 ' HB2' HD13 ' A' ' 76' ' ' LEU . 58.7 mtpt -87.36 -8.2 56.89 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 118.066 0.933 . . . . 0.99 111.192 178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.763 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 27.0 m-85 -118.12 174.42 6.22 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-O 122.421 1.105 . . . . 0.21 113.303 173.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.0 m -118.47 123.88 46.25 Favored 'General case' 0 N--CA 1.423 -1.819 0 CA-C-N 112.672 -2.058 . . . . 0.23 108.021 170.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.673 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.3 OUTLIER -95.66 141.33 29.27 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 119.291 -0.964 . . . . 0.38 111.519 -169.645 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.579 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.2 m -97.46 140.55 17.49 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 N-CA-C 107.802 -1.184 . . . . 0.42 107.802 172.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.415 ' HB3' ' HG3' ' A' ' 125' ' ' GLN . 8.7 t -93.93 -177.76 4.44 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 119.274 -0.971 . . . . 1.7 111.316 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.428 ' HA ' ' H ' ' A' ' 128' ' ' SER . . . -63.33 -25.88 68.51 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.295 -1.002 . . . . 0.55 108.295 177.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.667 ' O ' ' HG3' ' A' ' 129' ' ' MET . 32.8 mt-30 -51.6 -39.56 58.18 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 113.185 -1.825 . . . . 2.04 110.907 -178.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.579 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 8.9 mt-30 -98.62 -50.39 4.28 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.964 0.888 . . . . 0.41 110.098 172.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.894 HD11 ' O ' ' A' ' 89' ' ' VAL . 6.3 tt -62.43 -64.98 0.76 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 113.474 -1.693 . . . . 1.39 113.268 -168.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.707 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -53.92 -43.72 70.01 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 123.389 1.566 . . . . 1.05 109.116 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.694 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -55.59 -60.85 2.85 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 111.226 -2.715 . . . . 1.64 111.3 175.592 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.735 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.49 -46.22 6.77 Favored 'General case' 0 CA--C 1.497 -1.083 0 O-C-N 124.493 1.121 . . . . 0.31 111.807 177.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.605 ' HA ' HD11 ' A' ' 151' ' ' ILE . 5.8 mttt -53.32 -52.13 60.15 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.39 -0.596 . . . . 1.53 109.39 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -66.9 -38.63 86.6 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 115.542 -0.754 . . . . 0.41 110.878 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.694 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.2 mt-30 -59.04 -32.3 69.63 Favored 'General case' 0 CA--C 1.491 -1.301 0 CA-C-N 114.551 -1.204 . . . . 0.37 109.845 178.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.51 ' N ' HD23 ' A' ' 134' ' ' LEU . 0.7 OUTLIER -94.3 -30.49 14.51 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 114.123 -1.399 . . . . 0.24 109.929 -177.423 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.06 -50.72 0.46 Allowed Glycine 0 CA--C 1.497 -1.053 0 C-N-CA 120.012 -1.089 . . . . 0.33 113.664 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.591 HD13 ' O ' ' A' ' 141' ' ' SER . 92.9 mt -65.36 -171.03 0.07 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-N 112.496 -1.852 . . . . 0.31 115.954 -171.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.577 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.1 m -115.72 151.67 46.5 Favored Pre-proline 0 N--CA 1.424 -1.736 0 CA-C-N 110.65 -2.977 . . . . 0.81 107.985 174.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.707 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 36.2 Cg_endo -65.4 0.07 3.13 Favored 'Trans proline' 0 C--N 1.33 -0.432 0 C-N-CA 122.871 2.381 . . . . 0.32 112.651 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.405 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.1 tt0 -118.74 -25.33 6.39 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 121.869 0.843 . . . . 1.25 110.519 -177.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.602 ' O ' ' HB2' ' A' ' 141' ' ' SER . 9.1 t70 -60.98 -23.09 65.09 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.364 -1.744 . . . . 0.65 109.079 -173.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 140' ' ' ASP . 32.6 m 73.91 167.37 0.3 Allowed 'General case' 0 N--CA 1.421 -1.88 0 CA-C-N 112.848 -1.978 . . . . 0.6 109.393 -174.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.063 HD22 ' HA ' ' A' ' 148' ' ' ALA . 3.3 mt -64.46 -39.49 93.92 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-O 122.439 1.114 . . . . 0.86 108.421 -175.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.37 -7.29 1.39 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 113.062 -1.881 . . . . 0.31 114.163 177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -156.49 126.35 6.37 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.995 -0.743 . . . . 0.24 108.995 -176.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.675 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.2 mmt180 -41.83 -49.19 4.44 Favored 'General case' 0 C--O 1.211 -0.94 0 CA-C-N 118.039 0.381 . . . . 1.65 110.995 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.6 t -69.34 -28.16 65.98 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-O 121.368 0.604 . . . . 0.53 111.658 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 24.3 mttm -73.78 -29.95 62.49 Favored 'General case' 0 CA--C 1.51 -0.59 0 CA-C-O 122.618 1.199 . . . . 1.31 108.668 176.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 1.063 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -75.25 -46.27 34.84 Favored 'General case' 0 CA--C 1.486 -1.489 0 CA-C-N 112.358 -2.201 . . . . 0.12 110.358 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.612 HG13 ' HE1' ' A' ' 179' ' ' MET . 43.7 mt -65.97 -42.22 91.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.812 0 CA-C-N 112.71 -2.041 . . . . 0.11 110.046 178.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.0 -52.63 41.99 Favored Glycine 0 N--CA 1.442 -0.946 0 CA-C-N 114.849 -1.069 . . . . 0.15 111.433 172.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.735 HG23 ' CB ' ' A' ' 130' ' ' ALA . 16.7 mt -68.34 -46.95 79.88 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 N-CA-C 112.346 0.498 . . . . 0.18 112.346 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.64 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.71 -39.7 74.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 120.954 0.407 . . . . 0.13 110.693 -178.002 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.529 ' HD2' HG23 ' A' ' 149' ' ' ILE . 34.5 mtp180 -81.41 -23.13 37.77 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.52 0.676 . . . . 1.08 110.894 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.478 HD21 ' CD ' ' A' ' 133' ' ' GLN . 34.9 t30 -81.09 -13.18 58.98 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.627 -1.249 . . . . 0.5 107.627 175.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.682 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -104.92 -29.11 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.355 0 CA-C-N 113.196 -1.82 . . . . 0.17 110.772 -174.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.41 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 98.59 34.6 5.21 Favored Glycine 0 CA--C 1.501 -0.823 0 C-N-CA 120.198 -1.001 . . . . 0.16 112.408 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.692 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -108.92 157.27 18.79 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 112.693 0.627 . . . . 0.12 112.693 -170.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.676 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.7 m80 -96.74 -27.16 14.88 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-N 115.362 -0.835 . . . . 0.2 109.445 179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.581 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 6.1 m-85 -137.29 -174.53 3.78 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 115.061 -0.972 . . . . 0.13 111.325 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.686 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -136.48 140.57 43.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 114.583 -1.19 . . . . 0.08 108.553 166.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.62 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 26.2 tp -110.02 99.89 8.92 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 119.466 -0.893 . . . . 0.16 109.704 166.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 90' ' ' ASP . 2.3 m-85 -77.92 112.03 14.39 Favored 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 114.914 -1.039 . . . . 0.26 108.785 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.69 ' OG ' HD11 ' A' ' 109' ' ' LEU . 4.0 p -120.06 158.93 25.81 Favored 'General case' 0 C--N 1.281 -2.395 0 CA-C-N 115.093 -0.958 . . . . 1.05 109.56 -175.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.8 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.2 p -163.75 172.56 13.99 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 115.154 -0.93 . . . . 0.1 110.875 179.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.558 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -135.67 131.81 36.18 Favored 'General case' 0 N--CA 1.408 -2.559 0 CA-C-N 113.956 -1.475 . . . . 0.11 108.536 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.681 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -142.5 -176.39 4.83 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 109.158 -0.682 . . . . 1.09 109.158 179.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.2 -86.05 0.98 Allowed Glycine 0 CA--C 1.49 -1.492 0 C-N-CA 119.55 -1.309 . . . . 0.15 111.101 172.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.504 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 62.3 t30 -141.59 129.06 21.31 Favored 'General case' 0 C--O 1.198 -1.629 0 CA-C-N 113.867 -1.167 . . . . 0.59 107.963 175.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.586 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.7 p -64.7 -39.39 85.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 CA-C-N 115.226 -0.897 . . . . 0.15 111.991 -172.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.428 ' N ' HG13 ' A' ' 169' ' ' VAL . 14.4 m-20 -61.3 -31.15 70.98 Favored 'General case' 0 CA--C 1.511 -0.556 0 CA-C-O 121.696 0.76 . . . . 1.26 109.411 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.99 88.79 3.17 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 113.916 -1.493 . . . . 0.13 107.962 179.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.797 ' HD2' HG22 ' A' ' 194' ' ' VAL . 51.3 Cg_endo -90.21 165.32 4.61 Favored 'Trans proline' 0 CA--C 1.491 -1.645 0 C-N-CA 124.315 3.343 . . . . 0.09 114.837 -169.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.585 HG22 ' HB3' ' A' ' 191' ' ' LYS . 23.8 m -85.39 117.84 24.55 Favored 'General case' 0 N--CA 1.417 -2.087 0 CA-C-N 113.715 -1.584 . . . . 0.14 107.769 167.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.752 HD12 ' O ' ' A' ' 164' ' ' SER . 38.6 tp -84.31 97.77 9.63 Favored 'General case' 0 N--CA 1.413 -2.3 0 C-N-CA 119.485 -0.886 . . . . 0.16 108.88 177.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.648 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 36.1 mt-30 -87.48 109.0 19.29 Favored 'General case' 0 C--N 1.277 -2.587 0 CA-C-N 114.64 -1.163 . . . . 0.34 109.053 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.582 ' SD ' ' HB3' ' A' ' 163' ' ' SER . 2.6 mmm -111.03 163.57 13.71 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.51 -1.223 . . . . 1.09 111.464 -173.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.619 ' HG2' HD12 ' A' ' 186' ' ' ILE . 36.4 tt0 -172.08 117.59 0.38 Allowed 'General case' 0 C--O 1.202 -1.437 0 CA-C-N 115.978 -0.556 . . . . 0.5 110.114 -166.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.038 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -100.05 101.54 12.64 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.53 -0.915 . . . . 0.1 108.53 -172.34 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.675 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 17.0 ttp -90.66 122.86 33.8 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-N 115.468 -0.787 . . . . 0.07 109.639 176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 179' ' ' MET . 0.1 OUTLIER -59.19 127.19 30.91 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.268 -1.382 . . . . 0.22 107.268 166.466 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.599 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -82.16 -34.4 12.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.172 -1.011 . . . . 0.11 110.701 178.382 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.441 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 30.5 mt-30 -61.88 -15.95 46.69 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.333 -0.848 . . . . 0.35 111.604 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 68.7 p -130.38 -36.74 1.45 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.826 0.822 . . . . 0.19 110.202 176.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.551 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 90.89 23.84 29.18 Favored Glycine 0 N--CA 1.437 -1.25 0 CA-C-N 114.528 -1.214 . . . . 0.18 112.272 -179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -103.63 156.72 17.57 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.656 0.265 . . . . 0.73 110.653 -179.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.619 HD12 ' HG2' ' A' ' 177' ' ' GLN . 35.0 mm -90.07 120.02 38.17 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.616 0.722 . . . . 0.14 109.379 178.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.038 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -108.62 -30.19 2.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.089 0 CA-C-N 114.942 -1.026 . . . . 0.13 110.495 -173.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.671 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.9 t90 -136.36 152.85 51.09 Favored 'General case' 0 CA--C 1.504 -0.814 0 CA-C-N 115.108 -0.951 . . . . 0.07 109.501 172.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.522 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 35.6 p -153.32 163.19 40.35 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 113.253 0.834 . . . . 0.13 113.253 164.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.42 -175.55 29.47 Favored Glycine 0 N--CA 1.428 -1.846 0 N-CA-C 110.967 -0.853 . . . . 0.12 110.967 -178.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.4 mtmt -159.51 149.74 18.98 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 105.704 -1.961 . . . . 1.22 105.704 165.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.44 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -161.13 128.02 1.85 Allowed Glycine 0 C--N 1.28 -2.542 0 C-N-CA 119.601 -1.285 . . . . 0.12 112.142 179.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.597 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.3 120.2 17.57 Favored 'General case' 0 C--N 1.298 -1.661 0 CA-C-O 121.58 0.705 . . . . 0.17 111.116 -174.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.797 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -94.96 158.91 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.573 0 CA-C-N 114.65 -1.159 . . . . 0.11 109.753 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.68 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -100.35 171.34 7.83 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-N 112.981 -1.918 . . . . 0.18 109.292 -174.161 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.548 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 7.6 tt0 -101.5 130.35 47.74 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 109.253 -0.647 . . . . 0.91 109.253 169.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.54 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 19.5 mm-40 . . . . . 0 C--N 1.31 -1.146 0 CA-C-O 118.431 -0.795 . . . . 1.24 110.383 176.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.089 -0.404 . . . . 88.61 112.089 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.3 p -88.26 -5.89 58.1 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 122.137 0.175 . . . . 87.43 111.158 -178.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 26.3 m-70 67.57 172.32 0.27 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.177 0.513 . . . . 87.16 110.692 -176.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 23.4 ptp 40.88 44.94 2.06 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.591 -1.186 . . . . 85.34 111.868 -175.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.5 p -128.41 -26.04 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.326 -0.852 . . . . 85.05 111.098 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 128.01 84.37 0.44 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.692 -0.766 . . . . 84.68 112.383 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -146.65 23.02 1.27 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.651 -0.5 . . . . 85.57 109.651 177.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 58.9 mtm180 54.07 73.44 0.39 Allowed 'General case' 0 C--O 1.238 0.483 0 CA-C-N 115.879 -0.6 . . . . 85.04 110.811 -176.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.81 145.43 96.83 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.821 -0.627 . . . . 82.17 110.407 179.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -60.81 129.53 29.43 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.985 2.456 . . . . 81.51 112.012 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.57 -43.79 93.56 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 112.968 0.729 . . . . 79.56 112.968 -177.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.99 130.44 32.67 Favored 'Trans proline' 0 C--N 1.357 1.012 0 C-N-CA 121.465 1.444 . . . . 78.5 112.119 177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.4 m -133.18 158.42 43.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.427 -0.806 . . . . 77.0 109.968 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -96.38 85.1 3.85 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.322 0.582 . . . . 75.74 109.94 176.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -77.3 152.77 34.4 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.561 -0.745 . . . . 73.91 110.436 -179.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.1 t -70.32 102.46 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.459 -0.791 . . . . 72.3 110.368 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.601 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 0.3 OUTLIER -87.63 -34.3 0.44 Allowed Pre-proline 0 CA--C 1.546 0.801 0 N-CA-C 113.393 0.886 . . . . 71.22 113.393 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 17' ' ' LYS . 39.4 Cg_endo -65.92 102.03 0.51 Allowed 'Trans proline' 0 C--N 1.365 1.441 0 C-N-CA 121.424 1.416 . . . . 69.67 112.259 178.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -85.03 150.07 54.5 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 115.715 -0.675 . . . . 67.55 110.743 179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -50.39 -57.67 2.15 Favored 'Trans proline' 0 C--O 1.238 0.513 0 C-N-CA 123.124 2.549 . . . . 66.7 112.263 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 15.6 mm-40 66.52 161.36 0.15 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.517 0.675 . . . . 65.01 111.915 -179.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.455 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 16.2 mm100 -97.99 132.39 24.8 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.661 -0.7 . . . . 63.41 110.945 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 51.5 Cg_exo -62.66 150.89 86.41 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.939 2.426 . . . . 61.93 112.389 176.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -147.95 82.57 1.5 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.722 -0.672 . . . . 59.87 109.301 174.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.458 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 43.1 mt-10 -80.64 140.99 51.58 Favored Pre-proline 0 C--N 1.318 -0.762 0 CA-C-N 115.58 -0.736 . . . . 58.47 111.418 -175.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 25' ' ' GLU . 38.3 Cg_exo -62.53 98.61 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.927 2.418 . . . . 57.36 111.987 175.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.477 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 20.3 mt-30 -88.88 173.66 8.39 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.247 -0.433 . . . . 55.51 110.55 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 53.1 mt-30 -112.91 93.92 26.95 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.938 0.399 . . . . 53.87 111.12 -178.196 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 4.8 Cg_exo -78.73 137.22 14.11 Favored 'Trans proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.734 2.29 . . . . 52.76 111.542 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.2 t 64.27 97.31 0.04 OUTLIER Pre-proline 0 N--CA 1.464 0.253 0 O-C-N 123.523 0.515 . . . . 50.93 110.664 -177.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.05 -157.04 0.07 OUTLIER 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.63 2.22 . . . . 49.21 112.406 -177.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.0 p -62.44 142.42 57.89 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.224 0.535 . . . . 47.49 111.602 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 91.5 t -136.0 106.2 9.62 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.67 -0.695 . . . . 45.97 109.58 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -55.36 162.91 5.37 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.27 2.647 . . . . 45.28 113.46 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.1 m -86.31 124.57 32.83 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.422 -0.808 . . . . 42.79 110.675 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 52.6 t -115.14 99.39 52.26 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.081 -0.509 . . . . 40.79 110.257 178.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -79.54 -172.31 1.5 Allowed 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.752 2.301 . . . . 39.81 112.191 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 28.8 m -132.25 144.8 50.87 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.893 0.378 . . . . 37.5 110.795 -178.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 11.6 mt -105.2 105.21 51.0 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.087 -0.506 . . . . 35.65 109.959 177.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.48 ' HB2' HE21 ' A' ' 42' ' ' GLN . 8.5 Cg_exo -70.97 102.46 1.22 Allowed 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.493 2.129 . . . . 33.72 112.243 -179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 78.9 mm-40 -61.85 -51.3 68.75 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.916 -0.314 . . . . 31.51 110.169 -178.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.48 HE21 ' HB2' ' A' ' 40' ' ' PRO . 76.5 mt-30 61.09 75.33 0.46 Allowed Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.284 -0.871 . . . . 30.13 111.071 -178.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -68.72 141.62 50.27 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.686 2.258 . . . . 29.52 111.564 178.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -147.48 158.35 27.69 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.635 -0.793 . . . . 26.75 111.841 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.34 126.25 9.63 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.848 2.366 . . . . 25.08 113.02 -175.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 41.0 mt -74.65 -54.3 14.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.679 -0.489 . . . . 23.9 109.679 175.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 58.69 79.41 0.22 Allowed 'General case' 0 N--CA 1.464 0.243 0 O-C-N 123.83 0.706 . . . . 21.23 109.734 175.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 56.7 p-80 -133.93 149.33 51.27 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-N 115.816 -0.629 . . . . 19.92 111.862 -173.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -166.18 139.19 4.05 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 114.617 -1.174 . . . . 16.56 109.554 -176.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -121.75 45.1 2.4 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.679 0.752 . . . . 15.05 109.955 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -87.5 131.34 34.39 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.955 -1.021 . . . . 14.19 110.19 178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 46.9 p -64.66 148.73 50.39 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.591 0.71 . . . . 11.38 111.304 -179.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.14 -46.41 0.34 Allowed Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.044 -0.98 . . . . 8.29 113.397 -173.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -85.98 111.9 1.17 Allowed 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.232 1.955 . . . . 6.87 112.574 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_endo -85.53 76.71 2.91 Favored 'Trans proline' 0 N--CA 1.459 -0.55 0 C-N-CA 122.706 2.271 . . . . 5.04 111.751 177.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 66.23 106.96 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.338 0 O-C-N 123.668 0.605 . . . . 2.59 110.683 -176.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.16 -177.18 1.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.858 2.372 . . . . 1.64 113.372 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -132.4 153.46 50.78 Favored 'General case' 0 C--N 1.307 -1.242 0 CA-C-N 114.623 -1.171 . . . . 3.39 110.925 -173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.602 HG22 ' N ' ' A' ' 60' ' ' ARG . 8.5 mt -90.03 168.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 CA-C-N 114.86 -1.064 . . . . 0.44 110.665 178.315 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 59' ' ' ILE . 20.6 mtt85 -67.29 -158.92 0.02 OUTLIER 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.34 1.543 . . . . 2.34 111.743 179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.717 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 19.2 t-160 -160.09 149.07 17.39 Favored 'General case' 0 CA--C 1.468 -2.191 0 CA-C-N 112.105 -2.316 . . . . 2.22 105.911 178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.73 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.0 m-30 -125.3 160.94 28.07 Favored 'General case' 0 N--CA 1.415 -2.219 0 O-C-N 123.671 0.607 . . . . 0.21 109.41 -175.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.561 ' HB3' ' HB2' ' A' ' 195' ' ' SER . 6.1 t70 -81.49 67.51 7.47 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-O 123.499 1.619 . . . . 0.35 107.931 170.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.734 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 93.3 m95 -59.64 -42.34 92.55 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 111.933 -2.394 . . . . 0.1 111.911 174.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.487 ' N ' HG21 ' A' ' 108' ' ' THR . 8.9 t-20 -52.53 -24.88 8.94 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.062 -1.426 . . . . 1.11 111.452 173.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -79.49 -16.73 77.34 Favored Glycine 0 C--N 1.312 -0.773 0 CA-C-N 115.129 -0.941 . . . . 0.21 111.175 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.16 -55.11 2.55 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 113.897 -1.152 . . . . 0.13 111.41 -177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.729 ' O ' HG23 ' A' ' 72' ' ' VAL . 40.9 mtt -64.05 -57.21 10.34 Favored 'General case' 0 C--O 1.21 -1.024 0 CA-C-N 114.117 -1.401 . . . . 0.09 112.893 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.611 HE22 ' ND2' ' A' ' 115' ' ' ASN . 0.0 OUTLIER -38.85 -54.93 2.96 Favored Pre-proline 0 C--N 1.319 -0.754 0 N-CA-C 114.53 1.307 . . . . 0.63 114.53 -176.456 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.803 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 36.7 Cg_endo -64.71 -31.64 58.39 Favored 'Trans proline' 0 C--O 1.217 -0.558 0 C-N-CA 121.949 1.766 . . . . 0.14 110.956 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.754 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 10.2 mtm -79.58 -44.04 21.81 Favored 'General case' 0 CA--C 1.507 -0.695 0 CA-C-N 115.433 -0.803 . . . . 0.7 111.54 -177.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.729 HG23 ' O ' ' A' ' 68' ' ' MET . 40.5 t -57.17 -39.09 64.76 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 114.366 -1.288 . . . . 0.12 108.509 175.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.7 t -59.19 -36.44 75.35 Favored 'General case' 0 C--N 1.312 -1.031 0 CA-C-N 113.153 -1.839 . . . . 0.56 110.811 174.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.803 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 32.8 mtpt -81.55 -34.13 31.3 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 121.168 0.508 . . . . 1.3 110.823 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.85 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.54 -29.07 70.38 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.235 -0.893 . . . . 0.5 111.563 -171.785 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.564 HD13 ' HB2' ' A' ' 118' ' ' LYS . 6.0 mt -90.77 -8.07 50.7 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-O 121.922 0.867 . . . . 0.65 111.118 -177.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.38 13.09 58.49 Favored Glycine 0 N--CA 1.439 -1.142 0 N-CA-C 109.182 -1.567 . . . . 0.17 109.182 172.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.639 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -83.54 160.25 21.5 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 114.441 -0.879 . . . . 0.1 110.245 -179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -85.47 106.29 16.71 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 115.062 -0.972 . . . . 1.72 110.115 176.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.636 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.52 -22.8 3.67 Favored Glycine 0 N--CA 1.429 -1.773 0 N-CA-C 110.766 -0.933 . . . . 0.12 110.766 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 75' ' ' MET . 11.3 p -102.95 150.0 6.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.639 0.733 . . . . 0.16 111.514 -176.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 41.0 m -137.61 141.33 41.26 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.695 -1.139 . . . . 0.45 111.135 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.66 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.97 132.36 49.69 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 114.745 -1.116 . . . . 0.28 111.285 169.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.57 2.27 37.52 Favored Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.859 -0.686 . . . . 0.28 112.709 176.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.26 149.91 22.86 Favored 'General case' 0 CA--C 1.506 -0.73 0 C-N-CA 120.233 -0.587 . . . . 1.2 110.923 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.671 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.8 p -79.48 117.55 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 CA-C-O 122.196 0.998 . . . . 0.2 108.871 164.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.784 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -104.92 109.75 21.85 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.521 -0.918 . . . . 0.14 108.521 -172.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.693 ' HG ' ' HA ' ' A' ' 152' ' ' ALA . 0.8 OUTLIER -71.27 94.06 1.16 Allowed 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.788 -1.19 . . . . 0.15 107.788 176.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.519 HG11 ' HG3' ' A' ' 110' ' ' ARG . 1.1 m -72.87 116.14 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.767 0 N-CA-C 107.124 -1.436 . . . . 0.95 107.124 178.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.847 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 8.3 t0 -76.98 154.77 33.2 Favored 'General case' 0 CA--C 1.488 -1.413 0 N-CA-C 107.723 -1.214 . . . . 0.64 107.723 -177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.551 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.0 OUTLIER -58.05 136.38 57.15 Favored 'General case' 0 N--CA 1.423 -1.8 0 N-CA-C 107.527 -1.286 . . . . 0.37 107.527 171.648 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.509 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 21.8 t -64.0 139.0 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.091 0 N-CA-C 107.835 -1.172 . . . . 0.1 107.835 168.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.818 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.6 t-20 -85.61 163.24 18.45 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-N 115.128 -0.942 . . . . 0.18 110.063 174.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.751 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.31 85.25 2.38 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.407 -1.27 . . . . 0.12 108.187 176.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.476 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 9.7 mtp180 -108.88 -1.12 19.37 Favored 'General case' 0 CA--C 1.502 -0.87 0 CA-C-N 114.056 -1.429 . . . . 0.64 108.644 -172.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.732 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.6 p -53.36 -171.76 0.0 OUTLIER 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 112.991 -1.913 . . . . 0.14 115.106 -176.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.528 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 22.4 t30 -67.45 -13.31 61.92 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 112.712 -2.04 . . . . 0.48 110.479 172.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.579 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -149.71 -145.02 4.05 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.259 -0.972 . . . . 0.12 113.109 -176.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.619 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.4 p -121.89 132.65 54.67 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.18 0.514 . . . . 1.16 111.747 -178.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.751 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.0 pp -137.75 157.01 47.36 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 121.827 0.822 . . . . 0.1 110.641 -178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.627 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.4 t-20 -80.57 79.43 7.19 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 113.959 -1.473 . . . . 0.17 107.647 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.565 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.16 -14.26 62.85 Favored 'General case' 0 C--N 1.29 -2.002 0 CA-C-N 114.545 -1.207 . . . . 0.09 109.836 179.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.586 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.17 -30.01 38.78 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.632 -0.877 . . . . 0.15 108.632 -178.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.627 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.1 tp10 -67.93 -34.01 75.78 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-N 114.304 -1.317 . . . . 1.73 109.104 171.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.44 -43.69 66.23 Favored 'General case' 0 N--CA 1.431 -1.389 0 CA-C-N 113.213 -1.812 . . . . 0.12 109.613 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.551 ' CG2' ' HA ' ' A' ' 91' ' ' SER . 63.5 m -63.56 -28.13 69.73 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 113.73 -1.577 . . . . 0.11 110.159 179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.414 ' HB3' ' O ' ' A' ' 104' ' ' GLU . 3.7 tp10 -66.04 -52.06 52.5 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 108.16 -1.052 . . . . 1.47 108.16 169.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.665 HG21 ' HB2' ' A' ' 64' ' ' TRP . 32.2 m -56.36 -33.93 66.15 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.669 -0.696 . . . . 0.12 111.319 177.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.723 HD23 ' SD ' ' A' ' 68' ' ' MET . 8.7 mt -50.46 -68.02 0.21 Allowed 'General case' 0 CA--C 1.493 -1.239 0 CA-C-N 116.12 -0.491 . . . . 0.56 109.799 172.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.55 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.7 mtp180 -43.04 -35.47 1.28 Allowed 'General case' 0 C--N 1.311 -1.068 0 CA-C-O 122.129 0.966 . . . . 1.51 111.194 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.604 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -72.56 -45.62 58.36 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-N 114.49 -1.232 . . . . 0.28 112.101 -175.501 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -75.56 -33.59 60.66 Favored 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 108.309 -0.997 . . . . 0.09 108.309 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.5 mm? -62.99 -34.45 77.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 113.651 -1.613 . . . . 0.12 110.064 173.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -69.84 -38.28 76.45 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 114.521 -1.218 . . . . 0.2 111.208 -175.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . 0.611 ' ND2' HE22 ' A' ' 69' ' ' GLN . 0.0 OUTLIER -60.97 -29.21 69.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.736 -1.12 . . . . 1.17 111.179 -175.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -81.31 -30.25 33.98 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 115.746 -0.661 . . . . 2.05 111.141 -174.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 64.28 3.82 10.36 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.049 -0.596 . . . . 0.54 113.228 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.66 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 54.2 mtpt -88.28 -6.31 57.84 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-O 120.963 0.411 . . . . 0.99 110.092 178.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.784 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 27.8 m-85 -122.49 175.32 6.52 Favored 'General case' 0 CA--C 1.494 -1.204 0 CA-C-O 122.491 1.139 . . . . 0.21 113.099 172.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.568 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 7.1 m -121.11 119.26 31.9 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 112.621 -2.081 . . . . 0.23 107.947 168.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.65 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -89.6 139.44 30.55 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.345 -0.942 . . . . 0.38 111.319 -170.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.76 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.6 m -91.38 147.09 5.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 108.222 -1.029 . . . . 0.42 108.222 170.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.538 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -103.12 178.22 4.62 Favored 'General case' 0 C--N 1.314 -0.971 0 C-N-CA 120.188 -0.605 . . . . 1.7 110.574 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -60.23 -33.34 72.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.422 0.63 . . . . 0.55 110.414 178.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.683 ' O ' ' HG3' ' A' ' 129' ' ' MET . 9.6 pt20 -47.47 -35.88 9.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 114.285 -1.325 . . . . 2.04 111.374 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.76 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 4.3 mt-30 -97.93 -54.08 3.2 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 122.052 0.93 . . . . 0.41 110.107 173.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.67 HD13 HD21 ' A' ' 88' ' ' LEU . 26.1 tp -63.86 -65.23 0.71 Allowed 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 113.367 -1.742 . . . . 1.39 113.104 -168.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.66 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.8 t -50.47 -43.73 55.49 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 123.365 1.555 . . . . 1.05 109.117 -177.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.737 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.3 OUTLIER -57.69 -61.42 2.52 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-N 111.145 -2.752 . . . . 1.64 110.521 177.361 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.759 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.76 -45.79 7.35 Favored 'General case' 0 CA--C 1.503 -0.865 0 O-C-N 124.564 1.165 . . . . 0.31 112.169 175.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.513 ' HA ' HD11 ' A' ' 151' ' ' ILE . 0.4 OUTLIER -54.44 -53.23 56.96 Favored 'General case' 0 C--O 1.211 -0.947 0 N-CA-C 108.701 -0.851 . . . . 1.53 108.701 179.138 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 128' ' ' SER . 40.2 mt-30 -63.83 -39.89 95.29 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 115.563 -0.744 . . . . 0.41 111.287 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.737 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.9 mt-30 -58.89 -35.07 72.42 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 114.471 -1.24 . . . . 0.37 109.548 179.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.505 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -90.06 -30.67 17.57 Favored 'General case' 0 N--CA 1.424 -1.76 0 CA-C-N 113.798 -1.546 . . . . 0.24 109.502 -176.726 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 152.27 -45.89 0.6 Allowed Glycine 0 CA--C 1.495 -1.162 0 CA-C-O 122.422 1.012 . . . . 0.33 113.376 -179.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.602 HD13 ' O ' ' A' ' 141' ' ' SER . 92.3 mt -66.38 -171.09 0.11 Allowed 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.362 -1.919 . . . . 0.31 115.613 -170.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.575 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 5.1 m -115.78 151.45 46.33 Favored Pre-proline 0 N--CA 1.426 -1.641 0 CA-C-N 110.716 -2.947 . . . . 0.81 107.924 174.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.66 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 34.0 Cg_endo -64.81 0.2 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 122.526 2.151 . . . . 0.32 112.638 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.586 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -119.13 -23.9 6.66 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 121.871 0.843 . . . . 1.25 110.811 -178.433 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.575 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 14.4 t70 -61.4 -21.5 64.15 Favored 'General case' 0 CA--C 1.487 -1.459 0 CA-C-N 113.471 -1.695 . . . . 0.65 109.359 -173.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.602 ' O ' HD13 ' A' ' 136' ' ' LEU . 26.3 m 70.56 167.84 0.3 Allowed 'General case' 0 N--CA 1.42 -1.953 0 CA-C-N 112.641 -2.072 . . . . 0.6 110.12 -175.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.947 HD22 ' HA ' ' A' ' 148' ' ' ALA . 5.4 mt -64.97 -40.29 94.77 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.257 -1.016 . . . . 0.86 108.257 -177.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 62.39 -10.16 0.12 Allowed Glycine 0 C--N 1.32 -0.357 0 CA-C-N 113.098 -1.864 . . . . 0.31 114.586 177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.427 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.7 OUTLIER -153.8 124.51 7.19 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.026 -0.731 . . . . 0.24 109.026 -175.358 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.686 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.3 mmt180 -41.28 -45.69 3.02 Favored 'General case' 0 C--O 1.212 -0.884 0 N-CA-C 112.101 0.408 . . . . 1.65 112.101 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 31.3 t -75.04 -25.58 58.81 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.791 0.805 . . . . 0.53 111.247 -174.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.551 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 48.2 mttt -72.77 -29.28 63.18 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-O 122.755 1.264 . . . . 1.31 108.156 175.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.947 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -77.57 -49.02 15.52 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 112.31 -2.223 . . . . 0.12 110.273 179.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.629 HG13 ' HE1' ' A' ' 179' ' ' MET . 38.3 mt -65.26 -41.19 90.88 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-N 113.016 -1.902 . . . . 0.11 110.151 179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.84 -55.0 25.61 Favored Glycine 0 N--CA 1.437 -1.263 0 CA-C-N 114.745 -1.116 . . . . 0.15 111.09 171.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.759 HG23 ' CB ' ' A' ' 130' ' ' ALA . 87.6 mt -66.78 -47.34 83.16 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.075 0 N-CA-C 112.637 0.606 . . . . 0.18 112.637 -178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.693 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.0 -41.14 74.4 Favored 'General case' 0 C--N 1.307 -1.249 0 CA-C-O 121.046 0.45 . . . . 0.13 111.133 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.518 ' HD2' HG23 ' A' ' 149' ' ' ILE . 54.3 mtp180 -81.01 -23.15 38.86 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-O 121.852 0.835 . . . . 1.08 110.242 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.463 HD21 ' CD ' ' A' ' 133' ' ' GLN . 12.7 t30 -82.73 -10.7 58.78 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 107.323 -1.362 . . . . 0.5 107.323 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.723 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.14 -28.8 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 113.148 -1.842 . . . . 0.17 110.965 -174.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.403 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.74 35.26 4.66 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.443 -0.884 . . . . 0.16 112.6 -179.258 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.684 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.4 159.5 16.96 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 113.02 0.748 . . . . 0.12 113.02 -169.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.671 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -98.64 -29.11 13.23 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 115.211 -0.904 . . . . 0.2 109.434 178.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.577 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.4 m-85 -135.51 -173.17 3.27 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.055 -0.975 . . . . 0.13 111.037 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.691 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -136.74 138.54 46.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.864 0 CA-C-N 114.645 -1.161 . . . . 0.08 108.921 166.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.598 HD21 ' SD ' ' A' ' 176' ' ' MET . 35.1 tp -107.85 100.96 10.28 Favored 'General case' 0 N--CA 1.43 -1.453 0 C-N-CA 119.435 -0.906 . . . . 0.16 109.137 165.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.625 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.4 m-85 -78.5 119.04 21.24 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.401 -1.272 . . . . 0.26 108.131 177.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.864 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 13.3 t -130.69 158.76 39.19 Favored 'General case' 0 C--N 1.283 -2.294 0 CA-C-O 122.12 0.962 . . . . 1.05 110.413 178.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.818 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.5 p -162.03 170.67 18.86 Favored 'General case' 0 N--CA 1.418 -2.069 0 CA-C-N 114.038 -1.437 . . . . 0.1 110.718 -176.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -132.27 135.73 46.46 Favored 'General case' 0 N--CA 1.406 -2.666 0 CA-C-N 114.044 -1.434 . . . . 0.11 108.766 177.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.66 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.7 t -144.52 -170.69 3.44 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.608 -0.837 . . . . 1.09 110.376 176.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 89.84 -83.23 1.38 Allowed Glycine 0 C--N 1.289 -2.065 0 CA-C-N 114.906 -1.043 . . . . 0.15 111.062 175.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.528 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 57.7 t30 -141.67 129.37 21.6 Favored 'General case' 0 C--O 1.199 -1.602 0 CA-C-N 113.872 -1.164 . . . . 0.59 108.205 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.579 HG11 ' HA3' ' A' ' 98' ' ' GLY . 4.2 p -65.28 -41.88 92.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 CA-C-N 115.378 -0.828 . . . . 0.15 112.63 -171.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.425 ' N ' HG13 ' A' ' 169' ' ' VAL . 9.7 m120 -61.56 -29.44 70.02 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.378 0.608 . . . . 1.26 109.462 -178.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.35 88.93 3.35 Favored Pre-proline 0 C--N 1.315 -0.933 0 CA-C-N 114.592 -1.185 . . . . 0.13 108.9 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.812 ' HD2' HG22 ' A' ' 194' ' ' VAL . 40.7 Cg_endo -92.24 163.88 3.08 Favored 'Trans proline' 0 CA--C 1.501 -1.147 0 C-N-CA 124.858 3.705 . . . . 0.09 115.458 -170.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.743 HG22 ' HB3' ' A' ' 191' ' ' LYS . 14.3 m -82.73 120.54 25.72 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 113.837 -1.529 . . . . 0.14 107.563 168.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.889 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 22.1 tp -82.78 95.16 7.8 Favored 'General case' 0 CA--C 1.476 -1.901 0 C-N-CA 119.434 -0.906 . . . . 0.16 109.11 178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.503 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 35.8 mt-30 -86.18 107.74 18.02 Favored 'General case' 0 C--N 1.257 -3.434 0 CA-C-O 122.044 0.926 . . . . 0.34 108.61 -177.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.864 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.0 OUTLIER -111.85 163.18 14.48 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 114.893 -1.048 . . . . 1.09 111.245 -174.428 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 55.4 tt0 -170.48 117.81 0.53 Allowed 'General case' 0 C--O 1.204 -1.332 0 CA-C-N 115.87 -0.604 . . . . 0.5 110.327 -167.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.032 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -100.1 100.51 11.38 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.414 -0.958 . . . . 0.1 108.414 -173.315 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.686 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.6 ttp -90.61 123.39 34.2 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.492 -0.776 . . . . 0.07 109.608 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -59.96 126.65 28.37 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.096 -1.446 . . . . 0.22 107.096 166.689 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.613 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.3 OUTLIER -81.6 -35.06 13.46 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 C-N-CA 119.103 -1.039 . . . . 0.11 110.81 179.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.426 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 29.9 mt-30 -62.81 -15.06 52.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.377 -0.828 . . . . 0.35 111.58 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 81.1 p -130.05 -34.89 1.64 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-O 121.724 0.773 . . . . 0.19 110.276 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.478 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 84.6 29.83 28.65 Favored Glycine 0 N--CA 1.436 -1.327 0 CA-C-N 114.462 -1.244 . . . . 0.18 112.12 -178.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 179' ' ' MET . 9.8 pt-20 -105.3 158.19 16.79 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.42 -0.39 . . . . 0.73 110.447 179.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.619 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.0 mm -93.58 112.07 25.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-O 121.623 0.725 . . . . 0.14 109.659 177.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.032 HD11 HD13 ' A' ' 178' ' ' LEU . 1.2 pp -99.48 -30.85 3.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.067 -0.969 . . . . 0.13 110.853 -173.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.648 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 82.0 t90 -136.76 152.82 50.76 Favored 'General case' 0 CA--C 1.504 -0.82 0 CA-C-N 115.403 -0.817 . . . . 0.07 109.743 173.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.489 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 35.9 p -153.99 163.9 39.31 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 113.107 0.78 . . . . 0.13 113.107 165.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.01 -173.65 27.69 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 111.125 -0.79 . . . . 0.12 111.125 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.889 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.5 mttt -158.8 148.96 19.54 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 106.409 -1.7 . . . . 1.22 106.409 165.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.481 ' C ' ' H ' ' A' ' 174' ' ' LEU . . . -154.13 125.38 1.72 Allowed Glycine 0 N--CA 1.421 -2.32 0 C-N-CA 118.574 -1.774 . . . . 0.12 113.905 176.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.75 107.93 5.46 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.648 0.737 . . . . 0.17 110.862 -174.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.812 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -88.57 158.81 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.576 0 CA-C-N 114.224 -1.353 . . . . 0.11 110.586 -175.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.73 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -100.47 171.99 7.4 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 112.573 -2.103 . . . . 0.18 108.751 -175.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 8.8 tt0 -101.82 132.86 47.35 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 120.086 -0.646 . . . . 0.91 109.621 172.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.54 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 36.0 mm-40 . . . . . 0 C--O 1.25 1.127 0 CA-C-O 118.496 -0.764 . . . . 1.24 110.672 177.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.646 -0.582 . . . . 88.61 111.646 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -121.87 -57.66 1.78 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.639 0.257 . . . . 87.43 110.545 178.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 61.3 m80 67.52 114.02 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.477 -0.783 . . . . 87.16 110.847 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 90.8 mtp -120.5 147.73 44.76 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.128 -0.487 . . . . 85.34 110.436 -177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.5 p 48.91 15.75 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 C-N-CA 125.183 1.393 . . . . 85.05 113.411 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -99.38 -60.05 0.87 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.652 -0.785 . . . . 84.68 111.584 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.5 pm0 -87.81 43.69 1.13 Allowed 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 122.553 1.168 . . . . 85.57 110.573 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.462 ' C ' ' HD3' ' A' ' 10' ' ' PRO . 97.9 mtt180 59.93 63.59 1.43 Allowed 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 113.15 -1.841 . . . . 85.04 111.785 -175.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -125.86 69.2 64.41 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.166 -0.925 . . . . 82.17 110.324 178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.462 ' HD3' ' C ' ' A' ' 8' ' ' ARG . 3.5 Cg_exo -81.55 -71.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.417 2.745 . . . . 81.51 111.566 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -163.35 109.66 0.99 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 116.082 -0.508 . . . . 79.56 110.28 -178.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.03 137.7 69.63 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.947 2.432 . . . . 78.5 112.043 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.7 m -139.67 157.01 26.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.835 -0.62 . . . . 77.0 110.677 -176.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -103.71 139.3 39.15 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.738 -0.838 . . . . 75.74 108.738 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -58.9 137.74 57.69 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 116.368 -0.378 . . . . 73.91 111.59 -173.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.4 t -65.21 118.5 7.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.275 0.56 . . . . 72.3 109.531 177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.407 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 48.5 mttp -76.78 -45.9 3.05 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 115.631 -0.713 . . . . 71.22 111.816 -175.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.407 ' HD2' ' N ' ' A' ' 17' ' ' LYS . 72.0 Cg_endo -76.61 177.03 9.34 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 121.454 1.436 . . . . 69.67 111.679 171.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.539 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . . . -153.24 -61.58 0.02 OUTLIER Pre-proline 0 C--N 1.326 -0.414 0 CA-C-O 119.369 -0.348 . . . . 67.55 111.858 175.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 19' ' ' ALA . 94.5 Cg_endo -77.82 -7.6 16.57 Favored 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 121.521 1.481 . . . . 66.7 112.896 179.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 64.48 -171.46 0.18 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.78 -0.646 . . . . 65.01 110.563 -177.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -128.28 75.32 79.1 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.477 -0.564 . . . . 63.41 109.477 174.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -60.61 139.0 83.66 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.971 2.447 . . . . 61.93 113.058 -177.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.403 ' O ' ' HD3' ' A' ' 26' ' ' PRO . . . -126.54 92.44 3.56 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.328 -0.851 . . . . 59.87 110.0 -179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 25' ' ' GLU . 1.2 tt0 -93.21 110.83 48.81 Favored Pre-proline 0 N--CA 1.437 -1.093 0 CA-C-N 115.627 -0.715 . . . . 58.47 109.671 -177.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 24' ' ' ALA . 70.9 Cg_endo -93.5 102.68 0.15 Allowed 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 123.057 2.505 . . . . 57.36 112.31 178.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 84.6 mm-40 -127.98 -62.39 1.06 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.531 0.681 . . . . 55.51 110.659 177.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 56.96 71.55 1.12 Allowed Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 114.065 -1.425 . . . . 53.87 110.974 -176.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -64.89 -26.91 59.05 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.52 2.147 . . . . 52.76 112.768 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.7 m -71.02 123.37 89.21 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-O 120.853 0.359 . . . . 50.93 111.115 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.7 152.26 32.87 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.551 2.167 . . . . 49.21 112.588 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.58 170.73 10.23 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.398 0.618 . . . . 47.49 110.723 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.55 121.34 9.06 Favored Pre-proline 0 C--N 1.316 -0.88 0 CA-C-N 115.177 -0.919 . . . . 45.97 110.504 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_exo -57.66 159.37 17.19 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 123.287 2.658 . . . . 45.28 112.648 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.6 p -74.05 130.29 39.54 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.173 -0.922 . . . . 42.79 111.287 -176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.405 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.4 p -143.19 130.7 10.91 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 115.727 -0.67 . . . . 40.79 110.338 -178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 11.0 Cg_exo -71.24 -170.47 0.5 Allowed 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.609 2.206 . . . . 39.81 111.22 174.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.5 t -128.26 140.87 51.65 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.251 0.548 . . . . 37.5 110.733 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.9 mt -103.53 127.88 28.62 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.625 -0.716 . . . . 35.65 110.335 -179.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -66.1 113.72 2.73 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.183 1.922 . . . . 33.72 111.759 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.478 ' O ' ' HD3' ' A' ' 43' ' ' PRO . 14.8 mm100 -97.74 59.53 1.48 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.117 0.484 . . . . 31.51 110.172 178.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -109.65 92.47 12.24 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.109 -0.496 . . . . 30.13 110.637 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 41' ' ' GLN . 83.5 Cg_endo -91.86 154.91 3.38 Favored 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.899 2.399 . . . . 29.52 112.118 178.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.404 ' HA2' ' HD3' ' A' ' 45' ' ' PRO . . . -167.92 162.32 36.11 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.457 -0.878 . . . . 26.75 112.059 177.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' HD3' ' HA2' ' A' ' 44' ' ' GLY . 48.7 Cg_endo -97.17 135.32 0.4 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 123.911 3.074 . . . . 25.08 112.988 -175.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 25.2 mm -73.78 -50.03 31.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.053 -0.521 . . . . 23.9 110.21 172.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 36.16 74.51 0.07 Allowed 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.61 1.164 . . . . 21.23 113.246 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 25.9 p-80 -76.07 164.94 25.63 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.143 0.497 . . . . 19.92 110.858 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -119.36 174.92 6.07 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.542 -0.754 . . . . 16.56 109.305 178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -95.22 88.23 5.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.25 -0.648 . . . . 15.05 109.25 173.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.3 tt0 -64.95 82.14 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 O-C-N 123.853 0.72 . . . . 14.19 110.462 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 32.3 p -137.07 127.62 26.84 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 116.311 -0.404 . . . . 11.38 111.347 -179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.53 106.89 3.79 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-N 115.183 -0.917 . . . . 8.29 110.367 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -68.55 124.49 11.64 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.334 2.023 . . . . 6.87 111.957 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.77 -38.84 7.22 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 121.963 1.775 . . . . 5.04 111.636 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -147.05 148.45 32.39 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.814 -0.63 . . . . 2.59 110.351 -178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.78 -177.73 2.02 Favored 'Trans proline' 0 CA--C 1.509 -0.761 0 C-N-CA 123.389 2.726 . . . . 1.64 111.297 174.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.8 m170 -104.72 133.58 49.3 Favored 'General case' 0 C--N 1.3 -1.564 0 CA-C-N 114.727 -1.124 . . . . 3.39 111.098 -175.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.677 ' HB ' ' HB2' ' A' ' 101' ' ' ASN . 14.1 mt -79.15 174.38 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.571 -1.195 . . . . 0.44 112.213 -171.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.627 ' N ' HG22 ' A' ' 59' ' ' ILE . 45.9 mtt180 -62.76 -158.0 0.01 OUTLIER 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.12 -1.855 . . . . 2.34 112.432 176.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.686 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 16.8 t-160 -155.56 150.97 27.04 Favored 'General case' 0 CA--C 1.471 -2.08 0 CA-C-N 112.126 -2.306 . . . . 2.22 106.114 176.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.742 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 -125.24 160.13 29.97 Favored 'General case' 0 N--CA 1.418 -2.046 0 O-C-N 123.827 0.705 . . . . 0.21 109.499 -176.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.512 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 5.1 t70 -82.49 67.47 8.54 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-O 123.618 1.675 . . . . 0.35 108.144 171.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.732 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 91.9 m95 -57.58 -42.98 84.19 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 111.678 -2.51 . . . . 0.1 112.026 175.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.428 ' N ' HG21 ' A' ' 108' ' ' THR . 13.4 t-20 -51.21 -28.3 11.08 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 113.914 -1.494 . . . . 1.11 111.331 174.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.42 -18.56 79.06 Favored Glycine 0 N--CA 1.442 -0.952 0 CA-C-N 115.096 -0.956 . . . . 0.21 111.258 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.84 -54.35 2.84 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.868 -1.166 . . . . 0.13 110.879 -176.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.712 ' SD ' HD23 ' A' ' 109' ' ' LEU . 40.8 mtt -60.2 -62.54 1.79 Allowed 'General case' 0 C--O 1.21 -0.998 0 CA-C-N 113.878 -1.51 . . . . 0.09 111.61 -177.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.462 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 0.0 OUTLIER -37.22 -54.89 1.87 Allowed Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 114.593 1.331 . . . . 0.63 114.593 -172.259 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.745 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 34.4 Cg_endo -64.14 -31.56 64.54 Favored 'Trans proline' 0 C--N 1.357 0.976 0 C-N-CA 122.355 2.036 . . . . 0.14 111.001 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.718 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 8.1 mtm -78.24 -43.96 26.86 Favored 'General case' 0 C--O 1.21 -1.018 0 CA-C-N 114.988 -1.005 . . . . 0.7 111.271 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.662 HG23 ' O ' ' A' ' 68' ' ' MET . 42.4 t -58.57 -38.94 73.86 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.969 0 CA-C-N 114.284 -1.326 . . . . 0.12 108.716 176.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.2 t -58.71 -37.25 75.72 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 112.956 -1.929 . . . . 0.56 111.026 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.745 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 4.8 mtpm? -78.57 -41.92 30.63 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.627 -0.509 . . . . 1.3 109.627 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.841 ' SD ' ' HE2' ' A' ' 119' ' ' PHE . 1.0 OUTLIER -45.88 -53.53 9.64 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 123.724 0.809 . . . . 0.5 110.099 -175.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.64 ' N ' ' HG2' ' A' ' 75' ' ' MET . 3.9 mt -80.29 7.41 9.58 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.288 -1.324 . . . . 0.65 112.249 -170.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -120.55 15.62 9.82 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.075 -1.421 . . . . 0.17 109.805 170.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.595 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -80.54 165.25 22.29 Favored 'General case' 0 CA--C 1.51 -0.574 0 CA-C-O 121.235 0.54 . . . . 0.1 110.423 176.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -87.8 105.81 17.65 Favored 'General case' 0 CA--C 1.494 -1.202 0 CA-C-N 115.597 -0.729 . . . . 1.72 109.124 175.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.673 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.29 -25.37 3.02 Favored Glycine 0 N--CA 1.415 -2.731 0 C-N-CA 119.623 -1.275 . . . . 0.12 110.437 -178.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.763 HG11 ' O ' ' A' ' 75' ' ' MET . 12.8 p -103.21 149.35 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 121.86 0.838 . . . . 0.16 111.365 -177.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.1 m -135.52 140.33 44.66 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.692 -1.14 . . . . 0.45 110.744 177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.594 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -54.77 131.49 43.95 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.07 -0.968 . . . . 0.28 110.698 168.426 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 106.04 0.2 38.62 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.951 -0.642 . . . . 0.28 113.271 176.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.87 151.22 23.52 Favored 'General case' 0 CA--C 1.506 -0.732 0 C-N-CA 120.537 -0.465 . . . . 1.2 111.081 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.712 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.1 p -81.16 120.81 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.151 0 CA-C-O 121.865 0.84 . . . . 0.2 109.074 165.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.725 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -108.42 111.02 22.7 Favored 'General case' 0 C--N 1.303 -1.439 0 CA-C-N 115.412 -0.813 . . . . 0.14 109.061 -171.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.762 HD21 HD23 ' A' ' 127' ' ' LEU . 0.6 OUTLIER -72.31 101.09 2.78 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-N 114.849 -1.069 . . . . 0.15 109.329 -179.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.548 HG21 ' HG3' ' A' ' 110' ' ' ARG . 53.1 t -74.34 106.28 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.296 0 CA-C-N 114.495 -1.229 . . . . 0.95 109.511 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.912 ' OD1' ' HG ' ' A' ' 142' ' ' LEU . 2.3 t70 -78.29 158.39 28.89 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 114.592 -1.186 . . . . 0.64 108.344 178.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.622 ' OG ' ' HA ' ' A' ' 141' ' ' SER . 0.0 OUTLIER -62.32 135.28 57.39 Favored 'General case' 0 N--CA 1.42 -1.936 0 CA-C-N 115.378 -0.828 . . . . 0.37 109.325 175.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.599 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 33.4 t -62.28 138.49 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.015 0 N-CA-C 106.983 -1.488 . . . . 0.1 106.983 167.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.842 ' H ' ' HA ' ' A' ' 164' ' ' SER . 6.0 t-20 -85.01 161.49 19.73 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.836 0.827 . . . . 0.18 110.114 174.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.766 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.95 84.94 2.34 Favored 'General case' 0 C--N 1.291 -1.978 0 CA-C-N 114.368 -1.287 . . . . 0.12 108.261 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.405 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 14.1 mtp180 -108.51 -2.75 18.68 Favored 'General case' 0 CA--C 1.503 -0.853 0 CA-C-N 113.912 -1.495 . . . . 0.64 108.572 -172.07 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.745 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.5 p -51.1 -170.94 0.0 OUTLIER 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 112.683 -2.053 . . . . 0.14 115.107 -176.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.501 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 36.5 t30 -70.43 -10.45 59.14 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.134 -1.848 . . . . 0.48 110.567 173.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.595 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -152.22 -144.45 3.92 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.414 -0.898 . . . . 0.12 113.128 -176.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.609 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 54.6 p -122.14 131.73 54.11 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.165 0.432 . . . . 1.16 112.165 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.766 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.8 pp -136.84 156.76 48.06 Favored 'General case' 0 CA--C 1.502 -0.884 0 CA-C-O 121.772 0.796 . . . . 0.1 110.947 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.677 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 1.4 t-20 -79.81 81.18 6.11 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-N 113.814 -1.539 . . . . 0.17 107.961 175.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.599 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -67.97 -15.1 63.45 Favored 'General case' 0 C--N 1.286 -2.156 0 CA-C-N 113.933 -1.485 . . . . 0.09 110.112 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.796 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -79.92 -32.79 40.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.73 -0.841 . . . . 0.15 108.73 -177.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.589 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 12.8 tp10 -65.22 -34.48 78.46 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 114.432 -1.258 . . . . 1.73 108.929 171.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -72.06 -43.41 64.95 Favored 'General case' 0 N--CA 1.427 -1.576 0 CA-C-N 113.243 -1.798 . . . . 0.12 109.367 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.617 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 76.5 m -64.73 -28.8 69.84 Favored 'General case' 0 N--CA 1.429 -1.485 0 CA-C-N 114.062 -1.426 . . . . 0.11 110.405 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.16 -43.53 67.31 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 108.05 -1.093 . . . . 1.47 108.05 172.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.687 HG21 ' HB2' ' A' ' 64' ' ' TRP . 75.9 m -61.96 -31.6 71.96 Favored 'General case' 0 CA--C 1.515 -0.365 0 CA-C-N 115.327 -0.852 . . . . 0.12 110.613 176.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.716 ' O ' HD23 ' A' ' 113' ' ' LEU . 9.0 mt -51.43 -69.48 0.11 Allowed 'General case' 0 CA--C 1.493 -1.232 0 N-CA-C 109.209 -0.663 . . . . 0.56 109.209 171.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.692 ' O ' HD13 ' A' ' 121' ' ' LEU . 8.9 mtp180 -40.09 -38.86 0.79 Allowed 'General case' 0 C--N 1.318 -0.775 0 O-C-N 124.424 1.078 . . . . 1.51 111.182 175.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.528 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.88 -47.33 59.79 Favored 'General case' 0 C--N 1.31 -1.109 0 CA-C-N 114.473 -1.24 . . . . 0.28 112.159 -176.073 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -71.8 -33.08 68.25 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-O 122.107 0.956 . . . . 0.09 108.424 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.8 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.1 mm? -61.99 -32.98 73.5 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 113.437 -1.71 . . . . 0.12 109.894 173.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -74.43 -41.5 60.74 Favored 'General case' 0 CA--C 1.508 -0.648 0 CA-C-N 114.484 -1.234 . . . . 0.2 111.604 -175.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -64.93 -25.64 67.97 Favored 'General case' 0 N--CA 1.444 -0.743 0 CA-C-N 115.4 -0.818 . . . . 1.17 111.199 -175.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.441 ' O ' ' HG3' ' A' ' 118' ' ' LYS . 10.7 m120 -84.15 -16.53 43.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.529 -0.76 . . . . 2.05 110.844 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 56.6 17.2 19.17 Favored Glycine 0 C--N 1.332 0.308 0 N-CA-C 115.432 0.933 . . . . 0.54 115.432 164.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.594 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 53.3 mtpt -98.16 -34.4 10.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 117.541 0.67 . . . . 0.99 109.997 177.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.841 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 13.7 m-85 -89.32 177.85 6.49 Favored 'General case' 0 CA--C 1.492 -1.258 0 CA-C-O 122.728 1.251 . . . . 0.21 113.095 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.527 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 21.2 m -123.67 111.07 15.75 Favored 'General case' 0 N--CA 1.41 -2.451 0 CA-C-N 112.299 -2.228 . . . . 0.23 107.84 168.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.8 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -89.37 123.66 33.74 Favored 'General case' 0 N--CA 1.422 -1.855 0 CA-C-N 114.719 -1.128 . . . . 0.38 110.734 -170.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.535 HG11 HD23 ' A' ' 88' ' ' LEU . 0.7 OUTLIER -65.8 155.21 7.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-N 115.354 -0.839 . . . . 0.42 109.102 176.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.499 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 67.3 m -93.7 155.77 17.07 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.737 0.78 . . . . 1.7 110.029 175.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.566 ' HA ' ' HB3' ' A' ' 127' ' ' LEU . . . -72.91 -19.75 61.21 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.218 -1.355 . . . . 0.55 109.596 -178.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.726 ' O ' ' HG3' ' A' ' 129' ' ' MET . 1.2 pt20 -57.36 -29.09 63.73 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.11 -1.405 . . . . 2.04 109.993 172.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.646 ' HB2' HG22 ' A' ' 155' ' ' VAL . 0.0 OUTLIER -99.18 -46.75 5.45 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.154 -0.93 . . . . 0.41 110.625 171.792 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.762 HD23 HD21 ' A' ' 88' ' ' LEU . 1.1 tm? -73.47 -62.39 1.5 Allowed 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 114.682 -1.144 . . . . 1.39 113.514 -167.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.561 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.4 OUTLIER -50.8 -37.97 45.72 Favored 'General case' 0 CA--C 1.501 -0.907 0 CA-C-O 123.684 1.707 . . . . 1.05 108.637 178.756 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.726 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 29.2 mmm -62.82 -62.09 1.96 Allowed 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 110.417 -3.083 . . . . 1.64 111.403 177.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.775 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -40.99 -45.12 2.52 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 124.478 1.111 . . . . 0.31 111.905 174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.806 ' HE2' HD21 ' A' ' 142' ' ' LEU . 95.3 mttt -52.38 -58.09 7.77 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.847 -0.615 . . . . 1.53 109.845 177.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.591 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 41.7 mt-30 -58.12 -44.72 87.89 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.566 -1.197 . . . . 0.41 111.622 176.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.698 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.5 mt-30 -56.47 -36.37 68.99 Favored 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.627 -1.17 . . . . 0.37 109.871 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.51 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -88.49 -29.38 20.18 Favored 'General case' 0 N--CA 1.425 -1.717 0 CA-C-N 113.972 -1.467 . . . . 0.24 109.431 -177.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 155.8 -41.46 0.58 Allowed Glycine 0 CA--C 1.499 -0.967 0 C-N-CA 119.36 -1.4 . . . . 0.33 114.328 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.591 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 91.2 mt -73.75 -172.89 1.36 Allowed 'General case' 0 C--N 1.293 -1.884 0 CA-C-O 123.868 1.794 . . . . 0.31 115.262 -168.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.485 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 52.4 m -111.44 151.4 43.23 Favored Pre-proline 0 N--CA 1.425 -1.675 0 CA-C-N 110.783 -2.917 . . . . 0.81 107.964 169.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.652 ' HA ' ' HD2' ' A' ' 131' ' ' LYS . 14.3 Cg_endo -60.6 -3.27 2.51 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 122.736 2.29 . . . . 0.32 112.782 176.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.796 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.9 OUTLIER -118.6 -20.88 8.18 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 123.132 0.573 . . . . 1.25 109.954 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.56 ' O ' ' HB2' ' A' ' 141' ' ' SER . 12.6 t70 -60.44 -33.55 72.71 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 107.699 -1.223 . . . . 0.65 107.699 -174.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.622 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 18.4 m 78.92 156.64 0.16 Allowed 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 110.441 -3.072 . . . . 0.6 111.059 -173.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.912 ' HG ' ' OD1' ' A' ' 90' ' ' ASP . 7.2 mt -63.82 -39.34 94.0 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.15 -1.426 . . . . 0.86 107.15 -172.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.1 -3.6 0.16 Allowed Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 112.849 -1.978 . . . . 0.31 115.166 174.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 1.2 m -149.66 121.67 8.25 Favored 'General case' 0 CA--C 1.498 -1.029 0 N-CA-C 108.881 -0.785 . . . . 0.24 108.881 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.59 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.3 mmt180 -41.91 -45.06 3.62 Favored 'General case' 0 C--O 1.213 -0.827 0 O-C-N 123.61 0.569 . . . . 1.65 111.366 -175.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.3 t -73.17 -26.55 61.23 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-O 121.541 0.686 . . . . 0.53 111.525 -174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.559 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 49.1 mttt -73.15 -33.04 65.26 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 108.138 -1.06 . . . . 1.31 108.138 175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.863 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -74.98 -43.46 53.85 Favored 'General case' 0 CA--C 1.486 -1.488 0 CA-C-N 113.019 -1.901 . . . . 0.12 110.465 178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.609 ' HA ' HG23 ' A' ' 181' ' ' VAL . 43.4 mt -67.1 -42.69 88.64 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.866 0 CA-C-N 113.589 -1.641 . . . . 0.11 110.159 177.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.31 -52.33 41.4 Favored Glycine 0 N--CA 1.44 -1.087 0 CA-C-N 114.856 -1.065 . . . . 0.15 111.287 171.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.775 HG23 ' CB ' ' A' ' 130' ' ' ALA . 71.8 mt -68.5 -47.25 78.14 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.086 0 N-CA-C 112.891 0.7 . . . . 0.18 112.891 -178.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.695 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.28 -38.34 71.07 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-O 121.001 0.429 . . . . 0.13 111.23 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.479 ' HD2' HG23 ' A' ' 149' ' ' ILE . 30.4 mtp180 -84.04 -20.01 33.43 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.666 0.746 . . . . 1.08 110.443 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.468 HD22 ' CB ' ' A' ' 130' ' ' ALA . 16.6 t30 -84.36 -10.38 57.63 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 107.307 -1.368 . . . . 0.5 107.307 175.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.745 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -109.69 -29.24 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-N 113.262 -1.79 . . . . 0.17 111.094 -173.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.13 34.74 4.73 Favored Glycine 0 N--CA 1.448 -0.513 0 C-N-CA 120.391 -0.909 . . . . 0.16 112.833 -179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.624 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.64 161.29 15.53 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.15 0.796 . . . . 0.12 113.15 -169.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.712 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -101.91 -28.14 12.57 Favored 'General case' 0 CA--C 1.512 -0.51 0 CA-C-N 115.375 -0.829 . . . . 0.2 109.78 178.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.56 ' HD2' ' CD2' ' A' ' 178' ' ' LEU . 5.4 m-85 -135.39 -172.57 3.11 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.261 -0.881 . . . . 0.13 110.959 -175.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.769 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -138.85 139.62 40.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.098 -0.955 . . . . 0.08 109.221 167.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.594 HD21 ' SD ' ' A' ' 176' ' ' MET . 43.9 tp -107.62 99.84 9.29 Favored 'General case' 0 N--CA 1.427 -1.611 0 C-N-CA 119.386 -0.925 . . . . 0.16 109.395 165.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.594 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 3.0 m-85 -81.69 112.81 19.21 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 114.234 -1.348 . . . . 0.26 109.556 176.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.859 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 4.9 t -123.08 166.12 15.68 Favored 'General case' 0 C--N 1.284 -2.26 0 CA-C-O 121.77 0.795 . . . . 1.05 111.033 -178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.848 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -162.79 176.18 10.52 Favored 'General case' 0 N--CA 1.423 -1.809 0 CA-C-N 114.548 -1.205 . . . . 0.1 111.313 -179.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.65 133.4 30.58 Favored 'General case' 0 N--CA 1.411 -2.417 0 CA-C-N 113.865 -1.516 . . . . 0.11 108.279 177.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.67 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -143.14 -177.17 5.23 Favored 'General case' 0 C--N 1.301 -1.5 0 N-CA-C 109.354 -0.61 . . . . 1.09 109.354 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.76 -83.72 0.86 Allowed Glycine 0 CA--C 1.493 -1.336 0 C-N-CA 119.62 -1.276 . . . . 0.15 111.355 173.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.501 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 64.7 t30 -144.17 130.5 19.8 Favored 'General case' 0 C--O 1.199 -1.598 0 N-CA-C 107.972 -1.121 . . . . 0.59 107.972 175.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.595 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.2 p -64.48 -41.56 92.66 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 CA-C-N 115.123 -0.944 . . . . 0.15 112.36 -171.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.417 ' N ' HG13 ' A' ' 169' ' ' VAL . 10.9 m-20 -61.19 -30.76 70.61 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.793 0.806 . . . . 1.26 109.509 -177.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.11 88.39 3.49 Favored Pre-proline 0 C--N 1.311 -1.102 0 CA-C-N 113.868 -1.514 . . . . 0.13 108.376 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.814 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.0 Cg_endo -90.72 167.0 4.01 Favored 'Trans proline' 0 CA--C 1.492 -1.579 0 C-N-CA 124.579 3.52 . . . . 0.09 114.72 -170.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 23.7 m -86.39 119.41 26.63 Favored 'General case' 0 N--CA 1.417 -2.109 0 CA-C-N 113.732 -1.577 . . . . 0.14 107.643 166.51 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.848 HD12 ' O ' ' A' ' 164' ' ' SER . 42.2 tp -84.13 98.67 10.03 Favored 'General case' 0 N--CA 1.412 -2.354 0 N-CA-C 108.643 -0.873 . . . . 0.16 108.643 178.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.627 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.0 mt-30 -90.49 109.02 20.17 Favored 'General case' 0 C--N 1.273 -2.74 0 CA-C-O 122.089 0.947 . . . . 0.34 109.276 -176.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.859 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.8 OUTLIER -111.73 164.54 12.93 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.936 -1.029 . . . . 1.09 111.795 -172.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.614 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.0 tt0 -170.64 119.5 0.54 Allowed 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 115.813 -0.63 . . . . 0.5 110.245 -166.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.064 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.32 101.84 12.58 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.929 -0.767 . . . . 0.1 108.929 -173.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.599 ' HE1' HG13 ' A' ' 149' ' ' ILE . 14.4 ttp -90.88 118.35 30.21 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.755 -0.657 . . . . 0.07 109.675 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.498 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -61.7 117.89 6.41 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 106.936 -1.505 . . . . 0.22 106.936 168.881 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -71.9 -36.35 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 CA-C-N 119.05 0.841 . . . . 0.11 111.485 -176.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.449 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.0 mt-30 -60.85 -15.25 28.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.364 -0.835 . . . . 0.35 111.685 -176.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.43 ' OG1' ' HG2' ' A' ' 185' ' ' GLU . 40.5 p -127.91 -37.02 1.95 Allowed 'General case' 0 CA--C 1.508 -0.644 0 CA-C-O 122.308 1.051 . . . . 0.19 109.896 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.552 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 86.83 24.32 38.73 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 113.765 -1.561 . . . . 0.18 111.733 -178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.43 ' HG2' ' OG1' ' A' ' 183' ' ' THR . 11.0 pt-20 -105.22 158.03 16.88 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.882 0.372 . . . . 0.73 110.248 178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.614 HD12 ' HG2' ' A' ' 177' ' ' GLN . 36.0 mm -91.5 117.14 34.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-O 121.498 0.666 . . . . 0.14 109.391 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.064 HD11 HD13 ' A' ' 178' ' ' LEU . 1.8 pp -105.02 -29.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 114.777 -1.101 . . . . 0.13 110.44 -171.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.595 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 82.4 t90 -136.95 152.2 49.9 Favored 'General case' 0 CA--C 1.507 -0.684 0 CA-C-N 115.145 -0.934 . . . . 0.07 109.621 172.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 53.9 p -153.41 163.46 39.9 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 112.963 0.727 . . . . 0.13 112.963 164.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.69 -173.82 27.6 Favored Glycine 0 N--CA 1.428 -1.869 0 N-CA-C 111.214 -0.755 . . . . 0.12 111.214 -178.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.768 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 11.4 mtmt -158.91 151.44 21.69 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 105.668 -1.975 . . . . 1.22 105.668 165.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -161.02 127.74 1.81 Allowed Glycine 0 C--N 1.282 -2.43 0 C-N-CA 119.866 -1.159 . . . . 0.12 112.235 178.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -72.63 117.85 14.83 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 121.518 0.675 . . . . 0.17 111.528 -173.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.814 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -95.53 158.16 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.247 0 CA-C-O 122.633 1.206 . . . . 0.11 110.676 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.742 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.6 OUTLIER -99.56 172.2 7.44 Favored 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 112.531 -2.122 . . . . 0.18 108.966 -175.126 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.607 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 8.9 tt0 -102.67 134.04 46.69 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 120.19 -0.604 . . . . 0.91 109.877 171.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.539 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 15.2 mm-40 . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.477 -0.773 . . . . 1.24 110.524 176.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 111.828 -0.509 . . . . 88.61 111.828 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.9 m -92.12 171.08 9.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.698 0.285 . . . . 87.43 110.451 177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -132.78 -172.61 2.96 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.632 -0.258 . . . . 87.16 110.416 179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.47 ' O ' HG12 ' A' ' 5' ' ' VAL . 1.4 pmm? -56.57 150.33 15.7 Favored 'General case' 0 C--N 1.322 -0.605 0 O-C-N 123.613 0.571 . . . . 85.34 110.235 177.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 4' ' ' MET . 4.3 p 49.75 17.92 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.864 1.266 . . . . 85.05 112.667 -178.511 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -87.41 -101.15 0.86 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.75 -0.738 . . . . 84.68 111.473 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -142.53 37.7 1.5 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.755 0.788 . . . . 85.57 110.274 175.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 74.0 mtp180 65.7 178.59 0.2 Allowed 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 114.389 -1.278 . . . . 85.04 111.402 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 58.34 71.16 1.06 Allowed Pre-proline 0 C--O 1.225 -0.194 0 CA-C-N 113.487 -1.688 . . . . 82.17 112.004 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_exo -45.97 -72.17 0.05 OUTLIER 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.289 2.659 . . . . 81.51 112.346 -179.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.453 ' O ' HG13 ' A' ' 13' ' ' VAL . . . -155.44 114.32 2.27 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.218 -0.446 . . . . 79.56 110.477 -175.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -46.68 132.34 16.57 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 123.506 2.804 . . . . 78.5 112.966 178.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 11' ' ' ALA . 16.9 m -134.12 172.09 16.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.291 -0.868 . . . . 77.0 110.982 -175.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 70.8 60.23 0.2 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.727 -1.124 . . . . 75.74 109.911 178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.434 ' HG2' ' O ' ' A' ' 15' ' ' GLU . 0.2 OUTLIER -114.05 107.62 15.9 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.408 -0.815 . . . . 73.91 110.671 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 14.5 p -103.51 135.8 39.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-O 121.197 0.522 . . . . 72.3 111.445 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 63.3 mttm -97.5 119.26 63.16 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 116.037 -0.528 . . . . 71.22 109.893 174.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -75.39 -168.55 0.54 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 121.663 1.575 . . . . 69.67 112.209 178.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 63.65 98.82 0.04 OUTLIER Pre-proline 0 C--N 1.339 0.137 0 CA-C-N 114.691 -1.141 . . . . 67.55 111.771 179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -66.22 161.55 39.85 Favored 'Trans proline' 0 N--CA 1.461 -0.408 0 C-N-CA 122.135 1.89 . . . . 66.7 111.419 176.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -98.57 -5.98 30.95 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.382 -0.527 . . . . 65.01 111.932 -178.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.7 tp60 72.15 124.08 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.242 0 O-C-N 124.051 0.845 . . . . 63.41 110.28 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_exo -51.6 141.31 43.39 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.907 2.404 . . . . 61.93 112.567 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -129.86 111.49 12.63 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.935 -0.575 . . . . 59.87 110.446 -178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -121.4 83.86 40.85 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 58.47 110.85 -178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -68.76 -19.51 41.07 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.113 2.542 . . . . 57.36 111.519 177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 58.7 -105.8 0.27 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.348 -0.842 . . . . 55.51 110.69 178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' VAL . 19.4 mm-40 -144.56 156.01 56.72 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 109.895 -0.409 . . . . 53.87 109.895 -176.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_exo -72.93 35.88 0.35 Allowed 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.952 2.435 . . . . 52.76 112.534 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' GLN . 3.0 p -160.32 96.54 1.49 Allowed Pre-proline 0 C--N 1.324 -0.527 0 CA-C-O 121.288 0.566 . . . . 50.93 109.997 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.81 123.18 11.84 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 122.525 2.15 . . . . 49.21 111.551 177.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 39.3 p -118.21 141.95 47.97 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.6 -0.273 . . . . 47.49 111.046 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 56.5 t 57.38 93.85 0.05 OUTLIER Pre-proline 0 C--O 1.235 0.325 0 O-C-N 123.72 0.637 . . . . 45.97 111.222 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -55.92 159.37 12.07 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 123.045 2.497 . . . . 45.28 112.572 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.5 m -75.94 120.61 21.52 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.458 -0.792 . . . . 42.79 110.741 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 43.5 t -122.82 108.15 33.06 Favored Pre-proline 0 C--N 1.319 -0.747 0 CA-C-N 115.966 -0.561 . . . . 40.79 109.97 179.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -58.88 -41.75 59.32 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 123.041 2.494 . . . . 39.81 112.239 179.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 26.9 m -125.34 97.74 5.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.248 0.547 . . . . 37.5 110.281 178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.413 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 4.8 mt -67.99 123.59 87.54 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 115.279 -0.873 . . . . 35.65 110.789 -176.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 39' ' ' ILE . 32.4 Cg_exo -57.73 97.78 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.029 2.486 . . . . 33.72 112.812 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -164.68 118.12 1.31 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.899 -0.591 . . . . 31.51 109.723 178.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.662 ' H ' ' HD2' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -150.92 -55.56 0.02 OUTLIER Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 119.111 -0.471 . . . . 30.13 111.294 -175.549 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.662 ' HD2' ' H ' ' A' ' 42' ' ' GLN . 5.0 Cg_endo -46.49 123.47 6.87 Favored 'Trans proline' 0 C--N 1.359 1.103 0 C-N-CA 122.712 2.275 . . . . 29.52 113.444 -178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -126.57 171.98 18.25 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.557 -0.747 . . . . 26.75 111.273 175.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -61.74 129.86 29.24 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.556 2.17 . . . . 25.08 112.284 -178.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 20.5 mt -88.16 -66.91 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.471 -0.331 . . . . 23.9 110.896 -179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 61.82 92.32 0.06 Allowed 'General case' 0 C--O 1.233 0.188 0 O-C-N 123.712 0.633 . . . . 21.23 110.482 -174.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 23.2 p-80 -99.01 161.24 13.73 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.164 -0.471 . . . . 19.92 111.234 -177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -179.01 134.5 0.13 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.261 -0.881 . . . . 16.56 109.658 176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -126.02 64.39 1.22 Allowed 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.55 -0.75 . . . . 15.05 109.355 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.2 mm-40 -118.9 25.64 10.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 114.781 -1.099 . . . . 14.19 110.244 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.2 p -64.43 133.6 52.86 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.946 -0.57 . . . . 11.38 111.715 -174.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.66 73.65 40.74 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.32 -0.855 . . . . 8.29 111.387 -176.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.38 143.31 24.72 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.364 2.043 . . . . 6.87 111.737 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.84 130.27 39.65 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.751 2.3 . . . . 5.04 111.399 177.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 64.65 95.26 0.05 OUTLIER Pre-proline 0 C--O 1.233 0.231 0 O-C-N 123.995 0.809 . . . . 2.59 109.735 -169.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -66.7 -177.0 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.456 0 C-N-CA 123.458 2.772 . . . . 1.64 113.439 -172.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -120.64 146.4 46.43 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 114.45 -1.25 . . . . 3.39 110.901 -173.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 60' ' ' ARG . 11.0 mt -84.26 169.51 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.187 -0.915 . . . . 0.44 111.355 -177.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.614 ' N ' HG22 ' A' ' 59' ' ' ILE . 29.4 mtt85 -66.2 -157.67 0.02 OUTLIER 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 123.565 1.65 . . . . 2.34 112.301 178.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.676 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 19.2 t-160 -158.82 147.56 18.54 Favored 'General case' 0 CA--C 1.471 -2.072 0 CA-C-N 111.741 -2.481 . . . . 2.22 106.344 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.752 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.3 m-30 -125.03 159.87 30.32 Favored 'General case' 0 N--CA 1.415 -2.186 0 O-C-N 123.934 0.771 . . . . 0.21 109.264 -176.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 2.8 t70 -80.01 68.09 6.02 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 123.692 1.711 . . . . 0.35 108.36 171.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.726 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 90.3 m95 -59.41 -44.53 92.83 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 111.407 -2.633 . . . . 0.1 112.312 174.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.437 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 12.8 t-20 -51.36 -30.26 18.18 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.036 -1.438 . . . . 1.11 111.524 176.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.79 -16.31 80.74 Favored Glycine 0 C--N 1.314 -0.656 0 CA-C-N 115.601 -0.727 . . . . 0.21 111.385 -179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.96 -51.12 3.62 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 113.95 -1.125 . . . . 0.13 110.908 -177.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.718 ' O ' HG23 ' A' ' 72' ' ' VAL . 40.7 mtt -65.33 -55.62 17.21 Favored 'General case' 0 C--O 1.208 -1.109 0 CA-C-N 114.094 -1.412 . . . . 0.09 112.224 -178.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.486 ' N ' ' HD2' ' A' ' 70' ' ' PRO . 5.7 mm-40 -41.23 -54.76 5.68 Favored Pre-proline 0 C--N 1.32 -0.696 0 N-CA-C 114.558 1.318 . . . . 0.63 114.558 -176.229 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.824 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 23.7 Cg_endo -62.29 -31.61 81.91 Favored 'Trans proline' 0 CA--C 1.506 -0.891 0 C-N-CA 122.159 1.906 . . . . 0.14 110.478 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.799 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 6.7 mtm -79.62 -46.5 17.1 Favored 'General case' 0 C--O 1.213 -0.84 0 CA-C-N 114.863 -1.062 . . . . 0.7 111.587 -176.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.718 HG23 ' O ' ' A' ' 68' ' ' MET . 61.1 t -55.92 -41.13 66.17 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 CA-C-N 114.025 -1.443 . . . . 0.12 108.869 175.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 t -59.43 -35.26 73.68 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 113.248 -1.796 . . . . 0.56 110.952 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.824 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 21.0 mtpp -81.45 -34.67 31.29 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 122.926 0.49 . . . . 1.3 111.392 177.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.85 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -64.68 -27.66 69.07 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 115.693 -0.685 . . . . 0.5 111.592 -171.159 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.79 HD13 ' HB2' ' A' ' 118' ' ' LYS . 5.7 mt -92.92 -6.16 49.2 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 122.059 0.933 . . . . 0.65 110.817 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -102.72 18.02 51.41 Favored Glycine 0 N--CA 1.439 -1.115 0 N-CA-C 108.726 -1.75 . . . . 0.17 108.726 170.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.669 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.17 163.15 15.56 Favored 'General case' 0 N--CA 1.438 -1.036 0 CA-C-N 114.318 -0.941 . . . . 0.1 110.279 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.55 106.14 18.26 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-N 114.8 -1.091 . . . . 1.72 109.855 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.628 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 134.27 -23.85 3.62 Favored Glycine 0 N--CA 1.431 -1.681 0 C-N-CA 120.201 -0.999 . . . . 0.12 111.056 -179.401 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.85 HG11 ' O ' ' A' ' 75' ' ' MET . 10.4 p -100.22 152.13 4.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.661 0.743 . . . . 0.16 111.388 -174.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 10.5 m -135.25 139.45 44.45 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.643 -1.162 . . . . 0.45 111.011 -178.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.735 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -55.07 140.52 37.73 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 114.624 -1.171 . . . . 0.28 111.155 167.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 91.91 2.95 68.64 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 121.262 -0.494 . . . . 0.28 113.007 175.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.31 148.84 25.43 Favored 'General case' 0 CA--C 1.502 -0.886 0 C-N-CA 120.053 -0.659 . . . . 1.2 111.06 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.667 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -79.59 116.18 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 CA-C-O 122.196 0.998 . . . . 0.2 109.517 166.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.907 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -104.69 109.63 21.63 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-N 115.118 -0.946 . . . . 0.14 109.427 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 1.026 HD21 HD13 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -72.16 99.28 2.3 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.832 -1.531 . . . . 0.15 108.421 177.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.678 ' O ' HD21 ' A' ' 127' ' ' LEU . 3.0 m -72.02 117.6 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.861 0 N-CA-C 107.699 -1.223 . . . . 0.95 107.699 -179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.739 ' HB3' ' O ' ' A' ' 161' ' ' LEU . 0.0 OUTLIER -77.65 137.4 38.51 Favored 'General case' 0 C--N 1.295 -1.777 0 N-CA-C 107.846 -1.168 . . . . 0.64 107.846 -178.013 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.517 ' HA ' ' CG2' ' A' ' 106' ' ' THR . 1.2 m -53.51 127.98 27.22 Favored 'General case' 0 CA--C 1.49 -1.356 0 CA-C-O 122.064 0.935 . . . . 0.37 108.579 -178.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.596 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 19.8 t -55.53 134.97 19.01 Favored 'Isoleucine or valine' 0 N--CA 1.397 -3.121 0 N-CA-C 107.695 -1.224 . . . . 0.1 107.695 173.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.817 ' H ' ' HA ' ' A' ' 164' ' ' SER . 10.2 t-20 -85.62 163.59 18.23 Favored 'General case' 0 C--N 1.28 -2.444 0 CA-C-N 114.842 -1.072 . . . . 0.18 109.96 175.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.754 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.11 86.19 2.52 Favored 'General case' 0 C--N 1.288 -2.084 0 CA-C-N 114.383 -1.281 . . . . 0.12 107.894 176.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.421 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 15.1 mtp180 -109.5 -3.51 16.93 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.048 -1.433 . . . . 0.64 108.628 -172.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.734 HG21 ' HB3' ' A' ' 172' ' ' PRO . 20.5 p -50.81 -171.47 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 112.942 -1.935 . . . . 0.14 115.491 -176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.541 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 37.5 t30 -71.27 -4.46 25.96 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 112.776 -2.011 . . . . 0.48 110.719 173.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.597 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -157.85 -145.99 4.38 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.428 -0.892 . . . . 0.12 113.062 -178.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.647 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 59.9 p -121.39 131.97 54.49 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 121.347 0.594 . . . . 1.16 112.274 -178.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.754 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -137.21 158.31 44.72 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-O 122.015 0.912 . . . . 0.1 110.808 -177.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.613 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -81.4 79.76 7.94 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 113.821 -1.536 . . . . 0.17 108.067 176.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -68.98 -14.38 63.0 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.377 -1.283 . . . . 0.09 109.991 179.082 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.472 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.77 -30.22 36.05 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 108.726 -0.842 . . . . 0.15 108.726 -178.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.613 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 14.1 tp10 -67.62 -33.84 75.78 Favored 'General case' 0 N--CA 1.433 -1.281 0 CA-C-N 114.451 -1.25 . . . . 1.73 108.96 170.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.45 -44.19 65.27 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 113.186 -1.824 . . . . 0.12 109.567 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 77.6 m -64.0 -30.97 72.0 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 114.013 -1.448 . . . . 0.11 110.372 179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.58 -43.32 76.77 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 108.077 -1.083 . . . . 1.47 108.077 172.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 64' ' ' TRP . 79.2 m -63.14 -30.6 71.72 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 115.317 -0.856 . . . . 0.12 110.714 177.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.716 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.1 mt -51.5 -69.04 0.12 Allowed 'General case' 0 CA--C 1.492 -1.281 0 N-CA-C 109.404 -0.591 . . . . 0.56 109.404 172.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.575 ' O ' HD13 ' A' ' 121' ' ' LEU . 18.5 mtp180 -41.06 -39.2 1.17 Allowed 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.644 -1.162 . . . . 1.51 110.989 175.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.534 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -70.0 -46.51 64.97 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.476 -1.238 . . . . 0.28 112.038 -176.271 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.405 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -72.81 -32.84 65.83 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 122.149 0.976 . . . . 0.09 108.594 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.701 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -64.17 -34.38 77.95 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 113.588 -1.642 . . . . 0.12 110.1 174.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.655 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -70.97 -38.47 72.77 Favored 'General case' 0 CA--C 1.506 -0.731 0 CA-C-N 114.83 -1.077 . . . . 0.2 111.45 -175.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 -60.82 -28.66 68.97 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 114.403 -1.271 . . . . 1.17 111.041 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -83.24 -36.25 24.74 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 114.913 -1.04 . . . . 2.05 110.19 -174.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 75.18 -5.23 35.35 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 120.62 -0.8 . . . . 0.54 114.35 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.79 ' HB2' HD13 ' A' ' 76' ' ' LEU . 53.7 mtpt -81.6 -9.89 59.56 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 117.774 0.787 . . . . 0.99 110.787 178.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.907 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 28.5 m-85 -115.73 176.08 5.24 Favored 'General case' 0 CA--C 1.494 -1.207 0 CA-C-O 122.505 1.145 . . . . 0.21 113.272 173.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.577 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 3.9 m -121.83 120.53 34.83 Favored 'General case' 0 N--CA 1.419 -2.009 0 CA-C-N 112.474 -2.148 . . . . 0.23 107.896 169.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.655 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.6 OUTLIER -88.1 140.01 29.92 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 119.512 -0.875 . . . . 0.38 109.929 -171.912 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.562 HG11 HD23 ' A' ' 88' ' ' LEU . 0.8 OUTLIER -88.07 155.11 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.477 0 N-CA-C 108.56 -0.904 . . . . 0.42 108.56 177.266 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.525 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 73.3 m -91.29 154.3 19.35 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 122.136 0.97 . . . . 1.7 110.773 178.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.95 -22.07 61.51 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 113.539 -1.664 . . . . 0.55 109.795 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.631 ' O ' ' HG3' ' A' ' 129' ' ' MET . 6.3 pt20 -54.63 -29.68 52.88 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.504 -1.225 . . . . 2.04 109.37 171.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.577 ' O ' ' HB2' ' A' ' 129' ' ' MET . 2.7 mt-30 -96.29 -56.49 2.61 Favored 'General case' 0 C--O 1.212 -0.889 0 CA-C-N 114.358 -1.292 . . . . 0.41 109.585 174.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 1.026 HD13 HD21 ' A' ' 88' ' ' LEU . 13.6 tp -72.6 -58.21 3.54 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 113.685 -1.598 . . . . 1.39 114.58 -159.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.585 ' HB3' ' HB3' ' A' ' 138' ' ' PRO . 66.6 m -56.23 -36.95 69.07 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 123.227 1.489 . . . . 1.05 108.456 178.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.631 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 9.3 mmt -62.98 -58.66 6.55 Favored 'General case' 0 C--O 1.211 -0.959 0 CA-C-N 111.614 -2.539 . . . . 1.64 110.997 174.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.744 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.63 -41.66 3.16 Favored 'General case' 0 CA--C 1.501 -0.927 0 O-C-N 124.224 0.953 . . . . 0.31 111.91 176.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.821 ' HZ2' HD13 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -52.46 -57.61 9.34 Favored 'General case' 0 N--CA 1.44 -0.932 0 C-N-CA 120.153 -0.619 . . . . 1.53 109.912 175.846 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 40.2 mt-30 -61.4 -43.0 99.62 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 114.636 -1.166 . . . . 0.41 111.445 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.616 ' HG3' ' O ' ' A' ' 129' ' ' MET . 47.8 mt-30 -56.29 -35.99 68.13 Favored 'General case' 0 CA--C 1.485 -1.553 0 CA-C-N 114.434 -1.257 . . . . 0.37 109.683 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.501 HD12 HG13 ' A' ' 151' ' ' ILE . 0.6 OUTLIER -90.34 -29.95 17.75 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 114.029 -1.442 . . . . 0.24 109.408 -178.052 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.62 -53.62 0.38 Allowed Glycine 0 CA--C 1.498 -0.976 0 C-N-CA 119.657 -1.259 . . . . 0.33 114.174 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.794 HD13 ' O ' ' A' ' 141' ' ' SER . 14.9 mt -62.36 -171.07 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.02 0 CA-C-N 112.254 -1.973 . . . . 0.31 116.226 -169.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.552 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 27.5 m -109.41 150.89 41.73 Favored Pre-proline 0 N--CA 1.421 -1.893 0 CA-C-N 110.759 -2.928 . . . . 0.81 108.146 171.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.585 ' HB3' ' HB3' ' A' ' 128' ' ' SER . 57.2 Cg_endo -66.06 0.19 3.45 Favored 'Trans proline' 0 C--N 1.33 -0.417 0 C-N-CA 122.991 2.461 . . . . 0.32 112.139 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.472 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 1.5 tt0 -117.62 -31.01 5.32 Favored 'General case' 0 CA--C 1.508 -0.644 0 CA-C-N 114.717 -1.129 . . . . 1.25 109.39 -175.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.552 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 25.7 t0 -61.71 -27.01 68.4 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 113.028 -1.896 . . . . 0.65 107.889 178.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.794 ' O ' HD13 ' A' ' 136' ' ' LEU . 0.4 OUTLIER 73.28 -170.29 0.13 Allowed 'General case' 0 CA--C 1.477 -1.854 0 CA-C-N 112.233 -2.258 . . . . 0.6 109.933 -177.77 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.827 HD22 ' HA ' ' A' ' 148' ' ' ALA . 10.1 mt -65.25 -37.97 88.89 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 114.148 -1.387 . . . . 0.86 107.707 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.37 -12.04 0.13 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 112.701 -2.045 . . . . 0.31 115.186 177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.34 131.68 10.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 118.708 -0.663 . . . . 0.24 109.226 -175.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.689 ' O ' ' HB3' ' A' ' 148' ' ' ALA . 18.6 mmt180 -45.21 -50.07 11.82 Favored 'General case' 0 C--O 1.214 -0.791 0 CA-C-N 118.069 0.395 . . . . 1.65 111.446 -175.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.418 ' HA ' ' HB ' ' A' ' 149' ' ' ILE . 71.1 m -71.13 -28.13 64.07 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-O 121.384 0.611 . . . . 0.53 111.55 -175.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -72.43 -32.17 66.08 Favored 'General case' 0 CA--C 1.509 -0.599 0 CA-C-O 122.777 1.275 . . . . 1.31 108.803 177.047 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.827 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -68.11 -44.82 75.33 Favored 'General case' 0 CA--C 1.483 -1.603 0 CA-C-N 112.218 -2.265 . . . . 0.12 109.906 174.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.605 HG13 ' HE1' ' A' ' 179' ' ' MET . 37.3 mt -68.72 -43.75 82.78 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.908 0 CA-C-N 112.958 -1.928 . . . . 0.11 110.411 -179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.41 -53.22 32.85 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.935 -1.03 . . . . 0.15 111.036 172.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.821 HD13 ' HZ2' ' A' ' 131' ' ' LYS . 79.1 mt -66.98 -47.7 81.54 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.109 0 N-CA-C 112.845 0.683 . . . . 0.18 112.845 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.647 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.37 -39.28 72.66 Favored 'General case' 0 C--N 1.307 -1.257 0 CA-C-O 120.878 0.37 . . . . 0.13 110.506 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.474 ' HD2' HG23 ' A' ' 149' ' ' ILE . 21.7 mtp180 -82.74 -21.78 34.6 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.464 0.649 . . . . 1.08 110.664 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.463 ' HB3' ' HA ' ' A' ' 151' ' ' ILE . 17.0 t30 -82.16 -11.2 58.86 Favored 'General case' 0 CA--C 1.504 -0.815 0 N-CA-C 107.116 -1.438 . . . . 0.5 107.116 176.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.713 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -108.65 -29.74 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.479 0 CA-C-N 113.13 -1.85 . . . . 0.17 110.978 -174.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.48 35.75 4.57 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.226 -0.988 . . . . 0.16 112.64 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.645 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.54 155.11 22.76 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 113.353 0.872 . . . . 0.12 113.353 -170.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.667 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.2 m80 -94.03 -28.93 15.47 Favored 'General case' 0 CA--C 1.515 -0.402 0 C-N-CA 123.784 0.833 . . . . 0.2 109.852 178.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.594 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 10.3 m-85 -136.59 -178.16 5.05 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 115.342 -0.845 . . . . 0.13 111.15 -173.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.696 ' O ' HD23 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -135.31 139.21 47.28 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.103 -0.953 . . . . 0.08 109.012 166.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.739 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 22.6 tp -109.96 98.92 8.12 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.607 -0.837 . . . . 0.16 109.932 167.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.629 ' HB2' ' O ' ' A' ' 177' ' ' GLN . 2.0 m-85 -78.42 112.22 15.23 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 115.252 -0.885 . . . . 0.26 109.367 -177.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.868 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 7.0 t -124.07 159.62 29.53 Favored 'General case' 0 C--N 1.282 -2.354 0 CA-C-O 122.397 1.094 . . . . 1.05 110.323 -176.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.817 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.4 p -164.44 171.97 13.98 Favored 'General case' 0 N--CA 1.417 -2.103 0 CA-C-N 114.016 -1.447 . . . . 0.1 111.098 -176.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -133.28 133.96 43.3 Favored 'General case' 0 N--CA 1.407 -2.611 0 CA-C-N 114.082 -1.417 . . . . 0.11 108.714 178.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.673 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 2.1 m -143.67 -176.33 4.93 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 109.025 -0.732 . . . . 1.09 109.025 179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 94.93 -83.21 0.91 Allowed Glycine 0 C--N 1.301 -1.387 0 C-N-CA 119.698 -1.239 . . . . 0.15 111.454 172.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.541 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 60.2 t30 -144.7 126.67 15.45 Favored 'General case' 0 C--O 1.196 -1.748 0 N-CA-C 108.066 -1.087 . . . . 0.59 108.066 176.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.597 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.0 p -62.43 -44.12 98.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 CA-C-N 115.316 -0.856 . . . . 0.15 113.217 -170.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.428 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.9 m120 -62.1 -28.59 69.73 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.398 0.618 . . . . 1.26 109.728 -177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.86 88.2 3.59 Favored Pre-proline 0 C--N 1.313 -0.991 0 CA-C-N 114.681 -1.145 . . . . 0.13 108.436 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.839 ' HD2' HG22 ' A' ' 194' ' ' VAL . 42.9 Cg_endo -91.69 167.7 3.26 Favored 'Trans proline' 0 CA--C 1.498 -1.321 0 C-N-CA 125.045 3.83 . . . . 0.09 115.151 -169.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.655 HG22 ' HB3' ' A' ' 191' ' ' LYS . 32.3 m -84.35 118.96 24.55 Favored 'General case' 0 N--CA 1.423 -1.783 0 CA-C-N 113.796 -1.547 . . . . 0.14 107.381 165.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.801 HD12 ' O ' ' A' ' 164' ' ' SER . 48.8 tp -84.43 98.11 9.89 Favored 'General case' 0 N--CA 1.414 -2.255 0 N-CA-C 108.378 -0.971 . . . . 0.16 108.378 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.555 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 31.4 mt-30 -88.96 109.3 20.13 Favored 'General case' 0 C--N 1.272 -2.761 0 CA-C-O 121.891 0.853 . . . . 0.34 109.239 -176.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.868 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 0.6 OUTLIER -112.34 164.28 13.42 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 115.109 -0.951 . . . . 1.09 111.495 -174.556 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.629 ' O ' ' HB2' ' A' ' 162' ' ' TYR . 60.1 tt0 -171.71 116.92 0.4 Allowed 'General case' 0 C--O 1.202 -1.446 0 CA-C-N 116.027 -0.533 . . . . 0.5 110.588 -166.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.053 HD13 HD11 ' A' ' 187' ' ' ILE . 0.8 OUTLIER -98.85 103.23 15.16 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.353 -0.842 . . . . 0.1 108.851 -170.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.662 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 16.3 ttp -92.12 122.29 34.48 Favored 'General case' 0 CA--C 1.505 -0.785 0 CA-C-N 115.261 -0.882 . . . . 0.07 109.713 176.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.433 HD22 ' CE2' ' A' ' 159' ' ' TYR . 0.1 OUTLIER -59.45 126.75 28.89 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.215 -1.402 . . . . 0.22 107.215 166.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.596 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -80.45 -35.56 15.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 C-N-CA 119.433 -0.907 . . . . 0.11 110.682 178.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.43 ' N ' HD12 ' A' ' 180' ' ' LEU . 29.4 mt-30 -64.02 -13.98 50.77 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.282 -0.872 . . . . 0.35 111.527 -178.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.406 ' OG1' ' HB3' ' A' ' 180' ' ' LEU . 80.6 p -131.12 -32.62 1.58 Allowed 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.902 0.858 . . . . 0.19 110.623 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.454 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 82.95 28.03 39.12 Favored Glycine 0 N--CA 1.436 -1.321 0 CA-C-N 114.357 -1.292 . . . . 0.18 112.136 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -107.43 152.38 24.28 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.64 -0.28 . . . . 0.73 110.502 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.588 HD12 ' HG2' ' A' ' 177' ' ' GLN . 30.4 mm -86.48 121.34 37.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-O 121.368 0.604 . . . . 0.14 109.464 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.053 HD11 HD13 ' A' ' 178' ' ' LEU . 1.2 pp -109.28 -29.93 2.47 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.091 0 CA-C-N 115.112 -0.949 . . . . 0.13 110.402 -174.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.669 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 80.6 t90 -136.48 153.43 51.04 Favored 'General case' 0 CA--C 1.505 -0.751 0 CA-C-N 115.056 -0.975 . . . . 0.07 109.562 173.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.526 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 58.1 p -153.36 164.34 38.31 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.235 0.828 . . . . 0.13 113.235 164.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -159.2 -173.78 28.07 Favored Glycine 0 N--CA 1.427 -1.945 0 N-CA-C 111.244 -0.742 . . . . 0.12 111.244 -179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.77 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 18.1 mttt -157.69 153.73 27.15 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 105.221 -2.14 . . . . 1.22 105.221 165.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -158.19 126.89 1.78 Allowed Glycine 0 C--N 1.279 -2.585 0 C-N-CA 119.525 -1.321 . . . . 0.12 111.663 174.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -73.94 111.87 9.52 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.508 0.67 . . . . 0.17 110.774 -174.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.839 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -91.3 158.42 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.447 0 CA-C-O 122.693 1.235 . . . . 0.11 111.051 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.752 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -98.67 172.38 7.52 Favored 'General case' 0 C--N 1.29 -1.982 0 CA-C-N 112.38 -2.191 . . . . 0.18 108.722 -174.548 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.576 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 9.6 tt0 -102.61 133.16 48.06 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 119.997 -0.681 . . . . 0.91 109.505 169.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.523 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 14.8 mm-40 . . . . . 0 C--O 1.248 1.004 0 CA-C-O 118.795 -0.622 . . . . 1.24 110.602 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 112.556 -0.218 . . . . 88.61 112.556 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 33.7 t -160.94 125.11 3.5 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.76 -0.459 . . . . 87.43 109.76 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 2' ' ' SER . 53.0 m80 70.26 122.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 O-C-N 123.662 0.601 . . . . 87.16 111.63 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 22.7 ttt 61.3 48.97 5.69 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.888 0.851 . . . . 85.34 110.264 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.9 t -127.35 -38.14 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 114.697 -1.138 . . . . 85.05 110.177 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.99 -25.62 48.36 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.618 -0.801 . . . . 84.68 112.149 179.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.417 ' O ' ' HB2' ' A' ' 8' ' ' ARG . 10.2 pt20 -87.85 -145.8 0.14 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.652 -0.129 . . . . 85.57 110.652 178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.556 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 67.8 mtm180 71.32 178.2 0.26 Allowed 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.075 0.55 . . . . 85.04 110.456 -178.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -104.07 90.38 3.01 Favored Pre-proline 0 C--N 1.317 -0.846 0 CA-C-N 115.55 -0.75 . . . . 82.17 109.545 172.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 5.0 Cg_exo -73.83 123.57 8.56 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.707 2.271 . . . . 81.51 112.412 -177.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -109.46 99.93 39.32 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.027 -0.533 . . . . 79.56 109.632 175.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -64.75 130.98 27.73 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.012 1.808 . . . . 78.5 112.201 -177.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 m -138.28 156.55 30.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.465 -0.789 . . . . 77.0 110.493 -178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -139.17 -71.05 0.4 Allowed 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.593 -0.73 . . . . 75.74 109.646 177.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -95.21 90.0 5.71 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.11 0.481 . . . . 73.91 110.403 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.5 t -78.07 113.99 18.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.72 -0.673 . . . . 72.3 109.666 178.136 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -119.91 136.1 24.7 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.468 -0.333 . . . . 71.22 110.538 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -64.88 140.12 65.33 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 121.913 1.742 . . . . 69.67 110.613 170.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -130.26 73.23 81.49 Favored Pre-proline 0 C--N 1.318 -0.793 0 C-N-CA 121.092 -0.243 . . . . 67.55 110.954 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -60.29 -49.47 9.2 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.329 2.019 . . . . 66.7 111.596 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 66.85 132.03 0.02 OUTLIER 'General case' 0 C--O 1.235 0.3 0 O-C-N 123.785 0.678 . . . . 65.01 111.358 -178.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -127.9 78.85 74.61 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 116.008 -0.542 . . . . 63.41 110.63 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -64.61 143.65 81.97 Favored 'Trans proline' 0 C--O 1.233 0.24 0 C-N-CA 123.443 2.762 . . . . 61.93 112.673 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -126.86 82.51 2.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.403 0.62 . . . . 59.87 110.24 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -112.2 87.39 9.02 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 114.954 -1.021 . . . . 58.47 109.965 -178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.18 155.03 42.08 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.301 2.001 . . . . 57.36 112.644 -175.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -90.93 141.36 28.92 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.138 0.494 . . . . 55.51 110.803 -176.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -143.36 125.09 8.41 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 115.732 -0.667 . . . . 53.87 109.609 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.24 -154.79 0.05 OUTLIER 'Trans proline' 0 CA--C 1.53 0.302 0 C-N-CA 122.532 2.155 . . . . 52.76 111.872 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 15.9 m -61.38 127.97 89.1 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-O 121.142 0.496 . . . . 50.93 111.283 178.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.94 -10.37 19.7 Favored 'Trans proline' 0 CA--C 1.527 0.143 0 C-N-CA 122.629 2.219 . . . . 49.21 111.85 176.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.6 p -94.43 143.04 26.75 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.947 -0.57 . . . . 47.49 110.979 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -132.96 119.2 15.67 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 115.726 -0.67 . . . . 45.97 110.068 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -65.03 152.64 81.68 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.755 2.303 . . . . 45.28 112.47 176.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 40.8 p 45.16 100.39 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 114.845 -1.07 . . . . 42.79 113.072 -175.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HB ' ' HD3' ' A' ' 37' ' ' PRO . 88.7 t -127.83 -51.26 0.03 OUTLIER Pre-proline 0 C--N 1.314 -0.953 0 CA-C-N 115.346 -0.843 . . . . 40.79 111.983 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.519 ' HD3' ' HB ' ' A' ' 36' ' ' VAL . 10.9 Cg_exo -72.7 -159.8 0.08 OUTLIER 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 122.097 1.865 . . . . 39.81 112.539 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 16.4 m -57.63 130.79 47.99 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.998 0.428 . . . . 37.5 110.865 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 9.8 mt -73.49 112.49 16.26 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.837 -0.62 . . . . 35.65 110.0 -179.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.08 79.02 3.51 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.541 2.161 . . . . 33.72 113.354 -173.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -145.21 133.57 21.81 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 31.51 109.986 174.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -134.82 79.92 50.83 Favored Pre-proline 0 C--N 1.323 -0.549 0 CA-C-N 116.554 -0.294 . . . . 30.13 111.017 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -69.39 147.5 65.42 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.173 1.916 . . . . 29.52 111.54 175.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -177.96 -173.09 43.09 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.915 -0.659 . . . . 26.75 111.609 179.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -69.68 132.5 23.58 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.484 2.122 . . . . 25.08 111.663 177.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 21.7 mt -87.44 -62.39 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 116.369 -0.378 . . . . 23.9 110.154 178.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 53.23 73.2 0.38 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.564 -0.744 . . . . 21.23 110.883 -178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -73.28 164.48 26.61 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.668 -0.696 . . . . 19.92 110.841 -178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -111.36 177.08 4.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.408 -0.815 . . . . 16.56 110.49 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -118.94 45.93 1.98 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.75 0.786 . . . . 15.05 110.043 178.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -81.35 53.05 1.97 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.495 -0.775 . . . . 14.19 110.418 -177.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 74.2 p -109.25 144.97 36.66 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.963 -0.562 . . . . 11.38 111.109 -178.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -138.32 67.34 46.09 Favored Pre-proline 0 C--N 1.316 -0.848 0 CA-C-N 115.52 -0.764 . . . . 8.29 110.383 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 22.7 Cg_exo -64.63 130.45 26.46 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 122.503 2.135 . . . . 6.87 111.759 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 54' ' ' PRO . 9.5 Cg_exo -71.7 -149.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.932 2.421 . . . . 5.04 110.912 173.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -56.41 107.61 0.95 Allowed Pre-proline 0 C--O 1.235 0.293 0 N-CA-C 109.942 -0.392 . . . . 2.59 109.942 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -75.38 -176.59 3.01 Favored 'Trans proline' 0 CA--C 1.507 -0.868 0 C-N-CA 123.319 2.679 . . . . 1.64 113.145 -172.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -118.35 139.56 51.17 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 114.174 -1.375 . . . . 3.39 110.168 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.623 HG22 ' N ' ' A' ' 60' ' ' ARG . 9.7 mt -88.02 171.42 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-O 121.968 0.889 . . . . 0.44 111.574 -176.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.623 ' N ' HG22 ' A' ' 59' ' ' ILE . 50.1 mtt-85 -72.04 -157.16 0.03 OUTLIER 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 113.746 -1.57 . . . . 2.34 112.232 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.627 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 19.1 t-160 -158.09 146.96 19.22 Favored 'General case' 0 CA--C 1.476 -1.904 0 CA-C-N 112.237 -2.256 . . . . 2.22 106.616 178.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.768 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.0 m-30 -125.62 158.58 34.33 Favored 'General case' 0 N--CA 1.421 -1.88 0 O-C-N 123.967 0.792 . . . . 0.21 109.821 -175.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.541 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 4.4 t70 -80.73 67.54 6.65 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 123.761 1.743 . . . . 0.35 108.25 171.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.715 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.1 m95 -56.23 -42.28 77.05 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 111.361 -2.654 . . . . 0.1 112.345 174.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.579 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 9.8 t-20 -49.55 -31.14 9.76 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 113.537 -1.665 . . . . 1.11 112.183 175.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.2 -16.58 80.52 Favored Glycine 0 CA--C 1.505 -0.547 0 CA-C-O 122.091 0.828 . . . . 0.21 111.193 -179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.537 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -100.89 -54.14 2.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 113.846 -1.177 . . . . 0.13 110.874 -176.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.716 ' O ' HG23 ' A' ' 72' ' ' VAL . 41.8 mtt -64.33 -59.12 4.75 Favored 'General case' 0 C--O 1.212 -0.905 0 CA-C-N 114.256 -1.338 . . . . 0.09 112.798 -176.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.579 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -39.47 -55.12 3.47 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 114.548 1.314 . . . . 0.63 114.548 -175.94 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.812 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 43.1 Cg_endo -66.14 -29.68 47.52 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 121.708 1.605 . . . . 0.14 110.471 -177.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.656 ' HE2' ' N ' ' A' ' 192' ' ' GLY . 11.1 mtm -82.19 -40.46 21.7 Favored 'General case' 0 C--O 1.215 -0.753 0 CA-C-N 115.292 -0.867 . . . . 0.7 111.397 -177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.716 HG23 ' O ' ' A' ' 68' ' ' MET . 47.9 t -57.44 -39.06 66.46 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.024 0 CA-C-N 114.608 -1.178 . . . . 0.12 108.382 172.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -62.12 -33.6 74.76 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.204 -1.816 . . . . 0.56 110.94 174.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.812 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 32.9 mtpt -82.4 -31.57 29.55 Favored 'General case' 0 N--CA 1.473 0.686 0 CA-C-O 121.203 0.525 . . . . 1.3 110.886 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.849 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.32 -28.52 68.06 Favored 'General case' 0 N--CA 1.44 -0.942 0 CA-C-N 115.255 -0.884 . . . . 0.5 111.425 -172.168 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.659 HD13 ' HD3' ' A' ' 118' ' ' LYS . 5.6 mt -93.53 -4.18 51.5 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-O 122.412 1.101 . . . . 0.65 110.588 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.49 17.93 42.31 Favored Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 108.837 -1.705 . . . . 0.17 108.837 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.614 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.33 163.98 15.1 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.615 -0.792 . . . . 0.1 109.897 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -92.26 106.42 18.43 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-N 115.517 -0.765 . . . . 1.72 109.732 177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.639 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.21 -24.69 3.07 Favored Glycine 0 N--CA 1.418 -2.519 0 C-N-CA 119.998 -1.096 . . . . 0.12 110.373 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.849 HG11 ' O ' ' A' ' 75' ' ' MET . 11.4 p -99.59 153.57 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-N 114.738 -0.731 . . . . 0.16 111.153 -175.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 6.6 m -134.55 139.27 45.28 Favored 'General case' 0 C--N 1.302 -1.46 0 CA-C-N 114.795 -1.093 . . . . 0.45 110.267 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.502 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -58.89 143.9 46.24 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.432 -0.804 . . . . 0.28 110.514 168.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.5 0.62 69.64 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.89 -0.672 . . . . 0.28 113.141 176.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.95 153.65 22.03 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-N 117.078 0.439 . . . . 1.2 110.658 -177.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.722 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.2 p -81.91 116.49 26.26 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 CA-C-O 122.051 0.929 . . . . 0.2 109.301 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.589 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.4 tm? -104.37 110.06 22.16 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 115.173 -0.922 . . . . 0.14 109.106 -172.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.75 HD23 HG11 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -71.65 101.09 2.45 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-N 114.954 -1.021 . . . . 0.15 108.65 177.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.669 ' O ' ' HG ' ' A' ' 127' ' ' LEU . 73.0 t -73.66 111.18 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.432 0 CA-C-N 114.863 -1.062 . . . . 0.95 109.048 179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.792 ' HB2' HD11 ' A' ' 142' ' ' LEU . 6.1 t0 -77.35 152.87 34.25 Favored 'General case' 0 CA--C 1.491 -1.311 0 CA-C-N 114.735 -1.12 . . . . 0.64 108.167 178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.541 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.7 OUTLIER -61.39 137.24 58.24 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-N 114.718 -1.128 . . . . 0.37 107.999 173.253 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.56 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 20.6 t -63.58 138.84 22.3 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.88 0 N-CA-C 107.903 -1.147 . . . . 0.1 107.903 167.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.815 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.8 t-20 -84.21 162.81 20.06 Favored 'General case' 0 C--N 1.288 -2.079 0 CA-C-N 115.123 -0.944 . . . . 0.18 110.138 173.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.758 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.0 t-20 -125.22 85.7 2.44 Favored 'General case' 0 C--N 1.291 -1.965 0 CA-C-N 114.37 -1.287 . . . . 0.12 108.241 175.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.462 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 12.4 mtp180 -108.73 -1.69 19.19 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-N 114.029 -1.441 . . . . 0.64 108.823 -172.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.712 HG21 ' HB3' ' A' ' 172' ' ' PRO . 24.6 p -52.46 -171.63 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 112.927 -1.942 . . . . 0.14 115.281 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.448 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 30.5 t30 -71.24 -9.39 58.03 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 113.107 -1.861 . . . . 0.48 110.539 173.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.547 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -151.73 -146.34 4.32 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.358 -0.925 . . . . 0.12 112.841 -177.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.587 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.1 p -121.19 129.7 53.35 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.119 0.485 . . . . 1.16 112.147 -177.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.758 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.3 pp -134.73 156.76 48.24 Favored 'General case' 0 CA--C 1.5 -0.944 0 CA-C-O 121.876 0.846 . . . . 0.1 110.855 -177.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.62 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.2 t-20 -80.44 80.7 6.84 Favored 'General case' 0 C--N 1.298 -1.634 0 CA-C-N 113.845 -1.525 . . . . 0.17 107.977 176.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.04 -14.71 63.19 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.261 -1.336 . . . . 0.09 110.027 -179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.754 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.33 -32.63 37.86 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 108.812 -0.81 . . . . 0.15 108.812 -178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.62 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 8.0 tp10 -65.5 -32.84 74.66 Favored 'General case' 0 N--CA 1.433 -1.322 0 CA-C-N 114.384 -1.28 . . . . 1.73 108.901 172.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -73.58 -45.18 54.84 Favored 'General case' 0 N--CA 1.429 -1.511 0 CA-C-N 112.96 -1.927 . . . . 0.12 109.683 178.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.62 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 73.1 m -62.84 -31.49 72.51 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-N 114.155 -1.384 . . . . 0.11 110.228 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 110' ' ' ARG . 0.1 OUTLIER -66.85 -44.09 81.91 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 108.136 -1.061 . . . . 1.47 108.136 172.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.67 HG21 ' HB2' ' A' ' 64' ' ' TRP . 51.7 m -62.79 -31.73 72.77 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.4 -0.818 . . . . 0.12 110.584 178.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.689 ' O ' HD23 ' A' ' 113' ' ' LEU . 10.3 mt -52.67 -69.66 0.11 Allowed 'General case' 0 CA--C 1.494 -1.192 0 CA-C-N 115.737 -0.665 . . . . 0.56 109.283 171.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.539 ' HG3' HG21 ' A' ' 89' ' ' VAL . 9.4 mtp180 -40.05 -36.57 0.5 Allowed 'General case' 0 C--N 1.313 -0.991 0 O-C-N 124.365 1.041 . . . . 1.51 111.606 175.095 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.516 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -73.4 -46.98 45.55 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.501 -1.227 . . . . 0.28 111.97 -176.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.415 ' CB ' ' HG2' ' A' ' 69' ' ' GLN . . . -72.2 -31.99 66.39 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-O 122.261 1.029 . . . . 0.09 108.455 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.866 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.5 mm? -63.23 -35.75 81.38 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 113.213 -1.812 . . . . 0.12 109.579 172.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.557 ' HA ' HD21 ' A' ' 121' ' ' LEU . . . -73.61 -39.93 64.21 Favored 'General case' 0 CA--C 1.505 -0.772 0 CA-C-N 114.855 -1.066 . . . . 0.2 111.383 -175.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -61.01 -32.03 71.63 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-N 115.623 -0.717 . . . . 1.17 110.85 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -76.46 -21.34 56.0 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.412 -0.813 . . . . 2.05 111.076 -179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 60.91 11.83 26.23 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 115.492 0.957 . . . . 0.54 115.492 162.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.659 ' HD3' HD13 ' A' ' 76' ' ' LEU . 8.6 ptmt -108.47 -23.64 11.77 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.413 0.606 . . . . 0.99 111.225 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.654 ' HE2' ' SD ' ' A' ' 75' ' ' MET . 3.2 m-85 -87.87 170.15 11.42 Favored 'General case' 0 CA--C 1.492 -1.288 0 CA-C-O 121.924 0.869 . . . . 0.21 111.676 172.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.531 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 23.5 m -120.66 105.44 10.78 Favored 'General case' 0 N--CA 1.414 -2.243 0 CA-C-N 113.425 -1.716 . . . . 0.23 108.064 170.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.866 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.1 OUTLIER -98.17 130.67 44.91 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 114.379 -1.282 . . . . 0.38 112.249 -168.023 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.78 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.7 OUTLIER -75.48 150.86 6.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 CA-C-N 113.973 -1.467 . . . . 0.42 107.77 174.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.6 t -101.24 -173.07 2.28 Favored 'General case' 0 N--CA 1.44 -0.965 0 C-N-CA 119.803 -0.759 . . . . 1.7 109.765 176.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -63.32 -25.28 68.23 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.1 -1.074 . . . . 0.55 108.1 174.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.618 ' O ' ' HG3' ' A' ' 129' ' ' MET . 36.2 mt-30 -52.52 -39.09 60.94 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 113.392 -1.731 . . . . 2.04 110.79 -179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.78 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 5.7 mt-30 -99.15 -51.16 3.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.774 0.797 . . . . 0.41 110.316 172.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.675 HD23 HD21 ' A' ' 88' ' ' LEU . 1.8 tm? -64.26 -62.5 1.57 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 113.801 -1.545 . . . . 1.39 112.906 -167.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.726 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -50.89 -39.15 53.45 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 123.62 1.676 . . . . 1.05 109.248 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.705 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 0.0 OUTLIER -63.87 -61.81 2.04 Favored 'General case' 0 C--N 1.309 -1.163 0 CA-C-N 110.904 -2.862 . . . . 1.64 110.837 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.782 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -42.82 -44.78 4.61 Favored 'General case' 0 CA--C 1.507 -0.698 0 O-C-N 124.496 1.122 . . . . 0.31 112.134 174.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.53 ' HZ3' ' N ' ' A' ' 142' ' ' LEU . 13.3 mmtt -49.32 -60.37 2.88 Favored 'General case' 0 CA--C 1.503 -0.862 0 N-CA-C 109.471 -0.566 . . . . 1.53 109.471 175.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -59.16 -43.11 92.09 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.234 -0.894 . . . . 0.41 111.059 -179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.705 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.1 mt-30 -56.41 -36.3 68.76 Favored 'General case' 0 CA--C 1.489 -1.372 0 CA-C-N 114.238 -1.346 . . . . 0.37 109.69 -179.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.489 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -89.94 -31.36 17.3 Favored 'General case' 0 N--CA 1.425 -1.72 0 CA-C-N 114.162 -1.381 . . . . 0.24 109.622 -176.441 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 154.53 -45.41 0.55 Allowed Glycine 0 CA--C 1.495 -1.207 0 C-N-CA 120.096 -1.05 . . . . 0.33 113.278 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.585 HD13 ' O ' ' A' ' 141' ' ' SER . 95.7 mt -67.95 -171.16 0.2 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 112.448 -1.876 . . . . 0.31 115.486 -169.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.612 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 9.5 m -115.1 149.91 43.38 Favored Pre-proline 0 N--CA 1.422 -1.875 0 CA-C-N 110.7 -2.954 . . . . 0.81 107.765 174.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.726 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 28.8 Cg_endo -64.5 1.02 1.91 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.534 2.156 . . . . 0.32 112.034 177.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.754 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.5 OUTLIER -117.36 -21.62 8.61 Favored 'General case' 0 CA--C 1.507 -0.692 0 CA-C-N 115.382 -0.826 . . . . 1.25 110.862 -177.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.612 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 16.3 t70 -71.42 -20.32 62.13 Favored 'General case' 0 CA--C 1.487 -1.473 0 CA-C-N 114.222 -1.354 . . . . 0.65 108.932 -171.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.585 ' O ' HD13 ' A' ' 136' ' ' LEU . 26.3 m 72.84 169.05 0.32 Allowed 'General case' 0 N--CA 1.422 -1.861 0 CA-C-N 113.005 -1.907 . . . . 0.6 109.338 -174.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.002 HD22 ' HA ' ' A' ' 148' ' ' ALA . 4.9 mt -63.48 -39.12 93.62 Favored 'General case' 0 C--N 1.293 -1.857 0 N-CA-C 107.685 -1.228 . . . . 0.86 107.685 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.43 -11.84 2.1 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 113.369 -1.741 . . . . 0.31 114.402 175.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 1.5 m -157.04 128.76 7.09 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 109.068 -0.716 . . . . 0.24 109.068 -177.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.658 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 15.3 mmt180 -43.93 -46.46 8.14 Favored 'General case' 0 C--O 1.211 -0.935 0 CA-C-N 117.991 0.359 . . . . 1.65 111.385 -178.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.404 ' HA ' ' HB ' ' A' ' 149' ' ' ILE . 40.7 t -71.27 -25.81 62.62 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.68 0.753 . . . . 0.53 111.459 -175.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.431 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 22.8 mttm -75.04 -32.21 61.5 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 122.588 1.185 . . . . 1.31 108.678 176.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 1.002 ' HA ' HD22 ' A' ' 142' ' ' LEU . . . -72.57 -46.02 56.37 Favored 'General case' 0 CA--C 1.486 -1.51 0 CA-C-N 112.385 -2.189 . . . . 0.12 110.017 177.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.598 HG13 ' HE1' ' A' ' 179' ' ' MET . 41.5 mt -67.14 -42.38 88.11 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.851 0 CA-C-N 112.768 -2.015 . . . . 0.11 109.995 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -52.92 -52.72 37.48 Favored Glycine 0 N--CA 1.439 -1.1 0 CA-C-N 114.74 -1.118 . . . . 0.15 111.301 171.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.782 HG23 ' CB ' ' A' ' 130' ' ' ALA . 69.5 mt -67.12 -48.44 78.86 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.072 0 N-CA-C 112.7 0.63 . . . . 0.18 112.7 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.696 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.94 -40.39 73.09 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-O 120.826 0.345 . . . . 0.13 111.344 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.524 ' HD2' HG23 ' A' ' 149' ' ' ILE . 43.0 mtp180 -81.64 -22.26 37.71 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.625 0.726 . . . . 1.08 110.321 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.423 HD21 ' CD ' ' A' ' 133' ' ' GLN . 15.4 t30 -81.83 -12.95 58.27 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 107.16 -1.422 . . . . 0.5 107.16 175.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.75 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -106.05 -29.17 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.394 0 CA-C-N 113.231 -1.804 . . . . 0.17 110.898 -174.024 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 98.99 35.63 4.75 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.357 -0.925 . . . . 0.16 112.466 -178.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.669 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -111.68 158.13 19.65 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 113.275 0.842 . . . . 0.12 113.275 -169.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.722 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.5 m80 -98.66 -27.79 13.83 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.322 -0.854 . . . . 0.2 109.757 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.624 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 9.3 m-85 -135.58 -173.35 3.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.049 -0.978 . . . . 0.13 111.281 -175.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.697 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.1 t -138.42 139.9 40.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 114.9 -1.045 . . . . 0.08 109.231 167.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.735 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 40.8 tp -108.5 97.27 6.96 Favored 'General case' 0 N--CA 1.43 -1.429 0 C-N-CA 119.468 -0.893 . . . . 0.16 109.505 165.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.704 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 1.4 m-85 -78.82 112.45 15.99 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 114.687 -1.142 . . . . 0.26 108.959 179.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.719 ' OG ' HD11 ' A' ' 174' ' ' LEU . 27.0 t -122.26 163.19 20.08 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-O 122.002 0.906 . . . . 1.05 110.515 -178.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.823 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -164.33 173.15 12.59 Favored 'General case' 0 CA--C 1.479 -1.776 0 CA-C-N 114.37 -1.286 . . . . 0.1 111.049 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.73 139.72 42.09 Favored 'General case' 0 N--CA 1.411 -2.421 0 CA-C-N 114.14 -1.391 . . . . 0.11 108.758 177.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.68 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 9.4 t -146.42 -172.54 3.98 Favored 'General case' 0 C--N 1.302 -1.46 0 C-N-CA 119.954 -0.698 . . . . 1.09 110.267 176.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 97' ' ' ASN . . . 90.3 -84.49 1.34 Allowed Glycine 0 N--CA 1.424 -2.16 0 CA-C-N 114.883 -1.053 . . . . 0.15 111.593 174.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.448 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 49.2 t-20 -135.29 128.04 31.05 Favored 'General case' 0 C--O 1.196 -1.719 0 N-CA-C 106.925 -1.509 . . . . 0.59 106.925 178.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.547 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.9 p -64.03 -41.51 92.69 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 CA-C-N 115.553 -0.749 . . . . 0.15 112.37 -177.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.42 ' N ' HG13 ' A' ' 169' ' ' VAL . 11.9 m120 -67.56 -26.45 66.31 Favored 'General case' 0 CA--C 1.507 -0.693 0 CA-C-O 121.468 0.651 . . . . 1.26 109.461 -175.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -154.52 89.21 3.26 Favored Pre-proline 0 C--N 1.308 -1.199 0 CA-C-N 114.887 -1.051 . . . . 0.13 108.304 175.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.852 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.6 Cg_endo -90.27 165.0 4.56 Favored 'Trans proline' 0 CA--C 1.488 -1.804 0 C-N-CA 124.519 3.479 . . . . 0.09 114.97 -171.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.597 HG22 ' HB3' ' A' ' 191' ' ' LYS . 19.4 m -83.24 117.32 22.87 Favored 'General case' 0 N--CA 1.416 -2.151 0 CA-C-N 113.548 -1.66 . . . . 0.14 107.602 166.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.823 HD12 ' O ' ' A' ' 164' ' ' SER . 49.1 tp -84.09 98.53 9.93 Favored 'General case' 0 N--CA 1.411 -2.381 0 C-N-CA 119.641 -0.824 . . . . 0.16 109.055 178.345 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.623 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 38.8 mt-30 -89.13 107.21 18.92 Favored 'General case' 0 C--N 1.273 -2.749 0 CA-C-N 114.811 -1.086 . . . . 0.34 108.95 -177.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.556 ' HA ' ' HA ' ' A' ' 163' ' ' SER . 37.0 mtp -107.08 163.73 12.74 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.138 -0.937 . . . . 1.09 110.393 -176.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.592 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.9 tt0 -170.09 117.41 0.55 Allowed 'General case' 0 C--O 1.202 -1.445 0 CA-C-O 121.179 0.514 . . . . 0.5 110.208 -167.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.101 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -100.12 102.06 13.28 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.705 -0.85 . . . . 0.1 108.705 -172.447 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.658 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.8 ttp -91.67 122.57 34.35 Favored 'General case' 0 N--CA 1.441 -0.902 0 CA-C-N 115.416 -0.811 . . . . 0.07 109.755 176.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.467 ' HB3' ' OG1' ' A' ' 183' ' ' THR . 0.1 OUTLIER -58.53 126.45 27.66 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.311 -1.366 . . . . 0.22 107.311 166.238 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.62 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.63 -33.36 12.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 O-C-N 120.939 -1.101 . . . . 0.11 110.55 178.798 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.418 ' N ' HD12 ' A' ' 180' ' ' LEU . 29.0 mt-30 -63.85 -13.95 49.15 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.235 -0.893 . . . . 0.35 111.449 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . 0.467 ' OG1' ' HB3' ' A' ' 180' ' ' LEU . 60.3 p -130.62 -36.69 1.41 Allowed 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 121.945 0.878 . . . . 0.19 110.26 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.531 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 87.08 24.35 37.81 Favored Glycine 0 N--CA 1.433 -1.515 0 CA-C-N 114.334 -1.303 . . . . 0.18 112.022 -177.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 186' ' ' ILE . 0.2 OUTLIER -104.26 152.37 22.29 Favored 'General case' 0 N--CA 1.428 -1.547 0 CA-C-N 115.621 -0.29 . . . . 0.73 110.658 -179.489 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.592 HD12 ' HG2' ' A' ' 177' ' ' GLN . 33.0 mm -87.85 113.6 25.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-O 121.811 0.815 . . . . 0.14 109.532 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.101 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -101.8 -29.61 3.08 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-N 114.729 -1.123 . . . . 0.13 110.587 -173.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.637 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.4 t90 -136.82 152.47 50.31 Favored 'General case' 0 CA--C 1.503 -0.833 0 CA-C-N 115.304 -0.862 . . . . 0.07 109.737 172.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 37.3 p -153.78 162.93 40.82 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 113.003 0.742 . . . . 0.13 113.003 164.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -156.53 -178.24 30.46 Favored Glycine 0 N--CA 1.425 -2.043 0 N-CA-C 110.985 -0.846 . . . . 0.12 110.985 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.748 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.1 mtmt -157.12 149.39 22.97 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 106.343 -1.725 . . . . 1.22 106.343 166.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.656 ' N ' ' HE2' ' A' ' 71' ' ' MET . . . -159.35 127.69 1.88 Allowed Glycine 0 C--N 1.285 -2.258 0 C-N-CA 119.973 -1.108 . . . . 0.12 112.258 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.09 114.45 12.43 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.547 0.689 . . . . 0.17 111.472 -173.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.852 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -91.73 159.47 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-O 122.609 1.195 . . . . 0.11 111.065 -175.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.768 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -99.68 173.78 6.54 Favored 'General case' 0 C--N 1.294 -1.828 0 CA-C-N 112.319 -2.218 . . . . 0.18 108.974 -173.051 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -102.94 130.3 49.95 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 120.64 -0.424 . . . . 0.91 110.895 171.35 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.541 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 15.3 mm-40 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.609 -0.71 . . . . 1.24 110.722 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.801 -0.519 . . . . 88.61 111.801 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.6 p -82.32 114.27 20.68 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.84 0.353 . . . . 87.43 110.71 -179.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -114.54 142.6 46.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.121 -0.49 . . . . 87.16 109.801 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 24.3 ptm 40.23 39.32 0.64 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.085 1.354 . . . . 85.34 113.725 174.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.6 p -119.81 -38.17 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.697 -0.683 . . . . 85.05 110.585 -179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -166.5 -110.26 0.23 Allowed Glycine 0 N--CA 1.437 -1.242 0 N-CA-C 111.445 -0.662 . . . . 84.68 111.445 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 55.49 -100.84 0.12 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 122.949 0.5 . . . . 85.57 111.258 -178.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 81.3 mtm180 49.95 68.7 0.7 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.401 0.62 . . . . 85.04 111.055 -178.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -123.85 99.34 38.49 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.654 -0.703 . . . . 82.17 110.409 -175.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -76.01 78.74 3.08 Favored 'Trans proline' 0 N--CA 1.461 -0.415 0 C-N-CA 122.462 2.108 . . . . 81.51 112.644 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 61.95 86.36 0.15 Allowed Pre-proline 0 CA--C 1.53 0.204 0 CA-C-N 115.077 -0.965 . . . . 79.56 111.7 177.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -66.73 145.51 75.62 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.354 2.036 . . . . 78.5 112.389 -178.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.4 m -78.76 156.28 4.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.11 0.481 . . . . 77.0 111.507 -178.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.473 ' HG2' ' N ' ' A' ' 15' ' ' GLU . 39.3 tt0 -163.17 162.99 25.78 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.277 -0.874 . . . . 75.74 109.447 176.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.473 ' N ' ' HG2' ' A' ' 14' ' ' GLU . 39.1 tt0 76.86 148.81 0.1 Allowed 'General case' 0 N--CA 1.463 0.182 0 O-C-N 124.192 0.932 . . . . 73.91 110.925 176.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 75.2 t -70.39 103.22 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.742 -0.663 . . . . 72.3 110.006 176.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -75.92 147.06 80.2 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.673 -0.694 . . . . 71.22 110.51 -178.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -67.7 89.37 0.35 Allowed 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.118 1.879 . . . . 69.67 111.695 176.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.455 ' HB3' ' HD3' ' A' ' 20' ' ' PRO . . . -101.45 -51.71 0.17 Allowed Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 116.208 -0.451 . . . . 67.55 111.955 178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.455 ' HD3' ' HB3' ' A' ' 19' ' ' ALA . 5.9 Cg_exo -79.48 42.36 1.28 Allowed 'Trans proline' 0 C--N 1.359 1.115 0 C-N-CA 122.606 2.204 . . . . 66.7 112.833 -175.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -76.16 127.85 33.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.818 0.342 . . . . 65.01 110.09 178.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 8.7 tt0 -136.71 133.22 18.85 Favored Pre-proline 0 C--N 1.319 -0.759 0 CA-C-N 116.149 -0.478 . . . . 63.41 109.975 -178.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 83.7 Cg_exo -57.27 143.19 94.29 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.952 2.435 . . . . 61.93 112.114 175.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -138.03 118.45 13.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.314 -0.403 . . . . 59.87 111.039 -177.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -103.35 105.55 47.19 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 116.042 -0.526 . . . . 58.47 109.884 176.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.65 -137.52 0.01 OUTLIER 'Trans proline' 0 CA--C 1.534 0.517 0 C-N-CA 122.831 2.354 . . . . 57.36 113.34 -177.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -91.11 138.16 31.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.0 0.429 . . . . 55.51 110.441 178.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.429 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -143.59 144.41 27.41 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 116.469 -0.332 . . . . 53.87 110.233 178.138 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 28' ' ' GLN . 19.5 Cg_exo -66.67 107.95 1.35 Allowed 'Trans proline' 0 C--O 1.234 0.303 0 C-N-CA 122.776 2.318 . . . . 52.76 112.305 -179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.4 m -98.36 148.8 35.02 Favored Pre-proline 0 C--N 1.32 -0.706 0 CA-C-N 115.926 -0.579 . . . . 50.93 109.785 176.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -63.82 88.8 0.15 Allowed 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 123.039 2.493 . . . . 49.21 112.643 -178.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.6 p -69.66 148.49 49.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.735 -0.666 . . . . 47.49 110.761 177.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -85.54 117.03 67.95 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.227 -0.442 . . . . 45.97 111.11 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -60.28 162.07 18.19 Favored 'Trans proline' 0 C--O 1.235 0.36 0 C-N-CA 123.073 2.516 . . . . 45.28 113.066 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.6 p -89.02 144.13 26.37 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.445 -0.798 . . . . 42.79 111.233 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.451 ' HA ' ' HD3' ' A' ' 37' ' ' PRO . 7.5 p -67.48 128.2 93.56 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 115.428 -0.806 . . . . 40.79 110.495 177.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 36' ' ' VAL . 34.4 Cg_exo -63.15 156.37 55.65 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.785 2.323 . . . . 39.81 112.677 178.027 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 11.1 m -77.51 135.95 38.28 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.9 -0.591 . . . . 37.5 110.914 -179.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 12.0 mt -105.04 105.04 50.01 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 115.898 -0.592 . . . . 35.65 110.138 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -93.45 75.67 0.3 Allowed 'Trans proline' 0 N--CA 1.449 -1.116 0 C-N-CA 122.874 2.383 . . . . 33.72 112.572 179.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -125.24 73.01 1.27 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.111 0.481 . . . . 31.51 110.554 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -129.57 87.35 53.15 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.193 -0.458 . . . . 30.13 110.329 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -72.89 139.34 30.11 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.482 2.122 . . . . 29.52 111.137 175.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -66.63 153.8 52.37 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.754 -0.736 . . . . 26.75 112.656 -179.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.7 129.06 20.18 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 123.031 2.487 . . . . 25.08 112.356 179.579 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 46.0 mt -74.86 -57.85 5.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.791 -0.641 . . . . 23.9 110.523 179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 57.79 86.08 0.08 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.947 -0.569 . . . . 21.23 110.867 -178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.8 p-80 -89.47 167.02 13.32 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.23 0.538 . . . . 19.92 110.684 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.14 173.08 6.77 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 115.312 -0.858 . . . . 16.56 110.496 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -103.66 56.78 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.473 0.654 . . . . 15.05 110.369 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 26.5 tt0 -97.15 97.01 8.83 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 115.613 -0.721 . . . . 14.19 110.44 -175.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.2 p -95.56 162.28 13.7 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.837 -0.619 . . . . 11.38 111.001 178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -126.87 77.25 74.88 Favored Pre-proline 0 C--N 1.316 -0.85 0 CA-C-N 115.294 -0.866 . . . . 8.29 111.368 -179.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.81 146.8 21.13 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.868 2.378 . . . . 6.87 110.827 175.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.62 140.52 47.5 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 121.847 1.698 . . . . 5.04 112.499 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -143.18 92.07 6.86 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.786 -0.643 . . . . 2.59 109.892 176.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -71.48 -175.98 1.79 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 122.673 2.249 . . . . 1.64 112.819 -178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 22.6 m80 -130.99 146.23 52.31 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.991 -1.004 . . . . 3.39 111.229 -179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.632 HG22 ' N ' ' A' ' 60' ' ' ARG . 11.4 mt -93.04 174.62 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 114.948 -1.024 . . . . 0.44 111.421 -176.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.632 ' N ' HG22 ' A' ' 59' ' ' ILE . 25.4 mtt180 -65.05 -157.44 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 113.722 -1.581 . . . . 2.34 112.06 176.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.792 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 18.6 t-160 -159.64 147.53 17.18 Favored 'General case' 0 CA--C 1.473 -2.012 0 CA-C-N 112.032 -2.349 . . . . 2.22 106.238 177.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.792 ' HD1' ' C ' ' A' ' 61' ' ' HIS . 2.8 m-30 -125.21 158.3 34.37 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.866 -0.606 . . . . 0.21 109.593 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.525 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 3.0 t70 -79.24 67.39 4.95 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 123.762 1.744 . . . . 0.35 108.291 171.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.75 ' NE1' ' HB2' ' A' ' 62' ' ' TYR . 89.3 m95 -59.83 -44.43 94.07 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-N 111.478 -2.601 . . . . 0.1 112.113 174.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.415 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 13.4 t-20 -51.04 -31.44 18.53 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 113.939 -1.482 . . . . 1.11 111.35 175.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.35 -16.61 79.81 Favored Glycine 0 C--N 1.312 -0.754 0 CA-C-N 115.504 -0.771 . . . . 0.21 111.318 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.434 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.57 -53.67 2.93 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 113.996 -1.102 . . . . 0.13 110.817 -176.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.697 ' SD ' HD23 ' A' ' 109' ' ' LEU . 42.4 mtt -62.89 -59.61 4.61 Favored 'General case' 0 C--O 1.212 -0.883 0 CA-C-N 114.206 -1.361 . . . . 0.09 112.554 -177.556 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.448 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 0.0 OUTLIER -38.53 -55.23 2.64 Favored Pre-proline 0 C--N 1.323 -0.572 0 N-CA-C 114.83 1.419 . . . . 0.63 114.83 -176.226 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.795 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.1 Cg_endo -65.46 -30.13 52.91 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.674 1.583 . . . . 0.14 110.588 -177.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.672 ' HE1' ' N ' ' A' ' 192' ' ' GLY . 13.7 mtm -83.35 -39.69 20.39 Favored 'General case' 0 C--O 1.216 -0.706 0 CA-C-N 115.413 -0.812 . . . . 0.7 111.205 -178.324 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.692 HG23 ' O ' ' A' ' 68' ' ' MET . 58.9 t -56.82 -39.29 63.5 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.081 0 CA-C-N 114.555 -1.202 . . . . 0.12 108.465 172.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.1 t -61.67 -35.33 77.65 Favored 'General case' 0 C--N 1.307 -1.261 0 CA-C-N 113.176 -1.829 . . . . 0.56 110.9 174.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.795 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 31.3 mtpt -81.31 -31.55 33.49 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 121.093 0.473 . . . . 1.3 110.618 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.874 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -67.26 -25.17 65.94 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.355 -0.839 . . . . 0.5 111.119 -173.086 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' A' ' 118' ' ' LYS . 6.7 mt -95.2 -5.09 44.69 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-O 122.069 0.938 . . . . 0.65 110.762 -178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -105.92 17.46 41.7 Favored Glycine 0 N--CA 1.437 -1.261 0 N-CA-C 108.888 -1.685 . . . . 0.17 108.888 169.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.648 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -87.39 162.08 17.52 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.576 -0.812 . . . . 0.1 110.036 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -90.4 105.32 17.73 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.253 -0.885 . . . . 1.72 110.273 177.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.647 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 135.92 -22.2 3.47 Favored Glycine 0 N--CA 1.429 -1.774 0 CA-C-N 114.978 -1.01 . . . . 0.12 110.807 -178.292 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.874 HG11 ' O ' ' A' ' 75' ' ' MET . 10.7 p -102.08 153.88 5.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.678 0.752 . . . . 0.16 111.704 -175.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 14.6 m -135.14 139.9 45.0 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 114.726 -1.124 . . . . 0.45 110.796 176.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.664 ' HB2' ' HE3' ' A' ' 118' ' ' LYS . . . -59.81 126.89 29.34 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.332 -0.849 . . . . 0.28 110.481 166.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 108.05 8.25 29.83 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.849 -0.691 . . . . 0.28 112.56 177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.31 153.2 19.36 Favored 'General case' 0 CA--C 1.509 -0.606 0 C-N-CA 120.721 -0.392 . . . . 1.2 110.52 177.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.67 HG13 ' N ' ' A' ' 158' ' ' HIS . 2.0 p -82.1 117.32 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.053 0 CA-C-O 122.009 0.909 . . . . 0.2 108.956 166.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.662 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.1 tm? -105.42 110.23 22.5 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.301 -0.863 . . . . 0.14 109.267 -171.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.724 HD21 HD23 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -73.04 94.5 1.9 Allowed 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 114.446 -1.252 . . . . 0.15 109.133 178.044 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.479 ' HA ' ' HB3' ' A' ' 161' ' ' LEU . 1.4 m -73.39 116.78 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.565 0 N-CA-C 107.542 -1.281 . . . . 0.95 107.542 176.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.813 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 7.0 t0 -79.26 170.81 16.07 Favored 'General case' 0 CA--C 1.504 -0.824 0 N-CA-C 108.201 -1.036 . . . . 0.64 108.201 178.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.59 ' OG ' ' HA ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -59.96 149.42 31.95 Favored 'General case' 0 N--CA 1.413 -2.284 0 CA-C-O 122.773 1.273 . . . . 0.37 108.937 171.548 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.559 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 36.7 t -74.34 138.55 20.9 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.476 0 CA-C-N 113.576 -1.647 . . . . 0.1 106.612 163.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.828 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.4 t-20 -84.45 158.97 20.87 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-O 121.888 0.852 . . . . 0.18 109.875 173.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.748 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -122.81 84.8 2.32 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-N 114.281 -1.327 . . . . 0.12 107.938 176.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.448 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 15.0 mtp180 -107.67 -1.83 20.73 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-N 113.547 -1.66 . . . . 0.64 108.574 -172.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.747 HG21 ' HB3' ' A' ' 172' ' ' PRO . 24.1 p -51.82 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 113.156 -1.838 . . . . 0.14 114.216 -177.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.462 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 0.3 OUTLIER -76.06 -2.99 33.43 Favored 'General case' 0 C--N 1.309 -1.18 0 CA-C-N 113.233 -1.803 . . . . 0.48 110.33 174.692 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.638 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -149.66 -150.22 5.19 Favored Glycine 0 CA--C 1.52 0.378 0 C-N-CA 120.922 -0.656 . . . . 0.12 112.905 178.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.6 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 60.1 p -121.83 130.58 53.49 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.514 0.561 . . . . 1.16 112.514 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.748 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -135.6 157.38 47.02 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 121.855 0.836 . . . . 0.1 111.155 -176.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.605 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.3 t-20 -80.14 79.49 6.69 Favored 'General case' 0 C--N 1.305 -1.364 0 CA-C-N 114.002 -1.454 . . . . 0.17 107.993 175.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.576 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -67.38 -15.57 63.75 Favored 'General case' 0 C--N 1.288 -2.08 0 CA-C-N 114.285 -1.325 . . . . 0.09 109.997 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -80.57 -29.97 37.01 Favored 'General case' 0 N--CA 1.441 -0.879 0 N-CA-C 108.944 -0.762 . . . . 0.15 108.944 -177.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.605 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 10.3 tp10 -66.46 -34.64 78.4 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-O 122.681 1.229 . . . . 1.73 109.131 170.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.99 -43.4 65.17 Favored 'General case' 0 N--CA 1.429 -1.5 0 CA-C-N 113.203 -1.817 . . . . 0.12 109.664 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.628 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 55.7 m -63.77 -31.02 72.06 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 113.898 -1.501 . . . . 0.11 110.536 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' A' ' 104' ' ' GLU . 0.5 OUTLIER -67.85 -42.45 81.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 107.609 -1.256 . . . . 1.47 107.609 172.436 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.692 HG21 ' HB2' ' A' ' 64' ' ' TRP . 57.2 m -63.56 -31.02 72.06 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 115.171 -0.922 . . . . 0.12 110.672 178.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.735 HD11 ' OG ' ' A' ' 163' ' ' SER . 8.3 mt -50.9 -70.47 0.08 Allowed 'General case' 0 CA--C 1.496 -1.101 0 CA-C-N 115.776 -0.647 . . . . 0.56 109.278 171.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.52 ' O ' HD13 ' A' ' 121' ' ' LEU . 17.0 mtp180 -41.0 -38.78 1.04 Allowed 'General case' 0 C--N 1.314 -0.978 0 O-C-N 124.475 1.109 . . . . 1.51 111.197 176.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -68.37 -46.49 69.93 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 114.367 -1.288 . . . . 0.28 112.358 -177.5 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.448 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.38 -33.4 65.01 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 122.299 1.047 . . . . 0.09 108.417 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.71 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.2 mm? -65.2 -31.89 73.28 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 113.186 -1.824 . . . . 0.12 110.131 176.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.65 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.85 -44.69 61.07 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-N 114.335 -1.302 . . . . 0.2 111.713 -174.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -65.72 -28.75 69.28 Favored 'General case' 0 N--CA 1.441 -0.889 0 CA-C-N 114.54 -1.209 . . . . 1.17 110.832 -176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -81.43 -19.78 41.77 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.3 -0.864 . . . . 2.05 111.885 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 59.24 11.05 11.53 Favored Glycine 0 C--N 1.332 0.328 0 N-CA-C 115.586 0.995 . . . . 0.54 115.586 163.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.664 ' HE3' ' HB2' ' A' ' 83' ' ' ALA . 56.2 mtpt -96.93 -3.96 40.87 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.35 0.575 . . . . 0.99 109.759 176.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.662 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 29.0 m-85 -121.22 173.2 7.46 Favored 'General case' 0 CA--C 1.493 -1.246 0 CA-C-O 122.481 1.134 . . . . 0.21 112.726 172.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 16.3 m -117.85 115.82 25.74 Favored 'General case' 0 N--CA 1.409 -2.497 0 CA-C-N 112.658 -2.065 . . . . 0.23 107.776 170.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.65 HD11 ' HB2' ' A' ' 114' ' ' ALA . 0.3 OUTLIER -83.07 137.57 34.05 Favored 'General case' 0 N--CA 1.413 -2.314 0 CA-C-N 115.152 -0.931 . . . . 0.38 110.376 -172.473 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.552 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.7 OUTLIER -83.54 152.93 3.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 108.074 -1.084 . . . . 0.42 108.074 171.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.712 ' HB2' ' HG2' ' A' ' 125' ' ' GLN . 0.9 OUTLIER -101.4 163.19 12.4 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-O 122.023 0.916 . . . . 1.7 109.827 179.695 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -68.38 -31.59 71.06 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 113.65 -1.613 . . . . 0.55 111.225 -170.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.712 ' HG2' ' HB2' ' A' ' 123' ' ' SER . 3.7 pt20 -52.28 -28.35 18.57 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 113.656 -1.611 . . . . 2.04 110.973 173.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.618 ' HB2' HG22 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -96.94 -53.15 3.61 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.244 -1.344 . . . . 0.41 110.404 170.458 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.724 HD23 HD21 ' A' ' 88' ' ' LEU . 1.2 tm? -72.45 -63.9 1.06 Allowed 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 114.94 -1.027 . . . . 1.39 113.574 -165.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.595 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 0.9 OUTLIER -51.94 -37.56 53.22 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 123.582 1.658 . . . . 1.05 108.407 -179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.667 ' HG3' ' O ' ' A' ' 125' ' ' GLN . 0.4 OUTLIER -62.89 -60.13 3.89 Favored 'General case' 0 C--O 1.21 -1.002 0 CA-C-N 110.714 -2.948 . . . . 1.64 111.292 178.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.778 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -44.15 -43.03 6.77 Favored 'General case' 0 CA--C 1.503 -0.831 0 O-C-N 124.304 1.003 . . . . 0.31 112.148 176.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.703 ' HE3' ' CD2' ' A' ' 127' ' ' LEU . 22.3 mttt -52.77 -55.52 22.25 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 120.326 -0.549 . . . . 1.53 109.691 176.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 40.8 mt-30 -62.14 -41.74 98.57 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 115.021 -0.99 . . . . 0.41 111.28 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.651 ' HG3' ' O ' ' A' ' 129' ' ' MET . 53.5 mt-30 -57.06 -36.45 70.56 Favored 'General case' 0 CA--C 1.489 -1.398 0 CA-C-N 114.257 -1.338 . . . . 0.37 110.034 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.531 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.5 OUTLIER -91.06 -31.0 16.44 Favored 'General case' 0 N--CA 1.423 -1.816 0 CA-C-N 114.243 -1.344 . . . . 0.24 109.084 -176.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 160.52 -51.24 0.36 Allowed Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.015 -1.088 . . . . 0.33 113.979 -178.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.534 HD13 ' O ' ' A' ' 141' ' ' SER . 46.8 mt -67.41 -171.1 0.16 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 116.12 1.896 . . . . 0.31 116.12 -169.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.591 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.8 m -115.58 152.55 47.31 Favored Pre-proline 0 N--CA 1.427 -1.62 0 CA-C-N 110.732 -2.94 . . . . 0.81 108.158 173.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.686 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 11.8 Cg_endo -59.2 -4.9 2.51 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.027 2.485 . . . . 0.32 113.171 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -117.49 -30.41 5.53 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 121.826 0.822 . . . . 1.25 111.104 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.591 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.4 t70 -58.28 -25.49 61.87 Favored 'General case' 0 CA--C 1.491 -1.307 0 CA-C-N 113.42 -1.718 . . . . 0.65 109.065 -174.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.59 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 5.5 m 72.9 161.37 0.24 Allowed 'General case' 0 N--CA 1.42 -1.962 0 CA-C-N 111.495 -2.593 . . . . 0.6 111.822 -178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.909 HD13 ' HA ' ' A' ' 148' ' ' ALA . 8.5 mt -66.64 -38.76 87.58 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.25 -1.389 . . . . 0.86 107.25 -174.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 61.34 -4.78 0.32 Allowed Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 112.576 -2.102 . . . . 0.31 114.703 175.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.48 124.35 9.24 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 118.603 -0.713 . . . . 0.24 109.369 -174.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.586 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 16.6 mmt85 -41.66 -51.16 4.11 Favored 'General case' 0 C--O 1.212 -0.92 0 O-C-N 123.563 0.539 . . . . 1.65 111.046 -177.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.9 t -67.81 -29.16 68.27 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.493 0.663 . . . . 0.53 111.21 -174.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.486 ' HD2' ' O ' ' A' ' 142' ' ' LEU . 20.6 mttm -72.76 -31.17 64.72 Favored 'General case' 0 CA--C 1.506 -0.718 0 CA-C-O 122.355 1.074 . . . . 1.31 108.519 177.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.909 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -76.97 -41.91 41.12 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-N 113.049 -1.887 . . . . 0.12 110.746 178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.609 ' HA ' HG23 ' A' ' 181' ' ' VAL . 43.0 mt -69.12 -42.21 81.72 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.906 0 CA-C-N 113.393 -1.731 . . . . 0.11 110.189 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -54.66 -48.77 64.13 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 114.904 -1.044 . . . . 0.15 111.27 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.778 HG23 ' CB ' ' A' ' 130' ' ' ALA . 67.2 mt -71.23 -48.08 56.58 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.003 0 N-CA-C 112.87 0.693 . . . . 0.18 112.87 -178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.666 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -55.57 -39.42 70.63 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-O 120.935 0.398 . . . . 0.13 110.633 -179.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.487 ' HD2' HG23 ' A' ' 149' ' ' ILE . 28.7 mtp180 -81.01 -24.4 37.96 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-O 121.522 0.677 . . . . 1.08 110.672 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.536 HD21 ' CD ' ' A' ' 133' ' ' GLN . 32.3 t30 -79.28 -14.12 59.23 Favored 'General case' 0 CA--C 1.505 -0.761 0 N-CA-C 107.508 -1.293 . . . . 0.5 107.508 175.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.71 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -104.69 -29.98 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 CA-C-N 113.196 -1.82 . . . . 0.17 110.967 -173.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 100.05 33.04 5.36 Favored Glycine 0 CA--C 1.504 -0.626 0 C-N-CA 120.681 -0.771 . . . . 0.16 112.437 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.689 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -106.89 159.75 16.02 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.92 0.711 . . . . 0.12 112.92 -170.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.67 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.9 m80 -99.65 -27.24 13.77 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-N 115.379 -0.828 . . . . 0.2 109.686 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.556 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 5.6 m-85 -135.58 -173.02 3.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.262 -0.881 . . . . 0.13 110.941 -175.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.776 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.0 OUTLIER -137.63 138.6 44.34 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 114.941 -1.027 . . . . 0.08 108.897 166.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.479 ' HB3' ' HA ' ' A' ' 89' ' ' VAL . 45.5 tp -107.93 101.36 10.63 Favored 'General case' 0 N--CA 1.427 -1.584 0 C-N-CA 119.715 -0.794 . . . . 0.16 109.038 165.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.605 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.4 m-85 -81.38 113.03 19.19 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.087 -1.415 . . . . 0.26 109.559 177.02 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.735 ' OG ' HD11 ' A' ' 109' ' ' LEU . 4.2 p -118.09 159.99 22.3 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-O 121.717 0.77 . . . . 1.05 110.749 -176.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.828 ' HA ' ' H ' ' A' ' 93' ' ' ASN . 1.9 p -163.94 173.6 12.45 Favored 'General case' 0 CA--C 1.483 -1.634 0 CA-C-N 114.862 -1.063 . . . . 0.1 111.414 179.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.631 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.09 139.01 37.58 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-N 113.951 -1.477 . . . . 0.11 108.464 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 8.4 t -147.2 -171.47 3.79 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 120.055 -0.658 . . . . 1.09 110.073 176.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 90.05 -80.71 1.43 Allowed Glycine 0 N--CA 1.424 -2.102 0 C-N-CA 120.128 -1.034 . . . . 0.15 111.773 174.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 61.5 t30 -144.52 125.47 14.4 Favored 'General case' 0 C--O 1.198 -1.649 0 N-CA-C 107.99 -1.115 . . . . 0.59 107.99 178.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.638 HG11 ' HA3' ' A' ' 98' ' ' GLY . 3.3 p -63.12 -42.97 98.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.707 0 CA-C-N 115.479 -0.782 . . . . 0.15 112.934 -171.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.441 ' N ' HG13 ' A' ' 169' ' ' VAL . 9.7 m120 -61.66 -29.53 70.13 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.391 0.615 . . . . 1.26 109.532 -177.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -153.9 88.52 3.54 Favored Pre-proline 0 C--N 1.314 -0.969 0 CA-C-N 114.634 -1.167 . . . . 0.13 108.508 178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.844 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.3 Cg_endo -91.55 167.7 3.34 Favored 'Trans proline' 0 CA--C 1.497 -1.374 0 C-N-CA 124.927 3.751 . . . . 0.09 115.015 -169.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.631 ' O ' ' HA ' ' A' ' 165' ' ' ALA . 14.5 m -85.73 118.0 24.96 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.041 -1.436 . . . . 0.14 108.098 166.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 164' ' ' SER . 43.4 tp -84.49 98.66 10.23 Favored 'General case' 0 N--CA 1.416 -2.128 0 CA-C-O 122.057 0.932 . . . . 0.16 109.386 177.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.682 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 37.7 mt-30 -87.7 108.08 18.94 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.576 -1.193 . . . . 0.34 109.088 -178.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.56 ' HG3' ' HG ' ' A' ' 174' ' ' LEU . 80.9 mtp -105.74 162.42 13.55 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 115.059 -0.973 . . . . 1.09 110.483 -176.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.612 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.7 tt0 -169.74 119.38 0.64 Allowed 'General case' 0 C--O 1.203 -1.39 0 CA-C-O 121.324 0.583 . . . . 0.5 109.792 -170.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.084 HD13 HD11 ' A' ' 187' ' ' ILE . 0.6 OUTLIER -101.2 100.85 11.45 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.542 -0.91 . . . . 0.1 108.542 -172.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.586 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 14.9 ttp -90.47 120.06 31.26 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.764 -0.653 . . . . 0.07 109.448 176.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.544 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.66 117.77 6.73 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.222 -1.399 . . . . 0.22 107.222 169.315 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.609 HG23 ' HA ' ' A' ' 149' ' ' ILE . 0.2 OUTLIER -71.72 -35.71 56.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 CA-C-N 119.162 0.892 . . . . 0.11 111.439 -176.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.437 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 32.5 mt-30 -61.38 -13.62 21.26 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.411 -0.813 . . . . 0.35 111.581 -176.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 34.5 p -130.22 -37.96 1.42 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.176 0.989 . . . . 0.19 110.086 177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.572 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 91.59 16.27 52.79 Favored Glycine 0 N--CA 1.432 -1.569 0 CA-C-N 113.801 -1.545 . . . . 0.18 112.138 -178.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -98.09 156.34 16.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.94 0.4 . . . . 0.73 110.619 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.612 HD12 ' HG2' ' A' ' 177' ' ' GLN . 31.6 mm -88.78 118.74 34.76 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 CA-C-O 121.572 0.701 . . . . 0.14 109.404 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.084 HD11 HD13 ' A' ' 178' ' ' LEU . 1.7 pp -106.49 -29.08 2.72 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.804 -1.089 . . . . 0.13 110.123 -172.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.661 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 80.3 t90 -137.92 153.37 49.52 Favored 'General case' 0 CA--C 1.509 -0.623 0 CA-C-N 115.547 -0.751 . . . . 0.07 110.135 171.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 54.9 p -153.52 164.4 38.29 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 113.379 0.881 . . . . 0.13 113.379 164.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -158.93 -178.49 32.99 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.039 -0.825 . . . . 0.12 111.039 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.725 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 10.3 mtmt -157.86 146.5 19.22 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.446 -1.687 . . . . 1.22 106.446 166.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.672 ' N ' ' HE1' ' A' ' 71' ' ' MET . . . -157.45 128.02 2.04 Favored Glycine 0 C--N 1.284 -2.357 0 CA-C-N 114.677 -1.147 . . . . 0.12 112.064 -177.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.495 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -74.52 116.05 14.75 Favored 'General case' 0 C--N 1.296 -1.723 0 CA-C-O 121.544 0.687 . . . . 0.17 111.343 -173.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.844 HG22 ' HD2' ' A' ' 172' ' ' PRO . 1.9 m -94.1 158.82 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.345 0 CA-C-O 122.618 1.199 . . . . 0.11 110.979 -176.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.729 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -100.89 171.98 7.32 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 112.527 -2.124 . . . . 0.18 108.844 -174.794 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 7.7 tt0 -101.56 131.6 47.65 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 120.121 -0.632 . . . . 0.91 109.376 169.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.525 ' HG2' ' N ' ' A' ' 63' ' ' ASP . 15.2 mm-40 . . . . . 0 C--O 1.248 1.005 0 CA-C-O 118.418 -0.801 . . . . 1.24 110.931 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.673 0 N-CA-C 111.865 -0.494 . . . . 88.61 111.865 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -81.08 74.75 8.07 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.071 0.463 . . . . 87.43 111.706 -175.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.457 ' HB2' ' OE1' ' A' ' 7' ' ' GLN . 31.7 m170 -121.1 82.04 1.87 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.351 -0.386 . . . . 87.16 110.201 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 13.7 tpt -55.95 114.5 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.545 . . . . 85.34 110.803 -178.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.9 p 42.98 31.17 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 122.486 1.136 . . . . 85.05 111.628 -175.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.49 11.42 7.13 Favored Glycine 0 N--CA 1.443 -0.859 0 CA-C-N 115.056 -0.975 . . . . 84.68 111.282 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.457 ' OE1' ' HB2' ' A' ' 3' ' ' HIS . 17.3 mm-40 -68.2 -43.74 77.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.174 -0.513 . . . . 85.57 109.924 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 54.9 73.04 0.43 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.478 -0.783 . . . . 85.04 110.322 -176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 37.0 tt0 -149.72 127.63 5.76 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.38 -0.827 . . . . 82.17 109.554 -178.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 9' ' ' GLU . 13.2 Cg_exo -68.96 -179.84 2.81 Favored 'Trans proline' 0 C--O 1.237 0.457 0 C-N-CA 122.046 1.831 . . . . 81.51 111.976 177.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 68.92 91.01 0.08 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 114.826 -1.079 . . . . 79.56 110.717 -176.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -62.1 146.62 96.05 Favored 'Trans proline' 0 C--O 1.236 0.392 0 C-N-CA 122.464 2.109 . . . . 78.5 112.46 -176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 27.5 m -78.08 145.79 9.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.537 -0.301 . . . . 77.0 110.611 177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 49.52 63.56 2.11 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.453 -0.794 . . . . 75.74 111.04 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -131.69 148.62 52.6 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.002 -0.545 . . . . 73.91 110.371 -178.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.2 t -73.91 135.0 28.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.492 -0.776 . . . . 72.3 110.32 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 34.9 mtmm -89.95 153.91 47.35 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.271 -0.422 . . . . 71.22 110.397 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -75.33 63.73 6.28 Favored 'Trans proline' 0 CA--C 1.533 0.43 0 C-N-CA 122.672 2.248 . . . . 69.67 111.946 177.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.408 ' HB1' ' HG2' ' A' ' 21' ' ' GLU . . . -104.17 112.2 65.39 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 116.114 -0.494 . . . . 67.55 111.146 -177.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.0 52.9 4.46 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.097 2.532 . . . . 66.7 111.847 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' HG2' ' HB1' ' A' ' 19' ' ' ALA . 13.6 mm-40 -75.47 83.83 2.55 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.379 -0.828 . . . . 65.01 111.021 -176.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.41 ' HA ' ' HD3' ' A' ' 23' ' ' PRO . 14.3 pt20 -146.43 128.5 7.68 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 115.648 -0.705 . . . . 63.41 110.162 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 22' ' ' GLN . 88.2 Cg_exo -55.84 142.89 83.23 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.019 2.479 . . . . 61.93 112.45 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -139.18 119.65 13.92 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.285 -0.416 . . . . 59.87 110.995 -177.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -74.58 155.81 87.17 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.982 -0.554 . . . . 58.47 110.266 178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -50.99 -58.75 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.314 2.01 . . . . 57.36 111.361 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -139.32 -162.59 1.35 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.149 -0.478 . . . . 55.51 109.829 171.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.438 ' HB2' ' HD3' ' A' ' 29' ' ' PRO . 26.9 mm-40 -107.61 -49.15 0.1 OUTLIER Pre-proline 0 C--N 1.318 -0.791 0 C-N-CA 120.368 -0.533 . . . . 53.87 111.648 170.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.438 ' HD3' ' HB2' ' A' ' 28' ' ' GLN . 50.6 Cg_exo -56.6 114.12 1.77 Allowed 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.875 1.717 . . . . 52.76 112.033 175.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.403 ' HA ' ' HD3' ' A' ' 31' ' ' PRO . 13.2 m -95.05 126.82 45.14 Favored Pre-proline 0 C--N 1.322 -0.604 0 CA-C-N 115.808 -0.633 . . . . 50.93 110.569 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 30' ' ' VAL . 38.1 Cg_exo -59.88 134.66 58.31 Favored 'Trans proline' 0 C--O 1.234 0.301 0 C-N-CA 122.674 2.249 . . . . 49.21 112.377 -178.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.6 p -134.47 142.83 47.2 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.118 -0.492 . . . . 47.49 110.6 178.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.15 111.4 65.13 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.388 -0.369 . . . . 45.97 110.846 -178.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -58.95 155.85 36.6 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 123.338 2.692 . . . . 45.28 112.426 176.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.6 m -144.32 114.23 7.3 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 115.453 -0.794 . . . . 42.79 110.533 -177.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 60.7 t -111.92 118.0 47.22 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.737 -0.665 . . . . 40.79 110.625 -178.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.34 162.55 40.06 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.474 2.116 . . . . 39.81 112.478 179.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.5 t -98.15 153.94 18.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.134 0.492 . . . . 37.5 110.677 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 15.0 mt -104.74 104.5 46.24 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.795 -0.639 . . . . 35.65 110.696 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -81.97 -179.06 4.5 Favored 'Trans proline' 0 N--CA 1.459 -0.539 0 C-N-CA 122.901 2.401 . . . . 33.72 112.286 178.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.14 127.87 56.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.452 -0.34 . . . . 31.51 110.413 178.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -117.34 89.17 30.62 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.348 -0.387 . . . . 30.13 110.633 -177.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -87.09 164.97 8.56 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.808 2.339 . . . . 29.52 112.585 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -102.48 174.22 23.62 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.811 -0.631 . . . . 26.75 112.106 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -69.21 131.75 22.69 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 123.119 2.546 . . . . 25.08 112.138 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 40.9 mt -74.25 -54.26 15.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.736 -0.665 . . . . 23.9 110.766 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 56.76 83.04 0.1 Allowed 'General case' 0 C--O 1.236 0.354 0 O-C-N 123.823 0.702 . . . . 21.23 111.306 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -81.96 160.75 23.27 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.254 -0.43 . . . . 19.92 110.182 178.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HG3' ' H ' ' A' ' 51' ' ' GLN . 12.6 pt-20 -115.46 169.75 8.93 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 116.079 -0.51 . . . . 16.56 111.054 -176.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -105.32 26.79 8.96 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.959 0.885 . . . . 15.05 110.06 176.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.404 ' H ' ' HG3' ' A' ' 49' ' ' GLU . 2.3 mp0 55.01 -107.13 0.36 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.327 -1.76 . . . . 14.19 111.286 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -142.87 150.84 40.39 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.105 0.479 . . . . 11.38 110.757 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.436 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -128.26 73.07 79.99 Favored Pre-proline 0 C--N 1.317 -0.814 0 CA-C-N 115.513 -0.767 . . . . 8.29 110.5 -179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -95.18 107.18 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.449 2.766 . . . . 6.87 112.221 -179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 52.9 Cg_exo -56.14 -68.37 0.06 OUTLIER 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.889 2.393 . . . . 5.04 111.348 177.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -167.01 92.32 0.72 Allowed Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.838 -0.619 . . . . 2.59 110.104 -179.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -70.21 -178.56 2.57 Favored 'Trans proline' 0 CA--C 1.508 -0.778 0 C-N-CA 123.235 2.624 . . . . 1.64 111.639 178.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -99.65 135.74 40.61 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-N 113.908 -1.496 . . . . 3.39 110.494 -175.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.643 ' HB ' ' HB2' ' A' ' 101' ' ' ASN . 12.4 mt -83.19 168.52 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 CA-C-O 122.124 0.964 . . . . 0.44 111.994 -173.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.602 ' N ' HG22 ' A' ' 59' ' ' ILE . 48.2 mtt-85 -70.95 -157.36 0.03 OUTLIER 'General case' 0 C--N 1.308 -1.228 0 CA-C-N 113.57 -1.65 . . . . 2.34 112.017 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.598 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 18.1 t-160 -155.35 147.71 23.88 Favored 'General case' 0 CA--C 1.473 -2.017 0 CA-C-N 112.486 -2.143 . . . . 2.22 106.858 177.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.774 ' HB3' ' O ' ' A' ' 195' ' ' SER . 4.5 m-30 -125.54 159.27 32.48 Favored 'General case' 0 N--CA 1.418 -2.041 0 CA-C-N 115.351 -0.841 . . . . 0.21 109.936 -175.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.521 ' HB3' ' CB ' ' A' ' 195' ' ' SER . 4.0 t70 -80.97 68.28 7.19 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-O 123.68 1.705 . . . . 0.35 108.125 171.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.731 ' HZ3' HD13 ' A' ' 174' ' ' LEU . 93.5 m95 -57.85 -41.52 82.53 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 111.599 -2.546 . . . . 0.1 111.94 174.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.581 ' ND2' ' HG3' ' A' ' 69' ' ' GLN . 13.0 t-20 -52.98 -27.71 20.4 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 113.99 -1.459 . . . . 1.11 111.496 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.57 -15.2 81.21 Favored Glycine 0 C--N 1.314 -0.655 0 CA-C-N 115.412 -0.813 . . . . 0.21 111.129 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 71' ' ' MET . . . -101.96 -53.64 2.9 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 113.908 -1.146 . . . . 0.13 111.17 -176.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.726 ' SD ' HD23 ' A' ' 109' ' ' LEU . 38.5 mtt -65.27 -57.77 7.62 Favored 'General case' 0 C--O 1.215 -0.748 0 CA-C-N 114.263 -1.335 . . . . 0.09 112.132 -177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.581 ' HG3' ' ND2' ' A' ' 65' ' ' ASN . 5.1 mm-40 -40.25 -55.88 3.8 Favored Pre-proline 0 C--N 1.319 -0.723 0 N-CA-C 114.348 1.24 . . . . 0.63 114.348 -176.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.775 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 38.3 Cg_endo -63.88 -27.3 67.11 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.541 1.494 . . . . 0.14 110.74 -177.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.666 ' HE1' ' O ' ' A' ' 174' ' ' LEU . 12.7 mtm -85.56 -43.2 13.72 Favored 'General case' 0 C--O 1.214 -0.797 0 CA-C-N 115.562 -0.745 . . . . 0.7 112.174 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 68' ' ' MET . 31.5 t -59.0 -37.91 70.63 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.17 0 CA-C-N 115.011 -0.995 . . . . 0.12 108.826 175.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 69' ' ' GLN . 0.9 OUTLIER -57.11 -36.56 70.78 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 113.409 -1.723 . . . . 0.56 110.396 174.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.775 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 30.7 mtpt -80.91 -37.3 29.85 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.087 -0.96 . . . . 1.3 110.49 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.872 ' O ' HG11 ' A' ' 81' ' ' VAL . 2.5 ttp -57.65 -31.61 66.46 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 114.421 -1.263 . . . . 0.5 111.439 -175.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.615 ' HB3' ' HE2' ' A' ' 118' ' ' LYS . 22.5 mt -88.51 -5.31 58.3 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-O 121.917 0.865 . . . . 0.65 111.594 -178.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -107.96 17.4 35.32 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.286 -1.525 . . . . 0.17 109.286 172.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.711 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -89.03 161.76 16.39 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-N 114.807 -0.696 . . . . 0.1 109.733 179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.446 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 9.7 p-10 -89.16 107.73 19.21 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-O 122.362 1.077 . . . . 1.72 111.443 176.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.666 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 137.73 -24.32 3.03 Favored Glycine 0 N--CA 1.423 -2.229 0 CA-C-N 114.268 -1.333 . . . . 0.12 110.45 -178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.872 HG11 ' O ' ' A' ' 75' ' ' MET . 14.9 p -102.83 153.05 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-O 121.526 0.679 . . . . 0.16 111.762 -173.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 5.4 m -134.98 138.82 44.36 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 114.653 -1.158 . . . . 0.45 110.577 178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.59 131.26 50.29 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.757 -0.656 . . . . 0.28 110.182 166.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 109.14 -1.47 31.35 Favored Glycine 0 N--CA 1.443 -0.838 0 C-N-CA 121.026 -0.607 . . . . 0.28 112.593 178.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.89 150.64 23.96 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 120.264 -0.575 . . . . 1.2 111.016 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.65 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.6 p -80.05 113.81 20.0 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.23 0 CA-C-O 122.277 1.037 . . . . 0.2 109.01 164.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.855 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.5 tm? -100.88 107.21 18.67 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.814 -1.085 . . . . 0.14 108.722 -172.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.683 HD23 HG11 ' A' ' 155' ' ' VAL . 0.8 OUTLIER -70.92 97.88 1.5 Allowed 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 114.169 -1.378 . . . . 0.15 108.019 177.713 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.475 HG12 ' CD1' ' A' ' 87' ' ' LEU . 2.2 m -71.37 118.27 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.243 0 N-CA-C 106.888 -1.523 . . . . 0.95 106.888 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.79 ' HB2' HD11 ' A' ' 142' ' ' LEU . 0.8 OUTLIER -77.09 146.32 37.31 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 107.159 -1.422 . . . . 0.64 107.159 178.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.497 ' HA ' ' OG1' ' A' ' 106' ' ' THR . 0.9 OUTLIER -55.36 134.43 50.19 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.448 -1.315 . . . . 0.37 107.448 175.9 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.54 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 22.0 t -61.46 138.4 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.399 -3.011 0 N-CA-C 107.768 -1.197 . . . . 0.1 107.768 170.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.784 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.4 t-20 -84.95 163.02 19.19 Favored 'General case' 0 C--N 1.287 -2.126 0 CA-C-N 115.156 -0.929 . . . . 0.18 109.714 175.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.757 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.1 t-20 -124.88 86.12 2.51 Favored 'General case' 0 C--N 1.287 -2.129 0 CA-C-N 114.524 -1.216 . . . . 0.12 108.185 175.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -106.88 -4.22 19.43 Favored 'General case' 0 CA--C 1.502 -0.896 0 CA-C-N 113.97 -1.468 . . . . 0.64 108.827 -173.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.76 HG21 ' HB3' ' A' ' 172' ' ' PRO . 21.8 p -50.67 -177.84 0.0 OUTLIER 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.516 -1.674 . . . . 0.14 114.318 -176.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 1.4 t30 -70.13 -10.7 59.62 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 113.476 -1.693 . . . . 0.48 110.325 174.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.572 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -140.55 -152.56 5.81 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.668 -0.696 . . . . 0.12 112.564 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.609 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 70.7 m -122.44 129.36 51.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.071 0.462 . . . . 1.16 111.129 -179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.757 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 1.9 pp -132.5 160.1 37.47 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 121.786 0.803 . . . . 0.1 110.551 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.643 ' HB2' ' HB ' ' A' ' 59' ' ' ILE . 1.2 t-20 -82.94 79.85 9.17 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 113.902 -1.499 . . . . 0.17 107.889 176.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.573 ' O ' ' HB3' ' A' ' 105' ' ' ALA . . . -68.28 -14.11 62.75 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 114.483 -1.235 . . . . 0.09 109.958 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . 0.631 ' HB2' ' HG3' ' A' ' 139' ' ' GLN . . . -80.07 -32.23 39.34 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 108.545 -0.909 . . . . 0.15 108.545 -177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.616 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 42.8 tp10 -66.43 -33.71 76.32 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-N 114.325 -1.307 . . . . 1.73 109.05 171.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -71.54 -43.91 65.55 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.113 -1.858 . . . . 0.12 109.509 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.601 ' O ' ' HB2' ' A' ' 109' ' ' LEU . 62.9 m -63.34 -29.73 70.99 Favored 'General case' 0 N--CA 1.429 -1.514 0 CA-C-N 113.808 -1.542 . . . . 0.11 110.417 178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.85 -44.68 76.58 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.119 -1.067 . . . . 1.47 108.119 171.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.683 HG21 ' HB2' ' A' ' 64' ' ' TRP . 73.2 m -62.48 -30.79 71.52 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-N 115.412 -0.813 . . . . 0.12 110.718 178.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.726 HD23 ' SD ' ' A' ' 68' ' ' MET . 9.4 mt -50.99 -68.98 0.12 Allowed 'General case' 0 CA--C 1.495 -1.167 0 N-CA-C 109.326 -0.62 . . . . 0.56 109.326 171.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.555 ' O ' HD13 ' A' ' 121' ' ' LEU . 9.3 mtp180 -40.99 -37.61 0.84 Allowed 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.345 1.028 . . . . 1.51 111.411 175.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.553 ' N ' HD22 ' A' ' 111' ' ' ASN . 0.9 OUTLIER -71.54 -46.12 60.41 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 114.576 -1.193 . . . . 0.28 111.968 -176.365 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.505 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.56 -32.04 63.95 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 122.402 1.096 . . . . 0.09 108.701 179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.694 HD23 ' O ' ' A' ' 109' ' ' LEU . 4.4 mm? -65.79 -33.67 76.4 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 113.498 -1.683 . . . . 0.12 109.88 174.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.49 ' HB2' HD11 ' A' ' 121' ' ' LEU . . . -72.93 -41.49 64.45 Favored 'General case' 0 CA--C 1.5 -0.948 0 CA-C-N 114.636 -1.166 . . . . 0.2 111.06 -176.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -64.21 -27.2 68.9 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 114.895 -1.048 . . . . 1.17 110.332 -178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -81.92 -21.76 37.15 Favored 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 115.466 -0.788 . . . . 2.05 111.01 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 59.78 15.61 34.98 Favored Glycine 0 C--N 1.332 0.361 0 N-CA-C 115.588 0.995 . . . . 0.54 115.588 163.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.615 ' HE2' ' HB3' ' A' ' 76' ' ' LEU . 19.7 mtmt -101.81 -28.62 12.34 Favored 'General case' 0 C--O 1.218 -0.574 0 CA-C-N 117.719 0.76 . . . . 0.99 109.969 174.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.855 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 26.1 m-85 -92.23 173.81 7.63 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 122.152 0.977 . . . . 0.21 112.447 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.606 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 4.7 m -118.4 123.19 44.63 Favored 'General case' 0 N--CA 1.421 -1.885 0 CA-C-N 113.31 -1.768 . . . . 0.23 107.89 169.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.659 ' CD2' ' HB3' ' A' ' 113' ' ' LEU . 0.5 OUTLIER -94.05 139.55 30.82 Favored 'General case' 0 N--CA 1.415 -2.177 0 C-N-CA 119.329 -0.949 . . . . 0.38 111.865 -170.023 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.847 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 1.3 m -93.88 148.54 4.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 107.786 -1.19 . . . . 0.42 107.786 170.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.3 t -101.59 -173.71 2.42 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 119.759 -0.777 . . . . 1.7 110.222 177.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.503 ' O ' ' HB3' ' A' ' 128' ' ' SER . . . -64.69 -26.36 68.34 Favored 'General case' 0 C--N 1.31 -1.146 0 N-CA-C 107.95 -1.13 . . . . 0.55 107.95 173.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.62 ' O ' ' HG3' ' A' ' 129' ' ' MET . 35.0 mt-30 -50.88 -39.07 53.15 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 113.273 -1.785 . . . . 2.04 110.806 179.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.847 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 4.8 mt-30 -99.12 -52.78 3.44 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.141 0.972 . . . . 0.41 110.212 172.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.679 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 35.3 tp -61.7 -63.14 1.36 Allowed 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 113.585 -1.643 . . . . 1.39 113.456 -168.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.655 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 3.5 t -50.67 -47.35 58.82 Favored 'General case' 0 CA--C 1.5 -0.962 0 CA-C-O 123.396 1.57 . . . . 1.05 109.374 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.693 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 16.7 mmt -54.0 -61.82 2.06 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 111.24 -2.709 . . . . 1.64 110.818 175.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.77 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.83 -44.97 7.16 Favored 'General case' 0 CA--C 1.502 -0.873 0 O-C-N 124.124 0.89 . . . . 0.31 112.626 176.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.702 ' NZ ' HD13 ' A' ' 151' ' ' ILE . 0.0 OUTLIER -55.94 -51.5 67.44 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 107.343 -1.354 . . . . 1.53 107.343 -178.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 128' ' ' SER . 38.3 mt-30 -65.15 -41.03 95.11 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 114.672 -1.149 . . . . 0.41 111.173 -178.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.693 ' HG3' ' O ' ' A' ' 129' ' ' MET . 50.2 mt-30 -57.6 -32.56 67.31 Favored 'General case' 0 CA--C 1.489 -1.388 0 CA-C-N 114.628 -1.169 . . . . 0.37 109.574 178.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 130' ' ' ALA . 0.8 OUTLIER -93.96 -27.15 16.51 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 113.911 -1.495 . . . . 0.24 109.719 -177.455 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 151.38 -50.12 0.53 Allowed Glycine 0 CA--C 1.5 -0.904 0 CA-C-O 122.766 1.204 . . . . 0.33 113.428 -178.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.634 HD13 ' O ' ' A' ' 141' ' ' SER . 78.4 mt -66.58 -170.95 0.11 Allowed 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 112.175 -2.012 . . . . 0.31 116.025 -170.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.595 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 4.1 m -116.22 152.86 48.37 Favored Pre-proline 0 N--CA 1.431 -1.415 0 CA-C-N 111.129 -2.759 . . . . 0.81 108.56 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.655 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 18.1 Cg_endo -62.34 -2.0 2.86 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 123.086 2.524 . . . . 0.32 112.993 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.631 ' HG3' ' HB2' ' A' ' 103' ' ' ALA . 0.7 OUTLIER -118.74 -26.85 5.99 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 121.579 0.704 . . . . 1.25 110.746 -177.602 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.595 ' HB2' ' HB2' ' A' ' 137' ' ' SER . 5.3 t70 -63.04 -21.89 66.47 Favored 'General case' 0 CA--C 1.487 -1.466 0 CA-C-N 113.895 -1.502 . . . . 0.65 109.127 -173.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.634 ' O ' HD13 ' A' ' 136' ' ' LEU . 38.1 m 74.4 168.59 0.3 Allowed 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.666 -2.061 . . . . 0.6 110.653 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 90' ' ' ASP . 6.4 mt -64.78 -40.53 95.4 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 122.321 1.058 . . . . 0.86 108.331 -179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 63.7 -12.01 0.16 Allowed Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 112.823 -1.99 . . . . 0.31 114.507 177.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.417 ' H ' ' C ' ' A' ' 142' ' ' LEU . 0.2 OUTLIER -151.32 125.11 9.09 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.073 -0.714 . . . . 0.24 109.073 -174.692 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.657 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 17.3 mmt180 -42.6 -47.33 5.2 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-N 118.047 0.385 . . . . 1.65 111.936 -176.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 47.9 t -71.22 -25.85 62.67 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.664 0.745 . . . . 0.53 111.35 -175.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.406 ' HD3' HD11 ' A' ' 136' ' ' LEU . 27.2 mttm -75.84 -30.75 59.06 Favored 'General case' 0 CA--C 1.511 -0.525 0 CA-C-O 122.766 1.269 . . . . 1.31 108.862 176.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.776 ' HB2' ' OH ' ' A' ' 162' ' ' TYR . . . -72.1 -46.77 55.4 Favored 'General case' 0 CA--C 1.487 -1.479 0 CA-C-N 112.184 -2.28 . . . . 0.12 110.236 176.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.607 HG13 ' HE1' ' A' ' 179' ' ' MET . 37.3 mt -68.07 -41.4 84.32 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.927 0 CA-C-N 112.909 -1.95 . . . . 0.11 110.054 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.42 -54.83 27.82 Favored Glycine 0 N--CA 1.436 -1.332 0 CA-C-N 114.51 -1.223 . . . . 0.15 111.107 170.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.77 HG23 ' CB ' ' A' ' 130' ' ' ALA . 12.4 mt -66.27 -46.6 86.82 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.062 0 N-CA-C 112.693 0.627 . . . . 0.18 112.693 -179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.665 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -57.73 -40.73 80.27 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 118.013 0.37 . . . . 0.13 111.015 -177.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.482 ' HD2' HG23 ' A' ' 149' ' ' ILE . 28.5 mtp-105 -81.49 -22.34 38.09 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.826 0.822 . . . . 1.08 110.346 -179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.508 HD21 ' CD ' ' A' ' 133' ' ' GLN . 12.7 t30 -82.01 -11.64 58.73 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-N 114.274 -1.33 . . . . 0.5 107.449 176.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.7 ' HB ' ' O ' ' A' ' 151' ' ' ILE . 1.2 t -106.91 -29.13 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.185 0 CA-C-N 113.267 -1.788 . . . . 0.17 110.794 -174.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.47 ' O ' HG11 ' A' ' 86' ' ' VAL . . . 99.37 34.92 4.88 Favored Glycine 0 CA--C 1.505 -0.581 0 C-N-CA 120.387 -0.911 . . . . 0.16 112.362 -178.763 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.663 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -109.98 160.57 16.31 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 113.138 0.792 . . . . 0.12 113.138 -169.591 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.65 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.0 OUTLIER -99.78 -28.96 12.89 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.0 -1.0 . . . . 0.2 109.744 179.462 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.672 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 11.6 m-85 -136.65 -175.43 4.01 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.96 -1.018 . . . . 0.13 110.83 -174.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.676 ' O ' HD23 ' A' ' 178' ' ' LEU . 1.0 OUTLIER -135.64 138.59 47.79 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.044 0 CA-C-N 115.062 -0.972 . . . . 0.08 108.562 166.282 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.669 ' O ' ' HB3' ' A' ' 90' ' ' ASP . 33.8 tp -108.26 99.59 8.99 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 119.281 -0.968 . . . . 0.16 109.483 166.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.776 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 2.2 m-85 -79.64 112.54 17.01 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-N 114.784 -1.098 . . . . 0.26 109.322 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.872 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 13.0 t -124.37 158.88 31.63 Favored 'General case' 0 C--N 1.281 -2.41 0 CA-C-O 122.157 0.979 . . . . 1.05 110.239 -177.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.831 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.8 p -160.75 173.47 15.36 Favored 'General case' 0 N--CA 1.417 -2.096 0 CA-C-N 114.166 -1.379 . . . . 0.1 110.564 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -136.88 132.07 34.02 Favored 'General case' 0 N--CA 1.406 -2.631 0 CA-C-N 114.36 -1.291 . . . . 0.11 108.613 178.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.667 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 1.5 m -140.89 -178.01 5.35 Favored 'General case' 0 C--N 1.303 -1.418 0 C-N-CA 120.055 -0.658 . . . . 1.09 109.73 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 95.43 -83.26 0.87 Allowed Glycine 0 N--CA 1.434 -1.462 0 C-N-CA 119.774 -1.203 . . . . 0.15 111.847 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.46 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 43.5 t-20 -140.08 127.18 20.97 Favored 'General case' 0 C--O 1.195 -1.794 0 N-CA-C 106.294 -1.743 . . . . 0.59 106.294 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.572 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.3 p -60.64 -44.52 97.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 CA-C-N 114.861 -1.063 . . . . 0.15 111.65 -178.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.465 ' HA ' HE21 ' A' ' 196' ' ' GLN . 43.2 m-80 -66.9 -24.92 66.15 Favored 'General case' 0 CA--C 1.51 -0.561 0 CA-C-O 121.338 0.59 . . . . 1.26 109.777 -174.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -155.04 88.28 3.21 Favored Pre-proline 0 C--N 1.311 -1.082 0 CA-C-N 114.996 -1.002 . . . . 0.13 108.474 174.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.826 ' HD2' HG22 ' A' ' 194' ' ' VAL . 44.1 Cg_endo -91.01 163.7 3.86 Favored 'Trans proline' 0 CA--C 1.492 -1.576 0 C-N-CA 124.652 3.568 . . . . 0.09 115.253 -170.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.632 HG22 ' HB3' ' A' ' 191' ' ' LYS . 7.7 m -84.83 119.71 25.62 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 113.668 -1.605 . . . . 0.14 107.998 170.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.893 ' O ' ' HA ' ' A' ' 191' ' ' LYS . 21.8 tp -82.59 95.83 7.89 Favored 'General case' 0 CA--C 1.472 -2.043 0 C-N-CA 119.655 -0.818 . . . . 0.16 109.474 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.58 ' HG2' ' HD2' ' A' ' 191' ' ' LYS . 39.1 mt-30 -87.2 106.76 18.12 Favored 'General case' 0 C--N 1.253 -3.609 0 CA-C-O 122.415 1.102 . . . . 0.34 108.663 -176.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.872 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.3 mmm -110.97 162.97 14.3 Favored 'General case' 0 C--N 1.305 -1.357 0 CA-C-N 114.516 -1.22 . . . . 1.09 110.944 -173.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.637 ' HG2' HD12 ' A' ' 186' ' ' ILE . 56.4 tt0 -171.41 118.92 0.46 Allowed 'General case' 0 C--O 1.205 -1.288 0 CA-C-O 121.165 0.507 . . . . 0.5 110.702 -166.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.061 HD13 HD11 ' A' ' 187' ' ' ILE . 0.4 OUTLIER -100.36 100.9 11.76 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.853 -0.795 . . . . 0.1 108.853 -172.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.657 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 15.2 ttp -91.16 120.95 32.52 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.161 -0.927 . . . . 0.07 109.398 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.44 HD12 ' N ' ' A' ' 182' ' ' GLN . 0.1 OUTLIER -58.49 126.76 28.93 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.066 -1.457 . . . . 0.22 107.066 166.38 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.612 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -81.18 -36.2 14.81 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 119.435 -0.906 . . . . 0.11 110.376 178.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.475 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 23.3 mt-30 -61.03 -16.26 41.5 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.093 -0.958 . . . . 0.35 111.529 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 66.9 p -129.04 -37.0 1.73 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 121.769 0.795 . . . . 0.19 110.077 177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.568 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.26 29.37 19.95 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 114.299 -1.319 . . . . 0.18 112.205 -179.346 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -109.73 154.3 23.1 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 120.674 0.273 . . . . 0.73 110.6 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.637 HD12 ' HG2' ' A' ' 177' ' ' GLN . 29.5 mm -86.53 121.4 37.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.923 0 CA-C-O 121.402 0.62 . . . . 0.14 109.365 177.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.061 HD11 HD13 ' A' ' 178' ' ' LEU . 1.4 pp -109.76 -33.06 2.36 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 CA-C-N 115.095 -0.957 . . . . 0.13 110.45 -174.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.711 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . 79.8 t90 -132.14 152.19 51.38 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-N 115.581 -0.736 . . . . 0.07 109.356 172.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 27.0 p -153.79 162.8 40.93 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 113.265 0.839 . . . . 0.13 113.265 164.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -157.69 -175.12 28.26 Favored Glycine 0 N--CA 1.427 -1.932 0 N-CA-C 110.817 -0.913 . . . . 0.12 110.817 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.893 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 9.2 mtmt -158.98 147.94 18.54 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.386 -1.709 . . . . 1.22 106.386 165.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 174' ' ' LEU . . . -156.05 125.89 1.72 Allowed Glycine 0 C--N 1.289 -2.047 0 C-N-CA 118.638 -1.744 . . . . 0.12 114.021 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -71.75 112.59 7.98 Favored 'General case' 0 C--N 1.299 -1.616 0 CA-C-O 121.619 0.723 . . . . 0.17 110.979 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.826 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -90.76 159.28 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 114.545 -1.207 . . . . 0.11 110.269 -176.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.774 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -100.08 174.18 6.29 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 112.801 -2.0 . . . . 0.18 108.825 -173.319 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.53 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -102.16 131.48 48.64 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.492 -0.483 . . . . 0.91 110.532 171.23 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.532 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 17.4 mm-40 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.514 -0.755 . . . . 1.24 110.264 176.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.762 0 N-CA-C 112.088 -0.405 . . . . 88.61 112.088 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.4 t -85.82 -15.48 41.81 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.684 0.278 . . . . 87.43 110.995 -178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -86.13 73.28 10.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 122.196 0.998 . . . . 87.16 111.212 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 59.6 mtt -83.68 -162.38 0.63 Allowed 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.906 -1.043 . . . . 85.34 109.23 174.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.8 p -66.3 -11.19 12.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.254 0.549 . . . . 85.05 110.48 175.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.73 29.09 69.86 Favored Glycine 0 C--N 1.335 0.477 0 CA-C-N 115.869 -0.605 . . . . 84.68 112.39 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.5 tp60 -127.98 110.93 13.0 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.971 0.891 . . . . 85.57 110.978 -176.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 21.7 mmt180 66.05 76.5 0.31 Allowed 'General case' 0 CA--C 1.518 -0.261 0 CA-C-N 113.535 -1.666 . . . . 85.04 112.444 176.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.558 ' CD ' ' H ' ' A' ' 9' ' ' GLU . 0.9 OUTLIER -75.9 146.7 79.74 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-N 115.93 -0.577 . . . . 82.17 110.5 178.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -68.43 113.33 3.09 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.517 2.145 . . . . 81.51 112.072 178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -95.52 113.7 62.34 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 116.378 -0.374 . . . . 79.56 110.968 -178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -91.1 138.47 2.33 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.955 2.436 . . . . 78.5 112.55 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.4 m -133.94 141.14 44.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.029 -0.532 . . . . 77.0 110.352 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -126.82 112.47 15.4 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.863 -0.608 . . . . 75.74 110.522 -174.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -109.36 140.55 42.91 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.849 -0.426 . . . . 73.91 109.849 176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 7.6 p -62.4 111.63 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.818 0.818 . . . . 72.3 111.233 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.545 ' N ' ' HD2' ' A' ' 18' ' ' PRO . 32.8 mmtp -87.85 -46.77 0.47 Allowed Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 115.515 -0.766 . . . . 71.22 111.988 -179.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 17' ' ' LYS . 19.9 Cg_endo -61.78 142.35 93.48 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.837 1.692 . . . . 69.67 111.841 174.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.22 85.97 59.13 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.351 -0.386 . . . . 67.55 110.798 -178.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.88 104.18 1.79 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.828 2.352 . . . . 66.7 112.285 -177.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -72.85 104.3 3.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.064 -0.517 . . . . 65.01 110.738 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.51 ' HB3' ' HD3' ' A' ' 23' ' ' PRO . 30.3 tt0 -69.78 -53.17 12.35 Favored Pre-proline 0 C--N 1.319 -0.744 0 C-N-CA 120.543 -0.463 . . . . 63.41 111.97 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.51 ' HD3' ' HB3' ' A' ' 22' ' ' GLN . 71.6 Cg_exo -56.85 143.54 90.89 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 122.663 2.242 . . . . 61.93 113.366 -175.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -143.12 133.19 24.31 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.702 -0.681 . . . . 59.87 110.286 179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 31.5 mm-40 -89.64 109.8 34.72 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.667 -0.242 . . . . 58.47 110.7 179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.432 ' HB2' HE21 ' A' ' 28' ' ' GLN . 15.2 Cg_endo -91.57 94.73 0.21 Allowed 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.936 2.424 . . . . 57.36 112.505 179.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -69.09 121.53 16.89 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.533 -0.303 . . . . 55.51 110.243 177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . 0.432 HE21 ' HB2' ' A' ' 26' ' ' PRO . 85.7 mm-40 -111.71 98.15 40.07 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.129 -0.487 . . . . 53.87 110.192 -178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -75.38 104.4 1.9 Allowed 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.41 2.074 . . . . 52.76 112.013 -178.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.5 t -85.22 120.17 73.11 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 116.286 -0.416 . . . . 50.93 110.201 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.79 167.25 27.69 Favored 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.587 2.191 . . . . 49.21 112.655 -179.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.473 ' O ' ' HD3' ' A' ' 34' ' ' PRO . 5.8 p -99.59 152.89 19.53 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.013 -0.539 . . . . 47.49 110.073 176.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.413 HG13 ' O ' ' A' ' 33' ' ' VAL . 5.9 p -110.9 95.01 22.0 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-O 121.422 0.63 . . . . 45.97 111.074 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 32' ' ' THR . 50.6 Cg_exo -61.52 174.93 1.85 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.298 2.666 . . . . 45.28 113.12 176.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 t 72.09 141.96 0.06 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.501 -1.227 . . . . 42.79 111.228 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 8.5 m -142.61 124.24 8.65 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.137 -0.938 . . . . 40.79 110.763 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.63 148.46 64.34 Favored 'Trans proline' 0 C--O 1.234 0.309 0 C-N-CA 122.833 2.356 . . . . 39.81 112.252 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 88.4 m -148.13 131.5 16.6 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.727 -0.67 . . . . 37.5 109.94 -178.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 14.8 mt -94.6 112.61 58.51 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.333 -0.394 . . . . 35.65 111.14 -174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -88.11 -177.19 1.81 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.953 2.435 . . . . 33.72 112.459 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 51.2 68.88 0.72 Allowed 'General case' 0 C--O 1.237 0.397 0 O-C-N 123.589 0.555 . . . . 31.51 112.08 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -116.63 87.65 21.95 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 109.379 -0.6 . . . . 30.13 109.379 175.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -89.12 168.18 5.37 Favored 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 122.792 2.328 . . . . 29.52 113.374 -175.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -111.44 -174.68 19.95 Favored Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 110.73 -0.948 . . . . 26.75 110.73 172.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -78.04 130.45 10.34 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 122.333 2.022 . . . . 25.08 111.836 -179.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 22.9 mt -80.17 -57.84 4.56 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.089 -0.505 . . . . 23.9 110.133 -178.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 61.48 84.07 0.14 Allowed 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.69 -0.686 . . . . 21.23 111.159 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -164.63 161.67 21.05 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.669 -0.696 . . . . 19.92 110.299 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -172.57 131.23 0.56 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 114.926 -1.034 . . . . 16.56 109.305 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -122.04 40.34 3.66 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-O 121.589 0.709 . . . . 15.05 109.99 -176.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.9 mp0 -99.64 168.8 9.71 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.386 -0.825 . . . . 14.19 110.674 178.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.9 p 61.46 142.93 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 O-C-N 124.769 1.293 . . . . 11.38 112.114 -172.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.673 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . -144.56 66.23 13.46 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 115.631 -0.713 . . . . 8.29 111.431 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.448 ' HD3' ' N ' ' A' ' 53' ' ' ALA . 60.0 Cg_endo -103.7 81.78 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 123.816 3.011 . . . . 6.87 112.575 176.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.673 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 5.4 Cg_exo -75.01 -40.06 1.01 Allowed 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.427 2.084 . . . . 5.04 111.931 -177.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . 50.05 59.45 16.52 Favored Pre-proline 0 C--O 1.234 0.264 0 O-C-N 123.874 0.734 . . . . 2.59 111.688 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.404 ' HD3' ' HB2' ' A' ' 55' ' ' PRO . 63.6 Cg_endo -77.85 -177.14 3.64 Favored 'Trans proline' 0 N--CA 1.452 -0.968 0 C-N-CA 122.346 2.031 . . . . 1.64 113.283 -176.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 26.3 p-80 -132.75 149.63 52.26 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-N 114.153 -1.385 . . . . 3.39 109.403 178.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 60' ' ' ARG . 12.5 mt -84.06 166.6 2.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.805 0.812 . . . . 0.44 111.92 -174.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.611 ' N ' HG22 ' A' ' 59' ' ' ILE . 31.5 mtt180 -73.17 -157.78 0.05 OUTLIER 'General case' 0 N--CA 1.431 -1.376 0 CA-C-O 123.265 1.507 . . . . 2.34 112.191 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.644 ' C ' ' HD1' ' A' ' 62' ' ' TYR . 18.8 t-160 -159.4 149.04 18.57 Favored 'General case' 0 CA--C 1.475 -1.908 0 CA-C-N 111.914 -2.403 . . . . 2.22 106.129 176.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.745 ' HB3' ' O ' ' A' ' 195' ' ' SER . 3.9 m-30 -125.33 159.3 32.09 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 123.768 0.667 . . . . 0.21 109.638 -176.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' N ' ' HG2' ' A' ' 197' ' ' GLN . 7.3 t70 -81.65 67.32 7.57 Favored 'General case' 0 N--CA 1.438 -1.044 0 CA-C-O 123.795 1.759 . . . . 0.35 107.978 171.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.754 ' CZ3' HG11 ' A' ' 194' ' ' VAL . 92.9 m95 -58.17 -42.15 85.38 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 111.361 -2.654 . . . . 0.1 111.847 173.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.497 ' N ' HG21 ' A' ' 108' ' ' THR . 0.2 OUTLIER -56.35 -27.76 56.9 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 114.138 -1.392 . . . . 1.11 110.285 178.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -82.23 -14.47 76.65 Favored Glycine 0 CA--C 1.498 -1.013 0 N-CA-C 110.816 -0.914 . . . . 0.21 110.816 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.436 ' O ' ' HD2' ' A' ' 70' ' ' PRO . . . -97.38 -54.56 3.11 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 113.966 -1.117 . . . . 0.13 110.32 -177.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' MET . . . . . 0.856 ' HA ' ' SD ' ' A' ' 71' ' ' MET . 40.6 mtt -61.87 -49.65 75.39 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 124.545 1.153 . . . . 0.09 112.454 -176.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.449 ' HG2' ' HB1' ' A' ' 112' ' ' ALA . 5.7 mm-40 -41.39 -55.33 5.44 Favored Pre-proline 0 C--N 1.312 -1.046 0 N-CA-C 115.269 1.581 . . . . 0.63 115.269 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.806 ' O ' ' HG3' ' A' ' 74' ' ' LYS . 35.8 Cg_endo -64.18 -29.22 64.73 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.063 1.842 . . . . 0.14 111.353 -177.354 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' MET . . . . . 0.856 ' SD ' ' HA ' ' A' ' 68' ' ' MET . 0.0 OUTLIER -80.96 -45.15 17.09 Favored 'General case' 0 C--O 1.212 -0.898 0 CA-C-N 114.98 -1.009 . . . . 0.7 110.122 -178.343 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.744 HG23 ' O ' ' A' ' 68' ' ' MET . 61.3 t -56.29 -40.78 68.11 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.099 0 CA-C-N 114.246 -1.343 . . . . 0.12 108.729 174.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -57.15 -35.25 69.31 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 113.075 -1.875 . . . . 0.56 111.189 173.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.806 ' HG3' ' O ' ' A' ' 70' ' ' PRO . 26.8 mtpt -85.96 -33.08 21.22 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.918 0.39 . . . . 1.3 110.981 179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.828 ' O ' HG11 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -63.98 -26.98 68.82 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.618 -0.719 . . . . 0.5 111.477 -170.3 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.583 HD13 ' HB2' ' A' ' 118' ' ' LYS . 3.3 mt -93.1 -7.17 46.28 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.971 0.891 . . . . 0.65 111.387 -178.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -103.27 13.84 55.03 Favored Glycine 0 N--CA 1.439 -1.127 0 N-CA-C 109.143 -1.583 . . . . 0.17 109.143 172.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.598 ' CB ' ' HB2' ' A' ' 188' ' ' TRP . . . -84.11 164.33 19.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 114.428 -0.886 . . . . 0.1 110.348 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -86.39 106.87 17.73 Favored 'General case' 0 C--N 1.305 -1.339 0 CA-C-N 115.324 -0.853 . . . . 1.72 109.844 175.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.655 ' HA3' ' HB ' ' A' ' 187' ' ' ILE . . . 132.92 -21.47 4.17 Favored Glycine 0 N--CA 1.43 -1.714 0 C-N-CA 120.4 -0.905 . . . . 0.12 111.146 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.828 HG11 ' O ' ' A' ' 75' ' ' MET . 12.5 p -103.74 152.56 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.853 0.835 . . . . 0.16 112.243 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 83' ' ' ALA . 25.7 m -136.4 144.43 44.51 Favored 'General case' 0 C--N 1.31 -1.143 0 CA-C-N 114.438 -1.256 . . . . 0.45 110.823 175.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.655 ' HB2' ' CE ' ' A' ' 118' ' ' LYS . . . -61.92 142.68 57.27 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.254 -0.884 . . . . 0.28 110.05 166.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.78 -0.34 69.94 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.847 -0.692 . . . . 0.28 112.568 176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . 0.487 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 63.1 m -94.57 145.83 24.54 Favored 'General case' 0 N--CA 1.442 -0.864 0 C-N-CA 120.552 -0.459 . . . . 1.2 109.977 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.687 HG13 ' N ' ' A' ' 158' ' ' HIS . 1.9 p -76.44 126.67 37.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.685 0.755 . . . . 0.2 109.882 176.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.9 ' HB2' ' CD1' ' A' ' 119' ' ' PHE . 2.0 tm? -113.68 108.24 16.85 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.203 -0.908 . . . . 0.14 109.399 -170.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.753 HD23 HG11 ' A' ' 155' ' ' VAL . 0.9 OUTLIER -73.32 94.51 2.04 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-N 114.39 -1.277 . . . . 0.15 108.868 176.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.536 HG23 HD23 ' A' ' 109' ' ' LEU . 2.0 m -73.12 116.72 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.382 0 N-CA-C 107.718 -1.215 . . . . 0.95 107.718 176.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.743 ' CG ' ' HG ' ' A' ' 142' ' ' LEU . 5.5 t0 -79.06 171.25 15.47 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.517 -0.92 . . . . 0.64 108.517 177.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.624 ' OG ' ' HA ' ' A' ' 141' ' ' SER . 0.1 OUTLIER -59.73 148.38 34.38 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-O 122.544 1.164 . . . . 0.37 108.757 171.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.638 ' O ' ' HB1' ' A' ' 102' ' ' ALA . 24.7 t -73.97 138.25 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.389 -3.498 0 N-CA-C 106.516 -1.661 . . . . 0.1 106.516 162.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.841 ' H ' ' HA ' ' A' ' 164' ' ' SER . 7.3 t-20 -85.23 163.73 18.5 Favored 'General case' 0 C--N 1.287 -2.134 0 CA-C-O 121.744 0.783 . . . . 0.18 110.108 174.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASN . . . . . 0.738 ' ND2' ' HG ' ' A' ' 100' ' ' LEU . 2.3 t-20 -124.82 86.23 2.53 Favored 'General case' 0 C--N 1.293 -1.853 0 CA-C-N 114.633 -1.167 . . . . 0.12 108.384 175.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.413 ' HD2' ' CB ' ' A' ' 164' ' ' SER . 11.3 mtp180 -107.72 -2.93 19.63 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 113.952 -1.476 . . . . 0.64 108.731 -173.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.701 HG21 ' HB3' ' A' ' 172' ' ' PRO . 32.7 p -51.85 -172.18 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.232 -1.804 . . . . 0.14 115.5 -176.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 168' ' ' ASN . 39.8 t30 -70.77 -8.91 55.81 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 112.537 -2.12 . . . . 0.48 110.562 173.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . 0.566 ' HA3' HG11 ' A' ' 169' ' ' VAL . . . -153.26 -145.41 4.14 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.518 -0.849 . . . . 0.12 113.045 -178.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.632 ' HA ' ' OD1' ' A' ' 94' ' ' ASN . 58.1 p -121.43 130.58 53.67 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 112.626 0.602 . . . . 1.16 112.626 -176.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.738 ' HG ' ' ND2' ' A' ' 94' ' ' ASN . 2.1 pp -136.17 153.5 51.24 Favored 'General case' 0 CA--C 1.502 -0.88 0 CA-C-O 121.626 0.727 . . . . 0.1 110.667 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.655 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 1.5 t-20 -76.57 80.11 3.24 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 114.155 -1.384 . . . . 0.17 107.771 175.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.638 ' HB1' ' O ' ' A' ' 92' ' ' VAL . . . -67.52 -15.23 63.55 Favored 'General case' 0 C--N 1.287 -2.143 0 CA-C-N 114.155 -1.384 . . . . 0.09 110.07 179.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ALA . . . . . . . . . . . . . . . -81.07 -30.2 34.8 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.72 -0.845 . . . . 0.15 108.72 -178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.655 ' HB2' ' OD1' ' A' ' 101' ' ' ASN . 9.2 tp10 -66.07 -35.67 81.14 Favored 'General case' 0 N--CA 1.434 -1.241 0 CA-C-N 114.503 -1.226 . . . . 1.73 108.877 170.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 102' ' ' ALA . . . -70.66 -44.98 65.98 Favored 'General case' 0 N--CA 1.426 -1.66 0 CA-C-N 113.251 -1.795 . . . . 0.12 109.232 179.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.59 ' OG1' ' HA ' ' A' ' 91' ' ' SER . 52.1 m -59.75 -32.03 70.2 Favored 'General case' 0 N--CA 1.427 -1.604 0 CA-C-N 113.965 -1.471 . . . . 0.11 110.947 178.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.6 -43.87 71.91 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.476 -0.935 . . . . 1.47 108.476 174.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.664 HG21 ' HB2' ' A' ' 64' ' ' TRP . 56.7 m -62.76 -29.48 70.72 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.328 -0.851 . . . . 0.12 110.54 176.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.728 ' O ' HD23 ' A' ' 113' ' ' LEU . 9.1 tp -56.27 -64.26 0.92 Allowed 'General case' 0 N--CA 1.431 -1.375 0 CA-C-N 114.937 -1.029 . . . . 0.56 109.185 177.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.601 ' O ' HD13 ' A' ' 121' ' ' LEU . 23.4 mtp180 -43.07 -37.38 1.95 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 122.172 0.987 . . . . 1.51 111.114 172.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.641 ' HB2' ' O ' ' A' ' 108' ' ' THR . 0.9 OUTLIER -69.21 -46.9 66.26 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 114.25 -1.341 . . . . 0.28 112.165 -175.584 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.449 ' HB1' ' HG2' ' A' ' 69' ' ' GLN . . . -73.19 -33.67 65.53 Favored 'General case' 0 C--N 1.311 -1.101 0 N-CA-C 108.58 -0.896 . . . . 0.09 108.58 -179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.805 ' HB3' HD22 ' A' ' 121' ' ' LEU . 4.2 mm? -59.21 -38.06 79.0 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 113.725 -1.579 . . . . 0.12 109.685 170.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.508 ' HA ' HD21 ' A' ' 121' ' ' LEU . . . -74.82 -40.68 60.94 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 115.177 -0.919 . . . . 0.2 110.926 -177.22 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -56.47 -36.17 68.77 Favored 'General case' 0 N--CA 1.443 -0.803 0 CA-C-N 114.633 -1.167 . . . . 1.17 110.393 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -72.07 -47.61 50.28 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 113.636 -1.62 . . . . 2.05 109.965 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 86.95 -11.96 63.28 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 114.947 0.739 . . . . 0.54 114.947 172.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.655 ' CE ' ' HB2' ' A' ' 83' ' ' ALA . 53.9 mtpt -69.42 -36.68 76.95 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 118.515 1.157 . . . . 0.99 111.081 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.9 ' CD1' ' HB2' ' A' ' 87' ' ' LEU . 20.6 m-85 -88.35 177.56 6.81 Favored 'General case' 0 CA--C 1.492 -1.252 0 CA-C-O 122.625 1.202 . . . . 0.21 113.412 -176.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.543 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 18.2 m -122.37 106.17 10.83 Favored 'General case' 0 N--CA 1.414 -2.259 0 CA-C-N 112.616 -2.083 . . . . 0.23 108.041 167.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.805 HD22 ' HB3' ' A' ' 113' ' ' LEU . 0.0 OUTLIER -94.42 128.6 41.07 Favored 'General case' 0 N--CA 1.421 -1.879 0 CA-C-N 114.563 -1.199 . . . . 0.38 112.277 -168.5 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.738 ' HB ' ' NE2' ' A' ' 126' ' ' GLN . 0.7 OUTLIER -72.08 153.79 7.74 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-N 114.218 -1.356 . . . . 0.42 108.066 174.101 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . 0.497 ' HB2' ' HG3' ' A' ' 125' ' ' GLN . 1.4 m -101.88 -179.05 3.89 Favored 'General case' 0 N--CA 1.439 -0.98 0 C-N-CA 119.598 -0.841 . . . . 1.7 110.045 176.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 128' ' ' SER . . . -65.77 -29.53 70.05 Favored 'General case' 0 C--N 1.313 -0.995 0 N-CA-C 108.602 -0.888 . . . . 0.55 108.602 177.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.606 ' O ' ' HG3' ' A' ' 129' ' ' MET . 6.1 mt-30 -43.77 -38.96 3.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 113.444 -1.707 . . . . 2.04 111.541 175.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLN . . . . . 0.738 ' NE2' ' HB ' ' A' ' 122' ' ' VAL . 2.2 mt-30 -96.04 -55.42 2.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 122.69 1.233 . . . . 0.41 108.561 172.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.766 HD11 ' HZ1' ' A' ' 131' ' ' LYS . 1.1 tm? -65.63 -58.62 5.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 112.671 -2.059 . . . . 1.39 113.721 -161.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.622 ' CB ' ' HB3' ' A' ' 138' ' ' PRO . 1.4 t -53.4 -38.99 63.92 Favored 'General case' 0 CA--C 1.502 -0.889 0 CA-C-O 123.547 1.642 . . . . 1.05 108.437 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.7 ' O ' ' HG3' ' A' ' 133' ' ' GLN . 41.9 mmm -63.37 -60.31 3.54 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 110.923 -2.853 . . . . 1.64 111.18 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.809 ' CB ' HG23 ' A' ' 151' ' ' ILE . . . -43.45 -44.19 5.72 Favored 'General case' 0 CA--C 1.501 -0.908 0 O-C-N 124.259 0.974 . . . . 0.31 112.166 176.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.766 ' HZ1' HD11 ' A' ' 127' ' ' LEU . 26.3 mttt -52.47 -55.52 21.4 Favored 'General case' 0 C--O 1.209 -1.071 0 C-N-CA 120.065 -0.654 . . . . 1.53 109.589 176.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 136' ' ' LEU . 42.4 mt-30 -61.49 -42.59 99.03 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.894 -1.048 . . . . 0.41 111.469 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 129' ' ' MET . 51.5 mt-30 -57.55 -37.0 72.39 Favored 'General case' 0 CA--C 1.491 -1.291 0 CA-C-N 114.334 -1.303 . . . . 0.37 109.703 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.507 HD23 ' HB2' ' A' ' 133' ' ' GLN . 0.4 OUTLIER -89.31 -31.36 17.86 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.804 -1.544 . . . . 0.24 109.063 -177.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 131' ' ' LYS . . . 159.64 -56.11 0.34 Allowed Glycine 0 N--CA 1.443 -0.861 0 CA-C-O 122.632 1.129 . . . . 0.33 113.921 -179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.483 ' O ' ' HA ' ' A' ' 132' ' ' GLN . 74.3 mt -61.88 -172.62 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.731 0 CA-C-N 112.372 -1.914 . . . . 0.31 116.025 -169.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.54 ' HB2' ' HB2' ' A' ' 140' ' ' ASP . 3.7 m -114.32 151.7 45.32 Favored Pre-proline 0 N--CA 1.428 -1.556 0 CA-C-N 110.846 -2.888 . . . . 0.81 108.581 175.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.642 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 10.2 Cg_endo -57.67 -7.56 3.31 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 123.177 2.585 . . . . 0.32 113.423 179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -116.98 -30.53 5.67 Favored 'General case' 0 CA--C 1.499 -1.008 0 O-C-N 123.709 0.63 . . . . 1.25 109.542 -177.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 141' ' ' SER . 8.7 t70 -50.74 -36.11 34.91 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.506 1.146 . . . . 0.65 108.778 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.624 ' HA ' ' OG ' ' A' ' 91' ' ' SER . 1.9 m 81.07 159.47 0.15 Allowed 'General case' 0 N--CA 1.426 -1.658 0 CA-C-N 110.747 -2.933 . . . . 0.6 111.149 -175.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.854 HD13 ' HA ' ' A' ' 148' ' ' ALA . 7.6 mt -66.27 -38.05 86.9 Favored 'General case' 0 C--N 1.286 -2.189 0 N-CA-C 107.233 -1.395 . . . . 0.86 107.233 -172.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 59.17 0.16 0.68 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 112.545 -2.116 . . . . 0.31 114.856 175.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . 0.426 ' HB ' ' HB2' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -152.31 120.49 6.28 Favored 'General case' 0 CA--C 1.499 -1.007 0 N-CA-C 108.69 -0.855 . . . . 0.24 108.69 -174.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . 0.671 ' HD2' ' SD ' ' A' ' 179' ' ' MET . 14.0 mmt180 -40.97 -48.08 3.12 Favored 'General case' 0 C--O 1.212 -0.874 0 O-C-N 123.691 0.619 . . . . 1.65 110.906 -177.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 34.0 t -69.68 -29.77 67.28 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.23 0.538 . . . . 0.53 111.817 -175.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.426 ' HB2' ' HB ' ' A' ' 144' ' ' THR . 23.9 mttm -72.36 -32.48 66.5 Favored 'General case' 0 CA--C 1.505 -0.769 0 CA-C-O 122.399 1.095 . . . . 1.31 108.611 176.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ALA . . . . . 0.854 ' HA ' HD13 ' A' ' 142' ' ' LEU . . . -74.02 -43.06 59.29 Favored 'General case' 0 CA--C 1.486 -1.509 0 CA-C-N 112.761 -2.018 . . . . 0.12 110.15 178.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.609 HG13 ' HE1' ' A' ' 179' ' ' MET . 40.2 mt -67.66 -42.66 86.71 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.021 0 CA-C-N 113.498 -1.683 . . . . 0.11 110.1 178.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLY . . . . . . . . . . . . . . . -53.42 -51.99 44.08 Favored Glycine 0 N--CA 1.441 -0.992 0 CA-C-N 114.955 -1.02 . . . . 0.15 111.096 172.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ILE . . . . . 0.809 HG23 ' CB ' ' A' ' 130' ' ' ALA . 65.7 mt -68.25 -47.22 79.07 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.983 0 N-CA-C 113.01 0.744 . . . . 0.18 113.01 -178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . 0.678 ' HA ' ' HG ' ' A' ' 88' ' ' LEU . . . -56.24 -39.58 72.78 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.985 0.421 . . . . 0.13 110.816 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . 0.428 ' HD2' HG23 ' A' ' 149' ' ' ILE . 23.6 mtp-105 -82.55 -19.9 37.66 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 121.526 0.679 . . . . 1.08 110.818 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.462 HD21 ' CD ' ' A' ' 133' ' ' GLN . 17.0 t30 -84.57 -11.22 56.46 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 107.344 -1.354 . . . . 0.5 107.344 175.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.753 HG11 HD23 ' A' ' 88' ' ' LEU . 1.2 t -108.08 -29.02 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.383 0 CA-C-N 113.137 -1.847 . . . . 0.17 111.052 -173.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . . . . . . . . . . . 99.48 35.38 4.7 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.283 -0.96 . . . . 0.16 112.485 -179.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.664 ' CB ' ' HB2' ' A' ' 88' ' ' LEU . . . -110.83 156.24 21.42 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 113.249 0.833 . . . . 0.12 113.249 -169.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' HIS . . . . . 0.687 ' N ' HG13 ' A' ' 86' ' ' VAL . 1.6 m80 -96.53 -26.53 15.23 Favored 'General case' 0 CA--C 1.512 -0.516 0 CA-C-N 114.838 -1.074 . . . . 0.2 109.751 177.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . 0.606 ' CE2' ' HA ' ' A' ' 81' ' ' VAL . 15.6 m-85 -135.99 -179.53 5.72 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.218 -0.901 . . . . 0.13 111.064 -173.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.771 HG21 ' HB1' ' A' ' 148' ' ' ALA . 1.1 t -133.06 139.79 48.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 N-CA-C 108.61 -0.885 . . . . 0.08 108.61 166.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.62 HD21 ' HE1' ' A' ' 176' ' ' MET . 46.4 tp -110.54 101.33 10.01 Favored 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 119.407 -0.917 . . . . 0.16 109.244 165.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . 0.639 ' OH ' ' HB2' ' A' ' 148' ' ' ALA . 4.5 m-85 -82.05 112.79 19.44 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.222 -1.354 . . . . 0.26 109.421 176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.874 ' HB2' ' SD ' ' A' ' 176' ' ' MET . 10.3 t -122.81 162.19 22.59 Favored 'General case' 0 C--N 1.289 -2.062 0 CA-C-O 121.768 0.794 . . . . 1.05 110.613 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' SER . . . . . 0.853 ' O ' HD12 ' A' ' 174' ' ' LEU . 1.6 p -162.85 175.09 11.59 Favored 'General case' 0 N--CA 1.424 -1.77 0 CA-C-N 114.522 -1.217 . . . . 0.1 111.101 -177.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 173' ' ' THR . . . -139.32 136.77 35.19 Favored 'General case' 0 N--CA 1.413 -2.317 0 CA-C-N 114.413 -1.267 . . . . 0.11 108.853 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.698 ' HA ' ' HA ' ' A' ' 96' ' ' THR . 3.5 m -144.97 -172.97 3.95 Favored 'General case' 0 N--CA 1.43 -1.465 0 N-CA-C 109.219 -0.66 . . . . 1.09 109.219 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . 93.14 -84.87 1.11 Allowed Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 119.606 -1.283 . . . . 0.15 110.834 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASN . . . . . 0.518 ' HA ' ' HB3' ' A' ' 97' ' ' ASN . 66.1 t30 -143.09 122.86 13.39 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.432 -0.884 . . . . 0.59 109.923 176.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.566 HG11 ' HA3' ' A' ' 98' ' ' GLY . 2.4 p -54.32 -49.73 61.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 112.678 0.622 . . . . 0.15 112.678 -169.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASN . . . . . 0.413 ' N ' HG13 ' A' ' 169' ' ' VAL . 5.5 m-20 -56.83 -31.89 65.21 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-O 121.777 0.798 . . . . 1.26 110.288 -174.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -152.49 87.51 4.15 Favored Pre-proline 0 C--N 1.307 -1.254 0 CA-C-N 114.263 -1.335 . . . . 0.13 108.119 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.813 ' HD2' HG22 ' A' ' 194' ' ' VAL . 48.1 Cg_endo -90.64 165.48 4.17 Favored 'Trans proline' 0 CA--C 1.498 -1.317 0 C-N-CA 124.712 3.608 . . . . 0.09 114.999 -170.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' THR . . . . . 0.651 HG22 ' HB3' ' A' ' 191' ' ' LYS . 28.7 m -81.31 117.91 22.19 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-N 113.745 -1.571 . . . . 0.14 107.098 165.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.853 HD12 ' O ' ' A' ' 164' ' ' SER . 43.1 tp -83.83 100.12 10.76 Favored 'General case' 0 N--CA 1.412 -2.327 0 N-CA-C 108.256 -1.016 . . . . 0.16 108.256 176.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLN . . . . . 0.598 ' HG2' ' HG2' ' A' ' 191' ' ' LYS . 35.5 mt-30 -90.05 109.56 20.61 Favored 'General case' 0 C--N 1.272 -2.794 0 CA-C-O 121.897 0.856 . . . . 0.34 109.152 -177.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' MET . . . . . 0.874 ' SD ' ' HB2' ' A' ' 163' ' ' SER . 1.0 OUTLIER -111.46 163.84 13.6 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 115.233 -0.894 . . . . 1.09 111.356 -174.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLN . . . . . 0.555 ' HG2' HD12 ' A' ' 186' ' ' ILE . 57.8 tt0 -169.65 118.19 0.62 Allowed 'General case' 0 C--O 1.207 -1.171 0 CA-C-O 121.353 0.597 . . . . 0.5 110.12 -165.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 1.07 HD13 HD11 ' A' ' 187' ' ' ILE . 0.7 OUTLIER -101.16 102.29 13.18 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 109.038 -0.727 . . . . 0.1 109.038 -173.069 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . 0.671 ' SD ' ' HD2' ' A' ' 145' ' ' ARG . 12.9 ttp -91.6 117.79 30.04 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.755 -0.657 . . . . 0.07 109.491 176.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.495 ' HB2' HG21 ' A' ' 187' ' ' ILE . 0.2 OUTLIER -62.48 113.0 2.7 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 107.655 -1.239 . . . . 0.22 107.655 170.616 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.59 HG21 ' HB3' ' A' ' 152' ' ' ALA . 0.2 OUTLIER -67.53 -35.76 74.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 CA-C-N 118.989 0.813 . . . . 0.11 111.611 -175.6 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.456 ' H ' ' HG3' ' A' ' 182' ' ' GLN . 31.5 mt-30 -61.3 -12.52 13.92 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.726 -0.67 . . . . 0.35 111.9 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' THR . . . . . . . . . . . . . 43.4 p -130.46 -37.26 1.41 Allowed 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 122.211 1.005 . . . . 0.19 110.333 177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.558 ' CA ' HD11 ' A' ' 149' ' ' ILE . . . 88.91 21.05 44.14 Favored Glycine 0 N--CA 1.428 -1.88 0 CA-C-N 113.528 -1.669 . . . . 0.18 111.596 -176.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -99.62 154.31 18.38 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.906 0.384 . . . . 0.73 110.537 -179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ILE . . . . . 0.555 HD12 ' HG2' ' A' ' 177' ' ' GLN . 32.7 mm -88.8 111.81 23.16 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 109.034 -0.728 . . . . 0.14 109.034 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 1.07 HD11 HD13 ' A' ' 178' ' ' LEU . 1.6 pp -98.49 -31.37 3.66 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 CA-C-N 114.815 -1.084 . . . . 0.13 110.248 -173.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . 0.687 ' CD1' ' HA ' ' A' ' 75' ' ' MET . 82.7 t90 -135.95 152.51 51.05 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 115.164 -0.925 . . . . 0.07 109.914 173.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 177' ' ' GLN . 64.9 p -154.01 162.71 41.01 Favored 'General case' 0 C--N 1.309 -1.159 0 N-CA-C 112.172 0.434 . . . . 0.13 112.172 163.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . -162.15 -177.98 35.64 Favored Glycine 0 N--CA 1.428 -1.864 0 N-CA-C 110.638 -0.985 . . . . 0.12 110.638 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' LYS . . . . . 0.766 ' HA ' ' O ' ' A' ' 174' ' ' LEU . 13.2 mttt -151.78 153.77 34.94 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 106.537 -1.653 . . . . 1.22 106.537 166.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 174' ' ' LEU . . . -159.82 128.22 1.95 Allowed Glycine 0 C--N 1.286 -2.236 0 CA-C-N 114.888 -1.051 . . . . 0.12 111.942 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ALA . . . . . 0.535 ' HA ' ' O ' ' A' ' 172' ' ' PRO . . . -73.2 119.35 17.31 Favored 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.699 0.761 . . . . 0.17 111.286 -174.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.813 HG22 ' HD2' ' A' ' 172' ' ' PRO . 2.0 m -94.42 159.22 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.322 0 CA-C-N 114.682 -1.145 . . . . 0.11 110.708 -176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.745 ' O ' ' HB3' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -99.34 172.84 7.08 Favored 'General case' 0 C--N 1.293 -1.874 0 CA-C-N 112.648 -2.069 . . . . 0.18 109.001 -174.408 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -102.47 130.93 49.42 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.733 -0.387 . . . . 0.91 110.17 171.693 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.544 ' H ' ' HA ' ' A' ' 62' ' ' TYR . 16.1 mm-40 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.408 -0.806 . . . . 1.24 110.391 177.322 . . . . . . . . 1 1 . 1 stop_ save_